PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shi, Z; Li, Z; Li, ZJ; Cheng, K; Du, Y; Fu, H; Khuri, FR				Shi, Z.; Li, Z.; Li, Z. J.; Cheng, K.; Du, Y.; Fu, H.; Khuri, F. R.			Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3	ONCOGENE			English	Article							CHROMOSOME 18Q; MEDIATED DEGRADATION; DEPENDENT REGULATION; COLORECTAL-CANCER; UBIQUITIN LIGASE; OVARIAN-CANCER; S-PHASE; P21; GENE; PHOSPHORYLATION	The cyclin-dependent kinase (CDK) inhibitor 1A, p21/Cip1, is a vital cell cycle regulator, dysregulation of which has been associated with a large number of human malignancies. One critical mechanism that controls p21 function is through its degradation, which allows the activation of its associated cell cycle-promoting kinases, CDK2 and CDK4. Thus delineating how p21 is stabilized and degraded will enhance our understanding of cell growth control and offer a basis for potential therapeutic interventions. Here we report a novel regulatory mechanism that controls the dynamic status of p21 through its interaction with Cdk5 and Abl enzyme substrate 1 (Cables1). Cables1 has a proposed role as a tumor suppressor. We found that upregulation of Cables1 protein was correlated with increased half-life of p21 protein, which was attributed to Cables1/p21 complex formation and supported by their co-localization in the nucleus. Mechanistically, Cables1 interferes with the proteasome (Prosome, Macropain) subunit alpha type 3 (PSMA3) binding to p21 and protects p21 from PSMA3-mediated proteasomal degradation. Moreover, silencing of p21 partially reverses the ability of Cables1 to induce cell death and inhibit cell proliferation. In further support of a potential pathophysiological role of Cables1, the expression level of Cables1 is tightly associated with p21 in both cancer cell lines and human lung cancer patient tumor samples. Together, these results suggest Cables1 as a novel p21 regulator through maintaining p21 stability and support the model that the tumor-suppressive function of Cables1 occurs at least in part through enhancing the tumor-suppressive activity of p21.	[Shi, Z.] Jinan Univ, Coll Life Sci & Technol, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Shi, Z.] Jinan Univ, Coll Life Sci & Technol, Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Shi, Z.; Li, Z.; Li, Z. J.; Cheng, K.; Du, Y.; Fu, H.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Li, Z. J.] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China; [Cheng, K.] Lishui Inst Agr Sci, Chem Biol Ctr, Lishui, Peoples R China; [Du, Y.; Fu, H.; Khuri, F. R.] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA; [Fu, H.; Khuri, F. R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Jinan University; Jinan University; Emory University; Peking University; Emory University; Emory University	Fu, H (corresponding author), Emory Univ, Dept Pharmacol, 5111 Rollins Res Ctr,1510 Clifton Rd, Atlanta, GA 30322 USA.	hfu@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Cheng, Kejun/0000-0002-1936-9129	National Institutes of Health Grant [P01 CA116676]; Georgia Cancer Coalition; Chinese National Natural Science Foundation [31271444, 81201726]; Foundation for Research Cultivation and Innovation of Jinan University [21612407]; Science and Technology Program of Guangzhou [14200010]; Specialized Research Fund for the Doctoral Program of Higher Education [20124401120007]; NATIONAL CANCER INSTITUTE [P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation for Research Cultivation and Innovation of Jinan University; Science and Technology Program of Guangzhou; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the past and present members of the Fu/Khuri laboratory for many stimulating discussions. We also thank Dr Zukerberg LR and Dr Rueda BR (Massachusetts General Hospital) for sharing reagents. This work was supported by the National Institutes of Health Grant P01 CA116676 (to FRK and HF), Georgia Cancer Coalition (to HF and FRK), the Chinese National Natural Science Foundation No. 31271444 and No. 81201726 (to ZS), the Foundation for Research Cultivation and Innovation of Jinan University No. 21612407 (to ZS), the Science and Technology Program of Guangzhou No. 14200010 (to ZS) and the Specialized Research Fund for the Doctoral Program of Higher Education No. 20124401120007 (to ZS).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Arnason T, 2013, CANCER BIOL THER, V14, P672, DOI 10.4161/cbt.25089; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Dong Q, 2003, MODERN PATHOL, V16, P863, DOI 10.1097/01.MP.0000084434.88269.0A; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kirley SD, 2005, CANCER BIOL THER, V4, P654, DOI 10.4161/cbt.4.6.1732; Kirley SD, 2005, CANCER BIOL THER, V4, P861, DOI 10.4161/cbt.4.8.1894; Komiya T, 1997, CLIN CANCER RES, V3, P1831; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Park DY, 2007, AM J PATHOL, V171, P1509, DOI 10.2353/ajpath.2007.070331; Sakamoto H, 2008, CANCER BIOL THER, V7, P180, DOI 10.4161/cbt.7.2.5253; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Tan DF, 2003, HUM PATHOL, V34, P143, DOI 10.1053/hupa.2003.26; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tsuji K, 2002, J BIOL CHEM, V277, P2951, DOI 10.1074/jbc.M108535200; Wang N, 2010, EMBO REP, V11, P633, DOI 10.1038/embor.2010.82; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Wu CL, 2001, CANCER RES, V61, P7325; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhu HY, 2005, J BIOL CHEM, V280, P29282, DOI 10.1074/jbc.M407352200; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3; Zukerberg LR, 2004, CANCER RES, V64, P202, DOI 10.1158/0008-5472.CAN-03-2833	31	39	39	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2538	2545		10.1038/onc.2014.171	http://dx.doi.org/10.1038/onc.2014.171			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24975575	Green Accepted			2022-12-25	WOS:000354190400012
J	Rakhshandehroo, M; Gijzel, SMW; Siersbaek, R; Broekema, MF; de Haar, C; Schipper, HS; Boes, M; Mandrup, S; Kalkhoven, E				Rakhshandehroo, Maryam; Gijzel, Sanne M. W.; Siersbaek, Rasmus; Broekema, Marjoleine F.; de Haar, Colin; Schipper, Henk S.; Boes, Marianne; Mandrup, Susanne; Kalkhoven, Eric			CD1d-mediated Presentation of Endogenous Lipid Antigens by Adipocytes Requires Microsomal Triglyceride Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; ADIPOSE-TISSUE; IMMUNE CELLS; MACROPHAGE POLARIZATION; INSULIN-RESISTANCE; CD1D EXPRESSION; ALPHA-CHAIN; C/EBP-BETA; ACTIVATION	Obesity-induced adipose tissue (AT) dysfunction results in a chronic low-grade inflammation that predisposes to the development of insulin resistance and type 2 diabetes. During the development of obesity, the AT-resident immune cell profile alters to create a pro-inflammatory state. Very recently, CD1d-restricted invariant (i) natural killerT(NKT) cells, a unique subset of lymphocytes that are reactive to so called lipid antigens, were implicated in AT homeostasis. Interestingly, recent data also suggest that human and mouse adipocytes can present such lipid antigens to iNKT cells in a CD1d-dependent fashion, but little is known about the lipid antigen presentation machinery in adipocytes. Here we show that CD1d, as well as the lipid antigen loading machinery genes pro-saposin (Psap), Niemann Pick type C2 (Npc2), alpha-galactosidase (Gla), are up-regulated in early adipogenesis, and are transcriptionally controlled by CCAAT/enhancer-binding protein (C/EBP)-beta and -delta. Moreover, adipocyte-induced Th1 and Th2 cytokine release by iNKT cells also occurred in the absence of exogenous ligands, suggesting the display of endogenous lipid antigen-D1d complexes by 3T3-L1 adipocytes. Furthermore, we identified microsomal triglyceride transfer protein, which we show is also under the transcriptional regulation of C/EBP beta and -delta, as a novel player in the presentation of endogenous lipid antigens by adipocytes. Overall, our findings indicate that adipocytes can function as non-professional lipid antigen presenting cells, which may present an important aspect of adipocyte-immune cell communication in the regulation of whole body energy metabolism and immune homeostasis.	[Rakhshandehroo, Maryam; Gijzel, Sanne M. W.; Broekema, Marjoleine F.; Schipper, Henk S.; Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands; [de Haar, Colin; Schipper, Henk S.; Boes, Marianne] Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 CG Utrecht, Netherlands; [Siersbaek, Rasmus; Mandrup, Susanne] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Southern Denmark	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl	Gijzel, Sanne M.W./P-8184-2015	Boes, Marianne/0000-0003-2590-1692; Siersbaek, Rasmus Damtoft/0000-0002-8481-2182; Schipper, Henk/0000-0003-1997-8060; Mandrup, Susanne/0000-0002-0961-5787; de Haar, Colin/0000-0003-4358-2410	Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW); Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Technology Programme of the Ministry of Economic Affairs; European Foundation for the Study of Diabetes (EFSD)/Lilly research grant	Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW)(Technologiestichting STW); Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Technology Programme of the Ministry of Economic Affairs; European Foundation for the Study of Diabetes (EFSD)/Lilly research grant	This work was supported by the Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW), the Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), the Technology Programme of the Ministry of Economic Affairs, and a European Foundation for the Study of Diabetes (EFSD)/Lilly research grant.	BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Exley M. A., 2010, CURR PROTOC IMMUNOL, V14; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Geng YB, 2005, J IMMUNOL, V175, P1022, DOI 10.4049/jimmunol.175.2.1022; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Powell K, 2007, NATURE, V447, P525, DOI 10.1038/447525a; Rakhshandehroo M, 2013, CELL MOL LIFE SCI, V70, P4711, DOI 10.1007/s00018-013-1414-1; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sikder H, 2009, J IMMUNOL, V183, P1657, DOI 10.4049/jimmunol.0900057; Skold M, 2005, J IMMUNOL, V175, P3584, DOI 10.4049/jimmunol.175.6.3584; Subramanian S, 2013, J LIPID RES, V54, P2831, DOI 10.1194/jlr.M041020; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109	57	24	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22128	22139		10.1074/jbc.M114.551242	http://dx.doi.org/10.1074/jbc.M114.551242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966328	Green Published, hybrid			2022-12-25	WOS:000340593500028
J	Meier, F; Giesert, F; Delic, S; Faus-Kessler, T; Matheus, F; Simeone, A; Holter, SM; Kuhn, R; Weisenhorn, DMV; Wurst, W; Prakash, N				Meier, Florian; Giesert, Florian; Delic, Sabit; Faus-Kessler, Theresa; Matheus, Friederike; Simeone, Antonio; Hoelter, Sabine M.; Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima			FGF/FGFR2 Signaling Regulates the Generation and Correct Positioning of Bergmann Glia Cells in the Developing Mouse Cerebellum	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; SONIC-HEDGEHOG; BINDING-PROTEIN; PURKINJE-CELLS; NEURONAL PROGENITORS; GRANULE NEURONS; MULTIPLE ROLES; RAT CEREBELLUM; NERVOUS-SYSTEM; FGF RECEPTOR-1	The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor receptor 2 (FGFR2)-mediated signaling to cerebellar development in conditional Fgfr2 single mutant mice. We show that during embryonic mouse development, Fgfr2 expression is higher in the anterior cerebellar primordium and excluded from the proliferative ventricular neuroepithelium. Consistent with this finding, conditional Fgfr2 single mutant mice display the most prominent defects in the anterior lobules of the adult cerebellum. In this context, FGFR2-mediated signaling is required for the proper generation of Bergmann glia cells and the correct positioning of these cells within the Purkinje cell layer, and for cell survival in the developing cerebellar primordium. Using cerebellar microexplant cultures treated with an FGFR agonist (FGF9) or antagonist (SU5402), we also show that FGF9/FGFR-mediated signaling inhibits the outward migration of radial glia and Bergmann glia precursors and cells, and might thus act as a positioning cue for these cells. Altogether, our findings reveal the specific functions of the FGFR2-mediated signaling pathway in the generation and positioning of Bergmann glia cells during cerebellar development in the mouse.	[Meier, Florian; Giesert, Florian; Delic, Sabit; Faus-Kessler, Theresa; Matheus, Friederike; Hoelter, Sabine M.; Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Delic, Sabit] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Simeone, Antonio] European Sch Mol Med, Ctr Genet Engn CEINGE Biotecnol Avanzate, Naples, Italy; [Simeone, Antonio] Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Weisenhorn, Daniela M. Vogt] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Munich, Germany; [Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Univ Munich, Adolf Butenandt Inst, Munich Cluster Syst Neurol SyNergy, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Munich	Wurst, W (corresponding author), Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	wurst@helmholtz-muenchen.de; nilima.prakash@helmholtz-muenchen.de	Prakash, Nilima/AAC-9402-2019; Kühn, Ralf/U-1278-2017; Giesert, Florian/AAF-6499-2020; Simeone, Antonio/ABG-5269-2020; Hölter, Sabine M./N-5868-2014	Prakash, Nilima/0000-0002-0568-6262; Kühn, Ralf/0000-0003-1694-9803; Simeone, Antonio/0000-0003-2693-9836; Hölter, Sabine M./0000-0003-4878-5241; Giesert, Florian/0000-0001-6825-8858; Wurst, Wolfgang/0000-0003-4422-7410; Vogt Weisenhorn, Daniela/0000-0002-4566-6506	EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS) [FP7-Health-F4-2010-2421291]; Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Bundesministerium fur Bildung und Forschung in the DiGtoP consortium [FKZ01GS0858]; BMBF in the network 'Neurogenesis from brain and skin cells' [01GN1009C]	EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS); Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Bundesministerium fur Bildung und Forschung in the DiGtoP consortium; BMBF in the network 'Neurogenesis from brain and skin cells'	This work was supported by the EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS (FP7-Health-F4-2010-2421291) and by the Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association. Part of this work was performed within the project framework of the German national genome research funded by the Bundesministerium fur Bildung und Forschung with grant number FKZ01GS0858 in the DiGtoP consortium and the BMBF funded grant 01GN1009C in the network 'Neurogenesis from brain and skin cells'. All responsibilities of this publication are due to the author(s). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1985, J COMP NEUROL, V231, P42, DOI 10.1002/cne.902310105; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bilovocky NA, 2003, J NEUROSCI, V23, P5105; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Brodski C, 2003, J NEUROSCI, V23, P4199; Chou DKH, 2000, J NEUROSCI RES, V59, P188, DOI 10.1002/(SICI)1097-4547(20000115)59:2<188::AID-JNR5>3.0.CO;2-M; Colvin JS, 1999, DEV DYNAM, V216, P72; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Doherty D, 2013, LANCET NEUROL, V12, P381, DOI 10.1016/S1474-4422(13)70024-3; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Hagihara K, 2009, DEV BIOL, V334, P276, DOI 10.1016/j.ydbio.2009.07.029; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Helms AW, 1998, DEVELOPMENT, V125, P919; Kallnik M, 2007, MAMM GENOME, V18, P173, DOI 10.1007/s00335-007-9002-z; Klein RS, 2001, DEVELOPMENT, V128, P1971; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li KR, 2014, J NEUROSCI, V34, P922, DOI 10.1523/JNEUROSCI.3476-13.2014; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Lin YS, 2006, GENESIS, V44, P150, DOI 10.1002/gene.20194; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Peng CG, 2011, J NEUROSCI, V31, P12802, DOI 10.1523/JNEUROSCI.0898-11.2011; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Reeber SL, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00083; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Smith KM, 2012, BRAIN RES, V1460, P12, DOI 10.1016/j.brainres.2012.04.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256; Yuasa S, 1996, ANAT EMBRYOL, V194, P223	61	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101124	10.1371/journal.pone.0101124	http://dx.doi.org/10.1371/journal.pone.0101124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983448	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000339635000055
J	Zeng, W; Rong, MY; Hu, XY; Xiao, W; Qi, FY; Huang, JH; Luo, ZJ				Zeng, Wen; Rong, Mengyao; Hu, Xueyu; Xiao, Wei; Qi, Fengyu; Huang, Jinghui; Luo, Zhuojing			Incorporation of Chitosan Microspheres into Collagen-Chitosan Scaffolds for the Controlled Release of Nerve Growth Factor	PLOS ONE			English	Article							AXONAL REGENERATION; CONTROLLED DELIVERY; CONDUITS; INJURY; EXPRESSION	Background: Artifical nerve scaffold can be used as a promising alternative to autologous nerve grafts to enhance the repair of peripheral nerve defects. However, current nerve scaffolds lack efficient microstructure and neurotrophic support. Methods: Microsphere-Scaffold composite was developed by incorporating chitosan microspheres loaded with nerve growth factor (NGF-CMSs) into collagen-chitosan scaffolds (CCH) with longitudinally oriented microchannels (NGF-CMSs/CCH). The morphological characterizations, in vitro release kinetics study, neurite outgrowth assay, and bioactivity assay were evaluated. After that, a 15-mm-long sciatic nerve gap in rats was bridged by the NGF-CMSs/CCH, CCH physically absorbed NGF (NGF/CCH), CCH or nerve autograft. 16 weeks after implantation, electrophysiology, fluoro-gold retrograde tracing, and nerve morphometry were performed. Results: The NGF-CMSs were evenly distributed throughout the longitudinally oriented microchannels of the scaffold. The NGF-CMSs/CCH was capable of sustained release of bioactive NGF within 28 days as compared with others in vitro. In vivo animal study demonstrated that the outcomes of NGF-CMSs/CCH were better than those of NGF/CCH or CCH. Conclusion: Our findings suggest that incorporation of NGF-CMSs into the CCH may be a promising tool in the repair of peripheral nerve defects.	[Zeng, Wen; Hu, Xueyu; Xiao, Wei; Qi, Fengyu; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Zeng, Wen] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Rong, Mengyao] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Huang, JH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	huangjh@fmmu.edu.cn; zhuojingl@163.com		zeng, wen/0000-0002-5614-5925; Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30770571, 30973052]; National Hi-Tech Research and Development Program of China (863 Program) [2002AA216101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30770571 and No. 30973052) and the National Hi-Tech Research and Development Program of China (863 Program) (No. 2002AA216101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046; Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798; DERBY A, 1993, EXP NEUROL, V119, P176, DOI 10.1006/exnr.1993.1019; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875; Gold BG, 1997, NEUROSCIENCE, V76, P1153, DOI 10.1016/S0306-4522(96)00416-2; He C, 1992, MICROSURG, V13, P141; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; MACKINNON SE, 1985, ANN PLAS SURG, V14, P428, DOI 10.1097/00000637-198505000-00005; Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c; Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642; Niu XF, 2011, ARTIF ORGANS, V35, pE119, DOI 10.1111/j.1525-1594.2011.01274.x; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5; Romero MI, 2000, J NEUROSCI, V20, P4435, DOI 10.1523/JNEUROSCI.20-12-04435.2000; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031; Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005; Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013; Zeng W, 2011, INT J PHARMACEUT, V421, P283, DOI 10.1016/j.ijpharm.2011.10.005	30	48	51	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101300	10.1371/journal.pone.0101300	http://dx.doi.org/10.1371/journal.pone.0101300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983464	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000085
J	Belchamber, K; Hall, DA; Hourani, SMO				Belchamber, Kylie; Hall, David A.; Hourani, Susanna M. O.			Smoking Enhances the Proinflammatory Effects of Nucleotides on Cytokine Release from Human Lung	PLOS ONE			English	Article							EXTRACELLULAR ATP TRIGGERS; INTERFERON-GAMMA; IFN-GAMMA; AIRWAY INFLAMMATION; P2X(7) RECEPTOR; P2 RECEPTORS; VAS-DEFERENS; IMMUNE; CELLS; PATHOGENESIS	Nucleotides have effects on immune cells which are complex but generally proinflammatory, and have been suggested to play a role in smoking-related lung diseases. However, there have been no studies directly measuring functional responses to nucleotides in human lungs taken from smokers. We used fragments of post mortem human lung from smokers and nonsmokers, incubated them with a range of nucleotides (4-1000 mu M) in the presence of lipopolysaccharide (LPS; 10 mu g/ml) for 24 hours and measured cytokines (IL-1 beta, IFN gamma, IL-17, TNF alpha, IL-6, IL-8, IL-2 and IL-10) in the supernatants using multiplex immunoassays. Although the basal cytokine levels in the smokers were generally higher in the smokers than the nonsmokers, there were no significant differences in either the basal release or the LPS-stimulated release of any of the cytokines when lungs from smokers and non-smokers were compared. There were no significant effects of ATP, ADP, AMP, UTP, alpha,beta-methylene-ATP, P-1, P-4-diATP, 2-methylthio-ATP or Bz-ATP on the release of cytokines from the lungs. However, the stable ATP analogue ATP gamma S increased the release of IL-1 beta and IFN gamma, and the effect was greatly increased in lungs from smokers. In non-smokers but not in smokers ATP gamma S increased the release of IL-17. Overall these results clearly demonstrate for the first time that in normal human lung a stable ATP analogue can enhance LPS-induced pro-inflammatory cytokine release, and that these effects are greatly altered by a prior history of smoking. This provides strong support for the suggestion that nucleotides are involved in the pathogenesis of smoking-related diseases.	[Belchamber, Kylie; Hourani, Susanna M. O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Hall, David A.] GlaxoSmithKline, Fibrosis Discovery Performance Unit, Stevenage, Herts, England	University of Surrey; GlaxoSmithKline	Hall, DA (corresponding author), GlaxoSmithKline, Fibrosis Discovery Performance Unit, Stevenage, Herts, England.	david.a.hall@gsk.com		Hall, David/0000-0002-3350-5705; Belchamber, Kylie/0000-0003-3241-258X	BBSRC; GlaxoSmithKline (BBSRC) [BB/G529716/1]; CASE Studentship, GSK	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (BBSRC); CASE Studentship, GSK	This project was funded by a BBSRC Industrial CASE studentship in collaboration with GlaxoSmithKline (BBSRC Research Industrial Partnership Grant BB/G529716/1). In addition to funding supplied under the terms of the CASE Studentship, GSK provided support in the form of salaries for author DAH, but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; BAILEY SJ, 1995, BRIT J PHARMACOL, V114, P1125, DOI 10.1111/j.1476-5381.1995.tb13324.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; EDEN E, 1986, AM REV RESPIR DIS, V133, P455; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Esther CR, 2011, CHEST, V140, P954, DOI 10.1378/chest.10-2471; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gabel CA, 2007, PURINERG SIGNAL, V3, P27, DOI 10.1007/s11302-006-9034-y; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HOLT PG, 1986, CLIN EXP IMMUNOL, V66, P188; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jacobson KA, 2002, J MED CHEM, V45, P4057, DOI 10.1021/jm020046y; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; King BF, 2008, J PHARMACOL EXP THER, V324, P1055, DOI 10.1124/jpet.107.131169; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Manthei DM, 2012, J ALLERGY CLIN IMMUN, V130, P496, DOI 10.1016/j.jaci.2012.05.040; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mortaz E, 2010, EUR J PHARMACOL, V638, P1, DOI 10.1016/j.ejphar.2010.04.019; Mortaz E, 2009, EUR J PHARMACOL, V619, P92, DOI 10.1016/j.ejphar.2009.07.022; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Pearl-Yafe M, 2007, SHOCK, V27, P226, DOI 10.1097/01.shk.0000239765.80033.37; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shan M, 2012, SCI TRANSL MED, V4; SONE S, 1994, EUR RESPIR J, V7, P657, DOI 10.1183/09031936.94.07040657; Thorne GR, 2012, BIOMED PHARMACOTHER, V66, P206; Thorne GR, 2009, INHAL TOXICOL, V21, P906; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; WELFORD LA, 1987, EUR J PHARMACOL, V141, P123, DOI 10.1016/0014-2999(87)90418-3; WELFORD LA, 1986, EUR J PHARMACOL, V129, P217, DOI 10.1016/0014-2999(86)90431-0; Westfall TD, 1996, BRIT J PHARMACOL, V117, P867, DOI 10.1111/j.1476-5381.1996.tb15273.x; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99711	10.1371/journal.pone.0099711	http://dx.doi.org/10.1371/journal.pone.0099711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978193	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400008
J	Zhang, P; Xi, M; Zhao, L; Li, QQ; He, LR; Liu, SL; Shen, JX; Liu, MZ				Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong			Unilateral Cervical Nodal Metastasis Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Patients Undergoing Chemoradiotherapy: A Retrospective Study	PLOS ONE			English	Article							TUMOR LENGTH; CANCER; SURVIVAL; PATTERN	Purpose: To determine the prognostic significance of unilateral cervical lymph nodal metastasis (CLNM) in patients with inoperable thoracic esophageal squamous cell carcinoma (SCC) and to identify significant prognostic factors in these patients. Patients and methods: This retrospective study involved 395 patients with inoperable esophageal SCC treated with concurrent chemoradiotherapy. The patients were classified into three groups according to their cervical lymph node status: group A, no evidence of CLNM; group B, unilateral CLNM; group C, other distant metastases. Overall survival (OS) and progression-free survival (PFS) were calculated. Significant prognostic factors were identified using univariate and multivariate analyses. Results: The 3-year OS rates in groups A, B and C were 46.7%, 33.5% and 8.3%, respectively (p<0.001, log-rank test). The corresponding PFS rates were 40.7%, 26.4% and 4.7% (p<0.001, log-rank test). Group B had a similar prognosis to that of group A and better 3-year OS (p = 0.009) and PFS (p = 0.006) rates than those of group C. Multivariate analysis demonstrated that T stage, chemotherapy regimen and cervical lymph node involvement were independent prognostic factors affecting OS and PFS. Conclusions: Compared to other distant metastases, unilateral CLNM is associated with longer OS in esophageal SCC and should be regarded as a regional disease. Sex, T stage, concurrent chemotherapy modality and cervical lymph node involvement are independent predictors of survival in esophageal SCC.	[Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Jingxian] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Liu, MZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	liumengzhong@126.com			Natural Science Foundation of China [81272487]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (No. 81272487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CHIN J RAD ONCOL, V19, P179, DOI DOI 10.3760/CMA.J.ISSN.1004-4221.2010.03.001; Chen JQ, 2009, EUR J CARDIO-THORAC, V36, P480, DOI 10.1016/j.ejcts.2009.03.056; Chen LQ, 2008, CHIN J CLIN THORAC C, V15, P52; Christie NA, 1999, J THORAC CARDIOV SUR, V118, P900, DOI 10.1016/S0022-5223(99)70060-7; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Heo M, 2013, INT J STAT MED RES, V2, P104; Huang W, 2010, RADIOTHER ONCOL, V95, P229, DOI 10.1016/j.radonc.2010.01.006; Isono K, 2004, ESOPHAGUS, V1, P61; Kato H, 2000, J SURG ONCOL, V74, P282, DOI 10.1002/1096-9098(200008)74:4<282::AID-JSO8>3.0.CO;2-R; Kim K, 2001, ANN THORAC SURG, V71, P290, DOI 10.1016/S0003-4975(00)02221-9; Li HC, 2007, EUR SURG RES, V39, P1, DOI 10.1159/000096925; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; Li WF, 2013, INT J RADIAT ONCOL, V86, P249, DOI 10.1016/j.ijrobp.2012.09.003; Liu H, 2011, RADIOTHER ONCOL, V99, P181, DOI 10.1016/j.radonc.2011.05.011; Micheli A, 1998, EUR J CANCER, V34, P2271, DOI 10.1016/S0959-8049(98)00324-4; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Nomura M, 2012, INT J RADIAT ONCOL, V82, P946, DOI 10.1016/j.ijrobp.2010.12.045; Prenzel KL, 2010, ANN THORAC SURG, V90, P1662, DOI 10.1016/j.athoracsur.2010.07.008; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Shimada H, 2007, HEPATO-GASTROENTEROL, V54, P100; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tong DKH, 2008, J GASTROINTEST SURG, V12, P1638, DOI 10.1007/s11605-008-0654-0; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Yendamuri S, 2009, CANCER-AM CANCER SOC, V115, P508, DOI 10.1002/cncr.24062	25	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101332	10.1371/journal.pone.0101332	http://dx.doi.org/10.1371/journal.pone.0101332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979040	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400119
J	Dai, L; Defee, MR; Cao, YY; Wen, JL; Wen, XF; Noverr, MC; Qin, ZQ				Dai, Lu; Defee, Michael R.; Cao, Yueyu; Wen, Jiling; Wen, Xiaofei; Noverr, Mairi C.; Qin, Zhiqiang			Lipoteichoic Acid (LTA) and Lipopolysaccharides (LPS) from Periodontal Pathogenic Bacteria Facilitate Oncogenic Herpesvirus Infection within Primary Oral Cells	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RESISTANT STAPHYLOCOCCUS-AUREUS; KAPPA-B ACTIVATION; DE-NOVO INFECTION; KAPOSIS-SARCOMA; PORPHYROMONAS-GINGIVALIS; HEPARAN-SULFATE; REACTIVE OXYGEN	Kaposi's sarcoma (KS) remains the most common tumor arising in patients with HIV/AIDS, and involvement of the oral cavity represents one of the most common clinical manifestations of this tumor. HIV infection incurs an increased risk for periodontal diseases and oral carriage of a variety of bacteria. Whether interactions involving pathogenic bacteria and oncogenic viruses in the local environment facilitate replication or maintenance of these viruses in the oral cavity remains unknown. In the current study, our data indicate that pretreatment of primary human oral fibroblasts with two prototypical pathogen-associated molecular patterns (PAMPs) produced by oral pathogenic bacteria-lipoteichoic acid (LTA) and lipopolysaccharide (LPS), increase KSHV entry and subsequent viral latent gene expression during de novo infection. Further experiments demonstrate that the underlying mechanisms induced by LTA and/or LPS include upregulation of cellular receptor, increasing production of reactive oxygen species (ROS), and activating intracellular signaling pathways such as MAPK and NF-kappa B, and all of which are closely associated with KSHV entry or gene expression within oral cells. Based on these findings, we hope to provide the framework of developing novel targeted approaches for treatment and prevention of oral KSHV infection and KS development in high-risk HIV-positive patients.	[Dai, Lu; Cao, Yueyu; Qin, Zhiqiang] Tongji Univ, East Hosp, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Dai, Lu; Cao, Yueyu; Qin, Zhiqiang] Tongji Univ, East Hosp, Sch Med, Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Microbiol Immunol Parasitol, New Orleans, LA USA; [Dai, Lu] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Med, New Orleans, LA USA; [Defee, Michael R.] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Noverr, Mairi C.] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA USA; [Wen, Jiling; Wen, Xiaofei] Tongji Univ, East Hosp, Sch Med, Dept Urol, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University	Qin, ZQ (corresponding author), Tongji Univ, East Hosp, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China.	zqin@lsuhsc.edu		Noverr, Mairi/0000-0002-8812-1450	Center for Biomedical Research Excellence Award [P20-RR021970]; SOM Research Enhancement Funding [5497400038]; Ladies Leukemia League Grant; National Natural Science Foundation of China [81272191]; NNSF for Young Scientists of China [81101791]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER	Center for Biomedical Research Excellence Award; SOM Research Enhancement Funding; Ladies Leukemia League Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NNSF for Young Scientists of China; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from a Center for Biomedical Research Excellence Award (P20-RR021970 to ZQ), the SOM Research Enhancement Funding (5497400038 to ZQ), the Ladies Leukemia League Grant (2014-2015 to ZQ), the National Natural Science Foundation of China (81272191 to ZQ), and the NNSF for Young Scientists of China (81101791 to ZQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; [Anonymous], J PERIODONTAL RES; [Anonymous], CLIN ORAL INVESTIG; [Anonymous], ACTA ODONTOL SCAND; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; BEAZLEY VCC, 1980, SCAND J DENT RES, V88, P193; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bottero V, 2013, J VIROL, V87, P1733, DOI 10.1128/JVI.02958-12; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Cassai E, 2003, J CLIN PERIODONTOL, V30, P184, DOI 10.1034/j.1600-051X.2003.00220.x; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cole J, 2013, CURR HIV-AIDS REP, V10, P244, DOI 10.1007/s11904-013-0161-0; Dai L, 2012, CANCER LETT, V318, P214, DOI 10.1016/j.canlet.2011.12.019; Defee MR, 2011, AM J CANCER RES, V1, P687; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Flaitz CM, 1997, ORAL SURG ORAL MED O, V83, P259, DOI 10.1016/S1079-2104(97)90014-7; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gorsky M, 2000, ORAL SURG ORAL MED O, V90, P612, DOI 10.1067/moe.2000.109518; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Groome MJ, 2012, PAEDIATR INT CHILD H, V32, P140, DOI 10.1179/1465328111Y.0000000044; Guo SJ, 2000, J CLIN PERIODONTOL, V27, P769, DOI 10.1034/j.1600-051x.2000.027010769.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kim H, 2014, INFLAMM RES, V63, P419, DOI 10.1007/s00011-014-0714-8; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lager I, 2003, ORAL SURG ORAL MED O, V96, P701, DOI 10.1016/S1079-2104(03)00370-6; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Lee JK, 2009, J ENDODONT, V35, P212, DOI 10.1016/j.joen.2008.10.018; Lee JM, 2012, PPAR RES, V2012, DOI 10.1155/2012/687570; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Ma Q, 2013, ANTIOXID REDOX SIGN, V18, P80, DOI 10.1089/ars.2012.4584; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Mutig N, 2013, MOL IMMUNOL, V56, P720, DOI 10.1016/j.molimm.2013.07.007; Nakou M, 1997, ANAEROBE, V3, P97, DOI 10.1006/anae.1997.0081; Nogueira G, 2014, J PERIODONTOL, V85, pE18, DOI 10.1902/jop.2013.120735; Offermann MK, 1996, TRENDS MICROBIOL, V4, P419, DOI 10.1016/0966-842X(96)84953-5; Osmond DH, 2002, JAMA-J AM MED ASSOC, V287, P221, DOI 10.1001/jama.287.2.221; Pak F, 2005, J CUTAN PATHOL, V32, P21, DOI 10.1111/j.0303-6987.2005.00256.x; Paramonov N, 2001, EUR J BIOCHEM, V268, P4698, DOI 10.1046/j.1432-1327.2001.02397.x; Paramonov NA, 2009, J BACTERIOL, V191, P5272, DOI 10.1128/JB.00019-09; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Phiri Reality, 2010, J Int Acad Periodontol, V12, P98; Qin ZQ, 2013, J VIROL, V87, P621, DOI 10.1128/JVI.01441-12; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Ramirez-Amador V, 2009, J ORAL PATHOL MED, V38, P328, DOI 10.1111/j.1600-0714.2008.00740.x; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Reddi HV, 2004, J VIROL, V78, P8909, DOI 10.1128/JVI.78.16.8909-8916.2004; Rohrmus B, 2000, LANCET, V356, P2160, DOI 10.1016/S0140-6736(00)03503-0; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Saygun I, 2005, J PERIODONTAL RES, V40, P187, DOI 10.1111/j.1600-0765.2005.00790.x; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Seaberg EC, 2010, CANCER-AM CANCER SOC, V116, P5507, DOI 10.1002/cncr.25530; Shadyab AH, 2012, HIV MED, V13, P319, DOI 10.1111/j.1468-1293.2011.00978.x; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Siqueira Jr José F., 2007, Braz. Dent. J., V18, P267, DOI 10.1590/S0103-64402007000400001; Slots Jorgen, 2011, J Calif Dent Assoc, V39, P393; Slots J, 2010, PERIODONTOL 2000, V53, P89, DOI 10.1111/j.1600-0757.2009.00325.x; Vanni T, 2006, CANCER TREAT REV, V32, P445, DOI 10.1016/j.ctrv.2006.06.001; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; Yu XL, 2014, J VIROL, V88, P4466, DOI 10.1128/JVI.03326-13; ZAMBON JJ, 1990, J PERIODONTOL, V61, P699, DOI 10.1902/jop.1990.61.11.699; Zeymn A, 2007, ADV EXP MED BIOL, V598, P342	79	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101326	10.1371/journal.pone.0101326	http://dx.doi.org/10.1371/journal.pone.0101326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971655	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200113
J	Sakurai, MA; Ozaki, Y; Okuzaki, D; Naito, Y; Sasakura, T; Okamoto, A; Tabara, H; Inoue, T; Hagiyama, M; Ito, A; Yabuta, N; Nojima, H				Sakurai, Minami A.; Ozaki, Yuki; Okuzaki, Daisuke; Naito, Yoko; Sasakura, Towa; Okamoto, Ayumi; Tabara, Hiroe; Inoue, Takao; Hagiyama, Man; Ito, Akihiko; Yabuta, Norikazu; Nojima, Hiroshi			Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630	PLOS ONE			English	Article							ANDROGEN RECEPTOR; MUTATION ANALYSIS; CELLULAR TARGETS; TYROSINE KINASE; LUNG-CANCER; THERAPY; OSTEOSARCOMA; TRAFFICKING; EXPRESSION; REGULATOR	Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate cancer patients. Embryonic fibroblasts from knockout mice expressing a kinase-dead (KD) form of GAK showed constitutive hyper-phosphorylation of the epidermal growth factor receptor (EGFR). In addition to the well-known EGFR inhibitors gefitinib and erlotinib, the dietary flavonoid luteolin was a potent inhibitor of the Ser/Thr kinase activity of GAK in vitro. Co-administration of luteolin and gefitinib to PC-3 cells had a greater effect on cell viability than administration of either compound alone; this decrease in viability was associated with drastic down-regulation of GAK protein expression. A comprehensive microRNA array analysis revealed increased expression of miR-630 and miR-5703 following treatment of PC-3 cells with luteolin and/or gefitinib, and exogenous overexpression of miR-630 caused growth arrest of these cells. GAK appears to be essential for cell death because co-administration of gefitinib and luteolin to EGFR-deficient U2OS osteosarcoma cells also had a greater effect on cell viability than administration of either compound alone. Taken together, these findings suggest that GAK may be a new therapeutic target for prostate cancer and osteosarcoma.	[Sakurai, Minami A.; Ozaki, Yuki; Okuzaki, Daisuke; Naito, Yoko; Sasakura, Towa; Okamoto, Ayumi; Tabara, Hiroe; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Suita, Osaka, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka, Japan; [Inoue, Takao; Hagiyama, Man; Ito, Akihiko] Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan	Osaka University; Osaka University; Kindai University (Kinki University)	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Suita, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science and Technology of Japan [15101006, 20370081, 23370086, 21651085, 22570185]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081 and 23370086), and Exploratory Research (No. 21651085) to HN; and Scientific Research C (No. 22570185) to NY from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehmer D, 2005, CANCER RES, V65, P379; Chowdhury AR, 2002, BIOCHEM J, V366, P653, DOI 10.1042/BJ20020098; Cimino S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/632959; D'Arcangelo M, 2013, EXPERT REV ANTICANC, V13, P523, DOI [10.1586/era.13.23, 10.1586/ERA.13.23]; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Joensuu G, 2010, INT J RADIAT ONCOL, V78, P42, DOI 10.1016/j.ijrobp.2009.07.1731; Kai L, 2011, ANTICANCER RES, V31, P3323; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Markaverich BM, 2010, J STEROID BIOCHEM, V122, P219, DOI 10.1016/j.jsbmb.2010.06.006; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Naito Y, 2012, CELL CYCLE, V11, P604, DOI 10.4161/cc.11.3.19114; Olszewski MB, 2014, TRAFFIC, V15, P60, DOI 10.1111/tra.12132; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Ray MR, 2006, INT J CANCER, V118, P1108, DOI 10.1002/ijc.21469; Roengvoraphoj M, 2013, CANCER TREAT REV, V39, P839, DOI 10.1016/j.ctrv.2013.05.001; Russo P, 2012, CURR MED CHEM, V19, P5287, DOI 10.2174/092986712803833272; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Susa M, 2010, MOL CANCER THER, V9, P3342, DOI 10.1158/1535-7163.MCT-10-0637; Tabara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026034; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Trojan L, 2005, ANTICANCER RES, V25, P551; Vulky J, 2009, CANCER, V115, P784, DOI 10.1002/cncr.24092; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101	35	56	58	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100124	10.1371/journal.pone.0100124	http://dx.doi.org/10.1371/journal.pone.0100124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971999	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200020
J	Sirvent, P; Douillard, A; Galbes, O; Ramonatxo, C; Py, G; Candau, R; Lacampagne, A				Sirvent, Pascal; Douillard, Aymerick; Galbes, Olivier; Ramonatxo, Christelle; Py, Guillaume; Candau, Robin; Lacampagne, Alain			Effects of Chronic Administration of Clenbuterol on Contractile Properties and Calcium Homeostasis in Rat Extensor Digitorum Longus Muscle	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM FUNCTION; CA2+ RELEASE CHANNELS; SKELETAL-MUSCLE; RYANODINE RECEPTOR; SOLEUS MUSCLE; EXERCISE PERFORMANCE; CARDIAC-MUSCLE; HEART-FAILURE; MDX MICE; FIBERS	Clenbuterol, a beta 2-agonist, induces skeletal muscle hypertrophy and a shift from slow-oxidative to fast-glycolytic muscle fiber type profile. However, the cellular mechanisms of the effects of chronic clenbuterol administration on skeletal muscle are not completely understood. As the intracellular Ca2+ concentration must be finely regulated in many cellular processes, the aim of this study was to investigate the effects of chronic clenbuterol treatment on force, fatigue, intracellular calcium (Ca2+) homeostasis and Ca2+-dependent proteolysis in fast-twitch skeletal muscles (the extensor digitorum longus, EDL, muscle), as they are more sensitive to clenbuterol-induced hypertrophy. Male Wistar rats were chronically treated with 4 mg.kg(-1) clenbuterol or saline vehicle (controls) for 21 days. Confocal microscopy was used to evaluate sarcoplasmic reticulum Ca2+ load, Ca2+-transient amplitude and Ca2+ spark properties. EDL muscles from clenbuterol-treated animals displayed hypertrophy, a shift from slow to fast fiber type profile and increased absolute force, while the relative force remained unchanged and resistance to fatigue decreased compared to control muscles from rats treated with saline vehicle. Compared to control animals, clenbuterol treatment decreased Ca2+-transient amplitude, Ca2+ spark amplitude and frequency and the sarcoplasmic reticulum Ca2+ load was markedly reduced. Conversely, calpain activity was increased by clenbuterol chronic treatment. These results indicate that chronic treatment with clenbuterol impairs Ca2+ homeostasis and this could contribute to the remodeling and functional impairment of fast-twitch skeletal muscle.	[Sirvent, Pascal] Blaise Pascal Univ, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-80026 Aubiere, France; [Sirvent, Pascal; Galbes, Olivier; Ramonatxo, Christelle; Lacampagne, Alain] Univ Montpellier 2, Univ Montpellier 1, INSERM, U1046, F-34295 Montpellier, France; [Sirvent, Pascal; Galbes, Olivier; Ramonatxo, Christelle; Lacampagne, Alain] CHRU Montpellier, F-34295 Montpellier, France; [Sirvent, Pascal; Douillard, Aymerick; Galbes, Olivier; Ramonatxo, Christelle; Py, Guillaume; Candau, Robin] Univ Montpellier, Natl Inst Agron Res INRA, UMR Muscular Dynam & Metab 866, F-34059 Montpellier, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; INRAE; Universite de Montpellier	Sirvent, P (corresponding author), Blaise Pascal Univ, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-80026 Aubiere, France.	Pascal.sirvent@univ-bpclermont.fr	Lacampagne, Alain/S-3719-2016; Ramonatxo, Christelle/B-2929-2017	Lacampagne, Alain/0000-0003-0264-1787; Ramonatxo, Christelle/0000-0001-6112-0864; candau, robin/0000-0002-5930-8750	World Anti Doping Agency; French Ministry of youth and sports; Fondation of Francaise des Jeux; Ministere de la Recherche et de la Technologie	World Anti Doping Agency; French Ministry of youth and sports; Fondation of Francaise des Jeux; Ministere de la Recherche et de la Technologie	This work was supported by World Anti Doping Agency (http://www.wada-ama.org/en/), French Ministry of youth and sports (http://www.sports.gouv.fr/), Fondation of Francaise des Jeux (http://www.groupefdj.com/fr). Drs Olivier Galbes and A Douillard held a graduate fellowship from the Ministere de la Recherche et de la Technologie (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1718, DOI 10.1152/ajpcell.1998.274.6.C1718; BARDSLEY RG, 1992, BIOCHIMIE, V74, P267, DOI 10.1016/0300-9084(92)90125-X; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Burniston JG, 2007, MUSCLE NERVE, V35, P217, DOI 10.1002/mus.20684; Burniston JG, 2005, J APPL PHYSIOL, V98, P1379, DOI 10.1152/japplphysiol.00642.2004; Burniston JG, 2002, J APPL PHYSIOL, V93, P1824, DOI 10.1152/japplphysiol.00139.2002; Cancelliero KM, 2008, BRAZ J MED BIOL RES, V41, P1054, DOI 10.1590/S0100-879X2008001200003; Castle A, 2001, LIFE SCI, V69, P599, DOI 10.1016/S0024-3205(01)01149-3; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Divet A, 2002, PFLUG ARCH EUR J PHY, V444, P634, DOI 10.1007/s00424-002-0854-5; Douillard A, 2012, CLIN EXP PHARMACOL P, V39, P364, DOI 10.1111/j.1440-1681.2012.05677.x; Douillard A, 2011, CAN J PHYSIOL PHARM, V89, P117, DOI [10.1139/Y10-114, 10.1139/y10-114]; Duncan ND, 2000, CLIN SCI, V98, P339, DOI 10.1042/CS19990069; EDELSTEIN CL, 1995, P NATL ACAD SCI USA, V92, P7662, DOI 10.1073/pnas.92.17.7662; EMERY PW, 1984, BIOSCIENCE REP, V4, P83, DOI 10.1007/BF01120827; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20857; Gokhin DS, 2014, MOL BIOL CELL, V25, P852, DOI 10.1091/mbc.E13-10-0608; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harcourt LJ, 2007, NEUROMUSCULAR DISORD, V17, P47, DOI 10.1016/j.nmd.2006.08.012; Head SI, 2011, CLIN EXP PHARMACOL P, V38, P638, DOI 10.1111/j.1440-1681.2011.05574.x; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Hoshino D, 2012, AM J PHYSIOL-REG I, V302, pR373, DOI 10.1152/ajpregu.00183.2011; Ingalls CP, 1996, J APPL PHYSIOL, V80, P795, DOI 10.1152/jappl.1996.80.3.795; Kabbara AA, 1999, J PHYSIOL-LONDON, V519, P169, DOI 10.1111/j.1469-7793.1999.0169o.x; Kabbara AA, 1999, CELL CALCIUM, V25, P227, DOI 10.1054/ceca.1999.0023; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Lunde PK, 2001, CIRC RES, V88, P1299, DOI 10.1161/hh1201.092041; MALTIN CA, 1993, CLIN SCI, V84, P651, DOI 10.1042/cs0840651; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; Rajab P, 2000, AM J PHYSIOL-REG I, V279, pR1076, DOI 10.1152/ajpregu.2000.279.3.R1076; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Ricart-Firinga C, 2000, AM J PHYSIOL-CELL PH, V278, pC582, DOI 10.1152/ajpcell.2000.278.3.C582; Ryall JG, 2008, PHARMACOL THERAPEUT, V120, P219, DOI 10.1016/j.pharmthera.2008.06.003; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Smith WN, 2002, J APPL PHYSIOL, V92, P941, DOI 10.1152/japplphysiol.00576.2001; Sneddon AA, 2000, AM J PHYSIOL-ENDOC M, V279, pE188, DOI 10.1152/ajpendo.2000.279.1.E188; Song LS, 1997, J PHYSIOL-LONDON, V505, P665, DOI 10.1111/j.1469-7793.1997.665ba.x; Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004; Teng YD, 2006, NEUROSCI LETT, V397, P155, DOI 10.1016/j.neulet.2005.12.007; TORGAN CE, 1995, J APPL PHYSIOL, V79, P163, DOI 10.1152/jappl.1995.79.1.163; Verburg E, 2009, AM J PHYSIOL-CELL PH, V296, pC1115, DOI 10.1152/ajpcell.00008.2009; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; WATERFIELD CJ, 1995, EUR J PHARM-ENVIRON, V293, P141, DOI 10.1016/0926-6917(95)00010-0; Yimlamai T, 2005, J APPL PHYSIOL, V99, P71, DOI 10.1152/japplphysiol.00448.2004; ZEMAN RJ, 1988, AM J PHYSIOL, V254, pE726, DOI 10.1152/ajpendo.1988.254.6.E726	52	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100281	10.1371/journal.pone.0100281	http://dx.doi.org/10.1371/journal.pone.0100281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971566	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200023
J	Xia, Y; Zhao, Y; Yang, MP; Zeng, SQ; Shu, YS				Xia, Yang; Zhao, Yuan; Yang, Mingpo; Zeng, Shaoqun; Shu, Yousheng			Regulation of Action Potential Waveforms by Axonal GABA(A) Receptors in Cortical Pyramidal Neurons	PLOS ONE			English	Article							PRESYNAPTIC INHIBITION; TRANSMITTER RELEASE; EXCITATORY ACTIONS; INITIAL SEGMENT; CELLS; CHANNELS; MODULATION; ACTIVATION; RESPONSES; DEPOLARIZATION	GABA(A) receptors distributed in somatodendritic compartments play critical roles in regulating neuronal activities, including spike timing and firing pattern; however, the properties and functions of GABA(A) receptors at the axon are still poorly understood. By recording from the cut end (bleb) of the main axon trunk of layer -5 pyramidal neurons in prefrontal cortical slices, we found that currents evoked by GABA iontophoresis could be blocked by picrotoxin, indicating the expression of GABA(A) receptors in axons. Stationary noise analysis revealed that single-channel properties of axonal GABA(A) receptors were similar to those of somatic receptors. Perforated patch recording with gramicidin revealed that the reversal potential of the GABA response was more negative than the resting membrane potential at the axon trunk, suggesting that GABA may hyperpolarize the axonal membrane potential. Further experiments demonstrated that the activation of axonal GABA(A) receptors regulated the amplitude and duration of action potentials (APs) and decreased the AP-induced Ca2+ transients at the axon. Together, our results indicate that the waveform of axonal APs and the downstream Ca2+ signals are modulated by axonal GABA(A) receptors.	[Xia, Yang; Yang, Mingpo] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Zhao, Yuan; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Shu, Yousheng] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Yousheng] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Beijing Normal University; Beijing Normal University	Zeng, SQ (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.	sqzeng@hust.edu.cn; yousheng@bnu.edu.cn	Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876	973 Program [2011CBA00400]; National Natural Science Foundation of China Project [31025012, 81327802]; Chinese Academy of Sciences	973 Program(National Basic Research Program of China); National Natural Science Foundation of China Project(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the 973 Program (No. 2011CBA00400 YS), the National Natural Science Foundation of China Project (No. 31025012 YS, 81327802 SZ), and the Hundreds of Talents Program (YS) from Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; BARKER JL, 1982, J PHYSIOL-LONDON, V322, P365, DOI 10.1113/jphysiol.1982.sp014042; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Chavas J, 2003, J NEUROSCI, V23, P2019; Chiang PH, 2012, J NEUROSCI, V32, P62, DOI 10.1523/JNEUROSCI.3393-11.2012; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Golding NL, 1996, J NEUROSCI, V16, P2208; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; HOWE JR, 1987, J PHYSIOL-LONDON, V384, P539, DOI 10.1113/jphysiol.1987.sp016469; Hu WQ, 2012, NEUROSCI BULL, V28, P342, DOI 10.1007/s12264-012-1247-1; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mozrzymas JW, 2004, NEUROPHARMACOLOGY, V47, P945, DOI 10.1016/j.neuropharm.2004.07.003; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouzat C, 1999, J NEUROSCI, V19, P1675; Pugh JR, 2011, J NEUROSCI, V31, P565, DOI 10.1523/JNEUROSCI.4506-10.2011; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vardi N, 2000, J NEUROSCI, V20, P7657; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Yang J, 2013, J PHYSIOL-LONDON, V591, P3233, DOI 10.1113/jphysiol.2013.251058; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100968	10.1371/journal.pone.0100968	http://dx.doi.org/10.1371/journal.pone.0100968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971996	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200076
J	Xie, Y; Wang, BB; Li, FC; Ma, L; Ni, M; Shen, WD; Hong, FS; Li, B				Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Hong, Fashui; Li, Bing			Molecular Mechanisms of Reduced Nerve Toxicity by Titanium Dioxide Nanoparticles in the Phoxim-Exposed Brain of Bombyx mori	PLOS ONE			English	Article							ACETYLCHOLINESTERASE GENES; OXIDATIVE STRESS; EXPRESSION; APOPTOSIS; MITOCHONDRIA; SILKWORM; REMEDIATION; NANO-TIO2; PROTEINS; TISSUES	Bombyx mori (B. mori), silkworm, is one of the most important economic insects in the world, while phoxim, an organophosphorus (OP) pesticide, impact its economic benefits seriously. Phoxim exposure can damage the brain, fatbody, midgut and haemolymph of B. mori. However the metabolism of proteins and carbohydrates in phoxim-exposed B. mori can be improved by Titanium dioxide nanoparticles (TiO2 NPs). In this study, we explored whether TiO2 NPs treatment can reduce the phoxim-induced brain damage of the 5th larval instar of B. mori. We observed that TiO2 NPs pretreatments significantly reduced the mortality of phoxim-exposed larva and relieved severe brain damage and oxidative stress under phoxim exposure in the brain. The treatments also relieved the phoxim-induced increases in the contents of acetylcholine (Ach), glutamate (Glu) and nitric oxide (NO) and the phoxim-induced decreases in the contents of norepinephrine (NE), Dopamine (DA), and 5-hydroxytryptamine (5-HT), and reduced the inhibition of acetylcholinesterase (AChE), Na+/K+-ATPase, Ca2+-ATPase, and Ca2+/Mg2+-ATPase activities and the activation of total nitric oxide synthase (TNOS) in the brain. Furthermore, digital gene expression profile (DGE) analysis and real time quantitative PCR (qRT-PCR) assay revealed that TiO2 NPs pretreatment inhibited the up-regulated expression of ace1, cytochrome c, caspase-9, caspase-3, Bm109 and down-regulated expression of BmIap caused by phoxim; these genes are involved in nerve conduction, oxidative stress and apoptosis. TiO2 NPs pretreatment also inhibited the down-regulated expression of H+ transporting ATP synthase and vacuolar ATP synthase under phoxim exposure, which are involved in ion transport and energy metabolism. These results indicate that TiO2 NPs pretreatment reduced the phoxim-induced nerve toxicity in the brain of B. mori.	[Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Hong, Fashui; Li, Bing] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China; [Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Li, Bing] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Hong, FS (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China.	hongfsh_cn@sina.com; lib@suda.edu.cn	li, bing/GWQ-9617-2022		National High Technology Research and Development Program of China (863 Program) [2013AA102507]; transformation project of agriculture scientific and technological achievements [2013GB2C100180]; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctoral Fund of Ministry of Education of China [20113201110008]; China Agriculture Research System [CARS-22-ZJ0305]; Science & Technology support Program of Suzhou [ZXS2012005, SNG201352]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); transformation project of agriculture scientific and technological achievements; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Agriculture Research System; Science & Technology support Program of Suzhou	This work was supported by the National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA102507), the transformation project of agriculture scientific and technological achievements (2013GB2C100180), the projects sponsored by the national cocoons silk development funds in 2014, the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Doctoral Fund of Ministry of Education of China (20113201110008), the China Agriculture Research System (CARS-22-ZJ0305), and the Science & Technology support Program of Suzhou (ZXS2012005, SNG201352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALRAJHI DH, 1990, PESTIC BIOCHEM PHYS, V37, P116, DOI 10.1016/0048-3575(90)90116-J; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Astiz M, 2009, ECOTOX ENVIRON SAFE, V72, P2025, DOI 10.1016/j.ecoenv.2009.05.001; Azuma M, 1998, J EXP BIOL, V201, P479; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carlson K, 1999, TOXICOL APPL PHARM, V160, P33, DOI 10.1006/taap.1999.8741; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Esterkin CR, 2005, AICHE J, V51, P2298, DOI 10.1002/aic.10472; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Gu ZY, 2013, BOMBYX MORI CHEMOSPH, V96, P33; Higarashi MM, 2002, CATAL TODAY, V76, P201, DOI 10.1016/S0920-5861(02)00219-5; Hong FH, 2005, BIOL TRACE ELEM RES, V104, P249, DOI 10.1385/BTER:104:3:249; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011; Huang QH, 2001, BBA-MOL CELL RES, V1499, P191, DOI 10.1016/S0167-4889(00)00105-1; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Kopecka-Pilarczyk J, 2010, J FISH BIOL, V76, P716, DOI 10.1111/j.1095-8649.2009.02503.x; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; Li B, 2013, J AGR FOOD CHEM, V61, P12238, DOI 10.1021/jf4039259; Li B, 2012, CHEMOSPHERE, V89, P609, DOI 10.1016/j.chemosphere.2012.05.061; Li B, 2010, AFR J BIOTECHNOL, V9, P8477; Meneses A, 2012, REV NEUROSCIENCE, V23, P543, DOI 10.1515/revneuro-2012-0060; Mohammadi R, 2013, BIOL TRACE ELEM RES, V152, P403, DOI 10.1007/s12011-013-9631-x; Nath BS, 1999, ECOTOX ENVIRON SAFE, V42, P157, DOI 10.1006/eesa.1998.1735; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nordlund J, 2012, LEUKEMIA, V26, P1218, DOI 10.1038/leu.2011.358; Park SY, 2012, COMP BIOCHEM PHYS C, V156, P187, DOI 10.1016/j.cbpc.2012.06.003; Peng GD, 2011, PESTIC BIOCHEM PHYS, V101, P154, DOI 10.1016/j.pestbp.2011.08.010; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Su JJ, 2014, ENVIRON TOXICOL, V29, P1355, DOI 10.1002/tox.21866; Tambunan J, 1998, GENE, V212, P287, DOI 10.1016/S0378-1119(98)00126-7; Tokiwa H, 1999, FREE RADICAL BIO MED, V27, P1251, DOI 10.1016/S0891-5849(99)00156-2; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Yang ZP, 1998, J PHYSIOLOGY-PARIS, V92, P157, DOI 10.1016/S0928-4257(98)80002-8; Yano M, 2007, EXP CELL RES, V313, P3767, DOI 10.1016/j.yexcr.2007.07.031; Yu QY, 2011, J ECON ENTOMOL, V104, P101, DOI 10.1603/EC10260; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381; Zheng L, 2005, BIOL TRACE ELEM RES, V104, P83, DOI 10.1385/BTER:104:1:083	45	24	29	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101062	10.1371/journal.pone.0101062	http://dx.doi.org/10.1371/journal.pone.0101062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971466	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200086
J	Music, N; Reber, AJ; Lipatov, AS; Kamal, RP; Blanchfield, K; Wilson, JR; Donis, RO; Katz, JM; York, IA				Music, Nedzad; Reber, Adrian J.; Lipatov, Aleksandr S.; Kamal, Ram P.; Blanchfield, Kristy; Wilson, Jason R.; Donis, Ruben O.; Katz, Jacqueline M.; York, Ian A.			Influenza Vaccination Accelerates Recovery of Ferrets from Lymphopenia	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; A H1N1; VIRUS-INFECTION; MONOCLONAL-ANTIBODIES; HOSPITALIZED-PATIENTS; RELATIVE LYMPHOPENIA; SEASONAL INFLUENZA; GLOBAL BURDEN; UNITED-STATES; MOUSE MODEL	Ferrets are a useful animal model for human influenza virus infections, since they closely mimic the pathogenesis of influenza viruses observed in humans. However, a lack of reagents, especially for flow cytometry of immune cell subsets, has limited research in this model. Here we use a panel of primarily species cross-reactive antibodies to identify ferret T cells, cytotoxic T lymphocytes (CTL), B cells, and granulocytes in peripheral blood. Following infection with seasonal H3N2 or H1N1pdm09 influenza viruses, these cell types showed rapid and dramatic changes in frequency, even though clinically the infections were mild. The loss of B cells and CD4 and CD8 T cells, and the increase in neutrophils, were especially marked 1 - 2 days after infection, when about 90% of CD8+ T cells disappeared from the peripheral blood. The different virus strains led to different kinetics of leukocyte subset alterations. Vaccination with homologous vaccine reduced clinical symptoms slightly, but led to a much more rapid return to normal leukocyte parameters. Assessment of clinical symptoms may underestimate the effectiveness of influenza vaccine in restoring homeostasis.	[Music, Nedzad; Reber, Adrian J.; Lipatov, Aleksandr S.; Kamal, Ram P.; Blanchfield, Kristy; Wilson, Jason R.; Donis, Ruben O.; Katz, Jacqueline M.; York, Ian A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	York, IA (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ite1@cdc.gov	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The source of funding for this work was the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P402; AULITZKY WE, 1991, ANN HEMATOL, V62, P25, DOI 10.1007/BF01714980; Banner D, 2012, J INFECT DEV COUNTR, V6, P465; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bergman Hagit, 2011, Open Respir Med J, V5, P19, DOI 10.2174/1874306401105010019; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brown C, 2006, LAB ANIMAL, V35, P23, DOI 10.1038/laban0206-23; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Coskun O, 2010, J CLIN VIROL, V47, P388, DOI 10.1016/j.jcv.2010.01.007; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Cunha BA, 2010, INFECT DIS CLIN N AM, V24, P203, DOI 10.1016/j.idc.2009.10.001; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Goldberg L, 2011, PEDIATR INFECT DIS J, V30, P530, DOI 10.1097/INF.0b013e31821810ff; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; Ibrahim HM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/148725; Ishigaki H, 2011, PEDIATR INT, V53, P669, DOI 10.1111/j.1442-200X.2011.03324.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kanchana S, 2013, AM J TROP MED HYG, V88, P461, DOI 10.4269/ajtmh.12-0132; Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Lee SE, 2008, VACCINE, V26, P3383, DOI 10.1016/j.vaccine.2008.04.041; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martel CJM, 2009, VET IMMUNOL IMMUNOP, V132, P109, DOI 10.1016/j.vetimm.2009.05.011; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; MEIKLEJOHN G, 1952, AM J HYG, V55, P1; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Mina MJ, 2013, J INFECT DIS, V208, P1281, DOI 10.1093/infdis/jit317; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Moore DM, 2000, SCHALMS VET HEMATOLO, P1096; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Pearce MB, 2012, J VIROL, V86, P7118, DOI 10.1128/JVI.00674-12; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Pillet S, 2009, CURR TOP MICROBIOL, V330, P73; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; REED L. J., 1938, AMER JOUR HYG, V27, P493; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2003, AVIAN DIS, V47, P931, DOI 10.1637/0005-2086-47.s3.931; Russell S M, 1977, Dev Biol Stand, V39, P397; Rutigliano JA, 2008, J IMMUNOL METHODS, V336, P71, DOI 10.1016/j.jim.2008.04.003; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; van den Brand JMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042343; World Health Organization, 2011, MAN LAB DIAGN VIR SU	60	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100926	10.1371/journal.pone.0100926	http://dx.doi.org/10.1371/journal.pone.0100926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968319	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800083
J	Berry, R; Vivian, JP; Deuss, FA; Balaji, GR; Saunders, PM; Lin, J; Littler, DR; Brooks, AG; Rossjohn, J				Berry, Richard; Vivian, Julian P.; Deuss, Felix A.; Balaji, Gautham R.; Saunders, Philippa M.; Lin, Jie; Littler, Dene R.; Brooks, Andrew G.; Rossjohn, Jamie			The Structure of the Cytomegalovirus-Encoded m04 Glycoprotein, a Prototypical Member of the m02 Family of Immunoevasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Structure; Immunoglobulin-like Domain; Immunology; Natural Killer Cells (NK Cells); Viral Protein	KILLER-CELL RECEPTORS; IMMUNOGLOBULIN-LIKE RECEPTOR; COMPLEX CLASS-I; MURINE CYTOMEGALOVIRUS; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; IMMUNE EVASION; VIRAL IMMUNOEVASIN; SEQUENCE; RECOGNITION	Background: Cytomegalovirus-encoded m02 family members are involved in immune evasion. Results: m04 binds murine MHC-I via an Ig-V-like ectodomain. Conclusion: m04 is the prototype of the m02 family, whose members mimic proteins derived from the host immune system. Significance: The results provide insight into the structural scaffold that defines a large family of immunoevasins. The ability of CMVs to evade the immune system of the host is dependent on the expression of a wide array of glycoproteins, many of which interfere with natural killer cell function. In murine CMV, two large protein families mediate this immune-evasive function. Although it is established that the m145 family members mimic the structure of MHC-I molecules, the structure of the m02 family remains unknown. The most extensively studied m02 family member is m04, a glycoprotein that escorts newly assembled MHC-I molecules to the cell surface, presumably to avoid missing self recognition. Here we report the crystal structure of the m04 ectodomain, thereby providing insight into this large immunoevasin family. m04 adopted a -sandwich immunoglobulin variable (Ig-V)-like fold, despite sharing very little sequence identity with the Ig-V superfamily. In addition to the Ig-V core, m04 possesses several unique structural features that included an unusual -strand topology, a number of extended loops and a prominent -helix. The m04 interior was packed by a myriad of hydrophobic residues that form distinct clusters around two conserved tryptophan residues. This hydrophobic core was well conserved throughout the m02 family, thereby indicating that murine CMV encodes a number of Ig-V-like molecules. We show that m04 binds a range of MHC-I molecules with low affinity in a peptide-independent manner. Accordingly, the structure of m04, which represents the first example of an murine CMV encoded Ig-V fold, provides a basis for understanding the structure and function of this enigmatic and large family of immunoevasins.	[Berry, Richard; Vivian, Julian P.; Deuss, Felix A.; Balaji, Gautham R.; Littler, Dene R.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Saunders, Philippa M.; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Melbourne; Cardiff University	Berry, R (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	Richard.berry@monash.edu; Jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Balaji, Gautham/0000-0002-7436-4689; Littler, Dene/0000-0001-5904-1905; Vivian, Julian/0000-0002-9400-4437; berry, richard/0000-0001-7043-0469; Deuss, Felix/0000-0002-0386-4336; Brooks, Andrew/0000-0002-4085-9683	Australian Research Council; National Health and Medical Research Council of Australia; National Health and Medical Research Council Peter Doherty Fellowship; Australian Research Council Discovery Early Career Researcher Award; National Health and Medical Research Council Australia Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the Australian Research Council and the National Health and Medical Research Council of Australia, a National Health and Medical Research Council Peter Doherty Fellowship (to R. B.), an Australian Research Council Discovery Early Career Researcher Award (to J. P. V.), and a National Health and Medical Research Council Australia Fellowship (to J. R.).	Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Clements CS, 2006, ACTA CRYSTALLOGR F, V62, P70, DOI 10.1107/S1744309105041473; Corbett AJ, 2007, J GEN VIROL, V88, P758, DOI 10.1099/vir.0.82623-0; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtappels R, 2006, J VIROL, V80, P7613, DOI 10.1128/JVI.00723-06; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Loenen WAM, 2001, SEMIN IMMUNOL, V13, P41, DOI 10.1006/smim.2001.0294; Mans J, 2007, J BIOL CHEM, V282, P35247, DOI 10.1074/jbc.M706782200; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Natarajan K, 2006, J MOL BIOL, V358, P157, DOI 10.1016/j.jmb.2006.01.068; Nemoviova I., 2014, ACTA CRYSTALLOGR D, V70, P851; Oliveira SA, 2002, J VIROL, V76, P885, DOI 10.1128/JVI.76.2.885-894.2002; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Petersen JL, 2003, J IMMUNOL, V171, P4473, DOI 10.4049/jimmunol.171.9.4473; Pyzik M, 2011, J EXP MED, V208, P1105, DOI 10.1084/jem.20101831; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Romasanta PN, 2014, J BIOL CHEM, V289, P5083, DOI 10.1074/jbc.M113.532929; Sissons JGP, 2002, SPRINGER SEMIN IMMUN, V24, P169, DOI 10.1007/s00281-002-0104-0; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yang ZR, 2008, P NATL ACAD SCI USA, V105, P10095, DOI 10.1073/pnas.0804551105	46	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23753	23763		10.1074/jbc.M114.584128	http://dx.doi.org/10.1074/jbc.M114.584128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24982419	Green Published, hybrid			2022-12-25	WOS:000341505000043
J	Tao, WJ; Chen, Q; Zhou, WJ; Wang, YP; Wang, L; Zhang, Z				Tao, Wenjuan; Chen, Quan; Zhou, Wenjie; Wang, Yunping; Wang, Lu; Zhang, Zhi			Persistent Inflammation-induced Up-regulation of Brain-derived Neurotrophic Factor (BDNF) Promotes Synaptic Delivery of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor GluA1 Subunits in Descending Pain Modulatory Circuits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; ANTERIOR CINGULATE CORTEX; GLUTAMATE RECEPTORS; PERIAQUEDUCTAL GRAY; NEUROPATHIC PAIN; AMPA RECEPTORS; MESSENGER-RNA; GLUR1 SUBUNIT; PHOSPHORYLATION; EXPRESSION	The enhanced AMP A receptor phosphorylation at GluA1 serine 831 sites in the central pain-modulating system plays a pivotal role in descending pain facilitation after inflammation, but the underlying mechanisms remain unclear. Weshow here that, in the rat brain stem, in the nucleus raphe magnus, which is a critical relay in the descending pain-modulating system of the brain, persistent inflammatory pain induced by complete Freund adjuvant (CFA) can enhance AMPA receptor-mediated excitatory postsynaptic currents and the GluA2-lacking AMPA receptor-mediated rectification index. Western blot analysis showed an increase in GluA1 phosphorylation at Ser-831 but not at Ser-845. This was accompanied by an increase in distribution of the synaptic GluA1 subunit. In parallel, the level of histone H3 acetylation at bdnf gene promoter regions was reduced significantly 3 days after CFA injection, as indicated by ChIP assays. This was correlated with an increase in BDNF mRNA levels and BDNF protein levels. Sequestering endogenous extracellular BDNF with TrkB-IgG in the nucleus raphe magnus decreased AMPA receptor-mediated synaptic transmission and GluA1 phosphorylation at Ser-831 3 days after CFA injection. Under the same conditions, blockade of TrkB receptor functions, phospholipase C, or PKC impaired GluA1 phosphorylation at Ser-831 and decreased excitatory postsynaptic currents mediated by GluA2-lacking AMPA receptors. Taken together, these results suggest that epigenetic up-regulation of BDNF by peripheral inflammation induces GluR1 phosphorylation at Ser-831 sites through activation of the phospholipase C-PKC signaling cascade, leading to the trafficking of GluA1 to pain-modulating neuronal synapses.	[Tao, Wenjuan; Chen, Quan; Zhou, Wenjie; Wang, Yunping; Wang, Lu; Zhang, Zhi] Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Tao, Wenjuan] Anhui Coll Tradit Chinese Med, Dept Pharm, Wuhu 241000, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University of Chinese Medicine	Zhang, Z (corresponding author), Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China.	zhizhang@ustc.edu.cn			973 Program [2014CB548100]; National Natural Science Foundation of China [31100802, 91332109]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grant 2014CB548100 and by National Natural Science Foundation of China Grants 31100802 and 91332109 (to Z. Z.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bie BH, 2005, J NEUROSCI, V25, P3824, DOI 10.1523/JNEUROSCI.5010-04.2005; Bie BH, 2012, NEUROPSYCHOPHARMACOL, V37, P2780, DOI 10.1038/npp.2012.144; Bie BH, 2011, EUR J PHARMACOL, V653, P26, DOI 10.1016/j.ejphar.2010.11.027; Biggs JE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-44; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Block F, 2003, SCHMERZ, V17, P261, DOI 10.1007/s00482-003-0218-x; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Conner JM, 1997, J NEUROSCI, V17, P2295; Descalzi G, 2009, MOL NEUROBIOL, V40, P253, DOI 10.1007/s12035-009-8085-9; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Garry EA, 2004, PAIN, V109, P210, DOI 10.1016/j.pain.2004.04.002; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Guan Y, 2004, NEUROSCI LETT, V366, P201, DOI 10.1016/j.neulet.2004.05.051; Guan Y, 2003, PAIN, V104, P401, DOI 10.1016/S0304-3959(03)00048-4; Guan Y, 2002, J PHARMACOL EXP THER, V300, P513, DOI 10.1124/jpet.300.2.513; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ho YC, 2013, J NEUROSCI, V33, P7825, DOI 10.1523/JNEUROSCI.5583-12.2013; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; King VR, 1999, NEUROSCIENCE, V92, P935, DOI 10.1016/S0306-4522(99)00072-X; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Ma JY, 2006, PAIN, V122, P163, DOI 10.1016/j.pain.2006.01.031; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Nakata H, 2007, FEBS LETT, V581, P2047, DOI 10.1016/j.febslet.2007.04.041; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; Pan ZZ, 1997, NATURE, V389, P382, DOI 10.1038/38730; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Radhakrishnan R, 2009, NEUROSCI LETT, V457, P141, DOI 10.1016/j.neulet.2009.03.086; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Tao YX, 2012, NEUROSCI BULL, V28, P111, DOI 10.1007/s12264-012-1204-z; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Wei F, 1999, J NEUROSCI, V19, P9346; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yamada T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-67; Zhang L, 2010, PAIN, V149, P107, DOI 10.1016/j.pain.2010.01.017; Zhang Z, 2013, MOL PHARMACOL, V84, P511, DOI 10.1124/mol.113.086496; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010	59	25	27	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22196	22204		10.1074/jbc.M114.580381	http://dx.doi.org/10.1074/jbc.M114.580381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966334	hybrid, Green Published			2022-12-25	WOS:000340593500034
J	Barnette, DN; VandeKopple, M; Wu, YG; Willoughby, DA; Lincoln, J				Barnette, Damien N.; VandeKopple, Matthew; Wu, Yonggan; Willoughby, David A.; Lincoln, Joy			RNA-Seq Analysis to Identify Novel Roles of Scleraxis during Embryonic Mouse Heart Valve Remodeling	PLOS ONE			English	Article							GENE-EXPRESSION; DISEASE; DIFFERENTIATION; TENDONS; CHICKEN; DOMAIN	Heart valve disease affects up to 30% of the population and has been shown to have origins during embryonic development. Valvulogenesis begins with formation of endocardial cushions in the atrioventricular canal and outflow tract regions. Subsequently, endocardial cushions remodel, elongate and progressively form mature valve structures composed of a highly organized connective tissue that provides the necessary biomechanical function throughout life. While endocardial cushion formation has been well studied, the processes required for valve remodeling are less well understood. The transcription factor Scleraxis (Scx) is detected in mouse valves from E15.5 during initial stages of remodeling, and expression remains high until birth when formation of the highly organized mature structure is complete. Heart valves from Scx(-/-) mice are abnormally thick and develop fibrotic phenotypes similar to human disease by juvenile stages. These phenotypes begin around E15.5 and are associated with defects in connective tissue organization and valve interstitial cell differentiation. In order to understand the etiology of this phenotype, we analyzed the transcriptome of remodeling valves isolated from E15.5 Scx(-/-) embryos using RNA-seq. From this, we have identified a profile of protein and non-protein mRNAs that are dependent on Scx function and using bioinformatics we can predict the molecular functions and biological processes affected by these genes. These include processes and functions associated with gene regulation (methyltransferase activity, DNA binding, Notch signaling), vitamin A metabolism (retinoic acid biosynthesis) and cellular development (cell morphology, cell assembly and organization). In addition, several mRNAs are affected by alternative splicing events in the absence of Scx, suggesting additional roles in post-transcriptional modification. In summary, our findings have identified transcriptome profiles from abnormal heart valves isolated from E15.5 Scx(-/-) embryos that could be used in the future to understand mechanisms of heart valve disease in the human population.	[Barnette, Damien N.] Leonard M Miller Sch Med, Mol & Cellular Pharmacol Grad Program, Miami, FL USA; [Barnette, Damien N.; VandeKopple, Matthew; Lincoln, Joy] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA; [Barnette, Damien N.; VandeKopple, Matthew; Lincoln, Joy] Nationwide Childrens Hosp, Res Inst, Ctr Heart, Columbus, OH USA; [VandeKopple, Matthew] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Wu, Yonggan; Willoughby, David A.] Ocean Ridge Biosci LLC, Palm Beach Gardens, FL USA; [Lincoln, Joy] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lincoln, J (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA.	joy.lincoln@nationwidechildrens.org		Lincoln, Joy/0000-0003-1517-6888	NIH [NHLBI R01HL091878]; American Heart Association [PRE16270014]; Ocean Ridge Biosciences LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091878] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ocean Ridge Biosciences LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (NHLBI R01HL091878 (JL)) and The American Heart Association (PRE16270014 (DNB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ocean Ridge Biosciences LLC provided support in the form of salaries for authors Yonggan Wu and David A. Willoughby, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors is articulated in the 'author contributions' section.	Bach DS, 2007, J HEART VALVE DIS, V16, P362; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Barnette DN, 2013, J MOL CELL CARDIOL; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gould R. A., 2010, J VIS EXP; Hinton RB, 2006, J HEART VALVE DIS, V15, P352; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Levay AK, 2008, CIRC RES, V103, P948, DOI 10.1161/CIRCRESAHA.108.177238; Li N, 2013, MICROSC MICROANAL, V19, P842, DOI 10.1017/S1431927613001633; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Lincoln J, 2011, BIRTH DEFECTS RES A, V91, P526, DOI 10.1002/bdra.20799; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Singer MS, 1998, GENETICS, V150, P613; Tao G, 2013, DEV DYNAM, V242, P699, DOI 10.1002/dvdy.23967; Tao G, 2012, CURR TOP DEV BIOL, V100, P203, DOI 10.1016/B978-0-12-387786-4.00006-3; Yamamoto K, 2013, J BIOL CHEM, V288, P21648, DOI 10.1074/jbc.M113.481424	26	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101425	10.1371/journal.pone.0101425	http://dx.doi.org/10.1371/journal.pone.0101425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983472	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000105
J	Jiao, TF; Wang, YJ; Zhang, QR; Yan, XH; Zhao, XQ; Zhou, JX; Gao, FM				Jiao, Tifeng; Wang, Yujin; Zhang, Qingrui; Yan, Xuehai; Zhao, Xiaoqing; Zhou, Jingxin; Gao, Faming			Self-Assembly and Headgroup Effect in Nanostructured Organogels via Cationic Amphiphile-Graphene Oxide Composites	PLOS ONE			English	Article							SENSITIZED SOLAR-CELLS; GRAPHITE OXIDE; POLYMER NANOCOMPOSITES; CHEMICAL-REDUCTION; IMIDE DERIVATIVES; IONIC LIQUIDS; HYDROGELS; NANOSHEETS; FABRICATION; SUPERCAPACITORS	Self-assembly of hierarchical graphene oxide (GO)-based nanomaterials with novel functions has received a great deal of attentions. In this study, nanostructured organogels based on cationic amphiphile-GO composites were prepared. The gelation behaviors of amphiphile-GO composites in organic solvents can be regulated by changing the headgroups of amphiphiles. Ammonium substituted headgroup in molecular structures in present self-assembled composites is more favorable for the gelation in comparison to pyridinium headgroup. A possible mechanism for headgroup effects on self-assembly and as-prepared nanostructures is proposed. It is believed that the present amphiphile-GO self-assembled system will provide an alternative platform for the design of new GO nanomaterials and soft matters.	[Jiao, Tifeng; Wang, Yujin; Zhang, Qingrui; Zhao, Xiaoqing; Zhou, Jingxin; Gao, Faming] Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, Qinhuangdao, Peoples R China; [Jiao, Tifeng; Yan, Xuehai] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China	Yanshan University; Chinese Academy of Sciences; Institute of Process Engineering, CAS	Jiao, TF (corresponding author), Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, Qinhuangdao, Peoples R China.	tfjiao@ysu.edu.cn; zhangqr@ysu.edu.cn; yanxh@home.ipe.ac.cn	Yan, Xuehai/E-8722-2012	Yan, Xuehai/0000-0002-0890-0340; Zhou, Jingxin/0000-0003-0471-1961; Jiao, Tifeng/0000-0003-1238-0277	National Natural Science Foundation of China [21207112]; Natural Science Foundation of Hebei Province [B2012203060, B2013203108]; Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province [Y2011113, YQ2013026]; Support Program for the Top Young Talents of Hebei Province; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province; Support Program for the Top Young Talents of Hebei Province; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS	National Natural Science Foundation of China (No. 21207112), http://www.nsfc.gov.cn/, QZ; Natural Science Foundation of Hebei Province (Nos. B2012203060 and B2013203108) http://www.hensf.gov.cn/, QZ, TJ; Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province (Nos. Y2011113 and YQ2013026), http://www.hee.cn/, QZ, TJ; Support Program for the Top Young Talents of Hebei Province, http://www.hebei.gov.cn/, TJ; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS, http://www.ipe.cas.cn/, TJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2011, CHEM-EUR J, V17, P11488, DOI 10.1002/chem.201101360; Ahmad I, 2011, J MATER CHEM, V21, P16990, DOI 10.1039/c1jm11537e; Atsbeha T, 2011, J MOL STRUCT, V993, P459, DOI 10.1016/j.molstruc.2010.12.046; Bai H, 2011, J PHYS CHEM C, V115, P5545, DOI 10.1021/jp1120299; Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e; Bissessur R, 2006, SYNTHETIC MET, V156, P1023, DOI 10.1016/j.synthmet.2006.06.024; Bora C, 2012, POLYMER, V53, P923, DOI 10.1016/j.polymer.2011.12.054; Bose S, 2010, POLYMER, V51, P5921, DOI 10.1016/j.polymer.2010.10.014; Cheng QY, 2012, LANGMUIR, V28, P3005, DOI 10.1021/la204558f; Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934; Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g; Gao HC, 2013, ACS APPL MATER INTER, V5, P425, DOI 10.1021/am302500v; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Greaves TL, 2013, CHEM SOC REV, V42, P1096, DOI 10.1039/c2cs35339c; Gun J, 2012, ELECTROCHEM COMMUN, V19, P108, DOI 10.1016/j.elecom.2012.03.025; Guo CX, 2010, ANGEW CHEM INT EDIT, V49, P3014, DOI 10.1002/anie.200906291; Hang F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0993; He QY, 2012, CHEM SCI, V3, P1764, DOI 10.1039/c2sc20205k; Huang CC, 2011, CHEM COMMUN, V47, P4962, DOI 10.1039/c1cc10412h; Huang H, 2013, SMALL, V9, P1397, DOI 10.1002/smll.201202965; Huang H, 2012, SOFT MATTER, V8, P4609, DOI 10.1039/c2sm25090j; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Huang X, 2012, ADV MATER, V24, P5979, DOI 10.1002/adma.201201587; Huang X, 2011, SMALL, V7, P1876, DOI 10.1002/smll.201002009; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Jiao TF, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-278; Jiao TF, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-160; Kaczmarek H, 2007, POLYM DEGRAD STABIL, V92, P939, DOI 10.1016/j.polymdegradstab.2007.03.013; Konwer S, 2011, J ELECTRON MATER, V40, P2248, DOI 10.1007/s11664-011-1749-z; Kumar NA, 2013, J MATER CHEM A, V1, P4431, DOI 10.1039/c3ta10337d; Kumar NA, 2012, J MATER CHEM, V22, P12268, DOI 10.1039/c2jm30701d; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Mulet X, 2013, ACCOUNTS CHEM RES, V46, P1497, DOI 10.1021/ar300285u; Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Qi XY, 2013, NANOSCALE, V5, P1440, DOI 10.1039/c2nr33145d; Qi XY, 2010, ANGEW CHEM INT EDIT, V49, P9426, DOI 10.1002/anie.201004497; Qi XY, 2010, SMALL, V6, P663, DOI 10.1002/smll.200902221; Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678; Sharma A, 2009, INT J HYDROGEN ENERG, V34, P3977, DOI 10.1016/j.ijhydene.2009.02.068; Sheng KX, 2011, NEW CARBON MATER, V26, P9, DOI 10.1016/S1872-5805(11)60062-0; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Sui ZY, 2011, CARBON, V49, P4314, DOI 10.1016/j.carbon.2011.06.006; Sun YQ, 2011, PHYS CHEM CHEM PHYS, V13, P17249, DOI 10.1039/c1cp22409c; Tai ZX, 2013, RSC ADV, V3, P12751, DOI 10.1039/c3ra22335c; Tao CA, 2012, J MATER CHEM, V22, P24856, DOI 10.1039/c2jm34461k; Titelman GI, 2005, CARBON, V43, P641, DOI 10.1016/j.carbon.2004.10.035; Vickery JL, 2009, ADV MATER, V21, P2180, DOI 10.1002/adma.200803606; Wang Z, 2013, J MATER SCI, V48, P2284, DOI 10.1007/s10853-012-7006-x; Wu SX, 2013, SMALL, V9, P1160, DOI 10.1002/smll.201202896; Xin H, 2011, J MOL LIQ, V160, P17, DOI 10.1016/j.molliq.2011.02.002; Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104; Xu YX, 2010, ACS NANO, V4, P4324, DOI 10.1021/nn101187z; Xu YX, 2009, J AM CHEM SOC, V131, P13490, DOI 10.1021/ja905032g; Xue P, 2007, CHEM-EUR J, V13, P8231, DOI 10.1002/chem.200700321; Yan L, 2012, CHEM SOC REV, V41, P97, DOI 10.1039/c1cs15193b; Yan XH, 2008, CHEM MATER, V20, P1522, DOI 10.1021/cm702931b; Yang SB, 2010, ANGEW CHEM INT EDIT, V49, P4795, DOI 10.1002/anie.201001634; Zhang L, 2006, COLLOID SURFACE A, V284, P130, DOI 10.1016/j.colsurfa.2005.11.013; Zhang L, 2011, J PHYS CHEM C, V115, P17206, DOI 10.1021/jp204036a; Zhang XT, 2011, J MATER CHEM, V21, P6494, DOI 10.1039/c1jm10239g; Zhu PL, 2010, CHEM-EUR J, V16, P3176, DOI 10.1002/chem.200902139; Zu SZ, 2009, J PHYS CHEM C, V113, P13651, DOI 10.1021/jp9035887	67	25	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101620	10.1371/journal.pone.0101620	http://dx.doi.org/10.1371/journal.pone.0101620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983466	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000125
J	Cheung, CMG; Li, X; Mathur, R; Lee, SY; Chan, CM; Yeo, I; Loh, BK; Williams, R; Wong, EYM; Wong, D; Wong, TY				Cheung, Chui Ming Gemmy; Li, Xiang; Mathur, Ranjana; Lee, Shu Yen; Chan, Choi Mun; Yeo, Ian; Loh, Boon Kwang; Williams, Rachel; Wong, Edmund Yick-Mun; Wong, Doric; Wong, Tien Yin			A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHOTODYNAMIC THERAPY; RANIBIZUMAB TREATMENT; INTRAVITREAL BEVACIZUMAB; VERTEPORFIN; SAFETY; PREVALENCE; EFFICACY	Objective: To study the treatment patterns and visual outcome over one year in Asian patients with choroidal neovascular membrane secondary to age-related macular degeneration (AMD-CNV) and polypoidal choroidal vasculopathy (PCV). Design: Prospective cohort, non-interventional study. Methods: 132 treatment-naive patients who received treatment for AMD-CNV and PCV were included. All patients underwent standardized examination procedures including retinal imaging at baseline and follow-up. AMD-CNV and PCV were defined on fundus fluorescein angiography and indocyanine green angiography at baseline. Patients were treated according to standard of care. We report the visual acuity (VA) and optical coherence tomography (OCT) measurements at baseline, month 3 and month 12 The factors influencing month 12 outcomes were analyzed. Main Outcome Measure: Type of treatment, number of Anti-vascular endothelial growth factor (VEGF) treatments, visual outcome over one year. Results: Anti-VEGF monotherapy was the initial treatment in 89.1% of AMD-CNV, but only 15.1% of PCV. The mean number of anti-VEGF injections up to month 12 was 3.97 (4.51 AMD-CNV, 3.43 PCV, p = 0.021). Baseline OCT, month 3 OCT and month 3 VA were significant in determining continuation of treatment after month 3. At month12, mean VA improved from 0.82 (similar to 20/132) at baseline to 0.68 (similar to 20/96) at month 12 (mean gain 6.5 ETDRS letters, p = 0.002). 34.2% of eyes (38/113 eyes) gained >= 15 ETDRS letters and 14.4% (16/113 eyes) lost >= 15 ETDRS letters. There were no significant differences in visual outcome between AMD-CNV and PCV (p = 0.51). Factors predictive of month 12 visual outcome were baseline VA, baseline OCT central macular thickness, month 3 VA and age. Conclusions: There is significant variation in treatment patterns in Asian eyes with exudative maculopathy. There is significant visual improvement in all treatment groups at one year. These data highlight the need for high quality clinical trial data to provide evidence-based management of Asian AMD.	[Cheung, Chui Ming Gemmy; Mathur, Ranjana; Lee, Shu Yen; Chan, Choi Mun; Yeo, Ian; Loh, Boon Kwang; Wong, Edmund Yick-Mun; Wong, Doric; Wong, Tien Yin] Singapore Natl Eye Ctr, Vitreoretinal Serv, Singapore, Singapore; [Cheung, Chui Ming Gemmy; Li, Xiang; Wong, Tien Yin] Singapore Eye Res Inst, Singapore, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Li, Xiang] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Williams, Rachel] GlaxoSmithKline, R&D Projects, Clin Platforms & Sci, Worldwide Epidemiol, Philadelphia, PA USA	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; GlaxoSmithKline	Cheung, CMG (corresponding author), Singapore Natl Eye Ctr, Vitreoretinal Serv, Singapore, Singapore.	gemmy.cheung.c.m@snec.com.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Cheung, Chui Ming Gemmy/0000-0003-3358-3516; Wong, Damon/0000-0003-4601-9121	National Medical Research Council [NMRC/NIG/1003/2009]; GlaxoSimthKline [WEUSKOP5855]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSimthKline	This study was supported by National Medical Research Council grant: NMRC/NIG/1003/2009; GlaxoSimthKline Research and Development Protocol WEUSKOP5855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashshur ZF, 2008, AM J OPHTHALMOL, V145, P249, DOI 10.1016/j.ajo.2007.09.031; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Cheung CMG, 2011, NEW ENGL J MED, V365, P2237, DOI 10.1056/NEJMc1107895; Cheung CMG, 2013, GRAEF ARCH CLIN EXP, V251, P19, DOI 10.1007/s00417-012-2029-1; Cohen SY, 2009, AM J OPHTHALMOL, V148, P409, DOI 10.1016/j.ajo.2009.04.001; Curtis LH, 2012, AM J OPHTHALMOL, V153, P1116, DOI 10.1016/j.ajo.2011.11.032; Finger RP, 2013, ACTA OPHTHALMOL, V91, P540, DOI 10.1111/j.1755-3768.2012.02493.x; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hjelmqvist L, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/405724; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P1161, DOI 10.1136/bjophthalmol-2013-303232; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, Nippon Ganka Gakkai Zasshi, V109, P417; Kang S, 2011, JPN J OPHTHALMOL, V55, P123, DOI 10.1007/s10384-010-0910-1; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Kurashige Y, 2008, AM J OPHTHALMOL, V146, P513, DOI 10.1016/j.ajo.2008.05.025; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Lamoureux EL, 2011, BRIT J OPHTHALMOL, V95, P666, DOI 10.1136/bjo.2010.185207; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; *MAC PHOT STUD GRO, 1991, ARCH OPHTHALMOL-CHIC, V109, P1219; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Pushpoth S, 2012, BRIT J OPHTHALMOL, V96, P1469, DOI 10.1136/bjophthalmol-2012-302167; Rakic JM, 2013, CLIN OPHTHALMOL, V7, P1849, DOI 10.2147/OPTH.S49385; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481	33	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101057	10.1371/journal.pone.0101057	http://dx.doi.org/10.1371/journal.pone.0101057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978485	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400069
J	Johnson, DC; Bhatta, MP; Smith, JS; Kempf, MC; Broker, TR; Vermund, SH; Chamot, E; Aryal, S; Lhaki, P; Shrestha, S				Johnson, Derek C.; Bhatta, Madhav P.; Smith, Jennifer S.; Kempf, Mirjam-Colette; Broker, Thomas R.; Vermund, Sten H.; Chamot, Eric; Aryal, Shilu; Lhaki, Pema; Shrestha, Sadeep			Assessment of High-Risk Human Papillomavirus Infections Using Clinician- and Self-Collected Cervical Sampling Methods in Rural Women from Far Western Nepal	PLOS ONE			English	Article							HPV DNA; SCREENING METHOD; POOLED ANALYSIS; CANCER; PREVALENCE; SPECIMENS; METAANALYSIS; POPULATION; WORLDWIDE; KNOWLEDGE	Introduction: Nepal has one of the highest cervical cancer rates in South Asia. Only a few studies in populations from urban areas have investigated type specific distribution of human papillomavirus (HPV) in Nepali women. Data on high-risk HPV (HR-HPV) types are not currently available for rural populations in Nepal. We aimed to assess the distribution of HR-HPV among rural Nepali women while assessing self-collected and clinician-collected cervico-vaginal specimens as sample collection methods for HPV screening. Methods: Study participants were recruited during a health camp conducted by Nepal Fertility Care Center in Achham District of rural far western Nepal. Women of reproductive age completed a socio-demographic and clinical questionnaire, and provided two specimens; one cervical-vaginal specimen using a self-collection method and another cervical specimen collected by health camp auxiliary nurse midwives during a pelvic examination. All samples were tested for 14 different HR-HPV mRNA and also specific for HPV16/18/45 mRNA. Results: Of 261 women with both clinician-and self-collected cervical samples, 25 tested positive for HR-HPV, resulting in an overall HR-HPV prevalence of 9.6% (95% confidence Interval [CI]: 6.3-13.8). The overall Kappa value assessing agreement between clinician-and self-collected tests was 0.62 (95% CI: 0.43-0.81), indicating a "good" level of agreement. Abnormal cytology was reported for 8 women. One woman identified with squamous cell carcinoma (SCC), and 7 women with high grade squamous intraepithelial lesions (HSIL). Seven of the 8 women tested positive for HR-HPV (87.5%) in clinician-collected samples and 6 in self-collected samples (75.0%). Conclusion: This is the first study to assess HR-HPV among rural Nepali women. Self-collected sampling methods should be the subject of additional research in Nepal for screening HR-HPV, associated with pre-cancer lesions and cancer, in women in rural areas with limited access to health services.	[Johnson, Derek C.; Chamot, Eric; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Bhatta, Madhav P.] Kent State Univ, Coll Publ Hlth, Kent, OH 44242 USA; [Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA; [Broker, Thomas R.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Vermund, Sten H.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Aryal, Shilu] Nepal Family Hlth Div, Kathmandu, Nepal; [Lhaki, Pema] Nepal Fertil Care Ctr, Kathmandu, Nepal	University of Alabama System; University of Alabama Birmingham; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	sshrestha@uab.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	Department of Epidemiology, UAB School of Public Health (EC SS); National Institutes of Health Cancer Prevention and Control Training Grant [R25CA47888]; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER	Department of Epidemiology, UAB School of Public Health (EC SS); National Institutes of Health Cancer Prevention and Control Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the pilot fund from the Department of Epidemiology, UAB School of Public Health (EC & SS). Derek Johnson was supported by a National Institutes of Health Cancer Prevention and Control Training Grant (R25CA47888). Hologic/GenProbe Inc. (San Diego) donated reagents and kits and provided testing of HPV, STI and liquid cytology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT POP HOUS CENS 20; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arbyn M, 2013, INT J CANCER, V132, P101, DOI 10.1002/ijc.27636; Baral Y R, 2010, Kathmandu Univ Med J (KUMJ), V8, P325; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bhusal CL, 2012, WHO S E ASIA J PUBLI, V1, P4; Binu V, 2007, ASIAN PAC J CANCER P, V8, P183; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Central Bureau of Statistics & UNICEF Nepal., 2012, NEP MULT IND CLUST S; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Department of Health Services Ministry of Health & Population, 2010, NAT GUID CERV CANC S; Dhakal HP, 2009, J NEPAL MED ASSOC, V48, P301; Franco EL, 2012, VACCINE, V30, pF175, DOI 10.1016/j.vaccine.2012.06.092; Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV C; Johnson D, 2014, KATHMANDU U IN PRESS; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Monsonego J, 2012, GYNECOL ONCOL, V125, P175, DOI 10.1016/j.ygyno.2012.01.002; Nepal Living Standards Survey, 2010, NEP LIV STAND SURV 2; Poertner E, 2011, CRIT ASIAN STUD, V43, P23, DOI 10.1080/14672715.2011.537850; Poudel KC, 2004, TROP MED INT HEALTH, V9, P897, DOI 10.1111/j.1365-3156.2004.01276.x; Pradhan B, 2007, Kathmandu Univ Med J (KUMJ), V5, P461; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Salmeron J, 2003, CANCER CAUSE CONTROL, V14, P505, DOI 10.1023/A:1024806707399; Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790; Srivastava S, 2012, J BIOSCIENCES, V37, P63, DOI 10.1007/s12038-012-9181-y; Ting J, 2013, SEX TRANSM DIS, V40, P584, DOI 10.1097/OLQ.0b013e31828e5a91; Wheeler CM, 2013, OBSTET GYN CLIN N AM, V40, P165, DOI 10.1016/j.ogc.2013.02.004; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HUM PAP REL CANC NEP; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178; Zhao FH, 2012, J NATL CANCER I, V104, P178, DOI 10.1093/jnci/djr532	37	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101255	10.1371/journal.pone.0101255	http://dx.doi.org/10.1371/journal.pone.0101255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978811	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400106
J	Rego, ROM; Bestor, A; Stefka, J; Rosa, PA				Rego, Ryan O. M.; Bestor, Aaron; Stefka, Jan; Rosa, Patricia A.			Population Bottlenecks during the Infectious Cycle of the Lyme Disease Spirochete Borrelia burgdorferi	PLOS ONE			English	Article							SENSU-STRICTO; PEROMYSCUS-LEUCOPUS; NORTH-AMERICA; TICKS; MICE; HOST; DISSEMINATION; TRANSMISSION; DYNAMICS; STRAINS	Borrelia burgdorferi is a zoonotic pathogen whose maintenance in nature depends upon an infectious cycle that alternates between a tick vector and mammalian hosts. Lyme disease in humans results from transmission of B. burgdorferi by the bite of an infected tick. The population dynamics of B. burgdorferi throughout its natural infectious cycle are not well understood. We addressed this topic by assessing the colonization, dissemination and persistence of B. burgdorferi within and between the disparate mammalian and tick environments. To follow bacterial populations during infection, we generated seven isogenic but distinguishable B. burgdorferi clones, each with a unique sequence tag. These tags resulted in no phenotypic changes relative to wild type organisms, yet permitted highly sensitive and specific detection of individual clones by PCR. We followed the composition of the spirochete population throughout an experimental infectious cycle that was initiated with a mixed inoculum of all clones. We observed heterogeneity in the spirochete population disseminating within mice at very early time points, but all clones displayed the ability to colonize most mouse tissues by 3 weeks of infection. The complexity of clones subsequently declined as murine infection persisted. Larval ticks typically acquired a reduced and variable number of clones relative to what was present in infected mice at the time of tick feeding, and maintained the same spirochete population through the molt to nymphs. However, only a random subset of infectious spirochetes was transmitted to naive mice when these ticks next fed. Our results clearly demonstrate that the spirochete population experiences stochastic bottlenecks during both acquisition and transmission by the tick vector, as well as during persistent infection of its murine host. The experimental system that we have developed can be used to further explore the forces that shape the population of this vector-borne bacterial pathogen throughout its infectious cycle.	[Rego, Ryan O. M.; Bestor, Aaron; Rosa, Patricia A.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Stefka, Jan] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Stefka, Jan] ASCR, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Rego, ROM (corresponding author), NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	ryanrego@paru.cas.cz	Štefka, Jan/N-3924-2019; Štefka, Jan/G-9267-2014; Rego, Ryan Oliver Marino O. M./G-9773-2014; Rego, Ryan O. M./AAL-1316-2020	Štefka, Jan/0000-0002-1283-9730; Štefka, Jan/0000-0002-1283-9730; Rego, Ryan Oliver Marino O. M./0000-0001-6932-0940; Rego, Ryan O. M./0000-0001-6932-0940	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000917] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; ANDERSON JF, 1984, YALE J BIOL MED, V57, P627; Andersson M, 2013, AM NAT, V181, P545, DOI 10.1086/669905; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Barnes PD, 2006, J EXP MED, V203, P1591, DOI 10.1084/jem.20060905; Bestor A, 2012, INFECT IMMUN, V80, P3501, DOI 10.1128/IAI.00521-12; Binder SC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00104; Boonstra R, 2012, OECOLOGIA, V168, P601, DOI 10.1007/s00442-011-2120-z; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Coward C, 2008, APPL ENVIRON MICROB, V74, P3857, DOI 10.1128/AEM.02835-07; de Silva AM, 2009, FRONT BIOSCI-LANDMRK, V14, P3051, DOI 10.2741/3434; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Dolan MC, 2004, INFECT IMMUN, V72, P5262, DOI 10.1128/IAI.72.9.5262-5266.2004; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Ellis TC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003567; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Gutierrez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003009; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Herrmann C, 2013, APPL ENVIRON MICROB, V79, P7273, DOI 10.1128/AEM.02158-13; Hunfeld KP, 2006, WIEN KLIN WOCHENSCHR, V118, P659, DOI 10.1007/s00508-006-0693-z; Imai DM, 2013, LAB INVEST, V93, P900, DOI 10.1038/labinvest.2013.81; Imai DM, 2013, INFECT IMMUN, V81, P1663, DOI 10.1128/IAI.01359-12; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; JOHNSON RC, 1984, INT J SYST BACTERIOL, V34, P496, DOI 10.1099/00207713-34-4-496; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; KELLY R, 1971, SCIENCE, V173, P443, DOI 10.1126/science.173.3995.443; Kim HC, 2013, SYST APPL ACAROL-UK, V18, P201, DOI 10.11158/saa.18.3.1; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liveris D, 2011, J CLIN MICROBIOL, V49, P2166, DOI 10.1128/JCM.00350-11; Mihalca AD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-266; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Ohnishi J, 2003, J BACTERIOL, V185, P4432, DOI 10.1128/JB.185.15.4432-4441.2003; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; OLSEN B, 1993, NATURE, V362, P340, DOI 10.1038/362340a0; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Restif O, 2009, MICROBE, V4, P176; RIBEIRO JMC, 1987, J MED ENTOMOL, V24, P201, DOI 10.1093/jmedent/24.2.201; Rosa PA, 2005, NAT REV MICROBIOL, V3, P129, DOI 10.1038/nrmicro1086; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sarkar A, 2009, ANTIMICROB AGENTS CH, V53, P4490, DOI 10.1128/AAC.00558-09; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schwartz DJ, 2011, INFECT IMMUN, V79, P4250, DOI 10.1128/IAI.05339-11; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Vuong HB, 2013, INFECT GENE IN PRESS; Walters MS, 2012, MBIO, V3, DOI 10.1128/mBio.00303-11; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279	74	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101009	10.1371/journal.pone.0101009	http://dx.doi.org/10.1371/journal.pone.0101009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979342	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400061
J	Almarza, G; Sanchez, F; Barrantes, FJ				Almarza, Gonzalo; Sanchez, Francisco; Barrantes, Francisco J.			Transient Cholesterol Effects on Nicotinic Acetylcholine Receptor Cell-Surface Mobility	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; LIPID RAFTS; PROTEIN HETEROGENEITY; LATERAL DIFFUSION; DYNAMICS; ORGANIZATION; ACTIN; SITES; MAINTENANCE; CLUSTERS	To what extent do cholesterol-rich lipid platforms modulate the supramolecular organization of the nicotinic acetylcholine receptor (AChR)? To address this question, the dynamics of AChR particles at high density and its cholesterol dependence at the surface of mammalian cells were studied by combining total internal reflection fluorescence microscopy and single-particle tracking. AChR particles tagged with a monovalent ligand, fluorescent alpha-bungarotoxin (alpha BTX), exhibited two mobile pools: i) a highly mobile one undergoing simple Brownian motion (16%) and ii) one with restricted motion (similar to 50%), the rest being relatively immobile (similar to 44%). Depletion of membrane cholesterol by methyl-alpha-cyclodextrin increased the fraction of the first pool to 22% and 33% after 15 and 40 min, respectively; the pool undergoing restricted motion diminished from 50% to 44% and 37%, respectively. Monoclonal antibody binding results in AChR crosslinking-internalization after 2 h; here, antibody binding immobilized within minutes similar to 20% of the totally mobile AChR. This proportion dramatically increased upon cholesterol depletion, especially during the initial 10 min (83.3%). Thus, antibody crosslinking and cholesterol depletion exhibited a mutually synergistic effect, increasing the average lifetime of cell-surface AChRs similar to 10 s to similar to 20 s. The instantaneous (microscopic) diffusion coefficient D2-4 of the AChR obtained from the MSD analysis diminished from similar to 0.001 mu m(2) s(-1) to similar to 0.0001-0.00033 mu m(2) s(-1) upon cholesterol depletion, similar to 30% of all particles falling into the stationary mode. Thus, muscle-type AChR exhibits heterogeneous motional regimes at the cell surface, modulated by the combination of intrinsic (its supramolecular organization) and extrinsic (membrane cholesterol content) factors.	[Barrantes, Francisco J.] Pontifical Catholic Univ Argentina UCA, Biomed Res Inst, Mol Neurobiol Lab, Buenos Aires, DF, Argentina; Natl Sci & Tech Res Council Argentina CONICET, Buenos Aires, DF, Argentina	Pontifical Catholic University of Argentina	Barrantes, FJ (corresponding author), Pontifical Catholic Univ Argentina UCA, Biomed Res Inst, Mol Neurobiol Lab, Buenos Aires, DF, Argentina.	rtfjb1@yahoo.com	Barrantes, Francisco J./HCH-0258-2022	Barrantes, Francisco J./0000-0002-4745-681X; Sanchez, Francisco/0000-0002-8795-168X	PICT from FONCYT [2008-1003, 2011-0604]; Ministry of Science and Technology of Argentina; PIP from the National Scientific and Technical Research Council of Argentina (CONICET) [112-201101-01023]	PICT from FONCYT; Ministry of Science and Technology of Argentina; PIP from the National Scientific and Technical Research Council of Argentina (CONICET)	Grants PICT 2008-1003 and 2011-0604 from FONCYT, Ministry of Science and Technology of Argentina and PIP No. No 112-201101-01023 from the National Scientific and Technical Research Council of Argentina (CONICET) to FJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; AXELROD D, 1980, P NATL ACAD SCI-BIOL, V77, P4823, DOI 10.1073/pnas.77.8.4823; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baier CJ, 2010, EUR BIOPHYS J BIOPHY, V39, P213, DOI 10.1007/s00249-009-0521-2; BARRANTES FJ, 1989, CRIT REV BIOCHEM MOL, V24, P437, DOI 10.3109/10409238909086961; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; BARRANTES FJ, 1979, ANNU REV BIOPHYS BIO, V8, P287, DOI 10.1146/annurev.bb.08.060179.001443; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; Barrantes FJ, 2010, SUBCELL BIOCHEM, V51, P467, DOI 10.1007/978-90-481-8622-8_17; BLOCH RJ, 1989, EXP CELL RES, V182, P583, DOI 10.1016/0014-4827(89)90261-9; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Dedecker P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126008; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; LEIBEL WS, 1987, BIOCHIM BIOPHYS ACTA, V897, P249, DOI 10.1016/0005-2736(87)90421-4; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; McCann CM, 2008, NAT NEUROSCI, V11, P807, DOI 10.1038/nn.2145; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Pediconi MF, 2004, NEUROSCIENCE, V128, P239, DOI 10.1016/j.neuroscience.2004.06.007; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; Piguet J, 2011, J BIOL CHEM, V286, P363, DOI 10.1074/jbc.M110.139782; PUMPLIN DW, 1989, J CELL BIOL, V109, P739, DOI 10.1083/jcb.109.2.739; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Roccamo AM, 1999, EUR J NEUROSCI, V11, P1615, DOI 10.1046/j.1460-9568.1999.00574.x; Rossy J, 2014, HISTOCHEM CELL BIOL; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SAXTON MJ, 1995, BIOPHYS J, V69, P389, DOI 10.1016/S0006-3495(95)79911-8; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Tejedor V, 2010, BIOPHYS J, V98, P1364, DOI 10.1016/j.bpj.2009.12.4282; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006	73	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100346	10.1371/journal.pone.0100346	http://dx.doi.org/10.1371/journal.pone.0100346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971757	Green Published, gold			2022-12-25	WOS:000338512200026
J	Chen, LZ; Li, XY; Huang, H; Xing, W; Guo, W; He, J; Sun, ZY; Luo, AX; Liang, HP; Hu, J; Xu, X; Xu, YS; Wang, ZG				Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Liang, Hua-ping; Hu, Jing; Xu, Xiang; Xu, Yun-sheng; Wang, Zheng-guo			SUMO-2 Promotes mRNA Translation by Enhancing Interaction between eIF4E and eIF4G	PLOS ONE			English	Article							INITIATION-FACTOR 4E; UBIQUITIN-CONJUGATING ENZYME; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PHAS-I; PHOSPHORYLATION; SUMOYLATION; INSULIN; BINDING; IDENTIFICATION	Small ubiquitin-like modifier (SUMO) proteins regulate many important eukaryotic cellular processes through reversible covalent conjugation to target proteins. In addition to its many well-known biological consequences, like subcellular translocation of protein, subnuclear structure formation, and modulation of transcriptional activity, we show here that SUMO-2 also plays a role in mRNA translation. SUMO-2 promoted formation of the active eukaryotic initiation factor 4F (eIF4F) complex by enhancing interaction between Eukaryotic Initiation Factor 4E (eIF4E) and Eukaryotic Initiation Factor 4G (eIF4G), and induced translation of a subset of proteins, such as cyclinD1 and c-myc, which essential for cell proliferation and apoptosis. As expected, overexpression of SUMO-2 can partially cancel out the disrupting effect of 4EGI-1, a small molecule inhibitor of eIF4E/eIF4G interaction, on formation of the eIF4F complex, translation of the cap-dependent protein, cell proliferation and apoptosis. On the other hand, SUMO-2 knockdown via shRNA partially impaired cap-dependent translation and cell proliferation and promoted apoptosis. These results collectively suggest that SUMO-2 conjugation plays a crucial regulatory role in protein synthesis. Thus, this report might contribute to the basic understanding of mammalian protein translation and sheds some new light on the role of SUMO in this process.	[Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; Liang, Hua-ping; Xu, Xiang] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 1, Chongqing, Peoples R China; [Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Liang, Hua-ping; Xu, Xiang; Wang, Zheng-guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Chen, Li-zhao] Third Mil Med Univ, Inst Surg Res, Dept Neurosurg, Chongqing, Peoples R China; [Li, Xiang-yun; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Xu, Xiang] Third Mil Med Univ, Inst Surg Res, Cell Based Biotherapy Ctr, Chongqing, Peoples R China; [Wang, Zheng-guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing, Peoples R China; [Hu, Jing] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Xu, Yun-sheng] Wenzhou Med Coll, Affiliated Hosp 1, Dept Dermatol, Wenzhou, Zhejiang, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wenzhou Medical University	Xu, X (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 1, Chongqing, Peoples R China.	xiangxu@ymail.com; xuyunsh@sohu.com; wangzhg@cae.cn	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	Huang, Hong/0000-0001-7688-3506; xu, xiang/0000-0002-1026-2210	National Natural Science Foundation of China (NSFC) [81172988, 30970651, 30972800]; National Natural Science Foundation of Chongqing [CSTC, 2014yykfB0196]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Chongqing	This study was supported by the National Natural Science Foundation of China (NSFC, No. 81172988; No. 30970651; 30972800) and the National Natural Science Foundation of Chongqing (No. CSTC, 2014yykfB0196). But The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Chen LJ, 2002, TOXICOL SCI, V69, P149, DOI 10.1093/toxsci/69.1.149; Fan SQ, 2010, NEOPLASIA, V12, P346, DOI 10.1593/neo.10144; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HAYSTEAD TAJ, 1994, J BIOL CHEM, V269, P23185; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kim KI, 2006, MOL CELLS, V22, P247; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MADER S, 1995, BIOCHIMIE, V77, P40, DOI 10.1016/0300-9084(96)88102-8; MAKKINJE A, 1995, J BIOL CHEM, V270, P14824, DOI 10.1074/jbc.270.24.14824; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; MORLEY SJ, 1993, BIOCHIMIE, V75, P985, DOI 10.1016/0300-9084(93)90149-M; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PFAHL M, 1990, METHOD ENZYMOL, V189, P256; RINKERSCHAEFFER CW, 1992, J BIOL CHEM, V267, P10659; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Wang J, 2007, BIOCHEM BIOPH RES CO, V363, P63, DOI 10.1016/j.bbrc.2007.08.125; Wang LM, 2004, ONCOL REP, V11, P1319; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Yang W, 2009, BIOCHEM BIOPH RES CO, V382, P215, DOI 10.1016/j.bbrc.2009.03.013	48	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100457	10.1371/journal.pone.0100457	http://dx.doi.org/10.1371/journal.pone.0100457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971752	Green Accepted, gold, Green Published			2022-12-25	WOS:000338512200034
J	Dougherty, MJ; Tran, HM; Stavila, V; Knierim, B; George, A; Auer, M; Adams, PD; Hadi, MZ				Dougherty, Michael J.; Tran, Huu M.; Stavila, Vitalie; Knierim, Bernhard; George, Anthe; Auer, Manfred; Adams, Paul D.; Hadi, Masood Z.			Cellulosic Biomass Pretreatment and Sugar Yields as a Function of Biomass Particle Size	PLOS ONE			English	Article							IONIC LIQUID PRETREATMENT; ENZYMATIC-HYDROLYSIS; LIGNIN CONTENT; DECONSTRUCTION; CELLULASE; ACID; BETA	Three lignocellulosic pretreatment techniques (ammonia fiber expansion, dilute acid and ionic liquid) are compared with respect to saccharification efficiency, particle size and biomass composition. In particular, the effects of switchgrass particle size (32-200) on each pretreatment regime are examined. Physical properties of untreated and pretreated samples are characterized using crystallinity, surface accessibility measurements and scanning electron microscopy (SEM) imaging. At every particle size tested, ionic liquid (IL) pretreatment results in greater cell wall disruption, reduced crystallinity, increased accessible surface area, and higher saccharification efficiencies compared with dilute acid and AFEX pretreatments. The advantages of using IL pretreatment are greatest at larger particle sizes (>75 mu m).	[Dougherty, Michael J.; Tran, Huu M.; Knierim, Bernhard; George, Anthe; Auer, Manfred; Adams, Paul D.; Hadi, Masood Z.] Joint BioEnergy Inst, Emeryville, CA USA; [Dougherty, Michael J.; Tran, Huu M.; Stavila, Vitalie; George, Anthe; Hadi, Masood Z.] Sandia Natl Labs, Livermore, CA USA; [Knierim, Bernhard; Auer, Manfred; Adams, Paul D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hadi, MZ (corresponding author), NASA, Ames Res Ctr, Space BioSci Div, Synthet Biol Program, Moffett Field, CA 94035 USA.	Masood.Hadi@NASA.gov	Stavila, Vitalie/B-6464-2008; Adams, Paul David/A-1977-2013	Stavila, Vitalie/0000-0003-0981-0432; Adams, Paul David/0000-0001-9333-8219	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2010, BIOENERG RES, V3, P134, DOI 10.1007/s12155-010-9087-1; Balan V, 2009, METHODS MOL BIOL, V581, P61, DOI 10.1007/978-1-60761-214-8_5; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Cheng G, 2012, J PHYS CHEM B, V116, P10049, DOI 10.1021/jp304538v; Chundawat SPS, 2007, BIOTECHNOL BIOENG, V96, P219, DOI 10.1002/bit.21132; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dasari RK, 2007, APPL BIOCHEM BIOTECH, V137, P289, DOI 10.1007/s12010-007-9059-x; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Liu HB, 2012, J PHYS CHEM B, V116, P8131, DOI 10.1021/jp301673h; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Papa G, 2012, BIORESOURCE TECHNOL, V117, P352, DOI 10.1016/j.biortech.2012.04.065; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Yeh AI, 2010, CARBOHYD POLYM, V79, P192, DOI 10.1016/j.carbpol.2009.07.049; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	21	21	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100836	10.1371/journal.pone.0100836	http://dx.doi.org/10.1371/journal.pone.0100836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971883	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200067
J	Pedersen, RO; Sandel, B; Svenning, JC				Pedersen, Rasmus Ostergaard; Sandel, Brody; Svenning, Jens-Christian			Macroecological Evidence for Competitive Regional-Scale Interactions between the Two Major Clades of Mammal Carnivores (Feliformia and Caniformia)	PLOS ONE			English	Article							AMERICAN BIOTIC INTERCHANGE; SPATIAL AUTOCORRELATION; LATE-PLEISTOCENE; EVOLUTION; HISTORY; NICHE; SYSTEMATICS; DIVERSITY; RICHNESS; PATTERNS	Geographical gradients in species diversity are often explained by environmental factors such as climate and productivity. Biotic interactions play a key role in evolutionary diversification and may therefore also affect diversity patterns, but this has rarely been assessed. Here, we investigate whether negative competitive interactions shape the diversity patterns of the two major mammalian clades of carnivores, the suborders Caniformia (dogs and allies) and Feliformia (cats and allies) within the order Carnivora. We specifically test for a negative effect of feliform species richness on caniform species richness by a natural experiment, The Great American Interchange, which due to biogeographic lineage history and climate patterns caused tropical South America to be colonized by most caniform families, but only one feliform family. To this end we used regression modelling to investigate feliform and caniform richness patterns and their determinants with emphasis on contrasting the Old and New World tropics. We find that feliform richness is elevated in the Old World Tropics, while caniform richness is elevated in the New World Tropics. Models based on environmental variables alone underpredict caniform richness and overpredict feliform richness in the New World and vice versa in the Old World. We further show that models including feliform richness as a predictor for caniform species richness significantly improve predictions at the continental scale, albeit not at finer scales. Our results are consistent with a negative effect of feliforms on regional-scale caniform diversification within the tropics, probably indicating that niche space occupancy by the one clade constrains diversification in the other in the build-up of regional faunas, while negative interactions at smaller scales may be unimportant due to niche differentiation within the regional faunas.	[Pedersen, Rasmus Ostergaard; Sandel, Brody; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark	Aarhus University	Pedersen, RO (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark.	rasmus.oestergaard.pedersen@gmail.com	Pedersen, Rasmus Ø/AAA-2520-2020; Svenning, Jens-Christian/C-8977-2012	Pedersen, Rasmus Ø/0000-0001-8538-8646; Svenning, Jens-Christian/0000-0002-3415-0862	HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council)) [310886]	HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council))	This article is a contribution of the HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council) Starting Grant 310886 to J. -C. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEXAGON BINNING OVER; Barycka E, 2007, MAMM BIOL, V72, P257, DOI 10.1016/j.mambio.2006.10.011; Berta A, 1998, EVOLUTION TERTIARY M, V1, P243; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bivand R, 2012, SPDEP SPATIAL DEPEND; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; C?lix M., 2018, EUROPEAN RED LIST SA; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kok OB, 2004, BIOL J LINN SOC, V83, P527, DOI 10.1111/j.1095-8312.2004.00409.x; Kurten B., 1980, PLEISTOCENE MAMMALS; KurtUn B., 1968, PLEISTOCENE MAMMALS; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Macdonald D, 2001, NEW ENCY MAMMALS; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; Murphy KM, 1998, URSUS-SERIES, V10, P55; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; R Core Team, 2014, R LANG ENV STAT COMP; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Sommer RS, 2006, J ZOOL, V269, P7, DOI 10.1111/j.1469-7998.2005.00040.x; Tucker C.J., 2004, GLOBAL INVENTORY MOD; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Veron G, 2004, MOL PHYLOGENET EVOL, V30, P582, DOI 10.1016/S1055-7903(03)00229-X; Wang SW, 2009, J ZOOL, V277, P275, DOI 10.1111/j.1469-7998.2008.00537.x; Webb SD, 2006, ANN MO BOT GARD, V93, P245; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	43	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100553	10.1371/journal.pone.0100553	http://dx.doi.org/10.1371/journal.pone.0100553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971629	Green Published, gold			2022-12-25	WOS:000338512200040
J	Afshar, AS; Xu, J; Goutsias, J				Afshar, Ali Sobhi; Xu, Joseph; Goutsias, John			Integrative Identification of Deregulated MiRNA/TF-Mediated Gene Regulatory Loops and Networks in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; SET ENRICHMENT ANALYSIS; TUMOR-SUPPRESSOR P53; TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; RECEPTOR EXPRESSION; C-MYC; COMBINATORIAL REGULATION; TMPRSS2-ERG FUSION	MicroRNAs (miRNAs) have attracted a great deal of attention in biology and medicine. It has been hypothesized that miRNAs interact with transcription factors (TFs) in a coordinated fashion to play key roles in regulating signaling and transcriptional pathways and in achieving robust gene regulation. Here, we propose a novel integrative computational method to infer certain types of deregulated miRNA-mediated regulatory circuits at the transcriptional, post-transcriptional and signaling levels. To reliably predict miRNA-target interactions from mRNA/miRNA expression data, our method collectively utilizes sequence-based miRNA-target predictions obtained from several algorithms, known information about mRNA and miRNA targets of TFs available in existing databases, certain molecular structures identified to be statistically over-represented in gene regulatory networks, available molecular subtyping information, and state-of-the-art statistical techniques to appropriately constrain the underlying analysis. In this way, the method exploits almost every aspect of extractable information in the expression data. We apply our procedure on mRNA/miRNA expression data from prostate tumor and normal samples and detect numerous known and novel miRNA-mediated deregulated loops and networks in prostate cancer. We also demonstrate instances of the results in a number of distinct biological settings, which are known to play crucial roles in prostate and other types of cancer. Our findings show that the proposed computational method can be used to effectively achieve notable insights into the poorly understood molecular mechanisms of miRNA-mediated interactions and dissect their functional roles in cancer in an effort to pave the way for miRNA-based therapeutics in clinical settings.	[Afshar, Ali Sobhi; Xu, Joseph; Goutsias, John] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Goutsias, J (corresponding author), Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA.	goutsias@jhu.edu			National Science Foundation (NSF) [CCF-0849907, CCF-1217213]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the National Science Foundation (NSF) Grants CCF-0849907 and CCF-1217213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Artmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038365; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048474; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldrup Linda, 2012, J Carcinog, V11, P18, DOI 10.4103/1477-3163.104007; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chakraborty S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-236; Chakraborty S, 2012, BIOINFORMATICS, V28, P799, DOI 10.1093/bioinformatics/bts022; Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cooper SJ, 2010, ONCOGENE, V29, P2905, DOI 10.1038/onc.2010.64; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Demichelis F, 2013, NAT MED, V19, P966, DOI 10.1038/nm.3285; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Fisher RA, 1990, STAT METHODS EXPT DE; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gennarino VA, 2011, GENE, V480, P51, DOI 10.1016/j.gene.2011.03.005; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Heinrich EM, 2013, FEBS LETT, V587, P2405, DOI 10.1016/j.febslet.2013.06.008; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kossenkov A, 2003, BIOINFORMATICS, V19, P675, DOI 10.1093/bioinformatics/btg056; Kost JT, 2002, STAT PROBABIL LETT, V60, P183, DOI 10.1016/S0167-7152(02)00310-3; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li J, 2012, BIOINFORMATICS, V28, pI509, DOI 10.1093/bioinformatics/bts387; Li YW, 2012, EPIGENETICS-US, V7, P940, DOI 10.4161/epi.21236; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park SY, 2012, BIOCHEM BIOPH RES CO, V420, P350, DOI 10.1016/j.bbrc.2012.03.001; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Schaefer A, 2008, UROL ONCOL, V28, P4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Sikand K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-21; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Speier W, 2012, BIOINFORMATICS, V28, P2858, DOI 10.1093/bioinformatics/bts530; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Tran DH, 2010, BIOINFORMATION, V4, P371, DOI 10.6026/97320630004371; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vlachos IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/j.clinbiochem.2013.03.006; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; WESTBERG M, 1985, J ROY STAT SOC D-STA, V34, P287; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	123	25	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100806	10.1371/journal.pone.0100806	http://dx.doi.org/10.1371/journal.pone.0100806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968068	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800070
J	Ferrari, N; Mohammed, ZMA; Nixon, C; Mason, SM; Mallon, E; McMillan, DC; Morris, JS; Cameron, ER; Edwards, J; Blyth, K				Ferrari, Nicola; Mohammed, Zahra M. A.; Nixon, Colin; Mason, Susan M.; Mallon, Elizabeth; McMillan, Donald C.; Morris, Joanna S.; Cameron, Ewan R.; Edwards, Joanne; Blyth, Karen			Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TARGETED THERAPIES; TUMOR PROGRESSION; EPITHELIAL-CELLS; IDENTIFICATION; LEUKEMIA; SUBTYPES; PROLIFERATION; INHIBITION; PROTEINS	The RUNX1 transcription factor is widely recognised for its tumour suppressor effects in leukaemia. Recently a putative link to breast cancer has started to emerge, however the function of RUNX1 in breast cancer is still unknown. To investigate if RUNX1 expression was important to clinical outcome in primary breast tumours a tissue microarray (TMA) containing biopsies from 483 patients with primary operable invasive ductal breast cancer was stained by immunohistochemistry. RUNX1 was associated with progesterone receptor (PR)-positive tumours (P < 0.05), more tumour CD4+(P < 0.05) and CD8+(P < 0.01) T-lymphocytic infiltrate, increased tumour CD138+plasma cell (P < 0.01) and more CD68+macrophage infiltrate (P < 0.001). RUNX1 expression did not influence outcome of oestrogen receptor (ER)-positive or HER2-positive disease, however on univariate analysis a high RUNX1 protein was significantly associated with poorer cancer-specific survival in patients with ER-negative (P < 0.05) and with triple negative (TN) invasive breast cancer (P < 0.05). Furthermore, multivariate Cox regression analysis of cancer-specific survival showed a trend towards significance in ER-negative patients (P < 0.1) and was significant in triple negative patients (P < 0.05). Of relevance, triple negative breast cancer currently lacks good biomarkers and patients with this subtype do not benefit from the option of targeted therapy unlike patients with ER-positive or HER2-positive disease. Using multivariate analysis RUNX1 was identified as an independent prognostic marker in the triple negative subgroup. Overall, our study identifies RUNX1 as a new prognostic indicator correlating with poor prognosis specifically in the triple negative subtype of human breast cancer.	[Ferrari, Nicola; Nixon, Colin; Mason, Susan M.; Blyth, Karen] Canc Res UK Beatson Inst, Transgen Models Lab, Glasgow, Lanark, Scotland; [Mohammed, Zahra M. A.; McMillan, Donald C.] Univ Glasgow, Coll Med Vet & Life Sci, Acad Unit Surg, Glasgow, Lanark, Scotland; [Mallon, Elizabeth] So Gen Hosp, Univ Pathol Unit, Glasgow G51 4TF, Lanark, Scotland; [Morris, Joanna S.; Cameron, Ewan R.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Edwards, Joanne] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Blyth, K (corresponding author), Canc Res UK Beatson Inst, Transgen Models Lab, Glasgow, Lanark, Scotland.	K.Blyth@beatson.gla.ac.uk	Ferrari, Nicola/AAO-6180-2020; Edwards, Joanne/J-1903-2015	Ferrari, Nicola/0000-0001-7925-8335; Edwards, Joanne/0000-0002-7192-6906; Blyth, Karen/0000-0002-9304-439X; McMillan, Donald/0000-0003-4260-5334; Mason, Susan/0000-0002-3327-7693	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah TMA, 2013, ANN ONCOL, V24, P2801, DOI 10.1093/annonc/mdt277; Arnedos M, 2012, THER ADV MED ONCOL, V4, P195, DOI 10.1177/1758834012444711; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gorczynski MJ, 2007, CHEM BIOL, V14, P1186, DOI 10.1016/j.chembiol.2007.09.006; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hoi CSL, 2010, MOL CELL BIOL, V30, P2518, DOI 10.1128/MCB.01308-09; Janes KA, 2011, CELL CYCLE, V10, P3461, DOI 10.4161/cc.10.20.18029; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Keita M, 2013, CELL CYCLE, V12, P972, DOI 10.4161/cc.23963; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Mohammed ZMA, 2013, BRIT J CANCER, V109, P1676, DOI 10.1038/bjc.2013.493; Mohammed ZMA, 2012, BRIT J CANCER, V107, P864, DOI 10.1038/bjc.2012.347; Mohammed ZMA, 2013, HUM PATHOL, V44, P1688, DOI 10.1016/j.humpath.2012.11.023; Mohammed ZMA, 2012, HISTOPATHOLOGY, V61, P675, DOI 10.1111/j.1365-2559.2012.04280.x; Mohammed ZMA, 2012, HISTOPATHOLOGY, V61, P283, DOI 10.1111/j.1365-2559.2012.04244.x; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Taniuchi I, 2012, EMBO J, V31, P4098, DOI 10.1038/emboj.2012.282; Thibodeaux CA, 2009, BREAST CANCER RES TR, V116, P281, DOI 10.1007/s10549-008-0127-x; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wotton S, 2002, CANCER RES, V62, P7181; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; Zhou L, 2013, HUM PATHOL, V44, P2180, DOI 10.1016/j.humpath.2013.03.021	40	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100759	10.1371/journal.pone.0100759	http://dx.doi.org/10.1371/journal.pone.0100759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967588	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000338280800064
J	Jin, ZN; Pu, LM; Sun, L; Chen, WJ; Nan, N; Li, H; Zhu, HG; Yang, XM; Wang, NN; Hui, J; Zhang, YR; Zhou, Q; Zhao, F; Yang, F; Shi, XH; Zhu, XQ; Yang, YG; Zhang, WD; Zheng, CG; Li, X; Yang, D; Jia, RF; Meng, S; Yang, Z				Jin, Zening; Pu, Lianmei; Sun, Liang; Chen, Weijun; Nan, Nan; Li, Hong; Zhu, Huagang; Yang, Xinmiao; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhou, Qin; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Zhang, Wandong; Zheng, Chenguang; Li, Xiang; Yang, Duo; Jia, Ruofei; Meng, Shuai; Yang, Ze			Identification of Susceptibility Variants in ADIPOR1 Gene Associated with Type 2 Diabetes, Coronary Artery Disease and the Comorbidity of Type 2 Diabetes and Coronary Artery Disease	PLOS ONE			English	Article							ADIPONECTIN RECEPTOR 1; OVEREXPRESSION; PHENOTYPES; LOCUS	Objective: Adiponectin receptor 1 (encoded by ADIPOR1) is one of the major adiponectin receptors, and plays an important role in glucose and lipid metabolism. However, few studies have reported simultaneous associations between ADIPOR1 variants and type 2 diabetes (T2D), coronary artery disease (CAD) and T2D with CAD. Based on the "common soil'' hypothesis, we investigated whether ADIPOR1 polymorphisms contributed to the etiology of T2D, CAD, or T2D with CAD in a Northern Han Chinese population. Methods: Our multi-disease comparison study enrolled 657 subjects, including 165 with T2D, 173 with CAD, 174 with both T2D and CAD (T2D+CAD), and 145 local healthy controls. Six ADIPOR1 single nucleotide polymorphisms (SNPs) were genotyped and their association with disease risk was analyzed. Results: Multi-case-control comparison identified two ADIPOR1 variants: rs3737884-G, which was simultaneously associated with an increased risk of T2D, CAD, and T2D+CAD (P-value range, 9.80 x 10(-5)-6.30 x 10(-4); odds ratio (OR) range: 1.96-2.42) and 16850797-C, which was separately associated with T2D and T2D+CAD (P-value range: 0.007-0.014; OR range: 1.71-1.77). The risk genotypes of both rs3737884 and 16850797 were consistently associated with common metabolic phenotypes in all three diseases (P-value range: 4.81 x 10(-42)-0.001). We observed an increase in the genetic dose-dependent cumulative risk with increasing risk allele numbers in T2D, CAD and T2D+CAD (P-trend from 1.35 x 10(-5)-0.002). Conclusions: Our results suggest that ADIPOR1 risk polymorphisms are a strong candidate for the " common soil'' hypothesis and could partially contribute to disease susceptibility to T2D, CAD, and T2D with CAD in the Northern Han Chinese population.	[Jin, Zening; Pu, Lianmei; Li, Hong; Zhu, Huagang; Li, Xiang; Yang, Duo; Jia, Ruofei; Meng, Shuai] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessels, Anzhen Hosp, Dept Emergency Med, Beijing, Peoples R China; [Sun, Liang; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Sun, Liang; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Yang, Ze] Chinese Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Chen, Weijun] Capital Med Univ, Beijing Ditan Hosp, Dept Cardiol, Beijing, Peoples R China; [Nan, Nan] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessels, Dept Cardiol, Beijing, Peoples R China; [Yang, Xinmiao] Capital Med Univ, Beijing You An Hosp, Dept Funct Tests, Beijing, Peoples R China; [Zhou, Qin] Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China; [Zhang, Wandong] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Zheng, Chenguang] Guangxi Zhuang Autonomous Region Women & Children, Dept Cardiac Surg, Nanning, Peoples R China	Capital Medical University; Beijing Hospital; Capital Medical University; Capital Medical University; Capital Medical University; National Research Council Canada	Yang, Z (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	yang.ze@live.cn		Zhang, Wandong/0000-0001-6412-8124	Natural Science Foundation of China [30972709, 81061120527, 81241082, 81370445]; Beijing Hospital [BJ-2010-30]; Ministry of Health [10120101]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; National Program from Ministry of Scientific Technology of China, Beijing Nova Program [2012BAI10B01, Z121107002512058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospital; Ministry of Health; National Department Public Benefit Research Foundation by Ministry of Health P. R. China; National Program from Ministry of Scientific Technology of China, Beijing Nova Program	This study was funded by the Natural Science Foundation of China (30972709, 81061120527, 81241082, 81370445), the major funding from Beijing Hospital (BJ-2010-30), funding from the key project of clinical disciplines at the subordinate hospital, Ministry of Health (10120101), National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201302008) and 12th 5-year National Program from Ministry of Scientific Technology (2012BAI10B01) of China, Beijing Nova Program (Z121107002512058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alobeidy BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066976; [Anonymous], 2008, DIABETIC MED, V25, P400, DOI 10.1111/j.1464-5491.2008.02396.x; Damcott CM, 2005, DIABETES, V54, P2245, DOI 10.2337/diabetes.54.7.2245; Kim JT, 2009, CLIN ENDOCRINOL, V70, P66, DOI 10.1111/j.1365-2265.2008.03296.x; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo NL, 2012, DIABETES, V61, pA415; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Mather KJ, 2012, DIABETIC MED, V29, P1579, DOI 10.1111/j.1464-5491.2012.03662.x; Mente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066808; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Qi L, 2007, DIABETES, V56, P1586, DOI 10.2337/db06-1447; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang M, 2013, ATHEROSCLEROSIS, V229, P62, DOI 10.1016/j.atherosclerosis.2013.01.017; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	18	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100339	10.1371/journal.pone.0100339	http://dx.doi.org/10.1371/journal.pone.0100339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967709	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800036
J	Yrttiaho, S; Forssman, L; Kaatiala, J; Leppanen, JM				Yrttiaho, Santeri; Forssman, Linda; Kaatiala, Jussi; Leppanen, Jukka M.			Developmental Precursors of Social Brain Networks: The Emergence of Attentional and Cortical Sensitivity to Facial Expressions in 5 to 7 Months Old Infants	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AMYGDALA; FEARFUL FACES; RESPONSES; DISCRIMINATION; EMOTION; RECOGNITION; PERCEPTION; GAZE; SPECIALIZATION	Biases in attention towards facial cues during infancy may have an important role in the development of social brain networks. The current study used a longitudinal design to examine the stability of infants' attentional biases towards facial expressions and to elucidate how these biases relate to emerging cortical sensitivity to facial expressions. Event-related potential (ERP) and attention disengagement data were acquired in response to the presentation of fearful, happy, neutral, and phase-scrambled face stimuli from the same infants at 5 and 7 months of age. The tendency to disengage from faces was highly consistent across both ages. However, the modulation of this behavior by fearful facial expressions was uncorrelated between 5 and 7 months. In the ERP data, fear-sensitive activity was observed over posterior scalp regions, starting at the latency of the N290 wave. The scalp distribution of this sensitivity to fear in ERPs was dissociable from the topography of face-sensitive modulation within the same latency range. While attentional bias scores were independent of co-registered ERPs, attention bias towards fearful faces at 5 months of age predicted the fear-sensitivity in ERPs at 7 months of age. The current results suggest that the attention bias towards fear could be involved in the developmental tuning of cortical networks for social signals of emotion.	[Yrttiaho, Santeri; Forssman, Linda; Kaatiala, Jussi; Leppanen, Jukka M.] Univ Tampere, Sch Med, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland	Tampere University	Yrttiaho, S (corresponding author), Univ Tampere, Sch Med, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	santeri.yrttiaho@uta.fi		Forssman, Linda/0000-0003-0208-4212; Yrttiaho, Santeri/0000-0002-5724-1222	European Research Council [283763]; Academy of Finland [218284]	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland)	This research was supported by grants from the European Research Council (# 283763) and the Academy of Finland (# 218284) (http://erc.europa.eu/) (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Block J., 1971, LIVES TIME; Borghans L, 2008, J HUM RESOUR, V43, P972; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; BORNSTEIN MH, 1986, CHILD DEV, V57, P87, DOI 10.1111/j.1467-8624.1986.tb00009.x; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cheour M., 2007, INFANT EEG EVENT REL, P19; Coch D., 2012, HDB EVENT RELATED PO, P475; Colombo J, 2012, HDB PSYCHOL, V6, P61; COURCHESNE E, 1981, CHILD DEV, V52, P804, DOI 10.2307/1129080; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; CZIGLER I, 1992, PSYCHOPHYSIOLOGY, V29, P471, DOI 10.1111/j.1469-8986.1992.tb01722.x; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; desHaan M., 2007, INFANT EEG EVENT REL, P78; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Forssman L, 2014, J CHILD PSYCHOL PSYC, V55, P793, DOI 10.1111/jcpp.12181; GOREN CC, 1975, PEDIATRICS, V56, P544; GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.2307/1130197; Grossmann T, 2011, DEV COGN NEUROS-NETH, V1, P57, DOI 10.1016/j.dcn.2010.07.001; Grossmann T, 2009, J COGNITIVE NEUROSCI, V21, P2276, DOI 10.1162/jocn.2009.21188; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Halit H, 2004, J CHILD PSYCHOL PSYC, V45, P1228, DOI 10.1111/j.1469-7610.2004.00321.x; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hoehl S, 2010, DEVELOPMENTAL SCI, V6, P813; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kaatiala J, 2014, BEHAV RES METHODS, V46, P745, DOI 10.3758/s13428-013-0404-4; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; KUCHUK A, 1986, CHILD DEV, V57, P1054; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Leppanen JM, 2015, BEHAV RES METHODS, V47, P538, DOI 10.3758/s13428-014-0473-z; Leppanen JM, 2011, J CHILD PSYCHOL PSYC, V52, P1144, DOI 10.1111/j.1469-7610.2011.02391.x; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; Leventon JS, 2013, DEVELOPMENTAL SCI, V16, P485, DOI 10.1111/desc.12041; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; NELSON CA, 1991, DEV PSYCHOL, V27, P50, DOI 10.1037/0012-1649.27.1.50; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Peltola MJ, 2013, INFANCY, V18, P905, DOI 10.1111/infa.12013; Peltola MJ, 2009, SOC COGN AFFECT NEUR, V4, P134, DOI 10.1093/scan/nsn046; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Peykarjou S, 2013, DEV NEUROPSYCHOL, V38, P272, DOI 10.1080/87565641.2013.786719; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pihko E, 1999, NEUROREPORT, V10, P901, DOI 10.1097/00001756-199904060-00002; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Taylor MJ, 2001, COGNITIVE BRAIN RES, V10, P333, DOI 10.1016/S0926-6410(00)00051-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	70	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100811	10.1371/journal.pone.0100811	http://dx.doi.org/10.1371/journal.pone.0100811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968161	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800071
J	Stotland, NE; Sutton, P; Trowbridge, J; Atchley, DS; Conry, J; Trasande, L; Gerbert, B; Charlesworth, A; Woodruff, TJ				Stotland, Naomi E.; Sutton, Patrice; Trowbridge, Jessica; Atchley, Dylan S.; Conry, Jeanne; Trasande, Leonardo; Gerbert, Barbara; Charlesworth, Annemarie; Woodruff, Tracey J.			Counseling Patients on Preventing Prenatal Environmental Exposures - A Mixed- Methods Study of Obstetricians	PLOS ONE			English	Article							BISPHENOL-A; CHEMICALS; PHTHALATE; DISPARITIES; EXPERIENCE; POLLUTION	Objective: Describe the attitudes, beliefs, and practices of U. S. obstetricians on the topic of prenatal environmental exposures. Study Design: A national online survey of American Congress of Obstetricians and Gynecologists (ACOG) fellows and 3 focus groups of obstetricians. Results: We received 2,514 eligible survey responses, for a response rate of 14%. The majority (78%) of obstetricians agreed that they can reduce patient exposures to environmental health hazards by counseling patients; but 50% reported that they rarely take an environmental health history; less than 20% reported routinely asking about environmental exposures commonly found in pregnant women in the U.S.; and only 1 in 15 reported any training on the topic. Barriers to counseling included: a lack of knowledge of and uncertainty about the evidence; concerns that patients lack the capacity to reduce harmful exposures; and fear of causing anxiety among patients. Conclusion: U.S. obstetricians in our study recognized the potential impact of the environment on reproductive health, and the role that physicians could play in prevention, but reported numerous barriers to counseling patients. Medical education and training, evidence-based guidelines, and tools for communicating risks to patients are needed to support the clinical role in preventing environmental exposures that threaten patient health.	[Stotland, Naomi E.; Sutton, Patrice; Trowbridge, Jessica; Atchley, Dylan S.; Charlesworth, Annemarie; Woodruff, Tracey J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Conry, Jeanne] Amer Coll Congress Obstetricians & Gynecologists, Washington, DC USA; [Conry, Jeanne] Roseville Sacramento Kaiser Permanente, Sacramento, CA USA; [Trasande, Leonardo] NYU, New York, NY USA; [Gerbert, Barbara] Univ Calif San Francisco, Sch Dent, Div Behav Sci Professionalism & Eth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Kaiser Permanente; New York University; University of California System; University of California San Francisco	Stotland, NE (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	stotlandn@obgyn.ucsf.edu	Trasande, Leonardo/ABE-6339-2020	Woodruff, Tracey/0000-0003-3622-1297	National Institute for Environmental Health Sciences [ES018135]; United States Environmental Protection Agency STAR [RD83467801]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P20ES018135] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Environmental Protection Agency STAR(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support for this survey was provided to UCSF Program on Reproductive Health and the Environment by: New York Community Trust, Passport Foundation, Johnson Family Foundation, the National Institute for Environmental Health Sciences (ES018135) and United States Environmental Protection Agency STAR (RD83467801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz G, 2011, AM J PUBLIC HEALTH, V101, pS238, DOI 10.2105/AJPH.2011.300119; Adams C, 2011, J HEALTH SOC BEHAV, V52, P180, DOI 10.1177/0022146510395593; Adler NE, 2009, MILBANK Q, V87, P49, DOI 10.1111/j.1468-0009.2009.00547.x; Altman RG, 2008, J HEALTH SOC BEHAV, V49, P417, DOI 10.1177/002214650804900404; Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; American Congress of Gynecologists and Gynecologists, 2008, 2008 SOC SURV ACOG F; Bellingham M, 2013, SCI ADVISORY COMMITT; California Environmental Protection Agency Office of Environmental Health Hazard Assessment Reproductive and Cancer Hazard Branch, 2007, OCC HLTH HAZ RISK AS; Chenseng L., 2006, ENVIRON HEALTH PERSP, V114, P260, DOI DOI 10.1289/ehp.8418; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gee GC, 2004, ENVIRON HEALTH PERSP, V112, P1645, DOI 10.1289/ehp.7074; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; HEMMINKI K, 1985, TERATOGEN CARCIN MUT, V5, P251, DOI 10.1002/tcm.1770050405; Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008; Kimmel CA, 1984, RELIABILITY EXPT STU; Lubick N, 2011, ENVIRON HEALTH PERSP, V119, pA437; Miller WL, 1999, DOING QUALITATIVE RE; Morello-Frosch R, 2011, HEALTH AFFAIR, V30, P879, DOI 10.1377/hlthaff.2011.0153; Morello-Frosch R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-6; National Research Council (U.S.) Committee on Developmental Toxicology National Research Council (U.S.) Commission on Life Sciences, 2000, SCI FRONT DEV TOX RI; NEMEC MD, 2006, SIGNIFICANCE RELIABI; Newbold R, 2010, ENV IMPACTS REPROD H; NISBET ICT, 1983, CHEM HAZARDS HUMAN R; Raffensperger C., 1999, PROTECTING PUBLIC HL; Rayburn W, 2011, OBSTETRICIAN GYNECOL; Reuben S. H., 2010, REDUCING ENV CANC RI; Rice P., 1999, QUALITATIVE RES METH; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Sathyanarayana S, 2013, J EXPO SCI ENV EPID, V23, P378, DOI 10.1038/jes.2013.9; Sathyanarayana S, 2012, AM J OBSTET GYNECOL, V207, P463, DOI 10.1016/j.ajog.2012.02.004; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Strauss A., 2007, BASICS QUALITATIVE R; Sutton P, 2012, AM J OBSTET GYNECOL, V207, P164, DOI 10.1016/j.ajog.2012.01.034; Trasande L, 2006, J URBAN HEALTH, V83, P760, DOI 10.1007/s11524-006-9071-4; U. S. Environmental Protection Agency, 2007, OFF POLL PREV TOX PR; UCSF Program on Reproductive Health and the Environment, 2012, PROF STAT DAT; US Environmental Protection Agency, 2011, TSCA CHEM SUBST INV; Vogel SA, 2011, HEALTH AFFAIR, V30, P898, DOI 10.1377/hlthaff.2011.0211; Wilson MP, 2009, ENVIRON HEALTH PERSP, V117, P1202, DOI 10.1289/ehp.0800404; Woodruff TJ, 2003, ENVIRON HEALTH PERSP, V111, P942, DOI 10.1289/ehp.5317; Woodruff TJ, 2008, FERTIL STERIL, V89, P281, DOI [10.1016/j.fertnstert.2007.10.002, 10.1016/j.fertnstert.2008.01.065]; Woodruff TJ, 2011, HEALTH AFFAIR, V30, P931, DOI 10.1377/hlthaff.2010.1219; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wu N, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-4	44	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98771	10.1371/journal.pone.0098771	http://dx.doi.org/10.1371/journal.pone.0098771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964083	gold, Green Published			2022-12-25	WOS:000338709500006
J	Wilson, JL; Vachon, VK; Sunita, S; Schwartz, SL; Conn, GL				Wilson, Jo L.; Vachon, Virginia K.; Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.			Dissection of the Adenoviral VA RNA(I) Central Domain Structure Reveals Minimum Requirements for RNA-mediated Inhibition of PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-ASSOCIATED RNA; PROTEIN-KINASE PKR; SELECTIVE 2'-HYDROXYL ACYLATION; STRANDED-RNA; TERTIARY STRUCTURE; BINDING DOMAIN; NONCODING RNA; ACTIVATION; STEM; EVOLUTION	Virus-associated RNA I (VA RNA(I)) is a short (similar to 160-nucleotide) non-coding RNA transcript employed by adenoviruses to subvert the innate immune system protein double-stranded RNA-activated protein kinase (PKR). The central domain of VA RNA(I) is proposed to contain a complex tertiary structure that contributes to its optimal inhibitory activity against PKR. Here we use a combination of VA RNA(I) mutagenesis, structural analyses, as well as PKR activity and binding assays to dissect this tertiary structure and assess its functional role. Our results support the existence of a pH-and Mg2+-dependent tertiary structure involving pseudoknot formation within the central domain. Unexpectedly, this structure appears to play no direct role in PKR inhibition. Deletion of central domain sequences within a minimal but fully active construct lacking the tertiary structure reveals a crucial role in PKR binding and inhibition for nucleotides in the 5' half of the central domain. Deletion of the central domain 3' half also significantly impacts activity but appears to arise indirectly by reducing its capacity to assist in optimally presenting the 5' half sequence. Collectively, our results identify regions of VA RNA(I) critical for PKR inhibition and reveal that the requirements for an effective RNA inhibitor of PKR are simpler than appreciated previously.	[Wilson, Jo L.; Vachon, Virginia K.; Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Subramanian, Sunita/F-9818-2015	subramanian, sunita/0000-0002-0858-9193; Schwartz, Samantha/0000-0002-3378-0184	National Institutes of Health [R21-AI097803]; Emory University Research Council [URC 2010050]; National Science Foundation MRI Program [104177]; Winship Cancer Institute shared resource program; Biochemistry Department of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Council; National Science Foundation MRI Program(National Science Foundation (NSF)); Winship Cancer Institute shared resource program; Biochemistry Department of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grant R21-AI097803. This work was also supported by Emory University Research Council Grant URC 2010050. The Auto-iTC<INF>200</INF> instrument was purchased with support from National Science Foundation MRI Program Grant 104177, the Winship Cancer Institute shared resource program, and the Biochemistry Department of Emory University.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; CLARKE PA, 1994, NUCLEIC ACIDS RES, V22, P4364, DOI 10.1093/nar/22.21.4364; CLARKE PA, 1995, RNA, V1, P7; Coventry VK, 2008, NUCLEIC ACIDS RES, V36, P1645, DOI 10.1093/nar/gkn020; DESAI SY, 1995, J BIOL CHEM, V270, P3454, DOI 10.1074/jbc.270.7.3454; Dzananovic E, 2014, J STRUCT BIOL, V185, P48, DOI 10.1016/j.jsb.2013.11.007; FOWLKES DM, 1980, CELL, V22, P405, DOI 10.1016/0092-8674(80)90351-7; FURTADO MR, 1989, J VIROL, V63, P3423, DOI 10.1128/JVI.63.8.3423-3434.1989; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GHADGE GD, 1994, J VIROL, V68, P4137, DOI 10.1128/JVI.68.7.4137-4151.1994; GHADGE GD, 1991, P NATL ACAD SCI USA, V88, P7140, DOI 10.1073/pnas.88.16.7140; Hargittai MRS, 2000, RNA, V6, P1672, DOI 10.1017/S135583820000128X; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Launer-Felty K, 2014, J MOL BIOL, V426, P1285, DOI 10.1016/j.jmb.2013.12.019; Launer-Felty K, 2010, J MOL BIOL, V402, P638, DOI 10.1016/j.jmb.2010.08.015; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; MA YL, 1993, J VIROL, V67, P6605, DOI 10.1128/JVI.67.11.6605-6617.1993; Ma YL, 1996, RNA, V2, P937; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MELLITS KH, 1988, EMBO J, V7, P2849, DOI 10.1002/j.1460-2075.1988.tb03141.x; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Peery T, 1997, METHODS, V11, P371, DOI 10.1006/meth.1996.0435; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Spanggord RJ, 2002, BIOCHEMISTRY-US, V41, P4511, DOI 10.1021/bi0120594; Spanggord RJ, 2001, BIOCHEMISTRY-US, V40, P4272, DOI 10.1021/bi002512w; Vachon Virginia K, 2012, Methods Mol Biol, V941, P157, DOI 10.1007/978-1-62703-113-4_12; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wahid AM, 2009, NUCLEIC ACIDS RES, V37, P5830, DOI 10.1093/nar/gkp595; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249	41	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23233	23245		10.1074/jbc.M114.550046	http://dx.doi.org/10.1074/jbc.M114.550046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970889	hybrid, Green Published			2022-12-25	WOS:000341017200059
J	Zhai, PF; Wang, F; Su, R; Lin, HS; Jiang, CL; Yang, GH; Yu, J; Zhang, JW				Zhai, Peng-Fei; Wang, Fang; Su, Rui; Lin, Hai-Shuang; Jiang, Chong-Liang; Yang, Gui-Hua; Yu, Jia; Zhang, Jun-Wu			The Regulatory Roles of MicroRNA-146b-5p and Its Target Platelet-derived Growth Factor Receptor alpha (PDGFRA) in Erythropoiesis and Megakaryocytopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ERYTHROID-DIFFERENTIATION; MOUSE DEVELOPMENT; EPITHELIAL-CELLS; IMMUNE FUNCTION; K562 CELLS; EXPRESSION; ACTIVATION; MICRORNAS; GENE	Emerging evidence has shown that microRNAs have key roles in regulating various normal physiological processes, whereas their deregulated expression is correlated with various diseases. The miR-146 family includes miR-146a and miR-146b, with a distinct expression spectrum in different hematopoietic cells. Recent work indicated that miR-146a has a close relationship with inflammation and autoimmune diseases. miR-146-deficient mice have developed some abnormal hematopoietic phenotypes, suggesting the potential functions of miR-146 in hematopoietic development. In this study, we found that miR-146b was consistently up-regulated in both K562 and CD34(+) hematopoietic stem/progenitor cells (HSPCs) undergoing either erythroid or megakaryocytic differentiation. Remarkably, erythroid and megakaryocytic maturation of K562 cells was induced by excess miR-146b but inhibited by decreased miR-146b levels. More importantly, an mRNA encoding receptor tyrosine kinase, namely platelet-derived growth factor receptor alpha (PDGFRA), was identified and validated as a direct target of miR-146b in hematopoietic cells. Gain-of-function and loss-of-function assays showed that PDGFRA functioned as a negative regulator in erythroid and megakaryocytic differentiation. miR-146b could ultimately affect the expression of the GATA-1 gene, which is regulated by HEY1 (Hairy/enhancer-of-split related with YRPW motif protein 1), a transcriptional repressor, via inhibition of the PDGFRA/JNK/JUN/HEY1 pathway. Lentivirus-mediated gene transfer also demonstrated that the overexpression of miR-146b promoted erythropoiesis and megakaryocytopoiesis of HSPCs via its regulation on the PDGFRA gene and effects on GATA-1 expression. Moreover, we confirmed that the binding of GATA-1 to the miR-146b promoter and induction of miR-146b during hematopoietic maturation were dependent on GATA-1. Therefore, miR-146b, PDGFRA, and GATA-1 formed a regulatory circuit to promote erythroid and megakaryocytic differentiation.	Chinese Acad Med Sci, Inst Basic Med Sci, Key State Lab Med Mol Biol, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [Zhang, Jun-Wu] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JW (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	junwu_zhang@pumc.edu.cn	Su, Rui/Y-8157-2018	Su, Rui/0000-0002-4807-6229	National Natural Science Foundation of China [30871249, 31171311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30871249 and 31171311.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Besancon F, 1998, P NATL ACAD SCI USA, V95, P8081, DOI 10.1073/pnas.95.14.8081; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bruchova-Votavova H, 2010, LEUKEMIA LYMPHOMA, V51, P686, DOI 10.3109/10428191003629362; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao YH, 2005, CELL CYCLE, V4, P228; Chen J, 2014, BIOCHEM J, V458, P171, DOI 10.1042/BJ20130628; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Erovic BM, 2012, ENDOCR PATHOL, V23, P221, DOI 10.1007/s12022-012-9222-y; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Kafasla P, 2012, WIRES SYST BIOL MED, V4, P509, DOI 10.1002/wsbm.1179; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin CC, 2014, MOL NEUROBIOL, V49, P658, DOI 10.1007/s12035-013-8547-y; Lokker NA, 1997, J BIOL CHEM, V272, P33037, DOI 10.1074/jbc.272.52.33037; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin CS, 2011, GENOME MED, V3, DOI 10.1186/gm299; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; Smith Clayton, 2003, Cancer Control, V10, P9; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xiong W, 2010, CURR EYE RES, V35, P389, DOI 10.3109/02713680903584686; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	52	43	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22600	22613		10.1074/jbc.M114.547380	http://dx.doi.org/10.1074/jbc.M114.547380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982425	Green Published, hybrid			2022-12-25	WOS:000341017200007
J	Lecomte, M; Hamama, L; Voisine, L; Gatto, J; Helesbeux, JJ; Seraphin, D; Pena-Rodriguez, LM; Richomme, P; Boedo, C; Yovanopoulos, C; Gyomlai, M; Briard, M; Simoneau, P; Poupard, P; Berruyer, R				Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Gatto, Julia; Helesbeux, Jean-Jacques; Seraphin, Denis; Pena-Rodriguez, Luis M.; Richomme, Pascal; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain			Partial Resistance of Carrot to Alternaria dauci Correlates with In Vitro Cultured Carrot Cell Resistance to Fungal Exudates	PLOS ONE			English	Article							DISEASE RESISTANCE; BOTRYTIS-CINEREA; KINASE GENE; ZINNIOL; PHYTOTOXIN; ARABIDOPSIS; METABOLISM; RESPONSES; GROWTH	Although different mechanisms have been proposed in the recent years, plant pathogen partial resistance is still poorly understood. Components of the chemical warfare, including the production of plant defense compounds and plant resistance to pathogen-produced toxins, are likely to play a role. Toxins are indeed recognized as important determinants of pathogenicity in necrotrophic fungi. Partial resistance based on quantitative resistance loci and linked to a pathogen-produced toxin has never been fully described. We tested this hypothesis using the Alternaria dauci - carrot pathosystem. Alternaria dauci, causing carrot leaf blight, is a necrotrophic fungus known to produce zinniol, a compound described as a non-host selective toxin. Embryogenic cellular cultures from carrot genotypes varying in resistance against A. dauci were confronted with zinniol at different concentrations or to fungal exudates (raw, organic or aqueous extracts). The plant response was analyzed through the measurement of cytoplasmic esterase activity, as a marker of cell viability, and the differentiation of somatic embryos in cellular cultures. A differential response to toxicity was demonstrated between susceptible and partially resistant genotypes, with a good correlation noted between the resistance to the fungus at the whole plant level and resistance at the cellular level to fungal exudates from raw and organic extracts. No toxic reaction of embryogenic cultures was observed after treatment with the aqueous extract or zinniol used at physiological concentration. Moreover, we did not detect zinniol in toxic fungal extracts by UHPLC analysis. These results suggest that strong phytotoxic compounds are present in the organic extract and remain to be characterized. Our results clearly show that carrot tolerance to A. dauci toxins is one component of its partial resistance.	[Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] Agrocampus Ouest, UMR IRHS 1345, Angers, France; [Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France; [Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] INRA, UMR IRHS 1345, F-49000 Angers, France; [Gatto, Julia; Helesbeux, Jean-Jacques; Seraphin, Denis; Richomme, Pascal] Univ Angers, UPRES EA921SONAS, SFR QUASAV 4207, Angers, France; [Pena-Rodriguez, Luis M.] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico	Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE; Universite d'Angers; Universite d'Angers; Centro de Investigacion Cientifica de Yucatan	Berruyer, R (corresponding author), Agrocampus Ouest, UMR IRHS 1345, Angers, France.	romain.berruyer@univ-angers.fr	martel, celine/O-6651-2016; Simoneau, Philippe/GPG-0546-2022; Simoneau, Philippe/AAV-4324-2021	martel, celine/0000-0002-1800-4558; Simoneau, Philippe/0000-0002-3890-9848; HELESBEUX, Jean-Jacques/0000-0002-1894-8911; SERAPHIN, DENIS/0000-0002-0509-5788	 [SFR 4207 QUASAV]		M. Lecomte was granted a doctoral fellowship by SFR 4207 QUASAV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2008, MYCOL RES, V112, P241, DOI 10.1016/j.mycres.2007.09.004; BARASH I, 1981, PHYSIOL PLANT PATHOL, V19, P7; Berestetskii AO, 2010, APPL BIOCHEM MICRO+, V46, P75, DOI 10.1134/S0003683810010138; Berruyer R, 2006, PHYTOPATHOLOGY, V96, P346, DOI 10.1094/PHYTO-96-0346; Bessire M, 2007, EMBO J, V26, P2158, DOI 10.1038/sj.emboj.7601658; Bithell A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010392; Boedo C, 2010, PLANT PATHOL, V59, P368, DOI 10.1111/j.1365-3059.2009.02218.x; Boedo C, 2012, PLANT PATHOL, V121, P55; Boedo C, 2008, EUR J PLANT PATHOL, V121, P55, DOI 10.1007/s10658-007-9241-6; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calmes B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00131; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; COTTY PJ, 1983, PHYTOPATHOLOGY, V73, P1326, DOI 10.1094/Phyto-73-1326; COTTY PJ, 1984, PHYTOPATHOLOGY, V74, P785, DOI 10.1094/Phyto-74-785; Dubouzet JG, 2011, PLANT BIOTECHNOL J, V9, P466, DOI 10.1111/j.1467-7652.2010.00568.x; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; GAMBORG OL, 1976, IN VITRO CELL DEV B, V12, P473; George EF, 2008, PLANT PROPAGATION TI, V1; Graf E, 2012, INT J FOOD MICROBIOL, V157, P353, DOI 10.1016/j.ijfoodmicro.2012.06.004; Green VS, 2006, SOIL BIOL BIOCHEM, V38, P693, DOI 10.1016/j.soilbio.2005.06.020; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lai ZB, 2013, CURR OPIN PLANT BIOL, V16, P505, DOI 10.1016/j.pbi.2013.06.014; Lecomte M, 2012, PHYSIOL MOL PLANT P, V80, P58, DOI 10.1016/j.pmpp.2012.10.002; Lima MRM, 2012, EUR J PLANT PATHOL, V132, P133, DOI 10.1007/s10658-011-9857-4; MARTIN JA, 1980, TETRAHEDRON, V36, P791, DOI 10.1016/S0040-4020(01)93696-8; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Montemurro N., 1992, ALTERNARIA, P449; Montillet JL, 1986, DOSAGE RADIOIMMUNOLO; Qui JA, 2010, J GEN PLANT PATHOL, V76, P94, DOI 10.1007/s10327-010-0222-9; REINERT J, 1958, NATURWISSENSCHAFTEN, V45, P344, DOI 10.1007/BF00640240; Repka V, 2006, BIOL PLANTARUM, V50, P94, DOI 10.1007/s10535-005-0080-z; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; Schweizer P, 2011, MOL PLANT MICROBE IN, V24, P1492, DOI 10.1094/MPMI-05-11-0107; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Somma S, 2011, INT J FOOD MICROBIOL, V145, P414, DOI 10.1016/j.ijfoodmicro.2011.01.006; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; STEWARD FC, 1958, AM J BOT, V45, P705, DOI 10.2307/2439728; Steward N, 1999, PLANT CELL REP, V19, P171, DOI 10.1007/s002990050729; SUGAWARA F, 1986, PLANT SCI, V43, P19, DOI 10.1016/0168-9452(86)90102-0; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; THULEAU P, 1988, P NATL ACAD SCI USA, V85, P5932, DOI 10.1073/pnas.85.16.5932; Vitecek J, 2007, SENSORS-BASEL, V7, P222, DOI 10.3390/s7030222; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Zhang Y, 2013, J GENET GENOMICS, V40, P23, DOI 10.1016/j.jgg.2012.11.003; Zheng L, 2010, PLANT DIS, V94, P1231, DOI 10.1094/PDIS-03-10-0183; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	58	13	14	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101008	10.1371/journal.pone.0101008	http://dx.doi.org/10.1371/journal.pone.0101008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983469	Green Published, gold			2022-12-25	WOS:000339635000045
J	Aglieri, G; Papetti, C; Zane, L; Milisenda, G; Boero, F; Piraino, S				Aglieri, Giorgio; Papetti, Chiara; Zane, Lorenzo; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano			First Evidence of Inbreeding, Relatedness and Chaotic Genetic Patchiness in the Holoplanktonic Jellyfish Pelagia noctiluca (Scyphozoa, Cnidaria)	PLOS ONE			English	Article							URCHIN STRONGYLOCENTROTUS-PURPURATUS; BARNACLE SEMIBALANUS-BALANOIDES; MICROSATELLITE NULL ALLELES; WESTERN MEDITERRANEAN-SEA; LONG-TERM FLUCTUATIONS; REPRODUCTIVE SUCCESS; PARENTAGE ANALYSIS; MARINE FISH; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD	Genetic drift and non-random mating seldom influence species with large breeding populations and high dispersal potential, characterized by unstructured gene pool and panmixia at a scale lower than the minimum dispersal range of individuals. In the present study, a set of nine microsatellite markers was developed and used to investigate the spatio-temporal genetic patterns of the holoplanktonic jellyfish Pelagia noctiluca (Scyphozoa) in the Southern Tyrrhenian Sea. Homozygote excess was detected at eight loci, and individuals exhibited intra-population relatedness higher than expected by chance in at least three samples. This result was supported by the presence of siblings in at least 5 out 8 samples, 4 of which contained full-sib in addition to half-sib dyads. Having tested and ruled out alternative explanations as null alleles, our results suggest the influence of reproductive and behavioural features in shaping the genetic structure of P. noctiluca, as outcomes of population genetics analyses pointed out. Indeed, the genetic differentiation among populations was globally small but highlighted: a) a spatial genetic patchiness uncorrelated with distance between sampling locations, and b) a significant genetic heterogeneity between samples collected in the same locations in different years. Therefore, despite its extreme dispersal potential, P. noctiluca does not maintain a single homogenous population, but rather these jellyfish appear to have intra-bloom localized recruitment and/or individual cohesiveness, whereby siblings more likely swarm together as a single group and remain close after spawning events. These findings provide the first evidence of family structures and consequent genetic patchiness in a species with highly dispersive potential throughout its whole life cycle, contributing to understanding the patterns of dispersal and connectivity in marine environments.	[Aglieri, Giorgio; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy; [Aglieri, Giorgio; Papetti, Chiara; Zane, Lorenzo; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare CoNISMa, Rome, Italy; [Papetti, Chiara; Zane, Lorenzo] Univ Padua, Dipartimento Biol, Padua, Italy; [Papetti, Chiara] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Boero, Ferdinando] Inst Marine Sci CNR ISMAR, Italian Natl Res Council, Genoa, Italy	University of Salento; CoNISMa; University of Padua; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Aglieri, G (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy.	giorgio.aglieri@unisalento.it	Milisenda, Giacomo/L-6882-2019; Piraino, Stefano/J-5234-2012; Aglieri, Giorgio/AAF-1632-2019; Zane, Lorenzo/G-6249-2010; CNR, Ismar/P-1247-2014	Milisenda, Giacomo/0000-0003-1334-9749; Piraino, Stefano/0000-0002-8752-9390; Zane, Lorenzo/0000-0002-6963-2132; Papetti, Chiara/0000-0002-4567-459X; Aglieri, Giorgio/0000-0002-5831-9706; Boero, Ferdinando/0000-0002-6317-2710; CNR, Ismar/0000-0001-5351-1486	European Community [266445]; STFC [ST/K000977/1] Funding Source: UKRI	European Community(European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS - http://www.marine-vectors.eu). Logistic/technical support was also provided by the FP7 EU projects COCONET, PERSEUS, the ENPI-CBCMED programme MED-JELLYRISK, and by the Italian Flagship project RITMARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; AVIAN M, 1986, B ZOOL, V53, P385; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Belkhir K, 1996, 5000 CNRS UMR; Bernardi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044953; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; BOERO F, 1994, MAR ECOL-P S Z N I, V15, P3, DOI 10.1111/j.1439-0485.1994.tb00038.x; Boero F., 2013, GFCM STUDIES REV, V92; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Calderon I, 2012, MAR BIOL, V159, P187, DOI 10.1007/s00227-011-1799-z; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Canepa Antonio, 2014, P237; CARGO DAVID G., 1967, CHESAPEAKE SCI, V8, P209, DOI 10.2307/1350339; CARSON HL, 1975, AM NAT, V109, P83, DOI 10.1086/282975; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; David P, 1997, EVOLUTION, V51, P1318, DOI 10.1111/j.1558-5646.1997.tb03979.x; Dawson MN, 1998, MOL MAR BIOL BIOTECH, V7, P145; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Della Tommasa L, 2000, HYDROBIOLOGIA, V440, P249, DOI 10.1023/A:1004139715482; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Edmands S, 1996, MAR BIOL, V126, P443, DOI 10.1007/BF00354626; Eldon B, 2006, GENETICS, V172, P2621, DOI 10.1534/genetics.105.052175; Eldon B, 2009, GENETICS, V181, P615, DOI 10.1534/genetics.108.094342; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Giorgi R, 1991, JELLYFISH BLOOMS MED, P102; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; GOUDET J., 2001, FSTAT VERSION 2 9 3; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Hansson LJ, 2003, J MAR BIOL ASSOC UK, V83, P923, DOI 10.1017/S0025315403008063h; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hickey B.M, 1995, SOEST SPECIAL PUBLIC, P95; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hood GM, 2010, POPTOLLS VERSION 3 2; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; Ishii Haruto, 2004, Plankton Biology and Ecology, V51, P26; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1993, MAR BIOL, V117, P91, DOI 10.1007/BF00346429; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Jolly MT, 2003, HELGOLAND MAR RES, V56, P238, DOI 10.1007/s10152-002-0123-1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; Laurent V, 2007, BIOL J LINN SOC, V90, P591, DOI 10.1111/j.1095-8312.2007.00747.x; Lee PLM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0920; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Magalon H, 2005, MOL ECOL, V14, P1861, DOI 10.1111/j.1365-294X.2005.02430.x; Malej A, 2004, NATO SCI S SS IV EAR, V35, P273; MALEJ A, 1993, MAR BIOL, V116, P565, DOI 10.1007/BF00355475; MALEJ A, 1992, OLSEN INT S, P215; MALEJ A, 1989, J EXP MAR BIOL ECOL, V126, P259, DOI 10.1016/0022-0981(89)90191-3; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; Marino IAM, 2010, ESTUAR COAST SHELF S, V87, P135, DOI 10.1016/j.ecss.2010.01.003; McClintock JB, 2001, MARINE CHEM ECOLOGY; Miller BJ, 2012, AFR J MAR SCI, V34, P425, DOI 10.2989/1814232X.2012.726646; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; MILLOT C, 1991, DYNAM ATMOS OCEANS, V15, P179, DOI 10.1016/0377-0265(91)90020-G; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Moberg PE, 2000, MAR BIOL, V136, P773, DOI 10.1007/s002270000281; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Papetti C, 2013, ICES J MAR SCI, V70, P387, DOI 10.1093/icesjms/fss201; Parrish R.H., 1981, Biological Oceanography, V1, P175; Planes S, 2002, MOL ECOL, V11, P1515, DOI 10.1046/j.1365-294X.2002.01521.x; Puig P, 2000, DEEP-SEA RES PT I, V47, P343, DOI 10.1016/S0967-0637(99)00062-X; Pujolar JM, 2009, J FISH BIOL, V74, P2034, DOI 10.1111/j.1095-8649.2009.02267.x; Pujolar JM, 2011, MOL PHYLOGENET EVOL, V58, P198, DOI 10.1016/j.ympev.2010.11.019; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 1996, CAN J FISH AQUAT SCI, V53, P2695, DOI 10.1139/cjfas-53-12-2695; SANDRINI LR, 1991, HYDROBIOLOGIA, V216, P197, DOI 10.1007/BF00026462; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Toonen RJ, 2011, CRUSTACEAN ISS, V19, P75; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; VERMEIJ GJ, 1987, EVOLUTION, V41, P1046, DOI 10.1111/j.1558-5646.1987.tb05875.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waples RS, 2011, MOL ECOL RESOUR, V11, P162, DOI 10.1111/j.1755-0998.2010.02942.x; WATTS RJ, 1990, MAR BIOL, V105, P145, DOI 10.1007/BF01344280; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS, 1996, GENETIC DATA ANAL 2, VII; WRIGHT S, 1922, AM NAT, V56, P836; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187; ZAVODNIK D, 1987, MAR BIOL, V94, P265, DOI 10.1007/BF00392939; Zavodnik D., 1991, JELLYFISH BLOOMS MED, P212	116	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99647	10.1371/journal.pone.0099647	http://dx.doi.org/10.1371/journal.pone.0099647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977703	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400006
J	Mitchell, P; Bressler, N; Doan, QV; Dolan, C; Ferreira, A; Osborne, A; Rochtchina, E; Danese, M; Colman, S; Wong, TY				Mitchell, Paul; Bressler, Neil; Doan, Quan V.; Dolan, Chantal; Ferreira, Alberto; Osborne, Aaron; Rochtchina, Elena; Danese, Mark; Colman, Shoshana; Wong, Tien Y.			Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; OLDER-ADULTS; RESOURCE UTILIZATION; INJURIOUS FALLS; LEGAL BLINDNESS; PUBLIC-HEALTH; BURDEN; MACULOPATHY; LIMITATIONS; POPULATION	Intravitreal injections of anti-vascular endothelial growth factor agents, such as ranibizumab, have significantly improved the management of neovascular age-related macular degeneration. This study used patient-level simulation modelling to estimate the number of individuals in Australia who would have been likely to avoid legal blindness or visual impairment due to neovascular age-related macular degeneration over a 2-year period as a result of intravitreal ranibizumab injections. The modelling approach used existing data for the incidence of neovascular age-related macular degeneration in Australia and outcomes from ranibizumab trials. Blindness and visual impairment were defined as visual acuity in the better-seeing eye of worse than 6/60 or 6/12, respectively. In 2010, 14 634 individuals in Australia were estimated to develop neovascular age-related macular degeneration who would be eligible for ranibizumab therapy. Without treatment, 2246 individuals would become legally blind over 2 years. Monthly 0.5 mg intravitreal ranibizumab would reduce incident blindness by 72% (95% simulation interval, 70-74%). Ranibizumab given as needed would reduce incident blindness by 68% (64-71%). Without treatment, 4846 individuals would become visually impaired over 2 years; this proportion would be reduced by 37% (34-39%) with monthly intravitreal ranibizumab, and by 28% (23-33%) with ranibizumab given as needed. These data suggest that intravitreal injections of ranibizumab, given either monthly or as needed, can substantially lower the number of cases of blindness and visual impairment over 2 years after the diagnosis of neovascular age-related macular degeneration.	[Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Dept Ophthalmol, Westmead, NSW 2145, Australia; [Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Bressler, Neil] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Doan, Quan V.; Danese, Mark] Outcomes Insights Inc, Westlake Village, CA USA; [Dolan, Chantal] CMD Consulting Inc, Sandy, UT USA; [Ferreira, Alberto; Osborne, Aaron] Novartis, Basel, Switzerland; [Colman, Shoshana] Genentech Inc, San Francisco, CA 94080 USA; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Parkville, Vic 3052, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Johns Hopkins University; Johns Hopkins Medicine; Roche Holding; Genentech; National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; University of Melbourne	Mitchell, P (corresponding author), Univ Sydney, Dept Ophthalmol, Westmead, NSW 2145, Australia.	paul.mitchell@sydney.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014	Wong, Tien Yin/0000-0002-8448-1264; 	Novartis AG; Genentech, Inc.	Novartis AG; Genentech, Inc.(Roche HoldingGenentech)	This study was funded by Novartis AG and Genentech, Inc. Novartis AG and Genentech, Inc. participated in the design and conduct of the study, in the distribution of the raw data to Outcomes Insights, in the analysis and interpretation of the data and in the preparation of the manuscript. Novartis AG and Genentech, Inc. reviewed the manuscript before submission. Third-party medical writing assistance, but not editorial content sufficient to meet International Committee of Medical Journal Editors (ICMJE) authorship criteria, was funded by Novartis AG.	Abedi F, 2014, RETINA; Australian Bureau of Statistics, 2010, 33020 AUSTR BUR STAT; Australian Bureau of Statistics, 2010, 32010 AUSTR BUR STAT; Australian Institute of Health and Welfare, 2005, BULLETIN, V27; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Campbell JP, 2012, ARCH OPHTHALMOL-CHIC, V130, P794, DOI 10.1001/archophthalmol.2011.2480; Cheung N, 2012, AM J OPHTHALMOL, V153, P193, DOI 10.1016/j.ajo.2011.11.022; Cruess A, 2007, CAN J OPHTHALMOL, V42, P836, DOI 10.3129/i07-153; Gillies MC, 2014, OPHTHALMOLOGY, V121, P676, DOI 10.1016/j.ophtha.2013.09.050; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; Macular Degeneration Foundation, 2011, EYES FUT; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Popescu ML, 2011, INVEST OPHTH VIS SCI, V52, P7168, DOI 10.1167/iovs.11-7564; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Skaat A, 2012, AM J OPHTHALMOL, V153, P214, DOI 10.1016/j.ajo.2011.08.035; Soubrane G, 2007, ARCH OPHTHALMOL-CHIC, V125, P1249, DOI 10.1001/archopht.125.9.1249; Szabo SM, 2010, OSTEOPOROSIS INT, V21, P855, DOI 10.1007/s00198-009-1025-8; Tufail A, 2014, OPHTHALMOLOGY, V121, P1092, DOI 10.1016/j.ophtha.2013.11.031; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644	30	41	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101072	10.1371/journal.pone.0101072	http://dx.doi.org/10.1371/journal.pone.0101072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979237	Green Published, gold			2022-12-25	WOS:000338506400072
J	Dohn, MN; Pilkington, H				Dohn, Michael N.; Pilkington, Hugo			Sharing Medicine: The Candidacy of Medicines and Other Household Items for Sharing, Dominican Republic	PLOS ONE			English	Article							PRESCRIPTION-MEDICATION; ADVERTISEMENTS; COMMODITIES; EXCHANGE; EXPOSURE; SMOKING; GIFTS	Background: People share medicines and problems can result from this behavior. Successful interventions to change sharing behavior will require understanding people's motives and purposes for sharing medicines. Better information about how medicines fit into the gifting and reciprocity system could be useful in designing interventions to modify medicine sharing behavior. However, it is uncertain how people situate medicines among other items that might be shared. This investigation is a descriptive study of how people sort medicines and other shareable items. Methods and Findings: This study in the Dominican Republic examined how a convenience sample (31 people) sorted medicines and rated their shareability in relation to other common household items. We used non-metric multidimensional scaling to produce association maps in which the distances between items offer a visual representation of the collective opinion of the participants regarding the relationships among the items. In addition, from a pile sort constrained by four categories of whether sharing or loaning the item was acceptable (on a scale from not shareable to very shareable), we assessed the degree to which the participants rated the medicines as shareable compared to other items. Participants consistently grouped medicines together in all pile sort activities; yet, medicines were mixed with other items when rated by their candidacy to be shared. Compared to the other items, participants had more variability of opinion as to whether medicines should be shared. Conclusions: People think of medicines as a distinct group, suggesting that interventions might be designed to apply to medicines as a group. People's differing opinions as to whether it was appropriate to share medicines imply a degree of uncertainty or ambiguity that health promotion interventions might exploit to alter attitudes and behaviors. These findings have implications for the design of health promotion interventions to impact medicine sharing behavior.	[Dohn, Michael N.] Nica Episcopal Esperanza & Caridad, Community Hlth, San Pedro De Macoris, Dominican Rep; [Dohn, Michael N.] Soc Anglican Missionaries & Senders, Ambridge, PA USA; [Pilkington, Hugo] Univ Paris 08, Dept Geog, St Denis, France; [Pilkington, Hugo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Universite Paris-VIII; University of London; London School of Hygiene & Tropical Medicine	Dohn, MN (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Community Hlth, Ctr Global Hlth, Dayton, OH 45435 USA.	michael.dohn@wright.edu		Pilkington, Hugo/0000-0002-8245-2806				Amare G, 1997, E AFR MED J, V74, P362; [Anonymous], MED ANTHR Q; Appadurai A., 1986, SOCIAL LIFE THINGS; Arnett JJ, 1998, TOB CONTROL, V7, P129, DOI 10.1136/tc.7.2.129; BERNARD HR, 2006, RES METHODS CULTURAL, P299; Bernard HR, 2006, RES METHODS ANTHR, P649; CARRIER J, 1991, SOCIOL FORUM, V6, P119, DOI 10.1007/BF01112730; Daniel KL, 2003, PEDIATRICS, V111, P1167; DARNELL JC, 1986, J AM GERIATR SOC, V34, P1; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dohn MN, 2007, AM J TROP MED HYG, V77, P40; Dohn MN, 2012, J RELIG HLTH, V51; Dumit Joseph, 2010, Anthropol Med, V17, P245, DOI 10.1080/13648470.2010.493708; Ellis J, 2009, AUST FAM PHYSICIAN, V38, P816; FOSTER GM, 1961, AM ANTHROPOL, V63, P1173, DOI 10.1525/aa.1961.63.6.02a00020; Garnier LM, 2010, J CLIN PSYCHIAT, V71, P262, DOI 10.4088/JCP.09m05189ecr; Goldsworthy RC, 2008, AM J PUBLIC HEALTH, V98, P1115, DOI 10.2105/AJPH.2007.123257; Goldsworthy RC, 2009, J ADOLESCENT HEALTH, V45, P634, DOI 10.1016/j.jadohealth.2009.06.002; Goulding E, 2011, IRISH J MED SCI, V180, P687, DOI 10.1007/s11845-011-0698-0; Green J, 2005, PRINCIPLES SOCIAL RE, P23; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Holloway K., 2011, WORLD MED SITUATION; Kirkwood B. R., 2003, MED STAT; Kleinman Arthur, 1995, WRITING MARGIN DISCO; Lapavitsas C, 2004, SCI SOC, V68, P33, DOI 10.1521/siso.68.1.33.25757; Leeson PT, 2008, J LEGAL STUD, V37, P161, DOI 10.1086/588262; Mauss M, 1950, ESSAI SER DON; McCabe SE, 2005, ADDICT BEHAV, V30, P1342, DOI 10.1016/j.addbeh.2005.01.012; Mitchell AA, 2008, AM J PUBLIC HEALTH, V98, P1926, DOI 10.2105/AJPH.2008.144261; Nutbeam D, 2006, HLTH PROMOTION THEOR, P24; Page RM, 2009, J PEDIATR HEALTH CAR, V23, P150, DOI 10.1016/j.pedhc.2008.01.006; Petersen EE, 2008, J WOMENS HEALTH, V17, P1073, DOI 10.1089/jwh.2007.0769; Pierce JP, 1999, TOB CONTROL, V8, P37, DOI 10.1136/tc.8.1.37; Planta MB, 2007, J AM BOARD FAM MED, V20, P533, DOI 10.3122/jabfm.2007.06.070019; Pool R, 2005, MED ANTHROPOL, P88; Pool R, 2005, MED ANTHROPOL, P39; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Rouse Carolyn, 2010, Anthropol Med, V17, P187, DOI 10.1080/13648470.2010.493602; Rus A., 2008, ANTHROPOL NOTEB, V14, P81; Tanne JH, 1996, BRIT MED J, V313, P1349, DOI 10.1136/bmj.313.7069.1349a; van der Geest S, 1990, HLTH POLICY PLANNING, V5, P182; van der Geest S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-48; vanderGeest S, 1996, ANNU REV ANTHROPOL, V25, P153, DOI 10.1146/annurev.anthro.25.1.153; Ward L, 2011, J URBAN HEALTH, V88, P997, DOI 10.1007/s11524-011-9589-y; Whyte SR, 2002, SOCIAL LIVES MED	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101007	10.1371/journal.pone.0101007	http://dx.doi.org/10.1371/journal.pone.0101007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971939	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200083
J	Piyatrakul, P; Yang, M; Putranto, RA; Pirrello, J; Dessailly, F; Hu, SN; Summo, M; Theeravatanasuk, K; Leclercq, J; Kuswanhadi; Montoro, P				Piyatrakul, Piyanuch; Yang, Meng; Putranto, Riza-Arief; Pirrello, Julien; Dessailly, Florence; Hu, Songnian; Summo, Marilyne; Theeravatanasuk, Kannikar; Leclercq, Julie; Kuswanhadi; Montoro, Pascal			Sequence and Expression Analyses of Ethylene Response Factors Highly Expressed in Latex Cells from Hevea brasiliensis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; END RULE PATHWAY; RUBBER-TREE; TRANSCRIPTION FACTORS; SUBMERGENCE TOLERANCE; AP2/ERF SUPERFAMILY; FREEZING TOLERANCE; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; NATURAL VARIATION	The AP2/ERF superfamily encodes transcription factors that play a key role in plant development and responses to abiotic and biotic stress. In Hevea brasiliensis, ERF genes have been identified by RNA sequencing. This study set out to validate the number of HbERF genes, and identify ERF genes involved in the regulation of latex cell metabolism. A comprehensive Hevea transcriptome was improved using additional RNA reads from reproductive tissues. Newly assembled contigs were annotated in the Gene Ontology database and were assigned to 3 main categories. The AP2/ERF superfamily is the third most represented compared with other transcription factor families. A comparison with genomic scaffolds led to an estimation of 114 AP2/ERF genes and 1 soloist in Hevea brasiliensis. Based on a phylogenetic analysis, functions were predicted for 26 HbERF genes. A relative transcript abundance analysis was performed by real-time RT-PCR in various tissues. Transcripts of ERFs from group I and VIII were very abundant in all tissues while those of group VII were highly accumulated in latex cells. Seven of the thirty-five ERF expression marker genes were highly expressed in latex. Subcellular localization and transactivation analyses suggested that HbERF-VII candidate genes encoded functional transcription factors.	[Piyatrakul, Piyanuch; Putranto, Riza-Arief; Pirrello, Julien; Dessailly, Florence; Summo, Marilyne; Leclercq, Julie; Montoro, Pascal] Ctr Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Piyatrakul, Piyanuch; Theeravatanasuk, Kannikar] Rubber Res Inst, Dept Agr, Bangkok, Thailand; [Yang, Meng; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Putranto, Riza-Arief] Indonesian Biotechnol Res Inst Estate Crops, Bogor, Indonesia; [Kuswanhadi] Indonesian Rubber Res Inst, Sembawa Res Ctr, Palembang, Indonesia	CIRAD; Universite de Montpellier; Ministry of Agriculture & Cooperatives - Thailand; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI)	Montoro, P (corresponding author), Ctr Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	pascal.montoro@cirad.fr	Summo, Marilyne/AAR-1367-2021; Pirrello, Julien/AAI-1692-2020; Putranto, Riza-Arief/X-3130-2019; Leclercq, Julie/B-2147-2012; Hu, Songnian/C-6509-2013	Summo, Marilyne/0000-0002-9308-974X; Pirrello, Julien/0000-0002-5725-885X; Putranto, Riza-Arief/0000-0002-1327-1200; Hu, Songnian/0000-0003-3966-3111; Leclercq, Julie/0000-0001-8110-3762; , Meng/0000-0002-2672-3069	Rubber Research Institute of Thailand; Institut Francais du Caoutchouc; Michelin company; Socfinco company; SIPH company	Rubber Research Institute of Thailand; Institut Francais du Caoutchouc; Michelin company; Socfinco company; SIPH company	This work was supported by the Rubber Research Institute of Thailand, the Institut Francais du Caoutchouc, and the Michelin, Socfinco and SIPH companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; [Anonymous], SURVEY BRANCH SUPPOR; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Azar S, 2012, FACTEURS TRANSCRIPTI; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Byrne M, 1997, THEOR APPL GENET, V95, P975, DOI 10.1007/s001220050650; Cai HB, 2008, TROPICAL AGR SCI TEC, V31, P424; CAZAUX E, 1995, PLANT CELL TISS ORG, V41, P211, DOI 10.1007/BF00045084; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chen YY, 2012, MOL BIOL REP, V39, P3713, DOI 10.1007/s11033-011-1146-y; Chow KS, 2007, J EXP BOT, V58, P2429, DOI 10.1093/jxb/erm093; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Chrestin H, 1997, EUPHYTICA, V96, P77, DOI 10.1023/A:1002950300536; Chrestin H., 1989, PHYSL RUBBER TREE LA, P431; CHYE ML, 1992, PLANT MOL BIOL, V19, P473, DOI 10.1007/BF00023395; D'Auzac J., 1989, PHYSL RUBBER TREE LA; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etchells JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002997; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Fukao T, 2013, CURR OPIN PLANT BIOL, V16, P196, DOI 10.1016/j.pbi.2013.02.003; Fukao T, 2012, PLANT PHYSIOL, V160, P1795, DOI 10.1104/pp.112.207738; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; Gery C, 2011, PLANT SCI, V180, P12, DOI 10.1016/j.plantsci.2010.07.010; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; GIDROL X, 1994, J BIOL CHEM, V269, P9278; GIDROL X, 1988, PLANT PHYSIOL, V86, P899, DOI 10.1104/pp.86.3.899; Girardi CL, 2013, SCI HORTIC-AMSTERDAM, V151, P112, DOI 10.1016/j.scienta.2012.12.017; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han KH, 2000, TREE PHYSIOL, V20, P503; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hess N, 2011, PHYSIOL PLANTARUM, V143, P41, DOI 10.1111/j.1399-3054.2011.01486.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob J.L., 1989, PHYSL RUBBER TREE LA, P101; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Ko JH, 2003, PLANT MOL BIOL, V53, P479, DOI 10.1023/B:PLAN.0000019119.66643.5d; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuswanhadi, 2010, J RUBBER RES, V13, P185; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lertpanyasampatha M, 2012, PLANTA, V236, P437, DOI 10.1007/s00425-012-1622-1; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HY, 2008, J EXP BOT, V59, P3997, DOI 10.1093/jxb/ern241; Licausi F, 2013, J INTEGR PLANT BIOL, V55, P31, DOI 10.1111/jipb.12011; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liengprayoon S, 2011, PHYTOCHEMISTRY, V72, P1902, DOI 10.1016/j.phytochem.2011.04.023; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Pan L, 2001, FEBS LETT, V508, P375, DOI 10.1016/S0014-5793(01)03098-8; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Park HY, 2011, BIOCHEM BIOPH RES CO, V414, P135, DOI 10.1016/j.bbrc.2011.09.039; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Perata P, 2007, TRENDS PLANT SCI, V12, P43, DOI 10.1016/j.tplants.2006.12.005; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; PUJADERENAUD V, 1994, PLANT PHYSIOL, V105, P127, DOI 10.1104/pp.105.1.127; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sambrook J., 2002, MOL CLONING LAB MANU; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schmitz AJ, 2013, NEW PHYTOL, V198, P1060, DOI 10.1111/nph.12202; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Thevenin J, 2012, NEW PHYTOL, V193, P504, DOI 10.1111/j.1469-8137.2011.03936.x; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Tupy J., 1989, PHYSL RUBBER TREE LA, P179; Venkatachalam P, 2009, MOL BIOTECHNOL, V41, P42, DOI 10.1007/s12033-008-9095-y; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Wu H., 2010, CHINESE AGR SCI B, V5; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zhang CH, 2012, GENET MOL RES, V11, P4789, DOI 10.4238/2012.October.17.6; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738; Zhu L, 2013, PLANT PHYSIOL, V161, P904, DOI 10.1104/pp.112.204487; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	104	31	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99367	10.1371/journal.pone.0099367	http://dx.doi.org/10.1371/journal.pone.0099367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971876	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200010
J	Zhang, Y; Tian, XY; Ji, H; Guan, XY; Xu, W; Dong, B; Zhao, M; Wei, M; Ye, CX; Sun, Y; Yuan, XS; Yang, C; Hao, CY				Zhang, Yi; Tian, Xiuyun; Ji, Hong; Guan, Xiaoya; Xu, Wei; Dong, Bin; Zhao, Min; Wei, Meng; Ye, Chunxiang; Sun, Yuan; Yuan, Xiaosun; Yang, Chen; Hao, Chunyi			Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer	PLOS ONE			English	Article							MAR-BINDING PROTEIN; T-CELL DEVELOPMENT; VEGF-B; PROGNOSTIC-SIGNIFICANCE; GENE-EXPRESSION; MULTIPLE GENES; GASTRIC-CANCER; DIFFERENTIATION; OVEREXPRESSION; ANGIOGENESIS	Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that reprograms chromatin organization and transcription profiles. SATB1 promotes tumor growth and metastasis in breast cancer and is associated with poor prognosis in several cancer types. The association between SATB1 and colorectal cancer (CRC) has not been studied intensively. Therefore, this study aimed to investigate the effect of SATB1 on CRC growth and metastasis in vitro and in vivo and its correlation with overall survival and clinicopathological factors in CRC patients. Stable SATB1 knockdown and SATB1-overexpressing cell lines were established. SATB1 knockdown decreased cell growth, colony formation, migration, and invasion and increased apoptosis in CRC cells in vitro (p < 0.05), whereas SATB1 overexpression had the opposite effect. SATB1 overexpression increased tumor growth and metastasis to lung and liver in vivo by using xenograft animal models (p < 0.05). Thus, SATB1 promoted an aggressive CRC phenotype in vitro and in vivo. Immunohistochemical analysis of 560 CRC specimens showed that SATB1 expression was significantly higher in CRC tissues than in matched non-tumor mucosa (p < 0.001). In addition, SATB1 expression was significantly higher in patients with poorly differentiated tumors, higher invasion depth, distant metastasis, and advanced TNM stage. SATB1-positive patients had a poorer prognosis than SATB1-negative patients, and SATB1 was identified as an independent prognostic factor for CRC (p = 0.009). Strikingly, we also evaluated SATB2 expression in CRC and found that SATB2 was more abundantly expressed in non-cancerous mucosa compared to colorectal cancer tissues (p < 0.001). However, SATB2 expression had no influence on prognosis of CRC patients (p = 0.836). SATB1 expression was significantly associated with shorter survival time either in SATB2-positive patients or in SATB2-negative patients (p < 0.001). In conclusion, our findings indicated an important role for SATB1 in CRC tumorigenesis and metastasis. Therefore, SATB1 may represent an important prognostic biomarker and therapeutic target for CRC.	[Zhang, Yi; Tian, Xiuyun; Guan, Xiaoya; Xu, Wei; Wei, Meng; Ye, Chunxiang; Sun, Yuan; Yuan, Xiaosun; Hao, Chunyi] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreato Biliary Surg, Sch Oncol,Canc Hosp & Inst,Minist Educ, Beijing 100871, Peoples R China; [Zhang, Yi; Ji, Hong] Aerosp Ctr Hosp, Dept Gereol, Beijing, Peoples R China; [Dong, Bin; Zhao, Min] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Sch Oncol,Ctr Lab,Minist Educ, Beijing 100871, Peoples R China; [Yang, Chen] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Sch Oncol,Etiol Lab,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Hao, CY (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreato Biliary Surg, Sch Oncol,Canc Hosp & Inst,Minist Educ, Beijing 100871, Peoples R China.	haochunyi@126.com			National Natural Science funding [81272765]; Capital Characteristic Clinical Application Research [Z121107001012083]; Capital Medical Development Fund [2009-2095]; Beijing Municipal Natural Science Foundation [7122030]; Beijing's Outstanding Talents Subsidy Scheme (215 Program) [2009-2-18]; Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital [10-04]	National Natural Science funding(National Natural Science Foundation of China (NSFC)); Capital Characteristic Clinical Application Research; Capital Medical Development Fund; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing's Outstanding Talents Subsidy Scheme (215 Program); Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital	This study was supported by National Natural Science funding (No: 81272765), Capital Characteristic Clinical Application Research (No: Z121107001012083), the Key Project of Capital Medical Development Fund (No: 2009-2095), Beijing Municipal Natural Science Foundation (No: 7122030), Beijing's Outstanding Talents Subsidy Scheme (215 Program, No: 2009-2-18), Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital (No: 10-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Burute M, 2012, IMMUNOL CELL BIOL, V90, P852, DOI 10.1038/icb.2012.28; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Darrington E, 2012, ASIAN J ANDROL, V14, P745, DOI 10.1038/aja.2011.197; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Eberhard J, 2012, BRIT J CANCER, V106, P931, DOI 10.1038/bjc.2012.34; Fang XF, 2013, WORLD J GASTROENTERO, V19, P2331, DOI 10.3748/wjg.v19.i15.2331; FOSTER JH, 1984, SEMIN LIVER DIS, V4, P170, DOI 10.1055/s-2008-1040656; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mahmoud N, 2010, DIS COLON RECTUM, V53, P1080, DOI 10.1007/DCR.0b013e3181dcadbc; MASSAGUE J, 1992, CANCER SURV, V12, P81; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Meng WJ, 2011, MED HYPOTHESES, V76, P277, DOI 10.1016/j.mehy.2010.10.022; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Nie H, 2005, J IMMUNOL, V174, P4745, DOI 10.4049/jimmunol.174.8.4745; Nodin B, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-115; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Xu L, 1997, CYTOGENET CELL GENET, V77, P205, DOI 10.1159/000134577; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777	40	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100413	10.1371/journal.pone.0100413	http://dx.doi.org/10.1371/journal.pone.0100413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971456	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200030
J	Hsieh, TC; Lin, CY; Bennett, DJ; Wu, E; Wu, JM				Hsieh, Tze-Chen; Lin, Chia-Yi; Bennett, Dylan John; Wu, Erxi; Wu, Joseph M.			Biochemical and Cellular Evidence Demonstrating AKT-1 as a Binding Partner for Resveratrol Targeting Protein NQO2	PLOS ONE			English	Article							QUINONE REDUCTASE 2; FAST INTERACTION REFINEMENT; PROSTATE-CANCER CELLS; PHOSPHOINOSITIDE 3-KINASE; CYCLIN D1; AFFINITY-CHROMATOGRAPHY; MOLECULAR DOCKING; TUMOR SUPPRESSION; WEB SERVER; PATHWAY	Background: AKT plays an important role in the control of cell proliferation and survival. Aberrant activation of AKT frequently occurs in human cancers making it an attractive drug targets and leading to the synthesis of numerous AKT inhibitors as therapeutic candidates. Less is known regarding proteins that control AKT. We recently reported that quinone reductase 2 (NQO2) inhibited AKT activity, by unknown mechanisms. Methodology/Principal Findings: In this study, molecular modeling was used to query interaction between NQO2 and AKT. We found that pleckstrin homology (PH) and kinase domains of AKT bind to chains A and B of NQO2. Pull-down and deletion assays revealed that PH domain of AKT is essential for interaction with NQO2. Modeling analysis further revealed that kinase domain of AKT binds NQO2 in the vicinity of asparagine 161 located in the resveratrol-binding domain of NQO2. In studies to test whether exposure to resveratrol potentiates or diminishes AKT binding to NQO2, we showed that pre-binding by resveratrol in wild type but not histidine-161 (N161H) mutant NQO2 significantly affected this interaction. To obtain information on interplay between resveratrol and AKT, resveratrol affinity chromatography was performed. AKT binds with high affinity to the column suggesting that it is a target of resveratrol. The half-life of AKT mRNA decreased from similar to 4 h in control cells to similar to 1 h in NQO2-knockdown cells. The inhibition of AKT by resveratrol was attenuated in NQO2-expressing relative to NQO2-knockdown cells. Conclusion/Significance: Both NQO2 and AKT are targets of resveratrol; NQO2: AKT interaction is a novel physiological regulator of AKT activation/function.	[Hsieh, Tze-Chen; Bennett, Dylan John; Wu, Joseph M.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Lin, Chia-Yi] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	New York Medical College; National Taiwan University; North Dakota State University Fargo	Hsieh, TC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Tze-chen_Hsieh@nymc.edu		Wu, Erxi/0000-0002-1680-3639	Intramural Sponsored Research Program of New York Medical College [49-432-1, 49-466-1]	Intramural Sponsored Research Program of New York Medical College	This research was supported by the Intramural Sponsored Research Program of New York Medical College to T. C. H. (49-432-1 and 49-466-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Benitez DA, 2007, BRIT J CANCER, V96, P1595, DOI 10.1038/sj.bjc.6603755; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chan T O, 2001, Sci STKE, V2001, ppe1, DOI 10.1126/stke.2001.66.pe1; Davies MA, 1999, CANCER RES, V59, P2551; Davies MA, 1998, CANCER RES, V58, P5285; de Souza PL, 2009, CURR CANCER DRUG TAR, V9, P163, DOI 10.2174/156800909787581006; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsieh TC, 2008, ANTICANCER RES, V28, P29; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Hsieh TC, 2011, INT J CANCER, V129, P2732, DOI 10.1002/ijc.25930; Hsieh TC, 2009, ASIAN J ANDROL, V11, P653, DOI 10.1038/aja.2009.56; Hsieh TC, 2009, ANTICANCER RES, V29, P3011; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Jetzt A, 2003, CANCER RES, V63, P6697; Li RL, 2009, CLIN CANCER RES, V15, P3568, DOI 10.1158/1078-0432.CCR-08-0826; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang ZR, 2006, BIOCHEM BIOPH RES CO, V346, P367, DOI 10.1016/j.bbrc.2006.05.156; Wang ZR, 2004, BIOCHEM BIOPH RES CO, V323, P743, DOI 10.1016/j.bbrc.2004.08.174; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7	44	23	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101070	10.1371/journal.pone.0101070	http://dx.doi.org/10.1371/journal.pone.0101070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968355	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800103
J	Karatas, OF; Guzel, E; Suer, I; Ekici, ID; Caskurlu, T; Creighton, CJ; Ittmann, M; Ozen, M				Karatas, Omer Faruk; Guzel, Esra; Suer, Ilknur; Ekici, Isin D.; Caskurlu, Turhan; Creighton, Chad J.; Ittmann, Michael; Ozen, Mustafa			miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; BIOCHEMICAL RELAPSE; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROGNOSTIC MARKER; DOWN-REGULATION; MICRORNA; PROGRESSION; METASTASIS	Prostate cancer (PCa) is currently the most frequently diagnosed malignancy in the western countries. It is more prevalent in older men with 75% of the incident cases above 65 years old. After radical prostatectomy, approximately 30% of men develop clinical recurrence with elevated serum prostate-specific antigen levels. Therefore, it is important to unravel the molecular mechanisms underlying PCa progression to develop novel diagnostic/therapeutic approaches. In this study, it is aimed to compare the microRNA (miRNA) profile of recurrent and non-recurrent prostate tumor tissues to explore the possible involvement of miRNAs in PCa progression. Total RNA from 41 recurrent and 41 non-recurrent PCa tissue samples were used to investigate the miRNA signature in PCa specimens. First of all, 20 recurrent and 20 non-recurrent PCa samples were profiled using miRNA microarray chips. Of the differentially expressed miRNAs, miR-1, miR-133b and miR-145* were selected for further validation with qRT-PCR in a different set of 21 recurrent and 21 non-recurrent PCa samples. Data were statistically analyzed using two-sided Student's t-test, Pearson Correlation test, Receiver operating characteristic analysis. Our results demonstrated that miR-1 and mir-133b have been significantly downregulated in recurrent PCa specimens in comparison to non-recurrent PCa samples and have sufficient power to distinguish recurrent specimens from non-recurrent ones on their own. Here, we report that the relative expression of miR-1 and mir-133b have been significantly reduced in recurrent PCa specimens in comparison to non-recurrent PCa samples, which can serve as novel biomarkers for prediction of PCa progression.	[Karatas, Omer Faruk; Guzel, Esra; Suer, Ilknur; Ozen, Mustafa] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, Istanbul, Turkey; [Karatas, Omer Faruk] Erzurum Tech Univ, Dept Mol Biol & Genet, Erzurum, Turkey; [Guzel, Esra; Ozen, Mustafa] Biruni Univ, Istanbul, Turkey; [Ekici, Isin D.] Yeditepe Univ, Dept Med Pathol, Istanbul, Turkey; [Caskurlu, Turhan] Goztepe Educ & Res Hosp, Dept Urol, Istanbul, Turkey; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Ittmann, Michael; Ozen, Mustafa] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael; Ozen, Mustafa] Michael E DeBakey VAMC, Houston, TX USA	Istanbul University; Istanbul University - Cerrahpasa; Erzurum Technical University; Biruni University; Yeditepe University; Istanbul Goztepe Training and Research Hospital; Baylor College of Medicine; Baylor College of Medicine	Ozen, M (corresponding author), Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, Istanbul, Turkey.	mozen@bcm.edu	Guzel, Esra/AAB-8509-2019; Karatas, Omer/I-5103-2013; Suer, Ilknur/AAY-8643-2020	Suer, Ilknur/0000-0003-1954-4190; Ozen, Mustafa/0000-0002-6142-5294; Guzel Tanoglu, Esra/0000-0002-0909-8935; Karatas, Omer/0000-0002-0379-2088; Dogan Ekici, Asiye Isin/0000-0003-4062-9519	Scientific and Technological Research Council of Turkey (TUBITAK) [108S051]; United States' National Institute of Health [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); United States' National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) (grant number 108S051), as well as in part by the United States' National Institute of Health (CJC and MI, grant P30 CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya P, 2011, INT J ONCOL, V39, P311, DOI 10.3892/ijo.2011.1043; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Brookman-Amissah N, 2007, CANCER GENET CYTOGEN, V179, P118, DOI 10.1016/j.cancergencyto.2007.08.017; Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chatterton Z, 2010, EPIGENOMICS-UK, V2, P697, DOI 10.2217/EPI.10.39; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; Duan FT, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-164; Fendler A, 2011, INT J ONCOL, V39, P1183, DOI 10.3892/ijo.2011.1128; Gallagher RP, 1998, CAN MED ASSOC J, V159, P807; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jansen FH, 2009, EUR UROL, V55, P563, DOI 10.1016/j.eururo.2008.11.040; Jung SJ, 2011, KOREAN J UROL, V52, P607, DOI 10.4111/kju.2011.52.9.607; Karatas OF, 2013, MOL BIOL REP, V40, P4619, DOI 10.1007/s11033-013-2555-x; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Li X, 2014, CLIN CANC RES; Liang JJ, 2010, CANCER EPIDEM BIOMAR, V19, P2598, DOI 10.1158/1055-9965.EPI-10-0405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lughezzani G, 2010, EUR UROL, V58, P687, DOI 10.1016/j.eururo.2010.07.034; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Maqbool R., 2014, CELL TISSUE RES; Miyake H, 2013, INT J UROL, V20, P301, DOI 10.1111/j.1442-2042.2012.03175.x; Nohata N, 2012, ONCOTARGET, V3, P9; Oh SY, 2012, J SURG RES, V172, P102, DOI 10.1016/j.jss.2010.07.015; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Yang F, 2013, INT J CLIN EXP PATHO, V6, P2846	40	68	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98675	10.1371/journal.pone.0098675	http://dx.doi.org/10.1371/journal.pone.0098675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967583	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800004
J	Li, WY; Wang, X; Li, R; Li, WQ; Chen, KM				Li, Wen-Yan; Wang, Xiang; Li, Ri; Li, Wen-Qiang; Chen, Kun-Ming			Genome-Wide Analysis of the NADK Gene Family in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; KINASE-ACTIVITY; CYANIDIOSCHYZON-MEROLAE; REGULATORY ELEMENTS; OXIDATIVE STRESS; EVOLUTION; IDENTIFICATION; REVEALS	Background: NAD(H) kinase (NADK) is the key enzyme that catalyzes de novo synthesis of NADP(H) from NAD(H) for NADP(H)-based metabolic pathways. In plants, NADKs form functional subfamilies. Studies of these families in Arabidopsis thaliana indicate that they have undergone considerable evolutionary selection; however, the detailed evolutionary history and functions of the various NADKs in plants are not clearly understood. Principal Findings: We performed a comparative genomic analysis that identified 74 NADK gene homologs from 24 species representing the eight major plant lineages within the supergroup Plantae: glaucophytes, rhodophytes, chlorophytes, bryophytes, lycophytes, gymnosperms, monocots and eudicots. Phylogenetic and structural analysis classified these NADK genes into four well-conserved subfamilies with considerable variety in the domain organization and gene structure among subfamily members. In addition to the typical NAD_kinase domain, additional domains, such as adenylate kinase, dual-specificity phosphatase, and protein tyrosine phosphatase catalytic domains, were found in subfamily II. Interestingly, NADKs in subfamily III exhibited low sequence similarity (similar to 30%) in the kinase domain within the subfamily and with the other subfamilies. These observations suggest that gene fusion and exon shuffling may have occurred after gene duplication, leading to specific domain organization seen in subfamilies II and III, respectively. Further analysis of the exon/intron structures showed that single intron loss and gain had occurred, yielding the diversified gene structures, during the process of structural evolution of NADK family genes. Finally, both available global microarray data analysis and qRT-RCR experiments revealed that the NADK genes in Arabidopsis and Oryza sativa show different expression patterns in different developmental stages and under several different abiotic/biotic stresses and hormone treatments, underscoring the functional diversity and functional divergence of the NADK family in plants. Conclusions: These findings will facilitate further studies of the NADK family and provide valuable information for functional validation of this family in plants.	[Li, Wen-Yan; Wang, Xiang; Li, Ri; Li, Wen-Qiang; Chen, Kun-Ming] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Chen, KM (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	kunmingchen@nwsuaf.edu.cn	Chen, Kun-Ming/AAU-6087-2021	Chen, Kun-Ming/0000-0002-0016-9995	National Natural Science Foundation of China [31270299]; State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU [CSBAAZD1301]; NWAFU [2014YB033]; Program for New Century Excellent Talents in University of China [NCET-11-0440]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU; NWAFU; Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This research was supported by grants from the National Natural Science Foundation of China (grant number 31270299), the Basic Scientific Fund of The State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU (CSBAAZD1301), the Basic Scientific Fund of NWAFU (2014YB033), and the Program for New Century Excellent Talents in University of China (NCET-11-0440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1980, BIOCHEMISTRY-US, V19, P3113, DOI 10.1021/bi00554a043; Ando T, 2011, J BIOL CHEM, V286, P29984, DOI 10.1074/jbc.M111.249011; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berrin JG, 2005, MOL GENET GENOMICS, V273, P10, DOI 10.1007/s00438-005-1113-1; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chai MF, 2006, PLANT J, V47, P665, DOI 10.1111/j.1365-313X.2006.02816.x; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; [周丛义 Congyi Zhou], 2010, [植物学报, Chinese Bulletin of Botany], V45, P615; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delumeau O, 2000, PLANT CELL ENVIRON, V23, P329, DOI 10.1046/j.1365-3040.2000.00545.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harding SA, 1997, EMBO J, V16, P1137, DOI 10.1093/emboj/16.6.1137; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kawai S, 2000, BIOCHEM BIOPH RES CO, V276, P57, DOI 10.1006/bbrc.2000.3433; Kawai S, 2005, J BIOL CHEM, V280, P39200, DOI 10.1074/jbc.M506426200; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Kawai S, 2008, BIOSCI BIOTECH BIOCH, V72, P919, DOI 10.1271/bbb.70738; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Labesse G, 2002, TRENDS BIOCHEM SCI, V27, P273, DOI 10.1016/S0968-0004(02)02093-5; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li WY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-90; Li YF, 2006, ACTA BIOCH BIOPH SIN, V38, P293, DOI 10.1111/j.1745-7270.2006.00162.x; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma QC, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-4; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mori S, 2005, BIOCHEM BIOPH RES CO, V327, P500, DOI 10.1016/j.bbrc.2004.11.163; Mori S, 2001, ACTA CRYSTALLOGR D, V57, P1319, DOI 10.1107/S0907444901011362; Oganesyan V, 2005, ACTA CRYSTALLOGR F, V61, P640, DOI 10.1107/S1744309105019780; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Retief J D, 2000, Methods Mol Biol, V132, P243; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Ruiz JM, 2002, PHYTOCHEMISTRY, V59, P473, DOI 10.1016/S0031-9422(01)00481-2; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shi F, 2009, ACTA BIOCH BIOPH SIN, V41, P352, DOI 10.1093/abbs/gmp029; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Stephan C, 2000, INT J BIOCHEM CELL B, V32, P855, DOI 10.1016/S1357-2725(00)00032-7; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Waller JC, 2010, PLANTA, V231, P305, DOI 10.1007/s00425-009-1047-7; Wang GF, 2013, INT J MOL SCI, V14, P9440, DOI 10.3390/ijms14059440; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wilkerson MD, 2009, BRIEF BIOINFORM, V10, P631, DOI 10.1093/bib/bbp051; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu LL, 2011, J NUCL AGR SCI, V25; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; ZAGDANSKA B, 1990, ACTA BIOCHIM POL, V37, P385; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang Z, 2004, GENETICS, V166, P1995, DOI 10.1534/genetics.166.4.1995; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	106	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101051	10.1371/journal.pone.0101051	http://dx.doi.org/10.1371/journal.pone.0101051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968225	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800101
J	Mishra, NK; Chang, J; Zhao, PX				Mishra, Nitish K.; Chang, Junil; Zhao, Patrick X.			Prediction of Membrane Transport Proteins and Their Substrate Specificities Using Primary Sequence Information	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; HIDDEN MARKOV-MODELS; SUBCELLULAR LOCATIONS; PSI-BLAST; CLASSIFICATION; NETWORKS; RESIDUES; DATABASE; RATES	Background: Membrane transport proteins (transporters) move hydrophilic substrates across hydrophobic membranes and play vital roles in most cellular functions. Transporters represent a diverse group of proteins that differ in topology, energy coupling mechanism, and substrate specificity as well as sequence similarity. Among the functional annotations of transporters, information about their transporting substrates is especially important. The experimental identification and characterization of transporters is currently costly and time-consuming. The development of robust bioinformatics-based methods for the prediction of membrane transport proteins and their substrate specificities is therefore an important and urgent task. Results: Support vector machine (SVM)-based computational models, which comprehensively utilize integrative protein sequence features such as amino acid composition, dipeptide composition, physico-chemical composition, biochemical composition, and position-specific scoring matrices (PSSM), were developed to predict the substrate specificity of seven transporter classes: amino acid, anion, cation, electron, protein/mRNA, sugar, and other transporters. An additional model to differentiate transporters from non-transporters was also developed. Among the developed models, the biochemical composition and PSSM hybrid model outperformed other models and achieved an overall average prediction accuracy of 76.69% with a Mathews correlation coefficient (MCC) of 0.49 and a receiver operating characteristic area under the curve (AUC) of 0.833 on our main dataset. This model also achieved an overall average prediction accuracy of 78.88% and MCC of 0.41 on an independent dataset. Conclusions: Our analyses suggest that evolutionary information (i.e., the PSSM) and the AAIndex are key features for the substrate specificity prediction of transport proteins. In comparison, similarity-based methods such as BLAST, PSI-BLAST, and hidden Markov models do not provide accurate predictions for the substrate specificity of membrane transport proteins. TrSSP: The Transporter Substrate Specificity Prediction Server, a web server that implements the SVM models developed in this paper, is freely available at http://bioinfo.noble.org/TrSSP.	[Mishra, Nitish K.; Chang, Junil; Zhao, Patrick X.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Zhao, PX (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA.	pzhao@noble.org	Mishra, Nitish/AAR-3757-2021; Mishra, Nitish Kumar/D-5577-2009	Chang, Junil/0000-0002-4765-5157; Zhao, Patrick Xuechun/0000-0002-3460-5564	National Science Foundation [0960897]; Samuel Roberts Noble Foundation; Div Of Biological Infrastructure [0960897] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation award #0960897 to PXZ and The Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barghash A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-343; Benedito VA, 2010, PLANT PHYSIOL, V152, P1716, DOI 10.1104/pp.109.148684; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2006, J CHEM INF MODEL, V46, P1503, DOI 10.1021/ci050417u; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Gromiha MM, 1999, BIOPHYS CHEM, V77, P49, DOI 10.1016/S0301-4622(99)00010-1; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kumar Manish, 2008, In Silico Biology, V8, P121; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Lee TJ, 2008, BIOINFORMATICS, V24, pI259, DOI 10.1093/bioinformatics/btn180; Li HQ, 2008, BIOINFORMATICS, V24, P1129, DOI 10.1093/bioinformatics/btn099; Li HQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-418; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HH, 2006, PROTEINS, V62, P218, DOI 10.1002/prot.20605; Mishra NK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S48; Mishra NK, 2007, PROTEIN PEPTIDE LETT, V14, P575; Mishra NK, 2011, LETT DRUG DES DISCOV, V8, P223; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Park Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-302; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schaadt NS, 2010, J CHEM INF MODEL, V50, P1899, DOI 10.1021/ci100243m; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Zavaljevski N, 2002, BIOINFORMATICS, V18, P689, DOI 10.1093/bioinformatics/18.5.689	39	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100278	10.1371/journal.pone.0100278	http://dx.doi.org/10.1371/journal.pone.0100278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968309	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800032
J	Inoue, T; Hagiyama, M; Yoneshige, A; Kato, T; Enoki, E; Maenishi, O; Chikugo, T; Kimura, M; Satou, T; Ito, A				Inoue, Takao; Hagiyama, Man; Yoneshige, Azusa; Kato, Takashi; Enoki, Eisuke; Maenishi, Osamu; Chikugo, Takaaki; Kimura, Masatomo; Satou, Takao; Ito, Akihiko			Increased Ectodomain Shedding of Cell Adhesion Molecule 1 from Pancreatic Islets in Type 2 Diabetic Pancreata: Correlation with Hemoglobin A1c Levels	PLOS ONE			English	Article							PROTEIN-KINASE-C; INDUCED INSULIN-SECRETION; GLUCAGON-LIKE PEPTIDE-1; GENE-EXPRESSION; MELLITUS; APOPTOSIS; ALPHA; RISK; GLUCOTOXICITY; PATHOGENESIS	Pulmonary emphysema and type 2 diabetes mellitus (T2DM), both caused by lifestyle factors, frequently concur. Respectively, the diseases affect lung alveolar and pancreatic islet cells, which express cell adhesion molecule 1 (CADM1), an immunoglobulin superfamily member. Protease-mediated ectodomain shedding of full-length CADM1 produces C-terminal fragments (CTFs) with proapoptotic activity. In emphysematous lungs, the CADM1 shedding rate and thus the level of CTFs in alveolar cells increase. In this study, CADM1 expression in islet cells was examined by western blotting. Protein was extracted from formalin-fixed, paraffin-embedded sections of pancreata isolated from patients with T2DM (n = 12) or from patients without pancreatic disease (n = 8) at autopsy. After adjusting for the number of islet cells present in the adjacent section, we found that full-length CADM1 decreased in T2DM islets, while ectodomain shedding increased. Hemoglobin A1c levels, measured when patients were alive, correlated inversely with full-length CADM1 levels (P = 0.041) and positively with ectodomain shedding rates (P = 0.001). In immunofluorescence images of T2DM islet cells, CADM1 was detected in the cytoplasm, but not on the cell membrane. Consistently, when MIN6-m9 mouse beta cells were treated with phorbol ester and trypsin to induce shedding, CADM1 immunostaining was diffuse in the cytoplasm. When a form of CTFs was exogenously expressed in MIN6-m9 cells, it localized diffusely in the cytoplasm and increased the number of apoptotic cells. These results suggest that increased CADM1 ectodomain shedding contributes to blood glucose dysregulation in T2DM by decreasing full-length CADM1 and producing CTFs that accumulate in the cytoplasm and promote apoptosis of beta cells. Thus, this study has identified a molecular alteration shared by pulmonary emphysema and T2DM.	[Inoue, Takao; Hagiyama, Man; Yoneshige, Azusa; Kato, Takashi; Enoki, Eisuke; Maenishi, Osamu; Chikugo, Takaaki; Kimura, Masatomo; Satou, Takao; Ito, Akihiko] Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan	Kindai University (Kinki University)	Ito, A (corresponding author), Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan.	aito@med.kindai.ac.jp			Japan Society for the Promotion of Science Kakenhi [24659184, 24890274, 25860302, 24590492]; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [26860268] Funding Source: KAKEN	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science Kakenhi (24659184 to TI, 24890274 and 25860302 to MH, and 24590492 to AI), and a grant from Japan Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Ito A, 2012, ISLETS, V4, DOI 10.4161/isl.18675; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kumar V, 2009, ROBBINS COTRAN PATHO; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; MEDA P, 1991, EXP CELL RES, V192, P469, DOI 10.1016/0014-4827(91)90066-4; Mimae T, 2014, THORAX, V69, P223, DOI 10.1136/thoraxjnl-2013-203867; Mimae T, 2012, CLIN CANCER RES, V18, P945, DOI 10.1158/1078-0432.CCR-11-1946; Minakata Y, 2008, INTERNAL MED, V47, P77, DOI 10.2169/internalmedicine.47.0489; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Zhao HL, 2010, PANCREAS, V39, P843, DOI 10.1097/MPA.0b013e3181d12613	53	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100988	10.1371/journal.pone.0100988	http://dx.doi.org/10.1371/journal.pone.0100988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964098	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500106
J	Xia, S; Fan, X; Huang, ZG; Xia, L; Xiao, M; Chen, RC; Xu, YC; Zhuo, C				Xia, Shu; Fan, Xin; Huang, Zengguang; Xia, Liang; Xiao, Meng; Chen, Rongchang; Xu, Yingchun; Zhuo, Chao			Dominance of CTX-M-Type Extended-Spectrum beta-Lactamase (ESBL)-Producing Escherichia coli Isolated from Patients with Community-Onset and Hospital-Onset Infection in China	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; BLOOD-STREAM INFECTIONS; FECAL CARRIAGE; ANTIMICROBIAL SUSCEPTIBILITY; KLEBSIELLA-PNEUMONIAE; GENOTYPE DISTRIBUTION; ACQUIRED INFECTIONS; MEDICAL-CENTERS; FOOD ANIMALS; RISK-FACTORS	Objective: To investigate CTX-M genotypes among extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) isolated from patients with community-onset and hospital-onset infections in China, their clonality and the distribution of CTX-M variants in different specimens of community-onset and hospital-onset infections. Methods: ESBL-EC isolates were collected from general hospitals from 2011 to 2012 in China. Broth microdilution method antimicrobial susceptibility testing of 16 antibiotics was performed. Clinical data from community-onset and hospital-onset infections due to ESBL-EC were analyzed. ESBL-encoding genes were amplified by PCR and sequenced, and multilocus sequence typing (MLST) was performed for a random selection of predominant CTX-M type strains identified. Results: A total of 1,168 ESBL-EC isolates were obtained from various clinical specimens, 41.7% of which were responsible for causing community-onset infections. The presence of urinary calculi was higher in community-onset infections, whereas malignancy, cardiovascular and cerebrovascular diseases, dementia, chronic renal disease, diabetes mellitus and surgical treatment were found to have higher proportions in hospital-onset infections. There was no significant difference in trauma between community-onset and hospital-onset infections. 96.2% of the isolates were detected to harbor bla(CTX-M) genes. bla(CTX-M-1) group and bla(CTX-M-9) group were detected at 40.7% and 48.7% respectively, and both positive group accounted for 10.6%. bla(CTX-M-55) (24.8%) and bla(CTX-M-15) (18.2%) were the major genotypes in bla(CTX-M-1) group while bla(CTX-M-14) (46.8%) was predominant in bla(CTX-M-9) group. A comparison of bla(CTX-M) distribution in different specimens between ESBL-EC causing community-onset and hospital-onset infection showed no significant difference. A total of 229 isolates were tested for MLST. ST131 (14%) was the predominant type. ST648, ST405 and ST1193 were also detected. Conclusions: Community-onset ESBL-EC has emerged as a common pathogen in China. CTX-M-14 is the most commonly encountered, CTX-M-55 and CTX-M-15 have spread rapidly. ST131 is the predominant clonal group, and the great diversity of CTX-M-producing isolates of E. coli has emerged in China.	[Xia, Shu; Huang, Zengguang; Chen, Rongchang; Zhuo, Chao] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Fan, Xin; Xiao, Meng; Xu, Yingchun] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Xia, Liang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chongqing Medical University	Xu, YC (corresponding author), Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China.	xycpumch@139.com; chao_sheep@263.net	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Natural Science Foundation of China [81271881]; Special Fund for Scientific Research of Public Health Service Industry of China [201002021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Scientific Research of Public Health Service Industry of China	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal0/default.htm) (grant number: 81271881) and Special Fund for Scientific Research of Public Health Service Industry of China (http://www.nhfpc.gov.cn/) ( grant number: 201002021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; Cao XL, 2011, J CLIN MICROBIOL, V49, P2496, DOI 10.1128/JCM.02503-10; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; He DD, 2013, ANTIMICROB AGENTS CH, V57, P4068, DOI 10.1128/AAC.00541-13; Jones RN, 2013, DIAGN MICR INFEC DIS, V77, P258, DOI 10.1016/j.diagmicrobio.2013.07.003; Kiratisin P, 2007, DIAGN MICR INFEC DIS, V58, P349, DOI 10.1016/j.diagmicrobio.2007.02.005; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Lv LC, 2013, ANTIMICROB AGENTS CH, V57, P2824, DOI 10.1128/AAC.02155-12; Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11; Miano R, 2007, UROL INT, V79, P32, DOI 10.1159/000104439; Nicolas-Chanoine MH, 2013, J ANTIMICROB CHEMOTH, V68, P562, DOI 10.1093/jac/dks429; Novais A, 2012, ANTIMICROB AGENTS CH, V56, P3973, DOI 10.1128/AAC.00475-12; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Trecarichi EM, 2012, FUTURE MICROBIOL, V7, P1173, DOI [10.2217/FMB.12.100, 10.2217/fmb.12.100]; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001; Zhuo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052222; [卓超 ZHUO Chao], 2009, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V32, P1114; Zong ZY, 2008, ANTIMICROB AGENTS CH, V52, P4198, DOI 10.1128/AAC.00107-08	31	56	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100707	10.1371/journal.pone.0100707	http://dx.doi.org/10.1371/journal.pone.0100707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983621	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000036
J	Kawashima, A; Satta, Y				Kawashima, Ayaka; Satta, Yoko			Substrate-Dependent Evolution of Cytochrome P450: Rapid Turnover of the Detoxification-Type and Conservation of the Biosynthesis-Type	PLOS ONE			English	Article							LANOSTEROL 14-ALPHA-DEMETHYLASE; GENE-CLUSTER; P450; SEQUENCES; FAMILY; RAT	Members of the cytochrome P450 family are important metabolic enzymes that are present in all metazoans. Genes encoding cytochrome P450s form a multi-gene family, and the number of genes varies widely among species. The enzymes are classified as either biosynthesis-or detoxification-type, depending on their substrates, but their origin and evolution have not been fully understood. In order to elucidate the birth and death process of cytochrome P450 genes, we performed a phylogenetic analysis of 710 sequences from 14 vertebrate genomes and 543 sequences from 6 invertebrate genomes. Our results showed that vertebrate detoxification-type genes have independently emerged three times from biosynthesis-type genes and that invertebrate detoxification-type genes differ from vertebrates in their origins. Biosynthetic-type genes exhibit more conserved evolutionary processes than do detoxification-type genes, with regard to the rate of gene duplication, pseudogenization, and amino acid substitution. The differences in the evolutionary mode between biosynthesis- and detoxification-type genes may reflect differences in their respective substrates. The phylogenetic tree also revealed 11 clans comprising an upper category to families in the cytochrome P450 nomenclature. Here, we report novel clan-specific amino acids that may be used for the qualitative definition of clans.	[Kawashima, Ayaka; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp		Satta, Yoko/0000-0002-5305-493X	Japan Society for the Promotion of Science (JSPS) [21370106]; Center for the Promotion of Integrated Sciences (CPIS) of Sokendai	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for the Promotion of Integrated Sciences (CPIS) of Sokendai(Graduate University for Advanced Studies - Japan)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (B) Grant Number 21370106 and for JSPS Fellows. This work was also supported in part by the Center for the Promotion of Integrated Sciences (CPIS) of Sokendai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Debeljak N, 2003, ARCH BIOCHEM BIOPHYS, V409, P159, DOI 10.1016/S0003-9861(02)00418-6; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gotoh O, 2012, BIOL PHARM BULL, V35, P812; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hoffman SMG, 2006, MUTAT RES, V616, P133; Hu SY, 2008, GENETICA, V133, P215, DOI 10.1007/s10709-007-9206-x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao GH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-169; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0474; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Ohmura T, 2009, MOL BIOL P450; OMURA T, 1962, J BIOL CHEM, V237, P1375; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quaderer R, 2006, J AM CHEM SOC, V128, P13036, DOI 10.1021/ja0639214; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawai H, 2008, IMMUNOGENETICS, V60, P295, DOI 10.1007/s00251-008-0291-5; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; URABE K, 1990, AM J HUM GENET, V46, P1178; Yasukochi Y, 2011, GENES GENET SYST, V86, P109, DOI 10.1266/ggs.86.109; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030	37	19	19	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100059	10.1371/journal.pone.0100059	http://dx.doi.org/10.1371/journal.pone.0100059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977709	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400018
J	Latombe, G; Parrott, L; Basille, M; Fortin, D				Latombe, Guillaume; Parrott, Lael; Basille, Mathieu; Fortin, Daniel			Uniting Statistical and Individual-Based Approaches for Animal Movement Modelling	PLOS ONE			English	Article							CONDITIONAL LOGISTIC-REGRESSION; RESOURCE SELECTION FUNCTIONS; ADULT FEMALE CARIBOU; STATE-SPACE MODELS; WOODLAND CARIBOU; FUNCTIONAL-RESPONSES; DENALI HERD; HABITAT USE; LANDSCAPE; CONSERVATION	The dynamic nature of their internal states and the environment directly shape animals' spatial behaviours and give rise to emergent properties at broader scales in natural systems. However, integrating these dynamic features into habitat selection studies remains challenging, due to practically impossible field work to access internal states and the inability of current statistical models to produce dynamic outputs. To address these issues, we developed a robust method, which combines statistical and individual-based modelling. Using a statistical technique for forward modelling of the IBM has the advantage of being faster for parameterization than a pure inverse modelling technique and allows for robust selection of parameters. Using GPS locations from caribou monitored in Quebec, caribou movements were modelled based on generative mechanisms accounting for dynamic variables at a low level of emergence. These variables were accessed by replicating real individuals' movements in parallel sub-models, and movement parameters were then empirically parameterized using Step Selection Functions. The final IBM model was validated using both k-fold cross-validation and emergent patterns validation and was tested for two different scenarios, with varying hardwood encroachment. Our results highlighted a functional response in habitat selection, which suggests that our method was able to capture the complexity of the natural system, and adequately provided projections on future possible states of the system in response to different management plans. This is especially relevant for testing the long-term impact of scenarios corresponding to environmental configurations that have yet to be observed in real systems.	[Latombe, Guillaume] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Latombe, Guillaume] Univ Montreal, Dept Geog, Montreal, PQ H3C 3J7, Canada; [Parrott, Lael] Univ British Columbia, Earth & Environm Sci Unit, Kelowna, BC, Canada; [Parrott, Lael] Univ British Columbia, Biol Unit, Kelowna, BC, Canada; [Basille, Mathieu; Fortin, Daniel] Univ Laval, Dept Biol, Chaire Rech Ind CRSNG Univ Laval Sylviculture & F, Quebec City, PQ G1K 7P4, Canada; [Basille, Mathieu] Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA	Monash University; Universite de Montreal; University of British Columbia; University of British Columbia; Laval University; State University System of Florida; University of Florida	Latombe, G (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	guillaume.latombe@monash.edu	Fortin, Daniel/ABG-3554-2020; Latombe, Guillaume/AAI-1012-2021; Basille, Mathieu/A-6133-2017	Latombe, Guillaume/0000-0002-8589-8387; Basille, Mathieu/0000-0001-9366-7127	Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair; Ministere des Ressources Naturelles et de la Faune du Quebec; Canadian Foundation for Innovation; Fondation de la faune du Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair; Ministere des Ressources Naturelles et de la Faune du Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fondation de la faune du Quebec	Financial support for field efforts and data analysis were funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair, Ministere des Ressources Naturelles et de la Faune du Quebec, the Canadian Foundation for Innovation, and Fondation de la faune du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; BERGERUD AT, 1986, CAN J ZOOL, V64, P1515, DOI 10.1139/z86-226; BOERTJE RD, 1990, J APPL ECOL, V27, P420, DOI 10.2307/2404291; BOERTJE RD, 1985, J RANGE MANAGE, V38, P468, DOI 10.2307/3899725; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brown GS, 2007, FOREST ECOL MANAG, V245, P137, DOI 10.1016/j.foreco.2007.04.016; Burrough P. A, 1998, PRINCIPLES GEOGRAPHI, V333; COSEWIC, 2006, CAN SPEC RISK; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; COURTOIS R, 2003, THESIS U QUEBEC RIMO; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Gautestad AO, 2013, J ANIM ECOL, V82, P572, DOI 10.1111/1365-2656.12027; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Graniero PA, 2006, INT J GEOGR INF SCI, V20, P965, DOI 10.1080/13658810600830541; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grunbaum D, 1998, AM NAT, V151, P97, DOI 10.1086/286105; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Hardin J., 2003, GEN ESTIMATING EQUAT; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HOLLEMAN DF, 1979, J WILDLIFE MANAGE, V43, P192, DOI 10.2307/3800651; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; Howery L. D., 1999, GRAZING BEHAV LIVEST, V3, P91; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Latombe G, 2011, ECOL MODEL, V222, P1557, DOI 10.1016/j.ecolmodel.2011.02.020; Lenth R., 2019, Journal of Statistical Software, V60, P1; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NEWMAN JA, 1995, FUNCT ECOL, V9, P255, DOI 10.2307/2390572; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Weclaw P, 2004, ECOL MODEL, V177, P75, DOI 10.1016/j.ecolmodel.2003.12.052; Weclaw P, 2001, THESIS U ALBERTA CAN; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wiegand T, 2004, BIODIVERS CONSERV, V13, P79, DOI 10.1023/B:BIOC.0000004314.38828.db; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x	60	20	20	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99938	10.1371/journal.pone.0099938	http://dx.doi.org/10.1371/journal.pone.0099938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979047	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400011
J	Lotan, D; Cunningham, M; Joel, D				Lotan, Dafna; Cunningham, Madeleine; Joel, Daphna			Antibiotic Treatment Attenuates Behavioral and Neurochemical Changes Induced by Exposure of Rats to Group A Streptococcal Antigen	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INCREASES GLUTAMATE UPTAKE; BETA-LACTAM ANTIBIOTICS; R6/2 MOUSE MODEL; SYDENHAMS CHOREA; NEUROPSYCHIATRIC DISORDERS; HUNTINGTONS-DISEASE; PSYCHIATRIC-DISORDERS; MULTIPLE-SCLEROSIS; UP-REGULATION	Post-streptococcal A (GAS) sequelae including movement and neuropsychiatric disorders have been associated with improvement in response to antibiotic therapy. Besides eradication of infection, the underlying basis of attenuation of neuropsychiatric symptoms following antibiotic treatment is not known. The aim of the present study was to test the efficacy of antibiotic treatment in a rat model of GAS-related neuropsychiatric disorders. In the model, rats were not infected but were exposed to GAS-antigen or to adjuvants only (Control rats) and treated continuously with the antibiotic ampicillin in their drinking water from the first day of GAS-antigen exposure. Two additional groups of rats (GAS and Control) did not receive ampicillin in their drinking water. Behavior of the four groups was assessed in the forced swim, marble burying and food manipulation assays. We assessed levels of D1 and D2 dopamine receptors and tyrosine hydroxylase in the prefrontal cortex and striatum, and IgG deposition in the prefrontal cortex, striatum and thalamus. Ampicillin treatment prevented emergence of the motor and some of the behavioral alterations induced by GAS-antigen exposure, reduced IgG deposition in the thalamus of GAS-exposed rats, and tended to attenuate the increase in the level of TH and D1 and D2 receptors in their striatum, without concomitantly reducing the level of sera anti-GAS antibodies. Our results reinforce the link between exposure to GAS antigen, dysfunction of central dopaminergic pathways and motor and behavioral alterations. Our data further show that some of these deleterious effects can be attenuated by antibiotic treatment, and supports the latter's possible efficacy as a prophylactic treatment in GAS-related neuropsychiatric disorders.	[Lotan, Dafna; Joel, Daphna] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Lotan, Dafna; Joel, Daphna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Cunningham, Madeleine] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	Tel Aviv University; Tel Aviv University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Joel, D (corresponding author), Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel.	djoel@post.tau.ac.il		Joel, Daphna/0000-0002-2003-4190	Israel Science Foundation [341/07]; National Institutes of Health [HL56267]; National Institutes of Mental Health; Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267, R01HL056267] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Israel Science Foundation (grant No. 341/07) to DJ and by the National Institutes of Health grant HL56267, Bench to Bedside grant from the National Institutes of Mental Health, and the Oklahoma Center for the Advancement of Science and Technology grant to MWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbahr FR, 2005, BIOL PSYCHIAT, V57, P1073, DOI 10.1016/j.biopsych.2005.01.037; Bercik P, 2012, NEUROGASTROENT MOTIL, V24, P405, DOI 10.1111/j.1365-2982.2012.01906.x; Bonthius Daniel J, 2003, Semin Pediatr Neurol, V10, P11, DOI 10.1016/S1071-9091(02)00004-9; Brimberg L, 2012, NEUROPSYCHOPHARMACOL, V37, P2076, DOI 10.1038/npp.2012.56; Brooks BM, 2005, J ANTIMICROB CHEMOTH, V56, P1122, DOI 10.1093/jac/dki373; Calabro Rocco Salvatore, 2011, Ann Pharmacother, V45, pe65, DOI 10.1345/aph.1Q366; Citak EC, 2004, J CHILD NEUROL, V19, P387, DOI 10.1177/088307380401900513; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale RC, 2005, DEV MED CHILD NEUROL, V47, P785, DOI 10.1017/S0012162205001647; Dale RC, 2004, ARCH DIS CHILD, V89, P604, DOI 10.1136/adc.2003.031856; Dale RC, 2012, BRAIN, V135, P3453, DOI 10.1093/brain/aws256; Demiroren K, 2007, J CHILD NEUROL, V22, P550, DOI 10.1177/0883073807302614; Diamond B, 2011, BIOESSAYS, V33, P588, DOI 10.1002/bies.201100042; Doyle F, 2012, NEUROSCI LETT, V523, P186, DOI 10.1016/j.neulet.2012.06.073; Ganzinelli S, 2006, NEUROPHARMACOLOGY, V50, P362, DOI 10.1016/j.neuropharm.2005.09.013; Goodrich GS, 2013, J NEUROTRAUMA; Gordon N, 2009, BRAIN DEV-JPN, V31, P11, DOI 10.1016/j.braindev.2008.05.001; Hansen N, 2013, EXP NEUROL, V239, P202, DOI 10.1016/j.expneurol.2012.10.013; Hirjak D, 2012, J PSYCHIATR RES, V46, P533, DOI 10.1016/j.jpsychires.2012.01.015; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kirvan CA, 2006, AUTOIMMUNITY, V39, P21, DOI 10.1080/08916930500484757; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kirvan CA, 2006, J NEUROIMMUNOL, V179, P173, DOI 10.1016/j.jneuroim.2006.06.017; Kobayashi T, 2008, PSYCHOPHARMACOLOGY, V197, P567, DOI 10.1007/s00213-008-1070-6; KOLB B, 1983, BEHAV NEUROSCI, V97, P697, DOI 10.1037/0735-7044.97.5.697; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lee PH, 1999, ARCH NEUROL-CHICAGO, V56, P237, DOI 10.1001/archneur.56.2.237; Lee SJ, 2012, CLIN NUCL MED, V37, P663, DOI 10.1097/RLU.0b013e3182478bf2; Leung TCH, 2012, ACS CHEM NEUROSCI, V3, P22, DOI 10.1021/cn200072h; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Lotan D., 2014, BRAIN BEHAV IMMUN; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maling N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044215; Marques-Dias MJ, 1997, PSYCHIAT CLIN N AM, V20, P809, DOI 10.1016/S0193-953X(05)70346-4; Martin Judith M, 2006, Semin Pediatr Infect Dis, V17, P140, DOI 10.1053/j.spid.2006.07.001; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Millan MJ, 2000, J PHARMACOL EXP THER, V295, P1206; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Miller BR, 2012, J NEUROCHEM, V121, P629, DOI 10.1111/j.1471-4159.2012.07691.x; Murphy TK, 2010, J CHILD ADOL PSYCHOP, V20, P317, DOI 10.1089/cap.2010.0043; Nieuwenhuis EES, 2000, ARTHRITIS RHEUM, V43, P2583, DOI 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U; Nishino R, 2013, NEUROGASTROENTEROL M; Nizzardo M, 2011, EXP NEUROL, V229, P214, DOI 10.1016/j.expneurol.2011.01.017; Ridel KR, 2010, PEDIATR NEUROL, V42, P243, DOI 10.1016/j.pediatrneurol.2009.12.004; Rorick-Kehn LM, 2007, PSYCHOPHARMACOLOGY, V193, P121, DOI 10.1007/s00213-007-0758-3; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Samadi P, 2013, GENES BRAIN BEHAV, V12, P108, DOI 10.1111/j.1601-183X.2012.00858.x; Saydoff JA, 2003, BRAIN RES, V994, P44, DOI 10.1016/j.brainres.2003.09.049; SCHLIAMSER SE, 1991, J ANTIMICROB CHEMOTH, V27, P405, DOI 10.1093/jac/27.4.405; Snider LA, 2005, BIOL PSYCHIAT, V57, P788, DOI 10.1016/j.biopsych.2004.12.035; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; SWEDO SE, 1993, PEDIATRICS, V91, P706; Takahashi T, 2011, CASE REP NEUROL, V4, P194, DOI 10.1159/000345227; Takeuchi Y, 2002, J NEUROCHEM, V83, P784, DOI 10.1046/j.1471-4159.2002.01180.x; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; van Coevorden-Hameete MH, 2014, AUTOIMMUN REV, V13, P299, DOI 10.1016/j.autrev.2013.10.016; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622	66	13	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101257	10.1371/journal.pone.0101257	http://dx.doi.org/10.1371/journal.pone.0101257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979049	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400107
J	Shi, WB; Yang, LJ; Hu, X; Zhou, J; Zhang, Q; Shao, ZM				Shi, Wen-Biao; Yang, Lin-Jun; Hu, Xin; Zhou, Jian; Zhang, Qiang; Shao, Zhi-Ming			Clinico-Pathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma: A Population-Based Study from China	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BREAST-CARCINOMA; CANCER; SURVIVAL; SUBTYPES; VARIANT	Background: Invasive micropapillary carcinoma (IMPC) of the breast is a rare subtype of breast cancer that is associated with a high incidence of regional lymph node metastases and a poor clinical outcome. However, the clinico-pathological features and prognostic factors of IMPC are not well understood. Patients and Methods: A total of 188 IMPC cases and 1,289 invasive ductal carcinoma (IDC) cases were included. The clinical features, breast cancer-specific survival (BCSS) and recurrence/metastasis-free survival (RFS) of the patients were compared between these two groups. Results: The IMPC patients exhibited more features of aggressive carcinoma than the IDC patients, including larger tumor size, higher tumor stage, a greater proportion of nodal involvement and an increased incidence of lymphovascular invasion. Patients with IMPC had lower 5-year BCSS and RFS rates (75.9% and 67.1%, respectively) than patients with IDC (89.5% and 84.5%, respectively). Compared to IDC patients, the patients with IMPC had a significantly higher percentage of stage III breast cancer (51.3% versus 21.7%). In a stage-matched Kaplan-Meier analysis, the patients with stage III IMPC had lower 5-year BCSS and RFS rates than patients with stage III IDC (BCSS, P = 0.004; RFS, P = 0.034). A multivariate analysis revealed that TNM stage was an independent prognostic factor for patients with IMPC. The proportion of cancers with a luminal-like subtype was significantly higher in IMPC than in IDC (P < 0.001). However, after matching by molecular subtype, the patients with IMPC had significantly worse clinical outcomes than patients with IDC. Conclusions: In Chinese women, IMPCs displayed more aggressive behaviors than IDCs, resulting in poorer clinical outcomes for patients with IMPC, regardless of a favorable molecular subtype. Our findings illustrate that the poorer survival of patients with IMPC might be due to an increased incidence and aggressiveness of tumors in TNM stage III.	[Shi, Wen-Biao; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China; [Shi, Wen-Biao; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Wen-Biao; Yang, Lin-Jun; Zhou, Jian; Zhang, Qiang] Taizhou Municipal Hosp, Dept Surg Oncol, Taizhou, Zhejiang, Peoples R China	Fudan University; Fudan University; Taizhou University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81001169]; Shanghai Committee of Science and Technology Funds [12ZR1406200, 12DZ2260100, 12140901502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, and 81001169) and the Shanghai Committee of Science and Technology Funds (12ZR1406200, 12DZ2260100 and 12140901502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen AC, 2013, CLIN BREAST CANCER, V13, P133, DOI 10.1016/j.clbc.2012.10.001; Chen L, 2008, INT J SURG PATHOL, V16, P155, DOI 10.1177/1066896907307047; De La Cruz C, 2004, PATHOL INT, V54, P90, DOI 10.1111/j.1440-1827.2004.01590.x; Engstrom MJ, 2013, BREAST CANCER RES TR, V140, P463, DOI 10.1007/s10549-013-2647-2; Gokce H, 2013, BREAST J, V19, P374, DOI 10.1111/tbj.12128; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Guo XJ, 2006, AM J CLIN PATHOL, V126, P740, DOI 10.1309/AXYY4AJTMNW6FRMW; Ide Y, 2011, PATHOL INT, V61, P731, DOI 10.1111/j.1440-1827.2011.02735.x; Kuroda Hajime, 2004, Breast Cancer, V11, P169, DOI 10.1007/BF02968297; Nassar H, 2001, MODERN PATHOL, V14, P836, DOI 10.1038/modpathol.3880399; Paterakos M, 1999, HUM PATHOL, V30, P1459, DOI 10.1016/S0046-8177(99)90168-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pettinato G, 2004, AM J CLIN PATHOL, V121, P857, DOI 10.1309/XTJ7VHB49UD78X60; Reyal F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020297; SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavassoli FA, 2003, WHO CLASSIFICATION T; Vargo JA, 2011, ONCOLOGY-BASEL, V80, P341, DOI 10.1159/000330203; Vingiani A, 2013, HISTOPATHOLOGY, V63, P217, DOI 10.1111/his.12147; Yu JI, 2010, BREAST, V19, P231, DOI 10.1016/j.breast.2010.01.020; Zekioglu O, 2004, HISTOPATHOLOGY, V44, P18, DOI 10.1111/j.1365-2559.2004.01757.x	22	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101390	10.1371/journal.pone.0101390	http://dx.doi.org/10.1371/journal.pone.0101390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977705	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400126
J	Browne, JA; Harris, A; Leir, SH				Browne, James A.; Harris, Ann; Leir, Shih-Hsing			An Optimized Protocol for Isolating Primary Epithelial Cell Chromatin for ChIP	PLOS ONE			English	Article							CYSTIC-FIBROSIS	A critical part of generating robust chromatin immunoprecipitation (ChIP) data is the optimization of chromatin purification and size selection. This is particularly important when ChIP is combined with next-generation sequencing (ChIP-seq) to identify targets of DNA-binding proteins, genome-wide. Current protocols refined by the ENCODE consortium generally use a two-step cell lysis procedure that is applicable to a wide variety of cell types. However, the isolation and size selection of chromatin from primary human epithelial cells may often be particularly challenging. These cells tend to form sheets of formaldehyde cross-linked material in which cells are resistant to membrane lysis, nuclei are not released and subsequent sonication produces extensive high molecular weight contamination. Here we describe an optimized protocol to prepare high quality ChIP-grade chromatin from primary human bronchial epithelial cells. The ENCODE protocol was used as a starting point to which we added the following key steps to separate the sheets of formaldehyde-fixed cells prior to lysis. (1) Incubation of the formaldehyde-fixed adherent cells in Trypsin-EDTA (0.25% room temperature) for no longer than 5 min. (2) Equilibration of the fixed cells in detergent-free lysis buffers prior to each lysis step. (3) The addition of 0.5% Triton X-100 to the complete cell membrane lysis buffer. (4) Passing the cell suspension (in complete cell membrane lysis buffer) through a 25-gauge needle followed by continuous agitation on ice for 35 min. Each step of the modified protocol was documented by light microscopy using the Methyl Green-Pyronin dual dye, which stains cytoplasm red (Pyronin) and the nuclei grey-blue (Methyl green). This modified method is reproducibly effective at producing high quality sheared chromatin for ChIP and is equally applicable to other epithelial cell types.	[Browne, James A.; Harris, Ann; Leir, Shih-Hsing] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA; [Browne, James A.; Harris, Ann; Leir, Shih-Hsing] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Leir, SH (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA.	s-leir@northwestern.edu	Leir, Shih-Hsing/AAG-1086-2019; Leir, Shih-Hsing/O-6739-2019	Leir, Shih-Hsing/0000-0001-9524-3379; Browne, James/0000-0002-6473-3567	National Institutes of Health [R01HD068901, R01HL094585, R01HL117843]; Cystic Fibrosis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All the funding sources were from the National Institutes of Health (R01HD068901, R01HL094585, R01HL117843 (PI: A. H.)) and the Cystic Fibrosis Foundation (www.cff.org) (PI: A. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLEMAN L, 1991, J CELL SCI, V98, P85; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; HARRIS A, 1989, J CELL SCI, V92, P687; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KAPUSCINSKI J, 1987, CYTOMETRY, V8, P129, DOI 10.1002/cyto.990080205; KURNICK NB, 1952, STAIN TECHNOL, V27, P233, DOI 10.3109/10520295209105083; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Marconett CN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003513; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3	12	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100099	10.1371/journal.pone.0100099	http://dx.doi.org/10.1371/journal.pone.0100099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971909	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200019
J	Chen, JW; Xie, ZR; Wu, YH				Chen, Jiawen; Xie, Zhong-Ru; Wu, Yinghao			Computational Modeling of the Interplay between Cadherin-Mediated Cell Adhesion and Wnt Signaling Pathway	PLOS ONE			English	Article							BETA-CATENIN; ALPHA-CATENIN; COMPLEX; ROLES; APC; CONVERGENCE; PRINCIPLES; MUTATIONS; STABILITY; CLUSTERS	Wnt signaling and cadherin-mediated adhesion have been implicated in both processes of embryonic development and the progression of carcinomas. Recent experimental studies revealed that Wnt signaling and cadherin-mediated cell adhesion have close crosstalk with each other. A comprehensive model that investigates the dynamic balance of beta-catenins in Wnt signaling and cell adhesion will improve our understanding to embryonic development and carcinomas. We constructed a network model to evaluate the dynamic interplay between adhesion and Wnt signaling. The network is decomposed into three interdependent modules: the cell adhesion, the degradation circle and the transcriptional regulation. In the cell adhesion module, we consider the effect of cadherin's lateral clustering. We found adhesion negatively contributes to Wnt signaling through competition for cytoplasmic beta-catenins. In the network of degradation circle, we incorporated features from various existing models. Our simulations reproduced the most recent experimental phenomena with semi-quantitative accuracy. Finally, in the transcriptional regulation module, we developed a function selection strategy to analyze the outcomes of genetic feedback loops in modulating the gene expression of Wnt targets. The specific cellular phenomena such as cadherin switch and Axin oscillation were archived and their biological insights were discussed. Our model provides the theoretical basis of how spatial organization regulates the dynamics of cellular signaling pathways. We suggest that cell adhesion affects Wnt signaling in both negative and positive ways. Cadherins can inhibit Wnt signaling not only in a way as a stoichiometric binding partner of beta-catenins that sequesters them from signaling, but also in a way through their clustering to impacts the rate at which beta-catenins are involved in the destruction loop. Additionally, cadherin clustering increases the phosphorylation rate of beta-catenins and promotes its signaling in nucleus.	[Chen, Jiawen; Xie, Zhong-Ru; Wu, Yinghao] Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10033 USA	Yeshiva University; Albert Einstein College of Medicine	Wu, YH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10033 USA.	yinghao.wu@einstein.yu.edu	Xie, Paul Zhongru/O-3547-2014	Xie, Paul Zhongru/0000-0002-1539-5100	Albert Einstein College of Medicine	Albert Einstein College of Medicine	YW was supported by a start-up grant from Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Heuberger J, 2010, COLD SPRING HARBOR P, P2; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Kruger Roland, 2004, Genome Inform, V15, P138; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacDonald BT, 2012, COLD SPRING HARB PER, V4; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; Mirams GR, 2010, J MATH BIOL, V60, P131, DOI 10.1007/s00285-009-0262-y; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pronobis MI, 2012, CURR BIOL, V22, pR137, DOI 10.1016/j.cub.2012.01.002; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Schmitz Y, 2011, J THEOR BIOL, V279, P132, DOI 10.1016/j.jtbi.2011.03.018; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun J., 2007, J CHEM PHYS, V127; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Weis W. I., 2013, COLD SPRING HARBOR P, V5; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Xie ZR, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4863992; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yuan JM, 2008, PROTEIN SCI, V17, P2156, DOI 10.1110/ps.037325.108; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	74	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100702	10.1371/journal.pone.0100702	http://dx.doi.org/10.1371/journal.pone.0100702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967587	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800054
J	Liu, ZY; Wei, WJ; Bai, LJ; Dai, RW; You, YB; Chen, SJ; Tian, J				Liu, Zhenyu; Wei, Wenjuan; Bai, Lijun; Dai, Ruwei; You, Youbo; Chen, Shangjie; Tian, Jie			Exploring the Patterns of Acupuncture on Mild Cognitive Impairment Patients Using Regional Homogeneity	PLOS ONE			English	Article							FMRI CONNECTIVITY ANALYSIS; HUMAN BRAIN; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; NETWORK; STIMULATION; DEFAULT; MODULATION	Purpose: To investigate the different responses to acupuncture in MCI patients and age-matched healthy subjects reflected by the Regional Homogeneity (ReHo) indices. Methods: The experiment was performed at the acupoint KI3 in 12 MCI patients and 12 healthy controls, respectively. A novel non-repeated event-related (NRER) fMRI design paradigm was applied to separately detect neural activities related to different stages of acupuncture (pre-acupuncture resting state, needling manipulation and post-acupuncture resting state). ReHo values were calculated for MCI patients and healthy controls in pre-and post-acupuncture resting state. Then, a two-way ANCOVA with repeated measures with post-hoc two sample t-tests was performed to explore the different responses to acupuncture in the two groups. Results: The ANCOVA revealed a significant main effect of group, but no significant main effect of acupuncture and interactions between group and acupuncture. During the pre-acupuncture resting state, ReHo values increased in the precentral gyrus (PCG), superior frontal gyrus (SFG), and insula (INS) and decreased mainly in middle temporal gyrus (MTG), parahippocampal (PHIP) and cingulate cortex in MCI patients compared with healthy controls. Furthermore, we found that the regions including precuneus (PCUN), and cingulate cortex showed increased ReHo values for MCI patients following acupuncture. For healthy controls, the medial frontal gyrus, PCG, anterior cingulate cortex (ACC) and INS showed enhanced ReHo values following acupuncture. During the post-acupuncture resting state, MCI patients showed increased ReHo values mainly in the MTG, superior parietal lobule (SPL), middle frontal gyrus (MFG), supramarginal (SMG), and PCG, and decreased ReHo values mainly in the frontal regions, PHIP, and posterior cingulated cortex (PCC) compared to healthy controls. Conclusion: Though we found some ReHo changes between MCI patients and healthy controls, the two-way ANCOVA results showed no significant effects after multiple corrections. Further study is needed to reveal the real acupuncture effects on MCI patients.	[Liu, Zhenyu; Wei, Wenjuan; Bai, Lijun; Dai, Ruwei; You, Youbo; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China; [Chen, Shangjie] Southern Med Univ, Baoan Hosp, Dept Acupuncture & Massage, Shenzhen, Peoples R China; [Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Southern Medical University - China; Xidian University	Bai, LJ (corresponding author), Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China.	bailj4152615@gmail.com; tian@ieee.org	Bai, Lijun/C-5119-2015; Liu, Zhenyu/G-8444-2018; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013	Bai, Lijun/0000-0001-8790-5424; Liu, Zhenyu/0000-0001-7559-8519; Tian, Jie/0000-0003-0498-0432; 	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217]; Fundamental Research Funds for the Central Universities [2011JBM226]; NIH [R01HD046526, R01HD060595]; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]; Fellowship for Young International Scientists of the Chinese Academy of Sciences [2010Y2GA03]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1G0036, 2010T2G36, 2012T1G0039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526, R01HD060595] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fellowship for Young International Scientists of the Chinese Academy of Sciences; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This paper is supported by the National Basic Research Program of China (973 Program) under grant 2011CB707700 (http://www.973.gov.cn/Default_3. aspx), the National Natural Science Foundation of China under grant no. 81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217 (http://www. nsfc.gov.cn/Portal0/default152.htm), the Fundamental Research Funds for the Central Universities (2011JBM226) and NIH (R01HD046526 & R01HD060595), the Beijing Nova program (grant number Z111101054511116), and Beijing Natural Science Foundation (grant number 4122082), the Fellowship for Young International Scientists of the Chinese Academy of Sciences under grant no. 2010Y2GA03, the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under grant no. 2012T1G0036, 2010T2G36, 2012T1G0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2010, J MAGN RESON IMAGING, V31, P71, DOI 10.1002/jmri.22006; Bai LJ, 2009, CURR MED IMAGING REV, V5, P167, DOI 10.2174/157340509789000589; Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Bai LJ, 2009, PROG NAT SCI-MATER, V19, P827, DOI 10.1016/j.pnsc.2008.09.009; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Beijing Shanghai and Nanjing College of Traditional Chinese Medicine. Acupuncture Institute of the Academy of Traditional Chinese Medicine, 1980, ESS CHIN AC; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goddard G, 2005, J PAIN, V6, P237, DOI 10.1016/j.jpain.2004.12.009; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Luijpen MW, 2004, NEUROREHAB NEURAL RE, V18, P166, DOI 10.1177/0888439004268785; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; Molsberger AF, 2010, PAIN, V151, P146, DOI 10.1016/j.pain.2010.06.036; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; NIH, 1998, JAMA; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yu JC, 2006, NEUROL RES, V28, P97, DOI 10.1179/016164106X91951; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong CG, 2012, J MAGN RESON IMAGING, V35, P572, DOI 10.1002/jmri.22887; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186; Zhu L, 1954, NEW ACUPUNCTURE XIN; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	52	10	16	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99335	10.1371/journal.pone.0099335	http://dx.doi.org/10.1371/journal.pone.0099335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968124	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800010
J	Putila, J; Guo, NL				Putila, Joseph; Guo, Nancy Lan			Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							COMORBIDITY INDEX; SURVIVAL; VALIDATION; SMOKING; PREVALENCE; MORBIDITY; SMOKERS; MODEL; STAGE	Background: Accurate assessment of a patient's risk of recurrence and treatment response is an important prerequisite of personalized therapy in lung cancer. This study extends a previously described non-small cell lung cancer prognostic model by the addition of chemotherapy and co-morbidities through the use of linked SEER-Medicare data. Methodology/Principal Findings: Data on 34,203 lung adenocarcinoma and 26,967 squamous cell lung carcinoma patients were used to determine the contribution of Chronic Obstructive Pulmonary Disease (COPD) to prognostication in 30 treatment combinations. A Cox model including COPD was estimated on 1,000 bootstrap samples, with the resulting model assessed on ROC, Brier Score, Harrell's C, and Nagelkerke's R-2 metrics in order to evaluate improvements in prognostication over a model without COPD. The addition of COPD to the model incorporating cancer stage, age, gender, race, and tumor grade was shown to improve prognostication in multiple patient groups. For lung adenocarcinoma patients, there was an improvement on the prognostication in the overall patient population and in patients without receiving chemotherapy, including those receiving surgery only. For squamous cell carcinoma, an improvement on prognostication was seen in both the overall patient population and in patients receiving multiple types of chemotherapy. COPD condition was able to stratify patients receiving the same treatments into significantly (log-rank p<0.05) different prognostic groups, independent of cancer stage. Conclusion/Significance: Combining patient information on COPD, cancer stage, age, gender, race, and tumor grade could improve prognostication and prediction of treatment response in individual non-small cell lung cancer patients. This model enables refined prognosis and estimation of clinical outcome of comprehensive treatment regimens, providing a useful tool for personalized clinical decision-making.	[Putila, Joseph; Guo, Nancy Lan] W Virginia Univ, Sch Publ Hlth, Mary Babb Randolph Canc Ctr, Dept Environm & Occupat Hlth Sci, Morgantown, WV 26506 USA	West Virginia University	Guo, NL (corresponding author), W Virginia Univ, Sch Publ Hlth, Mary Babb Randolph Canc Ctr, Dept Environm & Occupat Hlth Sci, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			National Institutes of Health (NIH) [R01/R56LM009500];  [NCRRP20 RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500, R56LM009500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by NCRRP20 RR16440 Stimulus Grant (PD: Dr. Nancy Guo) (http://recovery.nih.gov/Stories/ViewStory.aspx?id=449) and National Institutes of Health (NIH) R01/R56LM009500 (PI: Dr. Nancy Guo) (http://www.nlm.nih.gov/ep/AwardsShortTerm.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIGURES 2; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Birim O, 2006, J THORAC CARDIOV SUR, V132, P491, DOI 10.1016/j.jtcvs.2006.04.010; Bryant A, 2007, CHEST, V132, P185, DOI 10.1378/chest.07-0442; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; General thoracic surgery, 2009, GEN THORACIC SURG; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2009, LUNG CANCER, V66, P386, DOI 10.1016/j.lungcan.2009.02.012; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Janssen-Heijnen MLG, 1998, LUNG CANCER, V21, P105, DOI 10.1016/S0169-5002(98)00039-7; Karoor V, 2012, CANCER PREV RES, V5, P1061, DOI 10.1158/1940-6207.CAPR-12-0069-T; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Kiri VA, 2010, PRIM CARE RESP J, V19, P57, DOI 10.4104/pcrj.2009.00048; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Morth C, 2014, LUNG CANC; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Papi A, 2004, THORAX, V59, P679, DOI 10.1136/thx.2003.018291; Putila JJ, 2012, THESIS; Putila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017493; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; SEER, 2010, SURV EP END RES SEER; Sorenson S, 2001, ACTA ONCOL, V40, P327; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tammemagi CM, 2004, CHEST, V125, P27, DOI 10.1378/chest.125.1.27; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Thorpe Kenneth E, 2003, Health Aff (Millwood), VSuppl Web Exclusives, pW3; Wan YW, 2012, LUNG CANCER, V76, P98, DOI 10.1016/j.lungcan.2011.09.016; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Warren JL, 2002, MED CARE, V40, P3; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	43	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100994	10.1371/journal.pone.0100994	http://dx.doi.org/10.1371/journal.pone.0100994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967586	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800094
J	Wang, CH; Chen, CL; More, SV; Hsiao, PW; Hung, WC; Li, WS				Wang, Chie-Hong; Chen, Chia-Ling; More, Shivaji V.; Hsiao, Pei-Wen; Hung, Wen-Chun; Li, Wen-Shan			The Tetraindole SK228 Reverses the Epithelial-to-Mesenchymal Transition of Breast Cancer Cells by Up-Regulating Members of the miR-200 Family	PLOS ONE			English	Article							E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; ZEB1; MICRORNA; INVASIVENESS; EXPRESSION; INVASION; METASTASIS; TARGETS; GROWTH	The results of recent studies have shown that metastasis, the most common malignancy and primary cause of mortality promoted by breast cancer in women, is associated with the epithelial-to-mesenchymal transition (EMT). The results of the current study show that SK228, a novel indole containing substance, exhibits anti-cancer activity. In addition, the effects of SK228 on the regulation of EMT in breast cancer cells as well as the underlying mechanism have been explored. SK228 was observed to induce a fibroblastoid to epithelial-like change in the appearance of various breast cancer cell lines and to suppress the migration and invasion of these cancer cells in vitro. Moreover, expression of E-cadherin was found to increase following SK228 treatment whereas ZEB1 expression was repressed. Expression of other major EMT inducers, including ZEB2, Slug and Twist1, is also repressed by SK228 as a consequence of up-regulation of members of the miR-200 family, especially miR-200c. The results of animal studies demonstrate that SK228 treatment leads to effective suppression of breast cancer growth and metastasis in vivo. The observations made in this investigation show that SK228 reverses the EMT process in breast cancer cells via an effect on the miR-200c/ZEB1/E-cadherin signalling pathway. In addition, the results of a detailed analysis of the in vivo anti-cancer activities of SK228, carried out using a breast cancer xenograft animal model, show that this substance is a potential chemotherapeutic agent for the treatment of breast cancer.	[Wang, Chie-Hong; Chen, Chia-Ling; More, Shivaji V.; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan; [Wang, Chie-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Li, Wen-Shan] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan	Academia Sinica - Taiwan; National Sun Yat Sen University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Sun Yat Sen University	Hung, WC (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	hung1228@nhri.org.tw; wenshan@gate.sinica.edu.tw	Li, Wen-Shan/F-1972-2015; Hung, Wen-Chun/F-4846-2011; Hsiao, Pei-Wen/V-5653-2018	Li, Wen-Shan/0000-0002-8359-4582; Wang, Chie-Hong/0000-0003-0774-5323; Hsiao, Pei-Wen/0000-0002-3589-6754	Academia Sinica; National Science Council [101-2113-M-001-009-MY2]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	The authors are grateful for funding of this study provided by the Academia Sinica and the National Science Council (101-2113-M-001-009-MY2; http://web1.nsc.gov.tw/mp.aspx?mp=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang SM, 2012, INT J CANCER, V131, P722, DOI 10.1002/ijc.26401; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Li WS, 2012, J MED CHEM, V55, P1583, DOI 10.1021/jm2013425; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wu W, 2010, DRUGS R&D, V10, P1, DOI 10.2165/11537800-000000000-00000	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101088	10.1371/journal.pone.0101088	http://dx.doi.org/10.1371/journal.pone.0101088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967704	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800106
J	Brambila-Tapia, AJL; Armenta-Medina, D; Rivera-Gomez, N; Perez-Rueda, E				Leticia Brambila-Tapia, Aniel Jessica; Armenta-Medina, Dagoberto; Rivera-Gomez, Nancy; Perez-Rueda, Ernesto			Main Functions and Taxonomic Distribution of Virulence Genes in Brucella melitensis 16 M	PLOS ONE			English	Article							B-MELITENSIS; MICE; MUTANTS; MUTAGENESIS; INFECTION; SURVIVAL; IDENTIFICATION; PERSISTENCE; EXPRESSION; PATHOGEN	Many virulence genes have been detected in attenuated mutants of Brucella melitensis 16 M; nevertheless, a complete report of these genes, including the main Cluster of Orthologous Groups (COG) represented as well as the taxonomical distribution among all complete bacterial and archaeal genomes, has not been analyzed. In this work a total of 160 virulence genes that have been reported in attenuated mutants in B. melitensis were included and analyzed. Additionally, we obtained 250 B. melitensis randomly selected genes as a reference group for the taxonomical comparisons. The COGs and the taxonomical distribution profile for 789 nonredundant bacterial and archaeal genomes were obtained and compared with the whole-genome COG distribution and with the 250 randomly selected genes, respectively. The main COGs associated with virulence genes corresponded to the following: intracellular trafficking, secretion and vesicular transport (U); cell motility (N); nucleotide transport and metabolism (F); transcription (K); and cell wall/membrane/envelope biogenesis (M). In addition, we found that virulence genes presented a higher proportion of orthologs in the Euryarchaeota and Proteobacteria phyla, with a significant decrease in Chlamydiae, Bacteroidetes, Tenericutes, Firmicutes and Thermotogae. In conclusion, we found that genes related to specific functions are more relevant to B. melitensis virulence, with the COG U the most significant. Additionally, the taxonomical distribution of virulence genes highlights the importance of these genes in the related Proteobacteria, being less relevant in distant groups of organisms with the exception of Euryarchaeota.	[Leticia Brambila-Tapia, Aniel Jessica; Armenta-Medina, Dagoberto; Rivera-Gomez, Nancy; Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Dept Ingn Celular & Biocatalisis, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Brambila-Tapia, AJL (corresponding author), Univ Nacl Autonoma Mexico, Dept Ingn Celular & Biocatalisis, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	anieljessica@hotmail.com; erueda@ibt.unam.mx	Brambila-Tapia, Aniel Jessica Leticia/AAG-8886-2020; Perez-Rueda, Ernesto/D-7468-2016	Perez-Rueda, Ernesto/0000-0002-6879-0673; Brambila-Tapia, Aniel Jessica Leticia/0000-0002-6455-3662	Consejo Nacional de Ciencia y Tecnologia (CONACYT); DGAPA-UNAM [IN-204714]; CONACYT [155116]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank the Consejo Nacional de Ciencia y Tecnologia (CONACYT) for the postdoctoral scholarship granted to A.J.L. Brambila-Tapia. Support from DGAPA-UNAM (IN-204714) and CONACYT (155116) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi Pablo C, 2013, Recent Pat Antiinfect Drug Discov, V8, P18; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; De Iannino NI, 1998, J BACTERIOL, V180, P4392; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Dokuzoguz B, 2005, J INFECTION, V50, P41, DOI 10.1016/j.jinf.2004.02.005; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2006, J BACTERIOL, V188, P1615, DOI 10.1128/JB.188.4.1615-1619.2006; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002; Janga SC, 2004, NUCLEIC ACIDS RES, V32, P5392, DOI 10.1093/nar/gkh882; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Mirabella A, 2012, MICROBIOL-SGM, V158, P2642, DOI 10.1099/mic.0.060863-0; Nijskens C, 2008, MICROB PATHOGENESIS, V45, P134, DOI 10.1016/j.micpath.2008.04.005; Novichkov PS, 2004, J BACTERIOL, V186, P6575, DOI 10.1128/JB.186.19.6575-6585.2004; Petersen E, 2011, J BACTERIOL, V193, P5683, DOI 10.1128/JB.00428-11; Rajashekara G, 2006, INFECT IMMUN, V74, P2925, DOI 10.1128/IAI.74.5.2925-2936.2006; Rajashekara G, 2008, J BACTERIOL, V190, P6243, DOI 10.1128/JB.00520-08; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Troy SB, 2005, MEDICINE, V84, P174, DOI 10.1097/01.md.0000165659.20988.25; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Wang Z, 2013, CLIN VACCINE IMMUNOL, V20, P174, DOI 10.1128/CVI.00573-12; Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102; Zhang XL, 2009, INT J BIOL SCI, V5, P570; Zygmunt MS, 2006, MICROBES INFECT, V8, P2849, DOI 10.1016/j.micinf.2006.09.002	29	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100349	10.1371/journal.pone.0100349	http://dx.doi.org/10.1371/journal.pone.0100349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964015	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500041
J	Yu, CJ; Fan, LL; Wu, Q; Fu, KH; Gao, SG; Wang, M; Gao, JX; Li, YQ; Chen, J				Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie			Biological Role of Trichoderma harzianum-Derived Platelet-Activating Factor Acetylhydrolase (PAF-AH) on Stress Response and Antagonism	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GENE-EXPRESSION; BIOCONTROL; A(2)	We investigated the properties of platelet-activating factor acetylhydrolase (PAF-AH) derived from Trichoderma harzianum. The enzyme, comprised of 572 amino acids, shares high homology with PAF-AH proteins from T. koningii and other microbial species. The optimum enzymatic activity of PAF-AH occurred at pH 6 in the absence of Ca2+ and it localized in the cytoplasm, and we observed the upregulation of PAF-AH expression in response to carbon starvation and strong heat shock. Furthermore, PAF-AH knockout transformant growth occurred more slowly than wild type cells and over-expression strains grown in SM medium at 37 degrees C and 42 degrees C. In addition, PAF-AH expression significantly increased under a series of maize root induction assay. Eicosanoic acid and ergosterol levels decreased in the PAF-AH knockouts compared to wild type cells, as revealed by GC/MS analysis. We also determined stress responses mediated by PAF-AH were related to proteins HEX1, Cu/Zn superoxide dismutase, and cytochrome c. Finally, PAF-AH exhibited antagonistic activity against Rhizoctonia solani in plate confrontation assays. Our results indicate PAF-AH may play an important role in T. harzianum stress response and antagonism under diverse environmental conditions.	[Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Resource & Environm Sci, Shanghai 200030, Peoples R China; [Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Resource & Environm Sci, Shanghai 200030, Peoples R China.	jiechen59@gmail.com	Gao, Jinxin/AAG-8521-2020	Gao, Jinxin/0000-0001-5429-7442	National Natural Science Foundation of China [30971949, 31270155, 31171798]; China Agriculture Research System Project [CARS-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System Project	The work was supported by a grant from the National Natural Science Foundation of China ( Nos. 30971949, 31270155, 31171798) and China Agriculture Research System Project (CARS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Agbagwa IO, 2012, GENET MOL RES, V11, P4632, DOI 10.4238/2012.September.14.1; Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Benitez T, 2004, INT MICROBIOL, V7, P249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dan P, 2012, EUR J PHARMACOL, V691, P1, DOI 10.1016/j.ejphar.2012.07.023; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Dubey MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036152; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Fu KH, 2012, MICROBIOL RES, V167, P536, DOI 10.1016/j.micres.2012.02.002; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Jeffries TW, 2000, ADV APPL MICROBIOL, V47, P221, DOI 10.1016/S0065-2164(00)47006-1; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Kirschnek S, 2006, INFECT IMMUN, V74, P850, DOI 10.1128/IAI.74.2.850-860.2006; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kunitake E, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-46; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Liu JD, 2013, J APPL MICROBIOL, V114, P482, DOI 10.1111/jam.12046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montero-Barrientos M, 2008, FUNGAL GENET BIOL, V45, P1506, DOI 10.1016/j.fgb.2008.09.003; Moretti-Almeida G, 2013, FEBS LETT; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Pliego C, 2009, FUNGAL GENET BIOL, V46, P137, DOI 10.1016/j.fgb.2008.11.009; Rohrich CR, 2013, CHEM BIODIVERS, V10, P787, DOI 10.1002/cbdv.201200339; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Suarez MB, 2005, FUNGAL GENET BIOL, V42, P924, DOI 10.1016/j.fgb.2005.08.002; Tang J, 2010, CAN J MICROBIOL, V56, P121, DOI 10.1139/W09-110; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; Viterbo A, 2002, ANTON LEEUW INT J G, V81, P549, DOI 10.1023/A:1020553421740; Wang B, 2009, CHEMOSPHERE, V74, P1400, DOI 10.1016/j.chemosphere.2008.11.027; Zeilinger S, 1999, FUNGAL GENET BIOL, V26, P131, DOI 10.1006/fgbi.1998.1111; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173	39	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100367	10.1371/journal.pone.0100367	http://dx.doi.org/10.1371/journal.pone.0100367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964161	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500044
J	Doria, ML; Ribeiro, AS; Wang, J; Cotrim, CZ; Domingues, P; Williams, C; Domingues, MR; Helguero, LA				Doria, M. Luisa; Ribeiro, Ana S.; Wang, Jun; Cotrim, Candida Z.; Domingues, Pedro; Williams, Cecilia; Domingues, M. Rosario; Helguero, Luisa A.			Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival	FASEB JOURNAL			English	Article						lipidomics; gene expression; mass spectrometry; Kennedy pathway; basal-like cancer	LYSOPHOSPHATIDIC ACID; GENE-EXPRESSION; MICROARRAY DATA; OVARIAN-CANCER; IN-VITRO; MEMBRANE; CHOLESTEROL; METABOLISM; GLAND; LINE	This work combined gene and protein expression, gas chromatography-flame ionization detector, and hydrophilic interaction liquid chromatography-tandem mass spectrometry to compare lipid metabolism changes in undifferentiated/proliferating vs. functionally differentiated mammary epithelial cells (MECs) and to study their correlation to breast cancer survival. Sixty-eight genes involved in lipid metabolism were changed in MEC differentiation. Differentiated cells showed induction of Elovl6 (2-fold), Scd1 (4-fold), and Fads2 (2-fold), which correlated with increased levels of C16:1 n-7 and C18:1 n-9 (1.5-fold), C20:3 n-6 (2.5-fold), and C20:4 n-6 (6-fold) fatty acids (FAs) and more phospholipids (PLs) containing these species. Further, increased expression (2- to 3-fold) of genes in phosphatidylethanolamine (PE) de novo biosynthesis resulted in a 20% PE increase. Proliferating/undifferentiated cells showed higher C16:0 (1.7-fold) and C18:2 n-6 (4.2-fold) levels and more PLs containing C16:0 FAs [PC(16:0/16:1), PG(16:0/18:2), PG(16:0/18:1), and SM(16:0/18:0)]. Kaplan-Meier analysis of data from 3455 patients with breast cancer disclosed a positive correlation for 59% of genes expressed in differentiated MECs with better survival. PE biosynthesis and FA oxidation correlated with better prognosis in patients with breast cancer, including the basal-like subtype. Therefore, genes involved in mammary gland FA and PL metabolism and their resulting molecular species reflect the cellular proliferative ability and differentiation state and deserve further studies as potential markers of breast cancer progression.	[Doria, M. Luisa; Ribeiro, Ana S.; Cotrim, Candida Z.; Domingues, Pedro; Domingues, M. Rosario; Helguero, Luisa A.] Univ Aveiro, Organ Chem & Nat Prod Res Unit, Mass Spectrometry Ctr, P-3810193 Aveiro, Portugal; [Wang, Jun; Williams, Cecilia] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA	Universidade de Aveiro; University of Houston System; University of Houston	Helguero, LA (corresponding author), Univ Aveiro, Dept Chem, Campus Santiago, P-3810193 Aveiro, Portugal.	luisa.helguero@ua.pt	Cruz e Silva, Odete/AAH-5595-2020; Williams, Cecilia/A-6677-2009; Domingues, Pedro/E-5202-2010; Helguero, Luisa/B-1221-2013; Domingues, Rosario M/K-7444-2014	Williams, Cecilia/0000-0002-0602-2062; Domingues, Pedro/0000-0002-8060-7675; Helguero, Luisa/0000-0001-8237-2390; Domingues, Rosario M/0000-0001-5357-3601; Cotrim, Candida Zita/0000-0002-2489-274X	European Community Fund (FEDER); Fundacao para a Cienncia e Tecnologia (FCT) [PTDC/SAU-ONC/112671/2009, PTDC/SAU-ONC/118346/2010]; Project Ciencia; University of Aveiro; European Union; Quadro de Referencia Estrategico Nacional (QREN); COMPETE [PEst-C/QUI/UI0062/2011, PEst-C/QUI/UI0062/2013]; RNEM; Texas Emerging Technology Fund [300-9-1958]; University of Houston	European Community Fund (FEDER)(European Commission); Fundacao para a Cienncia e Tecnologia (FCT); Project Ciencia; University of Aveiro(European Commission); European Union(European Commission); Quadro de Referencia Estrategico Nacional (QREN); COMPETE; RNEM; Texas Emerging Technology Fund; University of Houston	The authors thank Celeste Resende for technical help with mammary gland histological sectioning. This work was supported by federal funds through Programa Operacional Tematico Factores de Competitividade (COMPETE) with coparticipation from the European Community Fund (FEDER) and national funds through Fundacao para a Cienncia e Tecnologia (FCT) under the projects PTDC/SAU-ONC/112671/2009 and PTDC/SAU-ONC/118346/2010 (L.A.H.), Project Ciencia 2008 (L.A.H.). The Mass Spectrometry Center, within the Organic Chemistry and Natural Products (QOPNA) research unit, is funded by the University of Aveiro, FCT, European Union, Quadro de Referencia Estrategico Nacional (QREN), FEDER, and COMPETE projects PEst-C/QUI/UI0062/2011 and PEst-C/QUI/UI0062/2013 and RNEM. This work was also supported by grants from the Texas Emerging Technology Fund, under agreement 300-9-1958 and by faculty start-up funding from the University of Houston (C.W.).	Abraham J, 2011, ALCOHOL CLIN EXP RES, V35, P2113, DOI 10.1111/j.1530-0277.2011.01563.x; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; ALESSANDRI JM, 1990, REPROD NUTR DEV, V30, P551, DOI 10.1051/rnd:19900501; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; [Anonymous], 2002, NEW COMPREHENSIVE BI, DOI [DOI 10.1016/S0167-7306(02)36009-5, 10.1016/S0167-7306(02)36009-5]; Archer A, 2013, J LIPID RES, V54, P1300, DOI 10.1194/jlr.M033977; Aued-Pimentel S, 2004, J CHROMATOGR A, V1054, P235, DOI 10.1016/j.chroma.2004.07.090; Aydogdu E, 2012, CARCINOGENESIS, V33, P1502, DOI 10.1093/carcin/bgs161; Balgoma D, 2010, J IMMUNOL, V184, P3857, DOI 10.4049/jimmunol.0902883; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BARZILAI A, 1991, CANCER, V67, P2919, DOI 10.1002/1097-0142(19910601)67:11<2919::AID-CNCR2820671135>3.0.CO;2-Z; Bligh E. G., 1959, J BIOL CHEM, V234, P469; Calder PC, 2003, BRAZ J MED BIOL RES, V36, P433, DOI 10.1590/S0100-879X2003000400004; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; FLESHOOD HL, 1970, J BIOL CHEM, V245, P4414; Fuchs B, 2008, ANAL BIOANAL CHEM, V392, P849, DOI 10.1007/s00216-008-2301-8; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Gu YC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1841; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Humphreys RC, 1997, CELL GROWTH DIFFER, V8, P839; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Iwabuchi K, 2010, FEBS LETT, V584, P1642, DOI 10.1016/j.febslet.2009.10.043; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kovacs A, 2005, J PEDIATR GASTR NUTR, V41, P454, DOI 10.1097/01.mpg.0000176181.66390.54; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Lamb CA, 2005, J CELL PHYSIOL, V202, P672, DOI 10.1002/jcp.20143; Doria ML, 2013, J CELL PHYSIOL, V228, P457, DOI 10.1002/jcp.24152; Doria ML, 2012, BREAST CANCER RES TR, V133, P635, DOI 10.1007/s10549-011-1823-5; MacLennan M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2646; Madesh M, 1996, BIOCHEM MOL BIOL INT, V38, P659; MERCHANT TE, 1991, BRIT J CANCER, V63, P693, DOI 10.1038/bjc.1991.157; Mida K, 2012, J AGR FOOD CHEM, V60, P10657, DOI 10.1021/jf302757j; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Polyak K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013417; Pompeia C, 2003, CELL BIOCHEM FUNCT, V21, P97, DOI 10.1002/cbf.1012; Prydz K, 2001, BIOCHEM J, V357, P11, DOI 10.1042/0264-6021:3570011; ROSANO TG, 1976, J CELL BIOL, V69, P581, DOI 10.1083/jcb.69.3.581; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Shen ZZ, 2001, GYNECOL ONCOL, V83, P25, DOI 10.1006/gyno.2001.6357; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SMITH TAD, 1993, NMR BIOMED, V6, P209, DOI 10.1002/nbm.1940060307; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Sterin M, 2004, BREAST CANCER RES TR, V87, P1, DOI 10.1023/B:BREA.0000041572.07837.ec; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Williams C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2256; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaguchi H, 2003, BIOCHEM J, V374, P715, DOI 10.1042/BJ20030381; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108	63	33	34	0	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4247	4264		10.1096/fj.14-249672	http://dx.doi.org/10.1096/fj.14-249672			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970396				2022-12-25	WOS:000342222700006
J	Olsen, JA; Ahring, PK; Kastrup, JS; Gajhede, M; Balle, T				Olsen, Jeppe A.; Ahring, Philip K.; Kastrup, Jette S.; Gajhede, Michael; Balle, Thomas			Structural and Functional Studies of the Modulator NS9283 Reveal Agonist-like Mechanism of Action at alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATOR; CYS-LOOP RECEPTORS; ACH-BINDING PROTEIN; SUBUNIT INTERFACES; IN-VIVO; PHARMACOLOGY; EFFICACY; SUBTYPES; SYSTEM; SITES	Modulation of Cys loop receptor ion channels is a proven drug discovery strategy, but many underlying mechanisms of the mode of action are poorly understood. We report the x-ray structure of the acetylcholine-binding protein from Lymnaea stagnalis with NS9283, a stoichiometry selective positive modulator that targets the alpha 4-alpha 4 interface of alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs). Together with homology modeling, mutational data, quantum mechanical calculations, and pharmacological studies on alpha 4 beta 2 nAChRs, the structure reveals a modulator binding mode that overlaps the alpha 4-alpha 4 interface agonist (acetylcholine)-binding site. Analysis of contacts to residues known to govern agonist binding and function suggests that modulation occurs by an agonist-like mechanism. Selectivity for alpha 4-alpha 4 over alpha 4-beta 2 interfaces is determined mainly by steric restrictions from Val-136 on the beta 2-subunit and favorable interactions between NS9283 and His-142 at the complementary side of alpha 4. In the concentration ranges where modulation is observed, its selectivity prevents NS9283 from directly activating nAChRs because activation requires coordinated action from more than one interface. However, we demonstrate that in a mutant receptor with one natural and two engineered alpha 4-alpha 4 interfaces, NS9283 is an agonist. Modulation via extracellular binding sites is well known for benzodiazepines acting at gamma-aminobutyric acid type A receptors. Like NS9283, benzodiazepines increase the apparent agonist potency with a minimal effect on efficacy. The shared modulatory profile along with a binding site located in an extracellular subunit interface suggest that modulation via an agonist-like mechanism may be a common mechanism of action that potentially could apply to Cys loop receptors beyond the alpha 4 beta 2 nAChRs.	[Olsen, Jeppe A.] NeuroSearch AS, DK-2750 Ballerup, Denmark; [Olsen, Jeppe A.; Kastrup, Jette S.; Gajhede, Michael] Univ Copenhagen, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Olsen, Jeppe A.; Ahring, Philip K.; Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Saniona AB, DK-2750 Ballerup, Denmark	University of Copenhagen; University of Sydney	Balle, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	thomas.balle@sydney.edu.au		Balle, Thomas/0000-0002-0233-8350; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA Research School at the University of Copenhagen, Denmark; IMK Almene Fond, Denmark; Australian National Health and Medical Research Council [APP1069417]	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA Research School at the University of Copenhagen, Denmark; IMK Almene Fond, Denmark; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation, the DRA Research School at the University of Copenhagen, Denmark, the IMK Almene Fond, Denmark, and Australian National Health and Medical Research Council Grant APP1069417. J. A. O. and P. K. A. declare that at the time the described work was carried out they were employed by NeuroSearch A/S or Saniona AB, respectively. This does not alter the authors' adherence to all policies on sharing data and materials.	Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallivan JP, 1999, ORG LETT, V1, P103, DOI 10.1021/ol990577p; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hogg RC, 2004, CNS NEUROL DISORD-DR, V3, P123, DOI 10.2174/1568007043482507; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mirza NR, 2008, J PHARMACOL EXP THER, V327, P954, DOI 10.1124/jpet.108.138859; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Pandya A, 2011, BIOCHEM PHARMACOL, V82, P952, DOI 10.1016/j.bcp.2011.04.020; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Ussing CA, 2013, J MED CHEM, V56, P940, DOI 10.1021/jm301409f; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	30	30	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24911	24921		10.1074/jbc.M114.568097	http://dx.doi.org/10.1074/jbc.M114.568097			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24982426	Green Published, hybrid			2022-12-25	WOS:000341985300016
J	Wang, RX; Wang, JD; Acharya, D; Paul, AM; Bai, FW; Huang, FQ; Guo, YL				Wang, Ruoxing; Wang, Jundi; Acharya, Dhiraj; Paul, Amber M.; Bai, Fengwei; Huang, Faqing; Guo, Yan-Lin			Antiviral Responses in Mouse Embryonic Stem Cells DIFFERENTIAL DEVELOPMENT OF CELLULAR MECHANISMS IN TYPE I INTERFERON PRODUCTION AND RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ENDOTHELIAL-CELLS; VIRUS-INFECTION; SELF-RENEWAL; CHIKUNGUNYA VIRUS; VIRAL-INFECTIONS; INNATE IMMUNITY; VASCULAR CELLS; MAP KINASE; TNF-ALPHA	We have recently reported that mouse embryonic stem cells (mESCs) are deficient in expressing type I interferons (IFNs) in response to viral infection and synthetic viral RNA analogs (Wang, R., Wang, J., Paul, A. M., Acharya, D., Bai, F., Huang, F., and Guo, Y. L. (2013) J. Biol. Chem. 288, 15926-15936). Here, we report that mESCs are able to respond to type I IFNs, express IFN-stimulated genes, and mediate the antiviral effect of type I IFNs against La Crosse virus and chikungunya virus. The major signaling components in the IFN pathway are expressed in mESCs. Therefore, the basic molecular mechanisms that mediate the effects of type I IFNs are functional in mESCs; however, these mechanisms may not yet be fully developed as mESCs express lower levels of IFN-stimulated genes and display weaker antiviral activity in response to type I IFNs when compared with fibroblasts. Further analysis demonstrated that type I IFNs do not affect the stem cell state of mESCs. We conclude that mESCs are deficient in type I IFN expression, but they can respond to and mediate the cellular effects of type I IFNs. These findings represent unique and uncharacterized properties of mESCs and are important for understanding innate immunity development and ESC physiology.	[Wang, Ruoxing; Wang, Jundi; Acharya, Dhiraj; Paul, Amber M.; Bai, Fengwei; Guo, Yan-Lin] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Huang, Faqing] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	University of Southern Mississippi; University of Southern Mississippi	Guo, YL (corresponding author), Univ So Mississippi, Dept Biol Sci, 118 Coll Dr 5018, Hattiesburg, MS 39406 USA.	yanlin.guo@usm.edu		Paul, Amber/0000-0002-1657-3618	National Institutes of Health [HL082731, 1R15GM109299-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL082731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476, R15GM109299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082731 (to Y.-L.G.) and 1R15GM109299-01A1 (to Y.-L.G.).	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dalton S, 2009, CELL STEM CELL, V4, P9, DOI 10.1016/j.stem.2008.12.003; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Dissing-Olesen L, 2008, J PHARMACOL EXP THER, V326, P338, DOI 10.1124/jpet.108.138263; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Glaser DE, 2011, J VASC RES, V48, P415, DOI 10.1159/000324752; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; Guo YL, 1999, AM J PHYSIOL-RENAL, V276, pF390, DOI 10.1152/ajprenal.1999.276.3.F390; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hong XX, 2013, J BIOL CHEM, V288, P16196, DOI 10.1074/jbc.M112.435461; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KUBES M, 1994, J INTERFERON RES, V14, P57, DOI 10.1089/jir.1994.14.57; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rajan S, 2008, J CELL BIOCHEM, V105, P477, DOI 10.1002/jcb.21845; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; Soldan SS, 2010, VIROLOGY, V404, P139, DOI 10.1016/j.virol.2010.04.012; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Streitenfeld H, 2003, J VIROL, V77, P5507, DOI 10.1128/JVI.77.9.5507-5511.2003; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Torres J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036405; Wang RX, 2014, STEM CELLS DEV, V23, P594, DOI 10.1089/scd.2013.0417; Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438; Wang RX, 2012, EXP CELL RES, V318, P2094, DOI 10.1016/j.yexcr.2012.05.017; Wash R, 2012, J GEN VIROL, V93, P2118, DOI 10.1099/vir.0.043406-0; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08; Zampetaki A, 2007, AM J PHYSIOL-CELL PH, V293, pC1226, DOI 10.1152/ajpcell.00152.2007; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055	65	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25186	25198		10.1074/jbc.M113.537746	http://dx.doi.org/10.1074/jbc.M113.537746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24966329	hybrid, Green Published			2022-12-25	WOS:000341985300039
J	Mendez-Lucas, A; Hyrossova, P; Novellasdemunt, L; Vinals, F; Perales, JC				Mendez-Lucas, Andres; Hyrossova, Petra; Novellasdemunt, Laura; Vinals, Francesc; Perales, Jose C.			Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) Is a Pro-survival, Endoplasmic Reticulum (ER) Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; UNFOLDED PROTEIN RESPONSE; CANCER-CELLS; ACTIVATION; TRANSCRIPTION; EXPRESSION; KINASE; METABOLISM; HYPOXIA; PATHWAY	Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), encoded by the nuclear PCK2 gene, links TCA cycle intermediates and glycolytic pools through the conversion of mitochondrial oxaloacetate into phosphoenolpyruvate. In the liver PEPCK-M adjoins its profusely studied cytosolic isoform (PEPCK-C) potentiating gluconeogenesis and TCA flux. However, PEPCK-M is present in a variety of non-gluconeogenic tissues, including tumors of several origins. Despite its potential relevance to cancer metabolism, the mechanisms responsible for PCK2 gene regulation have not been elucidated. The present study demonstrates PEPCK-M overexpression in tumorigenic cells as well as the mechanism for the modulation of PCK2 abundance under several stress conditions. Amino acid limitation and ER stress inducers, conditions that activate the amino acid response (AAR) and the unfolded protein response (UPR), stimulate PCK2 gene transcription. Both the AAR and UPR lead to increased synthesis of ATF4, which mediates PCK2 transcriptional up-regulation through its binding to a putative ATF/CRE composite site within the PCK2 promoter functioning as an amino acid response element. In addition, activation of the GCN2-eIF2 alpha-ATF4 and PERK-eIF2 alpha-ATF4 signaling pathways are responsible for increased PEPCK-M levels. Finally, PEPCK-M knockdown using either siRNA or shRNA were sufficient to reduce MCF7 mammary carcinoma cell growth and increase cell death under glutamine deprivation or ER stress conditions. Our data demonstrate that this enzyme has a critical role in the survival program initiated upon stress and shed light on an unexpected and important role of mitochondrial PEPCK in cancer metabolism.	[Mendez-Lucas, Andres; Hyrossova, Petra; Novellasdemunt, Laura; Vinals, Francesc; Perales, Jose C.] Univ Barcelona, Dept Ciencies Fisiol 2, E-08907 Barcelona, Spain	University of Barcelona	Perales, JC (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Feixa Llarga S-N, E-08907 Barcelona, Spain.	jperales@ub.edu	Lucas, Andres Mendez/AAG-7488-2020; Viñals, Francesc/F-5928-2016; PERALES, JOSE C/J-7457-2017; PERALES, JOSE C. C/D-5586-2012; Vinals, Francesc/P-6278-2019; Hyroššová, Petra/AAT-6171-2021; PERALES, JOSE C./AAC-3156-2019	Lucas, Andres Mendez/0000-0002-0725-4375; Viñals, Francesc/0000-0002-9918-6751; PERALES, JOSE C/0000-0001-7363-2226; PERALES, JOSE C. C/0000-0001-7363-2226; Hyroššová, Petra/0000-0003-2337-2627; PERALES, JOSE C./0000-0001-7363-2226; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842	Ministerio de Economia and y Competitividad; FEDER [BFU2012-37177]; Ministerio de Educacion y Ciencia (FPU); Ministerio de Economia y Competitividad (FPI)	Ministerio de Economia and y Competitividad; FEDER(European Commission); Ministerio de Educacion y Ciencia (FPU)(Spanish Government); Ministerio de Economia y Competitividad (FPI)	This work was supported by a grant from the Ministerio de Economia and y Competitividad and FEDER (BFU2012-37177 (to J. C. P.)).; Recipient of fellowships from Ministerio de Educacion y Ciencia (FPU).; Recipient of a fellowship from the Ministerio de Economia y Competitividad (FPI).	Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; CHANG HC, 1966, J BIOL CHEM, V241, P2413; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Crosby JS, 2000, BLOOD, V96, P3241; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Leung-Pineda V, 2002, J BIOL CHEM, V277, P16585, DOI 10.1074/jbc.M110972200; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Park JW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-160; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Sood R, 2000, GENETICS, V154, P787; Stark R, 2014, J BIOL CHEM, V289, P7257, DOI 10.1074/jbc.C113.544759; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018	49	114	122	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22090	22102		10.1074/jbc.M114.566927	http://dx.doi.org/10.1074/jbc.M114.566927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973213	Green Published, hybrid			2022-12-25	WOS:000340593500025
J	Yun, N; Lee, YM; Kim, C; Shibayama, H; Tanimura, A; Hamanaka, Y; Kanakura, Y; Park, IS; Jo, A; Shin, JH; Ju, C; Kim, WK; Oh, YJ				Yun, Nuri; Lee, Young Mook; Kim, Chiho; Shibayama, Hirohiko; Tanimura, Akira; Hamanaka, Yuri; Kanakura, Yuzuru; Park, Il-Seon; Jo, Areum; Shin, Joo-Ho; Ju, Chung; Kim, Won-Ki; Oh, Young J.			Anamorsin, a Novel Caspase-3 Substrate in Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN BIOGENESIS; FAS-INDUCED APOPTOSIS; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; CELL-DEATH; MULTIDRUG-RESISTANCE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CANCER CELLS; ROCK-I	Activated caspases play a central role in the execution of apoptosis by cleaving endogenous substrates. Here, we developed a high throughput screening method to identify novel substrates for caspase-3 in a neuronal cell line. Critical steps in our strategy consist of two-dimensional electrophoresis-based protein separation and in vitro caspase-3 incubation of immobilized proteins to sort out direct substrates. Among 46 putative substrates identified in MN9D neuronal cells, we further evaluated whether caspase-3-mediated cleavage of anamorsin, a recently recognized cell death-defying factor in hematopoiesis, is a general feature of apoptosis. In vitro and cell-based cleavage assays indicated that anamorsin was specifically cleaved by caspase-3 but not by other caspases, generating 25- and 10-kDa fragments. Thus, in apoptosis of neuronal and non-neuronal cells induced by various stimuli including staurosporine, etoposide, or 6-hydroxydopamine, the cleavage of anamorsin was found to be blocked in the presence of caspase inhibitor. Among four tetrapeptide consensus DXXD motifs existing in anamorsin, we mapped a specific cleavage site for caspase-3 at DSVD209 down arrow L. Intriguingly, the 25-kDa cleaved fragment of anamorsin was also detected in post-mortem brains of Alzheimer and Parkinson disease patients. Although the RNA interference-mediated knockdown of anamorsin rendered neuronal cells more vulnerable to staurosporine treatment, reintroduction of full-length anamorsin into an anamorsin knock-out stromal cell line made cells resistant to staurosporine-induced caspase activation, indicating the antiapoptotic function of anamorsin. Taken together, our approach seems to be effective to identify novel substrates for caspases and has the potential to provide meaningful insights into newly identified substrates involved in neurodegenerative processes.	[Yun, Nuri; Lee, Young Mook; Kim, Chiho; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Shibayama, Hirohiko; Tanimura, Akira; Hamanaka, Yuri; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Park, Il-Seon] Chosun Univ, Dept Cellular & Mol Med, Coll Med, Kwangju 501759, South Korea; [Jo, Areum; Shin, Joo-Ho] Sungkyunkwan Univ, Sch Med, Div Pharmacol, Dept Mol Cell Biol,Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Ju, Chung; Kim, Won-Ki] Korea Univ, Dept Neurosci, Coll Med, Seoul 136705, South Korea	Yonsei University; Osaka University; Chosun University; Sungkyunkwan University (SKKU); Korea University; Korea University Medicine (KU Medicine)	Kim, WK (corresponding author), Korea Univ, Dept Neurosci, Coll Med, Anamdong 5 Ga, Seoul 136705, South Korea.	wonki@korea.ac.kr; yjoh@yonsei.ac.kr	Shin, Joo-Ho/P-1417-2018	Yun, Nuri/0000-0003-1853-1304; Tanimura, Akira/0000-0002-2039-5543	National Research Foundation of Korea (NRF) [2008-0061888]; NRF Bio and Medical Technology Development Program - Ministry of Science, Information/Communication Technology, and Future Planning [2011-0019440]; Grants-in-Aid for Scientific Research [25293220] Funding Source: KAKEN	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF Bio and Medical Technology Development Program - Ministry of Science, Information/Communication Technology, and Future Planning; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Research Foundation of Korea (NRF) Grant 2008-0061888 (to Y. J. O.) and NRF Bio and Medical Technology Development Program Grant 2011-0019440 (to W.-K. K.) funded by the Ministry of Science, Information/Communication Technology, and Future Planning.	Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Camins A, 2009, CURR DRUG METAB, V10, P433, DOI 10.2174/138920009788898028; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Demon D, 2009, TRENDS BIOTECHNOL, V27, P680, DOI 10.1016/j.tibtech.2009.09.007; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gerner C, 2002, CELL DEATH DIFFER, V9, P671, DOI 10.1038/sj.cdd.4401010; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Green KA, 2004, J BIOL CHEM, V279, P25149, DOI 10.1074/jbc.M402395200; Han BS, 2003, J NEUROSCI, V23, P5069; Hao ZM, 2006, CANCER BIOL THER, V5, P261, DOI 10.4161/cbt.5.3.2381; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Johnson CE, 2008, CELL, V134, P720, DOI 10.1016/j.cell.2008.08.019; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kang HJ, 2005, NEUROBIOL DIS, V18, P450, DOI 10.1016/j.nbd.2004.12.004; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; Karki P, 2007, BIOCHEM BIOPH RES CO, V356, P1056, DOI 10.1016/j.bbrc.2007.03.102; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Lu D, 2012, MOLECULES, V17, P7595, DOI 10.3390/molecules17067595; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Maeda K, 2007, J VET MED SCI, V69, P989, DOI 10.1292/jvms.69.989; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Murata K, 2007, IN VITRO CELL DEV-AN, V43, P235, DOI 10.1007/s11626-007-9048-y; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Park IS, 2004, BBA-PROTEINS PROTEOM, V1700, P5, DOI 10.1016/j.bbapap.2004.03.008; Park KA, 2011, J NEURAL TRANSM, V118, P433, DOI 10.1007/s00702-010-0490-8; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Saito Y, 2011, BIOCHEM BIOPH RES CO, V405, P303, DOI 10.1016/j.bbrc.2011.01.033; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Soler N, 2012, FEBS J, V279, P2108, DOI 10.1111/j.1742-4658.2012.08597.x; Talanian RV, 1997, J BIOL CHEM, V272, P9677; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yun N, 2013, BIOCHEM BIOPH RES CO, V432, P533, DOI 10.1016/j.bbrc.2013.02.017; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	53	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22183	22195		10.1074/jbc.M114.552679	http://dx.doi.org/10.1074/jbc.M114.552679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973211	Green Published, hybrid			2022-12-25	WOS:000340593500033
J	Jackson, R; Togtema, M; Lambert, PF; Zehbe, I				Jackson, Robert; Togtema, Melissa; Lambert, Paul F.; Zehbe, Ingeborg			Tumourigenesis Driven by the Human Papillomavirus Type 16 Asian-American E6 Variant in a Three-Dimensional Keratinocyte Model	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; POLYMERASE-CHAIN-REACTION; E2 GENE; ONCOGENE EXPRESSION; PHYSICAL STATUS; LIFE-CYCLE; CELL-LINE; IFN-KAPPA; HPV16 E6; CANCER	Infection with a transforming human papillomavirus (HPV) such as type 16 (of species Alphapapillomavirus 9) causes anogenital and oral tumours via viral persistence in human squamous cell epithelia. Epidemiological studies showed that the naturally occurring HPV16 Asian-American (AA) variant (sublineage D2/D3) is found more often than the European Prototype (EP) (sublineage A1) in high-grade cervical neoplasia and tumours compared to non-cancer controls. Just three amino acid changes within the early gene, E6, of HPV16 AA have been linked to this augmented tumourigenicity. The AAE6 variant's greater immortalizing and transforming potential over EPE6 has recently been confirmed in retrovirally-transduced keratinocytes expressing the E6 gene only. However, the tumourigenic role of the full-length viral genome of HPV16 has not yet been addressed with regard to these E6 variants. To investigate this process in the context of these two HPV16 E6 genotypes, an organotypic tissue culture model was used to simulate the HPV infectious life cycle. The AAE6 variant demonstrated an enhanced ability over EPE6 to drive the viral life cycle toward tumourigenesis, as evidenced phenotypically-by a more severe grade of epithelial dysplasia with higher proliferation and deregulated differentiation, and molecularly-by high viral oncogene E6 and E7 expression, but lack of productive viral life cycle markers. In contrast, EPE6 had low E6 and E7 but high E1<^>E4 expression, indicative of a productive life cycle. We suggest increased viral integration into the host genome for AAE6 as one possible mechanism for these observed differences from EPE6. Additionally, we found downstream effects on immortalization and host innate immune evasion. This study highlights how minor genomic variations in transforming viruses can have a significant affect on their tumourigenic ability.	[Jackson, Robert; Togtema, Melissa; Zehbe, Ingeborg] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Jackson, Robert; Togtema, Melissa; Zehbe, Ingeborg] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	Northern Ontario School of Medicine; Lakehead University; University of Wisconsin System; University of Wisconsin Madison	Zehbe, I (corresponding author), Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada.	zehbei@tbh.net	Jackson, Robert/AAP-7870-2021	Jackson, Robert/0000-0001-9898-5546	Natural Sciences and Engineering Council (NSERC), Canada [355858-2008]	Natural Sciences and Engineering Council (NSERC), Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Council (NSERC, to IZ), Canada (#355858-2008). URL: http://www.nserccrsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; Angiero F, 2008, ANTICANCER RES, V28, P2535; Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bodily JM, 2011, J VIROL, V85, P8852, DOI 10.1128/JVI.00664-11; Buontempo PJ, 2006, J INTERF CYTOK RES, V26, P40, DOI 10.1089/jir.2006.26.40; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Cheah PL, 2002, PATHOLOGY, V34, P326, DOI 10.1080/003130202760120472; CHOO KB, 1987, VIROLOGY, V161, P259, DOI 10.1016/0042-6822(87)90195-4; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; CRIPE TP, 1987, EMBO J, V6, P3745, DOI 10.1002/j.1460-2075.1987.tb02709.x; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; DeCarlo CA, 2008, ANAL BIOCHEM, V381, P59, DOI 10.1016/j.ab.2008.06.009; DeCarlo CA, 2010, LAB INVEST, V90, P1482, DOI 10.1038/labinvest.2010.95; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dray M, 2005, PATHOLOGY, V37, P112, DOI 10.1080/00313020500058607; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Francis DA, 2000, J VIROL, V74, P2679, DOI 10.1128/JVI.74.6.2679-2686.2000; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Goodwin EC, 1998, J VIROL, V72, P3925, DOI 10.1128/JVI.72.5.3925-3934.1998; Hansen LA, 2000, CANCER RES, V60, P3328; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; HAVRE PA, 1995, CANCER RES, V55, P4420; HUITFELDT HS, 1991, CARCINOGENESIS, V12, P2063, DOI 10.1093/carcin/12.11.2063; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kahla S, 2013, INT J BIOL MARKER; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kessis TD, 1996, ONCOGENE, V13, P427; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lambert PF, 2005, METH MOLEC MED, V119, P141; Liu HQ, 2011, J VIROL, V85, P9863, DOI 10.1128/JVI.00828-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Nagao S, 2002, J CLIN MICROBIOL, V40, P863, DOI 10.1128/JCM.40.3.863-867.2002; Niccoli S, 2012, J VIROL, V86, P12384, DOI 10.1128/JVI.01512-12; Nishimura A, 2000, J VIROL, V74, P3752, DOI 10.1128/JVI.74.8.3752-3760.2000; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Park RB, 2002, J VIROL, V76, P11359, DOI 10.1128/JVI.76.22.11359-11364.2002; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; R Core Team, 2021, R LANG ENV STAT COMP; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Riley RR, 2003, CANCER RES, V63, P4862; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Roberts I, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-57; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Si HX, 2005, J CLIN VIROL, V32, P19, DOI 10.1016/j.jcv.2004.04.004; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; TAN SH, 1992, NUCLEIC ACIDS RES, V20, P251, DOI 10.1093/nar/20.2.251; Tosun G, 2010, EUR J GYNAECOL ONCOL, V31, P627; Van Doorslaer K, 2012, VIROLOGY, V433, P216, DOI 10.1016/j.virol.2012.08.006; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vassallo J, 2000, INT J GYNECOL OBSTET, V71, P45, DOI 10.1016/S0020-7292(00)00248-4; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; Vicente-Duenas C, 2013, EMBO J, V32, P1502, DOI 10.1038/emboj.2013.97; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wang JL, 2004, CLIN CANCER RES, V10, P2407, DOI 10.1158/1078-0432.CCR-03-0242; Wechsler EI, 2012, J VIROL, V86, P6358, DOI 10.1128/JVI.07069-11; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Zehbe I, 1996, VIRCHOWS ARCH, V428, P151; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2001, CANCER RES, V61, P608; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	90	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101540	10.1371/journal.pone.0101540	http://dx.doi.org/10.1371/journal.pone.0101540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983759	gold, Green Published			2022-12-25	WOS:000339635000117
J	Ahkami, A; Scholz, U; Steuernagel, B; Strickert, M; Haensch, KT; Druege, U; Reinhardt, D; Nouri, E; von Wiren, N; Franken, P; Hajirezaei, MR				Ahkami, Amirhossein; Scholz, Uwe; Steuernagel, Burkhard; Strickert, Marc; Haensch, Klaus-Thomas; Druege, Uwe; Reinhardt, Didier; Nouri, Eva; von Wiren, Nicolaus; Franken, Philipp; Hajirezaei, Mohammad-Reza			Comprehensive Transcriptome Analysis Unravels the Existence of Crucial Genes Regulating Primary Metabolism during Adventitious Root Formation in Petunia hybrida	PLOS ONE			English	Article							POSTTRANSLATIONAL REDOX ACTIVATION; S-ADENOSYLMETHIONINE SYNTHETASE; TREHALOSE 6-PHOSPHATE; PROLINE ACCUMULATION; PHOSPHOENOLPYRUVATE CARBOXYLASE; PEROXIDASE-ACTIVITY; STARCH SYNTHESIS; EXPRESSION; CUTTINGS; GROWTH	To identify specific genes determining the initiation and formation of adventitious roots (AR), a microarray-based transcriptome analysis in the stem base of the cuttings of Petunia hybrida (line W115) was conducted. A microarray carrying 24,816 unique, non-redundant annotated sequences was hybridized to probes derived from different stages of AR formation. After exclusion of wound-responsive and root-regulated genes, 1,354 of them were identified which were significantly and specifically induced during various phases of AR formation. Based on a recent physiological model distinguishing three metabolic phases in AR formation, the present paper focuses on the response of genes related to particular metabolic pathways. Key genes involved in primary carbohydrate metabolism such as those mediating apoplastic sucrose unloading were induced at the early sink establishment phase of AR formation. Transcriptome changes also pointed to a possible role of trehalose metabolism and SnRK1 (sucrose non-fermenting 1-related protein kinase) in sugar sensing during this early step of AR formation. Symplastic sucrose unloading and nucleotide biosynthesis were the major processes induced during the later recovery and maintenance phases. Moreover, transcripts involved in peroxisomal beta-oxidation were up-regulated during different phases of AR formation. In addition to metabolic pathways, the analysis revealed the activation of cell division at the two later phases and in particular the induction of G1-specific genes in the maintenance phase. Furthermore, results point towards a specific demand for certain mineral nutrients starting in the recovery phase.	[Ahkami, Amirhossein] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Steuernagel, Burkhard] Sainsbury Lab, Norwich, Norfolk, England; [Strickert, Marc] Univ Marburg, SYNMIKRO, Marburg, Germany; [Haensch, Klaus-Thomas; Druege, Uwe; Franken, Philipp] Leibniz Inst Vegetable & Ornamental Crops IGZ, Grossbeeren, Germany; [Haensch, Klaus-Thomas; Druege, Uwe; Franken, Philipp] Leibniz Inst Vegetable & Ornamental Crops IGZ, Erfurt, Germany; [Reinhardt, Didier; Nouri, Eva] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Scholz, Uwe; von Wiren, Nicolaus; Hajirezaei, Mohammad-Reza] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany	Washington State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Philipps University Marburg; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); University of Fribourg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Hajirezaei, MR (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany.	mohammad@ipk-gatersleben.de	Reinhardt, Didier/M-8508-2014	Reinhardt, Didier/0000-0003-3495-6783; Haensch, Klaus-Thomas/0000-0002-3092-7881; Hajirezaei, Mohammad-Reza/0000-0002-9537-0121; Ahkami, Amir H./0000-0002-0545-1236; Steuernagel, Burkhard/0000-0002-8284-7728; Scholz, Uwe/0000-0001-6113-3518; von Wiren, Nicolaus/0000-0002-4966-425X	DFG (Deutsche Forschungsgemeinschaft)	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by DFG (Deutsche Forschungsgemeinschaft), http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca D., 2011, BMC P S7, V5, pP133, DOI [10.1186/1753-6561-5-s7-p133, DOI 10.1186/1753-6561-5-S7-P133]; Ahkami AH, 2013, PLANTA, V238, P499, DOI 10.1007/s00425-013-1907-z; Ahkami AH, 2009, NEW PHYTOL, V181, P613, DOI 10.1111/j.1469-8137.2008.02704.x; Alberts B, 2002, MOL BIOL CELL; Anbazhagan VR, 2008, IN VITRO CELL DEV-PL, V44, P494, DOI 10.1007/s11627-008-9134-1; Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blazich FA, 1988, ADVENTITIOUS ROOT FO, P61; BOOT KJM, 1993, PLANT PHYSIOL, V102, P513, DOI 10.1104/pp.102.2.513; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; Butler E, 1998, Symp Soc Exp Biol, V51, P79; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; da Costa CT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00133; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DELL B, 1985, PLANT SOIL, V88, P377, DOI 10.1007/BF02197494; Druege U, 2000, ANN BOT-LONDON, V85, P687, DOI 10.1006/anbo.2000.1132; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Fang WC, 2000, PLANT SCI, V158, P71, DOI 10.1016/S0168-9452(00)00307-1; Farrar J, 1996, PLANT SOIL, V185, P13, DOI 10.1007/BF02257561; Galston A.W., 1995, PLANT HORMONES PHYSL, P158, DOI DOI 10.1007/978-94-011-0473-9_; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; Giehl RFH, 2009, CURR OPIN PLANT BIOL, V12, P320, DOI 10.1016/j.pbi.2009.04.006; Goldberg R, 1986, MOL PHYSL ASPECTS PL, P208; GRAMBOW HJ, 1983, PLANTA, V157, P131; Grisebach H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 7. Secondary plant products., P457; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Haensch KT, 2004, PLANT CELL REP, V22, P376, DOI 10.1007/s00299-003-0726-2; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Journet EP, 2002, NUCLEIC ACIDS RES, V30, P5579, DOI 10.1093/nar/gkf685; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Koyuncu F, 2004, PAKISTAN J BOT, V36, P763; Kunne C, 2005, NUCLEIC ACIDS RES, V33, pD619, DOI 10.1093/nar/gki119; Kuroha T, 2002, J EXP BOT, V53, P2193, DOI 10.1093/jxb/erf077; Lindroth AM, 2001, PLANT PHYSIOL BIOCH, V39, P107, DOI 10.1016/S0981-9428(00)01229-8; Lindroth AM, 2001, PLANT MOL BIOL, V46, P335, DOI 10.1023/A:1010637012528; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lorbiecke R, 1999, PLANT PHYSIOL, V119, P21, DOI 10.1104/pp.119.1.21; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Mayne MB, 1996, PLANT CELL ENVIRON, V19, P958, DOI 10.1111/j.1365-3040.1996.tb00460.x; McDonald MS, 2003, IN VITRO CELL DEV-PL, V39, P234, DOI 10.1079/IVP2002390; McKeon Thomas A., 1995, P118; Meijer M, 2000, PLANT MOL BIOL, V43, P621, DOI 10.1023/A:1006482115915; MELZER E, 1987, PLANT PHYSIOL, V84, P58, DOI 10.1104/pp.84.1.58; Metaxas DJ, 2004, PLANT GROWTH REGUL, V44, P257, DOI 10.1007/s10725-004-5931-7; MICHELET B, 1994, PLANT CELL, V6, P1375, DOI 10.1105/tpc.6.10.1375; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Paul M, 2001, TRENDS PLANT SCI, V6, P197, DOI 10.1016/S1360-1385(01)01920-3; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Ramon M, 2007, TRENDS PLANT SCI, V12, P185, DOI 10.1016/j.tplants.2007.03.007; Rapaka VK, 2005, PLANT SCI, V168, P1547, DOI 10.1016/j.plantsci.2005.02.006; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santos KM, 2009, HORTSCIENCE, V44, P1974, DOI 10.21273/HORTSCI.44.7.1974; Santoso D, 1998, PLANT PHYSIOL, V116, P815, DOI 10.1104/pp.116.2.815; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Schwambach J, 2005, TREE PHYSIOL, V25, P487, DOI 10.1093/treephys/25.4.487; Sorin C, 2006, PLANT PHYSIOL, V140, P349, DOI 10.1104/pp.105.067868; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; STURM A, 1990, PLANT CELL, V2, P1107, DOI 10.1105/tpc.2.11.1107; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SUZUKI T, 1983, PHYSIOL PLANTARUM, V59, P455, DOI 10.1111/j.1399-3054.1983.tb04229.x; Ticconi CA, 2004, PLANT J, V37, P801, DOI 10.1111/j.1365-313X.2004.02005.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Truernit E, 1996, PLANT CELL, V8, P2169, DOI 10.1105/tpc.8.12.2169; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51	87	31	33	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100997	10.1371/journal.pone.0100997	http://dx.doi.org/10.1371/journal.pone.0100997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978694	Green Published, gold			2022-12-25	WOS:000338506400058
J	Burman, MA; Erickson, KJ; Deal, AL; Jacobson, RE				Burman, Michael A.; Erickson, Kristen J.; Deal, Alex L.; Jacobson, Rose E.			Contextual and Auditory Fear Conditioning Continue to Emerge during the Periweaning Period in Rats	PLOS ONE			English	Article							NEONATAL ALCOHOL EXPOSURE; COMORBIDITY SURVEY REPLICATION; HIPPOCAMPAL-FORMATION; POSTNATAL-DEVELOPMENT; ADULT RATS; DIFFERENTIAL CONTRIBUTION; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; POTENTIATED STARTLE; LIFETIME PREVALENCE	Anxiety disorders often emerge during childhood. Rodent models using classical fear conditioning have shown that different types of fear depend upon different neural structures and may emerge at different stages of development. For example, some work has suggested that contextual fear conditioning generally emerges later in development (postnatal day 23-24) than explicitly cued fear conditioning (postnatal day 15-17) in rats. This has been attributed to an inability of younger subjects to form a representation of the context due to an immature hippocampus. However, evidence that contextual fear can be observed in postnatal day 17 subjects and that cued fear conditioning continues to emerge past this age raises questions about the nature of this deficit. The current studies examine this question using both the context pre-exposure facilitation effect for immediate single-shock contextual fear conditioning and traditional cued fear conditioning using Sprague-Dawley rats. The data suggest that both cued and contextual fear conditioning are continuing to develop between PD 17 and 24, consistent with development occurring the in essential fear conditioning circuit.	[Burman, Michael A.; Erickson, Kristen J.; Deal, Alex L.] Univ New England, Ctr Excellence Neurosci, Dept Psychol, Biddeford, ME 04005 USA; [Jacobson, Rose E.] Univ New England, Dept Biol, Biddeford, ME USA	University of New England - Maine; University of New England - Maine	Burman, MA (corresponding author), Univ New England, Ctr Excellence Neurosci, Dept Psychol, Biddeford, ME 04005 USA.	mburman@une.edu			National Institute of Mental Health of the National Institutes of Health [R15MH093950]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH093950] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported in part by the National Institute of Mental Health of the National Institutes of Health under Award Number R15MH093950 to MAB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2011, DEV PSYCHOBIOL, V53, P1, DOI 10.1002/dev.20480; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Barnet RC, 2005, LEARN BEHAV, V33, P437, DOI 10.3758/BF03193182; Beane ML, 2002, HORM BEHAV, V41, P33, DOI 10.1006/hbeh.2001.1725; BEKENSTEIN JW, 1991, DEV BRAIN RES, V63, P237, DOI 10.1016/0165-3806(91)90083-U; BEKENSTEIN JW, 1991, DEV BRAIN RES, V63, P245, DOI 10.1016/0165-3806(91)90084-V; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Bevins RA, 1997, J EXP PSYCHOL ANIM B, V23, P312; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Brasser SM, 2004, NEUROBIOL LEARN MEM, V81, P46, DOI 10.1016/S1074-7427(03)00068-6; Brasser SM, 1998, BEHAV NEUROSCI, V112, P126, DOI 10.1037/0735-7044.112.1.126; Burman MA, 2009, BEHAV NEUROSCI, V123, P1148, DOI 10.1037/a0016733; Burman MA, 2006, HIPPOCAMPUS, V16, P103, DOI 10.1002/hipo.20137; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; CANDLAND DK, 1962, J COMP PHYSIOL PSYCH, V55, P593, DOI 10.1037/h0047206; Chareyron LJ, 2012, J COMP NEUROL, V520, P3745, DOI 10.1002/cne.23132; Claflin D. I., 2013, DEV PSYCHOBIOLOGY; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; DAVIS M, 1992, TRENDS PHARMACOL SCI, V13, P35, DOI 10.1016/0165-6147(92)90014-W; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Ehrlich DE, 2012, J PHYSIOL-LONDON, V590, P4819, DOI 10.1113/jphysiol.2012.237453; Esclassan F, 2009, HIPPOCAMPUS, V19, P33, DOI 10.1002/hipo.20473; Esmoris-Arranz FJ, 2008, BEHAV PROCESS, V78, P340, DOI 10.1016/j.beproc.2008.01.010; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Foster JA, 2010, LEARN MEMORY, V17, P259, DOI 10.1101/lm.1755810; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; Hamilton GF, 2011, BRAIN RES, V1412, P88, DOI 10.1016/j.brainres.2011.07.027; Huff NC, 2005, LEARN MEMORY, V12, P456, DOI 10.1101/lm.6705; Huff NC, 2004, BEHAV NEUROSCI, V118, P53, DOI 10.1037/0735-7044.118.1.53; Jablonski SA, 2012, DEV PSYCHOBIOL, V54, P714, DOI 10.1002/dev.20621; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; Kim JH, 2007, BEHAV NEUROSCI, V121, P131, DOI 10.1037/0735-7044.121.1.131; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lehmann H, 2010, NEUROSCIENCE, V167, P974, DOI 10.1016/j.neuroscience.2010.03.005; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Murawski NJ, 2012, NEUROSCIENCE, V206, P89, DOI 10.1016/j.neuroscience.2012.01.006; Murawski NJ, 2011, ALCOHOL CLIN EXP RES, V35, P1160, DOI 10.1111/j.1530-0277.2011.01449.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pine DS, 2007, J CHILD PSYCHOL PSYC, V48, P631, DOI 10.1111/j.1469-7610.2007.01751.x; Pisano MV, 2012, BEHAV BRAIN RES, V233, P176, DOI 10.1016/j.bbr.2012.04.030; Pugh CR, 1996, DEV PSYCHOBIOL, V29, P87, DOI 10.1002/(SICI)1098-2302(199603)29:2<87::AID-DEV1>3.0.CO;2-H; Raineki C, 2010, HIPPOCAMPUS, V20, P1037, DOI 10.1002/hipo.20702; Raineki C, 2010, BIOL PSYCHIAT, V67, P1137, DOI 10.1016/j.biopsych.2009.12.019; Revillo DA, 2014, DEV PSYCHOBIOL, V56, P713, DOI 10.1002/dev.21140; Revillo DA, 2013, BEHAV BRAIN RES, V253, P173, DOI 10.1016/j.bbr.2013.07.027; Rudy J. W., 1992, ADV INFANCY RES, P247; Rudy JW, 2009, LEARN MEMORY, V16, P573, DOI 10.1101/lm.1494409; Rudy JW, 2005, LEARN MEMORY, V12, P172, DOI 10.1101/lm.84005; RUDY JW, 1993, BEHAV NEUROSCI, V107, P887, DOI 10.1037/0735-7044.107.5.887; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Rudy JW, 2002, BEHAV NEUROSCI, V116, P530, DOI 10.1037//0735-7044.116.4.530; Schiffino FL, 2011, NEUROBIOL LEARN MEM, V95, P190, DOI 10.1016/j.nlm.2010.11.011; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shechner T, 2014, BIOL PSYCHOL; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; THOMAS DA, 1983, J COMP PSYCHOL, V97, P201, DOI 10.1037/0735-7036.97.3.201; Treffers PDA, 2001, ANXIETY DISORDERS CH, P1; WILSON DA, 1984, DEV BRAIN RES, V16, P61, DOI 10.1016/0165-3806(84)90063-4; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Woodcock EA, 2000, NEUROBIOL LEARN MEM, V74, P89, DOI 10.1006/nlme.1999.3949; Yap CSL, 2007, DEV PSYCHOBIOL, V49, P565, DOI 10.1002/dev.20244; Yap CSL, 2005, DEV PSYCHOBIOL, V47, P55, DOI 10.1002/dev.20074; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X	79	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100807	10.1371/journal.pone.0100807	http://dx.doi.org/10.1371/journal.pone.0100807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977415	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400041
J	Dewar, ML; Arnould, JPY; Krause, L; Trathan, P; Dann, P; Smith, SC				Dewar, Meagan L.; Arnould, John P. Y.; Krause, Lutz; Trathan, Phil; Dann, Peter; Smith, Stuart C.			Influence of Fasting during Moult on the Faecal Microbiota of Penguins	PLOS ONE			English	Article							GUT MICROBIOTA; EUDYPTULA-MINOR; KING PENGUINS; OBESITY; ENERGY; METABOLISM; ENERGETICS; DIVERSITY; ECOLOGY; CELLS	Many seabirds including penguins are adapted to long periods of fasting, particularly during parts of the reproductive cycle and during moult. However, the influence of fasting on the gastrointestinal (GI) microbiota has not been investigated in seabirds. Therefore, the present study aimed to examine the microbial composition and diversity of the GI microbiota of fasting little (Eudyptula minor) and king penguins (Aptenodytes patagonicus) penguins during early and late moult. The results from this study indicated that there was little change in the abundance of the major phyla during moult, except for a significant increase in the level of Proteobacteria in king penguins. In king penguins the abundance of Fusobacteria increases from 1.73% during early moult to 33.6% by late moult, whilst the abundance of Proteobacteria (35.7% to 17.2%) and Bacteroidetes (19.5% to 11%) decrease from early to late moult. In little penguins, a decrease in the abundances of Firmicutes (44% to 29%) and an increase in the abundance of Bacteroidetes (11% to 20%) were observed from early to late moult respectively. The results from this study indicate that the microbial composition of both king and little penguins alters during fasting. However, it appears that the microbial composition of king penguins is more affected by fasting than little penguins with the length of fast the most probable cause for this difference.	[Dewar, Meagan L.; Smith, Stuart C.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Australia; [Krause, Lutz] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Trathan, Phil] British Antarctic Survey, Cambridge CB3 0ET, England; [Dann, Peter] Phillip Isl Nat Pk, Phillip Isl, Australia; [Smith, Stuart C.] Deakin Univ, Ctr Mol & Med Res, Burwood, Australia	Deakin University; Deakin University; QIMR Berghofer Medical Research Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Deakin University	Smith, SC (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia.	stuart.smith@deakin.edu.au	Dewar, Meagan/AAI-3969-2021; Krause, Lutz/M-7305-2015; Krause, Lutz/G-6283-2013	Krause, Lutz/0000-0003-3806-0845; Krause, Lutz/0000-0003-3806-0845; Dewar, Meagan/0000-0003-0581-2422	Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences); Holsworth Wildlife Research Endowment; Phillip Island Nature Parks; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences); Holsworth Wildlife Research Endowment; Phillip Island Nature Parks; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was sponsored by Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences), Holsworth Wildlife Research Endowment (http://www.anz.com.au/personal/private-bank-trustees/trustees/granting/granting-programs/small-grants/) and Phillip Island Nature Parks (http://www.penguins.org.au/conservation/research/). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bourgeon S, 2007, ECOSCIENCE, V14, P519, DOI 10.2980/1195-6860(2007)14[519:HAILIK]2.0.CO;2; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHEREL Y, 1994, AM J PHYSIOL, V266, pR1182, DOI 10.1152/ajpregu.1994.266.4.R1182; CHEREL Y, 1992, J COMP PHYSIOL B, V162, P305, DOI 10.1007/BF00260757; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2008, P NATL ACAD SCI; GALES R, 1988, AUST J ZOOL, V36, P159, DOI 10.1071/ZO9880159; Gauthier-Clerc M, 2002, MAR ECOL PROG SER, V237, P291, DOI 10.3354/meps237291; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; Goyache J, 2003, INT J SYST EVOL MICR, V53, P43, DOI 10.1099/ijs.0.02343-0; Green JA, 2004, J AVIAN BIOL, V35, P153, DOI 10.1111/j.0908-8857.2004.03138.x; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Lavery TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036478; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; Potrykus J, 2008, PROTEOMICS, V8, P2691, DOI 10.1002/pmic.200700437; Razin S, 1999, BIOSCIENCE REP, V19, P367, DOI 10.1023/A:1020204020545; Reilly P., 1994, PENGUINS WORLD; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Smith SC, 2013, FEMS MICROBIOL ECOL, V86, P246, DOI 10.1111/1574-6941.12157; Sonoyama K, 2009, APPL ENVIRON MICROB, V75, P6451, DOI 10.1128/AEM.00692-09; Stone-house Bernard, 1975, BIOL PENGUINS; Sun YZ, 2011, AQUACULT NUTR, V17, pE733, DOI 10.1111/j.1365-2095.2010.00837.x; Tremaroli V, 2010, GUT; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; WILLIAMS AJ, 1977, COMP BIOCHEM PHYS A, V56, P27, DOI 10.1016/0300-9629(77)90437-6; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	42	46	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99996	10.1371/journal.pone.0099996	http://dx.doi.org/10.1371/journal.pone.0099996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979619	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000338506400014
J	Lavinder, JJ; Hoi, KH; Reddy, ST; Wine, Y; Georgioul, G				Lavinder, Jason J.; Hoi, Kam Hon; Reddy, Sai T.; Wine, Yariv; Georgioul, George			Systematic Characterization and Comparative Analysis of the Rabbit Immunoglobulin Repertoire	PLOS ONE			English	Article							GENE CONVERSION-LIKE; ANTIBODY REPERTOIRE; B-CELL; MONOCLONAL-ANTIBODIES; SEQUENCE-ANALYSIS; VH-GENE; HEAVY; DIVERSIFICATION; GENERATION; GERMLINE	Rabbits have been used extensively as a model system for h elucidation of the mechanism of immunoglobulin diversification and for he production of antibodies. We employed Next Generation Sequencing to analyze Ig germline V and J gene usage, CDR3 length and amino acid composition, and gene conversion frequencies within the functional (transcribed) IgG repertoire of he New Zealand white rabbit (Oryctolagus cuniculus). Several previously unannotated rabbit heavy chain variable (VH) and light chain variable (VL) germline elements were deduced bioinformatically using multidimensional scaling and k-means clustering methods. We estimated the gene conversion frequency in the rabbit at 23% of IgG sequences with a mean gene conversion tract length of 59 +/- 6 bp. Sequencing and gene conversion analysis of the chicken, human, and mouse repertoires revealed that gene conversion occurs much more extensively in the chicken (frequency 70%, tract length 79 +/- 57 bp), was observed to a small, yet statistically significant extent in humans, but was virtually absent in mice	[Lavinder, Jason J.; Reddy, Sai T.; Wine, Yariv; Georgioul, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Lavinder, Jason J.; Wine, Yariv; Georgioul, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hoi, Kam Hon; Reddy, Sai T.; Georgioul, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgioul, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgioul, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	; Reddy, Sai/B-4190-2012	Hoi, Kam Hon/0000-0003-4158-0446; Reddy, Sai/0000-0002-9177-0857	Defense Advanced Research Projects Agency (DARPA) [HR0011-10-0052]; Defense Threat Reduction Agency (DTRA) [HDTRA1-12-00007]; Cancer Prevention Research Institute of Texas (CPRIT)	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Cancer Prevention Research Institute of Texas (CPRIT)	This work was funded by the Defense Advanced Research Projects Agency (DARPA, www.darpa.mil) grant HR0011-10-0052 and the Defense Threat Reduction Agency (DTRA, www.dtra.mil) grant HDTRA1-12-00007. JJL was supported by a postdoctoral fellowship from the Cancer Prevention Research Institute of Texas (CPRIT, www.cprit.state.tx.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLA E, 1974, IMMUNOCHEMISTRY, V11, P395, DOI 10.1016/0019-2791(74)90072-X; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Arakawa H, 2002, J IMMUNOL, V169, P818, DOI 10.4049/jimmunol.169.2.818; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BERNSTEIN KE, 1985, J IMMUNOL, V134, P3480; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; D'Avirro N, 2005, J IMMUNOL, V175, P8133, DOI 10.4049/jimmunol.175.12.8133; Darlow JM, 2006, IMMUNOGENETICS, V58, P511, DOI 10.1007/s00251-006-0113-6; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; DRAY S, 1963, NATURE, V199, P52, DOI 10.1038/199052a0; DRAY S, 1962, NATURE, V195, P785, DOI 10.1038/195785a0; DUBISKI S, 1967, NATURE, V214, P696, DOI 10.1038/214696a0; Duvvuri B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00158; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteves PJ, 2005, IMMUNOGENETICS, V57, P874, DOI 10.1007/s00251-005-0022-0; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P383, DOI 10.1007/978-1-60761-913-0_21; FITTS MG, 1990, J IMMUNOL, V145, P2713; FRIEDMAN ML, 1994, J IMMUNOL, V152, P632; Gertz EM, 2013, IMMUNOGENETICS, V65, P749, DOI 10.1007/s00251-013-0722-9; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P15; Huston JS, 2012, PROTEIN ENG DES SEL, V25, P483, DOI 10.1093/protein/gzs069; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; KIM BS, 1973, J IMMUNOL, V111, P750; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; KNIGHT KL, 1990, CELL, V60, P963, DOI 10.1016/0092-8674(90)90344-E; Lanning D, 2000, J IMMUNOL, V165, P2012, DOI 10.4049/jimmunol.165.4.2012; Lanning DK, 2005, TRENDS IMMUNOL, V26, P419, DOI 10.1016/j.it.2005.06.001; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RAMAN C, 1994, J IMMUNOL, V152, P3935; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Ros F, 2004, GENE, V330, P49, DOI 10.1016/j.gene.2003.12.037; ROUX KH, 1991, J IMMUNOL, V146, P2027; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schroeder HW, 1998, VACCINE, V16, P1383, DOI 10.1016/S0264-410X(98)00096-6; Sehgal D, 1999, IMMUNOGENETICS, V50, P31, DOI 10.1007/s002510050683; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; WEINSTEIN PD, 1994, IMMUNITY, V1, P647, DOI 10.1016/1074-7613(94)90036-1; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhu XC, 1999, J IMMUNOL, V163, P3313	56	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101322	10.1371/journal.pone.0101322	http://dx.doi.org/10.1371/journal.pone.0101322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978027	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400115
J	Monson, MS; Settlage, RE; McMahon, KW; Mendoza, KM; Rawal, S; El-Nezami, HS; Coulombe, RA; Reed, KM				Monson, Melissa S.; Settlage, Robert E.; McMahon, Kevin W.; Mendoza, Kristelle M.; Rawal, Sumit; El-Nezami, Hani S.; Coulombe, Roger A.; Reed, Kent M.			Response of the Hepatic Transcriptome to Aflatoxin B-1 in Domestic Turkey (Meleagris gallopavo)	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; LIVER; LACTOBACILLUS; PROPIONIBACTERIUM; PERFORMANCE; METABOLISM; STRAINS; BINDING; MDM2	Dietary exposure to aflatoxin B-1 (AFB(1)) is detrimental to avian health and leads to major economic losses for the poultry industry. AFB(1) is especially hepatotoxic in domestic turkeys (Meleagris gallopavo), since these birds are unable to detoxify AFB(1) by glutathione-conjugation. The impacts of AFB(1) on the turkey hepatic transcriptome and the potential protection from pretreatment with a Lactobacillus-based probiotic mixture were investigated through RNA-sequencing. Animals were divided into four treatment groups and RNA was subsequently recovered from liver samples. Four pooled RNA-seq libraries were sequenced to produce over 322 M reads totaling 13.8 Gb of sequence. Approximately 170,000 predicted transcripts were de novo assembled, of which 803 had significant differential expression in at least one pair-wise comparison between treatment groups. Functional analysis linked many of the transcripts significantly affected by AFB(1) exposure to cancer, apoptosis, the cell cycle or lipid regulation. Most notable were transcripts from the genes encoding E3 ubiquitin-protein ligase Mdm2, osteopontin, S-adenosylmethionine synthase isoform type-2, and lipoprotein lipase. Expression was modulated by the probiotics, but treatment did not completely mitigate the effects of AFB(1). Genes identified through transcriptome analysis provide candidates for further study of AFB(1) toxicity and targets for efforts to improve the health of domestic turkeys exposed to AFB(1).	[Monson, Melissa S.; Mendoza, Kristelle M.; Reed, Kent M.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Settlage, Robert E.; McMahon, Kevin W.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Data Anal Core, Blacksburg, VA 24061 USA; [Rawal, Sumit; Coulombe, Roger A.] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr, Logan, UT 84322 USA; [El-Nezami, Hani S.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Virginia Polytechnic Institute & State University; Utah System of Higher Education; Utah State University; University of Hong Kong	Reed, KM (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	reedx054@umn.edu	Coulombe, Roger A/G-7523-2012	Monson, Melissa/0000-0002-4183-2888; El-Nezami, Hani/0000-0001-6700-4346	USDA-AFRI from the USDA NIFA Animal Genome Program [2007-35205-17880, 2009-35205-05302, 2013-01043]	USDA-AFRI from the USDA NIFA Animal Genome Program	This study was funded by USDA-AFRI Grants #2007-35205-17880, 2009-35205-05302 and 2013-01043 from the USDA NIFA Animal Genome Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V414, P664, DOI 10.1016/j.bbrc.2011.09.120; Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Blount W.P, 1961, TURKEYS, V9, P52; Blount W. P., 1961, J BRIT TURKEY FEDERA, V9; Blount WP, 1961, TURKEYS, V52, P55; Blout WP, 1961, TURKEYS, V9, P77; CAST, 1989, MYC EC HLTH RISKS; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORRIER DE, 1991, VET IMMUNOL IMMUNOP, V30, P73, DOI 10.1016/0165-2427(91)90010-A; COULOMBE RA, 1993, J DAIRY SCI, V76, P880, DOI 10.3168/jds.S0022-0302(93)77414-7; Davail S, 2000, COMP BIOCHEM PHYS A, V126, P91, DOI 10.1016/S1095-6433(00)00190-2; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; El-Nezami H, 1998, FOOD CHEM TOXICOL, V36, P321, DOI 10.1016/S0278-6915(97)00160-9; El-Nezami H, 2000, J FOOD PROTECT, V63, P549, DOI 10.4315/0362-028X-63.4.549; Endo K, 2000, LIVER, V20, P209, DOI 10.1034/j.1600-0676.2000.020003209.x; Farkas D, 2005, CHEM RES TOXICOL, V18, P1132, DOI 10.1021/tx0500225; GIAMBRONE JJ, 1985, POULTRY SCI, V64, P1678, DOI 10.3382/ps.0641678; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gratz S, 2006, APPL ENVIRON MICROB, V72, P7398, DOI 10.1128/AEM.01348-06; Gratz S, 2005, J FOOD PROTECT, V68, P2470, DOI 10.4315/0362-028X-68.11.2470; Han CC, 2008, ASIAN AUSTRAL J ANIM, V21, P590, DOI 10.5713/ajas.2008.70472; Ho AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-58; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Inoue J, 2011, MOL ENDOCRINOL, V25, P995, DOI 10.1210/me.2011-0070; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kim JE, 2011, TOXICOL SCI, V124, P45, DOI 10.1093/toxsci/kfr212; Klein PJ, 2002, TOXICOL APPL PHARM, V182, P11, DOI 10.1006/taap.2002.9433; Klein PJ, 2002, COMP BIOCHEM PHYS C, V132, P193, DOI 10.1016/S1532-0456(02)00065-0; Klein PJ, 2000, TOXICOL APPL PHARM, V165, P45, DOI 10.1006/taap.2000.8926; Lau WY, 2000, ONCOL RES, V12, P59; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lozano MC, 2006, BRIT POULTRY SCI, V47, P734, DOI 10.1080/00071660601084390; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Luo J, 2010, BENEF MICROBES, V1, P53, DOI 10.3920/BM2009.0017; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Murcia HW, 2011, J XENOBIOTICS, V1, P17, DOI 10.4081/xeno.2011.e4; Nagoshi S, 2014, HEPATOL RES, V44, P22, DOI 10.1111/hepr.12166; NEWBERNE PM, 1969, CANCER RES, V29, P236; Oatley JT, 2000, J FOOD PROTECT, V63, P1133, DOI 10.4315/0362-028X-63.8.1133; Oliveros JC, 2007, VENNY INTERACTIVE TO; Pandey I, 2007, BRIT POULTRY SCI, V48, P713, DOI 10.1080/00071660701713534; Pardina E, 2009, OBES SURG, V19, P608, DOI 10.1007/s11695-009-9827-5; Qureshi MA, 1998, POULTRY SCI, V77, P812, DOI 10.1093/ps/77.6.812; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rawal S, 2014, RES VET SCI IN PRESS; Rawal S, 2011, TOXICOL APPL PHARM, V254, P349, DOI 10.1016/j.taap.2011.05.010; Rawal S, 2010, RES VET SCI, V89, P325, DOI 10.1016/j.rvsc.2010.04.011; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Salim HM, 2013, POULTRY SCI, V92, P2084, DOI 10.3382/ps.2012-02947; Schlott T, 1999, BRIT J CANCER, V80, P73, DOI 10.1038/sj.bjc.6690324; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SIMS WM, 1970, POULTRY SCI, V49, P1082, DOI 10.3382/ps.0491082; Smorenburg SM, 1996, HEPATOLOGY, V23, P560; Van Vleet TR, 2006, TOXICOL SCI, V89, P399, DOI 10.1093/toxsci/kfj039; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yarru LP, 2009, POULTRY SCI, V88, P360, DOI 10.3382/ps.2008-00258; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100930	10.1371/journal.pone.0100930	http://dx.doi.org/10.1371/journal.pone.0100930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979717	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400051
J	Real, LM; Ruiz, A; Gayan, J; Gonzalez-Perez, A; Saez, ME; Ramirez-Lorca, R; Moron, FJ; Velasco, J; Marginet-Flinch, R; Musulen, E; Carrasco, JM; Moreno-Rey, C; Vazquez, E; Chaves-Conde, M; Moreno-Nogueira, JA; Hidalgo-Pascual, M; Ferrero-Herrero, E; Castellvi-Bel, S; Castells, A; Fernandez-Rozadilla, C; Ruiz-Ponte, C; Carracedo, A; Gonzalez, B; Alonso, S; Perucho, M				Real, Luis M.; Ruiz, Agustin; Gayan, Javier; Gonzalez-Perez, Antonio; Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Velasco, Juan; Marginet-Flinch, Ruth; Musulen, Eva; Carrasco, Jose M.; Moreno-Rey, Concha; Vazquez, Enrique; Chaves-Conde, Manuel; Moreno-Nogueira, Jose A.; Hidalgo-Pascual, Manuel; Ferrero-Herrero, Eduardo; Castellvi-Bel, Sergi; Castells, Antoni; Fernandez-Rozadilla, Ceres; Ruiz-Ponte, Clara; Carracedo, Angel; Gonzalez, Beatriz; Alonso, Sergio; Perucho, Manuel			A Colorectal Cancer Susceptibility New Variant at 4q26 in the Spanish Population Identified by Genome-Wide Association Analysis	PLOS ONE			English	Article							LONG NONCODING RNA; LOCI; SCAN; RISK; METAANALYSIS; EPISTASIS; 8Q24; LD	Background: Non-hereditary colorectal cancer (CRC) is a complex disorder resulting from the combination of genetic and non-genetic factors. Genome-wide association studies (GWAS) are useful for identifying such genetic susceptibility factors. However, the single loci so far associated with CRC only represent a fraction of the genetic risk for CRC development in the general population. Therefore, many other genetic risk variants alone and in combination must still remain to be discovered. The aim of this work was to search for genetic risk factors for CRC, by performing single-locus and two-locus GWAS in the Spanish population. Results: A total of 801 controls and 500 CRC cases were included in the discovery GWAS dataset. 77 single nucleotide polymorphisms (SNP)s from single-locus and 243 SNPs from two-locus association analyses were selected for replication in 423 additional CRC cases and 1382 controls. In the meta-analysis, one SNP, rs3987 at 4q26, reached GWAS significant p-value (p = 4.02x10(-8)), and one SNP pair, rs1100508 CG and rs8111948 AA, showed a trend for two-locus association (p = 4.35x10(-11)). Additionally, our GWAS confirmed the previously reported association with CRC of five SNPs located at 3q36.2 (rs10936599), 8q24 (rs10505477), 8q24.21(rs6983267), 11q13.4 (rs3824999) and 14q22.2 (rs4444235). Conclusions: Our GWAS for CRC patients from Spain confirmed some previously reported associations for CRC and yielded a novel candidate risk SNP, located at 4q26. Epistasis analyses also yielded several novel candidate susceptibility pairs that need to be validated in independent analyses.	[Real, Luis M.; Ruiz, Agustin; Gayan, Javier; Gonzalez-Perez, Antonio; Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Velasco, Juan; Marginet-Flinch, Ruth; Carrasco, Jose M.; Moreno-Rey, Concha; Vazquez, Enrique] Neocodex, Dept Struct Genom, Seville, Spain; [Real, Luis M.] Hosp Nuestra Senora de Valme, Infect Dis & Microbiol Unit, Seville, Spain; [Real, Luis M.; Ramirez-Lorca, Reposo; Moron, Francisco J.] Inst Biomed Seville IBIS, Seville, Spain; [Ruiz, Agustin] Fundacio ACE, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Gayan, Javier] Bioinfosol, Seville, Spain; [Gonzalez-Perez, Antonio; Saez, Maria E.] Andalusian Ctr Bioinformat Studies CAEBI, Seville, Spain; [Velasco, Juan; Gonzalez, Beatriz; Alonso, Sergio; Perucho, Manuel] IMPPC, Barcelona, Spain; [Marginet-Flinch, Ruth; Musulen, Eva] HUGTP, Dept Pathol, Barcelona, Spain; [Moreno-Rey, Concha; Chaves-Conde, Manuel; Moreno-Nogueira, Jose A.] Hosp Virgen del Rocio, Dept Oncol, Seville, Spain; [Hidalgo-Pascual, Manuel; Ferrero-Herrero, Eduardo] Hosp 12 Octubre, Colorectal Surg Unit, E-28041 Madrid, Spain; [Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, CIBEREHD, Hosp Clin, Dept Gastroenterol,IDIBAPS, Barcelona, Spain; [Fernandez-Rozadilla, Ceres; Ruiz-Ponte, Clara; Carracedo, Angel] Hosp Clin, Galician Publ Fdn Genom Med, Ctr Invest Biomed Red Enfermedades Rares, Genom Med Grp, Santiago De Compostela, A Coruna, Spain; [Perucho, Manuel] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Perucho, Manuel] ICREA, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Sanford Burnham Prebys Medical Discovery Institute; ICREA	Perucho, M (corresponding author), IMPPC, Barcelona, Spain.	mperucho@imppc.org	Ruiz, Agustín/L-4469-2019; Saez, Maria E/C-8093-2012; Ruiz, Agustin/G-5677-2012; Gonzalez, Beatriz/G-5158-2011; González-Pérez, Antonio/AAY-4179-2021; Ruiz-Ponte, Clara/I-3849-2015; Real, Luis M/K-9646-2014; Alonso, Sergio/GVR-8346-2022; Carracedo, Angel/D-4257-2012; Castells, Antoni/ABC-1002-2021; Musulen, Eva/AAI-9169-2020; Reposo, Ramirez-Lorca/D-7907-2014; IBIS, TERAPIA CELULA/P-3297-2015; Alonso, Sergio/G-5145-2011; Gonzalez-Perez, Antonio/A-5247-2010	Ruiz, Agustín/0000-0003-2633-2495; Gonzalez, Beatriz/0000-0002-3699-9392; González-Pérez, Antonio/0000-0001-9771-5982; Ruiz-Ponte, Clara/0000-0002-2200-0162; Real, Luis M/0000-0003-4932-7429; Carracedo, Angel/0000-0003-1085-8986; Castells, Antoni/0000-0001-8431-2033; Musulen, Eva/0000-0002-9667-6464; Alonso, Sergio/0000-0001-6497-892X; Gonzalez-Perez, Antonio/0000-0001-9771-5982; MORON CIVANTO, FRANCISCO J./0000-0002-1961-2723; Fernandez-Rozadilla, Ceres/0000-0001-7330-4804; Saez, Maria/0000-0001-9299-2534; Castellvi-Bel, Sergi/0000-0003-1217-5097; Perucho, Manuel/0000-0002-2169-2662; Ramirez Lorca, Reposo/0000-0002-1594-0404	CENIT program from the Centro Tecnologico Industrial [CEN-20091016]; Spanish Institute of Health Carlos III [ADE10/00026, PI09/02444, PI12/00511]; Fondo de Investigacion Sanitaria/FEDER [08/1276, 08/0024, PS09/02368, 11/00219, 11/00681]; COST office through COST action [BM1206]; Fondo de Investigacion Sanitaria [CP 03-0070]; ICREA Funding Source: Custom	CENIT program from the Centro Tecnologico Industrial; Spanish Institute of Health Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); COST office through COST action; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); ICREA(ICREA)	This work was partially supported by the CENIT program from the Centro Tecnologico Industrial (CEN-20091016), grants from the Spanish Institute of Health Carlos III (ADE10/00026, PI09/02444, PI12/00511, Accion Transversal de Cancer) grants from the Fondo de Investigacion Sanitaria/FEDER (08/1276, 08/0024, PS09/02368, 11/00219, 11/00681), and by COST office through COST action BM1206. SCB is supported by contracts from the Fondo de Investigacion Sanitaria (CP 03-0070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fernandez-Rozadilla C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-55; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeter JM, 2006, ONCOLOGY-NY, V20, P269; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052535; Li LJ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-104; Martinez-Mir A, 2013, J ALZHEIMERS DIS, V35, P403, DOI 10.3233/JAD-122257; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shriner D, 2007, SCIENCE, V316, P1840; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tzeng ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067040; Wang K, 2008, GENET EPIDEMIOL, V32, P606, DOI 10.1002/gepi.20336; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	43	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101178	10.1371/journal.pone.0101178	http://dx.doi.org/10.1371/journal.pone.0101178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978480	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400093
J	Zhang, R; Wan, XJ; Zhang, X; Kang, QX; Bian, JJ; Yu, GF; Wang, JF; Zhu, KM				Zhang, Ran; Wan, Xiao-jian; Zhang, Xu; Kang, Qiu-xiang; Bian, Jin-jun; Yu, Gui-fang; Wang, Jia-feng; Zhu, Ke-ming			Plasma HSPA12B Is a Potential Predictor for Poor Outcome in Severe Sepsis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED SEPSIS; C-REACTIVE PROTEIN; ATRIAL-FIBRILLATION; EPIDEMIOLOGY; INTERLEUKIN-10; BIOMARKERS; MORTALITY; PROCALCITONIN; DYSFUNCTION; THERAPY	Introduction: Endothelium-derived molecules may be predictive to organ injury. Heat shock protein (HSP) A12B is mainly located in endothelial cells, which can be detected in the plasma of septic patients. Whether it is correlated with prognosis of sepsis remains unclear. Methods: Extracellular HSPA12B (eHSPA12B) was determined in plasma of septic mice at 6h, 12h, 24h and 48h after cecal ligation and puncture (CLP). It was also detected in plasma of patients with severe sepsis, sepsis, systemic inflammatory response syndrome and healthy volunteers. The predictive value for prognosis of severe sepsis was assessed by receiver operating curve (ROC) and Cox regression analyses. Results: eHSPA12B was elevated in plasma of CLP mice at 6h and peaked at 24h after surgery. A total of 118 subjects were included in the clinical section, including 66 patients with severe sepsis, 21 patients with sepsis, 16 patients with SIRS and 15 volunteers. Plasma eHSPA12B was significantly higher in patients with severe sepsis than in patients with sepsis, SIRS and volunteers. The level of eHSPA12B was also higher in non-survivals than survivals with severe sepsis. The area under the curve (AUC) of eHSPA12B in predicting death among patients with severe sepsis was 0.782 (0.654-0.909) in ROC analysis, much higher than that of IL-6 and IL-10. Cox regression analysis showed that cardiovascular diseases, IL-6 and eHSPA12B were risk factors for mortality in patients with severe sepsis. Survival curve demonstrated a strikingly significant difference between 28-day survival rates of patients with an eHSPA12B lower or not lower than 1.466ng/ml. Conclusions: Plasma eHSPA12B is elevated in both septic mice and patients. It may be a good predictor for poor outcome in patients with severe sepsis.	[Zhang, Ran; Wan, Xiao-jian; Zhang, Xu; Kang, Qiu-xiang; Bian, Jin-jun; Wang, Jia-feng; Zhu, Ke-ming] Second Mil Med Univ, Dept Anesthesiol & Intens Care Med, Changhai Hosp, Shanghai, Peoples R China; [Yu, Gui-fang] Shanghai Jiao Tong Univ, Dept Anesthesiol, Peoples Hosp 3, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Wang, JF (corresponding author), Second Mil Med Univ, Dept Anesthesiol & Intens Care Med, Changhai Hosp, Shanghai, Peoples R China.	jfwang@smmu.edu.cn; kmzhu@aliyun.com		Wang, Jia-feng/0000-0002-1753-6499	National Natural Science Foundation of China [81270128, 81201493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81270128 to Dr. KM Zhu and 81201493 to Dr. JF Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Cardoso T, 2010, CRIT CARE, V14, DOI 10.1186/cc9008; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Guitton C, 2011, INTENS CARE MED, V37, P950, DOI 10.1007/s00134-011-2171-y; Han ZH, 2003, P NATL ACAD SCI USA, V100, P1256, DOI 10.1073/pnas.252764399; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Heper Y, 2006, EUR J CLIN MICROBIOL, V25, P481, DOI 10.1007/s10096-006-0168-1; Hu G, 2006, J CELL SCI, V119, P4117, DOI 10.1242/jcs.03179; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Lefrant JY, 2010, ANN FR ANESTH, V29, P621, DOI 10.1016/j.annfar.2010.04.007; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ma YJ, 2013, BBA-MOL BASIS DIS, V1832, P57, DOI 10.1016/j.bbadis.2012.10.003; Manley MO, 2005, SHOCK, V23, P521, DOI 10.1097/01.shk.0000161386.23817.7f; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Miguel-Bayarri V, 2012, MED INTENSIVA, V36, P556, DOI 10.1016/j.medin.2012.01.014; Ogawa K, 2012, CELL STRESS CHAPERON, V17, P349, DOI 10.1007/s12192-011-0310-6; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2013, SHOCK, V39, P127, DOI 10.1097/SHK.0b013e31827dafa7; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Sands Kenneth E., 1997, JAMA (Journal of the American Medical Association), V278, P234, DOI 10.1001/jama.278.3.234; Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Suarez D, 2011, INTENS CARE MED, V37, P444, DOI 10.1007/s00134-010-2102-3; Walkey AJ, 2013, AM HEART J, V165, P949, DOI 10.1016/j.ahj.2013.03.020; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Yeh CH, 2009, LEUKEMIA RES, V33, P212, DOI 10.1016/j.leukres.2008.07.012; Zhou HM, 2011, CARDIOVASC RES, V89, P109, DOI 10.1093/cvr/cvq268; Zhu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035523	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101215	10.1371/journal.pone.0101215	http://dx.doi.org/10.1371/journal.pone.0101215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977412	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400101
J	Zhang, W; Song, W; Zhang, ZQ; Wang, HD; Yang, MM; Guo, RJ; Li, ML				Zhang, Wei; Song, Wang; Zhang, Zhengqing; Wang, Haidong; Yang, Miaomiao; Guo, Ruijian; Li, Menglou			Transcriptome Analysis of Dastarcus helophoroides (Coleoptera: Bothrideridae) Using Illumina HiSeq Sequencing	PLOS ONE			English	Article							RNA-SEQ; GENOME; TOOL; INFECTION; DATABASE	Background: Dastarcus helophoroides is known as the most valuable natural enemy insect against many large-body longhorned beetles. The molecular mechanism of its long lifespan and reproduction makes it a unique resource for genomic research. However, molecular biological studies on this parasitic beetle are scarce, and genomic information for D. helophoroides is not currently available. Thus, transcriptome information for this species is an important resource that is required for a better understanding of the molecular mechanisms of D. helophoroides. In this study, we obtained transcriptome information of D. helophoroides using high-throughput RNA sequencing. Results: Using Illumina HiSeq 2000 sequencing, 27,543,746 clean reads corresponding to a total of 2.48 Gb nucleotides were obtained from a single run. These reads were assembled into 42,810 unigenes with a mean length of 683 bp. Using a sequence similarity search against the five public databases (NR, Swiss-Prot, GO, COG, KEGG) with a cut-off E-value of 10(-5) using Blastx, a total of 31,293 unigenes were annotated with gene description, gene ontology terms, or metabolic pathways. Conclusions: To the best of our knowledge, this is the first study on the transcriptome information of D. helophoroides. The transcriptome data presented in this study provide comprehensive information for future studies in D. helophoroides, particularly for functional genomic studies in this parasitic beetle.	[Zhang, Wei; Song, Wang; Zhang, Zhengqing; Guo, Ruijian; Li, Menglou] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Wang, Haidong] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Yang, Miaomiao] Shaanxi Inst Zool, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Ghent University	Li, ML (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	limenglou@hotmail.com	Sunny, QI/M-5188-2019	Sunny, QI/0000-0002-5817-1609	National Natural Sciences Foundation of China [31170608]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Sciences Foundation of China (No. 31170608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; BENNETT MD, 2003, ANN BOT, V91, P1; BOZINA K. D., 1961, PCHELOVODSTVO, V38, P13; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hollodobler B., 1990, ANTS; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang SN, 1989, LONGHORNED BEETLES C; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; [雷琼 Lei Qiong], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P62; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mittapalli O, 2011, PLOS ONE, V5; Miura K., 2003, Journal of the Japanese Forestry Society, V85, P12; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pu FJ, 1980, EC INSECT FAUNA CHIN, VXIX; Qin X.-x., 1988, Entomological Knowledge, V25, P109; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Urano Tadahisa, 2003, Bulletin of the Forestry and Forest Products Research Institute, V2, P255; Wang HD, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.28; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Ximeng, 1996, Acta Agriculturae Boreali-Occidentalis Sinica, V5, P75; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Wei JR, 2009, BIOCONTROL, V54, P733, DOI 10.1007/s10526-009-9224-y; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilson E.O., 1971, INSECT SOC; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [张翌楠 Zhang Yinan], 2006, [植物保护, Plant Protection], V32, P9	35	15	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100673	10.1371/journal.pone.0100673	http://dx.doi.org/10.1371/journal.pone.0100673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979346	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400037
J	Zhang, WQ; Han, XX; An, MH; Zhao, B; Hu, QH; Chu, ZX; Xu, JC; Cai, WP; Chen, X; Fu, JH; Wang, Z; Wu, JJ; Lu, L; Zhuang, MH; Wu, H; Yan, HJ; Liao, C; Takebe, Y; Shang, H				Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Cai, Weiping; Chen, Xi; Fu, Jihua; Wang, Zhe; Wu, Jianjun; Lu, Lin; Zhuang, Minghua; Wu, Hao; Yan, Hongjing; Liao, Christina; Takebe, Yutaka; Shang, Hong			Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China	PLOS ONE			English	Article							LENGTH SEQUENCE-ANALYSIS; INJECTING DRUG-USERS; SUBTYPE B; TYPE-1; THAILAND; GENOME; MSM; INFECTION; MALAYSIA; ASIA	The HIV-1 epidemic among men-who-have-sex-with-men (MSM) continues to expand in China. A large-scale national survey we conducted on HIV-1 strains among MSM in 11 provinces in China from 2008 to 2013 (n = 920) identified a novel transmission cluster consisting of six strains (0.7%) that belonged to a new circulating recombinant form (designated CRF59_01B). CRF59_01B contains two subtype B segments of U.S.-European origin (in the pol and vpu-env regions) in a CRF01_AE backbone. CRF59_01B is the second CRF (after CRF55_01B) circulating primarily among MSM in China. CRF59_01B occurs at a low frequency (less than 1%), but it was detected in four different provinces/regions in China: Liaoning (northeast China) (n = 3); Hunan (central China) (n = 1); Guangdong (south China) (n = 1); Yunnan (southwest China) (n = 1). One additional recombinant strain was detected in a heterosexual individual in Liaoning province but is not the focus of this paper. Bayesian molecular clock analyses indicate that CRF59_01B emerged as a result of recombination between CRF01_AE and subtype B around the year 2001. The emergence of multiple forms of recombinants and CRFs reflects the ever-increasing contribution of homosexual transmission in China's HIV epidemic and indicates an active HIV transmission network among MSM in China.	[Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Liao, Christina; Takebe, Yutaka; Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China; [Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Liao, Christina; Takebe, Yutaka; Shang, Hong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Cai, Weiping] Guangzhou 8 Renmin Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, AIDS STIs Prevent & Control Dept, Changsha, Hunan, Peoples R China; [Fu, Jihua] Shandong Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Jinan, Peoples R China; [Wang, Zhe] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Wu, Jianjun] Anhui Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Hefei, Peoples R China; [Lu, Lin] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Shanghai, Peoples R China; [Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Prevent & Control, Nanjing, Jiangsu, Peoples R China	China Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Institute of Infectious Diseases (NIID); Shanghai Center for Disease Control & Prevention; Capital Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Takebe, Y (corresponding author), China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China.	takebe@nih.go.jp; hongshang100@hotmail.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Mega-projects of National Science Research for the 12th Five-Year Plan [2012ZX10001-006]; Liaoning Province Department of Higher Education Programme for Excellence in Research [LJQ2012068]; Bill and Melinda Gates Foundation; Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China	Mega-projects of National Science Research for the 12th Five-Year Plan; Liaoning Province Department of Higher Education Programme for Excellence in Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China	This work was supported by Mega-projects of National Science Research for the 12th Five-Year Plan (2012ZX10001-006), Liaoning Province Department of Higher Education Programme for Excellence in Research 2012 (LJQ2012068), Bill and Melinda Gates Foundation, Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MH, 2012, J VIROL, V86, P12402, DOI 10.1128/JVI.00262-12; [Anonymous], GENOME ANNOUNC; China. MoHotPsRo, 2010, CHIN 2010 UNGASS COU; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Han X., 2013, J ACQUIR IMMUNE DEFI; He X., 2012, PLOS ONE, V7; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Liu YJ, 2011, AIDS RES HUM RETROV, V27, P445, DOI 10.1089/aid.2010.0212; Ministry of Health PsRoC HIV/AIDS JUNPo Organization WH, 2011, 2011 EST HIV AIDS EP; [Ministry of Health PsRoCJUNPoHAWHO CDC C], 2006, 2005 UPD HIV AIDS EP; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wang WH, 2008, AIDS RES HUM RETROV, V24, P1245, DOI 10.1089/aid.2008.0095; Wang WH, 2012, AIDS RES HUM RETROV, V28, P411, DOI [10.1089/aid.2011.0196, 10.1089/AID.2011.0196]; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang BC, 2005, CELL RES, V15, P858, DOI 10.1038/sj.cr.7290359; Zhang L. R., 2013, PLOS ONE, V8; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	34	22	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99693	10.1371/journal.pone.0099693	http://dx.doi.org/10.1371/journal.pone.0099693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978029	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400007
J	Cao, DP; Liu, Y; Walker, WB; Li, JH; Wang, GR				Cao, Depan; Liu, Yang; Walker, William B.; Li, Jianhong; Wang, Guirong			Molecular Characterization of the Aphis gossypii Olfactory Receptor Gene Families	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; LIGAND-BINDING CORE; CHEMORECEPTOR SUPERFAMILY; MEMBRANE TOPOLOGY; HOST LOCATION; PEA APHID; EXPRESSION; IDENTIFICATION; ALIGNMENT; PROTEINS	The cotton aphid, Aphis gossypii Glover, is a polyphagous pest that inflicts great damage to cotton yields worldwide. Antennal olfaction, which is extremely important for insect survival, mediates key behaviors such as host preference, mate choice, and oviposition site selection. In insects, odor detection is mediated by odorant receptors (ORs) and ionotropic receptors (IRs), which ensure the specificity of the olfactory sensory neuron responses. In this study, our aim is to identify chemosensory receptors in the cotton aphid genome, as a means to uncover olfactory encoding of the polyphagous feeding habits as well as to aid the discovery of new targets for behavioral interference. We identified a total of 45 candidate ORs and 14 IRs in the cotton aphid genome. Among the candidate AgoORs, 9 are apparent pseudogenes, while 19 can be clustered with ORs from the pea aphid, forming 16 AgoOR/ApOR orthologous subgroups. Among the candidate IRs, we identified homologs of the two highly conserved co-receptors IR8a and IR25a; no AgoIR retain the complete glutamic acid binding domain, suggesting that putative AgoIRs bind different ligands. Our results provide the necessary information for functional characterization of the chemosensory receptors of A. gossypii, with potential for new or refined applications of semiochemicals-based control of this pest insect.	[Cao, Depan; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China; [Cao, Depan; Liu, Yang; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Walker, William B.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol Res Grp, Alnarp, Sweden	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swedish University of Agricultural Sciences	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn; grwang@ippcaas.cn		Liu, Yang/0000-0002-3424-7111	National Basic Research Program of China (973 Program) [2012CB114104]; National Natural Science Foundation of China [31230062, 31201578]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program, 2012CB114104), National Natural Science Foundation of China (31230062, to G. W. and 31201578, to Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gereau R.W., 2008, GLUTAMATE RECEPTORS; Hegde M, 2011, J CHEM ECOL, V37, P741, DOI 10.1007/s10886-011-9980-x; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Koczor S, 2010, PEST MANAG SCI, V66, P1374, DOI 10.1002/ps.2030; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Quiroz A, 1998, J CHEM ECOL, V24, P113, DOI 10.1023/A:1022393029987; Rebora M, 2009, MICRON, V40, P571, DOI 10.1016/j.micron.2009.03.001; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schirmer S, 2008, EUR J ENTOMOL, V105, P121, DOI 10.14411/eje.2008.017; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	54	46	51	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101187	10.1371/journal.pone.0101187	http://dx.doi.org/10.1371/journal.pone.0101187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971460	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200102
J	Dennis, FE; Fujii, Y; Haga, K; Damanka, S; Lartey, B; Agbemabiese, CA; Ohta, N; Armah, GE; Katayama, K				Dennis, Francis E.; Fujii, Yoshiki; Haga, Kei; Damanka, Susan; Lartey, Belinda; Agbemabiese, Chantal A.; Ohta, Nobuo; Armah, George E.; Katayama, Kazuhiko			Identification of Novel Ghanaian G8P[6] Human-Bovine Reassortant Rotavirus Strain by Next Generation Sequencing	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; WHOLE-GENOME ANALYSIS; CLOSE RELATIONSHIP; G8 ROTAVIRUSES; GENOTYPES; DIARRHEA; REVEALS; GENE; CLASSIFICATION; VACCINE	Group A rotaviruses (RVAs) are the most important etiological agent of acute gastroenteritis in children <5 years of age worldwide. The monovalent rotavirus vaccine Rotarix was introduced into the national Expanded Programme on Immunization (EPI) in Ghana in May 2012. However, there is a paucity of genetic and phylogenetic data on the complete genomes of human RVAs in circulation pre-vaccine introduction. The common bovine rotavirus VP7 genotype G8 has been sporadically detected in Ghanaian children, usually in combination with the VP4 genotype P[6]. To investigate the genomic constellations and phylogeny of RVA strains in circulation prior to vaccine introduction, the full genomes of two unusual G8P[6] strains, GH018-08 and GH019-08, detected during burden of disease surveillance, were characterized by Illumina MiSeq sequencing. The Ghanaian isolates, GH018-08 and GH019-08, exhibited the unusual, previously unreported genotype constellation G8-P[6]-I2-R2-C2-M2-A2-N2-T2-E2-H3. Phylogenetic analyses confirmed that 10 out of the 11 genes of GH018-08 and GH019-08 were identical/nearly identical, with significant variation detected only in their VP1 genes, and clearly established the occurrence of multiple independent interspecies transmission and reassortment events between co-circulating bovine/ovine/caprine rotaviruses and human DS-1-like RVA strains. These findings highlight the contribution of reassortment and interspecies transmission events to the high rotavirus diversity in this region of Africa, and justify the need for simultaneous monitoring of animal and human rotavirus strains.	[Dennis, Francis E.; Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Dennis, Francis E.; Fujii, Yoshiki; Haga, Kei; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Musashimurayama, Tokyo, Japan; [Dennis, Francis E.; Damanka, Susan; Lartey, Belinda; Agbemabiese, Chantal A.; Armah, George E.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Ghana	Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); University of Ghana	Katayama, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Musashimurayama, Tokyo, Japan.	katayama@nih.go.jp	Fujii, Yoshiki/GOE-3566-2022	Agbemabiese, Chantal/0000-0003-1862-9408; Katayama, Kazuhiko/0000-0002-7692-1151	Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases by the Ministry of Health, Labour and Welfare, Japan (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adah MI, 2003, J CLIN MICROBIOL, V41, P3945, DOI 10.1128/JCM.41.8.3945-3950.2003; Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Armah GE, 2001, J MED VIROL, V63, P67, DOI 10.1002/1096-9071(200101)63:1&lt;67::AID-JMV1010&gt;3.0.CO;2-T; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Armah GE, 2010, J INFECT DIS, V202, pS64, DOI 10.1086/653571; Asmah RH, 2001, J CLIN MICROBIOL, V39, P1981, DOI 10.1128/JCM.39.5.1981-1984.2001; Banyai K, 2010, INFECT GENET EVOL, V10, P1140, DOI 10.1016/j.meegid.2010.05.001; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Binka E, 2011, PEDIATR INFECT DIS J, V30, P716, DOI 10.1097/INF.0b013e318223bd85; BROWNING GF, 1992, ARCH VIROL, V125, P121, DOI 10.1007/BF01309632; Chege GK, 2005, VACCINE, V23, P1522, DOI 10.1016/j.vaccine.2004.06.055; Chen YD, 2008, VIROLOGY, V375, P361, DOI 10.1016/j.virol.2008.01.003; Cunliffe NA, 2000, VIROLOGY, V274, P309, DOI 10.1006/viro.2000.0456; Enweronu-Laryea CC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-287; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; Estes MK, 1996, J INFECT DIS, V174, pS37, DOI 10.1093/infdis/174.Supplement_1.S37; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fodha I, 2005, J VET MED B, V52, P49, DOI 10.1111/j.1439-0450.2004.00810.x; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2011, J GEN VIROL, V92, P2201, DOI 10.1099/vir.0.033001-0; Ghosh S, 2011, J MED VIROL, V83, P367, DOI 10.1002/jmv.21974; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; GORZIGLIA M, 1988, J VIROL, V62, P2978, DOI 10.1128/JVI.62.8.2978-2984.1988; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Heylen E, 2013, INFECT GENET EVOL, V13, P27, DOI 10.1016/j.meegid.2012.08.019; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Jayaram H, 2004, VIRUS RES, V101, P67, DOI 10.1016/j.virusres.2003.12.007; Jere KC, 2014, INFECT GENET EVOL, V21, P58, DOI 10.1016/j.meegid.2013.10.002; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Jere KC, 2011, INFECT GENET EVOL, V11, P2072, DOI 10.1016/j.meegid.2011.09.023; Kirkwood CD, 1996, ARCH VIROL, V141, P587, DOI 10.1007/BF01718319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Monini M, 2008, VET MICROBIOL, V129, P384, DOI 10.1016/j.vetmic.2007.11.036; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; NAKAGOMI T, 1989, J VIROL, V63, P1431, DOI 10.1128/JVI.63.3.1431-1434.1989; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Nielsen NM, 2005, J CLIN VIROL, V34, P13, DOI 10.1016/j.jcv.2004.12.017; Page N, 2010, J MED VIROL, V82, P2073, DOI 10.1002/jmv.21912; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Rippinger CM, 2010, VIROLOGY, V405, P201, DOI 10.1016/j.virol.2010.06.005; Santos N, 2008, J CLIN MICROBIOL, V46, P462, DOI 10.1128/JCM.01361-07; Seheri M, 2014, PEDIATR INFECT DIS J, V33, pS76, DOI 10.1097/INF.0000000000000053; SUZUKI Y, 1993, J CLIN MICROBIOL, V31, P3046, DOI 10.1128/JCM.31.11.3046-3049.1993; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia MD, 2012, VACCINE, V30, pA79, DOI 10.1016/j.vaccine.2012.01.022; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; World Health Organization, 2002, GEN PROT HOSP BAS SU; Wu HX, 1998, J MED VIROL, V55, P168, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;168::AID-JMV14&gt;3.0.CO;2-E	63	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100699	10.1371/journal.pone.0100699	http://dx.doi.org/10.1371/journal.pone.0100699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971993	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200052
J	Liu, C; Zhan, XL; Xiao, ZM; Fan, Q; Deng, L; Cui, MX; Xiong, CX; Xue, JB; Xie, XT				Liu, Chong; Zhan, Xinli; Xiao, Zengming; Fan, Qie; Deng, Li; Cui, Mingxing; Xiong, Chunxiang; Xue, Jingbo; Xie, Xiangtao			Transcript Levels of Major Interleukins in Relation to the Clinicopathological Profile of Patients with Tuberculous Intervertebral Discs and Healthy Controls	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SPINAL TUBERCULOSIS; PLEURAL EFFUSIONS; PULMONARY TUBERCULOSIS; T-CELLS; MACROPHAGES; EXPRESSION; CYTOKINES; NICOTINE; DIFFERENTIATION	Objectives: The purpose of the present study was to simultaneously examine the transcript levels of a large number of interleukins (ILs; IL-9, IL-10, IL-12, IL-13, IL-16, IL-17, IL-18, IL-26, and IL-27) and investigate their correlation with the clinicopathological profiles of patients with tuberculous intervertebral discs. Methods: Clinical data were collected from 150 patients participating in the study from January 2013 to December 2013. mRNA expression levels in 70 tuberculous, 70 herniated, and 10 control intervertebral disc specimens were determined by real-time polymerase chain reaction. Results: IL-10, IL-16, IL-17, IL-18, and IL-27 displayed stronger expression in tuberculous spinal disc tissue than in normal intervertebral disc tissue (P < 0.05). Our results illustrated multiple correlations among IL-10, IL-16, IL-17, IL-18, and IL-27 mRNA expression in tuberculous samples. Smoking habits were found to have a positive correlation with IL-17 transcript levels and a negative correlation with IL-10 transcript levels (P < 0.05). Pain intensity, symptom duration, C-reactive protein levels, and the erythrocyte sedimentation rate exhibited multiple correlations with the transcript levels of several ILs (P < 0.05). Conclusions: The experimental data imply a double-sided effect on the activity of ILs in tuberculous spinal intervertebral discs, suggesting that they may be involved in intervertebral discs destruction. Our findings also suggest that smoking may affect the intervertebral discs destruction process of spinal tuberculosis. However, further studies are necessary to elucidate the exact role of ILs in the intervertebral discs destruction process of spinal tuberculosis.	[Liu, Chong; Zhan, Xinli; Xiao, Zengming; Fan, Qie; Deng, Li; Cui, Mingxing; Xiong, Chunxiang; Xue, Jingbo; Xie, Xiangtao] Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Zhan, XL (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China.	3cstar@163.com		, Qie/0000-0001-6391-4342				Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Alawneh KM, 2014, BIOL-TARGETS THER, V8, P193, DOI 10.2147/BTT.S59574; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Cheng L, 2013, INJURY, V44, P1805, DOI 10.1016/j.injury.2013.04.010; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Duanmu H, 2010, ZHONGHUA JIE HE HE H, V25, P3; ElAhmady O, 1997, ANN CLIN BIOCHEM, V34, P160, DOI 10.1177/000456329703400205; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Gergert V Ia, 1995, Vestn Ross Akad Med Nauk, P33; Guinet E, 2004, IMMUNOL LETT, V95, P45, DOI 10.1016/j.imlet.2004.06.003; Guo Li-Xin, 2010, Zhongguo Gu Shang, V23, P200; Ibrahim L, 2013, IMMUNOL INVEST, V42, P122, DOI 10.3109/08820139.2012.736116; Inoue H, 2008, BONE, V42, P1102, DOI 10.1016/j.bone.2008.01.031; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Joosten LAB, 1999, INFLAMM RES, V48, P48, DOI 10.1007/s000110050396; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; LAFOND EM, 1958, J BONE JOINT SURG AM, V40, P346, DOI 10.2106/00004623-195840020-00008; Matsuzaki Goro, 2011, Nihon Rinsho, V69, P1368; Vo N, 2011, J ORTHOP RES, V29, P1585, DOI 10.1002/jor.21417; Nouri-Shirazi M, 2003, IMMUNOLOGY, V109, P365, DOI 10.1046/j.1365-2567.2003.01655.x; O'Shea MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097366; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Palle Lalitha, 2010, Indian J Radiol Imaging, V20, P279, DOI 10.4103/0971-3026.73544; Qin XJ, 2005, EUR RESPIR J, V25, P605, DOI 10.1183/09031936.05.00090804; Reichmann MT, 2014, BMJ CASE REP 2014, V2014; Rovina N, 2013, CYTOKINE, V63, P166, DOI 10.1016/j.cyto.2013.04.017; Sharma S, 2001, ASIAN PAC J ALLERGY, V19, P213; Shigenaga T, 2001, IMMUNOLOGY, V102, P466, DOI 10.1046/j.1365-2567.2001.01195.x; Si JW, 2012, ARCH ORTHOP TRAUM SU, V132, P941, DOI 10.1007/s00402-012-1506-7; Skvortsova L A, 2003, Probl Tuberk Bolezn Legk, P9; Smith RE, 1997, J LEUKOCYTE BIOL, V62, P612, DOI 10.1002/jlb.62.5.612; Steinbock RT, 1976, PALEOPATHOLOGICAL DI, P374; Tsarouhas A, 2011, EUR SPINE J, V20, P781, DOI 10.1007/s00586-010-1573-9; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Valdes L, 2013, RESP CARE; Valsalan R, 2012, INDIAN J ORTHOP, V46, P138, DOI 10.4103/0019-5413.93673; van Zyl-Smit RN, 2013, CIGARETTE SMOKE IMPA; Wang B, 2011, TURK NEUROSURG, V21, P575, DOI [10.5137/1019-5149.JTN .4639-11.1, 10.5137/1019-5149.JTN.4639-11.1]; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Witchell J, 2010, VET IMMUNOL IMMUNOP, V138, P79, DOI 10.1016/j.vetimm.2010.07.004; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11	46	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101324	10.1371/journal.pone.0101324	http://dx.doi.org/10.1371/journal.pone.0101324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971599	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200112
J	Park, SY; Jung, HY; Gwak, JM; Jung, N; Cho, NY; Kang, GH				Park, So Yeon; Jung, Hae Yoen; Gwak, Jae Moon; Jung, Namhee; Cho, Nam-Yun; Kang, Gyeong Hoon			Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer	PLOS ONE			English	Article							CARCINOMA IN-SITU; ELEMENT 1 HYPOMETHYLATION; DNA METHYLATION PATTERNS; HORMONE-RECEPTOR STATUS; POOR-PROGNOSIS; CHROMOSOMAL INSTABILITY; MOLECULAR SUBTYPES; FAMILY-HISTORY; TUMOR; PROFILES	The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.	[Park, So Yeon; Gwak, Jae Moon; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, So Yeon; Jung, Hae Yoen; Gwak, Jae Moon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi, South Korea; [Jung, Namhee; Cho, Nam-Yun; Kang, Gyeong Hoon] Seoul Natl Univ, Canc Res Inst, Lab Epigenet, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675; Park, So Yeon/0000-0002-0299-7268	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0720540]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0093820]; National Research Foundation of Korea (NRF) by the Korea government (MSIP) [2011-0030049]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National Research Foundation of Korea (NRF) by the Korea government (MSIP)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0720540), by a Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0093820), and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Bae JM, 2012, INT J CANCER, V131, P1323, DOI 10.1002/ijc.27369; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Delgado-Cruzata L, 2014, EPIGENETICS-US, V9, P243, DOI 10.4161/epi.26880; Ellsworth RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-297; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Ikeda K, 2013, ANN THORAC SURG, V96, P1790, DOI 10.1016/j.athoracsur.2013.06.035; Isola J, 1999, CLIN CANCER RES, V5, P4140; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kim BH, 2009, VIRCHOWS ARCH, V455, P343, DOI 10.1007/s00428-009-0829-4; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kwon HJ, 2010, VIRCHOWS ARCH, V457, P433, DOI 10.1007/s00428-010-0958-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; van Hoesel AQ, 2012, BREAST CANCER RES TR, V134, P1103, DOI 10.1007/s10549-012-2038-0; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Yeon S, 2012, MODERN PATHOL, V25, P185, DOI 10.1038/modpathol.2011.160; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	42	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100429	10.1371/journal.pone.0100429	http://dx.doi.org/10.1371/journal.pone.0100429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971511	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200031
J	Pritchett, J; Athwal, VS; Harvey, E; Martin, K; Llewellyn, J; Ireland, P; Nicolaides, A; Humphries, MJ; Bobola, N; Hanley, NA; Hanley, KP				Pritchett, James; Athwal, Varinder S.; Harvey, Emma; Martin, Katherine; Llewellyn, Jessica; Ireland, Philip; Nicolaides, Alexander; Humphries, Martin J.; Bobola, Nicoletta; Hanley, Neil A.; Hanley, Karen Piper			Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells	PLOS ONE			English	Article							LIVER FIBROSIS; MORPHOGENIC PROTEIN; GENE-EXPRESSION; OSTEOPONTIN; RECOVERY; DEACTIVATION; HEPATOCYTES; DEGRADATION; PROGRESSION; RESOLUTION	Background and Aims: Liver fibrosis is a major cause of morbidity and mortality. It is characterised by excessive extracellular matrix (ECM) deposition from activated hepatic stellate cells (HSCs). Although potentially reversible, treatment remains limited. Understanding how ECM influences the pathogenesis of the disease may provide insight into novel therapeutic targets for the disease. The extracellular protein Epimorphin (EPIM) has been implicated in tissue repair mechanisms in several tissues, partially, through its ability to manipulate proteases. In this study, we have identified that EPIM modulates the ECM environment produced by activated hepatic stellate cells (HSCs), in part, through down-regulation of pro-fibrotic Sex-determining region Y-box 9 (SOX9). Methods: Influence of EPIM on ECM was investigated in cultured primary rat HSCs. Activated HSCs were treated with recombinant EPIM or SOX9 siRNA. Core fibrotic factors were evaluated by immunoblotting, qPCR and chromatin immunoprecipitation (ChIP). Results: During HSC activation EPIM became significantly decreased in contrast to pro-fibrotic markers SOX9, Collagen type 1 (COL1), and alpha-Smooth muscle actin (alpha-SMA). Treatment of activated HSCs with recombinant EPIM caused a reduction in alpha-SMA, SOX9, COL1 and Osteopontin (OPN), while increasing expression of the collagenase matrix metalloproteinase 13 (MMP13). Sox9 abrogation in activated HSCs increased EPIM and MMP13 expression. Conclusion: These data provide evidence for EPIM and SOX9 functioning by mutual negative feedback to regulate attributes of the quiescent or activated state of HSCs. Further understanding of EPIM's role may lead to opportunities to modulate SOX9 as a therapeutic avenue for liver fibrosis.	[Pritchett, James; Athwal, Varinder S.; Harvey, Emma; Martin, Katherine; Llewellyn, Jessica; Ireland, Philip; Nicolaides, Alexander; Hanley, Neil A.; Hanley, Karen Piper] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Endocrinol & Diabet, Manchester, Lancs, England; [Bobola, Nicoletta] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Dent, Manchester, Lancs, England; [Pritchett, James; Athwal, Varinder S.; Martin, Katherine; Llewellyn, Jessica; Hanley, Neil A.; Hanley, Karen Piper] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Biomed Res Ctr, Manchester, Lancs, England; [Humphries, Martin J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Hanley, KP (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Endocrinol & Diabet, Manchester, Lancs, England.	karen.piperhanley@manchester.ac.uk	Piper Hanley, Karen/O-8676-2015; Pritchett, James/C-2532-2008	Piper Hanley, Karen/0000-0001-9473-9647; Pritchett, James/0000-0003-2620-7061; Hanley, Neil/0000-0003-3234-4038; Llewellyn, Jessica/0000-0003-0359-6711; Humphries, Martin/0000-0002-4331-6967	Medical Research Council (MRC) [MR/J003352/1]; Manchester Biomedical Research Centre; Wellcome Trust [WT088566MA]; Biological & Biotechnological Sciences Research Council (BBSRC); Medical Research Council [MR/K003194/1, MR/J003352/1, 1233455] Funding Source: researchfish; MRC [MR/J003352/1, MR/K003194/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Biological & Biotechnological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC; KPH, MR/J003352/1; VSA and KM are MRC Clinical Training Fellows); the Manchester Biomedical Research Centre; the Wellcome Trust (NAH, WT088566MA) and the Biological & Biotechnological Sciences Research Council (BBSRC; studentship to EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hanley KP, 2010, J ENDOCRINOL, V207, P151, DOI 10.1677/JOE-10-0120; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; HIRAI Y, 1993, BIOCHEM BIOPH RES CO, V191, P1332, DOI 10.1006/bbrc.1993.1363; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; IREDALE JP, 1992, J CLIN INVEST, V90, P282, DOI 10.1172/JCI115850; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Jia Y, 2011, J CELL PHYSL; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Kim EJ, 2011, MOL THER, V19, P355, DOI 10.1038/mt.2010.262; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Shimada H, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S12; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Sohara N, 2002, J HEPATOL, V37, P214, DOI 10.1016/S0168-8278(02)00103-4; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Terasaki Y, 2000, AM J RESP CELL MOL, V23, P168, DOI 10.1165/ajrcmb.23.2.3973; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Watanabe T, 2000, J HEPATOL, V33, P224, DOI 10.1016/S0168-8278(00)80363-3; Xie H, 2007, DIGEST LIVER DIS, V39, P167, DOI 10.1016/j.dld.2006.10.015; Yamada M, 2010, LAB INVEST, V90, P867, DOI 10.1038/labinvest.2010.50; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x; Zhou J, 2011, PLOS ONE, V5, pe9732; Zhou JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009732	46	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100091	10.1371/journal.pone.0100091	http://dx.doi.org/10.1371/journal.pone.0100091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971829	Green Published, gold, Green Accepted			2022-12-25	WOS:000338512200018
J	Rusan, ZM; Kingsford, OA; Tanouye, MA				Rusan, Zeid M.; Kingsford, Olivia A.; Tanouye, Mark A.			Modeling Glial Contributions to Seizures and Epileptogenesis: Cation-Chloride Cotransporters in Drosophila melanogaster	PLOS ONE			English	Article							K-CL COTRANSPORTER; GIANT FIBER SYSTEM; EXPRESSION; BRAIN; SUSCEPTIBILITY; GENE; DISRUPTION; MUTATIONS; EPILEPSY; MUTANTS	Flies carrying a kcc loss-of-function mutation are more seizure-susceptible than wild-type flies. The kcc gene is the highly conserved Drosophila melanogaster ortholog of K+/Cl- cotransporter genes thought to be expressed in all animal cell types. Here, we examined the spatial and temporal requirements for kcc loss-of-function to modify seizure-susceptibility in flies. Targeted RNA interference (RNAi) of kcc in various sets of neurons was sufficient to induce severe seizure-sensitivity. Interestingly, kcc RNAi in glia was particularly effective in causing seizure-sensitivity. Knockdown of kcc in glia or neurons during development caused a reduction in seizure induction threshold, cell swelling, and brain volume increase in 24-48 hour old adult flies. Third instar larval peripheral nerves were enlarged when kcc RNAi was expressed in neurons or glia. Results suggest that a threshold of K+/Cl- cotransport dysfunction in the nervous system during development is an important determinant of seizure-susceptibility in Drosophila. The findings presented are the first attributing a causative role for glial cation-chloride cotransporters in seizures and epileptogenesis. The importance of elucidating glial cell contributions to seizure disorders and the utility of Drosophila models is discussed.	[Rusan, Zeid M.; Tanouye, Mark A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kingsford, Olivia A.; Tanouye, Mark A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Tanouye, Mark A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rusan, ZM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rusanz@anesthesia.ucsf.edu			McKnight Foundation; National Institutes of Health [NS31231]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031231] Funding Source: NIH RePORTER	McKnight Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by awards from the McKnight Foundation and the National Institutes of Health (NS31231) to M.A.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, GENES BRAIN BEHAV, V6, P347, DOI 10.1111/j.1601-183X.2006.00263.x; Allen M.J., 2010, COLD SPRING HARB PRO, V2010; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Benarroch EE, 2013, NEUROLOGY, V80, P756, DOI 10.1212/WNL.0b013e318283bb1c; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brink DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037876; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Chvatal A, 2000, PROG BRAIN RES, V125, P199; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; D'Ambrosio R, 2004, PHARMACOL THERAPEUT, V103, P95, DOI 10.1016/j.pharmthera.2004.05.004; Desalvo MK, 2011, GLIA, V59, P1322, DOI 10.1002/glia.21147; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Edwards TN, 2012, J COMP NEUROL, V520, P2067, DOI 10.1002/cne.23071; Featherstone DE, 2011, GLIA, V59, P1351, DOI 10.1002/glia.21085; Filippov V, 2003, INSECT MOL BIOL, V12, P319, DOI 10.1046/j.1365-2583.2003.00415.x; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P121, DOI 10.1159/000104160; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hekmat-Scafe DS, 2010, GENETICS, V184, P171, DOI 10.1534/genetics.109.109074; Hochman DW, 2012, EPILEPSIA, V53, P18, DOI 10.1111/j.1528-1167.2012.03471.x; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lee J, 2002, J NEUROSCI, V22, P11065; Lee J, 2006, J NEUROPHYSIOL, V96, P2465, DOI 10.1152/jn.00499.2006; Leiserson WM, 2011, GLIA, V59, P1312, DOI 10.1002/glia.21132; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; MacAulay N, 2012, NEUROCHEM RES, V37, P2299, DOI 10.1007/s11064-012-0731-3; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Park JH, 1996, J MEMBRANE BIOL, V149, P161, DOI 10.1007/s002329900016; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Pasantes-Morales H, 2006, CONTRIB NEPHROL, V152, P221, DOI 10.1159/000096326; PAVLIDIS P, 1995, J NEUROSCI, V15, P5810; Phelan P, 1996, J NEUROSCI, V16, P1101; Ringel F, 2008, NEUROSCI LETT, V442, P219, DOI 10.1016/j.neulet.2008.07.017; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Stork Tobias, 2012, Cold Spring Harb Protoc, V2012, P1, DOI 10.1101/pdb.top067587; Sun QF, 2010, AM J PHYSIOL-CELL PH, V298, pC26, DOI 10.1152/ajpcell.00376.2009; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zdebik AA, 2011, J PHYSIOL-LONDON, V589, P5903, DOI 10.1113/jphysiol.2011.221754	53	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101117	10.1371/journal.pone.0101117	http://dx.doi.org/10.1371/journal.pone.0101117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971529	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200095
J	Su, XL; Yao, J; Jiang, Y; Li, J; Han, JF; Sun, WD				Su, Xueli; Yao, Jun; Jiang, Yan; Li, Jie; Han, Jianfeng; Sun, Weidong			Promising Antibody Testing Strategies for Early Infant HIV Infection Diagnosis in China	PLOS ONE			English	Article							IMMUNODEFICIENCY; CHILDREN; PROGRESSION; RECOMBINANT; MORTALITY; AFRICA	Background: In China, 1.1% of people living with HIV were transmitted vertically, causing a heavy burden on families and society. Early infant diagnosis (EID) is critical for improving neonatal survival. The purpose of this study is to suggest improvement in antibody testing strategies with dried blood spots (DBSs) for EID in China through analysis of anti-HIV seroreversion of infants. Methods: A total of 280 infants born to HIV infected mothers in four diverse provinces of China where multiple subtypes coexist were enrolled. The status of the infants' infection was determined by HIV antibody enzyme immunoassay and Western blot analysis at >= 18 months of age or by convincing clinical and epidemiologic data for deceased infants. A total of 1028 DBSs were collected during follow-up, which were tested to obtain anti-HIV signal to cut-off ratio (S/CO) data. Results: For uninfected infants, anti-HIV S/CO decreased with age. Seropositivity percentage declined most rapidly at 6 months to 9 months of age and 98.7% children seroreverted by 12 months of age. For most infected infants, minimum S/CO values were obtained at <= 6 months of age. Antibody negative predictive value was 100% at >= 6 months of age. An S/CO increase >= 1.86 after three months follow-up can determine HIV infection. S/CO threshold of 3.17 can differentiate infected from uninfected infants for exposed kids at 9 months or older with sensitivity as 100% and specificity >= 94.2%. Significance: Suggestions obtained through studying seroreversion data of Chinese HIV-exposed infants help improve antibody strategies for HIV EID in China. The infection can be determined as early as 3 months of age and excluded as early as 6 months of age.	[Su, Xueli; Sun, Weidong] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yao, Jun; Jiang, Yan; Han, Jianfeng] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl HIV HCV Reference Lab, Beijing, Peoples R China; [Li, Jie] Kunming Ctr Dis Control & Prevent, Kunming, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yao, J (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl HIV HCV Reference Lab, Beijing, Peoples R China.	yaojuncdc@163.com; jiangyan03@263.net			National Natural Science Foundation of China [81302440]; Ministry of Science and Technology of China [2004BA719A03]; Clinton Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Clinton Foundation	The work was supported by National Natural Science Foundation of China (Grant No. 81302440), 'State Tenth 5 Year Plan' from Ministry of Science and Technology of China (Grant No. 2004BA719A03) and Clinton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaisomchit Sumonta, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P270; CHANTRY CJ, 1995, PEDIATR INFECT DIS J, V14, P382, DOI 10.1097/00006454-199505000-00009; Garcia F, 2012, IMMUNOTHERAPY-UK, V4, P245, DOI [10.2217/IMT.12.2, 10.2217/imt.12.2]; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Han JF, 2009, THESIS CHINESE CTR D; Li QR, 2005, INFECT DIS INFO, V18, P156; Li QR, 2005, CHIN J AIDS STD, V11, P393; Li QR, 2005, CHIN J AIDS STD, V11, P397; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b; Ministry of Health of the People&#x27; s Republic of China, 2012, 2012 CHIN AIDS RESP; MOODLEY D, 1995, PEDIATR INFECT DIS J, V14, P850, DOI 10.1097/00006454-199510000-00006; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Okamoto Y, 1997, MICROBIOL IMMUNOL, V41, P131, DOI 10.1111/j.1348-0421.1997.tb01178.x; PALASANTHIRAN P, 1994, J INFECT DIS, V170, P1593, DOI 10.1093/infdis/170.6.1593; Pan PinLiang, 1999, Chinese Journal of Virology, V15, P97; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Prendergast A, 2008, HIV WOM CHILDR SESS; Read JS, 2007, PEDIATRICS, V120, pE1547, DOI 10.1542/peds.2007-2951; Sohn AH, 2009, PEDIATR INFECT DIS J, V28, P273, DOI 10.1097/INF.0b013e31818e03b4; Stevens W, 2008, Open AIDS J, V2, P17, DOI 10.2174/1874613600802010017; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Su Ling, 1997, Chinese Journal of Virology, V13, P265; Violari A, 2007, 4 INT AIDS SOC C HIV; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO Technical Reference Group, 2008, PAED HIV ART CAR GUI; Xing H, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P157	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99935	10.1371/journal.pone.0099935	http://dx.doi.org/10.1371/journal.pone.0099935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971594	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200016
J	Beckham, Y; Vasquez, RJ; Stricker, J; Sayegh, K; Campillo, C; Gardel, ML				Beckham, Yvonne; Vasquez, Robert J.; Stricker, Jonathan; Sayegh, Kareem; Campillo, Clement; Gardel, Margaret L.			Arp2/3 Inhibition Induces Amoeboid-Like Protrusions in MCF10A Epithelial Cells by Reduced Cytoskeletal-Membrane Coupling and Focal Adhesion Assembly	PLOS ONE			English	Article							MIGRATION; LAMELLIPODIA; COMPLEX; DYNAMICS; TENSION; GROWTH; FIBROBLASTS; EXTENSION; MOTILITY; VINCULIN	Here we demonstrate that Arp2/3 regulates a transition between mesenchymal and amoeboid protrusions in MCF10A epithelial cells. Using genetic and pharmacological means, we first show Arp2/3 inhibition impairs directed cell migration. Arp2/3 inhibition results in a dramatically impaired cell adhesion, causing deficient cell attachment and spreading to ECM as well as an 8-fold decrease in nascent adhesion assembly at the leading edge. While Arp2/3 does not play a significant role in myosin-dependent adhesion growth, mature focal adhesions undergo large scale movements against the ECM suggesting reduced coupling to the ECM. Cell edge protrusions occur at similar rates when Arp2/3 is inhibited but their morphology is dramatically altered. Persistent lamellipodia are abrogated and we observe a markedly increased incidence of blebbing and unstable pseuodopods. Micropipette-aspiration assays indicate that Arp2/3-inhibited cells have a weak coupling between the cell cortex and the plasma membrane, and suggest a potential mechanism for increased pseudopod and bleb formation. Pseudopods are not sensitive to reduced in formin or myosin II activity. Collectively, these results indicate that Arp2/3 is not necessary for rapid protrusion of the cell edge but plays a crucial role in assembling focal adhesions required for its stabilization.	[Beckham, Yvonne; Gardel, Margaret L.] Univ Chicago, Med Ctr, Inst Biophys Dynam, Chicago, IL 60637 USA; [Vasquez, Robert J.] Univ Chicago, Med Ctr, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; [Stricker, Jonathan; Sayegh, Kareem; Gardel, Margaret L.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Stricker, Jonathan; Sayegh, Kareem; Gardel, Margaret L.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Campillo, Clement] Inst Curie, Ctr Rech, Lab Physicochim, Paris, France; [Campillo, Clement] Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, Evry, France	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS)	Gardel, ML (corresponding author), Univ Chicago, Med Ctr, Inst Biophys Dynam, Chicago, IL 60637 USA.	gardel@uchicago.edu	Campillo, Clément/AAE-5395-2019; vasquez, robert/G-9016-2013	Campillo, Clément/0000-0003-4698-8643; vasquez, robert/0000-0002-5321-2846	Packard Foundation Grant	Packard Foundation Grant	Packard Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Choi CK, 2008, NAT CELL BIOL, V109, P14434; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gardel M. L., 2010, ANNU REV CELL DEV BI, V26; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wu CY, 2013, J CELL BIOL, V203, P907, DOI 10.1083/jcb.201306032; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	38	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100943	10.1371/journal.pone.0100943	http://dx.doi.org/10.1371/journal.pone.0100943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967897	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800088
J	Flehmig, G; Scholz, M; Kloting, N; Fasshauer, M; Tonjes, A; Stumvoll, M; Youn, BS; Bluher, M				Flehmig, Gesine; Scholz, Markus; Kloeting, Nora; Fasshauer, Mathias; Toenjes, Anke; Stumvoll, Michael; Youn, Byung-Soo; Blueher, Matthias			Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; BONE MORPHOGENETIC PROTEIN-7; IMPAIRED GLUCOSE REGULATION; ADIPOSE-TISSUE DYSFUNCTION; VASPIN GENE-EXPRESSION; METABOLIC SYNDROME; HUMAN OBESITY; WEIGHT-LOSS; VISCERAL ADIPOSITY; BROWN ADIPOGENESIS	In obesity, elevated fat mass and ectopic fat accumulation are associated with changes in adipokine secretion, which may link obesity to inflammation and the development of insulin resistance. However, relationships among individual adipokines and between adipokines and parameters of obesity, glucose metabolism or inflammation are largely unknown. Serum concentrations of 20 adipokines were measured in 141 Caucasian obese men (n = 67) and women (n = 74) with a wide range of body weight, glycemia and insulin sensitivity. Unbiased, distance-based hierarchical cluster analyses were performed to recognize patterns among adipokines and their relationship with parameters of obesity, glucose metabolism, insulin sensitivity and inflammation. We identified two major adipokine clusters related to either (1) body fat mass and inflammation (leptin, ANGPTL3, DLL1, chemerin, Nampt, resistin) or insulin sensitivity/hyperglycemia, and lipid metabolism (vaspin, clusterin, glypican 4, progranulin, ANGPTL6, GPX3, RBP4, DLK1, SFRP5, BMP7, adiponectin, CTRP3 and 5, omentin). In addition, we found distinct adipokine clusters in subgroups of patients with or without type 2 diabetes (T2D). Logistic regression analyses revealed ANGPTL6, DLK1, Nampt and progranulin as strongest adipokine correlates of T2D in obese individuals. The panel of 20 adipokines predicted T2D compared to a combination of HbA1c, HOMA-IR and fasting plasma glucose with lower sensitivity (78% versus 91%) and specificity (76% versus 94%). Therefore, adipokine patterns may currently not be clinically useful for the diagnosis of metabolic diseases. Whether adipokine patterns are relevant for the predictive assessment of intervention outcomes needs to be further investigated.	[Flehmig, Gesine; Fasshauer, Mathias; Toenjes, Anke; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB ObesityDis, Jr Res Grp Anim Models, D-04109 Leipzig, Germany; [Youn, Byung-Soo] Korea Univ, Coll Life Sci & Biotechnol, AdipoGen, Seoul, South Korea; [Youn, Byung-Soo] Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea	Leipzig University; Leipzig University; Leipzig University; Korea University; University of Ulsan	Youn, BS (corresponding author), OsteoNeuroGen, 40 MiKeum RO, Songnam, Kyunggi Do, South Korea.	byung4jc@gmail.com; bluma@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240	Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft [SFB 1052/1]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft, the SFB 1052/1: "Obesity mechanisms'' (project B01) (both to MB), and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Dallmeier D, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-28; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Kadoglou NPE, 2011, EXP CLIN ENDOCR DIAB, V119, P63, DOI 10.1055/s-0030-1265174; Kadoglou NPE, 2011, CLIN CHIM ACTA, V412, P48, DOI 10.1016/j.cca.2010.09.012; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Kettaneh A, 2006, METABOLISM, V55, P1171, DOI 10.1016/j.metabol.2006.04.015; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Laudes M, 2010, HORM METAB RES, V42, P268, DOI 10.1055/s-0029-1243638; Lee JA, 2011, ENDOCR J, V58, P639, DOI 10.1507/endocrj.K11E-073; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Orlik B, 2014, CLIN ENDOCRINOL, V81, P529, DOI 10.1111/cen.12381; Park H, 2012, J HUM NUTR DIET, V25, P300, DOI 10.1111/j.1365-277X.2012.01262.x; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Tan BK, 2010, DIABETES, V59, P3023, DOI 10.2337/db10-0124; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Ussar S, 2012, DIABETES, V61, P2289, DOI 10.2337/db11-1395; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn B, 2007, DIABETES, V57, P372, DOI DOI 10.2337/DB07-1045); Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zeng J, 2011, DIABETES RES CLIN PR, V93, pE21, DOI 10.1016/j.diabres.2011.03.010; Zhang HB, 2010, MOL CELL BIOL, V30, P4224, DOI 10.1128/MCB.00363-10	66	96	101	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99785	10.1371/journal.pone.0099785	http://dx.doi.org/10.1371/journal.pone.0099785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968098	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800020
J	Gao, F; Li, FH; Tan, J; Yan, JP; Sun, HL				Gao, Fei; Li, Fenghui; Tan, Jie; Yan, Jingping; Sun, Huiling			Bacterial Community Composition in the Gut Content and Ambient Sediment of Sea Cucumber Apostichopus japonicus Revealed by 16S rRNA Gene Pyrosequencing	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; GRADIENT GEL-ELECTROPHORESIS; AEROBIC CULTURABLE BACTERIA; MARINE-SEDIMENTS; ORGANIC-MATTER; ONEIROPHANTA-MUTABILIS; ABYSSAL HOLOTHURIANS; DIVERSITY; AQUACULTURE; MICROBIOTA	The composition of the bacterial communities in the contents of the foregut and hindgut of the sea cucumber Apostichopus japonicus and in the ambient surface sediment was surveyed by 16S rRNA gene 454-pyrosequencing. A total of 188,623 optimized reads and 15,527 operational taxonomic units (OTUs) were obtained from the ten gut contents samples and four surface sediment samples. The sequences in the sediments, foregut contents, and hindgut contents were assigned to 38.0 +/- 4.7, 31.2 +/- 6.2 and 27.8 +/- 6.5 phyla, respectively. The bacterial richness and Shannon diversity index were both higher in the ambient sediments than in the gut contents. Proteobacteria was the predominant phylum in both the gut contents and sediment samples. The predominant classes in the foregut, hindgut, and ambient sediment were Holophagae and Gammaproteobacteria, Deltaproteobacteria and Gammaproteobacteria, and Gammaproteobacteria and Deltaproteobacteria, respectively. The potential probiotics, including sequences related to Bacillus, lactic acid bacteria (Lactobacillus, Lactococcus, and Streptococcus) and Pseudomonas were detected in the gut of A. japonicus. Principle component analysis and heatmap figure showed that the foregut, hindgut, and ambient sediment respectively harbored different characteristic bacterial communities. Selective feeding of A. japonicus may be the primary source of the different bacterial communities between the foregut contents and ambient sediments.	[Gao, Fei; Li, Fenghui; Tan, Jie; Yan, Jingping; Sun, Huiling] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Sun, HL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China.	sunhl@ysfri.ac.cn			National Science Foundation of China [41106145]; National Key Technology Research and Development Program [2011BAD13B02]; National High Technology Research and Development Program of China (863 program) [2012AA10A412]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation of China (No. 41106145), National Key Technology Research and Development Program (Nos. 2011BAD13B02) and the National High Technology Research and Development Program of China (863 program, No. 2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amaro T, 2009, DEEP-SEA RES PT I, V56, P1834, DOI 10.1016/j.dsr.2009.05.014; AMON R M W, 1991, Marine Ecology, V12, P163, DOI 10.1111/j.1439-0485.1991.tb00250.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Barlocher F, 1978, RECENT ADV AQUATIC M, P35; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DEMING JW, 1982, APPL ENVIRON MICROB, V44, P1222, DOI 10.1128/AEM.44.5.1222-1230.1982; Droge S, 2005, J GEN APPL MICROBIOL, V51, P57, DOI 10.2323/jgam.51.57; Gao F., 2010, J FISH SCI CHINA, V17, P672, DOI [10.3724/SP.J.1011.2010.01351, DOI 10.3724/SP.J.1011.2010.01351]; Gao F, 2008, COMP BIOCHEM PHYS B, V150, P255, DOI 10.1016/j.cbpb.2008.03.011; Gao F, 2014, J OCEAN U CHINA, V13, P303, DOI 10.1007/s11802-014-2078-7; Gao Fei, 2010, Journal of Fisheries of China, V34, P760, DOI 10.3724/SP.J.1231.2010.06768; GEBHART CJ, 1993, INT J SYST BACTERIOL, V43, P533, DOI 10.1099/00207713-43-3-533; GERLACH SA, 1978, OECOLOGIA, V33, P55, DOI 10.1007/BF00376996; GIBSON GR, 1988, J APPL BACTERIOL, V65, P241, DOI 10.1111/j.1365-2672.1988.tb01891.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAMMOND LS, 1983, MAR ECOL PROG SER, V10, P297, DOI 10.3354/meps010297; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Irianto A., 2002, J FISH DIS, V25, P1, DOI DOI 10.1046/J.1365-2761.2002.00375.X; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kjelleberg S., 1993, STARVATION BACTERIA, P55, DOI DOI 10.1007/978-1-4899-2439-1_3; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Li Bin, 2010, Marine Sciences (Beijing), V34, P64; Liao Y., 1997, FAUNA CHINA ECHINODE; LOPEZ GR, 1987, Q REV BIOL, V62, P235, DOI 10.1086/415511; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McElroy S, 1990, SPC BECHE DEMER INF, V2, P2; Michio K, 2003, MAR POLLUT BULL, V47, P118, DOI 10.1016/S0025-326X(02)00411-3; MORIARTY DJW, 1982, AUST J MAR FRESH RES, V33, P255, DOI 10.1071/MF9820255; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarro PG, 2013, MAR BIOL, V160, P2957, DOI 10.1007/s00227-013-2286-5; PHILLIPS NW, 1984, B MAR SCI, V35, P283; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ringo E, 2010, AQUACULT NUTR, V16, P117, DOI 10.1111/j.1365-2095.2009.00731.x; Roberts D, 2001, PROG OCEANOGR, V50, P443, DOI 10.1016/S0079-6611(01)00065-9; Roeselers G, 2011, ISME J, DOI [10.1038/ismej.2011.1038, DOI 10.1038/ISMEJ.2011.1038]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SLOAN NA, 1980, MAR ECOL PROG SER, V2, P257, DOI 10.3354/meps002257; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun Yi, 1989, Oceanologia et Limnologia Sinica, V20, P300; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang J, 2011, APPL MICROBIOL BIOT, V90, P2015, DOI 10.1007/s00253-011-3217-3; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; WardRainey N, 1996, J EXP MAR BIOL ECOL, V203, P11, DOI 10.1016/0022-0981(96)02566-X; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7; Wu SG, 2013, WORLD J MICROB BIOT, V29, P1585, DOI 10.1007/s11274-013-1322-4; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Yu Y, 2012, EUR J SOIL BIOL, V49, P12, DOI 10.1016/j.ejsobi.2011.08.006; Zhang B., 1995, MAR SCI-CHINA, V3, P11; [张文姬 ZHANG Wenji], 2011, [食品工业科技, Science & Technology of Food Industry], V32, P149; Zhang XC, 2013, J GEN APPL MICROBIOL, V59, P1; Zhang XC, 2012, J GEN APPL MICROBIOL, V58, P447, DOI 10.2323/jgam.58.447	64	64	68	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100092	10.1371/journal.pone.0100092	http://dx.doi.org/10.1371/journal.pone.0100092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967593	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800024
J	Jambhekar, A; Emerman, AB; Schweidenback, CTH; Blower, MD				Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.			RNA Stimulates Aurora B Kinase Activity during Mitosis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; MITOTIC SPINDLE; MESSENGER-RNA; BINDING-PROTEIN; IMPORTIN-BETA; EGG EXTRACTS; CAENORHABDITIS-ELEGANS; MICROTUBULE DYNAMICS	Accurate chromosome segregation is essential for cell viability. The mitotic spindle is crucial for chromosome segregation, but much remains unknown about factors that regulate spindle assembly. Recent work implicates RNA in promoting proper spindle assembly independently of mRNA translation; however, the mechanism by which RNA performs this function is currently unknown. Here, we show that RNA regulates both the localization and catalytic activity of the mitotic kinase, Aurora-B (AurB), which is present in a ribonucleoprotein (RNP) complex with many mRNAs. Interestingly, AurB kinase activity is reduced in Xenopus egg extracts treated with RNase, and its activity is stimulated in vitro by RNA binding. Spindle assembly defects following RNase-treatment are partially rescued by inhibiting MCAK, a microtubule depolymerase that is inactivated by AurB-dependent phosphorylation. These findings implicate AurB as an important RNA-dependent spindle assembly factor, and demonstrate a translation-independent role for RNA in stimulating AurB.	[Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Jambhekar, Ashwini/0000-0003-1078-6601; Blower, Michael/0000-0002-5037-1972	National Institutes of Health (NIH) [RO1GM086434]; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; National Science Foundation (NSF) GRFP; NIH [F32 GM090533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090533, R01GM086434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); National Science Foundation (NSF) GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded the following grants: National Institutes of Health (NIH) RO1 (RO1GM086434) (M. D. B.), Burroughs Wellcome Fund Career Award in the Biomedical Sciences (M. D. B.), National Science Foundation (NSF) GRFP (A. E.), and NIH F32 GM090533 (C. T. H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Cimini D, 2007, CELL CYCLE, V6, P1558, DOI 10.4161/cc.6.13.4452; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Edwards NS, 2005, MOL BIOL CELL, V16, P1800, DOI 10.1091/mbc.e04-09-0788; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Gent JI, 2012, ANNU REV GENET, V46, P443, DOI 10.1146/annurev-genet-110711-155419; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kingsley EP, 2007, EVOL DEV, V9, P527, DOI 10.1111/j.1525-142X.2007.00194.x; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Rabinowitz JS, 2010, DEVELOPMENT, V137, P4039, DOI 10.1242/dev.055269; RAFF JW, 1990, DEVELOPMENT, V110, P1249; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	77	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100748	10.1371/journal.pone.0100748	http://dx.doi.org/10.1371/journal.pone.0100748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968351	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800063
J	Mac Sharry, J; Shalaby, KH; Marchica, C; Farahnak, S; Chieh-Li, T; Lapthorne, S; Qureshi, ST; Shanahan, F; Martin, JG				Mac Sharry, John; Shalaby, Karim H.; Marchica, Cinzia; Farahnak, Soroor; Chieh-Li, Tien; Lapthorne, Susan; Qureshi, Salman T.; Shanahan, Fergus; Martin, James G.			Concomitant Exposure to Ovalbumin and Endotoxin Augments Airway Inflammation but Not Airway Hyperresponsiveness in a Murine Model of Asthma	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ALLERGIC-ASTHMA; MESSENGER-RNA; T-CELLS; LUNG INFLAMMATION; BINDING-PROTEIN; DENDRITIC CELLS; RESPONSES; EXPRESSION; IL-5	Varying concentrations of lipopolysaccharide (LPS) in ovalbumin (OVA) may influence the airway response to allergic sensitization and challenge. We assessed the contribution of LPS to allergic airway inflammatory responses following challenge with LPS-rich and LPS-free commercial OVA. BALB/c mice were sensitized with LPS-rich OVA and alum and then underwent challenge with the same OVA (10 mu g intranasally) or an LPS-free OVA. Following challenge, bronchoalveolar lavage (BAL), airway responsiveness to methacholine and the lung regulatory T cell population (Treg) were assessed. Both OVA preparations induced BAL eosinophilia but LPS-rich OVA also evoked BAL neutrophilia. LPS-free OVA increased interleukin (IL)-2, IL-4 and IL-5 whereas LPS-rich OVA additionally increased IL-1 beta, IL-12, IFN-gamma, TNF-alpha and KC. Both OVA-challenged groups developed airway hyperresponsiveness. TLR4-deficient mice challenged with either OVA preparation showed eosinophilia but not neutrophilia and had increased IL-5. Only LPS-rich OVA challenged mice had increased lung Tregs and LPS-rich OVA also induced in vitro Treg differentiation. LPS-rich OVA also induced a Th1 cytokine response in human peripheral blood mononuclear cells. We conclude that LPS-rich OVA evokes mixed Th1, Th2 and innate immune responses through the TLR-4 pathway, whereas LPS-free OVA evokes only a Th2 response. Contaminating LPS is not required for induction of airway hyperresponsiveness but amplifies the Th2 inflammatory response and is a critical mediator of the neutrophil, Th1 and T regulatory cell responses to OVA.	[Shalaby, Karim H.; Marchica, Cinzia; Farahnak, Soroor; Chieh-Li, Tien; Qureshi, Salman T.; Martin, James G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada; [Mac Sharry, John; Lapthorne, Susan; Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Sch Med, Alimentary Pharmabiot Ctr, Cork, Ireland	McGill University; University College Cork	Martin, JG (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada.	james.martin@mcgill.ca	Shanahan, Fergus/ABF-2390-2020; Sharry, John A Mac/M-7209-2017	Shanahan, Fergus/0000-0003-0467-0936; Sharry, John A Mac/0000-0002-9528-6261; Martin, James/0000-0001-7574-5363	Science Foundation of Ireland; Walton Fellowship; Short term travel fellowship (STTF); Canadian Thoracic Society	Science Foundation of Ireland(Science Foundation Ireland); Walton Fellowship(Science Foundation Ireland); Short term travel fellowship (STTF); Canadian Thoracic Society	This study was supported by the Science Foundation of Ireland research grants, Walton Fellowship and Short term travel fellowship (STTF), awarded to J.G. Martin and J. Mac Sharry, respectively. K. H. Shalaby was supported by a studentship from the Canadian Thoracic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Chapman TJ, 2013, J IMMUNOL, V191, P4423, DOI 10.4049/jimmunol.1300042; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; HAMID Q, 1991, INT ARCH ALLER A IMM, V94, P169, DOI 10.1159/000235353; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; KUNG TT, 1995, AM J RESP CELL MOL, V13, P360, DOI 10.1165/ajrcmb.13.3.7654390; Lambrecht BN, 2005, ALLERGY, V60, P271, DOI 10.1111/j.1398-9995.2005.00708.x; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; Machida I, 2004, J IMMUNOL, V172, P1833, DOI 10.4049/jimmunol.172.3.1833; MALO JL, 1992, J ALLERGY CLIN IMMUN, V90, P937, DOI 10.1016/0091-6749(92)90466-F; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; O'Carroll C, 2014, J IMMUNOL, V192, P427, DOI 10.4049/jimmunol.1301722; OKAYAMA Y, 1995, J IMMUNOL, V155, P1796; Olivenstein R, 1999, J ALLERGY CLIN IMMUN, V103, P238, DOI 10.1016/S0091-6749(99)70497-5; Peters M, 2010, IMMUNOL CELL BIOL, V88, P537, DOI 10.1038/icb.2010.3; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Shainheit MG, 2008, J IMMUNOL, V181, P8559, DOI 10.4049/jimmunol.181.12.8559; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Strohmeier GR, 2001, J IMMUNOL, V166, P2063, DOI 10.4049/jimmunol.166.3.2063; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Tsuchiya K, 2012, AM J PHYSIOL-LUNG C, V303, pL54, DOI 10.1152/ajplung.00208.2011; von Mutius Erika, 2007, Proc Am Thorac Soc, V4, P212, DOI 10.1513/pats.200701-028AW; W KL, 2007, ENDOTOXINS PYROGENS; Watanabe J, 2003, J BIOL CHEM, V278, P42361, DOI 10.1074/jbc.M307752200; Whitehead GS, 2013, ENV HLTH PERSPECTIVE; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98648	10.1371/journal.pone.0098648	http://dx.doi.org/10.1371/journal.pone.0098648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968337	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800003
J	Panek, J; El Alaoui, H; Mone, A; Urbach, S; Demettre, E; Texier, C; Brun, C; Zanzoni, A; Peyretaillade, E; Parisot, N; Lerat, E; Peyret, P; Delbac, F; Biron, DG				Panek, Johan; El Alaoui, Hicham; Mone, Anne; Urbach, Serge; Demettre, Edith; Texier, Catherine; Brun, Christine; Zanzoni, Andreas; Peyretaillade, Eric; Parisot, Nicolas; Lerat, Emmanuelle; Peyret, Pierre; Delbac, Frederic; Biron, David G.			Hijacking of Host Cellular Functions by an Intracellular Parasite, the Microsporidian Anncaliia algerae	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSPOSABLE ELEMENTS; BRACHIOLA-ALGERAE; AEDES-AEGYPTI; AMINO-ACIDS; GENOME; PROTEOMICS; PATHOGEN; IDENTIFICATION; ANNOTATION	Intracellular pathogens including bacteria, viruses and protozoa hijack host cell functions to access nutrients and to bypass cellular defenses and immune responses. These strategies have been acquired through selective pressure and allowed pathogens to reach an appropriate cellular niche for their survival and growth. To get new insights on how parasites hijack host cellular functions, we developed a SILAC (Stable Isotope Labeling by Amino Acids in Cell culture) quantitative proteomics workflow. Our study focused on deciphering the cross-talk in a host-parasite association, involving human foreskin fibroblasts (HFF) and the microsporidia Anncaliia algerae, a fungus related parasite with an obligate intracellular lifestyle and a strong host dependency. The host-parasite cross-talk was analyzed at five post-infection times 1, 6, 12 and 24 hours post-infection (hpi) and 8 days post-infection (dpi). A significant up-regulation of four interferon-induced proteins with tetratricopeptide repeats IFIT1, IFIT2, IFIT3 and MX1 was observed at 8 dpi suggesting a type 1 interferon (IFN) host response. Quantitative alteration of host proteins involved in biological functions such as signaling (STAT1, Ras) and reduction of the translation activity (EIF3) confirmed a host type 1 IFN response. Interestingly, the SILAC approach also allowed the detection of 148 A. algerae proteins during the kinetics of infection. Among these proteins many are involved in parasite proliferation, and an over-representation of putative secreted effectors proteins was observed. Finally our survey also suggests that A. algerae could use a transposable element as a lure strategy to escape the host innate immune system.	[Panek, Johan; El Alaoui, Hicham; Mone, Anne; Texier, Catherine; Delbac, Frederic; Biron, David G.] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Panek, Johan; El Alaoui, Hicham; Mone, Anne; Texier, Catherine; Delbac, Frederic; Biron, David G.] CNRS, UMR 6023, LMGE, Aubiere, France; [Urbach, Serge] CNRS, UMR 5203, Montpellier, France; [Demettre, Edith] CNRS, UMS 3426, Montpellier, France; [Brun, Christine; Zanzoni, Andreas] INSERM, UMR1090, TAGC, F-13258 Marseille, France; [Brun, Christine; Zanzoni, Andreas] Aix Marseille Univ, UMR1090, TAGC, Marseille, France; [Brun, Christine] CNRS, Marseille, France; [Peyretaillade, Eric; Parisot, Nicolas; Peyret, Pierre] Univ Auvergne, Clermont Univ, IUT, UFR Pharm, Clermont Ferrand, France; [Peyretaillade, Eric; Parisot, Nicolas; Peyret, Pierre] Univ Auvergne, Clermont Univ, EA 4678, Clermont Ferrand, France; [Lerat, Emmanuelle] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	El Alaoui, H (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France.	Hicham.EL_ALAOUI@univ-bpclermont.fr; david.biron1@univ-bpclermont.fr	Zanzoni, Andreas/I-1664-2019; Brun, Christine/B-4922-2008; Zanzoni, Andreas/D-2188-2012; Parisot, Nicolas/C-8116-2012	Zanzoni, Andreas/0000-0002-4818-6161; Brun, Christine/0000-0002-5563-6765; Zanzoni, Andreas/0000-0002-4818-6161; Parisot, Nicolas/0000-0001-5217-8415; El Alaoui, Hicham/0000-0003-1926-0905; PEYRET, Pierre/0000-0003-3114-0586; Panek, Johan/0000-0002-6026-9875; LERAT, Emmanuelle/0000-0001-6757-8796	Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France)	Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France)	This work was funded by a grant, Projets Exploratoires Pluridisciplinaires (PEPS) from the Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD). J. P. was supported by a scholarship from the Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Belkorchia A, 2008, PARASITOL INT, V57, P62, DOI 10.1016/j.parint.2007.09.002; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Biron DG, 2013, J EXP BIOL, V216, P148, DOI 10.1242/jeb.073825; Biron DG, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P263, DOI 10.1016/B978-0-12-384890-1.00011-X; Biron DG, 2005, INT J PARASITOL, V35, P1385, DOI 10.1016/j.ijpara.2005.05.015; Biron DG, 2005, TRENDS PARASITOL, V21, P162, DOI 10.1016/j.pt.2005.02.009; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Duncan AB, 2012, ECOL EVOL, V2, P681, DOI 10.1002/ece3.199; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Hughes C, 2012, TRENDS BIOTECHNOL, V30, P668, DOI 10.1016/j.tibtech.2012.09.007; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kostourou V, 2002, BRIT J CANCER, V87, P673, DOI 10.1038/sj.bjc.6600518; Kucerova Z, 2004, J EUKARYOT MICROBIOL, V51, P339, DOI 10.1111/j.1550-7408.2004.tb00577.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lerat E, 2007, J MOL EVOL, V65, P215, DOI 10.1007/s00239-007-9001-4; MARGOS G, 1992, PARASITOL RES, V78, P168, DOI 10.1007/BF00931661; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Motylewska E, 2013, ENDOKRYNOL POL, V64, P368, DOI 10.5603/EP.2013.0020; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Peyretaillade E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-607; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Prajapati SK, 2013, BLOOD CELL MOL DIS, V51, P195, DOI 10.1016/j.bcmd.2013.06.003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Scanlon M, 2004, J EUKARYOT MICROBIOL, V51, P81, DOI 10.1111/j.1550-7408.2004.tb00166.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; VAVRA J, 1970, J PROTOZOOL, V17, P240, DOI 10.1111/j.1550-7408.1970.tb02365.x; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Vincendeau P, 2003, TRENDS PARASITOL, V19, P9, DOI 10.1016/S1471-4922(02)00010-7; Visvesvara GS, 2005, FOLIA PARASIT, V52, P83, DOI 10.14411/fp.2005.011; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wastling JM, 2012, PARASITOLOGY, V139, P1103, DOI 10.1017/S0031182012000716; Weber B, 2009, CELL SIGNAL, V21, P1513, DOI 10.1016/j.cellsig.2009.05.011; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	61	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100791	10.1371/journal.pone.0100791	http://dx.doi.org/10.1371/journal.pone.0100791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967735	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800067
J	Pettersson, LME; Geremia, NM; Ying, ZX; Verge, VMK				Pettersson, Lina M. E.; Geremia, Nicole M.; Ying, Zhengxin; Verge, Valerie M. K.			Injury-Associated PACAP Expression in Rat Sensory and Motor Neurons Is Induced by Endogenous BDNF	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLIA; P75 NEUROTROPHIN RECEPTOR; SCIATIC-NERVE; SPINAL-CORD; MESSENGER-RNA; AXONAL REGENERATION; COLUMN NUCLEI; UP-REGULATION	Peripheral nerve injury results in dramatic upregulation in pituitary adenylate cyclase activating polypeptide (PACAP) expression in adult rat dorsal root ganglia and spinal motor neurons mirroring that described for the neurotrophin brain derived neurotrophic factor (BDNF). Thus, we posited that injury-associated alterations in BDNF expression regulate the changes in PACAP expression observed in the injured neurons. The role of endogenous BDNF in induction and/or maintenance of PACAP mRNA expression in injured adult rat motor and sensory neurons was examined by intrathecally infusing or intraperitoneally injecting BDNF-specific antibodies or control IgGs immediately at the time of L4-L6 spinal nerve injury, or in a delayed fashion one week later for 3 days followed by analysis of impact on PACAP expression. PACAP mRNA in injured lumbar sensory and motor neurons was detected using in situ hybridization, allowing quantification of relative changes between experimental groups, with ATF-3 immunofluorescence serving to identify the injured subpopulation of motor neurons. Both the incidence and level of PACAP mRNA expression were dramatically reduced in injured sensory and motor neurons in response to immediate intrathecal anti-BDNF treatment. In contrast, neither intraperitoneal injections nor delayed intrathecal infusions of anti-BDNF had any discernible impact on PACAP expression. This impact on PACAP expression in response to BDNF immunoneutralization in DRG was confirmed using qRT-PCR or by using BDNF selective siRNAs to reduce neuronal BDNF expression. Collectively, our findings support that endogenous injury-associated BDNF expression is critically involved in induction, but not maintenance, of injury-associated PACAP expression in sensory and motor neurons.	[Pettersson, Lina M. E.] Univ Saskatchewan, CMSNRC, Saskatoon, SK, Canada; Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Pettersson, LME (corresponding author), Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, BMC F10, Lund, Sweden.	Lina.Pettersson@med.lu.se	Ying, Zhengxin/A-8953-2011; Geremia, Nicole/AAC-3285-2021	Pettersson, Lina/0000-0002-6847-8823	Canadian Institutes of Health Research [MOP74747, ROP102801]; Saskatchewan Health Research Foundation PDF; University of Saskatchewan College of Medicine Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation PDF; University of Saskatchewan College of Medicine Scholarship	Support was contributed by: The Canadian Institutes of Health Research # MOP74747 and # ROP102801 to VMKV, the Saskatchewan Health Research Foundation PDF to LMEP & the University of Saskatchewan College of Medicine Scholarship to NMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; BOULDIN TW, 1991, J NEUROPATH EXP NEUR, V50, P719, DOI 10.1097/00005072-199111000-00004; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Buck CR, 2000, J COMP NEUROL, V416, P309, DOI 10.1002/(SICI)1096-9861(20000117)416:3<309::AID-CNE3>3.0.CO;2-U; Cellerino A, 2003, J COMP NEUROL, V467, P97, DOI 10.1002/cne.10908; Deng YS, 1999, NEUROTOX RES, V1, P311, DOI 10.1007/BF03033260; Dun NJ, 1996, NEUROSCIENCE, V73, P677, DOI 10.1016/0306-4522(96)00057-7; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022; GIUFFRIDA R, 1992, J COMP NEUROL, V316, P206, DOI 10.1002/cne.903160206; Guirland C, 2003, J NEUROSCI, V23, P2274; Hammarberg H, 2000, J COMP NEUROL, V426, P587, DOI 10.1002/1096-9861(20001030)426:4<587::AID-CNE7>3.0.CO;2-R; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hannibal J, 2002, J COMP NEUROL, V453, P389, DOI 10.1002/cne.10418; HURLEY JD, 1995, ENDOCRINOLOGY, V136, P550, DOI 10.1210/en.136.2.550; Jongsma H, 2001, NEUROREPORT, V12, P2215, DOI 10.1097/00001756-200107200-00034; Jongsma H, 2000, BRAIN RES, V853, P186, DOI 10.1016/S0006-8993(99)02233-7; Jongsma Wallin H, 2002, THESIS; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Karchewski LA, 1999, J COMP NEUROL, V413, P327, DOI 10.1002/(SICI)1096-9861(19991018)413:2<327::AID-CNE11>3.0.CO;2-3; Kimura H, 2004, REGUL PEPTIDES, V123, P135, DOI 10.1016/j.regpep.2004.04.020; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Li WP, 1999, NEUROSCI LETT, V260, P49, DOI 10.1016/S0304-3940(98)00958-6; Lindwall C, 2004, MOL CELL NEUROSCI, V27, P267, DOI 10.1016/j.mcn.2004.07.001; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; MOLLER K, 1993, NEUROSCIENCE, V57, P725, DOI 10.1016/0306-4522(93)90018-B; MULDER H, 1994, NEUROSCIENCE, V63, P307, DOI 10.1016/0306-4522(94)90025-6; Narita M, 1996, EUR J PHARMACOL, V311, P121, DOI 10.1016/0014-2999(96)00359-7; Ohsawa M, 2002, PAIN, V100, P27, DOI 10.1016/S0304-3959(02)00207-5; Pettersson LME, 2004, EUR J NEUROSCI, V20, P1838, DOI 10.1111/j.1460-9568.2004.03644.x; Pettersson LME, 2004, J COMP NEUROL, V471, P85, DOI 10.1002/cne.20015; Shortland PJ, 2006, EUR J NEUROSCI, V23, P365, DOI 10.1111/j.1460-9568.2005.04568.x; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Suarez V, 2006, EUR J NEUROSCI, V24, P1555, DOI 10.1111/j.1460-9568.2006.05029.x; Thompson SWN, 1999, P NATL ACAD SCI USA, V96, P7714, DOI 10.1073/pnas.96.14.7714; Tonra JR, 1998, J NEUROSCI, V18, P4374; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; VERGE VMK, 1995, J NEUROSCI, V15, P2081, DOI 10.1523/JNEUROSCI.15-03-02081.1995; Villuendas G, 2001, MOL BRAIN RES, V94, P59, DOI 10.1016/S0169-328X(01)00177-2; Wallin HJ, 2003, NEUROSCIENCE, V120, P325, DOI 10.1016/S0306-4522(03)00118-0; Wallin HJ, 2001, EUR J NEUROSCI, V14, P267, DOI 10.1046/j.0953-816x.2001.01641.x; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; Xu XJ, 1996, NEUROSCIENCE, V72, P801, DOI 10.1016/0306-4522(96)00006-1; YAN Q, 1988, NEURON, V1, P335; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhang Q, 1995, BRAIN RES, V705, P149, DOI 10.1016/0006-8993(95)01150-1; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439; Zhang YZ, 1998, NEUROREPORT, V9, P2833, DOI 10.1097/00001756-199808240-00027; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhou XF, 2005, NEUROSCIENCE, V132, P591, DOI 10.1016/j.neuroscience.2004.12.034; Zhou XF, 1999, EUR J NEUROSCI, V11, P1711, DOI 10.1046/j.1460-9568.1999.00589.x; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x	68	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100730	10.1371/journal.pone.0100730	http://dx.doi.org/10.1371/journal.pone.0100730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968020	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800059
J	Arai, T				Arai, Takaomi			Salmon Migration Patterns Revealed the Temporal and Spatial Fluctuations of the Radiocesium Levels in Terrestrial and Ocean Environments	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; FUKUSHIMA-DERIVED RADIONUCLIDES; CS-137; I-131	The disabling of the Fukushima Daiichi Nuclear Power Plant (F1NPP) resulted in the release of radionuclides, including Cs-134 and Cs-137, into the air and the ocean. The unpredicted nuclear accident is of global concern for human health and the ecosystem. Although investigations of radionuclides in environments were performed shortly after the accident started, the temporal and spatial impacts and fluctuations on the releasing radionuclides to natural environment remain unclear. I focused on salmon, which migrate from inland to the open ocean globally, to reveal the three-year (May 2011 to February 2014) fluctuations and accumulations of Cs-134 and Cs-137 from terrestrial to open ocean environments after the F1NPP accident. The Cs-134 and Cs-137 concentrations in six salmonids exhibited lower temporal variations for three years after the F1NPP accident, suggesting that these radionuclides are widely distributed and these radionuclides remain in the natural environment globally with less convergence. The accumulation patterns were significantly different among the different salmon species. Fluvial (freshwater residence) type salmons exhibited significantly higher accumulation in Cs-134 (25.3-40.2 Bq kg(-1) in mean) and Cs-137 (41.4-51.7 Bq kg(-1) in mean) than did the anadromous (sea-run) type salmons (0.64-8.03 Bq kg(-1) in mean Cs-134 and 0.42-10.2 Bq kg(-1) in mean Cs-137) suggesting widespread contamination in terrestrial environments versus the coastal and open ocean environments. Salmonids are the most highly migratory animals and are characterised by their strong tendency to return home to their natal site for reproduction. Salmonids have a potential to be a good indicator as an effective monitoring animal.	Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu	Arai, T (corresponding author), Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia.	arai@umt.edu.my	Arai, Takaomi/AAX-2641-2021	Arai, Takaomi/0000-0001-9440-7933				Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; Estournel C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007933; Harte J., 1991, TOXICS A Z GUIDE EVE; Ikeuchi Y, 2003, DEEP-SEA RES PT II, V50, P2713, DOI 10.1016/S0967-0645(03)00143-7; Japanese Ministry of Agriculture Forestry and Fisheries, 2014, RES INSP RAD MAT FIS; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; McDowall R.M., 1988, DIADROMY FISHES MIGR; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Nakanishi T, 2010, J RADIOANAL NUCL CH, V283, P831, DOI 10.1007/s10967-009-0422-y; Nelson J. S., 1976, FISHES WORLD; Povinec PP, 2004, J ENVIRON RADIOACTIV, V76, P113, DOI 10.1016/j.jenvrad.2004.03.022; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	19	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100779	10.1371/journal.pone.0100779	http://dx.doi.org/10.1371/journal.pone.0100779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964195	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500080
J	Baalbergen, E; Helwerda, R; Schelfhorst, R; Cajas, RFC; van Moorsel, CHM; Kundrata, R; Welter-Schultes, FW; Giokas, S; Schilthuizen, M				Baalbergen, Els; Helwerda, Renate; Schelfhorst, Rense; Cajas, Ruth F. Castillo; van Moorsel, Coline H. M.; Kundrata, Robin; Welter-Schultes, Francisco W.; Giokas, Sinos; Schilthuizen, Menno			Predator-Prey Interactions between Shell-Boring Beetle Larvae and Rock-Dwelling Land Snails	PLOS ONE			English	Article							SPECIES GASTROPODA; CLAUSILIIDAE; EVOLUTION; PULMONATA; ALBINARIA; BEHAVIOR	Drilus beetle larvae (Coleoptera: Elateridae) are specialized predators of land snails. Here, we describe various aspects of the predator-prey interactions between multiple Drilus species attacking multiple Albinaria (Gastropoda: Clausiliidae) species in Greece. We observe that Drilus species may be facultative or obligate Albinaria-specialists. We map geographically varying predation rates in Crete, where on average 24% of empty shells carry fatal Drilus bore holes. We also provide first-hand observations and video-footage of prey entry and exit strategies of the Drilus larvae, and evaluate the potential mutual evolutionary impacts. We find limited evidence for an effect of shell features and snail behavioral traits on inter-and intraspecifically differing predation rates. We also find that Drilus predators adjust their predation behavior based on specific shell traits of the prey. In conclusion, we suggest that, with these baseline data, this interesting predator-prey system will be available for further, detailed more evolutionary ecology studies.	[Baalbergen, Els; Helwerda, Renate; Schelfhorst, Rense; Schilthuizen, Menno] Nat Biodivers Ctr, Focus Grp Character Evolut, Leiden, Netherlands; [Cajas, Ruth F. Castillo; Schilthuizen, Menno] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Cajas, Ruth F. Castillo] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [van Moorsel, Coline H. M.] St Antonius Hosp, Nieuwegein, Netherlands; [van Moorsel, Coline H. M.; Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Kundrata, Robin] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Welter-Schultes, Francisco W.] Univ Gottingen, Zool Inst Univ, D-37073 Gottingen, Germany; [Giokas, Sinos] Univ Patras, Dept Biol, Patras, Greece	Naturalis Biodiversity Center; University of Groningen; University of Wurzburg; St. Antonius Hospital Utrecht; Leiden University; Leiden University - Excl LUMC; Palacky University Olomouc; University of Gottingen; University of Patras	Schilthuizen, M (corresponding author), Nat Biodivers Ctr, Focus Grp Character Evolut, Leiden, Netherlands.	menno.schilthuizen@naturalis.nl	Giokas, Sinos/C-3752-2008; KUNDRATA, Robin/AAI-5445-2021	Giokas, Sinos/0000-0003-2809-1605; Kundrata, Robin/0000-0001-9397-1030; Welter-Schultes, Francisco/0000-0002-6808-0049	NWO-ALW [819.01.012]; Jan-Joost ter Pelkwijkfonds; Uyttenboogaart-Eliasen Fonds; Kees Bakker award; Evangelisches Studienwerk	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); Jan-Joost ter Pelkwijkfonds; Uyttenboogaart-Eliasen Fonds; Kees Bakker award; Evangelisches Studienwerk	Funding for this study came from NWO-ALW (grant 819.01.012, awarded to M.S.), the Jan-Joost ter Pelkwijkfonds (awarded to E.B, R.S., and R.H.), the Uyttenboogaart-Eliasen Fonds (awarded to M.S.), the Kees Bakker award (awarded to R.H.), and a doctoral fellowship to F.W.-S. from the Evangelisches Studienwerk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baalbergen E, 2013, THESIS LEIDEN U; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Giokas S, 2002, MALACOLOGIA, V44, P33; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; KEMPERMAN T C M, 1988, Basteria, V52, P77; Konuma J, 2007, AM NAT, V170, P90, DOI 10.1086/518182; Kundrata R, 2011, ZOOL SCR, V40, P364, DOI 10.1111/j.1463-6409.2011.00476.x; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.329; Mesher CS, 2008, SPECIES PHYLOGENY EV, V1, P129; Nordsieck Hartmut, 1999, Mitteilungen der Deutschen Malakozoologischen Gesellschaft, V62-63, P1; Orstan Aydin, 1999, Schriften zur Malakozoologie aus dem Haus der Natur-Cismar, V13, P31; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; R Core Team, 2012, R LANG ENV STAT COMP; Roth, 1855, MALAKOZOOLOGISCHE BL, V2, P17; Schilthuizen M., 1994, Bios (Thessaloniki), V2, P177; Schilthuizen M, 1994, THESIS LEIDEN U; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; van Moorsel CHM, 2000, MOL PHYLOGENET EVOL, V17, P200, DOI 10.1006/mpev.2000.0826; Vermeij G.J, 1987, EVOLUTION ESCALATION; Vermeij GJ, 2011, PALEONTOL RES, V15, P54, DOI 10.2517/1342-8144-15.2.054; VERMEIJ GJ, 1979, EVOLUTION, V33, P686, DOI 10.1111/j.1558-5646.1979.tb04721.x; Welter-Schultes FW, 2010, ARCH MOLLUSKENKD, V139, P143, DOI 10.1127/arch.moll/1869-0963/139/143-245; Welter-Schultes F.W., 2012, EUROPEAN NON MARINE	24	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100366	10.1371/journal.pone.0100366	http://dx.doi.org/10.1371/journal.pone.0100366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964101	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500043
J	Mendoza, E; Colomb, J; Rybak, J; Pfluger, HJ; Zars, T; Scharff, C; Brembs, B				Mendoza, Ezequiel; Colomb, Julien; Rybak, Juergen; Pflueger, Hans-Joachim; Zars, Troy; Scharff, Constance; Brembs, Bjoern			Drosophila FoxP Mutants Are Deficient in Operant Self-Learning	PLOS ONE			English	Article							BASAL GANGLIA CIRCUITS; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; VISUAL-SYSTEM; SEVERE SPEECH; ZEBRA FINCH; TERM-MEMORY; GENE; EVOLUTION; LANGUAGE	Intact function of the Forkhead Box P2 (FOXP2) gene is necessary for normal development of speech and language. This important role has recently been extended, first to other forms of vocal learning in animals and then also to other forms of motor learning. The homology in structure and in function among the FoxP gene members raises the possibility that the ancestral FoxP gene may have evolved as a crucial component of the neural circuitry mediating motor learning. Here we report that genetic manipulations of the single Drosophila orthologue, dFoxP, disrupt operant self-learning, a form of motor learning sharing several conceptually analogous features with language acquisition. Structural alterations of the dFoxP locus uncovered the role of dFoxP in operant self-learning and habit formation, as well as the dispensability of dFoxP for operant world-learning, in which no motor learning occurs. These manipulations also led to subtle alterations in the brain anatomy, including a reduced volume of the optic glomeruli. RNAi-mediated interference with dFoxP expression levels copied the behavioral phenotype of the mutant flies, even in the absence of mRNA degradation. Our results provide evidence that motor learning and language acquisition share a common ancestral trait still present in extant invertebrates, manifest in operant self-learning. This 'deep' homology probably traces back to before the split between vertebrate and invertebrate animals.	[Mendoza, Ezequiel; Scharff, Constance] Free Univ Berlin, Inst Biol Behav Biol, Berlin, Germany; [Colomb, Julien; Pflueger, Hans-Joachim; Brembs, Bjoern] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Rybak, Juergen] Max Planck Inst Chem Ecol, Jena, Germany; [Zars, Troy] Univ Missouri, Columbia, MO USA; [Brembs, Bjoern] Univ Regensburg, Inst Zool Neurogenet, D-93053 Regensburg, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society; University of Missouri System; University of Missouri Columbia; University of Regensburg	Brembs, B (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	bjoern@brembs.net	mendoza, ezequiel/AAZ-7613-2020; Scharff, Constance/HHN-0673-2022; Colomb, Julien/H-4927-2019; Brembs, Björn/A-9970-2008; Rybak, Jürgen/G-9143-2014	Colomb, Julien/0000-0002-3127-5520; Brembs, Björn/0000-0001-7824-7650; Rybak, Jürgen/0000-0003-0571-9957; Zars, Troy/0000-0003-4114-9322; Mendoza, Ezequiel/0000-0003-4963-519X	FU Berlin; DFG [BR 1892/6-1, BR 1892/7-1]	FU Berlin; DFG(German Research Foundation (DFG))	This study was funded by the research commission of the FU Berlin (to HJP and CS) and the DFG (BR 1892/6-1 and BR 1892/7-1 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Bacon C, 2012, HUM GENET, V131, P1687, DOI 10.1007/s00439-012-1193-z; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bowers JM, 2012, DIS MARKERS, V33, P251, DOI [10.1155/2012/456787, 10.3233/DMA-2012-0919]; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Brembs B, 2008, CURR BIOL, V18, P1168, DOI 10.1016/j.cub.2008.07.041; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brembs B, 2006, LEARN MEMORY, V13, P629, DOI 10.1101/lm.319406; Brembs B, 2011, BEHAV PROCESS, V87, P157, DOI 10.1016/j.beproc.2011.02.005; Brembs Bjoern, 2008, J Vis Exp, DOI 10.3791/731; Brembs B, 2009, CURR BIOL, V19, P1351, DOI 10.1016/j.cub.2009.06.014; Callaway E, 2011, NATURE, DOI [10.1038/nature.2011.9395., DOI 10.1038/NATURE.2011.9395]; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; CHOMSKY N, 1959, LANGUAGE, V35, P26, DOI 10.2307/411334; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Colomb Julien, 2010, Communicative & Integrative Biology, V3, P142; Corballis MC, 2009, ANN NY ACAD SCI, V1156, P19, DOI 10.1111/j.1749-6632.2009.04423.x; Costa RM, 2011, CURR OPIN NEUROBIOL, V21, P579, DOI 10.1016/j.conb.2011.05.004; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; DasGupta S, 2014, SCIENCE, V344, P901, DOI 10.1126/science.1252114; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Engel JE, 1996, J NEUROSCI, V16, P3486; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; Fee MS, 2014, CURR OPIN NEUROBIOL, V25, P194, DOI 10.1016/j.conb.2014.01.012; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Horn D, 2011, MOL SYNDROMOL, V2, P213, DOI 10.1159/000330916; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kiya T, 2008, INSECT MOL BIOL, V17, P53, DOI 10.1111/j.1365-2583.2008.00775.x; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kurt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033130; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lawton KJ, 2014, BEHAV BRAIN RES, V268, P213, DOI 10.1016/j.bbr.2014.04.009; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2005, BRAIN DEV-JPN, V27, P207, DOI 10.1016/j.braindev.2004.06.002; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li T, 2013, WORLD J BIOL PSYCHIA, V14, P146, DOI 10.3109/15622975.2011.615860; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Lorenzetti FD, 2008, NEURON, V59, P815, DOI 10.1016/j.neuron.2008.07.019; Maguire LP, 2004, REV SCI INSTRUM, V75, P3077, DOI 10.1063/1.1786331; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MARLER P, 1991, TRENDS NEUROSCI, V14, P199, DOI 10.1016/0166-2236(91)90106-5; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; McCarthy-Jones S, 2014, J PSYCHIATR RES, V50, P66, DOI 10.1016/j.jpsychires.2013.11.012; Mooney R, 2004, ANN NY ACAD SCI, V1016, P476, DOI 10.1196/annals.1298.011; Naour P, 2009, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-0-387-89462-1; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Palumbo O, 2013, GENE, V516, P107, DOI 10.1016/j.gene.2012.12.073; Pflugfelder GO, 1998, BEHAV BRAIN RES, V95, P3, DOI 10.1016/S0166-4328(97)00204-0; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Rochefort C, 2011, SCIENCE, V334, P385, DOI 10.1126/science.1207403; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sakaguchi H, 1997, NEUROREPORT, V8, P2645, DOI 10.1097/00001756-199708180-00002; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Schulz SB, 2010, GENES BRAIN BEHAV, V9, P732, DOI 10.1111/j.1601-183X.2010.00607.x; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Skinner B. F., 1957, VERBAL BEHAV; Spaniel F, 2011, NEUROSCI LETT, V493, P131, DOI 10.1016/j.neulet.2011.02.024; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; STEKLIS HD, 1976, ANN NY ACAD SCI, V280, P445, DOI 10.1111/j.1749-6632.1976.tb25508.x; Strausfeld NJ, 2007, J COMP NEUROL, V500, P166, DOI 10.1002/cne.21196; Takahashi H, 2009, ADV EXP MED BIOL, V665, P117; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; Teramitsu I, 2008, CURR BIOL, V18, pR335, DOI 10.1016/j.cub.2008.02.048; Toma C, 2013, PSYCHIAT GENET, V23, P82, DOI 10.1097/YPG.0b013e32835d6fc6; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ueda A, 2012, J NEUROGENET, V26, P64, DOI 10.3109/01677063.2011.652752; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yoshida Y, 2003, NEUROREPORT, V14, P645, DOI 10.1097/00001756-200303240-00025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	100	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100648	10.1371/journal.pone.0100648	http://dx.doi.org/10.1371/journal.pone.0100648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964149	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500071
J	Zhang, B; Nardi, F; Hull-Sanders, H; Wan, XW; Liu, YH				Zhang, Bin; Nardi, Francesco; Hull-Sanders, Helen; Wan, Xuanwu; Liu, Yinghong			The Complete Nucleotide Sequence of the Mitochondrial Genome of Bactrocera minax (Diptera: Tephritidae)	PLOS ONE			English	Article							DIRECTIONAL MUTATION PRESSURE; TRANSFER-RNA; GENE REARRANGEMENTS; CONTROL REGION; COMPOSITIONAL HETEROGENEITY; DORSALIS DIPTERA; WING-SHAPE; EVOLUTION; DNA; LEPIDOPTERA	The complete 16,043 bp mitochondrial genome (mitogenome) of Bactrocera minax (Diptera: Tephritidae) has been sequenced. The genome encodes 37 genes usually found in insect mitogenomes. The mitogenome information for B. minax was compared to the homologous sequences of Bactrocera oleae, Bactrocera tryoni, Bactrocera philippinensis, Bactrocera carambolae, Bactrocera papayae, Bactrocera dorsalis, Bactrocera correcta, Bactrocera cucurbitae and Ceratitis capitata. The analysis indicated the structure and organization are typical of, and similar to, the nine closely related species mentioned above, although it contains the lowest genome-wide A+T content (67.3%). Four short intergenic spacers with a high degree of conservation among the nine tephritid species mentioned above and B. minax were observed, which also have clear counterparts in the control regions (CRs). Correlation analysis among these ten tephritid species revealed close positive correlation between the A+T content of zero-fold degenerate sites (P-OFD), the ratio of nucleotide substitution frequency at P-OFD sites to all degenerate sites (zero-fold degenerate sites, two-fold degenerate sites and four-fold degenerate sites) and amino acid sequence distance (ASD) were found. Further, significant positive correlation was observed between the A+T content of four-fold degenerate sites (P-4FD) and the ratio of nucleotide substitution frequency at P-4FD sites to all degenerate sites; however, we found significant negative correlation between ASD and the A+T content of P-4FD, and the ratio of nucleotide substitution frequency at P-4FD sites to all degenerate sites. A higher nucleotide substitution frequency at non-synonymous sites compared to synonymous sites was observed in nad4, the first time that has been observed in an insect mitogenome. A poly(T) stretch at the 5' end of the CR followed by a [TA(A)](n)-like stretch was also found. In addition, a highly conserved G+A-rich sequence block was observed in front of the poly(T) stretch among the ten tephritid species and two tandem repeats were present in the CR.	[Zhang, Bin] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Pest Management Shandong Prov, Qingdao, Peoples R China; [Liu, Yinghong] Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China; [Wan, Xuanwu] Sichuan Plant Protect Stn, Chengdu, Peoples R China; [Nardi, Francesco] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Hull-Sanders, Helen] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Qingdao Agricultural University; Southwest University - China; University of Siena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, YH (corresponding author), Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022	Nardi, Francesco/0000-0003-0271-9855	Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China; Startup Fund for Distinguished Scholars Qingdao Agricultural University, China [631316]	Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China; Startup Fund for Distinguished Scholars Qingdao Agricultural University, China	This work was supported in part by the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China and the Startup Fund for Distinguished Scholars (No. 631316) supported by Qingdao Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boykin LM, J APPL ENTO IN PRESS; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; DREW RAI, 1979, J AUST ENTOMOL SOC, V18, P71; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Friedrich M, 2003, MOL PHYLOGENET EVOL, V26, P502, DOI 10.1016/S1055-7903(02)00335-4; Hong GY, 2009, ACTA BIOCH BIOPH SIN, V41, P446, DOI 10.1093/abbs/gmp030; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Inohira K, 1997, MOL BIOL EVOL, V14, P814, DOI 10.1093/oxfordjournals.molbev.a025822; JERMIIN LS, 1994, J MOL EVOL, V39, P160; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jose MS, 2013, ANN ENTOMOL SOC AM, V106, P684, DOI 10.1603/AN13017; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Krosch MN, 2013, SYST ENTOMOL, V38, P2, DOI 10.1111/j.1365-3113.2012.00643.x; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Moriyama EN, 1997, J MOL EVOL, V45, P378, DOI 10.1007/PL00006243; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nei M, 1987, MOL EVOLUTIONARY GEN; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Rieger M, 2006, CITRUS LEMON LIME OR; SACCONE C, 1991, EUR J BIOCHEM, V195, P151, DOI 10.1111/j.1432-1033.1991.tb15688.x; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schutze MK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-130; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; STANTON DJ, 1994, GENETICS, V137, P233; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Stewart JB, 2006, GENOME, V49, P815, DOI 10.1139/G06-037; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Stewart JB, 2003, MOL PHYLOGENET EVOL, V26, P513, DOI 10.1016/S1055-7903(02)00421-9; SUEOKA N, 1992, J MOL EVOL, V34, P95, DOI 10.1007/BF00182387; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Thompson P. C., 1998, INT J N AM DIPTERIST; Wan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042056; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang Xing-Jian, 1995, Entomological Knowledge, V32, P310; White I.M., 1992, FRUIT FLIES EC SIGNI; WHITE IM, 1992, B ENTOMOL RES, V82, P275, DOI 10.1017/S0007485300051828; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	71	30	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100558	10.1371/journal.pone.0100558	http://dx.doi.org/10.1371/journal.pone.0100558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964138	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500061
J	Armstrong, D; Dregan, A				Armstrong, David; Dregan, Alex			A Population-Based Investigation into the Self-Reported Reasons for Sleep Problems	PLOS ONE			English	Article							INSOMNIA; DISTURBANCES; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; COHORT	Typologies of sleep problems have usually relied on identifying underlying causes or symptom clusters. In this study the value of using the patient's own reasons for sleep disturbance are explored. Using secondary data analysis of a nationally representative psychiatric survey the patterning of the various reasons respondents provided for self-reported sleep problems were examined. Over two thirds (69.3%) of respondents could identify a specific reason for their sleep problem with worry (37.9%) and illness (20.1%) representing the most commonly reported reasons. And while women reported more sleep problems for almost every reason compared with men, the patterning of reasons by age showed marked variability. Sleep problem symptoms such as difficulty getting to sleep or waking early also showed variability by different reasons as did the association with major correlates such as worry, depression, anxiety and poor health. While prevalence surveys of 'insomnia' or 'poor sleep' often assume the identification of an underlying homogeneous construct there may be grounds for recognising the existence of different sleep problem types particularly in the context of the patient's perceived reason for the problem.	[Armstrong, David; Dregan, Alex] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Dregan, Alex] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Dregan, A (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England.	alexandru.dregan@kcl.ac.uk	Armstrong, David/AAI-4476-2021	Armstrong, David/0000-0003-3652-9662; Dregan, Alex/0000-0002-7620-4902	AHRC; BBSRC; EPSRC; ESRC; MRC [RES-339-25-009]	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AHRC, BBSRC, EPSRC, ESRC, and MRC Grant no. RES-339-25-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders MP, 2013, EUR J PUBLIC HLTH; Billiard M, 2004, SLEEP MED, V5, pS35, DOI 10.1016/S1389-9457(04)90006-8; Bultmann U, 2013, EUR J PUBLIC HEALTH, V23, P123, DOI 10.1093/eurpub/ckr207; Dregan A, 2011, INT PSYCHOGERIATR, V23, P1413, DOI 10.1017/S1041610211000664; Dregan A, 2010, J ADOLESCENT HEALTH, V46, P482, DOI 10.1016/j.jadohealth.2009.11.197; Dregan A, 2009, SOC SCI MED, V69, P1432, DOI 10.1016/j.socscimed.2009.08.041; Foley DJ, 1999, SLEEP, V22, pS366; Hislop Jenny, 2006, AGE MATTERS REALIGNI, P225, DOI DOI 10.4324/9780203943434; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; MORGAN K, 1988, AGE AGEING, V17, P1, DOI 10.1093/ageing/17.1.1; Ohayon MM, 2010, SLEEP MED, V11, P980, DOI 10.1016/j.sleep.2010.07.012; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2001, J PSYCHOSOM RES, V51, P745, DOI 10.1016/S0022-3999(01)00285-9; Roberts RE, 1999, PSYCHOSOM MED, V61, P188, DOI 10.1097/00006842-199903000-00011; Singleton N., 2000, TECHNICAL REPORT; Tang NKY, 2004, BEHAV RES THER, V42, P27, DOI 10.1016/S0005-7967(03)00068-8; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; WEYERER S, 1991, SLEEP, V14, P392	20	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101368	10.1371/journal.pone.0101368	http://dx.doi.org/10.1371/journal.pone.0101368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983754	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000097
J	Osugi, T; Okamura, T; Son, YL; Ohkubo, M; Ubuka, T; Henmi, Y; Tsutsui, K				Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Henmi, Yasuhisa; Tsutsui, Kazuyoshi			Evolutionary Origin of GnIH and NPFF in Chordates: Insights from Novel Amphioxus RFamide Peptides	PLOS ONE			English	Article							GONADOTROPIN-INHIBITORY HORMONE; GROWTH-HORMONE; HYPOTHALAMIC NEUROPEPTIDE; LPXRFAMIDE PEPTIDES; PQRFAMIDE PEPTIDES; MESSENGER-RNA; CDNA CLONING; IDENTIFICATION; LOCALIZATION; RECEPTOR	Gonadotropin-inhibitory hormone (GnIH) is a newly identified hypothalamic neuropeptide that inhibits pituitary hormone secretion in vertebrates. GnIH has an LPXRFamide (X = L or Q) motif at the C-terminal in representative species of gnathostomes. On the other hand, neuropeptide FF (NPFF), a neuropeptide characterized as a pain-modulatory neuropeptide, in vertebrates has a PQRFamide motif similar to the C-terminal of GnIH, suggesting that GnIH and NPFF have diverged from a common ancestor. Because GnIH and NPFF belong to the RFamide peptide family in vertebrates, protochordate RFamide peptides may provide important insights into the evolutionary origin of GnIH and NPFF. In this study, we identified a novel gene encoding RFamide peptides and two genes of their putative receptors in the amphioxus Branchiostoma japonicum. Molecular phylogenetic analysis and synteny analysis indicated that these genes are closely related to the genes of GnIH and NPFF and their receptors of vertebrates. We further identified mature RFamide peptides and their receptors in protochordates. The identified amphioxus RFamide peptides inhibited forskolin induced cAMP signaling in the COS-7 cells with one of the identified amphioxus RFamide peptide receptors expressed. These results indicate that the identified protochordate RFamide peptide gene is a common ancestral form of GnIH and NPFF genes, suggesting that the origin of GnIH and NPFF may date back to the time of the emergence of early chordates. GnIH gene and NPFF gene may have diverged by whole-genome duplication in the course of vertebrate evolution.	[Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Lab Integrat Brain Sci, Dept Biol, Tokyo, Japan; [Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Tokyo, Japan; [Henmi, Yasuhisa] Kumamoto Univ, Ctr Marine Environm Studies, Aitsu Marine Stn, Kumamoto, Japan	Waseda University; Waseda University; Kumamoto University	Tsutsui, K (corresponding author), Waseda Univ, Lab Integrat Brain Sci, Dept Biol, Tokyo, Japan.	k-tsutsui@waseda.jp	Son, You Lee/AAM-3859-2020	Ubuka, Takayoshi/0000-0002-4731-8118; Osugi, Tomohiro/0000-0001-6987-9576; Son, You Lee/0000-0002-3429-5324	Ministry of Education, Science and Culture, Japan [18107002, 22132004, 22227002]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (18107002, 22132004 and 22227002 to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2006, J ENDOCRINOL, V188, P417, DOI 10.1677/joe.1.06494; Anko ML, 2006, J NEUROCHEM, V96, P573, DOI 10.1111/j.1471-4159.2005.03581.x; Bentley GE, 2010, BRAIN RES, V1364, P62, DOI 10.1016/j.brainres.2010.10.001; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chartrel N, 2002, J COMP NEUROL, V448, P111, DOI 10.1002/cne.10253; Chowdhury VS, 2011, J ENDOCRINOL, V209, P211, DOI 10.1530/JOE-10-0494; Daukss D, 2012, GEN COMP ENDOCR, V177, P215, DOI 10.1016/j.ygcen.2012.04.024; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Henmi Y, 2003, ZOOL SCI, V20, P897, DOI 10.2108/zsj.20.897; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Ikemoto T, 2005, J REPROD DEVELOP, V51, P359, DOI 10.1262/jrd.16087; Koda A, 2002, ENDOCRINOLOGY, V143, P411, DOI 10.1210/en.143.2.411; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; McVeigh P, 2009, INT J PARASITOL, V39, P1243, DOI 10.1016/j.ijpara.2009.03.005; Osugi T, 2006, FEBS J, V273, P1731, DOI 10.1111/j.1742-4658.2006.05187.x; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Osugi T, 2012, ENDOCRINOLOGY, V153, P2362, DOI 10.1210/en.2011-2046; Osugi T, 2011, ENDOCRINOLOGY, V152, P4252, DOI 10.1210/en.2011-1375; Satake H, 2001, BIOCHEM J, V354, P79; Sawada K, 2002, EUR J BIOCHEM, V269, P6000, DOI 10.1046/j.1432-1033.2002.03351.x; Sawada K, 2002, J ENDOCRINOL, V174, P395, DOI 10.1677/joe.0.1740395; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Son YL, 2012, ENDOCRINOLOGY, V153, P2332, DOI 10.1210/en.2011-1904; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tando Y, 2009, ZOOL SCI, V26, P409, DOI 10.2108/zsj.26.409; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Ubuka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4061; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ukena K, 2002, FEBS LETT, V512, P255, DOI 10.1016/S0014-5793(02)02275-5; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Ukena K, 2003, ENDOCRINOLOGY, V144, P3879, DOI 10.1210/en.2003-0359; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Yang HYT, 2006, PEPTIDES, V27, P943, DOI 10.1016/j.peptides.2005.06.030; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100962	10.1371/journal.pone.0100962	http://dx.doi.org/10.1371/journal.pone.0100962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983238	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000043
J	Pesce, M; Sergi, MR; Rizzuto, A; Tatangelo, R; Tommasi, M; Picconi, L; Balsamo, M; Gatta, V; Stuppia, L; Siegling, AB; Gokcen, E; Grilli, A; Saggino, A				Pesce, Mirko; Sergi, Maria R.; Rizzuto, Alessia; Tatangelo, Raffaella; Tommasi, Marco; Picconi, Laura; Balsamo, Michela; Gatta, Valentina; Stuppia, Liborio; Siegling, Alexander B.; Goekcen, Elif; Grilli, Alfredo; Saggino, Aristide			Associations between the Antioxidant Network and Emotional Intelligence: A Preliminary Study	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; GLUTATHIONE-PEROXIDASE; COGNITIVE IMPAIRMENT; PSYCHOLOGICAL STRESS; VALIDATION; DAMAGE; EXPRESSION; EXERCISE; ANXIETY	Background: Emotional intelligence (EI) can be broadly defined as the ability to cope with environmental demands. In the scientific research, however, there is not a univocal precise definition of EI and recent articles have underlined the necessity to explore its biological basis to advance understanding of the construct. The aim of study was to investigate if the antioxidant network may be associated with typical-performance or trait EI. Methods: The study group consisted of 50 women (age, M = 25.10, SD = 3.87). Super Oxide Dismutase (SOD), Catalase (CAT), Glutathione Reductase (GR), and Glutathione Peroxidase (GPx) activities were evaluated on proteins extracted from Peripheral Blood Mononuclear Cells. Participants completed the Italian version of the EQ-i (Bar-On, 1997) as a measure of trait EI. Results: We observed positive and significant correlations between some biological variables and EQ-i scores, and a significant predictive effect of CAT activity when controlling for related biological variables, age, and smoking. Conclusions: Our preliminary study suggests that the antioxidant network may constitute some of trait EI's biological basis. In particular, CAT and the SOD/CAT ratio could be two biological variables involved in some specific components of EI.	[Pesce, Mirko; Sergi, Maria R.; Rizzuto, Alessia; Tatangelo, Raffaella; Tommasi, Marco; Picconi, Laura; Balsamo, Michela; Gatta, Valentina; Stuppia, Liborio; Grilli, Alfredo; Saggino, Aristide] Univ G DAnnunzio, Dept Psychol Humanist & Terr Sci, Chieti, Italy; [Siegling, Alexander B.; Goekcen, Elif] UCL, London Psychometr Lab, London, England	G d'Annunzio University of Chieti-Pescara; University of London; University College London	Pesce, M (corresponding author), Univ G DAnnunzio, Dept Psychol Humanist & Terr Sci, Chieti, Italy.	mirkopesce@unich.it	Siegling, Alex/O-2327-2019; Tommasi, Marco/G-4917-2013; Balsamo, Michela/AAP-1182-2020; Gatta, Valentina/G-5765-2014	Tommasi, Marco/0000-0002-4876-0530; Balsamo, Michela/0000-0001-5396-3853; SERGI, MARIA RITA/0000-0002-8821-3304; Pesce, Mirko/0000-0001-8836-2564; Stuppia, Liborio/0000-0002-6232-0996; Siegling, Alex/0000-0003-2411-9826; grilli, alfredo/0000-0002-5746-5007; GATTA, Valentina/0000-0002-9999-5823	Italian ministry of University and Research	Italian ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The Italian ministry of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablij Hans, 2002, Eur J Intern Med, V13, P412, DOI 10.1016/S0953-6205(02)00132-2; Aebi H., 1974, CATALASE METHODS ENZ; Bar-On R, 2009, EMOTIONAL QUOTIENT I; Behr GA, 2012, CELL BIOL TOXICOL, V28, P317, DOI 10.1007/s10565-012-9226-x; Biasucci LM, 2004, CIRCULATION, V110, pE560, DOI 10.1161/01.CIR.0000148983.88334.80; Di Fabio A, 2010, EMPOWERING EMOTIONAL; DIILIO C, 1986, J MOL CELL CARDIOL, V18, P983; Dulewicz V, 2003, J MANAGERIAL PSYCHOL, V18, P405, DOI DOI 10.1108/02683940310484017; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; Grewal D, 2008, JAMA-J AM MED ASSOC, V300, P1200, DOI 10.1001/jama.300.10.1200; Huang G, 2006, EMOTIONAL INTELLIGEN; Jordan PJ, 2009, J MANAGE ORGAN, V15, P452, DOI 10.5172/jmo.15.4.452; Kupper N, 2009, PSYCHOSOM MED, V71, P973, DOI 10.1097/PSY.0b013e3181bee6dc; Landy FJ, 2005, J ORGAN BEHAV, V26, P411, DOI 10.1002/job.317; Li Q, 2011, PHYSIOL BEHAV, V104, P365, DOI 10.1016/j.physbeh.2011.04.012; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Locke EA, 2005, J ORGAN BEHAV, V26, P425, DOI 10.1002/job.318; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Matsushita M, 2010, PSYCHIAT CLIN NEUROS, V64, P435, DOI 10.1111/j.1440-1819.2010.02109.x; Matthews G, 2002, EMOTIONAL INTELLIGENCE: SCIENCE AND MYTH, P1; Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Ozdemir O, 2012, NEUROPSYCHOBIOLOGY, V66, P244, DOI 10.1159/000341880; Patruno A, 2012, NITRIC OXIDE-BIOL CH, V27, P143, DOI 10.1016/j.niox.2012.06.002; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Radak Z, 2007, APPL PHYSIOL NUTR ME, V32, P942, DOI 10.1139/H07-081; Rawdin BJ, 2013, BRAIN BEHAV IMMUN, V31, P143, DOI 10.1016/j.bbi.2012.11.011; Reale M, 2012, CNS NEUROL DISORD-DR, V11, P430, DOI 10.2174/187152712800792875; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Scapagnini G, 2012, CNS DRUGS, V26, P477, DOI 10.2165/11633190-000000000-00000; Schutte NS, 1998, PERS INDIV DIFFER, V25, P167, DOI 10.1016/S0191-8869(98)00001-4; Siegling AB, 2012, PERS INDIV DIFFER, V52, P776, DOI 10.1016/j.paid.2012.01.003; Speranza L, 2008, INT J IMMUNOPATH PH, V21, P879, DOI 10.1177/039463200802100412; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Tapia M, 2006, PSICOTHEMA, V18, P55; Tett RP, 2005, PERS SOC PSYCHOL B, V31, P859, DOI 10.1177/0146167204272860; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Van Rooy DL, 2004, J VOCAT BEHAV, V65, P71, DOI 10.1016/S0001-8791(03)00076-9; Williams LM, 2003, COGNITION EMOTION, V17, P747, DOI 10.1080/02699930302284; Zhang XY, 2013, J PSYCHIATR RES, V47, P1049, DOI 10.1016/j.jpsychires.2013.03.014	44	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101247	10.1371/journal.pone.0101247	http://dx.doi.org/10.1371/journal.pone.0101247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983620	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000076
J	Wang, CQ; Yang, SL; Zhang, NB; Mu, YL; Ren, HY; Wang, YF; Li, K				Wang, Chaoqun; Yang, Shulin; Zhang, Ningbo; Mu, Yulian; Ren, Hongyan; Wang, Yefu; Li, Kui			Long-Term Supranutritional Supplementation with Selenate Decreases Hyperglycemia and Promotes Fatty Liver Degeneration by Inducing Hyperinsulinemia in Diabetic db/db Mice	PLOS ONE			English	Article							HEREDITARY FRUCTOSE INTOLERANCE; INSULIN-RESISTANCE; HUMAN HEALTH; SKELETAL-MUSCLE; GENE-EXPRESSION; DBDB MICE; SELENIUM; METABOLISM; CALRETICULIN; CELLS	There are conflicting reports on the link between the micronutrient selenium and the prevalence of diabetes. To investigate the possibility that selenium acts as a "double-edged sword" in diabetes, cDNA microarray profiling and two-dimensional differential gel electrophoresis coupled with mass spectrometry were used to determine changes in mRNA and protein expression in pancreatic and liver tissues of diabetic db/db mice in response to dietary selenate supplementation. Fasting blood glucose levels increased continuously in db/db mice administered placebo (DMCtrl), but decreased gradually in selenate-supplemented db/db mice (DMSe) and approached normal levels after termination of the experiment. Pancreatic islet size was increased in DMSe mice compared with DMCtrl mice, resulting in a clear increase in insulin production and a doubling of plasma insulin concentration. Genes that encode proteins involved in key pancreatic beta-cell functions, including regulation of beta-cell proliferation and differentiation and insulin synthesis, were found to be specifically upregulated in DMSe mice. In contrast, apoptosis-associated genes were downregulated, indicating that islet function was protected by selenate treatment. Conversely, liver fat accumulation increased in DMSe mice together with significant upregulation of lipogenic and inflammatory genes. Genes related to detoxification were downregulated and antioxidant enzymatic activity was reduced, indicating an unexpected reduction in antioxidant defense capacity and exacerbation of fatty liver degeneration. Moreover, proteomic analysis of the liver showed differential expression of proteins involved in glucolipid metabolism and the endoplasmic reticulum assembly pathway. Taken together, these results suggest that dietary selenate supplementation in db/db mice decreased hyperglycemia by increasing insulin production and secretion; however, long-term hyperinsulinemia eventually led to reduced antioxidant defense capacity, which exacerbated fatty liver degeneration.	[Wang, Chaoqun; Wang, Yefu] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wang, Chaoqun; Yang, Shulin; Zhang, Ningbo; Mu, Yulian; Ren, Hongyan; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Wuhan University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wang, YF (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	wangyefu@whu.edu.cn; likui@caas.cn			national high technology research and development program 863 [2012AA020603]; State Key Laboratory of Animal Nutrition of China, Independent Research Project [2004DA125184G1109]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]	national high technology research and development program 863; State Key Laboratory of Animal Nutrition of China, Independent Research Project; Agricultural Science and Technology Innovation Program	This research was supported by grants from the national high technology research and development program 863 (2012AA020603), the State Key Laboratory of Animal Nutrition of China, Independent Research Project (2004DA125184G1109) and the Agricultural Science and Technology Innovation Program (ASTIP-IAS05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Becker DJ, 1996, DIABETOLOGIA, V39, P3, DOI 10.1007/BF00400407; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Bouteldja N, 2010, J INHERIT METAB DIS, V33, P105, DOI 10.1007/s10545-010-9053-2; Burk Raymond F, 2002, Nutr Clin Care, V5, P75, DOI 10.1046/j.1523-5408.2002.00006.x; Bystrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026591; Campbell SC, 2008, FEBS LETT, V582, P2333, DOI 10.1016/j.febslet.2008.05.038; Coffee EM, 2010, J INHERIT METAB DIS, V33, P715, DOI 10.1007/s10545-010-9192-5; Dalby AR, 2001, ACTA CRYSTALLOGR D, V57, P1526, DOI 10.1107/S0907444901012719; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Faghihi T, 2013, AM J THER; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Faure P, 2004, EUR J CLIN INVEST, V34, P475, DOI 10.1111/j.1365-2362.2004.01362.x; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Iizuka Y, 2010, BIOL TRACE ELEM RES, V138, P265, DOI 10.1007/s12011-010-8622-4; Karkoulias G, 2006, CELL SIGNAL, V18, P729, DOI 10.1016/j.cellsig.2005.06.014; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Leyva A, 2008, BIOLOGICALS, V36, P134, DOI 10.1016/j.biologicals.2007.09.001; Li RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038716; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006; Mueller AS, 2009, FREE RADICAL RES, V43, P1029, DOI 10.1080/10715760903196925; Mueller AS, 2003, J NUTR BIOCHEM, V14, P637, DOI 10.1016/j.jnutbio.2003.08.001; Muller AS, 2005, J ANIM PHYSIOL AN N, V89, P94, DOI 10.1111/j.1439-0396.2005.00559.x; OLDFIELD JE, 1987, J NUTR, V117, P2002, DOI 10.1093/jn/117.12.2002; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Pinto A, 2012, J INORG BIOCHEM, V114, P47, DOI 10.1016/j.jinorgbio.2012.04.011; Pinto A, 2011, J INORG BIOCHEM, V105, P812, DOI 10.1016/j.jinorgbio.2011.03.010; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 2013, FREE RADICAL BIO MED, V65, P1557, DOI 10.1016/j.freeradbiomed.2013.04.003; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rios JJ, 2010, J SCI FOOD AGR, V90, P1914, DOI 10.1002/jsfa.4032; Rocourt CRB, 2013, NUTRIENTS, V5, P1349, DOI 10.3390/nu5041349; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stapleton SR, 2000, CELL MOL LIFE SCI, V57, P1874, DOI 10.1007/PL00000669; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Zeng MS, 2012, FREE RADICAL BIO MED, V52, P1335, DOI 10.1016/j.freeradbiomed.2012.01.017; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200; Zhao G, 2012, J LIPID RES, V53, P456, DOI 10.1194/jlr.M017319; Zimmerman KA, 2013, J BIOL CHEM, V288, P14584, DOI 10.1074/jbc.M112.447243	48	25	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101315	10.1371/journal.pone.0101315	http://dx.doi.org/10.1371/journal.pone.0101315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983750	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000087
J	Beyer, F; Munte, TF; Wiechert, J; Heldmann, M; Kramer, UM				Beyer, Frederike; Muente, Thomas F.; Wiechert, Juliana; Heldmann, Marcus; Kraemer, Ulrike M.			Trait Aggressiveness Is Not Related to Structural Connectivity between Orbitofrontal Cortex and Amygdala	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; PREFRONTAL CORTEX; CONDUCT DISORDER; BRAIN; PSYCHOPATHY; EMOTION; ANXIETY; LOBE	Studies in both pathological and healthy samples have suggested altered functional connectivity between orbitofrontal cortex (OFC) and amygdala as a possible cause of anger and aggression. In patient populations presenting with pathological aggression, there is also evidence for changes in structural connectivity between OFC and amygdala. In healthy samples, however, the relationship between white matter integrity and aggression has not been studied to date. Here, we investigated the relationship between trait aggressiveness and structural OFC-amygdala connectivity in a large sample (n = 93) of healthy young men. Using diffusion tensor imaging, we measured the distribution of fractional anisotropy and mean diffusivity along the uncinate fascicle bilaterally. We found no differences in either measure between participants high and low in physical aggressiveness, or between those high and low in trait anger. Our results therefore argue against a direct relationship between structural OFC-amygdala connectivity and normal-range trait aggressiveness.	[Beyer, Frederike; Muente, Thomas F.; Wiechert, Juliana; Heldmann, Marcus; Kraemer, Ulrike M.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	University of Lubeck	Kramer, UM (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	umkraemer@gmail.com	Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019	Krämer, Ulrike M./0000-0002-3841-1812	German Research Foundation [KR3691/5-1]; University of Lubeck [E36-2011]	German Research Foundation(German Research Foundation (DFG)); University of Lubeck	This study was supported by the German Research Foundation (KR3691/5-1) and through intramural funding by the University of Lubeck (E36-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beyer F, 2014, CEREBRAL CO IN PRESS; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Herzberg P. Y., 2003, J DIFFERENTIAL DIAGN, V24, P311; Hoptman MJ, 2002, BIOL PSYCHIAT, V52, P9, DOI 10.1016/S0006-3223(02)01311-2; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; KLINGLER J, 1960, J COMP NEUROL, V115, P333, DOI 10.1002/cne.901150305; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Montag C, 2012, NEUROSCIENCE, V217, P77, DOI 10.1016/j.neuroscience.2012.05.017; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Xu JS, 2012, HUM BRAIN MAPP, V33, P994, DOI 10.1002/hbm.21275; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	28	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101105	10.1371/journal.pone.0101105	http://dx.doi.org/10.1371/journal.pone.0101105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977414	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400077
J	Galal, IF; Zakaria, Z; Allam, WR; Mahmoud, MA; Ezzat, AR; Osman, A; Waked, I; Strickland, GT; Abdelwahab, SF				Galal, Iman F.; Zakaria, Zainab; Allam, Walaa R.; Mahmoud, Mohamed A.; Ezzat, Ahmed R.; Osman, Ahmed; Waked, Imam; Strickland, G. Thomas; Abdelwahab, Sayed F.			Cross Reactive Cellular Immune Response to HCV Genotype 1 and 4 Antigens among Genotype 4 Exposed Subjects	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEALTH-CARE WORKERS; INFECTION; MEMORY; PROTECTION; VACCINE; CD4(+); EGYPT; REPLICATION; RECHALLENGE	Background: Hepatitis C Virus (HCV) infection is a global health burden particularly in Egypt, where HCV genotype 4a (GT-4a) predominates. The prevention and control of HCV infection will remain a challenge until the development of an effective vaccine that protects against different genotypes. Several HCV GT-1-based vaccines are in different stages of clinical trials, but antigenic differences could make protection against other genotypes problematic. In this regard, data comparing the cell-mediated immune (CMI) response to different HCV genotypes are limited. We aimed to ex vivo investigate whether GT-1-based vaccine may protect against HCV GT-4 infections. This was carried out on samples collected from genotype 4 infected/exposed subjects. Methods/Principal Findings: The CMI responses of 35 subjects; infected with HCV GT-4/or who had spontaneously-resolved the infection and 10 healthy control subjects; to two sets of seven HCV overlapping 15-mer peptide pools derived from both genotypes; and covering most of the viral proteins; were evaluated. This was carried out using an interferon gamma (IFN gamma) enzyme-linked immunospot (ELISpot) assay. Peripheral blood mononuclear cells (PBMC) from 17 subjects (48%) responded to at least one peptide pool derived from GT-1b/GT-4a with 13 subjects responding to peptide pools from both genotypes. A strong correlation was found in the responses to both genotypes (r = 0.82, p<0.001; 95% confidence interval = 0.562-0.933). The average IFNc total spot forming cells (SFC)/10(6) PBMC (+/- SE) from the responding subjects for GT-1b and GT-4a was 216 +/- 56 and 199 +/- 55, respectively (p = 0.833). Also, there were no significant differences between those who cleared their HCV infection or who remained HCV-RNA positive (p = 0.8). Conclusion/Significance: Our data suggest that an effective GT-1b vaccine could protect from GT-4a infection. These data could help in HCV rationale vaccine design and efficacy studies and further our understanding of HCV cross protection against different genotypes.	[Galal, Iman F.; Zakaria, Zainab; Allam, Walaa R.; Abdelwahab, Sayed F.] Egyptian Co Blood Transfus Serv Egyblood VACSERA, Giza, Egypt; [Mahmoud, Mohamed A.; Waked, Imam] Menoufiya Univ, Dept Hepatol, Natl Liver Inst, Menoufia, Egypt; [Ezzat, Ahmed R.] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Osman, Ahmed] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt; [Strickland, G. Thomas] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Abdelwahab, Sayed F.] Menia Univ, Dept Microbiol & Immunol, Fac Med, Al Minya, Egypt	Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; University System of Maryland; University of Maryland Baltimore; Egyptian Knowledge Bank (EKB); Minia University	Abdelwahab, SF (corresponding author), Egyptian Co Blood Transfus Serv Egyblood VACSERA, Giza, Egypt.	sayed.awahab@mu.edu.eg	Waked/V-1221-2018; Abdelwahab, Sayed F./P-1481-2016; Zakaria, Zainab/ABC-3220-2020; Galal, Iman/AAK-6415-2020; Ali, Zainab/HHD-2051-2022	Waked/0000-0002-9857-8972; Abdelwahab, Sayed F./0000-0002-9636-7485; Zakaria, Zainab/0000-0003-4987-3649; Ali, Zainab/0000-0002-7792-7985; Abdel-Samiee, Mohamed/0000-0002-8970-0286	6th Framework Program [0374435]; Okairos; Egyptian Company for Blood Transfusion Services (Egyblood)	6th Framework Program(European Commission); Okairos; Egyptian Company for Blood Transfusion Services (Egyblood)	This work was supported by the 6th Framework Program, Contract# 0374435 to the HEPACIVAC Consortium; by Okairos, and by the Egyptian Company for Blood Transfusion Services (Egyblood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Abdelwahab SF, 2012, CLIN VACCINE IMMUNOL, V19, P780, DOI 10.1128/CVI.00050-12; Abdelwahab SF, 2013, J CLIN VIROL; Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; El Khayat Hisham R, 2012, Trop Gastroenterol, V33, P112; El-Kamary SS, 2013, J PEDIATR-US, V162, P148, DOI 10.1016/j.jpeds.2012.06.057; El-Zanaty F, 2008, EGYPT DEMOGRAPHIC HL; El-Zayadi A, 1994, J Egypt Public Health Assoc, V69, P327; Elrefaei M, 2004, J HEPATOL, V40, P313, DOI 10.1016/j.jhep.2003.10.007; Esmat G, 2013, LIVER INT, V33, P41, DOI 10.1111/liv.12059; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; Farid A, 2005, PARASITE IMMUNOL, V27, P189, DOI 10.1111/j.1365-3024.2005.00762.x; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Fytili P, 2008, VACCINE, V26, P3818, DOI 10.1016/j.vaccine.2008.05.045; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Kamal SM, 2004, J VIROL, V78, P12252, DOI 10.1128/JVI.78.22.12252-12258.2004; Kamal SM, 2004, J INFECT DIS, V189, P1140, DOI 10.1086/382278; Kamal SM, 2001, J INFECT DIS, V184, P972, DOI 10.1086/323352; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Nelson DR, 1997, J IMMUNOL, V158, P1473; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Prince AM, 2005, J INFECT DIS, V192, P1701, DOI 10.1086/496889; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Shata MT, 2007, J IMMUNOL METHODS, V328, P152, DOI 10.1016/j.jim.2007.08.014; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Strickland GT, 2008, LANCET INFECT DIS, V8, P379, DOI 10.1016/S1473-3099(08)70126-9; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Ward S, 2002, CLIN EXP IMMUNOL, V128, P195, DOI 10.1046/j.1365-2249.2002.01840.x; Welsh RM, 2006, CURR TOP MICROBIOL, V311, P117; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101264	10.1371/journal.pone.0101264	http://dx.doi.org/10.1371/journal.pone.0101264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979366	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400109
J	Kandala, NB; Stranges, S				Kandala, Ngianga-Bakwin; Stranges, Saverio			Geographic Variation of Overweight and Obesity among Women in Nigeria: A Case for Nutritional Transition in Sub-Saharan Africa	PLOS ONE			English	Article							NORTH-WEST PROVINCE; SOUTH-AFRICA; PREVALENCE; HEALTH; URBANIZATION; PERSPECTIVE; MODELS	Background: Nutritional research in sub-Saharan Africa has primarily focused on under-nutrition. However, there is evidence of an ongoing nutritional transition in these settings. This study aimed to examine the geographic variation of overweight and obesity prevalence at the state-level among women in Nigeria, while accounting for individual-level risk factors. Methods: The analysis was based on the 2008 Nigerian Demographic and Health Survey (NDHS), including 27,967 women aged 15-49 years. Individual data were collected on socio-demographics, but were aggregated to the country's states. We used a Bayesian geo-additive mixed model to map the geographic distribution of overweight and obesity at the state-level, accounting for individual-level risk factors. Results: The overall prevalence of combined overweight and obesity (body mass index >= 25) was 20.9%. In multivariate Bayesian geo-additive models, higher education [odds ratio (OR) & 95% Credible Region (CR): 1.68 (1.38, 2.00)], higher wealth index [3.45 (2.98, 4.05)], living in urban settings [1.24 (1.14, 1.36)] and increasing age were all significantly associated with a higher prevalence of overweight/obesity. There was also a striking variation in overweight/obesity prevalence across ethnic groups and state of residence, the highest being in Cross River State, in south-eastern Nigeria [2.32 (1.62, 3.40)], the lowest in Osun State in south-western Nigeria [0.48 (0.36, 0.61)]. Conclusions: This study suggests distinct geographic patterns in the combined prevalence of overweight and obesity among Nigerian women, as well as the role of demographic, socio-economic and environmental factors in the ongoing nutritional transition in these settings.	[Kandala, Ngianga-Bakwin; Stranges, Saverio] Univ Warwick, Div Hlth Sci, Sch Med, Coventry CV4 7AL, W Midlands, England; [Kandala, Ngianga-Bakwin] Univ Witwatersrand, Sch Publ Hlth, Epidemiol & Biostat Div, Johannesburg, South Africa; [Kandala, Ngianga-Bakwin] Univ Oxford, KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya	University of Warwick; University of Witwatersrand	Stranges, S (corresponding author), Univ Warwick, Div Hlth Sci, Sch Med, Coventry CV4 7AL, W Midlands, England.	S.Stranges@warwick.ac.uk		Stranges, Saverio/0000-0001-5226-8373	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	Ngianga-Bakwin Kandala is also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2008, PUBLIC HEALTH, V122, P173, DOI 10.1016/j.puhe.2007.06.012; Adedoyin Rufus A, 2009, Nig Q J Hosp Med, V19, P100; AmiraCO SokunbiDOB, 2011, NIG MED J, V52, P110; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Ayopo Olotu O., 2011, INT J MARKETING STUD, V3, P162, DOI 10.5539/ijms.v3n1p162; Brezger A, 2012, BAYESX SOFTWARE BAYE; Brezger A, 2005, J STAT SOFTWARE, V14, P11; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Chigbu CO, 2011, ANN MED HEALTH SCI R, V1, P135; Chukwuonye II, 2013, DIABET METAB SYND OB, V6, P285, DOI 10.2147/DMSO.S43545; Chukwuonye II, 2013, DIABET METAB SYND OB, V6, P43, DOI 10.2147/DMSO.S38626; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Desalu OO, 2008, SAHEL MED J, V11, P61; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; Kandala NB, 2006, QUAL QUANT, V40, P935, DOI 10.1007/s11135-005-3268-6; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Kennedy Gina, 2004, FAO Food Nutr Pap, V83, P1; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Loaiza E, 1997, DHS COMPARATIVE STUD; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Oyeyemi AL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-32; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Popkin BM, 2003, DEV POLICY REV, V21, P581, DOI DOI 10.1111/J.1467-8659.2003.00225.X; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Raschke V, 2008, PUBLIC HEALTH NUTR, V11, P662, DOI 10.1017/S1368980007001140; RK Udo, 1975, POPULATION GROWTH SO, P298; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; United Nations Population Division, 1999, WORLD URB PROSP 1999; Vorster HH, 2005, PUBLIC HEALTH NUTR, V8, P480, DOI 10.1079/PHN2005784; Vorster HH, 2000, S AFR J SCI, V96, P505; WHO, 1995, WORLD HLTH ORG WHO E, V854; World Health Organization, 2000, WHO TECHN REP SERIES, V894; World Health Organization Regional Committee for Africa, 2005, CARD DIS AFR REG CUR; World Reference Base for Soil Resources, 2006, 84 FAO	40	58	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101103	10.1371/journal.pone.0101103	http://dx.doi.org/10.1371/journal.pone.0101103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979753	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400076
J	Mesquita, M; Fintelman-Rodrigues, N; Sacramento, CQ; Abrantes, JL; Costa, E; Temerozo, JR; Siqueira, MM; Bou-Habib, DC; Souza, TML				Mesquita, Milene; Fintelman-Rodrigues, Natalia; Sacramento, Carolina Q.; Abrantes, Juliana L.; Costa, Eduardo; Temerozo, Jairo R.; Siqueira, Marilda M.; Bou-Habib, Dumith Chequer; Souza, Thiago Moreno L.			HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALVEOLAR EPITHELIAL-CELLS; PANDEMIC H1N1 2009; A H1N1; ALPHA-INTERFERON; REPLICATION; INFECTION; LUNG; MACROPHAGES; RESPONSES	HIV-1-infected patients co-infected with A(H1N1)pdm09 surprisingly presented benign clinical outcome. The knowledge that HIV-1 changes the host homeostatic equilibrium, which may favor the patient resistance to some co-pathogens, prompted us to investigate whether HIV-1 infection could influence A(H1N1)pdm09 life cycle in vitro. We show here that exposure of A(H1N1)pdm09-infected epithelial cells to HIV-1 viral particles or its gp120 enhanced by 25% the IFITM3 content, resulting in a decrease in influenza replication. This event was dependent on toll-like receptor 2 and 4. Moreover, knockdown of IFITM3 prevented HIV-1 ability to inhibit A(H1N1)pdm09 replication. HIV-1 infection also increased IFITM3 levels in human primary macrophages by almost 100%. Consequently, the arrival of influenza ribonucleoproteins (RNPs) to nucleus of macrophages was inhibited, as evaluated by different approaches. Reduction of influenza RNPs entry into the nucleus tolled A(H1N1) pdm09 life cycle in macrophages earlier than usual, limiting influenza's ability to induce TNF-alpha. As judged by analysis of the influenza hemagglutin (HA) gene from in vitro experiments and from samples of HIV-1/A(H1N1)pdm09 co-infected individuals, the HIV-1-induced reduction of influenza replication resulted in delayed viral evolution. Our results may provide insights on the mechanisms that may have attenuated the clinical course of Influenza in HIV-1/A(H1N1)pdm09 co-infected patients during the recent influenza form 2009/2010.	[Mesquita, Milene; Fintelman-Rodrigues, Natalia; Sacramento, Carolina Q.; Abrantes, Juliana L.; Costa, Eduardo; Siqueira, Marilda M.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Oswaldo Cruz, WHO, Resp Viruses Lab,NIC, BR-21045900 Rio De Janeiro, RJ, Brazil; [Temerozo, Jairo R.; Bou-Habib, Dumith Chequer] Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; World Health Organization; Fundacao Oswaldo Cruz	Souza, TML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, WHO, Resp Viruses Lab,NIC, BR-21045900 Rio De Janeiro, RJ, Brazil.	tmoreno@ioc.fiocruz.br	Miranda, Milene/ABD-8472-2021; Bou-Habib, Dumith/GPP-1624-2022; Temerozo, Jairo R/K-4894-2012; Souza, Thiago Moreno L./G-2900-2012	Miranda, Milene/0000-0003-0037-059X; Bou-Habib, Dumith/0000-0003-0552-9045; Temerozo, Jairo R/0000-0002-8092-2149; Souza, Thiago Moreno L./0000-0003-2212-3899	PAPES/Fiocruz; CNPq; Faperj	PAPES/Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from PAPES/Fiocruz (www.ioc.fiocruz.br), CNPq (www.cnpq.br), and Faperj (www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes JL, 2012, BBA-MOL BASIS DIS, V1822, P1198, DOI 10.1016/j.bbadis.2012.04.011; [Anonymous], 2012, GLOB REP UNAIDS REP; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Barchi E, 2010, EMERG INFECT DIS, V16, P1643, DOI 10.3201/eid1610.100341; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Camp JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056602; Chua PK, 2009, J GEN VIROL, V90, P2929, DOI 10.1099/vir.0.013128-0; Cline TD, 2013, J VIROL, V87, P1411, DOI 10.1128/JVI.02682-12; Cohen SS, 1999, P NATL ACAD SCI USA, V96, P10842, DOI 10.1073/pnas.96.19.10842; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Douek Daniel, 2007, Top HIV Med, V15, P114; Elton D, 2005, BIOL LETTERS, V1, P113, DOI 10.1098/rsbl.2004.0253; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Feiterna-Sperling C, 2010, CLIN INFECT DIS, V51, pE90, DOI 10.1086/657121; Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479; Gao RB, 2013, AM J PATHOL, V183, P1258, DOI 10.1016/j.ajpath.2013.06.023; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Heath L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006949; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Iwata K, 2010, J INFECT CHEMOTHER, V16, P298, DOI 10.1007/s10156-010-0054-8; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Karaivanova G M, 1995, Afr J Med Med Sci, V24, P1; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; Lisco A, 2009, CELL HOST MICROBE, V6, P403, DOI 10.1016/j.chom.2009.10.010; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martinez E, 2011, HIV MED, V12, P236, DOI 10.1111/j.1468-1293.2010.00905.x; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Monteerarat Y, 2010, ARCH VIROL, V155, P1273, DOI 10.1007/s00705-010-0716-y; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Ormsby CE, 2011, AIDS, V25, P435, DOI 10.1097/QAD.0b013e3283434844; Perez CM, 2010, AIDS, V24, P2867, DOI 10.1097/QAD.0b013e32833e92d5; PESCHKE T, 1993, IMMUNOBIOLOGY, V189, P340, DOI 10.1016/S0171-2985(11)80365-7; Pomerantz RJ, 2003, HIV CLIN TRIALS, V4, P137, DOI 10.1310/80JH-148K-NADQ-U927; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Short KR, 2013, LANCET INFECT DIS; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tang JW, 2010, INFECT DIS CLIN N AM, V24, P603, DOI 10.1016/j.idc.2010.04.001; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Wagner TA, 2009, AIDS, V23, P923, DOI 10.1097/QAD.0b013e328329f964; Wahl SM, 2003, J LEUKOCYTE BIOL, V74, P726, DOI 10.1189/jlb.0503220; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101056	10.1371/journal.pone.0101056	http://dx.doi.org/10.1371/journal.pone.0101056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978204	Green Published, gold			2022-12-25	WOS:000338506400068
J	O'Dwyer, L; Tanner, C; van Dongen, EV; Greven, CU; Braten, J; Zwiersl, MP; Franke, B; Oosterlaan, J; Heslenfeld, D; Hoekstra, P; Hartman, CA; Rommelse, N; Buitelaar, JK				O'Dwyer, Laurence; Tanner, Colby; van Dongen, Eelco V.; Greven, Corina U.; Braten, Janita; Zwiersl, Marcel P.; Franke, Barbara; Oosterlaan, Jaap; Heslenfeld, Dirk; Hoekstra, Pieter; Hartman, Catharina A.; Rommelse, Nanda; Buitelaar, Jan K.			Brain Volumetric Correlates of Autism Spectrum Disorder Symptoms in Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; BEHAVIOR QUESTIONNAIRE CSBQ; LARGE MULTICENTER ADHD; REPETITIVE BEHAVIORS; DIAGNOSTIC-APPROACH; LANGUAGE DISORDER; CORPUS-CALLOSUM; CAUDATE-NUCLEUS; FAMILIAL TRAIT	Autism spectrum disorder (ASD) symptoms frequently occur in subjects with attention deficit/hyperactivity disord (ADHD). While there is evidence that both ADHD and ASD have differential structural correlates, no study to date has nvestigated these structural correlates within a framework that robustly accounts for the phenotypic overlap between the two disorders. The presence of ASD symptoms was measured by the parent-reported Children's Social and Behavioural Questionnaire (CSBQ) in ADHD subject n = 180) their unaffected siblings (n = 118) and healthy controls (n = 146). ADHD symptoms were assessed by a structured interview K-SADS-PL) and the Conners' ADHD questionnaires. Whole brain T1 Weighted MPRAGE images were acquired and the structural MRI correlates of ASD symptom scores were analysed by modelling ASD symptom scores against white matter (WM) and grey matter (GM) volumes using mixed effects models which controlled for ADHD symptom levels. ASD symptoms were significantly elevated in ADHD subjects relative to bot h controls and unaffected siblings. ASD scores were predicted by the interaction between WM and GM volumes. Increasing ASD score was associated with greater GM volume. Equivocal results from previous structural studies in ADHD and ASD may be due to the fact that comorbidity has not been taken into account in studies to date. The current findings stress he need. to account for issues of ASD comorbidity ADHD.	[O'Dwyer, Laurence; van Dongen, Eelco V.; Greven, Corina U.; Braten, Janita; Zwiersl, Marcel P.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Tanner, Colby] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Greven, Corina U.] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Braten, Janita; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara; Rommelse, Nanda] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Oosterlaan, Jaap; Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hoekstra, Pieter; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr Nij, Nijmegen, Netherlands	Radboud University Nijmegen; University of Lausanne; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Radboud University Nijmegen	O'Dwyer, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	larodwyer@gmail.com	Bralten, Janita/D-4647-2011; Buitelaar, J.K./AAY-7522-2020; Lambregts-Rommelse, N.N.J./L-4470-2015; Zwiers, Marcel P/D-2968-2009; Rommelse, Nanda NJ/D-4872-2009; Franke, Barbara/D-4836-2009; Hassan, Randa/AAW-3624-2021; Greven, Corina/GRS-7921-2022; Greven, Corina U/F-9729-2010	Zwiers, Marcel P/0000-0001-5483-2935; Rommelse, Nanda NJ/0000-0002-1711-0359; Franke, Barbara/0000-0003-4375-6572; Greven, Corina U/0000-0002-5433-7878; Greven, Corina U./0000-0003-2402-3074	National Institutes of Health [RO1MH62873]; NWO Large Investment Grant [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; European Community's Seventh Framework Programme [278948]; Innovative Medicines Initiative Joint Undertaking (IMI) under (EU-AIMS) [115300-01]; Irish Research Council for Science, Engineering and Technology (IRCSET); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO Large Investment Grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; European Community's Seventh Framework Programme(European Commission); Innovative Medicines Initiative Joint Undertaking (IMI) under (EU-AIMS); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The NeuroIMAGE study was supported by National Institutes of Health grant RO1MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar) and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. The research leading to these results also received support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278948 (TACTICS), and from the Innovative Medicines Initiative Joint Undertaking (IMI) under grant agreement number 115300-01 (EU-AIMS). CT was supported by a fellowship from the Irish Research Council for Science, Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2002, MODEL SELECTION MULT; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Association AP, 2000, DIAGNOTIC STAT MANUA; Bates D, IME4 LINEAR MIXED EF; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Crawley MJ., 2007, R BOOK; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1464, DOI 10.1007/s10803-009-0764-x; DIVAC I, 1967, J COMP PHYSIOL PSYCH, V63, P184, DOI 10.1037/h0024348; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P57, DOI 10.1007/s10803-008-0599-x; Fine JG, 2008, J AUTISM DEV DISORD, V38, P1797, DOI 10.1007/s10803-008-0570-x; Freitag CM, 2009, BIOL PSYCHIAT, V66, P316, DOI 10.1016/j.biopsych.2009.03.011; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Geluk CAML, 2012, J CHILD PSYCHOL PSYC, V53, P160, DOI 10.1111/j.1469-7610.2011.02456.x; Geurts HM, 2008, J CHILD PSYCHOL PSYC, V49, P848, DOI 10.1111/j.1469-7610.2008.01916.x; Geurts HM, 2013, J AUTISM DEV DISORD, V43, P1630, DOI 10.1007/s10803-012-1708-4; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greaves-Lord K, 2013, J AUTISM DEV DISORD, V43, P1784, DOI 10.1007/s10803-012-1724-4; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Helt M, 2008, NEUROPSYCHOL REV, V18, P339, DOI 10.1007/s11065-008-9075-9; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jaspers M, 2013, J ABNORM CHILD PSYCH, V41, P71, DOI 10.1007/s10802-012-9653-4; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KIRKBY RJ, 1969, PHYSIOL BEHAV, V4, P451, DOI 10.1016/0031-9384(69)90135-8; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Luteijn EF, 2000, EUR CHILD ADOLES PSY, V9, P168, DOI 10.1007/s007870070040; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-55; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-54; Mulligan A, 2009, J AUTISM DEV DISORD, V39, P197, DOI 10.1007/s10803-008-0621-3; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Nijmeijer JS, 2009, J ABNORM CHILD PSYCH, V37, P443, DOI 10.1007/s10802-008-9282-0; Nijmeijer JS, 2014, J AUTISM DEV DISORD, V44, P1671, DOI 10.1007/s10803-014-2039-4; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Piven J, 1996, J AM ACAD CHILD PSY, V35, P530, DOI 10.1097/00004583-199604000-00020; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Scarpa A, 2011, BEHAV COGN PSYCHOTH, V39, P495, DOI 10.1017/S1352465811000063; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2010, HUM BRAIN MAPP, V31, P917, DOI 10.1002/hbm.21028; Shea S, 2004, PEDIATRICS, V114, pE634, DOI 10.1542/peds.2003-0264-F; STETTNER LJ, 1967, SCIENCE, V155, P1689, DOI 10.1126/science.155.3770.1689; Sze KM, 2008, BEHAV COGNITIVE PSYC, V36; 't Hart-Kerkhoffs LA, 2009, J CLIN PSYCHIAT, V70, P266, DOI 10.4088/JCP.08m04635; Taylor JL, 2010, J AUTISM DEV DISORD, V40, P1431, DOI 10.1007/s10803-010-1005-z; THOMPSON RL, 1959, J COMP PHYSIOL PSYCH, V52, P650, DOI 10.1037/h0038893; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van der Meer JMJ, 2012, J AM ACAD CHILD PSY, V51, P1160, DOI 10.1016/j.jaac.2012.08.024; van Steijn DJ, 2012, J CHILD PSYCHOL PSYC, V53, P954, DOI 10.1111/j.1469-7610.2012.02556.x; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Waiter GD, 2005, NEUROIMAGE, V24, P455, DOI 10.1016/j.neuroimage.2004.08.049	91	14	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101130	10.1371/journal.pone.0101130	http://dx.doi.org/10.1371/journal.pone.0101130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979066	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400083
J	Zhang, HY; Zhang, Q; Yang, B; Wang, JF				Zhang, Huyuan; Zhang, Qing; Yang, Bo; Wang, Jinfang			Compacted Sewage Sludge as a Barrier for Tailings: The Heavy Metal Speciation and Total Organic Carbon Content in the Compacted Sludge Specimen	PLOS ONE			English	Article							MINE DRAINAGE; SORPTION; SOIL	Acid mine drainage (AMD) was the main environmental problem facing the mining industry. For AMD had high heavy metals content and low pH, the compacted sewage sludge might be a barrier for tailings whose oxidation and weathering produced AMD, with its own carbon source, microorganism reduction ability and impermeability. To study the heavy metals environmental risk, under the simulate AMD, the deionized water (DW), and the pH 2.1 sulfuric acid water (SA) seepage conditions, respectively, the changes of the chemical speciation of heavy metals Cd, Cu, Fe, Ni, Zn and total organic carbon (TOC) content in the compacted sewage sludge were assessed in the different periods. The results indicated according to the distribution of heavy metals, the potential mobility was for Cd: 6.08 under AMD, 7.48 under SA, infinity under DW; for Cu: 0.08 under AMD, 0.17 under SA, 0.59 under DW; for Fe: 0.15 under AMD, 0.22 under SA, 0.22 under DW; for Ni: 2.60 under AMD, 1.69 under SA, 1.67 under DW; and for Zn: 0.15 under AMD, 0.23 under SA and 0.21 under DW at the second checking time. TOC content firstly decreased from 67.62 +/- 0% to 66.29 +/- 0.35%, then increased to 67.74 +/- 0.65% under the AMD seepage while TOC decreased to 63.30 +/- 0.53%, then to 61.33 +/- 0.37% under the DW seepage, decreased to 63.86 +/- 0.41%, then to 63.28 +/- 0.49% under SA seepage. That indicated under the AMD seepage, the suitable microorganisms communities in the compacted sewage sludge were activated. And the heavy metals environmental risk of compacted sewage sludge was lower with AMD condition than with other two. So the compacted sewage sludge as a barrier for tailings was feasible as the aspect of environmental risk assessment.	[Zhang, Huyuan; Zhang, Qing; Yang, Bo; Wang, Jinfang] Lanzhou Univ, Minist Educ, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China; [Zhang, Huyuan; Zhang, Qing; Wang, Jinfang] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Zhang, Qing] Lanzhou City Univ, Sch Chem & Environm Sci, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou City University	Zhang, Q (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China.	m35t@163.com		ZHANG, Qing/0000-0002-4997-2586	Doctoral Program of Higher Education of China [20110211110025]; National Natural Science Foundation of China [31160118, 30960060]	Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Doctoral Program of Higher Education of China (No. 20110211110025) and National Natural Science Foundation of China (No. 31160118 & No. 30960060), http://www.nsfc.gov.cn/publish/portal0/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY BJ, 1991, SCI TOTAL ENVIRON, V100, P151, DOI 10.1016/0048-9697(91)90377-Q; Ashworth DJ, 2004, ENVIRON POLLUT, V127, P137, DOI 10.1016/S0269-7491(03)00237-9; Brown M., 2002, MINEWATER TREATMENT; China EPA, 2002, WAT WAST MON AN METH; Clemente R, 2007, J ENVIRON QUAL, V36, P1137, DOI 10.2134/jeq2006.0304; Domene X, 2010, J SOIL SEDIMENT, V10, P30, DOI 10.1007/s11368-009-0073-1; ELLIOTT HA, 1990, J ENVIRON QUAL, V19, P330, DOI 10.2134/jeq1990.00472425001900020021x; Gibert O, 2005, WATER RES, V39, P2827, DOI 10.1016/j.watres.2005.04.056; Gibert O, 2005, APPL GEOCHEM, V20, P1648, DOI 10.1016/j.apgeochem.2005.04.012; Gibert O, 2010, ENVIRON GEOCHEM HLTH, V32, P373, DOI 10.1007/s10653-010-9290-1; Gulec S, 2003, EFFECT ACID MINE DRA; Gulec SB, 2005, J GEOTECH GEOENVIRON, V131, P937, DOI 10.1061/(ASCE)1090-0241(2005)131:8(937); Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; Kamon M, 2002, SOILS FOUND, V42, P79, DOI 10.3208/sandf.42.6_79; Lin CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091981; Lottermoser BG, 2007, MINE WASTES CHARACTE; Miller S, 1998, THEORY DESIGN OPERAT, P115; Munk L, 2002, APPL GEOCHEM, V17, P421, DOI 10.1016/S0883-2927(01)00098-1; Nason P, 2014, MINE WATER ENVIRON, V33, P66, DOI 10.1007/s10230-013-0244-6; Nason P, 2013, ENVIRON EARTH SCI, V70, P3093, DOI 10.1007/s12665-013-2369-0; Singh AK, 1999, ENVIRON GEOL, V39, P90, DOI 10.1007/s002540050439; Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Wang B, 2010, ENVIRON EARTH SCI, V61, P931, DOI 10.1007/s12665-009-0410-0; Zhang Hu-yuan, 2010, Huanjing Kexue, V31, P2705; Zhou YF, 2010, CRIT REV ENV SCI TEC, V40, P909, DOI 10.1080/10643380802586857; Zufiaurre R, 1998, ANALYST, V123, P255, DOI 10.1039/a705168i	27	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100932	10.1371/journal.pone.0100932	http://dx.doi.org/10.1371/journal.pone.0100932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979755	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400052
J	Ezzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA				Ezzatizadeh, Vahid; Sandi, Chiranjeevi; Sandi, Madhavi; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.			MutL alpha Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia	PLOS ONE			English	Article							DNA MISMATCH REPAIR; GAA TRIPLET-REPEAT; MISSENSE MUTATIONS; PARENTAL GENDER; RNA-POLYMERASE; STICKY DNA; TRANSCRIPTION; INSTABILITY; EXPANSION; FRATAXIN	Background: Friedreich ataxia (FRDA), the most common autosomal recessive ataxia disorder, is caused by a dynamic GAA repeat expansion mutation within intron 1 of FXN gene, resulting in down-regulation of frataxin expression. Studies of cell and mouse models have revealed a role for the mismatch repair (MMR) MutS-heterodimer complexes and the PMS2 component of the MutL alpha complex in the dynamics of intergenerational and somatic GAA repeat expansions: MSH2, MSH3 and MSH6 promote GAA repeat expansions, while PMS2 inhibits GAA repeat expansions. Methodology/Principal Findings: To determine the potential role of the other component of the MutL alpha complex, MLH1, in GAA repeat instability in FRDA, we have analyzed intergenerational and somatic GAA repeat expansions from FXN transgenic mice that have been crossed with Mlh1 deficient mice. We find that loss of Mlh1 activity reduces both intergenerational and somatic GAA repeat expansions. However, we also find that loss of either Mlh1 or Pms2 reduces FXN transcription, suggesting different mechanisms of action for Mlh1 and Pms2 on GAA repeat expansion dynamics and regulation of FXN transcription. Conclusions/Significance: Both MutL alpha components, PMS2 and MLH1, have now been shown to modify the molecular phenotype of FRDA. We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic approaches to increase FXN transcription.	[Ezzatizadeh, Vahid; Sandi, Chiranjeevi; Sandi, Madhavi; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ London, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge, Middx, England	Brunel University	Pook, MA (corresponding author), Brunel Univ London, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge, Middx, England.	Mark.Pook@brunel.ac.uk			European Union [242193/EFACTS]; Wellcome Trust [089757]; GoFAR; Ataxia UK; FARA	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GoFAR; Ataxia UK; FARA	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement number 242193/EFACTS (CS, MS), the Wellcome Trust [089757] (SA), GoFAR, Ataxia UK and FARA (VE) to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Belvederesi L, 2006, EUR J HUM GENET, V14, P853, DOI 10.1038/sj.ejhg.5201628; Bourn RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047085; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chahwan R, 2012, J EXP MED, V209, P671, DOI 10.1084/jem.20111531; Chandok GS, 2012, NUCLEIC ACIDS RES, V40, P3964, DOI 10.1093/nar/gks021; Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Davis TW, 1998, CANCER RES, V58, P767; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Delatycki MB, 1998, J MED GENET, V35, P713, DOI 10.1136/jmg.35.9.713; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Ellison AR, 2004, NUCLEIC ACIDS RES, V32, P5321, DOI 10.1093/nar/gkh855; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Frizzell A, 2014, CELL REP, V6, P827, DOI 10.1016/j.celrep.2014.01.034; Gibson SL, 2006, CANCER LETT, V244, P195, DOI 10.1016/j.canlet.2005.12.009; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kobayashi Katsutoshi, 2005, Hum Cell, V18, P103; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046807; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Michalowski J, 2001, ONCOGENE, V20, P5856, DOI 10.1038/sj.onc.1204721; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pianese L, 1997, AM J HUM GENET, V60, P460; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Tomassini B, 2012, HUM MOL GENET, V21, P2855, DOI 10.1093/hmg/dds110; Vetcher AA, 2002, J BIOL CHEM, V277, P39217, DOI 10.1074/jbc.M205209200; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544	58	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100523	10.1371/journal.pone.0100523	http://dx.doi.org/10.1371/journal.pone.0100523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971578	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200039
J	Kumar, A; Sahu, SK; Mohanty, S; Chakrabarti, S; Maji, S; Reddy, RR; Jha, AK; Goswami, C; Kundu, CN; Rajasubramaniam, S; Verma, SC; Choudhuri, T				Kumar, Amit; Sahu, Sushil Kumar; Mohanty, Suchitra; Chakrabarti, Sudipta; Maji, Santanu; Reddy, R. Rajendra; Jha, Asutosh K.; Goswami, Chandan; Kundu, Chanakya N.; Rajasubramaniam, Shanmugam; Verma, Subhash C.; Choudhuri, Tathagata			Kaposi Sarcoma Herpes Virus Latency Associated Nuclear Antigen Protein Release the G2/M Cell Cycle Blocks by Modulating ATM/ATR Mediated Checkpoint Pathway	PLOS ONE			English	Article							MULTICENTRIC CASTLEMANS-DISEASE; PRIMARY EFFUSION LYMPHOMA; REVERSE-TRANSCRIPTASE PROMOTER; DNA-SEQUENCES; HUMAN PAPILLOMAVIRUSES; BINDING PROTEIN; GENE-EXPRESSION; TUMOR-VIRUSES; LANA PROTEIN; HUMAN-HERPESVIRUS-8	The Kaposi's sarcoma-associated herpesvirus infects the human population and maintains latency stage of viral life cycle in a variety of cell types including cells of epithelial, mesenchymal and endothelial origin. The establishment of latent infection by KSHV requires the expression of an unique repertoire of genes among which latency associated nuclear antigen (LANA) plays a critical role in the replication of the viral genome. LANA regulates the transcription of a number of viral and cellular genes essential for the survival of the virus in the host cell. The present study demonstrates the disruption of the host G2/M cell cycle checkpoint regulation as an associated function of LANA. DNA profile of LANA expressing human B-cells demonstrated the ability of this nuclear antigen in relieving the drug (Nocodazole) induced G2/M checkpoint arrest. Caffeine suppressed nocodazole induced G2/M arrest indicating involvement of the ATM/ATR. Notably, we have also shown the direct interaction of LANA with Chk2, the ATM/ATR signalling effector and is responsible for the release of the G2/M cell cycle block.	[Kumar, Amit; Sahu, Sushil Kumar; Mohanty, Suchitra; Chakrabarti, Sudipta; Maji, Santanu; Reddy, R. Rajendra; Choudhuri, Tathagata] Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India; [Choudhuri, Tathagata] Dept Biotechnol, Santini Ketan, Bolpur, India; [Kundu, Chanakya N.] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Verma, Subhash C.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Jha, Asutosh K.; Goswami, Chandan] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India; [Rajasubramaniam, Shanmugam] Reg Med Res Ctr Tribals, Dept Biotechnol, Jabalpur, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Kalinga Institute of Industrial Technology (KIIT); Nevada System of Higher Education (NSHE); University of Nevada Reno; National Institute of Science Education & Research (NISER); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH)	Choudhuri, T (corresponding author), Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India.	tatha@ils.res.in	Choudhuri, Tathagata/F-8139-2011; maji, santanu/HCH-0463-2022; Chakrabarti, Sudipta/ABG-5682-2021; Kumar, Ashutosh/AFX-7442-2022; Mohanty, Suchitra/ABG-6763-2020; Kumar, Amit/AAO-4055-2020	maji, santanu/0000-0002-8939-0636; Chakrabarti, Sudipta/0000-0002-4867-160X; Mohanty, Suchitra/0000-0002-8154-6093; Kundu, Chanakya/0000-0003-0297-1030	Council of Scientific and Industrial Research, Government of India; DBT through RGYI grant, Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); DBT through RGYI grant, Department of Biotechnology, Government of India	AK, SKS, SM was supported by Council of Scientific and Industrial Research, Government of India. This work was supported by DBT through its RGYI grant, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Barbera AJ, 2006, CELL CYCLE, V5, P1048, DOI 10.4161/cc.5.10.2768; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Darbon JM, 2000, J BIOL CHEM, V275, P15363, DOI 10.1074/jbc.275.20.15363; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, J VIROL, V77, P8019, DOI 10.1128/JVI.77.14.8019-8030.2003; Gabrielli B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00009; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Howe AK, 1998, J VIROL, V72, P9637, DOI 10.1128/JVI.72.12.9637-9644.1998; Kaul R, 2007, VIROLOGY, V364, P317, DOI 10.1016/j.virol.2007.03.010; Knight JS, 2001, J BIOL CHEM, V276, P22971, DOI 10.1074/jbc.M101890200; Krauer KG, 2004, ONCOGENE, V23, P1342, DOI 10.1038/sj.onc.1207253; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lan K, 2005, J VIROL, V79, P3468, DOI 10.1128/JVI.79.6.3468-3478.2005; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lu F, 2012, J VIROL, V86, P5752, DOI 10.1128/JVI.07216-11; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Saha A, 2010, CANCER BIOL THER, V10, P961, DOI 10.4161/cbt.10.10.13923; SCHOLLER A, 1994, MOL PHARMACOL, V45, P944; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Southern SA, 2000, INT J GYNECOL CANCER, V10, P263, DOI 10.1046/j.1525-1438.2000.010004263.x; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Vahteristo P, 2001, CANCER RES, V61, P5718; Vazquez ED, 2011, J VIROL, V85, P7622, DOI 10.1128/JVI.00304-11; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	57	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100228	10.1371/journal.pone.0100228	http://dx.doi.org/10.1371/journal.pone.0100228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972086	gold, Green Submitted, Green Published			2022-12-25	WOS:000338512200021
J	Elks, PM; van der Vaart, M; van Hensbergen, V; Schutz, E; Redd, MJ; Murayama, E; Spaink, HP; Meijer, AH				Elks, Philip M.; van der Vaart, Michiel; van Hensbergen, Vincent; Schutz, Esther; Redd, Michael J.; Murayama, Emi; Spaink, Herman P.; Meijer, Annemarie H.			Mycobacteria Counteract a TLR-Mediated Nitrosative Defense Mechanism in a Zebrafish Infection Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; HUMAN ALVEOLAR MACROPHAGES; OXIDATIVE STRESS-RESPONSE; TOLL-LIKE RECEPTORS; REACTIVE OXYGEN; HOST-DEFENSE; TUBERCULOUS-GRANULOMAS; ARGININE METABOLISM; TYROSINE NITRATION	Pulmonary tuberculosis (TB), caused by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb), is a major world health problem. The production of reactive nitrogen species (RNS) is a potent cytostatic and cytotoxic defense mechanism against intracellular pathogens. Nevertheless, the protective role of RNS during Mtb infection remains controversial. Here we use an anti-nitrotyrosine antibody as a readout to study nitration output by the zebrafish host during early mycobacterial pathogenesis. We found that recognition of Mycobacterium marinum, a close relative of Mtb, was sufficient to induce a nitrosative defense mechanism in a manner dependent on MyD88, the central adaptor protein in Toll like receptor (TLR) mediated pathogen recognition. However, this host response was attenuated by mycobacteria via a virulence mechanism independent of the well-characterized RD1 virulence locus. Our results indicate a mechanism of pathogenic mycobacteria to circumvent host defense in vivo. Shifting the balance of host-pathogen interactions in favor of the host by targeting this virulence mechanism may help to alleviate the problem of infection with Mtb strains that are resistant to multiple drug treatments.	[Elks, Philip M.; van der Vaart, Michiel; van Hensbergen, Vincent; Schutz, Esther; Spaink, Herman P.; Meijer, Annemarie H.] Leiden Univ, Inst Biol, Leiden, South Holland, Netherlands; [Elks, Philip M.] Univ Sheffield, Bateson Ctr, Sheffield, S Yorkshire, England; [Elks, Philip M.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Redd, Michael J.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Murayama, Emi] Inst Pasteur, Unite Macrophages & Dev Immun, Paris, France; [Murayama, Emi] Inst Pasteur, Ctr Natl Rech Sci, Unite Rech Associee 2578, Paris, France	Leiden University; Leiden University - Excl LUMC; University of Sheffield; University of Sheffield; Utah System of Higher Education; University of Utah; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meijer, AH (corresponding author), Leiden Univ, Inst Biol, Leiden, South Holland, Netherlands.	a.h.meijer@biology.leidenuniv.nl	Spaink, Herman P./S-3586-2017; Meijer, Annemarie/W-3726-2019	Spaink, Herman P./0000-0003-4128-9501; Meijer, Annemarie H./0000-0002-1325-0725; van der Vaart, Michiel/0000-0003-0828-7088; van Hensbergen, Vincent/0000-0002-6316-3400; Murayama, Emi/0000-0002-5311-1594; Elks, Philip/0000-0003-1683-0749	European Respiratory Society Fellowship (LTRF fellowship) [176-2011]; University of Sheffield Vice-Chancellor's Fellowship; European Commission [LSHG-CT-2003-503496]; Netherlands Ministry of Economic Affairs; Ministry of Education, Culture and Science; European Commission 7th framework project ZF-HEALTH [HEALTH-F4-2010-242048]; Leiden University Fund (LUF)	European Respiratory Society Fellowship (LTRF fellowship); University of Sheffield Vice-Chancellor's Fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission 7th framework project ZF-HEALTH; Leiden University Fund (LUF)	P.M.E. is the recipient of a European Respiratory Society Fellowship (LTRF fellowship n degrees 176-2011). P.M.E. is further funded by a University of Sheffield Vice-Chancellor's Fellowship. The identification of the mpx-/-spotless mutant used in this study was supported by the European Commission through a FP6 Integrated Project ZF-MODELS grant (LSHG-CT-2003-503496) to P. Herbomel (Institut Pasteur, Paris). A.H.M, M.vdV., and H.P.S. are funded by the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Ministry of Education, Culture and Science. This work is further supported by the European Commission 7th framework project ZF-HEALTH (HEALTH-F4-2010-242048), and by the Leiden University Fund (LUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Cardona PJ, 2001, SCAND J IMMUNOL, V53, P65, DOI 10.1046/j.1365-3083.2001.00842.x; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Elks PM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003789; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall CJ, 2012, CELL STEM CELL, V10, P198, DOI 10.1016/j.stem.2012.01.007; Idh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039891; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lau YL, 1998, CLIN INFECT DIS, V26, P226, DOI 10.1086/517036; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; LEE J, 1992, J BIOL CHEM, V267, P16283; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; PACELLI R, 1995, J EXP MED, V182, P1469, DOI 10.1084/jem.182.5.1469; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Ramakrishnan L, 2013, ADV EXP MED BIOL, V783, P251, DOI 10.1007/978-1-4614-6111-1_13; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Toossi Zahra, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P513; Trivedi A, 2012, ADV MICROB PHYSIOL, V60, P263, DOI 10.1016/B978-0-12-398264-3.00004-8; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430	93	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100928	10.1371/journal.pone.0100928	http://dx.doi.org/10.1371/journal.pone.0100928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967596	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800084
J	Hochman, EY; Vaidya, AR; Fellows, LK				Hochman, Eldad Yitzhak; Vaidya, Avinash Rao; Fellows, Lesley K.			Evidence for a Role for the Dorsal Anterior Cingulate Cortex in Disengaging from an Incorrect Action	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ERROR-DETECTION; FRONTAL-CORTEX; RESPONSE CONFLICT; FINGER MOVEMENTS; BRAIN ACTIVITY; NEURAL SYSTEM; MOTOR CORTEX; NEGATIVITY; COMPONENTS	Adjusting for an error requires both disengaging from the wrong course of action and initiating a corrective response. The dorsal anterior cingulate cortex (dACC) has been implicated in both these processes in the decision-making and action monitoring literatures. Here, we aimed to distinguish between these putative functions with a variant of the Eriksen flanker task that manipulated response requirements (i.e. one or two finger responses). We found that two event-related potentials originating from the dACC (error-related negativity (ERN) and anterior N2) only reflected the representation of the incorrect response: these waveforms were larger when the incorrect response involved two fingers rather than one finger. The increase in ERN magnitude was also accompanied by a reduction in spontaneous error corrections. These results argue that activity in the dACC reflects a process involved in disengaging from an ongoing incorrect action, clearing the way for the correct response.	[Hochman, Eldad Yitzhak; Vaidya, Avinash Rao; Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Vaidya, AR (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	avinash.vaidya@mail.mcgill.ca	Vaidya, Avinash/H-7034-2019; Fellows, Lesley K/B-1778-2018	Vaidya, Avinash/0000-0001-5423-5655; Fellows, Lesley/0000-0002-9144-092X	Jeanne Timmins Costello Fellowship; CIHR [MOP 119291]	Jeanne Timmins Costello Fellowship; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Jeanne Timmins Costello Fellowship to EYH and an operating grant from CIHR (MOP 119291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Bonini F, 2014, SCIENCE, V343, P888, DOI 10.1126/science.1247412; Boorman ED, 2013, J NEUROSCI, V33, P2242, DOI 10.1523/JNEUROSCI.3022-12.2013; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Carbonnell L, 2006, BRAIN RES, V1095, P124, DOI 10.1016/j.brainres.2006.04.004; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 1996, INT CONGR SER, V1099, P579; Fiehler K, 2005, PSYCHOPHYSIOLOGY, V42, P72, DOI 10.1111/j.1469-8986.2005.00265.x; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hochman EY, 2012, CEREB CORTEX; Indovina I, 2001, NEUROIMAGE, V13, P1027, DOI 10.1006/nimg.2001.0776; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Kybic J, 2005, IEEE T MED IMAGING, V24, P12, DOI 10.1109/TMI.2004.837363; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luu P., 2000, DETERMINATION GEODES, P1; Maier ME, 2012, PSYCHOPHYSIOLOGY, V49, P899, DOI 10.1111/j.1469-8986.2012.01373.x; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PAUS T, 1991, BRAIN, V114, P2051, DOI 10.1093/brain/114.5.2051; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rabbitt P, 2002, Q J EXP PSYCHOL-A, V55, P1081, DOI 10.1080/02724980244000080; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Srinivasan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055247; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wessel JR, 2014, CORTEX, V50, P45, DOI 10.1016/j.cortex.2013.09.002; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101126	10.1371/journal.pone.0101126	http://dx.doi.org/10.1371/journal.pone.0101126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968256	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800112
J	O'Donnell, JJ; Birukova, AA; Beyer, EC; Birukov, KG				O'Donnell, James J., III; Birukova, Anna A.; Beyer, Eric C.; Birukov, Konstantin G.			Gap Junction Protein Connexin43 Exacerbates Lung Vascular Permeability	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; DIFFERENTIAL REGULATION; BARRIER FUNCTION; EXPRESSION; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; STRETCH; INJURY; RHO	Increased vascular permeability causes pulmonary edema that impairs arterial oxygenation and thus contributes to morbidity and mortality associated with Acute Respiratory Distress Syndrome and sepsis. Although components of intercellular adhesive and tight junctions are critical for maintaining the endothelial barrier, there has been limited study of the roles of gap junctions and their component proteins (connexins). Since connexins can modulate inflammatory signaling in other systems, we hypothesized that connexins may also regulate pulmonary endothelial permeability. The relationships between connexins and the permeability response to inflammatory stimuli were studied in cultured human pulmonary endothelial cells. Prolonged treatment with thrombin, lipopolysaccharide, or pathological cyclic stretch increased levels of mRNA and protein for the major connexin, connexin43 (Cx43). Thrombin and lipopolysaccharide both increased intercellular communication assayed by transfer of microinjected Lucifer yellow. Although thrombin decreased transendothelial resistance in these cells, the response was attenuated by pretreatment with the connexin inhibitor carbenoxolone. Additionally, the decreases of transendothelial resistance produced by either thrombin or lipopolysaccharide were attenuated by reducing Cx43 expression by siRNA knockdown. Both carbenoxolone and Cx43 knockdown also abrogated thrombin-induced phosphorylation of myosin light chain. Taken together, these data suggest that increased lung vascular permeability induced by inflammatory conditions may be amplified via increased expression of Cx43 and intercellular communication among pulmonary endothelial cells.	[O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Chicago, IL 60637 USA; [Beyer, Eric C.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022	Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [NHLBI HL089257]; NIH [NHLBI HL087823];  [T32HL007605];  [HL59199]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087823, T32HL007605, R01HL076259, R01HL089257, R01HL059199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding sources that supported this work include: T32HL007605, HL59199, National Institutes of Health NHLBI HL089257, and NIH NHLBI HL087823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2012, AM J PHYSIOL-LUNG C, V303, pL634, DOI 10.1152/ajplung.00195.2012; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Bastarache JA, 2006, SEMIN RESP CRIT CARE, V27, P365, DOI 10.1055/s-2006-948290; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Bolon ML, 2007, J CELL PHYSIOL, V211, P159, DOI 10.1002/jcp.20928; Chadjichristos CE, 2010, CIRCULATION, V121, P123, DOI 10.1161/CIRCULATIONAHA.109.867176; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Gemel J, 2012, J MEMBRANE BIOL, V245, P231, DOI 10.1007/s00232-012-9444-4; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; JARA PI, 1995, P NATL ACAD SCI USA, V92, P7011, DOI 10.1073/pnas.92.15.7011; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1; LARSON DM, 1990, CIRC RES, V66, P1074, DOI 10.1161/01.RES.66.4.1074; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Parthasarathi K, 2012, AM J PHYSIOL-LUNG C, V303, pL33, DOI 10.1152/ajplung.00219.2011; Rignault S, 2007, SHOCK, V28, P78, DOI 10.1097/shk.0b013e3180310bd1; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Tyml K, 2011, CAN J PHYSIOL PHARM, V89, P1, DOI 10.1139/y10-099; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051; Ziliene Violeta, 2004, Medicina (Kaunas), V40, P1124	45	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100931	10.1371/journal.pone.0100931	http://dx.doi.org/10.1371/journal.pone.0100931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967639	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800085
J	Walters, RD; McSwiggen, DT; Goodrich, JA; Kugel, JF				Walters, Ryan D.; McSwiggen, David T.; Goodrich, James A.; Kugel, Jennifer F.			Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATE INTERLEUKIN-2 TRANSCRIPTION; RNA APTAMER; C-JUN; IN-VITRO; AP-1; BINDING; COACTIVATOR; SPECIFICITY; HOMODIMERS	The AP-1 family of transcriptional activators plays pivotal roles in regulating a wide range of biological processes from the immune response to tumorigenesis. Determining the roles of specific AP-1 dimers in cells, however, has remained challenging because common molecular biology techniques are unable to distinguish between the role of, for example, cJun/cJun homodimers versus cJun/cFos heterodimers. Here we used SELEX (systematic evolution of ligands by exponential enrichment) to identify and characterize DNA aptamers that are > 100-fold more specific for binding cJun/cJun compared to cJun/cFos, setting the foundation to investigate the biological functions of different AP-1 dimer compositions.	[Walters, Ryan D.; McSwiggen, David T.; Goodrich, James A.; Kugel, Jennifer F.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Goodrich, JA (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	james.goodrich@colorado.edu; jennifer.kugel@colorado.edu			Department of Defense [BC074015]; National Institutes of Health [R01 GM055235, T32 GM08759]; Undergraduate Research Opportunities Program at the University of Colorado, Boulder; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Research Opportunities Program at the University of Colorado, Boulder; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant BC074015 from the Department of Defense, and R01 GM055235 from the National Institutes of Health. RDW was supported in part by National Institutes of Health Training Grant T32 GM08759. DTS was supported by the Undergraduate Research Opportunities Program at the University of Colorado, Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cho JS, 2004, MOL CELLS, V18, P17; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan XC, 2004, P NATL ACAD SCI USA, V101, P6934, DOI 10.1073/pnas.0401523101; Fennewald SM, 2007, J GEN VIROL, V88, P981, DOI 10.1099/vir.0.82499-0; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim Loree J., 2000, BMC Immunology, V1, P1, DOI 10.1186/1471-2172-1-1; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Nguyen TN, 2010, MOL IMMUNOL, V47, P2314, DOI 10.1016/j.molimm.2010.05.287; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Park MW, 2005, BIOCHEM BIOPH RES CO, V330, P11, DOI 10.1016/j.bbrc.2005.02.119; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; Shi H, 2007, P NATL ACAD SCI USA, V104, P3742, DOI 10.1073/pnas.0607805104; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Walters RD, 2013, MOL IMMUNOL, V56, P48, DOI 10.1016/j.molimm.2013.03.022; Wisniewska MB, 2007, J MOL BIOL, V371, P569, DOI 10.1016/j.jmb.2007.05.079; Zhao XC, 2006, NUCLEIC ACIDS RES, V34, P3755, DOI 10.1093/nar/gkl470; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101015	10.1371/journal.pone.0101015	http://dx.doi.org/10.1371/journal.pone.0101015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968026	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800099
J	Schaudinn, C; Stoodley, P; Hall-Stoodley, L; Gorur, A; Remis, J; Wu, S; Auer, M; Hertwig, S; Guerrero-Given, D; Hu, FZ; Ehrlich, GD; Costerton, JW; Robinson, DH; Webster, P				Schaudinn, Christoph; Stoodley, Paul; Hall-Stoodley, Luanne; Gorur, Amita; Remis, Jonathan; Wu, Siva; Auer, Manfred; Hertwig, Stefan; Guerrero-Given, Debbie; Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William; Robinson, Douglas H.; Webster, Paul			Death and Transfiguration in Static Staphylococcus epidermidis Cultures	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; TARGETED OLIGONUCLEOTIDE PROBES; IN-SITU HYBRIDIZATION; BIOFILM FORMATION; BINDING; ACCUMULATION; POPULATIONS; MICROSCOPY; ORGANISMS; BACTERIA	The overwhelming majority of bacteria live in slime embedded microbial communities termed biofilms, which are typically adherent to a surface. However, when several Staphylococcus epidermidis strains were cultivated in static liquid cultures, macroscopic aggregates were seen floating within the broth and also sedimented at the test tube bottom. Light-and electron microscopy revealed that early-stage aggregates consisted of bacteria and extracellular matrix, organized in sheet-like structures. Perpendicular under the sheets hung a network of periodically arranged, bacteria-associated strands. During the extended cultivation, the strands of a subpopulation of aggregates developed into cross-connected wall-like structures, in which aligned bacteria formed the walls. The resulting architecture had a compartmentalized appearance. In late-stage cultures, the wall-associated bacteria disintegrated so that, henceforth, the walls were made of the coalescing remnants of lysed bacteria, while the compartment-like organization remained intact. At the same time, the majority of strand-containing aggregates with associated culturable bacteria continued to exist. These observations indicate that some strains of Staphylococcus epidermidis are able to build highly sophisticated structures, in which a subpopulation undergoes cell lysis, presumably to provide continued access to nutrients in a nutrient-limited environment, whilst maintaining structural integrity.	[Schaudinn, Christoph] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany; [Stoodley, Paul; Hall-Stoodley, Luanne] Dept Microbial Infect & Immun, Columbus, OH USA; [Stoodley, Paul; Hall-Stoodley, Luanne] Dept Orthoped, Columbus, OH USA; [Gorur, Amita; Remis, Jonathan; Wu, Siva; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hertwig, Stefan] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Guerrero-Given, Debbie] Max Planck Florida Inst, Jupiter, FL USA; [Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William] Drexel Univ, Coll Med, Ctr Genom Sci, Philadelphia, PA 19104 USA; [Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William] Drexel Univ, Coll Med, Ctr Adv Microbial Proc, Inst Mol Med & Infect Dis,Dept Microbiol & Immuno, Philadelphia, PA 19104 USA; [Robinson, Douglas H.] DeNovo Biol LLC, Arlington, VA USA; [Webster, Paul] Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA USA; [Webster, Paul] Oak Crest Inst Sci, Pasadena, CA USA	Robert Koch Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Federal Institute for Risk Assessment; Max Planck Society; Drexel University; Drexel University; University of Southern California	Schaudinn, C (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.	schaudinnc@rki.de	Stoodley, Paul/E-5079-2013; Hall-Stoodley, Luanne/AAF-1925-2020	Stoodley, Paul/0000-0001-6069-273X; Ehrlich, Garth/0000-0003-1140-6594; Webster, Paul/0000-0002-1980-6931	Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; NIDCD [5 P-30 DC006276-03]; National Science Foundation (NSF) [0722354]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	J. P. Remis and M. Auer acknowledge support by the Office of Biological and Environmental Research of the US Department of Energy under contract number DE-AC02-05CH11231. Furthermore, the authors would like to express gratitude to the House Research Institute (Los Angeles) for funding this project in part, and for the generosity of the Ahmanson Foundation in supporting the Ahmanson Imaging Core. Grants from the NIDCD (5 P-30 DC006276-03) and the National Science Foundation (NSF #0722354) also supported the Ahmanson Imaging Core where a substantial part of this work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baum MM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-103; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bockelmann U, 2002, J MICROBIOL METH, V49, P75, DOI 10.1016/S0167-7012(01)00354-2; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cafiso V, 2004, CLIN MICROBIOL INFEC, V10, P1081, DOI 10.1111/j.1469-0691.2004.01024.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1997, ADV DENT RES, V11, P192; Dice B, 2009, BIOFOULING, V25, P367, DOI 10.1080/08927010902803297; EMERMAN M, 1982, J HISTOCHEM CYTOCHEM, V30, P395, DOI 10.1177/30.4.7061831; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0; Hunter RC, 2005, J BACTERIOL, V187, P7619, DOI 10.1128/JB.187.22.7619-7630.2005; JARLOV JO, 1992, J MED MICROBIOL, V37, P195, DOI 10.1099/00222615-37-3-195; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palsdottir H, 2009, J BACTERIOL, V191, P2077, DOI 10.1128/JB.01333-08; Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Robinson DH, 2005, MED HYPOTHESES, V64, P177, DOI 10.1016/j.mehy.2004.04.023; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; RUPP ME, 1992, INFECT IMMUN, V60, P4322, DOI 10.1128/IAI.60.10.4322-4327.1992; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Thar R, 2002, APPL ENVIRON MICROB, V68, P6310, DOI 10.1128/AEM.68.12.6310-6320.2002; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Webster P, 2004, BIOFILMS, V1, P165, DOI DOI 10.1017/S1479050504001425; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x	35	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100002	10.1371/journal.pone.0100002	http://dx.doi.org/10.1371/journal.pone.0100002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964210	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338709500026
J	Sung, HY; Choi, EN; Lyu, D; Mook-Jung, I; Ahn, JH				Sung, Hye Youn; Choi, Eun Nam; Lyu, Dahyun; Mook-Jung, Inhee; Ahn, Jung-Hyuck			Amyloid Beta-Mediated Epigenetic Alteration of Insulin-Like Growth Factor Binding Protein 3 Controls Cell Survival in Alzheimer's Disease	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; MAMMARY EPITHELIAL-CELLS; FACTOR-I; PRECURSOR PROTEIN; EXPRESSION; APOPTOSIS; IGFBP-3; CANCER; SERUM; BRAIN	Swedish double mutation (KM670/671NL) of amyloid precursor protein (APP) is reported to increase toxic amyloid b (Ab) production via aberrant cleavage at the beta-secretase site and thereby cause early-onset Alzheimer's disease (AD). However, the underlying molecular mechanisms leading to AD pathogenesis remains largely unknown. Previously, our transcriptome sequence analyses revealed global expressional modifications of over 600 genes in APP-Swedish mutant-expressing H4 (H4sw) cells compared to wild type H4 cells. Insulin-like growth factor binding protein 3 (IGFBP3) is one gene that showed significantly decreased mRNA expression in H4-sw cells. In this study, we investigated the functional role of IGFBP3 in AD pathogenesis and elucidated the mechanisms regulating its expression. We observed decreased IGFBP3 expression in the H4-sw cell line as well as the hippocampus of AD model transgenic mice. Treatment with exogenous IGFBP3 protein inhibited A beta(1-42)-induced cell death and caspase-3 activity, whereas siRNA-mediated suppression of IGFBP3 expression induced cell death and caspase-3 cleavage. In primary hippocampal neurons, administration of IGFBP3 protein blocked apoptotic cell death due to A beta(1-42) toxicity. These data implicate a protective role for IGFBP3 against A beta(1-42)-mediated apoptosis. Next, we investigated the regulatory mechanisms of IGFBP3 expression in AD pathogenesis. We observed abnormal IGFBP3 hypermethylation within the promoter CpG island in H4-sw cells. Treatment with the DNA methyltransferase inhibitor 5-aza-29-deoxycytidine restored IGFBP3 expression at both the mRNA and protein levels. Chronic exposure to A beta(1-42) induced IGFBP3 hypermethylation at CpGs, particularly at loci 2164 and 2173, and subsequently suppressed IGFBP3 expression. Therefore, we demonstrate that expression of anti-apoptotic IGFBP3 is regulated by epigenetic DNA methylation, suggesting a mechanism that contributes to AD pathogenesis.	[Sung, Hye Youn; Choi, Eun Nam; Lyu, Dahyun; Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Ahn, Jung-Hyuck] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Seoul, South Korea; [Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	ahnj@ewha.ac.kr		Ahn, Jung-Hyuck/0000-0001-9589-3881	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013882]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A5A2A32671867]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A1A2004214]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013882) and this work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A32671867). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A1A2004214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER RC, 1994, ENDOCRINOLOGY, V134, P848, DOI 10.1210/en.134.2.848; Borchelt DR, 1998, BRAIN PATHOL, V8, P735, DOI 10.1111/j.1750-3639.1998.tb00198.x; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Chae SS, 2010, J NEUROSCI RES, V88, P1926, DOI 10.1002/jnr.22356; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Firth SM, 2002, ENDOCRINOLOGY, V143, P1669, DOI 10.1210/en.143.5.1669; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kennedy BP, 2004, J NEURAL TRANSM, V111, P547, DOI 10.1007/s00702-003-0096-5; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Niikura T, 2001, J NEUROSCI, V21, P1902, DOI 10.1523/JNEUROSCI.21-06-01902.2001; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Rensink AAM, 2002, ACTA NEUROPATHOL, V104, P525, DOI 10.1007/s00401-002-0585-x; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Torng PL, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-120; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005	41	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99047	10.1371/journal.pone.0099047	http://dx.doi.org/10.1371/journal.pone.0099047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964199	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500008
J	Tonna, S; Takyar, FM; Vrahnas, C; Crimeen-Irwin, B; Ho, PWM; Poulton, IJ; Brennan, HJ; McGregor, NE; Allan, EH; Nguyen, H; Forwood, MR; Tatarczuch, L; Mackie, EJ; Martin, TJ; Sims, NA				Tonna, Stephen; Takyar, Farzin M.; Vrahnas, Christina; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Poulton, Ingrid J.; Brennan, Holly J.; McGregor, Narelle E.; Allan, Elizabeth H.; Nguyen, Huynh; Forwood, Mark R.; Tatarczuch, Liliana; Mackie, Eleanor J.; Martin, T. John; Sims, Natalie A. z			EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis	FASEB JOURNAL			English	Article						osteocyte; osteoclast; bone matrix; bone strength	PARATHYROID-HORMONE; COLLAGEN SECRETION; KAPOSI-SARCOMA; EPH RECEPTORS; TUMOR-GROWTH; IN-VIVO; INHIBITION; GENE; MICE; DIFFERENTIATION	Cells that form bone (osteoblasts) express both ephrinB2 and EphB4, and previous work has shown that pharmacological inhibition of the ephrinB2/EphB4 interaction impairs osteoblast differentiation in vitro and in vivo. The purpose of this study was to determine the role of ephrinB2 signaling in the osteoblast lineage in the process of bone formation. Cultured osteoblasts from mice with osteoblast-specific ablation of ephrinB2 showed delayed expression of osteoblast differentiation markers, a finding that was reproduced by ephrinB2, but not EphB4, RNA interference. Microcomputed tomography, histomorphometry, and mechanical testing of the mice lacking ephrinB2 in osteoblasts revealed a 2-fold delay in bone mineralization, a significant reduction in bone stiffness, and a 50% reduction in osteoblast differentiation induced by anabolic parathyroid hormone (PTH) treatment, compared to littermate sex- and age-matched controls. mRNA levels of late osteoblast differentiation markers and greater levels of osteoblast and osteocyte apoptosis, indicated by TUNEL staining and transmission electron microscopy of bone samples, and a 2-fold increase in annexin V staining and 7-fold increase in caspase 8 activation in cultured ephrinB2 deficient osteoblasts. We conclude that osteoblast differentiation and bone strength are maintained by antiapoptotic actions of ephrinB2 signaling within the osteoblast lineage.-Tonna, S., Takyar, F. M., Vrahnas, C., Crimeen-Irwin, B., Ho, P. W. M., Poulton, I. J., Brennan, H. J., McGregor, N. E., Allan, E. H., Nguyen, H., Forwood, M. R., Tatarczuch, L., Mackie, E. J., Martin, T. J., Sims, N. A. EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis.	[Tonna, Stephen; Takyar, Farzin M.; Vrahnas, Christina; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Poulton, Ingrid J.; Brennan, Holly J.; McGregor, Narelle E.; Allan, Elizabeth H.; Martin, T. John; Sims, Natalie A. z] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Tonna, Stephen; Takyar, Farzin M.; Vrahnas, Christina; Martin, T. John; Sims, Natalie A. z] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Tatarczuch, Liliana; Mackie, Eleanor J.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Nguyen, Huynh; Forwood, Mark R.] Griffith Univ, Sch Med Sci, Griffith Hlth Inst, Gold Coast, Qld, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; Griffith University; Menzies Health Institute Queensland	Sims, NA (corresponding author), St Vincents Inst Med Res, Bone Cell Biol & Dis Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	nsims@svi.edu.au	Mackie, Eleanor J/B-2045-2008; Sims, Natalie Ann/A-7192-2012; Forwood, Mark/ABA-9040-2021	Mackie, Eleanor J/0000-0002-8057-5407; Sims, Natalie Ann/0000-0003-1421-8468; Tatarczuch, Liliana/0000-0001-9556-0753; Forwood, Mark/0000-0002-9963-1616	National Health and Medical Research Council (NHMRC; Australia) [620600, 1042129]; NHMRC; University of Melbourne at Melbourne Research Scholarship; Melbourne International Fee Remission Scholarship; St. Vincent's Institute Foundation; Victorian State Government Operational Infrastructure Program	National Health and Medical Research Council (NHMRC; Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne at Melbourne Research Scholarship; Melbourne International Fee Remission Scholarship; St. Vincent's Institute Foundation; Victorian State Government Operational Infrastructure Program	The authors thank Joshua Johnson for technical assistance, St. Vincent's BioResources Centre staff for animal care, and Carl Walkley and Brian Liddicoat for helpful advice and assistance with the preparation of lenti-Cre reagents. This work was supported by National Health and Medical Research Council (NHMRC; Australia) project grants 620600 and 1042129; N.A.S. is supported by an NHMRC Senior Research Fellowship. S.T. is supported by an NHMRC Peter Doherty Postdoctoral Fellowship. F.T. was supported by a University of Melbourne at Melbourne Research Scholarship, a Melbourne International Fee Remission Scholarship, and a St. Vincent's Institute Foundation Scholarship. St. Vincent's Institute receives support from the Victorian State Government Operational Infrastructure Program. N.A.S. and T.J.M. jointly conceived the study; S.T., F.M.T., C.V., B.C.-I., P.W.M.H., N.E.M., E.H.A., I.J.P., and H.J.B. performed experiments and carried out analyses; H.N. and M.J.F. carried out 3-point bending tests with C.V. and provided interpretation; L.T. and E.J.M. carried out TEM analysis and provided interpretation; N.A.S., T.J.M., and S.T. wrote the manuscript; all authors discussed the results and commented on the manuscript at all stages. The authors declare no conflicts of interest.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arthur A, 2013, J BONE MINER RES, V28, P926, DOI 10.1002/jbmr.1821; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Cerri PS, 2005, ANAT REC PART A, V286A, P833, DOI 10.1002/ar.a.20220; Davydova N, 2012, PROTEIN EXPRES PURIF, V82, P232, DOI 10.1016/j.pep.2012.01.001; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frost HM, 1964, BONE BIODYNAMICS, V1st, P315; Gerety SS, 2002, DEVELOPMENT, V129, P1397; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOUSSAMI S, 1994, ENDOCRINOLOGY, V135, P183, DOI 10.1210/en.135.1.183; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Lindsay R, 2007, J BONE MINER RES, V22, P495, DOI 10.1359/JBMR.070104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Masood R, 2005, BLOOD, V105, P1310, DOI 10.1182/blood-2004-03-0933; MELSEN F, 1980, ACTA PATH MICRO IM A, V88, P83; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Parfitt AM, 1996, ANN INTERN MED, V125, P413, DOI 10.7326/0003-4819-125-5-199609010-00009; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Quinn JMW, 2008, J IMMUNOL, V181, P5720, DOI 10.4049/jimmunol.181.8.5720; Roche B, 2012, BONE, V50, P390, DOI 10.1016/j.bone.2011.09.051; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Sarathchandra P, 2000, J PATHOL, V192, P385; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Takyar FM, 2013, J BONE MINER RES, V28, P912, DOI 10.1002/jbmr.1820; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Walker EC, 2012, J BONE MINER RES, V27, P902, DOI 10.1002/jbmr.1506; Weiler S, 2009, DEV GROWTH DIFFER, V51, P809, DOI 10.1111/j.1440-169X.2009.01140.x; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	57	53	57	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4482	4496		10.1096/fj.14-254300	http://dx.doi.org/10.1096/fj.14-254300			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24982128				2022-12-25	WOS:000342222700025
J	Rizvi, S; Mertens, JC; Bronk, SF; Hirsova, P; Dai, HM; Roberts, LR; Kaufmann, SH; Gores, GJ				Rizvi, Sumera; Mertens, Joachim C.; Bronk, Steven F.; Hirsova, Petra; Dai, Haiming; Roberts, Lewis R.; Kaufmann, Scott H.; Gores, Gregory J.			Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR-ACTIVITY; CELL; DEATH; BAX; INHIBITION; EXPRESSION; EVOLUTION; PATHWAY; POTENT; PUMA	Desmoplastic malignancies such as cholangiocarcinoma (CCA) are characterized by a dense stroma containing an abundance of myofibroblasts termed cancer-associated fibroblasts (CAF). The CAF phenotype represents an "activated state" in which cells are primed for cell death triggered by BH3 mimetics. Accordingly, this primed state may be therapeutically exploited. To elucidate the mechanisms underlying this poorly understood apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for cell death given its prominent role in CAF activation. PDGF isomers PDGF-B and PDGF-D are abundantly expressed in CCA cells derived from human specimens. Either isomer sensitizes myofibroblasts to cell death triggered by BH3 mimetics. Similar apoptotic sensitization was observed with co-culture of myofibroblasts and CCA cells. Profiling of Bcl-2 proteins expressed by PDGF-primed myofibroblasts demonstrated an increase in cellular levels of Puma. PDGF-mediated increases in cellular Puma levels induced proapoptotic changes in Bak, which resulted in its binding to Bcl-2. Short hairpin RNA-mediated down-regulation of Puma conferred resistance to PDGF-mediated apoptotic priming. Conversely, the BH3 mimetic navitoclax disrupted Bcl-2/Bak heterodimers, allowing Bak to execute the cell death program. Treatment with a Bcl-2-specific BH3 mimetic, ABT-199, reduced tumor formation and tumor burden in a murine model of cholangiocarcinoma. Collectively, these findings indicate that apoptotic priming of CAF by PDGF occurs via Puma-mediated Bak activation, which can be converted to active full-blown apoptosis by navitoclax or ABT-199 for therapeutic benefit.	[Rizvi, Sumera; Bronk, Steven F.; Hirsova, Petra; Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Mertens, Joachim C.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Dai, Haiming; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; University of Zurich; University Zurich Hospital; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Hirsova, Petra/B-8943-2018	Hirsova, Petra/0000-0003-0494-0924; Dai, Haiming/0000-0002-0484-7407; Roberts, Lewis/0000-0001-7885-8574; Mertens, Joachim C./0000-0003-2007-0308; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [DK59427, T32DK007198, RO1 CA165076, RO1 CA166704, DK84567]; Mayo Foundation; American Liver Foundation; International Liver Cancer Association; Swiss National Science Foundation (Schweizerischer Nationalfond SNF) [PBSKP3_130612/1]; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA165076, R01CA166741] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007198, R01DK059427, P30DK084567, R56DK059427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Liver Foundation; International Liver Cancer Association; Swiss National Science Foundation (Schweizerischer Nationalfond SNF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59427 (to G. J. G.), T32DK007198 (to S. R.), RO1 CA165076 (to L. R. R.), RO1 CA166704 (to S. H. K.), and DK84567 (to Optical Microscopy Core for the Mayo Center for Cell Signaling in Gastroenterology). This work was also supported by the Mayo Foundation.; Supported by the American Liver Foundation and International Liver Cancer Association.; A scholar of the Swiss National Science Foundation (Schweizerischer Nationalfond SNF; Grant PBSKP3_130612/1) and the Bangerter-Rhyner Foundation.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Cadamuro M, 2013, HEPATOLOGY, V58, P1042, DOI 10.1002/hep.26384; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Cheng JW, 2013, J CELL BIOCHEM, V114, P1510, DOI 10.1002/jcb.24492; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2014, J BIOL CHEM, V289, P89, DOI 10.1074/jbc.M113.505701; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Di Martino MT, 2013, ONCOTARGET, V4, P242, DOI 10.18632/oncotarget.820; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00331; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hwang RF, 2012, MOL CANCER RES, V10, P1147, DOI 10.1158/1541-7786.MCR-12-0022; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KIM HRC, 1995, P NATL ACAD SCI USA, V92, P9500, DOI 10.1073/pnas.92.21.9500; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mertens JC, 2013, CANCER RES, V73, P897, DOI 10.1158/0008-5472.CAN-12-2130; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Okabe H, 2009, ANN SURG ONCOL, V16, P2555, DOI 10.1245/s10434-009-0568-4; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Sandow JJ, 2012, CELL DEATH DIFFER, V19, P633, DOI 10.1038/cdd.2011.131; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; YANO H, 1992, CANCER, V69, P1664, DOI 10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P	50	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22835	22849		10.1074/jbc.M114.563064	http://dx.doi.org/10.1074/jbc.M114.563064			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973208	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-25	WOS:000341017200026
J	Morris, MC; Gilliam, EA; Button, J; Li, LW				Morris, Matthew C.; Gilliam, Elizabeth A.; Button, Julia; Li, Liwu			Dynamic Modulation of Innate Immune Response by Varying Dosages of Lipopolysaccharide (LPS) in Human Monocytic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; CYTOKINE PRODUCTION; PROTEIN-KINASE; INDUCED IL-6; INHIBITION; INFLAMMATION; MACROPHAGES; ACTIVATION	Innate monocytes and macrophages can be dynamically programmed into distinct states depending upon the strength of external stimuli. Innate programming may bear significant relevance to the pathogenesis and resolution of human inflammatory diseases. However, systems analyses with regard to the dynamic programming of innate leukocytes are lacking. In this study, we focused on the dynamic responses of human promonocytic THP-1 cells to lipopolysaccharide (LPS). We observed that varying dosages of LPS differentially modulate the expression of selected pro-and anti-inflammatory mediators such as IL-6 and IL-33. Super-low dosages of LPS preferentially induced the pro-inflammatory mediator IL-6, while higher dosages of LPS induced both IL-6 and IL-33. Mechanistically, we demonstrated that super-low and high doses of LPS cause differential activation of GSK3 and Akt, as well as the transcription factors FoxO1 and CREB. Inhibition of GSK3 enabled THP-1 cells to express IL-33 when challenged with super-low dose LPS. On the other hand, activation of CREB with adenosine suppressed IL-6 expression. Taken together, our study reveals a dynamic modulation of monocytic cells in response to varying dosages of endotoxin, and may shed light on our understanding of the dynamic balance that controls pathogenesis and resolution of inflammatory diseases.	[Morris, Matthew C.; Button, Julia; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Gilliam, Elizabeth A.; Li, Liwu] Virginia Tech, Carill Sch Med, Roanoke, VA 24016 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, 970 Washington St SW, Blacksburg, VA 24061 USA.	lwli@vt.edu		Li, Liwu/0000-0001-8870-5299; Morris, Matthew/0000-0002-1236-1255	National Institutes of Health [R01 HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL115835 (to L. L.).	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Babcock AS, 2013, TOXICOL APPL PHARM, V266, P157, DOI 10.1016/j.taap.2012.10.011; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Erridge C, 2009, J INNATE IMMUN, V1, P340, DOI 10.1159/000191413; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Huet O, 2014, CLIN SCI, V126, P31, DOI 10.1042/CS20120668; Jang S, 2010, BRAIN RES, V1313, P25, DOI 10.1016/j.brainres.2009.12.012; Kim DH, 2014, ARCH PHARM RES, V37, P813, DOI 10.1007/s12272-013-0223-2; Lee J.S., 2011, P NATL ACAD SCI US, V108; Li JQ, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/657182; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Livingston M, 2004, INFLAMM RES, V53, P171, DOI 10.1007/s00011-004-1248-2; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Motegi A, 2006, J LEUKOCYTE BIOL, V79, P463, DOI 10.1189/jlb.0705396; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Park S. H., 2011, NAT IMMUNOL; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rastogi R, 2013, J BIOL CHEM, V288, P33966, DOI 10.1074/jbc.M113.492702; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Sivapalaratnam S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-64; Slofstra SH, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-13; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Wu SS, 2006, CELL SIGNAL, V18, P1932, DOI 10.1016/j.cellsig.2006.02.013; Yamaguchi Y, 2011, EUR J PAIN, V15, P724, DOI 10.1016/j.ejpain.2011.01.001	54	46	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21584	21590		10.1074/jbc.M114.583518	http://dx.doi.org/10.1074/jbc.M114.583518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24970893	Green Published, hybrid			2022-12-25	WOS:000340558300033
J	Goller, CC; Arshad, M; Noah, JW; Ananthan, S; Evans, CW; Nebane, NM; Rasmussen, L; Sosa, M; Tower, NA; White, EL; Neuenswander, B; Porubsky, P; Maki, BE; Rogers, SA; Schoenen, F; Seed, PC				Goller, Carlos C.; Arshad, Mehreen; Noah, James W.; Ananthan, Subramaniam; Evans, Carrie W.; Nebane, N. Miranda; Rasmussen, Lynn; Sosa, Melinda; Tower, Nichole A.; White, E. Lucile; Neuenswander, Benjamin; Porubsky, Patrick; Maki, Brooks E.; Rogers, Steven A.; Schoenen, Frank; Seed, Patrick C.			Lifting the Mask: Identification of New Small Molecule Inhibitors of Uropathogenic Escherichia coli Group 2 Capsule Biogenesis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ACUTE UNCOMPLICATED CYSTITIS; ANTIBIOTIC-RESISTANCE; GENE-CLUSTER; POLYSACCHARIDE; K5; EPIDEMIOLOGY; LIBRARIES; VIRULENCE; WOMEN	Uropathogenic Escherichia coli (UPEC) is the leading cause of community-acquired urinary tract infections (UTIs), with over 100 million UTIs occurring annually throughout the world. Increasing antimicrobial resistance among UPEC limits ambulatory care options, delays effective treatment, and may increase overall morbidity and mortality from complications such as urosepsis. The polysaccharide capsules of UPEC are an attractive target a therapeutic, based on their importance in defense against the host immune responses; however, the large number of antigenic types has limited their incorporation into vaccine development. The objective of this study was to identify small-molecule inhibitors of UPEC capsule biogenesis. A large-scale screening effort entailing 338,740 compounds was conducted in a cell-based, phenotypic screen for inhibition of capsule biogenesis in UPEC. The primary and concentration-response assays yielded 29 putative inhibitors of capsule biogenesis, of which 6 were selected for further studies. Secondary confirmatory assays identified two highly active agents, named DU003 and DU011, with 50% inhibitory concentrations of 1.0 mu M and 0.69 mu M, respectively. Confirmatory assays for capsular antigen and biochemical measurement of capsular sugars verified the inhibitory action of both compounds and demonstrated minimal toxicity and off-target effects. Serum sensitivity assays demonstrated that both compounds produced significant bacterial death upon exposure to active human serum. DU011 administration in mice provided near complete protection against a lethal systemic infection with the prototypic UPEC K1 isolate UTI89. This work has provided a conceptually new class of molecules to combat UPEC infection, and future studies will establish the molecular basis for their action along with efficacy in UTI and other UPEC infections.	[Goller, Carlos C.; Arshad, Mehreen; Seed, Patrick C.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Noah, James W.; Ananthan, Subramaniam; Evans, Carrie W.; Nebane, N. Miranda; Rasmussen, Lynn; Sosa, Melinda; Tower, Nichole A.; White, E. Lucile] So Res Inst, Southern Res Specialized Biocontainment Screening, Birmingham, AL 35255 USA; [Neuenswander, Benjamin; Porubsky, Patrick; Maki, Brooks E.; Rogers, Steven A.; Schoenen, Frank] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66045 USA; [Seed, Patrick C.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Ctr Microbial Pathogenesis, Sch Med, Durham, NC 27706 USA	Duke University; University of Kansas; Duke University; Duke University	Seed, PC (corresponding author), Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA.	patrick.seed@duke.edu	Goller, Carlos C./AAJ-9924-2021	Schoenen, Frank/0000-0003-2711-1117; Arshad, Mehreen/0000-0002-7517-9274; Goller, Carlos/0000-0002-2013-0334	NIH [R03MH090791]; NIH Molecular Libraries Probe Production Centers Network [5U54HG005031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH090791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Libraries Probe Production Centers Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant R03MH090791 (PI, Seed) and the NIH Molecular Libraries Probe Production Centers Network grant 5U54HG005031 (PI, Jeffrey Aube). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; [Anonymous], 2014, MOL LIB PROGRAM PATH; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Edlin RS, 2013, J UROLOGY, V190, P222, DOI 10.1016/j.juro.2013.01.069; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Fritsch E.F., 1989, MOL CLONING LAB MANU; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Goller CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011642; GUPTA DS, 1982, FEMS MICROBIOL LETT, V14, P75, DOI 10.1111/j.1574-6968.1982.tb08638.x; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hang L, 1998, J UROLOGY, V159, P2185, DOI 10.1016/S0022-5347(01)63303-2; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; King T, 2012, BJU INT, V110, P300, DOI 10.1111/j.1464-410X.2012.11142.x; Li K, 2008, MOL IMMUNOL, V45, P954, DOI 10.1016/j.molimm.2007.07.037; Litwin MS, 2007, UROLOGIC DIS AM, P3; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Ma JF, 2004, UROL CLIN N AM, V31, P517, DOI 10.1016/j.ucl.2004.04.016; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mushtaq N, 2005, J ANTIMICROB CHEMOTH, V56, P160, DOI 10.1093/jac/dki177; NKUDIC, 2005, UR TRACT INF AD; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Noah JW, 2013, 3 2 6 DIFLUOROBENZAM; Noah JW, 2013, N PYRIDIN 4 YL BENZO; Olson RP, 2009, ANTIMICROB AGENTS CH, V53, P1285, DOI 10.1128/AAC.01188-08; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; Roberts JA, 1997, J UROLOGY, V158, P1610, DOI 10.1016/S0022-5347(01)64290-3; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Schappert S, 2011, VITAL HLTH STAT SERI, V13; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Scholl D, 2005, J BACTERIOL, V187, P8499, DOI 10.1128/JB.187.24.8499-8503.2005; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; SERWER P, 1974, VIROLOGY, V59, P70, DOI 10.1016/0042-6822(74)90207-4; Singh N, 2009, J CHEM INF MODEL, V49, P1010, DOI 10.1021/ci800426u; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; SVANBORG C, 1993, ZBL BAKT-INT J MED M, V278, P359, DOI 10.1016/S0934-8840(11)80852-2; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; YAMADA K, 1963, NATURE, V198, P799, DOI 10.1038/198799a0; Yang QW, 2013, J MED MICROBIOL, V62, P1343, DOI 10.1099/jmm.0.059816-0	56	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96054	10.1371/journal.pone.0096054	http://dx.doi.org/10.1371/journal.pone.0096054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983234	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000003
J	Obermeier, A; Schneider, J; Wehner, S; Matl, FD; Schieker, M; von Eisenhart-Rothe, R; Stemberger, A; Burgkart, R				Obermeier, Andreas; Schneider, Jochen; Wehner, Steffen; Matl, Florian Dominik; Schieker, Matthias; von Eisenhart-Rothe, Ruediger; Stemberger, Axel; Burgkart, Rainer			Novel High Efficient Coatings for Anti-Microbial Surgical Sutures Using Chlorhexidine in Fatty Acid Slow-Release Carrier Systems	PLOS ONE			English	Article							SITE INFECTION; COATED SUTURES; ANTIINFECTIVE COATINGS; BACTERIAL ADHERENCE; RANDOMIZED-TRIAL; POVIDONE-IODINE; IN-VITRO; TRICLOSAN; PREVENTION; EFFICACY	Sutures can cause challenging surgical site infections, due to capillary effects resulting in bacteria permeating wounds. Antimicrobial sutures may avoid these complications by inhibiting bacterial pathogens. Recently, first triclosan-resistances were reported and therefore alternative substances are becoming clinically relevant. As triclosan alternative chlorhexidine, the "gold standard'' in oral antiseptics was used. The aim of the study was to optimize novel slow release chlorhexidine coatings based on fatty acids in surgical sutures, to reach a high anti-microbial efficacy and simultaneously high biocompatibility. Sutures were coated with chlorhexidine laurate and chlorhexidine palmitate solutions leading to 11, 22 or 33 mu g/cm drug concentration per length. Drug release profiles were determined in aqueous elutions. Antibacterial efficacy against Staphylococcus aureus was assessed in agar diffusion tests. Biocompatibility was evaluated via established cytotoxicity assay (WST-1). A commercially triclosan-containing suture (Vicryl Plus), was used as anti-microbial reference. All coated sutures fulfilled European Pharmacopoeia required tensile strength and proved continuous slow drug release over 96 hours without complete wash out of the coated drug. High anti-microbial efficacy for up to 5 days was observed. Regarding biocompatibility, sutures using 11 mg/cm drug content displayed acceptable cytotoxic levels according to ISO 10993-5. The highest potential for human application were shown by the 11 mg/cm chlorhexidine coated sutures with palmitic acid. These novel coated sutures might be alternatives to already established anti-microbial sutures such as Vicryl Plus in case of triclosan-resistance. Chlorhexidine is already an established oral antiseptic, safety and efficacy should be proven for clinical applications in anti-microbial sutures.	[Obermeier, Andreas; Wehner, Steffen; Matl, Florian Dominik; von Eisenhart-Rothe, Ruediger; Stemberger, Axel; Burgkart, Rainer] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-80290 Munich, Bavaria, Germany; [Schneider, Jochen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mikrobiol Immunol & Hyg, D-80290 Munich, Bavaria, Germany; [Schieker, Matthias] Klinikum Univ Munchen, Chirurg Klin, Munich, Bavaria, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Obermeier, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-80290 Munich, Bavaria, Germany.	aobermeier@tum.de	von Eisenhart-Rothe, Ruediger/E-4839-2017; Schieker, Matthias/J-6511-2015; Schieker, Matthias/AGZ-2030-2022; Obermeier, Andreas/B-3020-2016	Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Obermeier, Andreas/0000-0002-1774-5194; Schneider, Jochen/0000-0002-0300-0159	Heraeus Medical GmbH, Wehrheim, Germany; Klinikum rechts der Isar, Technische Universitat Munchen [8895117_HeraeusCoating]; German Research Foundation (DFG); Technische Universitat Munchen	Heraeus Medical GmbH, Wehrheim, Germany; Klinikum rechts der Isar, Technische Universitat Munchen; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was financially supported by the Heraeus Medical GmbH, Wehrheim, Germany (http://www.heraeus-medical.com/de/home_15.html). Within the Klinikum rechts der Isar, Technische Universitat Munchen the external funding number was 8895117_HeraeusCoating. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funder's financial support does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funding organization didn't play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support and research materials.	Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Baracs J, 2011, SURG INFECT, V12, P483, DOI 10.1089/sur.2011.001; Barnett Todd E, 2007, AORN J, V86, P249, DOI 10.1016/j.aorn.2007.03.012; Chang WK, 2012, ANN SURG, V255, P854, DOI 10.1097/SLA.0b013e31824e7005; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cooney CM, 2010, ENVIRON HEALTH PERSP, V118, pA242, DOI 10.1289/ehp.118-a242; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026; Ethicon, 2010, IHR ZUS SCHUTZ VOR P; Fujita T, 2010, SURGERY, V147, P464, DOI 10.1016/j.surg.2009.04.019; Geiger Dieter, 2005, Surg Infect (Larchmt), V6, P377, DOI 10.1089/sur.2005.6.377; Hranjec T, 2010, SURG INFECT, V11, P289, DOI 10.1089/sur.2010.021; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; Justinger C, 2011, LANGENBECK ARCH SURG, P1; Justinger C, 2013, SURGERY, V154, P589, DOI 10.1016/j.surg.2013.04.011; Kathju S, 2009, SURG INFECT, V10, P457, DOI 10.1089/sur.2008.062; KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007; Leaper DJ, 2010, BRIT J SURG, V97, P1601, DOI 10.1002/bjs.7275; Leaper D, 2011, INT WOUND J, V8, P556, DOI 10.1111/j.1742-481X.2011.00841.x; Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07; Matl FD, 2009, J BIOMAT SCI-POLYM E, V20, P1439, DOI 10.1163/092050609X12457418973107; Menderes G, 2012, OBSTET GYNECOL, V120, P1037, DOI [10.1097/AOG.0b013e31826f3bd9, http://10.1097/AOG.0b013e31826f3bd9]; Ming XT, 2008, SURG INFECT, V9, P451, DOI 10.1089/sur.2007.061; Mingmalairak, 2011, SCI MICROBIAL PATHOG, V313, P23; Mingmalairak Chatchai, 2009, Journal of the Medical Association of Thailand, V92, P770; Obermeier A, 2012, J MATER SCI-MATER M, V23, P1675, DOI 10.1007/s10856-012-4631-5; Rupp ME, 2005, ANN INTERN MED, V143, P570, DOI 10.7326/0003-4819-143-8-200510180-00007; Sanders D, 2013, HERNIA, V17, P779, DOI 10.1007/s10029-013-1124-5; Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Stone J, 2010, PEDIATR NEUROSURG, V46, P19, DOI 10.1159/000314053; Suwanpimolkul G, 2008, J INFECTION, V56, P354, DOI 10.1016/j.jinf.2008.03.001; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Wang ZX, 2013, BRIT J SURG, V100, P465, DOI 10.1002/bjs.9062; Williams N, 2011, SURG INFECT, V12, P469, DOI 10.1089/sur.2011.045; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Young B, 2011, ANTIMICROB AGENTS CH, V55, P4659, DOI 10.1128/AAC.00562-11	38	54	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101426	10.1371/journal.pone.0101426	http://dx.doi.org/10.1371/journal.pone.0101426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983633	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000106
J	Trairatphisan, P; Mizera, A; Pang, J; Tantar, AA; Sauter, T				Trairatphisan, Panuwat; Mizera, Andrzej; Pang, Jun; Tantar, Alexandru Adrian; Sauter, Thomas			optPBN: An Optimisation Toolbox for Probabilistic Boolean Networks	PLOS ONE			English	Article							MODELS	Background: There exist several computational tools which allow for the optimisation and inference of biological networks using a Boolean formalism. Nevertheless, the results from such tools yield only limited quantitative insights into the complexity of biological systems because of the inherited qualitative nature of Boolean networks. Results: We introduce optPBN, a Matlab-based toolbox for the optimisation of probabilistic Boolean networks (PBN) which operates under the framework of the BN/PBN toolbox. optPBN offers an easy generation of probabilistic Boolean networks from rule-based Boolean model specification and it allows for flexible measurement data integration from multiple experiments. Subsequently, optPBN generates integrated optimisation problems which can be solved by various optimisers. In term of functionalities, optPBN allows for the construction of a probabilistic Boolean network from a given set of potential constitutive Boolean networks by optimising the selection probabilities for these networks so that the resulting PBN fits experimental data. Furthermore, the optPBN pipeline can also be operated on large-scale computational platforms to solve complex optimisation problems. Apart from exemplary case studies which we correctly inferred the original network, we also successfully applied optPBN to study a large-scale Boolean model of apoptosis where it allows identifying the inverse correlation between UVB irradiation, NFkB and Caspase 3 activations, and apoptosis in primary hepatocytes quantitatively. Also, the results from optPBN help elucidating the relevancy of crosstalk interactions in the apoptotic network. Summary: The optPBN toolbox provides a simple yet comprehensive pipeline for integrated optimisation problem generation in the PBN formalism that can readily be solved by various optimisers on local or grid-based computational platforms. optPBN can be further applied to various biological studies such as the inference of gene regulatory networks or the identification of the interaction's relevancy in signal transduction networks.	[Trairatphisan, Panuwat; Sauter, Thomas] Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg; [Mizera, Andrzej; Pang, Jun] Univ Luxembourg, Comp Sci & Commun Res Unit, Luxembourg, Luxembourg; [Pang, Jun; Tantar, Alexandru Adrian] Univ Luxembourg, Interdisciplinary Ctr Secur Reliabil & Trust, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg; University of Luxembourg	Sauter, T (corresponding author), Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg.	thomas.sauter@uni.lu		Pang, Jun/0000-0002-4521-4112; Trairatphisan, Panuwat/0000-0001-9015-5855; Sauter, Thomas/0000-0001-8225-2954	Fonds National de la Recherche (FNR) Luxembourg [1233900]	Fonds National de la Recherche (FNR) Luxembourg(Luxembourg National Research Fund)	We acknowledge with thanks financial support from the Fonds National de la Recherche (FNR) Luxembourg (grant 1233900), http://www.fnr.lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender C, 2012, BIOINFORMATICS, V26, pi596; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Cahon S, 2004, J HEURISTICS, V10, P357, DOI 10.1023/B:HEUR.0000026900.92269.ec; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Fertig Elana J., 2011, Frontiers in Genetics, V2, P77, DOI 10.3389/fgene.2011.00077; Flottmann M, 2012, FRONT PHYSIOL, V3, P1; HASHIMOTO R. F., 2009, P IEEE INT WORKSHOP, P1, DOI DOI 10.1109/GENSIPS.2009.5174356; Holland JH, 1992, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Kaderali L, 2009, BIOINFORMATICS, V25, P2229, DOI 10.1093/bioinformatics/btp375; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma Z, 2008, IEEE J-STSP, V2, P975, DOI 10.1109/JSTSP.2008.2007816; MIRANDA EN, 1989, EUROPHYS LETT, V10, P293, DOI 10.1209/0295-5075/10/4/002; Pal R, 2005, BIOINFORMATICS, V21, P1211, DOI 10.1093/bioinformatics/bti131; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Shmulevich I., 2010, PROB BOOL NETW; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tay Joc C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5315; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Vaz AIF, 2007, J GLOBAL OPTIM, V39, P197, DOI 10.1007/s10898-007-9133-5; Yu L, 2006, IEEE INT WORK GENOM, P45, DOI 10.1109/GENSIPS.2006.353148	31	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98001	10.1371/journal.pone.0098001	http://dx.doi.org/10.1371/journal.pone.0098001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983623	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000006
J	David, MS; Kelly, E; Cheung, I; Xaymardan, M; Moore, MAS; Zoellner, H				David, Manu S.; Kelly, Elizabeth; Cheung, Ivan; Xaymardan, Munira; Moore, Malcolm A. S.; Zoellner, Hans			SAOS-2 Osteosarcoma Cells Bind Fibroblasts via ICAM-1 and This Is Increased by Tumour Necrosis Factor-alpha	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ENDOTHELIAL-CELLS; ADHESION MOLECULE-1; MEDIATED APOPTOSIS; CARCINOMA CELLS; POLYMYXIN-B; TNF-ALPHA; CYTOKINES; CANCER; METASTASIS	We recently reported exchange of membrane and cytoplasmic markers between SAOS-2 osteosarcoma cells and human gingival fibroblasts (h-GF) without comparable exchange of nuclear markers, while similar h-GF exchange was seen for melanoma and ovarian carcinoma cells. This process of "cellular sipping'' changes phenotype such that cells sharing markers of both SAOS-2 and h-GF have morphology intermediate to that of either cell population cultured alone, evidencing increased tumour cell diversity without genetic change. TNF-alpha increases cellular sipping between h-GF and SAOS-2, and we here study binding of SAOS-2 to TNF-alpha treated h-GF to determine if increased cellular sipping can be accounted for by cytokine stimulated SAOS-2 binding. More SAOS-2 bound h-GF pe-seeded wells than culture plastic alone (p<0.001), and this was increased by h-GF pre-treatment with TNF-alpha (p<0.001). TNF-alpha stimulated binding was dose dependent and maximal at 1.16nM (p<0.05) with no activity below 0.006 nM. SAOS-2 binding to h-GF was independent of serum, while the lipopolysaccharide antagonist Polymyxin B did not affect results, and TNF-alpha activity was lost on boiling. h-GF binding of SAOS-2 started to increase after 30min TNF-alpha stimulation and was maximal by 1.5hr pre-treatment (p<0.001). h-GF retained maximal binding up to 6hrs after TNF-alpha stimulation, but this was lost by 18hrs (p<0.001). FACS analysis demonstrated increased ICAM-1 consistent with the time course of SAOS-2 binding, while antibody against ICAM-1 inhibited SAOS-2 adhesion (p<0.04). Pre-treating SAOS-2 with TNF-alpha reduced h-GF binding to background levels (p<0.003), and this opposite effect to h-GF cytokine stimulation suggests that the history of cytokine exposure of malignant cells migrating across different microenvironments can influence subsequent interactions with fibroblasts. Since cytokine stimulated binding was comparable in magnitude to earlier reported TNF-alpha stimulated cellular sipping, we conclude that TNF-alpha stimulated cellular sipping likely reflects increased SAOS-2 binding as opposed to enhanced exchange mechanisms.	[David, Manu S.; Kelly, Elizabeth; Cheung, Ivan; Xaymardan, Munira; Zoellner, Hans] Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent,Westmead, Westmead, NSW 2145, Australia; [Moore, Malcolm A. S.; Zoellner, Hans] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Sydney; Memorial Sloan Kettering Cancer Center	Zoellner, H (corresponding author), Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent,Westmead, Westmead, NSW 2145, Australia.	hans.zoellner@sydney.edu.au	Zoellner, Hans/GWQ-7168-2022	Zoellner, Hans/0000-0003-4804-2464; Xaymardan, Munira/0000-0003-0078-0863	Australian Dental Research Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Australian Dental Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Australian Dental Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bendall LJ, 1997, EXP HEMATOL, V25, P132; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; CAVAILLON JM, 1986, MOL IMMUNOL, V23, P965, DOI 10.1016/0161-5890(86)90127-6; David MS, 2013, CYTOKINE, V62, P48, DOI 10.1016/j.cyto.2013.02.028; David MS, 2012, J PATHOL, V228, P495, DOI 10.1002/path.4063; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Hayashi S, 2007, ARTHRITIS RHEUM, V56, P1067, DOI 10.1002/art.22494; Hess S, 1998, EUR J IMMUNOL, V28, P3594, DOI 10.1002/(SICI)1521-4141(199811)28:11<3594::AID-IMMU3594>3.3.CO;2-4; HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V144, P494, DOI 10.1111/j.1365-2249.2006.03064.x; Kim Se Jong, 1993, Journal of Korean Medical Science, V8, P41; Klein CL, 1995, PATHOBIOLOGY, V63, P204, DOI 10.1159/000163953; Kumar V, 2005, ROBBINS COTRAN PATHO, Vxv; LAURI D, 1991, JNCI-J NATL CANCER I, V83, P1321, DOI 10.1093/jnci/83.18.1321; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; MARLOR CW, 1992, AM J PATHOL, V140, P1055; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McEwen A, 2003, J PATHOL, V201, P395, DOI 10.1002/path.1457; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; MORRISON DC, 1976, INFECT IMMUN, V13, P298, DOI 10.1128/IAI.13.1.298-301.1976; Okamoto K, 2002, APOPTOSIS, V7, P77, DOI 10.1023/A:1013569029907; RICE GE, 1988, AM J PATHOL, V133, P204; Steinbach F, 1996, J UROLOGY, V155, P743, DOI 10.1016/S0022-5347(01)66513-3; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; TSUTSUI T, 1973, JPN J MED SCI BIOL, V26, P169, DOI 10.7883/yoken1952.26.169; van Grevenstein WMU, 2007, DIGEST DIS SCI, V52, P2775, DOI 10.1007/s10620-007-9778-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; ZOELLNER H, 1992, BLOOD, V80, P2805; ZOELLNER H, 1993, LYMPHOKINE CYTOK RES, V12, P93; ZOELLNER HFA, 1989, J HISTOCHEM CYTOCHEM, V37, P1893, DOI 10.1177/37.12.2584695	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101202	10.1371/journal.pone.0101202	http://dx.doi.org/10.1371/journal.pone.0101202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979620	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400098
J	Liu, JL; Ke, F; Xu, ZY; Liu, ZY; Zhang, LY; Yan, S; Wang, Z; Wang, H; Wang, HL				Liu, Jinlin; Ke, Fang; Xu, Zhenyao; Liu, Zhaoyuan; Zhang, Lingyun; Yan, Sha; Wang, Zhe; Wang, Hong; Wang, Honglin			CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN-3-ALPHA/CCL20; LYMPH-NODE METASTASIS; MOLECULAR-CLONING; E-CADHERIN; EXPRESSION; CELLS; LIVER; LOCALIZATION; ACTIVATION	The chemokine receptor CCR6 has been recently shown to be associated with colorectal cancer (CRC) progression. However, the direct evidence for whether CCR6 in tumors is a prognostic marker for the survival of patients with CRC and whether it plays a critical role in CRC metastasis in vivo is lacking. Here we show that the levels of CCR6 were upregulated in CRC cell lines and primary CRC clinical samples. CCR6 upregulation was closely correlated with disease stages and the survival time of CRC patients. Knockdown of CCR6 inhibited the migration of CRC cells in vitro. Overexpression of CCR6 in CRC cells increased their proliferation, migration, and colony formation in vitro and promoted their metastatic potential in vivo. CCR6 activated Akt signaling, upregulated metastasis genes and downregulated metastasis suppressor genes. Selective targeting of CCR6 in tumors dramatically inhibited the growth of CRC in mice. Thus, the tumor expression of CCR6 plays a critical role in CRC metastasis, upregulated CCR6 predicts poor survival in CRC patients, and targeting CCR6 expression in tumors may be a potential therapeutic strategy for CRC.	[Liu, Jinlin; Ke, Fang; Xu, Zhenyao; Liu, Zhaoyuan; Zhang, Lingyun; Yan, Sha; Wang, Zhe; Wang, Hong; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	honglin.wang@sjtu.edu.cn	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927	National Natural Science Foundation of China; 973 Program [91029730, 81202304, 2012CB917100, 2010CB529700, 30972787]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [09140902600]; Leading Academic Discipline Project of the Shanghai Municipal Education Commission [J50208, J50207]; Shanghai Pujiang Program [10PJ407300]; Shanghai Committee of Science and Technology [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Leading Academic Discipline Project of the Shanghai Municipal Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work is supported by grants from National Natural Science Foundation of China and 973 Program (No: 91029730, No: 81202304, No: 2012CB917100, No: 2010CB529700 and No: 30972787), by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, by the Science and Technology Commission of Shanghai Municipality (No: 09140902600), by the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (No: J50208 and No: J50207), by Shanghai Pujiang Program (No: 10PJ407300), and by Shanghai Committee of Science and Technology (11DZ2260200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero S, 2003, CANCER RES, V63, P1969; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Luangdilok S, 2007, CANCER RES, V67, P7907, DOI 10.1158/0008-5472.CAN-07-0331; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mashino K, 2002, CANCER RES, V62, P2937; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rescigno M, 2006, IMMUNITY, V24, P508, DOI 10.1016/j.immuni.2006.05.005; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shimamura T, 2003, J CLIN ONCOL, V21, P659, DOI 10.1200/JCO.2003.06.179; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Taichman RS, 2002, CANCER RES, V62, P1832; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456	37	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101137	10.1371/journal.pone.0101137	http://dx.doi.org/10.1371/journal.pone.0101137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979261	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400084
J	de Alencar, MCN; Rocha, MOD; Lima, MMD; Costa, HS; Sousa, GR; Carneiro, RDB; Silva, GCR; Brandao, FV; Kreuser, LJ; Ribeiro, ALP; Nunes, MCP				Noman de Alencar, Maria Clara; da Costa Rocha, Manoel Otavio; de Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Sousa, Giovane Rodrigo; Carneiro, Renata de Carvalho Bicalho; Rodrigues Silva, Guilherme Canabrava; Brandao, Fernando Vieira; Kreuser, Lucas Jordan; Pinho Ribeiro, Antonio Luiz; Pereira Nunes, Maria Carmo			Heart Rate Recovery in Asymptomatic Patients with Chagas Disease	PLOS ONE			English	Article							CHRONOTROPIC RESPONSE; TRYPANOSOMA-CRUZI; EXERCISE; DYSFUNCTION; PREDICTOR; MORTALITY; RECOMMENDATIONS; AUTOANTIBODIES; DYSAUTONOMIA; MODULATION	Background: Chagas disease patients with right bundle-branch block (RBBB) have diverse clinical presentation and prognosis, depending on left ventricular (LV) function. Autonomic disorder can be an early marker of heart involvement. The heart rate recovery (HRR) after exercise may identify autonomic dysfunction, with impact on therapeutic strategies. This study was designed to assess the HRR after symptom-limited exercise testing in asymptomatic Chagas disease patients with RBBB without ventricular dysfunction compared to patients with indeterminate form of Chagas disease and healthy controls. Methods: One hundred and forty-nine subjects divided into 3 groups were included. A control group was comprised of healthy individuals; group 1 included patients in the indeterminate form of Chagas disease; and group 2 included patients with complete RBBB with or without left anterior hemiblock, and normal ventricular systolic function. A symptom-limited exercise test was performed and heart rate (HR) response to exercise was assessed. HRR was defined as the difference between HR at peak exercise and 1 min following test termination. Results: There were no differences in heart-rate profile during exercise between healthy individuals and patients in indeterminate form, whereas patients with RBBB had more prevalence of chronotropic incompetence, lower exercise capacity and lower HRR compared with patients in indeterminate form and controls. A delayed decrease in the HR after exercise was found in 17 patients (15%), 9% in indeterminate form and 24% with RBBB, associated with older age, worse functional capacity, impaired chronotropic response, and ventricular arrhythmias during both exercise and recovery. By multivariable analysis, the independent predictors of a delayed decrease in the HRR were age (odds ratio [OR] 1.11; 95% confidence interval [CI] 1.03 to 1.21; p = 0.010) and presence of RBBB (OR 3.97; 95% CI 1.05 to 15.01; p = 0.042). Conclusions: A small proportion (15%) of asymptomatic Chagas patients had attenuated HRR after exercise, being more prevalent in patients with RBBB compared with patients in indeterminate form and controls.	[Noman de Alencar, Maria Clara; da Costa Rocha, Manoel Otavio; de Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Sousa, Giovane Rodrigo; Carneiro, Renata de Carvalho Bicalho; Pinho Ribeiro, Antonio Luiz; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Rodrigues Silva, Guilherme Canabrava; Brandao, Fernando Vieira] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Kreuser, Lucas Jordan] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Costa, Henrique Silveira/H-8286-2014; Sousa, Giovane R./H-6102-2016; Ribeiro, Antonio L/C-2707-2009; Ribeiro, Ana Cristina/HHN-7466-2022; Nunes, Maria Carmo/AAV-5185-2020	Costa, Henrique Silveira/0000-0002-1426-7246; Sousa, Giovane R./0000-0003-0085-3882; Ribeiro, Antonio L/0000-0002-2740-0042; Ribeiro, Ana Cristina/0000-0002-0493-8376; 				Azarbal B, 2004, J AM COLL CARDIOL, V44, P423, DOI 10.1016/j.jacc.2004.02.060; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Cahalin LP, 2013, EUR J HEART FAIL, V15, P519, DOI 10.1093/eurjhf/hfs216; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Junqueira LF, 2012, REV SOC BRAS MED TRO, V45, P243, DOI 10.1590/S0037-86822012000200020; JUNQUEIRA LF, 1992, CARDIOVASC RES, V26, P324, DOI 10.1093/cvr/26.4.324; Kligfield P, 2006, CIRCULATION, V114, P2070, DOI 10.1161/CIRCULATIONAHA.105.561944; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauer Michael S, 2009, Cleve Clin J Med, V76 Suppl 2, pS18, DOI 10.3949/ccjm.76.s2.04; Lauer MS, 2004, J AM COLL CARDIOL, V44, P431, DOI 10.1016/j.jacc.2004.05.001; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Maddox TM, 2008, AM HEART J, V156, P736, DOI 10.1016/j.ahj.2008.05.025; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Molina RBG, 2006, INT J CARDIOL, V113, P188, DOI 10.1016/j.ijcard.2005.11.010; Myers J, 2007, EUR J CARDIOV PREV R, V14, P215, DOI 10.1097/HJR.0b013e328088cb92; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nunes MCP, 2011, INT J CARDIOL, V147, P294, DOI 10.1016/j.ijcard.2010.12.044; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Nunes MCP, 2012, EXPERT REV CARDIOVAS, V10, P1173, DOI [10.1586/erc.12.111, 10.1586/ERC.12.111]; Pierpont GL, 2000, J AUTONOM NERV SYST, V80, P169, DOI 10.1016/S0165-1838(00)00090-4; Ribeiro ALP, 2007, INT J CARDIOL, V117, P59, DOI 10.1016/j.ijcard.2006.04.053; Ramos RP, 2012, AM HEART J, V163, P580, DOI 10.1016/j.ahj.2012.01.023; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Ribeiro A L, 1998, Rev Soc Bras Med Trop, V31, P301, DOI 10.1590/S0037-86821998000300008; Ribeiro ALP, 2005, INT J CARDIOL, V103, P225, DOI 10.1016/j.ijcard.2004.11.007; Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406; Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rocha ALL, 2006, ANN NONINVAS ELECTRO, V11, P3, DOI 10.1111/j.1542-474X.2006.00054.x; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Surawicz B, 2009, CIRCULATION, V119, pE235, DOI 10.1161/CIRCULATIONAHA.108.191095; Talvani A, 2006, MICROBES INFECT, V8, P2459, DOI 10.1016/j.micinf.2006.06.006; Tang Yi-Da, 2009, J Card Fail, V15, P850, DOI 10.1016/j.cardfail.2009.06.437; Villar JC, 2004, INT J CARDIOL, V93, P189, DOI 10.1016/j.ijcard.2003.03.002; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Zaim S, 2010, ANN NONINVAS ELECTRO, V15, P43, DOI 10.1111/j.1542-474X.2009.00338.x	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100753	10.1371/journal.pone.0100753	http://dx.doi.org/10.1371/journal.pone.0100753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979699	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400039
J	Su, XJ; Yuan, W; Tan, H; Liu, XY; Li, D; Li, DK; Huang, GY; Zhang, LW; Miao, MH				Su, Xiu-Juan; Yuan, Wei; Tan, Hui; Liu, Xiang-Yun; Li, Dan; Li, De-Kun; Huang, Guo-Ying; Zhang, Li-Wen; Miao, Mao-Hua			Correlation between Exposure to Magnetic Fields and Embryonic Development in the First Trimester	PLOS ONE			English	Article							LEGHORN CHICKEN EMBRYOS; ELECTROMAGNETIC-FIELDS; SPONTANEOUS-ABORTION; PERSONAL EXPOSURE; APOPTOSIS; GROWTH; RISK; RATS	Objective: To explore the correlation between maternal magnetic field (MF) exposure in daily life and embryonic development. Methods: A cross-sectional study was conducted among 149 pregnant women who were seeking induced abortion of unwanted pregnancies. Participating women were asked to wear an EMDEX Lite magnetic field meter for a 24-h period to obtain MF exposure level within 4 weeks following the abortion. Embryonic bud and sac lengths were measured through B-mode ultrasound before the surgical abortion. Embryo sections were prepared and examined for histological changes, and the apoptosis status of the deciduas was examined using the TUNEL apoptosis assay. Results: Embryonic bud length was inversely associated with maternal daily MF exposure level; the association was statistically significant at the time-weighted-average and 75th percentile of MF exposure levels, with coefficients of -3.09 (P = 0.0479) and -3.07(P = 0.0228), respectively. Logistic regression for examining the risk of higher MF exposure indicated that women with her 75th percentile of daily MF measurements >= 0.82 mG had a 3.95-fold risk of having a fetus with a shorter embryonic bud length than those whose daily MF exposure were <0.82 mG. MF exposure was associated with a higher degree of apoptosis, but the association was not statistically significant. We failed to find a statistical correlation between MF exposure and embryonic sac length and histological changes in the first trimester. Conclusion: Prenatal MF exposure may have an adverse effect on embryonic development.	[Su, Xiu-Juan] Tongji Univ Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai, Peoples R China; [Yuan, Wei; Liu, Xiang-Yun; Miao, Mao-Hua] Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China; [Tan, Hui] Fudan Univ, Dept Child & Adolescent Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Li, Dan] Maternal & Child Hosp Xuhui Dist, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Li, De-Kun] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA USA; [Huang, Guo-Ying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Li-Wen] Fudan Univ, Peoples Hosp Shanghai 5, Dept Obstet & Gynecol, Sch Med, Shanghai 200433, Peoples R China	Tongji University; Fudan University; Kaiser Permanente; Fudan University; Fudan University	Zhang, LW (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Dept Obstet & Gynecol, Sch Med, Shanghai 200433, Peoples R China.	zhlw902@gmail.com; miaomaohua@163.com			National Basic Research Program of China (973 program) [2010CB529504]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work is supported by the National Basic Research Program of China (973 program), 2010CB529504, (URL: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Akhras MA, 2001, BIOELECTROMAGNETICS, V22, P340, DOI 10.1002/bem.59; Bayat PD, 2011, INDIAN J EXP BIOL, V49, P634; Belanger K, 1998, EPIDEMIOLOGY, V9, P36, DOI 10.1097/00001648-199801000-00009; Bliss Robin, 2012, J Biom Biostat, V3, P142; Cao Xing-wu, 2009, Zhonghua Nan Ke Xue, V15, P530; Cho SI, 2012, BIOELECTROMAGNETICS, V33, P568, DOI 10.1002/bem.21715; Choi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035464; Costa EVL, 2013, BIOELECTROMAGNETICS, V34, P114, DOI 10.1002/bem.21759; Davis S, 2006, ANN EPIDEMIOL, V16, P622, DOI 10.1016/j.annepidem.2005.11.005; Fadel Raouf A. R., 2006, Anthropologischer Anzeiger, V64, P211; GOLDSTEIN I, 1991, OBSTET GYNECOL, V77, P885; Ilijin L, 2011, INT J RADIAT BIOL, V87, P461, DOI 10.3109/09553002.2011.542544; Kaczmarek E, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P155; Khaki A. A., 2006, Folia Morphologica, V65, P188; Kokawa K, 1998, PLACENTA, V19, P21, DOI 10.1016/S0143-4004(98)90094-7; Lahijani MS, 2011, ELECTROMAGN BIOL MED, V30, P146, DOI 10.3109/15368378.2011.596250; Lahijani MS, 2011, ELECTROMAGN BIOL MED, V30, P158, DOI [10.3109/15368378.2011.596603, 10.3109/15368378.2011.596250]; Lahijani MS, 2009, ELECTROMAGN BIOL MED, V28, P391, DOI 10.3109/15368370903287689; Lee GM, 2002, EPIDEMIOLOGY, V13, P21, DOI 10.1097/00001648-200201000-00005; Li DK, 2010, REPROD TOXICOL, V29, P86, DOI 10.1016/j.reprotox.2009.09.004; Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004; Marcilio Izabel, 2011, Rev. bras. epidemiol., V14, P580, DOI 10.1590/S1415-790X2011000400005; McDevitt JJ, 2002, J EXPO ANAL ENV EPID, V12, P1, DOI 10.1038/sj.jea.7500194; Nishimura I, 2012, REGUL TOXICOL PHARM, V64, P394, DOI 10.1016/j.yrtph.2012.10.005; Reichenbach A, 2011, NEUROIMAGE, V54, P1375, DOI 10.1016/j.neuroimage.2010.08.047; Roda O, 2011, HISTOL HISTOPATHOL, V26, P873, DOI 10.14670/HH-26.873; Simko M, 2001, MUTAT RES-GEN TOX EN, V495, P43, DOI 10.1016/S1383-5718(01)00192-9; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Xu You-Qiong, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P332; Zhao TY, 2007, NEUROSCI LETT, V412, P34, DOI 10.1016/j.neulet.2006.09.092	30	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101050	10.1371/journal.pone.0101050	http://dx.doi.org/10.1371/journal.pone.0101050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977708	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400066
J	Yumnam, S; Park, HS; Kim, MK; Nagappan, A; Hong, GE; Lee, HJ; Lee, WS; Kim, EH; Cho, JH; Shin, SC; Kim, GS				Yumnam, Silvia; Park, Hyeon Soo; Kim, Mun Ki; Nagappan, Arulkumar; Hong, Gyeong Eun; Lee, Ho Jeong; Lee, Won Sup; Kim, Eun Hee; Cho, Jae Hyeon; Shin, Sung Chul; Kim, Gon Sup			Hesperidin Induces Paraptosis Like Cell Death in Hepatoblatoma, HepG2 Cells: Involvement of ERK1/2 MAPK	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CANCER-CELLS; ANTICANCER AGENTS; BREAST-CANCER; APOPTOSIS; FLAVONOIDS; MICE; CARCINOGENESIS; INHIBITION; CASPASES	Hesperidin, a natural flavonoid abundantly present in Citrus is known for its anti-cancer, anti-oxidant and anti-inflammatory properties. In this study we examined the effect of hesperidin on HepG2 cells. HepG2 cells treated with various concentration of hesperidin undergo a distinct type of programed cell death. Cytoplasmic vacuolization, mitochondria and endoplasmic reticulum swelling and uncondensed chromatin were observed in hesperidin treated cells. DNA electrophoresis show lack of DNA fragmentation and western blot analysis demonstrates lack of caspase activation and PARP cleavage. It was observed that hesperidin induced cell death is nonautophagic and also activate mitogen activated protein kinase ERK1/2. Taken together, the data indicate that hesperidin induces paraptosis like cell death in HepG2 cells with the activation of ERK1/2. Thus our finding suggests that hesperidin inducing paraptosis may offer an alternative tool in human liver carcinoma therapy.	[Yumnam, Silvia; Park, Hyeon Soo; Kim, Mun Ki; Nagappan, Arulkumar; Hong, Gyeong Eun; Lee, Ho Jeong; Cho, Jae Hyeon; Kim, Gon Sup] Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Plus Project BK21, Gazwa, Jinju, South Korea; [Lee, Won Sup] Gyeongsang Natl Univ, Dept Internal Med, Inst Hlth Sci, Sch Med,Gyeongnam Reg Canc Ctr,Gyeongsang Natl Un, Jinju, South Korea; [Kim, Eun Hee] Int Univ Korea, Dept Nursing Sci, Jinju, South Korea; [Shin, Sung Chul] Gyeongsang Natl Univ, Dept Chem, Life Sci Res Inst, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University; International University Korea; Gyeongsang National University	Kim, GS (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Plus Project BK21, Gazwa, Jinju, South Korea.	gonskim@gnu.ac.kr		Yumnam, Silvia/0000-0002-4518-2464	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2012M3A9B8019303, 2012R1A2A2A06045015]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0820050]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2012M3A9B8019303 and No. 2012R1A2A2A06045015) and National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (No. 0820050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2010, PHARMACOL THERAPEUT, V126, P9, DOI 10.1016/j.pharmthera.2010.01.009; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chen TS, 2008, CANCER LETT, V270, P164, DOI 10.1016/j.canlet.2008.05.008; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GALATI EM, 1994, FARMACO, V49, P709; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Kamaraj S, 2009, INVEST NEW DRUG, V27, P214, DOI 10.1007/s10637-008-9159-7; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SO, 2001, J ENDOTOXIN RES, V7, P292, DOI 10.1179/096805101101532873; Korsnes MS, 2011, TOXICOL IN VITRO, V25, P1764, DOI 10.1016/j.tiv.2011.09.005; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Lee DH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/515901; Lee KH, 2010, J NAT PROD, V73, P500, DOI 10.1021/np900821e; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Lee KA, 2012, BIOMOL THER, V20, P273, DOI 10.4062/biomolther.2012.20.3.273; Li BH, 2011, CANCER LETT, V301, P185, DOI 10.1016/j.canlet.2010.11.015; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; Palmeri CM, 2009, TOXICOL APPL PHARM, V240, P55, DOI 10.1016/j.taap.2009.07.002; Natarajan N., 2011, BIOMEDICINE PREVENTI, V1, P207, DOI DOI 10.1016/j.bionut.2011.07.001; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Park HS, 2012, FOOD CHEM TOXICOL, V50, P2407, DOI 10.1016/j.fct.2012.04.034; Park KI, 2011, J ETHNOPHARMACOL, V133, P634, DOI 10.1016/j.jep.2010.10.057; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Souza LC, 2013, PROG NEURO-PSYCHOPH, V40, P103, DOI 10.1016/j.pnpbp.2012.09.003; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wang Y, 2013, BIOCHEM BIOPH RES CO, V430, P876, DOI 10.1016/j.bbrc.2012.12.063; Wyllie AH, 2001, P NATL ACAD SCI USA, V98, P11, DOI 10.1073/pnas.98.1.11; Yang MZ, 1997, INT J CANCER, V73, P719, DOI 10.1002/(SICI)1097-0215(19971127)73:5<719::AID-IJC18>3.0.CO;2-0; Yeh MH, 2009, TOXICOL LETT, V184, P204, DOI 10.1016/j.toxlet.2008.11.018; Yoon MJ, 2012, CANCER LETT, V324, P197, DOI 10.1016/j.canlet.2012.05.018; Zhang FJ, 2010, PHARM BIOL, V48, P883, DOI 10.3109/13880200903311102; Zhang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057779; Zhang Y, 2014, EUR REV MED PHARMACO, V18, P1018	43	41	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101321	10.1371/journal.pone.0101321	http://dx.doi.org/10.1371/journal.pone.0101321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977707	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400114
J	Blasi, F; Cesana, G; Conti, S; Chiodini, V; Aliberti, S; Fornari, C; Mantovani, LG				Blasi, Francesco; Cesana, Giancarlo; Conti, Sara; Chiodini, Virginio; Aliberti, Stefano; Fornari, Carla; Mantovani, Lorenzo Giovanni			The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients	PLOS ONE			English	Article							COPD EXACERBATIONS; MORTALITY; SPIROMETRY; OUTCOMES; COSTS	Background: Chronic Obstructive Pulmonary Disease (COPD) is a common disease with significant health and economic consequences. This study assesses the burden of COPD in the general population, and the influence of exacerbations (E-COPD) on disease progression and costs. Methods: This is a secondary data analysis of healthcare administrative databases of the region of Lombardy, in northern Italy. The study included >= 40 year-old patients hospitalized for a severe E-COPD (index event) during 2006. Patients were classified in relation to the number and type of E-COPD experienced in a three-year pre-index period. Subjects were followed up until December 31st, 2009, collecting data on healthcare resource use and vital status. Results: 15857 patients were enrolled -9911 males, mean age: 76 years (SD 10). Over a mean follow-up time of 2.4 years (1.36), 81% of patients had at least one E-COPD with an annual rate of 3.2 exacerbations per person-year and an all-cause mortality of 47%. A history of exacerbation influenced the occurrence of new E-COPD and mortality after discharge for an E-COPD. On average, the healthcare system spent 6725(sic) per year per person (95% CI 6590-6863). Occurrence and type of exacerbations drove the direct healthcare cost. Less than one quarter of patients presented claims for pulmonary function tests. Conclusions: COPD imposes a substantial burden on healthcare systems, mainly attributable to the type and occurrence of E-COPD, or in other words, to the exacerbator phenotypes. A more tailored approach to the management of COPD patients is required.	[Blasi, Francesco] Univ Milan, Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dept Pathophysiol & Transplantat, Milan, Italy; [Cesana, Giancarlo; Conti, Sara; Chiodini, Virginio; Fornari, Carla; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, CESP, Res Ctr Publ Hlth, Dept Stat & Quantitat Methods, Monza, Italy; [Aliberti, Stefano] Univ Milano Bicocca, AO San Gerardo, Dept Hlth Sci, Resp Unit, Monza, Italy; [Mantovani, Lorenzo Giovanni] Univ Napoli Federico II, Naples, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milano-Bicocca; University of Milano-Bicocca; University of Naples Federico II	Fornari, C (corresponding author), Univ Milano Bicocca, CESP, Res Ctr Publ Hlth, Dept Stat & Quantitat Methods, Monza, Italy.	carla.fornari@unimib.it	BLASI, FRANCESCO B/O-5885-2017; Aliberti, Stefano/AAL-8032-2021; Aliberti, Stefano/K-9115-2016; Mantovani, Lorenzo Giovanni/AAC-4263-2021; Conti, Sara/J-4891-2019	BLASI, FRANCESCO B/0000-0002-2285-9970; Aliberti, Stefano/0000-0002-0090-4531; Aliberti, Stefano/0000-0002-0090-4531; Conti, Sara/0000-0002-5774-3740; Fornari, Carla/0000-0002-9609-9556; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199	Nycomed-Takeda SpA	Nycomed-Takeda SpA	Nycomed-Takeda SpA funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abramson MJ, 2010, MED J AUSTRALIA, V193, P104, DOI 10.5694/j.1326-5377.2010.tb03817.x; Almagro P, 2002, CHEST, V2002, P5; [Anonymous], 2008, WORLD HLTH STAT 2008; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Bertella E, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-24; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Celli BR, 2004, EUROPEAN RESP J, V23, P942; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dal Negro Roberto, 2008, Int J Chron Obstruct Pulmon Dis, V3, P1; Dalal Anand A, 2010, Int J Chron Obstruct Pulmon Dis, V5, P341, DOI 10.2147/COPD.S13771; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Johnson AK, 2008, CHRONIC OBSTRUCTIVE, P15; Lokke A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004069; Mapel DW, 2012, PHARMACOECONOMICS, V30, P869, DOI 10.2165/11633330-000000000-00000; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Monteagudo M, 2011, ARCH BRONCONEUMOL, V47, P226, DOI 10.1016/j.arbres.2010.10.009; Pasquale MK, 2012, INT J CHRONIC OBSTR, V7, P757, DOI 10.2147/COPD.S36997; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Press W, 2007, GLOBAL SURVEILLANCE; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodriguez-Roisin R, 2006, THORAX, V61, P535, DOI 10.1136/thx.2005.041863; Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203; Simoens S, 2007, INT J CLIN PRACT, V61, P200, DOI 10.1111/j.1742-1241.2006.01240.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; Yu Andrew P, 2011, J Med Econ, V14, P315, DOI 10.3111/13696998.2011.576295	31	72	72	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101228	10.1371/journal.pone.0101228	http://dx.doi.org/10.1371/journal.pone.0101228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971791	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200106
J	De Marco, MA; Delogu, M; Sivay, M; Sharshov, K; Yurlov, A; Cotti, C; Shestopalov, A				De Marco, Maria A.; Delogu, Mauro; Sivay, Mariya; Sharshov, Kirill; Yurlov, Alexander; Cotti, Claudia; Shestopalov, Alexander			Virological Evaluation of Avian Influenza Virus Persistence in Natural and Anthropic Ecosystems of Western Siberia (Novosibirsk Region, Summer 2012)	PLOS ONE			English	Article							WILD BIRDS; A VIRUSES; H5N1 VIRUSES; SURVEILLANCE; WATERFOWL; POULTRY; RUSSIA; PCR	Background: Wild aquatic birds, reservoir of low-pathogenicity (LP) avian influenza viruses (AIVs), congregate in huge numbers in Western Siberia wetlands, where major intra- and inter-continental bird flyways overlap. In 2005 and 2006, highly pathogenic (HP) AIV H5N1 epizootics affected wild and domestic birds in the Novosibirsk Region. In 2012, we evaluated AIV persistence in Siberian natural and anthropic ecosystems. Methodology/Principal Findings: In Novosibirsk Region, 166 wild birds ecologically linked to aquatic environments and 152 domestic waterfowl were examined for AIV isolation in embryonating chicken eggs. Biological samples were obtained by integrating the conventional cloacal swab collection with the harvesting of samples from birds' plumage. Haemagglutinating allantoic fluids were further characterized by serological and molecular methods. In August-September 2012, 17 AIVs, including three H3N8, eight H4N6, two H4N?, one H2N?, one H?N2, and two unsubtyped LPAIVs, were isolated from 15 wild ducks. Whereas comparable proportions of wild Anseriformes (n.118) tested virus isolation (VI)-positive from cloaca and feathers (5.9% vs 8.5%) were detected, the overall prevalence of virus isolation, obtained from both sampling methods, was 2.4 times higher than that calculated on results from cloacal swab examination only (14.4% vs 5.9%). Unlike previously described in this area, the H4N6 antigenic subtype was found to be the prevalent one in 2012. Both cloacal and feather samples collected from domestic waterfowl tested VI-negative. Conclusion/Significance: We found lack of evidence for the H5N1 HPAIV circulation, explainable by the poor environmental fitness of HPAIVs in natural ecosystems. Our LPAIV isolation data emphasise the importance of Siberia wetlands in influenza A virus ecology, providing evidence of changes in circulation dynamics of HN antigenic subtypes harboured in wild bird reservoirs. Further studies of isolates, based on bioinformatic approaches to virus molecular evolution and phylogenesis, will be needed to better elucidate mechanisms involved in AIV perpetuation in this area.	[De Marco, Maria A.] ISPRA, Genet Lab, Ozzano Dell Emilia, BO, Italy; [Delogu, Mauro; Cotti, Claudia] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, BO, Italy; [Sivay, Mariya; Sharshov, Kirill; Shestopalov, Alexander] Russian Acad Med Sci, Siberian Div, Res Ctr Clin & Expt Med, Novosibirsk, Russia; [Yurlov, Alexander] RAS, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Shestopalov, Alexander] Novosibirsk State Univ, Div Res, Novosibirsk 630090, Russia	Italian Institute for Environmental Protection & Research (ISPRA); University of Bologna; Russian Academy of Medical Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Novosibirsk State University	De Marco, MA (corresponding author), ISPRA, Genet Lab, Ozzano Dell Emilia, BO, Italy.	mariaalessandra.demarco@isprambiente.it	Yurlov, Alexander/R-4483-2016; Sivay, Mariya/AAI-2085-2020; Shestopalov, Alexander/AAO-5569-2020		RFBR [13-04-91179- GFEN-a]; USDA [58-0210-2-040F]	RFBR(Russian Foundation for Basic Research (RFBR)); USDA(United States Department of Agriculture (USDA))	RFBR project No. 13-04-91179- GFEN-a, and USDA grant no. 58-0210-2-040F provided financial and logistical support in sample collection and analysis. The funders had no role in study design, decision to publish, or preparation of the manuscript.	BAKER K, 1993, BTO GUIDES, V24; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; Bourouiba L, 2010, J R SOC INTERFACE, V7, P1627, DOI 10.1098/rsif.2010.0126; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Delogu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011315; [ДОНЧЕНКО А.С. DONCHENKO A.S.], 2012, [Сибирский вестник сельскохозяйственной науки, Sibirskii vestnik sel'skokhozyaistvennoi nauki], P84; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; GILBERT M, 2012, PLOS ONE, V7, DOI DOI 10.1371/ANNOTATION/2CED0370-4F34-4380-9CA9-954BA328E160; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Ilyicheva T, 2013, INFECT GENET EVOL, V20, P177, DOI 10.1016/j.meegid.2013.08.025; Iushkov Iu G, 2006, Zh Mikrobiol Epidemiol Immunobiol, P59; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2013, AVIAN DIS, V57, P677, DOI 10.1637/10455-112512-ResNote.1; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539, DOI 10.3201/eid1304.061266; Lvov D. K., 2006, Voprosy Virusologii, V51, P15; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; PRILIPOV AG, 2005, DIRECT SUBMISSION SU; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Razumova Yu. V., 2006, Voprosy Virusologii, V51, P32; Sharshov K. A., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P53; Sharshov K, 2010, ARCH VIROL, V155, P1145, DOI 10.1007/s00705-010-0676-2; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Shestopalov AM, 2006, EMERG INFECT DIS, V12, P1167, DOI 10.3201/eid1207.051338; Sivay MV, 2013, J VIROL, V87, P3578, DOI 10.1128/JVI.02521-12; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Svensson L., 1992, IDENTIFICATION GUIDE; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Veen J., 2005, ATLAS MOVEMENTS SW S; *WAHID, 2014, COUNTR INF; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2012, H5N1 AV INFL TIM MAJ; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Zhang G, 2006, J VIROL, V80, P12229, DOI 10.1128/JVI.00986-06; 2001, NATL TRAINING COURSE	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100859	10.1371/journal.pone.0100859	http://dx.doi.org/10.1371/journal.pone.0100859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972026	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200069
J	Lisboa, FJG; Peres-Neto, PR; Chaer, GM; Jesus, ED; Mitchell, RJ; Chapman, SJ; Berbara, RLL				Goncalves Lisboa, Francy Junio; Peres-Neto, Pedro R.; Chaer, Guilherme Montandon; Jesus, Ederson da Conceicao; Mitchell, Ruth Joy; Chapman, Stephen James; Louro Berbara, Ricardo Luis			Much beyond Mantel: Bringing Procrustes Association Metric to the Plant and Soil Ecologist's Toolbox	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; AMAZONIAN RAIN-FOREST; CO-INERTIA ANALYSIS; VEGETATION COMPOSITION; BACTERIAL COMMUNITY; FLORISTIC VARIATION; MYCORRHIZAL FUNGI; BETA DIVERSITY; ENVIRONMENT; CHEMISTRY	The correlation of multivariate data is a common task in investigations of soil biology and in ecology in general. Procrustes analysis and the Mantel test are two approaches that often meet this objective and are considered analogous in many situations especially when used as a statistical test to assess the statistical significance between multivariate data tables. Here we call the attention of ecologists to the advantages of a less familiar application of the Procrustean framework, namely the Procrustean association metric (a vector of Procrustean residuals). These residuals represent differences in fit between multivariate data tables regarding homologous observations (e. g., sampling sites) that can be used to estimate local levels of association (e. g., some groups of sites are more similar in their association between biotic and environmental features than other groups of sites). Given that in the Mantel framework, multivariate information is translated into a pairwise distance matrix, we lose the ability to contrast homologous data points across dimensions and data matrices after their fit. In this paper, we attempt to familiarize ecologists with the benefits of using these Procrustean residual differences to further gain insights about the processes underlying the association among multivariate data tables using real and hypothetical examples.	[Goncalves Lisboa, Francy Junio; Louro Berbara, Ricardo Luis] Univ Fed Rural Rio de Janeiro, Inst Agron, Dept Soil Sci, Seropedica, RJ, Brazil; [Peres-Neto, Pedro R.] Univ Quebec Montreal, Canada Res Chair Spatial Modelling & Biodivers, Quebec City, PQ, Canada; [Chaer, Guilherme Montandon; Jesus, Ederson da Conceicao] Embrapa Agrobiol, Seropedica, RJ, Brazil; [Goncalves Lisboa, Francy Junio; Mitchell, Ruth Joy; Chapman, Stephen James] James Hutton Inst, Aberdeen, Scotland	Instituto Agronomico de Campinas (IAC); Universidade Federal Rural do Rio de Janeiro (UFRRJ); University of Quebec; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); James Hutton Institute	Lisboa, FJG (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Agron, Dept Soil Sci, Seropedica, RJ, Brazil.	agrolisboa@gmail.com	Mitchell, Ruth/F-4159-2010; Berbara, Ricardo L.L./F-6672-2012; berbara, ricardo l/AAE-4318-2020; Jesus, Ederson/AAC-5305-2019; Chaer, Guilherme Montandon/B-1241-2013; Chapman, Stephen James/B-3599-2010	Mitchell, Ruth/0000-0001-8151-2769; Berbara, Ricardo L.L./0000-0002-3649-9443; berbara, ricardo l/0000-0002-9133-7754; Chaer, Guilherme Montandon/0000-0003-0734-2866; Chapman, Stephen James/0000-0003-3397-3418; Peres Neto, Pedro/0000-0002-5629-8067	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq-563304/2010-3, 562955/2010-0]; Fundacao de Amparo a Pesquisa de Minas Gerais [FAPEMIG CRA-APQ-00001-11]; Inter-American Institute for Global Change Research [IAI-CRN II-021]; CAPES/EMBRAPA (Carbioma)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Inter-American Institute for Global Change Research; CAPES/EMBRAPA (Carbioma)	This work was carried out with the aid of a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-563304/2010-3 and 562955/2010-0), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG CRA-APQ-00001-11), and the Inter-American Institute for Global Change Research (IAI-CRN II-021). Francy Lisboa greatly acknowledges a research scholarship from CAPES/EMBRAPA (Carbioma) and Dr. Beata Madari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Artz RRE, 2006, SOIL BIOL BIOCHEM, V38, P2958, DOI 10.1016/j.soilbio.2006.04.017; Burkle L, 2009, OIKOS, V118, P1816, DOI 10.1111/j.1600-0706.2009.17740.x; Castillo-Monroy AP, 2011, J VEG SCI, V22, P165, DOI 10.1111/j.1654-1103.2010.01236.x; Chaer GM, 2009, SOIL SCI SOC AM J, V73, P1327, DOI 10.2136/sssaj2008.0276; Dijksterhuis G. B., 1991, FOOD QUAL PREFER, V3, P67; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dray S, 2003, ECOSCIENCE, V10, P110, DOI 10.1080/11956860.2003.11682757; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fitzsimons MS, 2008, OECOLOGIA, V158, P117, DOI 10.1007/s00442-008-1117-8; GOWER JC, 1971, MATH ARCHAEOLOGICAL, P138; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hirst CN, 2007, DIVERS DISTRIB, V13, P361, DOI 10.1111/j.1472-4642.2007.00307.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Kang SH, 2004, SOIL SCI, V169, P55, DOI 10.1097/01.ss.0000112014.97541.ba; Kuehnelt-Leddihn ER, 2007, MENACE HERD PROCRUST; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2012, NUMERICAL ECOLOGY, P516; Lisboa FJG, 2013, PLANT SOIL, V367, P551, DOI 10.1007/s11104-012-1491-1; MANTEL N, 1967, CANCER RES, V27, P209; Merila P, 2010, APPL SOIL ECOL, V46, P259, DOI 10.1016/j.apsoil.2010.08.003; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Mitchell RJ, 2012, PLANT SOIL, V351, P355, DOI 10.1007/s11104-011-0968-7; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Peixoto RS, 2010, ANTON LEEUW INT J G, V98, P403, DOI 10.1007/s10482-010-9454-0; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pomara LY, 2012, BIOTROPICA, V44, P545, DOI 10.1111/j.1744-7429.2011.00851.x; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Poulsen AD, 2006, BIOTROPICA, V38, P468, DOI 10.1111/j.1744-7429.2006.00168.x; Powers JS, 2009, FOREST ECOL MANAG, V258, P959, DOI 10.1016/j.foreco.2008.10.036; Singh BK, 2006, EUR J SOIL SCI, V57, P72, DOI 10.1111/j.1365-2389.2005.00781.x; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Siqueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043626; TENBERGE JMF, 1993, BRIT J MATH STAT PSY, V46, P119; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; Trivedi MR, 2008, BIOL CONSERV, V141, P1665, DOI 10.1016/j.biocon.2008.04.008; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vinten AJA, 2011, J MICROBIOL METH, V85, P190, DOI 10.1016/j.mimet.2011.03.001; Zheng YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063375	48	46	46	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101238	10.1371/journal.pone.0101238	http://dx.doi.org/10.1371/journal.pone.0101238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971901	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200107
J	Liu, F; Wang, W; Xu, Y; Wang, Y; Chen, LF; Fang, Q; Yan, XW				Liu, Fang; Wang, Wei; Xu, Yan; Wang, Yu; Chen, Lian-Feng; Fang, Quan; Yan, Xiao-Wei			ABCG1 rs57137919G > A Polymorphism Is Functionally Associated with Varying Gene Expression and Apoptosis of Macrophages	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; DEFICIENT MICE; LESION STAGE; BONE-MARROW; FOAM CELL; ATHEROSCLEROSIS; EFFLUX; ACCUMULATION; DISEASE; ABCA1	ATP-binding cassette transporter G1 (ABCG1) is a transmembrane cholesterol transporter involved in macrophage sterol homeostasis, reverse cholesterol transport (RCT), and atherosclerosis. The role of ABCG1 in atherosclerosis remains controversial, especially in animal models. Our previous study showed that single nucleotide polymorphism rs57137919 (-367G>A) in the ABCG1 promoter region was associated with reduced risk for atherosclerotic coronary artery disease (CAD). This study was designed to provide functional evidence for the role of rs57137919G>A in atherosclerosis in humans. We combined in vitro and ex vivo studies using cell lines and human monocyte-derived macrophages to investigate the functional consequences of the promoter polymorphism by observing the effects of the rs57137919A allele on promoter activity, transcription factor binding, gene expression, cholesterol efflux, and apoptosis levels. The results showed that the rs57137919A allele was significantly associated with decreased ABCG1 gene expression possibly due to the impaired ability of protein-DNA binding. ABCG1-mediated cholesterol efflux decreased by 23% with rs57137919 A/A versus the G/G genotype. Cholesterol-loaded macrophage apoptosis was induced 2-fold with the A/A genotype compared with the G/G genotype. Proapoptotic genes Bok and Bid mRNA levels were significantly increased in macrophages from the A/A genotype compared with those from the G/G genotype. These findings demonstrated that the ABCG1 promoter rs57137919G>A variant had an allele-specific effect on ABCG1 expression and was associated with an increased apoptosis in cholesterol-loaded macrophages, providing functional evidence to explain the reduced risk for atherosclerosis in subjects with the ABCG1 promoter rs57137919A allele as reported in our previous study.	[Yan, Xiao-Wei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, XW (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China.	xwy_pumc@163.com			National Natural Sciences Foundation of China [81270381]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Sciences Foundation of China (81270381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Baldan A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Burgess B, 2008, ARTERIOSCL THROM VAS, V28, P1731, DOI 10.1161/ATVBAHA.108.168542; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Engel T, 2007, FEBS LETT, V581, P1673, DOI 10.1016/j.febslet.2007.03.038; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; Heinloth A, 2002, ATHEROSCLEROSIS, V162, P93, DOI 10.1016/S0021-9150(01)00687-6; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kyriakou T, 2005, ARTERIOSCL THROM VAS, V25, P418, DOI 10.1161/01.ATV.0000149379.72018.20; Le Goff W, 2011, ATHEROSCLEROSIS, V219, P393, DOI 10.1016/j.atherosclerosis.2011.07.015; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; Natunen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080700; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schou J, 2012, ARTERIOSCL THROM VAS, V32, P506, DOI 10.1161/ATVBAHA.111.234872; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Tarling EJ, 2010, ARTERIOSCL THROM VAS, V30, P1174, DOI 10.1161/ATVBAHA.110.205617; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Terasaka N, 2010, ARTERIOSCL THROM VAS, V30, P2219, DOI 10.1161/ATVBAHA.110.213215; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wang W, 2013, J CARDIOVASC PHARM, V62, P90, DOI 10.1097/FJC.0b013e3182927e7c; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Xu Y, 2011, ATHEROSCLEROSIS, V219, P648, DOI 10.1016/j.atherosclerosis.2011.05.043; Xue JH, 2013, J PHYSIOL SCI, V63, P435, DOI 10.1007/s12576-013-0281-8; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang J, 2011, ASSAY DRUG DEV TECHN, V9, P136, DOI 10.1089/adt.2010.0288	38	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e97044	10.1371/journal.pone.0097044	http://dx.doi.org/10.1371/journal.pone.0097044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972087	gold, Green Submitted, Green Published			2022-12-25	WOS:000338512200004
J	Niikura, T; Kita, Y; Abe, Y				Niikura, Takako; Kita, Yoshiko; Abe, Yoichiro			SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GLUTAMATE TRANSPORTER EAAT2; SPINAL-CORD; PROTEIN SUMOYLATION; UBIQUITIN; NEURONS; TDP-43; IDENTIFICATION; MECHANISMS; INCLUSIONS	Mutations in superoxide dismutase 1 (SOD1) are a major cause of familial amyotrophic lateral sclerosis (ALS), whereby the mutant proteins misfold and aggregate to form intracellular inclusions. We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS. In these cells, SUMO1 modification occurred on both lysine 75 and lysine 9 of SOD1, and modification of ALS-linked SOD1 mutant proteins by SUMO3, rather than by SUMO1, significantly increased the stability of the proteins and accelerated intracellular aggregate formation. These findings suggest the contribution of sumoylation, particularly by SUMO3, to the protein aggregation process underlying the pathogenesis of ALS.	[Niikura, Takako] Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, Tokyo 102, Japan; [Kita, Yoshiko; Abe, Yoichiro] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan	Sophia University; Keio University	Niikura, T (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, Tokyo 102, Japan.	niikura@sophia.ac.jp	Abe, Yoichiro/J-5576-2013; Abe, Yoichiro/AAN-8801-2020	Abe, Yoichiro/0000-0001-6163-8794; Abe, Yoichiro/0000-0001-6163-8794	Japan Society for the Promotion of Science [15590908]; Keio Gijuku Academic Development funds	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development funds	This work was supported by grants from Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) (15590908, http://www.jsps.go.jp) to TN and Keio Gijuku Academic Development funds (no number, http://www.med.keio.ac.jp/research/) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Foran E, 2011, GLIA, V59, P1719, DOI 10.1002/glia.21218; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; McFadden K, 2005, J NEUROPATH EXP NEUR, V64, P545, DOI 10.1093/jnen/64.6.545; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Obata Y, 2005, J NEUROSCI RES, V81, P720, DOI 10.1002/jnr.20594; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2011, INT REV CEL MOL BIO, V288, P167, DOI 10.1016/B978-0-12-386041-5.00004-2; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tohgi H, 1999, NEUROSCI LETT, V260, P204, DOI 10.1016/S0304-3940(98)00986-0; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang Z, 2013, SPINAL CORD, V51, P139, DOI 10.1038/sc.2012.100; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Woo CH, 2010, CURR OPIN PHARMACOL, V10, P146, DOI 10.1016/j.coph.2009.12.001; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	41	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101080	10.1371/journal.pone.0101080	http://dx.doi.org/10.1371/journal.pone.0101080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971881	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200090
J	Taylor, L; Vasudevan, SR; Jones, CI; Gibbins, JM; Churchill, GC; Campbell, RD; Coxon, CH				Taylor, Lewis; Vasudevan, Sridhar R.; Jones, Chris I.; Gibbins, Jonathan M.; Churchill, Grant C.; Campbell, R. Duncan; Coxon, Carmen H.			Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PLATELET GLYCOPROTEIN VI; END-POINT REDUCTION; CARDIOVASCULAR MORBIDITY; LOSARTAN INTERVENTION; DISEASE; AGGREGATION; ACTIVATION; ASPIRIN; STROKE	Inappropriate platelet aggregation creates a cardiovascular risk that is largely managed with thienopyridines and aspirin. Although effective, these drugs carry risks of increased bleeding and drug 'resistance', underpinning a drive for new antiplatelet agents. To discover such drugs, one strategy is to identify a suitable druggable target and then find small molecules that modulate it. A good and unexploited target is the platelet collagen receptor, GPVI, which promotes thrombus formation. To identify inhibitors of GPVI that are safe and bioavailable, we docked a FDA-approved drug library into the GPVI collagen-binding site in silico. We now report that losartan and cinanserin inhibit GPVI-mediated platelet activation in a selective, competitive and dose-dependent manner. This mechanism of action likely underpins the cardioprotective effects of losartan that could not be ascribed to its antihypertensive effects. We have, therefore, identified small molecule inhibitors of GPVI-mediated platelet activation, and also demonstrated the utility of structure-based repurposing.	[Taylor, Lewis; Campbell, R. Duncan; Coxon, Carmen H.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Vasudevan, Sridhar R.; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Jones, Chris I.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England	University of Oxford; University of Oxford; University of Reading	Coxon, CH (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Pk Rd, Oxford, England.	carmen.coxon@imm.ox.ac.uk	Vasudevan, Sridhar/B-1841-2015	Vasudevan, Sridhar/0000-0003-0516-2984; Jones, Chris/0000-0001-7537-1509; Gibbins, Jonathan/0000-0002-0372-5352	BHF Centre for Research Excellence (Oxford) [RE/08/004]; BHF [RG/05/007]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; British Heart Foundation [RG/09/011/28094] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI	BHF Centre for Research Excellence (Oxford); BHF(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BHF Centre for Research Excellence (Oxford), grant number: RE/08/004 and the BHF, grant number RG/05/007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi M, 2012, BLOOD, V119, P4311, DOI 10.1182/blood-2011-10-386607; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ballester PJ, 2012, J R SOC INTERFACE; Belhassen L, 2003, J AM COLL CARDIOL, V41, P1198, DOI 10.1016/S0735-1097(03)00048-2; BHF, 2009, BHF COR HEART DIS ST; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Feher G, 2009, CLIN GENET, V75, P1, DOI 10.1111/j.1399-0004.2008.01105.x; Franchini M, 2009, EUR J INTERN MED, V20, P733, DOI 10.1016/j.ejim.2009.09.005; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Goebel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066960; Grothusen C, 2007, ARTERIOSCL THROM VAS, V27, P1184, DOI 10.1161/ATVBAHA.106.138693; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerra JI, 2000, REV ESP CARDIOL, V53, P525, DOI 10.1016/S0300-8932(00)75123-2; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kehoe PG, 2012, J ALZHEIMERS DIS, V30, pS251, DOI 10.3233/JAD-2012-111376; Kjeldsen SE, 2002, JAMA-J AM MED ASSOC, V288, P1491, DOI 10.1001/jama.288.12.1491; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lepantalo A, 2006, THROMB HAEMOSTASIS, V95, P253, DOI 10.1160/TH05-07-0516; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Maree AO, 2005, J THROMB HAEMOST, V3, P2340, DOI 10.1111/j.1538-7836.2005.01555.x; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; Mizushima T, 2011, J BIOCHEM, V149, P499, DOI 10.1093/jb/mvr032; Murad JP, 2012, J CARDIOVASC PHARM T, V17, P308, DOI 10.1177/1074248411425491; Murad JP, 2011, J CARDIOVASC PHARM T; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; NIH, 2012, RESC REP DRUGS; O'Connor MN, 2006, J THROMB HAEMOST, V4, P869, DOI 10.1111/j.1538-7836.2005.01764.x; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; Ono K, 2010, J MED CHEM, V53, P2087, DOI 10.1021/jm901534d; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Sollier CBD, 2009, CEREBROVASC DIS, V28, P505, DOI 10.1159/000236915; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Ungerer M, 2011, CIRCULATION, V123, P1891, DOI 10.1161/CIRCULATIONAHA.110.980623; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Yang QG, 2008, CHEM PHARM BULL, V56, P1400, DOI 10.1248/cpb.56.1400; Yeung J, 2012, J BLOOD MED, V3, P33, DOI 10.2147/JBM.S25421	51	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101209	10.1371/journal.pone.0101209	http://dx.doi.org/10.1371/journal.pone.0101209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971515	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200103
J	Baig, SA; Sheng, TT; Sun, C; Xue, XQ; Tan, LS; Xu, XH				Baig, Shams Ali; Sheng, TianTian; Sun, Chen; Xue, XiaoQin; Tan, LiSha; Xu, XinHua			Arsenic Removal from Aqueous Solutions Using Fe3O4-HBC Composite: Effect of Calcination on Adsorbents Performance	PLOS ONE			English	Article							METAL-IONS; MECHANICAL-PROPERTIES; CONTAMINATED WATER; ADSORPTION; IRON; SORPTION; TEMPERATURE; OXIDE; NANOPARTICLES; MAGNETITE	The presence of elevated concentration of arsenic in water sources is considered to be health hazard globally. Calcination process is known to change the surface efficacy of the adsorbent. In current study, five adsorbent composites: uncalcined and calcined Fe3O4-HBC prepared at different temperatures (400 degrees C and 1000 degrees C) and environment (air and nitrogen) were investigated for the adsorptive removal of As(V) and As(III) from aqueous solutions determining the influence of solution's pH, contact time, temperature, arsenic concentration and phosphate anions. Characterizations from FTIR, XRD, HT-XRD, BET and SEM analyses revealed that the Fe3O4-HBC composite at higher calcination temperature under nitrogen formed a new product (fayalite, Fe2SiO4) via phase transformation. In aqueous medium, ligand exchange between arsenic and the effective sorbent site (=FeOOH) was established from the release of hydroxyl group. Langmuir model suggested data of the five adsorbent composites follow the order: Fe3O4-HBC-1000 degrees C(N-2)>Fe3O4-HBC (uncalcined)>Fe3O4-HBC-400 degrees C(N-2)>Fe3O4-HBC-400 degrees C(air)>Fe3O4-HBC-1000 degrees C(air) and the maximum As(V) and As(III) adsorption capacities were found to be about 3.35 mg g(-1) and 3.07 mg g(-1), respectively. The adsorption of As(V) and As(III) remained stable in a wider pH range (4-10) using Fe3O4-HBC-1000 degrees C(N-2). Additionally, adsorption data fitted well in pseudo-second-order (R-2>0.99) rather than pseudo-first-order kinetics model. The adsorption of As(V) and As(III) onto adsorbent composites increase with increase in temperatures indicating that it is an endothermic process. Phosphate concentration (0.01 mM or higher) strongly inhibited As(V) and As(III) removal through the mechanism of competitive adsorption. This study suggests that the selective calcination process could be useful to improve the adsorbent efficiency for enhanced arsenic removal from contaminated water.	[Baig, Shams Ali; Sheng, TianTian; Sun, Chen; Xue, XiaoQin; Tan, LiSha; Xu, XinHua] Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, XH (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	xuxinhua@zju.edu.cn	Xu, Xinhua/ABG-6289-2021	Xu, Xinhua/0000-0001-7139-1246	National Natural Science Foundation [21277119]; Science and Technology Project of Zhejiang Province, China [2012C23061]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province, China	The authors acknowledge the financial support of the National Natural Science Foundation (No. 21277119) and the Science and Technology Project of Zhejiang Province, China (No. 2012C23061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badruzzaman M, 2004, WATER RES, V38, P4002, DOI 10.1016/j.watres.2004.07.007; Baig SA, 2015, CLEAN-SOIL AIR WATER, V43, P13, DOI 10.1002/clen.201200466; Baig SA, 2013, ECOL ENG, V60, P345, DOI 10.1016/j.ecoleng.2013.09.001; Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897; Chowdhury SR, 2010, J ENVIRON MANAGE, V91, P2238, DOI 10.1016/j.jenvman.2010.06.003; Diaz-Parralejo A, 2010, J NON-CRYST SOLIDS, V356, P175, DOI 10.1016/j.jnoncrysol.2009.11.007; Feng LY, 2012, J HAZARD MATER, V217, P439, DOI 10.1016/j.jhazmat.2012.03.073; Gerente C, 2010, CHEM ENG J, V158, P593, DOI 10.1016/j.cej.2010.02.005; Goldberg S, 2002, SOIL SCI SOC AM J, V66, P413, DOI 10.2136/sssaj2002.0413; Gupta K, 2012, J COLLOID INTERF SCI, V377, P269, DOI 10.1016/j.jcis.2012.01.066; Haarhoff J, 2010, WATER SA, V36, P97; Hering JG, 1996, J AM WATER WORKS ASS, V88, P155; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5; Johnson MC, 2007, MAT SCI ENG A-STRUCT, V456, P58, DOI 10.1016/j.msea.2006.11.106; Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1; Kolodynska D, 2012, CHEM ENG J, V197, P295, DOI 10.1016/j.cej.2012.05.025; Kurtoglu ME, 2011, J AM CERAM SOC, V94, P1101, DOI 10.1111/j.1551-2916.2010.04218.x; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Luo XB, 2012, CHEM ENG J, V187, P45, DOI 10.1016/j.cej.2012.01.073; Mahmood T, 2012, CHEM ENG J, V192, P90, DOI 10.1016/j.cej.2012.03.048; McNeill LS, 1997, J AM WATER WORKS ASS, V89, P75; Meng XG, 2002, TOXICOL LETT, V133, P103, DOI 10.1016/S0378-4274(02)00080-2; Michel R, 2013, CERAM INT, V39, P5287, DOI 10.1016/j.ceramint.2012.12.031; Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006; Mucke A, 2003, J AFR EARTH SCI, V36, P55, DOI 10.1016/S0899-5362(03)00015-0; Rehman K, 2012, METALLOMICS, V4, P881, DOI 10.1039/c2mt00181k; Sakthivel R, 2011, POWDER TECHNOL, V208, P747, DOI 10.1016/j.powtec.2011.01.010; Seco-Reigosa N, 2013, ENVIRON SCI POLLUT R, P1; Shahar A, 2008, EARTH PLANET SC LETT, V268, P330, DOI 10.1016/j.epsl.2008.01.026; Shan C, 2013, WATER RES, V47, P3411, DOI 10.1016/j.watres.2013.03.035; Sheng TT, 2014, ARAB J CHEM, V7, P27, DOI 10.1016/j.arabjc.2013.05.032; Tian Y, 2011, J HAZARD MATER, V193, P10, DOI 10.1016/j.jhazmat.2011.04.093; WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204; Weng CH, 2013, ULTRASON SONOCHEM, V20, P970, DOI 10.1016/j.ultsonch.2012.09.014; Wu K, 2013, CHEM ENG J, V226, P393, DOI 10.1016/j.cej.2013.04.076; Yue X, 2011, J HAZARD MATER, V190, P553, DOI 10.1016/j.jhazmat.2011.03.076; Zhang M, 2013, BIORESOURCE TECHNOL, V130, P457, DOI 10.1016/j.biortech.2012.11.132; Zhang W, 2004, MINER ENG, V17, P517, DOI 10.1016/j.mineng.2003.11.020	40	41	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100704	10.1371/journal.pone.0100704	http://dx.doi.org/10.1371/journal.pone.0100704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967645	Green Submitted, gold, Green Published			2022-12-25	WOS:000338280800055
J	Choe, R; Putt, ME; Carlile, PM; Durduran, T; Giammarco, JM; Busch, DR; Jung, KW; Czerniecki, BJ; Tchou, J; Feldman, MD; Mies, C; Rosen, MA; Schnall, MD; DeMichele, A; Yodh, AG				Choe, Regine; Putt, Mary E.; Carlile, Peter M.; Durduran, Turgut; Giammarco, Joseph M.; Busch, David R.; Jung, Ki Won; Czerniecki, Brian J.; Tchou, Julia; Feldman, Michael D.; Mies, Carolyn; Rosen, Mark A.; Schnall, Mitchell D.; DeMichele, Angela; Yodh, Arjun G.			Optically Measured Microvascular Blood Flow Contrast of Malignant Breast Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY RESPONSE; PRIMARY MEDICAL THERAPY; COLOR DOPPLER; GLUCOSE-METABOLISM; CANCER; SPECTROSCOPY; MAMMOGRAPHY; OXYGEN; BENIGN	Microvascular blood flow contrast is an important hemodynamic and metabolic parameter with potential to enhance in vivo breast cancer detection and therapy monitoring. Here we report on non-invasive line-scan measurements of malignant breast tumors with a hand-held optical probe in the remission geometry. The probe employs diffuse correlation spectroscopy (DCS), a near-infrared optical method that quantifies deep tissue microvascular blood flow. Tumor-to-normal perfusion ratios are derived from thirty-two human subjects. Mean (95% confidence interval) tumor-to-normal ratio using surrounding normal tissue was 2.25 (1.92-2.63); tumor-to-normal ratio using normal tissues at the corresponding tumor location in the contralateral breast was 2.27 (1.94-2.66), and using normal tissue in the contralateral breast was 2.27 (1.90-2.70). Thus, the mean tumor-to-normal ratios were significantly different from unity irrespective of the normal tissue chosen, implying that tumors have significantly higher blood flow than normal tissues. Therefore, the study demonstrates existence of breast cancer contrast in blood flow measured by DCS. The new, optically accessible cancer contrast holds potential for cancer detection and therapy monitoring applications, and it is likely to be especially useful when combined with diffuse optical spectroscopy/tomography.	[Choe, Regine; Carlile, Peter M.; Jung, Ki Won] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Putt, Mary E.] Univ Penn, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Durduran, Turgut] ICFO Inst Ciencies Foton, Castelldefels, Barcelona, Spain; [Giammarco, Joseph M.] Eastern Univ, Dept Phys & Astron, St Davids, PA USA; [Busch, David R.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Busch, David R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Czerniecki, Brian J.; Tchou, Julia] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Feldman, Michael D.; Mies, Carolyn] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Rosen, Mark A.; Schnall, Mitchell D.] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [DeMichele, Angela] Hosp Univ Penn, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA	University of Rochester; University of Pennsylvania; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Choe, R (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	Regine_Choe@urmc.rochester.edu	Busch, David R/B-5543-2013; Durduran, Turgut/N-7768-2015	Busch, David R/0000-0002-9488-944X; Durduran, Turgut/0000-0001-5838-1027; Jung, Ki Won/0000-0001-9847-3532; Choe, Regine/0000-0001-5851-4504	NIH [K99/R00-CA126187, R01-EB002109]; NHLBI [HL007915]; Thrasher Early Career Award [P41-RR002305]; Fundacio Cellex Barcelona; Marie Curie IRG (FP7); LASERLAB Europe; Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran); NATIONAL CANCER INSTITUTE [R00CA126187, K99CA126187] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072338, R01NS060653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Thrasher Early Career Award; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); Marie Curie IRG (FP7); LASERLAB Europe; Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH K99/R00-CA126187 (Choe), R01-EB002109 (Yodh), NHLBI HL007915, Thrasher Early Career Award (Busch), P41-RR002305 (Reddy-Yodh), Fundacio Cellex Barcelona, Marie Curie IRG (RTPAMON, FP7), LASERLAB Europe (BIOPTHICAL), Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEANEY RP, 1984, LANCET, V1, P131; Busch DR, 2013, PET CLIN, V8, P345, DOI 10.1016/j.cpet.2013.04.004; Busch DR, 2014, ACAD RADIOL, V21, P151, DOI 10.1016/j.acra.2013.10.009; Carp SA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2397572; Carp SA, 2013, BIOMED OPT EXPRESS, V4, P2911, DOI 10.1364/BOE.4.002911; Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; Cerussi AE, 2011, PHILOS T R SOC A, V369, P4512, DOI 10.1098/rsta.2011.0279; Cerussi Albert E, 2010, Acad Radiol, V17, P1031, DOI 10.1016/j.acra.2010.05.002; Chance B, 2005, ACAD RADIOL, V12, P925, DOI 10.1016/j.acra.2005.04.016; Choe R, 2005, MED PHYS, V32, P1128, DOI 10.1118/1.1869612; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Cochet A, 2012, J NUCL MED, V53, P512, DOI 10.2967/jnumed.111.096834; Colak SB, 1999, IEEE J SEL TOP QUANT, V5, P1143, DOI 10.1109/2944.796341; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; COSGROVE DO, 1990, RADIOLOGY, V176, P175, DOI 10.1148/radiology.176.1.2191364; Dehghani H, 2003, APPL OPTICS, V42, P3117, DOI 10.1364/AO.42.003117; Delille JP, 2002, RADIOLOGY, V223, P558, DOI 10.1148/radiol.2232010428; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Doughty JC, 1996, BRIT J SURG, V83, P1128, DOI 10.1002/bjs.1800830830; Dunnwald LK, 2008, J CLIN ONCOL, V26, P4449, DOI 10.1200/JCO.2007.15.4385; Dunnwald LK, 2005, CANCER-AM CANCER SOC, V103, P680, DOI 10.1002/cncr.20831; Durduran T, 2005, OPT LETT, V30, P2915, DOI 10.1364/OL.30.002915; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2004, THESIS U PENNSYLVANI; Eby PR, 2008, ACAD RADIOL, V15, P1246, DOI 10.1016/j.acra.2008.03.019; Enfield LC, 2011, TECHNOL CANCER RES T, V10, P533, DOI 10.1177/153303461101000604; Enfield LC, 2007, APPL OPTICS, V46, P3628, DOI 10.1364/AO.46.003628; Enfield LC, 2009, TARGET ONCOL, V4, P219, DOI 10.1007/s11523-009-0115-z; Fang QQ, 2011, RADIOLOGY, V258, P89, DOI 10.1148/radiol.10082176; Flexman ML, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096012; Franceschini MA, 1997, P NATL ACAD SCI USA, V94, P6468, DOI 10.1073/pnas.94.12.6468; Grosenick D, 2005, PHYS MED BIOL, V50, P2429, DOI 10.1088/0031-9155/50/11/001; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Hagen A, 2009, OPT EXPRESS, V17, P17016, DOI 10.1364/OE.17.017016; Hajihashemi MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045714; Hentschel M, 2007, NUCL MED COMMUN, V28, P789, DOI 10.1097/MNM.0b013e3282e2a880; Huber KE, 2009, SEMIN RADIAT ONCOL, V19, P204, DOI 10.1016/j.semradonc.2009.05.004; Intes X, 2005, ACAD RADIOL, V12, P934, DOI 10.1016/j.acra.2005.05.006; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jakubowski DB, 2004, J BIOMED OPT, V9, P230, DOI 10.1117/1.1629681; Jiang H, 2001, IEEE T MED IMAGING, V20, P1334, DOI 10.1109/42.974928; Jiang SD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076011; Jiang SD, 2009, RADIOLOGY, V252, P551, DOI 10.1148/radiol.2522081202; Kawashima M, 2012, J MAGN RESON IMAGING, V35, P436, DOI 10.1002/jmri.22882; KEDAR RP, 1994, RADIOLOGY, V190, P825, DOI 10.1148/radiology.190.3.8115634; Krak N, 2008, MOL IMAGING BIOL, V10, P356, DOI 10.1007/s11307-008-0163-2; Leff DR, 2008, BREAST CANCER RES TR, V108, P9, DOI 10.1007/s10549-007-9582-z; Leproux A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3485; Madjar H, 1997, GYNECOL ONCOL, V64, P392, DOI 10.1006/gyno.1996.4585; Makkat S, 2008, RADIOLOGY, V249, P471, DOI 10.1148/radiol.2492071147; Mankoff DA, 2003, J NUCL MED, V44, P1806; Mankoff DA, 2002, NUCL MED BIOL, V29, P719, DOI 10.1016/S0969-8051(02)00333-5; Mankoff DA, 2002, J NUCL MED, V43, P500; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Mincey BA, 2004, MAYO CLIN PROC, V79, P810; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Pakalniskis MG, 2011, RADIOLOGY, V259, P365, DOI 10.1148/radiol.11100699; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poellinger A, 2012, J BIOPHOTONICS, V5, P815, DOI 10.1002/jbio.201200123; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Santoro Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3638135; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Sehgal CM, 2006, J MAMMARY GLAND BIOL, V11, P113, DOI 10.1007/s10911-006-9018-0; Shah N, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070147; Soliman H, 2010, CLIN CANCER RES, V16, P2605, DOI 10.1158/1078-0432.CCR-09-1510; Specht JM, 2010, CLIN CANCER RES, V16, P2803, DOI 10.1158/1078-0432.CCR-10-0026; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Tanamai W, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3028012; Tiling R, 2001, EUR J NUCL MED, V28, P711, DOI 10.1007/s002590100539; Tozaki M, 2011, ACTA RADIOL, V52, P706, DOI 10.1258/ar.2011.110039; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; Vaupel P, 2005, ADV EXP MED BIOL, V566, P333; WILSON CBJH, 1992, CANCER RES, V52, P1592; Xu RX, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1837; Yang WT, 2002, J ULTRAS MED, V21, P1227, DOI 10.1023/A:1016580715595; Yu GQ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1884603; Zhou C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798595; Zhu Q, 2005, RADIOLOGY, V237, P57, DOI 10.1148/radiol.2371041236; Zhu QN, 2005, NEOPLASIA, V7, P263, DOI 10.1593/neo.04526; Zhu Q, 2008, NEOPLASIA, V10, P1028, DOI 10.1593/neo.08602; Zhu Q, 2013, RADIOLOGY, V266, P433, DOI 10.1148/radiol.12112415; Zhu Q, 2010, RADIOLOGY, V256, P367, DOI 10.1148/radiol.10091237	88	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99683	10.1371/journal.pone.0099683	http://dx.doi.org/10.1371/journal.pone.0099683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967878	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800018
J	McKinley, SA; Chen, A; Shi, F; Wang, SM; Mucha, PJ; Forest, MG; Lai, SK				McKinley, Scott A.; Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory; Lai, Samuel K.			Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUAL TRANSMISSION; VAGINAL FLUID; BINDING; DIFFUSION; MACAQUES; EPITOPE; STOICHIOMETRY; PROTECTION; INFECTION	Eliciting broadly neutralizing antibodies (bnAb) in cervicovaginal mucus (CVM) represents a promising "first line of defense'' strategy to reduce vaginal HIV transmission. However, it remains unclear what levels of bnAb must be present in CVM to effectively reduce infection. We approached this complex question by modeling the dynamic tally of bnAb coverage on HIV. This analysis introduces a critical, timescale-dependent competition: to protect, bnAb must accumulate at sufficient stoichiometry to neutralize HIV faster than virions penetrate CVM and reach target cells. We developed a model that incorporates concentrations and diffusivities of HIV and bnAb in semen and CVM, kinetic rates for binding (k(on)) and unbinding (k(off)) of select bnAb, and physiologically relevant thicknesses of CVM and semen layers. Comprehensive model simulations lead to robust conclusions about neutralization kinetics in CVM. First, due to the limited time virions in semen need to penetrate CVM, substantially greater bnAb concentrations than in vitro estimates must be present in CVM to neutralize HIV. Second, the model predicts that bnAb with more rapid k(on), almost independent of k(off), should offer greater neutralization potency in vivo. These findings suggest the fastest arriving virions at target cells present the greatest likelihood of infection. It also implies the marked improvements in in vitro neutralization potency of many recently discovered bnAb may not translate to comparable reduction in the bnAb dose needed to confer protection against initial vaginal infections. Our modeling framework offers a valuable tool to gaining quantitative insights into the dynamics of mucosal immunity against HIV and other infectious diseases.	[McKinley, Scott A.] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC USA; [Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC USA; [Chen, Alex] Stat & Appl Math Sci Inst, Res Triangle Pk, NC USA; [Lai, Samuel K.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA; [Forest, M. Gregory; Lai, Samuel K.] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA	State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill	McKinley, SA (corresponding author), Univ Florida, Dept Math, Gainesville, FL 32611 USA.	scott.mckinley@ufl.edu; lai@unc.edu	Shi, Feng/H-9103-2019	Shi, Feng/0000-0001-5369-6695; Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [R21AI093242, U19AI096398]; National Science Foundation [DMS-1122483, DMS-1100281, DMS-0645369, DMS-1127914]; CAREER Award [DMR-1151477]; Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R21AI093242, U19AI096398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CAREER Award; Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants R21AI093242 (S.K.L) and U19AI096398 (S.K.L.), National Science Foundation DMS-1122483 (G.F.), DMS-1100281 (G.F.), DMS-0645369 (P.J.M.), DMS-1127914 (A.C.) and CAREER Award DMR-1151477 (S.K.L), and startup funds from the Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill (S.K.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen S., 2007, STOCHASTIC SIMULATIO, V57; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Geonnotti AR, 2006, BIOPHYS J, V91, P2121, DOI 10.1529/biophysj.106.086322; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Jamison P L, 1988, J Sex Res, V24, P177, DOI 10.1080/00224498809551408; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Lai BE, 2009, BIOPHYS J, V97, P2379, DOI 10.1016/j.bpj.2009.08.010; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Magnus C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002900; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McGhee JerryR., 1994, HDB MUCOSAL IMMUNOLO, P127, DOI 10.1016/b978-0-12-524730-6; MCLAIN L, 1994, J GEN VIROL, V75, P1457, DOI 10.1099/0022-1317-75-6-1457; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Norris J.R., 1998, CAMBRIDGE SERIES STA; NORVELL MK, 1984, J REPROD MED, V29, P269; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Rehan N, 1975, Fertil Steril, V26, P492; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schonning K, 1999, J VIROL, V73, P8364; SCHUMACHER GFB, 1988, HUM REPROD, V3, P289, DOI 10.1093/oxfordjournals.humrep.a136698; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shukair SA, 2012, MUCOSAL IMMUNOL; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; STONE A, 1959, AM J OBSTET GYNECOL, V78, P279, DOI 10.1016/0002-9378(59)90173-5; USALA SJ, 1989, J REPROD MED, V34, P292; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; VANCOTT TC, 1994, J IMMUNOL, V153, P449; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang Y.Y., 2014, MUCOSAL IMMUNOL; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wu H, 2005, J MOL BIOL, V350, P126, DOI 10.1016/j.jmb.2005.04.049; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2005, J VIROL, V79, P3500, DOI 10.1128/JVI.79.6.3500-3508.2005; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100598	10.1371/journal.pone.0100598	http://dx.doi.org/10.1371/journal.pone.0100598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967706	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800046
J	Metzler-Zebeli, BU; Deckardt, K; Schollenberger, M; Rodehutscord, M; Zebeli, Q				Metzler-Zebeli, Barbara U.; Deckardt, Kathrin; Schollenberger, Margit; Rodehutscord, Markus; Zebeli, Qendrim			Lactic Acid and Thermal Treatments Trigger the Hydrolysis of Myo-Inositol Hexakisphosphate and Modify the Abundance of Lower Myo-Inositol Phosphates in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							MILK-FAT CONTENT; LIQUID FEED; PHYTIC ACID; GASTROINTESTINAL ECOLOGY; PHOSPHORUS DIGESTIBILITY; INOSITOL PHOSPHATES; MICROBIAL PHYTASE; RESISTANT STARCH; FORMIC-ACID; WHEAT	Barley is an important source of dietary minerals, but it also contains myo-inositol hexakisphosphate (InsP(6)) that lowers their absorption. This study evaluated the effects of increasing concentrations (0.5, 1, and 5%, vol/vol) of lactic acid (LA), without or with an additional thermal treatment at 55 degrees C (LA-H), on InsP(6) hydrolysis, formation of lower phosphorylated myo-inositol phosphates, and changes in chemical composition of barley grain. Increasing LA concentrations and thermal treatment linearly reduced (P<0.001) InsP(6)-phosphate (InsP(6)-P) by 0.5 to 1 g compared to the native barley. In particular, treating barley with 5% LA-H was the most efficient treatment to reduce the concentrations of InsP(6)-P, and stimulate the formation of lower phosphorylated myo-inositol phosphates such as myo-inositol tetraphosphate (InsP(4)) and myo-inositol pentaphosphates (InsP(5)). Also, LA and thermal treatment changed the abundance of InsP(4) and InsP(5) isomers with Ins(1,2,5,6)P-4 and Ins(1,2,3,4,5)P-5 as the dominating isomers with 5% LA, 1% LA-H and 5% LA-H treatment of barley, resembling to profiles found when microbial 6-phytase is applied. Treating barley with LA at room temperature (22 degrees C) increased the concentration of resistant starch and dietary fiber but lowered those of total starch and crude ash. Interestingly, total phosphorus (P) was only reduced (P<0.05) in barley treated with LA-H but not after processing of barley with LA at room temperature. In conclusion, LA and LA-H treatment may be effective processing techniques to reduce InsP(6) in cereals used in animal feeding with the highest degradation of InsP(6) at 5% LA-H. Further in vivo studies are warranted to determine the actual intestinal P availability and to assess the impact of changes in nutrient composition of LA treated barley on animal performance.	[Metzler-Zebeli, Barbara U.; Deckardt, Kathrin; Zebeli, Qendrim] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Univ Clin Swine, Vienna, Austria; [Schollenberger, Margit; Rodehutscord, Markus] Univ Hohenheim, Inst Anim Nutr, Stuttgart, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University Hohenheim	Zebeli, Q (corresponding author), Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	Qendrim.Zebeli@vetmeduni.ac.at		Zebeli, Qendrim/0000-0001-5188-9004; Rodehutscord, Markus/0000-0003-3156-7889				Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; Agger J, 2011, NEW BIOTECHNOL, V28, P125, DOI 10.1016/j.nbt.2010.09.012; [Anonymous], 1997, HDB LANDW VERS UNT; Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Beal JD, 2005, J SCI FOOD AGR, V85, P433, DOI 10.1002/jsfa.2013; Bergman EL, 1999, J CEREAL SCI, V29, P261, DOI 10.1006/jcrs.1999.0239; Blaabjerg K, 2012, J ANIM SCI, V90, P206, DOI 10.2527/jas.53920; Blaabjerg K, 2011, J ANIM SCI, V89, P3153, DOI 10.2527/jas.2010-3358; Blaabjerg K, 2010, ANIMAL, V4, P876, DOI 10.1017/S1751731110000054; Bohn L, 2008, J ZHEJIANG UNIV-SC B, V9, P165, DOI 10.1631/jzus.B0710640; Canibe N, 2008, LIVEST SCI, V114, P251, DOI 10.1016/j.livsci.2007.05.002; Canibe N, 2003, J ANIM SCI, V81, P2019; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Deckardt K, 2014, STARCH-STARKE, V66, P558, DOI 10.1002/star.201300200; Deckardt K, 2013, NUTRIENTS, V5, P1970, DOI 10.3390/nu5061970; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; Esmaeilipour O, 2012, ANIM FEED SCI TECH, V175, P168, DOI 10.1016/j.anifeedsci.2012.05.007; Fredlund K, 1997, J CEREAL SCI, V25, P83, DOI 10.1006/jcrs.1996.0070; Greiner R, 2000, J CEREAL SCI, V31, P127, DOI 10.1006/jcrs.1999.0254; Greiner R, 2007, PROTEIN J, V26, P577, DOI 10.1007/s10930-007-9100-5; Haraldsson AK, 2004, J SCI FOOD AGR, V84, P653, DOI 10.1002/jsfa.1724; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Holopainen-Mantila U, 2013, BIORESOURCE TECHNOL, V138, P156, DOI 10.1016/j.biortech.2013.03.152; Hurrell RF, 2004, INT J VITAM NUTR RES, V74, P445, DOI 10.1024/0300-9831.74.6.445; Iqbal S, 2012, J ANIM SCI, V90, P3143, DOI 10.2527/jas.2011-3983; Iqbal S, 2012, ANIM FEED SCI TECH, V172, P141, DOI 10.1016/j.anifeedsci.2011.12.024; Iqbal S, 2010, J DAIRY SCI, V93, P5147, DOI 10.3168/jds.2010-3118; Iqbal S, 2009, J DAIRY SCI, V92, P6023, DOI 10.3168/jds.2009-2380; Jarrett JP, 2014, J DAIRY SCI, V97, P411, DOI 10.3168/jds.2013-7124; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; Leenhardt F, 2005, J AGR FOOD CHEM, V53, P98, DOI 10.1021/jf049193q; March JG, 1998, ANAL CHIM ACTA, V367, P63, DOI 10.1016/S0003-2670(98)00164-0; Sanz-Penella JM, 2012, J AGR FOOD CHEM, V60, P11787, DOI 10.1021/jf3034013; Pable A, 2014, J FOOD BIOCHEM, V38, P18, DOI 10.1111/jfbc.12020; PHILLIPPY BQ, 1988, ANAL BIOCHEM, V175, P162, DOI 10.1016/0003-2697(88)90374-0; Plumed-Ferrer C, 2009, J APPL MICROBIOL, V106, P351, DOI 10.1111/j.1365-2672.2008.03938.x; Pontoppidan K, 2007, ANIM FEED SCI TECH, V132, P137, DOI 10.1016/j.anifeedsci.2006.03.008; Proulx AK, 2007, J AGR FOOD CHEM, V55, P2749, DOI 10.1021/jf0630015; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Regmi PR, 2011, J NUTR, V141, P1273, DOI 10.3945/jn.111.140509; Rutherfurd SM, 2014, J ANIM SCI, V92, P189, DOI 10.2527/jas.2013-6923; Sandberg AS, 1999, AM J CLIN NUTR, V70, P240; Sandberg AS, 2002, FOOD PHYTATES, P139; SANDBERG AS, 1991, ADV EXP MED BIOL, V289, P499; Selvendran R R, 1987, Adv Food Res, V31, P117; Shastak Y, 2012, POULTRY SCI, V91, P2201, DOI 10.3382/ps.2011-02063; Shen YR, 2005, J AGR FOOD CHEM, V53, P853, DOI 10.1021/jf049116v; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; STEWART A, 1988, PLANT PHYSIOL, V86, P93, DOI 10.1104/pp.86.1.93; TABEKHIA MM, 1980, J FOOD SCI, V45, P406, DOI 10.1111/j.1365-2621.1980.tb02631.x; Tanaka T, 2010, J VET MED SCI, V72, P827, DOI 10.1292/jvms.09-0490; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Willamil J, 2011, ARCH ANIM NUTR, V65, P431, DOI 10.1080/1745039X.2011.623047; Zebeli Q, 2007, J DAIRY SCI, V90, P1929, DOI 10.3168/jds.2006-354	56	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101166	10.1371/journal.pone.0101166	http://dx.doi.org/10.1371/journal.pone.0101166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967651	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800115
J	Feng, ST; Li, JG; Luo, YJ; Yin, TH; Cai, HS; Wang, Y; Dong, Z; Shuai, XT; Li, ZP				Feng, Shi-Ting; Li, Jingguo; Luo, Yanji; Yin, Tinghui; Cai, Huasong; Wang, Yong; Dong, Zhi; Shuai, Xintao; Li, Zi-Ping			pH-Sensitive Nanomicelles for Controlled and Efficient Drug Delivery to Human Colorectal Carcinoma LoVo Cells	PLOS ONE			English	Article							PHARMACEUTICAL NANOCARRIERS; COPOLYMER MICELLES; POLYMERIC MICELLES; IRON-OXIDE; CANCER; TUMOR; NANOPARTICLES; PACLITAXEL; SYSTEMS; RELEASE	Background: The triblock copolymers PEG-P(Asp-DIP)-P(Lys-Ca) (PEALCa) of polyethylene glycol (PEG), poly(N-(N', N'-diisopropylaminoethyl) aspartamide) (P(Asp-DIP)), and poly (lysine-cholic acid) (P(Lys-Ca)) were synthesized as a pH-sensitive drug delivery system. In neutral aqueous environment such as physiological environment, PEALCa can self-assemble into stable vesicles with a size around 50-60 nm, avoid uptake by the reticuloendothelial system (RES), and encase the drug in the core. However, the PEALCa micelles disassemble and release drug rapidly in acidic environment that resembles lysosomal compartments. Methodology/Principal Findings: The anticancer drug Paclitaxel (PTX) and hydrophilic superparamagnetic iron oxide (SPIO) were encapsulated inside the core of the PEALCa micelles and used for potential cancer therapy. Drug release study revealed that PTX in the micelles was released faster at pH 5.0 than at pH 7.4. Cell culture studies showed that the PTX-SPIO-PEALCa micelle was effectively internalized by human colon carcinoma cell line (LoVo cells), and PTX could be embedded inside lysosomal compartments. Moreover, the human colorectal carcinoma (CRC) LoVo cells delivery effect was verified in vivo by magnetic resonance imaging (MRI) and histology analysis. Consequently effective suppression of CRC LoVo cell growth was evaluated. Conclusions/Significance: These results indicated that the PTX-SPION-loaded pH-sensitive micelles were a promising MRI-visible drug release system for colorectal cancer therapy.	[Feng, Shi-Ting; Luo, Yanji; Cai, Huasong; Dong, Zhi; Li, Zi-Ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jingguo; Wang, Yong; Shuai, Xintao] Sun Yat Sen Univ, Sch Chem & Chem Engn, Minist Educ, PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Tinghui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	liziping163@163.com	Shuai, Xintao/C-5819-2008; Li, Jingguo/E-7523-2015; 庭辉, 尹/I-5114-2014	Shuai, Xintao/0000-0003-4271-0310; Yin, Tinghui/0000-0003-4201-3953; Wang, Yong/0000-0002-8349-7555	National Natural Science Foundation of China [81000626]; Zhujiang Scientific and Technological New Star Foundation [2012J2200084]; Fundamental Research Funds for the Central Universities [10ykpy11]; Natural Science Foundation of Guangdong Province [S2013010016004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhujiang Scientific and Technological New Star Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by: 1. National Natural Science Foundation of China (81000626); 2. Zhujiang Scientific and Technological New Star Foundation (2012J2200084); 3. Fundamental Research Funds for the Central Universities (10ykpy11); 4. Natural Science Foundation of Guangdong Province (S2013010016004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lorenzo C, 2008, MINI-REV MED CHEM, V8, P1065, DOI 10.2174/138955708785909952; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Chang GT, 2010, MACROMOL BIOSCI, V10, P1248, DOI 10.1002/mabi.201000117; Chen YT, 2012, INT J NANOMED, V7, P359, DOI 10.2147/IJN.S24083; Chen YB, 2007, CHINESE MED J-PEKING, V120, P703, DOI 10.1097/00029330-200704020-00017; Dai J, 2011, ANGEW CHEM INT EDIT, V50, P9404, DOI 10.1002/anie.201103806; Foersch S, 2012, DIGEST DIS, V30, P469, DOI 10.1159/000341692; Gao GH, 2010, SMALL, V6, P1201, DOI 10.1002/smll.200902317; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; Hu YQ, 2007, POLYMER, V48, P3437, DOI 10.1016/j.polymer.2007.04.011; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649; Khemtong C, 2009, CANCER RES, V69, P1651, DOI 10.1158/0008-5472.CAN-08-3231; Klaikherd A, 2009, J AM CHEM SOC, V131, P4830, DOI 10.1021/ja809475a; Lee ES, 2003, J CONTROL RELEASE, V90, P363, DOI 10.1016/S0168-3659(03)00205-0; Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Liao CD, 2011, EUR J RADIOL, V80, P699, DOI 10.1016/j.ejrad.2010.08.005; Liu J, 2010, CARBOHYD POLYM, V82, P432, DOI 10.1016/j.carbpol.2010.04.084; Luo JT, 2009, BIOMACROMOLECULES, V10, P900, DOI 10.1021/bm801423p; Lutz JF, 2006, BIOMACROMOLECULES, V7, P3132, DOI 10.1021/bm0607527; Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p; Mei L, 2009, J PHARM SCI-US, V98, P2040, DOI 10.1002/jps.21581; Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022; Mo R, 2011, BIOMATERIALS, V32, P4609, DOI 10.1016/j.biomaterials.2011.03.005; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Panchagnula R, 1998, INT J PHARMACEUT, V172, P1, DOI 10.1016/S0378-5173(98)00188-4; Ranganathan R, 2012, INT J NANOMED, V7, P1043, DOI 10.2147/IJN.S25182; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066; Wu H, 2013, BIOMATERIALS, V34, P1213, DOI 10.1016/j.biomaterials.2012.08.072; Yang R, 2009, INT J PHARMACEUT, V371, P142, DOI 10.1016/j.ijpharm.2008.12.007; Yang XQ, 2010, BIOCONJUGATE CHEM, V21, P496, DOI 10.1021/bc900422j; Yin HQ, 2008, J CONTROL RELEASE, V126, P130, DOI 10.1016/j.jconrel.2007.11.014	37	41	41	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100732	10.1371/journal.pone.0100732	http://dx.doi.org/10.1371/journal.pone.0100732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964012	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500077
J	Lu, XD; Zhang, DY; Li, SP; Su, YP; Liang, QJ; Meng, HY; Shen, SD; Fan, YL; Liu, CM; Zhang, CY				Lu, Xiaoduo; Zhang, Dongyuan; Li, Shipeng; Su, Yanping; Liang, Qiuju; Meng, Hongyan; Shen, Songdong; Fan, Yunliu; Liu, Chunming; Zhang, Chunyi			FtsHi4 Is Essential for Embryogenesis Due to Its Influence on Chloroplast Development in Arabidopsis	PLOS ONE			English	Article							PHOTOSYSTEM-II REPAIR; THYLAKOID MEMBRANE; EMBRYO DEVELOPMENT; GENE-EXPRESSION; CHLOROPHYLL FLUORESCENCE; PLANT DEVELOPMENT; LEAF VARIEGATION; SEED DEVELOPMENT; PROTEIN IMPORT; D1 PROTEIN	Chloroplast formation is associated with embryo development and seedling growth. However, the relationship between chloroplast differentiation and embryo development remains unclear. Five FtsHi genes that encode proteins with high similarity to FtsH proteins, but lack Zn2+-binding motifs, are present in the Arabidopsis genome. In this study, we showed that T-DNA insertion mutations in the Arabidopsis FtsHi4 gene resulted in embryo arrest at the globular-to-heart-shaped transition stage. Transmission electron microscopic analyses revealed abnormal plastid differentiation with a severe defect in thylakoid formation in the mutant embryos. Immunocytological studies demonstrated that FtsHi4 localized in chloroplasts as a thylakoid membrane-associated protein, supporting its essential role in thylakoid membrane formation. We further showed that FtsHi4 forms protein complexes, and that there was a significant reduction in the accumulation of D2 and PsbO (two photosystem II proteins) in mutant ovules. The role of FtsHi4 in chloroplast development was confirmed using an RNA-interfering approach. Additionally, mutations in other FtsHi genes including FtsHi1, FtsHi2, and FtsHi5 caused phenotypic abnormalities similar to ftshi4 with respect to plastid differentiation during embryogenesis. Taken together, our data suggest that FtsHi4, together with FtsHi1, FtsHi2, and FtsHi5 are essential for chloroplast development in Arabidopsis.	[Lu, Xiaoduo; Li, Shipeng] Qilu Normal Univ, Dept Life Sci, Jinan, Peoples R China; [Zhang, Dongyuan] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Su, Yanping; Shen, Songdong] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Liang, Qiuju; Meng, Hongyan; Fan, Yunliu; Zhang, Chunyi] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Liang, Qiuju; Fan, Yunliu; Zhang, Chunyi] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Liu, Chunming] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Qilu Normal University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Soochow University - China; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, CY (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangchunyi@caas.cn	Liu, Chun-Ming/G-1006-2010; 刘, 春明/GLU-4320-2022; Shen, Songdong/G-9385-2011	Liu, Chun-Ming/0000-0002-7271-362X; 刘, 春明/0000-0002-7271-362X; Shen, Songdong/0000-0002-5731-1681	National Science Foundation of China [31071077]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (grant number 31071077 to C. Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARKAN A, 1993, PLANT CELL, V5, P389, DOI 10.1105/tpc.5.4.389; Berleth T, 2002, ARABIDOPSIS BOOK; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; CONSTANTINE NT, 1994, J VIROL METHODS, V47, P153, DOI 10.1016/0166-0934(94)90074-4; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Gao ZP, 2011, PLANT PHYSIOL, V157, P1733, DOI 10.1104/pp.111.184762; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Huang XZ, 2009, CELL RES, V19, P1205, DOI 10.1038/cr.2009.84; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kadirjan-Kalbach DK, 2012, PLANT J, V72, P856, DOI 10.1111/tpj.12001; Kim HU, 2004, PLANT PHYSIOL, V134, P1206, DOI 10.1104/pp.103.035832; Kim J, 2009, PLANT CELL, V21, P1669, DOI 10.1105/tpc.108.063784; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kwon KC, 2008, PLANT J, V55, P428, DOI 10.1111/j.1365-313X.2008.03523.x; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Liang QJ, 2010, PHYSIOL PLANTARUM, V140, P380, DOI 10.1111/j.1399-3054.2010.01407.x; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XD, 2008, CELL RES, V18, P589, DOI 10.1038/cr.2008.44; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; McElver J, 2001, GENETICS, V159, P1751; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OELMULLER R, 1989, PLANT MOL BIOL, V13, P223, DOI 10.1007/BF00016140; Ostersetzer O, 1997, PLANT CELL, V9, P957, DOI 10.1105/tpc.9.6.957; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Roy LM, 1998, J CELL BIOL, V141, P385, DOI 10.1083/jcb.141.2.385; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; SANTOS D, 1975, J BACTERIOL, V124, P1502, DOI 10.1128/JB.124.3.1502-1507.1975; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; TAYLOR WC, 1989, ANNU REV PLANT PHYS, V40, P211, DOI 10.1146/annurev.pp.40.060189.001235; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; Tzafrir I, 2003, NUCLEIC ACIDS RES, V31, P90, DOI 10.1093/nar/gkg028; Uwer U, 1998, PLANT CELL, V10, P1277, DOI 10.1105/tpc.10.8.1277; Wagner R, 2012, PHYSIOL PLANTARUM, V145, P203, DOI 10.1111/j.1399-3054.2011.01548.x; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yoshioka M, 2010, J BIOL CHEM, V285, P41972, DOI 10.1074/jbc.M110.117432; Yu B., 2004, PLANT CELL PHYSL, V45, P503, DOI 10.1093/pcp/pch064; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062	68	21	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99741	10.1371/journal.pone.0099741	http://dx.doi.org/10.1371/journal.pone.0099741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964212	Green Published, gold			2022-12-25	WOS:000338709500017
J	Kim, J; Kwak, HJ; Cha, JY; Jeong, YS; Rhee, SD; Kim, KR; Cheon, HG				Kim, Juyoung; Kwak, Hyun Jeong; Cha, Ji-Young; Jeong, Yun-Seung; Rhee, Sang Dahl; Kim, Kwang Rok; Cheon, Hyae Gyeong			Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; PROTEIN-KINASE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; NEGATIVE REGULATOR; DIABETES-MELLITUS; RESPIRATORY-CHAIN; GENE-EXPRESSION; MECHANISM	Metformin, a well known antidiabetic agent that improves peripheral insulin sensitivity, also elicits anti-inflammatory actions, but its mechanism is unclear. Here, we investigated the mechanism responsible for the anti-inflammatory effect of metformin action in lipopolysaccharide (LPS)-stimulated murine macrophages. Metformin inhibited LPS-induced production of tumor necrosis factor-alpha (TNF-alpha) and interleukin- 6 (IL-6) in a concentration-dependent manner and in parallel induction of activating transcription factor-3 (ATF3), a transcription factor and member of the cAMP-responsive element-binding protein family. ATF-3 knockdown abolished the inhibitory effects of metformin on LPS-induced proinflammatory cytokine production accompanied with reversal of metformin-induced suppression of mitogen-activated protein kinase (MAPK) phosphorylation. Conversely, AMP-activated protein kinase (AMPK) phosphorylation and NF-kappa B suppression by metformin were unaffected by ATF-3 knockdown. ChIP-PCR analysis revealed that LPS-induced NF-kappa B enrichments on the promoters of IL-6 and TNF-alpha were replaced by ATF-3 upon metformin treatment. AMPK knockdown blunted all the effects of metformin (ATF-3 induction, proinflammatory cytokine inhibition, and MAPK inactivation), suggesting that AMPK activation by metformin is required for and precedes ATF-3 induction. Oral administration of metformin to either mice with LPS-induced endotoxemia or ob/ob mice lowered the plasma and tissue levels of TNF-alpha and IL-6 and increased ATF-3 expression in spleen and lungs. These results suggest that metformin exhibits anti-inflammatory action in macrophages at least in part via pathways involving AMPK activation and ATF-3 induction.	[Kim, Juyoung; Kwak, Hyun Jeong; Cheon, Hyae Gyeong] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Pharmacol & Pharmaceut Sci, Inchon 406799, South Korea; [Cha, Ji-Young; Jeong, Yun-Seung] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406799, South Korea; [Rhee, Sang Dahl; Kim, Kwang Rok] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305343, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Inchon 405760, South Korea	Gachon University; Gachon University; Korea Research Institute of Chemical Technology (KRICT); Gachon University	Cheon, HG (corresponding author), Gachon Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Yeonsu 3 Dong, Inchon 406799, South Korea.	hgcheon@gachon.ac.kr		Cha, JI-Young/0000-0002-8557-6214	Basic Science Research Program of the Korean National Research Foundation (NRF) - Korean Ministry of Education and Technology [2010-0007517]	Basic Science Research Program of the Korean National Research Foundation (NRF) - Korean Ministry of Education and Technology	This work was supported by the Basic Science Research Program of the Korean National Research Foundation (NRF) funded by the Korean Ministry of Education and Technology (Grant 2010-0007517).	Burcelin R, 2012, PHYSIOLOGY, V27, P300, DOI 10.1152/physiol.00023.2012; Caballero AE, 2004, J CLIN ENDOCR METAB, V89, P3943, DOI 10.1210/jc.2004-0019; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; De Jager J, 2005, J INTERN MED, V257, P100; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; GALUSKA D, 1994, DIABETOLOGIA, V37, P826, DOI 10.1007/s001250050184; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Hai T, 1999, GENE EXPRESSION, V7, P321; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim YD, 2012, DIABETOLOGIA, V55, P1482, DOI 10.1007/s00125-012-2494-4; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nguyen TT, 2010, J BIOL CHEM, V285, P17011, DOI 10.1074/jbc.M109.068817; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	37	138	143	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23246	23255		10.1074/jbc.M114.577908	http://dx.doi.org/10.1074/jbc.M114.577908			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973221	Green Published, hybrid			2022-12-25	WOS:000341017200060
J	Meijles, DN; Fan, LM; Howlin, BJ; Li, JM				Meijles, Daniel N.; Fan, Lampson M.; Howlin, Brendan J.; Li, Jian-Mei			Molecular Insights of p47(phox) Phosphorylation Dynamics in the Regulation of NADPH Oxidase Activation and Superoxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; SH3 DOMAINS; OXIDATIVE STRESS; ANGIOTENSIN-II; NOX FAMILY; PROTEIN; BINDING; SUBUNIT; ALPHA; PATHOPHYSIOLOGY	Phagocyte superoxide production by a multicomponent NADPH oxidase is important in host defense against microbial invasion. However inappropriate NADPH oxidase activation causes inflammation. Endothelial cells express NADPH oxidase and endothelial oxidative stress due to prolonged NADPH oxidase activation predisposes many diseases. Discovering the mechanism of NADPH oxidase activation is essential for developing novel treatment of these diseases. The p47(phox) is a key regulatory subunit of NADPH oxidase; however, due to the lack of full protein structural information, the mechanistic insight of p47(phox) phosphorylation in NADPH oxidase activation remains incomplete. Based on crystal structures of three functional domains, we generated a computational structural model of the full p47(phox) protein. Using a combination of in silico phosphorylation, molecular dynamics simulation and protein/protein docking, we discovered that the C-terminal tail of p47(phox) is critical for stabilizing its autoinhibited structure. Ser-379 phosphorylation disrupts H-bonds that link the C-terminal tail to the autoinhibitory region (AIR) and the tandem Src homology 3 (SH3) domains, allowing the AIR to undergo phosphorylation to expose the SH3 pocket for p22(phox) binding. These findings were confirmed by site-directed mutagenesis and gene transfection of p47(phox-/-) coronary microvascular cells. Compared with wild-type p47(phox) cDNA transfected cells, the single mutation of S379A completely blocked p47(phox) membrane translocation, binding to p22(phox) and endothelial O-2 radical anion. production in response to acute stimulation of PKC. p47(phox) C-terminal tail plays a key role in stabilizing intramolecular interactions at rest. Ser-379 phosphorylation is a molecular switch which initiates p47(phox) conformational changes and NADPH oxidase-dependent superoxide production by cells.	[Meijles, Daniel N.; Li, Jian-Mei] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Fan, Lampson M.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Meijles, Daniel N.; Howlin, Brendan J.] Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 7XH, Surrey, England	University of Surrey; University of Oxford; University of Surrey	Li, JM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, AY Bldg, Guildford GU2 7XH, Surrey, England.	j.li@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Meijles, Daniel/J-6457-2014	Howlin, Brendan J/0000-0002-9398-7152; Meijles, Daniel/0000-0002-5557-3549; Li, Jian-Mei/0000-0002-3294-3818	University of Surrey Seed Fund; Wellcome Trust [07863/Z/05/Z]	University of Surrey Seed Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the University of Surrey Seed Fund and the Wellcome Trust (Grant 07863/Z/05/Z).	Autore F, 2010, BIOPHYS J, V99, P3716, DOI 10.1016/j.bpj.2010.09.008; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Du JJ, 2013, BRIT J PHARMACOL, V170, P1064, DOI 10.1111/bph.12336; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Fan LM, 2014, J PHARMACOL TOX MET, V70, P40, DOI 10.1016/j.vascn.2014.03.173; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li JM, 2001, J MOL CELL CARDIOL, V33, P1119, DOI 10.1006/jmcc.2001.1372; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; MCPHAIL LC, 1994, J EXP MED, V180, P2011, DOI 10.1084/jem.180.6.2011; Meijles DN, 2012, COMPUT BIOL CHEM, V39, P6, DOI 10.1016/j.compbiolchem.2012.05.001; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen HD, 2011, IMMUNOL CELL BIOL, V89, P225, DOI 10.1038/icb.2010.77; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Teng L, 2012, ARTERIOSCL THROM VAS, V32, P1488, DOI 10.1161/ATVBAHA.112.247775; Watanabe Y, 2006, COMPUT BIOL CHEM, V30, P303, DOI 10.1016/j.compbiolchem.2006.04.004	38	46	49	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22759	22770		10.1074/jbc.M114.561159	http://dx.doi.org/10.1074/jbc.M114.561159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970888	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000341017200021
J	Diao, DM; Wang, Z; Cheng, Y; Zhang, H; Guo, Q; Song, YC; Zhu, K; Li, K; Liu, D; Dang, CX				Diao, Dongmei; Wang, Zhe; Cheng, Yao; Zhang, Hao; Guo, Qi; Song, Yongchun; Zhu, Kun; Li, Kang; Liu, Di; Dang, Chengxue			D-Dimer: Not Just an Indicator of Venous Thrombosis but a Predictor of Asymptomatic Hematogenous Metastasis in Gastric Cancer Patients	PLOS ONE			English	Article							ELEVATED D-DIMER; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; ESOPHAGEAL CANCER; PLASMA-LEVELS; LUNG-CANCER; TUMOR-CELLS; PLATELETS; THROMBOEMBOLISM; DIAGNOSIS	Background: Plasma D-dimer levels have been shown to be high in advanced tumor stage patients and can be used to predict clinical outcome in cancer patients. As most advanced tumor stage patients exhibit asymptomatic metastasis, which contributes to early tumor recurrence after surgery, we hypothesized that plasma D-dimer levels can be used to predict patients with potential metastasis. Methods: We enrolled 1042 primary gastric cancer patients in three multiple cancer centers in Northwest China and examined plasma D-dimer levels using the latex-enhanced immunoturbidimetric assay (LEA) method. Plasma D-dimer levels were compared with the clinicopathological characteristics in this large-scale case-control study with follow up. We also performed regular follow-up studies for 395 patients to analyze the 2-year survival rate and early tumor recurrence. Results: In this large-scale clinical study, we found that plasma D-dimer levels were increased in patients with distant metastasis and especially hematogenous metastasis patients. The cut-off value of the D-dimer levels was determined to be 1.5 mg/ml based on the ROC curve, and the sensitivity and specificity for metastasis prediction were 61.9% and 86.6%, respectively. Additionally, patients with high D-dimer levels displayed early tumor recurrence and poor outcome during the follow-up study. Conclusion: Plasma D-dimer may represent an easy to measure and lower cost marker for the testing of gastric cancer patients to predict asymptomatic hematogenous metastasis.	[Diao, Dongmei; Cheng, Yao; Zhang, Hao; Guo, Qi; Song, Yongchun; Zhu, Kun; Li, Kang; Dang, Chengxue] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian, Peoples R China; [Wang, Zhe] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian, Peoples R China; [Liu, Di] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Surg Oncol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Dang, CX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian, Peoples R China.	dangchengxue@mail.xjtu.edu.cn	diao, dongmei/HGD-6807-2022		National Natural Scientific Foundation of China [30973489]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Scientific Foundation of China (No. 30973489 (to CD)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2012, BRIT J CANCER, V106, P733, DOI 10.1038/bjc.2011.592; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; Antoniou D, 2006, LUNG CANCER, V53, P205, DOI 10.1016/j.lungcan.2006.03.015; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Ay C, 2009, J CLIN ONCOL, V27, P4124, DOI 10.1200/JCO.2008.21.7752; Batschauer APB, 2010, ANN ONCOL, V21, P1267, DOI 10.1093/annonc/mdp474; Biggerstaff JP, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-12; Diao DM, 2013, J SURG ONCOL, V108, P34, DOI 10.1002/jso.23339; Dompmartin A, 2009, ARCH DERMATOL, V145, P1239, DOI 10.1001/archdermatol.2009.296; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Horowitz NA, 2011, BLOOD, V118, P2889, DOI 10.1182/blood-2011-03-341222; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kilic M, 2008, COLORECTAL DIS, V10, P238, DOI 10.1111/j.1463-1318.2007.01374.x; Kwon HC, 2008, JPN J CLIN ONCOL, V38, P2, DOI 10.1093/jjco/hym157; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lippi G, 2007, Haematologica, V92, pe53, DOI 10.3324/haematol.12237; MIRSHAHI SS, 1992, CANCER, V69, P2289, DOI 10.1002/1097-0142(19920501)69:9<2289::AID-CNCR2820690914>3.0.CO;2-A; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Raj SD, 2012, AM J CLIN ONCOL-CANC, V35, P462, DOI 10.1097/COC.0b013e31821d4529; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Stender MT, 2012, J THROMB HAEMOST, V10, P2027, DOI 10.1111/j.1538-7836.2012.04887.x; Tas F, 2012, MELANOMA RES, V22, P368, DOI 10.1097/CMR.0b013e328357be7c; Tomimaru Y, 2006, J AM COLL SURGEONS, V202, P139, DOI 10.1016/j.jamcollsurg.2005.08.008; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Yamamoto M, 2012, ONCOLOGY-BASEL, V83, P10, DOI 10.1159/000338329; Zhang W, 2012, BLOOD, V120, P2889, DOI 10.1182/blood-2012-04-425207	31	34	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101125	10.1371/journal.pone.0101125	http://dx.doi.org/10.1371/journal.pone.0101125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983619	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000056
J	Amico, E; Gomez, F; Di Perri, C; Vanhaudenhuyse, A; Lesenfants, D; Boveroux, P; Bonhomme, V; Brichant, JF; Marinazzo, D; Laureys, S				Amico, Enrico; Gomez, Francisco; Di Perri, Carol; Vanhaudenhuyse, Audrey; Lesenfants, Damien; Boveroux, Pierre; Bonhomme, Vincent; Brichant, Jean-Francois; Marinazzo, Daniele; Laureys, Steven			Posterior Cingulate Cortex-Related Co-Activation Patterns: A Resting State fMRI Study in Propofol-Induced Loss of Consciousness	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; BRAIN; STIMULATION; MECHANISMS; RESPONSES; SEDATION; NEURONS; HUMANS	Background: Recent studies have been shown that functional connectivity of cerebral areas is not a static phenomenon, but exhibits spontaneous fluctuations over time. There is evidence that fluctuating connectivity is an intrinsic phenomenon of brain dynamics that persists during anesthesia. Lately, point process analysis applied on functional data has revealed that much of the information regarding brain connectivity is contained in a fraction of critical time points of a resting state dataset. In the present study we want to extend this methodology for the investigation of resting state fMRI spatial pattern changes during propofol-induced modulation of consciousness, with the aim of extracting new insights on brain networks consciousness-dependent fluctuations. Methods: Resting-state fMRI volumes on 18 healthy subjects were acquired in four clinical states during propofol injection: wakefulness, sedation, unconsciousness, and recovery. The dataset was reduced to a spatio-temporal point process by selecting time points in the Posterior Cingulate Cortex (PCC) at which the signal is higher than a given threshold (i.e., BOLD intensity above 1 standard deviation). Spatial clustering on the PCC time frames extracted was then performed (number of clusters = 8), to obtain 8 different PCC co-activation patterns (CAPs) for each level of consciousness. Results: The current analysis shows that the core of the PCC-CAPs throughout consciousness modulation seems to be preserved. Nonetheless, this methodology enables to differentiate region-specific propofol-induced reductions in PCC-CAPs, some of them already present in the functional connectivity literature (e. g., disconnections of the prefrontal cortex, thalamus, auditory cortex), some others new (e. g., reduced co-activation in motor cortex and visual area). Conclusion: In conclusion, our results indicate that the employed methodology can help in improving and refining the characterization of local functional changes in the brain associated to propofol-induced modulation of consciousness.	[Amico, Enrico; Gomez, Francisco; Vanhaudenhuyse, Audrey; Lesenfants, Damien; Boveroux, Pierre; Bonhomme, Vincent; Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Amico, Enrico; Marinazzo, Daniele] Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Laureys, Steven] Univ Liege, Dept Neurol, Liege, Belgium; [Boveroux, Pierre; Bonhomme, Vincent; Brichant, Jean-Francois] Univ Liege, CHU Sart Tilman Hosp, Dept Anesthesia & Intens Care Med, Liege, Belgium; [Bonhomme, Vincent] Univ Liege, CHR Citadelle, Dept Anesthesia & Intens Care Med, Liege, Belgium; [Vanhaudenhuyse, Audrey] Univ Liege, CHU Sart Tilman Hosp, Dept Algol & Palliat Care, Liege, Belgium; [Di Perri, Carol] Natl Neurol Inst C Mondino, Dept Neuroradiol, Pavia, Italy	University of Liege; Ghent University; University of Liege; University of Liege; University of Liege; University of Liege; IRCCS Istituto Neurologico Besta	Amico, E (corresponding author), Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium.	eamico@ulg.ac.be	Marinazzo, Daniele/H-4793-2019; Vanhaudenhuyse, Audrey/AAP-2455-2020; Bonhomme, Vincent/J-7144-2019; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Amico, Enrico/AAB-2581-2019	Marinazzo, Daniele/0000-0002-9803-0122; Bonhomme, Vincent/0000-0001-6356-547X; Laureys, Steven/0000-0002-3096-3807; Amico, Enrico/0000-0001-6705-9689; Di Perri, Carol/0000-0003-0284-770X	Belgian Funds for Scientific Research (FRS); European Commission (DECODER); Belgian Science Policy (CEREBNET); McDonnell Foundation; European Space Agency; Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation; University of Liege	Belgian Funds for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); European Commission (DECODER); Belgian Science Policy (CEREBNET); McDonnell Foundation; European Space Agency(European Space AgencyEuropean Commission); Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation; University of Liege(University of Liege)	This research was supported by the Belgian Funds for Scientific Research (FRS), European Commission (DECODER), Belgian Science Policy (CEREBNET), McDonnell Foundation, European Space Agency, Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation, University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Allen E. A., 2012, CEREBRAL CORTEX; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Boveroux P, 2008, INT ANESTHESIOL CLIN, V46, P131, DOI 10.1097/AIA.0b013e318181a8b3; Chang C, 2010, FILM COMMENT, V46, P81; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; Dueck MH, 2005, ACTA ANAESTH SCAND, V49, P784, DOI 10.1111/j.1399-6576.2005.00703.x; Fiset P, 1999, J NEUROSCI, V19, P5506; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; KALKMAN CJ, 1992, ANESTHESIOLOGY, V76, P502, DOI 10.1097/00000542-199204000-00003; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lee U, 2009, CONSCIOUS COGN, V18, P56, DOI 10.1016/j.concog.2008.10.005; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; MacLaren R, 2000, PHARMACOTHERAPY, V20, P662, DOI 10.1592/phco.20.7.662.35172; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tenenbein PK, 2006, J NEUROSURGICAL ANES, V18, P310; Untergehrer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087498; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	41	72	74	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100012	10.1371/journal.pone.0100012	http://dx.doi.org/10.1371/journal.pone.0100012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979748	Green Published, gold			2022-12-25	WOS:000338506400016
J	Sun, FL; Wang, W; Cheng, H; Wang, Y; Li, L; Xue, JL; Wang, XF; Ai, HX; Zhang, L; Xu, JD; Wang, XM; Ji, XM				Sun, Fang-Ling; Wang, Wen; Cheng, Hua; Wang, Ying; Li, Lei; Xue, Jin-Long; Wang, Xiao-feng; Ai, Hou-Xi; Zhang, Li; Xu, Jing-dong; Wang, Xiao-Min; Ji, Xun-Ming			Morroniside Improves Microvascular Functional Integrity of the Neurovascular Unit after Cerebral Ischemia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL GROWTH-FACTOR; TIGHT JUNCTION PROTEINS; MCA-OCCLUSION MODEL; UP-REGULATION; RAT-BRAIN; CD34(+) CELLS; STROKE; ANGIOGENESIS; EXPRESSION	Treating the vascular elements within the neurovascular unit is essential for protecting and repairing the brain after stroke. Acute injury on endothelial systems results in the disruption of blood-brain barrier (BBB), while post-ischemic angiogenesis plays an important role in delayed functional recovery. Here, we considered alterations in microvessel integrity to be targets for brain recovery, and tested the natural compound morroniside as a therapeutic approach to restore the vascular elements of injured tissue in a rat model of focal cerebral ischemia. Sprague-Dawley rats were subjected to middle cerebral artery occlusion (MCAO) model, and morroniside was then administered intragastrically once a day at doses of 30, 90, and 270 mg/kg. BBB integrity and associated factors were analyzed to identify cerebrovascular permeability 3 days after MCAO. The recruitment of endothelial progenitor cells (EPCs), the expression of angiogenic factors and the new vessel formation in the peri-infarct cortex of rats were examined 7 days after MCAO to identify the angiogenesis. We demonstrated that at 3 days post-ischemia, morroniside preserved neurovascular unit function by ameliorating BBB injury. By 7 days post-ischemia, morroniside amplified angiogenesis, in part by enhancing endothelial progenitor cell proliferation and expression of angiogenic factors. Morever, the increase in the amount of vWF(+) vessels induced by ischemia could be extended to 28 days after administration of morroniside, indicating the crucial role of morroniside in angiogenesis during the chronic phase. Taken together, our findings suggested that morroniside might offer a novel therapeutic approach for promoting microvascular integrity recovery and provide a thoroughly new direction for stroke therapy.	[Sun, Fang-Ling; Wang, Wen; Cheng, Hua; Wang, Ying; Li, Lei; Xue, Jin-Long; Wang, Xiao-feng; Ai, Hou-Xi; Zhang, Li] Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing, Peoples R China; [Xu, Jing-dong] Capital Med Univ, Dept Physiol, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Xiao-Min] Capital Med Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing, Peoples R China; [Ji, Xun-Ming] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Wang, W (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing, Peoples R China.	lzwwang@163.com; xmwang@ccmu.edu.cn; robertjixm@hotmail.com	xu, jing/GRR-8698-2022; Ji, Xunming/AAN-3370-2021		National Science and Technology Major Project [2012ZX09102201-106, 2009ZX09103-366]; National Natural Science Foundation of China [81173575, 30973893, 81274173]; China Postdoctoral Science Foundation [106455]; Beijing Natural Science Foundation [7102077, 7211017]; Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund [111219]; Beijing Health System Experts of High-level [2011-3-097]; Beijing Municipal Commission of Education [KM201010025004]; Beijing Postdoctoral Science Foundation [106455]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund; Beijing Health System Experts of High-level; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Science and Technology Major Project (2012ZX09102201-106 and 2009ZX09103-366); National Natural Science Foundation of China (81173575, 30973893 and 81274173); China Postdoctoral Science Foundation funded project (106455); Beijing Natural Science Foundation (7102077 and 7211017); Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund (111219); a grant of Beijing Health System Experts of High-level (2011-3-097); Beijing Municipal Commission of Education (KM201010025004); Beijing Postdoctoral Science Foundation funded project (106455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Anthony DC, 1997, NEUROPATH APPL NEURO, V23, P406, DOI 10.1111/j.1365-2990.1997.tb01315.x; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Blamire AM, 2000, J NEUROSCI, V20, P8153; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Liu WB, 2005, CYTOKINE, V32, P206, DOI 10.1016/j.cyto.2005.09.009; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Ma XL, 2013, CURR NEUROVASC RES, V10, P103, DOI 10.2174/1567202611310020003; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Mey L, 2013, NEUROBIOL DIS, V59, P111, DOI 10.1016/j.nbd.2013.06.009; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Parry-Jones AR, 2008, MAGN RESON MED, V59, P1239, DOI 10.1002/mrm.21531; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Qin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061831; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wang W, 2008, CELL MOL NEUROBIOL, V28, P293, DOI 10.1007/s10571-007-9168-7; Wang W, 2010, BRAIN RES BULL, V83, P196, DOI 10.1016/j.brainresbull.2010.07.003; Wang W, 2009, EUR J PHARMACOL, V613, P19, DOI 10.1016/j.ejphar.2009.04.013; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yao RQ, 2009, BRAIN RES BULL, V79, P69, DOI 10.1016/j.brainresbull.2008.12.010; Zhang ZG, 2001, J CEREBR BLOOD F MET, V21, P541, DOI 10.1097/00004647-200105000-00008; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zheng QP, 2011, TOHOKU J EXP MED, V224, P221, DOI 10.1620/tjem.224.221; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101194	10.1371/journal.pone.0101194	http://dx.doi.org/10.1371/journal.pone.0101194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979385	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400097
J	Chan, TC; Fu, YC; Wang, DW; Chuang, JH				Chan, Ta-Chien; Fu, Yang-chih; Wang, Da-Wei; Chuang, Jen-Hsiang			Determinants of Receiving the Pandemic (H1N1) 2009 Vaccine and Intention to Receive the Seasonal Influenza Vaccine in Taiwan	PLOS ONE			English	Article							COST-EFFECTIVENESS; SOCIAL NETWORKS; CHILDREN; SPREAD; IMPACT	Objectives: The paper examines the factors associated with both receiving pandemic (H1N1) 2009 vaccines and individuals' intentions to get the next seasonal influenza vaccine in Taiwan. Methods: We conducted a representative nationwide survey with in-person household interviews during April-July 2010. Multivariate logistic regression incorporated socio-demographic background, household characteristics, health status, behaviors, and perceptions of influenza and vaccination. Results: We completed interviews with 1,954 respondents. Among those, 548 (28.0%) received the pandemic (H1N1) 2009 vaccination, and 469 (24.0%) intended to get the next seasonal influenza vaccine. Receipt of the H1N1 vaccine was more prevalent among schoolchildren, the elderly, those who had contact with more people in their daily lives, and those who had received influenza vaccinations in previous years. In comparison, the intention to receive the next seasonal influenza vaccine tended to be stronger among children, the elderly, and those who reported less healthy status or lived with children, who received a seasonal influenza vaccination before, and who worried more about a possible new pandemic. Conclusions: Children, the elderly, and those who had gotten seasonal flu shots before in Taiwan were more likely to both receive a pandemic H1N1 vaccination and intend to receive a seasonal influenza vaccine.	[Chan, Ta-Chien] Acad Sinica, Res Ctr Human & Social Sci, Taipei 115, Taiwan; [Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University	Chuang, JH (corresponding author), Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan.	jhchuang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418	Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China [DOH99-DC-1004, DOH101-DC-1011]	Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China	This work was supported in part by the grants DOH99-DC-1004 and DOH101-DC-1011 from the Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058852; Blank PR, 2009, J INFECTION, V58, P446, DOI 10.1016/j.jinf.2009.04.001; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Brunson EK, 2013, PEDIATRICS, V131, pE1397, DOI 10.1542/peds.2012-2452; Carpenter LR, 2007, PEDIATRICS, V120, pE172, DOI 10.1542/peds.2006-2603; Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011317; Chang YH, 2004, JGSS S 2003 BIRTH JG, P149; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Heikkinen T, 2011, VACCINE, V29, P7529, DOI 10.1016/j.vaccine.2011.08.011; Huang JH, 2012, EUR J PUBLIC HEALTH, V22, P796, DOI 10.1093/eurpub/ckr167; Lemeshow, 2000, APPL LOGISTIC REGRES, P95; Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009; Liao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068019; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; Mamelund SE, 2011, VACCINE, V29, P9441, DOI 10.1016/j.vaccine.2011.10.035; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; Marchetti M, 2007, HUM VACCINES, V3, P14, DOI 10.4161/hv.3.1.3657; Mok E, 2006, PUBLIC HEALTH NURS, V23, P506, DOI 10.1111/j.1525-1446.2006.00590.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Muller D, 2007, INFECTION, V35, P308, DOI 10.1007/s15010-007-6218-5; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Painter JE, 2010, HEALTH EDUC RES, V25, P853, DOI 10.1093/her/cyq037; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Shim E, 2013, MATH BIOSCI ENG, V10, P1615, DOI 10.3934/mbe.2013.10.1615; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Szucs TD, 2006, VACCINE, V24, P6776, DOI 10.1016/j.vaccine.2006.06.072; Tarride JE, 2011, VALUE HEALTH, V14, pA119, DOI 10.1016/j.jval.2011.02.665; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Yang CL., 2013, TAIWAN EPIDEMIOL B, V29, P252	36	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101083	10.1371/journal.pone.0101083	http://dx.doi.org/10.1371/journal.pone.0101083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971941	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200091
J	O'Rourke, BP; Gomez-Ferreria, MA; Berk, RH; Hackl, AMU; Nicholas, MP; O'Rourke, SC; Pelletier, L; Sharp, DJ				O'Rourke, Brian P.; Gomez-Ferreria, Maria Ana; Berk, Robin H.; Hackl, Alexandra M. U.; Nicholas, Matthew P.; O'Rourke, Sean C.; Pelletier, Laurence; Sharp, David J.			Cep192 Controls the Balance of Centrosome and Non-Centrosomal Microtubules during Interphase	PLOS ONE			English	Article							SEVERING ENZYME; GOLGI-COMPLEX; PROTEIN; TUBULIN; ORGANIZATION; NUCLEATION; INTERACTS; DYNAMICS; REVEALS; EB1	Cep192 is a centrosomal protein that contributes to the formation and function of the mitotic spindle in mammalian cells. Cep192's mitotic activities stem largely from its role in the recruitment to the centrosome of numerous additional proteins such as gamma-tubulin and Pericentrin. Here, we examine Cep192's function in interphase cells. Our data indicate that, as in mitosis, Cep192 stimulates the nucleation of centrosomal microtubules thereby regulating the morphology of interphase microtubule arrays. Interestingly, however, cells lacking Cep192 remain capable of generating normal levels of MTs as the loss of centrosomal microtubules is augmented by MT nucleation from other sites, most notably the Golgi apparatus. The depletion of Cep192 results in a significant decrease in the level of centrosome-associated gamma-tubulin, likely explaining its impact on centrosome microtubule nucleation. However, in stark contrast to mitosis, Cep192 appears to maintain an antagonistic relationship with Pericentrin at interphase centrosomes. Interphase cells depleted of Cep192 display significantly higher levels of centrosome-associated Pericentrin while overexpression of Cep192 reduces the levels of centrosomal Pericentrin. Conversely, depletion of Pericentrin results in elevated levels of centrosomal Cep192 and enhances microtubule nucleation at centrosomes, at least during interphase. Finally, we show that depletion of Cep192 negatively impacts cell motility and alters normal cell polarization. Our current working hypothesis is that the microtubule nucleating capacity of the interphase centrosome is determined by an antagonistic balance of Cep192, which promotes nucleation, and Pericentrin, which inhibits nucleation. This in turn determines the relative abundance of centrosomal and non-centrosomal microtubules that tune cell movement and shape.	[O'Rourke, Brian P.; Berk, Robin H.; Hackl, Alexandra M. U.; O'Rourke, Sean C.; Sharp, David J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Gomez-Ferreria, Maria Ana; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nicholas, Matthew P.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Yeshiva University; Albert Einstein College of Medicine	Sharp, DJ (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	david.sharp@einstein.yu.edu	Pelletier, Laurence/F-8858-2013		Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH1210379]; NIH MSTP [T32-GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DJS and the Sharp lab were supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) through award W81XWH1210379. MPN was supported by the NIH MSTP Training Grant T32-GM007288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gomez-Ferreria MA, 2012, CELL CYCLE, V11, P3555, DOI 10.4161/cc.21574; Grimaldi AD, 2013, METHOD CELL BIOL, V118, P401, DOI 10.1016/B978-0-12-417164-0.00024-0; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lerit DA, 2013, J CELL BIOL, V202, P1013, DOI 10.1083/jcb.201303141; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Nishimura Y, 2012, PLOS ONE, V7, P24; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sonbuchner TM, 2010, CELL CYCLE, V9, P2403, DOI 10.4161/cc.9.12.11916; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vinogradova T, 2012, MOL BIOL CELL, V23, P820, DOI 10.1091/mbc.E11-06-0550; Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; WEBSTER DR, 1989, J CELL SCI, V92, P57; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	36	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101001	10.1371/journal.pone.0101001	http://dx.doi.org/10.1371/journal.pone.0101001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971877	gold, Green Published			2022-12-25	WOS:000338512200082
J	Kabbout, M; Dakhlallah, D; Sharma, S; Bronisz, A; Srinivasan, R; Piper, M; Marsh, CB; Ostrowski, MC				Kabbout, Mohamed; Dakhlallah, Duaa; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Piper, Melissa; Marsh, Clay B.; Ostrowski, Michael C.			MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation	PLOS ONE			English	Article							C-MYC; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELLULAR-TRANSFORMATION; MIR-17-92 CLUSTER; BREAST-CANCER; CELLS; SURVIVAL; FAMILY; PROLIFERATION	The ETS-family transcription factors Ets1 and Ets2 are evolutionarily conserved effectors of the RAS/ERK signaling pathway, but their function in Ras cellular transformation and biology remains unclear. Taking advantage of Ets1 and Ets2 mouse models to generate Ets1/Ets2 double knockout mouse embryonic fibroblasts, we demonstrate that deletion of both Ets1 and Ets2 was necessary to inhibit Hras(G12V) induced transformation both in vitro and in vivo. Hras(G12V) expression in mouse embryonic fibroblasts increased ETS1 and ETS2 expression and binding to cis-regulatory elements on the c-Myc proximal promoter, and consequently induced a robust increase in MYC expression. The expression of the oncogenic microRNA 17-92 cluster was increased in Hras(G12V) transformed cells, but was significantly reduced when ETS1 and ETS2 were absent. MYC and ETS1 or ETS2 collaborated to increase expression of the oncogenic microRNA 17-92 cluster in Hras(G12V) transformed cells. Enforced expression of exogenous MYC or microRNA 17-92 rescued Hras(G12V) transformation in Ets1/Ets2-null cells, revealing a direct function for MYC and microRNA 17-92 in ETS1/ETS2-dependent Hras(G12V) transformation.	[Kabbout, Mohamed; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Ostrowski, Michael C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Kabbout, Mohamed; Dakhlallah, Duaa; Srinivasan, Ruchika] Ohio State Univ, Grad Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Kabbout, Mohamed; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Solid Tumor Program, Columbus, OH 43210 USA; [Dakhlallah, Duaa; Piper, Melissa; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Piper, Melissa; Marsh, Clay B.] Ohio State Univ, Coll Med, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	Sharma, Sudarshana Mangalore/AAI-2475-2019; Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019; Ostrowski, Michael/H-3108-2011	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Dakhlallah, Duaa A/0000-0002-6288-4927; Ostrowski, Michael/0000-0003-2948-6297; Sharma, Sudarshana/0000-0002-9745-0061	National Institutes of Health [P01CA097189, R01CA053271]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants P01CA097189 (M.C.O.) and R01CA053271 (M.C.O.) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; de Nigris F, 2001, CANCER RES, V61, P2267; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hever A, 2003, EXP CELL RES, V290, P132, DOI 10.1016/S0014-4827(03)00315-X; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; KLAMBT C, 1993, DEVELOPMENT, V117, P163; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Mattingly RR., 2013, ISRN ONCOL, V2013; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Reichek JL, 2011, CLIN CANCER RES, V17, P1463, DOI 10.1158/1078-0432.CCR-10-0091; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; WASYLYK C, 1994, ONCOGENE, V9, P3665; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Williamson D, 2005, J CLIN ONCOL, V23, P880, DOI 10.1200/JCO.2005.11.078; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yang BS, 1996, MOL CELL BIOL, V16, P538	40	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100693	10.1371/journal.pone.0100693	http://dx.doi.org/10.1371/journal.pone.0100693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968297	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800052
J	Li, RY; Zhang, LL; Jia, LZ; Duan, Y; Li, Y; Bao, LD; Sha, N				Li, Ruiya; Zhang, Lingli; Jia, Lizhou; Duan, Yan; Li, Yan; Bao, Lidao; Sha, Na			Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation	PLOS ONE			English	Article							EPIDERMAL NEOPLASIA; INHIBITOR U0126; CANCER; KINASE; DISEASE; GROWTH; TUMOR; METASTASIS; MECHANISMS; CELLS	Long non-coding RNAs (lncRNAs) have been shown to be implicated in the complex network of cancer including malignant melanoma and play important roles in tumorigenesis and progression. However, their functions and downstream mechanisms are largely unknown. This study aimed to investigate whether BRAF-activated non-coding RNA (BANCR), a novel and potential regulator of melanoma cell, participates in the proliferation of malignant melanoma and elucidate the underlying mechanism in this process. We found that BANCR was abnormally overexpressed in human malignant melanoma cell lines and tissues, and increased with tumor stages by quantitative PCR. BANCR knockdown induced by shRNA transfection significantly inhibited proliferation of tumor cells and inactivated MAPK pathway, especially by silencing the ERK1/2 and JNK component. Moreover, combination treatment of BANCR knockdown and suppression ERK1/2 or JNK (induced by specific inhibitors U0126 or SP600125 respectively) produced synergistic inhibitory effects in vitro. And the inhibitory effects induced by ERK1/2 or JNK could be rescued by BANCR overexpression. By tumorigenicity assay in BALB/c nude mice, we further found that BANCR knockdown inhibited tumor growth in vivo. In addition, patients with high expression of BANCR had a lower survival rate. Taken together, we confirmed the abnormal upregulation of a novel lncRNA, BANCR, in human malignant melanoma. BANCR was involved in melanoma cell proliferation both in vitro and in vivo. The linkage between BANCR and MAPK pathway may provide a novel interpretation for the mechanism of proliferation regulation in malignant melanoma.	[Li, Ruiya; Duan, Yan; Sha, Na] Inner Mongolia Peoples Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lingli] Inner Mongolia Peoples Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China; [Jia, Lizhou] Inner Mongolia Med Univ, Affiliated Peoples Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China; [Li, Yan] Inner Mongolia Med Univ, Affiliated Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Bao, Lidao] Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University; Inner Mongolia Medical University	Sha, N (corresponding author), Inner Mongolia Peoples Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China.	drnasha@126.com						Basu S, 2009, P NATL ACAD SCI USA, V106, P7957, DOI 10.1073/pnas.0902857106; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Ellis B. C, 2013, BIOCH BIOPHYS ACTA; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Flores LG, 2013, MOL IMAGING BIOL, V15, P175, DOI 10.1007/s11307-012-0588-5; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hombach S, 2013, BIOESSAYS, V35, P1093, DOI 10.1002/bies.201300068; Jiang M, 2013, BIOCH PHARM; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Ke HN, 2013, J INVEST DERMATOL, V133, P221, DOI 10.1038/jid.2012.253; Ke HN, 2010, CANCER RES, V70, P3080, DOI 10.1158/0008-5472.CAN-09-2923; Lasithiotakis KG, J INVEST DERMATOL, V128, P2013; Lee DJ, 2013, CANCER RES, V73, P4744, DOI 10.1158/0008-5472.CAN-12-4226; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Margue C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073473; McCarthy N, 2012, NAT REV CANCER, V12, P454, DOI 10.1038/nrc3302; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Solus JF, 2013, ADV ANAT PATHOL, V20, P217, DOI 10.1097/PAP.0b013e3182976c94; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu W, 2013, ACTA GEOTECH, V8, P1, DOI 10.1007/s11440-013-0214-y; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yang X, 2013, GUT, V9; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	36	132	145	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100893	10.1371/journal.pone.0100893	http://dx.doi.org/10.1371/journal.pone.0100893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967732	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800077
J	Lu, ZH; Rynkiewicz, MJ; Madico, G; Li, S; Yang, CY; Perkins, HM; Sompuram, SR; Kodela, V; Liu, T; Morris, T; Wang, D; Roche, MI; Seaton, BA; Sharon, J				Lu, Zhaohua; Rynkiewicz, Michael J.; Madico, Guillermo; Li, Sheng; Yang, Chiou-Ying; Perkins, Hillary M.; Sompuram, Seshi R.; Kodela, Vani; Liu, Tong; Morris, Timothy; Wang, Daphne; Roche, Marly I.; Seaton, Barbara A.; Sharon, Jacqueline			B-Cell Epitopes in GroEL of Francisella tularensis	PLOS ONE			English	Article							LIVE VACCINE STRAIN; OUTER-MEMBRANE PROTEIN; BETA T-CELLS; HEAT-SHOCK PROTEINS; PROTECTIVE IMMUNITY; O-ANTIGEN; MONOCLONAL-ANTIBODIES; SWISS-MODEL; CHLAMYDIA-TRACHOMATIS; MASS-SPECTROMETRY	The chaperonin protein GroEL, also known as heat shock protein 60 (Hsp60), is a prominent antigen in the human and mouse antibody response to the facultative intracellular bacterium Francisella tularensis (Ft), the causative agent of tularemia. In addition to its presumed cytoplasmic location, FtGroEL has been reported to be a potential component of the bacterial surface and to be released from the bacteria. In the current study, 13 IgG2a and one IgG3 mouse monoclonal antibodies (mAbs) specific for FtGroEL were classified into eleven unique groups based on shared VH-VL germline genes, and seven crossblocking profiles revealing at least three non-overlapping epitope areas in competition ELISA. In a mouse model of respiratory tularemia with the highly pathogenic Ft type A strain SchuS4, the Ab64 and N200 IgG2a mAbs, which block each other's binding to and are sensitive to the same two point mutations in FtGroEL, reduced bacterial burden indicating that they target protective GroEL B-cell epitopes. The Ab64 and N200 epitopes, as well as those of three other mAbs with different crossblocking profiles, Ab53, N3, and N30, were mapped by hydrogen/deuterium exchange-mass spectrometry (DXMS) and visualized on a homology model of FtGroEL. This model was further supported by its experimentally-validated computational docking to the X-ray crystal structures of Ab64 and Ab53 Fabs. The structural analysis and DXMS profiles of the Ab64 and N200 mAbs suggest that their protective effects may be due to induction or stabilization of a conformational change in FtGroEL.	[Lu, Zhaohua; Madico, Guillermo; Yang, Chiou-Ying; Perkins, Hillary M.; Roche, Marly I.; Sharon, Jacqueline] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Madico, Guillermo] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Li, Sheng; Liu, Tong; Morris, Timothy; Wang, Daphne] Univ Calif San Diego, Dept Med, Sch Med, San Diego, CA 92103 USA; [Yang, Chiou-Ying] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Sompuram, Seshi R.; Kodela, Vani] Med Discovery Partners LLC, Boston, MA USA	Boston University; Boston University; Boston University; University of California System; University of California San Diego; National Chung Hsing University	Sharon, J (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	jsharon@bu.edu		Rynkiewicz, Michael/0000-0002-4717-5700; Yang, Chiou-Ying/0000-0001-7130-1781	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200900054C]; NIH [1S10RR029388]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH, http://www.nih.gov/), Department of Health and Human Services, under Contract No. HHSN272200900054C to JS, and NIH grant No. 1S10RR029388 to Virgil L. Woods Jr. (now deceased). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aiyegbo MS, 2014, J VIROL, V88, P469, DOI 10.1128/JVI.01665-13; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JE, 2002, VET MICROBIOL, V88, P189, DOI 10.1016/S0378-1135(02)00101-3; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bansal A, 2010, MOL CELL BIOCHEM, V337, P213, DOI 10.1007/s11010-009-0301-4; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson M, 2001, SCAND J INFECT DIS, V33, P145, DOI 10.1080/003655401750065562; ERICSSON M, 1994, INFECT IMMUN, V62, P178, DOI 10.1128/IAI.62.1.178-183.1994; Eyles JE, 2008, MICROB PATHOGENESIS, V44, P164, DOI 10.1016/j.micpath.2007.08.009; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Foshay L, 1940, MEDICINE, V19, P1, DOI 10.1097/00005792-194002000-00001; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; HAVLIR DV, 1991, INFECT IMMUN, V59, P665, DOI 10.1128/IAI.59.2.665-670.1991; Hechard C, 2004, J MED MICROBIOL, V53, P861, DOI 10.1099/jmm.0.05442-0; Henderson B, 2010, CELL BIOCHEM FUNCT, V28, P1, DOI 10.1002/cbf.1609; HERLYN DM, 1980, CANCER RES, V40, P717; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; Hoffman P S, 1999, Infect Dis Obstet Gynecol, V7, P58, DOI 10.1002/(SICI)1098-0997(1999)7:1/2<58::AID-IDOG12>3.3.CO;2-1; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; KHLEBNIKOV VS, 1992, ZH MIKROB EPID IMMUN, P67; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Klimpel GR, 2008, VACCINE, V26, P6874, DOI 10.1016/j.vaccine.2008.09.077; Klimpel GR, 2008, VACCINE; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulis M, 2013, MOL NUTR FOOD RES, V57, P906, DOI 10.1002/mnfr.201200410; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lin JS, 1996, INFECT IMMUN, V64, P4396, DOI 10.1128/IAI.64.10.4396-4400.1996; Linhares IM, 2010, CELL STRESS CHAPERON, V15, P467, DOI 10.1007/s12192-010-0171-4; Lu Z, 2007, IMMUNOL LETT, V112, P92, DOI 10.1016/j.imlet.2007.07.006; Lu ZH, 2012, IMMUNOLOGY, V136, P352, DOI 10.1111/j.1365-2567.2012.03589.x; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Madico G, 1998, J CLIN MICROBIOL, V36, P3205, DOI 10.1128/JCM.36.11.3205-3210.1998; Madico G, 2000, J CLIN MICROBIOL, V38, P1085, DOI 10.1128/JCM.38.3.1085-1093.2000; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; Noll A, 1996, INFECT IMMUN, V64, P2955, DOI 10.1128/IAI.64.8.2955-2961.1996; NOLL A, 1994, INFECT IMMUN, V62, P2784, DOI 10.1128/IAI.62.7.2784-2791.1994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Prakken B, 1998, BIOTHERAPY, V10, P205, DOI 10.1007/BF02678298; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rynkiewicz MJ, 2012, BIOCHEMISTRY-US, V51, P5684, DOI 10.1021/bi201711m; Savitt AG, 2009, CLIN VACCINE IMMUNOL, V16, P414, DOI 10.1128/CVI.00362-08; SCHLIMOK G, 1986, HYBRIDOMA, V5, pS163; Sebastian S, 2009, VACCINE, V27, P597, DOI 10.1016/j.vaccine.2008.10.079; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; Sharon J, 2014, IMMUNOLOGY, V142, P1, DOI 10.1111/imm.12213; Sharon Jacqueline, 2002, Methods Mol Biol, V178, P101; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; Stenmark S, 1999, INFECT IMMUN, V67, P1789; Takahashi I, 1996, J PERIODONTAL RES, V31, P589, DOI 10.1111/j.1600-0765.1996.tb00524.x; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Thomas LD, 2010, INFECT DIS CLIN N AM, V24, P43, DOI 10.1016/j.idc.2009.10.012; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Twine SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010000; Valentino MD, 2011, IMMUNOLOGY, V132, P348, DOI 10.1111/j.1365-2567.2010.03387.x; van der Zee R, 1998, SEMIN IMMUNOL, V10, P35, DOI 10.1006/smim.1997.0103; van Eden W, 2000, CELL STRESS CHAPERON, V5, P452, DOI 10.1379/1466-1268(2000)005<0452:APRPOS>2.0.CO;2; Vanniasinkam T, 2004, VET IMMUNOL IMMUNOP, V98, P91, DOI 10.1016/j.vetimm.2003.11.001; Wang Q, 2011, BIOCHEMISTRY-US, V50, P10941, DOI 10.1021/bi201450v; Wendling U, 1998, BIOTHERAPY, V10, P223, DOI 10.1007/BF02678300; Wick G, 2000, HERZ, V25, P87, DOI 10.1007/PL00001957; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yamaguchi H, 2000, INFECT IMMUN, V68, P3448, DOI 10.1128/IAI.68.6.3448-3454.2000; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	113	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99847	10.1371/journal.pone.0099847	http://dx.doi.org/10.1371/journal.pone.0099847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968190	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800021
J	Schiavoni, I; Fedele, G; Quattrini, A; Bianco, M; Schnoeller, C; Openshaw, PJ; Locht, C; Ausiello, CM				Schiavoni, Ilaria; Fedele, Giorgio; Quattrini, Adriano; Bianco, Manuela; Schnoeller, Corinna; Openshaw, Peter J.; Locht, Camille; Ausiello, Clara M.			Live Attenuated B. pertussis BPZE1 Rescues the Immune Functions of Respiratory Syncytial Virus Infected Human Dendritic Cells by Promoting Th1/Th17 Responses	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; T-CELLS; INTERFERON; VACCINE; MATURATION; LUNG; ACTIVATION; MIGRATION; DISEASE; INNATE	Respiratory Syncytial virus (RSV) is the leading cause of acute lower respiratory tract viral infection in young children and a major cause of winter hospitalization. Bordetella pertussis is a common cause of bacterial lung disease, affecting a similar age group. Although vaccines are available for B. pertussis infection, disease rates have recently increased in many countries. We have therefore developed a novel live attenuated B. pertussis strain (BPZE1), which has recently undergone a successful clinical phase I trial. In mice, BPZE1 provides protection against disease caused by respiratory viral challenge. Here, we analyze the effect of BPZE1 on antiviral T cell responses induced by human monocyte-derived dendritic cells (MDDC). We found that BPZE1 influences antiviral immune responses at several levels, enhancing MDDC maturation, IL-12p70 production, and shifting T cell cytokine profile towards a Th1/Th17 pattern. These data were supported by the intracellular signaling analysis. RSV infection of MDDC caused MyD88-independent STAT1 phosphorylation, whereas BPZE1 activated MyD88-dependent signaling pathways; co-infection caused both pathways to be activated. These findings suggest that BPZE1 given during infancy might improve the course and outcome of viral lung disease in addition to providing specific protection against B. pertussis infection.	[Schiavoni, Ilaria; Fedele, Giorgio; Quattrini, Adriano; Bianco, Manuela; Ausiello, Clara M.] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Schnoeller, Corinna; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Resp Infect, London, England; [Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Locht, Camille] Univ Lille Nord France, Lille, France	Istituto Superiore di Sanita (ISS); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Ausiello, CM (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	clara.ausiello@iss.it	Locht, Camille/L-3516-2018; FEDELE, GIORGIO/M-4357-2015; fedele, giorgio/N-4681-2015; SCHIAVONI, ILARIA/M-4367-2015; schiavoni, ilaria/N-5524-2015; Ausiello, Clara/G-3232-2011; Openshaw, Peter/AAL-9442-2020	FEDELE, GIORGIO/0000-0003-0017-6711; SCHIAVONI, ILARIA/0000-0003-1870-8907; Openshaw, Peter/0000-0002-7220-2555; Locht, Camille/0000-0001-7295-7336	European Commission [201502]; Italian Ministry of Health [RF-2010-2317709]; Wellcome Trust [087805/Z/08/Z]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the European Commission under the grant agreement # 201502 (ChildINNOVAC), and a grant from the Italian Ministry of Health, RF-2010-2317709. PO is an NIHR Senior Investigator, supported by the Wellcome Trust (Programme 087805/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Raya B, 2013, PEDIATR INFECT DIS J, V32, P619, DOI 10.1097/INF.0b013e3182877973; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gonzalez PA, 2012, REV MED VIROL, V22, P230, DOI 10.1002/rmv.1704; Gonzalez PA, 2008, P NATL ACAD SCI USA, V105, P14999, DOI 10.1073/pnas.0802555105; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Le Nouen C, 2009, VIROLOGY, V385, P169, DOI 10.1016/j.virol.2008.11.043; Li R, 2010, J VIROL, V84, P7105, DOI 10.1128/JVI.02542-09; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Liotta F, 2008, J ALLERGY CLIN IMMUN, V121, P1000, DOI 10.1016/j.jaci.2008.01.004; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; McDermott DS, 2011, FUTURE VIROL, V6, P963, DOI 10.2217/fvl.11.62; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Moreno G, 2013, MICROBES INFECT, V15, P708, DOI 10.1016/j.micinf.2013.06.010; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; Openshaw PJM, 2004, J ALLERGY CLIN IMMUN, V114, P1275, DOI 10.1016/j.jaci.2004.08.024; Pinto RA, 2006, PEDIATRICS, V117, pE878, DOI 10.1542/peds.2005-2119; Schnoeller C, 2014, AM J RESP CRIT CARE, V189, P194, DOI [10.1164/rccm.201307-1227OC, 10.1164/rccm.201307-227OC]; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Skerry CM, 2009, CLIN VACCINE IMMUNOL, V16, P1344, DOI 10.1128/CVI.00082-09; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Stein MF, 2013, MOL CELL BIOL, V33, P1331, DOI 10.1128/MCB.01051-12; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Tekkanat KK, 2001, AM J PATHOL, V159, P631, DOI 10.1016/S0002-9440(10)61734-8; Thorstensson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083449; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wolfe DN, 2010, J IMMUNOL, V184, P1392, DOI 10.4049/jimmunol.0803045	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100166	10.1371/journal.pone.0100166	http://dx.doi.org/10.1371/journal.pone.0100166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967823	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800027
J	Zhang, HL; Gu, LB; Liu, T; Chiang, KY; Zhou, MX				Zhang, Hailong; Gu, Lubing; Liu, Tao; Chiang, Kuang-Yueh; Zhou, Muxiang			Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; WILD-TYPE P53; BCR-ABL; POOR-PROGNOSIS; C-ABL; CYTOGENETIC RESPONSES; CHILDHOOD LEUKEMIAS; HEMATOPOIETIC-CELLS; IMATINIB	Nilotinib is a selective BCR-ABL tyrosine kinase inhibitor related to imatinib that is more potent than imatinib. Nilotinib is widely used to treat chronic myelogenous leukemia (CML) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL). The present study identifies Mouse double minute 2 homolog (MDM2) as a target of nilotinib. In studying ALL cell lines, we found that the expression of MDM2 in both Philadelphia positive (Ph+) and Philadelphia negative (Ph-) ALL cells was remarkably inhibited by nilotinib, in a dose-and time-dependent manner. Further studies demonstrated that nilotinib inhibited MDM2 at the post-translational level by inducing MDM2 self-ubiquitination and degradation. Nilotinib-mediated MDM2 downregulation did not result in accumulation and activation of p53. Inhibition of MDM2 in nilotinib-treated ALL cells led to downregulation of the anti-apoptotic protein X-linked inhibitor of apoptosis protein (XIAP), a translational target of MDM2, resulting in activation of caspases. Inhibition of XIAP following nilotinib-mediated downregulation of MDM2 resulted in apoptosis of MDM2-expressing ALL; however, similar nilotinib treatment induced stronger apoptosis in Ph+/MDM2+ ALL than in Ph-/MDM2+ or Ph+/MDM2-ALL. The ALL cells that were Ph-/MDM2- were totally resistant to nilotinib. These results suggested that nilotinib can inhibit MDM2 and induce a p53-independent apoptosis pathway by downregulating XIAP; thus, nilotinib can treat not only Ph+, but also Ph-ALL patients whose cancer cells overexpress MDM2.	[Zhou, Muxiang] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30332 USA; Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA	Emory University; Emory University	Zhou, MX (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30332 USA.	mzhou@emory.edu			National Institutes of Health [R01 CA123490, R01CA143107]; CURE; NATIONAL CANCER INSTITUTE [R01CA180519, R01CA143107, R01CA123490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA123490 and R01CA143107 to MZ) and CURE (to MZ and LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUESORAMOS CE, 1993, BLOOD, V82, P2617; Camgoz A, 2013, LEUKEMIA LYMPHOMA, V54, P1279, DOI 10.3109/10428194.2012.737919; Carter BZ, 2006, BLOOD, V107, P1555, DOI 10.1182/blood-2004-12-4704; Chow KU, 2007, LEUKEMIA LYMPHOMA, V48, P1379, DOI 10.1080/10428190701385181; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Fava C, 2009, BLOOD, V113, P5058, DOI 10.1182/blood-2008-10-184960; Goetz AW, 2001, CANCER RES, V61, P7635; Goldberg Z, 2004, CELL CYCLE, V3, P1188; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Gustafsson B, 1998, PEDIATR HEMAT ONCOL, V15, P519, DOI 10.3109/08880019809018313; Gustafsson B, 2001, PEDIATR HEMAT ONCOL, V18, P497, DOI 10.1080/088800101753328466; Gustafsson B, 2000, MED PEDIATR ONCOL, V34, P117, DOI 10.1002/(SICI)1096-911X(200002)34:2<117::AID-MPO9>3.0.CO;2-8; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang M, 2013, MOL CANCER THER, V12, P184, DOI 10.1158/1535-7163.MCT-12-0425; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Jing Y, 2007, J BIOCHEM, V141, P621, DOI 10.1093/jb/mvm068; JUVEN T, 1993, ONCOGENE, V8, P3411; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Marks DI, 1997, J CLIN ONCOL, V15, P1158, DOI 10.1200/JCO.1997.15.3.1158; Marks DI, 1996, BLOOD, V87, P1155, DOI 10.1182/blood.V87.3.1155.bloodjournal8731155; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; NAUMOVSKI L, 1988, CANCER RES, V48, P2876; Nawata R, 2003, ONCOGENE, V22, P7774, DOI 10.1038/sj.onc.1206901; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Shaker ME, 2013, BBA-MOL CELL RES, V1833, P1992, DOI 10.1016/j.bbamcr.2013.02.033; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Waning DL, 2011, J BIOL CHEM, V286, P216, DOI 10.1074/jbc.M110.183012; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100960	10.1371/journal.pone.0100960	http://dx.doi.org/10.1371/journal.pone.0100960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968304	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800092
J	Hu, YH; Parvin, JD				Hu, Yiheng; Parvin, Jeffrey D.			Small Ubiquitin-like Modifier (SUMO) Isoforms and Conjugation-independent Function in DNA Double-strand Break Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; RAD52 SUMOYLATION; GENOTOXIC STRESS; E3 LIGASE; PROTEIN; CEREVISIAE; DAMAGE; BRCA1	Small ubiquitin-like modifier (SUMO) proteins act in DNA double-strand break (DSB) repair, but the pathway specificity of the three major isoforms has not been defined. In experiments in which we depleted the endogenous SUMO protein by RNAi, we found that SUMO1 functioned in all subpathways of either homologous recombination (HR) or non-homologous end joining (NHEJ), whereas SUMO2/3 was required for the major NHEJ pathway, called conservative NHEJ, but dispensable in other DSB repair pathways. To our surprise, we found that depletion of UBC9, the unique SUMO E2 enzyme, had no effect in HR or alternative NHEJ (Alt-NHEJ) but was required for conservative NHEJ. Consistent with this result, both non-conjugatable mutant and wild-type SUMO1 proteins functioned similarly in HR and Alt-NHEJ. These results detail the functional roles of specific SUMO isoforms in DSB repair in mammalian cells and reveal that SUMO1 functions in HR or Alt-NHEJ as a free protein and not as a protein conjugate.	[Hu, Yiheng; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parvin, JD (corresponding author), Ohio State Univ, Dept Biomed Informat, 460 W 12th Ave, Columbus, OH 43210 USA.	Jeffrey.Parvin@osumc.edu	Parvin, Jeffrey D/C-8955-2009		National Institutes of Health Grant [CA141090]; NATIONAL CANCER INSTITUTE [R01CA141090] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA141090 (to J. D. P.).	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guo WZ, 2009, ARCH BIOCHEM BIOPHYS, V486, P81, DOI 10.1016/j.abb.2009.03.011; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Li WH, 2000, NUCLEIC ACIDS RES, V28, P1145, DOI 10.1093/nar/28.5.1145; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yamada K, 2012, BIOSCI BIOTECH BIOCH, V76, P1035, DOI 10.1271/bbb.120019; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	50	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21289	21295		10.1074/jbc.C114.582122	http://dx.doi.org/10.1074/jbc.C114.582122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24966330	Green Published, hybrid			2022-12-25	WOS:000340558300008
J	Xiao, ZJ; Zhang, AW; Lin, JW; Zheng, ZY; Shi, XL; Di, W; Qi, WW; Zhu, YT; Zhou, GJ; Fang, YN				Xiao, Zijian; Zhang, Aiwu; Lin, Jianwen; Zheng, Zhenyang; Shi, Xiaolei; Di, Wei; Qi, Weiwei; Zhu, Yingting; Zhou, Guijuan; Fang, Yannan			Telomerase: A Target for Therapeutic Effects of Curcumin and a Curcumin Derivative in A beta 1-42 Insult In Vitro	PLOS ONE			English	Article							OXIDATIVE STRESS; INHIBITS TELOMERASE; ALZHEIMERS-DISEASE; AMYLOID PATHOLOGY; BRAIN; ANTIOXIDANT; DAMAGE; PROTEINS	This study was designed to investigate whether telomerase was involved in the neuroprotective effect of curcumin and Cur1. Alzheimer's disease is a consequence of an imbalance between the generation and clearance of amyloid-beta peptide in the brain. In this study, we used A beta 1-42 (10 mu g/ml) to establish a damaged cell model, and curcumin and Cur1 were used in treatment groups. We measured cell survival and cell growth, intracellular oxidative stress and hTERT expression. After RNA interference, the effects of curcumin and Cur1 on cells were verified. Exposure to A beta 1-42 resulted in significant oxidative stress and cell toxicity, and the expression of hTERT was significantly decreased. Curcumin and Cur1 both protected SK-N-SH cells from A beta 1-42 and up-regulated the expression of hTERT. Furthermore, Cur1 demonstrated stronger protective effects than curcumin. However, when telomerase was inhibited by TERT siRNA, the neuroprotection by curcumin and Cur1 were ceased. Our study indicated that the neuroprotective effects of curcumin and Cur1 depend on telomerase, and thus telomerase may be a target for therapeutic effects of curcumin and Cur1.	[Xiao, Zijian; Zhang, Aiwu; Lin, Jianwen; Zheng, Zhenyang; Shi, Xiaolei; Di, Wei; Qi, Weiwei; Zhou, Guijuan; Fang, Yannan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yingting] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Fang, YN (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	fangyannan@21cn.com						Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Ancelin ML, 2007, DEMENT GERIATR COGN, V24, P1, DOI 10.1159/000102567; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Chiu WT, 2011, J CELL PHYSIOL, V226, P2041, DOI 10.1002/jcp.22536; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Franco Sonia, 2006, Alzheimers Dement, V2, P164, DOI 10.1016/j.jalz.2006.03.001; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gonzalez-Reyes S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/801418; Kant V, 2014, INT IMMUNOPHARMACOL, V20, P322, DOI 10.1016/j.intimp.2014.03.009; Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466; Kim E, 2003, HUM GENE THER, V14, P1415, DOI 10.1089/104303403769211637; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mollazade M, 2013, ASIAN PAC J CANCER P, V14, P6925, DOI 10.7314/APJCP.2013.14.11.6925; Ramachandran C, 2002, CANCER LETT, V184, P1, DOI 10.1016/S0304-3835(02)00192-1; Sattayasai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085053; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Swomley AM, 2013, BIOCH BIOPHYS ACTA; Tichon A, 2013, CURR MOL MED, V13, P1010, DOI 10.2174/1566524011313060013; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Xiao ZJ, 2010, BRAIN RES, V1361, P115, DOI 10.1016/j.brainres.2010.09.019; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	34	81	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101251	10.1371/journal.pone.0101251	http://dx.doi.org/10.1371/journal.pone.0101251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983737	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000077
J	de Barra, M; Islam, MS; Curtis, V				de Barra, Micheal; Islam, M. Sirajul; Curtis, Val			Disgust Sensitivity Is Not Associated with Health in a Rural Bangladeshi Sample	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; DISEASE; INTERVIEWER; DOMAINS; ILLNESS	Disgust can be considered a psychological arm of the immune system that acts to prevent exposure to infectious agents. High disgust sensitivity is associated with greater behavioral avoidance of disease vectors and thus may reduce infection risk. A cross-sectional survey in rural Bangladesh provided no strong support for this hypothesis. In many species, the expression of pathogen- and predator-avoidance mechanisms is contingent on early life exposure to predators and pathogens. Using childhood health data collected in the 1990s, we examined if adults with more infectious diseases in childhood showed greater adult disgust sensitivity: no support for this association was found. Explanations for these null finding and possible directions for future research are discussed.	[de Barra, Micheal; Curtis, Val] London Sch Hyg & Trop Med, Environm Hlth Grp, London WC1, England; [Islam, M. Sirajul] ICDDR B, Environm Microbiol Lab, Dhaka, Bangladesh	University of London; London School of Hygiene & Tropical Medicine; International Centre for Diarrhoeal Disease Research (ICDDR)	de Barra, M (corresponding author), London Sch Hyg & Trop Med, Environm Hlth Grp, London WC1, England.	mdebarra@gmail.com			Hindustan Unilever Ltd	Hindustan Unilever Ltd(Unilever)	This research was supported by a grant from Hindustan Unilever Ltd to Valerie A. Curtis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOM CONTROL IEEE T; Albers R, 2005, BRIT J NUTR, V94, P452, DOI 10.1079/BJN20051469; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Bayliss AP, 2007, COGNITION, V104, P644, DOI 10.1016/j.cognition.2006.07.012; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; Curtis V., 2013, DONT LOOK DONT TOUCH; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Davey GCL, 2006, J BEHAV THER EXP PSY, V37, P4, DOI 10.1016/j.jbtep.2005.09.001; De Barra M, 2013, FIGSHARE, DOI [10.6084/m9.figshare.839646, DOI 10.6084/M9.FIGSHARE.839646]; de Barra M, 2013, EVOL HUM BEHAV, V34, P384, DOI 10.1016/j.evolhumbehav.2013.07.001; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; FREEMAN J, 1976, PUBLIC OPIN QUART, V40, P79, DOI 10.1086/268269; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hoefling A, 2009, EMOTION, V9, P50, DOI 10.1037/a0014449; HOX JJ, 1994, SOCIOL METHOD RES, V22, P300, DOI 10.1177/0049124194022003002; Hutchings MR, 2006, MAMMAL REV, V36, P1, DOI 10.1111/j.1365-2907.2006.00080.x; Janeway CA, 2001, IMMUNOBIOLOGY; LIVELY CM, 1986, EVOLUTION, V40, P232, DOI 10.1111/j.1558-5646.1986.tb00466.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013371; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Olatunji BO, 2009, J CROSS CULT PSYCHOL, V40, P234, DOI 10.1177/0022022108328918; Rahman MM, 2012, HLTH DEMOGRAPHIC SUR, V44; Rahman O, 1999, 1996 MATLAB HLTH SOC; Rozin P, 1999, J RES PERS, V33, P330, DOI 10.1006/jrpe.1999.2251; Rozin P, 2008, JUDGM DECIS MAK, V3, P191; Stevenson RJ, 2009, EVOL HUM BEHAV, V30, P363, DOI 10.1016/j.evolhumbehav.2009.02.005; Tybur JM, 2011, PERS INDIV DIFFER, V51, P343, DOI 10.1016/j.paid.2011.04.003; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Waynforth D, 2012, P ROY SOC B-BIOL SCI, V279, P2998, DOI 10.1098/rspb.2012.0220; Wisenden BD, 2003, FISH DEFENSES, V2, P151	37	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100444	10.1371/journal.pone.0100444	http://dx.doi.org/10.1371/journal.pone.0100444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24977418	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000338506400029
J	Majumder, R; Koklic, T; Sengupta, T; Cole, D; Chattopadhyay, R; Biswas, S; Monroe, D; Lentz, BR				Majumder, Rinku; Koklic, Tilen; Sengupta, Tanusree; Cole, Daud; Chattopadhyay, Rima; Biswas, Subir; Monroe, Dougald; Lentz, Barry R.			Soluble Phosphatidylserine Binds to Two Sites on Human Factor IXa in a Ca2+ Dependent Fashion to Specifically Regulate Structure and Activity	PLOS ONE			English	Article							FACTOR X-A; COAGULATION FACTOR-X; BOVINE FACTOR-X; FACTOR V-A; BLOOD-COAGULATION; PROTHROMBIN ACTIVATION; SODIUM DEOXYCHOLATE; MEMBRANE-SURFACE; FACTOR-VIIIA; FACTOR XASE	Clinical studies have demonstrated a correlation between elevated levels of FIX and the risk of coronary heart disease, while reduced plasma FIX causes hemophilia B. FIXa interacts with FVIIIa in the presence of Ca2+ and phosphatidylserine (PS)-containing membranes to form a factor X-activating complex (Xase) that is key to propagation of the initiated blood coagulation process in human. We test the hypothesis that PS in these membranes up-regulates the catalytic activity of this essential enzyme. We used a soluble form of phosphatidylserine, 1, 2-dicaproyl-sn-glycero-3-phospho-L-serine (C6PS), as a tool to do so. C6PS and PS in membranes are reported to regulate the homologous FXa nearly identically. FIXa binds a molecule of C6PS at each of with two sites with such different affinities (similar to 100-fold) that these appear to be independent. A high affinity C6PS binding site (K-d similar to 1.4 mu M) regulates structure, whereas a low-affinity binding site (K-d similar to 140 mu M) regulates activity. Equilibrium dialysis experiments were analyzed globally with four other data sets (proteolytic and amidolytic activities, intrinsic fluorescence, ellipticity) to unequivocally demonstrate stoichiometries of one for both sites. Michaelis-Menten parameters for FIXa proteolytic activity were the same in the presence of C6PS or PS/PC membranes. We conclude that the PS molecule and not a membrane surface is the key regulator of both factors Xa and IXa. Despite some minor differences in the details of regulation of factors Xa and IXa, the similarities we found suggest that lipid regulation of these two proteases may be similar, a hypothesis that we continue to test.	[Majumder, Rinku; Koklic, Tilen; Sengupta, Tanusree; Cole, Daud; Chattopadhyay, Rima; Biswas, Subir; Lentz, Barry R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Monroe, Dougald] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Majumder, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	rinku_majumder@med.unc.edu	S, Tanusree/AAI-8680-2021; Majumder, Rinku/J-7512-2019	S, Tanusree/0000-0002-6828-667X; Lentz, Barry/0000-0001-9685-8690; Monroe, Dougald/0000-0002-0493-2943; majumder, Rinku/0000-0002-1727-7220	National Institute of Health USPHS [HL 45916]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045916] Funding Source: NIH RePORTER	National Institute of Health USPHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Health USPHS Grant HL 45916 to BRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardoin SP, 2007, SCAND J IMMUNOL, V66, P159, DOI 10.1111/j.1365-3083.2007.01984.x; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Chattopadhyay R, 2009, BIOPHYS J, V96, P974, DOI 10.1016/j.bpj.2008.10.013; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FURIE B, 1982, J BIOL CHEM, V257, P3875; HAQUE ME, 1995, J PHYS CHEM-US, V99, P14032, DOI 10.1021/j100038a039; Haque ME, 1999, J COLLOID INTERF SCI, V217, P1, DOI 10.1006/jcis.1999.6267; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; JACOBS M, 1994, J BIOL CHEM, V269, P25494; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Majumder R, 2002, J BIOL CHEM, V277, P29765, DOI 10.1074/jbc.M200893200; Majumder R, 2013, BIOCHEMISTRY-US, V52, P143, DOI 10.1021/bi301239z; Majumder R, 2011, J BIOL CHEM, V286, P35535, DOI 10.1074/jbc.M111.260141; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Monroe DM, 1996, BLOOD COAGUL FIBRIN, V7, P459, DOI 10.1097/00001721-199606000-00005; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; RAWALASHEIKH R, 1990, BIOCHEMISTRY-US, V29, P2606, DOI 10.1021/bi00462a025; RAWALASHEIKH R, 1992, BLOOD, V79, P398; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Weinreb GE, 2003, J BIOL CHEM, V278, P5679, DOI 10.1074/jbc.M208423200; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d	29	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100006	10.1371/journal.pone.0100006	http://dx.doi.org/10.1371/journal.pone.0100006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979705	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400015
J	Najafi, A; Masoudi-Nejad, A; Ghanei, M; Nourani, MR; Moeini, A				Najafi, Ali; Masoudi-Nejad, Ali; Ghanei, Mostafa; Nourani, Mohamad-Reza; Moeini, Ali			Pathway Reconstruction of Airway Remodeling in Chronic Lung Diseases: A Systems Biology Approach	PLOS ONE			English	Article							SULFUR MUSTARD; BRONCHIOLITIS OBLITERANS; GENE-EXPRESSION; PROTEIN; APOPTOSIS; DATABASE; EXPOSURE; CELLS; TRANSCRIPTOME; INTEGRATION	Airway remodeling is a pathophysiologic process at the clinical, cellular, and molecular level relating to chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD), asthma and mustard lung. These diseases are associated with the dysregulation of multiple molecular pathways in the airway cells. Little progress has so far been made in discovering the molecular causes of complex disease in a holistic systems manner. Therefore, pathway and network reconstruction is an essential part of a systems biology approach to solve this challenging problem. In this paper, multiple data sources were used to construct the molecular process of airway remodeling pathway in mustard lung as a model of airway disease. We first compiled a master list of genes that change with airway remodeling in the mustard lung disease and then reconstructed the pathway by generating and merging the protein-protein interaction and the gene regulatory networks. Experimental observations and literature mining were used to identify and validate the master list. The outcome of this paper can provide valuable information about closely related chronic obstructive airway diseases which are of great importance for biologists and their future research. Reconstructing the airway remodeling interactome provides a starting point and reference for the future experimental study of mustard lung, and further analysis and development of these maps will be critical to understanding airway diseases in patients.	[Najafi, Ali; Masoudi-Nejad, Ali; Moeini, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Ghanei, Mostafa; Nourani, Mohamad-Reza] Baqiyatallah Univ Med Sci, Genom Div, Chem Injury Res Ctr, Tehran, Iran; [Moeini, Ali] Univ Tehran, Dept Algorithms & Computat, Coll Engn, Tehran, Iran	University of Tehran; Baqiyatallah University of Medical Sciences (BMSU); University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Najafi, Ali/K-1113-2015; Ghanei, Mostafa/V-1975-2019; Masoudi-Nejad, Ali/ABH-2078-2021	Najafi, Ali/0000-0001-7700-2053; Ghanei, Mostafa/0000-0001-9372-0928; Najafi, Ali/0000-0002-2540-4955				Adelipour M, 2011, IRAN J ALLERGY ASTHM, V10, P147, DOI 010.03/ijaai.147154; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024495; Cheung AKL, 2011, P NATL ACAD SCI USA, V108, P8390, DOI 10.1073/pnas.1101747108; Dillman JF, 2005, CHEM RES TOXICOL, V18, P28, DOI 10.1021/tx049745z; Fernandez JM, 2007, NUCLEIC ACIDS RES, V35, pW21, DOI 10.1093/nar/gkm298; Fischer BM, 2002, AM J RESP CELL MOL, V26, P447, DOI 10.1165/ajrcmb.26.4.4473; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2004, EUR J RADIOL, V52, P164, DOI 10.1016/j.ejrad.2004.03.018; Ghanei M, 2008, Chron Respir Dis, V5, P95, DOI 10.1177/1479972307087191; Ghanei M, 2007, INHAL TOXICOL, V19, P451, DOI 10.1080/08958370601174990; Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278; Greeley MA, 2010, TOXICOL SCI, V113, P453, DOI 10.1093/toxsci/kfp268; Hallock P, 2012, OMICS, V16, P37, DOI 10.1089/omi.2011.0054; Junker B. H., 2011, ANAL BIOL NETWORKS; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kim HJ, 2010, AM J RESP CELL MOL, V43, P349, DOI 10.1165/rcmb.2009-0205OC; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lo PHY, 2012, CANCER LETT, V316, P39, DOI 10.1016/j.canlet.2011.10.020; Loscalzo Joseph, 2011, Proc Am Thorac Soc, V8, P196, DOI 10.1513/pats.201006-041MS; Matsui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044080; Mishra NC, 2012, INT IMMUNOPHARMACOL, V13, P101, DOI 10.1016/j.intimp.2012.03.010; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Najafi A, 2014, J RECEPT SIG TRANSD, P1; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; Rogers JV, 2004, J BIOCHEM MOL TOXIC, V18, P289, DOI 10.1002/jbt.20043; Royce SG, 2013, AM J RESP CELL MOL, V48, P135, DOI 10.1165/rcmb.2011-0320OC; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thomason JWW, 2003, JAMA-J AM MED ASSOC, V290, P598, DOI 10.1001/jama.290.5.598; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Werneburg NW, 2012, J BIOL CHEM, V287, P24427, DOI 10.1074/jbc.M112.342238; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; Willems-Widyastuti A, 2011, TRANSFORMING GROWTH; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yazdani S, 2011, J RECEPT SIG TRANSD, V31, P367, DOI 10.3109/10799893.2011.602415; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	52	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100094	10.1371/journal.pone.0100094	http://dx.doi.org/10.1371/journal.pone.0100094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978043	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400019
J	Schou, J; Kelstrup, CD; Hayward, DG; Olsen, JV; Nilsson, J				Schou, Julie; Kelstrup, Christian D.; Hayward, Daniel G.; Olsen, Jesper V.; Nilsson, Jakob			Comprehensive Identification of SUMO2/3 Targets and Their Dynamics during Mitosis	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; AURORA-B; TOPOISOMERASE-II; RHO GTPASE; CENP-E; SUMOYLATION; PROTEINS; MODIFIER; REVEALS; SUMO-1	During mitosis large alterations in cellular structures occur rapidly, which to a large extent is regulated by post-translational modification of proteins. Modification of proteins with the small ubiquitin-related protein SUMO2/3 regulates mitotic progression, but few mitotic targets have been identified so far. To deepen our understanding of SUMO2/3 during this window of the cell cycle, we undertook a comprehensive proteomic characterization of SUMO2/3 modified proteins in mitosis and upon mitotic exit. We developed an efficient tandem affinity purification strategy of SUMO2/3 modified proteins from mitotic cells. Combining this purification strategy with cell synchronization procedures and quantitative mass spectrometry allowed for the mapping of numerous novel targets and their dynamics as cells progressed out of mitosis. This identified RhoGDI alpha as a major SUMO2/3 modified protein, specifically during mitosis, mediated by the SUMO ligases PIAS2 and PIAS3. Our data provide a rich resource for further exploring the role of SUMO2/3 modifications in mitosis and cell cycle regulation.	[Schou, Julie; Kelstrup, Christian D.; Hayward, Daniel G.; Olsen, Jesper V.; Nilsson, Jakob] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark	University of Copenhagen	Nilsson, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark.	jakob.nilsson@cpr.ku.dk	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938; Kelstrup, Christian Dahl/0000-0003-4647-1425; Nilsson, Jakob/0000-0003-4100-1125	Lundbeck Foundation; Novo Nordisk Foundation	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Lundbeck Foundation (www.lundbeckfonden.com) supported this work through a Junior Group Leader Fellowship to JN. The Novo Nordisk Foundation (www.novonordiskfonden.dk) supported this through institute funding for JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Andersen Jens S., 2009, V497, P19, DOI 10.1007/978-1-59745-566-4_2; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson J, 2011, BIOESSAYS, V33, P903, DOI 10.1002/bies.201100094; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	46	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100692	10.1371/journal.pone.0100692	http://dx.doi.org/10.1371/journal.pone.0100692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971888	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200051
J	Zheng, FP; Zhang, SF; Lu, WN; Wu, F; Yin, XY; Yu, D; Pan, QQ; Li, H				Zheng, Fenping; Zhang, Saifei; Lu, Weina; Wu, Fang; Yin, Xueyao; Yu, Dan; Pan, Qianqian; Li, Hong			Regulation of Insulin Resistance and Adiponectin Signaling in Adipose Tissue by Liver X Receptor Activation Highlights a Cross-Talk with PPAR gamma	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; PHARMACOLOGICAL ACTIVATION; NUTRITIONAL REGULATION; GLUCOSE-UPTAKE; LXR; ADIPOCYTES; INHIBITION; MICE; LIPOGENESIS; ALPHA	Liver X receptors (LXRs) have been recognized as a promising therapeutic target for atherosclerosis; however, their role in insulin sensitivity is controversial. Adiponectin plays a unique role in maintaining insulin sensitivity. Currently, no systematic experiments elucidating the role of LXR activation in insulin function based on adiponectin signaling have been reported. Here, we investigated the role of LXR activation in insulin resistance based on adiponectin signaling, and possible mechanisms. C57BL/6 mice maintained on a regular chow received the LXR agonist, T0901317 (30 mg/kg.d) for 3 weeks by intraperitoneal injection, and differentiated 3T3-L1 adipocytes were treated with T0901317 or GW3965. T0901317 treatment induced significant insulin resistance in C57BL/6 mice. It decreased adiponectin gene transcription in epididymal fat, as well as serum adiponectin levels. Activity of AMPK, a key mediator of adiponectin signaling, was also decreased, resulting in decreased Glut-4 membrane translocation in epididymal fat. In contrast, adiponectin activity was not changed in the liver of T0901317 treated mice. In vitro, both T0901317 and GW3965 decreased adiponectin expression in adipocytes in a dose-dependent manner, an effect which was diminished by LXR alpha silencing. ChIP-qPCR studies demonstrated that T0901317 decreased the binding of PPAR gamma to the PPAR-responsive element (PPRE) of the adiponectin promoter in a dose-dependent manner. Furthermore, T0901317 exerted an antagonistic effect on the expression of adiponectin in adipocytes co-treated with 3 mu M Pioglitazone. In luciferase reporter gene assays, T0901317 dose-dependently inhibited PPRE-Luc activity in HEK293 cells co-transfected with LXR alpha and PPAR gamma. These results suggest that LXR activation induces insulin resistance with decreased adiponectin signaling in epididymal fat, probably due to negative regulation of PPAR gamma signaling. These findings indicate that the potential of LXR activation as a therapeutic target for atherosclerosis may be limited by the possibility of exacerbating insulin resistance-related disease.	[Zheng, Fenping; Zhang, Saifei; Lu, Weina; Wu, Fang; Yin, Xueyao; Yu, Dan; Li, Hong] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Qianqian] Zhejiang Univ, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Qianqian] Zhejiang Univ, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Provapw, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, H (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China.	lihongheyi@126.com			National Natural Science Foundation of China [81270924]; Science and Technology Project of Zhejiang Province [2012C33131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province	This study was supported by grant of National Natural Science Foundation of China (81270924, http://www.nsfc.gov.cn) and grant of Science and Technology Project of Zhejiang Province (2012C33131, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2013, J LIPID RES, V54, P1300, DOI 10.1194/jlr.M033977; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen JL, 2010, J CEREBR BLOOD F MET, V30, P102, DOI 10.1038/jcbfm.2009.187; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Dib L, 2014, J LIPID RES, V55, P247, DOI 10.1194/jlr.M043422; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gaidhu MP, 2010, MOL ENDOCRINOL, V24, P1434, DOI 10.1210/me.2009-0502; Gao M, 2013, PLOS ONE, V8; Ge Q, 2011, AM J PHYSIOL-ENDOC M, V301, pE326, DOI 10.1152/ajpendo.00153.2011; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Hong C, 2011, J LIPID RES, V52, P531, DOI 10.1194/jlr.M010686; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Pettersson AML, 2013, DIABETOLOGIA, V56, P2044, DOI 10.1007/s00125-013-2954-5; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; Stohr R, 2013, BIOCHEM J, V454, P1, DOI 10.1042/BJ20130121; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190	42	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101269	10.1371/journal.pone.0101269	http://dx.doi.org/10.1371/journal.pone.0101269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972069	gold, Green Submitted, Green Published			2022-12-25	WOS:000338512200109
J	Kermani, N; Abu Hassan, ZA; Suhaimi, A; Abuzid, I; Ismail, NF; Attia, M; Abd Ghani, I				Kermani, Nadia; Abu Hassan, Zainal-Abidin; Suhaimi, Amalina; Abuzid, Ismail; Ismail, Noor Farehan; Attia, Mansour; Abd Ghani, Idris			Parasitism Performance and Fitness of Cotesia vestalis (Hymenoptera: Braconidae) Infected with Nosema sp (Microsporidia: Nosematidae): Implications in Integrated Pest Management Strategy	PLOS ONE			English	Article							MUSCIDIFURAX-RAPTOR HYMENOPTERA; VAIRIMORPHA SP MICROSPORIDIA; PLUTELLA-XYLOSTELLA LEPIDOPTERA; DIAMONDBACK MOTH; MACROCENTRUS-GRANDII; ENTOMOPATHOGENIC MICROSPORIDIUM; HOST; TRANSMISSION; PTEROMALIDAE; LARVAE	The diamondback moth (DBM) Plutella xylostella (L.) has traditionally been managed using synthetic insecticides. However, the increasing resistance of DBM to insecticides offers an impetus to practice integrated pest management (IPM) strategies by exploiting its natural enemies such as pathogens, parasitoids, and predators. Nevertheless, the interactions between pathogens and parasitoids and/or predators might affect the effectiveness of the parasitoids in regulating the host population. Thus, the parasitism rate of Nosema-infected DBM by Cotesia vestalis (Haliday) (Hym., Braconidae) can be negatively influenced by such interactions. In this study, we investigated the effects of Nosema infection in DBM on the parasitism performance of C. vestalis. The results of no-choice test showed that C. vestalis had a higher parasitism rate on non-infected host larvae than on Nosema-treated host larvae. The C. vestalis individuals that emerged from Nosema-infected DBM (F1) and their progeny (F2) had smaller pupae, a decreased rate of emergence, lowered fecundity, and a prolonged development period compared to those of the control group. DBM infection by Nosema sp. also negatively affected the morphometrics of C. vestalis. The eggs of female C. vestalis that developed in Nosema-infected DBM were larger than those of females that developed in non-infected DBM. These detrimental effects on the F1 and F2 generations of C. vestalis might severely impact the effectiveness of combining pathogens and parasitoids as parts of an IPM strategy for DBM control.	[Kermani, Nadia; Suhaimi, Amalina; Abuzid, Ismail; Ismail, Noor Farehan; Attia, Mansour; Abd Ghani, Idris] Univ Natl Malaysia, Sch Environm & Nat Resource Sci, Bangi, Malaysia; [Abu Hassan, Zainal-Abidin] Univ Technol MARA UITM, Fac Med, Shah Alam, Malaysia	Universiti Teknologi MARA	Abd Ghani, I (corresponding author), Univ Natl Malaysia, Sch Environm & Nat Resource Sci, Bangi, Malaysia.	idrisgh@ukm.edu.my	KERMANI, NADIA/ABH-4897-2020	ABUZID, ISMAIL/0000-0002-2789-1574; KERMANI, NADIA/0000-0003-1914-1068	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) [02-01-02-SF0601, 05-01-02-SF1019]; Research University Grant (OUP) [OUP-2012-043, OUP-2013-043]	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI); Research University Grant (OUP)	This research was funded by grant No. (02-01-02-SF0601) and (05-01-02-SF1019) from the Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) and Research University Grant (OUP): OUP-2012-043, OUP-2013-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 1999, P ROY SOC B-BIOL SCI, V266, P947, DOI 10.1098/rspb.1999.0728; ANDREADIS TG, 1980, J INVERTEBR PATHOL, V35, P229, DOI 10.1016/0022-2011(80)90155-X; Batoto T. C., 2010, Malaysian Applied Biology, V39, P1; BECNEL J, 1999, MICROSPORIDIA MICROS; Becnel James J., 1999, P447; BECNEL JJ, 1994, J EUKARYOT MICROBIOL, V41, P236, DOI 10.1111/j.1550-7408.1994.tb01504.x; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Boohene CK, 2003, BIOL CONTROL, V26, P1, DOI 10.1016/S1049-9644(02)00106-8; BROOKS W M, 1973, Miscellaneous Publications of the Entomological Society of America, V9, P105; Brooks Wayne M., 1993, P231; Canning EU, 1999, J INVERTEBR PATHOL, V74, P29, DOI 10.1006/jipa.1999.4861; CANTWELL G E, 1970, American Bee Journal, V110, P222; Casas J, 2005, ECOLOGY, V86, P545, DOI 10.1890/04-0812; COSSENTINE JE, 1987, CAN J ZOOL, V65, P2532, DOI 10.1139/z87-382; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Doury G, 1997, J INSECT PHYSIOL, V43, P69, DOI 10.1016/S0022-1910(96)00053-4; Down RE, 2005, B ENTOMOL RES, V95, P133, DOI 10.1079/BER2004343; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Ellers J, 1996, NETH J ZOOL, V46, P227, DOI 10.1163/156854295X00186; Elzinga JA, 2003, ENTOMOL EXP APPL, V108, P95, DOI 10.1046/j.1570-7458.2003.00072.x; Endersby NM, 2004, P 4 INT WORKSH MAN D; Federici BA, 1996, BIOSCIENCE, V46, P410, DOI 10.2307/1312875; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Geden CJ, 2003, ENVIRON ENTOMOL, V32, P1139, DOI 10.1603/0046-225X-32.5.1139; GEDEN CJ, 1995, BIOL CONTROL, V5, P607, DOI 10.1006/bcon.1995.1072; Haque MA, 1999, B ENTOMOL RES, V89, P147, DOI 10.1017/S0007485399000231; Henn MW, 2000, J INVERTEBR PATHOL, V76, P263, DOI 10.1006/jipa.2000.4977; Hoch G, 2000, J INVERTEBR PATHOL, V75, P59, DOI 10.1006/jipa.1999.4894; Hoch G, 2002, ARCH INSECT BIOCHEM, V50, P109, DOI 10.1002/arch.10030; Idris A. B., 1997, Malaysian Applied Biology, V26, P105; Idris AB, 2003, INT J PEST MANAGE, V49, P71, DOI 10.1080/713867831; Idris AB, 2001, ONLINE J BIOL SCI, V1, P905; Idris AB, 1999, SAINS MALAYS, V28, P39; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Kermani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062884; Kurtz J, 2000, J INVERTEBR PATHOL, V75, P237, DOI 10.1006/jipa.1999.4909; Lange CE, 2008, J INVERTEBR PATHOL, V99, P357, DOI 10.1016/j.jip.2008.09.002; Lange Carlos E., 2002, Revista de la Sociedad Entomologica Argentina, V61, P1; Lange CE, 2010, BIOCONTROL SCI TECHN, V20, P19, DOI 10.1080/09583150903338746; Linde Andreas, 2000, IOBC-WPRS Bulletin, V23, P285; Maddox JV, 1999, J INVERTEBR PATHOL, V73, P1, DOI 10.1006/jipa.1998.4817; Mewis I, 2003, BIOL CONTROL, V26, P202, DOI 10.1016/S1049-9644(02)00126-3; MITCHELL MJ, 1994, J ECON ENTOMOL, V87, P933, DOI 10.1093/jee/87.4.933; ORR DB, 1994, ENVIRON ENTOMOL, V23, P1020, DOI 10.1093/ee/23.4.1020; Parkinson N, 2002, INSECT BIOCHEM MOLEC, V32, P729, DOI 10.1016/S0965-1748(01)00155-2; Remadevi O. K., 2010, International Journal of Tropical Insect Science, V30, P138, DOI 10.1017/S1742758410000214; Riddick EW, 2006, BIOCONTROL, V51, P603, DOI 10.1007/s10526-005-2939-5; SAJAP AS, 1988, J INVERTEBR PATHOL, V52, P294, DOI 10.1016/0022-2011(88)90138-3; Sarfraz M, 2005, J APPL ENTOMOL, V129, P149, DOI 10.1111/j.1439-0418.2005.00930.x; Sayyed AH, 2004, PEST MANAG SCI, V60, P827, DOI 10.1002/ps.869; Schuld M, 1999, J INVERTEBR PATHOL, V74, P120, DOI 10.1006/jipa.1999.4865; Shelton A.M., 2008, P 5 INT WORKSH MAN D; Simoes RA, 2012, BIOL CONTROL, V63, P164, DOI 10.1016/j.biocontrol.2012.06.012; SOLTER L. F., 2007, FIELD MANUAL TECHNIQ, P199; Solter Leellen F., 2000, P231; Srinivasan R, 2011, P 6 INT WORKSH MAN D, P321; Tabashnik BE, 1990, J ECON ENTOMOL, V83, P1651; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tsai SJ, 2003, J INVERTEBR PATHOL, V83, P51, DOI 10.1016/S0022-2011(03)00035-1; Verkerk RHJ, 1996, B ENTOMOL RES, V86, P205, DOI 10.1017/S0007485300052482; Visser B, 2008, J INSECT PHYSIOL, V54, P1315, DOI 10.1016/j.jinsphys.2008.07.014; Visser B, 2012, GENOME BIOL EVOL, V4, P864, DOI 10.1093/gbe/evs065; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; WITTNER M, 1999, MICROSPORIDIA MICROS, P553; ZCHORIFEIN E, 1992, J INVERTEBR PATHOL, V60, P292, DOI 10.1016/0022-2011(92)90011-R; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	70	5	5	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100671	10.1371/journal.pone.0100671	http://dx.doi.org/10.1371/journal.pone.0100671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968125	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800050
J	Li, Y; Kromer, B; Schukraft, G; Bubenzer, O; Huang, MR; Wang, ZM; Bian, LG; Li, CS				Li, Ying; Kromer, Bernd; Schukraft, Gerd; Bubenzer, Olaf; Huang, Man-Rong; Wang, Ze-Min; Bian, Lin-Gen; Li, Cheng-Sen			Growth Rate of Usnea aurantiacoatra (Jacq.) Bory on Fildes Peninsula, Antarctica and Its Climatic Background	PLOS ONE			English	Article							KING-GEORGE-ISLAND; RHIZOCARPON-GEOGRAPHICUM; LICHEN COLONIZATION; PARMELIACEAE; MORAINES; RANGE	The ages of a fruticose lichen of Usnea aurantiacoatra (Jacq.) Bory, from Fildes Peninsula, King George Island, Southwest Antarctic, were determined by radiocarbon (C-14), and it is 1993-1996 at bottom and 2006-2007 at top of the lichen branch. The growth rates of U. aurantiacoatra calculated are 4.3 to 5.5 mm year(-1) based on its length and ages. The comparisons show that the growth rates of U. aurantiacoatra are higher than those of U. antarctica (0.4 to 1.1 mm year(-1)). The growth rates of fruticose lichens are always higher, usually > 2 mm year(-1), than those of crustose ones, usually < 1 mm year(-1), in polar areas. A warming trend on Fildes Peninsula is recorded in the period from 1969 to 2010 obviously: the mean annual temperature rose from -2.75 to -1.9 degrees C and the average temperature of summer months from 0.95 to 1.4 degrees C, as well as the average temperature of winter months from -6.75 to -5.5 degrees C. The alteration of lichen growth rates in polar areas may respond to the climatic and environmental changes, and the lichens may act as bio-monitor of natural condition.	[Li, Ying; Li, Cheng-Sen] Acad Sinica, Inst Bot, Beijing 100044, Peoples R China; [Li, Ying; Schukraft, Gerd; Bubenzer, Olaf] Heidelberg Univ, Heidelberg, Germany; [Kromer, Bernd] Klaus Tschira Labor Curt Engelhorn Zentrum Archao, Mannheim, Germany; [Huang, Man-Rong] Beijing Museum Nat Hist, Beijing, Peoples R China; [Wang, Ze-Min] Wuhan Univ, Wuhan, Hubei, Peoples R China; [Bian, Lin-Gen] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Ruprecht Karls University Heidelberg; Wuhan University; Chinese Academy of Meteorological Sciences (CAMS)	Li, CS (corresponding author), Acad Sinica, Inst Bot, Beijing 100044, Peoples R China.	lics@ibcas.ac.cn			International Cooperation Project of Chinese Arctic and Antarctic Administration [IC 201103]; Innovation Key Program of the Chinese Academy of Sciences [KSCX2-EW-J-1]; National Natural Science Foundation of China [41271222]; Curt-Engelhorn-Zentrum Archaometrie gGmbH	International Cooperation Project of Chinese Arctic and Antarctic Administration; Innovation Key Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Curt-Engelhorn-Zentrum Archaometrie gGmbH	This study was supported by the International Cooperation Project of Chinese Arctic and Antarctic Administration (No. IC 201103), the Innovation Key Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-1) and the National Natural Science Foundation of China (No. 41271222). Curt-Engelhorn-Zentrum Archaometrie gGmbH provided support in the form of a salary for author BK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahti T, 1962, COLOGICAL INVESTIGAT; Andreyev VN, 1954, GEOBOTANIKA, V9, P11; Articus K, 2004, TAXON, V53, P925, DOI 10.2307/4135560; Chen J.Y., 1988, SCI CHINA, V1, P95; Chen JB, 1996, ACTA MYCOLOGICA SINI, V15, P21; Chen JB, 1995, CHINESE BIODIVERSITY, V3, P113; Chen JY, 1984, J GLACIOLOGY GEOCRYO, V6, P85; Chipev N, 2005, P INT C HIGH PREC AT, P12; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; DEGELIUS GUNNAR, 1964, ACTA HORTI GOTOBURGENSIS [MEDD GOTEBORGS BOT TRADGARD], V27, P11; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Frey E, 1953, ERGBN WISS UNTERS SC, V2, P361; Galum M, 1988, CRC HDB LICHENOLOGY, VIII; Hale M.E., 1973, LICHENS, P473; Hale ME, 1967, BIOL LICHENS, P78; Hale ME, 1974, BIOL LICHENS; Hale ME, 1957, LICHEN HDB; Helle T., 1983, RANGIFER, V3, P2, DOI DOI 10.7557/2.3.2.471; Herre AC, 1904, BOT GAZ, V38, P0218, DOI 10.1086/328543; Hooker T, 1980, BRIT ANTARCTIC SURVE, V50, P27; INNES JL, 1985, PROG PHYS GEOG, V9, P187, DOI 10.1177/030913338500900202; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Kappen L, 2000, ANTARCT SCI, V12, P314, DOI 10.1017/S0954102000000377; Kim JH, 2006, J MICROBIOL, V44, P480; LANGE OL, 1990, ISRAEL J BOT, V39, P383; Lechowicz MJ, 1972, ECOLOGY, V54, P413; Lee JS, 2008, J MICROBIOL BIOTECHN, V18, P1016; Li YL, 1999, CHINESE J POLAR RES, V11, P69; Lindsay DC, 1975, BRIT ANTARCTIC SURVE, V40, P49; Longton E.R., 1988, BIOL POLAR BRYOPHYTE; Lumbsch HT, 2011, LICHENOLOGIST, V43, P553, DOI 10.1017/S0024282911000417; M Galum, 1988, CRC HDB LICHENOLOGY, VI; M Galum, 1988, CRC HDB LICHENOLOGY, VII; Michel R. F. M., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Symposium 1.1.1 Soil morphology and climate change, P1; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Olech M., 2004, LICHENS KING GEORGE; PEGAU RE, 1968, ARCTIC, V21, P255; PORTER SC, 1981, ARCTIC ALPINE RES, V13, P11, DOI 10.2307/1550622; PROCTOR MCF, 1983, LICHENOLOGIST, V15, P249, DOI 10.1017/S0024282983000389; Sancho LG, 2007, FLORA, V202, P667, DOI 10.1016/j.flora.2007.05.005; Sancho LG, 2004, POLAR BIOL, V27, P312, DOI 10.1007/s00300-004-0594-4; SANCHO LG, 1993, POLAR BIOL, V13, P227; Sancho LG, 2001, CATENA, V43, P323, DOI 10.1016/S0341-8162(00)00131-4; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Smith RIL, 1995, LICHENOLOGIST, V27, P473, DOI 10.1016/S0024-2829(95)80007-7; SMITH RIL, 1990, ANTARCTIC ECOSYSTEMS, P32; Soper T., 2008, ANTARCTICA GUIDE WIL; Stevenson SK, 1985, IWIFR 26 VICT BC US; Victoria F de C, 2005, CHARACTERIZATION PLA; Wacker L, 2010, RADIOCARBON, V52, P252, DOI 10.1017/S0033822200045288; WALKER FJ, 1985, B BRIT MUS NAT HIST, V13, P1; Xayidin Hurnisa, 2005, Journal of Fungal Research, V3, P51	52	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100735	10.1371/journal.pone.0100735	http://dx.doi.org/10.1371/journal.pone.0100735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968131	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800060
J	Sasaki, H; Sasaki, N; Nishino, T; Nagasaki, K; Kitamura, H; Torigoe, D; Agui, T				Sasaki, Hayato; Sasaki, Nobuya; Nishino, Tomohiro; Nagasaki, Ken-ichi; Kitamura, Hiroshi; Torigoe, Daisuke; Agui, Takashi			Quantitative Trait Loci for Resistance to the Congenital Nephropathy in Tensin 2-Deficient Mice	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; NEPHROTIC SYNDROME; ICGN STRAIN; MESANGIAL SCLEROSIS; GENETIC-ANALYSIS; RENAL-DISEASE; BLOOD-CELL; PODOCYTE	The ICR-derived glomerulonephritis (ICGN) mouse is a chronic kidney disease (CKD) model that is characterized histologically by glomerulosclerosis, vascular sclerosis and tubulointerstitial fibrosis, and clinically by proteinuria and anemia, which are common symptoms and pathological changes associated with a variety of kidney diseases. Previously, we performed a quantitative trait locus (QTL) analysis to identify the causative genes for proteinuria in ICGN mice, and found a deletion mutation of the tensin 2 gene (Tns2(nph), MGI no: 2447990). Interestingly, the congenic strain carrying the Tns2(nph) mutation on a C57BL/6J (B6) genetic background exhibited milder phenotypes than did ICGN mice, indicating the presence of several modifier genes controlling the disease phenotype. In this study, to identify the modifier/resistant loci for CKD progression in Tns2-deficient mice, we performed QTL analysis using backcross progenies from susceptible ICGN and resistant B6 mice. We identified a significant locus on chromosome (Chr) 2 (LOD = 5.36; 31 cM) and two suggestive loci on Chrs 10 (LOD = 2.27; 64 cM) and X (LOD = 2.65; 67 cM) with linkage to the severity of tubulointerstitial injury. One significant locus on Chr 13 (LOD = 3.49; approximately 14 cM) and one suggestive locus on Chr 2 (LOD = 2.41; 51 cM) were identified as QTLs for the severity of glomerulosclerosis. Suggestive locus in BUN was also detected in the same Chr 2 region (LOD = 2.34; 51 cM). A locus on Chr 2 (36 cM) was significantly linked with HGB (LOD = 4.47) and HCT (LOD = 3.58). Four novel epistatic loci controlling either HGB or tubulointerstitial injury were discovered. Further genetic analysis should lead to identification of CKD modifier gene(s), aiding early diagnosis and providing novel approaches to the discovery of drugs for the treatment and possible prevention of kidney disease.	[Sasaki, Hayato; Nishino, Tomohiro; Torigoe, Daisuke; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan; [Sasaki, Nobuya] Kitasato Univ, Lab Anim Sci & Med, Towada, Aomori, Japan; [Nagasaki, Ken-ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Japan; [Kitamura, Hiroshi] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Physiol, Ebetsu, Hokkaido 069, Japan	Hokkaido University; Kitasato University; Rakuno Gakuen University	Sasaki, N (corresponding author), Kitasato Univ, Lab Anim Sci & Med, Towada, Aomori, Japan.	nobsasa@vmas.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); KAKENHI [20302614]; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Glant-in-Aid for Scientific Research, KAKENHI (20302614) to N.S. H.S. was a research assistant of the Program of Leading Graduate School supported by MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2002, AM J PATHOL, V160, P721, DOI 10.1016/S0002-9440(10)64892-4; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Burghardt T, 2013, J AM SOC NEPHROL, V24, P1830, DOI 10.1681/ASN.2012080788; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; Davis RC, 2013, MAMM GENOME, V24, P105, DOI 10.1007/s00335-013-9448-0; Doorenbos C, 2008, GENETICS, V179, P693, DOI 10.1534/genetics.107.085142; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Elliot SJ, 2003, AM J PATHOL, V162, P1441, DOI 10.1016/S0002-9440(10)64277-0; Freedman BI, 2004, J AM SOC NEPHROL, V15, P2719, DOI 10.1097/01.ASN.0000141312.39483.4F; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Harendza S, 2009, CELL MOL BIOL LETT, V14, P679, DOI 10.2478/s11658-009-0026-0; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Kato T, 2008, BIOMED RES-TOKYO, V29, P279, DOI 10.2220/biomedres.29.279; Kelada SNP, 2012, G3-GENES GENOM GENET, V2, P157, DOI 10.1534/g3.111.001776; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; KRUGLYAK L, 1995, GENETICS, V139, P1421; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mizuno S, 1999, AM J NEPHROL, V19, P73, DOI 10.1159/000013430; Mizuno S, 1997, EXP NEPHROL, V5, P498; Mizuno S, 2000, KIDNEY INT, V57, P937; Mundel P, 2001, Adv Nephrol Necker Hosp, V31, P235; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nishino T, 2012, EXP ANIM TOKYO, V61, P525, DOI 10.1538/expanim.61.525; Nishino T, 2012, BIOMED RES-TOKYO, V33, P53, DOI 10.2220/biomedres.33.53; Nishino T, 2010, J VET MED SCI, V72, P1313, DOI 10.1292/jvms.10-0144; OGURA A, 1989, LAB ANIM, V23, P169, DOI 10.1258/002367789780863628; OGURA A, 1995, VET PATHOL, V32, P321, DOI 10.1177/030098589503200317; Papeta N, 2009, J CLIN INVEST, V119, P1178, DOI 10.1172/JCI37131; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Peters LL, 2010, BLOOD, V116, pE139, DOI 10.1182/blood-2010-05-283879; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Sheehan S, 2007, AM J PHYSIOL-RENAL, V293, pF1649, DOI 10.1152/ajprenal.00233.2007; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Uchio-Yamada K, 2013, NEPHRON EXP NEPHROL, V123, P22, DOI 10.1159/000354058; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Warsow G, 2013, KIDNEY INT, V84, P104, DOI 10.1038/ki.2013.64; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99602	10.1371/journal.pone.0099602	http://dx.doi.org/10.1371/journal.pone.0099602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967628	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800015
J	Yoshihisa, A; Suzuki, S; Takiguchi, M; Shimizu, T; Abe, S; Sato, T; Yamaki, T; Sugimoto, K; Kunii, H; Nakazato, K; Suzuki, H; Saitoh, S; Takeishi, Y				Yoshihisa, Akiomi; Suzuki, Satoshi; Takiguchi, Mai; Shimizu, Takeshi; Abe, Satoshi; Sato, Takamasa; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Impact of Sleep-Disordered Breathing on Heart Rate Turbulence in Heart Failure Patients	PLOS ONE			English	Article							BLOOD-PRESSURE; VENTRICULAR-ARRHYTHMIAS; NERVE-STIMULATION; RATE-VARIABILITY; SUDDEN-DEATH; APNEA; MORTALITY; MODULATION; DISEASE; ASSOCIATION	Background: Sleep-disordered breathing (SDB) is associated with adverse outcomes in patients with chronic heart failure (CHF). Additionally, heart rate turbulence (HRT) reflects changes in the sinus cycle length of baroreceptor in response to hemodynamic fluctuations after ventricular premature beat. Recent studies have suggested that HRT as a marker of vagal activity has a predictive value of poor prognosis in CHF patients. However, little is known about the relationship between SDB and HRT in CHF patients. Methods and Results: In this study, 75 patients with CHF were enrolled. We simultaneously performed Holter ECG during a 24-hr period and portable sleep monitoring at nighttime, and determined the respiratory disturbance index (RDI), HRT (turbulence onset (TO) and turbulence slope (TS)) during that 24-hr period. These patients were divided into two groups based on the presence of severe SDB: Group A (RDI >= 30, n = 17) and Group B (RDI<30, n = 58). TS was significantly lower in Group A than in Group B across the 24-hr period (nighttime: 3.6 +/- 1.1 vs. 6.9 +/- 1.3; daytime: 3.7 +/- 0.8 vs. 7.0 +/- 1.1; all-day: 3.5 +/- 0.7 vs. 6.7 +/- 0.9% ms/RR, P<0.05, respectively). TO did not differ between the two groups. Furthermore, there was a significant negative correlation between all-day TS and RDI (R = -0.257, P = 0.027). Moreover, in the multiple regression analysis, RDI was an independent factor to determine all-day TS. Conclusions: In patients with severe SDB, blunted TS was observed across 24 hours. These results suggest that SDB induce impairment of vagal activity across a 24-hour period and may be associated with poor prognosis in CHF patients.	[Yoshihisa, Akiomi; Suzuki, Satoshi; Takiguchi, Mai; Shimizu, Takeshi; Abe, Satoshi; Sato, Takamasa; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Yoshihisa, Akiomi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Yoshihisa, A (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	yoshihis@fmu.ac.jp			Japan Society for the Promotion of Science [25461061]; Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for Scientific Research (No. 25461061) from the Japan Society for the Promotion of Science, and grants-in-aid from the Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytemir K, 2007, RESP MED, V101, P1277, DOI 10.1016/j.rmed.2006.10.016; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Camm AJ, 1996, CIRCULATION, V93, P1043; Cygankiewicz I, 2008, HEART RHYTHM, V5, P1095, DOI 10.1016/j.hrthm.2008.04.017; Cygankiewicz I, 2006, AM J CARDIOL, V98, P1635, DOI 10.1016/j.amjcard.2006.07.042; Davies LC, 2001, AM J CARDIOL, V87, P737, DOI 10.1016/S0002-9149(00)01493-4; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Fauchier L, 1997, J AM COLL CARDIOL, V30, P1009, DOI 10.1016/S0735-1097(97)00265-9; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; HIRSCH AT, 1987, CIRCULATION, V75, P36; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Koyama J, 2002, CIRC J, V66, P902, DOI 10.1253/circj.66.902; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Lin LY, 2004, J CARDIOVASC ELECTR, V15, P752, DOI 10.1046/j.1540-8167.2004.03289.x; Manzano-Fernandez S, 2011, J CARD FAIL, V17, P735, DOI 10.1016/j.cardfail.2011.05.007; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Moore RKG, 2006, EUR J HEART FAIL, V8, P585, DOI 10.1016/j.ejheart.2005.11.012; Mortara A, 1997, CIRCULATION, V96, P3450; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schmidt G, 1999, LANCET, V353, P1390, DOI 10.1016/S0140-6736(98)08428-1; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Ueno LM, 2011, INT J CARDIOL, V148, P53, DOI 10.1016/j.ijcard.2009.10.023; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Yamada S, 2013, CIRC J, V77, P1466, DOI 10.1253/circj.CJ-12-0836; Yang A, 2005, BASIC RES CARDIOL, V100, P439, DOI 10.1007/s00395-005-0536-5; Yumino D, 2013, AM J RESP CRIT CARE, V187, P433, DOI 10.1164/rccm.201205-0894OC	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101307	10.1371/journal.pone.0101307	http://dx.doi.org/10.1371/journal.pone.0101307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968229	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800121
J	Joshi, S; Singh, AR; Durden, DL				Joshi, Shweta; Singh, Alok R.; Durden, Donald L.			MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1 alpha Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INDUCED ANGIOGENESIS; ADVANCED SOLID TUMORS; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; 3-KINASE/AKT PATHWAY; ANTITUMOR-ACTIVITY; FACTOR EXPRESSION; HIF-ALPHA; PHASE-I; HIF-1-ALPHA	Hypoxia-inducible factor 1 (HIF1) is a heterodimeric transcription factor containing an inducibly expressed HIF1 alpha subunit and a constitutively expressed HIF1 beta subunit. Under hypoxic conditions, the HIF1 alpha subunit accumulates because of a decrease in the rate of proteolytic degradation, and the resulting HIF1 alpha-HIF1 beta heterodimers undergo post-translational modifications that promote transactivation. Previous reports suggest that amplified signaling through PI3K enhances HIF1-dependent gene expression; however, its role is controversial, and the mechanism is unclear. Using genetically engineered PTEN-deficient cell lines, we demonstrate that PTEN specifically inhibited the accumulation of HIF1 alpha in response to hypoxia. Furthermore, we report that in glioblastoma cell lines, inhibition of PI3K pathway, using pan as well as isoform-specific PI3K inhibitors SF1126, PF4691502, BEZ-235, GDC0941, and TGX221 blocked the induction of HIF1 alpha protein and its targets vascular endothelial growth factor, HK1, and GLUT1 mRNA in response to hypoxia. Herein, we describe the first evidence that HIF1 alpha can be degraded under hypoxic conditions via the 26 S proteasome and that MDM2 is the E3 ligase that induces the hypoxic degradation of HIF1 alpha. Moreover, the action of MDM2 on HIF1 alpha under hypoxia occurs in the cytoplasm and is controlled by the PTEN-PI3K-AKT signaling axis. These data strongly suggest a new role for PTEN in the regulation of HIF1 alpha and importantly that PI3K-AKT activation is required for the hypoxic stabilization of HIF1 alpha and that hypoxia alone is not sufficient to render HIF1 alpha resistant to proteasomal cleavage and degradation. Moreover, these findings suggest new therapeutic considerations for PI3K and/or AKT inhibitors for cancer therapeutics.	[Joshi, Shweta; Singh, Alok R.; Durden, Donald L.] UC San Diego Hlth Syst, Dept Pediat, Moores Canc Ctr, La Jolla, CA 92093 USA; [Durden, Donald L.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92123 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Durden, DL (corresponding author), UC San Diego Hlth Syst, Dept Pediat, Moores Canc Ctr, La Jolla, CA 92093 USA.	ddurden@ucsd.edu	Joshi, Shweta/D-4711-2015		National Institutes of Health [HL091385, CA94233]; Alex Lemonade Stand Foundation; Hyundai Hope Grant; Cricket corporation; NATIONAL CANCER INSTITUTE [R56CA094233, R01CA094233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex Lemonade Stand Foundation; Hyundai Hope Grant; Cricket corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091385 and CA94233 (to D. L. D.). This work was also supported by the Alex Lemonade Stand Foundation, a Hyundai Hope Grant, and the Cricket corporation (to D. L. D.).	Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Ding H, 2001, CANCER RES, V61, P3826; Feldser D, 1999, CANCER RES, V59, P3915; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mahadevan D, 2012, EUR J CANCER, V48, P3319, DOI 10.1016/j.ejca.2012.06.027; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Ravi R, 2000, GENE DEV, V14, P34; Rong Y, 2005, CANCER RES, V65, P1406, DOI 10.1158/0008-5472.CAN-04-3376; Ryan HE, 2000, CANCER RES, V60, P4010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Su JD, 2003, CANCER RES, V63, P3585; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	54	63	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22785	22797		10.1074/jbc.M114.587493	http://dx.doi.org/10.1074/jbc.M114.587493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982421	Green Published, hybrid			2022-12-25	WOS:000341017200023
J	Robinson, BG; Franke, A; Derocher, AE				Robinson, Barry G.; Franke, Alastair; Derocher, Andrew E.			The Influence of Weather and Lemmings on Spatiotemporal Variation in the Abundance of Multiple Avian Guilds in the Arctic	PLOS ONE			English	Article							CLIMATE-CHANGE; REPRODUCTIVE SUCCESS; BREEDING PHENOLOGY; ELLESMERE-ISLAND; ALEXANDRA FJORD; NESTING SUCCESS; TESHEKPUK LAKE; BYLOT ISLAND; HABITAT USE; SNOW COVER	Climate change is occurring more rapidly in the Arctic than other places in the world, which is likely to alter the distribution and abundance of migratory birds breeding there. A warming climate can provide benefits to birds by decreasing spring snow cover, but increases in the frequency of summer rainstorms, another product of climate change, may reduce foraging opportunities for insectivorous birds. Cyclic lemming populations in the Arctic also influence bird abundance because Arctic foxes begin consuming bird eggs when lemmings decline. The complex interaction between summer temperature, precipitation, and the lemming cycle hinder our ability to predict how Arctic-breeding birds will respond to climate change. The main objective of this study was to investigate the relationship between annual variation in weather, spring snow cover, lemming abundance and spatiotemporal variation in the abundance of multiple avian guilds in a tundra ecosystem in central Nunavut, Canada: songbirds, shorebirds, gulls, loons, and geese. We spatially stratified our study area based on vegetation productivity, terrain ruggedness, and freshwater abundance, and conducted distance sampling to estimate strata-specific densities of each guild during the summers of 2010-2012. We also monitored temperature, rainfall, spring snow cover, and lemming abundance each year. Spatial variation in bird abundance matched what was expected based on previous ecological knowledge, but weather and lemming abundance also significantly influenced the abundance of some guilds. In particular, songbirds were less abundant during the cool, wet summer with moderate snow cover, and shorebirds and gulls declined with lemming abundance. The abundance of geese did not vary over time, possibly because benefits created by moderate spring snow cover were offset by increased fox predation when lemmings were scarce. Our study provides an example of a simple way to monitor the correlation between weather, spring snow cover, lemming abundance, and spatiotemporal variations in Arctic-breeding birds.	[Robinson, Barry G.; Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Franke, Alastair] Univ Alberta, Canadian Circumpolar Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Robinson, BG (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	bgrobi@gmail.com	Robinson, Barry/O-4406-2014; Derocher, Andrew/J-4469-2012	Robinson, Barry/0000-0002-2646-2508; Derocher, Andrew/0000-0002-1104-7774	Government of Nunavut; Nunavut Wildlife Management Board; Wilson Ornithological Society; Canadian Wildlife Federation; Canadian Circumpolar Institute; Aboriginal and Northern Affairs Canada; Arctic Net; Peregrine Fund; Natural Sciences and Engineering Research Council of Canada [305472-2008, 261231-2008]; Alberta Innovates Technology Futures; W. Garfield Weston Fountain	Government of Nunavut; Nunavut Wildlife Management Board; Wilson Ornithological Society; Canadian Wildlife Federation; Canadian Circumpolar Institute; Aboriginal and Northern Affairs Canada; Arctic Net; Peregrine Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; W. Garfield Weston Fountain	This project was funded by the Government of Nunavut (www.gov.nu.ca; grant to A. Franke), the Nunavut Wildlife Management Board (www.nwmb.com; grant to A. Franke), the Wilson Ornithological Society (www.wilsonsociety.org; Paul A. Stewart Award to B. Robinson), the Canadian Wildlife Federation (www.cwf-fcf.org/; Foundation Grant to B. Robinson), the Canadian Circumpolar Institute (www.cci.ualberta.ca; Circumpolar/Boral Alberta Research grant to B. Robinson), Aboriginal and Northern Affairs Canada (www.aadnc-aandc.gc.c; Northern Science Training Program grant to B. Robinson), Arctic Net (www.arcticnet.ulaval.ca; grant to A. Franke), The Peregrine Fund (www.peregrinefund.org; grant to A. Franke) the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca; Canadian Graduate Scholarship, Doctoral, to B. Robinson; Discovery Grant no. 305472-2008 and Northern Research Supplement no. 261231-2008 to A. Derocher), Alberta Innovates Technology Futures (www.albertatechfutures.ca; Graduate Student Scholarship to B. Robinson), and the W. Garfield Weston Fountain (Award for Northern Research to B. Robinson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil A, 2013, OECOLOGIA, P1; Andres BA, 2012, ARCTIC, V65, P411; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Ashley NT, 2012, J EXPT ZOOLOGY A, V319A, P10; Aubry LM, 2013, GLOBAL CHANGE BIOL, V19, P149, DOI 10.1111/gcb.12013; Barr JF, 2000, BIRDS N AM ONLINE; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bety J, 2001, OIKOS, V93, P388, DOI 10.1034/j.1600-0706.2001.930304.x; Bliss L.C., 1973, Annual Res Ecol Syst, V4, P359, DOI 10.1146/annurev.es.04.110173.002043; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; Boelman NT, 2003, OECOLOGIA, V135, P414, DOI 10.1007/s00442-003-1198-3; Bolduc E, 2013, CAN ENTOMOL, V145, P155, DOI 10.4039/tce.2013.4; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Brommer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043648; Brown RD, 2011, CRYOSPHERE, V5, P219, DOI 10.5194/tc-5-219-2011; Buckland S.T., 2001, pi; Buckland ST, 2009, J AGR BIOL ENVIR ST, V14, P432, DOI 10.1198/jabes.2009.08030; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Callaghan Terry V., 2005, P243; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; CUSHING DH, 1969, J CONSEIL, V33, P81; CUSTER TW, 1978, CONDOR, V80, P295, DOI 10.2307/1368039; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; Earnst SL, 2006, HYDROBIOLOGIA, V567, P227, DOI 10.1007/s10750-006-0042-2; FORBES G, 1992, ARCTIC, V45, P295; Fortin D, 2000, CONDOR, V102, P163, DOI 10.1650/0010-5422(2000)102[0163:BTARBO]2.0.CO;2; FREEDMAN B, 1982, CAN FIELD NAT, V96, P56; Gaston AJ, 2012, ICES J MAR SCI, V69, P1218, DOI 10.1093/icesjms/fss040; Gaston AJ, 2012, POLAR BIOL, V35, P1221, DOI 10.1007/s00300-012-1168-5; Gauthier G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0482; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Grabowski MM, 2013, POLAR BIOL, V36, P1097, DOI 10.1007/s00300-013-1332-6; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Hall D. K., 2006, MODIS TERRA SNOW COV, DOI 10.5067/ACYTYZB9BEOS; HATCH JJ, 2002, BIRDS N AM ONLINE; Hendricks P, 2012, BIRDS N AM ONLINE; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Huemmrich KF, 2010, REMOTE SENS ENVIRON, V114, P481, DOI 10.1016/j.rse.2009.10.003; HUGHES RJ, 1994, J WILDLIFE MANAGE, V58, P536, DOI 10.2307/3809326; Hussell DJT, 2002, BIRDS N AM ONLINE; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; Johnson O. W., 2010, BIRDS N AM ONLINE; Kattsov V. M., 2005, ARCTIC CLIMATE IMPAC, P101; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Kendall S, 2011, GYRFALCONS PTARMIGAN; Krebs CJ, 2006, CLIM RES, V32, P143, DOI 10.3354/cr032143; Latour PB, 2005, ARCTIC, V58, P55; Lecomte N, 2009, ECOLOGY, V90, P465, DOI 10.1890/08-0215.1; Liebezeit JR, 2011, ARCTIC, V64, P32, DOI 10.14430/arctic4078; LINDHOLM A, 1994, CONDOR, V96, P898, DOI 10.2307/1369100; Madsen J, 2007, POLAR BIOL, V30, P1363, DOI 10.1007/s00300-007-0296-9; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marshall IB, 1996, ENVIRON MONIT ASSESS, V39, P25, DOI 10.1007/BF00396133; McKinnon L, 2012, CAN J ZOOL, V90, P961, DOI 10.1139/Z2012-064; McKinnon L, 2013, SCI REPORTS, V3, P6; McKinnon L, 2013, OIKOS, V122, P1042, DOI 10.1111/j.1600-0706.2012.20708.x; Meltofte H., 2007, EFFECTS CLIMATE VARI; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Montgomerie R., 2011, BIRDS N AM ONLINE; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; Morrison RIG, 1997, ARCTIC, V50, P55; Mowbray Thomas B., 2002, BIRDS N AM ONLINE; Nol E, 1999, BIRDS N AM ONLINE; Nolet BA, 2013, J ANIM ECOL, V82, P804, DOI 10.1111/1365-2656.12060; Parmelee D.F., 1992, BIRDS N AM ONLINE; Pearce-Higgins JW, 2005, OECOLOGIA, V143, P470, DOI 10.1007/s00442-004-1820-z; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perkins DE, 2007, POLAR REC, V43, P135, DOI 10.1017/S0032247407006092; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pokrovsky I, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17294; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Provencher JF, 2012, MARINE; RCoreTeam, 2012, R LANG ENV STAT COMP; Russell RW, 2002, BIRDS N AM ONLINE; Sammler JE, 2008, CONDOR, V110, P325, DOI 10.1525/cond.2008.8438; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; Schekkerman H, 2001, AUK, V118, P944, DOI 10.1642/0004-8038(2001)118[0944:PERISE]2.0.CO;2; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Sokolov V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050335; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stenhouse IJ, 2001, CONDOR, V103, P98, DOI 10.1650/0010-5422(2001)103[0098:RBOSSG]2.0.CO;2; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Therrien JF, 2014, ECOLOGY, V95, P56, DOI 10.1890/13-0458.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tracy D. M., 2002, BIRDS N AM ONLINE; Trefry SA, 2010, ARCTIC, V63, P308; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; UNDERHILL LG, 1993, IBIS, V135, P277, DOI 10.1111/j.1474-919X.1993.tb02845.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Weiser E, 2012, BIRDS N AM ONLINE; Weiser EL, 2011, ARCTIC, V64, P220; Wiley R. H., 1998, BIRDS N AM ONLINE; [No title captured]; [No title captured]	102	19	20	5	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101495	10.1371/journal.pone.0101495	http://dx.doi.org/10.1371/journal.pone.0101495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983471	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000115
J	Yu, MF; Ast, S; Yu, Q; Lo, ATS; Flehr, R; Todd, MH; Rutledge, PJ				Yu, Mingfeng; Ast, Sandra; Yu, Qun; Lo, Anthony T. S.; Flehr, Roman; Todd, Matthew H.; Rutledge, Peter J.			Incorporating a Piperidinyl Group in the Fluorophore Extends the Fluorescence Lifetime of Click-Derived Cyclam-Naphthalimide Conjugates	PLOS ONE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; TRANSITION-METAL IONS; RATIOMETRIC FLUORESCENT; ARYL AZIDES; CHEMOSENSORS; RECOGNITION; SENSORS; COMPLEXES; MECHANISM; AMINES	Ligands incorporating a tetraazamacrocycle receptor, a 'click'-derived triazole and a 1,8-naphthalimide fluorophore have proven utility as probes for metal ions. Three new cyclam-based molecular probes are reported, in which a piperidinyl group has been introduced at the 4-position of the naphthalimide fluorophore. These compounds have been synthesized using the copper(I)-catalyzed azide-alkyne Huisgen cycloaddition and their photophysical properties studied in detail. The alkylamino group induces the expected red-shift in absorption and emission spectra relative to the simple naphthalimide derivatives and gives rise to extended fluorescence lifetimes in aqueous buffer. The photophysical properties of these systems are shown to be highly solvent-dependent. Screening the fluorescence responses of the new conjugates to a wide variety of metal ions reveals significant and selective fluorescence quenching in the presence of copper(II), yet no fluorescence enhancement with zinc(II) as observed previously for the simple naphthalimide derivatives. Reasons for this different behaviour are proposed. Cytotoxicity testing shows that these new cyclam-triazole-dye conjugates display little or no toxicity against either DLD-1 colon carcinoma cells or MDA-MB-231 breast carcinoma cells, suggesting a potential role for these and related systems in biological sensing applications.	[Yu, Mingfeng; Ast, Sandra; Yu, Qun; Lo, Anthony T. S.; Todd, Matthew H.; Rutledge, Peter J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Flehr, Roman] Univ Potsdam, Inst Chem, Potsdam, Brandenburg, Germany	University of Sydney; University of Potsdam	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au; peter.rutledge@sydney.edu.au	Rutledge, Peter J/D-6253-2012; Yu, Mingfeng/F-4325-2013; Todd, Matthew/S-2678-2018	Yu, Mingfeng/0000-0002-0860-4816; Rutledge, Peter/0000-0002-0767-5196; Lo, Anthony/0000-0002-5921-9854; Todd, Matthew/0000-0001-7096-4751	National Breast Cancer Fund [NC-10-69]; Australian Research Council [DP120104035]; University of Sydney	National Breast Cancer Fund; Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This work was supported by the National Breast Cancer Fund (http://www.nbcf.org.au/) with Novel Concept Grant NC-10-69, the Australian Research Council (http://www.arc.gov.au/) with Discovery Project Grant DP120104035, and the University of Sydney, with a University of Sydney International Scholarship (USydIS) to Mingfeng Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2005, SYNLETT, P2209, DOI 10.1055/s-2005-872248; Ast S, 2012, EUR J INORG CHEM, P5611, DOI 10.1002/ejic.201201072; Baier MC, 2009, J AM CHEM SOC, V131, P14267, DOI 10.1021/ja905077c; Dai HL, 2012, CHEM-EUR J, V18, P11188, DOI 10.1002/chem.201201604; Dai HL, 2012, CHINESE J CHEM, V30, P267, DOI 10.1002/cjoc.201180481; Dai HL, 2011, BIOORG MED CHEM LETT, V21, P5141, DOI 10.1016/j.bmcl.2011.07.085; De Costa MDP, 2004, J PHOTOCH PHOTOBIO A, V162, P591, DOI 10.1016/S1010-6030(03)00419-2; DE SILVA AP, 1995, ANGEW CHEM INT EDIT, V34, P1728, DOI 10.1002/anie.199517281; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Ding GH, 2008, RES CHEM INTERMEDIAT, V34, P299, DOI 10.1163/156856708783623401; Fegley MEA, 2012, INORG CHIM ACTA, V381, P78, DOI 10.1016/j.ica.2011.11.040; Filarowski A, 2010, PHOTOCH PHOTOBIO SCI, V9, P996, DOI 10.1039/c0pp00035c; Grabchev I, 2012, CURR MED CHEM, V19, P4976; Gunnlaugsson T, 2003, TETRAHEDRON LETT, V44, P6575, DOI 10.1016/S0040-4039(03)01699-X; Huang JH, 2009, ORG BIOMOL CHEM, V7, P1299, DOI 10.1039/b818611a; Hyman LM, 2012, COORDIN CHEM REV, V256, P2333, DOI 10.1016/j.ccr.2012.03.009; Jeong Y, 2012, INORG CHIM ACTA, V381, P2, DOI 10.1016/j.ica.2011.09.011; Jobe K, 2011, CHEM COMMUN, V47, P6036, DOI 10.1039/c1cc11213a; Kim BJ, 2011, CHEM SCI, V2, P2135, DOI 10.1039/c1sc00337b; KRONICK MN, 1983, CLIN CHEM, V29, P1582; Lau YH, 2011, CHEM-EUR J, V17, P2850, DOI 10.1002/chem.201002477; LIPPERT E, 1955, Z NATURFORSCH PT A, V10, P541, DOI 10.1515/zna-1955-0707; Markiewicz JT, 2010, J ORG CHEM, V75, P4887, DOI 10.1021/jo101002p; MASUHARA H, 1984, J PHYS CHEM-US, V88, P5868, DOI 10.1021/j150668a026; MATAGA N, 1956, B CHEM SOC JPN, V29, P465, DOI 10.1246/bcsj.29.465; MATAGA N, 1955, B CHEM SOC JPN, V28, P690, DOI 10.1246/bcsj.28.690; Mbatia HW, 2012, BIOCHEMISTRY-US, V51, P7212, DOI 10.1021/bi3001769; MCCLURE DS, 1952, J CHEM PHYS, V20, P682, DOI 10.1063/1.1700516; Mednykh YA, 2004, RUSS J GEN CHEM+, V74, P1728, DOI 10.1007/s11176-005-0091-7; Parkesh R, 2007, ORG BIOMOL CHEM, V5, P310, DOI 10.1039/b614529a; Schaferling M, 2012, ANGEW CHEM INT EDIT, V51, P3532, DOI 10.1002/anie.201105459; Singh N, 2010, TETRAHEDRON LETT, V51, P3385, DOI 10.1016/j.tetlet.2010.04.099; Tagg T, 2008, ACTA CRYSTALLOGR C, V64, pO388, DOI 10.1107/S0108270108016120; Tamanini E, 2010, INORG CHEM, V49, P3789, DOI 10.1021/ic901939x; Tamanini E, 2009, CHEM-EUR J, V15, P3720, DOI 10.1002/chem.200802425; Tamanini E, 2009, INORG CHEM, V48, P319, DOI 10.1021/ic8017634; VARNES AW, 1972, J AM CHEM SOC, V94, P946, DOI 10.1021/ja00758a037; Wang DH, 2010, ORG BIOMOL CHEM, V8, P2923, DOI 10.1039/c004148c; WERNER TC, 1973, J PHYS CHEM-US, V77, P1611, DOI 10.1021/j100632a003; Xu H, 2011, CHINESE J CHEM, V29, P2165, DOI 10.1002/cjoc.201180375; Xu ZC, 2005, ORG LETT, V7, P3029, DOI 10.1021/ol051131d; Xu ZC, 2005, ORG LETT, V7, P889, DOI 10.1021/ol0473445; Xu Z, 2007, TETRAHEDRON LETT, V48, P9151, DOI 10.1016/j.tetlet.2007.10.109; Xu ZC, 2010, TETRAHEDRON, V66, P1678, DOI 10.1016/j.tet.2010.01.008; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Yu MF, 2013, CHEMSTRYOPEN, V2, P99, DOI 10.1002/open.201300014; Yu MF, 2013, CHEMBIOCHEM, V14, P224, DOI 10.1002/cbic.201200637; Yu MF, 2011, INORG CHEM, V50, P12823, DOI 10.1021/ic2020012; Zhang JZ, 2012, METALLOMICS, V4, P1209, DOI 10.1039/c2mt20168b; Zhu W, 2004, CHEM COMMUN, P888, DOI 10.1039/b400878b	50	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100761	10.1371/journal.pone.0100761	http://dx.doi.org/10.1371/journal.pone.0100761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983863	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000038
J	Zhang, DD; Liu, YZ; Zhou, CL; Chen, YM; Luo, YJ				Zhang, Dandan; Liu, Yunzhe; Zhou, Chenglin; Chen, Yuming; Luo, Yuejia			Spatial Attention Effects of Disgusted and Fearful Faces	PLOS ONE			English	Article							TOP-DOWN MODULATION; FACIAL EXPRESSION; DISEASE-AVOIDANCE; BRAIN POTENTIALS; VISUAL-ATTENTION; TIME-COURSE; EMOTION; THREAT; FMRI; BIAS	Effective processing of threat-related stimuli is of significant evolutionary advantage. Given the intricate relationship between attention and the neural processing of threat-related emotions, this study manipulated attention allocation and emotional categories of threat-related stimuli as independent factors and investigated the time course of spatial-attention-modulated processing of disgusting and fearful stimuli. The participants were instructed to direct their attention either to the two vertical or to the two horizontal locations, where two faces and two houses would be presented. The task was to respond regarding the physical identity of the two stimuli at cued locations. Event-related potentials (ERP) evidences were found to support a two-stage model of attention-modulated processing of threat-related emotions. In the early processing stage, disgusted faces evoked larger P1 component at right occipital region despite the attention allocation while larger N170 component was elicited by fearful faces at right occipito-temporal region only when participants attended to houses. In the late processing stage, the amplitudes of the parietal P3 component enhanced for both disgusted and fearful facial expressions only when the attention was focused on faces. According to the results, we propose that the temporal dynamics of the emotion-by-attention interaction consist of two stages. The early stage is characterized by quick and specialized neural encoding of disgusting and fearful stimuli irrespective of voluntary attention allocation, indicating an automatic detection and perception of threat-related emotions. The late stage is represented by attention-gated separation between threat-related stimuli and neutral stimuli; the similar ERP pattern evoked by disgusted and fearful faces suggests a more generalized processing of threat-related emotions via top-down attentional modulation, based on which the defensive behavior in response to threat events is largely facilitated.	[Zhang, Dandan; Chen, Yuming; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Zhang, Dandan; Liu, Yunzhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhou, Chenglin] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China	Shenzhen University; Beijing Normal University; Shanghai University of Sport	Zhou, CL (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	chenglin_600@126.com			National Natural Science Foundation of China [31300867]; National Basic Research Program of China (973 Program) [2014CB744600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31300867) and the National Basic Research Program of China (973 Program, 2014CB744600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; Anderson AK, 2003, J NEUROSCI, V23, P5627; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Charash M, 2002, J ANXIETY DISORD, V16, P529, DOI 10.1016/S0887-6185(02)00171-8; Charash M, 2006, ANXIETY STRESS COPIN, V19, P353, DOI 10.1080/10615800601055915; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20003; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vermeulen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007924; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weymar M, 2011, NEUROIMAGE, V58, P946, DOI 10.1016/j.neuroimage.2011.06.061; Williams Leanne M., 2006, Journal of Integrative Neuroscience, V5, P1, DOI 10.1142/S0219635206001082; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zhang DD, 2013, NEUROPSYCHOLOGIA, V51, P1397, DOI 10.1016/j.neuropsychologia.2013.04.014; Zhang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049517	49	5	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101608	10.1371/journal.pone.0101608	http://dx.doi.org/10.1371/journal.pone.0101608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983360	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000124
J	Martins, VDA; Bastos, MD; Ramasawmy, R; de Figueiredo, RP; Gimaque, JBL; Braga, WSM; Nogueira, ML; Nozawa, S; Naveca, FG; Figueiredo, LTM; Mourao, MPG				Alves Martins, Valquiria do Carmo; Bastos, Michele de Souza; Ramasawmy, Rajendranath; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Miranda Braga, Wornei Silva; Nogueira, Mauricio Lacerda; Nozawa, Sergio; Naveca, Felipe Gomes; Moraes Figueiredo, Luiz Tadeu; Gomes Mourao, Maria Paula			Clinical and Virological Descriptive Study in the 2011 Outbreak of Dengue in the Amazonas, Brazil	PLOS ONE			English	Article							NEUROLOGICAL MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; VIRUS TYPE-2; INFECTION; CIRCULATION; SEROTYPES; PARAGUAY; MANAUS; STATE; PCR	Background: Dengue is a vector-borne disease in the tropical and subtropical region of the world and is transmitted by the mosquito Aedes aegypti. In the state of Amazonas, Brazil during the 2011 outbreak of dengue all the four Dengue virus (DENV) serotypes circulating simultaneously were observed. The aim of the study was to describe the clinical epidemiology of dengue in Manaus, the capital city of the state of the Amazonas, where all the four DENV serotypes were co-circulating simultaneously. Methodology: Patients with acute febrile illness during the 2011 outbreak of dengue, enrolled at the Fundacao de Medicina Tropical Dr. Heitor Viera Dourado (FMT-HVD), a referral centre for tropical and infectious diseases in Manaus, were invited to participate in a clinical and virological descriptive study. Sera from 677 patients were analyzed by RT-nested-PCRs for flaviviruses (DENV 1-4, Saint Louis encephalitis virus-SLEV, Bussuquara virus-BSQV and Ilheus virus-ILHV), alphavirus (Mayaro virus-MAYV) and orthobunyavirus (Oropouche virus-OROV). Principal Findings: Only dengue viruses were detected in 260 patients (38.4%). Thirteen patients were co-infected with more than one DENV serotype and six (46.1%) of them had a more severe clinical presentation of the disease. Nucleotide sequencing showed that DENV-1 belonged to genotype V, DENV-2 to the Asian/American genotype, DENV-3 to genotype III and DENV-4 to genotype II. Conclusions: Co-infection with more than one DENV serotype was observed. This finding should be warning signs to health authorities in situations of the large dispersal of serotypes that are occurring in the world.	[Bastos, Michele de Souza; Ramasawmy, Rajendranath; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Miranda Braga, Wornei Silva; Nogueira, Mauricio Lacerda; Moraes Figueiredo, Luiz Tadeu; Gomes Mourao, Maria Paula] Fundacao Med Trop Dr Heitor Viera Dourado FMT HVD, Manaus, Amazonas, Brazil; [Alves Martins, Valquiria do Carmo; Bastos, Michele de Souza; Ramasawmy, Rajendranath; Miranda Braga, Wornei Silva; Gomes Mourao, Maria Paula] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Nozawa, Sergio; Gomes Mourao, Maria Paula] Univ Nilton Lins, Manaus, Amazonas, Brazil; [Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto FAMERP, Sao Paulo, Brazil; [Naveca, Felipe Gomes] Fundacao Oswaldo Cruz FIOCRUZ, Inst Leonidas & Maria Deane ILMD, Manaus, Amazonas, Brazil; [Moraes Figueiredo, Luiz Tadeu] Fac Med Ribeirao Preto FMRP USP, Ctr Pesquisas Virol, Sao Paulo, Brazil	Universidade do Estado do Amazonas; Centro Universitario Nilton Lins; Fundacao Oswaldo Cruz	Martins, VDA (corresponding author), Univ Estado Amazonas, Manaus, Amazonas, Brazil.	alvesvalquiria@yahoo.com.br; mariapaula.mourao@gmail.com	Mourao, Maria/AAW-5989-2021; Nogueira, Mauricio L/B-7599-2012; Bastos, Michele/AAS-7386-2020; Ramasawmy, Rajendranath/V-4926-2019; Naveca, Felipe/H-1130-2012	Nogueira, Mauricio L/0000-0003-1102-2419; Bastos, Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060; Mourao, Maria Paula/0000-0002-6458-0900	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM) [887/2010]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM)	This research was financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM) through grant 887/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso HL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-124; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005; Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Bona ACD, 2012, REV SOC BRAS MED TRO, V45, P297, DOI 10.1590/S0037-86822012000300003; Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017; de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, P28; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001; Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122; Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Peng WM, 2005, J CLIN VIROL, V32, P194, DOI 10.1016/j.jcv.2004.04.010; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rocco Iray Maria, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P151, DOI 10.1590/S0036-46651998000300004; Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WHO/TDR, 2012, HDB CLIN MAN DENG, P124; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Yu Man, 2004, Weishengwu Xuebao, V44, P717	37	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100535	10.1371/journal.pone.0100535	http://dx.doi.org/10.1371/journal.pone.0100535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978469	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400033
J	Benjamin, CFA; Saling, MM; Wood, AG; Reutens, DC				Benjamin, Christopher F. A.; Saling, Michael M.; Wood, Amanda G.; Reutens, David C.			Elemental Spatial and Temporal Association Formation in Left Temporal Lobe Epilepsy	PLOS ONE			English	Article							MEMORY FORMATION; FUNCTIONAL MRI; HIPPOCAMPAL PATHOLOGY; EPISODIC MEMORY; WORKING-MEMORY; BRAIN; FMRI; PARAHIPPOCAMPAL; ACTIVATION; RESECTION	The mesial temporal lobe (MTL) is typically understood as a memory structure in clinical settings, with the sine qua non of MTL damage in epilepsy being memory impairment. Recent models, however, understand memory as one of a number of higher cognitive functions that recruit the MTL through their reliance on more fundamental processes, such as "self-projection'' or "association formation''. We examined how damage to the left MTL influences these fundamental processes through the encoding of elemental spatial and temporal associations. We used a novel fMRI task to image the encoding of simple visual stimuli, either rich or impoverished, in spatial or spatial plus temporal information. Participants included 14 typical adults (36.4 years, sd. 10.5 years) and 14 patients with left mesial temporal lobe damage as evidenced by a clinical diagnosis of left temporal lobe epilepsy (TLE) and left MTL impairment on imaging (34.3 years, sd. 6.6 years). In-scanner behavioral performance was equivalent across groups. In the typical group whole-brain analysis revealed highly significant bilateral parahippocampal activation (right. left) during spatial associative processing and left hippocampal/parahippocampal deactivation in joint spatial-temporal associative processing. In the left TLE group identical analyses indicated patients used MTL structures contralateral to the seizure focus differently and relied on extra-MTL regions to a greater extent. These results are consistent with the notion that epileptogenic MTL damage is followed by reorganization of networks underlying elemental associative processes. In addition, they provide further evidence that task-related fMRI deactivation can meaningfully index brain function. The implications of these findings for clinical and cognitive neuropsychological models of MTL function in TLE are discussed.	[Benjamin, Christopher F. A.] Univ Calif Los Angeles, Dept Psychiat, Semel Inst, Los Angeles, CA 90095 USA; [Benjamin, Christopher F. A.] Harvard Univ, Sch Med, Computat Radiol Lab, Boston, MA USA; [Saling, Michael M.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Wood, Amanda G.] Univ Birmingham, Dept Psychol, Birmingham, England; [Wood, Amanda G.] Monash Univ, Southern Clin Sch, Clayton, Vic, Australia; [Reutens, David C.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of Melbourne; University of Birmingham; Monash University; University of Queensland	Benjamin, CFA (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Semel Inst, Los Angeles, CA 90095 USA.	cbenjamin@mednet.ucla.edu	Reutens, David/C-7226-2018; Benjamin, Christopher/Z-2728-2019; Wood, Amanda/K-9595-2013	Benjamin, Christopher/0000-0002-2000-9016; Reutens, David/0000-0002-1652-9369; Wood, Amanda/0000-0002-1537-6858	NH&MRC Program Grant [400121]; National Academy of Neuropsychology Clinical Research Grant	NH&MRC Program Grant; National Academy of Neuropsychology Clinical Research Grant	This research was supported by NH&MRC Program Grant 400121 and in part by a National Academy of Neuropsychology Clinical Research Grant (PI: Benjamin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Alessio A, 2013, HUM BRAIN MAPP, V34, P186, DOI 10.1002/hbm.21432; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; [Anonymous], 2007, MATL R2007B; Astur RS, 2004, BEHAV NEUROSCI, V118, P667, DOI 10.1037/0735-7044.118.4.667; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bonelli SB, 2013, BRAIN, V136, P1889, DOI 10.1093/brain/awt105; Bonelli SB, 2010, BRAIN, V133, P1186, DOI 10.1093/brain/awq006; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diaz-Asper CM, 2006, J CLIN EXP NEUROPSYC, V28, P1462, DOI 10.1080/13803390500434359; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2006, NEUROSCI LETT, V407, P37, DOI 10.1016/j.neulet.2006.07.074; Glikmann-Johnston Y, 2008, BRAIN, V131, P3006, DOI 10.1093/brain/awn213; Haag A, 2008, EPILEPSY BEHAV, V13, P83, DOI 10.1016/j.yebeh.2008.02.012; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; McAndrews Mary Pat, 2012, Epilepsy Res Treat, V2012, P925238, DOI 10.1155/2012/925238; Meltzer JA, 2008, HUM BRAIN MAPP, V29, P385, DOI 10.1002/hbm.20391; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Neurobehavioral Systems, 2007, PRESENTATION; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Powell HWR, 2007, EPILEPSIA, V48, P1512, DOI 10.1111/j.1528-1167.2007.01053.x; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Saling MM, 2005, MAGNETIC RESONANCE IN EPILEPSY: NEUROIMAGING TECHNIQUES, 2ND EDITION, P271, DOI 10.1016/B978-012431152-7/50013-6; Saling MM, 2009, BRAIN, V132, P570, DOI 10.1093/brain/awp012; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Treyer V, 2005, HIPPOCAMPUS, V15, P684, DOI 10.1002/hipo.20093; Tsukiura T, 2002, HUM BRAIN MAPP, V17, P203, DOI 10.1002/hbm.10068; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Tulving E, 2002, EPISODIC MEMORY MIND; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Voets NL, 2009, HUM BRAIN MAPP, V30, P4070, DOI 10.1002/hbm.20830; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030; Zeidman P, 2012, NEUROREPORT, V23, P503, DOI 10.1097/WNR.0b013e328353766a	58	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100891	10.1371/journal.pone.0100891	http://dx.doi.org/10.1371/journal.pone.0100891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978828	Green Published, Green Accepted, gold			2022-12-25	WOS:000338506400046
J	Cohen, M; Hamilton, J; Narang, I				Cohen, Michal; Hamilton, Jill; Narang, Indra			Clinically Important Age-Related Differences in Sleep Related Disordered Breathing in Infants and Children with Prader-Willi Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE THERAPY; POLYSOMNOGRAPHIC VALUES; BODY-COMPOSITION; APNEA; MANAGEMENT; CHILDHOOD; ADOLESCENTS; DIAGNOSIS; TODDLERS; OBESITY	Background: Sleep related disordered breathing (SDB) in pediatric Prader-Willi Syndrome is gaining increased attention due to the possible association of growth hormone therapy, SDB and sudden death. However data on the patterns of SDB and their management, particularly in infants in this population, is lacking. Objective: The aim of this study was to 1) describe patterns of SDB in growth hormone naive infants with PWS and the management of these disorders in our institution 2) Compare the patterns of sleep disorders between infants and children with PWS. Methods and Design: Polysomnograms of infants and children (0-18 years of age) with Prader-Willi Syndrome were reviewed. Age, sex, anthropometrics, sleep architecture, obstructive and central apnea indices and oxygen saturations were recorded. Data of infants with central sleep apnea treated with oxygen were analyzed to evaluate the efficacy of this treatment. The main outcome measures were obstructive and central apnea indices on a polysomnogram. Results: Data of 44 patients, 23 under 2 years of age and 21 older children were included. Infants when compared with older children were more likely to experience central sleep apnea (43% vs. 5%; p = 0.003). In older children obstructive was significantly more prevalent than central sleep apnea. Supplemental oxygen was used to treat 9/23 infants with central sleep apnea. Oxygen therapy resulted in a significant decrease in the median central apnea index from 14 (5,68) to 1 (0,6; p = 0.008) events/hour and an improvement in the oxygen saturation nadir from 70% (52, 92) to 81% (64, 95; p = 0.080). Conclusions: Central sleep apnea with associated oxygen desaturations is more prevalent in infants compared with older children with Prader-Willi Syndrome. Supplemental oxygen was efficacious in treating central sleep apnea in infants. Routine sleep surveillance for all children with Prader-Willi Syndrome and treatment with oxygen for central sleep apnea should be considered.	[Cohen, Michal; Hamilton, Jill] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Cohen, Michal; Hamilton, Jill; Narang, Indra] Univ Toronto, Toronto, ON, Canada; [Narang, Indra] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cohen, M (corresponding author), Hosp Sick Children, Div Endocrinol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	indra.narang@sickkids.ca						ARENS R, 1994, J APPL PHYSIOL, V77, P2224, DOI 10.1152/jappl.1994.77.5.2224; Barbera Joseph VI, 2010, SLEEP MENTAL ILLNESS; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Beck SE, 2009, SLEEP MED CLIN, V4, P393, DOI 10.1016/j.jsmc.2009.04.007; Bekx MT, 2003, J PEDIATR-US, V143, P372, DOI 10.1067/S0022-3476(03)00386-X; Bruni O, 2010, CURR OPIN PULM MED, V16, P568, DOI 10.1097/MCP.0b013e32833ef547; Capdevila Oscar Sans, 2008, Proc Am Thorac Soc, V5, P274, DOI 10.1513/pats.200708-138MG; Carrel AL, 2004, J PEDIATR-US, V145, P744, DOI 10.1016/j.jpeds.2004.08.002; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Eiholzer U, 1999, J PEDIATR-US, V134, P222, DOI 10.1016/S0022-3476(99)70419-1; Festen DAM, 2008, CLIN ENDOCRINOL, V68, P919, DOI 10.1111/j.1365-2265.2007.03126.x; Festen DAM, 2006, J CLIN ENDOCR METAB, V91, P4911, DOI 10.1210/jc.2006-0765; Festen DAM, 2007, PEDIATR RES, V62, P221, DOI 10.1203/PDR.0b013e31809871dd; Goldstone AP, 2008, J CLIN ENDOCR METAB, V93, P4183, DOI 10.1210/jc.2008-0649; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; HELBINGZWANENBURG B, 1993, J INTELL DISABIL RES, V37, P533; HERTZ G, 1995, AM J MED GENET, V56, P188, DOI 10.1002/ajmg.1320560215; Iber C., 2007, AASM MANUAL SCORING; Lin HY, 2007, PEDIATR PULM, V42, P881, DOI 10.1002/ppul.20673; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; MARCUS CL, 1992, AM REV RESPIR DIS, V146, P1235, DOI 10.1164/ajrccm/146.5_Pt_1.1235; Mary Cataletto GH, 2010, ROMANIAN J RARE DIS; McCandless SE, 2011, PEDIATRICS, V127, P195, DOI 10.1542/peds.2010-2820; Miller JL, 2012, J CLIN ENDOCR METAB, V97, P3837, DOI 10.1210/jc.2012-2543; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Miller JL, 2009, J CLIN SLEEP MED, V5, P448; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Nixon GM, 2002, PEDIATR PULM, V34, P209, DOI 10.1002/ppul.10152; O'Donoghue FJ, 2005, J PEDIATR-US, V147, P823, DOI 10.1016/j.jpeds.2005.07.021; RICHARDS A, 1994, CLIN OTOLARYNGOL, V19, P193, DOI 10.1111/j.1365-2273.1994.tb01213.x; Sacco M, 2005, HORM RES, V63, P29, DOI 10.1159/000082525; Scholle S, 2011, SLEEP MED, V12, P988, DOI 10.1016/j.sleep.2011.05.006; Tapia IE, 2008, SLEEP, V31, P1737, DOI 10.1093/sleep/31.12.1737; Tauber M, 2008, AM J MED GENET A, V146A, P881, DOI 10.1002/ajmg.a.32131; Traeger N, 2005, PEDIATR PULM, V40, P22, DOI 10.1002/ppul.20236; Urquhart DS, 2013, ARCH DIS CHILD, V98, P592, DOI 10.1136/archdischild-2012-303441; Vandeleur M, 2013, J PAEDIATR CHILD H, V49, P238, DOI 10.1111/jpc.12109; Williams K, 2008, J CLIN SLEEP MED, V4, P111	38	63	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101012	10.1371/journal.pone.0101012	http://dx.doi.org/10.1371/journal.pone.0101012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979549	gold, Green Submitted, Green Published			2022-12-25	WOS:000338506400062
J	de Bruin, M; Smeulders, MJ; Kreulen, M; Huijing, PA; Jaspers, RT				de Bruin, Marije; Smeulders, Mark J.; Kreulen, Michiel; Huijing, Peter A.; Jaspers, Richard T.			Intramuscular Connective Tissue Differences in Spastic and Control Muscle: A Mechanical and Histological Study	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; CHRONIC ELECTRICAL-STIMULATION; FLEXOR CARPI ULNARIS; CEREBRAL-PALSY; SKELETAL-MUSCLE; FIBER TYPES; SARCOMERE-LENGTH; EXTRACELLULAR-MATRIX; COMPUTED-TOMOGRAPHY; MEASUREMENTS REVEAL	Cerebral palsy (CP) of the spastic type is a neurological disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks. Secondary to the spasticity, muscle adaptation is presumed to contribute to limitations in the passive range of joint motion. However, the mechanisms underlying these limitations are unknown. Using biopsies, we compared mechanical as well as histological properties of flexor carpi ulnaris muscle (FCU) from CP patients (n = 29) and healthy controls (n = 10). The sarcomere slack length (mean 2.5 mu m, SEM 0.05) and slope of the normalized sarcomere length-tension characteristics of spastic fascicle segments and single myofibre segments were not different from those of control muscle. Fibre type distribution also showed no significant differences. Fibre size was significantly smaller (1933 mu m(2), SEM 190) in spastic muscle than in controls (2572 mu m(2), SEM 322). However, our statistical analyses indicate that the latter difference is likely to be explained by age, rather than by the affliction. Quantities of endomysial and perimysial networks within biopsies of control and spastic muscle were unchanged with one exception: a significant thickening of the tertiary perimysium (3-fold), i.e. the connective tissue reinforcement of neurovascular tissues penetrating the muscle. Note that this thickening in tertiary perimysium was shown in the majority of CP patients, however a small number of patients (n = 4 out of 23) did not have this feature. These results are taken as indications that enhanced myofascial loads on FCU is one among several factors contributing in a major way to the aetiology of limitation of movement at the wrist in CP and the characteristic wrist position of such patients.	[de Bruin, Marije; Smeulders, Mark J.; Kreulen, Michiel] Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1105 AZ Amsterdam, Netherlands; [Kreulen, Michiel] Red Cross Hosp, Dept Plast Reconstruct & Hand Surg, Beverwijk, Netherlands; [Huijing, Peter A.; Jaspers, Richard T.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Lab Myol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Jaspers, RT (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Lab Myol, Amsterdam, Netherlands.	r.t.jaspers@vu.nl		Jaspers, Richard/0000-0002-6951-0952	Phelps Stichting voor Spastici [2006009]	Phelps Stichting voor Spastici	This study was supported by the Phelps Stichting voor Spastici (Grant No. 2006009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1971, J NEUROL SCI, V14, P171, DOI 10.1016/0022-510X(71)90085-2; ALNAQEEB MA, 1984, J ANAT, V139, P677; Barber L, 2011, DEV MED CHILD NEUROL, V53, P543, DOI 10.1111/j.1469-8749.2011.03913.x; Benard MR, 2010, CLIN BIOMECH, V25, P802, DOI 10.1016/j.clinbiomech.2010.04.010; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Booth CM, 2001, DEV MED CHILD NEUROL, V43, P314, DOI 10.1017/S0012162201000597; BORG TK, 1980, TISSUE CELL, V12, P197, DOI 10.1016/0040-8166(80)90061-0; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Burkholder TJ, 2001, J APPL PHYSIOL, V91, P2466, DOI 10.1152/jappl.2001.91.6.2466; CASTLE ME, 1979, CLIN ORTHOP RELAT R, P223; de Bruin M, 2011, CLIN BIOMECH, V26, P725, DOI 10.1016/j.clinbiomech.2011.03.007; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; Fry NR, 2003, GAIT POSTURE, V17, P119, DOI 10.1016/S0966-6362(02)00059-0; Gollapudi SK, 2009, J BIOMECH, V42, P2011, DOI 10.1016/j.jbiomech.2009.06.013; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; HESLINGA JW, 1995, EUR J APPL PHYSIOL, V70, P49, DOI 10.1007/BF00601808; HOFFER MM, 1993, CLIN ORTHOP RELAT R, P135; Huijing PA, 2005, SCAND J MED SCI SPOR, V15, P349, DOI 10.1111/j.1600-0838.2005.00457.x; Huijing PA, 2003, J MORPHOL, V256, P306, DOI 10.1002/jmor.10097; Huijing PA, 2007, J ELECTROMYOGR KINES, V17, P708, DOI 10.1016/j.jelekin.2007.02.003; Ito J, 1996, BRAIN DEV-JPN, V18, P299, DOI 10.1016/0387-7604(96)00006-X; Jaspers RT, 2006, CELL TISSUE RES, V326, P795, DOI 10.1007/s00441-006-0227-z; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; LEXELL J, 1991, J ANAT, V174, P239; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lieber RL, 1997, J EXP BIOL, V200, P19; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lieber RL, 1997, J BIOMECH ENG-T ASME, V119, P386, DOI 10.1115/1.2798283; LIEBER RL, 1986, DEV MED CHILD NEUROL, V28, P662; Maas H, 2005, CELLS TISSUES ORGANS, V181, P38, DOI 10.1159/000089967; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; Meijer HJM, 2007, J ELECTROMYOGR KINES, V17, P698, DOI 10.1016/j.jelekin.2007.02.006; Nishimura T, 2009, ANIM SCI J, V80, P85, DOI 10.1111/j.1740-0929.2008.00600.x; OERTEL G, 1988, J NEUROL SCI, V88, P303, DOI 10.1016/0022-510X(88)90227-4; OVEREND TJ, 1992, CLIN PHYSIOL, V12, P629, DOI 10.1111/j.1475-097X.1992.tb00366.x; Pette D, 1999, MUSCLE NERVE, V22, P666, DOI 10.1002/(SICI)1097-4598(199906)22:6<666::AID-MUS3>3.0.CO;2-Z; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Ponten E, 2005, DEV MED CHILD NEUROL, V47, P384, DOI 10.1017/S0012162205000757; Ponten EM, 2007, J NEUROL SCI, V253, P25, DOI 10.1016/j.jns.2006.11.006; Ponten E, 2007, MUSCLE NERVE, V36, P47, DOI 10.1002/mus.20780; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Ranatunga KW, 1996, BIOPHYS J, V71, P1905, DOI 10.1016/S0006-3495(96)79389-X; RICE CL, 1989, CLIN PHYSIOL, V9, P207, DOI 10.1111/j.1475-097X.1989.tb00973.x; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; ROMANINI L, 1989, Italian Journal of Orthopaedics and Traumatology, V15, P87; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; ROWE RWD, 1981, TISSUE CELL, V13, P681, DOI 10.1016/S0040-8166(81)80005-5; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smeulders MJC, 2005, MUSCLE NERVE, V32, P208, DOI 10.1002/mus.20360; Smeulders MJC, 2004, J ORTHOP RES, V22, P1331, DOI 10.1016/j.orthres.2004.04.006; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Smith LR, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-44; TARDIEU C, 1979, Journal of the Neurological Sciences, V42, P357, DOI 10.1016/0022-510X(79)90169-2; TARDIEU C, 1974, J PHYSIOL-PARIS, V68, P205; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; VOGLER C, 1985, ARCH PATHOL LAB MED, V109, P238; WILLIAMS PE, 1978, J ANAT, V127, P459; ZANCOLLI EA, 1987, CLIN ORTHOP RELAT R, P14	63	60	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101038	10.1371/journal.pone.0101038	http://dx.doi.org/10.1371/journal.pone.0101038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977410	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400065
J	Duftner, C; Seiler, R; Dejaco, C; Chemelli-Steingruber, I; Schennach, H; Klotz, W; Rieger, M; Herold, M; Falkensammer, J; Fraedrich, G; Schirmer, M				Duftner, Christina; Seiler, Ruediger; Dejaco, Christian; Chemelli-Steingruber, Iris; Schennach, Harald; Klotz, Werner; Rieger, Michael; Herold, Manfred; Falkensammer, Juergen; Fraedrich, Gustav; Schirmer, Michael			Antiphospholipid Antibodies Predict Progression of Abdominal Aortic Aneurysms	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GIANT-CELL ARTERITIS; INTERNATIONAL CONSENSUS STATEMENT; ANTICARDIOLIPIN ANTIBODIES; INTRALUMINAL THROMBUS; CLASSIFICATION CRITERIA; POLYARTERITIS-NODOSA; WALL STRESS; MATRIX-METALLOPROTEINASE-9; PREVALENCE	Antiphospholipid antibodies (aPLs) frequently occur in autoimmune and cardiovascular diseases and correlate with a worse clinical outcome. In the present study, we evaluated the association between antiphospholipid antibodies (aPLs), markers of inflammation, disease progression and the presence of an intra-aneurysmal thrombus in abdominal aortic aneurysm (AAA) patients. APLs ELISAs were performed in frozen serum samples of 96 consecutive AAA patients and 48 healthy controls yielding positive test results in 13 patients (13.5%) and 3 controls (6.3%; n.s.). Nine of the 13 aPL-positive AAA patients underwent a second antibody testing >12 weeks apart revealing a positive result in 6 cases. APL-positive patients had increased levels of inflammatory markers compared to aPL-negative patients. Disease progression was defined as an increase of the AAA diameter >0.5 cm/year measured by sonography. Follow-up was performed in 69 patients identifying 41 (59.4%) patients with progressive disease. Performing multipredictor logistic regression analysis adjusting for classical AAA risk factors as confounders, the presence of aPLs at baseline revealed an odds ratio of 9.4 (95% CI 1.0-86.8, p = 0.049) to predict AAA progression. Fifty-five patients underwent a computed tomography in addition to ultrasound assessment indicating intra-aneurysmal thrombus formation in 82.3%. Median thrombus volume was 46.7 cm(3) (1.9-377.5). AAA diameter correlated with the size of the intra-aneurysmal thrombus (corr(coeff) = 0.721, p<0.001), however neither the presence nor the size of the intra-aneurysmal thrombus were related to the presence of aPLs. In conclusion, the presence of aPLs is associated with elevated levels of inflammatory markers and is an independent predictor of progressive disease in AAA patients.	[Duftner, Christina; Dejaco, Christian; Klotz, Werner; Herold, Manfred; Schirmer, Michael] Med Univ Innsbruck, Dept Internal Med, Clin Internal Med 6, A-6020 Innsbruck, Austria; [Seiler, Ruediger; Falkensammer, Juergen; Fraedrich, Gustav] Med Univ Innsbruck, Dept Operat Med, Clin Vasc Surg, A-6020 Innsbruck, Austria; [Chemelli-Steingruber, Iris; Rieger, Michael] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Schennach, Harald] Med Univ Innsbruck, Inst Blood Transfus & Immunol, A-6020 Innsbruck, Austria; [Duftner, Christina] Gen Hosp Kufstein, Dept Internal Med, Kufstein, Austria; [Dejaco, Christian] Med Univ Graz, Dept Rheumatol, Graz, Austria; [Falkensammer, Juergen] Wilhelminenhospital, Dept Vasc & Endovasc Surg, Vienna, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Graz; Wilhelminenspital	Schirmer, M (corresponding author), Med Univ Innsbruck, Dept Internal Med, Clin Internal Med 6, A-6020 Innsbruck, Austria.	michael.schirmer@i-med.ac.at	Klotz, Werner/L-2803-2019; Schirmer, Michael/B-1893-2012	Schirmer, Michael/0000-0001-9208-7809; Dejaco, Christian/0000-0002-0173-0668; Klotz, Werner/0000-0002-1104-5613	Research Fund of the Austrian National Bank (ONB), Innsbruck Medical University [8825, 9715]; Tyrolean Medical Research Fund (MFF); Verein zur Forderung der Hamatologie, Onkologie und Immunologie	Research Fund of the Austrian National Bank (ONB), Innsbruck Medical University; Tyrolean Medical Research Fund (MFF); Verein zur Forderung der Hamatologie, Onkologie und Immunologie	This study was funded by the Research Fund of the Austrian National Bank (ONB, project 8825 and 9715), Innsbruck Medical University, the Tyrolean Medical Research Fund (MFF) and the Verein zur Forderung der Hamatologie, Onkologie und Immunologie. The funders had no role in study design, data collection and anlaysis, decision to publish or preparation of the manuscript.	Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Carrell TWG, 2006, VASCULAR, V14, P9, DOI 10.2310/6670.2006.00008; Cervera R, 2003, IMMUNOBIOLOGY, V207, P5, DOI 10.1078/0171-2985-00213; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Chew DKW, 2003, J SURG RES, V114, P25, DOI 10.1016/S0022-4804(03)00208-7; Czermak BV, 2001, J ENDOVASC THER, V8, P380, DOI 10.1583/1545-1550(2001)008<0380:SCVMAE>2.0.CO;2; Dasgupta B, 1997, BRIT J RHEUMATOL, V36, P1210; Dawson JA, 2011, EUR J VASC ENDOVASC, V41, P28, DOI 10.1016/j.ejvs.2010.08.023; Di Martino E, 1998, EUR J VASC ENDOVASC, V15, P290, DOI 10.1016/S1078-5884(98)80031-2; Di Martino ES, 2003, ANN BIOMED ENG, V31, P804, DOI 10.1114/1.1581880; Duftner C, 2005, ARTERIOSCL THROM VAS, V25, P1347, DOI 10.1161/01.ATV.0000167520.41436.c0; Duhaut P, 1998, ARTHRITIS RHEUM-US, V41, P701, DOI 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P; Espinosa G, 2001, SEMIN ARTHRITIS RHEU, V31, P12, DOI 10.1053/sarh.2001.23499; Faber-Elmann A, 2002, CLIN EXP IMMUNOL, V127, P393, DOI 10.1046/j.1365-2249.2002.01758.x; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Golledge J, 2008, EUR RADIOL, V18, P1987, DOI 10.1007/s00330-008-0956-3; Greco TP, 2009, AM J CLIN PATHOL, V132, P613, DOI 10.1309/AJCP2FJUT2YZGITK; Hans SS, 2005, J VASC SURG, V41, P584, DOI 10.1016/j.jvs.2005.01.004; Hans SS, 2003, J VASC SURG, V37, P949, DOI 10.1067/mva.2003.256; HULL RG, 1984, ANN RHEUM DIS, V43, P746, DOI 10.1136/ard.43.5.746; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; LEVINE SR, 1992, STROKE, V23, pI29; Liozon E, 2000, RHEUMATOLOGY, V39, P1089, DOI 10.1093/rheumatology/39.10.1089; MCHUGH NJ, 1990, J RHEUMATOL, V17, P916; Merkel PA, 1996, AM J MED, V101, P576, DOI 10.1016/S0002-9343(96)00335-X; Meroni PL, 2004, EXP GERONTOL, V39, P1459, DOI 10.1016/j.exger.2004.08.003; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Motoki Y, 2012, THROMB RES, V130, P667, DOI 10.1016/j.thromres.2011.11.048; Mower WR, 1997, J VASC SURG, V26, P602, DOI 10.1016/S0741-5214(97)70058-2; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Roberts WC, 2006, AM J CARDIOL, V98, P1519, DOI 10.1016/j.amjcard.2006.06.057; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Schoonjans R, 1996, CLIN RHEUMATOL, V15, P410, DOI 10.1007/BF02230368; Stenbaek J, 2000, EUR J VASC ENDOVASC, V20, P466, DOI 10.1053/ejvs.2000.1217; Szyper-Kravitz M, 2008, ISR MED ASSOC J, V10, P48; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; VAARALA O, 1995, CIRCULATION, V91, P23, DOI 10.1161/01.CIR.91.1.23; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; WOLF YG, 1994, J VASC SURG, V20, P529, DOI 10.1016/0741-5214(94)90277-1; Yokoi K, 1996, ANGIOLOGY, V47, P315, DOI 10.1177/000331979604700317	43	12	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99302	10.1371/journal.pone.0099302	http://dx.doi.org/10.1371/journal.pone.0099302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979700	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400004
J	Jang, HC; Choi, SM; Kim, HK; Kim, SE; Kang, SJ; Park, KH; Ryu, PY; Lee, TH; Kim, YR; Rhee, JH; Jung, SI; Choy, HE				Jang, Hee-Chang; Choi, Su-Mi; Kim, Hee Kyung; Kim, Sung-Eun; Kang, Seung-Ji; Park, Kyung-Hwa; Ryu, Phil Youl; Lee, Tae-Hoon; Kim, Young Ran; Rhee, Joon Haeng; Jung, Sook-In; Choy, Hyon E.			In Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SUBINHIBITORY CONCENTRATIONS; PATHOGENIC SIGNIFICANCE; PROGNOSTIC-FACTORS; VITRO SYNERGISM; ANTIBIOTICS; INFECTION; THERAPY; GENE; MINOCYCLINE	Objectives: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus and the effects on rtxA1 expression of commonly used antibiotics are unknown. Methods: In vitro time-kill studies were performed to evaluate synergism. Female BALB/c mice were injected subcutaneously with 1x10(7) or 1x10(8) cfu of V. vulnificus. Antibiotic therapy was initiated at 2 h after inoculation in the following four therapy groups: cefotaxime; ciprofloxacin; cefotaxime-plus-ciprofloxacin; and cefotaxime-plus-minocycline. The cytotoxicity of V. vulnificus for HeLa cells was measured using the lactate dehydrogenase assay; rtxA1 transcription was measured in a transcriptional reporter strain using a beta-galactosidase assay. Results: In vitro time-kill assays exhibited synergism between cefotaxime and ciprofloxacin. In the animal experiments, the 96-h survival rate for the cefotaxime-plus-ciprofloxacin group (85%; 17/20) was significantly higher than that of the cefotaxime-plus-minocycline (35%; 7/20) and cefotaxime alone (0%; 0/20) groups (P<0.05 for both). Bacterial counts in the liver and spleen were significantly lower in the cefotaxime-plus-ciprofloxacin group 24 and 48 h after treatment, relative to the other groups. At sub-inhibitory concentrations, ciprofloxacin inhibited more effectively rtxA1 transcription and mammalian cell cytotoxicity than either minocycline or cefotaxime (P<0.05 for both). Conclusions: Ciprofloxacin is more effective at reducing rtxA1 transcription and subsequent cytotoxicity than either minocycline or cefotaxime, and the combination of ciprofloxacin and cefotaxime was more effective in clearing V. vulnificus in vivo than previously used regimens. These data suggest that the combination of ciprofloxacin and cefotaxime is an effective option for the treatment of V. vulnificus sepsis in humans.	[Jang, Hee-Chang; Choi, Su-Mi; Kim, Hee Kyung; Kim, Sung-Eun; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In] Chonnam Natl Univ, Dept Infect Dis, Sch Med, Kwangju, South Korea; [Jang, Hee-Chang; Rhee, Joon Haeng; Choy, Hyon E.] Res Inst Vibrio Infect, Kwangju, South Korea; [Jang, Hee-Chang; Rhee, Joon Haeng; Choy, Hyon E.] Genome Res Ctr Enteropathogen Bacteria, Kwangju, South Korea; [Ryu, Phil Youl; Rhee, Joon Haeng; Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Kwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Dept Biochem, Kwangju, South Korea; [Kim, Young Ran] Dongshin Univ, Dept Pharmaceut Engn, Naju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Dongshin University	Jung, SI (corresponding author), Chonnam Natl Univ, Dept Infect Dis, Sch Med, Kwangju, South Korea.	sijung@chonnam.ac.kr; hyonchoy@chonnam.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Ryu, Pan Dong/AGX-5700-2022	Lee, Tae-Hoon/0000-0003-0105-1750; Jang, Hee-Chang/0000-0002-3407-8493; Kang, Seung ji/0000-0002-3298-0520; Ryu, Pan Dong/0000-0003-4130-2251	Research Institute of Medical Sciences, Chonnam National University [2011-CURIMS-DR005]	Research Institute of Medical Sciences, Chonnam National University	This work was supported by a grant from the Research Institute of Medical Sciences, Chonnam National University (2011-CURIMS-DR005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CM, 2009, INT J ANTIMICROB AG, V33, P593, DOI 10.1016/j.ijantimicag.2008.10.027; CHAPMAN JS, 1988, ANTIMICROB AGENTS CH, V32, P438, DOI 10.1128/AAC.32.4.438; Chen SC, 2012, J ANTIMICROB CHEMOTH, V67, P488, DOI 10.1093/jac/dkr476; Chen SC, 2010, CRIT CARE MED, V38, P1984, DOI 10.1097/CCM.0b013e3181eeda2c; Chuang YC, 1998, ANTIMICROB AGENTS CH, V42, P1319, DOI 10.1128/AAC.42.6.1319; Chuang YC, 1997, ANTIMICROB AGENTS CH, V41, P2214, DOI 10.1128/AAC.41.10.2214; Chung KJ, 2010, J INFECT DIS, V201, P97, DOI 10.1086/648612; Clinical and Laboratory Standards Institute, 2009, M07A8 CLIN LAB STAND; Dechet AM, 2008, CLIN INFECT DIS, V46, P970, DOI 10.1086/529148; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Kim CM, 2007, J INFECT DIS, V195, P90, DOI 10.1086/509822; Kim DM, 2005, ANTIMICROB AGENTS CH, V49, P3489, DOI 10.1128/AAC.49.8.3489-3491.2005; Kim DM, 2010, INT J ANTIMICROB AG, V36, P155, DOI 10.1016/j.ijantimicag.2010.03.022; Kim DM, 2008, J INFECTION, V57, P489, DOI 10.1016/j.jinf.2008.08.003; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim JR, 2010, EUR J PHARMACOL, V642, P163, DOI 10.1016/j.ejphar.2010.05.037; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kim YR, 2013, J INFECT DIS; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; Korea Food and Drug Administration, 2011, GUID AN EXP IACUC ST; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Lee SE, 2004, BIOCHEM BIOPH RES CO, V324, P86, DOI 10.1016/j.bbrc.2004.09.020; Lee SE, 2007, INFECT IMMUN, V75, P2795, DOI 10.1128/IAI.01499-06; Liu JW, 2006, ARCH INTERN MED, V166, P2117, DOI 10.1001/archinte.166.19.2117; Lo HR, 2011, J INFECT DIS, V203, P1866, DOI 10.1093/infdis/jir070; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Na HS, 2011, FEMS IMMUNOL MED MIC, V63, P355, DOI 10.1111/j.1574-695X.2011.00855.x; Neupane GP, 2012, EUR J CLIN MICROBIOL, V31, P2461, DOI 10.1007/s10096-012-1592-z; Neupane GP, 2010, ANTIMICROB AGENTS CH, V54, P3696, DOI 10.1128/AAC.00988-09; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Otsuki M, 1996, J ANTIMICROB CHEMOTH, V38, P771; Piccoli L, 2005, J CHEMOTHERAPY, V17, P355, DOI 10.1179/joc.2005.17.4.355; Saleh-Mghir A, 2012, ANTIMICROB AGENTS CH, V56, P6291, DOI 10.1128/AAC.00926-12; Sugiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026018; Tang HJ, 2002, ANTIMICROB AGENTS CH, V46, P3580, DOI 10.1128/AAC.46.11.3580-3584.2002; Yokochi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055219	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101118	10.1371/journal.pone.0101118	http://dx.doi.org/10.1371/journal.pone.0101118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978586	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400081
J	Li, T; Blande, JD; Gundel, PE; Helander, M; Saikkonen, K				Li, Tao; Blande, James D.; Gundel, Pedro E.; Helander, Marjo; Saikkonen, Kari			Epichloe Endophytes Alter Inducible Indirect Defences in Host Grasses	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; INDUCED RESISTANCE; INSECT HERBIVORES; METHYL SALICYLATE; SYMBIOTIC FUNGI; TALL FESCUE; VOLATILES; DIVERSITY; EMISSION; PLANTS	Epichloe endophytes are common symbionts living asymptomatically in pooid grasses and may provide chemical defences against herbivorous insects. While the mechanisms underlying these fungal defences have been well studied, it remains unknown whether endophyte presence affects the host's own defences. We addressed this issue by examining variation in the impact of Epichloe on constitutive and herbivore-induced emissions of volatile organic compounds (VOC), a well-known indirect plant defence, between two grass species, Schedonorus phoenix (ex. Festuca arundinacea; tall fescue) and Festuca pratensis (meadow fescue). We found that feeding by a generalist aphid species, Rhopalosiphum padi, induced VOC emissions by uninfected plants of both grass species but to varying extents, while mechanical wounding failed to do so in both species after one day of damage. Interestingly, regardless of damage treatment, Epichloe uncinata-infected F. pratensis emitted significantly lower quantities of VOCs than their uninfected counterparts. In contrast, Epichloe coenophiala-infected S. phoenix did not differ from their uninfected counterparts in constitutive VOC emissions but tended to increase VOC emissions under intense aphid feeding. A multivariate analysis showed that endophyte status imposed stronger differences in VOC profiles of F. pratensis than damage treatment, while the reverse was true for S. phoenix. Additionally, both endophytes inhibited R. padi population growth as measured by aphid dry biomass, with the inhibition appearing greater in E. uncinata-infected F. pratensis. Our results suggest, not only that Epichloe endophytes may play important roles in mediating host VOC responses to herbivory, but also that the magnitude and direction of such responses may vary with the identity of the Epichloe-grass symbiosis. Whether Epichloe-mediated host VOC responses will eventually translate into effects on higher trophic levels merits future investigation.	[Li, Tao; Blande, James D.] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [Gundel, Pedro E.; Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke); University of Turku	Li, T (corresponding author), Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland.	tao.li@uef.fi	Gundel, Pedro/A-5314-2013; Blande, James/Q-9611-2019	Gundel, Pedro/0000-0003-3246-0282; Li, Tao/0000-0003-1462-5135; Helander, Marjo/0000-0002-9759-4321; Blande, James/0000-0001-6822-0649	Academy of Finland [256050, 251898, 137909]	Academy of Finland(Academy of Finland)	This research was funded by the Academy of Finland (Project nos. 256050, 251898 and 137909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami ME, 2009, ENVIRON ENTOMOL, V38, P1086, DOI 10.1603/022.038.0416; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Babikova Z, 2014, FUNCT ECOL, V28, P375, DOI 10.1111/1365-2435.12181; Ballhorn DJ, 2013, OECOLOGIA, V172, P833, DOI 10.1007/s00442-012-2539-x; Blande JD, 2010, TREE PHYSIOL, V30, P404, DOI 10.1093/treephys/tpp124; Bultman TL, 2004, ECOLOGY, V85, P679, DOI 10.1890/03-0073; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Clement SL, 2001, CROP SCI, V41, P570, DOI 10.2135/cropsci2001.412570x; de Sassi C, 2006, P R SOC B, V273, P1301, DOI 10.1098/rspb.2005.3442; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Eriksson L, 2006, MULTI MEGAVARIATE 1, V2nd; Estrada C, 2013, NEW PHYTOL, V198, P241, DOI 10.1111/nph.12140; Faeth SH, 2012, FUNGAL ECOL, V5, P364, DOI 10.1016/j.funeco.2011.09.003; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Glinwood RT, 2000, ENTOMOL EXP APPL, V94, P325, DOI 10.1023/A:1003902321787; Guerrieri E, 2004, ECOL ENTOMOL, V29, P753, DOI 10.1111/j.0307-6946.2004.00644.x; Halbert SE, 2009, ANN APPL BIOL, V154, P303, DOI 10.1111/j.1744-7348.2008.00300.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Jallow MFA, 2008, ARTHROPOD-PLANT INTE, V2, P53, DOI 10.1007/s11829-008-9033-8; Karban R, 1997, SERIES INTERSPECIFIC; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Kigathi RN, 2009, J CHEM ECOL, V35, P1335, DOI 10.1007/s10886-009-9716-3; Leitner M, 2010, MYCORRHIZA, V20, P89, DOI 10.1007/s00572-009-0264-z; Leuchtmann A, 2014, MYCOLOGIA, V106, P202, DOI 10.3852/106.2.202; Li T, 2012, FUNCT ECOL, V26, P1176, DOI 10.1111/j.1365-2435.2012.01984.x; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mucciarelli M, 2007, MICROB ECOL, V54, P685, DOI 10.1007/s00248-007-9227-0; Muller CB, 2005, CURR OPIN PLANT BIOL, V8, P450, DOI 10.1016/j.pbi.2005.05.007; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Panaccione DG, 2014, FUNCT ECOL, V28, P299, DOI 10.1111/1365-2435.12076; Panka D, 2013, J PLANT PHYSIOL, V170, P1010, DOI 10.1016/j.jplph.2013.02.009; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Pineda A, 2013, FUNCT ECOL, V27, P574, DOI 10.1111/1365-2435.12050; Rapparini F, 2008, PLANT BIOLOGY, V10, P108, DOI 10.1055/s-2007-964963; Rudgers JA, 2004, ECOL LETT, V7, P42, DOI 10.1046/j.1461-0248.2003.00543.x; Rudgers JA, 2009, ECOLOGY, V90, P1531, DOI 10.1890/08-0116.1; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sasso R, 2009, CHEMOECOLOGY, V19, P195, DOI 10.1007/s00049-009-0023-9; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; Schausberger P, 2012, FUNCT ECOL, V26, P441, DOI 10.1111/j.1365-2435.2011.01947.x; Simons L, 2008, J CHEM ECOL, V34, P1511, DOI 10.1007/s10886-008-9551-y; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sullivan TJ, 2007, NEW PHYTOL, V176, P673, DOI 10.1111/j.1469-8137.2007.02201.x; Tabata J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023799; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Wali PR, 2011, PROSPECTS APPL PLANT, P64; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; Yue Q, 2001, PHYTOCHEMISTRY, V58, P935, DOI 10.1016/S0031-9422(01)00353-3; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; [No title captured]	56	30	33	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101331	10.1371/journal.pone.0101331	http://dx.doi.org/10.1371/journal.pone.0101331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978701	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400118
J	Lyle, S; Hoover, K; Colpan, C; Zhu, ZQ; Matijasevic, Z; Jones, SN				Lyle, Stephen; Hoover, Kathleen; Colpan, Cansu; Zhu, Zhiqing; Matijasevic, Zdenka; Jones, Stephen N.			Dicer Cooperates with p53 to Suppress DNA Damage and Skin Carcinogenesis in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENZYME DICER; MORPHOGENESIS; BIOGENESIS; DEFICIENT; MICRORNA; TISSUE; SPECTRUM; CANCER; TUMORS	Dicer is required for the maturation of microRNA, and loss of Dicer and miRNA processing has been found to alter numerous biological events during embryogenesis, including the development of mammalian skin and hair. We have previously examined the role of miRNA biogenesis in mouse embryonic fibroblasts and found that deletion of Dicer induces cell senescence regulated, in part, by the p53 tumor suppressor. Although Dicer and miRNA molecules are thought to have either oncogenic or tumor suppressing roles in various types of cancer, a role for Dicer and miRNAs in skin carcinogenesis has not been established. Here we show that perinatal ablation of Dicer in the skin of mice leads to loss of fur in adult mice, increased epidermal cell proliferation and apoptosis, and the accumulation of widespread DNA damage in epidermal cells. Co- ablation of Dicer and p53 did not alter the timing or extent of fur loss, but greatly reduced survival of Dicer-skin ablated mice, as these mice developed multiple and highly aggressive skin carcinomas. Our results describe a new mouse model for spontaneous basal and squamous cell tumorigenesis. Furthermore, our findings reveal that loss of Dicer in the epidermis induces extensive DNA damage, activation of the DNA damage response and p53-dependent apoptosis, and that Dicer and p53 cooperate to suppress mammalian skin carcinogenesis.	[Lyle, Stephen; Zhu, Zhiqing; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01655 USA; [Hoover, Kathleen; Colpan, Cansu; Zhu, Zhiqing; Matijasevic, Zdenka; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jones, SN (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01655 USA.	stephen.jones@umassmed.edu			NIH from the National Cancer Institute [CA077735]; NATIONAL CANCER INSTITUTE [R56CA077735, R01CA077735] Funding Source: NIH RePORTER	NIH from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant CA077735 from the National Cancer Institute to SNJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bcnjamin CL, 2008, ADV EXP MED BIOL, V624, P265, DOI 10.1007/978-0-387-77574-6_21; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Di Leva G, 2013, ANN REV PATHOL  0925; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Marino S, 2000, GENE DEV, V14, P994; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Sand M, 2012, CANCER BIOMARK, V11, P253, DOI 10.3233/CBM-2012-0274; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Teta M, 2012, DEVELOPMENT, V139, P1405, DOI 10.1242/dev.070920; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zhang Z, 2011, DEV BIOL, V351, P254, DOI 10.1016/j.ydbio.2011.01.005; Zhou MJ, 2013, CARCINOGENESIS, V34, P1653, DOI 10.1093/carcin/bgt097	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100920	10.1371/journal.pone.0100920	http://dx.doi.org/10.1371/journal.pone.0100920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979267	gold, Green Published			2022-12-25	WOS:000338506400048
J	Rojo-Martinez, G; Maymo-Masip, E; Rodriguez, MM; Solano, E; Goday, A; Soriguer, F; Valdes, S; Chaves, FJ; Delgado, E; Colomo, N; Hernandez, P; Vendrell, J; Chacon, MR				Rojo-Martinez, Gemma; Maymo-Masip, Elsa; Mar Rodriguez, M.; Solano, Esther; Goday, Albert; Soriguer, Federico; Valdes, Sergio; Javier Chaves, Felipe; Delgado, Elias; Colomo, Natalia; Hernandez, Pilar; Vendrell, Joan; Chacon, Matilde R.			Serum sCD163 Levels Are Associated with Type 2 Diabetes Mellitus and Are Influenced by Coffee and Wine Consumption: Results of the Di@bet.es Study	PLOS ONE			English	Article							HIGH CARDIOVASCULAR RISK; MEDITERRANEAN DIET; WEAK INDUCER; METABOLIC SYNDROME; SOLUBLE CD163; WEIGHT-LOSS; TNF-ALPHA; TWEAK; INFLAMMATION; OBESITY	Objective: Serum levels of soluble TNF-like weak inducer of apoptosis (sTWEAK) and its scavenger receptor CD163 (sCD163) have been linked to insulin resistance. We analysed the usefulness of these cytokines as biomarkers of type 2 diabetes in a Spanish cohort, together with their relationship to food consumption in the setting of the Di@bet.es study. Research Design and Methods: This is a cross-sectional, matched case-control study of 514 type 2 diabetes subjects and 517 controls with a Normal Oral Glucose Tolerance Test (NOGTT), using data from the Di@bet.es study. Study variables included clinical and demographic structured survey, food frequency questionnaire and physical examination. Serum concentrations of sTWEAK and sCD163 were measured by ELISA. Linear regression analysis determined which variables were related to sTWEAK and sCD163 levels. Logistic regression analysis was used to estimate odd ratios of presenting type 2 diabetes. Results: sCD163 concentrations and sCD163/sTWEAK ratio were 11.0% and 15.0% higher, respectively, (P<0.001) in type 2 diabetes than in controls. Following adjustment for various confounders, the OR for presenting type 2 diabetes in subjects in the highest vs the lowest tertile of sCD163 was [(OR), 2,01 (95% CI, 1,46-2,97); P for trend <0.001]. Coffee and red wine consumption was negatively associated with serum levels of sCD163 (P = 0.0001 and; P = 0.002 for coffee and red wine intake, respectively). Conclusions: High circulating levels of sCD163 are associated with type 2 diabetes in the Spanish population. The association between coffee and red wine intake and these biomarkers deserves further study to confirm its potential role in type 2 diabetes.	[Rojo-Martinez, Gemma; Soriguer, Federico; Valdes, Sergio; Colomo, Natalia] Hosp Reg Univ, UGCI Endocrinol & Nutr, Inst Biomed Malaga IBIMA, Malaga, Spain; [Rojo-Martinez, Gemma; Maymo-Masip, Elsa; Solano, Esther; Soriguer, Federico; Valdes, Sergio; Javier Chaves, Felipe; Colomo, Natalia; Vendrell, Joan; Chacon, Matilde R.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Maymo-Masip, Elsa; Solano, Esther; Hernandez, Pilar; Vendrell, Joan; Chacon, Matilde R.] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, IISPV, E-43007 Tarragona, Spain; [Mar Rodriguez, M.] Inst Invest Biomed Girona Dr Josep Trueta, CIBERObn Fisiopatol Obesidad & Nutr, Girona, Spain; [Goday, Albert] Univ Autonoma Barcelona, Dept Endocrinol & Nutr, Hosp del Mar, E-08193 Barcelona, Spain; [Javier Chaves, Felipe] Fdn Invest Hosp Clin Valencia INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain; [Delgado, Elias] Univ Oviedo, Dept Med Endocrinol & Nutr, HUCA, Oviedo, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; University of Oviedo	Rojo-Martinez, G (corresponding author), Hosp Reg Univ, UGCI Endocrinol & Nutr, Inst Biomed Malaga IBIMA, Malaga, Spain.	gemma.rojo.m@gmail.com; mrodriguez.hj23.ics@gencat.cat	Chacón, Matilde R./E-5574-2019; Rojo-martínez, Gemma/E-3351-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Maymó Masip, Elsa/T-1828-2017; Delgado, Elias/B-2634-2013; Vendrell, Joan j/V-4034-2018	Chacón, Matilde R./0000-0003-1531-2165; Rojo-martínez, Gemma/0000-0003-2179-2134; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Maymó Masip, Elsa/0000-0002-9133-3120; Delgado, Elias/0000-0001-6114-9712; Vendrell, Joan j/0000-0002-6994-6115	Fondo de Investigacion Sanitaria (FIS) [PI 11/00049, PI 11/0085, PI 11/02755]; European Regional Development Fund (ERDF); Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII); Institut Catala de Salut (ICS) in Catalonia; CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion); Spanish Society of Diabetes - SED; Ministerio de Sanidad	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII); Institut Catala de Salut (ICS) in Catalonia; CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion); Spanish Society of Diabetes - SED; Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government)	This study was supported by projects from the Fondo de Investigacion Sanitaria (FIS): PI 11/00049 (M. R. CH.), PI 11/0085 (J.V.) and PI 11/02755 (F. S.) co-financed by the European Regional Development Fund (ERDF). M. R. CH. is supported by the Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) co-financed by Institut Catala de Salut (ICS) in Catalonia. Di@bet.es study was supported by CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion), Ministerio de Sanidad and Spanish Society of Diabetes - SED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chacon MR, 2006, CYTOKINE, V33, P129, DOI 10.1016/j.cyto.2005.12.005; Dharmapatni AASSK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3294; Diaz-Lopez A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-51; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P3482, DOI 10.1210/jc.2013-1848; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Estruch R, 2010, P NUTR SOC, V69, P333, DOI 10.1017/S0029665110001539; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Fjeldborg K, 2013, OBESITY, V21, P2437, DOI 10.1002/oby.20376; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; Llaurado G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043919; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Maymo-Masip E, 2013, J CLIN ENDOCR METAB, V98, pE1323, DOI 10.1210/jc.2012-4177; Meksawan K, 2004, J AM COLL NUTR, V23, P331, DOI 10.1080/07315724.2004.10719376; Mercer JR, 2012, ARTERIOSCL THROM VAS, V32, P2461, DOI 10.1161/ATVBAHA.112.251322; Michaelson JS, 2012, J AUTOIMMUN, V39, P130, DOI 10.1016/j.jaut.2012.05.003; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Ortega E, 2013, ANN NUTR METAB, V62, P339, DOI 10.1159/000346553; Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61; Richard C, 2013, OBESITY, V21, P51, DOI 10.1002/oby.20239; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Spranger J, 2003, DIABETES, V52; Uddin MJ, 2013, FREE RADICAL BIO MED, V65, P1331, DOI 10.1016/j.freeradbiomed.2013.09.027; Vazquez-Carballo A, 2013, AM J PHYSIOL-ENDOC M, V305, pE101, DOI 10.1152/ajpendo.00589.2012; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x	36	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101250	10.1371/journal.pone.0101250	http://dx.doi.org/10.1371/journal.pone.0101250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978196	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400104
J	Bank, S; Andersen, PS; Burisch, J; Pedersen, N; Roug, S; Galsgaard, J; Turino, SY; Brodersen, JB; Rashid, S; Rasmussen, BK; Avlund, S; Olesen, TB; Hoffmann, HJ; Thomsen, MK; Thomsen, VO; Frydenberg, M; Nexo, BA; Sode, J; Vogel, U; Andersen, V				Bank, Steffen; Andersen, Paal Skytt; Burisch, Johan; Pedersen, Natalia; Roug, Stine; Galsgaard, Julie; Turino, Stine Ydegaard; Brodersen, Jacob Broder; Rashid, Shaista; Rasmussen, Britt Kaiser; Avlund, Sara; Olesen, Thomas Bastholm; Hoffmann, Hans Jurgen; Thomsen, Marianne Kragh; Thomsen, Vibeke Ostergaard; Frydenberg, Morten; Nexo, Bjorn Andersen; Sode, Jacob; Vogel, Ulla; Andersen, Vibeke			Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TOLL-LIKE RECEPTORS; COLITIS RISK LOCI; CROHNS-DISEASE; ULCERATIVE-COLITIS; PROMOTER; EXPRESSION; GAMMA	Background: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Polymorphisms in genes regulating inflammation may explain part of the genetic heritage. Methods: Using a candidate gene approach, 39 mainly functional single nucleotide polymorphisms (SNPs) in 26 genes regulating inflammation were assessed in a clinical homogeneous group of severely diseased patients consisting of 624 patients with CD, 411 patients with UC and 795 controls. The results were analysed using logistic regression. Results: Sixteen polymorphisms in 13 genes involved in regulation of inflammation were associated with risk of CD and/or UC (p <= 0.05). The polymorphisms TLR2 (rs1816702), NFKB1 (rs28362491), TNFRSF1A (rs4149570), IL6R (rs4537545), IL23R (rs11209026) and PTPN22 (rs2476601) were associated with risk of CD and the polymorphisms TLR2 (rs1816702), TLR4 (rs1554973 and rs12377632), TLR9 (rs352139), LY96 (rs11465996), NFKBIA (rs696), TNFA (rs1800629), TNFRSF1A (rs4149570), IL10 (rs3024505), IL23R (rs11209026), PTPN22 (rs2476601) and PPARG (rs1801282) were associated with risk of UC. When including all patients (IBD) the polymorphisms TLR2 (rs4696480 and rs1816702), TLR4 (rs1554973 and rs12377632), TLR9 (rs187084), TNFRSF1A (rs4149570), IL6R (rs4537545), IL10 (rs3024505), IL23R (rs11209026) and PTPN22 (rs2476601) were associated with risk. After Bonferroni correction for multiple testing, both the homozygous and the heterozygous variant genotypes of IL23R G>A(rs11209026) (ORCD,adj: 0.38, 95% CI: 0.21-0.67, p = 0.03; ORIBD,adj 0.43, 95% CI: 0.28-0.67, p = 0.007) and PTPN22 1858 G>A(rs2476601) (ORCD,unadj 0.54, 95% CI: 0.41-0.72, p = 7*10(-4); ORIBD,unadj: 0.61, 95% CI: 0.48-0.77, p = 0.001) were associated with reduced risk of CD. Conclusion: The biological effects of the studied polymorphisms suggest that genetically determined high inflammatory response was associated with increased risk of CD. The many SNPs found in TLRs suggest that the host microbial composition or environmental factors in the gut are involved in risk of IBD in genetically susceptible individuals.	[Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen; Nexo, Bjorn Andersen] Univ Aarhus, Aarhus, Denmark; [Andersen, Paal Skytt; Sode, Jacob] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Burisch, Johan; Pedersen, Natalia] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Roug, Stine] Hvidovre Univ Hosp, Dept Gastroenterol, Hvidovre, Denmark; [Galsgaard, Julie] Koge Hosp, Dept Med, Koge, Denmark; [Turino, Stine Ydegaard] Hillerod Hosp, Dept Med, Hillerod, Denmark; [Brodersen, Jacob Broder] Sydvestjysk Hosp, Dept Med, Esbjerg, Denmark; [Rashid, Shaista] Bispebjerg Hosp, Dept Med, Bispebjerg, Denmark; [Rasmussen, Britt Kaiser] Nykobing Falster Hosp, Dept Med, Nykobing, Denmark; [Avlund, Sara] Aarhus Univ Hosp, Dept Med 5, DK-8000 Aarhus, Denmark; [Olesen, Thomas Bastholm] Slagelse Hosp, Dept Med, Slagelse, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Inst Clin Med, Dept Resp Dis B, DK-8000 Aarhus, Denmark; [Thomsen, Marianne Kragh] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Thomsen, Vibeke Ostergaard] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Frydenberg, Morten] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Nexo, Bjorn Andersen; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Sode, Jacob] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland Aabenraa, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN Odense Patient data Explorat Network, DK-5000 Odense, Denmark	Aarhus University; Aarhus University; Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; Aarhus University; Statens Serum Institut; Aarhus University; University of Southern Denmark; National Research Centre for the Working Environment; University of Southern Denmark; Odense University Hospital	Bank, S (corresponding author), Viborg Reg Hosp, Dept Med, Viborg, Denmark.	stb@mb.au.dk	Sode, Jacob/AAD-9615-2020; Olesen, Thomas/AFS-2588-2022; Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Thomsen, Vibeke Østergaard/H-9370-2013; Burisch, Johan/AGJ-3893-2022; Andersen, Paal S/H-2087-2015; Hoffman, Hans Jurgen/I-6969-2018; Andersen, Vibeke/I-7932-2012; Thomsen, Marianne Kragh/AAJ-5115-2020	Sode, Jacob/0000-0002-2718-9320; Olesen, Thomas/0000-0003-1464-7342; Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Burisch, Johan/0000-0002-3312-5139; Andersen, Paal S/0000-0001-5656-0427; Hoffman, Hans Jurgen/0000-0002-6743-7931; Andersen, Vibeke/0000-0002-0127-2863; Brodersen, Jacob Broder/0000-0003-2530-7554; Thomsen, Marianne Kragh/0000-0002-3645-6689; Thomsen, Vibeke Ostergaard/0000-0002-1653-6294	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	The work was funded by Health Research Fund of Central Denmark Region, Colitis-Crohn Foreningen and University of Aarhus (PhD grant). VA receives compensation as a consultant for Merck & Co., Inc. (MSD) and Janssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahirwar Dinesh K, 2012, J Gastrointest Cancer, V43, P196, DOI 10.1007/s12029-010-9238-9; Andersen V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-139; Andersen V, 2011, INFLAMM BOWEL DIS, V17, P937, DOI 10.1002/ibd.21440; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Andersen V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-82; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aoyagi Y, 2010, PEDIATR INT, V52, P729, DOI 10.1111/j.1442-200X.2010.03195.x; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; Bielinski SJ, 2011, HUM GENET, V129, P655, DOI 10.1007/s00439-011-0962-4; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Elsby LM, 2010, CLIN EXP RHEUMATOL, V28, P708; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Ernst A, 2011, EUR J GASTROEN HEPAT, V23, P269, DOI 10.1097/MEG.0b013e3283438a44; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Ferguson LR, 2008, WORLD J GASTROENTERO, V14, P4652, DOI 10.3748/wjg.14.4652; Ferguson LR, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/591704; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Glas J, 2008, FUNCTIONAL TOLL LIKE, V46, P41; Gu W, 2007, ANN SURG, V246, P151, DOI 10.1097/01.sla.0000262788.67171.3f; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hong JW, 2007, J GASTROEN HEPATOL, V22, P1666, DOI 10.1111/j.1440-1746.2007.05020.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Karimi M, 2009, EUR J HUM GENET, V17, P1454, DOI 10.1038/ejhg.2009.80; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Klein W, 2004, INT J COLORECTAL DIS, V19, P153, DOI 10.1007/s00384-003-0531-y; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Mertens J, 2009, J MOL MED, V87, P815, DOI 10.1007/s00109-009-0479-7; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Oosting M, 2011, INFECT IMMUN, V79, P4681, DOI 10.1128/IAI.05242-11; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Park JY, 2007, AM J PHYSIOL-HEART C, V293, pH2320, DOI 10.1152/ajpheart.00186.2007; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Poliska S, 2012, INFLAMM BOWEL DIS, V18, P472, DOI 10.1002/ibd.21798; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Rafiq S, 2007, GENES IMMUN, V8, P344, DOI 10.1038/sj.gene.6364393; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Skieceviciene J, 2013, INFLAMM BOWEL DIS, V19, P2349, DOI 10.1097/MIB.0b013e3182a3eaeb; Smith AJP, 2008, CLIN CHEM, V54, P841, DOI 10.1373/clinchem.2007.098608; Song SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021726; Szamosi T, 2009, DIGEST DIS SCI, V54, P351, DOI 10.1007/s10620-008-0351-6; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Thair SA, 2011, J IMMUNOL, V186, P2321, DOI 10.4049/jimmunol.1002864; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wallis SK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3239; Wang GB, 2011, HUM IMMUNOL, V72, P451, DOI 10.1016/j.humimm.2011.02.004; Wang SY, 2011, LIFE SCI, V88, P792, DOI 10.1016/j.lfs.2011.02.016; Wen AQ, 2010, SHOCK, V33, P576, DOI 10.1097/SHK.0b013e3181cc0a8e; Yoshida M, 2012, SCHIZOPHR RES, V140, P185, DOI 10.1016/j.schres.2012.06.031; Zhang F, 2013, INFECTION, V41, P941, DOI 10.1007/s15010-013-0444-9; Zou YF, 2011, TISSUE ANTIGENS, V77, P9, DOI 10.1111/j.1399-0039.2010.01559.x	68	85	89	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e98815	10.1371/journal.pone.0098815	http://dx.doi.org/10.1371/journal.pone.0098815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971461	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200006
J	Bedford, KJA; Sharkey, AB				Bedford, K. Juliet A.; Sharkey, Alyssa B.			Local Barriers and Solutions to Improve Care-Seeking for Childhood Pneumonia, Diarrhoea and Malaria in Kenya, Nigeria and Niger: A Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE; NEWBORN BABIES; SOUTH-AFRICA; BEHAVIOR; ILLNESSES; CHILDREN; INTERVENTIONS; NUTRITION; COMMUNITY; FRAMEWORK	We present qualitative research findings on care-seeking and treatment uptake for pneumonia, diarrhoea and malaria among children under 5 in Kenya, Nigeria and Niger. The study aimed to determine the barriers caregivers face in accessing treatment for these conditions; to identify local solutions that facilitate more timely access to treatment; and to present these findings as a platform from which to develop context-specific strategies to improve care-seeking for childhood illness. Kenya, Nigeria and Niger are three high burden countries with low rates of related treatment coverage, particularly in underserved areas. Data were collected in Homa Bay County in Nyanza Province, Kenya; in Kebbi and Cross River States, Nigeria; and in the Maradi and Tillaberi regions of Niger. Primary caregivers of children under 5 who did not regularly engage with health services or present their child at a health facility during illness episodes were purposively selected for interview. Data underwent rigorous thematic analysis. We organise the identified barriers and related solutions by theme: financial barriers; distance/location of health facilities; socio-cultural barriers and gender dynamics; knowledge and information barriers; and health facility deterrents. The relative importance of each differed by locality. Participant suggested solutions ranged from community-level actions to facility-level and more policy-oriented actions, plus actions to change underlying problems such as social perceptions and practices and gender dynamics. We discuss the feasibility and implications of these suggested solutions. Given the high burden of childhood morbidity and mortality due to pneumonia, diarrhoea and malaria in Kenya, Nigeria and Niger, this study provides important insights relating to demand-side barriers and locally proposed solutions. Significant advancements are possible when communities participate in both problem identification and resolution, and are engaged as important partners in improving child health and survival.	[Bedford, K. Juliet A.] Anthrologica, Oxford, England; [Bedford, K. Juliet A.] Univ Oxford, Sch Anthropol, Oxford, England; [Sharkey, Alyssa B.] Program Div United Nations Childrens Fund UNICEF, Hlth Sect, Knowledge Management & Implementat Res Unit, New York, NY USA	University of Oxford; UNICEF	Sharkey, AB (corresponding author), Program Div United Nations Childrens Fund UNICEF, Hlth Sect, Knowledge Management & Implementat Res Unit, New York, NY USA.	asharkey@unicef.org			Bill and Melinda Gates Foundation; Rockefeller Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Rockefeller Foundation	This study was supported by a grant from the Bill and Melinda Gates Foundation (website: http://www.gatesfoundation.org/). Additional funding was received from the Rockefeller Foundation to support the publication of this manuscript (website: http://www.rockefellerfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimorah Gilbert N, 2011, BMC Res Notes, V4, P228, DOI 10.1186/1756-0500-4-228; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Bedford J, 2012, QUALITATIVE STUDY ID; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Charles JO, 2008, HEALTH CARE WOMEN IN, V29, P906, DOI 10.1080/07399330802269626; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edson WN, 2004, DEV JOB AIDS INCREAS; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Elam G., 2008, QUALITATIVE RES PRAC; Ellis AA, 2013, J BIOSOC SCI, V45, P743, DOI 10.1017/S0021932013000163; Enato EFO, 2006, SCAND J INFECT DIS, V38, P474, DOI 10.1080/00365540500525153; Falade CO, 2005, INT Q COMMUNITY HEAL, V24, P347, DOI 10.2190/GN66-9447-3984-4064; Federal Ministry of Health, 2010, HLTH PLANNING RS, P136; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69, DOI DOI 10.11648/J.SJPH.20130102.14; Garg R, 2001, AM J PUBLIC HEALTH, V91, P1611, DOI 10.2105/AJPH.91.10.1611; Guest G., 2011, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hahn R. A., 2009, ANTHR PUBLIC HLTH BR; Institut National de la Statistique et Macro International Inc, 2007, ENQ DEM SANT IND MUL; Iwelunmor J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-354; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Lock M., 1990, MED ANTHR CONT THEOR, P47; Mbagaya Grace M, 2005, Afr Health Sci, V5, P322; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Ministere de la Sante Publique Secretariat General Republique du Niger, 2011, PLAN DEV SAN PDS 201; Ministry of Medical Services and Ministry of Public Health & Sanitation Government of Kenya, 2012, ACC ATT HLTH GOALS K; National Population Commission of Nigeria & ICF Macro, 2009, NIG DEM HLTH SURV 20; Nichter M., 2008, GLOBAL HLTH WHY CULT; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Raquejo J, 2012, COUNTDOWN 2015 MATER; Scott K, 2014, HEALTH POLICY PLANN, V29, P292, DOI 10.1093/heapol/czt016; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; UN Inter-agency Group for Child Mortality Estimation, 2013, LEVELS TRENDS CHILD; UNDP, 2010, ASSESSING PROGR AFRI; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210	41	50	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100038	10.1371/journal.pone.0100038	http://dx.doi.org/10.1371/journal.pone.0100038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971642	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200017
J	Huang, F; Mazin, AV				Huang, Fei; Mazin, Alexander V.			A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts	PLOS ONE			English	Article							DISRUPTS HOMOLOGOUS RECOMBINATION; DNA-REPAIR; ANTISENSE INHIBITION; OVEREXPRESSION; DAMAGE; ACTIVATION; CHECKPOINT; RESISTANCE; PROTEIN; ATM	The homologous recombination pathway is responsible for the repair of DNA double strand breaks. RAD51, a key homologous recombination protein, promotes the search for homology and DNA strand exchange between homologous DNA molecules. RAD51 is overexpressed in a variety of cancer cells. Downregulation of RAD51 by siRNA increases radio-or chemo-sensitivity of cancer cells. We recently developed a specific RAD51 small molecule inhibitor, B02, which inhibits DNA strand exchange activity of RAD51 in vitro. In this study, we used human breast cancer cells MDA-MB-231 to investigate the ability of B02 to inhibit RAD51 and to potentiate an anti-cancer effect of chemotherapeutic agents including doxorubicin, etoposide, topotecan, and cisplatin. We found that the combination of B02 with cisplatin has the strongest killing effect on the cancer cells. We then tested the effect of B02 and cisplatin on the MDA-MB-231 cell proliferation in mouse xenografts. Our results showed that B02 significantly enhances the therapeutic effect of cisplatin on tumor cells in vivo. Our current data demonstrate that use of RAD51-specific small molecule inhibitor represents a feasible strategy of a combination anticancer therapy.	[Huang, Fei; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	amazin@drexelmed.edu			NIH [CA100839, DA033981, MH097512]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH097512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH grants CA100839, DA033981, MH097512 (to AVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bianco P R, 1998, Front Biosci, V3, pD570; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Gonzalez-Prieto R, 2013, EMBO J, V32, P1307, DOI 10.1038/emboj.2013.73; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Huang F, 2012, J MED CHEM, V55, P3011, DOI 10.1021/jm201173g; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Ishida T, 2009, NUCLEIC ACIDS RES, V37, P3367, DOI 10.1093/nar/gkp200; Ito M, 2005, J GENE MED, V7, P1044, DOI 10.1002/jgm.753; Keimling M, 2009, CARCINOGENESIS, V30, P1260, DOI 10.1093/carcin/bgp117; Kiyohara E, 2012, GENE THER, V19, P734, DOI 10.1038/gt.2011.123; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kocher S, 2013, RADIOTHER ONCOL, V108, P409, DOI 10.1016/j.radonc.2013.06.024; Koehn H, 2007, ANTI-CANCER DRUG, V18, P419, DOI 10.1097/CAD.0b013e328012a9a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Ohnishi T, 1998, BIOCHEM BIOPH RES CO, V245, P319, DOI 10.1006/bbrc.1998.8440; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Raderschall E, 2002, CANCER RES, V62, P219; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schonn I, 2011, APOPTOSIS, V16, P359, DOI 10.1007/s10495-010-0564-y; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Song H, 2013, MOL CANCER THER, V12, P2043, DOI 10.1158/1535-7163.MCT-13-0108; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takaku M, 2011, GENES CELLS, V16, P427, DOI 10.1111/j.1365-2443.2011.01494.x; Taki T, 1996, BIOCHEM BIOPH RES CO, V223, P434, DOI 10.1006/bbrc.1996.0911; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053	47	83	88	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100993	10.1371/journal.pone.0100993	http://dx.doi.org/10.1371/journal.pone.0100993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971740	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200081
J	Probst, AJ; Birarda, G; Holman, HYN; DeSantis, TZ; Wanner, G; Andersen, GL; Perras, AK; Meck, S; Volkel, J; Bechtel, HA; Wirth, R; Moissl-Eichinger, C				Probst, Alexander J.; Birarda, Giovanni; Holman, Hoi-Ying N.; DeSantis, Todd Z.; Wanner, Gerhard; Andersen, Gary L.; Perras, Alexandra K.; Meck, Sandra; Voelkel, Joerg; Bechtel, Hans A.; Wirth, Reinhard; Moissl-Eichinger, Christine			Coupling Genetic and Chemical Microbiome Profiling Reveals Heterogeneity of Archaeome and Bacteriome in Subsurface Biofilms That Are Dominated by the Same Archaeal Species	PLOS ONE			English	Article							PEARLS-LIKE MORPHOLOGY; NATURAL COMMUNITIES; SULFIDIC SPRINGS; SM1 EURYARCHAEON; DIVERSITY; GROWTH; LIPIDS; EPSILONPROTEOBACTERIA; ENVIRONMENTS; POPULATIONS	Earth harbors an enormous portion of subsurface microbial life, whose microbiome flux across geographical locations remains mainly unexplored due to difficult access to samples. Here, we investigated the microbiome relatedness of subsurface biofilms of two sulfidic springs in southeast Germany that have similar physical and chemical parameters and are fed by one deep groundwater current. Due to their unique hydrogeological setting these springs provide accessible windows to subsurface biofilms dominated by the same uncultivated archaeal species, called SM1 Euryarchaeon. Comparative analysis of infrared imaging spectra demonstrated great variations in archaeal membrane composition between biofilms of the two springs, suggesting different SM1 euryarchaeal strains of the same species at both aquifer outlets. This strain variation was supported by ultrastructural and metagenomic analyses of the archaeal biofilms, which included intergenic spacer region sequencing of the rRNA gene operon. At 16S rRNA gene level, PhyloChip G3 DNA microarray detected similar biofilm communities for archaea, but site-specific communities for bacteria. Both biofilms showed an enrichment of different deltaproteobacterial operational taxonomic units, whose families were, however, congruent as were their lipid spectra. Consequently, the function of the major proportion of the bacteriome appeared to be conserved across the geographic locations studied, which was confirmed by dsrB-directed quantitative PCR. Consequently, microbiome differences of these subsurface biofilms exist at subtle nuances for archaea (strain level variation) and at higher taxonomic levels for predominant bacteria without a substantial perturbation in bacteriome function. The results of this communication provide deep insight into the dynamics of subsurface microbial life and warrant its future investigation with regard to metabolic and genomic analyses.	[Probst, Alexander J.; Perras, Alexandra K.; Meck, Sandra; Wirth, Reinhard; Moissl-Eichinger, Christine] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Probst, Alexander J.; Perras, Alexandra K.; Meck, Sandra; Wirth, Reinhard; Moissl-Eichinger, Christine] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany; [Birarda, Giovanni; Holman, Hoi-Ying N.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Probst, Alexander J.; DeSantis, Todd Z.] Second Genome Inc, Dept Bioinformat, San Francisco, CA USA; [Wanner, Gerhard] Ludwig Maximilians Univ Munchen, Dept Biol 1, Biozentrum, Planegg Martinsried, Germany; [Voelkel, Joerg] Tech Univ Munich, Dept Geomorphol & Soil Sci, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Bechtel, Hans A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	University of Regensburg; University of Regensburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munich; Technical University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Moissl-Eichinger, C (corresponding author), Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany.	christine.moissl-eichinger@ur.de	Moissl-Eichinger, Christine/A-6682-2015; Andersen, Gary/G-2792-2015; Probst, Alexander J/K-2813-2016; Holman, Hoi-Ying/N-8451-2014	Moissl-Eichinger, Christine/0000-0001-6755-6263; Andersen, Gary/0000-0002-1618-9827; Holman, Hoi-Ying/0000-0002-7534-2625; Birarda, Giovanni/0000-0003-2418-058X; Probst, Alexander/0000-0002-9392-6544	DFG [MO 1977 3-1]; German National Academic Foundation (Studienstiftung des Deutschen Volkes); Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; German Research Foundation (DFG)	DFG(German Research Foundation (DFG)); German National Academic Foundation (Studienstiftung des Deutschen Volkes); Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by the DFG (grant MO 1977 3-1). AJP was supported by the German National Academic Foundation (Studienstiftung des Deutschen Volkes). The SR-FTIR spectromicroscopy work was conducted through the Berkeley Synchrotron Infrared Structural Biology (BSISB) Program at the Advanced Light Source, which is supported by the Director, Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy through contract DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele G, 1950, GEOLOGICA BAVARICA, V2, P94; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andres G., 1981, THERMAL SCHWEFELWASS, V15, P108; Baumann M, 1981, SCHRIFTENREIHE BAYER, V15, P4; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel AS, 2004, FEMS MICROBIOL ECOL, V51, P31, DOI 10.1016/j.femsec.2004.07.004; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; George S., 2001, INFRARED RAMAN CHARA, V3rd; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Henneberger R, 2006, APPL ENVIRON MICROB, V72, P192, DOI 10.1128/AEM.72.1.192-199.2006; Holman HYN, 2010, ANAL CHEM, V82, P8757, DOI 10.1021/ac100991d; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Koch M, 2006, FEMS MICROBIOL ECOL, V57, P55, DOI 10.1111/j.1574-6941.2006.00088.x; Kristjansson JK, 1992, THERMOPHILIC BACTERI; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Lamcke K(, 1976, BUU VER SCHWEIZ PETR, V42, P9; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Lovley DR, 2000, CURR OPIN MICROBIOL, V3, P252, DOI 10.1016/S1369-5274(00)00085-0; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mantsch H. H., 1996, INFRARED SPECTROSCOP; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Moissl C, 2005, MOL MICROBIOL, V56, P361, DOI 10.1111/j.1365-2958.2005.04294.x; Moissl C, 2003, ARCH MICROBIOL, V180, P211, DOI 10.1007/s00203-003-0580-1; Moissl C, 2002, APPL ENVIRON MICROB, V68, P933, DOI 10.1128/AEM.68.2.933-937.2002; Moissl-Eichinger C, 2011, ISME J, V5, P209, DOI 10.1038/ismej.2010.124; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Nielsen H, 1981, SCHRIFTENREIHE BAYER, V15, P99; Ortiz M, 2013, ISME J; PALMER AN, 1991, GEOL SOC AM BULL, V103, P1, DOI 10.1130/0016-7606(1991)103<0001:OAMOLC>2.3.CO;2; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Rudolph C, 2004, FEMS MICROBIOL ECOL, V50, P1, DOI 10.1016/j.femsec.2004.05.006; Rudolph C, 2001, APPL ENVIRON MICROB, V67, P2336, DOI 10.1128/AEM.67.5.2336-2344.2001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SPROTT GD, 1992, J BIOENERG BIOMEMBR, V24, P555, DOI 10.1007/BF00762348; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; THIRKELL D, 1974, A VAN LEEUW J MICROB, V40, P71, DOI 10.1007/BF00394555; Ulrich GA, 1998, MICROBIAL ECOL, V36, P141, DOI 10.1007/s002489900101; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	57	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99801	10.1371/journal.pone.0099801	http://dx.doi.org/10.1371/journal.pone.0099801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971452	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200014
J	Kleynen, M; Braun, SM; Bleijlevens, MH; Lexis, MA; Rasquin, SM; Halfens, J; Wilson, MR; Beurskens, AJ; Masters, RSW				Kleynen, Melanie; Braun, Susy M.; Bleijlevens, Michel H.; Lexis, Monique A.; Rasquin, Sascha M.; Halfens, Jos; Wilson, Mark R.; Beurskens, Anna J.; Masters, Rich S. W.			Using a Delphi Technique to Seek Consensus Regarding Definitions, Descriptions and Classification of Terms Related to Implicit and Explicit Forms of Motor Learning	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SKILL; PARKINSONS; SPORTS; STROKE; TASK	Background: Motor learning is central to domains such as sports and rehabilitation; however, often terminologies are insufficiently uniform to allow effective sharing of experience or translation of knowledge. A study using a Delphi technique was conducted to ascertain level of agreement between experts from different motor learning domains (i.e., therapists, coaches, researchers) with respect to definitions and descriptions of a fundamental conceptual distinction within motor learning, namely implicit and explicit motor learning. Methods: A Delphi technique was embedded in multiple rounds of a survey designed to collect and aggregate informed opinions of 49 international respondents with expertise related to motor learning. The survey was administered via an online survey program and accompanied by feedback after each round. Consensus was considered to be reached if >= 70% of the experts agreed on a topic. Results: Consensus was reached with respect to definitions of implicit and explicit motor learning, and seven common primary intervention strategies were identified in the context of implicit and explicit motor learning. Consensus was not reached with respect to whether the strategies promote implicit or explicit forms of learning. Discussion: The definitions and descriptions agreed upon may aid translation and transfer of knowledge between domains in the field of motor learning. Empirical and clinical research is required to confirm the accuracy of the definitions and to explore the feasibility of the strategies that were identified in research, everyday practice and education.	[Kleynen, Melanie; Braun, Susy M.; Beurskens, Anna J.] Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat People Chron Illness, Heerlen, Netherlands; [Kleynen, Melanie; Halfens, Jos] Adelante Rehabil Ctr, Dept Brain Injury, Hoensbroek, Netherlands; [Braun, Susy M.; Bleijlevens, Michel H.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands; [Bleijlevens, Michel H.] Sevagram Zorgcentra, Ctr Expertise Geriatr Rehabil & Chron Somat Care, Heerlen, Netherlands; [Lexis, Monique A.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [Rasquin, Sascha M.] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Rasquin, Sascha M.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Rehabil Med,CAPHRI, Maastricht, Netherlands; [Wilson, Mark R.] Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England; [Beurskens, Anna J.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Family Practice,CAPHRI, Maastricht, Netherlands; [Masters, Rich S. W.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [Masters, Rich S. W.] Univ Waikato, Dept Sport & Leisure Studies, Hamilton, New Zealand	Maastricht University; Maastricht University; University of Exeter; Maastricht University; University of Hong Kong; University of Waikato	Kleynen, M (corresponding author), Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat People Chron Illness, Heerlen, Netherlands.	melanie.kleynen@zuyd.nl	Masters, Richard/A-3889-2010	Masters, Richard/0000-0003-0707-6107; Wilson, Mark/0000-0001-8145-6971	Stichting Alliantie Innovatie (Innovation Alliance Foundation); RAAK-international [20113-33int]	Stichting Alliantie Innovatie (Innovation Alliance Foundation); RAAK-international	This study was financially supported by Stichting Alliantie Innovatie (Innovation Alliance Foundation), RAAK-international (Registration number: 20113-33int). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2009, EUR J PHYS REHAB MED, V45, P209; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Capio CM, 2013, J INTELL DISABIL RES, V57, P295, DOI 10.1111/j.1365-2788.2012.01535.x; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Frensch PA, 1998, HDB IMPLICIT LEARNIN; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Halsband U, 2006, J PHYSIOL-PARIS, V99, P414, DOI 10.1016/j.jphysparis.2006.03.007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Kleynen M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2604; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lam WK, 2009, J SPORT SCI, V27, P179, DOI 10.1080/02640410802448764; Larin HM, 2006, PHYS THERAPY CHILDRE, P131; Masters RSW, 2008, SURGERY, V143, P140, DOI 10.1016/j.surg.2007.06.018; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Masters RSW, 2012, SKILL ACQUISITION SP, P59; Maxwell JP, 2003, CONSCIOUS COGN, V12, P376, DOI 10.1016/S1053-8100(03)00005-9; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Mount J, 2007, NEUROREHABILITATION, V22, P123; Orrell AJ, 2006, PHYS THER, V86, P369, DOI 10.1093/ptj/86.3.369; Pohl PS, 2001, PHYS THER, V81, P1780, DOI 10.1093/ptj/81.11.1780; Poolton JM, 2005, HUM MOVEMENT SCI, V24, P362, DOI 10.1016/j.humov.2005.06.006; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Raab M, 2009, INT J SPORT EXERC PS, V7, P413, DOI 10.1080/1612197X.2009.9671917; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Schneider SA, 2010, MOVEMENT DISORD, V25, P1343, DOI 10.1002/mds.22692; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Turloff M., 1975, DELPHI METHOD TECHNI; van Halteren-van Tilborg IADA, 2007, NEUROPSYCHOL REV, V17, P203, DOI 10.1007/s11065-007-9030-1; van Tilborg IADA, 2011, NEUROREHABILITATION, V29, P295, DOI 10.3233/NRE-2011-0705; van Tilborg IADA, 2010, MOTOR CONTROL, V14, P344, DOI 10.1123/mcj.14.3.344; Waller SM, 2012, GAIT POSTURE, V36, P419, DOI 10.1016/j.gaitpost.2012.03.025; Williams AM, 2008, J SPORT SCI, V26, P401, DOI 10.1080/02640410701765631; Yang Y, 2011, INT J PSYCHOL, V46, P1, DOI 10.1080/00207594.2010.509800; Zafar SY, 2012, LANCET ONCOL, V13, pE77, DOI 10.1016/S1470-2045(11)70215-7	37	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100227	10.1371/journal.pone.0100227	http://dx.doi.org/10.1371/journal.pone.0100227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968228	Green Submitted, gold, Green Published			2022-12-25	WOS:000338280800031
J	Lakkam, M; Wager, S; Wise, PH; Wein, LM				Lakkam, Milinda; Wager, Stefan; Wise, Paul H.; Wein, Lawrence M.			Quantifying and Exploiting the Age Dependence in the Effect of Supplementary Food for Child Undernutrition	PLOS ONE			English	Article							USE THERAPEUTIC FOOD; NUTRITIONAL-STATUS; ADULT HEALTH; MORTALITY; GROWTH; MALNUTRITION; METAANALYSIS; PNEUMONIA; COUNTRIES; DIARRHEA	Motivated by the lack of randomized controlled trials with an intervention-free control arm in the area of child undernutrition, we fit a trivariate model of weight-for-age z score (WAZ), height-for-age z score (HAZ) and diarrhea status to data from an observational study of supplementary feeding (100 kCal/day for children with WAZ <-2.5) in 17 Guatemalan communities. Incorporating time lags, intention to treat (i.e., to give supplementary food), seasonality and age interactions, we estimate how the effect of supplementary food on WAZ, HAZ and diarrhea status varies with a child's age. We find that the effect of supplementary food on all 3 metrics decreases linearly with age from 6 to 20 mo and has little effect after 20 mo. We derive 2 food allocation policies that myopically (i.e., looking ahead 2 mo) minimize either the underweight or stunting severity -i.e., the sum of squared WAZ or HAZ scores for all children with WAZ or HAZ <0. A simulation study based on the statistical model predicts that the 2 derived policies reduce the underweight severity (averaged over all ages) by 13.6-14.1% and reduce the stunting severity at age 60 mo by 7.1-8.0% relative to the policy currently in use, where all policies have a budget that feeds approximate to 4% of children. While these findings need to be confirmed on additional data sets, it appears that in a low-dose (100 kCal/day) supplementary feeding setting in Guatemala, allocating food primarily to 6-12 mo infants can reduce the severity of underweight and stunting.	[Lakkam, Milinda] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Wager, Stefan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Wise, Paul H.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Wein, Lawrence M.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wein, LM (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	lwein@stanford.edu			Graduate School of Business, Stanford University; B.C. and E.J. Eaves Stanford Graduate Fellowship	Graduate School of Business, Stanford University(Stanford University); B.C. and E.J. Eaves Stanford Graduate Fellowship	Graduate School of Business, Stanford University and a B.C. and E.J. Eaves Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Bhagowalia P, 2011, ECON HUM BIOL, V9, P66, DOI 10.1016/j.ehb.2010.05.002; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey KG, 2009, MATERN CHILD NUTR, V5, P283, DOI 10.1111/j.1740-8709.2009.00190.x; Garenne M, 2006, J NUTR, V136, P2893, DOI 10.1093/jn/136.11.2893; Hastie TJ., 1990, GEN ADDITIVE MODELS; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; McDonald C., 2010, SCALING NUTR WHAT WI; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Richard SA, 2012, J NUTR, V142, P1291, DOI 10.3945/jn.111.154922; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Shoham J, 2013, TECHNICAL REPORT; Singh AS, 2010, INDIAN PEDIATR, V47, P679, DOI 10.1007/s13312-010-0100-8; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; VICTORA CG, 1992, J NUTR, V122, P1105, DOI 10.1093/jn/122.5.1105; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Yang Y, 2013, P NATL ACAD SCI USA, V110, P4545, DOI 10.1073/pnas.1216075110; Yoon PW, 1997, AM J CLIN NUTR, V65, P1070, DOI 10.1093/ajcn/65.4.1070	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99632	10.1371/journal.pone.0099632	http://dx.doi.org/10.1371/journal.pone.0099632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967745	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800017
J	Pishva, E; Drukker, M; Viechtbauer, W; Decoster, J; Collip, D; van Winkel, R; Wichers, M; Jacobs, N; Thiery, E; Derom, C; Geschwind, N; van den Hove, D; Lataster, T; Myin-Germeys, I; van Os, J; Rutten, BPF; Kenis, G				Pishva, Ehsan; Drukker, Marjan; Viechtbauer, Wolfgang; Decoster, Jeroen; Collip, Dina; van Winkel, Ruud; Wichers, Marieke; Jacobs, Nele; Thiery, Evert; Derom, Catherine; Geschwind, Nicole; van den Hove, Daniel; Lataster, Tineke; Myin-Germeys, Inez; van Os, Jim; Rutten, Bart P. F.; Kenis, Gunter			Epigenetic Genes and Emotional Reactivity to Daily Life Events: A Multi-Step Gene-Environment Interaction Study	PLOS ONE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; GLUCOCORTICOID-RECEPTOR; PSYCHOTIC EXPERIENCES; MAMMALIAN DEVELOPMENT; STRESS; DNMT3A; PSYCHIATRY; CORTISOL; CELLS	Recent human and animal studies suggest that epigenetic mechanisms mediate the impact of environment on development of mental disorders. Therefore, we hypothesized that polymorphisms in epigenetic-regulatory genes impact stress-induced emotional changes. A multi-step, multi-sample gene-environment interaction analysis was conducted to test whether 31 single nucleotide polymorphisms (SNPs) in epigenetic-regulatory genes, i.e. three DNA methyltransferase genes DNMT1, DNMT3A, DNMT3B, and methylenetetrahydrofolate reductase (MTHFR), moderate emotional responses to stressful and pleasant stimuli in daily life as measured by Experience Sampling Methodology (ESM). In the first step, main and interactive effects were tested in a sample of 112 healthy individuals. Significant associations in this discovery sample were then investigated in a population-based sample of 434 individuals for replication. SNPs showing significant effects in both the discovery and replication samples were subsequently tested in three other samples of: (i) 85 unaffected siblings of patients with psychosis, (ii) 110 patients with psychotic disorders, and iii) 126 patients with a history of major depressive disorder. Multilevel linear regression analyses showed no significant association between SNPs and negative affect or positive affect. No SNPs moderated the effect of pleasant stimuli on positive affect. Three SNPs of DNMT3A (rs11683424, rs1465764, rs1465825) and 1 SNP of MTHFR (rs1801131) moderated the effect of stressful events on negative affect. Only rs11683424 of DNMT3A showed consistent directions of effect in the majority of the 5 samples. These data provide the first evidence that emotional responses to daily life stressors may be moderated by genetic variation in the genes involved in the epigenetic machinery.	[Pishva, Ehsan; Drukker, Marjan; Viechtbauer, Wolfgang; Decoster, Jeroen; Collip, Dina; van Winkel, Ruud; Wichers, Marieke; Jacobs, Nele; van den Hove, Daniel; Lataster, Tineke; Myin-Germeys, Inez; van Os, Jim; Rutten, Bart P. F.; Kenis, Gunter] Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Jacobs, Nele] Open Univ Netherlands, Sch Psychol, Heerlen, Netherlands; [Thiery, Evert] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium; [Derom, Catherine] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Derom, Catherine] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Geschwind, Nicole] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [van den Hove, Daniel] Univ Wurzburg, Dept Psychiat & Mol Psychiat, Lab Translat Neurosci, D-97070 Wurzburg, Germany; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England	Maastricht University; Open University Netherlands; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; University of Wurzburg; University of London; King's College London	Rutten, BPF (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	b.rutten@maastrichtuniversity.nl	Wichers, Marieke/N-6667-2014; Myin-Germeys, Inez/L-5106-2014; Geschwind, Nicole/J-4617-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Viechtbauer, Wolfgang/M-1549-2013	Wichers, Marieke/0000-0001-5024-9064; Geschwind, Nicole/0000-0001-7171-6426; van Os, Jim/0000-0002-7245-1586; Viechtbauer, Wolfgang/0000-0003-3463-4063; Myin-Germeys, Inez/0000-0002-3731-4930; Derom, Catherine/0000-0001-5574-796X; Pishva, Ehsan/0000-0002-8964-0682; Rutten, Bart/0000-0002-9834-6346; van den Hove, Daniel/0000-0003-4047-3198	NARSAD Young Investigator; Dutch Organisation for Scientific Research (NWO) (VENI grant) [916.76.147]; Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium); Servier (unrestricted grant)	NARSAD Young Investigator(NARSAD); Dutch Organisation for Scientific Research (NWO) (VENI grant); Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium); Servier (unrestricted grant)	Part of this study was supported by a 2006 NARSAD Young Investigator awarded to Inez Myin-Germeys and by a grant from the Dutch Organisation for Scientific Research (NWO) (VENI grant number: 916.76.147) to M. Wichers. The TWIN population study has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium). Data collection was financially supported by Servier (unrestricted grant). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Delespaul P, 2002, SOC PSYCH PSYCH EPID, V37, P97, DOI 10.1007/s001270200000; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Edlund CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-174; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Frissen A, 2014, SOCIAL PSYCHIAT PSYC; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kember RL, 2012, BRAIN BEHAV, V2, P455, DOI 10.1002/brb3.69; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin PI, 2007, AM J HUM GENET, V80, P1002; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Melas PA, 2013, INT J NEUROPSYCHOPH, P1; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2002, AM J PSYCHIAT, V159, P443, DOI 10.1176/appi.ajp.159.3.443; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ouellet-Morin I, 2012, PSYCHOL MED, P1; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Pishva E, 2012, TRANSL NEUROSCI, V3, P196, DOI 10.2478/s13380-012-0024-y; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Souren NYP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r44; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Yang XJ, 2012, BIOCHEM BIOPH RES CO, V420, P570, DOI 10.1016/j.bbrc.2012.03.035	49	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100935	10.1371/journal.pone.0100935	http://dx.doi.org/10.1371/journal.pone.0100935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967710	gold, Green Published			2022-12-25	WOS:000338280800086
J	Rossato, FA; Zecchin, KG; La Guardia, PG; Ortega, RM; Alberici, LC; Costa, RAP; Catharino, RR; Graner, E; Castilho, RF; Vercesi, AE				Rossato, Franco A.; Zecchin, Karina G.; La Guardia, Paolo G.; Ortega, Rose M.; Alberici, Luciane C.; Costa, Rute A. P.; Catharino, Rodrigo R.; Graner, Edgard; Castilho, Roger F.; Vercesi, Anibal E.			Fatty Acid Synthase Inhibitors Induce Apoptosis in Non-Tumorigenic Melan-A Cells Associated with Inhibition of Mitochondrial Respiration	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYTOCHROME-C RELEASE; REACTIVE OXYGEN; IMMUNOHISTOCHEMICAL EXPRESSION; ELECTRON-TRANSPORT; N-ACETYLCYSTEINE; ANTIOBESITY DRUG; SKELETAL-MUSCLE; ORLISTAT; DEATH	The metabolic enzyme fatty acid synthase (FASN) is responsible for the endogenous synthesis of palmitate, a saturated long-chain fatty acid. In contrast to most normal tissues, a variety of human cancers overexpress FASN. One such cancer is cutaneous melanoma, in which the level of FASN expression is associated with tumor invasion and poor prognosis. We previously reported that two FASN inhibitors, cerulenin and orlistat, induce apoptosis in B16-F10 mouse melanoma cells via the intrinsic apoptosis pathway. Here, we investigated the effects of these inhibitors on non-tumorigenic melan-a cells. Cerulenin-and orlistat treatments were found to induce apoptosis and decrease cell proliferation, in addition to inducing the release of mitochondrial cytochrome c and activating caspases-9 and -3. Transfection with FASN siRNA did not result in apoptosis. Mass spectrometry analysis demonstrated that treatment with the FASN inhibitors did not alter either the mitochondrial free fatty acid content or composition. This result suggests that cerulenin- and orlistat-induced apoptosis events are independent of FASN inhibition. Analysis of the energy-linked functions of melan-a mitochondria demonstrated the inhibition of respiration, followed by a significant decrease in mitochondrial membrane potential (Delta psi m) and the stimulation of superoxide anion generation. The inhibition of NADH-linked substrate oxidation was approximately 40% and 61% for cerulenin and orlistat treatments, respectively, and the inhibition of succinate oxidation was approximately 46% and 52%, respectively. In contrast, no significant inhibition occurred when respiration was supported by the complex IV substrate N,N,N',N' -tetramethyl-p-phenylenediamine (TMPD). The protection conferred by the free radical scavenger acetyl-cysteine indicates that the FASN inhibitors induced apoptosis through an oxidative stress-associated mechanism. In combination, the present results demonstrate that cerulenin and orlistat induce apoptosis in non-tumorigenic cells via mitochondrial dysfunction, independent of FASN inhibition.	[Rossato, Franco A.; Zecchin, Karina G.; La Guardia, Paolo G.; Costa, Rute A. P.; Catharino, Rodrigo R.; Castilho, Roger F.; Vercesi, Anibal E.] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil; [Zecchin, Karina G.; Ortega, Rose M.; Graner, Edgard] Univ Estadual Campinas UNICAMP, Fac Odontol Piracicaba, Dept Diagnost Oral, Piracicaba, SP, Brazil; [Alberici, Luciane C.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Quim & Fis, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Vercesi, AE (corresponding author), Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil.	anibal@unicamp.br	Alberici, Luciane C/J-3013-2015; Graner, Edgard/K-4411-2012; Catharino, Rodrigo/AAH-4333-2021; Zecchin, Karina G/F-5298-2013; Catharino, Rodrigo/G-1487-2013; Graner, Edgard/P-4651-2019; Castilho, Roger F/G-3906-2012; Vercesi, Aníbal E/C-8767-2012; Rossato, Franco Aparecido/K-7981-2014	Alberici, Luciane C/0000-0002-7464-9385; Graner, Edgard/0000-0002-4737-7935; Catharino, Rodrigo/0000-0001-7219-2644; Catharino, Rodrigo/0000-0001-7219-2644; Castilho, Roger/0000-0003-2338-8717; Rossato, Franco Aparecido/0000-0002-4132-2271; Vercesi, Anibal Eugenio/0000-0001-6671-7125	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/59786-0, 07/54639-1, 08/57471- 7, 11/50400-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [470539/2008-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP -06/59786-0, 07/54639-1, 08/57471- 7, and 11/50400-0), Coordenacao, de Aperfeic,oamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ( CNPq - 470539/2008-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; Almeida JP, 2005, J PERIODONTOL, V76, P272, DOI 10.1902/jop.2005.76.2.272; Alo PL, 2000, ONCOL REP, V7, P1383; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Balkova P, 2011, PHYSIOL RES, V60, P467, DOI 10.33549/physiolres.932042; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Campos CBL, 2004, BIOCHEM PHARMACOL, V68, P2197, DOI 10.1016/j.bcp.2004.08.006; Campos CBL, 2006, CYTOM PART A, V69A, P515, DOI 10.1002/cyto.a.20273; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chirala SS, 2001, P NATL ACAD SCI USA, V98, P3104, DOI 10.1073/pnas.051635998; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; da Silva SD, 2009, ORAL ONCOL, V45, pE134, DOI 10.1016/j.oraloncology.2009.02.004; Deepa PR, 2012, BASIC CLIN PHARMACOL, V110, P494, DOI 10.1111/j.1742-7843.2011.00844.x; Dowling S, 2009, LIPIDS, V44, P489, DOI 10.1007/s11745-009-3298-2; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Heiligtag SJ, 2002, CELL DEATH DIFFER, V9, P1017, DOI 10.1038/sj.cdd.4401055; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho TS, 2007, BIOMED PHARMACOTHER, V61, P578, DOI 10.1016/j.biopha.2007.08.020; HOLDEN MJ, 1989, PLANT PHYSIOL, V91, P1296, DOI 10.1104/pp.91.4.1296; Innocenzi D, 2003, J CUTAN PATHOL, V30, P23, DOI 10.1034/j.1600-0560.2003.300104.x; Kapur P, 2005, MODERN PATHOL, V18, P1107, DOI 10.1038/modpathol.3800395; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Krontiras H, 1999, HEAD NECK-J SCI SPEC, V21, P325, DOI 10.1002/(SICI)1097-0347(199907)21:4<325::AID-HED6>3.3.CO;2-G; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Kusakabe T, 2002, HISTOPATHOLOGY, V40, P71, DOI 10.1046/j.1365-2559.2002.01289.x; La Guardia PG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00103; Li JN, 2001, CANCER RES, V61, P1493; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 2006, MOL CANCER THER, V5, P494, DOI 10.1158/1535-7163.MCT-05-0049; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Menendez JA, 2005, ANN ONCOL, V16, P1253, DOI 10.1093/annonc/mdi239; Menendez JA, 2005, EXP BIOL MED, V230, P151; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Nemoto T, 2001, PATHOBIOLOGY, V69, P297, DOI 10.1159/000064636; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Oliveira KAP, 2008, J BIOENERG BIOMEMBR, V40, P307, DOI 10.1007/s10863-008-9155-9; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Pizer ES, 2000, P AM ASSOC CANC RES, V41, P655; Rangan VS, 2001, BIOCHEMISTRY-US, V40, P10792, DOI 10.1021/bi015535z; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Richardson RD, 2007, MOL CANCER THER, V6, P2120, DOI 10.1158/1535-7163.MCT-07-0187; Rossi S, 2006, J PATHOL, V209, P369, DOI 10.1002/path.1983; Rossi S, 2003, MOL CANCER RES, V1, P707; Rudel T, 1998, J IMMUNOL, V160, P7; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Silva SD, 2008, VIRCHOWS ARCH, V453, P57, DOI 10.1007/s00428-008-0626-5; Silva SD, 2004, ORAL ONCOL, V40, P688, DOI 10.1016/j.oraloncology.2004.01.004; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; TSUKAMOTO Y, 1983, J BIOL CHEM, V258, P5312; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Ueda SM, 2010, J ONCOL, V2010, DOI 10.1155/2010/285191; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Visca P, 1999, CLIN CANCER RES, V5, P4111; Visca P, 2003, ANTICANCER RES, V23, P335; Vlad LD, 1999, MODERN PATHOL, V12, P70; Walter K, 2009, CANCER EPIDEM BIOMAR, V18, P2380, DOI 10.1158/1055-9965.EPI-09-0144; WEISS L, 1986, BIOL CHEM H-S, V367, P905, DOI 10.1515/bchm3.1986.367.2.905; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Xia J, 2009, NUCLEIC ACIDS RES, V40, pW127, DOI DOI 10.1093/NAR/GKS374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zecchin KG, 2007, J BIOENERG BIOMEMBR, V39, P186, DOI 10.1007/s10863-007-9076-z; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zecchin KG, 2011, RAPID COMMUN MASS SP, V25, P449, DOI 10.1002/rcm.4875; Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	95	29	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101060	10.1371/journal.pone.0101060	http://dx.doi.org/10.1371/journal.pone.0101060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964211	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500116
J	Corriden, R; Kilpatrick, LE; Kellam, B; Briddon, SJ; Hill, SJ				Corriden, Ross; Kilpatrick, Laura E.; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.			Kinetic analysis of antagonist-occupied adenosine-A(3) receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism	FASEB JOURNAL			English	Article						GPCR; dissociation; fluorescence correlation spectroscopy; fluorescent ligand	PROTEIN-COUPLED RECEPTOR; FLUORESCENCE CORRELATION SPECTROSCOPY; LIPID RAFTS; IN-VIVO; AGONIST; BINDING; MODULATION; QUANTIFICATION; COMPLEXES; DIFFUSION	In our previous work, using a fluorescent adenosine-A(3) receptor (A(3)AR) agonist and fluorescence correlation spectroscopy (FCS), we demonstrated high-affinity labeling of the active receptor (R*) conformation. In the current study, we used a fluorescent A(3)AR antagonist (CA200645) to study the binding characteristics of antagonist-occupied inactive receptor (R) conformations in membrane microdomains of individual cells. FCS analysis of CA200645-occupied A(3)ARs revealed 2 species, tau(D2) and tau(D3), that diffused at 2.29 +/- 0.35 and 0.09 +/- 0.03 mu m(2)/s, respectively. FCS analysis of a green fluorescent protein (GFP)-tagged A3AR exhibited a single diffusing species (0.105 mu m(2)/s). The binding of CA200645 to tau(D3) was antagonized by nano-molar concentrations of the A(3) antagonist MRS 1220, but not by the agonist NECA (up to 300 nM), consistent with labeling of R. CA200645 normally dissociated slowly from the A(3)AR, but inclusion of xanthine amine congener (XAC) or VUF 5455 during washout markedly accelerated the reduction in the number of particles exhibiting tau(D3) characteristics. It is notable that this effect was accompanied by a significant increase in the number of particles with tau(D2) diffusion. These data show that FCS analysis of ligand-occupied receptors provides a unique means of monitoring ligand A(3)AR residence times that are significantly reduced as a consequence of allosteric interaction across the dimer interface.	[Corriden, Ross; Kilpatrick, Laura E.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Med, Sch Life Sci, Inst Cell Signalling, Nottingham, England; [Kellam, Barrie] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Hill, SJ (corresponding author), Queens Med Ctr, Sch Med, Sch Life Sci, Inst Cell Signalling, Nottingham NG7 2UH, England.	stephen.hill@nottingham.ac.uk	Hill, Stephen/N-6753-2013; Hill, Stephen J/M-6243-2018; Kellam, Barrie/AAE-2960-2019	Hill, Stephen/0000-0002-4424-239X; Hill, Stephen J/0000-0002-4424-239X; Kellam, Barrie/0000-0003-0030-9908; Briddon, Stephen/0000-0001-8514-0827	UK Medical Research Council (MRC) [G0800006]; MRC [G0800006] Funding Source: UKRI; Medical Research Council [G0800006] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the UK Medical Research Council (MRC) for financial support (grant G0800006) and Dr. L. Bridge (University of Swansea, Swansea, UK) for helpful discussions.	Albrecht-Kupper BE, 2012, PURINERG SIGNAL, V8, pS91, DOI 10.1007/s11302-011-9274-3; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2011, J MED CHEM, V54, P6874, DOI 10.1021/jm2008562; Bar-Yehuda S, 2011, INT J MOL MED, V28, P727, DOI 10.3892/ijmm.2011.753; Briddon S.J., 2010, G PROTEIN COUPLED RE, P169; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Briddon SJ, 2004, FARADAY DISCUSS, V126, P197, DOI 10.1039/b307407b; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Briddon SJ, 2008, BBA-MOL CELL RES, V1783, P2262, DOI 10.1016/j.bbamcr.2008.07.006; Bridge LJ, 2010, MATH BIOSCI, V223, P115, DOI 10.1016/j.mbs.2009.11.005; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; CLARK EA, 1995, BRIT J PHARMACOL, V114, P357, DOI 10.1111/j.1476-5381.1995.tb13234.x; Cohen S, 2011, J CELL PHYSIOL, V226, P2438, DOI 10.1002/jcp.22593; Cordeaux Y, 2008, FASEB J, V22, P850, DOI 10.1096/fj.07-8180com; Corriden R, 2013, EMBO REP, V14, P726, DOI 10.1038/embor.2013.89; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gao ZG, 2001, MOL PHARMACOL, V60, P1057, DOI 10.1124/mol.60.5.1057; Gines S, 2001, MOL PHARMACOL, V59, P1314, DOI 10.1124/mol.59.5.1314; Hill SJ, 2014, BRIT J PHARMACOL, V171, P1102, DOI 10.1111/bph.12345; Hugo Gutierrez-de-Tera H., 2013, STRUCTURE, V21, P1; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; May LT, 2010, MOL PHARMACOL, V77, P678, DOI 10.1124/mol.109.063065; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; Middleton RJ, 2007, J MED CHEM, V50, P782, DOI 10.1021/jm061279i; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Stoddart LA, 2012, CHEM BIOL, V19, P1105, DOI 10.1016/j.chembiol.2012.07.014; Sykes DA, 2014, MOL PHARMACOL, V85, P608, DOI 10.1124/mol.113.090209; Tendera M, 2012, CLIN RES CARDIOL, V101, P585, DOI 10.1007/s00392-012-0430-8; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vernall A. J., 2013, BRIT J PHARMACOL, V171, P1073; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	46	46	46	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4211	4222		10.1096/fj.13-247270	http://dx.doi.org/10.1096/fj.13-247270			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970394	Green Published, hybrid			2022-12-25	WOS:000342222700003
J	Nass, N; Bromme, HJ; Hartig, R; Korkmaz, S; Sel, S; Hirche, F; Ward, A; Simm, A; Wiemann, S; Lykkesfeldt, AE; Roessner, A; Kalinski, T				Nass, Norbert; Broemme, Hans-Juergen; Hartig, Roland; Korkmaz, Sevil; Sel, Saadettin; Hirche, Frank; Ward, Aoife; Simm, Andreas; Wiemann, Stefan; Lykkesfeldt, Anne E.; Roessner, Albert; Kalinski, Thomas			Differential Response to alpha-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							METHYLGLYOXAL INDUCES APOPTOSIS; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; ACTIVATION; EXPRESSION; RECEPTOR; PROTEIN; GLYOXAL; KINASE; ACCUMULATION	Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell line MCF-7 and was analyzed for putative differences in the aldehyde defence system and accumulation of advanced glycation end products (AGE). In comparison to wt MCF-7 cells, these tamoxifen resistant cells were more sensitive to the dicarbonyl compounds glyoxal and methylglyoxal and displayed increased caspase activity, p38-MAPK- and I kappa B alpha-phosphorylation. However, mRNA accumulation of the aldehyde-and AGE-defence enzymes glyoxalase-1 and -2 (GLO1, GLO2) as well as fructosamine-3-kinase (FN3K) was not significantly altered. Tamoxifen resistant cells contained less free sulfhydryl-groups (glutathione) suggesting that the increased sensitivity towards the dicarbonyls was due to a higher sensitivity towards reactive oxygen species which are associated with dicarbonyl stress. To further analyse, if these data are of more general importance, key experiments were replicated with tamoxifen resistant MCF-7 cell lines from two independent sources. These cell lines were also more sensitive to aldehydes, especially glyoxal, but were different in their cellular signalling responses to the aldehydes. In conclusion, glyoxalases and other aldehyde defence enzymes might represent a promising target for the therapy of tamoxifen resistant breast cancers.	[Nass, Norbert; Roessner, Albert; Kalinski, Thomas] Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany; [Broemme, Hans-Juergen; Simm, Andreas] Univ Halle Wittenberg, Ctr Basic Med Res ZMG, D-06108 Halle, Germany; [Hartig, Roland] Otto Von Guericke Univ, Fac Med, Magdeburg, Germany; [Korkmaz, Sevil] Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Hirche, Frank] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany; [Ward, Aoife; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Lykkesfeldt, Anne E.] Danish Canc Soc, Res Ctr, Breast Canc Grp, Copenhagen, Denmark	Otto von Guericke University; Martin Luther University Halle Wittenberg; Otto von Guericke University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Danish Cancer Society	Nass, N (corresponding author), Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany.	norbert.nass@med.ovgu.de	Wiemann, Stefan/E-4424-2013; Nass, Norbert/A-5592-2011	Wiemann, Stefan/0000-0003-4683-3174; Nass, Norbert/0000-0003-2563-0386; Hartig, Roland/0000-0002-3706-7458; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305; Ward Gahlawat, Aoife/0000-0001-7854-7207	Danish Cancer Society Research Center; Federal Ministry of Education and Research [BMBF - e:Bio FKZ 0316168C]; German Cancer Research Center DKFZ; Otto von Guericke University Magdeburg; Martin-Luther University Halle-Wittenberg	Danish Cancer Society Research Center; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center DKFZ; Otto von Guericke University Magdeburg; Martin-Luther University Halle-Wittenberg	The study was funded by the Danish Cancer Society Research Center, the Federal Ministry of Education and Research (BMBF - e:Bio FKZ 0316168C), German Cancer Research Center DKFZ, Otto von Guericke University Magdeburg, Martin-Luther University Halle-Wittenberg and Otto von Guericke University Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Akhand AA, 1999, J CELL BIOCHEM, V72, P1, DOI 10.1002/(SICI)1097-4644(19990101)72:1<1::AID-JCB1>3.0.CO;2-Y; Bachmeier BE, 2008, ANN NY ACAD SCI, V1126, P283, DOI 10.1196/annals.1433.057; Bansode SB, 2013, MOL CELL PROTEOMICS, V12, P228, DOI 10.1074/mcp.M112.020651; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Chan WH, 2007, J CELL BIOCHEM, V100, P1056, DOI 10.1002/jcb.21114; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Clemons M, 2002, CANCER TREAT REV, V28, P165, DOI 10.1016/S0305-7372(02)00036-1; Creighton DJ, 2003, BIOCHEM SOC T, V31, P1378; Droog M, 2013, EUR J PHARMACOL, V717, P47, DOI 10.1016/j.ejphar.2012.11.071; Du J, 2003, J CELL BIOCHEM, V88, P1235, DOI 10.1002/jcb.10478; Fonseca-Sanchez MA, 2012, INT J ONCOL, V41, P670, DOI 10.3892/ijo.2012.1478; Fukunaga M, 2004, BIOCHEM BIOPH RES CO, V320, P689, DOI 10.1016/j.bbrc.2004.06.011; Germanova A, 2009, CANCER INVEST, V27, P655, DOI 10.1080/07357900802350822; Ghosh M, 2006, TOXICOL APPL PHARM, V212, P45, DOI 10.1016/j.taap.2005.07.003; Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200; Hunter SJ, 2003, DIABETES, V52, P492, DOI 10.2337/diabetes.52.2.492; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jia XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036610; Jiang Q, 2013, FUTURE MED CHEM, V5, P1023, DOI 10.4155/fmc.13.63; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kuntz S, 2010, MOL NUTR FOOD RES, V54, P1458, DOI 10.1002/mnfr.200900408; Kurebayashi J, 2005, CANCER CHEMOTH PHARM, V56, pS39, DOI 10.1007/s00280-005-0099-z; Liu BF, 2003, KIDNEY INT, V63, P947, DOI 10.1046/j.1523-1755.2003.00829.x; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Nass N, 2010, INT J BIOCHEM CELL B, V42, P749, DOI 10.1016/j.biocel.2010.01.012; Nass N, 2009, BIOL CHEM, V390, P915, DOI 10.1515/BC.2009.083; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; POURMOTABBED T, 1986, J BIOL CHEM, V261, P14240; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Roepke TA, 2009, J NEUROENDOCRINOL, V21, P263, DOI 10.1111/j.1365-2826.2009.01846.x; Sakamoto H, 2001, CLIN CANCER RES, V7, P2513; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Sato T, 2006, CURR MOL MED, V6, P351, DOI 10.2174/156652406776894536; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Upadhyay M, 2012, PHARMACOL THERAPEUT, V137, P318; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Veiga-Da-Cunha M, 2006, BIOCHEM J, V399, P257, DOI 10.1042/BJ20060684; Vienonen A, 2003, EUR J ENDOCRINOL, V148, P469, DOI 10.1530/eje.0.1480469; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; WEINER LM, 1991, FEBS LETT, V290, P243, DOI 10.1016/0014-5793(91)81270-I; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	57	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101473	10.1371/journal.pone.0101473	http://dx.doi.org/10.1371/journal.pone.0101473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983248	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000113
J	Goktas, O; Solmaz, M; Goktas, G; Olze, H				Goektas, Oender; Solmaz, Mustafa; Goektas, Goekhan; Olze, Heidi			Long-Term Results in Obstructive Sleep Apnea Syndrome (OSAS) after Laser-Assisted Uvulopalatoplasty (LAUP)	PLOS ONE			English	Article							UPPER AIRWAY; SURGICAL MODIFICATIONS; ADULTS; MANAGEMENT	Obstructive sleep apnea syndrome (OSAS) is a serious disease. The etiology of and optimum therapy options for this disorder have been much discussed and have been the subject of many publications. One much discussed therapy option is laser-assisted uvulopalatoplasty (LAUP). Despite conflicting opinions and guidelines which recommend that it should not be used, it remains in use. Patients who had previously undergone this procedure were invited for follow-up appointments, at which they were asked to complete a questionnaire, underwent an ENT examination and underwent sleep laboratory analysis using a portable sleep lab device. The average time since LAUP treatment was 11 years. The cohort comprised 25 patients. The average preoperative apnea-hypopnea-index (AHI) score was 25.25/h; the average postoperative AHI score 23.62/h. Closer examination of our data enabled us to identify 10 responders (40%) and 15 non-responders (60%). 12% (3/25) of non-responders experienced either no reduction in their AHI score or an increase compared to their preoperative AHI score of less than 5/h. In the remaining 48% (12/25), AHI increased by more than 5/h compared to the preoperative figure. Our questionnaire showed that 40% (10/25) of patients suffered from dry mouth and 20% (5/25) from foreign body sensation. The data led us to conclude that laser-assisted uvulopalatoplasty can indeed result in a reduction in AHI score comparable to other mucosal resection methods. Also in common with these methods, the efficacy of the therapy reduces with time and the procedure carries a high risk of bringing about an increase in the patient's AHI score.	[Goektas, Oender; Solmaz, Mustafa; Goektas, Goekhan; Olze, Heidi] Charite, CCM, Dept Otorhinolaryngol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goktas, O (corresponding author), Charite, CCM, Dept Otorhinolaryngol, Berlin, Germany.	oender.goektas@charite.de		Olze, Heidi/0000-0001-9987-6392				Berger G, 1999, ARCH OTOLARYNGOL, V125, P786, DOI 10.1001/archotol.125.7.786; Berger G, 2003, ARCH OTOLARYNGOL, V129, P447, DOI 10.1001/archotol.129.4.447; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Ferguson KA, 2003, AM J RESP CRIT CARE, V167, P15, DOI 10.1164/rccm.2108050; Finkelstein Y, 2002, ARCH OTOLARYNGOL, V128, P429, DOI 10.1001/archotol.128.4.429; Iyngkaran T, 2006, J LARYNGOL OTOL, V120, P932, DOI 10.1017/S002221510600209X; Kamami Y V, 1994, J Clin Laser Med Surg, V12, P215; KAMAMI Y-V, 1990, Acta Oto-Rhino-Laryngologica Belgica, V44, P451; Kotecha B, 1998, CLIN OTOLARYNGOL, V23, P354, DOI 10.1046/j.1365-2273.1998.00162.x; Littner M, 2001, SLEEP, V24, P603, DOI 10.1093/sleep/24.5.603; Rombaux P, 2003, LARYNGOSCOPE, V113, P2169, DOI 10.1097/00005537-200312000-00023; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Verse T, 2009, HNO, V57, P1136, DOI 10.1007/s00106-009-2013-1; Won Christine H J, 2008, Proc Am Thorac Soc, V5, P193, DOI 10.1513/pats.200708-121MG	16	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100211	10.1371/journal.pone.0100211	http://dx.doi.org/10.1371/journal.pone.0100211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979228	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400024
J	Morris, P; Buys, L; Vine, D				Morris, Peter; Buys, Laurie; Vine, Desley			Moving from Outsider to Insider: Peer Status and Partnerships between Electricity Utilities and Residential Consumers	PLOS ONE			English	Article							ENERGY-CONSERVATION; CONSUMPTION; FEEDBACK; BEHAVIOR; POLICY	An electricity demand reduction project based on comprehensive residential consumer engagement was established within an Australian community in 2008. By 2011, both the peak demand and grid supplied electricity consumption had decreased to below pre-intervention levels. This case study research explored the relationship developed between the utility, community and individual consumer from the residential customer perspective through qualitative research of 22 residential households. It is proposed that an energy utility can be highly successful at peak demand reduction by becoming a community member and a peer to residential consumers and developing the necessary trust, access, influence and partnership required to create the responsive environment to change. A peer-community approach could provide policymakers with a pathway for implementing pro-environmental behaviour for low carbon communities, as well as peak demand reduction, thereby addressing government emission targets while limiting the cost of living increases from infrastructure expenditure.	[Morris, Peter; Buys, Laurie] Queensland Univ Technol, Sch Design, Creat Ind Fac, Brisbane, Qld 4001, Australia; [Vine, Desley] Queensland Univ Technol, Fac Sci & Engn, Sch Elect Engineer & Comp Sci, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Vine, D (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Sch Elect Engineer & Comp Sci, Brisbane, Qld 4001, Australia.	d.vine@qut.edu.au		Buys, Laurie/0000-0001-8917-0863; Vine, Desley/0000-0002-8414-9210	Australian Research Council [LP110201139]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Linkage Project funding scheme (http://www.arc.gov.au/ncgp/lp/lp_default.htm), project number LP110201139. The findings and views expressed in this article are those of the authors and are not necessarily those of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Alexander B.R., 2010, ELECT J, V23, P39, DOI [DOI 10.1016/J.TEJ.2010.05.014, 10.1016/j.tej.2010.05.014]; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Allcott H, 2010, SCIENCE, V327, P1204, DOI 10.1126/science.1180775; Aronson, 1994, QUALITATIVE REPORT, V2, P1, DOI [10.46743/2160-3715/1995.2069, DOI 10.46743/2160-3715/1995.2069]; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bomberg E, 2012, ENERG POLICY, V51, P435, DOI 10.1016/j.enpol.2012.08.045; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; Bouwen R, 2004, J COMMUNITY APPL SOC, V14, P137, DOI 10.1002/casp.777; Brandon G, 1999, J ENVIRON PSYCHOL, V19, P75, DOI 10.1006/jevp.1998.0105; Buller DB, 2007, HEALTH EDUC RES, V22, P609, DOI 10.1093/her/cyl130; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; Churchman A., 2002, HDB ENV PSYCHOL, P525; Cockerell L., 2008, CREATING MAGIC 10 CO; COSTANZO M, 1986, AM PSYCHOL, V41, P521, DOI 10.1037/0003-066X.41.5.521; Darby S, 2006, ENERG POLICY, V34, P2929, DOI 10.1016/j.enpol.2005.04.013; Davis MA, 1997, NATL CIVIC REV, V86, P227, DOI DOI 10.1002/(ISSN)1542-7811; Eilbert A, 2013, HOME ENERGY AUDIT RE; Faruqui A., 2007, ELECT J, V20, P68, DOI DOI 10.1016/J.TEJ.2007.08.003; Faruqui A, 2011, J REGUL ECON, V40, P82, DOI 10.1007/s11149-011-9152-5; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; GELLER ES, 1981, J CONSUM RES, V8, P331, DOI 10.1086/208872; Giesecke J, 2012, J LIBR ADM, V52, P36, DOI 10.1080/01930826.2012.629964; Gillingham K, 2009, SSRN WORKING PAPER S; Godfrey BJ, 1984, INNER CITY NEIGHBORH; Gram-Hanssen K, 2007, ENERG POLICY, V35, P2879, DOI 10.1016/j.enpol.2006.10.017; Gyamfi S, 2011, ENERG POLICY, V39, P2993, DOI 10.1016/j.enpol.2011.03.012; Hausman A, 2001, J BUS IND MARK, V16, P600, DOI 10.1108/EUM0000000006194; Heiskanen E, 2010, ENERG POLICY, V38, P7586, DOI 10.1016/j.enpol.2009.07.002; HIRST E, 1981, ENERGY, V6, P621, DOI 10.1016/0360-5442(81)90017-7; Holstein J. A., 1995, ACTIVE INTERVIEW; KATZEV R, 1981, J ENVIRON SYST, V10, P215; Leighty W, 2011, ENERG POLICY, V39, P2299, DOI 10.1016/j.enpol.2011.01.041; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; LUTZENHISER L, 1993, ANNU REV ENERG ENV, V18, P247, DOI 10.1146/annurev.energy.18.1.247; Marechal K, 2009, J ECON ISSUES, V43, P69, DOI 10.2753/JEI0021-3624430104; McKenzie-Mohr D., 2011, FOSTERING SUSTAINABL, Vthird; McMakin AH, 2002, ENVIRON BEHAV, V34, P848, DOI 10.1177/001391602237252; Miller R. D., 1985, SHARED SAVINGS RESID; MOORMAN C, 1993, J MARKETING, V57, P81, DOI 10.2307/1252059; Morris Aldon D., 1992, FRONTIERS SOCIAL MOV; Murray C., 2006, CHILD SOC, V20, P273, DOI [https://doi.org/10.1002/CHI.892, DOI 10.1002/CHI.892]; Polatidis H, 2004, ENERG SOURCE, V26, P1253, DOI 10.1080/00908310490441584; Roussopoulos D, 1999, PUBLIC PLACE CITIZEN; SANSTAD AH, 1994, ENERG POLICY, V22, P811, DOI 10.1016/0301-4215(94)90139-2; SELIGMAN C, 1977, J APPL PSYCHOL, V62, P363, DOI 10.1037/0021-9010.62.4.363; Shove E., 2004, CHANGING HUMAN BEHAV; Simon H, 2005, DARWINISM ALTRUISM E; Speer PW, 2001, HEALTH EDUC BEHAV, V28, P716, DOI 10.1177/109019810102800605; Spees K., 2007, ELECT J, V20, P69, DOI [DOI 10.1016/J.TEJ.2007.01.006, 10.1016/j.tej.2007.01.006]; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Stern P.C., 1984, ENERGY USE HUMAN DIM; Thumann A., 2008, HDB ENERGY AUDITS, Vsixth; Tindall JA, 2008, PEER POWER BOOK ONE; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; VANHOUWELINGEN JH, 1989, J CONSUM RES, V16, P98, DOI 10.1086/209197; WINETT RA, 1983, J ECON PSYCHOL, V3, P203, DOI 10.1016/0167-4870(83)90003-X; Wiser R. H., 1998, Utilities Policy, V7, P107, DOI 10.1016/S0957-1787(98)00005-8; Yin R. K., 2012, APPL CASE STUDY RES, V3rd; Yoeli E, 2009, DOES SOCIAL APPROVAL	60	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101189	10.1371/journal.pone.0101189	http://dx.doi.org/10.1371/journal.pone.0101189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979234	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400096
J	Penzkofer, D; Bonauer, A; Fischer, A; Tups, A; Brandes, RP; Zeiher, AM; Dimmeler, S				Penzkofer, Daniela; Bonauer, Angelika; Fischer, Ariane; Tups, Alexander; Brandes, Ralf P.; Zeiher, Andreas M.; Dimmeler, Stefanie			Phenotypic Characterization of miR-92a(-/-) Mice Reveals an Important Function of miR-92a in Skeletal Development	PLOS ONE			English	Article							CLUSTER; PROLIFERATION; INHIBITION; ANGIOGENESIS; DELETION; FAMILY; CANCER	MicroRNAs (miRNAs, miRs) emerged as key regulators of gene expression. Germline hemizygous deletion of the gene that encodes the miR-17 similar to 92 miRNA cluster was associated with microcephaly, short stature and digital abnormalities in humans. Mice deficient for the miR-17 similar to 92 cluster phenocopy several features such as growth and skeletal development defects and exhibit impaired B cell development. However, the individual contribution of miR-17 similar to 92 cluster members to this phenotype is unknown. Here we show that germline deletion of miR-92a in mice is not affecting heart development and does not reduce circulating or bone marrow-derived hematopoietic cells, but induces skeletal defects. MiR-92a(-/-) mice are born at a reduced Mendelian ratio, but surviving mice are viable and fertile. However, body weight of miR-92a(-/-) mice was reduced during embryonic and postnatal development and adulthood. A significantly reduced body and skull length was observed in miR-92a(-/-) mice compared to wild type littermates. mu CT analysis revealed that the length of the 5th mesophalanx to 5th metacarpal bone of the forelimbs was significantly reduced, but bones of the hindlimbs were not altered. Bone density was not affected. These findings demonstrate that deletion of miR-92a is sufficient to induce a developmental skeletal defect.	[Penzkofer, Daniela; Bonauer, Angelika; Fischer, Ariane; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany; [Tups, Alexander] Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Zeiher, Andreas M.] JW Goethe Univ Hosp Frankfurt, Dept Cardiol, Frankfurt, Germany; [Brandes, Ralf P.; Zeiher, Andreas M.; Dimmeler, Stefanie] Partner Site RheinMain, German Ctr Cardiovasc Res DZHK, Frankfurt, Germany	Goethe University Frankfurt; Philipps University Marburg; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; German Centre for Cardiovascular Research	Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Brandes, Ralf P/L-3058-2017	Brandes, Ralf P/0000-0002-8035-0048; Dimmeler, Stefanie/0000-0002-1045-2436	European Union (ERC); German Center of Cardiovascular Research (BMBF)	European Union (ERC)(European Research Council (ERC)European Commission); German Center of Cardiovascular Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by the European Union (ERC advanced grant "AngiomiR"). The mu CT core facility is supported by the German Center of Cardiovascular Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Celli J, 2003, AM J MED GENET A, V122A, P294, DOI 10.1002/ajmg.a.20471; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Daniel J-M, 2014, CARDIOVAS R IN PRESS; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Iaconetti C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0296-y; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Li FF, 2012, GENE, V495, P95, DOI 10.1016/j.gene.2011.12.057; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Murata K, 2014, J BONE MINER RES, V29, P316, DOI 10.1002/jbmr.2040; Ning GZ, 2013, DEV CELL, V24, P283, DOI 10.1016/j.devcel.2012.12.016; Sengul A, 2013, PHYSIOL RES, V62, P221, DOI 10.33549/physiolres.932410; Sharifi M, 2014, MOL BIOL REP, V41, P2799, DOI 10.1007/s11033-014-3134-5; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wu W, 2011, CIRCULATION; Zhang GJ, 2014, DIGEST DIS SCI, V59, P98, DOI 10.1007/s10620-013-2858-8; Zhou M., 2013, ENDOCRINE	27	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101153	10.1371/journal.pone.0101153	http://dx.doi.org/10.1371/journal.pone.0101153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979655	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400086
J	Coince, A; Cordier, T; Lengelle, J; Defossez, E; Vacher, C; Robin, C; Buee, M; Marcais, B				Coince, Aurore; Cordier, Tristan; Lengelle, Juliette; Defossez, Emmanuel; Vacher, Corinne; Robin, Cecile; Buee, Marc; Marcais, Benoit			Leaf and Root-Associated Fungal Assemblages Do Not Follow Similar Elevational Diversity Patterns	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; SPECIES RICHNESS; ALTITUDINAL GRADIENT; FOLIAR ENDOPHYTES; BACTERIAL; FOREST; SOIL; VARIABILITY; REVEAL	The diversity of fungi along environmental gradients has been little explored in contrast to plants and animals. Consequently, environmental factors influencing the composition of fungal assemblages are poorly understood. The aim of this study was to determine whether the diversity and composition of leaf and root-associated fungal assemblages vary with elevation and to investigate potential explanatory variables. High-throughput sequencing of the Internal Transcribed Spacer 1 region was used to explore fungal assemblages along three elevation gradients, located in French mountainous regions. Beech forest was selected as a study system to minimise the host effect. The variation in species richness and specific composition was investigated for ascomycetes and basidiomycetes assemblages with a particular focus on root-associated ectomycorrhizal fungi. The richness of fungal communities associated with leaves or roots did not significantly relate to any of the tested environmental drivers, i.e. elevation, mean temperature, precipitation or edaphic variables such as soil pH or the ratio carbon: nitrogen. Nevertheless, the ascomycete species richness peaked at mid-temperature, illustrating a mid-domain effect model. We found that leaf and root-associated fungal assemblages did not follow similar patterns of composition with elevation. While the composition of the leaf-associated fungal assemblage correlated primarily with the mean annual temperature, the composition of root-associated fungal assemblage was explained equally by soil pH and by temperature. The ectomycorrhizal composition was also related to these variables. Our results therefore suggest that above and below-ground fungal assemblages are not controlled by the same main environmental variables. This may be due to the larger amplitude of climatic variables in the tree foliage compared to the soil environment.	[Coince, Aurore; Lengelle, Juliette; Buee, Marc; Marcais, Benoit] Univ Lorraine Interact Arbres Microorganismes, Labex ARBRE, FR EFABA, UMR INRA 1136, Champenoux, France; [Cordier, Tristan; Vacher, Corinne; Robin, Cecile] INRA, BIOGECO, UMR1202, Cestas, France; [Cordier, Tristan; Vacher, Corinne; Robin, Cecile] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Defossez, Emmanuel] Irstea, UR EMGR Ecosyst Montagnards, F-38402 St Martin Dheres, France	INRAE; Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Buee, M (corresponding author), Univ Lorraine Interact Arbres Microorganismes, Labex ARBRE, FR EFABA, UMR INRA 1136, Champenoux, France.	marcais@nancy.inra.fr; buee@nancy.inra.fr	Vacher, Corinne/J-1777-2012; Vacher, Corinne/Q-3182-2019; defossez, emmanuel/ABE-9799-2020; Vacher, Corinne/ABG-8163-2020; Cordier, Tristan/B-7836-2018; Marcais, Benoit/O-5049-2019	Vacher, Corinne/0000-0003-3023-6113; defossez, emmanuel/0000-0002-3279-9190; Vacher, Corinne/0000-0003-3023-6113; Cordier, Tristan/0000-0001-7398-4790; Marcais, Benoit/0000-0002-8107-644X; Buee, Marc/0000-0001-8614-3886	European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA) [22000325]; Region Lorraine; French Ministry of Agriculture, Forest Health Department [E17/08, 22000285]; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01];  [42 AP09/10]	European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA); Region Lorraine(Region Grand-Est); French Ministry of Agriculture, Forest Health Department; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); 	This study was supported by joint grants from a European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA, no 22000325), the Region Lorraine and the French Ministry of Agriculture, Forest Health Department (Convention E17/08, no 22000285). The UMR IaM is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). The Genoscope contributed to the data collection through the 454 pyrosequencing steps (project #42 AP09/10). The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Benichou P., 1987, METEOROLOGIE, V7, P23; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUCHAUFOUR P., 1959, Bulletin de l'Association Francaise pour l'Etude du Sol, P193; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer Noah, 2008, P95; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kennedy PG, 2012, MOL ECOL, V21, P4151, DOI 10.1111/j.1365-294X.2012.05703.x; Kernaghan G, 2003, OIKOS, V102, P497, DOI 10.1034/j.1600-0706.2003.12415.x; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lugo MA, 2008, MICROB ECOL, V55, P705, DOI 10.1007/s00248-007-9313-3; Manter DK, 2010, APPL ENVIRON MICROB, V76, P2086, DOI 10.1128/AEM.03017-09; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1083, DOI 10.1016/j.soilbio.2010.03.005; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Pinheiro J, 2012, NLME LINEAR NONLINEA; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; Unterseher M, 2010, FUNGAL ECOL, V3, P366, DOI 10.1016/j.funeco.2010.03.001; Wu BY, 2007, MYCORRHIZA, V17, P495, DOI 10.1007/s00572-007-0114-9; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	54	79	81	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100668	10.1371/journal.pone.0100668	http://dx.doi.org/10.1371/journal.pone.0100668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971637	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200049
J	Joseph, SJ; Li, B; Ghonasgi, T; Haase, CP; Qin, ZHS; Dean, D; Read, TD				Joseph, Sandeep J.; Li, Ben; Ghonasgi, Tanvi; Haase, Chad P.; Qin, Zhaohui S.; Dean, Deborah; Read, Timothy D.			Direct Amplification, Sequencing and Profiling of Chlamydia trachomatis Strains in Single and Mixed Infection Clinical Samples	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; POPULATION-STRUCTURE; GENOME SEQUENCES; RECOMBINATION; ALIGNMENT; GENOTYPE; DISEASES; CULTURE; HUMANS	Sequencing bacterial genomes from DNA isolated directly from clinical samples offers the promise of rapid and precise acquisition of informative genetic information. In the case of Chlamydia trachomatis, direct sequencing is particularly desirable because it obviates the requirement for culture in mammalian cells, saving time, cost and the possibility of missing low abundance strains. In this proof of concept study, we developed methodology that would allow genome-scale direct sequencing, using a multiplexed microdroplet PCR enrichment technology to amplify a 100 kb region of the C. trachomatis genome with 500 1.1-1.3 kb overlapping amplicons (5-fold amplicon redundancy). We integrated comparative genomic data into a pipeline to preferentially select conserved sites for amplicon design. The 100 kb target region could be amplified from clinical samples, including remnants from diagnostics tests, originating from the cervix, urethra and urine, For rapid analysis of these data, we developed a framework for whole-genome based genotyping called binstrain. We used binstrain to estimate the proportion of SNPs originating from 14 C. trachomatis reference serotype genomes in each sample. Direct DNA sequencing methods such as the one described here may have an important role in understanding the biology of C. trachomatis mixed infections and the natural genetic variation of the species within clinically relevant ecological niches.	[Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Li, Ben; Qin, Zhaohui S.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostati & Bioinformat, Atlanta, GA 30322 USA; [Ghonasgi, Tanvi; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Haase, Chad P.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dean, Deborah] Univ Calif San Francisco, Joint Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif Berkeley, Berkeley, CA 94720 USA	Emory University; Emory University; Rollins School Public Health; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Emory University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Read, TD (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	tread@emory.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; Read, Timothy/0000-0001-8966-9680; Joseph, Sandeep/0000-0003-0697-2487	Emory University School of Medicine; National Institutes of Health [R01AI098843]; Georgia Research Alliance; Atlanta Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098843] Funding Source: NIH RePORTER	Emory University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Atlanta Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by development funds from Emory University School of Medicine (to TDR), and Public Health Service grant R01AI098843 from the National Institutes of Health (to DD and TDR). This project made use of the Emory Genomics Center, which used equipment funded by the Georgia Research Alliance and Atlanta Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Cook JA, 2008, NEW ENGL J MED, V358, P1777, DOI 10.1056/NEJMp0708546; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dean D, 1997, J CLIN INVEST, V99, P475, DOI 10.1172/JCI119182; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geniez S, 2012, SYMBIOSIS, V58, P201, DOI 10.1007/s13199-012-0215-x; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Joseph SJ, 2012, NAT GENET, V44, P364, DOI 10.1038/ng.2225; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Keim PS, 2009, NAT REV MICROBIOL, V7, P813, DOI 10.1038/nrmicro2219; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pritchard JK, 2000, GENETICS, V155, P945; Putman TE, 2013, MICROBIOL-SGM, V159, P2109, DOI 10.1099/mic.0.070029-0; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99290	10.1371/journal.pone.0099290	http://dx.doi.org/10.1371/journal.pone.0099290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971628	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200008
J	Sidik, SM; Hackett, CG; Tran, F; Westwood, NJ; Lourido, S				Sidik, Saima M.; Hackett, Caroline G.; Tran, Fanny; Westwood, Nicholas J.; Lourido, Sebastian			Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9	PLOS ONE			English	Article							INVASION; SYSTEMS; MARKER; GENES	Toxoplasma gondii is a parasite of humans and animals, and a model for other apicomplexans including Plasmodium spp., the causative agents of malaria. Despite many advances, manipulating the T. gondii genome remains labor intensive, and is often restricted to lab-adapted strains or lines carrying mutations that enable selection. Here, we use the RNA-guided Cas9 nuclease to efficiently generate knockouts without selection, and to introduce point mutations and epitope tags into the T. gondii genome. These methods will streamline the functional analysis of parasite genes and enable high-throughput engineering of their genomes.	[Sidik, Saima M.; Hackett, Caroline G.; Lourido, Sebastian] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tran, Fanny; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of St Andrews; University of St Andrews	Lourido, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lourido@wi.mit.edu		Westwood, Nicholas/0000-0003-0630-0138; Lourido, Sebastian/0000-0002-5237-1095	NIH [1DP5OD017892]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grant 1DP5OD017892 to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KIM K, 1995, EXP PARASITOL, V80, P46, DOI 10.1006/expr.1995.1006; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Tran F, 2013, MOLECULES, V18, P11639, DOI 10.3390/molecules180911639; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	20	153	158	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100450	10.1371/journal.pone.0100450	http://dx.doi.org/10.1371/journal.pone.0100450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971596	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200032
J	Tsai, VWW; Manandhar, R; Jorgensen, SB; Lee-Ng, KKM; Zhang, HP; Marquis, CP; Jiang, L; Husaini, Y; Lin, S; Sainsbury, A; Sawchenko, PE; Brown, DA; Breit, SN				Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Jorgensen, Sebastian Beck; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Marquis, Christopher Peter; Jiang, Lele; Husaini, Yasmin; Lin, Shu; Sainsbury, Amanda; Sawchenko, Paul E.; Brown, David A.; Breit, Samuel N.			The Anorectic Actions of the TGF beta Cytokine MIC-1/GDF15 Require an Intact Brainstem Area Postrema and Nucleus of the Solitary Tract	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; GLUCAGON-LIKE PEPTIDE-1; CENTRAL-NERVOUS-SYSTEM; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; ARCUATE NUCLEUS; HYPOTHALAMUS; NEURONS; SERUM; RAT	Macrophage inhibitory cytokine-1 (MIC-1/GDF15) modulates food intake and body weight under physiological and pathological conditions by acting on the hypothalamus and brainstem. When overexpressed in disease, such as in advanced cancer, elevated serum MIC-1/GDF15 levels lead to an anorexia/cachexia syndrome. To gain a better understanding of its actions in the brainstem we studied MIC-1/GDF15 induced neuronal activation identified by induction of Fos protein. Intraperitoneal injection of human MIC-1/GDF15 in mice activated brainstem neurons in the area postrema (AP) and the medial (m) portion of the nucleus of the solitary tract (NTS), which did not stain with tyrosine hydroxylase (TH). To determine the importance of these brainstem nuclei in the anorexigenic effect of MIC-1/GDF15, we ablated the AP alone or the AP and the NTS. The latter combined lesion completely reversed the anorexigenic effects of MIC-1/GDF15. Altogether, this study identified neurons in the AP and/or NTS, as being critical for the regulation of food intake and body weight by MIC-1/GDF15.	[Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Jorgensen, Sebastian Beck] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Marquis, Christopher Peter] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Lin, Shu; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Sawchenko, Paul E.] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Novo Nordisk; University of New South Wales Sydney; Garvan Institute of Medical Research; University of Sydney; Salk Institute	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Salis, Amanda/A-3187-2011; Marquis, Christopher/E-3847-2013	Salis, Amanda/0000-0001-9176-1574; Marquis, Christopher/0000-0003-1656-7215; lin, shu/0000-0002-4239-2028; Jiang, Lele/0000-0002-1326-5871; Brown, David/0000-0003-1382-9419	National Health and Medical Research Council of Australia (NHMRC); NHMRC; National Institute of Health (NIH) of U.S. [NS-21182]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021182, R37NS021182] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Health (NIH) of U.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). AS, DAB and SL are recipients of NHMRC Career Development Awards or Fellowships. Professor Paul E. Sawchenko is supported by grants (NS-21182) from the National Institute of Health (NIH) of U.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck VS, 2012, NEUROSCIENCE, V219, P48, DOI 10.1016/j.neuroscience.2012.05.070; ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bell ME, 2000, J NEUROSCI, V20, P6707, DOI 10.1523/JNEUROSCI.20-17-06707.2000; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; CUNNINGHAM ET, 1994, NEUROSCIENCE, V58, P635, DOI 10.1016/0306-4522(94)90087-6; EDWARDS GL, 1986, AM J PHYSIOL, V251, pR575, DOI 10.1152/ajpregu.1986.251.3.R575; Ericsson A, 1997, J NEUROSCI, V17, P7166; Fairlie WD, 2001, BIOCHEMISTRY-US, V40, P65, DOI 10.1021/bi001064p; Fuchs T, 2013, AGING CELL; Giza BK, 1996, CHEM SENSES, V21, P147, DOI 10.1093/chemse/21.2.147; Glattfelder KJ, 2008, AREA POSTREMA, P2053; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Johnen H, 2012, CARDIOVASC PATHOL, V21, P499, DOI 10.1016/j.carpath.2012.02.003; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Matzinger D, 1999, AM J PHYSIOL-REG I, V277, pR1718, DOI 10.1152/ajpregu.1999.277.6.R1718; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Moran TH, 2006, OBESITY, V14, P250; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Paul CA, 2008, CSH PROTOC, V2008; Paxinos G, 2001, MOUSE BRAIN STEREOTA, Vxxv; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rinaman L, 2003, J NEUROSCI, V23, P10084; RINAMAN L, 1995, J COMP NEUROL, V360, P246, DOI 10.1002/cne.903600204; Rinaman L, 2007, FRONT NEUROENDOCRIN, V28, P50, DOI 10.1016/j.yfrne.2007.02.002; Romano A, 2013, AM J PHYSIOL-ENDOC M, V305, pE1266, DOI 10.1152/ajpendo.00411.2013; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Schwartz GJ, 2010, FORUM NUTR, V63, P141, DOI 10.1159/000264402; SHAPIRO RE, 1985, J COMP NEUROL, V238, P473, DOI 10.1002/cne.902380411; Treece BR, 2000, BRAIN RES, V872, P37, DOI 10.1016/S0006-8993(00)02432-X; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Yamamoto H, 2003, J NEUROSCI, V23, P2939	55	63	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100370	10.1371/journal.pone.0100370	http://dx.doi.org/10.1371/journal.pone.0100370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971956	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200028
J	Tsujiura, M; Mazack, V; Sudol, M; Kaspar, HG; Nash, J; Carey, DJ; Gogoi, R				Tsujiura, Masahiro; Mazack, Virginia; Sudol, Marius; Kaspar, Hanna G.; Nash, John; Carey, David J.; Gogoi, Radhika			Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer	PLOS ONE			English	Article							HIPPO PATHWAY; CANDIDATE ONCOGENE; UTERINE CORPUS; CARCINOMA; OVEREXPRESSION; IDENTIFICATION; COACTIVATOR; EXPRESSION; MUTATIONS; INDUCTION	Background: Yes-associated protein (YAP) is a transcriptional co-activator and regulates cell proliferation and apoptosis. We investigated the clinical and biological significance of YAP in endometrial cancer (EMCA). Methods: YAP expression in 150 primary tumor tissues from patients with EMCA was evaluated by immunohistochemistry and its association with clinicopathological data was assessed. The biological functions of YAP were determined in EMCA cell lines through knockdown/overexpression of YAP. The role of YAP in modulating radiation sensitivity was also investigated in EMCA cells. Results: Increased nuclear YAP expression was significantly associated with higher grade, stage, lympho-vascular space invasion, postoperative recurrence/metastasis and overall survival in estrogen mediated EMCA, called type 1 cancer (p = 0.019, = 0.028, = 0.0008, = 0.046 and = 0.015, respectively). In multivariate analysis, nuclear YAP expression was confirmed as an independent prognostic factor for overall survival in type 1 EMCA. YAP knockdown by siRNA resulted in a significant decrease in cell proliferation (p < 0.05), anchorage-dependent growth (p = 0.015) and migration/invasion (p < 0.05), and a significant increase in the number of cells in G0/G1 phase (p = 0.002). Conversely, YAP overexpression promoted cell proliferation. Clonogenic assay demonstrated enhanced radiosensitivity by approximately 36% in YAP inhibited cells. Conclusions: Since YAP functions as a transcriptional co-activator, its differential localization in the nucleus of cancer cells and subsequent impact on cell proliferation could have important consequences with respect to its role as an oncogene in EMCA. Nuclear YAP expression could be useful as a prognostic indicator or therapeutic target and predict radiation sensitivity in patients with EMCA.	[Tsujiura, Masahiro; Mazack, Virginia; Sudol, Marius; Carey, David J.; Gogoi, Radhika] Geisinger Med Ctr, Weis Ctr Res, Danville, PA 17822 USA; [Sudol, Marius] Icahn Sch Med Mt Sinai, New York, NY USA; [Kaspar, Hanna G.] Geisinger Med Labs, Wilkes Barre, PA USA; [Nash, John; Gogoi, Radhika] Geisinger Med Ctr, Div Obstet & Gynecol, Danville, PA 17822 USA	Geisinger Medical Center; Icahn School of Medicine at Mount Sinai; Geisinger Medical Center; Geisinger Medical Center	Gogoi, R (corresponding author), Geisinger Med Ctr, Weis Ctr Res, Danville, PA 17822 USA.	rpgogoi@geisinger.edu			Geisinger Medical Center; Rice Cancer Foundation; Clinic Research Fund [SRC-075]	Geisinger Medical Center; Rice Cancer Foundation; Clinic Research Fund	Funding for work done in this publication was from Grant SRC-075 Clinic Research Fund, Geisinger Medical Center and the Rice Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2007, GYNECOL ONCOL, V106, P52, DOI 10.1016/j.ygyno.2007.02.033; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; Clement PB, 2004, ADV ANAT PATHOL, V11, P117, DOI 10.1097/00125480-200405000-00001; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Creasman W, 1989, GYNECOL ONCOL, V35, P7; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Creutzberg CL, 2003, GYNECOL ONCOL, V89, P201, DOI 10.1016/S0090-8258(03)00126-4; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Fader AN, 2009, GYNECOL ONCOL, V114, P121, DOI 10.1016/j.ygyno.2009.03.039; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Howlader N, 2013, SEER CANC STAT REV 1; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Sudol M, 2013, HIPPO SIGNALING PATH, P53; Tashiro H, 1997, CANCER RES, V57, P3935; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Wang H, 2013, CANC METASTASIS REV; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100974	10.1371/journal.pone.0100974	http://dx.doi.org/10.1371/journal.pone.0100974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972085	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200077
J	Paukner, R; Staudigl, P; Choosri, W; Sygmund, C; Halada, P; Haltrich, D; Leitner, C				Paukner, Regina; Staudigl, Petra; Choosri, Withu; Sygmund, Christoph; Halada, Petr; Haltrich, Dietmar; Leitner, Christian			Galactose Oxidase from Fusarium oxysporum - Expression in E-coli and P-pastoris and Biochemical Characterization	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEINS; COFACTOR; PURIFICATION; CLEAVAGE	A gene coding for galactose 6-oxidase from Fusarium oxysporum G12 was cloned together with its native preprosequence and a C-terminal His-tag, and successfully expressed both in Escherichia coli and Pichia pastoris. The enzyme was subsequently purified and characterized. Among all tested substrates, the highest catalytic efficiency (k(cat)/K-m) was found with 1-methyl-beta-D-galactopyranoside (2.2 mM(-1) s(-1)). The Michaelis constant (K-m) for D-galactose was determined to be 47 mM. Optimal pH and temperature for the enzyme activity were 7.0 and 40 degrees C, respectively, and the enzyme was thermoinactivated at temperatures above 50 degrees C. GalOx contains a unique metalloradical complex consisting of a copper atom and a tyrosine residue covalently attached to the sulphur of a cysteine. The correct formation of this thioether bond during the heterologous expression in E. coli and P. pastoris could be unequivocally confirmed by MALDI mass spectrometry, which offers a convenient alternative to prove this Tyr-Cys crosslink, which is essential for the catalytic activity of GalOx.	[Paukner, Regina; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Leitner, Christian] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Vienna, Austria; [Choosri, Withu] Ramkhamhang Univ, Dept Food Technol, Bangkok, Thailand; [Halada, Petr] Acad Sci Czech Republ, Inst Microbiol Vvi, Prague, Czech Republic	University of Natural Resources & Life Sciences, Vienna; Ramkhamhaeng University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Leitner, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Vienna, Austria.	christian.leitner@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Halada, Petr/H-3330-2014	Haltrich, Dietmar/0000-0002-8722-8176; Halada, Petr/0000-0002-7229-3450	Austrian Science Foundation [L 504-B11]; IMIC Institutional Research Project [RVO61388971]	Austrian Science Foundation(Austrian Science Fund (FWF)); IMIC Institutional Research Project	Funding came from the Austrian Science Foundation, http://www.fwf.ac.at Grant: L 504-B11, IMIC Institutional Research Project, Grant: RVO61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISAKA K, 1984, AGR BIOL CHEM TOKYO, V48, P1425, DOI 10.1080/00021369.1984.10866336; Alberton D, 2007, J BASIC MICROB, V47, P203, DOI 10.1002/jobm.200610290; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AVIGAD G, 1962, J BIOL CHEM, V237, P2736; Barbosa-Tessmann IP, 2001, J BASIC MICROB, V41, P143, DOI 10.1002/1521-4028(200107)41:3/4<143::AID-JOBM143>3.0.CO;2-G; BARON AJ, 1994, J BIOL CHEM, V269, P25095; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choosri W, 2011, WORLD J MICROB BIOT, V27, P1349, DOI 10.1007/s11274-010-0585-2; COOPER JAD, 1959, J BIOL CHEM, V234, P445; Cordeiro FA, 2010, J BASIC MICROB, V50, P527, DOI 10.1002/jobm.201000078; Deacon SE, 2011, CHEMBIOCHEM, V12, P593, DOI 10.1002/cbic.201000634; Deacon SE, 2004, CHEMBIOCHEM, V5, P972, DOI 10.1002/cbic.200300810; Dietzsch C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-85; ETTINGER MJ, 1974, BIOCHEMISTRY-US, V13, P1242, DOI 10.1021/bi00703a029; Firbank SJ, 2003, BIOCHEM SOC T, V31, P506, DOI 10.1042/bst0310506; Gasparotto EPL, 2006, BRAZ ARCH BIOL TECHN, V49, P557, DOI 10.1590/S1516-89132006000500004; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; ITO N, 1990, BIOCHEM SOC T, V18, P931, DOI 10.1042/bst0180931; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lis M, 1997, ANTIMICROB AGENTS CH, V41, P999, DOI 10.1128/AAC.41.5.999; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martinie RJ, 2012, METALLOMICS, V4, P1037, DOI 10.1039/c2mt20093g; Mazur Adam W, 1991, GALACTOSE OXIDASE EN, P99; MCPHERSON MJ, 1993, BIOCHEM SOC T, V21, P752, DOI 10.1042/bst0210752; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Rogers MS, 2008, BIOCHEMISTRY-US, V47, P10428, DOI 10.1021/bi8010835; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Saysell CG, 1997, J BIOL INORG CHEM, V2, P702, DOI 10.1007/s007750050186; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spadiut O, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-68; Sun LH, 2002, CHEMBIOCHEM, V3, P781, DOI 10.1002/1439-7633(20020802)3:8<781::AID-CBIC781>3.0.CO;2-8; Sun LH, 2001, PROTEIN ENG, V14, P699, DOI 10.1093/protein/14.9.699; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Whittaker JW, 2002, ADV PROTEIN CHEM, V60, P1; Whittaker JW, 1997, J INORG BIOCHEM, V67, P39; Whittaker MM, 2000, PROTEIN EXPRES PURIF, V20, P105, DOI 10.1006/prep.2000.1287; WHITTAKER MM, 1988, J BIOL CHEM, V263, P6074; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; Wilkinson D, 2004, PROTEIN ENG DES SEL, V17, P141, DOI 10.1093/protein/gzh018; Xu F, 2000, APPL BIOCHEM BIOTECH, V88, P23, DOI 10.1385/ABAB:88:1-3:023	44	16	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100116	10.1371/journal.pone.0100116	http://dx.doi.org/10.1371/journal.pone.0100116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967652	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800025
J	Qin, W; Chen, ZL; Zhang, YH; Yan, RB; Yan, GR; Li, S; Zhong, HB; Lin, S				Qin, Wei; Chen, Zelin; Zhang, Yihan; Yan, Ruibin; Yan, Guanrong; Li, Song; Zhong, Hanbing; Lin, Shuo			Nom1 Mediates Pancreas Development by Regulating Ribosome Biogenesis in Zebrafish	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; PROTEIN PHOSPHATASE-1; RNA-SEQ; DYSKERATOSIS-CONGENITA; DIGESTIVE ORGANS; GENE; EXPRESSION; NUCLEOLUS; IDENTIFICATION; ABNORMALITIES	Ribosome biogenesis is an important biological process for proper cellular function and development. Defects leading to improper ribosome biogenesis can cause diseases such as Diamond-Blackfan anemia and Shwachman-Bodian-Diamond syndrome. Nucleolar proteins are a large family of proteins and are involved in many cellular processes, including the regulation of ribosome biogenesis. Through a forward genetic screen and positional cloning, we identified and characterized a zebrafish line carrying mutation in nucleolar protein with MIF4G domain 1 (nom1), which encodes a conserved nulceolar protein with a role in pre-rRNA processing. Zebrafish nom1 mutants exhibit major defects in endoderm development, especially in exocrine pancreas. Further studies revealed that impaired proliferation of ptf1a-expressing pancreatic progenitor cells mainly contributed to the phenotype. RNA-seq and molecular analysis showed that ribosome biogenesis and pre-mRNA splicing were both affected in the mutant embryos. Several defects of ribosome assembly have been shown to have a p53-dependent mechanism. In the nom1 mutant, loss of p53 did not rescue the pancreatic defect, suggesting a p53-independent role. Further studies indicate that protein phosphatase 1 alpha, an interacting protein to Nom1, could partially rescue the pancreatic defect in nom1 morphants if a human nucleolar localization signal sequence was artificially added. This suggests that targeting Pp1 alpha into the nucleolus by Nom1 is important for pancreatic proliferation. Altogether, our studies revealed a new mechanism involving Nom1 in controlling vertebrate exocrine pancreas formation.	[Qin, Wei; Chen, Zelin; Zhang, Yihan; Yan, Ruibin; Yan, Guanrong; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen, Peoples R China; [Zhong, Hanbing] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; Southern University of Science & Technology; University of California System; University of California Los Angeles	Lin, S (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen, Peoples R China.	shuolin@ucla.edu		Qin, Wei/0000-0003-2158-0553	Shenzhen Science and Technology Program [JC201104220257A, CXC201104210009A]; National Natural Science Foundation of China [31271550]	Shenzhen Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Shenzhen Science and Technology Program (JC201104220257A, CXC201104210009A) and National Natural Science Foundation of China(31271550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boglev Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003279; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cohen PTW, 2002, J CELL SCI, V115, P241; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; Gunawardena SR, 2008, J BIOL CHEM, V283, P398, DOI 10.1074/jbc.M706708200; Heiss NS, 1999, HUM MOL GENET, V8, P2515, DOI 10.1093/hmg/8.13.2515; Hozumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033675; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460; Provost E, 2013, ZEBRAFISH, V10, P161, DOI 10.1089/zeb.2013.0884; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Rios Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001271; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Simmons HM, 2005, GENE, V347, P137, DOI 10.1016/j.gene.2004.12.027; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Yee NS, 2007, PLOS BIOL, V5, P2484, DOI 10.1371/journal.pbio.0050312; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188; Zhao CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004074	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100796	10.1371/journal.pone.0100796	http://dx.doi.org/10.1371/journal.pone.0100796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967912	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800069
J	Rudnicki, WR; Mroczek, T; Cudek, P				Rudnicki, Witold R.; Mroczek, Teresa; Cudek, Pawel			Amino Acid Properties Conserved in Molecular Evolution	PLOS ONE			English	Article							STANDARD GENETIC-CODE; SUBSTITUTION MATRICES; MUTATION MATRICES; PROTEIN EVOLUTION; ORIGIN; IDENTIFICATION; MODEL	That amino acid properties are responsible for the way protein molecules evolve is natural and is also reasonably well supported both by the structure of the genetic code and, to a large extent, by the experimental measures of the amino acid similarity. Nevertheless, there remains a significant gap between observed similarity matrices and their reconstructions from amino acid properties. Therefore, we introduce a simple theoretical model of amino acid similarity matrices, which allows splitting the matrix into two parts - one that depends only on mutabilities of amino acids and another that depends on pairwise similarities between them. Then the new synthetic amino acid properties are derived from the pairwise similarities and used to reconstruct similarity matrices covering a wide range of information entropies. Our model allows us to explain up to 94% of the variability in the BLOSUM family of the amino acids similarity matrices in terms of amino acid properties. The new properties derived from amino acid similarity matrices correlate highly with properties known to be important for molecular evolution such as hydrophobicity, size, shape and charge of amino acids. This result closes the gap in our understanding of the influence of amino acids on evolution at the molecular level. The methods were applied to the single family of similarity matrices used often in general sequence homology searches, but it is general and can be used also for more specific matrices. The new synthetic properties can be used in analyzes of protein sequences in various biological applications.	[Rudnicki, Witold R.] Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Mroczek, Teresa; Cudek, Pawel] Univ Informat Technol & Management, Chair Expert Syst & Artificial Intelligence, Rzeszow, Poland	University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Information Technology & Management Rzeszow	Rudnicki, WR (corresponding author), Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland.	W.Rudnicki@icm.edu.pl	Rudnicki, Witold R/B-6670-2012	Rudnicki, Witold R/0000-0002-7928-4944; Mroczek, Teresa/0000-0002-6064-9528	Polish Ministry of Science and Higher Education, Faculty of Applied IT, University of Information Technology and Management;  [503-07-04-03]	Polish Ministry of Science and Higher Education, Faculty of Applied IT, University of Information Technology and Management; 	This research was partially funded within project No. 503-07-04-03. The project is subsidized by the Polish Ministry of Science and Higher Education as part of the statutory research of the Faculty of Applied IT, University of Information Technology and Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1991, J MOL BIOL, V219, P55; Ardell DH, 1998, J MOL EVOL, V47, P1, DOI 10.1007/PL00006356; CLARKE B, 1970, NATURE, V228, P159, DOI 10.1038/228159a0; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dayhoff MO, 1968, ATLAS PROTEIN SEQUEN, P33; Di Giulio M, 2003, ORIGINS LIFE EVOL B, V33, P479, DOI 10.1023/A:1025772828039; Di Giulio M, 2001, J MOL EVOL, V53, P724, DOI 10.1007/s002390010259; EPSTEIN CJ, 1967, NATURE, V215, P355, DOI 10.1038/215355a0; Freeland SJ, 2003, ORIGINS LIFE EVOL B, V33, P457, DOI 10.1023/A:1025771327614; Gambin A, 2006, J COMPUT BIOL, V13, P81, DOI 10.1089/cmb.2006.13.81; GAMOW G, 1954, NATURE, V173, P318, DOI 10.1038/173318a0; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; Koshi JM, 1997, PROTEINS, V27, P336, DOI 10.1002/(SICI)1097-0134(199703)27:3<336::AID-PROT2>3.0.CO;2-B; KOSHI JM, 1995, PROTEIN ENG, V8, P641; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; Pokarowski P, 2007, PROTEINS, V69, P379, DOI 10.1002/prot.21509; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; SONNEBORN T. M., 1965, P377; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Yarus M, 2002, ANNU REV GENET, V36, P125, DOI 10.1146/annurev.genet.36.031902.105056; Zhu W, 2006, J THEOR BIOL, V239, P63, DOI 10.1016/j.jtbi.2005.07.012; Zimmermann K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-4; ZUCKERKANDL EMILE, 1965, P97	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98983	10.1371/journal.pone.0098983	http://dx.doi.org/10.1371/journal.pone.0098983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967708	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800006
J	Rose, JP; Todd, BD				Rose, Jonathan P.; Todd, Brian D.			Projecting Invasion Risk of Non-Native Watersnakes (Nerodia fasciata and Nerodia sipedon) in the Western United States	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SELECTING THRESHOLDS; BIOLOGICAL INVASIONS; RANA-CATESBEIANA; RANDOM FORESTS; PREDICTION; ECOLOGY; HOMOGENIZATION; CLASSIFICATION; HYBRIDIZATION	Species distribution models (SDMs) are increasingly used to project the potential distribution of introduced species outside their native range. Such studies rarely explicitly evaluate potential conflicts with native species should the range of introduced species expand. Two snake species native to eastern North America, Nerodia fasciata and Nerodia sipedon, have been introduced to California where they represent a new stressor to declining native amphibians, fish, and reptiles. To project the potential distributions of these non-native watersnakes in western North America, we built ensemble SDMs using MaxEnt, Boosted Regression Trees, and Random Forests and habitat and climatic variables. We then compared the overlap between the projected distribution of invasive watersnakes and the distributions of imperiled native amphibians, fish, and reptiles that can serve as prey or competitors for the invaders, to estimate the risk to native species posed by non-native watersnakes. Large areas of western North America were projected to be climatically suitable for both species of Nerodia according to our ensemble SDMs, including much of central California. The potential distributions of both N. fasciata and N. sipedon overlap extensively with the federally threatened Giant Gartersnake, Thamnophis gigas, which inhabits a similar ecological niche. N. fasciata also poses risk to the federally threatened California Tiger Salamander, Ambystoma californiense, whereas N. sipedon poses risk to some amphibians of conservation concern, including the Foothill Yellow-legged Frog, Rana boylii. We conclude that non-native watersnakes in California can likely inhabit ranges of several native species of conservation concern that are expected to suffer as prey or competing species for these invaders. Action should be taken now to eradicate or control these invasions before detrimental impacts on native species are widespread. Our methods can be applied broadly to quantify the risk posed by incipient invasions to native biodiversity.	[Rose, Jonathan P.; Todd, Brian D.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Rose, Jonathan P.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Rose, JP (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jprose@ucdavis.edu		Todd, Brian/0000-0003-3133-791X				Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Alfaro ME, 2001, MOL PHYLOGENET EVOL, V21, P408, DOI 10.1006/mpev.2001.1024; [Anonymous], 1985, REC PLAN SAN FRANC G; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Balfour Peter S., 2002, Herpetological Review, V33, P150; Balfour Peter S., 2007, Herpetological Review, V38, P489; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BLANEY RM, 1979, HERPETOLOGICA, V35, P350; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; BROWN LR, 1994, CALIF FISH GAME, V79, P96; BURY R B, 1976, Biological Conservation, V10, P1; Camper JD, 2010, HERPETOLOGICA, V66, P464, DOI 10.1655/09-029.1; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; CONANT ROGER, 1963, AMER MUS NOVITATES, V2122, P1; Coote T, 2003, ORYX, V37, P91, DOI 10.1017/S0030605303000176; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fuller Michael M., 2006, Herpetological Review, V37, P363; Fuller TE, 2011, RESTOR ECOL, V19, P204, DOI 10.1111/j.1526-100X.2010.00708.x; Gibbons J.W., 2004, N AM WATERSNAKES NAT; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; HUEY RB, 1979, AM ZOOL, V19, P357; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Light T, 2007, CONSERV BIOL, V21, P434, DOI 10.1111/j.1523-1739.2006.00643.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Mebert K, 2008, MOL ECOL, V17, P1918, DOI 10.1111/j.1365-294X.2008.03725.x; Miano Oliver J., 2012, Herpetological Review, V43, P348; MOYLE PB, 1973, COPEIA, P18; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Pattishall A, 2008, COPEIA, P752, DOI 10.1643/CH-07-228; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips BL, 2003, CONSERV BIOL, V17, P1738, DOI 10.1111/j.1523-1739.2003.00353.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Price SJ, 2011, HERPETOL CONSERV BIO, V6, P287; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; RODDA GH, 1992, J HERPETOL, V26, P166, DOI 10.2307/1564858; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Roe JH, 2004, BIOL CONSERV, V118, P79, DOI 10.1016/j.biocon.2003.07.010; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rogers H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043446; Rose JP, 2013, J HERPETOL, V47, P421, DOI 10.1670/12-119; Rossman DA, 1996, GARTER SNAKES EVOLUT; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schwaner T.D., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 45, P1; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Seigel RA, 1995, HERPETOLOGICA, V51, P424; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	80	12	13	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100277	10.1371/journal.pone.0100277	http://dx.doi.org/10.1371/journal.pone.0100277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964204	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500035
J	Kota, P; Buchner, G; Chakraborty, H; Dang, YL; He, H; Garcia, GJM; Kubelka, J; Gentzsch, M; Stutts, MJ; Dokholyan, NV				Kota, Pradeep; Buchner, Ginka; Chakraborty, Hirak; Dang, Yan L.; He, Hong; Garcia, Guilherme J. M.; Kubelka, Jan; Gentzsch, Martina; Stutts, M. Jackson; Dokholyan, Nikolay V.			The N-terminal Domain Allosterically Regulates Cleavage and Activation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; GAMMA-SUBUNIT; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; PROTEOLYTIC ACTIVATION; EXTRACELLULAR DOMAIN; ENAC; BINDING; INHIBITION; STABILITY; SITES	The epithelial sodium channel (ENaC) is activated upon endoproteolytic cleavage of specific segments in the extracellular domains of the alpha- and gamma-subunits. Cleavage is accomplished by intracellular proteases prior to membrane insertion and by surface-expressed or extracellular soluble proteases once ENaC resides at the cell surface. These cleavage events are partially regulated by intracellular signaling through an unknown allosteric mechanism. Here, using a combination of computational and experimental techniques, we show that the intracellular N terminus of gamma-ENaC undergoes secondary structural transitions upon interaction with phosphoinositides. From ab initio folding simulations of the N termini in the presence and absence of phosphatidylinositol 4,5-bisphosphate (PIP2), we found that PIP2 increases alpha-helical propensity in the N terminus of gamma-ENaC. Electrophysiology and mutation experiments revealed that a highly conserved cluster of lysines in the gamma-ENaC N terminus regulates accessibility of extracellular cleavage sites in gamma-ENaC. We also show that conditions that decrease PIP2 or enhance ubiquitination sharply limit access of the gamma-ENaC extracellular domain to proteases. Further, the efficiency of allosteric control of ENaC proteolysis is dependent on Tyr(370) in gamma-ENaC. Our findings provide an allosteric mechanism for ENaC activation regulated by the N termini and sheds light on a potential general mechanism of channel and receptor activation.	[Kota, Pradeep; Chakraborty, Hirak; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Dept Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Gentzsch, Martina] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Dang, Yan L.; He, Hong; Gentzsch, Martina; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Buchner, Ginka; Kubelka, Jan] Univ Wyoming, Dept Chem, Laramie, WY 82071 USA; [Garcia, Guilherme J. M.] Med Coll Wisconsin, Dept Otolaryngol & Human Commun, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wyoming; Medical College of Wisconsin	Dokholyan, NV (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dokh@unc.edu	Garcia, Guilherme/J-9555-2013; Dokholyan, Nikolay/D-8081-2018; Gentzsch, Martina/AAY-1815-2021	Garcia, Guilherme/0000-0003-2995-9226; Dokholyan, Nikolay/0000-0002-8225-4025; 	National Institutes of Health [P01 HL 110873-01]; National Science Foundation [0846140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 HL 110873-01. This work was also supported by National Science Foundation Career Grant 0846140 (to J. K.).	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Chakraborty H, 2012, BIOCHEMISTRY-US, V51, P1005, DOI 10.1021/bi300025c; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Tong QS, 2005, AM J PHYSIOL-RENAL, V288, pF150, DOI 10.1152/ajprenal.00261.2004; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang ZR, 2010, PFLUG ARCH EUR J PHY, V459, P377, DOI 10.1007/s00424-009-0733-4; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	47	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23029	23042		10.1074/jbc.M114.570952	http://dx.doi.org/10.1074/jbc.M114.570952			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973914	hybrid, Green Published			2022-12-25	WOS:000341017200041
J	Lyashchenko, AK; Redd, KJ; Goldstein, PA; Tibbs, GR				Lyashchenko, Alex K.; Redd, Kacy J.; Goldstein, Peter A.; Tibbs, Gareth R.			cAMP Control of HCN2 Channel Mg2+ Block Reveals Loose Coupling between the Cyclic Nucleotide-Gating Ring and the Pore	PLOS ONE			English	Article							ACTIVATED PACEMAKER CHANNELS; VOLTAGE-SENSING MECHANISM; I-F CHANNELS; GATED CHANNELS; TERMINAL REGION; CATION CHANNELS; ION CHANNELS; MOLECULAR CHARACTERIZATION; CONFORMATIONAL-CHANGES; POTASSIUM CHANNELS	Hyperpolarization-activated cyclic nucleotide-regulated HCN channels underlie the Na+-K+ permeable I-H pacemaker current. As with other voltage-gated members of the 6-transmembrane K-V channel superfamily, opening of HCN channels involves dilation of a helical bundle formed by the intracellular ends of S6 albeit this is promoted by inward, not outward, displacement of S4. Direct agonist binding to a ring of cyclic nucleotide-binding sites, one of which lies immediately distal to each S6 helix, imparts cAMP sensitivity to HCN channel opening. At depolarized potentials, HCN channels are further modulated by intracellular Mg2+ which blocks the open channel pore and blunts the inhibitory effect of outward K+ flux. Here, we show that cAMP binding to the gating ring enhances not only channel opening but also the kinetics of Mg2+ block. A combination of experimental and simulation studies demonstrates that agonist acceleration of block is mediated via acceleration of the blocking reaction itself rather than as a secondary consequence of the cAMP enhancement of channel opening. These results suggest that the activation status of the gating ring and the open state of the pore are not coupled in an obligate manner (as required by the often invoked Monod-Wyman-Changeux allosteric model) but couple more loosely (as envisioned in a modular model of protein activation). Importantly, the emergence of second messenger sensitivity of open channel rectification suggests that loose coupling may have an unexpected consequence: it may endow these erstwhile "slow" channels with an ability to exert voltage and ligand-modulated control over cellular excitability on the fastest of physiologically relevant time scales.	[Lyashchenko, Alex K.; Tibbs, Gareth R.] Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA; [Redd, Kacy J.] Columbia Univ, Dept Neurosci, New York, NY USA; [Goldstein, Peter A.; Tibbs, Gareth R.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA	Columbia University; Columbia University; Cornell University	Tibbs, GR (corresponding author), Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA.	gareth.r.tibbs@gmail.com		Redd, Kacy/0000-0002-2024-741X; Goldstein, Peter/0000-0002-5973-9104	Department of Anesthesiology of Columbia University; Weill Cornell Medical College	Department of Anesthesiology of Columbia University; Weill Cornell Medical College	This work was supported by the Department of Anesthesiology of Columbia University and Weill Cornell Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Azene EM, 2005, BIOCHEM BIOPH RES CO, V327, P1131, DOI 10.1016/j.bbrc.2004.12.127; Azene EM, 2003, J PHYSIOL-LONDON, V547, P349, DOI 10.1113/jphysiol.2003.039768; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Becchetti A, 2000, PFLUG ARCH EUR J PHY, V440, P556, DOI 10.1007/s004240050006; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P71, DOI 10.1085/jgp.200709769; Bruening-Wright A, 2007, J NEUROSCI, V27, P270, DOI 10.1523/JNEUROSCI.3801-06.2007; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Contreras JE, 2006, J GEN PHYSIOL, V127, P481, DOI 10.1085/jgp.200509440; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; D'Avanzo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007712; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; DIFRANCESCO D, 1984, J PHYSIOL-LONDON, V348, P341, DOI 10.1113/jphysiol.1984.sp015114; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Fodor AA, 1997, J GEN PHYSIOL, V110, P591, DOI 10.1085/jgp.110.5.591; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Griguoli M, 2010, J NEUROSCI, V30, P10773, DOI 10.1523/JNEUROSCI.2446-10.2010; Heginbotham L, 2004, BIOPHYS J, V86, P3663, DOI 10.1529/biophysj.103.039412; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hua L, 2005, J GEN PHYSIOL, V125, P335, DOI 10.1085/jgp.200409187; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Lyashchenko AK, 2008, J GEN PHYSIOL, V131, P227, DOI 10.1085/jgp.200709868; Lyashchenko AK, 2007, J PHYSIOL-LONDON, V583, P37, DOI 10.1113/jphysiol.2007.136465; Macri V, 2009, J BIOL CHEM, V284, P15659, DOI 10.1074/jbc.M809164200; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Martinez-Francois JR, 2009, J GEN PHYSIOL, V134, P151, DOI 10.1085/jgp.200910240; Michels G, 2005, CIRCULATION, V111, P399, DOI 10.1161/01.CIR.0000153799.65783.3A; Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Ryu S, 2012, J GEN PHYSIOL, V140, P469, DOI 10.1085/jgp.201210850; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Steffan R, 1997, J NEUROSCI METH, V78, P51, DOI 10.1016/S0165-0270(97)00139-8; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Swartz KJ, 2004, NAT STRUCT MOL BIOL, V11, P499, DOI 10.1038/nsmb0604-499; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trudeau MC, 2012, J GEN PHYSIOL, V140, P457, DOI 10.1085/jgp.201210898; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vemana S, 2003, J GEN PHYSL; Vemana S, 2008, AM J PHYSIOL-CELL PH, V295, pC557, DOI 10.1152/ajpcell.00154.2008; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Wu SJ, 2012, J GEN PHYSIOL, V140, P29, DOI 10.1085/jgp.201110749; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou L, 2012, NAT CHEM BIOL, V8, P136, DOI 10.1038/nchembio.776; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	107	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101236	10.1371/journal.pone.0101236	http://dx.doi.org/10.1371/journal.pone.0101236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983358	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000074
J	Numico, G; Pinto, C; Gori, S; Ucci, G; Di Maio, M; Cancian, M; De Lorenzo, F; Silvestris, N				Numico, Gianmauro; Pinto, Carmine; Gori, Stefania; Ucci, Giovanni; Di Maio, Massimo; Cancian, Maurizio; De Lorenzo, Francesco; Silvestris, Nicola			Clinical and Organizational Issues in the Management of Surviving Breast and Colorectal Cancer Patients: Attitudes and Feelings of Medical Oncologists	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SURVIVORSHIP CARE PLANS; FOLLOW-UP; TIME; HEALTH	Background: The fast growing demand and the shortage of resources are pushing toward more efficient models of survivorship care delivery. The Associazione ltaliana di Oncologia Medica (AIOM) established an interdisciplinary working group with the purpose of promoting organizational improvements at the national level. A survey aimed at assessing attitudes and feelings of oncologists was considered preliminary to further initiatives. Methods: A 25-item questionnaire, sent to the mailing list of the Society, explored the following issues on the practice of breast and colorectal cancer patients' follow up: 1) organization; 2) clinical features; 3) feelings about the different meanings of follow-up. Results: Ninety-one oncologists of 160 institutions (57%) answered to the questionnaire. Although follow up is considered a distinct oncological activity in 68%, a fully shared organization between specialists is not common and communications with Primary Care Physicians are not structured in the majority of the cases. Fifty-five and 30% of the oncologists follow breast and colorectal cancer patients indefinitely. In case of discharge a survivorship care plan is delivered in only 9%. The majority of respondents do not hold a role of follow up in mortality reduction. Conclusions: Although survivorship care represents a significant part of the oncologists' workload, an "oncology-centered" model is largely adopted and established care pathways are still incomplete. Survivorship care needs to be put at the center of an educational policy and of a widespread organizational effort, directed at improving appropriateness and quality.	[Numico, Gianmauro] Azienda USL Valle Aosta, Med Oncol Unit, Aosta, Italy; [Pinto, Carmine] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy; [Gori, Stefania] Sacro Cuore Don Calabria Hosp, Verona, Italy; [Ucci, Giovanni] Azienda Osped Lodi, Dept Oncol, Lodi, Italy; [Di Maio, Massimo] Natl Canc Inst G Pascale Fdn, Clin Trial Unit, Naples, Italy; [Cancian, Maurizio] SIMG, Conegliano, Italy; [De Lorenzo, Francesco] FAVO, Rome, Italy; [Silvestris, Nicola] Natl Canc Res Ctr Giovanni Paolo II, Med Oncol Unit, Bari, Italy	Azienda USL della Valle d'Aosta; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Sacro Cuore Don Calabria; IRCCS Fondazione Pascale; IRCCS Istituto Tumori Bari Giovanni Paolo II	Numico, G (corresponding author), Azienda USL Valle Aosta, Med Oncol Unit, Aosta, Italy.	gnumico@ausl.vda.it	Numico, Gianmauro/AAE-4489-2020; GORI, Stefania/N-8827-2016; Silvestris, Nicola/K-5889-2012; DI MAIO, Massimo/AAB-6074-2019; Di Maio, Massimo/K-9990-2016; Pinto, Carmine/AAC-2184-2020; GORI, Stefania/AAB-4802-2022	Numico, Gianmauro/0000-0003-3253-2960; GORI, Stefania/0000-0001-6320-405X; Silvestris, Nicola/0000-0001-7814-7318; DI MAIO, Massimo/0000-0001-8906-3785; Di Maio, Massimo/0000-0001-8906-3785; Pinto, Carmine/0000-0002-3159-5268; GORI, Stefania/0000-0001-6320-405X				Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Beaver K, 2009, BMJ-BRIT MED J, V338, P1; Bunnell CA, 2010, ONCOLOGY-NY, V24, P1343; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Debono D, 2010, J ONCOL PRACT, V6, P203, DOI 10.1200/JOP.777005; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Earle CC, 2006, J CLIN ONCOL, V24, P5112, DOI 10.1200/JCO.2006.06.5284; Erikson C, 2007, J ONCOL PRACT, V3, P79, DOI 10.1200/JOP.0723601; Fasola G, 2012, J ONCOL PRACT, V8, P13, DOI 10.1200/JOP.2011.000326; Ganz PA, 2008, J CLIN ONCOL, V26, P759, DOI 10.1200/JCO.2007.14.2851; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Grunfeld E, 2006, J CLIN ONCOL, V24, P848, DOI 10.1200/JCO.2005.03.2235; Grunfeld E, 1996, BMJ-BRIT MED J, V313, P665; Grunfeld E, 2006, J CLIN ONCOL, V24, P5166, DOI 10.1200/JCO.2006.06.5953; Grunfeld E, 2011, J CLIN ONCOL, V29, P4755, DOI 10.1200/JCO.2011.36.8373; Grunfeld Eva, 2010, Journal of the National Cancer Institute Monographs, P25, DOI 10.1093/jncimonographs/lgq002; Grunfeld E, 2010, J ONCOL PRACT, V6, P174, DOI 10.1200/JOP.200009; Gulliford T, 1997, BRIT MED J, V314, P171; Harrison SE, 2011, J CLIN ONCOL, V29, P2091, DOI 10.1200/JCO.2010.32.5167; Institute of Medicine, 2005, CANC PATIENT CANC SU; Jacobs HJM, 2001, ANN ONCOL, V12, P1107, DOI 10.1023/A:1011624829512; Jacobs LA, 2009, CA-CANCER J CLIN, V59, P391, DOI 10.3322/caac.20040; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Oeffinger KC, 2006, J CLIN ONCOL, V24, P5117, DOI 10.1200/JCO.2006.07.0474; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; Smith TJ, 2011, J CLIN ONCOL, V29, P4740, DOI 10.1200/JCO.2011.38.8397; Turner RM, 2011, J CLIN ONCOL, V29, P4641, DOI 10.1200/JCO.2010.34.2956; Virgo KS, 2013, J CLIN ONCOL, V31, P2322, DOI 10.1200/JCO.2012.45.6954; Wattchow DA, 2006, BRIT J CANCER, V94, P1116, DOI 10.1038/sj.bjc.6603052; Wheeler T, 1999, CLIN ONCOL-UK, V11, P169, DOI 10.1053/clon.1999.9035	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101170	10.1371/journal.pone.0101170	http://dx.doi.org/10.1371/journal.pone.0101170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983237	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000063
J	Neuman, Y; Marwan, N; Cohen, Y				Neuman, Yair; Marwan, Norbert; Cohen, Yohai			Change in the Embedding Dimension as an Indicator of an Approaching Transition	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; SYSTEMS; CLIMATE	Predicting a transition point in behavioral data should take into account the complexity of the signal being influenced by contextual factors. In this paper, we propose to analyze changes in the embedding dimension as contextual information indicating a proceeding transitive point, called OPtimal Embedding tRANsition Detection (OPERAND). Three texts were processed and translated to time-series of emotional polarity. It was found that changes in the embedding dimension proceeded transition points in the data. These preliminary results encourage further research into changes in the embedding dimension as generic markers of an approaching transition point.	[Neuman, Yair] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Marwan, Norbert] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Cohen, Yohai] Gilasio Coding, Tel Aviv, Israel	Ben Gurion University; Potsdam Institut fur Klimafolgenforschung	Neuman, Y (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	yneuman@bgu.ac.il	Marwan, Norbert/D-9576-2011	Marwan, Norbert/0000-0003-1437-7039	Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS) [03IS2191B]	Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS)	Part of this work has been supported by the Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS, support code 03IS2191B; http://www.earth-in-progress.de/). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bateson Gregory, 2000, STEPS ECOLOGY MIND; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Donner RV, 2011, EUR PHYS J B, V84, P653, DOI 10.1140/epjb/e2011-10899-1; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Lagi Marco, 2011, FOOD CRISES POLITICA; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Neuman Y, 2011, COMPLEXITY, V16, P58, DOI 10.1002/cplx.20347; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Roth D., 1998, 17 INT C COMP LING, P1136; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sinclair Upton, 1906, JUNGLE; Slater D, 2013, EARLY WARNING SIGNAL; Turney PD, 2003, ACM T INFORM SYST, V21, P315, DOI 10.1145/944012.944013	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101014	10.1371/journal.pone.0101014	http://dx.doi.org/10.1371/journal.pone.0101014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979691	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400063
J	Shimizu, M; Iwano, S; Uno, Y; Uehara, S; Inoue, T; Murayama, N; Onodera, J; Sasaki, E; Yamazaki, H				Shimizu, Makiko; Iwano, Shunsuke; Uno, Yasuhiro; Uehara, Shotaro; Inoue, Takashi; Murayama, Norie; Onodera, Jun; Sasaki, Erika; Yamazaki, Hiroshi			Qualitative De Novo Analysis of Full Length cDNA and Quantitative Analysis of Gene Expression for Common Marmoset (Callithrix jacchus) Transcriptomes Using Parallel Long-Read Technology and Short-Read Sequencing	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; DRUG-METABOLISM SYSTEMS-2009; FLX TITANIUM PLATFORM; HUMAN CYTOCHROME-P450; CYNOMOLGUS MONKEYS; LIVER-MICROSOMES; ANIMAL-MODEL; RNA-SEQ; BIOMEDICAL-RESEARCH; ENZYMATIC FUNCTIONS	The common marmoset (Callithrix jacchus) is a non-human primate that could prove useful as human pharmacokinetic and biomedical research models. The cytochromes P450 (P450s) are a superfamily of enzymes that have critical roles in drug metabolism and disposition via monooxygenation of a broad range of xenobiotics; however, information on some marmoset P450s is currently limited. Therefore, identification and quantitative analysis of tissue-specific mRNA transcripts, including those of P450s and flavin-containing monooxygenases (FMO, another monooxygenase family), need to be carried out in detail before the marmoset can be used as an animal model in drug development. De novo assembly and expression analysis of marmoset transcripts were conducted with pooled liver, intestine, kidney, and brain samples from three male and three female marmosets. After unique sequences were automatically aligned by assembling software, the mean contig length was 718 bp (with a standard deviation of 457 bp) among a total of 47,883 transcripts. Approximately 30% of the total transcripts were matched to known marmoset sequences. Gene expression in 18 marmoset P450- and 4 FMO-like genes displayed some tissue-specific patterns. Of these, the three most highly expressed in marmoset liver were P450 2D-, 2E-, and 3A-like genes. In extrahepatic tissues, including brain, gene expressions of these monooxygenases were lower than those in liver, although P450 3A4 (previously P450 3A21) in intestine and P450 4A11- and FMO1-like genes in kidney were relatively highly expressed. By means of massive parallel long-read sequencing and short-read technology applied to marmoset liver, intestine, kidney, and brain, the combined next-generation sequencing analyses reported here were able to identify novel marmoset drug-metabolizing P450 transcripts that have until now been little reported. These results provide a foundation for mechanistic studies and pave the way for the use of marmosets as model animals for drug development in the future.	[Shimizu, Makiko; Iwano, Shunsuke; Uehara, Shotaro; Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan; [Iwano, Shunsuke] Novartis Pharma KK, Tokyo, Japan; [Uno, Yasuhiro] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Wakayama, Japan; [Inoue, Takashi; Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki, Kanagawa, Japan; [Onodera, Jun] Eurofins Genom, Ohta Ku, Tokyo, Japan; [Sasaki, Erika] Keio Univ, Adv Res Ctr, Tokyo, Japan	Showa Pharmaceutical University; Novartis; Shin Nippon Biomedical Laboratories Ltd.; Keio University	Yamazaki, H (corresponding author), Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Inoue, Takashi/0000-0003-4691-7255; Uno, Yasuhiro/0000-0001-9040-1681; Shimizu, Makiko/0000-0002-2508-4031; Uehara, Shotaro/0000-0002-1359-8828	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research and Strategic Research Program for Brain Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, COMPARATIVE MED, V53, P339; Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; Garzon-Martinez GA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-151; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; Guengerich FP, 2010, CURR DRUG METAB, V11, P1; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hagenbuch B, 2010, CLIN PHARMACOL THER, V87, P39, DOI 10.1038/clpt.2009.235; Hichiya H, 2004, BIOCHEM PHARMACOL, V68, P165, DOI 10.1016/j.bcp.2004.03.018; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Iwasaki K, 2010, DRUG METAB PHARMACOK, V25, P388, DOI 10.2133/dmpk.DMPK-10-NT-022; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Liyou NE, 2003, J HISTOCHEM CYTOCHEM, V51, P1655, DOI 10.1177/002215540305101209; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mayumi K, 2013, BIOCHEM PHARMACOL, V85, P1182, DOI 10.1016/j.bcp.2013.01.024; MERKER HJ, 1988, ARCH TOXICOL, V61, P165, DOI 10.1007/BF00316631; Nakanishi Y, 2010, DRUG METAB PHARMACOK, V25, P290, DOI 10.2133/dmpk.25.290; Narimatsu S, 2005, CHEM-BIOL INTERACT, V152, P1, DOI 10.1016/j.cbi.2005.01.006; Narimatsu S, 2006, BIOCHEM PHARMACOL, V72, P1738, DOI 10.1016/j.bcp.2006.08.025; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Neubert R, 1999, NATURE, V400, P419, DOI 10.1038/22685; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Niwa T, 2011, CURR DRUG METAB, V12, P549; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; POSWILLO DE, 1972, NATURE, V239, P460, DOI 10.1038/239460a0; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Rendic S, 2010, CURR DRUG METAB, V11, P4, DOI 10.2174/138920010791110917; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHIMADA T, 1992, MOL PHARMACOL, V41, P856; Smith D, 2001, LAB ANIM-UK, V35, P117, DOI 10.1258/0023677011911444; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Strittmatter AW, 2011, BIOSPEKTRUM, V17, P434; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tatsumoto S, 2013, DNA RES, V20, P255, DOI 10.1093/dnares/dst007; Tokuno H, 2012, EXP ANIM TOKYO, V61, P389, DOI 10.1538/expanim.61.389; Uehara S, 2011, J PHARMACOL EXP THER, V339, P654, DOI 10.1124/jpet.111.185009; Uno Y, 2007, ARCH BIOCHEM BIOPHYS, V466, P98, DOI 10.1016/j.abb.2007.07.003; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2013, BIOCHEM PHARMACOL, V85, P1837, DOI 10.1016/j.bcp.2013.04.012; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; YAMAZAKI H, 1995, CARCINOGENESIS, V16, P2167, DOI 10.1093/carcin/16.9.2167; Yamazaki H, 2013, BIOCHEM PHARMACOL, V85, P1588, DOI 10.1016/j.bcp.2013.03.020; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-565	62	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100936	10.1371/journal.pone.0100936	http://dx.doi.org/10.1371/journal.pone.0100936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977701	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400054
J	Ma, ZW; Wang, WY; Wu, Y; He, YM; Wu, TH				Ma, Zhanwei; Wang, Wenyan; Wu, Ying; He, Yiming; Wu, Tinghua			Oxidative Degradation of Chitosan to the Low Molecular Water-Soluble Chitosan over Peroxotungstate as Chemical Scissors	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; AQUEOUS-SOLUTIONS; ALLYLIC ALCOHOLS; DINUCLEAR PEROXOTUNGSTATE; HETEROGENEOUS DEGRADATION; CATALYTIC-OXIDATION; EPOXIDATION; OLEFINS; GLUCOSAMINE; DERIVATIVES	Low molecular water-soluble chitosan was prepared by the depolymerization of chitosan in the presence of a series of catalysts with active W(O-2) sites. Both the peroxo species [W2O3(O-2)(4)](2-) and {PO4[WO(O-2)(2)](4)}(3-) showed high efficiency in the degradation of chitosan, indicating that the degradation mechanism did not follow the radical mechanism. That means center dot OH is not the active species, which has been proven by the fluorescence spectra. H2O2 acted as an oxidant to regenerate the active W(O-2) sites in the depolymerization of chitosan. The developed catalyst (TBA)(3){PO4[WO(O-2)(2)](4)} is recoverable.	[Ma, Zhanwei; Wang, Wenyan; Wu, Ying; Wu, Tinghua] Zhejiang Normal Univ, Inst Phys Chem, Minist Educ Adv Catalysis Mat, Key Lab, Jinhua, Peoples R China; [He, Yiming] Zhejiang Normal Univ, Dept Mat Phys, Jinhua, Peoples R China	Zhejiang Normal University; Zhejiang Normal University	Wu, Y (corresponding author), Zhejiang Normal Univ, Inst Phys Chem, Minist Educ Adv Catalysis Mat, Key Lab, Jinhua, Peoples R China.	yingwu@zjnu.cn; thwu@zjnu.cn	He, Yiming/Q-2987-2017	He, Yiming/0000-0002-1919-0719	Nature Science Foundation of China [21373188]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by grants from Nature Science Foundation of China (21373188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBRY C, 1991, INORG CHEM, V30, P4409, DOI 10.1021/ic00023a024; Boddu VM, 2008, SEP SCI TECHNOL, V43, P1365, DOI 10.1080/01496390801940762; Bregeault JM, 2003, DALTON T, P3289, DOI 10.1039/b303073n; Buonomenna MG, 2008, APPL CATAL B-ENVIRON, V79, P35, DOI 10.1016/j.apcatb.2007.10.003; CAMPBELL NJ, 1989, J CHEM SOC DALTON, P1203, DOI 10.1039/dt9890001203; Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]; DUNCAN DC, 1995, J AM CHEM SOC, V117, P681, DOI 10.1021/ja00107a012; Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1; Gallezot P, 2012, CHEM SOC REV, V41, P1538, DOI 10.1039/c1cs15147a; HOROWITZ ST, 1957, J AM CHEM SOC, V79, P5046, DOI 10.1021/ja01575a059; Hou SY, 2006, EUR J INORG CHEM, P1670, DOI 10.1002/ejic.200501008; Huang QZ, 2008, CARBOHYD POLYM, V72, P500, DOI 10.1016/j.carbpol.2007.09.022; Huang QZ, 2007, CARBOHYD POLYM, V68, P761, DOI 10.1016/j.carbpol.2006.08.015; Huang QZ, 2010, CARBOHYD RES, V345, P115, DOI 10.1016/j.carres.2009.09.027; Ishibashi K, 2000, J PHOTOCH PHOTOBIO A, V134, P139, DOI 10.1016/S1010-6030(00)00264-1; ISHII Y, 1988, J ORG CHEM, V53, P3587, DOI 10.1021/jo00250a032; Kamata K, 2004, CHEM-EUR J, V10, P4728, DOI 10.1002/chem.200400352; Kamata K, 2009, J AM CHEM SOC, V131, P6997, DOI 10.1021/ja901289r; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; KURITA K, 1977, MAKROMOL CHEM, V178, P3197; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Makuuchi K, 2010, RADIAT PHYS CHEM, V79, P267, DOI 10.1016/j.radphyschem.2009.10.011; Mizuno N, 2005, COORDIN CHEM REV, V249, P1944, DOI 10.1016/j.ccr.2004.11.019; Ngah WSW, 2006, ADSORPTION, V12, P249, DOI 10.1007/s10450-006-0501-0; Nge KL, 2006, PLANT SCI, V170, P1185, DOI 10.1016/j.plantsci.2006.02.006; Hien NQ, 2012, CARBOHYD POLYM, V87, P935, DOI 10.1016/j.carbpol.2011.08.018; No HK, 2007, J FOOD SCI, V72, pR87, DOI 10.1111/j.1750-3841.2007.00383.x; POSPIESZNY H, 1991, PLANT SCI, V79, P63, DOI 10.1016/0168-9452(91)90070-O; SAITO H, 1987, MACROMOLECULES, V20, P2424, DOI 10.1021/ma00176a017; Schnepp Z, 2013, ANGEW CHEM INT EDIT, V52, P1096, DOI 10.1002/anie.201206943; Swayampakula K, 2009, J HAZARD MATER, V170, P680, DOI 10.1016/j.jhazmat.2009.05.106; Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0; Wang SM, 2005, CARBOHYD RES, V340, P1143, DOI 10.1016/j.carres.2005.02.009; Yin H, 2009, CURR TOP MED CHEM, V9, P1546, DOI 10.2174/156802609789909795; Zhang BY, 2012, J CATAL, V287, P5, DOI 10.1016/j.jcat.2011.11.003	36	47	49	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100743	10.1371/journal.pone.0100743	http://dx.doi.org/10.1371/journal.pone.0100743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971631	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200056
J	Baccelli, I; Lombardi, L; Luti, S; Bernardi, R; Picciarelli, P; Scala, A; Pazzagli, L				Baccelli, Ivan; Lombardi, Lara; Luti, Simone; Bernardi, Rodolfo; Picciarelli, Piero; Scala, Aniello; Pazzagli, Luigia			Cerato-Platanin Induces Resistance in Arabidopsis Leaves through Stomatal Perception, Overexpression of Salicylic Acid- and Ethylene-Signalling Genes and Camalexin Biosynthesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; DEFENSE RESPONSES; PHYTOALEXIN BIOSYNTHESIS; PHYTOTOXIC PROTEIN; INNATE IMMUNITY; FAMILY PROTEIN; EXPRESSION; JASMONATE; STRESS	Microbe-associated molecular patterns (MAMPs) lead to the activation of the first line of plant defence. Few fungal molecules are universally qualified as MAMPs, and proteins belonging to the cerato-platanin protein (CPP) family seem to possess these features. Cerato-platanin (CP) is the name-giving protein of the CPP family and is produced by Ceratocystis platani, the causal agent of the canker stain disease of plane trees (Platanus spp.). On plane tree leaves, the biological activity of CP has been widely studied. Once applied on the leaf surface, CP acts as an elicitor of defence responses. The molecular mechanism by which CP elicits leaves is still unknown, and the protective effect of CP against virulent pathogens has not been clearly demonstrated. In the present study, we tried to address these questions in the model plant Arabidopsis thaliana. Our results suggest that stomata rapidly sense CP since they responded to the treatment with ROS signalling and stomatal closure, and that CP triggers salicylic acid (SA)- and ethylene (ET)-signalling pathways, but not the jasmonic acid (JA)-signalling pathway, as revealed by the expression pattern of 20 marker genes. Among these, EDS1, PAD4, NPR1, GRX480, WRKY70, ACS6, ERF1a/b, COI1, MYC2, PDF1.2a and the pathogenesis-related (PR) genes 1-5. CP rapidly induced MAPK phosphorylation and induced the biosynthesis of camalexin within 12 hours following treatment. The induction of localised resistance was shown by a reduced susceptibility of the leaves to the infection with Botrytis cinerea and Pseudomonas syringae pv. tomato. These results contribute to elucidate the key steps of the signalling process underlying the resistance induction in plants by CP and point out the central role played by the stomata in this process.	[Baccelli, Ivan; Scala, Aniello] Univ Florence, Dept Agri Food Prod & Environm Sci, Florence, Italy; [Lombardi, Lara] Univ Pisa, Dept Biol, Pisa, Italy; [Luti, Simone; Pazzagli, Luigia] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Bernardi, Rodolfo; Picciarelli, Piero] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	University of Florence; University of Pisa; University of Florence; University of Pisa	Baccelli, I (corresponding author), Univ Florence, Dept Agri Food Prod & Environm Sci, Florence, Italy.	ivan.baccelli@unifi.it	Baccelli, Ivan/GLS-8786-2022; Picciarelli, Piero/F-9698-2014	Baccelli, Ivan/0000-0002-1368-1250; Picciarelli, Piero/0000-0002-2372-0620; Luti, Simone/0000-0001-7050-6590	Ministero Italiano dell'Universita e della Ricerca Scientifica	Ministero Italiano dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero Italiano dell'Universita e della Ricerca Scientifica, Progetti di Ricerca di Interesse Nazionale (PRIN) 2009 (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Baccelli I, 2013, BIOL PLANTARUM, V57, P571, DOI 10.1007/s10535-013-0308-2; Baccelli I, 2014, APPL MICROBIOL BIOT, V98, P175, DOI 10.1007/s00253-013-4822-0; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Beets C, 2011, ANAL BIOCHEM, V419, P260, DOI 10.1016/j.ab.2011.08.031; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Cettul E, 2008, MOL PLANT PATHOL, V9, P675, DOI 10.1111/J.1364-3703.2008.00492.X; Chen HX, 2013, MYCOLOGIA, V105, P1479, DOI 10.3852/13-115; Comparini C, 2009, APPL MICROBIOL BIOT, V84, P309, DOI 10.1007/s00253-009-1998-4; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Fontana F, 2008, J PLANT PATHOL, V90, P295; Frias M, 2013, MOL PLANT P IN PRESS, DOI 10.1111/mpp.12097; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Frias M, 2011, NEW PHYTOL, V192, P483, DOI 10.1111/j.1469-8137.2011.03802.x; Frischmann A, 2013, J BIOL CHEM, V288, P4278, DOI 10.1074/jbc.M112.427633; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kumar MN, 2013, PLANT PHYSIOL, V161, P942, DOI 10.1104/pp.112.209791; Lake JA, 2002, J EXP BOT, V53, P183, DOI 10.1093/jexbot/53.367.183; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi L, 2013, PHYSIOL PLANTARUM, V149, P408, DOI 10.1111/ppl.12041; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Martellini F, 2013, MOL BIOTECHNOL, V55, P27, DOI 10.1007/s12033-012-9618-4; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2014, PLANT SCI IN PRESS; Pazzagli L, 2009, BBA-GEN SUBJECTS, V1790, P1334, DOI 10.1016/j.bbagen.2009.07.014; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Scala A, 2004, J PLANT PATHOL, V86, P27; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x	62	33	34	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100959	10.1371/journal.pone.0100959	http://dx.doi.org/10.1371/journal.pone.0100959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968226	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800091
J	Mundy, ME; Downing, PE; Honey, RC; Singh, KD; Graham, KS; Dwyer, DM				Mundy, Matthew E.; Downing, Paul E.; Honey, Robert C.; Singh, Krish D.; Graham, Kim S.; Dwyer, Dominic M.			Brain Correlates of Experience-Dependent Changes in Stimulus Discrimination Based on the Amount and Schedule of Exposure	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL MECHANISMS; AREAS; ATTENTION; ROBUST; OPTIMIZATION; REGISTRATION; ACTIVATIONS; PREEXPOSURE; SPECIFICITY	One product of simple exposure to similar visual stimuli is that they become easier to distinguish. The early visual cortex and other brain areas (such as the prefrontal cortex) have been implicated in such perceptual learning effects, but the anatomical specificity within visual cortex and the relationship between sensory cortex and other brain areas has yet to be examined. Moreover, while variations in the schedule (rather than merely the amount) of exposure influence experience-dependent improvement in discrimination, the neural sequelae of exposure schedule have not been fully investigated. In an event-related fMRI study, participants were exposed to confusable pairs of faces, scenes and dot patterns, using either intermixed or blocked presentation schedules. Participants then performed same/different judgements with exposed and novel pairs of stimuli. Stimulus independent activation, which was correlated with experience-dependent improvement in discrimination, was seen in frontal areas (e.g. frontal and supplementary eye fields and dorsolateral prefrontal cortex) and in early visual cortex (V1-4). In all regions, the difference in activation between exposed and novel stimuli decreased as a function of the degree of discrimination improvement. Overall levels of BOLD activation differed across regions, consistent with the possibility that, as a consequence of experience, processing shifts from initial engagement of early visual regions to higher order visual areas. Similar relationships were observed when contrasting intermixed with blocked exposure, suggesting that the schedule of exposure primarily influences the degree of, rather than the mechanisms for, discrimination performance.	[Mundy, Matthew E.; Graham, Kim S.] Cardiff Univ, Sch Psychol, WICN, Cardiff CF10 3AX, S Glam, Wales; [Downing, Paul E.] Bangor Univ, Sch Psychol, WICN, Bangor, Gwynedd, Wales; [Honey, Robert C.; Dwyer, Dominic M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Singh, Krish D.] Cardiff Univ, Cardiff Univ Brain Imaging Res Ctr CUBRIC, Cardiff CF10 3AX, S Glam, Wales; [Mundy, Matthew E.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Dwyer, Dominic M.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Cardiff University; Bangor University; Cardiff University; Cardiff University; Monash University; University of New South Wales Sydney	Mundy, ME (corresponding author), Cardiff Univ, Sch Psychol, WICN, Cardiff CF10 3AX, S Glam, Wales.	Matthew.Mundy@monash.edu	Singh, Krish/D-1066-2009; Dwyer, Dominic Michael/D-1498-2009	Dwyer, Dominic Michael/0000-0001-8069-5508; Mundy, Matthew/0000-0002-7073-0047; Downing, Paul/0000-0002-5046-2858; Singh, Krishna/0000-0002-3094-2475; Graham, Kim/0000-0002-1512-7667	BBSRC Grant [BB/I007091/1]; Wales Institute of Cognitive Neuroscience via Welsh Government; BBSRC [BB/I007091/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007091/1] Funding Source: researchfish	BBSRC Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wales Institute of Cognitive Neuroscience via Welsh Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by BBSRC Grant (BB/I007091/1) and the Wales Institute of Cognitive Neuroscience, which was established via a grant from the Welsh Government to the Schools of Psychology at Cardiff, Bangor and Swansea Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2002, PERCEPTUAL LEARNING, P253; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dubois S, 1999, NEUROIMAGE, V9, P278, DOI 10.1006/nimg.1998.0409; Dwyer DM, 2004, Q J EXP PSYCHOL-B, V57, P245, DOI 10.1080/02724990344000114; Dwyer DM, WILEY BLACK IN PRESS; Dwyer DM, 2011, J EXP PSYCHOL ANIM B, V37, P300, DOI 10.1037/a0023078; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gaffan D, 1996, COGNITIVE BRAIN RES, V5, P69, DOI 10.1016/S0926-6410(96)00042-0; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hall G, 2003, Q J EXP PSYCHOL-B, V56, P43, DOI 10.1080/02724990244000151; Hall G., 1991, PERCEPTUAL ASS LEARN; Honey RC, 1996, Q J EXP PSYCHOL-B, V49, P259; HONEY RC, 1994, Q J EXP PSYCHOL-B, V47, P83; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ibbotson MR, 2005, FITTING MIND WORLD A; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lavis Y, 2006, Q J EXP PSYCHOL, V59, P2083, DOI 10.1080/17470210600705198; McGovern DP, 2012, J VISION, V12, DOI 10.1167/12.11.4; McGovern DP, 2012, J NEUROSCI, V32, P13621, DOI 10.1523/JNEUROSCI.1363-12.2012; McLaren I.P.L., 1989, PARALLEL DISTRIBUTED, P102; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell C, 2014, PSYCHOL BULL, V140, P283, DOI 10.1037/a0032765; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Mundy ME, 2007, J EXP PSYCHOL ANIM B, V33, P124, DOI 10.1037/0097-7403.33.2.124; Mundy ME, 2013, J NEUROSCI, V33, P10490, DOI 10.1523/JNEUROSCI.2958-12.2013; Mundy ME, 2009, Q J EXP PSYCHOL, V62, P18, DOI 10.1080/17470210802240614; Mundy ME, 2009, NEUROREPORT, V20, P1397, DOI 10.1097/WNR.0b013e32832f81f4; Mundy ME, 2006, J EXP PSYCHOL ANIM B, V32, P178, DOI 10.1037/0097-7403.32.2.178; Peelen MV, 2005, HUM BRAIN MAPP, V25, P402, DOI 10.1002/hbm.20116; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 1998, J NEUROSCI, V18, P3816; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SYMONDS M, 1995, LEARN MOTIV, V26, P203, DOI 10.1016/0023-9690(95)90005-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	59	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101011	10.1371/journal.pone.0101011	http://dx.doi.org/10.1371/journal.pone.0101011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967903	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000338280800098
J	Woldehawariat, G; Martinez, PE; Hauser, P; Hoover, DM; Drevets, WWC; McMahon, FJ				Woldehawariat, Girma; Martinez, Pedro E.; Hauser, Peter; Hoover, David M.; Drevets, Wayne W. C.; McMahon, Francis J.			Corpus Callosum Size Is Highly Heritable in Humans, and May Reflect Distinct Genetic Influences on Ventral and Rostral Regions	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; BIPOLAR AFFECTIVE-DISORDER; HUMAN BRAIN; MOOD DISORDERS; INTERHEMISPHERIC COMMUNICATION; SCHIZOPHRENIA; TWINS; SPECIALIZATION; PERSPECTIVES; NEUROANATOMY	Anatomical differences in the corpus callosum have been found in various psychiatric disorders, but data on the genetic contributions to these differences have been limited. The current study used morphometric MRI data to assess the heritability of corpus callosum size and the genetic correlations among anatomical sub-regions of the corpus callosum among individuals with and without mood disorders. The corpus callosum (CC) was manually segmented at the mid-sagittal plane in 42 women (healthy, n = 14; major depressive disorder, n = 15; bipolar disorder, n = 13) and their 86 child or adolescent offspring. Four anatomical sub-regions (CC-genu, CC2, CC3 and CC-splenium) and total CC were measured and analyzed. Heritability and genetic correlations were estimated using a variance components method, with adjustment for age, sex, diagnosis, and diagnosis x age, where appropriate. Significant heritability was found for several CC sub-regions (P < 0.01), with estimated values ranging from 48% (splenium) to 67% (total CC). There were strong and significant genetic correlations among most sub regions. Correlations between the genu and mid-body, between the genu and total corpus callosum, and between anterior and mid body were all > 90%, but no significant genetic correlations were detected between ventral and rostral regions in this sample. Genetic factors play an important role in corpus callosum size among individuals. Distinct genetic factors seem to be involved in caudal and rostral regions, consistent with the divergent functional specialization of these brain areas.	[Woldehawariat, Girma; McMahon, Francis J.] NIMH, Genet Basis Mood & Anxiety Disorders Sect, Human Genet Branch, NIH,DHHS, Bethesda, MD 20892 USA; [Martinez, Pedro E.] NIMH, Sect Behav Endocrinol, NIH, DHHS, Bethesda, MD 20892 USA; [Hauser, Peter] VISN 22 Network Off, Long Beach, CA USA; [Hoover, David M.] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Drevets, Wayne W. C.] Laureate Inst Brain Res, Tulsa, OK USA; [Drevets, Wayne W. C.] Univ Oklahoma, Coll Med, Tulsa, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa	Woldehawariat, G (corresponding author), NIMH, Genet Basis Mood & Anxiety Disorders Sect, Human Genet Branch, NIH,DHHS, Bethesda, MD 20892 USA.	hawariag@mail.nih.gov	McMahon, Francis J/A-7290-2009	McMahon, Francis J/0000-0002-9469-305X	National Institutes of Mental Health (NIMH) of the US government; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002810] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH) of the US government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is funded by National Institutes of Mental Health (NIMH) of the US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ALMASY L, 2009, GENETICS COMPLEX HUM, P37; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Bachmann S, 2003, PSYCHOL MED, V33, P1019, DOI 10.1017/S0033291703008043; Badea A, 2009, NEUROIMAGE, V45, P1067, DOI 10.1016/j.neuroimage.2009.01.021; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Brambilla P, 2004, EPIDEMIOL PSICHIAT S, V11, P88; Brambilla Paolo, 2002, Epidemiol Psichiatr Soc, V11, P88; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Carmelli D, 2002, BIOL PSYCHOL, V61, P139, DOI 10.1016/S0301-0511(02)00056-X; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; Comuzzie AG, 1997, ARTERIOSCL THROM VAS, V17, P859, DOI 10.1161/01.ATV.17.5.859; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Evans AE, 2012, MOL REGULATION STRIA, V2012; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fears SC, 2014, JAMA PSYCHIAT, V71, P375, DOI 10.1001/jamapsychiatry.2013.4100; Frazier JA, 2007, BIPOLAR DISORD, V9, P799, DOI 10.1111/j.1399-5618.2007.00482.x; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Hamer RM, 2006, COMPUTE 6 INTERCLASS; HAUSER P, 1989, BIOL PSYCHIAT, V26, P659, DOI 10.1016/0006-3223(89)90100-5; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hulshoff-Pol HE, 2006, J NEUROSCI, V26, P10235, DOI 10.1523/JNEUROSCI.1312-06.2006; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Kochunov P, 2010, NEUROIMAGE, V53, P1116; Kochunov P, 2011, HYPERTENSION, V57, P330, DOI 10.1161/HYPERTENSIONAHA.110.162206; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Lopez-Larson M, 2010, BRAIN IMAGING BEHAV, V4, P220, DOI 10.1007/s11682-010-9101-4; Lyoo IK, 2002, BIOL PSYCHIAT, V52, P1134, DOI 10.1016/S0006-3223(02)01436-1; Martinez P, 2002, SOC NEUROSCI; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Phillips KA, 2012, TWIN RES HUM GENET, V15, P315, DOI 10.1017/thg.2012.10; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; RADKEYARROW M, 1992, J AM ACAD CHILD PSY, V31, P68, DOI 10.1097/00004583-199201000-00011; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; Scamvougeras A, 2003, NEUROSCI LETT, V338, P91, DOI 10.1016/S0304-3940(02)01333-2; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Soares JC, 1997, J PSYCHIATR RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Strenziok M, 2013, DIFFERENTIAL CONTRIB, V8, P2; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Todd RD, 2002, CHILD ADOL PSYCH CL, V11, P499, DOI 10.1016/S1056-4993(02)00013-5; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Walterfang M, 2009, AUST NZ J PSYCHIAT, V43, P838, DOI 10.1080/00048670903107534; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99980	10.1371/journal.pone.0099980	http://dx.doi.org/10.1371/journal.pone.0099980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968245	Green Submitted, gold, Green Published			2022-12-25	WOS:000338280800022
J	Bourgeon, S; Leat, EHK; Magnusdottir, E; Furness, RW; Strom, H; Petersen, A; Gabrielsen, GW; Hanssen, SA; Bustnes, JO				Bourgeon, Sophie; Leat, Eliza H. K.; Magnusdottir, Ellen; Furness, Robert W.; Strom, Hallvard; Petersen, Aevar; Gabrielsen, Geir W.; Hanssen, Sveinn Are; Bustnes, Jan Ove			Feather Corticosterone Levels on Wintering Grounds Have No Carry-Over Effects on Breeding among Three Populations of Great Skuas (Stercorarius skua)	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; BLACK-LEGGED KITTIWAKES; INDIVIDUAL VARIATION; STABLE-ISOTOPES; MIGRATORY BIRD; SEABIRD; QUALITY; GEOLOCATION; SPARROWS; DYNAMICS	Environmental conditions encountered by migratory seabirds in their wintering areas can shape their fitness. However, the underlying physiological mechanisms remain largely unknown as birds are relatively inaccessible during winter. To assess physiological condition during this period, we measured corticosterone concentrations in winter-grown primary feathers of female great skuas (Stercorarius skua) from three breeding colonies (Bjornoya, Iceland, Shetland) with wintering areas identified from characteristic stable isotope signatures. We subsequently compared winter feather corticosterone levels between three wintering areas (Africa, Europe and America). Among females breeding in 2009, we found significant differences in feather corticosterone levels between wintering areas. Surprisingly, levels were significantly higher in Africa despite seemingly better local ecological factors (based on lower foraging effort). Moreover, contrary to our predictions, females sharing the same wintering grounds showed significant differences in feather corticosterone levels depending on their colony of origin suggesting that some skuas could be using suboptimal wintering areas. Among females wintering in Africa, Shetland females showed feather corticosterone levels on average 22% lower than Bjornoya and Iceland females. Finally, the lack of significant relationships between winter feather corticosterone levels and any of the breeding phenology traits does not support the hypothesis of potential carry-over effects of winter feather corticosterone. Yet, the fitness consequences of elevated feather corticosterone levels remain to be determined.	[Bourgeon, Sophie; Hanssen, Sveinn Are; Bustnes, Jan Ove] Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway; [Bourgeon, Sophie; Strom, Hallvard; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Leat, Eliza H. K.; Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Magnusdottir, Ellen; Petersen, Aevar] Iceland Inst Nat Hist, Reykjavik, Iceland	Norwegian Institute Nature Research; Norwegian Polar Institute; University of Glasgow	Bourgeon, S (corresponding author), Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway.	sophie.bourgeon@npolar.no	Hanssen, Sveinn Are/C-9989-2009	Hanssen, Sveinn Are/0000-0003-1792-435X	Research Council of Norway [184830]	Research Council of Norway(Research Council of Norway)	This study was supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_ page/1177315753906), grant number 184830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2007, HORM BEHAV, V52, P482, DOI 10.1016/j.yhbeh.2007.07.003; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bourgeon S, 2013, ENVIRON SCI TECHNOL, V47, P5963, DOI 10.1021/es400442q; Bourgeon S, 2012, ENVIRON RES, V118, P31, DOI 10.1016/j.envres.2012.08.004; Carrete M, 2013, ANIM CONSERV, V16, P353, DOI 10.1111/acv.12001; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness R. W., 1987, SKUAS; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Kouwenberg AL, 2013, IBIS, V155, P413, DOI 10.1111/ibi.12030; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Leat EHK, 2013, MAR ECOL PROG SER, V491, P277, DOI 10.3354/meps10455; Lok T, 2011, ANIM BEHAV, V82, P837, DOI 10.1016/j.anbehav.2011.07.019; Magnusdottir E, 2012, THESIS U ICELAND; Magnusdottir E, 2012, BIRD STUDY, V59, P1; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; R Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Sedinger JS, 2011, AM NAT, V178, pE110, DOI 10.1086/662165; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Thompson DR, 1998, ENVIRON POLLUT, V101, P193, DOI 10.1016/S0269-7491(98)00078-5; WINGFIELD JC, 1983, AUK, V100, P56, DOI 10.1093/auk/100.1.56; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520	35	22	23	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100439	10.1371/journal.pone.0100439	http://dx.doi.org/10.1371/journal.pone.0100439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964085	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338709500051
J	Shin, YW; Jung, KH; Kim, JM; Cho, YD; Lee, ST; Chu, K; Kim, M; Lee, SK; Han, MH; Roh, JK				Shin, Yong-Won; Jung, Keun-Hwa; Kim, Jeong-Min; Cho, Young Dae; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Han, Moon Hee; Roh, Jae-Kyu			Echocardiographic Evidence of Innate Aortopathy in the Human Intracranial Aneurysm	PLOS ONE			English	Article							CERVICOCEPHALIC ARTERIAL DISSECTIONS; GENOME-WIDE ASSOCIATION; NEURAL CREST; RISK-FACTORS; DISEASE; CELLS; COARCTATION; POPULATION; PREVALENCE; VARIANT	Background: Intracranial aneurysm (IA) is significantly more prevalent in patients with coarctation of the aorta or bicuspid aortic valve than in the general population, suggesting a common pathophysiology connecting IA and aortopathy. Here, we analyzed echocardiographic aortic root dimension (ARD) in patients with IA to confirm this possibility. Methods: From January 2008 to December 2010, 260 consecutive patients with IA who were admitted to our institution for coil embolization or for acute stroke management and who also underwent echocardiography were enrolled. We hypothesized that patients with large, ruptured, or multiple IAs are more likely to harbor co-prevalent aortopathy as measured by ARD compared to patients with small, isolated, unruptured IAs. Eccentric group was defined as patients aged, <55 years with at least one ruptured aneurysm, an aneurysm >= 7 mm in size, or multiple aneurysms; the remainder was classified into a non-eccentric group. Clinical, angiographic, and echocardiographic findings of the two groups were compared. Results: ARD was significantly larger in the eccentric group than in the non-eccentric group (P = 0.049), and the difference was confirmed by multivariable analysis (P = 0.02). Subgroup analysis of patients aged <55 years showed similar result for ARD (P = 0.03), whereas hypertension was more associated with the non-eccentric group (P = 0.01). In addition, height was inversely related to aneurysm size after adjustment for age, sex, weight, ARD, smoking status, and number of aneurysms (P = 0.004). Conclusions: A certain group of IA patients share a common intrinsic wall defect with aortopathy. Shared neural crest cell origin may give rise to this phenomenon.	[Shin, Yong-Won; Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Dept Neurol, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea; [Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Program Neurosci, Neurosci Res Inst SNUMRC, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Coll Med, Dept Neurol, Med Ctr, Seoul 156756, South Korea; [Cho, Young Dae; Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Songnam, Gyeunggido, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea.	jungkh@gmail.com; stemcell.snu@gmail.com		Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005; Chu, Kon/0000-0001-5863-0302; Kim, Jeong-Min/0000-0001-7213-5527	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0421]; Seoul National University Hospital Research Fund [0420131120]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Seoul National University Hospital Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0421). Dr. Keun-Hwa Jung was supported by the Seoul National University Hospital Research Fund (0420131120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2258; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Campos C, 1998, INTERV NEURORADIOL, V4, P293, DOI 10.1177/159101999800400405; Casimiro MV, 2004, SURG NEUROL, V61, P541; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Connolly HM, 2003, MAYO CLIN PROC, V78, P1491, DOI 10.4065/78.12.1491; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Curtis SL, 2012, AM J NEURORADIOL, V33, P1182, DOI 10.3174/ajnr.A2915; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Etchevers HC, 2001, ENDOCRIN DEV, V4, P13; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee BC, 2006, AM J PREV MED, V31, pS243, DOI 10.1016/j.amepre.2006.08.019; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; NEHLS DG, 1985, J NEUROSURG, V63, P342, DOI 10.3171/jns.1985.63.3.0342; Nguyen TV, 2009, J STROKE CEREBROVASC, V18, P374, DOI 10.1016/j.jstrokecerebrovasdis.2008.12.004; NODEN DM, 1995, TRENDS CARDIOVAS MED, V5, P69, DOI 10.1016/S1050-1738(99)80002-4; Pasmant E, 2011, J NATL CANCER I, V103, P1713, DOI 10.1093/jnci/djr416; Pichiecchio A, 2002, NEUROLOGY, V59, P606, DOI 10.1212/WNL.59.4.606; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; RINNE J, 1994, NEUROSURGERY, V35, P803, DOI 10.1227/00006123-199411000-00001; ROSENQUIST TH, 1990, ANAT RECORD, V226, P347, DOI 10.1002/ar.1092260312; SCHIEVINK WI, 1995, STROKE, V26, P1935, DOI 10.1161/01.STR.26.10.1935; Schievink WI, 2005, AM J MED GENET A, V134A, P45, DOI 10.1002/ajmg.a.30475; Schievink WI, 1996, NEUROSURGERY, V39, P685, DOI 10.1097/00006123-199610000-00006; Schievink WI, 1996, NEUROSURGERY, V38, P1237, DOI 10.1097/00006123-199606000-00038; Schievink WI, 2010, NEUROLOGY, V74, P1430, DOI 10.1212/WNL.0b013e3181dc1acf; Southerland AM, 2013, CURR OPIN NEUROL, V26, P13, DOI 10.1097/WCO.0b013e32835c607f; VASAN RS, 1995, CIRCULATION, V91, P734, DOI 10.1161/01.CIR.91.3.734; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100569	10.1371/journal.pone.0100569	http://dx.doi.org/10.1371/journal.pone.0100569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964197	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500062
J	Visioli, F; Wang, YG; Alam, GN; Ning, Y; Rados, PV; Nor, JE; Polverini, PJ				Visioli, Fernanda; Wang, Yugang; Alam, Goleeta N.; Ning, Yu; Rados, Pantelis V.; Noer, Jacques E.; Polverini, Peter J.			Glucose-Regulated Protein 78 ( Grp78) Confers Chemoresistance to Tumor Endothelial Cells under Acidic Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; DRUG-RESISTANCE; P-GLYCOPROTEIN; NECK-CANCER; ER STRESS; IN-VIVO; APOPTOSIS; ACIDOSIS; ACTIVATION; DEATH	This study was designed to investigate the activation of the unfolded protein response (UPR) tumor associated endothelial cells (TECs) and its association with chemoresistance during acidic pH stress. Materials and Methods: Endothelial cells from human oral squamous cell carcinomas (OSCC) were excised by laser capture microdissection (LCM) followed by analysis of UPR markers (Grp78, ATF4 and CHOP) using quantitative PCR. Grp78 expression was also determined by immunostaining. Acidic stress was induced in primary human dermal microvascular endothelial cells (HDMECs) by treatment with conditioned medium (CM) from tumor cells grown under hypoxic conditions or by adjusting medium pH to 6.4 or 7.0 using lactic acid or hydrochloric acid (HCl). HDMEC resistance to the antiangiogenic drug Sunitinib was assessed with SRB assay. Results: UPR markers, Grp78, ATF4 and CHOP were significantly upregulated in TECs from OSCC compared to HDMECs. HDMECs cultured in acidic CM (pH 6.0-6.4) showed increased expression of the UPR markers. However, severe acidosis led to marked cell death in HDMECs. Alternatively, HDMECs were able to adapt when exposed to chronic acidosis at pH 7.0 for 7 days, with concomittant increase in Grp78 expression. Chronic acidosis also confers drug resistance to HDMECs against Sunitinib. Knockdown of Grp78 using shRNA resensitizes HDMECs to drug treatment. Conclusions: UPR induction in ECs under acidic pH conditions is related to chemoresistance and may contribute to therapeutic failures in response to chemotherapy. Targeting Grp78, the key component of the UPR pathway, may provide a promising approach to overcome ECs resistance in cancer therapy.	[Visioli, Fernanda; Wang, Yugang; Alam, Goleeta N.; Ning, Yu] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Visioli, Fernanda; Rados, Pantelis V.] Univ Fed Rio Grande do Sul, Sch Dent, Dept Conservat Dent, Porto Alegre, RS, Brazil; [Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Polverini, Peter J.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade Federal do Rio Grande do Sul; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Visioli, F (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	fernanda.visioli@ufrgs.br	Polverini, Peter/AAJ-8392-2020; Visioli, Fernanda/X-2368-2019; Rados, Pantelis/AAT-7032-2020; Nor, Jacques/AAJ-6139-2021; Rados, Pantelis/AAG-6643-2021; visioli, fernanda/G-4139-2012	Visioli, Fernanda/0000-0002-4033-8431; Nor, Jacques/0000-0002-4056-0235; Rados, Pantelis/0000-0001-9307-1980; visioli, fernanda/0000-0002-4033-8431	CAPES (Brazil); Sharon and Larry Daniels Cancer Biology Fellowship	CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sharon and Larry Daniels Cancer Biology Fellowship	This work was supported by CAPES (Brazil) and by Sharon and Larry Daniels Cancer Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Becelli R, 2007, J CRANIOFAC SURG, V18, P1051, DOI 10.1097/scs.0b013e3180de63eb; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Dudley AC, 2009, CLIN CANCER RES, V15, P4787, DOI 10.1158/1078-0432.CCR-09-0902; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kumar S, 2008, J CELL MOL MED, V12, P1584, DOI 10.1111/j.1582-4934.2007.00172.x; Kumar S, 2007, CARDIOVASC RES, V73, P172, DOI 10.1016/j.cardiores.2006.09.018; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Pamarthy D, 2007, CANCER BIOL THER, V6, P360, DOI 10.4161/cbt.6.3.3703; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sauvant C, 2008, INT J CANCER, V123, P2532, DOI 10.1002/ijc.23818; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Singh AK, 2011, CELL MOL LIFE SCI, V68, P1041, DOI 10.1007/s00018-010-0503-7; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Wolosker H, 1997, BIOCHEM J, V321, P545, DOI 10.1042/bj3210545; Xiong YQ, 2009, CLIN CANCER RES, V15, P4838, DOI 10.1158/1078-0432.CCR-08-2780; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691	35	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101053	10.1371/journal.pone.0101053	http://dx.doi.org/10.1371/journal.pone.0101053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964091	gold, Green Published			2022-12-25	WOS:000338709500114
J	Sommer, J; Garbers, C; Wolf, J; Trad, A; Moll, JM; Sack, M; Fischer, R; Grotzinger, J; Waetzig, GH; Floss, DM; Scheller, J				Sommer, Jan; Garbers, Christoph; Wolf, Janina; Trad, Ahmad; Moll, Jens M.; Sack, Markus; Fischer, Rainer; Groetzinger, Joachim; Waetzig, Georg H.; Floss, Doreen M.; Scheller, Juergen			Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; RHEUMATOID-ARTHRITIS; SOLUBLE GP130; IL-6 RECEPTOR; IN-VIVO; CYTOKINE; SERUM; IDENTIFICATION; ACTIVATION; EXPRESSION	Interleukin (IL)-6 signals via a receptor complex composed of the signal-transducing beta-receptor gp130 and the non-signaling membrane-bound or soluble IL-6 receptor alpha (IL-6R, sIL-6R), which is referred to as classic and trans-signaling, respectively. IL-6 trans-signaling is functionally associated with the development of chronic inflammatory diseases and cancer. Soluble gp130 (sgp130) variants are natural inhibitors of trans-signaling. Differential splicing yields sgp130 isoforms. Here, we describe that alternative intronic polyadenylation in intron 10 of the gp130 transcript results in a novel mRNA coding for an sgp130 protein isoform (sgp130-E10) of 70-80 kDa. The sgp130-E10 protein was expressed in vivo in human peripheral blood mononuclear cells. To assess the biological activity of sgp130-E10, we expressed this variant as Fc-tagged fusion protein (sgp130-E10Fc). Recombinant sgp130-E10Fc binds to a complex of IL-6 and sIL-6R, but not to IL-6 alone, and specifically inhibits IL-6 trans-signaling. Thus, it might play an important role in the regulation of trans-signaling in vivo.	[Sommer, Jan; Moll, Jens M.; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Garbers, Christoph; Wolf, Janina; Trad, Ahmad; Groetzinger, Joachim] Univ Kiel, Fac Med, Inst Biochem, D-24118 Kiel, Germany; [Sack, Markus; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, D-52062 Aachen, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel; RWTH Aachen University	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Sack, Markus/K-6681-2013; Waetzig, Georg/AAV-7486-2021; Sack, Markus/AAP-9252-2021; Garbers, Christoph/D-9932-2015	Sack, Markus/0000-0002-7380-9228; Garbers, Christoph/0000-0003-4939-6950	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SCHE 907/2-1]; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (SCHE 907/2-1, Bonn, Germany) (to J. S.).; Supported by a grant from Ferring Pharmaceuticals A/S (Copenhagen, Denmark).	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Clement HW, 2010, J NEURAL TRANSM, V117, P13, DOI 10.1007/s00702-009-0327-5; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Keul R, 1998, CYTOKINE, V10, P729, DOI 10.1006/cyto.1997.0343; Lateef Syed Salman, 2007, J Biomol Tech, V18, P173; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Robak T, 1998, MEDIAT INFLAMM, V7, P347, DOI 10.1080/09629359890875; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SHARKEY AM, 1995, BIOL REPROD, V53, P974, DOI 10.1095/biolreprod53.4.974; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sommer J, 2012, J BIOL CHEM, V287, P13743, DOI 10.1074/jbc.M111.349167; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Uson J, 1997, J RHEUMATOL, V24, P2069; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Zhang JG, 1998, J BIOL CHEM, V273, P10798, DOI 10.1074/jbc.273.17.10798	27	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22140	22150		10.1074/jbc.M114.560938	http://dx.doi.org/10.1074/jbc.M114.560938			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973212	Green Published, hybrid			2022-12-25	WOS:000340593500029
J	Choy, E; MacConaill, LE; Cote, GM; Le, LP; Shen, JK; Nielsen, GP; Iafrate, AJ; Garraway, LA; Hornicek, FJ; Duan, ZF				Choy, Edwin; MacConaill, Laura E.; Cote, Gregory M.; Le, Long P.; Shen, Jacson K.; Nielsen, Gunnlaugur P.; Iafrate, Anthony J.; Garraway, Levi A.; Hornicek, Francis J.; Duan, Zhenfeng			Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1	PLOS ONE			English	Article							MALIGNANT RHABDOID TUMORS; SWI/SNF COMPLEXES; LUNG-CANCER; INHIBITION; REEXPRESSION; COMBINATION; EFFICACY; IMPACT; GROWTH; SPINE	The molecular mechanisms underlying chordoma pathogenesis are unknown. We therefore sought to identify novel mutations to better understand chordoma biology and to potentially identify therapeutic targets. Given the relatively high costs of whole genome sequencing, we performed a focused genetic analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometer (Sequenom iPLEX genotyping). We tested 865 hotspot mutations in 111 oncogenes and selected tumor suppressor genes (OncoMap v.3.0) of 45 human chordoma tumor samples. Of the analyzed samples, seven were identified with at least one mutation. Six of these were from fresh frozen samples, and one was from a paraffin embedded sample. These observations were validated using an independent platform using homogeneous mass extend MALDI-TOF (Sequenom hME Genotyping). These genetic alterations include: ALK (A877S), CTNNB1 (T41A), NRAS (Q61R), PIK3CA (E545K), PTEN (R130), CDKN2A (R58*), and SMARCB1 (R40*). This study reports on the largest comprehensive mutational analysis of chordomas performed to date. To focus on mutations that have the greatest chance of clinical relevance, we tested only oncogenes and tumor suppressor genes that have been previously implicated in the tumorigenesis of more common malignancies. We identified rare genetic changes that may have functional significance to the underlying biology and potential therapeutics for chordomas. Mutations in CDKN2A and PTEN occurred in areas of chromosomal copy loss. When this data is paired with the studies showing 18 of 21 chordoma samples displaying copy loss at the locus for CDKN2A, 17 of 21 chordoma samples displaying copy loss at PTEN, and 3 of 4 chordoma samples displaying deletion at the SMARCB1 locus, we can infer that a loss of heterozygosity at these three loci may play a significant role in chordoma pathogenesis.	[Choy, Edwin; Cote, Gregory M.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Choy, Edwin; Cote, Gregory M.; Shen, Jacson K.; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA; [MacConaill, Laura E.; Garraway, Levi A.] Harvard Univ, Sch Med, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [MacConaill, Laura E.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Le, Long P.; Nielsen, Gunnlaugur P.; Iafrate, Anthony J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Choy, E (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.	echoy@partners.org		Cote, Gregory/0000-0003-0181-886X	Jennifer Hunter Yates Foundation; Stephan L. Harris Chordoma Fund; Cassandra Moseley Berry Sarcoma Endowed Fund; Gategno Fund; Wechsler Fund; KL2 Medical Research Investigator Training (MeRIT) grant (National Institutes of Health) [1KL2RR025757-01]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER	Jennifer Hunter Yates Foundation; Stephan L. Harris Chordoma Fund; Cassandra Moseley Berry Sarcoma Endowed Fund; Gategno Fund; Wechsler Fund; KL2 Medical Research Investigator Training (MeRIT) grant (National Institutes of Health); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported in part by the Jennifer Hunter Yates Foundation, the Stephan L. Harris Chordoma Fund, the Cassandra Moseley Berry Sarcoma Endowed Fund, the Gategno and Wechsler Funds, and the KL2 Medical Research Investigator Training (MeRIT) grant awarded to E.C. through Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Institutes of Health grant 1KL2RR025757-01), and by financial contributions from Harvard University and its affiliated academic health care centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova I, 2013, NEURO-ONCOLOGY, V15, P149, DOI 10.1093/neuonc/nos285; Biermann JS, 2013, J NATL COMPR CANC NE, V11, P688, DOI 10.6004/jnccn.2013.0088; Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Chen YL, 2013, SPINE, V38, pE930, DOI 10.1097/BRS.0b013e318296e7d7; Choy E, 2012, CANCER-AM CANCER SOC, V118, P2905, DOI 10.1002/cncr.26617; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; de Castro CV, 2013, HUM PATHOL, V44, P1747, DOI 10.1016/j.humpath.2012.11.024; DeLaney TF, 2009, INT J RADIAT ONCOL, V74, P732, DOI 10.1016/j.ijrobp.2008.08.058; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Di Maio S, 2012, NEUROSURGERY, V70, P1355, DOI 10.1227/NEU.0b013e3182446783; Diaz RJ, 2012, NEOPLASIA, V14, P788, DOI 10.1593/neo.12526; El-Khoueiry AB, 2013, J CLIN ONCOL, V31; Fernandez-Miranda JC, 2014, HEAD NECK-J SCI SPEC, V36, P892, DOI 10.1002/hed.23415; Housari G, 2013, CLIN TRANSL ONCOL, V15, P327, DOI 10.1007/s12094-012-0919-7; Imbalzano AN, 2005, CANCER CELL, V7, P294, DOI 10.1016/j.ccr.2005.04.001; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Koutourousiou M, 2011, OTOLARYNG CLIN N AM, V44, P1155, DOI 10.1016/j.otc.2011.06.002; Kuwahara Y, 2013, MOL CANCER RES, V11, P251, DOI 10.1158/1541-7786.MCR-12-0390; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Lewandrowski KU, 2004, SPINE, V29, P1150, DOI 10.1097/00007632-200405150-00019; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mobley BC, 2010, ACTA NEUROPATHOL, V120, P745, DOI 10.1007/s00401-010-0767-x; Nibu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826435; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park L, 2006, INT J RADIAT ONCOL, V65, P1514, DOI 10.1016/j.ijrobp.2006.02.059; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Schwab J, 2009, ANTICANCER RES, V29, P1867; Schwab JH, 2012, J BONE JOINT SURG AM, V94A, P1913, DOI 10.2106/JBJS.L.00955; Seward S, 2013, CANCER LETT, V336, P53, DOI 10.1016/j.canlet.2013.04.012; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wagner TD, 2009, INT J RADIAT ONCOL, V73, P259, DOI 10.1016/j.ijrobp.2008.03.074; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596; Yang C, 2009, MOL CANCER THER, V8, P2597, DOI 10.1158/1535-7163.MCT-09-0504	42	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101283	10.1371/journal.pone.0101283	http://dx.doi.org/10.1371/journal.pone.0101283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983247	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000083
J	Wan, X; Liu, JM; Cheung, WK; Tong, TJ				Wan, Xiang; Liu, Jiming; Cheung, William K.; Tong, Tiejun			Inferring Epidemic Network Topology from Surveillance Data	PLOS ONE			English	Article							INTERNATIONAL SPREAD; INFECTIOUS-DISEASES; POPULATION BIOLOGY; TRANSMISSION; INFLUENZA; FORECAST; DYNAMICS; MODELS; SEIR	The transmission of infectious diseases can be affected by many or even hidden factors, making it difficult to accurately predict when and where outbreaks may emerge. One approach at the moment is to develop and deploy surveillance systems in an effort to detect outbreaks as timely as possible. This enables policy makers to modify and implement strategies for the control of the transmission. The accumulated surveillance data including temporal, spatial, clinical, and demographic information, can provide valuable information with which to infer the underlying epidemic networks. Such networks can be quite informative and insightful as they characterize how infectious diseases transmit from one location to another. The aim of this work is to develop a computational model that allows inferences to be made regarding epidemic network topology in heterogeneous populations. We apply our model on the surveillance data from the 2009 H1N1 pandemic in Hong Kong. The inferred epidemic network displays significant effect on the propagation of infectious diseases.	[Wan, Xiang; Liu, Jiming; Cheung, William K.] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China; [Wan, Xiang; Tong, Tiejun] Hong Kong Baptist Univ, Inst Theoret & Computat Study, Kowloon, Hong Kong, Peoples R China; [Tong, Tiejun] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wan, X (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China.	xwan@comp.hkbu.edu.hk; jiming@comp.hkbu.edu.hk	Tong, Tiejun/F-3880-2010	Tong, Tiejun/0000-0003-0947-3990; Liu, Jiming/0000-0002-8669-9064; Cheung, William Kwok Wai/0000-0002-7428-2050	Hong Kong Baptist University [FRG1/13-14/021]	Hong Kong Baptist University	This study was supported by grants (FRG1/13-14/021) from Hong Kong Baptist University, who also supported the publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bailey NTJ, 1975, MATH THEORY INFECT D; Becker N, 2002, J ROYAL STAT SOC B, V61, P287; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Chen ZS, 2005, IEEE T NEURAL NETWOR, V16, P1291, DOI 10.1109/TNN.2005.853425; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gustafsson L, 2007, MATH BIOSCI, V209, P361, DOI 10.1016/j.mbs.2007.02.004; HETHCOTE H W, 1976, Mathematical Biosciences, V28, P335, DOI 10.1016/0025-5564(76)90132-2; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; KUZNETSOV YA, 1994, J MATH BIOL, V32, P109, DOI 10.1007/BF00163027; LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Mitchell Melanie, 1994, Artificial Life, V1, P267, DOI 10.1162/artl.1994.1.3.267; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Opper M, 2001, ADV MEAN FIELD METHO; Papoulis A., 1991, PROBABILITY RANDOM V; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2002, CONDMAT0205260 ARXIV; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Rogers E.M., 1995, DIFFUSION INNOVATION; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; West JD, 2010, COLL RES LIBR, V71, P236, DOI 10.5860/0710236	38	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100661	10.1371/journal.pone.0100661	http://dx.doi.org/10.1371/journal.pone.0100661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979215	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400036
J	Harbi, D; Harrison, PM				Harbi, Djamel; Harrison, Paul M.			Interaction Networks of Prion, Prionogenic and Prion-Like Proteins in Budding Yeast, and Their Role in Gene Regulation	PLOS ONE			English	Article							COILED COILS; COMPOSITIONAL BIAS; RICH DOMAINS; PREDICTION; SEQUENCES; PSI+; IDENTIFICATION; AGGREGATION; PROTEOMES; REGIONS	Prions are transmissible, propagating alternative states of proteins. Prions in budding yeast propagate heritable phenotypes and can function in large-scale gene regulation, or in some cases occur as diseases of yeast. Other 'prionogenic' proteins are likely prions that have been determined experimentally to form amyloid in vivo, and to have prion-like domains that are able to propagate heritable states. Furthermore, there are over 300 additional 'prion-like' yeast proteins that have similar amino-acid composition to prions (primarily a bias for asparagines and glutamines). Here, we examine the protein functional and interaction networks that involve prion, prionogenic and prion-like proteins. Set against a marked overall preference for N/Q-rich prion-like proteins not to interact with each other, we observe a significant tendency of prion/prionogenic proteins to interact with other, N/Q-rich prion-like proteins. This tendency is mostly due to a small number of networks involving the proteins NUP100p, LSM4p and PUB1p. In general, different data analyses of functional and interaction networks converge to indicate a strong linkage of prionogenic and prion-like proteins, to stress-granule assembly and related biological processes. These results further elucidate how prions may impact gene regulation, and reveal a broader horizon for the functional relevance of N/Q-rich prion-like domains.	[Harbi, Djamel; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Harrison, PM (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca			National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery grant from the National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Angarica VE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-316; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Harbi D, 2014, PRION, V8, P161, DOI 10.4161/pri.27960; Harbi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031785; Harbi D, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq031; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; Harrison PM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-441; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hiramatsu N, 2012, PROTEIN SCI, V21, P1481, DOI 10.1002/pro.2137; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; Klucevsek KM, 2012, GENETICS, V191, P1107, DOI 10.1534/genetics.112.141713; Kryndushkin D, 2013, PRION, V7, P464, DOI 10.4161/pri.27503; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kurahashi H, 2011, PRION, V5, P305, DOI [10.4161/pri.18307, 10.4161/pri.5.4.18307]; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Medina EM, 2011, J MOL EVOL, V73, P116, DOI 10.1007/s00239-011-9461-4; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ohte S, 2012, J CELL BIOCHEM, V113, P808, DOI 10.1002/jcb.23408; Oishi K, 2013, MICROBIOLOGYOPEN, V2, P415, DOI 10.1002/mbo3.83; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Ross Eric D, 2013, Methods Mol Biol, V1017, P219, DOI 10.1007/978-1-62703-438-8_16; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu K, 2009, J MOL BIOL, V392, P1253, DOI 10.1016/j.jmb.2009.07.088; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104	50	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100615	10.1371/journal.pone.0100615	http://dx.doi.org/10.1371/journal.pone.0100615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972093	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200045
J	Langevin, SA; Bowen, RA; Reisen, WK; Andrade, CC; Ramey, WN; Maharaj, PD; Anishchenko, M; Kenney, JL; Duggal, NK; Romo, H; Bera, AK; Sanders, TA; Bosco-Lauth, A; Smith, JL; Kuhn, R; Brault, AC				Langevin, Stanley A.; Bowen, Richard A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Anishchenko, Michael; Kenney, Joan L.; Duggal, Nisha K.; Romo, Hannah; Bera, Aloke Kumar; Sanders, Todd A.; Bosco-Lauth, Angela; Smith, Janet L.; Kuhn, Richard; Brault, Aaron C.			Host Competence and Helicase Activity Differences Exhibited by West Nile Viral Variants Expressing NS3-249 Amino Acid Polymorphisms	PLOS ONE			English	Article							VIRUS LINEAGE 2; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; AMERICAN CROWS; CENTRAL-EUROPE; NEW-YORK; STRAINS; BIRDS; FLAVIVIRUS; VIRULENCE	A single helicase amino acid substitution, NS3-T249P, has been shown to increase viremia magnitude/mortality in American crows (AMCRs) following West Nile virus (WNV) infection. Lineage/intra-lineage geographic variants exhibit consistent amino acid polymorphisms at this locus; however, the majority of WNV isolates associated with recent outbreaks reported worldwide have a proline at the NS3-249 residue. In order to evaluate the impact of NS3-249 variants on avian and mammalian virulence, multiple amino acid substitutions were engineered into a WNV infectious cDNA (NY99; NS3-249P) and the resulting viruses inoculated into AMCRs, house sparrows (HOSPs) and mice. Differential viremia profiles were observed between mutant viruses in the two bird species; however, the NS3-249P virus produced the highest mean peak viral loads in both avian models. In contrast, this avian modulating virulence determinant had no effect on LD50 or the neurovirulence phenotype in the murine model. Recombinant helicase proteins demonstrated variable helicase and ATPase activities; however, differences did not correlate with avian or murine viremia phenotypes. These in vitro and in vivo data indicate that avian-specific phenotypes are modulated by critical viral-host protein interactions involving the NS3-249 residue that directly influence transmission efficiency and therefore the magnitude of WNV epizootics in nature.	[Langevin, Stanley A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Brault, Aaron C.] Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Langevin, Stanley A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Brault, Aaron C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bowen, Richard A.; Bosco-Lauth, Angela] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Anishchenko, Michael; Kenney, Joan L.; Duggal, Nisha K.; Romo, Hannah; Bosco-Lauth, Angela; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Bera, Aloke Kumar; Kuhn, Richard] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sanders, Todd A.] US Fish & Wildlife Serv, Portland, OR USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California Davis; University of California System; University of California Davis; Colorado State University; Centers for Disease Control & Prevention - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of the Interior; US Fish & Wildlife Service; University of Michigan System; University of Michigan	Brault, AC (corresponding author), Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA.	abrault@cdc.gov	Bera, Aloke Kumar/AAD-9541-2022; Kenney, Joan L./AAE-7416-2019; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Maharaj, Payal/0000-0002-4157-4479; Kenney, Joanie/0000-0002-6761-4272	NIAID NIH [R01-AI55607, AI061822]; CDC [UO1 CI000235]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061822, R01AI055607] Funding Source: NIH RePORTER	NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the described studies were provided by NIAID NIH grants R01-AI55607 and AI061822 and CDC grant UO1 CI000235. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CC, 2011, J GEN VIROL, V92, P2523, DOI 10.1099/vir.0.032318-0; [Anonymous], VET PATHOL; [Anonymous], 2007, NATURE; [Anonymous], EMBO J; [Anonymous], 1 SEROLOGICAL EVIDEN; [Anonymous], VECTOR BORNE ZOONOTI; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Foppa IM, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-43; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032; Khan SA, 2011, EMERG INFECT DIS, V17, P947, DOI 10.3201/eid1705.100479; Kinney R, 2006, J GEN VIROL IN PRESS; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Misra M, 2007, BIOINFORMATICS, V23, P2645, DOI 10.1093/bioinformatics/btm383; Murata R, 2011, AM J TROP MED HYG, V84, P461, DOI 10.4269/ajtmh.2011.09-0714; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Nemeth NM, 2007, AM J TROP MED HYG, V76, P431, DOI 10.4269/ajtmh.2007.76.431; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Zimmerman E, 2009, HOUSE SPARROW HIST	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100802	10.1371/journal.pone.0100802	http://dx.doi.org/10.1371/journal.pone.0100802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971589	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200064
J	Mathur, A; Ware, C; Davis, L; Gazdar, A; Pan, BS; Lutterbach, B				Mathur, Anjili; Ware, Christopher; Davis, Lenora; Gazdar, Adi; Pan, Bo-Sheng; Lutterbach, Bart			FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival	PLOS ONE			English	Article							GENE AMPLIFICATION; LUNG-CANCER; CARCINOMA; MET; RECEPTOR; INHIBITOR; PROTEIN; HER-2; SENSITIVITY; RESISTANCE	Aberrant kinase activation resulting from mutation, amplification, or translocation can drive growth and survival in a subset of human cancer. FGFR2 is amplified in breast and gastric cancer, and we report here the first characterization of FGFR2 gene amplification in colorectal cancer in the NCI-H716 colorectal cancer cell line. FGFR2 is highly expressed and activated in NCI-H716 cells, and FGFR selective small molecule inhibitors or FGFR2 shRNA strongly inhibited cell viability in vitro, indicating "addiction'' of NCI-H716 cells to FGFR2. NCI-H716 growth in a xenograft model was also inhibited by an FGFR small molecule inhibitor. FGFR2 was required for activation of multiple downstream signaling proteins including AKT, ERK, S6RP and NFKB. Inhibition of downstream kinases such as AKT or ERK alone had modest effects on proliferation, whereas combined inhibition of AKT and ERK signaling resulted in a loss of viability similar to FGFR2 inhibition. We identified elevated FGFR2 expression in a small subset of primary colorectal cancer, however FGFR2 amplification was not observed. Although FGFR2 amplification is not common in primary colon cancer or lymph node and liver metastases, other subsets of colorectal cancer such as ascites, from which the NCI-H716 cell line was derived, have yet to be tested. These results suggest that emerging FGFR inhibitor therapeutics may have efficacy in a subset of colon cancer driven by FGFR2 amplification.	[Mathur, Anjili; Ware, Christopher; Davis, Lenora; Pan, Bo-Sheng; Lutterbach, Bart] Merck Res Labs, Boston, MA 02115 USA; [Gazdar, Adi] Univ Texas Southwestern, Hamon Ctr Therapeut Oncol, Dallas, TX USA	Merck & Company; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lutterbach, B (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	lutterba@gmail.com			Merck Research Labs	Merck Research Labs	This work was supported by Merck Research Labs. The funder provided support in the form of salaries for authors (AM, CW, LD, BP, BL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Dahlberg PS, 2004, ANN THORAC SURG, V78, P1790, DOI 10.1016/j.athoracsur.2004.05.037; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEBRUINE AP, 1992, VIRCHOWS ARCH B, V62, P311; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; ITOH H, 1994, CANCER RES, V54, P3237; Katz JD, 2011, J MED CHEM, V54, P4092, DOI 10.1021/jm200112k; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Moffa AB, 2004, MOL CANCER RES, V2, P643; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; PARK JG, 1987, CANCER RES, V47, P6710; Pavlakis K, 2007, APPL IMMUNOHISTO M M, V15, P441, DOI 10.1097/01.pai.0000213156.94804.b5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sorscher SM, 2011, CANCER INVEST, V29, P456, DOI 10.3109/07357907.2011.590569; Tanoue Y, 2009, WORLD J GASTROENTERO, V15, P248, DOI 10.3748/wjg.15.248; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; UNTAWALE S, 1993, CANCER RES, V53, P1630; YOSHIDA T, 1993, SEMIN CANCER BIOL, V4, P33; Zbuk K, 2009, SEMIN ONCOL, V36, P439, DOI 10.1053/j.seminoncol.2009.07.008	31	32	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98515	10.1371/journal.pone.0098515	http://dx.doi.org/10.1371/journal.pone.0098515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968263	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800002
J	Stein, AP; Saha, S; Liu, CZ; Hartig, GK; Lambert, PF; Kimple, RJ				Stein, Andrew P.; Saha, Sandeep; Liu, Cheng Z.; Hartig, Gregory K.; Lambert, Paul F.; Kimple, Randall J.			Influence of Handling Conditions on the Establishment and Propagation of Head and Neck Cancer Patient Derived Xenografts	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HPV-NEGATIVE HEAD; NUDE-MICE; MODELS; GROWTH; LINES; HETEROTRANSPLANTATION; TUMORS; KRAS	Background: Patient derived xenografts (PDXs) for head and neck cancer (HNC) and other cancers represent powerful research platforms. Most groups implant patient tissue into immunodeficient mice immediately although the significance of this time interval is anecdotal. We tested the hypothesis that the time from tumor excision to implantation is crucial for PDX passaging and establishment. Methods: We examined whether time or storage medium affected PDX viability for passaging two established HNC PDXs (UW-SCC34, UW-SCC52). Tumors were harvested, stored in ice-cold media or saline for 0-48 hours, and implanted into new mice. Tumor growth was compared by two-way ANOVA with respect to time and storage condition. Three new HNC PDXs (UW-SCC63-65) were generated by implanting patient tissue into mice immediately (Time 0) and 24 hours after receiving tissue from the operating room. Results: Similar quantities of tumor were implanted into each mouse. At the end of the experiment, no significant difference was seen in mean tumor weight between the media and saline storage conditions for UW-SCC34 or UW-SCC52 (p = 0.650 and p = 0.177, respectively). No difference in tumor formation prevalence was seen on the basis of time from harvest to implantation (>= 13 of 16 tumors grew at every time point). Histological analysis showed strong similarity to the initial tumor across all groups. Tumors developed at both Time 0 and 24 hours for UW-SCC63 and UW-SCC64. Conclusions: We demonstrated that neither storage medium nor time from tumor excision to implantation (up to 48 hours) affected viability or histological differentiation in a subsequent passage for two HNC PDXs. Moreover, we revealed that fresh patient tissue is viable up to 24 hours post-resection. This information is important as it applies to the development and sharing of PDXs.	[Stein, Andrew P.; Kimple, Randall J.] Univ Wisconsin, Dept Human Oncol, Carbone Canc Ctr, Madison, WI 53706 USA; [Saha, Sandeep] Univ Wisconsin, Dept Biostat, Carbone Canc Ctr, Madison, WI USA; [Liu, Cheng Z.] Univ Wisconsin, Dept Pathol, Carbone Canc Ctr, Madison, WI 53706 USA; [Hartig, Gregory K.] Univ Wisconsin, Dept Otolaryngol, Carbone Canc Ctr, Madison, WI USA; [Stein, Andrew P.; Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Carbone Canc Ctr, Madison, WI 53706 USA; [Stein, Andrew P.; Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimple, RJ (corresponding author), Univ Wisconsin, Dept Human Oncol, Carbone Canc Ctr, Madison, WI 53706 USA.	rkimple@humonc.wisc.edu	Kimple, Randall/L-6460-2019	Kimple, Randall/0000-0001-8336-8000; Stein, Andrew/0000-0002-2551-1064; Liu, Cheng/0000-0002-2219-1018	UW ICTR-Shapiro fellowship; UWCCC; UWCCC/MIR/WID;  [R00 CA160639]; NATIONAL CANCER INSTITUTE [K99CA160639, R00CA160639, P30CA014520] Funding Source: NIH RePORTER	UW ICTR-Shapiro fellowship; UWCCC; UWCCC/MIR/WID; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R00 CA160639 (RK), UWCCC and UWCCC/MIR/WID institutional grants (PL), and a UW ICTR-Shapiro fellowship (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Boyd MR, 1997, CLIN TRIALS APPROVAL, V20; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Chen JC, 1996, ORAL SURG ORAL MED O, V81, P197, DOI 10.1016/S1079-2104(96)80415-X; Choyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057798; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; GIOVANELLA BC, 1978, CANCER, V42, P2269, DOI 10.1002/1097-0142(197811)42:5<2269::AID-CNCR2820420527>3.0.CO;2-F; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Kimple RJ, 2013, CLIN CANCER RES, V19, P855, DOI 10.1158/1078-0432.CCR-12-2746; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075056; Qiu CP, 2003, J ORAL MAXIL SURG, V61, P696, DOI 10.1053/joms.2003.50139; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Uva P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011742; Wang Huixia, 2006, BMC Genomics, V7, P166; WENNERBERG J, 1983, ACTA OTO-LARYNGOL, V95, P183, DOI 10.3109/00016488309130933; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4; Xing-Dong Feng, 2007, Genomics Proteomics & Bioinformatics, V5, P15, DOI 10.1016/S1672-0229(07)60010-2; Yoon SS, 2009, INT J RADIAT ONCOL, V74, P1207, DOI 10.1016/j.ijrobp.2009.02.052; ZATTERSTROM UK, 1992, APMIS, V100, P976; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100995	10.1371/journal.pone.0100995	http://dx.doi.org/10.1371/journal.pone.0100995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967635	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800095
J	Sun, WM; Xiao, XS; Li, SQ; Guo, XM; Zhang, QJ				Sun, Wenmin; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Zhang, Qingjiong			Exome Sequencing of 18 Chinese Families with Congenital Cataracts: A New Sight of the NHS Gene	PLOS ONE			English	Article							NANCE-HORAN-SYNDROME; CHILDHOOD BLINDNESS; INDIAN FAMILIES; MUTATIONS; CRYSTALLIN; DANISH	Purpose: The aim of this study was to investigate the mutation spectrum and frequency of 34 known genes in 18 Chinese families with congenital cataracts. Methods: Genomic DNA and clinical data was collected from 18 families with congenital cataracts. Variations in 34 cataract-associated genes were screened by whole exome sequencing and then validated by Sanger sequencing. Results: Eleven candidate variants in seven of the 34 genes were detected by exome sequencing and then confirmed by Sanger sequencing, including two variants predicted to be benign and the other pathogenic mutations. The nine mutations were present in 9 of the 18 (50%) families with congenital cataracts. Of the four families with mutations in the X-linked NHS gene, no other abnormalities were recorded except for cataract, in which a pseudo-dominant inheritance form was suggested, as female carriers also had different forms of cataracts. Conclusion: This study expands the mutation spectrum and frequency of genes responsible for congenital cataract. Mutation in NHS is a common cause of nonsyndromic congenital cataract with pseudo-autosomal dominant inheritance. Combined with our previous studies, a genetic basis could be identified in 67.6% of families with congenital cataracts in our case series, in which mutations in genes encoding crystallins, genes encoding connexins, and NHS are responsible for 29.4%, 14.7%, and 11.8% of families, respectively. Our results suggest that mutations in NHS are the common cause of congenital cataract, both syndromic and nonsyndromic.	[Sun, Wenmin; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, QJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Natural Science Foundation of China [81170881]; National 973 plan [2010CB529904]; "985 project'' of Sun Yat-sen University; State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 plan(National Basic Research Program of China); "985 project'' of Sun Yat-sen University; State Key Laboratory of Ophthalmology	Supported by the National Natural Science Foundation of China (81170881), the National 973 plan (2010CB529904), the "985 project'' of Sun Yat-sen University, and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Coccia M, 2009, HUM MOL GENET, V18, P2643, DOI 10.1093/hmg/ddp206; Dave A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072518; Devi RR, 2008, MOL VIS, V14, P1157; Francis PJ, 2002, J MED GENET, V39, P105, DOI 10.1136/jmg.39.2.105; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Huang KM, 2007, MOL VIS, V13, P470; Kumar M, 2011, MOL VIS, V17, P693; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ponnam SPG, 2013, MOL VIS, V19, P1141; RAHI JS, 1995, EYE, V9, P545, DOI 10.1038/eye.1995.137; Ramprasad VL, 2005, INVEST OPHTH VIS SCI, V46, P17, DOI 10.1167/iovs.04-0477; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Sun WM, 2011, MOL VIS, V17, P2197; Sun WM, 2011, MOL VIS, V17, P1508; Tug E, 2013, GENE, V525, P141, DOI 10.1016/j.gene.2013.03.094; Wang KJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P337, DOI 10.1001/archophthalmol.2011.11; Wang Q, 2010, MOL VIS, V16, P303; Xiao Xueshan, 2011, Mol Vis, V17, P2049	27	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100455	10.1371/journal.pone.0100455	http://dx.doi.org/10.1371/journal.pone.0100455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968223	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800041
J	Papuchon, J; Pinson, P; Guidicelli, GL; Bellecave, P; Thomas, R; LeBlanc, R; Reigadas, S; Taupin, JL; Baril, JG; Routy, JP; Wainberg, M; Fleury, H				Papuchon, Jennifer; Pinson, Patricia; Guidicelli, Gwenda-Line; Bellecave, Pantxika; Thomas, Rejean; LeBlanc, Roger; Reigadas, Sandrine; Taupin, Jean-Luc; Baril, Jean Guy; Routy, Jean Pierre; Wainberg, Mark; Fleury, Herve		Provir Latitude 45 Study Grp	Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; VACCINE; RESERVOIR; ADAPTATION; LEVEL; AIDS; CURE	In patients responding successfully to ART, the next therapeutic step is viral cure. An interesting strategy is antiviral vaccination, particularly involving CD8 T cell epitopes. However, attempts at vaccination are dependent on the immunogenetic background of individuals. The Provir/Latitude 45 project aims to investigate which CTL epitopes in proviral HIV-1 will be recognized by the immune system when HLA alleles are taken into consideration. A prior study (Papuchon et al, PLoS ONE 2013) showed that chronically-infected patients under successful ART exhibited variations of proviral CTL epitopes compared to a reference viral strain (HXB2) and that a generic vaccine may not be efficient. Here, we investigated viral and/or proviral CTL epitopes at different time points in recently infected individuals of the Canadian primary HIV infection cohort and assessed the affinity of these epitopes for HLA alleles during the study period. An analysis of the results confirms that it is not possible to fully predict which epitopes will be recognized by the HLA alleles of the patients if the reference sequences and epitopes are taken as the basis of simulation. Epitopes may be seen to vary in circulating RNA and proviral DNA. Despite this confirmation, the overall variability of the epitopes was low in these patients who are temporally close to primary infection.	[Papuchon, Jennifer; Pinson, Patricia; Guidicelli, Gwenda-Line; Bellecave, Pantxika; Reigadas, Sandrine; Taupin, Jean-Luc; Fleury, Herve] Univ Hosp Bordeaux, Bordeaux, France; [Papuchon, Jennifer; Pinson, Patricia; Bellecave, Pantxika; Reigadas, Sandrine; Fleury, Herve] CNRS, UMR 5234, Bordeaux, France; [Guidicelli, Gwenda-Line; Taupin, Jean-Luc] CNRS, UMR 5164, Bordeaux, France; [Thomas, Rejean] Clin Med Actuel, Montreal, PQ, Canada; [LeBlanc, Roger] Clin Med Opus, Montreal, PQ, Canada; [Baril, Jean Guy] Clin Med Quartier Latin, Montreal, PQ, Canada; [Routy, Jean Pierre] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Wainberg, Mark] McGill AIDS Ctr, Montreal, PQ, Canada	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; McGill University; McGill University	Fleury, H (corresponding author), Univ Hosp Bordeaux, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr			Merck company	Merck company(Merck & Company)	This study has been funded by Merck company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Brumme ZL, 2012, CURR OPIN VIROL, V2, P599, DOI 10.1016/j.coviro.2012.08.003; Cale EM, 2011, J VIROL, V85, P3746, DOI 10.1128/JVI.02420-10; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Launay O, 2013, VACCINE, V31, P4406, DOI 10.1016/j.vaccine.2013.06.102; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Papuchon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069029; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Sriwanthana B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041696	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100452	10.1371/journal.pone.0100452	http://dx.doi.org/10.1371/journal.pone.0100452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964202	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500053
J	Stone, B; Vargo, J; Liu, P; Habeeb, D; DeLucia, A; Trail, M; Hu, YT; Russell, A				Stone, Brian, Jr.; Vargo, Jason; Liu, Peng; Habeeb, Dana; DeLucia, Anthony; Trail, Marcus; Hu, Yongtao; Russell, Armistead			Avoided Heat-Related Mortality through Climate Adaptation Strategies in Three US Cities	PLOS ONE			English	Article							UNITED-STATES; URBAN; TEMPERATURE; WEATHER; CALIFORNIA; IMPACTS; ISLAND; MODEL	Heat-related mortality in US cities is expected to more than double by the mid-to-late 21st century. Rising heat exposure in cities is projected to result from: 1) climate forcings from changing global atmospheric composition; and 2) local land surface characteristics responsible for the urban heat island effect. The extent to which heat management strategies designed to lessen the urban heat island effect could offset future heat-related mortality remains unexplored in the literature. Using coupled global and regional climate models with a human health effects model, we estimate changes in the number of heat-related deaths in 2050 resulting from modifications to vegetative cover and surface albedo across three climatically and demographically diverse US metropolitan areas: Atlanta, Georgia, Philadelphia, Pennsylvania, and Phoenix, Arizona. Employing separate health impact functions for average warm season and heat wave conditions in 2050, we find combinations of vegetation and albedo enhancement to offset projected increases in heat-related mortality by 40 to 99% across the three metropolitan regions. These results demonstrate the potential for extensive land surface changes in cities to provide adaptive benefits to urban populations at risk for rising heat exposure with climate change.	[Stone, Brian, Jr.; Habeeb, Dana] Georgia Inst Technol, Sch City & Reg Planning, Atlanta, GA 30332 USA; [Vargo, Jason] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA; [Liu, Peng; Trail, Marcus; Hu, Yongtao; Russell, Armistead] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [DeLucia, Anthony] E Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA	University System of Georgia; Georgia Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia Institute of Technology; East Tennessee State University	Stone, B (corresponding author), Georgia Inst Technol, Sch City & Reg Planning, Atlanta, GA 30332 USA.	stone@gatech.edu	Hu, Yongtao/H-7543-2016	Hu, Yongtao/0000-0002-5161-0592	US Centers for Disease Control and Prevention (CDC) [5U01EH000432-02]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000432] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was made possible by a grant from the US Centers for Disease Control and Prevention (CDC) through project #5U01EH000432-02. Although the research described in the article has been funded wholly or in part by the CDC, it has not been subjected to any CDC review and therefore does not necessarily reflect the views of the Center, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert D, 2012, ATLANTIC CITIES 0505; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Convertino M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02922; Fry J, 2009, 1379 US GEOL SURV, V1379; Hajat S, 2002, J EPIDEMIOL COMMUN H, V56, P367, DOI 10.1136/jech.56.5.367; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hart M, 2009, THEOR APPL CLIMATOL, V95, P397, DOI 10.1007/s00704-008-0017-5; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; KALKSTEIN LS, 1989, ANN ASSOC AM GEOGR, V79, P44, DOI 10.1111/j.1467-8306.1989.tb00249.x; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Liu P, 2012, ATMOS CHEM PHYS, V12, P3601, DOI 10.5194/acp-12-3601-2012; Lynn BH, 2010, CLIMATIC CHANGE, V99, P567, DOI 10.1007/s10584-009-9729-5; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Racherla PN, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018091; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Sheridan SC, 2012, CLIMATIC CHANGE, V115, P291, DOI 10.1007/s10584-012-0436-2; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Stone B, 2007, INT J CLIMATOL, V27, P1801, DOI 10.1002/joc.1555; TAHA H, 1991, THEOR APPL CLIMATOL, V44, P123, DOI 10.1007/BF00867999; Trail M, 2013, GEOSCI MODEL DEV, V6, P1429, DOI 10.5194/gmd-6-1429-2013; Vargo J, 2013, J ENVIRON MANAGE, V114, P243, DOI 10.1016/j.jenvman.2012.10.007; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101; Zhou Y, 2010, NAT HAZARDS, V52, P639, DOI 10.1007/s11069-009-9406-z	30	96	97	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100852	10.1371/journal.pone.0100852	http://dx.doi.org/10.1371/journal.pone.0100852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964213	Green Published, gold			2022-12-25	WOS:000338709500089
J	De Paula, VS; Pomin, VH; Valente, AP				De Paula, Viviane S.; Pomin, Vitor H.; Valente, Ana Paula			Unique Properties of Human beta-Defensin 6 (hBD6) and Glycosaminoglycan Complex SANDWICH-LIKE DIMERIZATION AND COMPETITION WITH THE CHEMOKINE RECEPTOR 2 (CCR2) BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; HEPARIN-BINDING; CHEMOKINE; OLIGOMERIZATION; SULFATE; MACROMOLECULES; RECOGNITION; DYNAMICS	Defensins are components of the innate immune system that promote the directional migration and activation of dendritic cells, thereby modulating the adaptive immune response. Because matrix glycosaminoglycan (GAG) is known to be important for these functions, we characterized the structural features of human beta-defensin 6 (hBD6) and GAG interaction using a combination of structural and in silico analyses. Our results showed that GAG model compounds, a pentasaccharide (fondaparinux, FX) and an octasaccharide heparin derivative (dp8) bind to the alpha-helix and in the loops between the beta 2 and beta 3 strands, inducing the formation of a ternary complex with a 2:1 hBD6:FX stoichiometry. Competition experiments indicated an overlap of GAG and chemokine receptor CCR2 binding sites. An NMR-derived model of the ternary complex revealed that FX interacts with hBD6 along the dimerization interface, primarily contacting the alpha-helices and beta 2-beta 3 loops from each monomer. We further demonstrated that high-pressure NMR spectroscopy could capture an intermediate stage of hBD6-FX interaction, exhibiting features of a cooperative binding mechanism. Collectively, these data suggest a "sandwich-like" model in which two hBD6 molecules bind a single FX chain and provide novel structural insights into how defensin orchestrates leukocyte recruitment through GAG binding and G protein-coupled receptor activation. Despite the similarity to chemokines and hBD2, our data indicate different properties for the hBD6-GAG complex. This work adds significant information to the currently limited data available for the molecular structures and dynamics of defensin carbohydrate binding.	[De Paula, Viviane S.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, RJ, Brazil; [De Paula, Viviane S.; Pomin, Vitor H.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	De Paula, VS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Av Carlos Chagas Filho 373,CCS,Bloco K, BR-21941902 Rio De Janeiro, RJ, Brazil.	vpaula@cnrmn.bioqmed.ufr.br; valente@cnrmn.bioqmed.ufrj.br	Valente, Ana Paula/J-3010-2017; De Paula, Viviane/L-1947-2013	Valente, Ana Paula/0000-0001-7219-1123; De Paula, Viviane/0000-0003-3171-6477	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Institute of Structural Biology and Bioimaging (INBEB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Structural Biology and Bioimaging (INBEB)	This research was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the National Institute of Structural Biology and Bioimaging (INBEB).	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Blaum BS, 2010, J AM CHEM SOC, V132, P6374, DOI 10.1021/ja1000517; Cordeiro Y, 2013, BIOPHYS CHEM, V183, P9, DOI 10.1016/j.bpc.2013.06.002; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; De Paula VS, 2013, J MOL BIOL, V425, P4479, DOI 10.1016/j.jmb.2013.08.001; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hayafune M, 2014, P NATL ACAD SCI USA, V111, pE404, DOI 10.1073/pnas.1312099111; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; HRICOVINI M, 1995, CARBOHYD RES, V268, P159, DOI 10.1016/0008-6215(94)00334-C; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kitahara R, 2013, PROG NUCL MAG RES SP, V71, P35, DOI 10.1016/j.pnmrs.2012.12.001; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; Niraula TN, 2004, P NATL ACAD SCI USA, V101, P4089, DOI 10.1073/pnas.0305798101; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; Prabhakar Vikas, 2009, V534, P147, DOI 10.1007/978-1-59745-022-5_11; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seo ES, 2010, BIOCHEMISTRY-US, V49, P10486, DOI 10.1021/bi1011749; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2013, EUR J IMMUNOL, V43, P1412, DOI 10.1002/eji.201243138; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	47	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22969	22979		10.1074/jbc.M114.572529	http://dx.doi.org/10.1074/jbc.M114.572529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970887	hybrid, Green Published			2022-12-25	WOS:000341017200036
J	Gavin, JM; Hoar, K; Xu, Q; Ma, JY; Lin, YF; Chen, JJ; Chen, W; Bruzzese, FJ; Harrison, S; Mallender, WD; Bump, NJ; Sintchak, MD; Bence, NF; Li, P; Dick, LR; Gould, AE; Chen, JJ				Gavin, James M.; Hoar, Kara; Xu, Qing; Ma, Jingya; Lin, Yafang; Chen, Jiejin; Chen, Wei; Bruzzese, Frank J.; Harrison, Sean; Mallender, William D.; Bump, Nancy J.; Sintchak, Michael D.; Bence, Neil F.; Li, Ping; Dick, Lawrence R.; Gould, Alexandra E.; Chen, Jesse J.			Mechanistic Study of Uba5 Enzyme and the Ufm1 Conjugation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; SUBSTRATE-ASSISTED INHIBITION; FOLD MODIFIER; PROTEIN-ACTIVATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUMO E1; INSIGHTS; NEDD8; UBIQUITIN-FOLD-MODIFIER-1	E1 enzymes activate ubiquitin or ubiquitin-like proteins (Ubl) via an adenylate intermediate and initiate the enzymatic cascade of Ubl conjugation to target proteins or lipids. Ubiquitin-fold modifier 1 (Ufm1) is activated by the E1 enzyme Uba5, and this pathway is proposed to play an important role in the endoplasmic reticulum (ER) stress response. However, the mechanisms of Ufm1 activation by Uba5 and subsequent transfer to the conjugating enzyme (E2), Ufc1, have not been studied in detail. In this work, we found that Uba5 activated Ufm1 via a two-step mechanism and formed a binary covalent complex of Uba5 similar to Ufm1 thioester. This feature contrasts with the three-step mechanism and ternary complex formation in ubiquitin-activating enzyme Uba1. Uba5 displayed random ordered binding with Ufm1 and ATP, and its ATP-pyrophosphate (PPi) exchange activity was inhibited by both AMP and PPi. Ufm1 activation and Uba5 similar to Ufm1 thioester formation were stimulated in the presence of Ufc1. Furthermore, binding of ATP to Uba5 similar to Ufm1 thioester was required for efficient transfer of Ufm1 from Uba5 to Ufc1 via transthiolation. Consistent with the two-step activation mechanism, the mechanism-based pan-E1 inhibitor, adenosine 5'-sulfamate (ADS), reacted with the Uba5 similar to Ufm1 thioester and formed a covalent, tight-binding Ufm1-ADS adduct in the active site of Uba5, which prevented further substrate binding or catalysis. ADS was also shown to inhibit the Uba5 conjugation pathway in the HCT116 cells through formation of the Ufm1-ADS adduct. This suggests that further development of more selective Uba5 inhibitors could be useful in interrogating the roles of the Uba5 pathway in cells.	[Gavin, James M.; Hoar, Kara; Xu, Qing; Ma, Jingya; Lin, Yafang; Chen, Jiejin; Chen, Wei; Bruzzese, Frank J.; Harrison, Sean; Mallender, William D.; Bump, Nancy J.; Sintchak, Michael D.; Bence, Neil F.; Li, Ping; Dick, Lawrence R.; Gould, Alexandra E.; Chen, Jesse J.] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Gavin, JM (corresponding author), Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA.	james.gavin@takeda.com; jesse.chen@takeda.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; Burroughs AM, 2012, METHODS MOL BIOL, V832, P15, DOI 10.1007/978-1-61779-474-2_2; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Dou TH, 2005, MOL BIOL REP, V32, P265, DOI 10.1007/s11033-005-4822-y; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Liu Gaohua, 2009, Journal of Structural and Functional Genomics, V10, P127, DOI 10.1007/s10969-008-9054-7; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048587; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	42	25	25	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22648	22658		10.1074/jbc.M114.573972	http://dx.doi.org/10.1074/jbc.M114.573972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24966333	hybrid, Green Published			2022-12-25	WOS:000341017200011
J	Morgan, SJ; Deshpande, DA; Tiegs, BC; Misior, AM; Yan, HD; Hershfeld, AV; Rich, TC; Panettieri, RA; An, SS; Penn, RB				Morgan, Sarah J.; Deshpande, Deepak A.; Tiegs, Brian C.; Misior, Anna M.; Yan, Huandong; Hershfeld, Alena V.; Rich, Thomas C.; Panettieri, Reynold A.; An, Steven S.; Penn, Raymond B.			beta-Agonist-mediated Relaxation of Airway Smooth Muscle Is Protein Kinase A-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; K-CA CHANNELS; COUPLED RECEPTORS; BRONCHODILATOR SUBSENSITIVITY; ASTHMATIC-PATIENTS; EPAC; ACTIVATION; CELLS; ANALOGS; EFORMOTEROL	Inhaled beta-agonists are effective at reversing bronchoconstriction in asthma, but the mechanism by which they exert this effect is unclear and controversial. PKA is the historically accepted effector, although this assumption is made on the basis of associative and not direct evidence. Recent studies have asserted that exchange protein activated by cAMP (Epac), not PKA, mediates the relaxation of airway smooth muscle (ASM) observed with beta-agonist treatment. This study aims to clarify the role of PKA in the prorelaxant effects of beta-agonists on ASM. Inhibition of PKA activity via expression of the PKI and RevAB peptides results in increased beta-agonist-mediated cAMP release, abolishes the inhibitory effect of isoproterenol on histamine-induced intracellular calcium flux, and significantly attenuates histamine-stimulated MLC-20 phosphorylation. Analyses of ASM cell and tissue contraction demonstrate that PKA inhibition eliminates most, if not all, beta-agonist-mediated relaxation of contracted smooth muscle. Conversely, Epac knockdown had no effect on the regulation of contraction or procontractile signaling by isoproterenol. These findings suggest that PKA, not Epac, is the predominant and physiologically relevant effector through which beta-agonists exert their relaxant effects.	[Morgan, Sarah J.; Deshpande, Deepak A.; Tiegs, Brian C.; Yan, Huandong; Hershfeld, Alena V.; Penn, Raymond B.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Dept Med, Baltimore, MD 21201 USA; [Misior, Anna M.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC 27106 USA; [Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Rich, Thomas C.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Panettieri, Reynold A.] Univ Penn, Perelman Sch Med, Airways Biol Initiat, Dept Med,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Div Pulm & Crit Care Med, Ctr Translat Med,Jane & Leonard Korman Lung Ctr, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University School of Medicine; University of South Alabama; University of South Alabama; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jefferson University	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Rm 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	Raymond.Penn@jefferson.edu	panettieri, reynold/AAG-9485-2019; An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888	National Institutes of Health [HL58506, AG041265, HL087560, HL114471]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058506, R01HL058506, P01HL066299, P01HL114471, R00HL087560, K99HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58506 (to R. B. P.), AG041265 and HL087560 (to D. A. D.), and HL114471 (to R. B. P., R. A. P., and S. S. A.).	ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Billington CK, 2003, RESP RES, V4; BUTT E, 1994, J BIOL CHEM, V269, P14509; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; GAVETT SH, 1993, AM J PHYSIOL, V265, pL493, DOI 10.1152/ajplung.1993.265.5.L493; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; JIANG H, 1992, J BIOL CHEM, V267, P1015; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; KUME H, 1994, J CLIN INVEST, V93, P371, DOI 10.1172/JCI116969; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; NEWNHAM DM, 1994, AM J MED, V97, P29, DOI 10.1016/0002-9343(94)90045-0; Ortega VE, 2010, CURR OPIN PHARMACOL, V10, P246, DOI 10.1016/j.coph.2010.04.009; PEARCE N, 1995, LANCET, V345, P41, DOI 10.1016/S0140-6736(95)91159-6; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Perez-Zoghbi JF, 2010, J GEN PHYSIOL, V135, P247, DOI 10.1085/jgp.200910365; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Roscioni SS, 2011, BRIT J PHARMACOL, V164, P958, DOI 10.1111/j.1476-5381.2011.01354.x; Roscioni SS, 2011, J CELL MOL MED, V15, P1551, DOI 10.1111/j.1582-4934.2010.01150.x; Roscioni SS, 2011, BRIT J PHARMACOL, V162, P193, DOI 10.1111/j.1476-5381.2010.01011.x; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Spicuzza L, 2001, BRIT J PHARMACOL, V133, P1201, DOI 10.1038/sj.bjp.0704213; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STOLLEY PD, 1978, PREV MED, V7, P519, DOI 10.1016/0091-7435(78)90265-7; Taylor DR, 2009, AM J RESP CRIT CARE, V179, P976, DOI 10.1164/rccm.200901-0055CC; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	46	55	57	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23065	23074		10.1074/jbc.M114.557652	http://dx.doi.org/10.1074/jbc.M114.557652			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973219	Green Published, hybrid			2022-12-25	WOS:000341017200044
J	Mueller, AM; Yoon, BH; Sadiq, SA				Mueller, Andre Michael; Yoon, Bo Hyung; Sadiq, Saud Ahmed			Inhibition of Hyaluronan Synthesis Protects against Central Nervous System (CNS) Autoimmunity and Increases CXCL12 Expression in the Inflamed CNS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE PROGENITOR MATURATION; MULTIPLE-SCLEROSIS; TH17 CELLS; T-CELLS; ENCEPHALOMYELITIS; 4-METHYLUMBELLIFERONE; ACID; EXTRAVASATION; REMYELINATION; DISEASE	Hyaluronan (HA) may have proinflammatory roles in the context of CNS autoimmunity. It accumulates in demyelinated multiple sclerosis (MS) lesions, promotes antigen presentation, and enhances T-cell activation and proliferation. HA facilitates lymphocyte binding to vessels and CNS infiltration at the CNS vascular endothelium. Furthermore, HA signals through Toll-like receptors 2 and 4 to stimulate inflammatory gene expression. We assessed the role of HA in experimental autoimmune encephalomyelitis (EAE), an animal model of MS by administration of 4-methylumbelliferone (4MU), a well established inhibitor of HA synthesis. 4MU decreased hyaluronan synthesis in vitro and in vivo. It was protective in active EAE of C57Bl/6 mice, decreased spinal inflammatory infiltrates and spinal infiltration of Th1 cells, and increased differentiation of regulatory T-cells. In adoptive transfer EAE, feeding of 4MU to donor mice significantly decreased the encephalitogenicity of lymph node cells. The transfer of proteolipid protein (PLP)-stimulated lymph node cells to 4MU-fed mice resulted in a delayed EAE onset and delayed spinal T-cell infiltration. Expression of CXCL12, an anti-inflammatory chemokine, is reduced in MS patients in CSF cells and in spinal cord tissue during EAE. Hyaluronan suppressed production of CXCL12, whereas 4MU increased spinal CXCL12 in naive animals and during neuroinflammation. Neutralization of CXCR4, the most prominent receptor of CXCL12, by administration of AMD3100 diminished the protective impact of 4MU in adoptive transfer EAE. In conclusion, hyaluronan exacerbates CNS autoimmunity, enhances encephalitogenic T-cell responses, and suppresses the protective chemokine CXCL12 in CNS tissue. Inhibition of hyaluronan synthesis with 4MU protects against an animal model of MS and may represent an important therapeutic option in MS and other neuroinflammatory diseases.	[Mueller, Andre Michael; Yoon, Bo Hyung; Sadiq, Saud Ahmed] Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA		Sadiq, SA (corresponding author), Tisch MS Res Ctr New York, 521 W 57th St, New York, NY 10019 USA.	ssadiq@tischms.org	Sadiq, Saud/AAA-9871-2020					Aarvak T, 1999, J IMMUNOL, V162, P1246; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Brennan FR, 1999, IMMUNOLOGY, V98, P427, DOI 10.1046/j.1365-2567.1999.00894.x; Brynedal B, 2010, NEUROBIOL DIS, V37, P613, DOI 10.1016/j.nbd.2009.11.014; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Guo NX, 2010, J BIOL CHEM, V285, P32012, DOI 10.1074/jbc.M110.127183; Hagemeier K, 2012, HISTOL HISTOPATHOL, V27, P277, DOI 10.14670/HH-27.277; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; HOARE K, 1993, CONNECT TISSUE RES, V30, P117, DOI 10.3109/03008209309041327; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Maeshima N, 2011, EUR J IMMUNOL, V41, P1108, DOI 10.1002/eji.201040870; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Miljkovic D, 2011, IMMUNOBIOLOGY, V216, P979, DOI 10.1016/j.imbio.2011.03.013; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Muller AM, 2012, J NEUROIMMUNOL, V251, P80, DOI 10.1016/j.jneuroim.2012.06.008; MULDER GJ, 1985, BIOCHEM PHARMACOL, V34, P1325, DOI 10.1016/0006-2952(85)90513-1; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKUNDRIC DS, 1993, J NEUROIMMUNOL, V46, P113, DOI 10.1016/0165-5728(93)90240-Y; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x; Winkler CW, 2012, J BIOL CHEM, V287, P33237, DOI 10.1074/jbc.M112.356287; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861	39	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22888	22899		10.1074/jbc.M114.559583	http://dx.doi.org/10.1074/jbc.M114.559583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973214	Green Published, hybrid			2022-12-25	WOS:000341017200030
J	van den Bosch, MWM; Palsson-Mcdermott, E; Johnson, DS; O'Neill, LAJ				van den Bosch, Mirjam W. M.; Palsson-Mcdermott, Eva; Johnson, Derek S.; O'Neill, Luke A. J.			LPS Induces the Degradation of Programmed Cell Death Protein 4 (PDCD4) to Release Twist2, Activating c-Maf Transcription to Promote Interleukin-10 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE INFLAMMATORY RESPONSE; MAMMALIAN TARGET; SUPPRESSOR PDCD4; KINASE-AKT; RAPAMYCIN; PATHWAY; IL-10; TRANSLATION; EXPRESSION; LIPOPOLYSACCHARIDE	Programmed cell death protein 4 (PDCD4) is a tumor suppressor and has also been shown to suppress production of the immunomodulatory cytokine IL-10. The precise role of PDCD4 in IL-10 induction in macrophages is still not fully understood. Incubation of macrophages with inhibitors of PI3K and mTOR blocked LPS-stimulated PDCD4 degradation and expression of c-Maf and IL-10 production. PDCD4 and the transcription factor Twist2 were shown to form a complex in untreated cells. LPS disrupted the complex allowing Twist2 to bind to the c-Maf promoter. PI3K and mTOR inhibitors prevented this disruption by stabilizing PDCD4 and thereby decreased Twist2 binding to the c-Maf promoter and induction of c-Maf mRNA. These results indicate a regulatory role for PDCD4 and Twist2 in LPS-induced IL-10 production in macrophages. LPS promotes PDCD4 degradation via a pathway involving PI3K and mTOR, releasing Twist2, which induces IL-10 via c-Maf.	[van den Bosch, Mirjam W. M.; Palsson-Mcdermott, Eva; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Johnson, Derek S.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	Trinity College Dublin; University of Pennsylvania	van den Bosch, MWM (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, 152-160 Pearse St, Dublin 2, Ireland.	vandenbm@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board/Marie Curie CoFund; European Research Council (based in Ireland)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board/Marie Curie CoFund; European Research Council (based in Ireland)	This work was supported by the Science Foundation Ireland, Health Research Board/Marie Curie CoFund, and the European Research Council (based in Ireland).	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baker AK, 2009, MOL IMMUNOL, V46, P2249, DOI 10.1016/j.molimm.2009.04.011; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433	27	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22980	22990		10.1074/jbc.M114.573089	http://dx.doi.org/10.1074/jbc.M114.573089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982420	Green Published, hybrid			2022-12-25	WOS:000341017200037
J	Weaver, J; Rye, HS				Weaver, Jeremy; Rye, Hays S.			The C-terminal Tails of the Bacterial Chaperonin GroEL Stimulate Protein Folding by Directly Altering the Conformation of a Substrate Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CENTRAL CAVITY; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; IN-VIVO; COMPLEX; POLYPEPTIDE; CYCLE; MECHANISM; EVOLUTION	Many essential cellular proteins fold only with the assistance of chaperonin machines like the GroEL-GroES system of Escherichia coli. However, the mechanistic details of assisted protein folding by GroEL-GroES remain the subject of ongoing debate. We previously demonstrated that GroEL-GroES enhances the productive folding of a kinetically trapped substrate protein through unfolding, where both binding energy and the energy of ATP hydrolysis are used to disrupt the inhibitory misfolded states. Here, we show that the intrinsically disordered yet highly conserved C-terminal sequence of the GroEL subunits directly contributes to substrate protein unfolding. Interactions between the C terminus and the non-native substrate protein alter the binding position of the substrate protein on the GroEL apical surface. The C-terminal tails also impact the conformational state of the substrate protein during capture and encapsulation on the GroEL ring. Importantly, removal of the C termini results in slower overall folding, reducing the fraction of the substrate protein that commits quickly to a productive folding pathway and slowing several kinetically distinct folding transitions that occur inside the GroEL-GroES cavity. The conserved C-terminal tails of GroEL are thus important for protein folding from the beginning to the end of the chaperonin reaction cycle.	[Weaver, Jeremy; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137; Weaver, Jeremy/0000-0002-5556-4757	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM065421 (to H. S. R.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Betancourt MR, 1999, J MOL BIOL, V287, P627, DOI 10.1006/jmbi.1999.2591; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Cetinbas M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003269; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Goldberg MS, 1997, P NATL ACAD SCI USA, V94, P1080, DOI 10.1073/pnas.94.4.1080; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JAMES DR, 1992, REV SCI INSTRUM, V63, P1710, DOI 10.1063/1.1143328; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Lin Z, 2013, J BIOL CHEM, V288, P30944, DOI 10.1074/jbc.M113.480178; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Motojima F, 2012, P NATL ACAD SCI USA, V109, P15740, DOI 10.1073/pnas.1204547109; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Williams TA, 2010, GENOME BIOL EVOL, V2, P609, DOI 10.1093/gbe/evq045; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	66	37	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23219	23232		10.1074/jbc.M114.577205	http://dx.doi.org/10.1074/jbc.M114.577205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970895	hybrid, Green Published			2022-12-25	WOS:000341017200058
J	Abdelli, S; Papas, KK; Mueller, KR; Murtaugh, MP; Hering, BJ; Bonny, C				Abdelli, Saida; Papas, Klearchos K.; Mueller, Kate R.; Murtaugh, Mike P.; Hering, Bernhard J.; Bonny, Christophe			Regulation of the JNK3 Signaling Pathway during Islet Isolation: JNK3 and c-fos as New Markers of Islet Quality for Transplantation	PLOS ONE			English	Article							OXYGEN-CONSUMPTION RATE; MEDIATED INFLAMMATORY REACTION; HUMAN PANCREATIC-ISLETS; CELL-DEATH; EDMONTON PROTOCOL; INDUCED APOPTOSIS; GENE-EXPRESSION; MAP-KINASES; NUDE-MICE; BETA	Stress conditions generated throughout pancreatic islet processing initiate the activation of pro-inflammatory pathways and beta-cell destruction. Our goal is to identify relevant and preferably beta-specific markers to assess the activation of beta-cell stress and apoptotic mechanisms, and therefore the general quality of the islet preparation prior to transplantation. Protein expression and activation were analyzed by Western blotting and kinase assays. ATP measurements were performed by a luminescence-based assay. Oxygen consumption rate (OCR) was measured based on standard protocols using fiber optic sensors. Total RNA was used for gene expression analyzes. Our results indicate that pancreas digestion initiates a potent stress response in the islets by activating two stress kinases, c-Jun N-terminal Kinase (JNK) and p38. JNK1 protein levels remained unchanged between different islet preparations and following culture. In contrast, levels of JNK3 increased after islet culture, but varied markedly, with a subset of preparations bearing low JNK3 expression. The observed changes in JNK3 protein content strongly correlated with OCR measurements as determined by the Spearman's rank correlation coefficient rho (rho = 0: 7853) in the matching islet samples, while inversely correlating with c-fos mRNA expression (rho = 0: 885). In conclusion, pancreas digestion recruits JNK and p38 kinases that are known to participate to beta- cell apoptosis. Concomitantly, the islet isolation alters JNK3 and c-fos expression, both strongly correlating with OCR. Thus, a comparative analysis of JNK3 and c-fos expression before and after culture may provide for novel markers to assess islet quality prior to transplantation. JNK3 has the advantage over all other proposed markers to be islet-specific, and thus to provide for a marker independent of non-beta cell contamination.	[Abdelli, Saida; Bonny, Christophe] Ctr Hosp Univ Vaudois CHUV, Dept Med Genet, Lausanne, Switzerland; [Abdelli, Saida; Bonny, Christophe] Univ Lausanne, Lausanne, Switzerland; [Papas, Klearchos K.; Mueller, Kate R.] Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ USA; [Murtaugh, Mike P.] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN USA; [Hering, Bernhard J.] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Minneapolis, MN 55455 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bonny, C (corresponding author), Ctr Hosp Univ Vaudois CHUV, Dept Med Genet, Lausanne, Switzerland.	christophe.bonny@chuv.ch	Bonny, Christophe/AAV-7214-2021		Swiss National Science Foundation [FNS 310030_133018]; National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR [R44DK069865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK069865] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant from the Swiss National Science Foundation (FNS 310030_133018) and a National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR grant (R44DK069865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Abdelli S, 2007, DIABETOLOGIA; Abdelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035997; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Caumo A, 2008, DIABETES CARE, V31, P301, DOI 10.2337/dc07-0975; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; GOTO S, 1994, TRANSPLANTATION, V58, P840, DOI 10.1097/00007890-199410150-00016; Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Keesler GA, 1998, PROTEIN EXPRES PURIF, V14, P221, DOI 10.1006/prep.1998.0947; Kim DS, 2001, PIGM CELL RES, V14, P110, DOI 10.1034/j.1600-0749.2001.140206.x; Mellert J, 1999, J MOL MED-JMM, V77, P126, DOI 10.1007/s001090050319; Mueller KR, 2013, XENOTRANSPLANTATION; NAGATA M, 1990, TRANSPLANT P, V22, P855; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Papas KK, 2007, AM J TRANSPLANT, V7, P707, DOI 10.1111/j.1600-6143.2006.01655.x; Papas KK, 2007, BIOTECHNOL BIOENG, V98, P1071, DOI 10.1002/bit.21486; Papas KK, 2010, J INVEST SURG, V23, P28, DOI 10.3109/08941930903410825; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; RICORDI C, 1988, TRANSPLANTATION, V45, P994, DOI 10.1097/00007890-198805000-00035; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Susini S, 1998, FASEB J, V12, P1173, DOI 10.1096/fasebj.12.12.1173; Suszynski TM, 2008, TRANSPL P, V40, P346, DOI 10.1016/j.transproceed.2008.01.061; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	49	8	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99796	10.1371/journal.pone.0099796	http://dx.doi.org/10.1371/journal.pone.0099796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983249	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000013
J	Galan, A; Dergham, P; Escoll, P; de-la-Hera, A; D'Onofrio, PM; Magharious, MM; Koeberle, PD; Frade, JM; Saragovi, HU				Galan, Alba; Dergham, Pauline; Escoll, Pedro; de-la-Hera, Antonio; D'Onofrio, Philippe M.; Magharious, Mark M.; Koeberle, Paulo D.; Maria Frade, Jose; Saragovi, H. Uri			Neuronal Injury External to the Retina Rapidly Activates Retinal Glia, Followed by Elevation of Markers for Cell Cycle Re-Entry and Death in Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE TRANSECTION; PROTEINS; EXPRESSION; ISCHEMIA; SURVIVAL; GLAUCOMA; KINASE; NEUROPROTECTION; INVOLVEMENT; INHIBITION	Retinal ganglion cells (RGCs) are neurons that relay visual signals from the retina to the brain. The RGC cell bodies reside in the retina and their fibers form the optic nerve. Full transection (axotomy) of the optic nerve is an extra-retinal injury model of RGC degeneration. Optic nerve transection permits time-kinetic studies of neurodegenerative mechanisms in neurons and resident glia of the retina, the early events of which are reported here. One day after injury, and before atrophy of RGC cell bodies was apparent, glia had increased levels of phospho-Akt, phospho-S6, and phospho-ERK1/2; however, these signals were not detected in injured RGCs. Three days after injury there were increased levels of phospho-Rb and cyclin A proteins detected in RGCs, whereas these signals were not detected in glia. DNA hyperploidy was also detected in RGCs, indicative of cell cycle re-entry by these post-mitotic neurons. These events culminated in RGC death, which is delayed by pharmacological inhibition of the MAPK/ERK pathway. Our data show that a remote injury to RGC axons rapidly conveys a signal that activates retinal glia, followed by RGC cell cycle re-entry, DNA hyperploidy, and neuronal death that is delayed by preventing glial MAPK/ERK activation. These results demonstrate that complex and variable neuro-glia interactions regulate healthy and injured states in the adult mammalian retina.	[Galan, Alba; Dergham, Pauline; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Escoll, Pedro; de-la-Hera, Antonio] Alcala Univ, Sch Med, Dept Med, Mol Med Inst IMMPA CSIC UAH, Madrid, Spain; [D'Onofrio, Philippe M.; Magharious, Mark M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Koeberle, Paulo D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Maria Frade, Jose] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	Lady Davis Institute; McGill University; Universidad de Alcala; University of Toronto; University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Frade, Jose M/E-7913-2013; Escoll, Pedro/H-9517-2019; Escoll, Pedro/B-2034-2017	Frade, Jose M/0000-0001-7067-2505; Escoll, Pedro/0000-0002-5933-094X	A King Carlos III Award; Canadian Institute of Health Research; Spanish Ministry of Science and Innovation (MICINN); FUNDALUCE; MICINN (DENDRIA) [SAF 2011-29405]	A King Carlos III Award; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FUNDALUCE; MICINN (DENDRIA)	A King Carlos III Award to HUS allowed travel between Spain and Canada. This work was partially supported by grants from the Canadian Institute of Health Research to HUS, and to PDK; the Spanish Ministry of Science and Innovation (MICINN) and FUNDALUCE to JMF; and MICINN (DENDRIA, SAF 2011-29405) to ADLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Frade Jose Maria, 2010, Commun Integr Biol, V3, P201; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Hollander A, 2012, INVEST OPHTH VIS SCI, V53, P3973, DOI 10.1167/iovs.11-8350; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Janssen A, 2011, NAT CELL BIOL, V13, P199, DOI 10.1038/ncb0311-199; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Magharious MM, 2011, J VIS EXP; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	47	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101349	10.1371/journal.pone.0101349	http://dx.doi.org/10.1371/journal.pone.0101349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983470	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000095
J	d'Adhemar, CJ; Spillane, CD; Gallagher, MF; Bates, M; Costello, KM; Barry-O'Crowley, J; Haley, K; Kernan, N; Murphy, C; Smyth, PC; O'Byrne, K; Pennington, S; Cooke, AA; Ffrench, B; Martin, CM; O'Donnell, D; Hennessy, B; Stordal, B; Finn, S; McCann, A; Gleeson, N; D'Arcy, T; Flood, B; O'Neill, LAJ; Sheils, O; O'Toole, S; O'Leary, JJ				d'Adhemar, Charles J.; Spillane, Cathy D.; Gallagher, Michael F.; Bates, Mark; Costello, Katie M.; Barry-O'Crowley, Jacqui; Haley, Kathryn; Kernan, Niamh; Murphy, Ciara; Smyth, Paul C.; O'Byrne, Ken; Pennington, Stephen; Cooke, Aoife A.; Ffrench, Brendan; Martin, Cara M.; O'Donnell, Dearbhaile; Hennessy, Bryan; Stordal, Britta; Finn, Stephen; McCann, Amanda; Gleeson, Noreen; D'Arcy, Tom; Flood, Brian; O'Neill, Luke A. J.; Sheils, Orla; O'Toole, Sharon; O'Leary, John J.			The MyD88+Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; TUMOR-GROWTH; STEM-CELLS; EXPRESSION; CARCINOMA; BREAST; DIFFERENTIATION; CHEMORESISTANCE; RESISTANCE	The prognosis of epithelial ovarian cancer is poor in part due to the high frequency of chemoresistance. Recent evidence points to the Toll-like receptor-4 (TLR4), and particularly its adaptor protein MyD88, as one potential mediator of this resistance. This study aims to provide further evidence that MyD88 positive cancer cells are clinically significant, stem-like and reproducibly detectable for the purposes of prognostic stratification. Expression of TLR4 and MyD88 was assessed immunohistochemically in 198 paraffin-embedded ovarian tissues and in an embryonal carcinoma model of cancer stemness. In parallel, expression of TLR4 and MyD88 mRNA and regulatory microRNAs (miR-21 and miR-146a) was assessed, as well as in a series of chemosensitive and resistant cancer cells lines. Functional analysis of the pathway was assessed in chemoresistant SKOV-3 ovarian cancer cells. TLR4 and MyD88 expression can be reproducibly assessed via immunohistochemistry using a semi-quantitative scoring system. TLR4 expression was present in all ovarian epithelium (normal and neoplastic), whereas MyD88 was restricted to neoplastic cells, independent of tumour grade and associated with reduced progression-free and overall survival, in an immunohistological specific subset of serous carcinomas, p<0.05. MiR-21 and miR-146a expression was significantly increased in MyD88 negative cancers (p<0.05), indicating their participation in regulation. Significant alterations in MyD88 mRNA expression were observed between chemosensitive and chemoresistant cells and tissue. Knockdown of TLR4 in SKOV-3 ovarian cells recovered chemosensitivity. Knockdown of MyD88 alone did not. MyD88 expression was down-regulated in differentiated embryonal carcinoma (NTera2) cells, supporting the MyD88+ cancer stem cell hypothesis. Our findings demonstrate that expression of MyD88 is associated with significantly reduced patient survival and altered microRNA levels and suggest an intact/functioning TLR4/MyD88 pathway is required for acquisition of the chemoresistant phenotype. Ex vivo manipulation of ovarian cancer stem cell (CSC) differentiation can decrease MyD88 expression, providing a potentially valuable CSC model for ovarian cancer.	[d'Adhemar, Charles J.; Spillane, Cathy D.; Gallagher, Michael F.; Bates, Mark; Smyth, Paul C.; Cooke, Aoife A.; Ffrench, Brendan; Martin, Cara M.; Stordal, Britta; Finn, Stephen; Flood, Brian; Sheils, Orla; O'Toole, Sharon; O'Leary, John J.] Univ Dublin Trinity Coll, Dept Histopathol, Dublin 2, Ireland; [Costello, Katie M.; Barry-O'Crowley, Jacqui; Kernan, Niamh; Murphy, Ciara; O'Leary, John J.] Coombe Womens & Infants Univ Hosp, Dept Pathol, Dublin, Ireland; [Haley, Kathryn; Gleeson, Noreen; D'Arcy, Tom; O'Toole, Sharon] Univ Dublin Trinity Coll, Dept Obstet & Gynaecol, Dublin 2, Ireland; [O'Byrne, Ken] Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld 4102, Australia; [Pennington, Stephen; McCann, Amanda] Univ Coll Dublin, Coll Hlth Sci, Dublin 2, Ireland; [O'Donnell, Dearbhaile] St James Hosp, Dept Med Oncol, Dublin 8, Ireland; [Hennessy, Bryan] Royal Coll Surgeons Ireland, Dept Med Oncol, Dublin 2, Ireland; [O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin	O'Toole, S (corresponding author), Univ Dublin Trinity Coll, Dept Histopathol, Dublin 2, Ireland.	shotoole@tcd.ie	Finn, Stephen/V-3236-2019; Pennington, Stephen R/C-7505-2015; Sheils, Orla Sheils M/B-8461-2015	Finn, Stephen/0000-0002-8628-5814; Sheils, Orla Sheils M/0000-0002-4493-9496; Martin, Cara/0000-0001-8411-8564; Pennington, Stephen/0000-0001-7529-1015; O'Neill, Luke/0000-0002-4333-2748; Cooke, Aoife/0000-0002-1618-1972; O'Byrne, Kenneth/0000-0002-6754-5633; Bates, Mark/0000-0002-5916-5403; McCann, Amanda/0000-0003-1911-3307; Gallagher, Michael/0000-0003-1636-2404; O'Leary, John/0000-0001-7311-9326; Hennessy, Bryan/0000-0002-7871-6477; o toole, sharon/0000-0002-9260-3225; Ffrench, Brendan/0000-0002-5647-3734; Stordal, Britta/0000-0002-7892-951X	Cancer Research Ireland [ICS CRP09OLE]; Meath foundation; Royal City of Dublin Hospital Trust; Emer Casey foundation; Irish Cancer Society; Marie Curie European Union grant;  [BDI-2 (10/CE/B1821)]	Cancer Research Ireland; Meath foundation; Royal City of Dublin Hospital Trust; Emer Casey foundation; Irish Cancer Society; Marie Curie European Union grant; 	This work was supported by Cancer Research Ireland (grant reference number ICS CRP09OLE), the Meath foundation, The Royal City of Dublin Hospital Trust, BDI-2 (10/CE/B1821), the Emer Casey foundation, the Irish Cancer Society, and a Marie Curie European Union grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2006, AM J REPROD IMMUNOL, V55, P399; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1987, INT J ANDROL, V10, P95, DOI 10.1111/j.1365-2605.1987.tb00170.x; ANDREWS PW, 1984, LAB INVEST, V50, P147; Armstrong D, 2008, ABELOFFS CLIN ONCOLO, P1827; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Gallagher MF, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-19; Geisler S, 2001, CANCER RES, V61, P2505; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Lee KR, 2003, WHO CLASSIFICATION T, P117; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P186; Marsden DE, 2000, SEMIN SURG ONCOL, V19, P11, DOI 10.1002/1098-2388(200007/08)19:1<11::AID-SSU3>3.0.CO;2-3; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; O'Lorcain P, 2006, INT J GYNECOL CANCER, V16, P1, DOI 10.1111/j.1525-1438.2006.00479.x; O'Lorcain P, 2007, EUR J CANCER PREV, V16, P167, DOI 10.1097/01.cej.0000228408.68353.ba; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Piver MS, 1998, CLIN OBSTET GYNECOL, V41, P215, DOI 10.1097/00003081-199803000-00026; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Silasi Dan-Arin, 2006, Yale J Biol Med, V79, P153; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szajnik ME, 2009, J CLIN ONCOL, V27; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tsan MF, 2006, SEMIN CANCER BIOL, V16, P32, DOI 10.1016/j.semcancer.2005.07.004; Zeromski J, 2008, CANCER MICROENVIRON, V1, P37, DOI 10.1007/s12307-008-0005-4; Zhu Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-77	42	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100816	10.1371/journal.pone.0100816	http://dx.doi.org/10.1371/journal.pone.0100816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977712	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400042
J	Jiang, ZB; Hu, P; Liu, JX; Wang, DJ; Jin, LY; Hong, C				Jiang, Zhibin; Hu, Ping; Liu, Jianxin; Wang, Dianjun; Jin, Longyu; Hong, Chao			Screening Preoperative Peptide Biomarkers for Predicting Postoperative Myocardial Infarction after Coronary Artery Bypass Grafting	PLOS ONE			English	Article							CARDIAC-SURGERY; RISK; DIAGNOSIS	Postoperative myocardial infarction (PMI) is one of the most serious complications of cardiac surgeries. No preoperative biomarker is currently available for predicting PMI after cardiac surgeries. In the present study, we used a phage display peptide library to screen potential preoperative peptide biomarkers for predicting PMI after coronary artery bypass grafting (CABG) surgery. Twenty patients who developed PMI after CABG and 20 age-, sex-, and body mass index-matched patients without PMI after CABG were enrolled as a discovery cohort. Another 50 patients who developed PMI after CABG and 50 randomly selected patients without PMI after CABG were enrolled as a validation cohort to validate the potential peptide biomarkers identified in the discovery cohort. Fifty randomly selected healthy volunteers were also enrolled in the validation phase as a healthy control group. In the discovery/screening phase, 17 out of 20 randomly selected phage clones exhibited specific reaction with purified sera IgG from the PMI group, among which 11 came from the same phage clone with inserted peptide sequence GVIMVIAVSCVF (named PMI-1). In the validation phase, phage ELISA showed that serum IgG from 90% of patients in the PMI group had a positive reaction with PMI-1; in contrast, only 14% and 6% of patients in the non-PMI group and the healthy control group had a positive reaction with PMI-1, respectively. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the PMI-1 phage clone to preoperatively identify patients who would develop PMI after CABG were 90.0%, 86.0%, 86.5, 89.5% and 88.0%, respectively. The absorbance value of the PMI-1 phage clone showed statistically significant correlation with the peak postoperative serum cardiac troponin I level (r = 0.349, p = 0.012) in the PMI group. In conclusion, we for the first time identified a mimic peptide (PMI-1) with high validity in preoperative prediction of PMI after CABG.	[Jiang, Zhibin; Liu, Jianxin; Wang, Dianjun; Jin, Longyu; Hong, Chao] Cent S Univ, Xiangya Hosp 3, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Hu, Ping] Cent S Univ, Xiangya Hosp, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, P (corresponding author), Cent S Univ, Xiangya Hosp, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	pingping_cpb@163.com			Hunan Provincial Development and Reform Commission [[2013]1199]	Hunan Provincial Development and Reform Commission	This work was supported by Hunan Provincial Development and Reform Commission grant No. [2013]1199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Goffinet M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-34; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Lim CCS, 2011, ANN THORAC SURG, V92, P2046, DOI 10.1016/j.athoracsur.2011.05.019; Molek P, 2011, MOLECULES, V228, P1315; Nalysnyk L, 2003, HEART, V89, P767, DOI 10.1136/heart.89.7.767; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Podgoreanu MV, 2006, CIRCULATION, V114, pI275, DOI 10.1161/CIRCULATIONAHA.105.001032; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Simple English Wikipedia, 2005, HAN CHIN; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wang M, 2011, RHEUMATOL INT, V31, P1009, DOI 10.1007/s00296-010-1403-8; Weng XJ, 2012, CLIN BIOCHEM, V45, P303, DOI 10.1016/j.clinbiochem.2011.12.018	16	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100149	10.1371/journal.pone.0100149	http://dx.doi.org/10.1371/journal.pone.0100149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979051	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400023
J	Kaushik, R; Balasubramanian, R; Dunstan, H				Kaushik, Rajni; Balasubramanian, Rajasekhar; Dunstan, Hugh			Microbial Quality and Phylogenetic Diversity of Fresh Rainwater and Tropical Freshwater Reservoir	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; ESCHERICHIA-COLI; DRINKING-WATER; BACTERIOPLANKTON COMMUNITY; BACTERIAL PATHOGENS; AIRBORNE PARTICLES; DISEASE OUTBREAKS; ABUNDANT GROUP; SARGASSO SEA; HUMIC LAKE	The impact of rainwater on the microbial quality of a tropical freshwater reservoir through atmospheric wet deposition of microorganisms was studied for the first time. Reservoir water samples were collected at four different sampling points and rainwater samples were collected in the immediate vicinity of the reservoir sites for a period of four months (January to April, 2012) during the Northeast monsoon period. Microbial quality of all fresh rainwater and reservoir water samples was assessed based on the counts for the microbial indicators: Escherichia coli (E. coli), total coliforms, and Enterococci along with total heterotrophic plate counts (HPC). The taxonomic richness and phylogenetic relationship of the freshwater reservoir with those of the fresh rainwater were also assessed using 16 S rRNA gene clone library construction. The levels of E. coli were found to be in the range of 0 CFU/100 mL - 75 CFU/100 mL for the rainwater, and were 10-94 CFU/100 mL for the reservoir water. The sampling sites that were influenced by highway traffic emissions showed the maximum counts for all the bacterial indicators assessed. There was no significant increase in the bacterial abundances observed in the reservoir water immediately following rainfall. However, the composite fresh rainwater and reservoir water samples exhibited broad phylogenetic diversity, including sequences representing Betaproteobacteria, Alphaproteobacteria, Gammaproteobacteria, Actinobacteria, Lentisphaerae and Bacteriodetes. Members of the Betaproteobacteria group were the most dominant in both fresh rainwater and reservoir water, followed by Alphaproteobacteria, Sphingobacteria, Actinobacteria and Gammaproteobacteria.	[Kaushik, Rajni; Balasubramanian, Rajasekhar] Natl Univ Singapore, Singapore Delft Water Alliance, Singapore 117548, Singapore; [Kaushik, Rajni; Balasubramanian, Rajasekhar] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore; [Dunstan, Hugh] Univ Newcastle, Sch Environm & Life Sci, Callahan, NSW, Australia	National University of Singapore; National University of Singapore; University of Newcastle	Balasubramanian, R (corresponding author), Natl Univ Singapore, Singapore Delft Water Alliance, Singapore 117548, Singapore.	ceerbala@nus.edu.sg	Balasubramanian, Rajasekhar/C-2243-2011	Balasubramanian, Rajasekhar/0000-0002-5627-3628	Singapore-Delft Water Alliance, National University of Singapore (NUS); SDWA	Singapore-Delft Water Alliance, National University of Singapore (NUS); SDWA	This study was financially supported by Singapore-Delft Water Alliance, National University of Singapore (NUS). Rajni Kaushik thanks SDWA for supporting her Ph.D. study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2012, ENVIRON SCI TECHNOL, V46, P11370, DOI 10.1021/es302222b; Ahmed W, 2013, AWA WATER, V40, P88; Altmann D, 2003, ENVIRON MICROBIOL, V5, P798, DOI 10.1046/j.1469-2920.2003.00469.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amato P, 2005, ATMOS ENVIRON, V39, P4143, DOI 10.1016/j.atmosenv.2005.04.002; Ariya PA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015637; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Brierley EDR, 2001, SOIL BIOL BIOCHEM, V33, P1403, DOI 10.1016/S0038-0717(01)00045-1; Brookes JD, 2004, ENVIRON INT, V30, P741, DOI 10.1016/j.envint.2003.11.006; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DIMMICK RL, 1979, APPL ENVIRON MICROB, V37, P924, DOI 10.1128/AEM.37.5.924-927.1979; EDBERG SC, 1990, APPL ENVIRON MICROB, V56, P366, DOI 10.1128/AEM.56.2.366-369.1990; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Evans CA, 2006, WATER RES, V40, P37, DOI 10.1016/j.watres.2005.10.034; Evans CA, 2009, SCI TOTAL ENVIRON, V407, P5206, DOI 10.1016/j.scitotenv.2009.06.009; Ferguson C, 2003, CRIT REV ENV SCI TEC, V33, P299, DOI 10.1080/10643380390814497; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hiorns WD, 1997, APPL ENVIRON MICROB, V63, P2957, DOI 10.1128/AEM.63.7.2957-2960.1997; Hofle MG, 1999, APPL ENVIRON MICROB, V65, P3164; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kaushik R, 2013, SCI TOTAL ENVIRON, V449, P237, DOI 10.1016/j.scitotenv.2013.01.065; Kaushik R, 2012, APPL ENVIRON MICROB, V78, P2813, DOI 10.1128/AEM.07695-11; Kaushik R, 2012, ATMOS ENVIRON, V46, P131, DOI 10.1016/j.atmosenv.2011.10.013; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Lemke MJ, 2009, MICROB ECOL, V57, P94, DOI 10.1007/s00248-008-9398-3; Liu ZH, 2012, FEMS MICROBIOL ECOL, V80, P30, DOI 10.1111/j.1574-6941.2011.01268.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin AR, 2010, J ENVIRON MONITOR, V12, P255, DOI [10.1039/b904042k, 10.1039/B904042K]; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meera V, 2006, J WATER SUPPLY RES T, V55, P257, DOI 10.2166/aqua.2006.0010; Merz J, 2006, J HYDROL, V331, P446, DOI 10.1016/j.jhydrol.2006.05.030; National Health and Medical Research Council, 2004, GUID DRINK WAT QUAL; Newton RJ, 2006, ENVIRON MICROBIOL, V8, P956, DOI 10.1111/j.1462-2920.2005.00979.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oliver JD, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P277; OLSON BH, 1984, ADV APPL MICROBIOL, V30, P73, DOI 10.1016/S0065-2164(08)70053-4; Pisciotta JM, 2002, APPL ENVIRON MICROB, V68, P539, DOI 10.1128/AEM.68.2.539-544.2002; Sargaonkar A, 2006, ENVIRON MONIT ASSESS, V117, P491, DOI 10.1007/s10661-006-0769-2; Sartory DP, 2004, INT J FOOD MICROBIOL, V92, P297, DOI 10.1016/j.ijfoodmicro.2003.08.006; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Turkum A, 2008, ATMOS RES, V89, P315, DOI 10.1016/j.atmosres.2008.03.010; USEPA, 2002, EPA821R02022 OFF WAT; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2001, BIOTECHNIQUES, V30, P938, DOI 10.2144/01305bm03; WARD NR, 1986, ADV APPL MICROBIOL, V31, P293, DOI 10.1016/S0065-2164(08)70446-5; Warnecke F, 2004, ENVIRON MICROBIOL, V6, P242, DOI 10.1111/j.1462-2920.2004.00561.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHO, 2006, GUID DRINK WAT QUAL; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu X, 2007, FEMS MICROBIOL ECOL, V61, P85, DOI 10.1111/j.1574-6941.2007.00326.x; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2	71	29	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100737	10.1371/journal.pone.0100737	http://dx.doi.org/10.1371/journal.pone.0100737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979573	Green Published, gold			2022-12-25	WOS:000338506400038
J	Lu, M; Wang, XX; Sun, GW; Qin, B; Xiao, JZ; Yan, SL; Pan, YJ; Wang, YJ				Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Yan, Shuling; Pan, Yingjie; Wang, Yongjie			Fine Structure of Tibetan Kefir Grains and Their Yeast Distribution, Diversity, and Shift	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SACCHAROMYCES-CEREVISIAE; MICROBIAL DIVERSITY; RIBOSOMAL-RNA; IDENTIFICATION; CULTURE; PCR; GENES	Tibetan kefir grains (TKGs), a kind of natural starter for fermented milk in Tibet, China, host various microorganisms of lactic acid bacteria, yeasts, and occasionally acetic acid bacteria in a polysaccharide/protein matrix. In the present study, the fine structure of TKGs was studied to shed light on this unusual symbiosis with stereomicroscopy and thin sections. The results reveal that TKGs consist of numerous small grain units, which are characterized by a hollow globular structure with a diameter between 2.0 and 9.0 mm and a wall thickness of approximately 200 mm. A polyhedron-like net structure, formed mainly by the bacteria, was observed in the wall of the grain units, which has not been reported previously to our knowledge. Towards the inside of the grain unit, the polyhedron-like net structures became gradually larger in diameter and fewer in number. Such fine structures may play a crucial role in the stability of the grains. Subsequently, the distribution, diversity, and shift of yeasts in TKGs were investigated based on thin section, scanning electron microscopy, cloning and sequencing of D1/D2 of the 26S rRNA gene, real-time quantitative PCR, and in situ hybridization with specific fluorescence-labeled oligonucleotide probes. These show that (i) yeasts appear to localize on the outer surface of the grains and grow normally together to form colonies embedded in the bacterial community; (ii) the diversity of yeasts is relatively low on genus level with three dominant species - Saccharomyces cerevisiae, Kluyveromyces marxianus, and Yarrowia lipolytica; (iii) S. cerevisiae is the stable predominant yeast species, while the composition of Kluyveromyces and Yarrowia are subject to change over time. Our results indicate that TKGs are relatively stable in structure, and culture conditions to some extent shape the microbial community and interaction in kefir grains. These findings pave the way for further study of the specific symbiotic associations between S. cerevisiae and Lactobacillus bacteria in TKGs.	[Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Pan, Yingjie; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Pan, Yingjie; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Yan, Shuling] Univ Goettingen, Inst Biochem & Mol Cell Biol, Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn		Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Program for Professor of Special Appointment from Shanghai Municipal Education Commission [20101222]; Shanghai Talent Development Fund from Shanghai Municipal Human Resources and Social Security Bureau, China [2011010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment from Shanghai Municipal Education Commission; Shanghai Talent Development Fund from Shanghai Municipal Human Resources and Social Security Bureau, China	This work was supported by the National Natural Science Foundation of China (Grant No. 41376135), the Program for Professor of Special Appointment (Eastern Scholar, 20101222) from Shanghai Municipal Education Commission and Shanghai Talent Development Fund (2011010) from Shanghai Municipal Human Resources and Social Security Bureau, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, CRIT REV FOOD SCI, V53, P422, DOI 10.1080/10408398.2010.540360; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; Brialy C, 1995, FOLIA MICROBIOL, V40, P198, DOI 10.1007/BF02815423; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Diniz RO, 2003, PHARMACOL RES, V47, P49, DOI 10.1016/S1043-6618(02)00240-2; Farnworth E. R., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P1, DOI 10.1616/1476-2137.13938; Ferreira IMPLVO, 2010, J DAIRY SCI, V93, P27, DOI 10.3168/jds.2009-2501; Foster HA, 2010, METHODS MOL BIOL, V659, P427, DOI 10.1007/978-1-60761-789-1_33; Gao J, 2013, EUR FOOD RES TECHNOL, V236, P549, DOI 10.1007/s00217-013-1912-2; Gao J, 2012, J FOOD SCI, V77, pM425, DOI 10.1111/j.1750-3841.2012.02805.x; Garner CD, 2010, J CLIN MICROBIOL, V48, P2140, DOI 10.1128/JCM.02306-09; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Ho JN, 2013, J SCI FOOD AGR, V93, P485, DOI 10.1002/jsfa.5792; Inacio J, 2003, APPL ENVIRON MICROB, V69, P2899, DOI 10.1128/AEM.69.5.2899-2905.2003; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Kowalczyk M, 2012, J DAIRY RES, V79, P26, DOI 10.1017/S0022029911000677; Kurtzman CP, 2014, INT J SYST EVOL MICR, V64, P325, DOI 10.1099/ijs.0.054197-0; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; LIBUDZISZ Z, 1990, DAIRY IND INT, V55, P31; Lin CW, 1999, AUST J DAIRY TECHNOL, V54, P14; Magalhaes KT, 2010, WORLD J MICROB BIOT, V26, P1241, DOI 10.1007/s11274-009-0294-x; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; MARSHALL VM, 1985, J DAIRY RES, V52, P451, DOI 10.1017/S0022029900024353; Mendes F, 2013, APPL ENVIRON MICROB, V79, P5949, DOI 10.1128/AEM.01115-13; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Park EJ, 2009, J MICROBIOL, V47, P682, DOI 10.1007/s12275-009-0297-1; Pei Y, 2011, ACS NANO, V5, P1441, DOI 10.1021/nn103217z; Plessas S, 2011, FOOD CHEM, V124, P627, DOI 10.1016/j.foodchem.2010.06.086; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Rodrigues KL, 2005, INT J ANTIMICROB AG, V25, P404, DOI 10.1016/j.ijantimicag.2004.09.020; Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012; Simova E, 2002, J IND MICROBIOL BIOT, V28, P1, DOI [10.1038/sj/jim/7000186, 10.1038/sj.jim.7000186]; Stadie J, 2013, FOOD MICROBIOL, V35, P92, DOI 10.1016/j.fm.2013.03.009; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urdaneta E, 2007, NUTR RES, V27, P653, DOI 10.1016/j.nutres.2007.08.002; VIEGAS CA, 1989, APPL ENVIRON MICROB, V55, P21, DOI 10.1128/AEM.55.1.21-28.1989; Vinderola CG, 2005, J DAIRY RES, V72, P195, DOI 10.1017/S0022029905000828; Wang SY, 2008, J DAIRY SCI, V91, P3798, DOI 10.3168/jds.2007-0468; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	41	9	12	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101387	10.1371/journal.pone.0101387	http://dx.doi.org/10.1371/journal.pone.0101387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977409	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400125
J	Mohapatra, S; Chakraborty, T; Prusty, AK; PaniPrasad, K; Mohanta, KN				Mohapatra, Sipra; Chakraborty, Tapas; Prusty, Ashisa K.; PaniPrasad, Kurchetti; Mohanta, Kedar N.			Beneficial Effects of Dietary Probiotics Mixture on Hemato-Immunology and Cell Apoptosis of Labeo rohita Fingerlings Reared at Higher Water Temperatures	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; INDIAN MAJOR CARP; GROWTH-PERFORMANCE; GILTHEAD SEABREAM; VITAMIN-C; FISH; METABOLISM; EXPRESSION; TOLERANCE; BACTERIA	Probiotics play an important role in growth increment, immune enhancement and stress mitigation in fish. Increasing temperature is a major concern in present aquaculture practices as it markedly deteriorates the health condition and reduces the growth in fish. In order to explore the possibilities of using probiotics as a counter measure for temperature associated problems, a 30 days feeding trial was conducted to study the hemato-immunological and apoptosis response of Labeo rohita (8.3 +/- 0.4 g) reared at different water temperatures, fed with or without dietary supplementation of a probiotic mixture (PM) consisting of Bacillus subtilis, Lactococcus lactis and Saccharomyces cerevisiae) (10(11) cfu kg(-1)). Three hundred and sixty fish were randomly distributed into eight treatment groups in triplicates, namely, T1(28 degrees C+BF(Basal feed)+PM), T2(31 degrees C+BF+PM), T3(34 degrees C+BF+PM), T4(37 degrees C+BF+PM), T5(28 degrees C+BF), T6(31 degrees C+BF), T7(34 degrees C+BF) and T8(37 degrees C+BF). A significant increase (P<0.01) in weight gain percentage was observed in the probiotic fed fish even when reared at higher water temperature (34-37 degrees C). Respiratory burst assay, blood glucose, erythrocyte count, total serum protein, albumin, alkaline phosphatase and acid phosphatase were significantly higher (P<0.01) in the probiotic fed groups compared to the non-probiotic fed groups. A significant (P<0.01) effect of rearing temperature and dietary probiotic mixture on serum myeloperoxidase activity, HSP70 level and immunoglobulin production was observed. Degree of apoptosis in different tissues was also significantly reduced in probiotic-supplemented groups. Hence, the present results show that a dietary PM could be beneficial in enhancing the immune status of the fish and also help in combating the stress caused to the organism by higher rearing water temperature.	[Mohapatra, Sipra] NIBB, Lab Bioresource, Okazaki, Aichi, Japan; [Chakraborty, Tapas] NIBB, Div Mol Environm Endocrinol, Okazaki, Aichi, Japan; [Mohapatra, Sipra; Chakraborty, Tapas] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Japan; [Prusty, Ashisa K.] Project Directorate Farming Syst Res, Meerut, Uttar Pradesh, India; [Mohapatra, Sipra; PaniPrasad, Kurchetti] Cent Inst Fisheries Educ, Bombay, Maharashtra, India; [Mohanta, Kedar N.] Cent Inst Freshwater Aquaculture, Bhubaneswar, Orissa, India	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Ehime University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Farming Systems Research; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture	Mohapatra, S (corresponding author), NIBB, Lab Bioresource, Okazaki, Aichi, Japan.	sipra@nibb.ac.jp; tapas_c@nibb.ac.jp	Mohanta, Dr Kedar Nath/AAZ-1086-2021; Chakraborty, Tapas/M-5865-2018	Mohapatra, Sipra/0000-0002-0891-6713; Chakraborty, Tapas/0000-0003-1984-234X; Prusty, Ashisa Kumar/0000-0003-3402-9744	Indian Council of Agricultural Research (ICAR), New Delhi, India; MEXT, Japan	Indian Council of Agricultural Research (ICAR), New Delhi, India(Indian Council of Agricultural Research (ICAR)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by Indian Council of Agricultural Research (ICAR), New Delhi, India and MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2011, J ANIMAL PHYSL ANIMA, V96, P581; Al-Dohail MA, 2009, AQUAC RES, V40, P1642, DOI 10.1111/j.1365-2109.2009.02265.x; Bly J.E., 1992, Fish & Shellfish Immunology, V2, P159, DOI 10.1016/S1050-4648(05)80056-7; Bozorgnia A., 2011, INT C ENV SCI TECHN, V6; Burel C, 1996, J FISH BIOL, V49, P678, DOI 10.1111/j.1095-8649.1996.tb00064.x; Das T, 2006, ASIAN AUSTRAL J ANIM, V19, P1033, DOI 10.5713/ajas.2006.1033; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; Dash G, 2011, CHRON YOUNG SCI, V2, P29, DOI DOI 10.4103/2229-5186.79347; DYER SD, 1991, CAN J ZOOL, V69, P2021, DOI 10.1139/z91-282; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Ekert PG, 1997, BRIT MED BULL, V53, P591; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; FOSTER GD, 1986, FISH PHYSIOL BIOCHEM, V1, P113, DOI 10.1007/BF02290211; Gomes LC, 2009, AQUAC RES, V40, P157, DOI 10.1111/j.1365-2109.2008.02077.x; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jhingran V.G., 1975, FISH FISHERIES INDIA; Kausar R., 2006, Pakistan Veterinary Journal, V26, P105; Koninkx JFJG, 2008, FOLIA MICROBIOL, V53, P189, DOI 10.1007/s12223-008-0023-0; Kumar R, 2006, AQUAC RES, V37, P1215, DOI 10.1111/j.1365-2109.2006.01551.x; Li SQ, 2012, J PHYSIOL SCI, V62, P29, DOI 10.1007/s12576-011-0183-6; Luzio A, 2013, AQUAT TOXICOL, V128, P183, DOI 10.1016/j.aquatox.2012.12.018; Marzouk M. S., 2008, From the pharaohs to the future. Eighth International Symposium on Tilapia in Aquaculture. Proceedings. Cairo, Egypt, 12-14 October, 2008, P1043; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mohanty S. N., 1996, Journal of Aquaculture in the Tropics, V11, P253; Mohapatra S, 2013, J ANIM PHYSIOL AN N, V97, P405, DOI 10.1111/j.1439-0396.2012.01301.x; Mohapatra S, 2012, AQUACULT NUTR, V18, P1, DOI 10.1111/j.1365-2095.2011.00866.x; Mohapatra S, 2011, FISH PHYSIOL BIOCHEM, V37, P177, DOI 10.1007/s10695-010-9428-1; Mohapatra S, 2012, PESTIC BIOCHEM PHYS, V104, P28, DOI 10.1016/j.pestbp.2012.06.006; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Nelson JW, 1945, HAWKS PHYSIOLOGICAL; OCONOR GT, 1986, CELL TISSUE KINET, V19, P539, DOI 10.1111/j.1365-2184.1986.tb00754.x; Ortuno J, 2003, FISH SHELLFISH IMMUN, V14, P145, DOI 10.1006/fsim.2002.0428; Oser B.L., 1965, HAWKS PHYSIOLOGICAL; Panigrahi A, 2007, FISH PHYSIOL BIOCHEM, V33, P429, DOI 10.1007/s10695-007-9160-7; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Picchietti S, 2009, FISH SHELLFISH IMMUN, V26, P368, DOI 10.1016/j.fsi.2008.10.008; Quade MJ, 1997, VET IMMUNOL IMMUNOP, V58, P239, DOI 10.1016/S0165-2427(97)00048-2; RENUKARADHYA KM, 1986, P INDIAN AS-ANIM SCI, V95, P103, DOI 10.1007/BF03179363; Sakai M, 1999, AQUACULTURE, V172, P63, DOI 10.1016/S0044-8486(98)00436-0; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Sarma K, 2009, SCI TOTAL ENVIRON, V407, P3668, DOI 10.1016/j.scitotenv.2009.02.031; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; SMITH LS, 1989, FISH NUTR, P331; Stasiak SA, 1996, FISH SHELLFISH IMMUN, V6, P537, DOI 10.1006/fsim.1996.0050; Stenslokken KO, 2010, AM J PHYSIOL-REG I, V298, pR1499, DOI 10.1152/ajpregu.00675.2009; Swain P, 2007, VET IMMUNOL IMMUNOP, V117, P137, DOI 10.1016/j.vetimm.2007.02.010; Taoka Y, 2006, FISHERIES SCI, V72, P310, DOI 10.1111/j.1444-2906.2006.01152.x; Tejpal Dahiya, 2012, Journal of Fisheries and Aquatic Science, V7, P279, DOI 10.3923/jfas.2012.279.290; Vasudevan DM, 1998, TXB BIOCH MED STUDEN; Wang YB, 2007, AQUACULTURE, V269, P259, DOI 10.1016/j.aquaculture.2007.05.035; Weber LP, 2001, AQUAT TOXICOL, V54, P39, DOI 10.1016/S0166-445X(00)00179-X; Yamashita Michiaki, 2010, Aqua-Bioscience Monographs, V3, P111, DOI 10.5047/absm.2010.00304.0111; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x; Zhou XX, 2010, FISH PHYSIOL BIOCHEM, V36, P501, DOI 10.1007/s10695-009-9320-z	55	46	51	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100929	10.1371/journal.pone.0100929	http://dx.doi.org/10.1371/journal.pone.0100929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979660	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400050
J	Reznik, B; Clement, SL; Lykke-Andersen, J				Reznik, Boris; Clement, Sandra L.; Lykke-Andersen, Jens			hnRNP F Complexes with Tristetraprolin and Stimulates ARE-mRNA Decay	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; AU-RICH ELEMENTS; BINDING PROPERTIES; NANOS TRANSLATION; GENE-EXPRESSION; MEDIATED DECAY; TTP; TURNOVER; REGULATOR; FAMILY	The tristetraprolin (TTP) family of zinc-finger proteins, TTP, BRF1 and BRF2, regulate the stability of a subset of mRNAs containing 3'UTR AU-rich elements (AREs), including mRNAs coding for cytokines, transcription factors, and proto-oncogenes. To better understand the mechanism by which TTP-family proteins control mRNA stability in mammalian cells, we aimed to identify TTP- and BRF1-interacting proteins as potential TTP-family co-factors. This revealed hnRNP F as a prominent interactor of TTP and BRF1. While TTP, BRF1 and hnRNP F are all RNA binding proteins (RBPs), the interaction of hnRNP F with TTP and BRF1 is independent of RNA. Depletion of hnRNP F impairs the decay of a subset of TTP-substrate ARE-mRNAs by a mechanism independent of the extent of hnRNP F binding to the mRNA. Taken together, these findings implicate hnRNP F as a co-factor in a subset of TTP/BRF-mediated mRNA decay and highlight the importance of RBP cooperativity in mRNA regulation.	[Reznik, Boris; Clement, Sandra L.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lykke-Andersen, J (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jlykkeandersen@ucsd.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	National Institutes of Health [R01 GM077243]; National Institutes of Health NRSA Institutional Training Grant from the National Institute of General Medical Sciences [GM007240]; American Cancer Society [PF-06-156-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA Institutional Training Grant from the National Institute of General Medical Sciences; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant R01 GM077243 to J.L.-A. from the National Institutes of Health. B. R. was supported by National Institutes of Health NRSA Institutional Training Grant GM007240 from the National Institute of General Medical Sciences. S. L. C. was supported by a postdoctoral fellowship (PF-06-156-01-GMC) from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Andrews S, 2011, RNA, V17, P967, DOI 10.1261/rna.2478611; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Desroches-Castan A, 2011, MOL BIOL CELL, V22, P3625, DOI 10.1091/mbc.E11-02-0149; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gingerich Timothy J., 2004, Animal Health Research Reviews, V5, P49, DOI [10.1079/AHR200460, 10.1079/AHRR200460]; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100992	10.1371/journal.pone.0100992	http://dx.doi.org/10.1371/journal.pone.0100992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978456	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400057
J	von Rintelen, T; Stelbrink, B; Marwoto, RM; Glaubrecht, M				von Rintelen, Thomas; Stelbrink, Bjoern; Marwoto, Ristiyanti M.; Glaubrecht, Matthias			A Snail Perspective on the Biogeography of Sulawesi, Indonesia: Origin and Intra-Island Dispersal of the Viviparous Freshwater Gastropod Tylomelania	PLOS ONE			English	Article							ADAPTIVE RADIATION; ANCIENT LAKES; PACHYCHILIDAE; MITOCHONDRIAL; CERITHIOIDEA; PHYLOGENY; EVOLUTION; DIVERSIFICATION; MODELS; ASIA	The complex geological history of the Indonesian island Sulawesi has shaped the origin and subsequent diversification of its taxa. For the endemic freshwater snail Tylomelania a vicariant origin from the Australian margin has been hypothesized. Divergence time estimates from a mtDNA phylogeny based on a comprehensive island-wide sampling of Tylomelania fit regional tectonic constraints and support the 'out-of-Australia' vicariance hypothesis. The Banggai-Sula region of the Sula Spur, the Australian promontory colliding with West Sulawesi during the Miocene, is identified as a possible source area for the colonization of Sulawesi by the ancestor of Tylomelania. The molecular phylogeny also shows a rapid diversification of Tylomelania into eight major lineages with very little overlap in their distribution on the island. Haplotype networks provide further evidence for a strong spatial structure of genetic diversity in Tylomelania. Distribution boundaries of the major lineages do at best partially coincide with previously identified contact zones for other endemic species groups on Sulawesi. This pattern has likely been influenced by the poor dispersal capabilities and altitudinal distribution limits of this strict freshwater inhabitant. We suggest that late Miocene and Pliocene orogeny in large parts of Sulawesi has been the vicariant event driving primary diversification in Tylomelania.	[von Rintelen, Thomas; Stelbrink, Bjoern; Glaubrecht, Matthias] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Marwoto, Ristiyanti M.] LIPI, Biol Res Ctr, Museum Zoologicum Bogoriense, Div Zool, Bogor, Indonesia	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Bogor Zoology Museum; Indonesian Institute of Sciences	von Rintelen, T (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany.	thomas.rintelen@mfn-berlin.de	Stelbrink, Björn/Y-5023-2019	Stelbrink, Björn/0000-0002-7471-4992; Marwoto, Ristiyanti/0000-0003-1724-8152	German Research Council (DFG) [GL 1738/1-1, GL 1738/7-1, GL 1738/7-2, GL 1738/7-3, RI 1738/4-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was financed by German Research Council (DFG, www.dfg.de) grants GL 1738/1-1, 7-1, 7-2, -3, and RI 1738/4-1 to MG and TvR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Avise J.C., 2004, MOL MARKERS NATURAL; Bridle JR, 2004, EVOLUTION, V58, P1394; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; BURRETT C, 1991, Australian Systematic Botany, V4, P13, DOI 10.1071/SB9910013; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clouse RM, 2010, J BIOGEOGR, V37, P1114, DOI 10.1111/j.1365-2699.2010.02274.x; COHEN A S, 1987, Palaios, V2, P426, DOI 10.2307/3514614; Cox CB, 2001, J BIOGEOGR, V28, P511; De Bruyn Mark, 2012, Systematics Association Special Volume Series, V82, P316; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BJ, 2008, BIOL LETTERS, V4, P430, DOI 10.1098/rsbl.2008.0166; Evans BJ, 1999, BIOL J LINN SOC, V66, P539, DOI 10.1111/j.1095-8312.1999.tb01925.x; Evans BJ, 2003, EVOLUTION, V57, P1931; Evans BJ, 2003, EVOLUTION, V57, P1436; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garrard R.A., 1988, P IND PETR ASS 17 AN, P23; Glaubrecht M, 2003, ZOOL SCR, V32, P415, DOI 10.1046/j.1463-6409.2003.00127.x; Glaubrecht M., 1996, EVOLUTIONSOKOLOGIE S; Glaubrecht M, 2008, HYDROBIOLOGIA, V615, P181, DOI 10.1007/s10750-008-9568-9; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R., 2012, BIOTIC EVOLUTION ENV, P32, DOI DOI 10.1017/CBO9780511735882.005; Hall R, 2011, GEOL SOC SPEC PUBL, V355, P75, DOI 10.1144/SP355.5; Keast A, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P287; Kohler F, 2010, BIOL J LINN SOC, V99, P867, DOI 10.1111/j.1095-8312.2009.01390.x; Kohler F, 2009, ZOOL J LINN SOC-LOND, V157, P679, DOI 10.1111/j.1096-3642.2009.00541.x; Kohler F, 2004, EVOLUTION, V58, P2215; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linkem CW, 2013, J BIOGEOGR, V40, P507, DOI 10.1111/jbi.12022; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Merker S, 2009, P NATL ACAD SCI USA, V106, P8459, DOI 10.1073/pnas.0900319106; Metcalfe I, 2011, GEOL SOC SPEC PUBL, V355, P7, DOI 10.1144/SP355.2; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Morley RJ, 2000, ORIGIN EVOLUTION TRO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedas LA, 2005, J MAMMAL, V86, P353, DOI 10.1644/BER-117.1; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; SIMPSON GG, 1977, P AM PHILOS SOC, V121, P107; Spakman W, 2010, NAT GEOSCI, V3, P562, DOI [10.1038/ngeo917, 10.1038/NGEO917]; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stelbrink B, 2012, EVOLUTION, V66, P2252, DOI 10.1111/j.1558-5646.2012.01588.x; Swofford D., 2002, PAUP VERSION 4 0 PHY; Taylor EH, 1928, DISTRIBUTION LIFE PH, V21, P214; Von Rintelen T, 2005, BIOL J LINN SOC, V85, P513, DOI 10.1111/j.1095-8312.2005.00515.x; von Rintelen T, 2004, P ROY SOC B-BIOL SCI, V271, P2541, DOI 10.1098/rspb.2004.2842; von Rintelen T., 2012, BIOTIC EVOLUTION ENV, P290, DOI DOI 10.1017/CBO9780511735882.014; Von Rintelen T, 2008, ZOOTAXA, P37; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P485, DOI 10.1007/978-3-642-12425-9_23; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whitten AJ, 2002, ECOLOGY SULAWESI; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Wilson MEJ, 1999, PALAEOGEOGR PALAEOCL, V145, P303, DOI 10.1016/S0031-0182(98)00127-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	63	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e98917	10.1371/journal.pone.0098917	http://dx.doi.org/10.1371/journal.pone.0098917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971564	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200007
J	La Paz, JL; Pla, M; Centeno, E; Vicient, CM; Puigdomenech, P				Luis La Paz, Jose; Pla, Maria; Centeno, Emilio; Vicient, Carlos M.; Puigdomenech, Pere			The Use of Massive Sequencing to Detect Differences between Immature Embryos of MON810 and a Comparable Non-GM Maize Variety	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; GENE-EXPRESSION; RNA-SEQ; TRANSCRIPTOME; DISCOVERY; PATTERNS; DORMANCY; RICE; TOOL; PCR	The insect resistant maize YieldGard MON810 was studied to assess the extent to which introduction of a transgene may putatively alter the expression of endogenous genes by comparison of various GM lines vs. their non-transgenic counterparts. To assess the extent to which introduction of a transgene may putatively alter the expression of endogenous genes, GM lines of the insect resistant maize YieldGard MON810 were compared with non-transgenic counterparts. For a more in-depth study, high-throughput deep sequencing together with microarrays were used to compare the transcriptomes of immature embryos of the MON810 variety DKC6575, with a cryIA(b) transgene, and its near-isogenic variety Tietar, grown under controlled environmental conditions. This technique also allows characterisation of the transgenic mRNAs produced. 39UTR-anchored mRNA-seq produced 1,802,571 sequences from DKC6575 and 1,170,973 from Tietar, which mapped to 14,712 and 14,854 unigenes, respectively. Up to 32 reads from the transgenic embryos matched to the synthetic cry1A(b) sequence, similar to medium-abundant mRNAs. Gene expression analysis, using the R-bioconductor packages EdgeR and DEseq, revealed 140 differentially expressed genes mainly involved in carbohydrate metabolism, protein metabolism and chromatin organisation. Comparison of the expression of 30 selected genes in two additional MON810 and near-isogenic variety pairs showed that most of them were differentially expressed in the three pairs of varieties analysed. Analysis of functional annotation and the precise moment of expression of the differentially expressed genes and physiological data obtained suggest a slight but significant delay in seed and plant maturation of MON810 plants. However, these transcriptomic changes were not associated to undesirable changes in the global phenotype or plant behaviour. Moreover, while most expression changes in MON810 immature embryos were maintained in other transgenic varieties, some gene expression was found to be modulated by the genetic background in which the transgene was introduced through conventional breeding programs.	[Luis La Paz, Jose; Pla, Maria; Centeno, Emilio; Vicient, Carlos M.; Puigdomenech, Pere] CSIC IRTA UAB UB, Consejo Super Invest Cient, Ctr Res Agrigen, Dept Mol Genet, Barcelona, Spain; [Pla, Maria] Univ Girona, Inst Food & Agr Technol INTEA, EPS I, Girona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Universitat de Girona	Puigdomenech, P (corresponding author), CSIC IRTA UAB UB, Consejo Super Invest Cient, Ctr Res Agrigen, Dept Mol Genet, Barcelona, Spain.	pere.puigdomenech@cragenomica.es	Vicient, Carlos M M/K-3878-2012; Centeno, Emilio/Q-4784-2019; Pla, Maria/K-5170-2017; Schulman, Alan/A-9322-2011	Vicient, Carlos M M/0000-0002-6897-9046; Centeno, Emilio/0000-0003-2798-978X; Pla, Maria/0000-0003-4382-5494; Schulman, Alan/0000-0002-4126-6177	Spanish MEC project [AGL2007-65903/AGR]; CONSOLIDER project; Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya	Spanish MEC project(Spanish Government); CONSOLIDER project(Spanish Government); Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya	This work was funded by the Spanish MEC project ref. AGL2007-65903/AGR, the CONSOLIDER project and the Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya. The authors thank the Massive Sequencing Service of CRAG for their help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; BOCHICCHIO A, 1988, AGRONOMIE, V8, P29, DOI 10.1051/agro:19880104; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Che P, 2006, PLANT MOL BIOL, V62, P1, DOI 10.1007/s11103-006-9013-2; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coetzer N, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-31; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; DALESSIO JM, 1988, NUCLEIC ACIDS RES, V16, P1999; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; He H, 2009, ACTA PHYSIOL PLANT, V31, P749, DOI 10.1007/s11738-009-0287-2; Hernandez M, 2003, TRANSGENIC RES, V12, P179, DOI 10.1023/A:1022979624333; Holck A, 2002, EUR FOOD RES TECHNOL, V214, P449, DOI 10.1007/s00217-001-0473-y; Kogel KH, 2010, P NATL ACAD SCI USA, V107, P6198, DOI 10.1073/pnas.1001945107; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Lohse M, 2012, NUCL ACIDS RES, V40; Lopez A, 2009, DOSSIER TECNIC N35 G; La Paz JL, 2010, ANAL BIOANAL CHEM, V396, P2125, DOI 10.1007/s00216-009-3176-z; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meuer S, 2001, RAPID CYCLE REAL TIM, P21, DOI 10.1007/978-3-642-59524-0; Montero M, 2011, PLANT BIOTECHNOL J, V9, P693, DOI 10.1111/j.1467-7652.2010.00572.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosati A, 2008, PLANT MOL BIOL, V67, P271, DOI 10.1007/s11103-008-9315-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Sekhon RS, 2014, PLANT PHYSIOL, V165, P658, DOI 10.1104/pp.114.235424; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; van Dijk JP, 2010, REGUL TOXICOL PHARM, V58, pS21, DOI 10.1016/j.yrtph.2010.06.012; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	45	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100895	10.1371/journal.pone.0100895	http://dx.doi.org/10.1371/journal.pone.0100895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967839	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800078
J	Pellon-Maison, M; Montanaro, MA; Lacunza, E; Garcia-Fabiani, MB; Soler-Gerino, MC; Cattaneo, ER; Quiroga, IY; Abba, MC; Coleman, RA; Gonzalez-Baro, MR				Pellon-Maison, Magali; Montanaro, Mauro A.; Lacunza, Ezequiel; Garcia-Fabiani, Maria B.; Soler-Gerino, Mercedes C.; Cattaneo, Elizabeth R.; Quiroga, Ivana Y.; Abba, Martin C.; Coleman, Rosalind A.; Gonzalez-Baro, Maria R.			Glycerol-3-Phosphate Acyltranferase-2 Behaves as a Cancer Testis Gene and Promotes Growth and Tumorigenicity of the Breast Cancer MDA-MB-231 Cell Line	PLOS ONE			English	Article							STEM-CELLS; CANCER/TESTIS ANTIGENS; GENOME-WIDE; EXPRESSION; OVEREXPRESSION; COEXPRESSION; GPAT2; PIRNA	The de novo synthesis of glycerolipids in mammalian cells begins with the acylation of glycerol-3-phosphate, catalyzed by glycerol-3-phosphate acyltransferase (GPAT). GPAT2 is a mitochondrial isoform primarily expressed in testis under physiological conditions. Because it is aberrantly expressed in multiple myeloma, it has been proposed as a novel cancer testis gene. Using a bioinformatics approach, we found that GPAT2 is highly expressed in melanoma, lung, prostate and breast cancer, and we validated GPAT2 expression at the protein level in breast cancer by immunohistochemistry. In this case GPAT2 expression correlated with a higher histological grade. 5-Aza-2' deoxycytidine treatment of human cells lines induced GPAT2 expression suggesting epigenetic regulation of gene expression. In order to evaluate the contribution of GPAT2 to the tumor phenotype, we silenced its expression in MDA-MB-231 cells. GPAT2 knockdown diminished cell proliferation, anchorage independent growth, migration and tumorigenicity, and increased staurosporine-induced apoptosis. In contrast, GPAT2 over-expression increased cell proliferation rate and resistance to staurosporine-induced apoptosis. To understand the functional role of GPAT2, we performed a co-expression analysis in mouse and human testis and found a significant association with semantic terms involved in cell cycle, DNA integrity maintenance, piRNA biogenesis and epigenetic regulation. Overall, these results indicate the GPAT2 would be directly associated with the control of cell proliferation. In conclusion, we confirm GPAT2 as a cancer testis gene and that its expression contributes to the tumor phenotype of MDA-MB-231 cells.	[Pellon-Maison, Magali; Montanaro, Mauro A.; Garcia-Fabiani, Maria B.; Soler-Gerino, Mercedes C.; Cattaneo, Elizabeth R.; Quiroga, Ivana Y.; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Lacunza, Ezequiel; Abba, Martin C.] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; University of North Carolina; University of North Carolina Chapel Hill	Gonzalez-Baro, MR (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar		Abba, Martin/0000-0002-9206-2369; Quiroga-Barber, Ivana/0000-0002-6799-0059; Pellon-Maison, Magali/0000-0002-7981-5258	NIH, USA [1R03TW008698, R01DK56598]; PICT [2246 ANPCyT]; UNLP, Argentina [M168]; FOGARTY INTERNATIONAL CENTER [R03TW008698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER	NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PICT(ANPCyT); UNLP, Argentina(National University of La Plata); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants 1R03TW008698 (MRGB) and R01DK56598 (RAC), USA, PICT 2246 ANPCyT and UNLP M168 (MRGB), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Condomines M, 2009, J IMMUNOL, V183, P832, DOI 10.4049/jimmunol.0803298; Costa FF, 2007, STEM CELLS, V25, P707, DOI 10.1634/stemcells.2006-0469; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Low J, 2010, J BIOMOL SCREEN, V15, P830, DOI 10.1177/1087057110374983; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pek JW, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-6; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010	29	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100896	10.1371/journal.pone.0100896	http://dx.doi.org/10.1371/journal.pone.0100896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967918	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800079
J	Havermann, S; Chovolou, Y; Humpf, HU; Watjen, W				Havermann, Susannah; Chovolou, Yvonni; Humpf, Hans-Ulrich; Waetjen, Wim			Caffeic Acid Phenethylester Increases Stress Resistance and Enhances Lifespan in Caenorhabditis elegans by Modulation of the Insulin-Like DAF-16 Signalling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; CANCER CELLS; FOXO FAMILY; ESTER CAPE; C-ELEGANS; ANTIOXIDANT; LONGEVITY; PROPOLIS; GENE	CAPE is an active constituent of propolis which is widely used in traditional medicine. This hydroxycinnamic acid derivate is a known activator of the redox-active Nrf2 signalling pathway in mammalian cells. We used C. elegans to investigate the effects of this compound on accumulation of reactive oxygen species and the modulation of the pivotal redox-active pathways SKN-1 and DAF-16 (homologues of Nrf2 and FoxO, respectively) in this model organism; these results were compared to the effects in Hct116 human colon carcinoma cells. CAPE exerts a strong antioxidative effect in C. elegans: The increase of reactive oxygen species induced by thermal stress was diminished by about 50%. CAPE caused a nuclear translocation of DAF-16, but not SKN-1. CAPE increased stress resistance of the nematode against thermal stress and finally a prolongation of the median and maximum lifespan by 9 and 17%, respectively. This increase in stress resistance and lifespan was dependent on DAF-16 as shown in experiments using a DAF-16 loss of function mutant strain. Life prolongation was retained under SKN-1 RNAi conditions showing that the effect is SKN-1 independent. The results of CAPE obtained in C. elegans differed from the results obtained in Hct116 colon carcinoma cells: CAPE also caused strong antioxidative effects in the mammalian cells, but no activation of the FoxO4 signalling pathway was detectable. Instead, an activation of the Nrf2 signalling pathway was shown by luciferase assay and western blots. CONCLUSION: CAPE activates the insulin-like DAF-16, but not the SKN-1 signalling pathway in C. elegans and therefore enhances the stress resistance and lifespan of this organism. Since modulation of the DAF-16 pathway was found to be a pivotal effect of CAPE in C. elegans, this has to be taken into account for the investigation of the molecular mechanisms of the traditional use of propolis.	[Havermann, Susannah; Chovolou, Yvonni; Waetjen, Wim] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Havermann, Susannah; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Havermann, Susannah; Waetjen, Wim] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany	Heinrich Heine University Dusseldorf; University of Munster; Martin Luther University Halle Wittenberg	Watjen, W (corresponding author), Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany.	wim.waetjen@landw.uni-halle.de	Wätjen, Wim/AAE-9018-2021; Humpf, Hans-Ulrich/AAV-4845-2020; Wätjen, Wim/G-8339-2015	Humpf, Hans-Ulrich/0000-0003-3296-3058	"Deutsche Forschungsgemeinschaft" (DFG) [1427]	"Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG))	Funding provided by the "Deutsche Forschungsgemeinschaft" (DFG - research training group 1427 "Food constituents as triggers of nuclear receptor mediated intestinal signalling"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chen YJ, 2001, ANTI-CANCER DRUG, V12, P143, DOI 10.1097/00001813-200102000-00008; Choe KP, 2012, DRUG METAB REV, V44, P209, DOI 10.3109/03602532.2012.684799; Dubtsova E A, 2008, Adv Gerontol, V21, P252; Esrefoglu M, 2012, ULTRASTRUCT PATHOL, V36, P244, DOI 10.3109/01913123.2012.679351; Esrefoglu M, 2011, FUND CLIN PHARMACOL, V25, P580, DOI 10.1111/j.1472-8206.2010.00876.x; Farooqui Tahira, 2012, Front Biosci (Elite Ed), V4, P779; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Havermann S, 2013, J AGR FOOD CHEM, V61, P2158, DOI 10.1021/jf304553g; He XQ, 2009, MOL PHARMACOL, V76, P1265, DOI 10.1124/mol.109.058453; Huang MT, 1996, CARCINOGENESIS, V17, P761, DOI 10.1093/carcin/17.4.761; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Lee KJ, 2008, FOOD CHEM TOXICOL, V46, P2445, DOI 10.1016/j.fct.2008.03.032; Lee Y, 2010, EUR J PHARMACOL, V643, P21, DOI 10.1016/j.ejphar.2010.06.016; LEWIS JA, 1995, CAENORHABDITIS ELEGA, P4; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ozturk G, 2012, EUR REV MED PHARMACO, V16, P2064; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; Pun PBL, 2010, BIOGERONTOLOGY, V11, P17, DOI 10.1007/s10522-009-9223-5; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Salatino A, 2011, NAT PROD REP, V28, P925, DOI 10.1039/c0np00072h; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Tolba MF, 2013, IUBMB LIFE, V65, P716, DOI 10.1002/iub.1188; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Yeh CT, 2009, J NUTR BIOCHEM, V20, P163, DOI 10.1016/j.jnutbio.2008.01.005; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	44	30	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100256	10.1371/journal.pone.0100256	http://dx.doi.org/10.1371/journal.pone.0100256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964141	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500034
J	Hu, ZY; Yang, JL; Wu, YP; Xiong, GL; Wang, YL; Yang, J; Deng, L				Hu, Zhangyong; Yang, Jinliang; Wu, Yangping; Xiong, Guolian; Wang, Yali; Yang, Jun; Deng, Lan			Polymorphisms in CISH Gene Are Associated with Persistent Hepatitis B Virus Infection in Han Chinese Population	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; PROTEIN; SUSCEPTIBILITY; SH2	Background and Aim: Cytokine-inducible SRC homology 2 domain protein (CISH) is the first member of the suppressors of cytokine signaling (SOCS) protein family. An association between multiple CISH polymorphisms and susceptibility to infectious diseases has been reported. This study aimed to investigate the possible association of these single nucleotide polymorphisms (SNPs) in CISH gene with different outcomes of Hepatitis B virus (HBV) infection. Methods: 1019 unrelated Chinese Han subjects, including 240 persistent asymptomatic HBV carriers, 217 chronic hepatitis B patients, 137 HBV-related liver cirrhosis patients, and 425 cases of spontaneously recovered HBV as controls, were studied. Four SNPs (rs622502, rs2239751, rs414171 and rs6768300) in CISH gene were genotyped with the snapshot technique. Transcriptional activity of the CISH promoter was assayed in vitro using the dual-luciferase reporter assay system. Results: At position rs414171, A allele and AA genotype frequencies were significantly higher in the HBV-resolved group as compared to the persistent HBV infection group. At position rs2239751, TT genotype was further observed in the HBV-resolved group. Using asymptomatic HBV carriers as controls, our results indicated that the rs414171 and rs2239751 polymorphisms were unrelated to HBV progression. The other two SNPs (rs622502 and rs6768300) showed no association with persistent HBV infection. Haplotype analysis revealed that the GGCA haplotype was associated with spontaneous clearance of HBV in this population. Moreover, luciferase activity was significantly higher in the PGL3-Basic-rs414171T construct as compared to the PGL3-Basic-rs414171A construct (p<0.001). Conclusion: Two SNPs (rs414171 and rs2239751) in the CISH gene were associated with persistent HBV infection in Han Chinese population, but not with HBV progression.	[Hu, Zhangyong; Yang, Jinliang; Wu, Yangping] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Hu, Zhangyong; Yang, Jinliang; Wu, Yangping] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Hu, Zhangyong; Xiong, Guolian; Wang, Yali; Yang, Jun; Deng, Lan] Chengdu Med Coll, Affiliated Hosp 1, Dept Infect Dis, Chengdu, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Chengdu Medical College	Yang, JL (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	jlyang011@163.com		Wu, Yangping/0000-0002-8937-4417	First Affiliated Hospital of Chengdu Medical College; Health Department of Sichuan Province	First Affiliated Hospital of Chengdu Medical College; Health Department of Sichuan Province	This work was financially supported by the First Affiliated Hospital of Chengdu Medical College and the Health Department of Sichuan Province. The funders had no role role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza L, 2007, VIROLOGY, V368, P41, DOI 10.1016/j.virol.2007.06.030; Borges S, 2008, ADV EXP MED BIOL, V617, P321, DOI 10.1007/978-0-387-69080-3_30; Chen S, 2003, INT IMMUNOL, V15, P403, DOI 10.1093/intimm/dxg039; de Andres MC, 2011, BIOCHEM BIOPH RES CO, V407, P54, DOI 10.1016/j.bbrc.2011.02.101; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Maini MK, 2000, J VIRAL HEPATITIS, V7, P321; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Miah MA, 2012, EUR J IMMUNOL, V42, P58, DOI 10.1002/eji.201141846; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Sprengers D, 2006, J HEPATOL, V45, P182, DOI 10.1016/j.jhep.2005.12.022; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Tsai SL, 2003, J BIOMED SCI, V10, P120, DOI [10.1159/000068091, 10.1007/BF02256004]; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yoshimura A, 2004, J LEUKOCYTE BIOL, V75, P422, DOI 10.1189/jlb.0403194; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741	29	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100826	10.1371/journal.pone.0100826	http://dx.doi.org/10.1371/journal.pone.0100826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964072	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500087
J	Baumann, H; Surrey, T				Baumann, Hella; Surrey, Thomas			Motor-mediated Cortical versus Astral Microtubule Organization in Lipid-monolayered Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ORGANIZATION; MICROFABRICATED CHAMBERS; EGG EXTRACTS; DYNAMICS; TUBULIN; DYNEIN; KINESIN-14; NUCLEATION; VESICLES; ASTERS	The correct spatial organization of microtubules is of crucial importance for determining the internal architecture of eukaryotic cells. Microtubules are arranged in space by a multitude of biochemical activities and by spatial constraints imposed by the cell boundary. The principles underlying the establishment of distinct intracellular architectures are only poorly understood. Here, we studied the effect of spatial confinement on the self-organization of purified motors and microtubules that are encapsulated in lipid-monolayered droplets in oil, varying in diameter from 5-100 mu m, which covers the size range of typical cell bodies. We found that droplet size alone had a major organizing influence. The presence of a microtubule-crosslinking motor protein decreased the number of accessible types of microtubule organizations. Depending on the degree of spatial confinement, the presence of the motor caused either the formation of a cortical array of bent microtubule bundles or the generation of single microtubule asters in the droplets. These are two of the most prominent forms of microtubule arrangements in plant and metazoan cells. Our results provide insights into the combined organizing influence of spatial constraints and cross-linking motor activities determining distinct microtubule architectures in a minimal biomimetic system. In the future, this simple lipid-monolayered droplet system characterized here can be expanded readily to include further biochemical activities or used as the starting point for the investigation of motor-mediated microtubule organization inside liposomes surrounded by a deformable lipid bilayer.	[Baumann, Hella; Surrey, Thomas] Canc Res UK, London Res Inst, London WC2A 3LY, England	Cancer Research UK	Surrey, T (corresponding author), Canc Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	thomas.surrey@cancer.org.uk	Surrey, Thomas/AAC-4608-2021	Surrey, Thomas/0000-0001-9082-1870	Boehringer-Ingelheim Fonds; Cancer Research UK; European Research Council; Cancer Research UK [14256] Funding Source: researchfish	Boehringer-Ingelheim Fonds(Boehringer Ingelheim); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	Supported by the Boehringer-Ingelheim Fonds.; Supported by Cancer Research UK and the European Research Council. To whom correspondence should be addressed. E-mail: thomas. surrey@cancer.org.uk.	Abu Shah E, 2014, ELIFE, V3, DOI 10.7554/eLife.01433; Allard JF, 2010, MOL BIOL CELL, V21, P278, DOI 10.1091/mbc.E09-07-0579; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; CARON JM, 1987, BIOCHEMISTRY-US, V26, P3681, DOI 10.1021/bi00386a063; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cosentino Lagomarsino M, 2007, BIOPHYS J, V92, P1046, DOI 10.1529/biophysj.105.076893; Deinum EE, 2013, CURR OPIN PLANT BIOL, V16, P688, DOI 10.1016/j.pbi.2013.10.001; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dogterom M, 2013, CURR OPIN CELL BIOL, V25, P23, DOI 10.1016/j.ceb.2012.12.002; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Faivre-Moskalenko C, 2002, P NATL ACAD SCI USA, V99, P16788, DOI 10.1073/pnas.252407099; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fygenson DK, 1997, PHYS REV LETT, V79, P4497, DOI 10.1103/PhysRevLett.79.4497; Ghosh S, 2013, ACS CHEM BIOL, V8, P673, DOI 10.1021/cb300583p; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Griffiths AD, 2006, TRENDS BIOTECHNOL, V24, P395, DOI 10.1016/j.tibtech.2006.06.009; Hawkins RJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011911; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Lindeboom JJ, 2013, PLANT PHYSIOL, V161, P1189, DOI 10.1104/pp.112.204057; MCINTOSH TJ, 1994, ANNU REV BIOPH BIOM, V23, P27, DOI 10.1146/annurev.bb.23.060194.000331; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vorobiev I, 2001, P NATL ACAD SCI USA, V98, P10160, DOI 10.1073/pnas.181354198; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	48	20	20	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22524	22535		10.1074/jbc.M114.582015	http://dx.doi.org/10.1074/jbc.M114.582015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966327	Green Published, hybrid			2022-12-25	WOS:000340593500061
J	Leyme, A; Marivin, A; Casler, J; Nguyen, LT; Garcia-Marcos, M				Leyme, Anthony; Marivin, Arthur; Casler, Jason; Nguyen, Lien T.; Garcia-Marcos, Mikel			Different Biochemical Properties Explain Why Two Equivalent G alpha Subunit Mutants Cause Unrelated Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; ALBRIGHT-HEREDITARY-OSTEODYSTROPHY; ADENYLYL-CYCLASE; G(S ALPHA); SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; UVEAL MELANOMA; GTP HYDROLYSIS; MUTATION; ACTIVATION	There is an increasing number of disease-associated G alpha mutations identified from genome-wide sequencing campaigns or targeted efforts. Albright's Hereditary Osteodystrophy (AHO) was the first inherited disease associated with loss-of-function mutations in a G protein (G alpha s) and other studies revealed gain-of-function G alpha mutations in cancer. Here we attempted to solve the apparent quandary posed by the fact that the same mutation in two different G proteins appeared associated with both AHO and cancer. We first confirmed the presence of an inherited G alpha s-R265H mutation from a previously described clinical case report of AHO. This mutation is structurally analogous to G alpha o-R243H, an oncogenic mutant with increased activity in vitro and in cells due to rapid nucleotide exchange. We found that, contrary to G alpha o-R243H, G alpha s-R265H activity is compromised due to greatly impaired nucleotide binding in vitro and in cells. We obtained equivalent results when comparing another AHO mutation in G alpha s (D173N) with a counterpart cancer mutation in G alpha o (D151N). G alpha o-R243H binds nucleotides efficiently under steady-state conditions but releases GDP much faster than the WT protein, suggesting diminished affinity for the nucleotide. These results indicate that the same disease-linked mutation in two different G proteins affects a common biochemical feature (nucleotide affinity) but to a different grade depending on the G protein (mild decrease for G alpha o and severe for G alpha s). We conclude that G alpha s-R265H has dramatically impaired nucleotide affinity leading to the loss-of-function in AHO whereas G alpha o-R243H has a mild decrease in nucleotide affinity that causes rapid nucleotide turnover and subsequent hyperactivity in cancer.	[Leyme, Anthony; Marivin, Arthur; Casler, Jason; Nguyen, Lien T.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu			American Cancer Society [RGS-13-362-01-TBE]; Elsa U. Pardee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112631] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Elsa U. Pardee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Cancer Society (RGS-13-362-01-TBE) and the Elsa U. Pardee Foundation (to M. G. M.).	Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Aldred MA, 2006, J PEDIATR ENDOCR MET, V19, P635; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bastida Eizaguirre M, 2001, An Esp Pediatr, V54, P598; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P756, DOI 10.1016/j.bbamem.2006.09.027; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Freson K, 2008, J CLIN ENDOCR METAB, V93, P4851, DOI 10.1210/jc.2008-0883; Garcia-Marcos M, 2011, ONCOGENE, V30, P2691, DOI 10.1038/onc.2010.645; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; KROLL SD, 1992, J BIOL CHEM, V267, P23183; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MIRIC A, 1993, J CLIN ENDOCR METAB, V76, P1560, DOI 10.1210/jc.76.6.1560; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; PRASAD MVVSV, 1994, ONCOGENE, V9, P2425; ROSS EM, 1994, METHOD ENZYMOL, V237, P26; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Warner DR, 1999, J BIOL CHEM, V274, P4977, DOI 10.1074/jbc.274.8.4977; Warner DR, 1998, J BIOL CHEM, V273, P23976, DOI 10.1074/jbc.273.37.23976; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WONG YH, 1995, ONCOGENE, V10, P1927; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Zurita AR, 2008, P NATL ACAD SCI USA, V105, P2363, DOI 10.1073/pnas.0712261105	52	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21818	21827		10.1074/jbc.M114.549790	http://dx.doi.org/10.1074/jbc.M114.549790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24982418	Green Published, hybrid			2022-12-25	WOS:000340593500002
J	Akiyama, K; Takeuchi, F; Isono, M; Chakrawarthy, S; Nguyen, QN; Wen, WQ; Yamamoto, K; Katsuya, T; Kasturiratne, A; Pham, ST; Zheng, W; Matsushita, Y; Kishimoto, M; Do, LD; Shu, XO; Wickremasinghe, AR; Kajio, H; Kato, N				Akiyama, Koichi; Takeuchi, Fumihiko; Isono, Masato; Chakrawarthy, Sureka; Quang Ngoc Nguyen; Wen, Wanqing; Yamamoto, Ken; Katsuya, Tomohiro; Kasturiratne, Anuradhani; Son Thai Pham; Zheng, Wei; Matsushita, Yumi; Kishimoto, Miyako; Loi Doan Do; Shu, Xiao-Ou; Wickremasinghe, Ananda R.; Kajio, Hiroshi; Kato, Norihiro			Systematic Fine-Mapping of Association with BMI and Type 2 Diabetes at the FTO Locus by Integrating Results from Multiple Ethnic Groups	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; CAUSAL VARIANTS; POPULATION; OBESITY; METAANALYSIS; GENE	Background/Objective: The 16q12.2 locus in the first intron of FTO has been robustly associated with body mass index (BMI) and type 2 diabetes in genome-wide association studies (GWAS). To improve the resolution of fine-scale mapping at FTO, we performed a systematic approach consisting of two parts. Methods: The first part is to partition the associated variants into linkage disequilibrium (LD) clusters, followed by conditional and haplotype analyses. The second part is to filter the list of potential causal variants through trans-ethnic comparison. Results: We first examined the LD relationship between FTO SNPs showing significant association with type 2 diabetes in Japanese GWAS and between those previously reported in European GWAS. We could partition all the assayed or imputed SNPs showing significant association in the target FTO region into 7 LD clusters. Assaying 9 selected SNPs in 4 Asian-descent populations-Japanese, Vietnamese, Sri Lankan and Chinese (n <= 26,109 for BMI association and n <= 24,079 for type 2 diabetes association), we identified a responsible haplotype tagged by a cluster of SNPs and successfully narrowed the list of potential causal variants to 25 SNPs, which are the smallest in number among the studies conducted to date for FTO. Conclusions: Our data support that the power to resolve the causal variants from those in strong LD increases consistently when three distant populations-Europeans, Asians and Africans-are included in the follow-up study. It has to be noted that this fine-mapping approach has the advantage of applicability to the existing GWAS data set in combination with direct genotyping of selected variants.	[Akiyama, Koichi; Takeuchi, Fumihiko; Isono, Masato; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Chakrawarthy, Sureka; Kasturiratne, Anuradhani; Wickremasinghe, Ananda R.] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka; [Quang Ngoc Nguyen; Son Thai Pham; Loi Doan Do] Bach Mai Hosp, Hanoi, Vietnam; [Wen, Wanqing; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr,Vanderbilt Ingr, Nashville, TN 37212 USA; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genom, Fukuoka 812, Japan; [Katsuya, Tomohiro] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Suita, Osaka, Japan; [Katsuya, Tomohiro] Osaka Univ, Dept Geriatr Med & Nephrol, Grad Sch Med, Suita, Osaka, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Tokyo, Japan; [Kishimoto, Miyako; Kajio, Hiroshi] Natl Ctr Global Hlth & Med, Ctr Hosp, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University Kelaniya; Vanderbilt University; Kyushu University; Osaka University; Osaka University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Kasturiratne, Anuradhani/0000-0001-5260-2394	National Center for Global Health and Medicine (NCGM) [22S-10, 23S-302, 25S-1]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI [23710228]; Japan Ministry of Education, Culture, Sports, Science and Technology; JSPS; Ministry of Health, Labour and Welfare [17C-1, 20S-6]; Manpei Suzuki Diabetes Foundation; NATIONAL CANCER INSTITUTE [UM1CA173640, UM1CA182910] Funding Source: NIH RePORTER	National Center for Global Health and Medicine (NCGM); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Manpei Suzuki Diabetes Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Center for Global Health and Medicine (NCGM) (22S-10, 23S-302 and 25S-1); a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI (Grant Number 23710228); Grants-in-Aid for the 21st Century Center of Excellence Program (Kyushu University) from the Japan Ministry of Education, Culture, Sports, Science and Technology and for Scientific Research (A) from JSPS; International Health Research (17C-1 and 20S-6) from the Ministry of Health, Labour and Welfare; and Manpei Suzuki Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Pinidiyapathirage M Janani, 2011, BMC Res Notes, V4, P513, DOI 10.1186/1756-0500-4-513; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	25	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101329	10.1371/journal.pone.0101329	http://dx.doi.org/10.1371/journal.pone.0101329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978468	gold, Green Submitted, Green Published			2022-12-25	WOS:000338506400117
J	Brittain, A; Stroebele, E; Erives, A				Brittain, Andrew; Stroebele, Elizabeth; Erives, Albert			Microsatellite Repeat Instability Fuels Evolution of Embryonic Enhancers in Hawaiian Drosophila	PLOS ONE			English	Article							NATURAL-POPULATIONS; PIGMENT PATTERNS; SHADOW ENHANCERS; GENE MASTERMIND; MELANOGASTER; GRADIENT; GENOME; MIMICA; NEUROECTODERM; VARIABILITY	For,30 million years, the eggs of Hawaiian Drosophila were laid in ever-changing environments caused by high rates of island formation. The associated diversification of the size and developmental rate of the syncytial fly embryo would have altered morphogenic gradients, thus necessitating frequent evolutionary compensation of transcriptional responses. We investigate the consequences these radiations had on transcriptional enhancers patterning the embryo to see whether their pattern of molecular evolution is different from non-Hawaiian species. We identify and functionally assay in transgenic D. melanogaster the Neurogenic Ectoderm Enhancers from two different Hawaiian Drosophila groups: (i) the picture wing group, and (ii) the modified mouthparts group. We find that the binding sites in this set of well-characterized enhancers are footprinted by diverse microsatellite repeat (MSR) sequences. We further show that Hawaiian embryonic enhancers in general are enriched in MSR relative to both Hawaiian non-embryonic enhancers and non-Hawaiian embryonic enhancers. We propose embryonic enhancers are sensitive to Activator spacing because they often serve as assembly scaffolds for the aggregation of transcription factor activator complexes. Furthermore, as most indels are produced by microsatellite repeat slippage, enhancers from Hawaiian Drosophila lineages, which experience dynamic evolutionary pressures, would become grossly enriched in MSR content.	[Brittain, Andrew; Stroebele, Elizabeth; Erives, Albert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu			National Science Foundation [1239673]; National Institutes of Health [T32GM082729]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082729] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1239673] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AE: National Science Foundation, Award: 1239673. ES: National Institutes of Health, Training Grant: T32GM082729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Ayala FJ, 1996, MOL BIOL EVOL, V13, P1363, DOI 10.1093/oxfordjournals.molbev.a025582; Bachtrog D, 2000, MOL BIOL EVOL, V17, P1277, DOI 10.1093/oxfordjournals.molbev.a026411; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Cande J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043888; Carson HL, 2002, GENETICA, V116, P383, DOI 10.1023/A:1021280325474; Carson HL, 1997, J HERED, V88, P343, DOI 10.1093/oxfordjournals.jhered.a023115; CARSON HL, 1973, NATURE, V241, P200, DOI 10.1038/241200a0; CARSON HL, 1967, P NATL ACAD SCI USA, V57, P1280, DOI 10.1073/pnas.57.5.1280; CARSON HL, 1982, HEREDITY, V48, P3, DOI 10.1038/hdy.1982.2; CARSON HL, 1983, GENETICS, V103, P465; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cooley AM, 2012, EVOL DEV, V14, P317, DOI 10.1111/j.1525-142X.2012.00550.x; Crocker J, 2013, DEV BIOL, V378, P64, DOI 10.1016/j.ydbio.2013.03.002; Crocker J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1102; Crocker J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000276; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Harr B, 1998, MOL BIOL EVOL, V15, P176, DOI 10.1093/oxfordjournals.molbev.a025913; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huntley MA, 2007, MOL BIOL EVOL, V24, P2598, DOI 10.1093/molbev/msm129; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; KAMBYSELLIS MP, 1971, AM NAT, V105, P31, DOI 10.1086/282700; KAMBYSELLIS MP, 1980, AM NAT, V115, P67, DOI 10.1086/283546; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Kofler R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-612; Li L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r101; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; NEWFELD SJ, 1994, J MOL EVOL, V38, P637; NEWFELD SJ, 1993, J MOL EVOL, V37, P483, DOI 10.1007/BF00160429; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; O'Grady PM, 2003, ANN ENTOMOL SOC AM, V96, P12, DOI 10.1603/0013-8746(2003)096[0012:ROTDMS]2.0.CO;2; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Powell J. R., 1997, PROGR PROSPECTS EVOL; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Stathopoulos A, 2004, CURR OPIN GENET DEV, V14, P477, DOI 10.1016/j.gde.2004.07.004; Sullivan W, 2000, DROSOPHILA PROTOCOLS, Vxiv; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Yanez-Cuna JO, 2014, GENOME RES	57	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101177	10.1371/journal.pone.0101177	http://dx.doi.org/10.1371/journal.pone.0101177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978198	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400092
J	Barrado, MJG; Blanco, EJ; Hernandez, MC; Osma, MCI; Carretero, M; Herrero, JJ; Burks, DJ; Carretero, J				Garcia Barrado, Maria Jose; Blanco, Enrique J.; Carretero Hernandez, Marta; Iglesias Osma, Maria Carmen; Carretero, Manuel; Herrero, Julio J.; Jane Burks, Deborah; Carretero, Jose			Local Transformations of Androgens into Estradiol by Aromatase P450 Is Involved in the Regulation of Prolactin and the Proliferation of Pituitary Prolactin-Positive Cells	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; RAT PITUITARY; GROWTH-HORMONE; SEX STEROIDS; IN-VIVO; RNA-EXPRESSION; ADULT MALE; ESTROGEN; SECRETION; RELEASE	In previous studies we demonstrated the immunohistochemical expression of aromatase in pituitary cells. In order to determine whether pituitary aromatase is involved in the paracrine regulation of prolactin-producing pituitary cells and the physiological relevance of pituitary aromatase in the control of these cells, an in vivo and in vitro immunocytochemical and morphometric study of prolactin-positive pituitary cells was carried out on the pituitary glands of adult male rats treated with the aromatase antagonist fadrozole. Moreover, we analyzed the expression of mRNA for the enzyme in pituitary cells of male adult rats by in situ hybridization. The aromatase-mRNA was seen to be located in the cytoplasm of 41% of pituitary cells and was well correlated with the immunocytochemical staining. After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased. Moreover, fadrozole decreased serum prolactin levels. In vitro, treatment with fadrozole plus testosterone induced similar effects on prolactin-positive cells, inhibiting their cellular proliferation. Our results suggest that under physiological conditions aromatase P450 exerts a relevant control over male pituitary prolactin-cells, probably transforming testosterone to estradiol in the pituitary gland.	[Blanco, Enrique J.; Carretero Hernandez, Marta; Carretero, Jose] Univ Salamanca, Fac Med, Dept Human Anat & Histol, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Blanco, Enrique J.; Iglesias Osma, Maria Carmen; Carretero, Jose] Univ Salamanca, Inst Neurosci Castilla & Leon, Neuroendocrinol Lab, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Blanco, Enrique J.; Iglesias Osma, Maria Carmen; Carretero, Jose] Univ Salamanca, Lab Endocrine Metab Dis IBSAL, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen] Univ Salamanca, Fac Med, Dept Physiol & Pharmacol, E-37008 Salamanca, Spain; [Carretero, Manuel] Univ Salamanca, Fac Human & Social Sci, E-37008 Salamanca, Spain; [Herrero, Julio J.] Univ Salamanca, Fac Med, Dept Surg, E-37008 Salamanca, Spain; [Jane Burks, Deborah] CIPF, Neuroendocrinol Lab, Valencia, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; Prince Felipe Research Center	Barrado, MJG (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, Neuroendocrinol Lab, E-37008 Salamanca, Spain.	barrado@usal.es	Carretero, José J/L-6930-2014; Carretero, Manuel/N-1717-2016; Barrado, Maria Jose Garcia/L-4852-2014; Blanco, Enrique J/B-2243-2017; Iglesias-Osma, Maria Carmen/B-1641-2013	Carretero, José J/0000-0003-3143-6512; Carretero, Manuel/0000-0002-3026-5304; Barrado, Maria Jose Garcia/0000-0003-2552-5973; Blanco, Enrique J/0000-0002-5332-4282; Iglesias-Osma, Maria Carmen/0000-0002-2206-9119	FIS Spanish program [PI0-21803]	FIS Spanish program	This work was financially supported by the FIS Spanish program No. PI0-21803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci H, 2013, PITUITARY, V16, P386, DOI 10.1007/s11102-012-0436-2; AMARA JF, 1987, ENDOCRINOLOGY, V120, P264, DOI 10.1210/endo-120-1-264; BARRACLOUGH CA, 1986, NEUROENDOCRINOLOGY, V42, P6, DOI 10.1159/000124241; BONSALL RW, 1992, HORM BEHAV, V26, P240, DOI 10.1016/0018-506X(92)90045-W; BURDMAN JA, 1984, J ENDOCRINOL, V101, P197, DOI 10.1677/joe.0.1010197; CARR LA, 1977, BRAIN RES, V133, P305, DOI 10.1016/0006-8993(77)90766-1; Carretero J, 1999, CELL TISSUE RES, V295, P419, DOI 10.1007/s004410051248; CARRETERO J, 1995, NEUROENDOCRINOLOGY, V62, P277, DOI 10.1159/000127014; Carretero Jose, 2002, Pituitary, V5, P5, DOI 10.1023/A:1022176631922; Carretero J, 2013, ANN ANAT, V195, P253, DOI 10.1016/j.aanat.2013.01.009; CARRILLO AJ, 1987, ENDOCRINOLOGY, V121, P1993, DOI 10.1210/endo-121-6-1993; CHANG RJ, 1982, AM J OBSTET GYNECOL, V144, P402, DOI 10.1016/0002-9378(82)90244-7; Chowen JA, 1998, J NEUROENDOCRINOL, V10, P493, DOI 10.1046/j.1365-2826.1998.00228.x; DADA MO, 1984, J ENDOCRINOL, V101, P87, DOI 10.1677/joe.0.1010087; DEYO SN, 1982, LIFE SCI, V31, P2171, DOI 10.1016/0024-3205(82)90111-4; Galmiche G, 2006, ANN NY ACAD SCI, V1070, P286, DOI 10.1196/annals.1317.028; Galmiche G, 2006, ENDOCRINOLOGY, V147, P4234, DOI 10.1210/en.2005-1650; GIGUERE V, 1982, ENDOCRINOLOGY, V111, P857, DOI 10.1210/endo-111-3-857; GOLUBOFF LG, 1969, J CLIN ENDOCR METAB, V29, P1533, DOI 10.1210/jcem-29-12-1533; Goto-Kazeto R, 2004, GEN COMP ENDOCR, V139, P72, DOI 10.1016/j.ygcen.2004.07.003; GUNSON DE, 1995, BRIT J CANCER, V72, P72, DOI 10.1038/bjc.1995.279; HAUG E, 1976, ENDOCRINOLOGY, V99, P1482, DOI 10.1210/endo-99-6-1482; Heidari Z, 2010, ENDOCR PRACT, V16, P669, DOI 10.4158/EP10026.CR; HICKEY GJ, 1990, MOL ENDOCRINOL, V4, P3, DOI 10.1210/mend-4-1-3; HYMER WC, 1961, ENDOCRINOLOGY, V69, P81, DOI 10.1210/endo-69-1-81; Kadioglu P, 2008, PITUITARY, V11, P29, DOI 10.1007/s11102-007-0065-3; KUBOTA T, 1989, NEUROENDOCRINOLOGY, V50, P400, DOI 10.1159/000125255; LANNIGAN DA, 1990, PROG CLIN BIOL RES, V322, P187; LIEBERMAN ME, 1978, P NATL ACAD SCI USA, V75, P5946, DOI 10.1073/pnas.75.12.5946; LLOYD HM, 1975, NATURE, V255, P497, DOI 10.1038/255497a0; LLOYD RV, 1988, AM J PATHOL, V133, P397; MACLEOD RM, 1969, ENDOCRINOLOGY, V84, P1475, DOI 10.1210/endo-84-6-1475; MAURER RA, 1982, J BIOL CHEM, V257, P2133; MAURER RA, 1977, ENDOCRINOLOGY, V101, P76, DOI 10.1210/endo-101-1-76; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Nocillado JN, 2007, MOL CELL ENDOCRINOL, V263, P65, DOI 10.1016/j.mce.2006.08.013; Nolan LA, 2006, J ENDOCRINOL, V188, P387, DOI 10.1677/joe.1.06508; PANTIC V, 1969, Z ZELLFORSCH MIK ANA, V95, P280, DOI 10.1007/BF00968458; PEREZ RL, 1986, J ENDOCRINOL, V108, P399, DOI 10.1677/joe.0.1080399; POOLE MC, 1980, AM J ANAT, V158, P3, DOI 10.1002/aja.1001580103; SAKUMA S, 1984, J ENDOCRINOL, V100, P323, DOI 10.1677/joe.0.1000323; SAUNDERS SL, 1983, CELL TISSUE RES, V232, P21; Schaufele F, 1999, MOL ENDOCRINOL, V13, P935, DOI 10.1210/me.13.6.935; SHULL JD, 1985, ENDOCRINOLOGY, V116, P2456, DOI 10.1210/endo-116-6-2456; SHULL JD, 1984, ENDOCRINOLOGY, V114, P1550, DOI 10.1210/endo-114-5-1550; SHULL JD, 1986, VITAM HORM, V43, P197; SHUPNIK MA, 1979, ENDOCRINOLOGY, V104, P729, DOI 10.1210/endo-104-3-729; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; SOMASEKHAR MB, 1988, GENE, V69, P13, DOI 10.1016/0378-1119(88)90373-3; STEELE R E, 1987, Steroids, V50, P147, DOI 10.1016/0039-128X(83)90068-5; TORRES AI, 1987, J ENDOCRINOL, V114, P213, DOI 10.1677/joe.0.1140213; Trubiroha A, 2012, GEN COMP ENDOCR, V178, P529, DOI 10.1016/j.ygcen.2012.07.002; TSAI PS, 1994, BIOL REPROD, V50, P144, DOI 10.1095/biolreprod50.1.144; VELDHUIS JD, 1989, AM J OBSTET GYNECOL, V161, P1149, DOI 10.1016/0002-9378(89)90654-6; VICIAN L, 1979, ENDOCRINOLOGY, V104, P736, DOI 10.1210/endo-104-3-736; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14; YAMAMOTO N, 1986, NEUROENDOCRINOLOGY, V42, P494, DOI 10.1159/000124493	59	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101403	10.1371/journal.pone.0101403	http://dx.doi.org/10.1371/journal.pone.0101403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978194	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400128
J	ManickamAchari, V; Bryce, RA; Hashim, R				ManickamAchari, Vijayan; Bryce, Richard A.; Hashim, Rauzah			Conformational Dynamics of Dry Lamellar Crystals of Sugar Based Lipids: An Atomistic Simulation Study	PLOS ONE			English	Article							THERMOTROPIC PHASE-BEHAVIOR; BRANCHED-CHAIN GLYCOSIDES; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; LYOTROPIC PHASES; BILAYER; GLYCOLIPIDS; SYSTEM; MODEL; UNSATURATION	The rational design of a glycolipid application (e. g. drug delivery) with a tailored property depends on the detailed understanding of its structure and dynamics. Because of the complexity of sugar stereochemistry, we have undertaken a simulation study on the conformational dynamics of a set of synthetic glycosides with different sugar groups and chain design, namely dodecyl beta-maltoside, dodecyl beta-cellobioside, dodecyl beta-isomaltoside and a C12C10 branched beta-maltoside under anhydrous conditions. We examined the chain structure in detail, including the chain packing, gauche/trans conformations and chain tilting. In addition, we also investigated the rotational dynamics of the headgroup and alkyl chains. Monoalkylated glycosides possess a small amount of gauche conformers (similar to 20%) in the hydrophobic region of the lamellar crystal (L-C) phase. In contrast, the branched chain glycolipid in the fluid L-alpha phase has a high gauche population of up to similar to 40%. Rotational diffusion analysis reveals that the carbons closest to the headgroup have the highest correlation times. Furthermore, its value depends on sugar type, where the rotational dynamics of an isomaltose was found to be 11-15% and more restrained near the sugar, possibly due to the chain disorder and partial inter-digitation compared to the other monoalkylated lipids. Intriguingly, the present simulation demonstrates the chain from the branched glycolipid bilayer has the ability to enter into the hydrophilic region. This interesting feature of the anhydrous glycolipid bilayer simulation appears to arise from a combination of lipid crowding and the amphoteric nature of the sugar headgroups.	[ManickamAchari, Vijayan; Hashim, Rauzah] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Bryce, Richard A.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [ManickamAchari, Vijayan; Hashim, Rauzah] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China	Universiti Malaya; University of Manchester; Chinese Academy of Sciences	Hashim, R (corresponding author), Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia.	rauzah@um.edu.my	Manickam Achari, Vijayan/S-7858-2016; Hashim, Rauzah/B-9566-2010; Bryce, Richard/F-9955-2015	Manickam Achari, Vijayan/0000-0002-0540-3728; Hashim, Rauzah/0000-0002-4074-9783; Bryce, Richard/0000-0002-8145-2345	High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia); University of Malaya [UM.C/625/1/HIR/MOHE/05]; European Union [233533]	High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia); University of Malaya(Universiti Malaya); European Union(European Commission)	The High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia) and University of Malaya UM.C/625/1/HIR/MOHE/05 supports this project. The European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 233533 (INFORM) also partially provides travel grant to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, J CHEM SOC PERK T 2, P177, DOI 10.1039/a702415k; Abe Y, 2000, J CHEM SOC PERK T 2, P341, DOI 10.1039/a905624f; Abeygunaratne S, 2007, LIQ CRYST, V34, P441, DOI 10.1080/02678290701223939; Achari VM, 2012, J PHYS CHEM B, V116, P11626, DOI 10.1021/jp302292s; Ahmad N, 2012, LANGMUIR, V28, P2395, DOI 10.1021/la203736b; ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Auvray X, 2001, EUR PHYS J E, V4, P489, DOI 10.1007/s101890170104; BALASUBRAMANIAN D, 1993, J AM CHEM SOC, V115, P74, DOI 10.1021/ja00054a010; BRUNDISH DE, 1966, BIOCHEM J, V99, P546; CARRIER D, 1989, BIOCHIM BIOPHYS ACTA, V983, P100, DOI 10.1016/0005-2736(89)90385-4; Case D, 2006, AMBER 9; CHEN CH, 1981, BIOPHYS J, V36, P359, DOI 10.1016/S0006-3495(81)84737-6; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DAMODARAN KV, 1992, BIOCHEMISTRY-US, V31, P7656, DOI 10.1021/bi00148a029; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Domanov YA, 2006, BIOPHYS J, V91, P4427, DOI 10.1529/biophysj.106.091702; Dormann P., 2010, ROLE GLYCOLIPIDS PHO, P265; Doxastakis M, 2007, BIOPHYS J, V92, P147, DOI 10.1529/biophysj.106.089631; Ericsson CA, 2005, PHYS CHEM CHEM PHYS, V7, P2970, DOI 10.1039/b502922h; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Essmann U, 1999, BIOPHYS J, V76, P2081, DOI 10.1016/S0006-3495(99)77364-9; GARELLICALVET R, 1993, SYNTHETIC COMMUN, V23, P35, DOI 10.1080/00397919308020398; Gawrisch K., 2005, STRUCTURE BIOL MEMBR, P147; Gentilcore A, 2009, MULTISCALE COMPUTATI; Goodby JW, 2007, CHEM SOC REV, V36, P1971, DOI 10.1039/b708458g; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P13554, DOI 10.1021/jp077094k; HAM JT, 1970, ACTA CRYSTALL B-STRU, VB 26, P1373, DOI 10.1107/S0567740870004132; Hamid Hairul A. A., 2014, Advanced Materials Research, V895, P111, DOI 10.4028/www.scientific.net/AMR.895.111; Hashim R, 2006, THIN SOLID FILMS, V509, P27, DOI 10.1016/j.tsf.2005.09.009; Hashim R, 2012, LIQ CRYST, V39, P1, DOI 10.1080/02678292.2011.614017; Hogberg CJ, 2007, BIOPHYS CHEM, V125, P416, DOI 10.1016/j.bpc.2006.10.005; Huang CH, 1999, BBA-REV BIOMEMBRANES, V1422, P273, DOI 10.1016/S0005-2736(99)00099-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayaraman N, 2007, J MATER CHEM, V17, P2228, DOI 10.1039/b618753f; JEFFREY GA, 1992, LIQ CRYST, V12, P179, DOI 10.1080/02678299208030392; JEFFREY GA, 1991, CARBOHYD RES, V222, P47, DOI 10.1016/0008-6215(91)89005-Z; JIMENEZBARBERO J, 1995, J AM CHEM SOC, V117, P11198, DOI 10.1021/ja00150a016; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KIWADA H, 1985, CHEM PHARM BULL, V33, P753; Kocherbitov V, 2004, LANGMUIR, V20, P3056, DOI 10.1021/la035553c; Kulkarni CV, 2012, NANOSCALE, V4, P5779, DOI 10.1039/c2nr31465g; LEMIEUX RU, 1989, CHEM SOC REV, V18, P347, DOI 10.1039/cs9891800347; Lewis R. N. A. H., 1992, STRUCTURE BIOL MEMBR, P73; Lipowsky R, 2013, FARADAY DISCUSS, V161, P305, DOI 10.1039/c2fd20105d; McNaught AD, 1996, PURE APPL CHEM, V68, P1919, DOI 10.1351/pac199668101919; Misran O, 2013, J PHYS CHEM B, V117, P7335, DOI 10.1021/jp401787b; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mizushima S-I, 1936, NATURE, V137, P945; Moore PB, 2001, BIOPHYS J, V81, P2484, DOI 10.1016/S0006-3495(01)75894-8; Nagle JF, 2001, BIOL PHYS SER, P1; Naidoo KJ, 2001, J COMPUT CHEM, V22, P445, DOI 10.1002/1096-987X(200103)22:4<445::AID-JCC1015>3.0.CO;2-P; Niemela P, 2004, BIOPHYS J, V87, P2976, DOI 10.1529/biophysj.104.048702; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Ott KH, 1996, CARBOHYD RES, V281, P11, DOI 10.1016/0008-6215(95)00320-7; Rog T, 2004, J LIPID RES, V45, P326, DOI 10.1194/jlr.M300187-JLR200; Rog T, 2007, J PHYS CHEM B, V111, P10146, DOI 10.1021/jp0730895; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakya P, 1997, LIQ CRYST, V23, P409, DOI 10.1080/026782997208334; Shinoda W, 2003, J PHYS CHEM B, V107, P14030, DOI 10.1021/jp035493j; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SMALL DM, 1984, J LIPID RES, V25, P1490; TARDIEU A, 1973, J MOL BIOL, V75, P711, DOI 10.1016/0022-2836(73)90303-3; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; Vill V, 2002, CURR OPIN COLLOID IN, V7, P395, DOI 10.1016/S1359-0294(02)00091-2; Yamashita I, 2004, COLLOID SURFACE A, V250, P485, DOI 10.1016/j.colsurfa.2004.04.093	68	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101110	10.1371/journal.pone.0101110	http://dx.doi.org/10.1371/journal.pone.0101110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978205	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400080
J	Okudela, K; Tateishi, Y; Umeda, S; Mitsui, H; Suzuki, T; Saito, Y; Woo, T; Tajiri, M; Masuda, M; Miyagi, Y; Ohashi, K				Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takeshisa; Saito, Yuichi; Woo, Tetsukan; Tajiri, Michihiko; Masuda, Munetaka; Miyagi, Yohei; Ohashi, Kenichi			Allelic Imbalance in the miR-31 Host Gene Locus in Lung Cancer - Its Potential Role in Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; C/EBP-ALPHA; MICRORNA MARKERS; BREAST-CANCER; EXPRESSION; MUTATIONS; ADENOCARCINOMA; METASTASIS; REGULATOR	Small non-protein coding RNA, microRNA (miR), which regulate messenger RNA levels, have recently been identified, and may play important roles in the pathogenesis of various diseases. The present study focused on miR-31 and investigated its potential involvement in lung carcinogenesis. The expression of miR-31 was altered in lung cancer cells through either the amplification or loss of the host gene locus. The strong expression of miR-31 in large cell carcinomas was attributed to the gene amplification. Meanwhile, the loss of miR-31 expression was more frequently observed in aggressive adenocarcinomas. Thus, miR-31 may play a pleiotropic role in the development of lung cancers among different histological types. To the best of our knowledge, this is the first study to show the potential causative mechanism of the altered expression of miR-31 and suggest its potentially diverse significance in the different histological types of lung cancers.	[Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takeshisa; Saito, Yuichi; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Woo, Tetsukan; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Cardiovasc & Resp Dis Ctr Hosp, Div Gen Thorac Surg, Yokohama, Kanagawa, Japan; [Miyagi, Yohei] Kanagawa Prefectural Canc Ctr Hosp, Clin Res Inst, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center; Kanagawa Prefectural Cancer Center	Okudela, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan.	kojixok@med.yokohama-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This work was supported by the Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan), and by a grant from the Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Halmos B, 2002, CANCER RES, V62, P528; Hoffman PC, 2002, LUNG CANCER-J IASLC, V38, P65, DOI 10.1016/S0169-5002(02)00144-7; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Masuda A, 1997, CANCER RES, V57, P4898; Meng W, 2013, CLIN CANC RES; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P2646, DOI 10.2353/ajpath.2009.080571; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; World Medical Association, 2009, J INDIAN MED ASSOC, V107, P403; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yazawa T, 1999, J PATHOL, V187, P191, DOI 10.1002/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x	34	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100581	10.1371/journal.pone.0100581	http://dx.doi.org/10.1371/journal.pone.0100581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978700	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400034
J	Pape-Zambito, D; Jiang, ZY; Wu, H; Devarajan, K; Slater, CM; Cai, KQ; Patchefsky, A; Daly, MB; Chen, XW				Pape-Zambito, Dana; Jiang, Zhengyu; Wu, Hong; Devarajan, Karthik; Slater, Carolyn M.; Cai, Kathy Q.; Patchefsky, Arthur; Daly, Mary B.; Chen, Xiaowei			Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients	PLOS ONE			English	Article							CARCINOMA IN-SITU; DUCTAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; BIOMARKER EXPRESSION; BIOLOGICAL MARKERS; ER-ALPHA; SUBTYPES; BIOPSY; RECURRENCE; HER-2/NEU	The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored. In this study formalin-fixed paraffin embedded sections from 36 patients concurrently diagnosed with DCIS and IDC were evaluated by immunohistochemistry. Ten DCIS lesions from each patient were then randomly selected and scored. Our results showed that expression of PR, HER2, Ki-67, and p16 varied significantly within DCIS lesions from a single patient (P<0.05 for PR; P<1x10(-8) for HER2, Ki-67 and p16). In addition, seventy-two percent of the individuals had heterogeneous expression of at least 2/6 markers. Importantly, by evaluating the expression of promising DCIS risk biomarkers (Ki-67, p53 and p16) among different DCIS subgroups classified by comparing DCIS molecular subtypes with those of adjacent normal terminal duct lobular units (TDLU) and IDC, our results suggest the existence of a highly-aggressive DCIS subgroup, which had the same molecular subtype as the adjacent IDC but not the same subtype as the adjacent normal TDLU. By using a systematic approach, our results clearly demonstrate that intra-individual heterogeneity in DCIS is very common in patients concurrently diagnosed with IDC. Our novel findings of a DCIS subpopulation with aggressive characteristics will provide a new paradigm for mechanistic studies of breast tumor progression and also have broad implications for prevention research as heterogeneous pre-invasive lesions are present in many other cancer types.	[Pape-Zambito, Dana; Jiang, Zhengyu; Slater, Carolyn M.; Cai, Kathy Q.; Chen, Xiaowei] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Wu, Hong; Patchefsky, Arthur] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Chen, XW (corresponding author), Fox Chase Canc Ctr, Canc Epigenet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Xiaowei.Chen@fccc.edu			Susan G. Komen for the Cure [KG100274]; National Institutes of Health [R01 CA138819, P30 CA006927]; Eileen Stein Jacoby Fund; Hedda L. Komins Fund; Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [P30CA006927, R21CA186853, R01CA138819] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Stein Jacoby Fund; Hedda L. Komins Fund; Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was kindly supported by the Susan G. Komen for the Cure to XC (KG100274), National Institutes of Health to MD (R01 CA138819) and to the Fox Chase Cancer Center (P30 CA006927), the Eileen Stein Jacoby Fund to XC, the Hedda L. Komins Fund (to XC), as well as the Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; BELLAMY COC, 1993, HUM PATHOL, V24, P16, DOI 10.1016/0046-8177(93)90057-N; Boughey JC, 2007, ONCOLOGIST, V12, P1276, DOI 10.1634/theoncologist.12-11-1276; Cai KQ, 2009, GYNECOL ONCOL, V114, P18, DOI 10.1016/j.ygyno.2009.03.023; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Cornfield DB, 2004, CANCER, V100, P2317, DOI 10.1002/cncr.20260; Dumay A, 2012, INT J CANC; Edgerton ME, 2011, ANAL CELL PATHOL, V34, P247, DOI [10.1155/2011/803816, 10.3233/ACP-2011-0019]; Engels CC, 2013, BREAST CANCER RES TR, V142, P323, DOI 10.1007/s10549-013-2748-y; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2002, J NATL CANCER I, V94, P1546; FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Hodi Z, 2007, J CLIN PATHOL, V60, P299, DOI 10.1136/jcp.2006.036665; JENSEN HM, 1976, SCIENCE, V191, P295, DOI 10.1126/science.1246614; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Kuerer HM, 2011, CANCER-AM CANCER SOC, V117, P39, DOI 10.1002/cncr.25399; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Lari SA, 2011, J CANCER, V2, P232, DOI 10.7150/jca.2.232; LENNINGTON WJ, 1994, CANCER, V73, P118, DOI 10.1002/1097-0142(19940101)73:1<118::AID-CNCR2820730121>3.0.CO;2-R; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Morrison DH, 2012, BRIT J CANCER, V107, P382, DOI 10.1038/bjc.2012.219; National Institutes of Health, 2009, STAT OF THE SCI C DI; Parton M, 2002, CLIN CANCER RES, V8, P2100; PAVELIC ZP, 1992, CANCER RES, V52, P2597; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Provenzano E, 2003, EUR J CANCER, V39, P622, DOI 10.1016/S0959-8049(02)00666-4; Quinn CM, 1997, J CLIN PATHOL, V50, P596, DOI 10.1136/jcp.50.7.596; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steinman S, 2007, ANN CLIN LAB SCI, V37, P127; Tang P, 2006, ANN CLIN LAB SCI, V36, P137; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012	38	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100488	10.1371/journal.pone.0100488	http://dx.doi.org/10.1371/journal.pone.0100488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978026	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400031
J	Akers, KG; Hamilton, DA				Akers, Katherine G.; Hamilton, Derek A.			Effect of High-Frequency Stimulation of the Perforant Path on Previously Acquired Spatial Memory in Rats: Influence of Memory Strength and Reactivation	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC-TRANSMISSION; EXTINCTION; RECOVERY	If memory depends on changes in synaptic strength, then manipulation of synaptic strength after learning should alter memory for what was learned. Here, we examined whether high frequency stimulation of the perforant path in vivo disrupts memory for a previously-learned hidden platform location in the Morris water task as well as whether this effect is modulated by memory strength or memory reactivation. We found that high frequency stimulation affected probe test performance regardless of memory strength or state of memory activation, although the precise nature of this effect differed depending on whether rats received minimal or extensive training prior to high frequency stimulation. These findings suggest that artificial manipulation of synaptic strength between the entorhinal cortex and hippocampus may destabilize memory for a previously-learned spatial location.	[Akers, Katherine G.; Hamilton, Derek A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Hamilton, Derek A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Akers, KG (corresponding author), Wayne State Univ, Shiffman Med Lib, Detroit, MI 48202 USA.	katherine.akers@wayne.edu	Akers, Katherine G./A-4537-2013; Hamilton, Derek A/H-4447-2013	Akers, Katherine G./0000-0002-4578-6575; Hamilton, Derek A/0000-0001-7021-3288	Quad-L Foundation; Student Resource Allocations Committee; Graduate Studies at the University of New Mexico; National Institutes of Health [AA015356, AA019462]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015356, R01AA019462] Funding Source: NIH RePORTER	Quad-L Foundation; Student Resource Allocations Committee; Graduate Studies at the University of New Mexico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grants from the Quad-L Foundation, Student Resource Allocations Committee, and Graduate Studies at the University of New Mexico to KGA and grants from the National Institutes of Health (AA015356 and AA019462) to DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER TW, 1984, SCIENCE, V224, P627, DOI 10.1126/science.6324350; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Lattal KM, 2003, BEHAV NEUROSCI, V117, P1017, DOI 10.1037/0735-7044.117.5.1017; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Prados J, 2003, LEARN BEHAV, V31, P299; Prados J, 2008, LEARN BEHAV, V36, P311, DOI 10.3758/LB.36.4.311; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73	17	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100766	10.1371/journal.pone.0100766	http://dx.doi.org/10.1371/journal.pone.0100766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971994	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200059
J	Hill-Cawthorne, GA; Hudson, LO; El Ghany, MFA; Piepenburg, O; Nair, M; Dodgson, A; Forrest, MS; Clark, TG; Pain, A				Hill-Cawthorne, Grant A.; Hudson, Lyndsey O.; El Ghany, Moataz Fouad Abd; Piepenburg, Olaf; Nair, Mridul; Dodgson, Andrew; Forrest, Matthew S.; Clark, Taane G.; Pain, Arnab			Recombinations in Staphylococcal Cassette Chromosome mec Elements Compromise the Molecular Detection of Methicillin Resistance in Staphylococcus aureus	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; RAPID DETECTION; COMMUNITY; VIRULENCE; STRAINS; MRSA; EVOLUTION; ASSAY; PCR; UK	Clinical laboratories are increasingly using molecular tests for methicillin-resistant Staphylococcus aureus (MRSA) screening. However, primers have to be targeted to a variable chromosomal region, the staphylococcal cassette chromosome mec (SCCmec). We initially screened 726 MRSA isolates from a single UK hospital trust by recombinase polymerase amplification (RPA), a novel, isothermal alternative to PCR. Undetected isolates were further characterised using multilocus sequence, spa typing and whole genome sequencing. 96% of our tested phenotypically MRSA isolates contained one of the six orfX-SCCmec junctions our RPA test and commercially available molecular tests target. However 30 isolates could not be detected. Sequencing of 24 of these isolates demonstrated recombinations within the SCCmec element with novel insertions that interfered with the RPA, preventing identification as MRSA. This result suggests that clinical laboratories cannot rely solely upon molecular assays to reliably detect all methicillin-resistance. The presence of significant recombinations in the SCCmec element, where the majority of assays target their primers, suggests that there will continue to be isolates that escape identification. We caution that dependence on amplification-based molecular assays will continue to result in failure to diagnose a small proportion (similar to 4%) of MRSA isolates, unless the true level of SCCmec natural diversity is determined by whole genome sequencing of a large collection of MRSA isolates.	[Hill-Cawthorne, Grant A.; El Ghany, Moataz Fouad Abd; Nair, Mridul; Pain, Arnab] King Abdullah Univ Sci & Technol KAUST, Pathogen Genom Lab, Thuwal, Saudi Arabia; [Hill-Cawthorne, Grant A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Hill-Cawthorne, Grant A.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Hudson, Lyndsey O.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Piepenburg, Olaf; Forrest, Matthew S.] TwistDx Ltd, Babraham, England; [Dodgson, Andrew] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Microbiol, Manchester, Lancs, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	King Abdullah University of Science & Technology; University of Sydney; University of Sydney; Imperial College London; University of Manchester; University of London; London School of Hygiene & Tropical Medicine	Pain, A (corresponding author), King Abdullah Univ Sci & Technol KAUST, Pathogen Genom Lab, Thuwal, Saudi Arabia.	arnab.pain@kaust.edu.sa	Hill-Cawthorne, Grant A/B-8039-2009; Clark, Taane G./AAM-2570-2020; Pain, Arnab/L-5766-2015	Hill-Cawthorne, Grant A/0000-0002-3828-5473; Clark, Taane G./0000-0001-8985-9265; Forrest, Matthew/0000-0002-2141-0303; Pain, Arnab/0000-0002-1755-2819; Abd El Ghany, Moataz/0000-0002-0020-261X	Smart Solutions for HCAI; North West Innovation service; King Abdullah University of Science and Technology; Biotechnology and Biological Sciences Research Council [BB/D52637X/1]; Wellcome Trust [096249/Z/11/B]	Smart Solutions for HCAI; North West Innovation service; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by TwistDx. The funder provided support in the form of salaries for authors OP and MSF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. This study was also supported by Smart Solutions for HCAI, run by TRUSTECH, The North West Innovation service, http://www.trustech.org.uk/[AD & MSF]; baseline faculty funding from the King Abdullah University of Science and Technology, www.kaust.edu.sa [GAH-C, MFM, MN & AP]; the Biotechnology and Biological Sciences Research Council, www.bbsrc.ac.uk [grant number BB/D52637X/1 to LOH, OP & MSF] and the Wellcome Trust, www.wellcome.ac.uk [grant number 096249/Z/11/B to TGC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MED MICROBIOL; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Bartels MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016193; Bartels MD, 2009, J CLIN MICROBIOL, V47, P1524, DOI 10.1128/JCM.02153-08; BD Diagnostics, MRSA PREV CONTR; Bischof LJ, 2009, J CLIN MICROBIOL, V47, P2281, DOI 10.1128/JCM.02256-08; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cepheid, XPERT MRSA TEST METH; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; Francois P, 2007, J CLIN MICROBIOL, V45, P2011, DOI 10.1128/JCM.00232-07; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Green SM, 2010, J MED MICROBIOL, V59, P1084, DOI 10.1099/jmm.0.018986-0; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hudson LO, 2012, METHICILLIN RESISTAN; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Huletsky A, 2011, SEQUENCES DETECTION; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Laurent C, 2010, EUR J CLIN MICROBIOL, V29, P995, DOI 10.1007/s10096-010-0958-3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malhotra-Kumar S, 2008, J CLIN MICROBIOL, V46, P1577, DOI 10.1128/JCM.00326-08; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Polisena J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-336; Ridom bioinformatics, 2004, DNA SEQ SP GEN RID; Roche, LIGHTCYCLER MRSA ADV; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Simons M, 2011, NUCLEIC ACIDS RES, V39, P7656, DOI 10.1093/nar/gkr479; Sissonen S, 2009, EUR J CLIN MICROBIOL, V28, P1271, DOI 10.1007/s10096-009-0771-z; Snyder JW, 2009, J CLIN MICROBIOL, V47, P3747, DOI 10.1128/JCM.01391-09; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tsubakishita S, 2010, ANTIMICROB AGENTS CH, V54, P4352, DOI 10.1128/AAC.00356-10; UK Health Protection Agency (HPA), 2008, INV SPEC SCREEN MRSA; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	48	50	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101419	10.1371/journal.pone.0101419	http://dx.doi.org/10.1371/journal.pone.0101419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972080	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000338512200117
J	Souverein, D; Boers, SA; Veenendaal, D; Euser, SM; Kluytmans, J; Den Boer, JW				Souverein, Dennis; Boers, Stefan A.; Veenendaal, Dick; Euser, Sjoerd M.; Kluytmans, Jan; Den Boer, Jeroen W.			Polyclonal Spread and Outbreaks with ESBL Positive Gentamicin Resistant Klebsiella spp. in the Region Kennemerland, The Netherlands	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; CHICKEN MEAT; PNEUMONIAE; MICROORGANISMS; HUMANS; GENES	Objective: The objective of this study was to analyze the transmission dynamics of ESBL positive Klebsiella spp. with an additional resistance towards gentamicin (ESBL-G) in a Dutch region of 650,000 inhabitants in 2012. Methods: All patient related ESBL-G isolates isolated in 2012 were genotyped using both Amplification Fragment Length Polymorphism (AFLP) and High-throughput MultiLocus Sequence Typing (HiMLST). HiMLST was used to analyze the presence of (unidentified) clusters of ESBL-G positive patients. Furthermore, all consecutive ESBL-G isolates within patients were studied in order to evaluate the intra-patient variation of antibiotic phenotypes. Results: There were 38 ESBL-G isolates, which were classified into 18 different sequence types (STs) and into 21 different AFLP types. Within the STs, four clusters were detected from which two were unknown resulting in a transmission index of 0.27. An analysis of consecutive ESBL-G isolates (with similar STs) within patients showed that for 68.8% of the patients at least one isolate had a different consecutive antibiotic phenotype. Conclusion: The transmission of ESBL-G in the region Kennemerland in 2012 was polyclonal with several outbreaks (with a high level of epidemiological linkage). Furthermore, clustering by antibiotic phenotype characterization seems to be an inadequate approach in this setting. The routine practice of molecular typing of collected ESBL-G isolates may help to detect transmission in an early stage, which opens the possibility of a rapid response.	[Souverein, Dennis; Boers, Stefan A.; Veenendaal, Dick; Euser, Sjoerd M.; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands; [Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Vrije Universiteit Amsterdam	Souverein, D (corresponding author), Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands.	d.souverein@streeklabhaarlem.nl		Boers, Stefan/0000-0002-1560-6799				Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Bonten MJM, 2011, NED TIJDSCHR GENEES, V155, pA3992; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; ECDC, 2012, SUMM LAT DAT ANT RES; European Centre for Disease Prevention and Control (ECDC), 2012, ANT RES SURV EUR 201; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Morris D, 2012, J ANTIMICROB CHEMOTH, V67, P2367, DOI 10.1093/jac/dks239; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; NVMM, 2013, GUID LAB DET HIGHL R; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Rakotonirina HC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-85; Rottier WC, 2012, J ANTIMICROB CHEMOTH, V67, P1311, DOI 10.1093/jac/dks065; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van der Zee A, 2003, J CLIN MICROBIOL, V41, P798, DOI [10.1128/JCM.41.2.798-802.2003, 10.1128/JCm.41.2.798-802.2003]; van der Zwet WC, 1999, J HOSP INFECT, V42, P295, DOI 10.1053/jhin.1998.0611; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Willemsen I, 2011, INFECT CONT HOSP EP, V32, P333, DOI 10.1086/658941; Willemsen I, 2008, INFECT CONT HOSP EP, V29, P1110, DOI 10.1086/592408; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101212	10.1371/journal.pone.0101212	http://dx.doi.org/10.1371/journal.pone.0101212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971598	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200104
J	Bilousov, O; Koval, A; Keshelava, A; Katanaev, VL				Bilousov, Oleksii; Koval, Alexey; Keshelava, Amiran; Katanaev, Vladimir L.			Identification of Novel Elements of the Drosophila Blisterome Sheds Light on Potential Pathological Mechanisms of Several Human Diseases	PLOS ONE			English	Article							WING MORPHOGENESIS; CELL-ADHESION; PS INTEGRINS; EPIDERMOLYSIS-BULLOSA; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; LAMININ-A; PROTEIN; GENES; MELANOGASTER	Main developmental programs are highly conserved among species of the animal kingdom. Improper execution of these programs often leads to progression of various diseases and disorders. Here we focused on Drosophila wing tissue morphogenesis, a fairly complex developmental program, one of the steps of which - apposition of the dorsal and ventral wing sheets during metamorphosis - is mediated by integrins. Disruption of this apposition leads to wing blistering which serves as an easily screenable phenotype for components regulating this process. By means of RNAi-silencing technique and the blister phenotype as readout, we identify numerous novel proteins potentially involved in wing sheet adhesion. Remarkably, our results reveal not only participants of the integrin-mediated machinery, but also components of other cellular processes, e.g. cell cycle, RNA splicing, and vesicular trafficking. With the use of bioinformatics tools, these data are assembled into a large blisterome network. Analysis of human orthologues of the Drosophila blisterome components shows that many disease-related genes may contribute to cell adhesion implementation, providing hints on possible mechanisms of these human pathologies.	[Bilousov, Oleksii; Koval, Alexey; Keshelava, Amiran; Katanaev, Vladimir L.] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Katanaev, VL (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	vladimir.katanaev@unil.ch	Koval, Alexey/AAU-4766-2020; Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617; Bilousov, Oleksii/0000-0001-5783-6325	Swiss National Science Foundation [31003A_138350]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (grant #31003A_138350) to V.L.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhuin T, 2011, INT J DEV BIOL, V55, P269, DOI 10.1387/ijdb.103149tb; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brabant MC, 1998, ANN NY ACAD SCI, V857, P99, DOI 10.1111/j.1749-6632.1998.tb10110.x; BRABANT MC, 1993, DEV BIOL, V157, P49, DOI 10.1006/dbio.1993.1111; Brabant MC, 1996, DEVELOPMENT, V122, P3307; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; BROWER DL, 1985, DEV BIOL, V108, P120, DOI 10.1016/0012-1606(85)90014-4; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Egoz-Matia N, 2011, DEV BIOL, V351, P99, DOI 10.1016/j.ydbio.2010.12.039; Fine JD, 2007, ANN NY ACAD SCI, V1112, P396, DOI 10.1196/annals.1415.017; Fine JD, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-12; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Fraichard S, 2010, DEV BIOL, V340, P504, DOI 10.1016/j.ydbio.2010.02.008; FRISTROM D, 1993, DEVELOPMENT, V117, P509; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Inoue Y, 2007, DEV BIOL, V304, P90, DOI 10.1016/j.ydbio.2006.12.022; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katanaev VL, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1556, DOI 10.1134/S0006297911130116; Katanayeva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012331; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Narasimha M, 2000, INTEGRINS ASS PROTEI; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Prout M, 1997, GENETICS, V146, P275; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; SCHUBIGER M, 1987, DEV BIOL, V123, P145, DOI 10.1016/0012-1606(87)90436-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Vakaloglou KM, 2012, J CELL SCI, V125, P3221, DOI 10.1242/jcs.102384; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Walsh EP, 1998, GENETICS, V150, P791; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Watt F. M., 2011, COLD SPRING HARBOR P, V3; WILCOX M, 1989, DEVELOPMENT, V107, P891; WILCOX M, 1981, CELL, V25, P159, DOI 10.1016/0092-8674(81)90240-3; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	68	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101133	10.1371/journal.pone.0101133	http://dx.doi.org/10.1371/journal.pone.0101133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968325	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800113
J	Yang, CY; Lu, RH; Lin, CH; Jen, CH; Tung, CY; Yang, SH; Lin, JK; Jiang, JK; Lin, CH				Yang, Chih-Yung; Lu, Ruey-Hwa; Lin, Chien-Hsing; Jen, Chih-Hung; Tung, Chien-Yi; Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai; Lin, Chi-Hung			Single Nucleotide Polymorphisms Associated with Colorectal Cancer Susceptibility and Loss of Heterozygosity in a Taiwanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR MOK2; HOMEOBOX GENE-EXPRESSION; BARRETTS-ESOPHAGUS; TUMOR PROGRESSION; RISK; ALLELOTYPE; SUPPRESSOR; PITX1; LOCI	Given the significant racial and ethnic diversity in genetic variation, we are intrigued to find out whether the single nucleotide polymorphisms (SNPs) identified in genome-wide association studies of colorectal cancer (CRC) susceptibility in East Asian populations are also relevant to the population of Taiwan. Moreover, loss of heterozygosity (LOH) may provide insight into how variants alter CRC risk and how regulatory elements control gene expression. To investigate the racial and ethnic diversity of CRC-susceptibility genetic variants and their relevance to the Taiwanese population, we genotyped 705 CRC cases and 1,802 healthy controls (Taiwan Biobank) for fifteen previously reported East Asian CRC-susceptibility SNPs and four novel genetic variants identified by whole-exome sequencing. We found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population. The previously unreported rs1338565 was associated with a significant increased risk of CRC. In addition, we also genotyped tumor tissue and paired adjacent normal tissues of these 705 CRC cases to search for LOH, as well as risk-associated and protective alleles. LOH analysis revealed preferential retention of three SNPs, rs12657484, rs3802842, and rs4444235, in tumor tissues. rs4444235 has been recently reported to be a cis-acting regulator of BMP4 gene; in this study, the C allele was preferentially retained in tumor tissues (p = 0.0023). rs4631962 and rs10795668 contribute to CRC risk in the Taiwanese and East Asian populations, and the newly identified rs1338565 was specifically associated with CRC, supporting the ethnic diversity of CRC-susceptibility SNPs. LOH analysis suggested that the three CRC risk variants, rs12657484, rs3802842, and rs4444235, exhibited somatic allele-specific imbalance and might be critical during neoplastic progression.	[Yang, Chih-Yung; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Yung; Lin, Chi-Hung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Lu, Ruey-Hwa] Taipei City Hosp, Dept Surg, Taipei, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan; [Jen, Chih-Hung; Tung, Chien-Yi; Lin, Chi-Hung] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Jiang, JK (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan.	jkjiang@vghtpe.gov.tw; linch@ym.edu.tw			National Science Council [NSC101-2321-B-075-001, NSC 102-2325-B-010-013, NSC102-2319-B-010-001]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by research grants NSC101-2321-B-075-001, NSC 102-2325-B-010-013 and NSC102-2319-B-010-001, National Science Council and Aim for the Top University Plan from Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Abuli A, 2013, CARCINOGENESIS, V34, P2286, DOI 10.1093/carcin/bgt179; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; [Anonymous], 2012, CANC REG ANN REP TAI; Arranz V, 2001, J BIOL CHEM, V276, P11963, DOI 10.1074/jbc.M011036200; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brown MA, 1997, ADV GENET, V36, P45, DOI 10.1016/S0065-2660(08)60307-7; Byeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Dreuillet C, 2008, BIOL CELL, V100, P51, DOI 10.1042/BC20070053; Ferlay J, 2010, IARC CANCERBASE, V2; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; FULTS D, 1990, CANCER RES, V50, P5784; Gerber MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037672; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; HANSEN MF, 1987, CANCER RES, V47, P5518; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; KNUDSON AG, 1985, CANCER RES, V45, P1437; Koboldt DC, VARSCAN VARIANT DETE; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Mates IN, 2012, J GASTROINTEST LIVER, V21, P45; Matsuo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-379; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Polakis P, 2000, GENE DEV, V14, P1837; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Sarkar R, 2010, COLORECTAL DIS, V12, P316, DOI 10.1111/j.1463-1318.2009.01829.x; SATO T, 1990, CANCER RES, V50, P7184; STANBRIDGE EJ, 1990, ANNU REV GENET, V24, P615; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Talseth-Palmer BA, 2011, J MED GENET, V48, P279, DOI 10.1136/jmg.2010.079962; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; THRASHBINGHAM CA, 1995, P NATL ACAD SCI USA, V92, P2854, DOI 10.1073/pnas.92.7.2854; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; TSUCHIYA E, 1992, CANCER RES, V52, P2478; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wijnen JT, 2009, GASTROENTEROLOGY, V136, P131, DOI 10.1053/j.gastro.2008.09.033; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; YAMAGUCHI T, 1992, CANCER RES, V52, P2419; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Zou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045461	78	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100060	10.1371/journal.pone.0100060	http://dx.doi.org/10.1371/journal.pone.0100060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968322	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800023
J	Zappasodi, F; Olejarczyk, E; Marzetti, L; Assenza, G; Pizzella, V; Tecchio, F				Zappasodi, Filippo; Olejarczyk, Elzbieta; Marzetti, Laura; Assenza, Giovanni; Pizzella, Vittorio; Tecchio, Franca			Fractal Dimension of EEG Activity Senses Neuronal Impairment in Acute Stroke	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTICAL DISINHIBITION; ALZHEIMERS-DISEASE; QUANTITATIVE EEG; HEMISPHERIC STROKE; TIME-SERIES; RECOVERY; SYNCHRONIZATION; VARIABILITY; RECORDINGS	The brain is a self-organizing system which displays self-similarities at different spatial and temporal scales. Thus, the complexity of its dynamics, associated to efficient processing and functional advantages, is expected to be captured by a measure of its scale-free (fractal) properties. Under the hypothesis that the fractal dimension (FD) of the electroencephalographic signal (EEG) is optimally sensitive to the neuronal dysfunction secondary to a brain lesion, we tested the FD's ability in assessing two key processes in acute stroke: the clinical impairment and the recovery prognosis. Resting EEG was collected in 36 patients 4-10 days after a unilateral ischemic stroke in the middle cerebral artery territory and 19 healthy controls. National Health Institute Stroke Scale (NIHss) was collected at T0 and 6 months later. Highuchi FD, its inter-hemispheric asymmetry (FDasy) and spectral band powers were calculated for EEG signals. FD was smaller in patients than in controls (1.447 +/- 0.092 vs 1.525 +/- 0.105) and its reduction was paired to a worse acute clinical status. FD decrease was associated to alpha increase and beta decrease of oscillatory activity power. Larger FDasy in acute phase was paired to a worse clinical recovery at six months. FD in our patients captured the loss of complexity reflecting the global system dysfunction resulting from the structural damage. This decrease seems to reveal the intimate nature of structure-function unity, where the regional neural multi-scale self-similar activity is impaired by the anatomical lesion. This picture is coherent with neuronal activity complexity decrease paired to a reduced repertoire of functional abilities. FDasy result highlights the functional relevance of the balance between homologous brain structures' activities in stroke recovery.	[Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Zappasodi, Filippo; Olejarczyk, Elzbieta; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Olejarczyk, Elzbieta] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Assenza, Giovanni] Campus Biomed Univ Rome, Inst Neurol, Rome, Italy; [Tecchio, Franca] Fatebenefratelli Hosp Isola Tiberina, CNR, ISTC, Lab Electrophysiol Translat NeuroScience LETS, Rome, Italy; [Tecchio, Franca] IRCCS San Raffale Pisana, Dept Imaging, Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); IRCCS San Raffaele Pisana	Zappasodi, F (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	f.zappasodi@unich.it	Assenza, Giovanni/K-6877-2018; Zappasodi, Filippo/AAL-4717-2020; Olejarczyk, Elzbieta/ABG-5529-2020; Zappasodi, Filippo/AAC-2414-2022; Marzetti, Laura/ABC-9763-2021; tecchio, franca/AAX-2770-2020; Marzetti, Laura/Q-2909-2016; Marzetti, Laura/AAA-4231-2020	Assenza, Giovanni/0000-0003-3129-1982; Marzetti, Laura/0000-0002-6481-3743; tecchio, franca/0000-0002-1325-5059; Marzetti, Laura/0000-0002-6481-3743; Pizzella, Vittorio/0000-0002-0452-1108; Olejarczyk, Elzbieta/0000-0002-6821-350X; Assenza, Giovanni/0000-0002-6160-4348	Italian Ministry of Health [Cod. GR-2008-1138642]; MIUR [Prot. 2010SH7H3F ConnAge]; PNR-CNR Aging Program	Italian Ministry of Health(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program	The research leading to these results has received funding from: 1. The Italian Ministry of Health, Cod. GR-2008-1138642; 2. MIUR Prot. 2010SH7H3F ConnAge; 3. PNR-CNR Aging Program 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 1997, BIOL CYBERN, V77, P339, DOI 10.1007/s004220050394; AHMED I, 1988, CLIN ELECTROENCEPHAL, V19, P205, DOI 10.1177/155005948801900406; Assenza G, 2013, RESTOR NEUROL NEUROS, V31, P177, DOI 10.3233/RNN-120244; Assenza G, 2009, NEUROIMAGE, V44, P1267, DOI 10.1016/j.neuroimage.2008.09.049; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cuspineda E, 2007, CLIN EEG NEUROSCI, V38, P155, DOI 10.1177/155005940703800312; Cuspineda E, 2003, CLIN ELECTROENCEPHAL, V34, P1; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Di Ieva A, 2013, NEUROSCIENTIST; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Fadel PJ, 2004, J APPL PHYSIOL, V97, P2056, DOI 10.1152/japplphysiol.00657.2004; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Freeman WJ, 2009, COGN NEURODYNAMICS, V3, P97, DOI 10.1007/s11571-008-9064-y; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; GIAQUINTO S, 1994, STROKE, V25, P2204, DOI 10.1161/01.STR.25.11.2204; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Graziadio S, 2012, EXP NEUROL, V238, P168, DOI 10.1016/j.expneurol.2012.08.031; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; JACKEL R A, 1989, Neurophysiologie Clinique, V19, P185, DOI 10.1016/S0987-7053(89)80036-X; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jiang T, 2012, NEUROSCIENCE, V226, P421, DOI 10.1016/j.neuroscience.2012.09.035; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Khedr EM, 2009, EUR J NEUROL, V16, P1323, DOI 10.1111/j.1468-1331.2009.02746.x; Le van Quyen M, 2003, EPILEPSIA S12, P30; Leao RN, 2005, P ROY SOC B-BIOL SCI, V272, P2551, DOI 10.1098/rspb.2005.3258; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Makela JP, 1998, ELECTROEN CLIN NEURO, V106, P433, DOI 10.1016/S0013-4694(98)00005-4; Manganotti P, 2008, NEUROREHAB NEURAL RE, V22, P396, DOI 10.1177/1545968307313505; Mansoori BK, 2014, EXP NEUROL; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; Meyer M, 2003, EUR J APPL PHYSIOL, V90, P305, DOI 10.1007/s00421-003-0915-2; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Murri L, 1998, NEUROPHYSIOL CLIN, V28, P249, DOI 10.1016/S0987-7053(98)80115-9; NAGATA K, 1982, J CEREBR BLOOD F MET, V2, P79, DOI 10.1038/jcbfm.1982.9; Niedermeyer E., 2005, ELECTROEN CLIN NEURO; NIESTROJ E, 1995, NEUROPSYCHOBIOLOGY, V31, P166, DOI 10.1159/000119187; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Oliviero A, 2004, NEUROIMAGE, V23, P542, DOI 10.1016/j.neuroimage.2004.06.040; Peruzzotti-Jametti L, 2013, STROKE, V44, P3166, DOI 10.1161/STROKEAHA.113.001687; PFURTSCHELLER G, 1986, American Journal of EEG Technology, V26, P19; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pomeroy VM, 2007, NEUROREHAB NEURAL RE, V21, P509, DOI 10.1177/1545968307300418; Pritchard W.S., 1991, DEMENTIA, V2, P102, DOI DOI 10.1159/000107183; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; Sauseng P, 2013, NEUROIMAGE, V65, P52, DOI 10.1016/j.neuroimage.2012.09.048; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Serletis D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056008; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Stam CJ, 1999, CLIN NEUROPHYSIOL, V110, P1801, DOI 10.1016/S1388-2457(99)00099-1; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Swie Y W, 2005, Electromyogr Clin Neurophysiol, V45, P329; Tecchio F, 2005, NEUROIMAGE, V28, P72, DOI 10.1016/j.neuroimage.2005.05.051; Tecchio F, 2007, J NEUROL, V254, P296, DOI 10.1007/s00415-006-0355-0; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Truong QDK, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/461426; Van der Drift JHA, 1972, HDB ELECTROENCEPHALO, V14a, p[12, 47]; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; Volz L.J., 2014, BRAIN STRUCT FUNCT; Voss RF, 1988, SCI FRACTAL IMAGES, P21, DOI DOI 10.1007/978-1-4612-3784-6_1; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zappasodi F, 2007, NEUROSCI LETT, V416, P310, DOI 10.1016/j.neulet.2007.02.017	87	89	93	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100199	10.1371/journal.pone.0100199	http://dx.doi.org/10.1371/journal.pone.0100199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967904	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800028
J	Amor, MD; Norman, MD; Cameron, HE; Strugnell, JM				Amor, Michael D.; Norman, Mark D.; Cameron, Hayley E.; Strugnell, Jan M.			Allopatric Speciation within a Cryptic Species Complex of Australasian Octopuses	PLOS ONE			English	Article							TETRICUS MOLLUSCA-CEPHALOPODA; MOLECULAR PHYLOGENY; MITOCHONDRIAL-DNA; LIFE-HISTORY; OCTOPODIDAE; NEMADACTYLUS; VULGARIS; CHEILODACTYLIDAE; BIOGEOGRAPHY; SUBDIVISION	Despite extensive revisions over recent decades, the taxonomy of benthic octopuses (Family Octopodidae) remains in a considerable flux. Among groups of unresolved status is a species complex of morphologically similar shallow- water octopods from subtropical Australasia, including: Allopatric populations of Octopus tetricus on the eastern and western coasts of Australia, of which the Western Australian form is speculated to be a distinct or sub- species; and Octopus gibbsi from New Zealand, a proposed synonym of Australian forms. This study employed a combination of molecular and morphological techniques to resolve the taxonomic status of the ` tetricus complex'. Phylogenetic analyses (based on five mitochondrial genes: 12S rRNA, 16S rRNA, COI, COIII and Cytb) and Generalised Mixed Yule Coalescent (GMYC) analysis (based on COI, COIII and Cytb) distinguished eastern and Western Australian O. tetricus as distinct species, while O. gibbsi was found to be synonymous with the east Australian form (BS = >97, PP = 1; GMYC p = 0.01). Discrete morphological differences in mature male octopuses (based on sixteen morphological traits) provided further evidence of cryptic speciation between east (including New Zealand) and west coast populations; although females proved less useful in morphological distinction among members of the tetricus complex. In addition, phylogenetic analyses suggested populations of octopuses currently treated under the name Octopus vulgaris are paraphyletic; providing evidence of cryptic speciation among global populations of O. vulgaris, the most commercially valuable octopus species worldwide.	[Amor, Michael D.; Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Amor, Michael D.; Norman, Mark D.] Museum Victoria, Dept Sci, Carlton, Vic, Australia; [Cameron, Hayley E.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	La Trobe University; Museum Victoria; Monash University	Amor, MD (corresponding author), La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia.	mdamor@students.latrobe.edu.au	Strugnell, Jan M/P-9921-2016	Strugnell, Jan/0000-0003-2994-637X; Amor, Michael/0000-0001-9015-860X	A La Trobe University Faculty of Science, Technology and Engineering grant	A La Trobe University Faculty of Science, Technology and Engineering grant	A La Trobe University Faculty of Science, Technology and Engineering grant supported this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allcock AL, 2007, POLAR BIOL, V30, P883, DOI 10.1007/s00300-006-0248-9; Allcock AL, 2008, BIOL J LINN SOC, V95, P205, DOI 10.1111/j.1095-8312.2008.01031.x; Anderson TJ, 1997, MAR ECOL PROG SER, V150, P137, DOI 10.3354/meps150137; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; BRASHER DJ, 1992, NEW ZEAL J MAR FRESH, V26, P53, DOI 10.1080/00288330.1992.9516499; Burridge CP, 1999, MOL PHYLOGENET EVOL, V13, P93, DOI 10.1006/mpev.1999.0622; Burridge CP, 2003, NEW ZEAL J MAR FRESH, V37, P223, DOI 10.1080/00288330.2003.9517160; Burridge CP, 2000, BIOL J LINN SOC, V70, P435, DOI 10.1006/bijl.1999.0413; Carlini DB, 2001, MOL PHYLOGENET EVOL, V21, P388, DOI 10.1006/mpev.2001.1022; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Dartnall A, 1974, BIOGEOGRAPHY ECOLOGY; Donnan Laboratories, 2001, EXTR DNA TISS HIGH S; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar G, 2000, AUSTR MARINE LIFE PL; Ezard T. H. G., 2009, SPLITS SPECIES LIMIT; FAO, 2009, GLOB PROD STAT 2007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frakes LA, 1987, FAUNA AUSTR A, P1; GREWE PM, 1994, CAN J FISH AQUAT SCI, V51, P1101, DOI 10.1139/f94-109; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; JOLL LM, 1977, AUST J MAR FRESH RES, V28, P45, DOI 10.1071/MF9770045; JOLL LM, 1978, AUST J MAR FRESH RES, V29, P19; JOLL LM, 1976, MAR BIOL, V36, P327, DOI 10.1007/BF00389194; Joll LM, 1983, OCTOPUS TETRICUS, P325; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ling SD, 2009, P NATL ACAD SCI; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Norman Mark D., 2006, National Science Museum Monographs, V34, P171; Norman MD, 1997, INVERTEBR TAXON, V11, P89, DOI 10.1071/IT95026; Norman MD, 2014, FAO SPECIES CATALOGU, V3, P36; Norman MD, 2000, CEPHALOPODS WORLD GU; Nottage JD, 2007, REV FISH BIOL FISHER, V17, P271, DOI 10.1007/s11160-006-9032-8; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; O'Loughlin P. Mark, 2003, Memoirs of Museum Victoria, V60, P181; O'Shea S, 1999, NIWA BIODIVERSITY ME; OVENDEN JR, 1992, MAR BIOL, V112, P319, DOI 10.1007/BF00702478; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quinn G, 2002, EXPT DESIGN ANAL BIO; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A, 2003, TRACER 1 3; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roper C. F. E., 1984, FAO FISH SYNOP, V125, P1; ROY SN, 1958, ANN MATH STAT, V29, P491, DOI 10.1214/aoms/1177706624; SIMON C, 1990, UCLA SYM BI, V122, P235; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Acosta-Jofre MS, 2012, SCI MAR, V76, P311, DOI 10.3989/scimar.03365.03B; Strugnell J, 2004, CURR BIOL, V14, pR300, DOI 10.1016/j.cub.2004.03.048; Strugnell JM, 2008, ANTARCT SCI, V20, P245, DOI 10.1017/S0954102008001132; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; Systat Software Inc, 2009, STST VERS 13; Talavera G, 2013, METHODS ECOLOGY EVOL; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, P28; Teske PR, 2007, MAR BIOL, V151, P2119, DOI 10.1007/s00227-007-0644-x; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; TOLL RB, 1988, AM MALACOL BULL, V6, P207; Undheim EAB, 2010, CR BIOL, V333, P395, DOI 10.1016/j.crvi.2010.02.002; VALENTINE JW, 1984, GEOLOGY, V12, P647, DOI 10.1130/0091-7613(1984)12<647:NMCTIF>2.0.CO;2; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; VOIGHT JR, 1995, BIOL BULL, V189, P113, DOI 10.2307/1542461; VOIGHT JR, 1991, B MAR SCI, V49, P98; VOIGHT JR, 1991, MALACOLOGIA, V33, P241; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x; WHITE BN, 1986, SYST ZOOL, V35, P176, DOI 10.2307/2413429; Wilson B.R., 1987, P43	78	39	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98982	10.1371/journal.pone.0098982	http://dx.doi.org/10.1371/journal.pone.0098982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964133	Green Accepted, Green Published, gold			2022-12-25	WOS:000338709500007
J	Elmariah, SB; Reddy, VB; Lerner, EA				Elmariah, Sarina B.; Reddy, Vemuri B.; Lerner, Ethan A.			Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; MHC CLASS-II; THROMBIN-RECEPTOR; CYSTEINE CATHEPSINS; HUMAN KERATINOCYTES; NETHERTON SYNDROME; INVARIANT CHAIN; EXPRESSION; IDENTIFICATION; SPECIFICITY	Protease-activated receptor-2 is widely expressed in mammalian epithelial, immune and neural tissues. Cleavage of PAR2 by serine proteases leads to self-activation of the receptor by the tethered ligand SLIGRL. The contribution of other classes of proteases to PAR activation has not been studied in detail. Cathepsin S is a widely expressed cysteine protease that is upregulated in inflammatory conditions. It has been suggested that cathepsin S activates PAR2. However, cathepsin S activation of PAR2 has not been demonstrated directly nor has the potential mechanism of activation been identified. We show that cathepsin S cleaves near the N-terminus of PAR2 to expose a novel tethered ligand, KVDGTS. The hexapeptide KVDGTS generates downstream signaling events specific to PAR2 but is weaker than SLIGRL. Mutation of the cathepsin S cleavage site prevents receptor activation by the protease while KVDGTS retains activity. In conclusion, the range of actions previously ascribed to cysteine cathepsins in general, and cathepsin S in particular, should be expanded to include molecular signaling. Such signaling may link together observations that had been attributed previously to PAR2 or cathepsin S individually. These interactions may contribute to inflammation.	[Lerner, Ethan A.] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lerner, EA (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA.	elerner@partners.org			NIAMS/NIH [1R01AR057744]; Dermatology Foundation; Women's Dermatologic Society; LaRoche-Posay; NIH training [5T32AR007098]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; Women's Dermatologic Society; LaRoche-Posay; NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant number 1R01AR057744 from NIAMS/NIH to EAL and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. In addition, SBE was supported by the Dermatology Foundation, the Women's Dermatologic Society, an award from LaRoche-Posay and by NIH training grant 5T32AR007098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Hwang HS, 2002, PROTEIN EXPRES PURIF, V25, P541, DOI 10.1016/S1046-5928(02)00033-5; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Ramachandran R, 2012, BIOL CHEM, V393, P421, DOI 10.1515/hsz-2011-0251; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Reddy VB, 2010, BRIT J DERMATOL, V163, P532, DOI 10.1111/j.1365-2133.2010.09862.x; Reddy VB, 2010, J INVEST DERMATOL, V130, P1468, DOI 10.1038/jid.2009.430; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Ruckrich T, 2006, BIOL CHEM, V387, P1503, DOI 10.1515/BC.2006.188; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Tobbell DA, 2002, PROTEIN EXPRES PURIF, V24, P242, DOI 10.1006/prep.2001.1573; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van's Gravesande KS, 2002, J IMMUNOL, V168, P4488, DOI 10.4049/jimmunol.168.9.4488; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; XIN XQ, 1992, ARCH BIOCHEM BIOPHYS, V299, P334, DOI 10.1016/0003-9861(92)90283-3	38	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99702	10.1371/journal.pone.0099702	http://dx.doi.org/10.1371/journal.pone.0099702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964046	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500014
J	Mantile, F; Trovato, M; Santoni, A; Barba, P; Ottonello, S; De Berardinis, P; Prisco, A				Mantile, Francesca; Trovato, Maria; Santoni, Andrea; Barba, Pasquale; Ottonello, Simone; De Berardinis, Piergiuseppe; Prisco, Antonella			Alum and Squalene-Oil-in-Water Emulsion Enhance the Titer and Avidity of Anti-A beta Antibodies Induced by Multimeric Protein Antigen (1-11)E2, Preserving the Igg1-Skewed Isotype Distribution	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; FOLLOW-UP; IMMUNOTHERAPY; IMMUNIZATION; PATHOLOGY; PEPTIDE; DECLINE; BURDEN	The development of active immunotherapy for Alzheimer's disease (AD) requires the identification of immunogens that can ensure a high titer antibody response toward A beta, while minimizing the risks of adverse reactions. Multimeric protein (1-11)E2 induces a robust and persistent antibody response to A beta in mice, when formulated in Freund's adjuvant. The goal of this translational study was to evaluate the immunogenicity of (1-11)E2 formulated in alum (Alhydrogel 2%), or in a squalene oil-in-water emulsion (AddaVax), or without adjuvant. A IgG1-skewed isotype distribution was observed for the anti-A beta antibodies generated in mice immunized with either the non-adjuvanted or the adjuvanted vaccine, indicating that (1-11)E2 induces a Th2-like response in all tested conditions. Both Alhydrogel 2% and AddaVax enhanced the titer and avidity of the anti-A beta response elicited by (1-11)E2. We conclude that (1-11)E2 is a promising candidate for anti-A beta immunization protocols that include alum or squalene-oil-in-water emulsion, or no adjuvant.	[Mantile, Francesca; Barba, Pasquale; Prisco, Antonella] CNR, Inst Genet & Biophys, I-80125 Naples, Italy; [Trovato, Maria; De Berardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Santoni, Andrea; Ottonello, Simone] Univ Parma, Dept Life Sci, I-43100 Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Parma	De Berardinis, P (corresponding author), CNR, Inst Prot Biochem, I-80125 Naples, Italy.	p.deberardinis@ibp.cnr.it; prisco@igb.cnr.it	Prisco, Antonella/X-5749-2019; De Berardinis, Piergiuseppe/AAX-1049-2020; De Berardinis, Piergiuseppe/HCI-0893-2022	De Berardinis, Piergiuseppe/0000-0001-6579-1729; Trovato, Maria/0000-0002-3831-6073; Mantile, Francesca/0000-0003-2130-3388; Prisco, Antonella/0000-0001-8061-0068; Santoni, Andrea/0000-0001-7404-8099	FIRB-Merit [RBNE08LN4P_002]; CNR-MIUR Epigenetics Flagship Project [v.n.3120]; Progetto invecchiamento CNR; National Institutes of Health [R01 AI074379]; MIUR-PON [01_00117]	FIRB-Merit(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CNR-MIUR Epigenetics Flagship Project; Progetto invecchiamento CNR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR-PON(Ministry of Education, Universities and Research (MIUR))	AP acknowledges support from FIRB-Merit RBNE08LN4P_002 and CNR-MIUR Epigenetics Flagship Project v.n.3120. AP and PDB acknowledge support from Progetto invecchiamento CNR. PDB and MT acknowledge support from grant National Institutes of Health R01 AI074379 and MIUR-PON 01_00117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Benilova I, NAT NEUROSCI, V15, P349; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Castiglione F, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/842329; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Esposito M, 2008, MOL IMMUNOL, V45, P1056, DOI 10.1016/j.molimm.2007.07.023; Golde TE, EXP NEUROL, V223, P252; Golde TE, 2009, CNS NEUROL DISORD-DR, V8, P31, DOI 10.2174/187152709787601830; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Mantile F, 2011, IMMUNOL CELL BIOL, V89, P604, DOI 10.1038/icb.2010.134; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Prisco Antonella, 2012, Biomol Concepts, V3, P479, DOI 10.1515/bmc-2012-0010; Prisco A, 2012, INT J MOL SCI, V13, P5179, DOI 10.3390/ijms13045179; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Vellas B, 2009, CURR ALZHEIMER RES, V6, P144, DOI 10.2174/156720509787602852; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843	28	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101474	10.1371/journal.pone.0101474	http://dx.doi.org/10.1371/journal.pone.0101474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983378	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000114
J	Epel, ES; Tomiyama, AJ; Mason, AE; Laraia, BA; Hartman, W; Ready, K; Acree, M; Adam, TC; St Jeor, S; Kessler, D				Epel, Elissa S.; Tomiyama, A. Janet; Mason, Ashley E.; Laraia, Barbara A.; Hartman, William; Ready, Karen; Acree, Michael; Adam, Tanja C.; St Jeor, Sachiko; Kessler, David			The Reward-Based Eating Drive Scale: A Self-Report Index of Reward-Based Eating	PLOS ONE			English	Article							FOOD ADDICTION; GRAY-MATTER; BODY-WEIGHT; PSYCHOLOGICAL STRESS; PHYSICAL-ACTIVITY; OBESITY; QUESTIONNAIRE; MORTALITY; CRITERIA; VOLUMES	Why are some individuals more vulnerable to persistent weight gain and obesity than are others? Some obese individuals report factors that drive overeating, including lack of control, lack of satiation, and preoccupation with food, which may stem from reward-related neural circuitry. These are normative and common symptoms and not the sole focus of any existing measures. Many eating scales capture these common behaviors, but are confounded with aspects of dysregulated eating such as binge eating or emotional overeating. Across five studies, we developed items that capture this reward-based eating drive (RED). Study 1 developed the items in lean to obese individuals (n = 327) and examined changes in weight over eight years. In Study 2, the scale was further developed and expert raters evaluated the set of items. Study 3 tested psychometric properties of the final 9 items in 400 participants. Study 4 examined psychometric properties and race invariance (n = 80 women). Study 5 examined psychometric properties and age/gender invariance (n = 381). Results showed that RED scores correlated with BMI and predicted earlier onset of obesity, greater weight fluctuations, and greater overall weight gain over eight years. Expert ratings of RED scale items indicated that the items reflected characteristics of reward-based eating. The RED scale evidenced high internal consistency and invariance across demographic factors. The RED scale, designed to tap vulnerability to reward-based eating behavior, appears to be a useful brief tool for identifying those at higher risk of weight gain over time. Given the heterogeneity of obesity, unique brief profiling of the reward-based aspect of obesity using a self-report instrument such as the RED scale may be critical for customizing effective treatments in the general population.	[Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94117 USA; [Epel, Elissa S.; Tomiyama, A. Janet; Laraia, Barbara A.] UCSF Ctr Obes Assessment Study & Treatment, San Francisco, CA USA; [Tomiyama, A. Janet] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Mason, Ashley E.; Acree, Michael] UCSF Osher Ctr Integrat Med, San Francisco, CA USA; [Laraia, Barbara A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Hartman, William; Ready, Karen] MD Weight Management Program, San Francisco, CA USA; [Adam, Tanja C.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [St Jeor, Sachiko] Univ Nevada, Sch Med, Div Endocrinol Nutr & Metab, Reno, NV 89557 USA; [Kessler, David] UCSF Sch Med, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Maastricht University; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Francisco	Epel, ES (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94117 USA.	eepel@lppi.ucsf.edu; tomiyama@psych.ucla.edu	Laraia, Barbara/GXG-1829-2022		UC Berkeley Population Center; University of the California Office of the President, Multi-campus Research Programs and Initiatives [142691]; National Center for Complementary & Integrative Health [T32AT003997] Funding Source: NIH RePORTER	UC Berkeley Population Center; University of the California Office of the President, Multi-campus Research Programs and Initiatives(University of California System); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the UC Berkeley Population Center. Funding for this project was provided by the University of the California Office of the President, Multi-campus Research Programs and Initiatives Grant 142691 to the Stress, Environment and Weight Center at UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S. H., 2013, NEUROSCIENCE 21 CENT, P2833; [Anonymous], CONFIRMATORY FACTOR; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brown I, 2006, J ADV NURS, V53, P221, DOI 10.1111/j.1365-2648.2006.03718.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cappelleri JC, 2009, INT J OBESITY, V33, P913, DOI 10.1038/ijo.2009.107; Cappelleri JC, 2003, EXPLORATORY FACTOR A, P343; Carr Katelyn A, 2011, Curr Drug Abuse Rev, V4, P190; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Corsica JA, 2010, CURR OPIN GASTROEN, V26, P165, DOI 10.1097/MOG.0b013e328336528d; Corsica Joyce A, 2008, Eat Behav, V9, P447, DOI 10.1016/j.eatbeh.2008.07.004; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006062.pub2; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Daubenmier J, 2014, APPETITE, V74, P92, DOI 10.1016/j.appet.2013.11.014; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Ender P, 2006, FAPARA COMMAND COMPU; Field AE, 1999, AM J EPIDEMIOL, V150, P573, DOI 10.1093/oxfordjournals.aje.a010055; Flint AJ, 2014, AM J CLIN NUTR AJCN; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Gaser C, 2003, J NEUROSCI, V23, P9240; Gearhardt A, 2013, PRELIMINARY VALIDATI; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kessler D.A., 2010, END OVEREATING TAKIN; Kittur A., 2008, CROWDSOURCING USER S; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; MORRISON JA, 1992, AM J PUBLIC HEALTH, V82, P1613; Moss M., 2013, SALT SUGAR FAT FOOD; Nijs IMT, 2007, APPETITE, V49, P38, DOI 10.1016/j.appet.2006.11.001; Pelchat ML, 2009, J NUTR, V139, P620, DOI 10.3945/jn.108.097816; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Sim ME, 2007, NEUROPSYCHOPHARMACOL, V32, P2229, DOI 10.1038/sj.npp.1301346; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; van Dillen SME, 2013, PATIENT EDUC COUNS, V90, P155, DOI 10.1016/j.pec.2012.10.022; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Velicer W.F., 2000, PROBLEMS SOLUTIONS H, P41, DOI [10.1007/978-1-4615-4397-8_3, DOI 10.1007/978-1-4615-4397-8_3]; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wadden TA, 2002, J CONSULT CLIN PSYCH, V70, P510, DOI 10.1037//0022-006X.70.3.510; Yokum S, 2012, INT J OBESITY, V36, P656, DOI 10.1038/ijo.2011.175; ZIPURSKY RB, 1992, ARCH GEN PSYCHIAT, V49, P195	60	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101350	10.1371/journal.pone.0101350	http://dx.doi.org/10.1371/journal.pone.0101350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979216	Green Published, gold			2022-12-25	WOS:000338506400120
J	Chen, FC; Liao, YC; Huang, JM; Lin, CH; Chen, YY; Dou, HY; Hsiung, CA				Chen, Feng-Chi; Liao, Yu-Chieh; Huang, Jie-Mao; Lin, Chieh-Hua; Chen, Yih-Yuan; Dou, Horng-Yunn; Hsiung, Chao Agnes			Pros and Cons of the Tuberculosis Drugome Approach - An Empirical Analysis	PLOS ONE			English	Article							PLASMA-LEVELS; PHARMACOKINETICS; TAMOXIFEN; SERUM; PHARMACOLOGY; INHIBITION; RESISTANCE; REGIMENS; BLOOD; FLUID	Drug-resistant Mycobacterium tuberculosis (MTB), the causative pathogen of tuberculosis (TB), has become a serious threat to global public health. Yet the development of novel drugs against MTB has been lagging. One potentially powerful approach to drug development is computation-aided repositioning of current drugs. However, the effectiveness of this approach has rarely been examined. Here we select the "TB drugome" approach - a protein structure-based method for drug repositioning for tuberculosis treatment - to (1) experimentally validate the efficacy of the identified drug candidates for inhibiting MTB growth, and (2) computationally examine how consistently drug candidates are prioritized, considering changes in input data. Twenty three drugs in the TB drugome were tested. Of them, only two drugs (tamoxifen and 4-hydroxytamoxifen) effectively suppressed MTB growth at relatively high concentrations. Both drugs significantly enhanced the inhibitory effects of three first-line anti-TB drugs (rifampin, isoniazid, and ethambutol). However, tamoxifen is not a top-listed drug in the TB drugome, and 4-hydroxytamoxifen is not approved for use in humans. Computational re-examination of the TB drugome indicated that the rankings were subject to technical and data-related biases. Thus, although our results support the effectiveness of the TB drugome approach for identifying drugs that can potentially be repositioned for stand-alone applications or for combination treatments for TB, the approach requires further refinements via incorporation of additional biological information. Our findings can also be extended to other structure-based drug repositioning methods.	[Chen, Feng-Chi; Liao, Yu-Chieh; Huang, Jie-Mao; Lin, Chieh-Hua; Hsiung, Chao Agnes] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Chen, Feng-Chi] Natl Chiao Tung Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Feng-Chi] China Med Univ, Dept Dent, Taichung, Taiwan; [Lin, Chieh-Hua] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Yih-Yuan; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; National Tsing Hua University; National Health Research Institutes - Taiwan	Chen, FC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan.	fcchen@nhri.org.tw; hsiung@nhri.org.tw	Dou, horng-yunn/F-1966-2015; Liao, Yu-Chieh/E-5031-2011; Chen, Feng-Chi/E-3841-2010; Liao, Yu-Chieh/L-5113-2019; Hsiung, Chao Agnes/E-3994-2010; Dou, Horng-Yunn/B-2652-2010	Liao, Yu-Chieh/0000-0002-4360-7932; 	National Health Research Institutes [PH-101-SP05, PH-102-SP04]	National Health Research Institutes(National Health Research Institutes, Japan)	This study was supported by the National Health Research Institutes intramural funding (PH-101-SP05 and PH-102-SP04: www.nhri.org.tw). The computational facilities for this work were partly supported by the Ministry of Science and Technology, Taiwan (Taiwan Bioinformatics Institute Core Facility (NSC102-2319-B-400-001): www.most.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Almond-Roesler B, 1998, DERMATOLOGY, V196, P176, DOI 10.1159/000017856; Castelnuovo B, 2010, AFR HEALTH SCI, V10, P320; Cioffi M, 2001, J PEDIATR ENDOCR MET, V14, P1635; Czock D, 2005, BRIT J CLIN PHARMACO, V59, P479, DOI 10.1111/j.1365-2125.2004.02326.x; Dheda K, 2008, NEW ENGL J MED, V359, P2390, DOI 10.1056/NEJMc081884; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; DONEHOWER RC, 1986, CANCER TREAT REP, V70, P1059; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Elbireer S, 2011, TROP MED INT HEALTH, V16, P981, DOI 10.1111/j.1365-3156.2011.02800.x; EMORI HW, 1976, ANN RHEUM DIS, V35, P333, DOI 10.1136/ard.35.4.333; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Garcia-Sosa AT, 2012, CURR MED CHEM, V19, P1646; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Gatti G, 1999, AIDS, V13, P2083, DOI 10.1097/00002030-199910220-00011; Harmsen S, 2010, CANCER CHEMOTH PHARM, V66, P765, DOI 10.1007/s00280-009-1221-4; Hempen C, 2012, ANN CLIN BIOCHEM, V49, P170, DOI 10.1258/acb.2011.011004; HOWELL SK, 1980, CLIN CHEM, V26, P734; Issa NT, 2013, CURR TOP MED CHEM, V13, P2328, DOI 10.2174/15680266113136660163; Jekarl DW, 2012, J CLIN LAB ANAL, V26, P412, DOI 10.1002/jcla.21535; JOYCE DA, 1990, BRIT J CLIN PHARMACO, V30, P511, DOI 10.1111/j.1365-2125.1990.tb03808.x; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; Letendre SL, 2000, ANTIMICROB AGENTS CH, V44, P2173, DOI 10.1128/AAC.44.8.2173-2175.2000; Liu K, 2014, DRUG METAB PHARMACOK, V29, P219, DOI 10.2133/dmpk.DMPK-13-NT-089; Macingwana L, 2012, J ANTIMICROB CHEMOTH, V67, P2908, DOI 10.1093/jac/dks306; Macquaire V, 2002, ACTA ANAESTH SCAND, V46, P1010, DOI 10.1034/j.1399-6576.2002.460814.x; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Marzolini C, 2001, THER DRUG MONIT, V23, P394, DOI 10.1097/00007691-200108000-00012; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Nencini C, 2008, EUR REV MED PHARMACO, V12, P293; Nichols K C, 1984, Obstet Gynecol Surv, V39, P230, DOI 10.1097/00006254-198404000-00022; Nishikawa N, 2009, PARKINSONISM RELAT D, V15, P351, DOI 10.1016/j.parkreldis.2008.08.005; OVERDIEK HWPM, 1985, CLIN PHARMACOL THER, V38, P469, DOI 10.1038/clpt.1985.206; Palomino JC, 2013, J ANTIMICROB CHEMOTH, V68, P275, DOI 10.1093/jac/dks405; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Ruslami R, 2006, ANTIMICROB AGENTS CH, V50, P822, DOI 10.1128/AAC.50.2.822-823.2006; RYLANCE GW, 1985, ARCH DIS CHILD, V60, P29, DOI 10.1136/adc.60.1.29; Seminari E, 2005, J ANTIMICROB CHEMOTH, V56, P790, DOI 10.1093/jac/dki314; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; WELLBY M, 1966, BRIT MED J, V2, P668, DOI 10.1136/bmj.2.5515.668; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yilmaz A, 2009, AIDS RES HUM RETROV, V25, P457, DOI 10.1089/aid.2008.0216; Zhao XJ, 2002, XENOBIOTICA, V32, P863, DOI 10.1080/00498250210158230	50	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100829	10.1371/journal.pone.0100829	http://dx.doi.org/10.1371/journal.pone.0100829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971632	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200065
J	Choleva, L; Musilova, Z; Kohoutova-Sediva, A; Paces, J; Rab, P; Janko, K				Choleva, Lukas; Musilova, Zuzana; Kohoutova-Sediva, Alena; Paces, Jan; Rab, Petr; Janko, Karel			Distinguishing between Incomplete Lineage Sorting and Genomic Introgressions: Complete Fixation of Allospecific Mitochondrial DNA in a Sexually Reproducing Fish (Cobitis; Teleostei), despite Clonal Reproduction of Hybrids	PLOS ONE			English	Article							LOACHES GENUS COBITIS; SPINED LOACHES; ANCIENT HYBRIDIZATION; RETICULATE EVOLUTION; NUCLEAR DISCORDANCE; POPULATION SIZES; MIGRATION RATES; SPECIES TREES; DIVERGENCE; HISTORY	Distinguishing between hybrid introgression and incomplete lineage sorting causing incongruence among gene trees in that they exhibit topological differences requires application of statistical approaches that are based on biologically relevant models. Such study is especially challenging in hybrid systems, where usual vectors mediating interspecific gene transfers hybrids with Mendelian heredity - are absent or unknown. Here we study a complex of hybridizing species, which are known to produce clonal hybrids, to discover how one of the species, Cobitis tanaitica, has achieved a pattern of mito-nuclear mosaic genome over the whole geographic range. We appplied three distinct methods, including the method using solely the information on gene tree topologies, and found that the contrasting mito-nuclear signal might not have resulted from the retention of ancestral polymorphism. Instead, we found two signs of hybridization events related to C. tanaitica; one concerning nuclear gene flow and the other suggested mitochondrial capture. Interestingly, clonal inheritance ( gynogenesis) of contemporary hybrids prevents genomic introgressions and non-clonal hybrids are either absent or too rare to be detected among European Cobitis. Our analyses therefore suggest that introgressive hybridizations are rather old episodes, mediated by previously existing hybrids whose inheritance was not entirely clonal. Cobitis complex thus supports the view that the type of resulting hybrids depends on a level of genomic divergence between sexual species.	[Choleva, Lukas; Musilova, Zuzana; Kohoutova-Sediva, Alena; Paces, Jan; Rab, Petr; Janko, Karel] AS CR, Vvi, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Choleva, Lukas] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Musilova, Zuzana] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Musilova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Kohoutova-Sediva, Alena] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Paces, Jan] Inst Mol Genet ASCR, Vvi, Lab Genom & Bioinformat, Prague, Czech Republic; [Janko, Karel] Univ Ostrava, Fac Nat Sci, Dept Biol & Ecol, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Helsinki; University of Basel; Charles University Prague; Slovak Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Ostrava	Choleva, L (corresponding author), AS CR, Vvi, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic.	choleva@iapg.cas.cz	Janko, Karel/G-7183-2014; Sediva, Alena/G-7204-2014; Musilova, Zuzana/S-2899-2017; Ráb, Petr/G-7176-2014; Pačes, Jan/C-8851-2009	Musilova, Zuzana/0000-0001-8759-8663; Pačes, Jan/0000-0003-3059-6127	Czech Science Foundation [P506/10/1155, P506/12/P857]; Academy of Sciences of the Czech Republic (ASCR); Program for internal support of projects of international cooperation ASCR [M200451271]; European Community under Synthesys [ES-TAF-169];  [RVO 67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic (ASCR)(Czech Academy of Sciences); Program for internal support of projects of international cooperation ASCR; European Community under Synthesys; 	The authors gratefully acknowledge the grant support no. P506/10/1155 to LC, PR and KJ provided by the Czech Science Foundation (www.gacr.cz). Further support was provided by the Academy of Sciences of the Czech Republic (ASCR) (www.cas.cz) by the Grant No. RVO 67985904 and by the Project No. M200451271 to LC within the Program for internal support of projects of international cooperation ASCR. LC is also profoundly grateful for the financial support (No. ES-TAF-169) from the European Community's Programme "Structuring the European Research Area'' under Synthesys (www.synthesys.info), hosted by I. Doadrio at the Museo Nacional de Ciencias Naturales CSIC and to the Czech Science Foundation (www.gacr.cz) by grant no. P506/12/P857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2009, MOL ECOL, V18, P1239, DOI 10.1111/j.1365-294X.2009.04094.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Arnold M. L., 2006, EVOLUTION GENETIC EX; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; Bogart JP, 2013, CYTOGENET GENOME RES, V140, P117, DOI 10.1159/000351593; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buj I, 2008, FOLIA ZOOL, V57, P71; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Choleva L, 2008, PHILOS T R SOC B, V363, P2911, DOI 10.1098/rstb.2008.0059; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Cui RF, 2013, EVOLUTION, V67, P2166, DOI 10.1111/evo.12099; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; De Gelas K, 2008, MOL ECOL RESOUR, V8, P1001, DOI 10.1111/j.1755-0998.2008.02135.x; Di Candia MR, 2007, MOL PHYLOGENET EVOL, V45, P564, DOI 10.1016/j.ympev.2007.06.014; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gaggiotti OE, 2011, MOL ECOL, V20, P2229, DOI 10.1111/j.1365-294X.2011.05104.x; Gerard D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-291; GODDARD KA, 1993, COPEIA, P650; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HOTZ H, 1992, MOL BIOL EVOL, V9, P610; Hudson RR, 2003, EVOLUTION, V57, P182; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2005, MOL ECOL, V14, P2991, DOI 10.1111/j.1365-294X.2005.02583.x; Janko K, 2003, J EVOLUTION BIOL, V16, P1280, DOI 10.1046/j.1420-9101.2003.00627.x; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Jennings WB, 2005, EVOLUTION, V59, P2033; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Jones JC, 2012, MOL ECOL, V21, P2692, DOI 10.1111/j.1365-294X.2012.05571.x; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Maddison, 2019, MESQUITE MODULAR SYS; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; Mee JA, 2012, CAN J ZOOL, V90, P577, DOI 10.1139/Z2012-023; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Morishima K, 2008, HEREDITY, V100, P581, DOI 10.1038/hdy.2008.17; Moritz C. C., 1989, EVOLUTION ECOLOGY UN, P87; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Nei M, 1987, MOL EVOLUTIONARY GEN; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2010, MOL ECOL, V19, P1513, DOI 10.1111/j.1365-294X.2010.04564.x; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Plotner J, 2008, J EVOLUTION BIOL, V21, P668, DOI 10.1111/j.1420-9101.2008.01527.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rannala B, 2003, GENETICS, V164, P1645; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Saat TV, 1991, SOVIET J DEV BIOL, V22, P332; Saitoh K, 2004, ZOOL SCI, V21, P795, DOI 10.2108/zsj.21.795; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Sousa VC, 2011, MOL ECOL, V20, P3956, DOI 10.1111/j.1365-294X.2011.05247.x; SPOLSKY C, 1984, P NATL ACAD SCI-BIOL, V81, P5802, DOI 10.1073/pnas.81.18.5802; Stenberg P, 2013, CYTOGENET GENOME RES, V140, P185, DOI 10.1159/000351731; Stock M, 2002, NAT GENET, V30, P325, DOI 10.1038/ng839; Stock M, 2012, P ROY SOC B-BIOL SCI, V279, P1293, DOI 10.1098/rspb.2011.1738; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; TAJIMA F, 1993, GENETICS, V135, P599; TAKAHATA N, 1989, GENETICS, V122, P957; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QY, 2008, HYDROBIOLOGIA, V605, P17, DOI 10.1007/s10750-008-9296-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vasil'ev VP, 2003, FOLIA BIOL-KRAKOW, V51, P67; Vergilino R, 2011, MOL ECOL, V20, P1191, DOI 10.1111/j.1365-294X.2011.05004.x; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	103	49	50	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e80641	10.1371/journal.pone.0080641	http://dx.doi.org/10.1371/journal.pone.0080641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971792	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200001
J	Iversen, M; Fauchald, P; Langeland, K; Ims, RA; Yoccoz, NG; Brathen, KA				Iversen, Marianne; Fauchald, Per; Langeland, Knut; Ims, Rolf A.; Yoccoz, Nigel G.; Brathen, Kari Anne			Phenology and Cover of Plant Growth Forms Predict Herbivore Habitat Selection in a High Latitude Ecosystem	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; 1ST-PASSAGE TIME; DIET SELECTION; FORAGE QUALITY; REINDEER; SCALE; VEGETATION; FEEDBACKS; DYNAMICS; CARIBOU	The spatial and temporal distribution of forage quality is among the most central factors affecting herbivore habitat selection. Yet, for high latitude areas, forage quantity has been found to be more important than quality. Studies on large ungulate foraging patterns are faced with methodological challenges in both assessing animal movements at the scale of forage distribution, and in assessing forage quality with relevant metrics. Here we use first-passage time analyses to assess how reindeer movements relate to forage quality and quantity measured as the phenology and cover of growth forms along reindeer tracks. The study was conducted in a high latitude ecosystem dominated by low-palatable growth forms. We found that the scale of reindeer movement was season dependent, with more extensive area use as the summer season advanced. Small-scale movement in the early season was related to selection for younger stages of phenology and for higher abundances of generally phenologically advanced palatable growth forms (grasses and deciduous shrubs). Also there was a clear selection for later phenological stages of the most dominant, yet generally phenologically slow and low-palatable growth form (evergreen shrubs). As the summer season advanced only quantity was important, with selection for higher quantities of one palatable growth form and avoidance of a low palatable growth form. We conclude that both forage quality and quantity are significant predictors to habitat selection by a large herbivore at high latitude. The early season selectivity reflected that among dominating low palatability growth forms there were palatable phenological stages and palatable growth forms available, causing herbivores to be selective in their habitat use. The diminishing selectivity and the increasing scale of movement as the season developed suggest a response by reindeer to homogenized forage availability of low quality.	[Iversen, Marianne; Ims, Rolf A.; Yoccoz, Nigel G.; Brathen, Kari Anne] UiT Arctic Univ Norway, Dept Arct & Marine Biol, Tromso, Norway; [Fauchald, Per; Langeland, Knut] Norwegian Inst Nat Res NINA, Dept Arct Ecol, Fram Ctr, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian Institute Nature Research	Brathen, KA (corresponding author), UiT Arctic Univ Norway, Dept Arct & Marine Biol, Tromso, Norway.	kari.brathen@uit.no	Bråthen, Kari Anne/AAN-4666-2020; Fauchald, Per/AAV-4242-2021; Yoccoz, Nigel/C-8561-2014	Bråthen, Kari Anne/0000-0003-0942-1074; Yoccoz, Nigel/0000-0003-2192-1039	Sami University College; Norwegian Research Council	Sami University College; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by a grant to Marianne Iversen from the Sami University College and is a contribution from the "Ecosystem Finnmark" project, financed by Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Ballesteros M, 2012, J ZOOL, V287, P34, DOI 10.1111/j.1469-7998.2011.00883.x; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Brathen KA, 2004, OIKOS, V105, P461, DOI 10.1111/j.0030-1299.2004.12926.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Chapin FS, 1996, J VEG SCI, V7, P347, DOI 10.2307/3236278; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dorrepaal E, 2007, J ECOL, V95, P1167, DOI 10.1111/j.1365-2745.2007.01294.x; Dorrepaal E, 2007, OECOLOGIA, V151, P251, DOI 10.1007/s00442-006-0580-3; Farbrot H, 2008, P 9 INT C PERM U AL, P427; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Grime J. P., 2001, PLANT STRATEGIES VEG; Hagemoen RIM, 2002, J ANIM ECOL, V71, P883, DOI 10.1046/j.1365-2656.2002.00654.x; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hanley TA, 1997, OIKOS, V79, P209, DOI 10.2307/3546006; Hansen BB, 2009, POLAR BIOL, V32, P971, DOI 10.1007/s00300-009-0597-2; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Inga Berit, 2007, Rangifer, V27, P93; Inga Berit, 2012, Rangifer, V32, P1; Iversen M, 2009, J VEG SCI, V20, P903, DOI 10.1111/j.1654-1103.2009.01088.x; JEFFERIES RL, 1994, OIKOS, V71, P193, DOI 10.2307/3546267; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KIRKERUD K, 1989, OBJECT ORIENTED PROG; KLEIN D R, 1990, Rangifer, P123; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; KUDO G, 1991, ARCTIC ALPINE RES, V23, P436, DOI 10.2307/1551685; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Marell A, 2006, BASIC APPL ECOL, V7, P13, DOI 10.1016/j.baae.2005.04.005; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; MCARTHUR C, 1993, CAN J ZOOL, V71, P2236, DOI 10.1139/z93-314; Meir P, 2006, TRENDS ECOL EVOL, V21, P254, DOI 10.1016/j.tree.2006.03.005; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Moen A., 1998, NATL ATLAS NORWAY VE; Mysterud A, 2000, J ANIM ECOL, V69, P959, DOI 10.1046/j.1365-2656.2000.00454.x; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; Nilsson MC, 1998, OIKOS, V81, P6, DOI 10.2307/3546462; Noble IR, 1996, J VEG SCI, V7, P329, DOI 10.2307/3236276; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Pettorelli N, 2003, OECOLOGIA, V137, P363, DOI 10.1007/s00442-003-1364-7; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pinheiro JC, 2000, LINEAR MIXED EFFECTS; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shevtsova A, 1997, OIKOS, V78, P440, DOI 10.2307/3545606; Skarin A, 2014, POLAR BIOL; Skjenneberg S., 1968, REINDRIFTEN DENS NAT; SKOGLAND T, 1989, OIKOS, V55, P101, DOI 10.2307/3565879; SKOGLAND T, 1980, J ANIM ECOL, V49, P81, DOI 10.2307/4278; SKOGLAND T, 1984, HOLARCTIC ECOL, V7, P345; TRUDELL J, 1981, J APPL ECOL, V18, P63, DOI 10.2307/2402479; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN, P7; Warenberg K., 1997, FLORA REINBEITELAND; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; WHITE RG, 1980, ARCTIC ALPINE RES, V12, P511, DOI 10.2307/1550498; Wielgolaski F, 1975, PLANTS MICROORGANISM, P94; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wintle BC, 2013, METHODS ECOL EVOL, V4, P53, DOI 10.1111/j.2041-210x.2012.00254.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	70	23	24	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100780	10.1371/journal.pone.0100780	http://dx.doi.org/10.1371/journal.pone.0100780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972188	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000338512200061
J	Kulkarni, R; Acharya, J; Ghaskadbi, S; Goel, P				Kulkarni, Rashmi; Acharya, Jhankar; Ghaskadbi, Saroj; Goel, Pranay			Thresholds of Oxidative Stress in Newly Diagnosed Diabetic Patients on Intensive Glucose-Control Therapy	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; REDOX STATE; MITOCHONDRIAL H2O2; GLUTATHIONE; TOLERANCE; CATALASE	Cellular and animal studies suggest that oxidative stress could be the central defect underlying both beta-cell dysfunction and insulin resistance in type 2 diabetes mellitus. A reduction of glycemic stress in diabetic patients on therapy alleviates systemic oxidative stress and improves insulin resistance and beta-cell secretion. Monitoring oxidative stress systematically with glucose can potentially identify an individual's recovery trajectory. To determine a quantitative model of serial changes in oxidative stress, as measured via the antioxidant glutathione, we followed patients newly diagnosed with diabetes over 8 weeks of starting anti-diabetic treatment. We developed a mathematical model which shows recovery is marked with a quantal response. For each individual the model predicts three theoretical quantities: an estimate of maximal glutathione at low stress, a glucose threshold for half-maximal glutathione, and a rate at which recovery progresses. Individual patients are seen to vary considerably in their response to glucose control. Thus, model estimates can potentially be used to determine whether an individual patient's response is better or worse than average in terms of each of these indices; they can therefore be useful in reassessing treatment strategy. We hypothesize that this method can aid the personalization of effective targets of glucose control in anti-diabetic therapy.	[Kulkarni, Rashmi] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Acharya, Jhankar; Ghaskadbi, Saroj] Univ Pune, Dept Zool, Pune, Maharashtra, India; [Goel, Pranay] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune; Savitribai Phule Pune University; Indian Institute of Science Education & Research (IISER) Pune	Goel, P (corresponding author), Indian Inst Sci Educ & Res, Pune, Maharashtra, India.	pgoel@iiserpune.ac.in		Acharya, Jhankar/0000-0003-2371-2230; Goel, Pranay/0000-0002-2249-0288	Department of Biotechnology, Government of India; University Grants Commission; Council for Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Department of Biotechnology, Government of India. JA was supported by University Grants Commission and RK by Council for Scientific and Industrial Research, India. The study sponsor(s) had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abdul-Ghani MA, 2007, DIABETES METAB SYND, V1, P105, DOI 10.1016/j.dsx.2007.02.004; Acharya JD, 2014, DIABETES ME IN PRESS; Akerboom T P, 1981, Methods Enzymol, V77, P373; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; PAOLISSO G, 1992, AM J PHYSIOL, V263, pE435, DOI 10.1152/ajpendo.1992.263.3.E435; PAOLISSO G, 1992, DIABETES CARE, V15, P1, DOI 10.2337/diacare.15.1.1; Raz I, 2013, DIABETES CARE, V36, P1779, DOI 10.2337/dc13-0512; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tajiri Y, 2000, Int J Exp Diabetes Res, V1, P111, DOI 10.1155/EDR.2000.111; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; The Oxford Centre for Diabetes, HOMA CALC 0315; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100897	10.1371/journal.pone.0100897	http://dx.doi.org/10.1371/journal.pone.0100897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971653	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200073
J	Lozano-Santos, C; Martinez-Velasquez, J; Fernandez-Cuevas, B; Polo, N; Navarro, B; Millan, I; Garcia, JM; Collado, R; Sanchez-Godoy, P; Carbonell, F; Garcia-Vela, JA; Garcia-Marco, JA; Gomez-Lozano, N				Lozano-Santos, Carol; Martinez-Velasquez, Jimena; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Millan, Isabel; Miguel Garcia, Jose; Collado, Rosa; Sanchez-Godoy, Pedro; Carbonell, Felix; Antonio Garcia-Vela, Jose; Antonio Garcia-Marco, Jose; Gomez-Lozano, Natalia			Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SEQUENCE VARIATION; AUTOCRINE VEGF; CLL; ANGIOGENESIS; EXPRESSION; PREDICT; RECEPTORS; PROMOTER; REGION; CELLS	Vascular endothelial growth factor (VEGF)-mediated angiogenesis contributes to the pathogenesis of B-cell chronic lymphocytic leukaemia (CLL). We investigated the impact of VEGFA gene diversity on the clinical outcome of patients with this disease. A VEGFA haplotype conformed by positions rs699947 (-1540C>A), rs833061 (-460T>C) and rs2010963 (405C>G) and two additional single-nucleotide polymorphisms (SNPs), rs3025039 (936C>T) and rs25648 (1032C>T), were analysed in 239 patients at the time of their CLL diagnosis. Here, we showed that homozygosity for rs699947/rs833061/rs2010963 ACG haplotype (ACG(+/+) genotype) correlated with a reduced survival in CLL patients (ACG(+/+) vs other genotypes: HR = 2.3, p = 0.002; recessive model). In multivariate analysis, the ACG(+/+) genotype was identified as a novel independent prognostic factor (HR = 2.1, p = 0.005). Moreover, ACG homozygosity subdivided patients with CLL with otherwise indolent parameters into prognostic subgroups with different outcomes. Specifically, patients carrying the ACG(+/+) genotype with mutated IgV(H), very low and low-risk cytogenetics, initial clinical stage, CD38 negative status or early age at diagnosis showed a shorter survival (ACG(+/+) vs other genotypes: HR = 3.5, p = 0.035; HR = 3.4, p = 0.001; HR = 2.2, p = 0.035; HR = 3.4, p = 0.0001 and HR = 3.1, p = 0.009, respectively). In conclusion, VEGFA ACG(+/+) genotype confers an adverse effect in overall survival in CLL patients with an indolent course of the disease. These observations support the biological and prognostic implications of VEGFA genetics in CLL.	[Lozano-Santos, Carol; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Antonio Garcia-Marco, Jose] Hosp Univ Puerta Hierro Majadahonda, Dept Hematol, Madrid, Spain; [Lozano-Santos, Carol; Martinez-Velasquez, Jimena; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Millan, Isabel; Miguel Garcia, Jose; Antonio Garcia-Marco, Jose; Gomez-Lozano, Natalia] Inst Invest Puerta Hierro Majadahonda IDIPHIM, Madrid, Spain; [Millan, Isabel] Hosp Univ Puerta Hierro Majadahonda, Dept Stat, Madrid, Spain; [Martinez-Velasquez, Jimena; Gomez-Lozano, Natalia] Hosp Univ Puerta Hierro Majadahonda, Grp Immunogenet, Madrid, Spain; [Miguel Garcia, Jose] Hosp Univ Puerta Hierro Majadahonda, Oncol Grp, Madrid, Spain; [Collado, Rosa; Carbonell, Felix] Univ Valencia, Consorcio Hosp, Dept Hematol, Valencia, Spain; [Sanchez-Godoy, Pedro] Hosp Severo Ochoa Madrid, Dept Hematol, Madrid, Spain; [Antonio Garcia-Vela, Jose] Hosp Univ Ramon & Cajal Madrid, Dept Hematol, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; University of Valencia; Severo Ochoa University Hospital	Gomez-Lozano, N (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Grp Immunogenet, Madrid, Spain.	ngomez@idiphim.org	Collado Nieto, Rosa María/GZK-9557-2022; Gomez-Lozano, Natalia/K-6488-2014; Garcia Marco, Jose/H-2554-2015	Gomez-Lozano, Natalia/0000-0003-3959-9519; Garcia Marco, Jose/0000-0002-8993-5982; Carbonell, Felix/0000-0001-9617-6171; Collado, Rosa/0000-0002-8205-6192	Fundacion para la Investigacion Biomedica; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS CP09-182]; programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; Roche Pharma; Fundacion para la Investigacion Biomedica Puerta de Hierro	Fundacion para la Investigacion Biomedica; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; Roche Pharma; Fundacion para la Investigacion Biomedica Puerta de Hierro	This work was supported by Fundacion para la Investigacion Biomedica and Fondo de Investigacion Sanitaria (FIS CP09-182), Instituto de Salud Carlos III. The authors were funded by the following institutions: NGL by a grant from programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; CLS by a research grant from Roche Pharma and JMV by Fundacion para la Investigacion Biomedica Puerta de Hierro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Bairey O, 2004, LEUKEMIA RES, V28, P243, DOI 10.1016/S0145-2126(03)00256-X; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Diao LP, 2009, J CANCER RES CLIN, V135, P1473, DOI 10.1007/s00432-009-0650-0; Edelmann J, 2008, LEUKEMIA RES, V32, P1565, DOI 10.1016/j.leukres.2008.03.003; Farahani M, 2005, LEUKEMIA, V19, P524, DOI 10.1038/sj.leu.2403631; Ferrajoli A, 2001, CLIN CANCER RES, V7, P795; Freathy RM, 2006, J PANCREAS, V7, P295; Gehrke I, 2011, MOL MED, V17, P619, DOI 10.2119/molmed.2010.00210; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Girnita DM, 2006, TRANSPLANTATION, V82, P1774, DOI 10.1097/01.tp.0000250656.33731.08; Gora-Tybor J, 2005, EUR CYTOKINE NETW, V16, P41; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Hussong JW, 2000, BLOOD, V95, P309; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Kim DH, 2010, ANN ONCOL, V21, P1179, DOI 10.1093/annonc/mdp452; Kim DH, 2008, BRIT J HAEMATOL, V140, P71, DOI 10.1111/j.1365-2141.2007.06887.x; Kini AR, 2000, LEUKEMIA, V14, P1414, DOI 10.1038/sj.leu.2401825; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Maffei R, 2010, LEUKEMIA RES, V34, P312, DOI 10.1016/j.leukres.2009.06.023; Molica S, 1999, BRIT J HAEMATOL, V107, P605, DOI 10.1046/j.1365-2141.1999.01752.x; Pepper C, 2007, LEUKEMIA, V21, P687, DOI 10.1038/sj.leu.2404587; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Shanafelt T, 2010, LEUKEMIA LYMPHOMA, V51, P2222, DOI 10.3109/10428194.2010.524327; Shanafelt TD, 2009, BRIT J HAEMATOL, V146, P660, DOI 10.1111/j.1365-2141.2009.07811.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens A, 2003, CANCER RES, V63, P812; Till KJ, 2005, BLOOD, V105, P4813, DOI 10.1182/blood-2004-10-4054; Ugarte-Berzal E, 2010, BLOOD, V115, P846, DOI 10.1182/blood-2009-08-239426; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Wrobel T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/159813; Wrobel T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0456-4	39	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101063	10.1371/journal.pone.0101063	http://dx.doi.org/10.1371/journal.pone.0101063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971577	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200087
J	Trivodaliev, K; Bogojeska, A; Kocarev, L				Trivodaliev, Kire; Bogojeska, Aleksandra; Kocarev, Ljupco			Exploring Function Prediction in Protein Interaction Networks via Clustering Methods	PLOS ONE			English	Article							MODULAR ORGANIZATION; RANDOM-WALKS; COMPLEXES; YEAST; ALGORITHM; TOPOLOGY; DATABASE	Complex networks have recently become the focus of research in many fields. Their structure reveals crucial information for the nodes, how they connect and share information. In our work we analyze protein interaction networks as complex networks for their functional modular structure and later use that information in the functional annotation of proteins within the network. We propose several graph representations for the protein interaction network, each having different level of complexity and inclusion of the annotation information within the graph. We aim to explore what the benefits and the drawbacks of these proposed graphs are, when they are used in the function prediction process via clustering methods. For making this cluster based prediction, we adopt well established approaches for cluster detection in complex networks using most recent representative algorithms that have been proven as efficient in the task at hand. The experiments are performed using a purified and reliable Saccharomyces cerevisiae protein interaction network, which is then used to generate the different graph representations. Each of the graph representations is later analysed in combination with each of the clustering algorithms, which have been possibly modified and implemented to fit the specific graph. We evaluate results in regards of biological validity and function prediction performance. Our results indicate that the novel ways of presenting the complex graph improve the prediction process, although the computational complexity should be taken into account when deciding on a particular approach.	[Trivodaliev, Kire; Bogojeska, Aleksandra; Kocarev, Ljupco] Fac Comp Sci & Engn, Dept Intelligent Syst, Skopje, North Macedonia; [Kocarev, Ljupco] Macedonian Acad Sci & Arts, Skopje, North Macedonia		Kocarev, L (corresponding author), Fac Comp Sci & Engn, Dept Intelligent Syst, Skopje, North Macedonia.	lkocarev@manu.edu.mk	Bogojeska, Aleksandra/K-1787-2014; Kocarev, Ljupco/AAS-3002-2020	Bogojeska, Aleksandra/0000-0002-6668-1000; 				Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], [No title captured]; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dong D, 2007, CHINESE SCI BULL, V52, P2938, DOI 10.1007/s11434-007-0454-z; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Friedel CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-519; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lambiotte Renaud, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P546; Lambiotte R, 2014, IEEE T NETW SCI ENG, V1, P76, DOI 10.1109/TNSE.2015.2391998; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Mukhopadhyay A, 2012, MOL BIOSYST, V8, P3036, DOI 10.1039/c2mb25302j; Newman M.E.J., 2004, PHYS REV E, V70; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sen TZ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-355; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yu GX, 2005, PROTEINS, V61, P907, DOI 10.1002/prot.20652; Zhang YJ, 2013, IEEE ACM T COMPUT BI, V10, P729, DOI 10.1109/TCBB.2013.86	58	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99755	10.1371/journal.pone.0099755	http://dx.doi.org/10.1371/journal.pone.0099755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972109	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200013
J	Yang, Y; Matsuzaki, M; Takahashi, F; Qu, L; Nozaki, H				Yang, Yi; Matsuzaki, Motomichi; Takahashi, Fumio; Qu, Lei; Nozaki, Hisayoshi			Phylogenomic Analysis of "Red" Genes from Two Divergent Species of the "Green" Secondary Phototrophs, the Chlorarachniophytes, Suggests Multiple Horizontal Gene Transfers from the Red Lineage before the Divergence of Extant Chlorarachniophytes	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DIVISION; ORIGIN; ARABIDOPSIS; CHLOROPLAST; PLASTIDS; PROTEIN; ALGAE; RNA; CLASSIFICATION	The plastids of chlorarachniophytes were derived from an ancestral green alga via secondary endosymbiosis. Thus, genes from the "green" lineage via secondary endosymbiotic gene transfer (EGT) are expected in the nuclear genomes of the Chlorarachniophyta. However, several recent studies have revealed the presence of "red" genes in their nuclear genomes. To elucidate the origin of such "red" genes in chlorarachniophyte nuclear genomes, we carried out exhaustive single-gene phylogenetic analyses, including two operational taxonomic units (OTUs) that represent two divergent sister lineages of the Chlorarachniophyta, Amorphochlora amoeboformis (=Lotharella amoeboformis; based on RNA sequences newly determined here) and Bigelowiella natans (based on the published genome sequence). We identified 10 genes of cyanobacterial origin, phylogenetic analysis of which showed the chlorarachniophytes to branch with the red lineage (red algae and/or red algal secondary or tertiary plastid-containing eukaryotes). Of the 10 genes, 7 demonstrated robust monophyly of the two chlorarachniophyte OTUs. Thus, the common ancestor of the extant chlorarachniophytes likely experienced multiple horizontal gene transfers from the red lineage. Because 4 of the 10 genes are obviously photosynthesis-and/or plastid-related, and almost all of the eukaryotic OTUs in the 10 trees possess plastids, such red genes most likely originated directly from photosynthetic eukaryotes. This situation could be explained by a possible cryptic endosymbiosis of a red algal plastid before the secondary endosymbiosis of the green algal plastid, or a long-term feeding on a single (or multiple closely related) red algal plastid-containing eukaryote(s) after the green secondary endosymbiosis.	[Yang, Yi; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Matsuzaki, Motomichi] Univ Tokyo, Grad Sch Sci, Dept Biomed Chem, Bunkyo Ku, Tokyo 113, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Takahashi, Fumio] JST, PRESTO, Kawaguchi, Saitama, Japan; [Qu, Lei] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China	University of Tokyo; University of Tokyo; Ritsumeikan University; Japan Science & Technology Agency (JST); Fudan University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Matsuzaki, Motomichi/D-4043-2016	Matsuzaki, Motomichi/0000-0001-5811-798X; Nozaki, Hisayoshi/0000-0002-9308-4498	MEXT/JSPS KAKENHI [24657045, 24247042]; Grants-in-Aid for Scientific Research [24657045] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Challenging Exploratory Research (number 24657045 to HN) and Scientific Research (A) (number 24247042 to HN) from MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Archibald JM, 2012, ADV BOT RES, V64, P87, DOI 10.1016/B978-0-12-391499-6.00003-7; Arichbald JM, 2003, PNAS, V100, P7678; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Blake C, 1997, NATURE, V385, P204, DOI 10.1038/385204a0; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsner G, 2011, GENOME BIOL EVOL, V3, P140, DOI 10.1093/gbe/evq074; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallegraeff GM, 2003, MANUAL HARMFUL MARIN; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; Ishida K, 1997, J MOL EVOL, V45, P682, DOI 10.1007/PL00006272; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; LUDWIG M, 1989, J PHYCOL, V25, P385, DOI 10.1111/j.1529-8817.1989.tb00135.x; Mackiewicz P, 2012, SYMBIOSIS, V58, P99, DOI 10.1007/s13199-012-0202-2; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; MCFADDEN GI, 1994, P NATL ACAD SCI USA, V91, P3690, DOI 10.1073/pnas.91.9.3690; McFadden GI, 1997, PLANT SYST EVOL, P175; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nozaki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050827; Nozaki H, 2009, MOL PHYLOGENET EVOL, V53, P872, DOI 10.1016/j.ympev.2009.08.015; Ota S, 2012, PROTIST, V163, P91, DOI 10.1016/j.protis.2011.02.004; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Pielak GJ, 2010, P NATL ACAD SCI USA, V107, P17457, DOI 10.1073/pnas.1013095107; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; SASA T, 1992, PLANT CELL PHYSIOL, V33, P921; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Takahashi F, 2007, J PHYCOL, V43, P1302, DOI 10.1111/j.1529-8817.2007.00411.x; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VanDePeer Y, 1996, P NATL ACAD SCI USA, V93, P7732, DOI 10.1073/pnas.93.15.7732; Yamaguchi A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-29; Yang Yi, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-330; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	55	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101158	10.1371/journal.pone.0101158	http://dx.doi.org/10.1371/journal.pone.0101158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972019	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200100
J	Teixeira, FB; Santana, LND; Bezerra, FR; De Carvalho, S; Fontes, EA; Prediger, RD; Crespo-Lopez, ME; Maia, CSF; Lima, RR				Teixeira, Francisco Bruno; da Silva Santana, Luana Nazare; Bezerra, Fernando Romualdo; De Carvalho, Sabrina; Fontes-Junior, Eneas Andrade; Prediger, Rui Daniel; Crespo-Lopez, Maria Elena; Ferraz Maia, Cristiane Socorro; Lima, Rafael Rodrigues			Chronic Ethanol Exposure during Adolescence in Rats Induces Motor Impairments and Cerebral Cortex Damage Associated with Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; ALCOHOL EXPOSURE; INFLAMMATORY MEDIATORS; COGNITIVE DEFICITS; PROTECT NEURONS; CELL-DEATH; ADULT RATS; BRAIN; MICROGLIA; HIPPOCAMPUS	Binge drinking is common among adolescents, and this type of ethanol exposure may lead to long-term nervous system damage. In the current study, we evaluated motor performance and tissue alterations in the cerebral cortex of rats subjected to intermittent intoxication with ethanol from adolescence to adulthood. Adolescent male Wistar rats (35 days old) were treated with distilled water or ethanol (6.5 g/kg/day, 22.5%w/v) during 55 days by gavage to complete 90 days of age. The open field, inclined plane and the rotarod tests were used to assess the spontaneous locomotor activity and motor coordination performance in adult animals. Following completion of behavioral tests, half of animals were submitted to immunohistochemical evaluation of NeuN (marker of neuronal bodies), GFAP (a marker of astrocytes) and Iba1 (microglia marker) in the cerebral cortex while the other half of the animals were subjected to analysis of oxidative stress markers by biochemical assays. Chronic ethanol intoxication in rats from adolescence to adulthood induced significant motor deficits including impaired spontaneous locomotion, coordination and muscle strength. These behavioral impairments were accompanied by marked changes in all cellular populations evaluated as well as increased levels of nitrite and lipid peroxidation in the cerebral cortex. These findings indicate that continuous ethanol intoxication from adolescence to adulthood is able to provide neurobehavioral and neurodegenerative damage to cerebral cortex.	[Teixeira, Francisco Bruno; da Silva Santana, Luana Nazare; Lima, Rafael Rodrigues] Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, BR-66059 Belem, Para, Brazil; [Bezerra, Fernando Romualdo; De Carvalho, Sabrina; Fontes-Junior, Eneas Andrade; Ferraz Maia, Cristiane Socorro] Fed Univ Para, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66059 Belem, Para, Brazil; [Fontes-Junior, Eneas Andrade; Crespo-Lopez, Maria Elena] Fed Univ Para, Inst Biol Sci, Mol Pharmacol Lab, BR-66059 Belem, Para, Brazil; [Prediger, Rui Daniel] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, Florianopolis, SC, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal de Santa Catarina (UFSC)	Maia, CSF (corresponding author), Fed Univ Para, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66059 Belem, Para, Brazil.	crismaia@ufpa.br	Crespo-Lopez, Maria Elena/X-7912-2018; Fontes-Júnior, Enéas Andrade/ABF-8064-2020; Prediger, Rui D/C-4036-2013; Fontes-Júnior, Enéas Andrade/R-6372-2018; Prediger, Rui/CAG-4328-2022; DE CARVALHO CARTÁGENES, SABRINA/AAU-3102-2021; Teixeira, Francisco/N-6442-2014; Lima, Rafael Rodrigues/M-7726-2019; Prediger, Rui Daniel/AAV-3419-2020; Maia, Cristiane/E-7217-2016	Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Prediger, Rui D/0000-0002-7547-6463; Fontes-Júnior, Enéas Andrade/0000-0002-6186-9581; Prediger, Rui/0000-0001-5102-0296; Teixeira, Francisco/0000-0001-8596-3727; Lima, Rafael Rodrigues/0000-0003-1486-4013; Prediger, Rui Daniel/0000-0002-7547-6463; Maia, Cristiane/0000-0003-4493-7375	Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship; Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; CNPq; PROPESP - UFPA	Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPESP - UFPA	Francisco Bruno Teixeira was supported by a Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship. Fernando Romualdo Bezerra was supported by a Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. R.D.P. is supported by a research fellowship from CNPq. The authors would like to thank the PROPESP - UFPA for providing financial support (PAPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA H, 1973, Physiologist, V16, P143; Bell RL, 2003, ALCOHOL, V29, P137, DOI 10.1016/S0741-8329(03)00022-3; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Maia CDF, 2009, NEUROTOXICOLOGY, V30, P23, DOI 10.1016/j.neuro.2008.11.008; Doremus F, 2010, BRAIN COGNITION, V72, P114; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; EVARTS EV, 1983, J NEUROPHYSIOL, V49, P1199, DOI 10.1152/jn.1983.49.5.1199; Franke H, 1997, ALCOHOL, V14, P445, DOI 10.1016/S0741-8329(96)00209-1; FRANKE H, 1995, ACTA HISTOCHEM, V97, P263, DOI 10.1016/S0065-1281(11)80187-X; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; HARPER CG, 1982, J NEUROL NEUROSUR PS, V45, P838, DOI 10.1136/jnnp.45.9.838; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Instituto Nacional de Ciencia e Tecnologia para Politicas Publicas do Alcool e Outras Drogas, 2013, LEV NAC ALC DROG LEN; Koss WA, 2012, BRAIN RES, V1466, P24, DOI 10.1016/j.brainres.2012.05.023; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lopez-Caneda E, 2014, ALCOHOL ALCOHOLISM, V49, P173, DOI 10.1093/alcalc/agt168; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; McClain JA, 2011, J COMP NEUROL, V519, P2697, DOI 10.1002/cne.22647; MURPHY MP, 1995, NEUROBIOL LEARN MEM, V64, P181, DOI 10.1006/nlme.1995.1057; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Oliveira GB, 2014, BRAIN RES, V1561, P23, DOI 10.1016/j.brainres.2014.03.005; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pascual M, 2014, ALCOHOL ALCOHOLISM, V49, P187, DOI 10.1093/alcalc/agt164; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Ros-Simo C, 2013, J NEUROCHEM, V125, P736, DOI 10.1111/jnc.12247; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schramm-Sapyta NL, 2014, PSYCHOPHARMACOLOGY, V231, P1831, DOI 10.1007/s00213-013-3319-y; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Skala K, 2013, NEUROPSYCHIATRIE, V27, P202, DOI 10.1007/s40211-013-0066-6; Stigger F, 2013, INT J DEV NEUROSCI, V31, P820, DOI 10.1016/j.ijdevneu.2013.10.003; Tiwari V, 2013, NEUROSCIENCE, V244, P147, DOI 10.1016/j.neuroscience.2013.03.042; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Toumbourou JW, 2014, ADDICTION, V109, P417, DOI 10.1111/add.12401; Valles SL, 2004, BRAIN PATHOL, V14, P365; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Watts LT, 2005, J NEUROSCI RES, V80, P655, DOI 10.1002/jnr.20502; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2; White AM, 2002, ALCOHOL CLIN EXP RES, V26, P960, DOI 10.1097/01.ALC.0000021334.47130.F9; World Health Organization, 2011, GLOB STAT REP ALC HL; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	60	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101074	10.1371/journal.pone.0101074	http://dx.doi.org/10.1371/journal.pone.0101074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967633	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800105
J	Wu, CC; Huang, PH; Lai, CL; Leu, HB; Chen, JW; Lin, SJ				Wu, Chih-Cheng; Huang, Po-Hsun; Lai, Chao-Lun; Leu, Hsin-Bang; Chen, Jaw-Wen; Lin, Shing-Jong			The Impact of Endothelial Progenitor Cells on Restenosis after Percutaneous Angioplasty of Hemodialysis Vascular Access	PLOS ONE			English	Article							IN-STENT RESTENOSIS; CORONARY INTERVENTION; NEOINTIMAL FORMATION; DYSFUNCTION; FISTULAS; NUMBER; MOBILIZATION; INFLAMMATION; GRAFTS; RISK	Objective: We prospectively investigate the relation between baseline circulating endothelial progenitor cells and the subsequent development of restenosis after angioplasty of hemodialysis vascular access. Background: Effect of angioplasty for hemodialysis vascular access is greatly attenuated by early and frequent restenosis. Circulating endothelial progenitor cells (EPCs) play a key role in vascular repair but are deficient in hemodialysis patients. Method: After excluding 14 patients due to arterial stenosis, central vein stenosis, and failed angioplasty, 130 patients undergoing angioplasty for dysfunctional vascular access were prospectively enrolled. Flow cytometry with quantification of EPC markers (defined as CD34+, CD34+ KDR+, CD34+ KDR+ CD133+) in peripheral blood immediately before angioplasty procedures was used to assess circulating EPC numbers. Patients were followed clinically for up to one year after angioplasty. Results: During the one-year follow-up, 95 patients (73%) received interventions for recurrent access dysfunction. Patients in the lower tertile of CD34+ KDR+ cell count had the highest restenosis rates (46%) at three month (early restenosis), compared with patients in the medium and upper tertiles of CD34+ KDR+ cell count (27% and 12% respectively, p = 0.002). Patients in the lower tertile of CD34+ KDR+ cell count received more re-interventions during one year. Patients with early restenosis had impaired EPC adhesive function and increased senescence and apoptosis. In multivariate analysis, the CD34+ KDR+ and CD34+ KDR+ CD133+ cell counts were independent predictors of target-lesion early restenosis. Conclusion: Our results suggest that the deficiency of circulating EPCs is associated with early and frequent restenosis after angioplasty of hemodialysis vascular access.	[Wu, Chih-Cheng; Lai, Chao-Lun; Leu, Hsin-Bang] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Hsinchu Branch, Hsinchu, Taiwan; [Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Wu, Chih-Cheng; Lai, Chao-Lun] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Chih-Cheng; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw		WU, CHIH-CHENG/0000-0002-9690-6573; Lai, Chao-Lun/0000-0002-0362-245X	National Taiwan University Hospital, Hsinchu Branch [HCH100-4, HCH101-13]; UST-UCSD International Centre of Excellence in Advanced Bio-engineering [NSC-100-2911-I-009-101-A2]	National Taiwan University Hospital, Hsinchu Branch; UST-UCSD International Centre of Excellence in Advanced Bio-engineering	This study was supported by grants from the National Taiwan University Hospital, Hsinchu Branch (HCH100-4, HCH101-13), and the UST-UCSD International Centre of Excellence in Advanced Bio-engineering NSC-100-2911-I-009-101-A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Bittl JA, 2010, JACC-CARDIOVASC INTE, V3, P1, DOI 10.1016/j.jcin.2009.10.021; Chiang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089942; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Kraan J, 2012, DRUG DISCOV TODAY, V17, P710, DOI 10.1016/j.drudis.2012.01.011; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Marboeuf P, 2008, J THROMB HAEMOST, V6, P195; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; Matsuo Y, 2006, INTERNAL MED, V45, P581, DOI 10.2169/internalmedicine.45.1663; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Rajan DK, 2004, RADIOLOGY, V232, P508, DOI 10.1148/radiol.2322030714; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wu CC, 2010, ATHEROSCLEROSIS, V209, P598, DOI 10.1016/j.atherosclerosis.2009.10.021; Wu CC, 2009, J AM SOC NEPHROL, V20, P213, DOI 10.1681/ASN.2008050476; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101058	10.1371/journal.pone.0101058	http://dx.doi.org/10.1371/journal.pone.0101058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964143	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500115
J	Lu, B; Kiessling, V; Tamm, LK; Cafiso, DS				Lu, Bin; Kiessling, Volker; Tamm, Lukas K.; Cafiso, David S.			The Juxtamembrane Linker of Full-length Synaptotagmin 1 Controls Oligomerization and Calcium-dependent Membrane Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LABELED SIDE-CHAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DOMAIN; FUSION; TRANSMEMBRANE; PROTEIN; SNARE; CA2+; REVEALS; PENETRATION	Synaptotagmin 1 (Syt1) is the calcium sensor for synchronous neurotransmitter release. The two C2 domains of Syt1, which may mediate fusion by bridging the vesicle and plasma membranes, are connected to the vesicle membrane by a 60-residue linker. Here, we use site-directed spin labeling and a novel total internal reflection fluorescence vesicle binding assay to characterize the juxtamembrane linker and to test the ability of reconstituted full-length Syt1 to interact with opposing membrane surfaces. EPR spectroscopy demonstrates that the majority of the linker interacts with the membrane interface, thereby limiting the extension of the C2A and C2B domains into the cytoplasm. Pulse dipolar EPR spectroscopy provides evidence that purified full-length Syt1 is oligomerized in the membrane, and mutagenesis indicates that a glycine zipper/GXXXG motif within the linker helps mediate oligomerization. The total internal reflection fluorescence-based vesicle binding assay demonstrates that full-length Syt1 that is reconstituted into supported lipid bilayers will capture vesicles containing negatively charged lipid in a Ca2+ -dependent manner. Moreover, the rate of vesicle capture increases with Syt1 density, and mutations in the GXXXG motif that inhibit oligomerization of Syt1 reduce the rate of vesicle capture. This work demonstrates that modifications within the 60-residue linker modulate both the oligomerization of Syt1 and its ability to interact with opposing bilayers. In addition to controlling its activity, the oligomerization of Syt1 may play a role in organizing proteins within the active zone of membrane fusion.	[Lu, Bin; Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22904 USA; [Lu, Bin; Kiessling, Volker; Tamm, Lukas K.; Cafiso, David S.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22904 USA	University of Virginia; University of Virginia; University of Virginia	Cafiso, DS (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.	cafiso@virginia.edu	Lu, Bin/G-7576-2016	Lu, Bin/0000-0002-0812-293X	National Institutes of Health, NIGMS [P01 GM072694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P01 GM072694 (to D. S. C. and L. K. T.).	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; Freed DM, 2011, BIOCHEMISTRY-US, V50, P8792, DOI 10.1021/bi200971x; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jimenez RHF, 2010, PROTEIN SCI, V19, P269, DOI 10.1002/pro.305; Kim M, 2006, BIOPHYS J, V90, P2922, DOI 10.1529/biophysj.105.078246; Kim M, 2007, P NATL ACAD SCI USA, V104, P11975, DOI 10.1073/pnas.0702172104; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; Lai AL, 2011, J MOL BIOL, V405, P696, DOI 10.1016/j.jmb.2010.11.015; Lai Y, 2013, BIOCHEM J, V456, P25, DOI 10.1042/BJ20130949; Lopez CJ, 2012, BIOCHEMISTRY-US, V51, P6568, DOI 10.1021/bi3005686; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; Lu B, 2010, J MOL BIOL, V396, P602, DOI 10.1016/j.jmb.2009.12.020; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	60	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22161	22171		10.1074/jbc.M114.569327	http://dx.doi.org/10.1074/jbc.M114.569327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973220	Green Published, hybrid			2022-12-25	WOS:000340593500031
J	Frederix, M; Hutter, K; Leu, J; Batth, TS; Turner, WJ; Ruegg, TL; Blanch, HW; Simmons, BA; Adams, PD; Keasling, JD; Thelen, MP; Dunlop, MJ; Petzold, CJ; Mukhopadhyay, A				Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Turner, William J.; Rueegg, Thomas L.; Blanch, Harvey W.; Simmons, Blake A.; Adams, Paul D.; Keasling, Jay D.; Thelen, Michael P.; Dunlop, Mary J.; Petzold, Christopher J.; Mukhopadhyay, Aindrila			Development of a Native Escherichia coli Induction System for Ionic Liquid Tolerance	PLOS ONE			English	Article							PROTEIN OVEREXPRESSION; MARR FAMILY; FERMENTATION; PRETREATMENT; EXPRESSION; BIOMASS; INHIBITORS; MECHANISM; TOXICITY; GROWTH	The ability to solubilize lignocellulose makes certain ionic liquids (ILs) very effective reagents pretreating biomass prior to saccharification for biofuel fermentation. However, residual IL in the aqueous sugar solution can inhibit he growth and unction of biofuel-producing microorganism In E. coli this toxicity can be partially overcome by the heterologous expression of an IL efflux pump encoded by eilA from Enterobacter lignolyticus. In the present work, we used microarray analysis to identify native E. coli IL-inducible promoters and develop control systems for regulating eilA gene expression. Three candidate promoters, PmarR' PydfO', and PydfA', were selected and compared to the IPTG-inducible PiacUV5 system for controlling expression of eilA. The PydfA' and PmarR' based systems are as effective as PlacUV5 in their ability to rescue E. oil from typically toxic levels of IL, thereby eliminating the need to use an IPTG-based system for such tolerance engineering. We Present a mechanistic model indicating that inducible control systems reduce target gene expression hen IL levels are low. Selected-reaction monitoring mass spectrometry analysis revealed that at high IL concentrations EilA protein levels were significantly elevated under the control of PydfA' and PmaR' in comparison to the other promoters Further, in a pooled culture competition designed to determine fitness, the strain containing pPmarR'-eilA outcompetecl rains with other promoter constructs, most significantly at IL concentrations above 150 mM. These results indicate that native promoters such as PmarR' can provide effective systems for regulating the expression of heterologous genes in host engineering and simplify the development of industrially useful strains.	[Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Rueegg, Thomas L.; Blanch, Harvey W.; Simmons, Blake A.; Adams, Paul D.; Keasling, Jay D.; Thelen, Michael P.; Petzold, Christopher J.; Mukhopadhyay, Aindrila] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Blanch, Harvey W.; Adams, Paul D.; Keasling, Jay D.; Petzold, Christopher J.; Mukhopadhyay, Aindrila] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Turner, William J.; Dunlop, Mary J.] Univ Vermont, Sch Engn, Burlington, VT USA; [Rueegg, Thomas L.] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Rueegg, Thomas L.; Thelen, Michael P.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA; [Blanch, Harvey W.; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem, Coll Chem, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Coll Chem, Berkeley, CA 94720 USA; [Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Vermont; University of Basel; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Mukhopadhyay, A (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.	amukhopadhyay@lbl.gov	Simmons, Blake/N-6022-2016; Keasling, Jay D/J-9162-2012; Thelen, Michael P/G-2032-2014; Mukhopadhyay, Aindrila/AAW-7257-2021; Adams, Paul David/A-1977-2013	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Thelen, Michael P/0000-0002-2479-5480; Adams, Paul David/0000-0001-9333-8219; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Mannheim University of Applied Sciences; Office of Science (BER) at the U.S. Department of Energy; NASA Vermont Space Grant Consortium	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Mannheim University of Applied Sciences; Office of Science (BER) at the U.S. Department of Energy(United States Department of Energy (DOE)); NASA Vermont Space Grant Consortium(National Aeronautics & Space Administration (NASA))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. Kimmo Hutter was supported by his Master program at the Mannheim University of Applied Sciences and Prof. Matthias Mack. William Turner and Mary Dunlop were supported by the Office of Science (BER) at the U.S. Department of Energy and the NASA Vermont Space Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Grkovic S, 2001, SEMIN CELL DEV BIOL, V12, P225, DOI 10.1006/scdb.2000.0248; Harrison ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00360; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; HOLTZAPPLE MT, 1991, APPL BIOCHEM BIOTECH, V28-9, P59, DOI 10.1007/BF02922589; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Khudyakov JI, 2012, P NATL ACAD SCI US; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Lau MW, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-30; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108; Nichols NN, 2008, ENZYME MICROB TECH, V42, P624, DOI 10.1016/j.enzmictec.2008.02.008; Ouellet M, 2011, GREEN CHEM, V13, P2743, DOI 10.1039/c1gc15327g; Ouellet M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-97; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Quijano G, 2010, BIORESOURCE TECHNOL, V101, P8923, DOI 10.1016/j.biortech.2010.06.161; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Suryawati L, 2009, PROCESS BIOCHEM, V44, P540, DOI 10.1016/j.procbio.2009.01.011; Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018; Yoon LW, 2011, J CHEM TECHNOL BIOT, V86, P1342, DOI 10.1002/jctb.2651; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	46	28	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101115	10.1371/journal.pone.0101115	http://dx.doi.org/10.1371/journal.pone.0101115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983352	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000054
J	Grynberg, D; Maurage, P				Grynberg, Delphine; Maurage, Pierre			Pain and Empathy: The Effect of Self-Oriented Feelings on the Detection of Painful Facial Expressions	PLOS ONE			English	Article							EMOTIONAL RESPONSES	Background: Painful facial expressions have been shown to trigger affective responses among observers. However, there is so far no clear indication about the self-or other-oriented nature of these feelings. The purpose of this study was to assess whether facial expressions of pain are unconsciously associated with other-oriented feelings (empathic concern) or with self-oriented feelings (personal distress). Method: 70 participants took part in a priming paradigm in which ambiguous facial expressions of pain were primed by words related to empathic concern, distress, negative or by neutral words. It was hypothesized that empathic concern or distress-related words might facilitate the detection of pain in ambiguous facial expressions of pain, independently of a mere effect of prime (i.e., neutral words) or an effect of valence congruency (negative primes). Results: The results showed an effect of prime on the detection and on the reaction time to answer "pain" when confronted to ambiguous facial expressions of pain. More specifically, the detection of pain was higher and faster when preceded by distress primes relative to either neutral or negative primes. Conclusion: The present study suggests that painful expressions are unconsciously related to self-oriented feelings of distress and that their threat value might account for this effect. These findings thus shed new light on the automatic relationship between painful expressions and the affective components of empathy.	[Grynberg, Delphine; Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Grynberg, D (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.	Delphine.Grynberg@uclouvain.be	Grynberg, Delphine/K-6853-2019	Grynberg, Delphine/0000-0002-4588-4116; Maurage, Pierre/0000-0003-0197-0810	Belgian National Fund for Scientific Research (FNRS-FRS) [1.1233.09]	Belgian National Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	study was also supported by grant 1.1233.09 from the Belgian National Fund for Scientific Research (FNRS-FRS) to Delphine Grynberg (Research Fellow). Pierre Maurage is a FNRS Research Associate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Goubert L, 2008, J PAIN, V9, P272, DOI 10.1016/j.jpain.2007.11.006; Goubert L, 2009, PAIN, V143, P5, DOI 10.1016/j.pain.2009.02.023; Grynberg D, 2013, NORMS FRENC IN PRESS; Grynberg D, 2014, INT J PSYCHOL, V49, P371, DOI 10.1002/ijop.12006; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Pfaller M, 2012, PAIN, V153, P1976, DOI 10.1016/j.pain.2012.05.031; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Yamada M, 2009, PAIN, V143, P71, DOI 10.1016/j.pain.2009.01.028	15	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100434	10.1371/journal.pone.0100434	http://dx.doi.org/10.1371/journal.pone.0100434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983356	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000024
J	Huang, YN; Lai, CC; Chiu, CT; Lin, JJ; Wang, JY				Huang, Ya-Ni; Lai, Chien-Cheng; Chiu, Chien-Tsai; Lin, Jhen-Jhe; Wang, Jia-Yi			L-Ascorbate Attenuates the Endotoxin-Induced Production of Inflammatory Mediators by Inhibiting MAPK Activation and NF-kappa B Translocation in Cortical Neurons/Glia Cocultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; VITAMIN-C; OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINES; DEHYDROASCORBIC ACID; CEREBROSPINAL-FLUID; NEUROINFLAMMATION; INDUCTION; DIFFERENTIATION	In response to acute insults to the central nervous system, such as pathogen invasion or neuronal injuries, glial cells become activated and secrete inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines. This neuroinflammation plays a crucial role in the pathophysiology of chronic neurodegenerative diseases. Endogenous ascorbate levels are significantly decreased among patients with septic encephalopathy. Using the bacterial endotoxin lipopolysaccharide (LPS) to induce neuroinflammation in primary neuron/glia cocultures, we investigated how L-ascorbate (vitamin C; Vit. C) affected neuroinflammation. LPS (100 ng/ml) induced the expression of inducible NO synthase (iNOS) and the production of NO, interleukin (IL)-6, and macrophage inflammatory protein-2 (MIP-2/CXCL2) in a time-dependent manner; however, cotreatment with Vit. C (5 or 10 mM) attenuated the LPS-induced iNOS expression and production of NO, IL-6, and MIP-2 production. The morphological features revealed after immunocytochemical staining confirmed that Vit. C suppressed LPS-induced astrocytic and microglial activation. Because Vit. C can be transported into neurons and glia via the sodium-dependent Vit. C transporter-2, we examined how Vit. C affected LPS-activated intracellular signaling in neuron/glia cocultures. The results indicated the increased activation (caused by phosphorylation) of mitogen-activated protein kinases (MAPKs), such as p38 at 30 min and extracellular signal-regulated kinases (ERKs) at 180 min after LPS treatment. The inhibition of p38 and ERK MAPK suppressed the LPS-induced production of inflammatory mediators. Vit. C also inhibited the LPS-induced activation of p38 and ERK. Combined treatments of Vit. C and the inhibitors of p38 and ERK yielded no additional inhibition compared with using the inhibitors alone, suggesting that Vit. C functions through the same signaling pathway (i.e., MAPK) as these inhibitors. Vit. C also reduced LPS-induced I kappa B-alpha degradation and NF-kappa B translocation. Thus, Vit. C suppressed the LPS-stimulated production of inflammatory mediators in neuron/glia cocultures by inhibiting the MAPK and NF-kappa B signaling pathways.	[Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Lai, Chien-Cheng] Far Eastern Mem Hosp, Dept Surg, Div Orthoped, New Taipei City, Taiwan; [Chiu, Chien-Tsai] En Chu Kong Hosp, Dept Neurosurg, New Taipei City, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan	Far Eastern Memorial Hospital; En Chu Kong Hospital; Taipei Medical University; Taipei Medical University	Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Hsin Sheng College of Medical Care and Management, Taiwan [HSC-102-005]; National Science Council, Taiwan [NSC99-2320-B-038-006-MY3, NSC 101-2321-B-038-003]	Hsin Sheng College of Medical Care and Management, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant (HSC-102-005) to YNH from the Hsin Sheng College of Medical Care and Management, Taiwan; and grants (NSC99-2320-B-038-006-MY3 and NSC 101-2321-B-038-003 to JYW) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chiu CT, 2011, J INFECT DIS, V204, P1563, DOI 10.1093/infdis/jir608; Christen S, 2001, FREE RADICAL BIO MED, V31, P754, DOI 10.1016/S0891-5849(01)00642-6; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hediger MA, 2002, NAT MED, V8, P445, DOI 10.1038/nm0502-445; HORNIG D, 1975, ANN NY ACAD SCI, V258, P103, DOI 10.1111/j.1749-6632.1975.tb29271.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Kim BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055792; Kim WI, 2012, NEUROL RES; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; Korcok J, 2002, J NEUROCHEM, V81, P185, DOI 10.1046/j.1471-4159.2002.00814.x; Lee JY, 2003, J NEUROSCI RES, V73, P156, DOI 10.1002/jnr.10647; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Lin CH, 2006, J NEUROSCI RES, V84, P1485, DOI 10.1002/jnr.21047; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; REBEC GV, 1994, PROG NEUROBIOL, V43, P537, DOI 10.1016/0301-0082(94)90052-3; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Ryu JR, 2002, EXP BRAIN RES, V143, P257, DOI 10.1007/s00221-001-0991-7; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shin DM, 2004, NEUROREPORT, V15, P1959, DOI 10.1097/00001756-200408260-00025; Sochocka M, 2013, CNS NEUROL DISORD DR; Son EW, 2004, ARCH PHARM RES, V27, P1073, DOI 10.1007/BF02975434; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Wang JY, 1998, LIFE SCI, V63, P1571, DOI 10.1016/S0024-3205(98)00424-X; Wang YP, 2011, J IMMUNOL, V173, P5196; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhao SQ, 2011, INT IMMUNOPHARMACOL, V11, P468, DOI 10.1016/j.intimp.2010.12.017; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	47	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e97276	10.1371/journal.pone.0097276	http://dx.doi.org/10.1371/journal.pone.0097276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983461	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000005
J	Esghaei, M; Daliri, MR				Esghaei, Moein; Daliri, Mohammad Reza			Decoding of Visual Attention from LFP Signals of Macaque MT	PLOS ONE			English	Article							RHYTHMIC NEURONAL SYNCHRONIZATION; BRAIN-COMPUTER INTERFACES; LOCAL-FIELD POTENTIALS; AREA MT; CORTEX; OSCILLATIONS; MODULATION; MONKEY; EEG; NETWORKS	The local field potential (LFP) has recently been widely used in brain computer interfaces (BCI). Here we used power of LFP recorded from area MT of a macaque monkey to decode where the animal covertly attended. Support vector machines (SVM) were used to learn the pattern of power at different frequencies for attention to two possible positions. We found that LFP power at both low (<9 Hz) and high (31-120 Hz) frequencies contains sufficient information to decode the focus of attention. Highest decoding performance was found for gamma frequencies (31-120 Hz) and reached 82%. In contrast low frequencies (<9 Hz) could help the classifier reach a higher decoding performance with a smaller amount of training data. Consequently, we suggest that low frequency LFP can provide fast but coarse information regarding the focus of attention, while higher frequencies of the LFP deliver more accurate but less timely information about the focus of attention.	[Esghaei, Moein; Daliri, Mohammad Reza] Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran; [Daliri, Mohammad Reza] Iran Univ Sci & Technol, Fac Elect Engn, Dept Biomed Engn, Tehran, Iran; [Esghaei, Moein; Daliri, Mohammad Reza] German Primate Ctr DPZ, Cognit Neurosci Lab, Gottingen, Germany	Iran University Science & Technology; Deutsches Primatenzentrum (DPZ)	Esghaei, M (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran.	esghaei@ipm.ir; daliri@iust.ac.ir	Daliri, Mohammad Reza/AAF-4609-2021; Daliri, Mohammad Reza/S-9308-2018	Daliri, Mohammad Reza/0000-0001-9241-8751	Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences	Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences	This work was funded by the Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chrobak JJ, 1998, J NEUROSCI, V18, P388; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Ince NF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014384; Kaliukhovich DAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074665; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Khayat PS, 2010, J NEUROSCI, V30, P7037, DOI 10.1523/JNEUROSCI.0404-10.2010; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Manyakov NV, 2010, IEEE T NEURAL NETWOR, V21, P1892, DOI 10.1109/TNN.2010.2078834; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McFarland DJ, 2011, COMMUN ACM, V54, P60, DOI 10.1145/1941487.1941506; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Mo J, 2011, J NEUROSCI, V31, P878, DOI 10.1523/JNEUROSCI.5295-10.2011; Moran D, 2010, CURR OPIN NEUROBIOL, V20, P741, DOI 10.1016/j.conb.2010.09.010; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rotermund D, 2013, J NEUROSCI, V33, P6001, DOI 10.1523/JNEUROSCI.4225-12.2013; Rotermund D, 2009, J NEUROSCI, V29, P10120, DOI 10.1523/JNEUROSCI.5508-08.2009; Slutzky MW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036013; Smith E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016010; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Womelsdorf T, 2011, RES PER NEUROSCI, P109, DOI 10.1007/978-3-642-18015-6_7; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P8850, DOI 10.1073/pnas.1100999108	43	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100381	10.1371/journal.pone.0100381	http://dx.doi.org/10.1371/journal.pone.0100381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979704	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400027
J	Ieda, S; Moriyama, M; Takashita, T; Maehara, T; Imabayashi, Y; Shinozaki, S; Tanaka, A; Hayashida, JN; Furukawa, S; Ohta, M; Yamashita, Y; Nakamura, S				Ieda, Shinsuke; Moriyama, Masafumi; Takashita, Toru; Maehara, Takashi; Imabayashi, Yumi; Shinozaki, Shoichi; Tanaka, Akihiko; Hayashida, Jun-Nosuke; Furukawa, Sachiko; Ohta, Miho; Yamashita, Yoshihisa; Nakamura, Seiji			Molecular Analysis of Fungal Populations in Patients with Oral Candidiasis Using Internal Transcribed Spacer Region	PLOS ONE			English	Article							IDENTIFICATION; DUBLINIENSIS; XEROSTOMIA; INFECTION; ALBICANS; RISK	Oral candidiasis is closely associated with changes in the oral fungal flora and is caused primarily by Candida albicans. Conventional methods of fungal culture are time-consuming and not always conclusive. However, molecular genetic analysis of internal transcribed spacer (ITS) regions of fungal rRNA is rapid, reproducible and simple to perform. In this study we examined the fungal flora in patients with oral candidiasis and investigated changes in the flora after antifungal treatment using length heterogeneity-polymerization chain reaction (LH-PCR) analysis of ITS regions. Fifty-two patients with pseudomembranous oral candidiasis (POC) and 30 healthy controls were included in the study. Fungal DNA from oral rinse was examined for fungal species diversity by LH-PCR. Fungal populations were quantified by real-time PCR and previously-unidentified signals were confirmed by nucleotide sequencing. Relationships between the oral fungal flora and treatment-resistant factors were also examined. POC patients showed significantly more fungal species and a greater density of fungi than control individuals. Sixteen fungi were newly identified. The fungal populations from both groups were composed predominantly of C. albicans, though the ratio of C. dubliniensis was significantly higher in POC patients than in controls. The diversity and density of fungi were significantly reduced after treatment. Furthermore, fungal diversity and the proportion of C. dubliniensis were positively correlated with treatment duration. These results suggest that C. dubliniensis and high fungal flora diversity might be involved in the pathogenesis of oral candidiasis. We therefore conclude that LH-PCR is a useful technique for diagnosing and assessing the severity of oral candidal infection.	[Ieda, Shinsuke; Moriyama, Masafumi; Maehara, Takashi; Imabayashi, Yumi; Shinozaki, Shoichi; Tanaka, Akihiko; Hayashida, Jun-Nosuke; Furukawa, Sachiko; Ohta, Miho; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 812, Japan; [Takashita, Toru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fukuoka 812, Japan	Kyushu University; Kyushu University	Moriyama, M (corresponding author), Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 812, Japan.	moriyama@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan [20452774]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://kaken.nii.ac.jp/d/p/26670868.en.html), grant number: 20452774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2013, DAN MED J, V60; Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218; Eraso E, 2006, J CLIN MICROBIOL, V44, P3340, DOI 10.1128/JCM.00213-06; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jabra-Rizk Mary Ann, 2007, J Clin Pediatr Dent, V31, P260; Klentrou P, 2002, EUR J APPL PHYSIOL, V87, P153, DOI 10.1007/s00421-002-0609-1; KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Le J, 2013, ANTIMICROB AGENTS CH, V57, P2550, DOI 10.1128/AAC.02088-12; Li H, 2012, ORAL DIS, V18, P771, DOI 10.1111/j.1601-0825.2012.01944.x; Lin HL, 2013, AM J INFECT CONTROL, V41, P850, DOI 10.1016/j.ajic.2013.04.021; Liu ZJ, 1996, NUCLEIC ACIDS RES, V24, P2458, DOI 10.1093/nar/24.12.2458; Moran GP, 1997, ANTIMICROB AGENTS CH, V41, P617, DOI 10.1128/AAC.41.3.617; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Pasqualotto AC, 2009, PAEDIATR RESPIR REV, V10, P186, DOI 10.1016/j.prrv.2009.09.001; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Sharifzadeh A, 2013, J MYCOL MED, V23, P105, DOI 10.1016/j.mycmed.2013.02.001; Shinozaki S, 2012, ORAL DIS, V18, P667, DOI 10.1111/j.1601-0825.2012.01923.x; Sullivan DJ, 2005, FEMS MICROBIOL LETT, V253, P9, DOI 10.1016/j.femsle.2005.09.015; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Williams EJ, 2013, ACTA PAEDIATR, V102, P999, DOI 10.1111/apa.12341; Yurayart C, 2011, VET MICROBIOL, V148, P356, DOI 10.1016/j.vetmic.2010.09.020	28	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101156	10.1371/journal.pone.0101156	http://dx.doi.org/10.1371/journal.pone.0101156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979710	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400087
J	Insenser, M; Montes-Nieto, R; Martinez-Garcia, MA; Duran, EF; Santiuste, C; Gomez, V; Kline, JA; Escobar-Morreale, HF; Jimenez, D				Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Santiuste, Carmen; Gomez, Vicente; Kline, Jeffrey A.; Escobar-Morreale, Hector F.; Jimenez, David			Identification of Reduced Circulating Haptoglobin Concentration as a Biomarker of the Severity of Pulmonary Embolism: A Nontargeted Proteomic Study	PLOS ONE			English	Article							SELECTING PATIENTS; PROGNOSTIC MODELS; HEMOPEXIN; PLASMA; THROMBOEMBOLISM; POLYMORPHISM; DIAGNOSIS; PROTEINS; CT	Risk stratification of patients with pulmonary embolism (PE) may identify patients at high risk of early death who may benefit from more intensive surveillance or aggressive therapy. Nontargeted proteomics may identify biomarkers useful for the risk stratification of patients with acute symptomatic pulmonary embolism (PE). We studied 6 patients presenting with low-risk PE and 6 patients presenting with intermediate (n = 3) or high-risk (n = 3) PE. Two-dimensional difference gel electrophoresis was used to compare their plasma protein abundances. Candidate protein markers were identified by matrix assisted laser desorption ionization time-of-flight mass spectrometry. A panel of four biomarkers (haptoglobin, hemopexin, alpha(2)-macroglobulin, and Ig alpha(1)-chain C region) showed differences in plasma abundance among patients with acute symptomatic PE of different severity. Haptoglobin and hemopexin were decreased, whereas alpha(2)-macroglobulin and Ig alpha(1)-chain C region were increased, in patients with high or intermediate-risk PE compared with low-risk PE patient. In a separate clinical population consisting of 104 adults with acute PE, serum haptoglobin concentrations had an 85% chance of correctly identifying patients with high-risk PE according to receiving operating characteristics curve analysis. Moreover, serum haptoglobin concentrations <= 1 g/l showed an 80% sensitivity and a 96% specificity for the diagnosis of high-risk PE. Nontargeted proteomics identified protein biomarkers for the severity of PE that are involved in iron metabolism pathways and acute-phase response. Among them, reduced serum haptoglobin concentrations show a high accuracy for the biochemical detection of high-risk PE.	[Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.] Hosp Univ Ramon & Cajal, Dept Endocrinol & Nutr, Diabet Obes & Human Reprod Res Grp, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.; Jimenez, David] Univ Alcala, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.; Jimenez, David] Inst Ramon &Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Santiuste, Carmen] Hosp Univ Ramon & Cajal, Dept Clin Biochem, Madrid, Spain; [Gomez, Vicente] Hosp Univ Ramon & Cajal, Dept Internal Med, Madrid, Spain; [Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Jimenez, David] Hosp Univ Ramon & Cajal, Resp Dept, Pulm Embolism Res Grp, Madrid, Spain	Hospital Universitario Ramon y Cajal; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Indiana University System; Indiana University Bloomington; Hospital Universitario Ramon y Cajal	Insenser, M (corresponding author), Hosp Univ Ramon & Cajal, Dept Endocrinol & Nutr, Diabet Obes & Human Reprod Res Grp, Madrid, Spain.	mariarosa.insenser@salud.madrid.org	Insenser, María/B-9674-2014; Escobar-Morreale, Héctor F/G-5468-2010; García, María Ángeles Martínez/B-9712-2014	Insenser, María/0000-0003-3168-7856; Escobar-Morreale, Héctor F/0000-0002-6890-1644; García, María Ángeles Martínez/0000-0002-8354-7284	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [PI080944, PI08200, PI110246, PI110357]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness	This study was supported by grants PI080944, PI08200, PI110246 and PI110357 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness. The sponsors had no role in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Buller HR, 2003, NEW ENGL J MED, V349, P1695; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Conget F, 2008, THROMB HAEMOSTASIS, V100, P937, DOI 10.1160/TH08-02-0065; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Fink MP, 2009, J LEUKOCYTE BIOL, V86, P203, DOI 10.1189/jlb.0309137; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Insenser M, 2010, PROTEOM CLIN APPL, V4, P739, DOI 10.1002/prca.201000007; Insenser M, 2010, J CLIN ENDOCR METAB, V95, P3863, DOI 10.1210/jc.2010-0220; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jimenez D, 2008, CURR OPIN PULM MED, V14, P414, DOI 10.1097/MCP.0b013e3283043e44; Jimenez D, 2007, CHEST, V132, P24, DOI 10.1378/chest.06-2921; Jimenez D, 2014, THORAX, V69, P109, DOI 10.1136/thoraxjnl-2012-202900; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kline JA, 2009, J THROMB HAEMOST, V7, P1597, DOI 10.1111/j.1538-7836.2009.03535.x; Koch W, 2002, CLIN CHEM, V48, P1377; Langlois MR, 1996, CLIN CHEM, V42, P1589; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; Lin TA, 2010, J INFECT DIS, V202, P624, DOI 10.1086/654929; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Verrills Nicole M, 2006, Clin Biochem Rev, V27, P99; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Watts JA, 2012, THROMB RES, V130, P122, DOI 10.1016/j.thromres.2011.09.016; Zagorski J, 2010, J THROMB HAEMOST, V8, P389, DOI 10.1111/j.1538-7836.2009.03704.x	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100902	10.1371/journal.pone.0100902	http://dx.doi.org/10.1371/journal.pone.0100902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979072	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400047
J	Mazoyer, B; Zago, L; Jobard, G; Crivello, F; Joliot, M; Perchey, G; Mellet, E; Petit, L; Tzourio-Mazoyer, N				Mazoyer, Bernard; Zago, Laure; Jobard, Gael; Crivello, Fabrice; Joliot, Marc; Perchey, Guy; Mellet, Emmanuel; Petit, Laurent; Tzourio-Mazoyer, Nathalie			Gaussian Mixture Modeling of Hemispheric Lateralization for Language in a Large Sample of Healthy Individuals Balanced for Handedness	PLOS ONE			English	Article							FUNCTIONAL TRANSCRANIAL DOPPLER; WADA TEST; DOMINANCE; FMRI; MRI; BRAIN; COMPLEMENTARY; ATTENTION; PEOPLE; TASK	Hemispheric lateralization for language production and its relationships with manual preference and manual preference strength were studied in a sample of 297 subjects, including 153 left-handers (LH). A hemispheric functional lateralization index (HFLI) for language was derived from fMRI acquired during a covert sentence generation task as compared with a covert word list recitation. The multimodal HFLI distribution was optimally modeled using a mixture of 3 and 4 Gaussian functions in right-handers (RH) and LH, respectively. Gaussian function parameters helped to define 3 types of language hemispheric lateralization, namely "Typical'' (left hemisphere dominance with clear positive HFLI values, 88% of RH, 78% of LH), "Ambilateral'' (no dominant hemisphere with HFLI values close to 0, 12% of RH, 15% of LH) and "Strongly-atypical'' (right-hemisphere dominance with clear negative HFLI values, 7% of LH). Concordance between dominant hemispheres for hand and for language did not exceed chance level, and most of the association between handedness and language lateralization was explained by the fact that all Strongly-atypical individuals were left-handed. Similarly, most of the relationship between language lateralization and manual preference strength was explained by the fact that Strongly-atypical individuals exhibited a strong preference for their left hand. These results indicate that concordance of hemispheric dominance for hand and for language occurs barely above the chance level, except in a group of rare individuals (less than 1% in the general population) who exhibit strong right hemisphere dominance for both language and their preferred hand. They call for a revisit of models hypothesizing common determinants for handedness and for language dominance.	[Mazoyer, Bernard] CEA, CNRS, Grp Imagerie Neurofonct, Bordeaux, France; Univ Bordeaux, Bordeaux, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Mazoyer, B (corresponding author), CEA, CNRS, Grp Imagerie Neurofonct, Bordeaux, France.	bernard.mazoyer@univ-bordeaux.fr	Petit, Laurent/M-3888-2019; Crivello, Fabrice/ABB-4531-2021; Jobard, Gaël/C-3166-2014; Jobard, Gaël/M-2970-2019; Tzourio-Mazoyer, Nathalie/B-5598-2008; Mazoyer, Bernard M/B-6303-2012; Mellet, Emmanuel/B-7125-2008; mazoyer, bernard m/A-5369-2009; Zago, Laure/B-7124-2008; Petit, Laurent/D-6583-2011	Petit, Laurent/0000-0003-2499-5367; Jobard, Gaël/0000-0003-4536-0643; Jobard, Gaël/0000-0003-4536-0643; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; Mazoyer, Bernard M/0000-0003-0970-2837; Mellet, Emmanuel/0000-0002-2676-9112; mazoyer, bernard m/0000-0003-0970-2837; Petit, Laurent/0000-0003-2499-5367; Crivello, Fabrice/0000-0001-6950-984X; Zago, Laure/0000-0001-8235-2154; joliot, marc/0000-0001-7792-308X	Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Financial support for this study was internal to the authors' Institution, i.e. the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armour JAL, 2014, HEREDITY, V112, P221, DOI 10.1038/hdy.2013.93; Badzakova-Trajkov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009682; Berl MM, 2014, ANN NEUROL, V75, P33, DOI 10.1002/ana.24015; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Corballis MC, 2012, PROG BRAIN RES, V195, P103, DOI 10.1016/B978-0-444-53860-4.00006-4; Drane DL, 2012, EPILEPSIA, V53, P1790, DOI 10.1111/j.1528-1167.2012.03573.x; Dym RJ, 2011, RADIOLOGY, V261, P446, DOI 10.1148/radiol.11101344; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Groen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064876; Gutbrod K, 2012, J NEUROIMAGING, V22, P266, DOI 10.1111/j.1552-6569.2011.00646.x; Hecaen H, 1971, Cortex, V7, P19; Hund-Georgiadis M, 2002, EXP BRAIN RES, V145, P166, DOI 10.1007/s00221-002-1090-0; Isaacs KL, 2006, NEUROLOGY, V66, P1855, DOI 10.1212/01.wnl.0000219623.28769.74; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Mateer CA, 1982, HUM NEUROBIOL, V2, P135; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petit L., 2012, 18 ANN M ORG HUM BRA; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rosch RE, 2012, NEUROPSYCHOLOGIA, V50, P810, DOI 10.1016/j.neuropsychologia.2012.01.015; Seghier ML, 2011, HUM BRAIN MAPP, V32, P1602, DOI 10.1002/hbm.21130; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Stroobant N, 2009, BEHAV BRAIN RES, V199, P190, DOI 10.1016/j.bbr.2008.11.040; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Van der Haegen L, 2011, NEUROPSYCHOLOGIA, V49, P2879, DOI 10.1016/j.neuropsychologia.2011.06.014; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Zaca D, 2012, NEURORADIOLOGY, V54, P1015, DOI 10.1007/s00234-012-1056-2	33	182	183	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101165	10.1371/journal.pone.0101165	http://dx.doi.org/10.1371/journal.pone.0101165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977417	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400089
J	Gupta, GD; Dey, G; Swetha, MG; Ramalingam, B; Shameer, K; Thottacherry, JJ; Kalappurakkal, JM; Howes, MT; Chandran, R; Das, A; Menon, S; Parton, RG; Sowdhamini, R; Thattai, M; Mayor, S				Gupta, Gagan D.; Dey, Gautam; Swetha, M. G.; Ramalingam, Balaji; Shameer, Khader; Thottacherry, Joseph Jose; Kalappurakkal, Joseph Mathew; Howes, Mark T.; Chandran, Ruma; Das, Anupam; Menon, Sindhu; Parton, Robert G.; Sowdhamini, R.; Thattai, Mukund; Mayor, Satyajit			Population Distribution Analyses Reveal a Hierarchy of Molecular Players Underlying Parallel Endocytic Pathways	PLOS ONE			English	Article							GENOME-WIDE RNAI; SNARE COMPLEX; NETWORK INTEGRATION; ESCRT MACHINERY; GENE-EXPRESSION; DEEP-ORANGE; PROTEIN; MUTATIONS; SCREEN; INTERNALIZATION	Single-cell-resolved measurements reveal heterogeneous distributions of clathrin-dependent (CD) and - independent (CLIC/GEEC: CG) endocytic activity in Drosophila cell populations. dsRNA-mediated knockdown of core versus peripheral endocytic machinery induces strong changes in the mean, or subtle changes in the shapes of these distributions, respectively. By quantifying these subtle shape changes for 27 single-cell features which report on endocytic activity and cell morphology, we organize 1072 Drosophila genes into a tree-like hierarchy. We find that tree nodes contain gene sets enriched in functional classes and protein complexes, providing a portrait of core and peripheral control of CD and CG endocytosis. For 470 genes we obtain additional features from separate assays and classify them into early-or late-acting genes of the endocytic pathways. Detailed analyses of specific genes at intermediate levels of the tree suggest that Vacuolar ATPase and lysosomal genes involved in vacuolar biogenesis play an evolutionarily conserved role in CG endocytosis.	[Gupta, Gagan D.; Dey, Gautam; Swetha, M. G.; Ramalingam, Balaji; Shameer, Khader; Thottacherry, Joseph Jose; Kalappurakkal, Joseph Mathew; Chandran, Ruma; Das, Anupam; Menon, Sindhu; Sowdhamini, R.; Thattai, Mukund; Mayor, Satyajit] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India; [Howes, Mark T.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Queensland	Thattai, M (corresponding author), Natl Ctr Biol Sci, Tata Inst Fundamental Res, UAS GKVK Campus, Bangalore, Karnataka, India.	thattai@ncbs.res.in; mayor@ncbs.res.in	Dey, Gautam/GON-6083-2022; Khader, Shameer/J-2564-2016; Dey, Gautam/AAQ-8917-2020; Parton, Robert/C-5673-2009	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Kalappurakkal, Joseph Mathew/0000-0001-9265-6821; Thottacherry, Joseph/0000-0001-6881-8819; Gupta, Gagan/0000-0002-1089-965X; Menon, Sindhu/0000-0001-6066-5520; Howes, Mark/0000-0002-9666-3364; Parton, Robert/0000-0002-7494-5248	Council for Scientific and Industrial Research; University Grants Commission; Wellcome Trust-DBT India Alliance; Natural Sciences and Engineering Research Council of Canada; JC Bose Fellowship of the DST; National Health and Medical Research Council of Australia [569542, 1045092]; DST (Nanotech Council, India);  [56954]	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Wellcome Trust-DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); JC Bose Fellowship of the DST; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); DST (Nanotech Council, India); 	The authors acknowledge support from the Council for Scientific and Industrial Research (JJT), University Grants Commission (JMK), Wellcome Trust-DBT India Alliance (MT), Natural Sciences and Engineering Research Council of Canada (GDG), and Project Grant 56954 (GDG), JC Bose Fellowship of the DST(SM) and the National Health and Medical Research Council of Australia (Australia Fellowship 569542, RGP, and Project Grant 1045092, RGP and MTH) and for support from the DST (Nanotech Council, India) to develop the cell array and HCS system, from the DBT (CoE, and RNAi) for help in establishing the NCBS Screening facility. RGP and MTH acknowledge the facilities, and the scientific and technical assistance, of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chan KT, 2011, TRENDS CELL BIOL; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dey G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090540; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Krag C, 2010, J CELL SCI, V123, P4240, DOI 10.1242/jcs.071712; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Luria SE, 1943, GENETICS, V28, P491; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rohn, 2011, JCB, V194, P789; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Sims D, 2006, NUCLEIC ACIDS RES, V34, pD479, DOI 10.1093/nar/gkj038; Slack M, 2009, CURR OPIN DRUG DISC, V12, P351; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.E03-12-0876; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002566; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106	84	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100554	10.1371/journal.pone.0100554	http://dx.doi.org/10.1371/journal.pone.0100554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971745	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200041
J	Schacter, JL; Henson, ES; Gibson, SB				Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.			Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; TARGETING MCL-1; GENE-EXPRESSION; CROSS-TALK; ER-ALPHA; PATHWAY; GROWTH; BETA; ACTIVATION; RESISTANCE	Estrogen is implicated as an important factor in stimulating breast cancer cell proliferation, and presence of estrogen receptor (ER) is an indication of a good prognosis in breast cancer patients. Mcl-1 is an anti-apoptotic Bcl-2 family member that is often over expressed in breast tumors, correlating with poor survival. In breast cancer, it was been previously shown that epidermal growth factor receptors up-regulate Mcl-1 but the role of estrogen in increasing Mcl-1 expression was unknown. In ER alpha positive cell lines MCF-7 and ZR-75, estrogen treatment increased Mcl-1 expression at both the protein and mRNA level. In two ER alpha negative cell lines, SK-BR-3 and MDA-MB-231, estrogen failed to increase in Mcl-1 protein expression. We found that ER alpha antagonists decreased estrogen mediated Mcl-1 expression at both the protein and mRNA level. Upon knockdown of ER alpha, Mcl-1 mRNA expression after estrogen treatment was also decreased. We also found that ER alpha binds to the Mcl-1 promoter at a region upstream of the translation start site containing a half ERE site. Streptavidin-pull down assay showed that both ER alpha and transcription factor Sp1 bind to this region. These results suggest that estrogen is involved in regulating Mcl-1 expression specifically through a mechanism involving ER alpha.	[Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.] CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Manitoba; CancerCare Manitoba Foundation	Gibson, SB (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	gibsonsb@cc.umanitoba.ca		Gibson, Spencer/0000-0003-0119-732X	Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant; Manitoba Health Research Council (MHRC)	Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant; Manitoba Health Research Council (MHRC)	This project was supported by the Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant. Dr. Gibson is also Manitoba Chair supported by the Manitoba Health Research Council (MHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Azijli K, 2013, APOPTOSIS, V18, P851, DOI 10.1007/s10495-013-0829-3; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Becker TM, 2013, ONCOGENE; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Britton DJ, 2006, BREAST CANCER RES TR, V96, P131, DOI 10.1007/s10549-005-9070-2; Burow ME, 2001, J STEROID BIOCHEM, V78, P409, DOI 10.1016/S0960-0760(01)00117-0; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Dowsett M, 2005, BREAST CANCER RES TR, V93, pS11, DOI 10.1007/s10549-005-9037-3; DUBIK D, 1992, ONCOGENE, V7, P1587; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fox EM, 2008, STEROIDS, V73, P1039, DOI 10.1016/j.steroids.2008.04.006; Goncharenko-Khaider N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-84; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Kanczuga-Koda L, 2010, ONCOL LETT, V1, P1067, DOI 10.3892/ol.2010.178; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Murphy LC, 2012, SEMIN REPROD MED, V30, P5, DOI 10.1055/s-0031-1299592; Orlando L, 2010, CANCER TREAT REV, V36, pS67, DOI 10.1016/S0305-7372(10)70023-2; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Warr MR, 2008, CURR MOL MED, V8, P138; Witters LM, 2007, ONCOL REP, V17, P465; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; Yang QF, 1999, PATHOL INT, V49, P775, DOI 10.1046/j.1440-1827.1999.00942.x	37	20	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100364	10.1371/journal.pone.0100364	http://dx.doi.org/10.1371/journal.pone.0100364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971890	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200027
J	Alam, MK; Hamza, MA; Khafiz, MA; Rahman, SA; Shaari, R; Hassan, A				Alam, Mohammad Khursheed; Hamza, Muhammad Asyraf; Khafiz, Muhammad Aizuddin; Rahman, Shaifulizan Abdul; Shaari, Ramizu; Hassan, Akram			Multivariate Analysis of Factors Affecting Presence and/or Agenesis of Third Molar Tooth	PLOS ONE			English	Article							ORTHODONTIC PATIENTS; HYPODONTIA; POPULATION; GERMS; AGE	To investigate the presence and/or agenesis of third molar (M3) tooth germs in orthodontics patients in Malaysian Malay and Chinese population and evaluate the relationship between presence and/or agenesis of M3 with different skeletal malocclusion patterns and sagittal maxillomandibular jaw dimensions. Pretreatment records of 300 orthodontic patients (140 males and 160 females, 219 Malaysian Malay and 81 Chinese, average age was 16.27 +/- 4.59) were used. Third-molar agenesis was calculated with respect to race, genders, number of missing teeth, jaws, skeletal malocclusion patterns and sagittal maxillomandibular jaw dimensions. The Pearson chi-square test and ANOVA was performed to determine potential differences. Associations between various factors and M3 presence/agenesis groups were assessed using logistic regression analysis. The percentages of subjects with 1 or more M3 agenesis were 30%, 33% and 31% in the Malaysian Malay, Chinese and total population, respectively. Overall prevalence of M3 agenesis in male and female was equal (P>0.05). The frequency of the agenesis of M3s is greater in maxilla as well in the right side (P>0.05). The prevalence of M3 agenesis in those with a Class III and Class II malocclusion was relatively higher in Malaysian Malay and Malaysian Chinese population respectively. Using stepwise regression analyses, significant associations were found between Mx (P<0.05) and ANB (P<0.05) and M3 agenesis. This multivariate analysis suggested that Mx and ANB were significantly correlated with the M3 presence/agenesis.	[Alam, Mohammad Khursheed; Hamza, Muhammad Asyraf; Khafiz, Muhammad Aizuddin] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia; [Rahman, Shaifulizan Abdul; Shaari, Ramizu] Univ Sains Malaysia, Sch Dent Sci, Oral & Maxillofacial Surg Unit, Kota Baharu, Kelantan, Malaysia; [Hassan, Akram] Univ Sains Malaysia, Sch Dent Sci, Periodontol Unit, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	alam, mohammed/GXH-3645-2022; Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; Hamza, Muhammad/GQH-0690-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; Hamza, Muhammad/0000-0001-7800-689X				Barka G, 2012, INT J GEN MED, V5, P441, DOI 10.2147/IJGM.S31200; Bishara SE, 1999, AM J ORTHOD DENTOFAC, V115, P628, DOI 10.1016/S0889-5406(99)70287-8; BREDY E, 1991, Deutsche Zahn- Mund- und Kieferheilkunde, V79, P357; Cameron J, 1996, AUST DENT J, V41, P1, DOI 10.1111/j.1834-7819.1996.tb05645.x; Celikoglu M, 2012, ANGLE ORTHOD, V82, P165, DOI 10.2319/041911-274.1; ELOMAA M, 1973, Proceedings of the Finnish Dental Society, V69, P141; Garcia-Hernandez F, 2008, INT J MORPHOL, V26, P825, DOI 10.4067/S0717-95022008000400008; GARN SM, 1962, J DENT RES, V41, P717, DOI 10.1177/00220345620410033001; Goren S, 2005, Refuat Hapeh Vehashinayim (1993), V22, P49; Gravely J F, 1965, Br Dent J, V119, P397; Harris EF, 2008, AM J ORTHOD DENTOFAC, V134, P761, DOI 10.1016/j.ajodo.2006.12.019; HATTAB FN, 1995, ORAL SURG ORAL MED O, V79, P24, DOI 10.1016/S1079-2104(05)80068-X; Hellman M., 1936, DENT COSM, V78, P750; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; John J, 2012, J DENT SCI, V7, P211, DOI 10.1016/j.jds.2012.05.002; Sanchez MJ, 2009, ANGLE ORTHOD, V79, P473, DOI 10.2319/052008-276.1; Kajii T, 2001, AM J ORTHOD DENTOFAC, V119, P245, DOI 10.1067/mod.2001.111222; Kajii TS, 2004, ANGLE ORTHOD, V74, P337; Keene H J, 1965, Angle Orthod, V35, P289; Kleinbaum DG, 1994, LOGISTIC REGRESSION; Kruger E, 2001, ORAL SURG ORAL MED O, V92, P150, DOI 10.1067/moe.2001.115461; Lee SH, 2009, FORENSIC SCI INT, V188, P107, DOI 10.1016/j.forsciint.2009.03.033; LEVESQUE GY, 1981, J DENT RES, V60, P1735, DOI 10.1177/00220345810600100201; Llarena del Rosario M E, 1990, Rev ADM, V47, P112; LYNHAM A, 1990, AUST DENT J, V35, P19, DOI 10.1111/j.1834-7819.1990.tb03021.x; Mok Y. Y., 1996, Annals Academy of Medicine Singapore, V25, P828; NANDA RS, 1954, AM J ORTHOD DENTOFAC, V40, P698, DOI 10.1016/0002-9416(54)90058-5; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Sandhu S, 2005, J ORAL MAXIL SURG, V63, P640, DOI 10.1016/j.joms.2004.12.014; Shinn D L, 1976, J Dent, V4, P42, DOI 10.1016/0300-5712(76)90069-5; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	31	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101157	10.1371/journal.pone.0101157	http://dx.doi.org/10.1371/journal.pone.0101157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967595	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800114
J	Du, CYQ; Choi, RCY; Dong, TTX; Lau, DTW; Tsim, KWK				Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.			Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Regulates the Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 and the Activity of Intestinal Alkaline Phosphatase in Cultures	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DANGGUI BUXUE TANG; URSOLIC ACID; RADIX ASTRAGALI; MUCOSAL DEFENSE; MACROPHAGES; MEDICINE; ALPHA; MODEL; COX-2	Yu Ping Feng San (YPFS), a Chinese herbal decoction comprising Astragali Radix (AR; Huangqi), Atractylodis Macrocephalae Rhizoma (AMR; Baizhu), and Saposhnikoviae Radix (SR; Fangfeng), has been used clinically to treat inflammatory bowel diseases (IBD). Previously, we demonstrated a dual role of YPFS in regulating cytokine release in cultured macrophages. In this study, we elucidated the anti-inflammatory effect of YPFS that is mediated through modulating the expression of three key enzymes involved in IBD: inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and intestinal alkaline phosphatase (IALP). In a lipopolysaccharide (LPS)-induced chronic-inflammation model of cultured murine macrophages, YPFS treatment suppressed the activation of iNOS and COX-2 expression in a dose-dependent manner. Conversely, application of YPFS in cultured small intestinal enterocytes markedly induced the expression of IALP in a time-dependent manner, which might strengthen the intestinal detoxification system. A duality of YPFS in modulating the expression of iNOS and COX-2 was determined here. The expression of iNOS and COX-2 in macrophages was induced by YPFS, and this activation was partially blocked by the NF-kappa B-specific inhibitor BAY 11-7082, indicating a role of NF-kappa B signaling. These YPFS-induced changes in gene regulation strongly suggest that the anti-inflammatory effects of YPFS are mediated through the regulation of inflammatory enzymes.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Du, Crystal Yingqing/AAH-5824-2020	Du, Crystal Yingqing/0000-0003-1353-4477; Lau, Tai Wai David/0000-0002-3443-1808; Tsim, Karl/0000-0003-4808-1674	Hong Kong Research Grants Council [T13-607/12R]; GRF [662911, 663012, 662713, N_HKUST629/13]; Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature [TAON12SC01]; ITC [GHP/059/12SZ]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); GRF; Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature; ITC	This research was supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), GRF (662911, 663012, 662713, N_HKUST629/13), The Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature (TAON12SC01) and ITC (GHP/059/12SZ) to Karl Tsim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Chen X, 2000, J Tradit Chin Med, V20, P302; Chiu SC, 2009, PHYTOTHER RES, V23, P363, DOI 10.1002/ptr.2633; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Du CYQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078622; Fang SP, 2005, BIOL PHARM BULL, V28, P829, DOI 10.1248/bpb.28.829; Gilroy DW, 1998, INFLAMMATION, V22, P509, DOI 10.1023/A:1022350111213; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hoo RLC, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-67; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; Kankuri E, 1999, INFLAMMATION, V23, P141, DOI 10.1023/A:1020241028723; Khan S, 2011, J CELL BIOCHEM, V112, P2179, DOI 10.1002/jcb.23137; Lanas A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2465; Lee JC, 2007, PHYTOMEDICINE, V14, P390, DOI 10.1016/j.phymed.2006.09.012; Li CQ, 2007, PHYTOTHER RES, V21, P347, DOI 10.1002/ptr.2040; LICHTENBERGER LM, 1983, SCIENCE, V219, P1327, DOI 10.1126/science.6828859; Liu Q, 2013, J ETHNOPHARMACOL, V150, P521, DOI 10.1016/j.jep.2013.08.056; Makino T, 2005, BIOL PHARM BULL, V28, P110, DOI 10.1248/bpb.28.110; Makino T, 2004, BIOL PHARM BULL, V27, P554, DOI 10.1248/bpb.27.554; McCafferty DM, 1997, GASTROENTEROLOGY, V112, P1022, DOI 10.1053/gast.1997.v112.pm9041266; MILLER TA, 1983, AM J PHYSIOL, V245, pG601, DOI 10.1152/ajpgi.1983.245.5.G601; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Molnar K, 2012, WORLD J GASTROENTERO, V18, P3254, DOI 10.3748/wjg.v18.i25.3254; Morin MJ, 2001, AM J PHYSIOL-GASTR L, V281, pG552, DOI 10.1152/ajpgi.2001.281.2.G552; NAJID A, 1992, FEBS LETT, V299, P213, DOI 10.1016/0014-5793(92)80117-Y; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; Sakamoto C, 1998, J GASTROENTEROL, V33, P618, DOI 10.1007/s005350050147; Shishodia S, 2003, CANCER RES, V63, P4375; Suh N, 1998, CANCER RES, V58, P717; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; WALLACE JL, 1995, ALIMENT PHARM THERAP, V9, P227; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wang CC, 1999, CANCER LETT, V145, P151, DOI 10.1016/S0304-3835(99)00248-7; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zheng KYZ, 2010, J ETHNOPHARMACOL, V132, P259, DOI 10.1016/j.jep.2010.08.029; Zheng YZ, 2010, PLANTA MED, V76, P439, DOI 10.1055/s-0029-1186222; Zhu KY, 2010, J SEP SCI, V33, P3666, DOI 10.1002/jssc.201000498	40	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100382	10.1371/journal.pone.0100382	http://dx.doi.org/10.1371/journal.pone.0100382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967898	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800038
J	Martorana, AM; Motta, S; Di Silvestre, D; Falchi, F; Deho, G; Mauri, P; Sperandeo, P; Polissi, A				Martorana, Alessandra M.; Motta, Sara; Di Silvestre, Dario; Falchi, Federica; Deho, Gianni; Mauri, Pierluigi; Sperandeo, Paola; Polissi, Alessandra			Dissecting Escherichia coli Outer Membrane Biogenesis Using Differential Proteomics	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; BARREL ASSEMBLY MACHINE; ABC FAMILY TRANSPORTER; GRAM-NEGATIVE BACTERIA; AAA PROTEASE FTSH; CELL-DIVISION; LIPOPOLYSACCHARIDE TRANSPORT; PEPTIDOGLYCAN SYNTHESIS; SALMONELLA-TYPHIMURIUM; SHOCK-PROTEIN	The cell envelope of Gram-negative bacteria is a complex multi-layered structure comprising an inner cytoplasmic membrane and an additional asymmetric lipid bilayer, the outer membrane, which functions as a selective permeability barrier and is essential for viability. Lipopolysaccharide, an essential glycolipid located in the outer leaflet of the outer membrane, greatly contributes to the peculiar properties exhibited by the outer membrane. This complex molecule is transported to the cell surface by a molecular machine composed of seven essential proteins LptABCDEFG that form a transenvelope complex and function as a single device. While advances in understanding the mechanisms that govern the biogenesis of the cell envelope have been recently made, only few studies are available on how bacterial cells respond to severe envelope biogenesis defects on a global scale. Here we report the use of differential proteomics based on Multidimensional Protein Identification Technology (MudPIT) to investigate how Escherichia coli cells respond to a block of lipopolysaccharide transport to the outer membrane. We analysed the envelope proteome of a lptC conditional mutant grown under permissive and non permissive conditions and identified 123 proteins whose level is modulated upon LptC depletion. Most such proteins belong to pathways implicated in cell envelope biogenesis, peptidoglycan remodelling, cell division and protein folding. Overall these data contribute to our understanding on how E. coli cells respond to LPS transport defects to restore outer membrane functionality.	[Martorana, Alessandra M.; Sperandeo, Paola; Polissi, Alessandra] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Motta, Sara; Di Silvestre, Dario; Mauri, Pierluigi] CNR, ITB, I-20133 Milan, Italy; [Falchi, Federica; Deho, Gianni] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Sperandeo, P (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	paola.sperandeo@unimib.it; alessandra.polissi@unimib.it	Martorana, Alessandra M./AAB-2017-2021; di silvestre, dario/AAB-5037-2022; Mauri, Pietro Luigi/AAC-3095-2019; MOTTA, SARA/P-9635-2018; Sperandeo, Paola/AAF-2755-2019	Martorana, Alessandra M./0000-0003-3996-4141; di silvestre, dario/0000-0002-7143-6229; Mauri, Pietro Luigi/0000-0003-4364-0393; MOTTA, SARA/0000-0001-8421-6287; POLISSI, ALESSANDRA/0000-0003-0903-8024; DEHO', GIOVANNI/0000-0001-5492-7766; FALCHI, FEDERICA ANNA/0000-0002-1692-8167	Fondazione Cariplo [2010-0653]; MIUR-Regione Lombardia [ID 30190679]; Regione Lombardia "Cooperazione scientifica e tecnologica internazionale' [16876 SAL-18]; Fondazione Banca del Monte di Lombardia; MIUR-PRIN [2012WJSX8K]	Fondazione Cariplo(Fondazione Cariplo); MIUR-Regione Lombardia(Regione Lombardia); Regione Lombardia "Cooperazione scientifica e tecnologica internazionale'(Regione Lombardia); Fondazione Banca del Monte di Lombardia; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Fondazione Cariplo (Grant no. 2010-0653) to P. S., MIUR-Regione Lombardia (ID 30190679) to A. P. and G. D., Regione Lombardia "Cooperazione scientifica e tecnologica internazionale'' (Grant 16876 SAL-18), Fondazione Banca del Monte di Lombardia and MIUR-PRIN 2012 (2012WJSX8K) to A. P. P. L. M. thanks the Italian Ministry of Economy and Finance, in particular the Project of CNR "FaReBio di Qualita.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng M, 1996, MOL MICROBIOL, V21, P605, DOI 10.1111/j.1365-2958.1996.tb02568.x; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Freinkman E, 2012, BIOCHEMISTRY; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; HSU L, 1991, J BIOL CHEM, V266, P13783; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin DA A.J., 2001, MULTIDIMENSIONAL PRO; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Martorana AM, 2011, RES MICROBIOL, V162, P470, DOI 10.1016/j.resmic.2011.03.007; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mauri P, 2008, METHOD ENZYMOL, V447, P99, DOI 10.1016/S0076-6879(08)02206-4; MISRA R, 1995, MOL MICROBIOL, V16, P779, DOI 10.1111/j.1365-2958.1995.tb02439.x; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Narita S, 2013, P NATL ACAD SCI USA, V110, pE3612, DOI 10.1073/pnas.1312012110; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Polissi A, 2014, MAR DRUGS, V12, P1023, DOI 10.3390/md12021023; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SABBATTINI P, 1995, J BACTERIOL, V177, P1425, DOI 10.1128/jb.177.6.1425-1434.1995; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stout V, 1996, J BACTERIOL, V178, P4273, DOI 10.1128/jb.178.14.4273-4280.1996; Tachikawa T, 2011, BIOSCI BIOTECH BIOCH, V75, P162, DOI 10.1271/bbb.100612; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Xiong XL, 1996, J BACTERIOL, V178, P1213, DOI 10.1128/jb.178.4.1213-1215.1996; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	85	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100941	10.1371/journal.pone.0100941	http://dx.doi.org/10.1371/journal.pone.0100941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967819	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800087
J	Rana, S; Rajakumar, A; Geahchan, C; Salahuddin, S; Cerdeira, AS; Burke, SD; George, EM; Granger, JP; Karumanchi, SA				Rana, Sarosh; Rajakumar, Augustine; Geahchan, Carl; Salahuddin, Saira; Cerdeira, Ana Sofia; Burke, Suzanne D.; George, Eric M.; Granger, Joey P.; Karumanchi, S. Ananth			Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1 alpha pathway	FASEB JOURNAL			English	Article						preeclampsia; hypertension; angiogenesis	UTERINE PERFUSION-PRESSURE; TYROSINE KINASE 1; SHOCK-PROTEIN 27; SOLUBLE FLT-1; SEVERE PREECLAMPSIA; ANGIOGENIC FACTORS; PREGNANT-WOMEN; BLOOD-PRESSURE; CELL-DEATH; HYPERTENSION	Up-regulation of placental soluble fms-like tyrosine kinase 1 (sFlt1) contributes to the pathogenesis of preeclampsia. To evaluate novel upstream pathways that regulate placental sFlt1 production, we screened a library of natural compounds (n=502) in human placental cell lines. Here, we report 3 compounds in the cardiac glycoside family, ouabain, gitoxigenin, and digitoxin, that inhibit placental sFlt1 production at nanomolar concentrations in vitro. We further characterized ouabain and demonstrated that it inhibits sFlt1 mRNA and protein expression in human placental cytotrophoblasts and explant cultures in a dose-and time-dependent manner. Ouabain down-regulated sFlt1 production by inhibiting hypoxia-inducible factor 1 (HIF-1 alpha) protein expression in the placenta. Furthermore, we found that phosphorylation of heat-shock protein 27 (HSP27) was necessary for ouabain to inhibit HIF-1 alpha translation. In a rat model of pregnancy-induced hypertension, ouabain reduced mean arterial pressure and enhanced placental HSP27 phosphorylation without any adverse effects on pups. Further studies are needed to explore the usefulness of targeting HIF-1 alpha/HSP27 pathway in preeclampsia.	[Rana, Sarosh; Salahuddin, Saira; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rajakumar, Augustine; Geahchan, Carl; Cerdeira, Ana Sofia; Burke, Suzanne D.; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, Boston, MA 02215 USA; [Rana, Sarosh; Rajakumar, Augustine; Salahuddin, Saira; Burke, Suzanne D.; Karumanchi, S. Ananth] Harvard Univ, Sch Med, Boston, MA USA; [Rajakumar, Augustine; Burke, Suzanne D.; Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA; [George, Eric M.; Granger, Joey P.] Univ Mississippi, Med Ctr, Dept Physiol, Jackson, MS 39216 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Mississippi; University of Mississippi Medical Center	Rana, S (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Kirstein 382, Boston, MA 02215 USA.	srana1@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; George, Eric/ABE-2767-2020	George, Eric/0000-0002-6622-7369; Burke, Suzanne/0000-0003-4594-4163; Cerdeira, A. Sofia/0000-0002-7643-3537	U.S. National Institutes of Health/National Institute of Child Health and Development [K08HD068398-01A1]; Gulbenkian Programme for Advanced Medical Education (Lisbon, Portugal); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108618] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Gulbenkian Programme for Advanced Medical Education (Lisbon, Portugal); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dawn McCullough, R.N., for patient placental sample collection. S. R. is supported by grant K08HD068398-01A1 (U.S. National Institutes of Health/National Institute of Child Health and Development). A.S.C is funded by the Gulbenkian Programme for Advanced Medical Education (Lisbon, Portugal). S.A.K is an investigator of the Howard Hughes Medical Institute. S.A.K. is a coinventor on multiple patents for preeclampsia markers and reports service as a consultant to Siemens Diagnostics (Munich, Germany) and has financial interest in Aggamin LLC (New York, NY, USA). The other authors report no conflicts of interest.	Abdulsid A, 2014, J REPROD IMMUNOL, V101, P89, DOI 10.1016/j.jri.2013.09.002; Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Adair CD, 2009, J PERINATOL, V29, P284, DOI 10.1038/jp.2008.224; Adair CD, 2010, AM J PERINAT, V27, P655, DOI 10.1055/s-0030-1249762; Alexander BT, 2001, HYPERTENSION, V37, P1191, DOI 10.1161/01.HYP.37.4.1191; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Conrad KP, 2011, SEMIN NEPHROL, V31, P15, DOI 10.1016/j.semnephrol.2010.10.003; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Granger JP, 2006, METH MOLEC MED, V122, P383; GRAVES SW, 1995, AM J HYPERTENS, V8, P5, DOI 10.1016/0895-7061(94)00167-A; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jacobs BE, 2012, AM J PHYSIOL-HEART C, V302, pH1317, DOI 10.1152/ajpheart.00532.2011; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Khankin EV, 2012, PREGNANCY HYPERTENS, V2, P84, DOI 10.1016/j.preghy.2011.11.002; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MULLER P, 1965, CIRC RES, V17, P46, DOI 10.1161/01.RES.17.1.46; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rajakumar A, 2003, PLACENTA, V24, P199, DOI 10.1053/plac.2002.0893; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Rajakumar A, 2001, BIOL REPROD, V64, P499, DOI 10.1093/biolreprod/64.2.499; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Shin JK, 2009, J OBSTET GYNAECOL RE, V35, P888, DOI 10.1111/j.1447-0756.2009.01053.x; Surmon L, 2014, HYPERTENS PREGNANCY, V33, P371, DOI 10.3109/10641955.2014.903963; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; YUAN CM, 1993, HYPERTENSION, V22, P178, DOI 10.1161/01.HYP.22.2.178; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou Y, 2013, J CLIN INVEST, V123, P2862, DOI 10.1172/JCI66966	41	39	42	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4324	4334		10.1096/fj.14-252684	http://dx.doi.org/10.1096/fj.14-252684			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970393	Green Published			2022-12-25	WOS:000342222700012
J	Kenniston, JA; Faucette, RR; Martik, D; Comeau, SR; Lindberg, AP; Kopacz, KJ; Conley, GP; Chen, J; Viswanathan, M; Kastrapeli, N; Cosic, J; Mason, S; DiLeo, M; Abendroth, J; Kuzmic, P; Ladner, RC; Edwards, TE; TenHoor, C; Adelman, BA; Nixon, AE; Sexton, DJ				Kenniston, Jon A.; Faucette, Ryan R.; Martik, Diana; Comeau, Stephen R.; Lindberg, Allison P.; Kopacz, Kris J.; Conley, Gregory P.; Chen, Jie; Viswanathan, Malini; Kastrapeli, Niksa; Cosic, Janja; Mason, Shauna; DiLeo, Mike; Abendroth, Jan; Kuzmic, Petr; Ladner, Robert C.; Edwards, Thomas E.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.; Sexton, Daniel J.			Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Enzyme Inhibitor; Inflammation; Kallikrein; Protease	MOLECULAR-WEIGHT KININOGEN; INDUCED PAW EDEMA; HEREDITARY ANGIOEDEMA; FACTOR-XII; CONTACT SYSTEM; C1-ESTERASE INHIBITOR; BLOOD-COAGULATION; C1 INHIBITOR; IN-VITRO; ACTIVATION	Background: Unregulated plasma kallikrein proteolytic activity can result from C1-inhibitor deficiency, causing excessive and potentially fatal edema. Results: The antibody DX-2930 potently and specifically inhibits plasma kallikrein and exhibits a long plasma half-life. Conclusion: An antibody protease inhibitor can lead to potent and specific bioactivity. Significance: DX-2930 could be an effective therapeutic for the prophylactic inhibition of plasma kallikrein-mediated diseases. Plasma kallikrein (pKal) proteolytically cleaves high molecular weight kininogen to generate the potent vasodilator and the pro-inflammatory peptide, bradykinin. pKal activity is tightly regulated in healthy individuals by the serpin C1-inhibitor, but individuals with hereditary angioedema (HAE) are deficient in C1-inhibitor and consequently exhibit excessive bradykinin generation that in turn causes debilitating and potentially fatal swelling attacks. To develop a potential therapeutic agent for HAE and other pKal-mediated disorders, we used phage display to discover a fully human IgG1 monoclonal antibody (DX-2930) against pKal. In vitro experiments demonstrated that DX-2930 potently inhibits active pKal (K-i = 0.120 +/- 0.005 nm) but does not target either the zymogen (prekallikrein) or any other serine protease tested. These findings are supported by a 2.1- resolution crystal structure of pKal complexed to a DX-2930 Fab construct, which establishes that the pKal active site is fully occluded by the antibody. DX-2930 injected subcutaneously into cynomolgus monkeys exhibited a long half-life (t(1/2) approximate to 12.5 days) and blocked high molecular weight kininogen proteolysis in activated plasma in a dose- and time-dependent manner. Furthermore, subcutaneous DX-2930 reduced carrageenan-induced paw edema in rats. A potent and long acting inhibitor of pKal activity could be an effective treatment option for pKal-mediated diseases, such as HAE.	[Kenniston, Jon A.; Faucette, Ryan R.; Martik, Diana; Comeau, Stephen R.; Lindberg, Allison P.; Kopacz, Kris J.; Conley, Gregory P.; Chen, Jie; Viswanathan, Malini; Kastrapeli, Niksa; Cosic, Janja; Mason, Shauna; DiLeo, Mike; Ladner, Robert C.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.; Sexton, Daniel J.] Dyax Corp, Burlington, MA 01803 USA; [Abendroth, Jan; Edwards, Thomas E.] Beryllium, Bainbridge Isl, WA 98110 USA; [Kuzmic, Petr] Biokin, Watertown, MA 02472 USA		Sexton, DJ (corresponding author), Dyax Corp, 55 Network Dr, Burlington, MA 01803 USA.	dsexton@dyax.com		Kuzmic, Petr/0000-0001-5250-8381; Edwards, Thomas/0000-0002-0474-8003; Nixon, Andrew/0000-0002-6090-0583				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerji A, 2008, ANN ALLERG ASTHMA IM, V100, pS19, DOI 10.1016/S1081-1206(10)60582-0; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; Bernstein JA, 2010, EXPERT REV CLIN IMMU, V6, P29, DOI 10.1586/ECI.09.60; BERRETTINI M, 1986, BLOOD, V68, P455; Bird JE, 2012, THROMB HAEMOSTASIS, V107, P1141, DOI [10.1160/TH11-10-0682, 10.1160/TH-11-10-0682]; BOCK PE, 1985, J BIOL CHEM, V260, P2434; Bork K, 2006, AM J MED, V119, P267, DOI 10.1016/j.amjmed.2005.09.064; Bork K, 2008, ANN ALLERG ASTHMA IM, V100, P153, DOI 10.1016/S1081-1206(10)60424-3; Bork K, 2012, CURR ALLERGY ASTHM R, V12, P273, DOI 10.1007/s11882-012-0273-4; Bork Konrad, 2010, Allergy Asthma Clin Immunol, V6, P15, DOI 10.1186/1710-1492-6-15; Brown EW, 2002, BLOOD COAGUL FIBRIN, V13, P711, DOI 10.1097/00001721-200212000-00007; Caliezi C, 2000, PHARMACOL REV, V52, P91; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chyung Y, 2014, ANN ALLERG ASTHMA IM, V113, P460, DOI 10.1016/j.anai.2014.05.028; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Coppola R, 1996, BLOOD COAGUL FIBRIN, V7, P530, DOI 10.1097/00001721-199607000-00004; Crosby JR, 2013, ARTERIOSCL THROM VAS, V33, P1670, DOI 10.1161/ATVBAHA.113.301282; Cugno M, 1997, BLOOD, V89, P3213, DOI 10.1182/blood.V89.9.3213; Cugno M, 2001, BLOOD COAGUL FIBRIN, V12, P253, DOI 10.1097/00001721-200106000-00005; CUGNO M, 1995, THROMB RES, V78, P277, DOI 10.1016/0049-3848(95)00060-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi PK, 2012, PHARMACOTHERAPY, V32, P902, DOI 10.1002/j.1875-9114.2012.01126; Girolami A, 2010, EXPERT REV HEMATOL, V3, P685, DOI [10.1586/ehm.10.69, 10.1586/EHM.10.69]; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; HALL SW, 1991, J BIOL CHEM, V266, P12329; Heeb MJ, 1998, BLOOD CELL MOL DIS, V24, P411; Hekim C, 2006, J BIOL CHEM, V281, P12555, DOI 10.1074/jbc.M600014200; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; KAUFMAN N, 1991, BLOOD, V77, P2660; KRUITHOF EKO, 1984, BLOOD, V64, P907; Kuzmic P, 2000, ANAL BIOCHEM, V286, P45, DOI 10.1006/abio.2000.4685; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; MAKEVNINA LG, 1994, BRAZ J MED BIOL RES, V27, P1955; MARKWARDT F, 1974, BIOCHEM PHARMACOL, V23, P2247, DOI 10.1016/0006-2952(74)90554-1; MARLAR RA, 1993, THROMB HAEMOSTASIS, V69, P16; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; MILLER RL, 1983, J NATL MED ASSOC, V75, P551; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P1247, DOI 10.1016/j.healun.2006.06.009; NILSSON T, 1983, EUR J BIOCHEM, V129, P663; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Phipps JA, 2008, KIDNEY INT, V73, P1114, DOI 10.1038/ki.2008.9; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Porebski G, 2013, ALLERGY, V68, P1207, DOI 10.1111/all.12165; RAHMAN MM, 1995, ANN RHEUM DIS, V54, P345, DOI 10.1136/ard.54.5.345; Renne T, 2012, THROMB HAEMOSTASIS, V107, P1012, DOI 10.1160/TH12-04-0264; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Sanchez J, 2008, THROMB RES, V122, P257, DOI 10.1016/j.thromres.2007.11.008; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Schousboe I, 2009, FEBS J, V276, P5228, DOI 10.1111/j.1742-4658.2009.07218.x; Sexton DJ, 2009, BIOCHEM J, V422, P383, DOI 10.1042/BJ20090010; Silverberg M, 1995, BLOOD PRINCIPLES PRA, P1127; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Stadnicki A, 1997, DIGEST DIS SCI, V42, P2356, DOI 10.1023/A:1018891323205; STEPHENS RW, 1991, SEMIN THROMB HEMOST, V17, P201, DOI 10.1055/s-2007-1002610; Stolz LE, 2012, EXPERT REV CLIN IMMU, V8, P25, DOI [10.1586/ECI.11.81, 10.1586/eci.11.81]; Sulikowski T, 2001, BLOOD COAGUL FIBRIN, V12, P75, DOI 10.1097/00001721-200101000-00011; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tapper H, 2000, BLOOD, V96, P2329; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Wassaf D, 2006, ANAL BIOCHEM, V351, P241, DOI 10.1016/j.ab.2006.01.043; Weiser P, 2010, PROG MOL BIOL TRANSL, V93, P443, DOI [10.1016/S1S77-1173(10)93019-6, 10.1016/S1877-1173(10)93019-6]; White-Adams TC, 2010, J THROMB HAEMOST, V8, P1295, DOI 10.1111/j.1538-7836.2010.03850.x; WIRTH KJ, 1992, AGENT ACTION SUPPL, V38, P428; Woodruff RS, 2013, J THROMB HAEMOST, V11, P1364, DOI 10.1111/jth.12302; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Wuillemin WA, 1996, J BIOL CHEM, V271, P12913, DOI 10.1074/jbc.271.22.12913; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	79	73	94	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23596	23608		10.1074/jbc.M114.569061	http://dx.doi.org/10.1074/jbc.M114.569061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24970892	Green Published, hybrid			2022-12-25	WOS:000341505000029
J	Silva, BA; Stambaugh, JR; Yokomori, K; Shah, JV; Berns, MW				Silva, Barbara Alcaraz; Stambaugh, Jessica R.; Yokomori, Kyoko; Shah, Jagesh V.; Berns, Michael W.			DNA Damage to a Single Chromosome End Delays Anaphase Onset	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SPINDLE-ASSEMBLY CHECKPOINT; LASER MICROIRRADIATION; MAMMALIAN TELOMERES; CELL-CYCLE; PROTEINS; MITOSIS; ACTIVATION; DYNAMICS; ATM	Chromosome ends contain nucleoprotein structures known as telomeres. Damage to chromosome ends during interphase elicits a DNA damage response (DDR) resulting in cell cycle arrest. However, little is known regarding the signaling from damaged chromosome ends (designated here as "TIPs") during mitosis. In the present study, we investigated the consequences of DNA damage induced at a single TIP in mitosis. We used laser microirradiation to damage mitotic TIPs or chromosome arms (non-TIPs) in PtK2 kidney epithelial cells. We found that damage to a single TIP, but not a non-TIP, delays anaphase onset. This TIP-specific checkpoint response is accompanied by differential recruitment of DDR proteins. Although phosphorylation of H2AX and the recruitment of several repair factors, such as Ku70-Ku80, occur in a comparable manner at both TIP and non-TIP damage sites, DDR factors such as ataxia telangiectasia mutated (ATM), MDC1, WRN, and FANCD2 are specifically recruited to TIPs but not to non-TIPs. In addition, Nbs1, BRCA1, and ubiquitin accumulate at damaged TIPs more rapidly than at damaged non-TIPs. ATR and 53BP1 are not detected at either TIPs or non-TIPs in mitosis. The observed delay in anaphase onset is dependent on the activity of DDR kinases ATM and Chk1, and the spindle assembly checkpoint kinase Mps1. Cells damaged at a single TIP or non-TIP eventually exit mitosis with unrepaired lesions. Damaged TIPs are segregated into micronuclei at a significantly higher frequency than damaged non-TIPs. Together, these findings reveal a mitosisspecific DDR uniquely associated with chromosome ends.	[Silva, Barbara Alcaraz; Stambaugh, Jessica R.; Berns, Michael W.] Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA; [Silva, Barbara Alcaraz] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92617 USA; [Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA; [Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Shah, JV (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 4 Blackfan Circle,HIM 564, Boston, MA 02115 USA.	jagesh@hms.harvard.edu; mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health, NIGMS [R01GM077238]; Air Force Office of Scientific Research Grant [FA9550-04-1-0101]; Beckman Laser Institute Inc. Foundation; Beckman Laser Institute Foundation Faculty Fellowship; National Academy of Sciences Ford Foundation Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Air Force Office of Scientific Research Grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Beckman Laser Institute Inc. Foundation; Beckman Laser Institute Foundation Faculty Fellowship; National Academy of Sciences Ford Foundation Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM077238 (to J. V. S.). This work was also supported by Air Force Office of Scientific Research Grant FA9550-04-1-0101), the Beckman Laser Institute Inc. Foundation (to M. W. B.), the Beckman Laser Institute Foundation Faculty Fellowship (to J. V. S.), and the National Academy of Sciences Ford Foundation Fellowship Program (to B. A. S.).	Albrecht DR, 2010, INTEGR BIOL-UK, V2, P278, DOI 10.1039/b923699f; Altmann SCA, 1925, Q J MICROSC SCI, V69, P463; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Baker NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012398; BERNS MW, 1974, SCIENCE, V186, P700, DOI 10.1126/science.186.4165.700; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Botchway SW, 2010, MUTAT RES-REV MUTAT, V704, P38, DOI 10.1016/j.mrrev.2010.01.003; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Chow JPH, 2003, MOL BIOL CELL, V14, P3989, DOI 10.1091/mbc.E03-03-0168; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Duquette ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003050; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Eller MS, 2006, P NATL ACAD SCI USA, V103, P15073, DOI 10.1073/pnas.0607332103; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; Ferrando-May Elisa, 2013, Frontiers in Genetics, V4, P135, DOI 10.3389/fgene.2013.00135; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gomez-Godinez V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq836; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Hartlerode AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049211; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; Reynolds P, 2013, MUTAT RES-GEN TOX EN, V756, P14, DOI 10.1016/j.mrgentox.2013.05.006; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shang Z, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.49; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Silva BA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.095003; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stout JR, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-26; Su TT, 2001, CURR BIOL, V11, P8, DOI 10.1016/S0960-9822(00)00042-7; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thanasoula M, 2012, EMBO J, V31, P3398, DOI 10.1038/emboj.2012.191; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Valerio-Santiago M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003859; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Yan QS, 2013, MOL CELL BIOL, V33, P845, DOI 10.1128/MCB.00990-12; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yu B, 2012, CANCER RES, V72, P5448, DOI 10.1158/0008-5472.CAN-12-2354; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	75	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22771	22784		10.1074/jbc.M113.535955	http://dx.doi.org/10.1074/jbc.M113.535955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982423	hybrid, Green Published			2022-12-25	WOS:000341017200022
J	Tang, R; Zhang, G; Chen, SY				Tang, Rui; Zhang, Gui; Chen, Shi-You			Response Gene to Complement 32 Protein Promotes Macrophage Phagocytosis via Activation of Protein Kinase C Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MEDIATED PHAGOCYTOSIS; TUMOR-ASSOCIATED MACROPHAGES; FACTOR-KAPPA-B; F-ACTIN; CUP FORMATION; RGC-32; CELLS; POLARIZATION; MECHANISMS; REGULATOR	Macrophage phagocytosis plays an important role in host defense. The molecular mechanism, especially factors regulating the phagocytosis, however, is not completely understood. In the present study, we found that response gene to complement 32 (RGC-32) is an important regulator of phagocytosis. Although RGC-32 is induced and abundantly expressed in macrophage during monocyte-macrophage differentiation, RGC-32 appears not to be important for this process because RGC-32-deficient bone marrow progenitor can normally differentiate to macrophage. However, both peritoneal macrophages and bone marrow-derived macrophages with RGC-32 deficiency exhibit significant defects in phagocytosis, whereas RGC-32-overexpressed macrophages show increased phagocytosis. Mechanistically, RGC-32 is recruited to macrophage membrane where it promotes F-actin assembly and the formation of phagocytic cups. RGC-32 knock-out impairs F-actin assembly. RGC-32 appears to interact with PKC to regulate PKC-induced phosphorylation of F-actin cross-linking protein myristoylated alanine-rich protein kinase C substrate. Taken together, our results demonstrate for the first time that RGC-32 is a novel membrane regulator for macrophage phagocytosis.	[Tang, Rui; Zhang, Gui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan 442000, Hubei, Peoples R China	University System of Georgia; University of Georgia; Hubei University of Medicine	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	sc229@uga.edu			National Institutes of Health [HL123302, HL119053, HL107526]; National Natural Science Foundation of China [81328002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL107526, R01HL119053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL123302, HL119053, and HL107526 (to S. Y. C.). This work was also supported by Grant 81328002 from the National Natural Science Foundation of China.	Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Banan A, 2004, AM J PHYSIOL-CELL PH, V286, pC723, DOI 10.1152/ajpcell.00329.2003; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GREENBERG S, 1990, J EXP MED, V172, P1853, DOI 10.1084/jem.172.6.1853; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Mancino A, 2010, CLIN CANCER RES, V16, P784, DOI 10.1158/1078-0432.CCR-09-1015; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; May RC, 2001, J CELL SCI, V114, P1061; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Oliveira CA, 1996, CHEM-BIOL INTERACT, V100, P141, DOI 10.1016/0009-2797(96)03695-2; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; Schlesinger LS, 2008, HDB TUBERCULOSIS IMM, P1; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096	42	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22715	22722		10.1074/jbc.M114.566653	http://dx.doi.org/10.1074/jbc.M114.566653			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973210	Green Published, hybrid			2022-12-25	WOS:000341017200017
J	Liu, XH; Matsushima, A; Shimohigashi, M; Shimohigashi, Y				Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Miki; Shimohigashi, Yasuyuki			A Characteristic Back Support Structure in the Bisphenol A-Binding Pocket in the Human Nuclear Receptor ERR gamma	PLOS ONE			English	Article							ESTROGEN; EXPRESSION; EXPOSURE; ALTERS; DOMAIN; ASSAY	The endocrine disruptor bisphenol A (BPA) affects various genes and hormones even at merely physiological levels. We recently demonstrated that BPA binds strongly to human nuclear receptor estrogen-related receptor (ERR) gamma and that the phenol-A group of BPA is in a receptacle pocket with essential amino acid residues to provide structural support at the backside. This led BPA to bind to ERR gamma in an induced-fit-type binding mode, for example, with a rotated motion of Val313 to support the Tyr326-binding site. A similar binding mechanism appears to occur at the binding site of the BPA phenol-B ring. X-ray crystal analysis of the ERR gamma-ligand-binding domain/BPA complex suggested that the ERR gamma receptor residues Leu342, Leu345, Asn346, and Ile349 function as intrinsic binding sites of the BPA phenol-B, whereas Leu265, Leu268, Ile310, Val313, Leu324, Tyr330, Lys430, Ala431, and His434 work as structural elements to assist these binding sites. In the present study, by evaluating the mutant receptors replaced by a series of amino acids, we demonstrated that a finely assembled structural network indeed exists around the two adjacent Leu(342)-Asn(346) and Leu(345)-Ile(349) ridges on the same alpha-helix 7 (H7), constructing a part of the binding pocket structure with back support residues for the BPA phenol-B ring. The results reveal that the double-layer binding sites, namely, the ordinary ligand binding sites and their back support residues, substantiate the strong binding of BPA to ERR gamma. When ERR gamma-Asn346 was replaced by the corresponding Gly and Tyr in ERR alpha and ERR beta, respectively, the binding affinity of BPA and even 4-hydroxytamxifen (4-OHT) is much reduced. Asn346 was found to be one of the residues that make ERRc to be exclusive to BPA.	[Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Yasuyuki] Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka 812, Japan; [Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Yasuyuki] Kyushu Univ, Risk Sci Res Ctr, Fukuoka 812, Japan; [Shimohigashi, Miki] Fukuoka Univ, Div Biol, Fac Sci, Fukuoka 81401, Japan	Kyushu University; Kyushu University; Fukuoka University	Shimohigashi, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka 812, Japan.	shimo@kyudai.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports, and Culture in Japan [19291912, 22221005, 20710053, 25701008, 23710080, 25740024]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Health and Labour Sciences Research Grants for Research on the Risk of Chemical Substances from the Ministry of Health, Labor and Welfare of Japan to Y.S. Grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan to Y.S. (19291912 and 22221005), to A.M. (20710053 and 25701008), and to X.L. (23710080 and 25740024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Birnbaum LS, 2018, TESTIMONY FEDERAL RO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao JY, 2013, TOXICOL SCI, V133, P157, DOI 10.1093/toxsci/kft035; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Kamrin MA, 2007, INT J TOXICOL, V26, P13, DOI 10.1080/10915810601117968; Kojo H, 2006, J STEROID BIOCHEM, V98, P181, DOI 10.1016/j.jsbmb.2005.10.004; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kunz N, 2011, INT J DEV NEUROSCI, V29, P37, DOI 10.1016/j.ijdevneu.2010.09.009; Liu X, 2007, FEBS J, V274, P6340, DOI 10.1111/j.1742-4658.2007.06152.x; Liu XH, 2012, J BIOCHEM, V151, P403, DOI 10.1093/jb/mvs008; Lui K, 2006, PROSTATE, V66, P1600, DOI 10.1002/pros.20429; Matsushima A, 2008, BIOCHEM BIOPH RES CO, V373, P408, DOI 10.1016/j.bbrc.2008.06.050; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; PICHON MF, 1973, STEROIDS, V21, P335; Poidatz D, 2012, PLACENTA, V33, P688, DOI 10.1016/j.placenta.2012.06.002; Sambrook J, 2001, MOL CLONING LAB MANU; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Takeda Y, 2009, J BIOCHEM, V146, P113, DOI 10.1093/jb/mvp049; Viberg H, 2012, NEUROTOXICOLOGY, V33, P1390, DOI 10.1016/j.neuro.2012.09.002; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Yan SJ, 2013, FOOD CHEM TOXICOL, V56, P75, DOI 10.1016/j.fct.2013.02.011	34	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101252	10.1371/journal.pone.0101252	http://dx.doi.org/10.1371/journal.pone.0101252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978476	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400105
J	Huang, YY; Meng, T; Wang, SZ; Zhang, H; Mues, G; Qin, CL; Feng, JQ; D'Souza, RN; Lu, YB				Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo			Twist1-and Twist2-Haploinsufficiency Results in Reduced Bone Formation	PLOS ONE			English	Article							SAETHRE-CHOTZEN-SYNDROME; OSTEOBLAST DIFFERENTIATION; DORSOVENTRAL PATTERN; GENE-EXPRESSION; ZYGOTIC GENE; GROWTH; FGF; TRANSCRIPTION; ROLES; MOUSE	Background: Twist1 and Twist2 are highly homologous bHLH transcription factors that exhibit extensive highly overlapping expression profiles during development. While both proteins have been shown to inhibit osteogenesis, only Twist1 haploinsufficiency is associated with the premature synostosis of cranial sutures in mice and humans. On the other hand, biallelic Twist2 deficiency causes only a focal facial dermal dysplasia syndrome or additional cachexia and perinatal lethality in certain mouse strains. It is unclear how these proteins cooperate to synergistically regulate bone formation. Methods: Twist1 floxed mice (Twist1(f/f)) were bred with Twist2-Cre knock-in mice (Twist2(Cre/+)) to generate Twist1 and Twist2 haploinsufficient mice (Twist1(f/+); Twist2(Cre/+)). X-radiography, micro-CT scans, alcian blue/alizarin red staining, trap staining, BrdU labeling, immunohistochemistry, in situ hybridizations, real-time PCR and dual luciferase assay were employed to investigate the overall skeletal defects and the bone-associated molecular and cellular changes of Twist1(f/+); Twist2(Cre/+) mice. Results: Twist1 and Twist2 haploinsufficient mice did not present with premature ossification and craniosynostosis; instead they displayed reduced bone formation, impaired proliferation and differentiation of osteoprogenitors. These mice exhibited decreased expressions of Fgf2 and Fgfr1-4 in bone, resulting in a down-regulation of FGF signaling. Furthermore, in vitro studies indicated that both Twist1 and Twist2 stimulated 4.9 kb Fgfr2 promoter activity in the presence of E12, a Twist binding partner. Conclusion: These data demonstrated that Twist1-and Twist2-haploinsufficiency caused reduced bone formation due to compromised FGF signaling.	[Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75252 USA; [Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX USA; [Huang, Yanyu] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Huang, Yanyu] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [D'Souza, Rena N.] Univ Utah, Sch Dent, Salt Lake City, UT USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wuhan University; Wuhan University; Utah System of Higher Education; University of Utah	Lu, YB (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75252 USA.	ylu@bcd.tamhsc.edu		D'Souza, Rena/0000-0002-1505-5173; Lu, Yongbo/0000-0003-3692-1736; Zhang, Hua/0000-0002-6789-9343	National Institute of Dental and Craniofacial Research/National Institutes of Health [DE021773, DE013368, DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013368] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research/National Institutes of Health grants DE021773 to YL, DE013368 to RD, and DE005092 to CQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Cao ZG, 2012, J BONE MINER RES, V27, P1080, DOI 10.1002/jbmr.1552; Carver EA, 2002, ANAT REC, V268, P90, DOI 10.1002/ar.10124; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; ElGhouzzi V, 1997, NAT GENET, V15, P42; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YB, 2012, DEV DYNAM, V241, P1708, DOI 10.1002/dvdy.23858; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miraoui H, 2010, J CELL BIOCHEM, V110, P1147, DOI 10.1002/jcb.22628; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rangiani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042329; Rice DPC, 2000, DEVELOPMENT, V127, P1845; SIMPSON P, 1983, GENETICS, V105, P615; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yousfi M, 2002, HUM MOL GENET, V11, P359, DOI 10.1093/hmg/11.4.359; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	36	15	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99331	10.1371/journal.pone.0099331	http://dx.doi.org/10.1371/journal.pone.0099331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971743	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200009
J	Khosravi, R; Sodek, KL; Xu, WP; Bais, MV; Saxena, D; Faibish, M; Trackman, PC				Khosravi, Roozbeh; Sodek, Katharine L.; Xu, Wan-Peng; Bais, Manish V.; Saxena, Debashree; Faibish, Michael; Trackman, Philip C.			A Novel Function for Lysyl Oxidase in Pluripotent Mesenchymal Cell Proliferation and Relevance to Inflammation-Associated Osteopenia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FORKHEAD-BOX-O; OXIDATIVE STRESS; BETA-CATENIN; CROSS-LINKS; GROWTH-FACTOR; BONE-DISEASE; APOPTOSIS; OSTEOPOROSIS; OSTEOBLASTS	Lysyl oxidase is a multifunctional enzyme required for collagen biosynthesis. Various growth factors regulate lysyl oxidase during osteoblast differentiation, subject to modulation by cytokines such as TNF-alpha in inflammatory osteopenic disorders including diabetic bone disease. Canonical Wnt signaling promotes osteoblast development. Here we investigated the effect of Wnt3a and TNF-alpha on lysyl oxidase expression in pluripotent C3H10T1/2 cells, bone marrow stromal cells, and committed osteoblasts. Lysyl oxidase was up-regulated by a transcriptional mechanism 3-fold in C3H10T1/2 cells, and 2.5-fold in bone marrow stromal cells. A putative functional TCF/LEF element was identified in the lysyl oxidase promoter. Interestingly, lysyl oxidase was not up-regulated in committed primary rat calvarial-or MC3T3-E1 osteoblasts. TNF-alpha down-regulated lysyl oxidase both in Wnt3a-treated and in non-treated C3H10T1/2 cells by a post-transcriptional mechanism mediated by miR203. Non-differentiated cells do not produce a collagen matrix; thus, a novel biological role for lysyl oxidase in pluripotent cells was investigated. Lysyl oxidase shRNAs effectively silenced lysyl oxidase expression, and suppressed the growth of C3H10T1/2 cells by 50%, and blocked osteoblast differentiation. We propose that interference with lysyl oxidase expression under excess inflammatory conditions such as those that occur in diabetes, osteoporosis, or rheumatoid arthritis can result in a diminished pool of pluripotent cells which ultimately contributes to osteopenia.	[Khosravi, Roozbeh; Sodek, Katharine L.; Xu, Wan-Peng; Bais, Manish V.; Saxena, Debashree; Faibish, Michael; Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA	Boston University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	trackman@bu.edu	Xu, Wanpeng/M-4664-2019; Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Khosravi, Roozbeh/0000-0002-9070-0339; Bais, Manish/0000-0003-4198-7377	NIH/NIDCR [R01 DE014066, DE 011004]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011004, R29DE011004] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR R01 DE014066 and DE 011004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; [Anonymous], AM J PHYSIOL CELL PH; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bais MV, 2014, ONCOGENE IN PRESS; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cagnetta V, 2012, CLIN CASES MINER BON, V9, P85; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Graves DT, 2006, J DENT RES, V85, P15, DOI 10.1177/154405910608500103; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosravi R, 2014, BONE, V58, P33, DOI 10.1016/j.bone.2013.10.001; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Merlotti D, 2010, NUTR METAB CARDIOVAS, V20, P683, DOI 10.1016/j.numecd.2010.07.008; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oxlund H, 1996, BONE, V19, P479, DOI 10.1016/S8756-3282(96)00283-9; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; Rauner M, 2013, INT ARCH ALLERGY IMM, V160, P114, DOI 10.1159/000342426; Reynaud C, 1999, CELL MOL BIOL, V45, P1237; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Saito Mitsuru, 2013, Front Endocrinol (Lausanne), V4, P72, DOI 10.3389/fendo.2013.00072; Saux CJ, 1997, J CELL BIOCHEM, V64, P328, DOI 10.1002/(SICI)1097-4644(199702)64:2<328::AID-JCB14>3.0.CO;2-E; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Yeh LCC, 2010, GROWTH FACTORS, V28, P117, DOI 10.3109/08977190903512586	42	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100669	10.1371/journal.pone.0100669	http://dx.doi.org/10.1371/journal.pone.0100669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971753	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200050
J	Vilanova, C; Marin, M; Baixeras, J; Latorre, A; Porcar, M				Vilanova, Cristina; Marin, Maria; Baixeras, Joaquin; Latorre, Amparo; Porcar, Manuel			Selecting Microbial Strains from Pine Tree Resin: Biotechnological Applications from a Terpene World	PLOS ONE			English	Article							ACID-DEGRADING BACTERIA; PSEUDOMONAS-AERUGINOSA; PULP; BIODEGRADATION; BIOSYNTHESIS; DEGRADATION; DIVERSITY; CHEMICALS; SEQUENCE	Resin is a chemical and physical defensive barrier secreted by many plants, especially coniferous trees, with insecticidal and antimicrobial properties. The degradation of terpenes, the main components accounting for the toxicity of resin, is highly relevant for a vast range of biotechnological processes, including bioremediation. In the present work, we used a resin-based selective medium in order to study the resin-tolerant microbial communities associated with the galls formed by the moth Retinia resinella; as well as resin from Pinus sylvestris forests, one of the largest ecosystems on Earth and a yet-unexplored source of terpene-degrading microorganisms. The taxonomic and functional diversity of the cultivated, resin-tolerant fraction of the whole microbiota were unveiled by high-throughput sequencing, which resulted in the detection of more than 40 bacterial genera among the terpene-degrading microorganisms, and a range of genes involved in the degradation of different terpene families. We further characterized through culture-based approaches and transcriptome sequencing selected microbial strains, including Pseudomonas sp., the most abundant species in both environmental resin and R. resinella resin-rich galls, and three fungal species, and experimentally confirmed their ability to degrade resin and also other terpene-based compounds and, thus, their potential use in biotechnological applications involving terpene catabolism.	[Vilanova, Cristina; Marin, Maria; Baixeras, Joaquin; Latorre, Amparo; Porcar, Manuel] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain; [Latorre, Amparo] CSISP, Unidad Mixta Invest Genom & Salud, Valencia, Spain; [Porcar, Manuel] Univ Valencia, Fundacio Gen, Valencia, Spain	University of Valencia; University of Valencia	Porcar, M (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain.	manuel.porcar@uv.es	Porcar, Manuel/D-2503-2010; Almela, Joaquin Baixeras/L-1734-2014; Latorre, Amparo/E-4997-2015	Porcar, Manuel/0000-0002-7916-9479; Almela, Joaquin Baixeras/0000-0002-6092-0496; Latorre, Amparo/0000-0002-9146-7284	Ministerio de Ciencia e Innovacion, Spain [BFU2012-39816-C02-01]; FEDER funds; Ministerio de Ciencia e Innovacion [CGL2008-00605]; FPU fellowship from Ministerio de Educacion (Spain)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER funds(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPU fellowship from Ministerio de Educacion (Spain)	Financial support was provided by grant BFU2012-39816-C02-01 (Ministerio de Ciencia e Innovacion, Spain) co-financed by FEDER funds to Amparo Latorre and CGL2008-00605 (Ministerio de Ciencia e Innovacion) to Joaquin Baixeras. Cristina Vilanova is a recipient of a FPU fellowship from the Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; BICHO PA, 1995, APPL ENVIRON MICROB, V61, P3245, DOI 10.1128/AEM.61.9.3245-3250.1995; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BUIJTENE.JP, 1972, CAN ENTOMOL, V104, P215, DOI 10.4039/Ent104215-2; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; DAGLEY S, 1975, AM SCI, V63, P681; de Carvalho CCCR, 2006, BIOTECHNOL ADV, V24, P134, DOI 10.1016/j.biotechadv.2005.08.004; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; HANOVER JW, 1975, ANNU REV ENTOMOL, V20, P75, DOI 10.1146/annurev.en.20.010175.000451; HELIOVAARA K, 1988, ENTOMOL GEN, V14, P37; HIMEJIMA M, 1992, J CHEM ECOL, V18, P1809, DOI 10.1007/BF02751105; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; LEUENBERGER C, 1985, WATER RES, V19, P885, DOI 10.1016/0043-1354(85)90147-2; de Araujo DAM, 2011, LIFE SCI, V89, P540, DOI 10.1016/j.lfs.2011.04.020; Marpeau A, 1989, TREES-STRUCT FUNCT, V3, P220, DOI 10.1007/BF00225355; Martin VJJ, 1999, ARCH MICROBIOL, V172, P131, DOI 10.1007/s002030050752; Martin VJJ, 2000, J BACTERIOL, V182, P3784, DOI 10.1128/JB.182.13.3784-3793.2000; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohn WW, 1999, SYST APPL MICROBIOL, V22, P68, DOI 10.1016/S0723-2020(99)80029-0; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Pearce RB, 1996, NEW PHYTOL, V132, P203, DOI 10.1111/j.1469-8137.1996.tb01842.x; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Savluchinske-Feio S, 2006, APPL MICROBIOL BIOT, V72, P430, DOI 10.1007/s00253-006-0517-0; Smith DJ, 2007, J BACTERIOL, V189, P6195, DOI 10.1128/JB.00179-07; SUNTIO LR, 1988, CHEMOSPHERE, V17, P1249, DOI 10.1016/0045-6535(88)90080-X; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tomlin ES, 2000, TREE PHYSIOL, V20, P1087; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Wang JF, 2012, CHEM COMMUN, V48, P916, DOI 10.1039/c1cc16432e; Wilson AEJ, 1996, APPL ENVIRON MICROB, V62, P3146, DOI 10.1128/AEM.62.9.3146-3151.1996; Xu MF, 2011, J ASIAN NAT PROD RES, V13, P260, DOI 10.1080/10286020.2010.550882; Yermakova TG, 1997, CHEM SUSTAINABLE DEV, V5, P149; Yu Z, 1999, MICROB ECOL, V38, P114, DOI 10.1007/s002489900163; ZHANG B-C., 1994, INDEX EC IMPORTANT L; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	41	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100740	10.1371/journal.pone.0100740	http://dx.doi.org/10.1371/journal.pone.0100740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971580	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200055
J	Guo, WX; Tsujimura, K; Otsuka, IM; Irie, K; Igarashi, K; Nakashima, K; Zhao, XY				Guo, Weixiang; Tsujimura, Keita; Otsuka, Maky, I; Irie, Koichiro; Igarashi, Katsuhide; Nakashima, Kinichi; Zhao, Xinyu			VPA Alleviates Neurological Deficits and Restores Gene Expression in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; VALPROIC ACID; DNA METHYLATION; MECP2; DISORDERS; NEURONS; MICE; MUTATIONS; EPILEPSY; DISEASE	Rett syndrome (RTT) is a devastating neurodevelopmental disorder that occurs once in every 10,000-15,000 live female births. Despite intensive research, no effective cure is yet available. Valproic acid (VPA) has been used widely to treat mood disorder, epilepsy, and a growing number of other disorders. In limited clinical studies, VPA has also been used to control seizure in RTT patients with promising albeit somewhat unclear efficacy. In this study we tested the effect of VPA on the neurological symptoms of RTT and discovered that short-term VPA treatment during the symptomatic period could reduce neurological symptoms in RTT mice. We found that VPA restores the expression of a subset of genes in RTT mouse brains, and these genes clustered in neurological disease and developmental disorder networks. Our data suggest that VPA could be used as a drug to alleviate RTT symptoms.	[Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI USA; [Tsujimura, Keita; Irie, Koichiro; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka 812, Japan; [Otsuka, Maky, I; Igarashi, Katsuhide] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Tokyo 142, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Kyushu University; Hoshi University	Igarashi, K (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Tokyo 142, Japan.	k-igarashi@hoshi.ac.jp; kin1@scb.med.kyushu-u.ac.jp; xzhao69@wisc.edu		Tsujimura, Keita/0000-0002-7464-6133	National Institutes of Health (NIH) [R01MH080434, R01MH078972]; International Rett Syndrome Foundation (IRSF) [2755]; NIH [P30HD03352]; University of Wisconsin Center for Stem Cells and Regenerative Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan; Neurological and Psychiatric Disorders of NCNP [24-12]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25281028] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation (IRSF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Center for Stem Cells and Regenerative Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Neurological and Psychiatric Disorders of NCNP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Institutes of Health (NIH) (R01MH080434 and R01MH078972 to X. Zhao), the International Rett Syndrome Foundation (IRSF, 2755 to X. Zhao), and a Center grant from the NIH to the Waisman Center (P30HD03352 to X. Zhao). W. Guo was funded by a postdoctoral fellowship from University of Wisconsin Center for Stem Cells and Regenerative Medicine. This work was also supported in part by a Grant-in-Aid for Scientific Research (A) (to K. Nakashima), a Grant-in-Aid for Scientific Research on Innovative Areas: Foundation of Synapse and Neurocircuit Pathology (to K. Nakashima), all from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by an Intramural Research Grant (24-12) for Neurological and Psychiatric Disorders of NCNP (to K. Nakashima). This work was also supported in part by a Grant-in-Aid for Challenging Exploratory Research and a Grant-in-Aid for Scientific Research (B) (to K. Igarashi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Keilani MA, 2011, ACTA NEUROL BELG, V111, P328; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chateauvieux S, 2010, J BIOMEDICINE BIOTEC, V2010; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; Faulkner MA, 2013, PHARMACOTHERAPY, V33, P330, DOI 10.1002/phar.1201; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Huppke P, 2007, EUR J PAEDIATR NEURO, V11, P10, DOI 10.1016/j.ejpn.2006.09.003; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; KOCHWESER J, 1980, NEW ENGL J MED, V302, P661, DOI 10.1056/NEJM198003203021204; Krajnc N, 2011, J CHILD NEUROL, V26, P1429, DOI 10.1177/0883073811408422; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Leonard H, 2010, ARCH DIS CHILD, V95, P444, DOI 10.1136/adc.2008.148932; Maunakea AK, 2013, CELL RES; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Palumbo O, 2013, GENE, V516, P107, DOI 10.1016/j.gene.2012.12.073; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2011, HUM MOL GENET, V20, P1834, DOI 10.1093/hmg/ddr066; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Trapp S, 2011, EXP PHYSIOL, V96, P451, DOI 10.1113/expphysiol.2010.055848; Vecsler M, 2010, EPIGENETICS-US, V5, P61, DOI 10.4161/epi.5.1.10630; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001	33	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100215	10.1371/journal.pone.0100215	http://dx.doi.org/10.1371/journal.pone.0100215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968028	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800029
J	Hung, SF; Hsieh, CM; Chen, YC; Wang, YC; Ho, HO; Sheu, MT				Hung, Sheng-Feng; Hsieh, Chien-Ming; Chen, Ying-Chen; Wang, Yu-Chun; Ho, Hsiu-O; Sheu, Ming-Thau			Characterizations of Plasticized Polymeric Film Coatings for Preparing Multiple-Unit Floating Drug Delivery Systems (muFDDSs) with Controlled-Release Characteristics	PLOS ONE			English	Article							GASTRORETENTIVE DOSAGE FORMS; IN-VITRO EVALUATION; HELICOBACTER-PYLORI; GASTROINTESTINAL-TRACT; MECHANICAL-PROPERTIES; MICROSPHERES; DESIGN; MICROBALLOONS; DENSITY; INVITRO	Effervescent multiple-unit floating drug delivery systems (muFDDSs) consisting of drug (lorsartan)- and effervescent (sodium bicarbonate)-containing pellets were characterized in this study. The mechanical properties (stress and strain at rupture, Young's modulus, and toughness) of these plasticized polymeric films of acrylic (Eudragit RS, RL, and NE) and cellulosic materials (ethyl cellulose (EC), and Surelease) were examined by a dynamic mechanical analyzer. Results demonstrated that polymeric films prepared from Surelease and EC were brittle with less elongation compared to acrylic films. Eudragit NE films were very flexible in both the dry and wet states. Because plasticizer leached from polymeric films during exposure to the aqueous medium, plasticization of wet Eudragit RS and RL films with 15% triethyl citrate (TEC) or diethyl phthalate (DEP) resulted in less elongation. DEP might be the plasticizer of choice among the plasticizers examined in this study for Eudragit RL to provide muFDDSs with a short time for all pellets to float (TPF) and a longer period of floating. Eudragit RL and RS at a 1:1 ratio plasticized with 15% DEP were optimally selected as the coating membrane for the floating system. Although the release of losartan from the pellets was still too fast as a result of losartan being freely soluble in water, muFDDSs coated with Eudragit RL and RS at a 1:1 ratio might have potential use for the sustained release of water-insoluble or the un-ionized form of drugs from gastroretentive drug delivery systems.	[Hung, Sheng-Feng; Hsieh, Chien-Ming; Chen, Ying-Chen; Wang, Yu-Chun; Ho, Hsiu-O; Sheu, Ming-Thau] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Clin Res Ctr, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan; [Hsieh, Chien-Ming] Providence Univ, Dept Cosmet Sci, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Providence University - Taiwan	Ho, HO (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan.	hsiuoho@tmu.edu.tw; mingsheu@tmu.edu.tw		Hsieh, Chien-Ming/0000-0002-7204-4681				Bardonnet PL, 2006, J CONTROL RELEASE, V111, P1, DOI 10.1016/j.jconrel.2005.10.031; BECHGAARD H, 1978, J PHARM PHARMACOL, V30, P690, DOI 10.1111/j.2042-7158.1978.tb13366.x; Bi YX, 1996, CHEM PHARM BULL, V44, P2121; BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524; Chen YC, 2012, J PHARM SCI-US, V101, P3811, DOI 10.1002/jps.23279; Dixit N, 2011, J CURR PHARM RES, V7, P6; Hamdani J, 2006, INT J PHARM, V322, P96, DOI 10.1016/j.ijpharm.2006.05.052; Iannuccelli V, 1998, INT J PHARM, V174, P47, DOI 10.1016/S0378-5173(98)00229-4; ICHIKAWA M, 1991, J PHARM SCI, V80, P1062, DOI 10.1002/jps.2600801113; Jain SK, 2005, J CONTROL RELEASE, V107, P300, DOI 10.1016/j.jconrel.2005.06.007; Kawano Yoshio, 2002, Polímeros, V12, P96, DOI 10.1590/S0104-14282002000200008; KAWASHIMA Y, 1991, J CONTROL RELEASE, V16, P279, DOI 10.1016/0168-3659(91)90004-W; Krogel I, 1999, INT J PHARM, V187, P175, DOI 10.1016/S0378-5173(99)00189-1; Munday DL, 2003, DRUG DEV IND PHARM, V29, P575, DOI 10.1081/DDC-120018646; Pawar VK, 2011, DRUG DELIV, V18, P97, DOI 10.3109/10717544.2010.520354; Prajapati VD, 2013, J CONTROL RELEASE, V168, P151, DOI 10.1016/j.jconrel.2013.02.028; Rouge N, 1996, INT J PHARMACEUT, V136, P117, DOI 10.1016/0378-5173(96)85200-8; Sato Y, 2004, INT J PHARM, V275, P97, DOI 10.1016/j.ijpharm.2004.01.036; SETA Y, 1988, INT J PHARM, V41, P245, DOI 10.1016/0378-5173(88)90201-3; Sica DA, 2005, CLIN PHARMACOKINET, V44, P797, DOI 10.2165/00003088-200544080-00003; Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7; Streubel A, 2003, J MICROENCAPSUL, V20, P329, DOI 10.1080/0265204021000058384; Sungthonjeen S, 2008, EUR J PHARM BIOPHARM, V69, P255, DOI 10.1016/j.ejpb.2007.09.013; Talukder R, 2004, DRUG DEV IND PHARM, V30, P405, DOI 10.1081/DDC-120030935; Umamaheshwari RB, 2003, J PHARM PHARMACOL, V55, P1607, DOI 10.1211/0022357022223; Waterman KC, 2007, PHARM DEV TECHNOL, V12, P1, DOI 10.1080/10837450601168680; Wu JS, 2001, EUR J PHARM SCI, V12, P417, DOI 10.1016/S0928-0987(00)00196-2; Wurster DE, 2003, J PHARM SCI-US, V92, P2008, DOI 10.1002/jps.10454; Yang LB, 1999, J CONTROL RELEASE, V57, P215, DOI 10.1016/S0168-3659(98)00066-2	29	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100321	10.1371/journal.pone.0100321	http://dx.doi.org/10.1371/journal.pone.0100321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967594	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800034
J	Miller, MA; Wright, H; Ji, C; Cappuccio, FP				Miller, Michelle A.; Wright, Hayley; Ji, Chen; Cappuccio, Francesco P.			Cross-Sectional Study of Sleep Quantity and Quality and Amnestic and Non-Amnestic Cognitive Function in an Ageing Population: The English Longitudinal Study of Ageing (ELSA)	PLOS ONE			English	Article							OLDER-ADULTS; DAYTIME SLEEPINESS; MEMORY IMPAIRMENT; UNITED-STATES; WHITEHALL II; LATER LIFE; DEMENTIA; DURATION; COHORT; ASSOCIATION	Background: The aim was to investigate the association between sleep disturbances and cognitive function in younger and older individuals from an ageing population. Methods: 3,968 male and 4,821 female white participants, aged 50 years and over, from the English Longitudinal Study of Ageing (ELSA) were studied. Information on sleep quality and quantity as well as both amnestic (memory, ACF) and non-amnestic (non-memory, nACF) function was available at Wave 4 (2008). Analysis of covariance was used to evaluate the relationship between sleep and cognitive function. Results: After adjustment for multiple confounders in the younger group (50-64 years) duration of sleep explained 15.2% of the variance in ACF (p = 0.003) and 20.6% of nACF (p = 0.010). In the older group (65+ years) the estimates were 21.3% (p<0.001) and 25.6% (p<0.001), respectively. For sleep quality, there was a statistically significant association between sleep quality and both ACF (p<0.001) and nACF (p<0.001) in the older age group, but not in the younger age group (p = 0.586 and p = 0.373, respectively; interaction between age and sleep quality in the study sample including both age groups: p<0.001 for ACF and p = 0.018 for nACF). Sleep quality explained between 15.1% and 25.5% of the variance in cognition. The interaction with age was independent of duration of sleep. At any level of sleep duration there was a steeper association between sleep quality and ACF in the older than the younger group. Conclusions: The associations between sleep disturbances and cognitive function vary between younger and older adults. Prospective studies will determine the temporal relationships between sleep disturbances and changes in cognition in different age groups.	[Miller, Michelle A.; Wright, Hayley; Ji, Chen; Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England	University of Warwick	Miller, MA (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	Michelle.miller@warwick.ac.uk	Miller, Michelle A/D-1840-2009	Miller, Michelle A/0000-0002-6696-0923; Wright, Hayley/0000-0003-2199-8255; Ji, Chen/0000-0003-4919-3299	Economic and Social Research Council (ESRC) [ES/K002910/1]; ESRC [ES/K002910/1] Funding Source: UKRI; Economic and Social Research Council [ES/K002910/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MAM and FPC received funding from the The Economic and Social Research Council (ESRC) grant number ES/K002910/1(www.esrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is part of the Sleep, Health and Society Research Programme of The University of Warwick.	Activity and Health Research, 1992, ALL DUNB NAT FITN SU; Banks J, 2011, EC J LONDON, V120, pF381; Behncke S, 2012, HEALTH ECON, V21, P282, DOI 10.1002/hec.1712; Bierman EJM, 2005, AM J GERIAT PSYCHIAT, V13, P686, DOI 10.1176/appi.ajgp.13.8.686; Blackwell T, 2014, SLEEP IN PRESS; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Bliwise DL., 2005, PRINCIPLES PRACTICE, V4th ed., P24; Boeve BF, 1998, NEUROLOGY, V51, P363, DOI 10.1212/WNL.51.2.363; Busse A, 2003, ACTA NEUROL SCAND, V108, P71, DOI 10.1034/j.1600-0404.2003.00118.x; Cappuccio FP, 2010, SLEEP HLTH SOC AETIO, DOI 10.1093/acprof: oso/9780199566594.001.0001/acprof-9780199566594; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Elwood PC, 2011, J EPIDEMIOL COMMUN H, V65, P820, DOI 10.1136/jech.2009.100503; Faubel R, 2009, J SLEEP RES, V18, P427, DOI 10.1111/j.1365-2869.2009.00759.x; Ferrie JE, 2011, SLEEP, V34, P565, DOI 10.1093/sleep/34.5.565; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Foley D, 2001, J AM GERIATR SOC, V49, P1628, DOI 10.1111/j.1532-5415.2001.49271.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hayes TL, 2014, ALZ DIS ASSOC DIS, V28, P145, DOI 10.1097/WAD.0000000000000010; Huppert F.A., 2006, RETIREMENT HLTH RELA, P217; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Hussey D, 2010, FINANCIAL CIRCUMSTAN, P386; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Jelicic M, 2002, INT J GERIATR PSYCH, V17, P73, DOI 10.1002/gps.529; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Kronholm E, 2009, J SLEEP RES, V18, P436, DOI 10.1111/j.1365-2869.2009.00765.x; Kumari M, 2010, FINANCIAL CIRCUMSTAN, P178; Lang I, 2007, AGE AGEING, V36, P256, DOI 10.1093/ageing/afm001; Lang IA, 2008, J AM GERIATR SOC, V56, P191, DOI 10.1111/j.1532-5415.2007.01557.x; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Llewellyn DJ, 2008, AGE AGEING, V37, P685, DOI 10.1093/ageing/afn194; Loerbroks A, 2010, INT J GERIATR PSYCH, V25, P100, DOI 10.1002/gps.2305; Lou PA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004436; Marmot M, 2003, HLTH WEALTH LIFESTYL; Ofstedal M.B., 2005, DOCUMENTATION COGNIT, V10; Palmer K, 2008, AM J GERIAT PSYCHIAT, V16, P603, DOI 10.1097/JGP.0b013e3181753a64; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramos AR, 2013, J CLIN SLEEP MED, V9, P669, DOI 10.5664/jcsm.2834; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Richards M, 1999, NEUROLOGY, V53, P308, DOI 10.1212/WNL.53.2.308; Sachdev PS, 2012, J AM GERIATR SOC, V60, P24, DOI 10.1111/j.1532-5415.2011.03774.x; Spiegel R, 1999, BIOL PSYCHIAT, V45, P435, DOI 10.1016/S0006-3223(98)00042-0; Steffick DE., 2000, DOCUMENTATION AFFECT; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Tworoger SS, 2006, ALZ DIS ASSOC DIS, V20, P41, DOI 10.1097/01.wad.0000201850.52707.80; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; Xu L, 2011, SLEEP, V34, P575, DOI 10.1093/sleep/34.5.575; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zhang J, 2014, J NEUROSCI, V34, P4418, DOI 10.1523/JNEUROSCI.5025-12.2014	53	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100991	10.1371/journal.pone.0100991	http://dx.doi.org/10.1371/journal.pone.0100991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968354	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800093
J	Touchon, JC; Wojdak, JM				Touchon, Justin C.; Wojdak, Jeremy M.			Plastic Hatching Timing by Red-Eyed Treefrog Embryos Interacts with Larval Predator Identity and Sublethal Predation to Affect Prey Morphology but Not Performance	PLOS ONE			English	Article							BEHAVIORAL PLASTICITY; SWIMMING PERFORMANCE; HABITAT COMPLEXITY; MULTIPLE PREDATORS; NONLETHAL INJURY; OPPOSITE SHIFTS; TAIL SHAPE; TRADE-OFFS; TADPOLES; METAMORPHOSIS	Many animals respond to predation risk by altering their morphology, behavior, or life-history. We know a great deal about the cues prey respond to and the changes to prey that can be induced by predation risk, but less is known about how plastic responses to predators may be affected by separate plastic responses occurring earlier in life, particularly during the embryonic period. Embryos of a broad array of taxa can respond to egg- or larval-stage risks by altering hatching timing, which may alter the way organisms respond to future predators. Using the red-eyed treefrog (Agalychnis callidryas), a model for understanding the effects of plasticity across life-stages, we assessed how the combined effects of induced variation in the timing of embryo hatching and variation in the larval predator community impacted tadpole morphology, pigmentation and swimming performance. We found that A. callidryas tadpoles developed deeper tail muscles and fins and darker pigmentation in response to fish predators, either when alone or in diverse community with other predators. Tadpoles altered morphology much less so to dragonfly naiads or water bugs. Interestingly, morphological responses to predators were also affected by induced differences in hatching age, with early and late-hatched tadpoles exhibiting different allometric relationships between tail height and body length in different predator environments. Beyond induced morphological changes, fish predators often damaged tadpoles' tails without killing them (i.e., sublethal predation), but these tadpoles swam equally quickly to those with fully intact tails. This was due to the fact that tadpoles with more damaged tails increased tail beats to achieve equal swimming speed. This study demonstrates that plastic phenotypic responses to predation risk can be influenced by a complex combination of responses to both the embryo and larval environments, but also that prey performance can be highly resilient to sublethal predation.	[Touchon, Justin C.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Touchon, Justin C.] Smithsonian Trop Res Inst, Balboa, Panama; [Wojdak, Jeremy M.] Radford Univ, Dept Biol, Radford, VA 24142 USA	Boston University; Smithsonian Institution; Smithsonian Tropical Research Institute; Radford University	Touchon, JC (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	justintouchon@gmail.com			Research Opportunity Award from the National Science Foundation; NSF [DEB-0717220, DEB-0716923]; Radford University; Smithsonian Tropical Research Institute;  [IIA-1064566]	Research Opportunity Award from the National Science Foundation; NSF(National Science Foundation (NSF)); Radford University; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); 	JMW was supported by a Research Opportunity Award from the National Science Foundation, stemming from NSF grant DEB-0717220 to James Vonesh. JCT was partially supported by NSF grant DEB-0716923 to Karen Warkentin and by IIA-1064566 to JCT. Radford University and the Smithsonian Tropical Research Institute also provided funding or support.	[Anonymous], DEV PLASTICITY EVOLU; Arnold E.N., 1988, Biology of Reptilia, V16, P235; Baber MJ, 2004, COPEIA, P173, DOI 10.1643/CE-03-056R1; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Bowerman J, 2010, ECOLOGY, V91, P242, DOI 10.1890/08-1687.1; Capellan E, 2007, EVOL ECOL, V21, P445, DOI 10.1007/s10682-006-9133-9; Crawley MJ., 2007, R BOOK; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; DeWitt TJ, 2003, J SEA RES, V49, P143, DOI 10.1016/S1385-1101(02)00220-4; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; FIGIEL CR, 1991, CAN J ZOOL, V69, P830, DOI 10.1139/z91-125; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gibbons ME, 2013, OECOLOGIA, V171, P831, DOI 10.1007/s00442-012-2443-4; Hoff KV, 2000, AM ZOOL, V40, P62, DOI 10.1668/0003-1569(2000)040[0062:TLAMAT]2.0.CO;2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011680; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028; Mandrillon AL, 2007, CHEMOECOLOGY, V17, P169, DOI 10.1007/s00049-007-0376-x; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Mccoy MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047495; Meyer JJ, 2005, ECOL LETT, V8, P160, DOI 10.1111/j.1461-0248.2004.00700.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; Nunes AL, 2010, BASIC APPL ECOL, V11, P645, DOI 10.1016/j.baae.2010.09.003; Orizaola G, 2005, FRESHWATER BIOL, V50, P438, DOI 10.1111/j.1365-2427.2005.01332.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rasband WS, 1997, IMAGEJ; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Shah AA, 2010, J HERPETOL, V44, P185, DOI 10.1670/09-025.1; SHERRATT TN, 1989, OIKOS, V56, P170, DOI 10.2307/3565332; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sinclair ELE, 2011, J ZOOL, V283, P243, DOI 10.1111/j.1469-7998.2010.00776.x; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, 2013, OECOLOGIA, V173, P801, DOI 10.1007/s00442-013-2714-8; Touchon JC, 2013, ECOLOGY, V94, P850, DOI 10.1890/12-0194.1; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 2004, COPEIA, P599, DOI 10.1643/CE-03-283R; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Vonesh JR, 2006, ECOLOGY, V87, P556, DOI 10.1890/05-0930; Walsh PT, 2008, FUNCT ECOL, V22, P699, DOI 10.1111/j.1365-2435.2008.01429.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; Warkentin KM, 1999, BIOL J LINN SOC, V68, P443, DOI 10.1006/bijl.1999.0325; Warkentin KM, 2000, ANIM BEHAV, V60, P503, DOI 10.1006/anbe.2000.1508; WARKENTIN KM, 1995, P NATL ACAD SCI USA, V92, P3507, DOI 10.1073/pnas.92.8.3507; Warkentin KM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P155, DOI 10.1086/339214; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Willink B, 2013, EVOL ECOL, V28, P1; Wilson RS, 2005, FUNCT ECOL, V19, P238, DOI 10.1111/j.1365-2435.2005.00958.x; Wojdak JM, 2014, OECOLOGIA IN PRESS	61	12	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100623	10.1371/journal.pone.0100623	http://dx.doi.org/10.1371/journal.pone.0100623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967896	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800048
J	Mu, XT; Nie, BB; Wang, H; Duan, SF; Zhang, Z; Dai, GH; Ma, QZ; Shan, BC; Ma, L				Mu, Xuetao; Nie, Binbin; Wang, Hong; Duan, Shaofeng; Zhang, Zan; Dai, Guanghui; Ma, Qiaozhi; Shan, Baoci; Ma, Lin			Spatial Patterns of Whole Brain Grey and White Matter Injury in Patients with Occult Spastic Diplegic Cerebral Palsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; PERIVENTRICULAR LEUKOMALACIA; GRAY-MATTER; PREMATURE-INFANT; DIFFUSION; CHILDREN; MOTOR; TERM; MRI; SURVIVORS	Spastic diplegic cerebral palsy(SDCP) is a common type of cerebral palsy (CP), which presents as a group of motor-impairment syndromes. Previous conventional MRI studies have reported abnormal structural changes in SDCP, such as periventricular leucomalacia. However, there are roughly 27.8% SDCP patients presenting normal appearance in conventional MRI, which were considered as occult SDCP. In this study, sixteen patients with occult SDCP and 16 age-and sex-matched healthy control subjects were collected and the data were acquired on a 3T MR system. We applied voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) analysis to investigate whole brain grey and white matter injury in occult SDCP. By using VBM method, the grey matter volume reduction was revealed in the bilateral basal ganglia regions, thalamus, insula, and left cerebral peduncle, whereas the white matter atrophy was found to be located in the posterior part of corpus callosum and right posterior corona radiata in the occult SDCP patients. By using TBSS, reduced fractional anisotropy (FA) values were detected in multiple white matter regions, including bilateral white matter tracts in prefrontal lobe, temporal lobe, internal and external capsule, corpus callosum, cingulum, thalamus, brainstem and cerebellum. Additionally, several regions of white matter tracts injury were found to be significantly correlated with motor dysfunction. These results collectively revealed the spatial patterns of whole brain grey and white matter injury in occult SDCP.	[Mu, Xuetao; Ma, Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Mu, Xuetao; Wang, Hong; Ma, Qiaozhi] Chinese Peoples Armed Police Forces, Gen Hosp, Dept MRI, Beijing, Peoples R China; [Nie, Binbin; Duan, Shaofeng; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing Engn Res Ctr Radiog Tech & Equipment, Beijing, Peoples R China; [Zhang, Zan; Dai, Guanghui] Chinese Peoples Armed Police Forces, Gen Hosp, Inst Neurosurg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Wang, H (corresponding author), Chinese Peoples Armed Police Forces, Gen Hosp, Dept MRI, Beijing, Peoples R China.	wanghongmri@sina.com; cjr.malin@vip.163.com	Ma, Lin/AAF-8728-2019	Duan, Shaofeng/0000-0002-2695-5898; Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063	Beijing Natural Science Foundation [7143186]; Scientific Foundation of General Hospital of Armed Police [WZ2010006]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Foundation of General Hospital of Armed Police	This work was supported by Beijing Natural Science Foundation (Grant No. 7143186) and the Scientific Foundation of General Hospital of Armed Police (Grant No. WZ2010006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Benini R, 2013, J PEDIATR-US, V162, P369, DOI 10.1016/j.jpeds.2012.07.044; Carducci F, 2013, FUNCT NEUROL, V28, P19, DOI 10.11138/FNeur/2013.28.1.019; Fan GG, 2006, CLIN RADIOL, V61, P358, DOI 10.1016/j.crad.2006.01.001; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Leviton A, 2007, TRENDS NEUROSCI, V30, P473, DOI 10.1016/j.tins.2007.05.009; Ligam P, 2009, PEDIATR RES, V65, P524, DOI 10.1203/PDR.0b013e3181998baf; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; Nagasunder AC, 2011, AM J NEURORADIOL, V32, P185, DOI 10.3174/ajnr.A2243; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Rai Y, 2013, EUR J PAEDIATR NEURO, V17, P294, DOI 10.1016/j.ejpn.2012.11.005; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Scheck SM, 2012, DEV MED CHILD NEUROL, V54, P684, DOI 10.1111/j.1469-8749.2012.04332.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Tan L, 2013, NEUROSCI BULL, V29, P642, DOI 10.1007/s12264-013-1370-7; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; Wang ZQ, 2010, EUR J RADIOL, V75, P129, DOI 10.1016/j.ejrad.2009.04.041; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Yoshida S, 2013, J MAGN RESON IMAGING, V38, P288, DOI 10.1002/jmri.23931; Yoshida S, 2010, DEV MED CHILD NEUROL, V52, P935, DOI 10.1111/j.1469-8749.2010.03669.x	40	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100451	10.1371/journal.pone.0100451	http://dx.doi.org/10.1371/journal.pone.0100451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964139	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500052
J	Wang, H; Flannery, SM; Dickhofer, S; Huhn, S; George, J; Kubarenko, AV; Lascorz, J; Bevier, M; Willemsen, J; Pichulik, T; Schafmayer, C; Binder, M; Manoury, B; Paludan, SR; Alarcon-Riquelme, M; Bowie, AG; Forsti, A; Weber, ANR				Wang, Hui; Flannery, Sinead M.; Dickhoefer, Sabine; Huhn, Stefanie; George, Julie; Kubarenko, Andriy V.; Lascorz, Jesus; Bevier, Melanie; Willemsen, Joschka; Pichulik, Tica; Schafmayer, Clemens; Binder, Marco; Manoury, Benedicte; Paludan, Soren R.; Alarcon-Riquelme, Marta; Bowie, Andrew G.; Foersti, Asta; Weber, Alexander N. R.			A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; MYD88; ACTIVATION; INHIBITORS; REGULATOR; COMPLEX; KINASE; MEMBER; TRAF6	Within innate immune signaling pathways, interleukin-1 receptor-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors and the interleukin-1 receptor. Although human IRAK4 deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-kappa B signaling and Toll-like receptor-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups, and our studies suggested a genetic association of rs35060588 with colorectal cancer survival. This for the first time implicates human IRAK2 in a human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point.	[Wang, Hui; George, Julie; Kubarenko, Andriy V.; Pichulik, Tica; Weber, Alexander N. R.] German Canc Res Ctr, Jr Res Grp Toll Like Receptors & Canc, D-69120 Heidelberg, Germany; [Huhn, Stefanie; Lascorz, Jesus; Bevier, Melanie; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Wang, Hui; Dickhoefer, Sabine; Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Flannery, Sinead M.; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Willemsen, Joschka; Binder, Marco] Heidelberg Univ, Dept Infect Dis Mol Virol, D-69120 Heidelberg, Germany; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schafmayer, Clemens] Univ Kiel, POPGEN Biobank Project, D-24105 Kiel, Germany; [Manoury, Benedicte] INSERM, U1013, F-75015 Paris, France; [Manoury, Benedicte] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75015 Paris, France; [Paludan, Soren R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Alarcon-Riquelme, Marta] Univ Granada, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res, Granada 18016, Spain; [Alarcon-Riquelme, Marta] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta] European Sci Fdn, BIOLUPUS Network, F-67080 Strasbourg, France; [Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Trinity College Dublin; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Aarhus University; Pfizer; University of Granada; Oklahoma Medical Research Foundation; Lund University	Weber, ANR (corresponding author), Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, Morgenstelle 15, D-72076 Tubingen, Germany.	alexander.weber@uni-tuebingen.de	Binder, Marco/E-9717-2011; Alarcón-Riquelme, Marta E./ABF-8163-2020; Willemsen, Joschka/O-6261-2017	Binder, Marco/0000-0002-5805-6109; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Manoury, Benedicte/0000-0001-7784-3389; Bowie, Andrew/0000-0001-5316-4373; Weber, Alexander/0000-0002-8627-7056; Willemsen, Joschka/0000-0003-3106-6697	German Cancer Research Center DKFZ; Deutsche Forschungsgemeinschaft [We-4195/1-1]; INST [37/888-1 CRC 685]; Chinese Scholarship Council CSC; University of Tubingen; Science Foundation Ireland [07/IN1/B934, 11/PI/1056]	German Cancer Research Center DKFZ(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); INST; Chinese Scholarship Council CSC(China Scholarship Council); University of Tubingen; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from the German Cancer Research Center DKFZ (to H. W., J. G., A. V. K., and A. N. R. W.), Deutsche Forschungsgemeinschaft Grants We-4195/1-1 (to H. W., J. G., A. V. K., and A. N. R. W.) and INST 37/888-1 CRC 685 "Immunotherapy" (to A. N. R. W.), the Chinese Scholarship Council CSC (to H. W.), the University of Tubingen (to H. W., S. D., T. P., and A. N. R. W.), Science Foundation Ireland Grants 07/IN1/B934 and 11/PI/1056 (to S. M. F. and A. G. B.).	Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lofgren SE, 2010, ARTHRITIS RHEUM-US, V62, P3404, DOI 10.1002/art.27677; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wang ZL, 2009, CURR TOP MED CHEM, V9, P724, DOI 10.2174/156802609789044407; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06	35	17	17	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23123	23131		10.1074/jbc.M113.492934	http://dx.doi.org/10.1074/jbc.M113.492934			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973222	Green Published, hybrid			2022-12-25	WOS:000341017200049
J	Zhang, YQ; Liu, CX; Duan, XL; Ren, FL; Li, S; Jin, Z; Wang, YY; Feng, YR; Liu, ZW; Chang, ZJ				Zhang, Yanquan; Liu, Chunxiao; Duan, Xiaolin; Ren, Fangli; Li, Shan; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Liu, Zewen; Chang, Zhijie			CREPT/RPRD1B, a Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the beta-Catenin center dot TCF4 Transcriptional Activity in Response to Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 GENE; BETA-CATENIN; GROUCHO; TARGET; PHOSPHORYLATION; ACETYLATION; PROMOTER; GROWTH; CANCER; DOMAIN	CREPT (cell cycle-related and expression elevated protein in tumor)/RPRD1B (regulation of nuclear pre-mRNA domain-containing protein 1B), highly expressed during tumorigenesis, was shown to enhance transcription of CCND1 and to promote cell proliferation by interacting with RNA polymerase II. However, which signaling pathway is involved in CREPT-mediated activation of gene transcription remains unclear. In this study, we reveal that CREPT participates in transcription of the Wnt/beta-catenin signaling activated genes through the beta-catenin and the TCF4 complex. Our results demonstrate that CREPT interacts with both beta-catenin and TCF4, and enhances the association of beta-catenin with TCF4, in response to Wnt stimulation. Furthermore, CREPT was shown to occupy at TCF4 binding sites (TBS) of the promoters of Wnt-targeted genes under Wnt stimulation. Interestingly, depletion of CREPT resulted in decreased occupancy of beta-catenin on TBS, and over-expression of CREPT enhances the activity of the beta-catenin center dot TCF4 complex to initiate transcription of Wnt target genes, which results in up-regulated cell proliferation and invasion. Our study suggests that CREPT acts as an activator to promote transcriptional activity of the beta-catenin center dot TCF4 complex in response to Wnt signaling.	[Zhang, Yanquan; Liu, Chunxiao; Ren, Fangli; Li, Shan; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Liu, Zewen; Chang, Zhijie] Tsinghua Univ, Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Sch Med, Beijing 100084, Peoples R China; [Zhang, Yanquan; Liu, Chunxiao; Ren, Fangli; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Chang, Zhijie] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China; [Duan, Xiaolin] Second Peoples Hosp Zhuhai, Guangzhou 519000, Guangdong, Peoples R China	Tsinghua University; Sichuan University	Chang, ZJ (corresponding author), Tsinghua Univ, Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Sch Med, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Zhang, Yanquan/D-5615-2017; Chang, Zhijie/AAH-8109-2019	Zhang, Yanquan/0000-0003-3527-9972; Chang, Zhijie/0000-0003-1567-3227	973 Project [2011CB910502]; Natural Science Foundation of China [81230044, 81372167]; Tsinghua Science Foundation [20121080018]; Natural Science Foundation of Beijing [511003]; Major Program Grant [2013ZX08011-006]; 863 project in China [2014AA020802, 2012AA021703]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020802] Funding Source: NIH RePORTER	973 Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Major Program Grant; 863 project in China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 973 Project Grant 2011CB910502, National Natural Science Foundation of China Grants 81230044 and 81372167, Tsinghua Science Foundation Grant 20121080018, Natural Science Foundation of Beijing Grant 511003, Major Program Grant 2013ZX08011-006, and 863 project Grants 2014AA020802 and 2012AA021703 in China.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CASTROP J, 1992, NUCLEIC ACIDS RES, V20, P611, DOI 10.1093/nar/20.3.611; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Jung HM, 2009, J CELL BIOCHEM, V106, P703, DOI 10.1002/jcb.22063; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Wang YM, 2014, CARCINOGENESIS, V35, P983, DOI 10.1093/carcin/bgt393; Wang YF, 2014, NORD J BOT, V32, P185, DOI 10.1111/j.1756-1051.2013.00200.x; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400	34	33	34	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22589	22599		10.1074/jbc.M114.560979	http://dx.doi.org/10.1074/jbc.M114.560979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982424	Green Published, hybrid			2022-12-25	WOS:000341017200006
J	Ell, B; Qiu, Q; Wei, Y; Mercatali, L; Ibrahim, T; Amadori, D; Kang, YB				Ell, Brian; Qiu, Qiong; Wei, Yong; Mercatali, Laura; Ibrahim, Toni; Amadori, Dino; Kang, Yibin			The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; MICRORNAS; CELLS; DIFFERENTIATION; SECRETION; PROTEIN; MIR-23B; P53	MicroRNAs (miRNAs) have been shown to function as key regulators of tumor progression and metastasis. Recent studies have indicated that the miRNAs comprising the miR-23b/27b/24 cluster might influence tumor metastasis, although the precise nature of this regulation remains unclear. Here, expression of the miR-23b/27b/24 cluster is found to correlate with metastatic potential in mouse and human breast cancer cell lines and is elevated in metastatic lung lesions in human breast cancer patients. Ectopic expression of the miRNAs in the weakly metastatic mouse 4TO7 mammary tumor cell line had no effect on proliferation or morphology of tumor cells in vitro but was found to increase lung metastasis in a mouse model of breast cancer metastasis. Furthermore, gene expression profiling analysis of miRNA overexpressing 4TO7 cells revealed the direct targeting of prosaposin (PSAP), which encodes a secreted protein found to be inversely correlated with metastatic progression in human breast cancer patients. Importantly, ectopic expression of PSAP was able to suppress the metastatic phenotype in highly metastatic 4T1 and MDA-MB-231 SCP28 cells, as well as in cells ectopically expressing miR-23b/27b/24. These findings support a metastasis-promoting function of the miR23b/27b/24 cluster of miRNAs, which functions in part through the direct inhibition of PSAP.	[Ell, Brian; Qiu, Qiong; Wei, Yong; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Mercatali, Laura; Ibrahim, Toni; Amadori, Dino] IRCCS Sci Inst Romagna Study & Treatment Canc IRS, Osteoncol & Rare Tumors Ctr, I-47014 Meldola, Italy; [Kang, Yibin] Rutgers Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ 08903 USA	Princeton University; IRCCS Meldola (IRST); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL255 Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu	Mercatali, Laura/J-9154-2016	Mercatali, Laura/0000-0003-2162-8238; Ibrahim, Toni/0000-0003-0259-4167; Kang, Yibin/0000-0002-1626-6730	NIGMS NIH HHS [T32 GM007388] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Campana WM, 1999, BBA-GEN SUBJECTS, V1427, P392, DOI 10.1016/S0304-4165(99)00036-7; Catena R, 2013, CANCER DISCOV, V3, P578, DOI 10.1158/2159-8290.CD-12-0476; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Du WW, 2013, J CELL SCI, V126, P1440, DOI 10.1242/jcs.118299; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ishteiwy RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052106; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060687; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	39	54	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21888	21895		10.1074/jbc.M114.582866	http://dx.doi.org/10.1074/jbc.M114.582866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966325	Green Published, hybrid			2022-12-25	WOS:000340593500007
J	Kelly, JN; Barr, SD				Kelly, Jenna N.; Barr, Stephen D.			In Silico Analysis of Functional Single Nucleotide Polymorphisms in the Human TRIM22 Gene	PLOS ONE			English	Article							HUMAN TRIM5-ALPHA; RETROVIRAL RESTRICTION; HIV-1 INFECTION; AMINO-ACID; POSTTRANSLATIONAL MODIFICATION; PHOSPHORYLATION SITES; B30.2(SPRY) DOMAIN; MISSENSE MUTATIONS; VIRUS RESTRICTION; B30.2/SPRY DOMAIN	Tripartite motif protein 22 (TRIM22) is an evolutionarily ancient protein that plays an integral role in the host innate immune response to viruses. The antiviral TRIM22 protein has been shown to inhibit the replication of a number of viruses, including HIV-1, hepatitis B, and influenza A. TRIM22 expression has also been associated with multiple sclerosis, cancer, and autoimmune disease. In this study, multiple in silico computational methods were used to identify non-synonymous or amino acid-changing SNPs (nsSNP) that are deleterious to TRIM22 structure and/or function. A sequence homology-based approach was adopted for screening nsSNPs in TRIM22, including six different in silico prediction algorithms and evolutionary conservation data from the ConSurf web server. In total, 14 high-risk nsSNPs were identified in TRIM22, most of which are located in a protein interaction module called the B30.2 domain. Additionally, 9 of the top high-risk nsSNPs altered the putative structure of TRIM22's B30.2 domain, particularly in the surface-exposed v2 and v3 regions. These same regions are critical for retroviral restriction by the closely-related TRIM5 alpha protein. A number of putative structural and functional residues, including several sites that undergo post-translational modification, were also identified in TRIM22. This study is the first extensive in silico analysis of the highly polymorphic TRIM22 gene and will be a valuable resource for future targeted mechanistic and population-based studies.	[Kelly, Jenna N.; Barr, Stephen D.] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, Ctr Human Immunol, London, ON, Canada	Western University (University of Western Ontario)	Barr, SD (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, Ctr Human Immunol, Dent Sci Bldg, London, ON, Canada.	stephen.barr@uwo.ca		Kelly, Jenna/0000-0001-7265-2233; Barr, Stephen/0000-0002-0028-7430	Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario HIV Treatment Network salary award; CIHR [HBF107546, HBF134179]	Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario HIV Treatment Network salary award; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by: an Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology to JNK; an Ontario HIV Treatment Network salary award to SDB; and CIHR grants HBF107546 and HBF134179 to SDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arriagada G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002019; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Bates PA, 2001, PROTEINS, P39; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Daley D, 2012, J ALLERGY CLIN IMMUN, V130, P1284, DOI 10.1016/j.jaci.2012.07.051; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Duan ZJ, 2008, BIOCHEM BIOPH RES CO, V374, P502, DOI 10.1016/j.bbrc.2008.07.070; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Goldschmidt V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-54; Gresko E, 2009, ONCOGENE, V28, P698, DOI 10.1038/onc.2008.420; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hattlmann Clayton J, 2012, Mol Biol Int, V2012, P153415, DOI 10.1155/2012/153415; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kono K, 2009, VIROLOGY, V388, P160, DOI 10.1016/j.virol.2009.03.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Lukic Z, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-10; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; Mavroconstanti T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071445; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Nakajima T, 2009, AIDS, V23, P2091, DOI 10.1097/QAD.0b013e328331567a; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ohmine S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016121; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts JD, 2007, AM J PHYSIOL-LUNG C, V293, pL903, DOI 10.1152/ajplung.00157.2007; Santana-de Anda K, 2011, AUTOIMMUN REV, V11, P98, DOI 10.1016/j.autrev.2011.08.006; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Singh R, 2011, J VIROL, V85, P208, DOI 10.1128/JVI.01810-10; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P1, DOI 10.1136/bjophthalmol-2014-305502; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sivaramakrishnan G, 2009, FEBS LETT, V583, P2093, DOI 10.1016/j.febslet.2009.05.036; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stacey KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034041; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, CYTOPLASMIC BODY COM, P427; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Valiyeva F, 2011, MOL CANCER THER, V10, P1229, DOI 10.1158/1535-7163.MCT-11-0077; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	84	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101436	10.1371/journal.pone.0101436	http://dx.doi.org/10.1371/journal.pone.0101436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983760	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000107
J	Guo, LJ; Yang, YH; Liu, J; Wang, L; Li, JF; Wang, Y; Liu, Y; Gu, S; Gan, HL; Cai, J; Yuan, JXJ; Wang, J; Wang, C				Guo, Lijuan; Yang, Yuanhua; Liu, Jie; Wang, Lei; Li, Jifeng; Wang, Ying; Liu, Yan; Gu, Song; Gan, Huili; Cai, Jun; Yuan, Jason X. -J.; Wang, Jun; Wang, Chen			Differentially Expressed Plasma MicroRNAs and the Potential Regulatory Function of Let-7b in Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; ARTERIAL-HYPERTENSION; CA2+ ENTRY; TGF-BETA; PROLIFERATION; GROWTH; SIGNATURE; DIAGNOSIS; BIOMARKER; PROTEIN	Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease characterized by misguided thrombolysis and remodeling of pulmonary arteries. MicroRNAs are small non-coding RNAs involved in multiple cell processes and functions. During CTEPH, circulating microRNA profile endued with characteristics of diseased cells could be identified as a biomarker, and might help in recognition of pathogenesis. Thus, in this study, we compared the differentially expressed microRNAs in plasma of CTEPH patients and healthy controls and investigated their potential functions. Microarray was used to identify microRNA expression profile and qRT-PCR for validation. The targets of differentially expressed microRNAs were identified in silico, and the Gene Ontology database and Kyoto Encyclopedia of Genes and Genomes pathway database were used for functional investigation of target gene profile. Targets of let-7b were validated by fluorescence reporter assay. Protein expression of target genes was determined by ELISA or western blotting. Cell migration was evaluated by wound healing assay. The results showed that 1) thirty five microRNAs were differentially expressed in CTEPH patients, among which, a signature of 17 microRNAs, which was shown to be related to the disease pathogenesis by in silico analysis, gave diagnostic efficacy of both sensitivity and specificity >0.9. 2) Let-7b, one of the down-regulated anti-oncogenic microRNAs in the signature, was validated to decrease to about 0.25 fold in CTEPH patients. 3) ET-1 and TGFBR1 were direct targets of let-7b. Altering let-7b level influenced ET-1 and TGFBR1 expression in pulmonary arterial endothelial cells (PAECs) as well as the migration of PAECs and pulmonary arterial smooth muscle cells (PASMCs). These results suggested that CTEPH patients had aberrant microRNA signature which might provide some clue for pathogenesis study and biomarker screening. Reduced let-7b might be involved in the pathogenesis of CTEPH by affecting ET-1 expression and the function of PAECs and PASMCs.	[Guo, Lijuan; Wang, Lei; Li, Jifeng; Wang, Ying; Wang, Jun; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China; [Guo, Lijuan; Yang, Yuanhua; Wang, Lei; Li, Jifeng; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, Beijing, Peoples R China; [Liu, Jie; Wang, Jun] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Liu, Yan; Gu, Song; Cai, Jun] Capital Med Univ, Beijing Chao Yang Hosp, Dept Cardiol, Beijing, Peoples R China; [Gan, Huili] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Gan, Huili] Capital Med Univ, Beijing Inst Heart Lung & Vessel Dis, Beijing, Peoples R China; [Yuan, Jason X. -J.] Univ Illinois, Dept Med, Chicago, IL USA; [Wang, Chen] Minist Hlth, Dept Beijing Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China.	wang_jun@ccmu.edu.cn; cyh-birm@263.net	wang, chen/GWM-9481-2022		Fund of National Natural Science Foundation of China [81070041, 81070042, 81111130212, 81228001, 81370152]	Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of National Natural Science Foundation of China (81070041, 81070042, 81111130212, 81228001, 81370152, 81228001). URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022; Arunthari Vichaya, 2009, Open Respir Med J, V3, P85, DOI 10.2174/1874306400903010085; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonderman D, 2009, EUR RESPIR J, V33, P325, DOI 10.1183/09031936.00087608; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Castanares C, 2006, EXP BIOL MED, V231, P700; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZY, 2010, HUM GENET, V128, P443, DOI 10.1007/s00439-010-0866-8; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Confalonieri Marco, 2009, Expert Rev Cardiovasc Ther, V7, P1503, DOI 10.1586/erc.09.148; Dentali F, 2009, THROMB RES, V124, P256, DOI 10.1016/j.thromres.2009.01.003; Dupuis J, 2008, EUR RESPIR J, V31, P407, DOI 10.1183/09031936.00078207; Fedullo PF, 2001, NEW ENGL J MED, V345, P1465, DOI 10.1056/NEJMra010902; Jachec W, 2008, INT J MOL MED, V21, P99; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kittleson MM, 2005, TRENDS CARDIOVAS MED, V15, P130, DOI 10.1016/j.tcm.2005.05.007; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; KURIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P1435, DOI 10.1016/0006-291X(89)92270-5; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Langer F, 2005, J THORAC CARDIOV SUR, V130, P1342, DOI 10.1016/j.jtcvs.2005.06.044; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Man TK, 2005, CANCER RES, V65, P8142, DOI 10.1158/0008-5472.CAN-05-0985; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peacock Andrew, 2006, Proc Am Thorac Soc, V3, P608, DOI 10.1513/pats.200605-114LR; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Reesink HJ, 2006, CIRC J, V70, P1058, DOI 10.1253/circj.70.1058; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Skoro-Sajer N, 2007, AM J RESP CRIT CARE, V176, P1154, DOI 10.1164/rccm.200702-278OC; Surie S, 2010, THROMB RES, V125, pE202, DOI 10.1016/j.thromres.2009.12.016; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Wang C, 2008, J PHARMACOL SCI, V108, P71, DOI 10.1254/jphs.08069FP; Wang L, 2013, PULM CIRC, V3, P654, DOI 10.1086/674310; Xiao JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-159; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	52	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101055	10.1371/journal.pone.0101055	http://dx.doi.org/10.1371/journal.pone.0101055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978044	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400067
J	Singh, SK; Shukla, AK; Dhawan, OP; Shasany, AK				Singh, Sharad K.; Shukla, Ashutosh K.; Dhawan, Om P.; Shasany, Ajit K.			Recessive Loci Pps-1 and OM Differentially Regulate PISTILLATA-1 and APETALA3-1 Expression for Sepal and Petal Development in Papaver somniferum	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HOMEOTIC GENE; MADS-BOX; MOLECULAR EVOLUTION; PLANT DEVELOPMENT; DNA-BINDING; CONSERVATION; PROTEINS; FLOWER; L.	The involvement of PISTILLATA (PI) and APETALA (AP) transcription factors in the development of floral organs has previously been elucidated but little is known about their upstream regulation. In this investigation, two novel mutants generated in Papaver somniferum were analyzed - one with partially petaloid sepals and another having sepaloid petals. Progeny from reciprocal crosses of respective mutant parent genotypes showed a good fit to the monogenic Mendelian inheritance model, indicating that the mutant traits are likely controlled by the single, recessive nuclear genes named "Pps1" and "OM" in the partially petaloid sepal and sepaloid petal phenotypes, respectively. Both paralogs of PISTILLATA (PapsPI-1 and PapsPI-3) were obtained from the sepals and petals of P. somniferum. Ectopic expression of PapsPI-1 in tobacco resulted in a partially petaloid sepal phenotype at a low frequency. Upregulation of PapsPI-1 and PapsAP3-1 in the petal and the petal part of partially petaloid sepal mutant and down-regulation of the same in sepaloid petal mutant indicates a differential pattern of regulation for flowering-related genes in various whorls. Similarly, it was found that the recessive mutation OM in sepaloid petal mutant downregulates PapsPI-1 and PapsAP3-1 transcripts. The recessive nature of the mutations was confirmed by the segregation ratios obtained in this analysis.	[Singh, Sharad K.; Dhawan, Om P.] CSIR Cent Inst Med & Aromat Plants, Genet & Plant Breeding Div, Lucknow, Uttar Pradesh, India; [Singh, Sharad K.; Shukla, Ashutosh K.; Shasany, Ajit K.] CSIR Cent Inst Med & Aromat Plants, Div Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Dhawan, OP (corresponding author), CSIR Cent Inst Med & Aromat Plants, Genet & Plant Breeding Div, Lucknow, Uttar Pradesh, India.	op.dhawan@cimap.res.in; akshasany@yahoo.com			Council of Scientific and Industrial Research (CSIR) [BSC0203]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Council of Scientific and Industrial Research (CSIR) through the Twelfth Five Year Plan project (BSC0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Berbel A, 2005, PLANT PHYSIOL, V139, P174, DOI 10.1104/pp.104.057687; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brunner AM, 2004, NEW PHYTOL, V164, P43, DOI 10.1111/j.1469-8137.2004.01165.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1996, PLANT J, V10, P663, DOI 10.1046/j.1365-313X.1996.10040663.x; Dhawan OP, 2007, J HERED, V98, P373, DOI 10.1093/jhered/esm037; Drea S, 2007, DEVELOPMENT, V134, P4157, DOI 10.1242/dev.013136; Dubey MK, 2009, J HERED, V100, P76, DOI 10.1093/jhered/esn071; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evangelisti AM, 2004, J EXP ZOOL PART B, V302B, P392, DOI 10.1002/jez.b.20027; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; HALFTER U, 1994, EMBO J, V13, P1443, DOI 10.1002/j.1460-2075.1994.tb06398.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Honma T, 2000, DEVELOPMENT, V127, P2021; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jack T, 2001, PLANT MOL BIOL, V46, P515, DOI 10.1023/A:1010689126632; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kramer EM, 1998, GENETICS, V149, P765; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Li JH, 2010, P NATL ACAD SCI USA, V107, P5664, DOI 10.1073/pnas.0910955107; Luo HR, 2006, AFR J BIOTECHNOL, V5, P1851; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Misra A, 2012, GENE, V510, P193, DOI 10.1016/j.gene.2012.09.015; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1997, BIOL CHEM, V378, P1079; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251, DOI 10.1002/j.1460-2075.1992.tb05048.x; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Whipple CJ, 2007, P NATL ACAD SCI USA, V104, P1081, DOI 10.1073/pnas.0606434104; Wilkinson M, 2000, DEVELOPMENT, V127, P3725; Winefield C, 2006, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF FLOWERING, 2ND EDITION, P237, DOI 10.1079/9781845930424.0237; Zhang XN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003563	42	7	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101272	10.1371/journal.pone.0101272	http://dx.doi.org/10.1371/journal.pone.0101272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979593	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400110
J	Van Hecke, T; Vossen, E; Bussche, JV; Raes, K; Vanhaecke, L; De Smet, S				Van Hecke, Thomas; Vossen, Els; Bussche, Julie Vanden; Raes, Katleen; Vanhaecke, Lynn; De Smet, Stefaan			Fat Content and Nitrite-Curing Influence the Formation of Oxidation Products and NOC-Specific DNA Adducts during In Vitro Digestion of Meat	PLOS ONE			English	Article							MUCIN-DEPLETED FOCI; RED MEAT; COLORECTAL-CANCER; COLON-CANCER; LIPID-PEROXIDATION; PROTEIN OXIDATION; RAT COLON; DAMAGE; HEME; CARCINOGENESIS	The effects of fat content and nitrite-curing of pork were investigated on the formation of cytotoxic and genotoxic lipid oxidation products (malondialdehyde, 4-hydroxy-2-nonenal, volatile simple aldehydes), protein oxidation products (protein carbonyl compounds) and NOC-specific DNA adducts (O-6-carboxy-methylguanine) during in vitro digestion. The formation of these products during digestion is suggested to be responsible for the association between red meat and processed meat consumption and colorectal cancer risk. Digestion of uncured pork to which fat was added (total fat content 5 or 20%), resulted in significantly higher lipid and protein oxidation in the mimicked duodenal and colonic fluids, compared to digestion of pork without added fat (1% fat). A higher fat content also significantly favored the formation of O-6-carboxy-methylguanine in the colon. Nitrite-curing of meat resulted in significantly lower lipid and protein oxidation before and after digestion, while an inconsistent effect on the formation of O-6-carboxy-methylguanine was observed. The presented results demonstrate that haem-Fe is not solely responsible for oxidation and nitrosation reactions throughout an in vitro digestion approach but its effect is promoted by a higher fat content in meat.	[Van Hecke, Thomas; Vossen, Els; De Smet, Stefaan] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Bussche, Julie Vanden; Vanhaecke, Lynn] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Fac Vet Med, Merelbeke, Belgium; [Raes, Katleen] Univ Ghent, Fac Biosci Engn, Dept Ind Biol Sci, Lab Food Microbiol & Biotechnol, Kortrijk, Belgium	Ghent University; Ghent University; Ghent University	De Smet, S (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium.	stefaan.desmet@ugent.be	DeSmet, Stefaan/N-7576-2017; Vanden Bussche, Julie/K-5134-2014; Vanhaecke, Lynn/N-1061-2017	DeSmet, Stefaan/0000-0003-1422-805X; Vanden Bussche, Julie/0000-0002-3831-6663; Vanhaecke, Lynn/0000-0003-0400-2188; Raes, Katleen/0000-0003-2382-120X	Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RF-11/625 MEATNOX]; Research Foundation - Flanders (FWO)	Federal Public Service of Health, Food Chain Safety and Environment, Belgium; Research Foundation - Flanders (FWO)(FWO)	This study was financed by the Federal Public Service of Health, Food Chain Safety and Environment, Belgium (grant RF-11/625 MEATNOX) (http://www.health.belgium.be/eportal). L. Vanhaecke is supported by a postdoctoral fellowship from the Research Foundation - Flanders (FWO) (http://www.fwo.be/Postdoctorale-mandaten.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J CHROMATOGR A, V1257, P25; Bajka BH, 2008, CARCINOGENESIS, V29, P2169, DOI 10.1093/carcin/bgn173; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chenni FZ, 2013, NUTR CANCER, V65, P227, DOI 10.1080/01635581.2013.749291; CORPET DE, 1995, NUTR CANCER, V23, P271, DOI 10.1080/01635589509514381; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; Cross AJ, 2003, CANCER RES, V63, P2358; Dabrowska-Ufniarz Elzbieta, 2002, Med Sci Monit, V8, pCR96; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dean RT, 1997, BIOCHEM J, V324, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganhao R, 2010, MEAT SCI, V85, P402, DOI 10.1016/j.meatsci.2010.02.008; Gorelik S, 2008, FASEB J, V22, P41, DOI 10.1096/fj.07-9041com; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Guven Y, 1996, J CLIN PERIODONTOL, V23, P879, DOI 10.1111/j.1600-051X.1996.tb00627.x; HOLLEY AE, 1993, FREE RADICAL BIO MED, V15, P281, DOI 10.1016/0891-5849(93)90075-6; Honikel KO, 2008, MEAT SCI, V78, P68, DOI 10.1016/j.meatsci.2007.05.030; Hornsey H.C., 1956, J SCI FOOD AGR, V7, P534, DOI [10.1002/jsfa.2740070804, DOI 10.1002/JSFA.2740070804]; Hur SJ, 2009, J FOOD SCI, V74, pC653, DOI 10.1111/j.1750-3841.2009.01344.x; Ismail HA, 2009, J FOOD SCI, V74, pC432, DOI 10.1111/j.1750-3841.2009.01207.x; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Lai C, 1997, CANCER LETT, V112, P87, DOI 10.1016/S0304-3835(96)04549-1; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Mirvish SS, 2002, J NUTR, V132, p3526S, DOI 10.1093/jn/132.11.3526S; MOLLY K, 1994, MICROB ECOL HEALTH D, V7, P191, DOI 10.3109/08910609409141354; Moore SA, 2010, ANAL BIOCHEM, V403, P67, DOI 10.1016/j.ab.2010.04.015; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; NALINI S, 1992, J GASTROEN HEPATOL, V7, P497, DOI 10.1111/j.1440-1746.1992.tb01027.x; Pierre FHF, 2010, NUTR CANCER, V62, P567, DOI 10.1080/01635580903532408; Raes K, 2001, ANIM SCI, V73, P253, DOI 10.1017/S1357729800058227; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; Santarelli RL, 2010, CANCER PREV RES, V3, P852, DOI 10.1158/1940-6207.CAPR-09-0160; Sante-Lhoijtellier V, 2008, J AGR FOOD CHEM, V56, P1488, DOI 10.1021/jf072999g; Sesink ALA, 2000, CARCINOGENESIS, V21, P1909, DOI 10.1093/carcin/21.10.1909; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P403, DOI 10.3748/wjg.v11.i3.403; Takahama U, 2003, J AGR FOOD CHEM, V51, P6014, DOI 10.1021/jf021253+; Trostchansky A, 2008, FREE RADICAL BIO MED, V44, P1887, DOI 10.1016/j.freeradbiomed.2008.03.006; Van de Wiele T, 2005, ENVIRON HEALTH PERSP, V113, P6, DOI 10.1289/ehp.7259; Versantvoort CHM, 2005, FOOD CHEM TOXICOL, V43, P31, DOI 10.1016/j.fct.2004.08.007; Yeh CC, 2010, CARCINOGENESIS, V31, P228, DOI 10.1093/carcin/bgp286	43	31	31	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101122	10.1371/journal.pone.0101122	http://dx.doi.org/10.1371/journal.pone.0101122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978825	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400082
J	Cui, X; Geffers, L; Eichele, G; Yan, J				Cui, Xiao; Geffers, Lars; Eichele, Gregor; Yan, Jun			A Computational Approach to Estimate Interorgan Metabolic Transport in a Mammal	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; MEMBRANE-TRANSPORT; RENAL METABOLISM; GENOME; RECONSTRUCTION; NETWORK; LIVER; PHYSIOLOGY; KIDNEY; INSUFFICIENCY	In multicellular organisms metabolism is distributed across different organs, each of which has specific requirements to perform its own specialized task. But different organs also have to support the metabolic homeostasis of the organism as a whole by interorgan metabolite transport. Recent studies have successfully reconstructed global metabolic networks in tissues and cell types and attempts have been made to connect organs with interorgan metabolite transport. Instead of these complicated approaches to reconstruct global metabolic networks, we proposed in this study a novel approach to study interorgan metabolite transport focusing on transport processes mediated by solute carrier (Slc) transporters and their couplings to cognate enzymatic reactions. We developed a computational approach to identify and score potential interorgan metabolite transports based on the integration of metabolism and transports in different organs in the adult mouse from quantitative gene expression data. This allowed us to computationally estimate the connectivity between 17 mouse organs via metabolite transport. Finally, by applying our method to circadian metabolism, we showed that our approach can shed new light on the current understanding of interorgan metabolite transport at a whole-body level in mammals.	[Cui, Xiao; Yan, Jun] CAS MPG Partner Inst Computat Biol, Funct Genom Grp, Shanghai, Peoples R China; [Geffers, Lars; Eichele, Gregor] Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Max Planck Society	Yan, J (corresponding author), CAS MPG Partner Inst Computat Biol, Funct Genom Grp, Shanghai, Peoples R China.	junyan@picb.ac.cn		Geffers, Lars/0000-0001-6800-4305	Chinese Academy of Sciences; German Max-Planck Society	Chinese Academy of Sciences(Chinese Academy of Sciences); German Max-Planck Society(Max Planck Society)	This research was supported by Chinese Academy of Sciences and German Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bean GJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r123; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; BIOLO G, 1995, METABOLISM, V44, P719, DOI 10.1016/0026-0495(95)90183-3; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; BROSNAN JT, 1987, CAN J PHYSIOL PHARM, V65, P2355, DOI 10.1139/y87-373; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193; Cori C F, 1981, Curr Top Cell Regul, V18, P377; DANTZLER WH, 1988, AM J PHYSIOL, V255, pF397, DOI 10.1152/ajprenal.1988.255.3.F397; DEJONG CHC, 1993, HEPATOLOGY, V18, P890, DOI 10.1002/hep.1840180422; Dejong CHC, 1998, CLIN SCI, V95, P409, DOI 10.1042/CS19980002; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ferreira GK, 2013, NEUROTOX RES, V23, P327, DOI 10.1007/s12640-012-9345-4; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KNELL AJ, 1974, BMJ-BRIT MED J, V1, P549, DOI 10.1136/bmj.1.5907.549; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Moraes TF, 2012, BBA-BIOMEMBRANES, V1818, P2687, DOI 10.1016/j.bbamem.2012.06.007; Najman L, 2004, P SOC PHOTO-OPT INS, V5300, P98, DOI 10.1117/12.526592; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617; Thiele I, 2013, NAT BIOTECHNOL; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; van de Poll MCG, 2007, AM J CLIN NUTR, V85, P167, DOI 10.1093/ajcn/85.1.167; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100963	10.1371/journal.pone.0100963	http://dx.doi.org/10.1371/journal.pone.0100963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971892	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200075
J	Flibotte, JJ; Jablonski, AM; Kalb, RG				Flibotte, John J.; Jablonski, Angela M.; Kalb, Robert G.			Oxygen Sensing Neurons and Neuropeptides Regulate Survival after Anoxia in Developing C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SUSPENDED ANIMATION; GUANYLATE CYCLASES; CELL-CYCLE; PROTEINS	Hypoxic brain injury remains a major source of neurodevelopmental impairment for both term and preterm infants. The perinatal period is a time of rapid transition in oxygen environments and developmental resetting of oxygen sensing. The relationship between neural oxygen sensing ability and hypoxic injury has not been studied. The oxygen sensing circuitry in the model organism C. elegans is well understood. We leveraged this information to investigate the effects of impairments in oxygen sensing on survival after anoxia. There was a significant survival advantage in developing worms specifically unable to sense oxygen shifts below their preferred physiologic range via genetic ablation of BAG neurons, which appear important for conferring sensitivity to anoxia. Oxygen sensing that is mediated through guanylate cyclases (gcy-31, 33, 35) is unlikely to be involved in conferring this sensitivity. Additionally, animals unable to process or elaborate neuropeptides displayed a survival advantage after anoxia. Based on these data, we hypothesized that elaboration of neuropeptides by BAG neurons sensitized animals to anoxia, but further experiments indicate that this is unlikely to be true. Instead, it seems that neuropeptides and signaling from oxygen sensing neurons operate through independent mechanisms, each conferring sensitivity to anoxia in wild type animals.	[Flibotte, John J.] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Jablonski, Angela M.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Childrens Hosp Philadelphia, Dept Pediat, Res Inst, Div Neurol, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Kalb, RG (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Res Inst, Div Neurol, Philadelphia, PA 19104 USA.	kalb@email.chop.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH [T32 HD060556-02]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Children's Hospital of Philadelphia Neonatology Fellows' Research Fund; L. Morton Morley Fund of the Philadelphia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060556] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Hospital of Philadelphia Neonatology Fellows' Research Fund; L. Morton Morley Fund of the Philadelphia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains used in this work were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The authors gratefully acknowledge the following additional funding sources, which supported this work: NIH T32 HD060556-02, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (JJF), the Children's Hospital of Philadelphia Neonatology Fellows' Research Fund (JJF), and the L. Morton Morley Fund of the Philadelphia Foundation (JJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Carrillo MA, 2013, J NEUROSCI, V33, P9675, DOI 10.1523/JNEUROSCI.4541-12.2013; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Higgins RD, 2011, EARLY HUM DEV, V87, pS17, DOI 10.1016/j.earlhumdev.2011.01.004; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Hung WL, 2013, EMBO J, V32, P1745, DOI 10.1038/emboj.2013.91; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; LI C, 2008, NEUROPEPTIDES, DOI DOI 10.1895/WORMBOOK.1.142.1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu TW, 2013, EMBO J, V32, P1529, DOI 10.1038/emboj.2013.75; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Padilla PA, 2012, CELL CYCLE, V11, P1672, DOI 10.4161/cc.19444; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Schmidt J. W., 2010, J NEONATAL PERINAT M, V3, P277, DOI DOI 10.3233/NPM-2010-0126; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	25	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101102	10.1371/journal.pone.0101102	http://dx.doi.org/10.1371/journal.pone.0101102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967811	gold, Green Submitted, Green Published			2022-12-25	WOS:000338280800107
J	Tian, XS; Guo, XJ; Ruan, Z; Lei, Y; Chen, YT; Zhang, HY				Tian, Xue Song; Guo, Xian Jun; Ruan, Zhi; Lei, Yun; Chen, Yu Ting; Zhang, Hai Yan			Long-Term Vision and Non-Vision Dominant Behavioral Deficits in the 2-VO Rats Are Accompanied by Time and Regional Glial Activation in the White Matter	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; COMMON CAROTID-ARTERY; BRAIN-DAMAGE; COGNITIVE FUNCTION; PERMANENT OCCLUSION; WORKING-MEMORY; MESSENGER-RNA; BLOOD-FLOW; IMPAIRMENT; ISCHEMIA	The permanent occlusion of common carotid arteries (2-VO) in rats has been shown to induce progressive and long-lasting deficits in cognitive performance, however, whether these aberrant behaviors are attributed to visual dysfunction or cognitive impairment and what are the underlying mechanisms, remain controversial. In the present study, vision dominant (Morris water maze) and non-vision dominant (voice-cued fear conditioning) behavioral tests were assigned to comprehensively evaluate the influence of 2-VO lesion on cognitive behaviors. In the Morris water maze test, escape latencies of 2-VO rats were markedly increased in both hidden and unfixed visible platform tasks, which were accompanied by severe retinal damage. In the voice-cued fear conditioning test, significant reduction in the percentage of freezing behavior was observed at 60 days after 2-VO lesion. Chronic lesion by 2-VO failed to cause noticeable changes in the grey matter, as indicated by intact hippocampal and prefrontal cortical structures, sustained synaptic protein levels and glial cell numbers. In contrast, aberrant arrangement of myelinated axons was observed in the optic tract, but not in the corpus callosum and inner capsule of 2-VO rats. Concurrently, marked astrocyte proliferation and microglia activation in the optic tract occurred at 3 days after 2-VO lesion, and continued for up to 60 days. Differently, robust glial activation was observed in the corpus callosum at 3 days after 2-VO surgery, and then gradually returned to the baseline level at 14 and 60 days. Our study reported for the first time about the effect of 2-VO on the long-term cognitive impairment in the non-vision dominant fear conditioning test, which may be more applicable than the Morris water maze test for assessing 2-VO associated cognitive function. The time and region specific glial activation in the white matter may relate to retinal impairment, even behavioral deficits, in the setting of chronic cerebral hypoperfusion.	[Tian, Xue Song; Guo, Xian Jun; Ruan, Zhi; Lei, Yun; Chen, Yu Ting; Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China.	hzhang@simm.ac.cn	Ruan, Zhi/P-7829-2016; Chen, Yuting/GSI-9211-2022; ruan, zhi/AAC-5421-2019	Ruan, Zhi/0000-0003-3587-9425; Tian, Xuesong/0000-0001-6162-2856; Lei, Yun/0000-0003-4572-6078	National Natural Science Foundation of China [81173034, 81072646]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China [2012ZX09301001-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China	This work is supported by the National Natural Science Foundation of China (No. 81173034, 81072646); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China (No. 2012ZX09301001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, J NEUROSCI, V33, P3989, DOI 10.1523/JNEUROSCI.1997-12.2013; Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; Bennett SAL, 1998, NEUROREPORT, V9, P161; Bhattacharjee AK, 2012, NEUROCHEM RES, V37, P1490, DOI 10.1007/s11064-012-0740-2; Cai QY, 2011, NEUROSCI LETT, V497, P22, DOI 10.1016/j.neulet.2011.04.013; Cechetti F, 2012, LIFE SCI, V91, P29, DOI 10.1016/j.lfs.2012.05.013; Davidson CM, 2000, BRAIN RES, V859, P96, DOI 10.1016/S0006-8993(00)01937-5; De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Feng ZB, 2012, J ETHNOPHARMACOL, V144, P313, DOI 10.1016/j.jep.2012.09.014; He XL, 2012, EUR J PHARMACOL, V680, P41, DOI 10.1016/j.ejphar.2012.01.025; Henrich-Noack P, 2011, BRAIN RES BULL, V85, P346, DOI 10.1016/j.brainresbull.2011.04.001; Holman MC, 2010, INVEST OPHTH VIS SCI, V51, P2197, DOI 10.1167/iovs.09-4191; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Kim SK, 2008, KOREAN J PHYSIOL PHA, V12, P89, DOI 10.4196/kjpp.2008.12.3.89; Kwak PA, 2012, J CLIN NEUROL, V8, P284, DOI 10.3988/jcn.2012.8.4.284; Lavinsky D, 2006, GRAEF ARCH CLIN EXP, V244, P199, DOI 10.1007/s00417-005-0006-7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murakami Y, 1997, JPN J PHARMACOL, V75, P443, DOI 10.1254/jjp.75.443; NI JW, 1995, BRAIN RES, V673, P290, DOI 10.1016/0006-8993(94)01436-L; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Ohtaki H, 2006, ACTA NEUROCHIR SUPPL, V96, P283; Osawa A, 2004, DISABIL REHABIL, V26, P739, DOI 10.1080/09638280410001704331; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pappas BA, 1996, BRAIN RES, V708, P50, DOI 10.1016/0006-8993(95)01267-2; Paul RH., 2005, VASCULAR DEMENTIA CE; Peng Y, 2007, J PHARMACOL EXP THER, V321, P902, DOI 10.1124/jpet.106.118760; Rathnasamy G, 2014, NEUROPHARMACOLOGY, V77, P428, DOI 10.1016/j.neuropharm.2013.10.024; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Sarti C, 2002, BEHAV BRAIN RES, V136, P13, DOI 10.1016/S0166-4328(02)00090-6; Schmid H, 2014, INVEST OPHTH VIS SCI, V55, P2777, DOI 10.1167/iovs.13-13372; Schmidt-Kastner R, 2005, BRAIN RES, V1052, P28, DOI 10.1016/j.brainres.2005.06.018; Schmidt-Kastner R, 2001, MOL BRAIN RES, V92, P157, DOI 10.1016/S0169-328X(01)00157-7; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Spencer SJ, 2008, STROKE, V39, P975, DOI 10.1161/STROKEAHA.107.497016; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Tian XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069252; Tohda M, 2004, BIOL PHARM BULL, V27, P2021, DOI 10.1248/bpb.27.2021; TSUCHIYA M, 1993, EXP BRAIN RES, V95, P1; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; WAKITA H, 1995, STROKE, V26, P1415, DOI 10.1161/01.STR.26.8.1415; Wang J, 2010, J NEUROSCI RES, V88, P807, DOI 10.1002/jnr.22237; Wang ZF, 2007, FEBS LETT, V581, P596, DOI 10.1016/j.febslet.2007.01.016; Winocur G, 2013, BEHAV BRAIN RES, V252, P144, DOI 10.1016/j.bbr.2013.05.052; Yaldizli O, 2014, MULT SCLER J, V20, P356, DOI 10.1177/1352458513496880; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019	53	8	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101120	10.1371/journal.pone.0101120	http://dx.doi.org/10.1371/journal.pone.0101120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968196	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800111
J	de Araujo, MA; Marques, TEBS; Taniele-Silva, J; Souza, FMD; de Andrade, TG; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Taniele-Silva, Jamile; de Araujo Souza, Fernanda Maria; de Andrade, Tiago Gomes; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Identification of Endogenous Reference Genes for the Analysis of microRNA Expression in the Hippocampus of the Pilocarpine-Induced Model of Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; IMMATURE RAT MODEL; MESSENGER-RNA; RT-PCR; UP-REGULATION; EPILEPTOGENESIS; QUANTIFICATION; NORMALIZATION; BIOGENESIS; SEIZURE	Real-time quantitative RT-PCR (qPCR) is one of the most powerful techniques for analyzing miRNA expression because of its sensitivity and specificity. However, in this type of analysis, a suitable normalizer is required to ensure that gene expression is unaffected by the experimental condition. To the best of our knowledge, there are no reported studies that performed a detailed identification and validation of suitable reference genes for miRNA qPCR during the epileptogenic process. Here, using a pilocarpine (PILO) model of mesial temporal lobe epilepsy (MTLE), we investigated five potential reference genes, performing a stability expression analysis using geNorm and NormFinder softwares. As a validation strategy, we used each one of the candidate reference genes to measure PILO-induced changes in microRNA-146a levels, a gene whose expression pattern variation in the PILO injected model is known. Our results indicated U6SnRNA and SnoRNA as the most stable candidate reference genes. By geNorm analysis, the normalization factor should preferably contain at least two of the best candidate reference genes (snoRNA and U6SnRNA). In fact, when normalized using the best combination of reference genes, microRNA-146a transcripts were found to be significantly increased in chronic stage, which is consistent with the pattern reported in different models. Conversely, when reference genes were individually employed for normalization, we failed to detect up-regulation of the microRNA-146a gene in the hippocampus of epileptic rats. The data presented here support that the combination of snoRNA and U6SnRNA was the minimum necessary for an accurate normalization of gene expression at the different stages of epileptogenesis that we tested.	[de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Taniele-Silva, Jamile; de Araujo Souza, Fernanda Maria; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cell, Maceio, Alagoas, Brazil; [de Andrade, Tiago Gomes] Univ Fed Alagoas, Maceio, Alagoas, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, Sao Paulo, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cellular & Mol Biol, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cell, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	de Araújo, Mykaella Andrade/X-3778-2018; Cairasco, Norberto Garcia/E-3250-2015; de Andrade, Tiago/I-3522-2013; Gitai, Daniel LG/A-7982-2019; Paço-Larson, Maria L/I-8613-2012; De Andrade, Tiago G/I-5572-2015	Cairasco, Norberto Garcia/0000-0001-8857-3775; Gitai, Daniel LG/0000-0001-7056-2373; De Andrade, Tiago G/0000-0003-0948-6329; Araujo, Mykaella/0000-0002-6425-2595; Souza, Fernanda/0000-0002-9514-3092	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo)	This work was supported by the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Elliott RC, 2003, J NEUROSCI, V23, P2218; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lukiw WJ, 2011, J TOXICOL ENV HEAL A, V74, P1460, DOI 10.1080/15287394.2011.618973; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Matos G, 2014, PROG NEURO-PSYCHOPH, V51, P159, DOI 10.1016/j.pnpbp.2014.02.001; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peng J, 2013, J MOL NEUROSCI, V50, P291, DOI 10.1007/s12031-013-9953-3; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	56	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100529	10.1371/journal.pone.0100529	http://dx.doi.org/10.1371/journal.pone.0100529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964029	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500059
J	Schiffer, TA; Ekblom, B; Lundberg, JO; Weitzberg, E; Larsen, FJ				Schiffer, Tomas A.; Ekblom, Bjorn; Lundberg, Jon O.; Weitzberg, Eddie; Larsen, Filip J.			Dynamic regulation of metabolic efficiency explains tolerance to acute hypoxia in humans	FASEB JOURNAL			English	Article						mitochondria; maximum power principle; mitochondrial oxygen affinity; altitude	SKELETAL-MUSCLE MITOCHONDRIA; MAXIMAL OXYGEN-UPTAKE; CYTOCHROME-C-OXIDASE; OXIDATIVE-PHOSPHORYLATION; ENDURANCE PERFORMANCE; CYCLING EFFICIENCY; EXERCISE ECONOMY; CARDIAC-OUTPUT; HIGH-ALTITUDE; SEA-LEVEL	The maximum power principle dictates that open biological systems tend to self-organize to a level of efficiency that allows maximal power production. Applying this principle to cellular energetics and whole-body physiology would suggest that for every metabolic challenge, an optimal efficiency exists that maximizes power production. On exposure to hypoxia, it would be favorable if metabolic efficiency would rapidly adjust so as to better preserve work performance. We tested this idea in humans by measuring metabolic efficiency and exercise tolerance under normoxic (FiO2=20.9%) and hypoxic (FiO2=16%) conditions, where FiO2 is fraction of inhaled oxygen. The results were compared with respirometric analyses of skeletal muscle mitochondria from the same individuals. We found that among healthy trained subjects (n=14) with a wide range of metabolic efficiency (ME), those with a high ME during normoxic exercise were able to better maintain exercise capacity (W-max) in hypoxia. On hypoxic exposure, these subjects acutely decreased their efficiency from 19.2 to 17.4%, thereby likely shifting it closer to a degree of efficiency where maximal power production is achieved. In addition, mitochondria from these subjects had a lower intrinsic respiration compared to subjects that showed a large drop in Wmax in hypoxia An acute shift in efficiency was also demonstrated in isolated mitochondria exposed to physiological levels of hypoxia as P/O ratio increased from 0.9 to 1.3 with hypoxic exposure. These findings suggest the existence of a physiological adaptive response by which metabolic efficiency is dynamically optimized to maximize power production.	[Schiffer, Tomas A.; Lundberg, Jon O.; Weitzberg, Eddie; Larsen, Filip J.] Karolinska Inst, Dept Physiol & Pharmacol, S-11486 Stockholm, Sweden; [Ekblom, Bjorn] Swedish Sch Sports & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden	Karolinska Institutet; Swedish School of Sport & Health Sciences	Larsen, FJ (corresponding author), Karolinska Inst, Nanna Svartz 2, S-11486 Stockholm, Sweden.	filip.larsen@ki.se	Schiffer, Tomas/X-1343-2018	Schiffer, Tomas/0000-0002-9077-2682; Lundberg, Jon/0000-0002-0174-5210				Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Benoit H, 1997, INT J SPORTS MED, V18, P101, DOI 10.1055/s-2007-972603; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; CERRETELLI P, 1992, RESPIRATION, V59, P24; Clerc P, 2007, J BIOENERG BIOMEMBR, V39, P158, DOI 10.1007/s10863-007-9074-1; Curran LS, 1998, AM J PHYS ANTHROPOL, V105, P21, DOI 10.1002/(SICI)1096-8644(199801)105:1<21::AID-AJPA3>3.0.CO;2-G; Fukuda T, 2010, INT HEART J, V51, P170, DOI 10.1536/ihj.51.170; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; HOCHACHKA PW, 1991, J APPL PHYSIOL, V70, P1720, DOI 10.1152/jappl.1991.70.4.1720; HOWALD H, 1990, INT J SPORTS MED, V11, pS10, DOI 10.1055/s-2007-1024847; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Katayama K, 2003, HIGH ALT MED BIOL, V4, P291, DOI 10.1089/152702903769192250; KRAMER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5807, DOI 10.1073/pnas.80.19.5807; Kudin A, 2002, MOL BIOL REP, V29, P89, DOI 10.1023/A:1020374924550; Lador F, 2013, RESP PHYSIOL NEUROBI, V186, P206, DOI 10.1016/j.resp.2013.01.017; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen FJ, 2011, FASEB J, V25, P2843, DOI 10.1096/fj.11-182139; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Latshang TD, 2013, SCAND J MED SCI SPOR, V23, P458, DOI 10.1111/j.1600-0838.2011.01403.x; LAWLER J, 1988, J APPL PHYSIOL, V64, P1486, DOI 10.1152/jappl.1988.64.4.1486; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lundby C, 2002, ACTA PHYSIOL SCAND, V176, P195, DOI 10.1046/j.1365-201X.2002.01030.x; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Mollard P, 2007, EUR J APPL PHYSIOL, V100, P663, DOI 10.1007/s00421-007-0457-0; ODUM HT, 1955, AM SCI, V43, P331; Ponsot E, 2010, AM J PHYSIOL-REG I, V298, pR558, DOI 10.1152/ajpregu.00216.2009; Prieur F, 2005, MED SCI SPORT EXER, V37, P664, DOI 10.1249/01.MSS.0000159140.11938.97; Richardson RS, 2001, J APPL PHYSIOL, V91, P2679, DOI 10.1152/jappl.2001.91.6.2679; Saltin B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P209; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; STUCKI JW, 1980, EUR J BIOCHEM, V109, P269, DOI 10.1111/j.1432-1033.1980.tb04792.x	37	7	7	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4303	4311		10.1096/fj.14-251710	http://dx.doi.org/10.1096/fj.14-251710			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970395				2022-12-25	WOS:000342222700010
J	Michailidis, E; Huber, AD; Ryan, EM; Ong, YT; Leslie, MD; Matzek, KB; Singh, K; Marchand, B; Hagedorn, AN; Kirby, KA; Rohan, LC; Kodama, EN; Mitsuya, H; Parniak, MA; Sarafianos, SG				Michailidis, Eleftherios; Huber, Andrew D.; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.			4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; Enzyme Inhibitor; Human Immunodeficiency Virus (HIV); Nucleoside; Nucleotide Analogue; Reverse Transcription; EFdA; NRTIs; Antivirals; Reverse Transcriptase	HUMAN IMMUNODEFICIENCY VIRUSES; CONNECTION SUBDOMAIN; NUCLEOTIDE ANALOGS; DRUG-RESISTANCE; HEPATITIS-B; IN-VITRO; DNA; TRANSLOCATION; PRIMER; TENOFOVIR	Background: 4-Ethynyl-2-fluoro-2-deoxyadenosine (EFdA) is a highly potent nucleoside analog reverse transcriptase (RT) inhibitor with a 3-OH. Results: EFdA inhibits RT as an immediate or delayed chain terminator depending on the DNA substrate sequence. RT efficiently misincorporates EFdA, producing non-extendable mismatched primers protected from excision. Conclusion: EFdA blocks RT by multiple mechanisms. Significance: Understanding the EFdA inhibition mechanism will help develop better antivirals. 4-Ethynyl-2-fluoro-2-deoxyadenosine (EFdA) is a nucleoside analog that, unlike approved anti-human immunodeficiency virus type 1 (HIV-1) nucleoside reverse transcriptase inhibitors, has a 3-OH and exhibits remarkable potency against wild-type and drug-resistant HIVs. EFdA triphosphate (EFdA-TP) is unique among nucleoside reverse transcriptase inhibitors because it inhibits HIV-1 reverse transcriptase (RT) with multiple mechanisms. (a) EFdA-TP can block RT as a translocation-defective RT inhibitor that dramatically slows DNA synthesis, acting as a de facto immediate chain terminator. Although non-translocated EFdA-MP-terminated primers can be unblocked, they can be efficiently converted back to the EFdA-MP-terminated form. (b) EFdA-TP can function as a delayed chain terminator, allowing incorporation of an additional dNTP before blocking DNA synthesis. In such cases, EFdA-MP-terminated primers are protected from excision. (c) EFdA-MP can be efficiently misincorporated by RT, leading to mismatched primers that are extremely hard to extend and are also protected from excision. The context of template sequence defines the relative contribution of each mechanism and affects the affinity of EFdA-MP for potential incorporation sites, explaining in part the lack of antagonism between EFdA and tenofovir. Changes in the type of nucleotide before EFdA-MP incorporation can alter its mechanism of inhibition from delayed chain terminator to immediate chain terminator. The versatility of EFdA in inhibiting HIV replication by multiple mechanisms may explain why resistance to EFdA is more difficult to emerge.	[Michailidis, Eleftherios; Huber, Andrew D.; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Huber, Andrew D.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Michailidis, Eleftherios; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Kodama, Eiichi N.] Tohoku Univ, Div Emerging Infect Dis, Sendai, Miyagi 9808575, Japan; [Mitsuya, Hiroaki] Kumamoto Univ, Dept Internal Med, Kumamoto 8608556, Japan; [Mitsuya, Hiroaki] NIH, Expt Retrovirol Sect, HIV AIDS Malignancy Branch, Bethesda, MD 20892 USA; [Parniak, Michael A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tohoku University; Kumamoto University; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sarafianos, SG (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Kirby, Karen A./0000-0003-2468-4796; Michailidis, Eleftherios/0000-0002-9907-4346; Ong, Yee Tsuey/0000-0001-9361-2855; Huber, Andrew/0000-0002-3790-8368	National Institutes of Health [R01AI076119, R01AI076119-S1, R01AI076119-02S1, R01AI099284, R01AI100890, R21AI112417, P01GM103368, AI079801]; Mizzou Advantage; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL CANCER INSTITUTE [ZIASC006738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112417, R01AI100890, R01AI076119, R33AI079801, R01AI099284, R21AI079801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI076119, R01AI076119-S1, R01AI076119-02S1, R01AI099284, R01AI100890, R21AI112417, and P01GM103368 (to S. G. S.) and AI079801 (to M. A. P.). This work was also supported by Mizzou Advantage and the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea. Coauthors Drs. Hiroaki Mitsuya and Eiichi N. Kodama are inventors of EFdA, and thus there is a potential conflict of interest.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Bauman JD, 2008, NUCLEIC ACIDS RES, V36, P5083, DOI 10.1093/nar/gkn464; Biaglow JE, 1997, RADIAT RES, V148, P181, DOI 10.2307/3579576; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Gentile I, 2013, CURR MED CHEM, V20, P3733, DOI 10.2174/09298673113209990178; Hachiya A, 2013, ANTIMICROB AGENTS CH, V57, P4554, DOI 10.1128/AAC.00283-13; Hachiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016242; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kageyama M, 2011, ORG LETT, V13, P5264, DOI 10.1021/ol202116k; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kim J, 2012, J MOL BIOL, V415, P866, DOI 10.1016/j.jmb.2011.12.034; Kirby KA, 2013, ANTIMICROB AGENTS CH, V57, P6254, DOI 10.1128/AAC.01703-13; Kirby KA, 2012, ANTIMICROB AGENTS CH, V56, P2048, DOI 10.1128/AAC.06000-11; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lansdon EB, 2010, J MOL BIOL, V397, P967, DOI 10.1016/j.jmb.2010.02.019; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Maeda K, 2014, ANTIVIR THER, V19, P179, DOI 10.3851/IMP2697; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2012, CELL MOL BIOL, V58, P187, DOI 10.1170/T940; Michailidis E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-65; Michailidis E, 2012, INT J BIOCHEM CELL B, V44, P1060, DOI 10.1016/j.biocel.2012.04.006; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Muftuoglu Y, 2014, ANTIVIR RES, V106, P1, DOI 10.1016/j.antiviral.2014.03.001; Murphey-Corb M, 2012, ANTIMICROB AGENTS CH, V56, P4707, DOI 10.1128/AAC.00723-12; Ndongwe TP, 2012, NUCLEIC ACIDS RES, V40, P345, DOI 10.1093/nar/gkr694; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Parniak M A, 2000, Adv Pharmacol, V49, P67; Sarafianos SG, 2004, INT J BIOCHEM CELL B, V36, P1706, DOI 10.1016/j.biocel.2004.02.027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Singh K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398180; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042	49	62	64	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24533	24548		10.1074/jbc.M114.562694	http://dx.doi.org/10.1074/jbc.M114.562694			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24970894	Green Published, hybrid			2022-12-25	WOS:000341505600045
J	Dweck, D; Sanchez-Gonzalez, MA; Chang, AN; Dulce, RA; Badger, CD; Koutnik, AP; Ruiz, EL; Griffin, B; Liang, JS; Kabbaj, M; Fincham, FD; Hare, JM; Overton, M; Pinto, JR				Dweck, David; Sanchez-Gonzalez, Marcos A.; Chang, Audrey N.; Dulce, Raul A.; Badger, Crystal-Dawn; Koutnik, Andrew P.; Ruiz, Edda L.; Griffin, Brittany; Liang, Jingsheng; Kabbaj, Mohamed; Fincham, Frank D.; Hare, Joshua M.; Overton, Michael; Pinto, Jose R.			Long Term Ablation of Protein Kinase A (PKA)-mediated Cardiac Troponin I Phosphorylation Leads to Excitation-Contraction Uncoupling and Diastolic Dysfunction in a Knock-in Mouse Model of Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREQUENCY-DEPENDENT ACCELERATION; CA2+ SENSITIVITY; C PHOSPHORYLATION; HEART-FAILURE; CROSS-BRIDGES; CALCIUM; RELAXATION; MUTATIONS; PHOSPHOLAMBAN; BINDING	The cardiac troponin I (cTnI) R21C (cTnI-R21C) mutation has been linked to hypertrophic cardiomyopathy and renders cTnI incapable of phosphorylation by PKA in vivo. Echocardiographic imaging of homozygous knock-in mice expressing the cTnI-R21C mutation shows that they develop hypertrophy after 12 months of age and have abnormal diastolic function that is characterized by longer filling times and impaired relaxation. Electrocardiographic analyses show that older R21C mice have elevated heart rates and reduced cardiovagal tone. Cardiac myocytes isolated from older R21C mice demonstrate that in the presence of isoproterenol, significant delays in Ca2+ decay and sarcomere relaxation occur that are not present at 6 months of age. Although isoproterenol and stepwise increases in stimulation frequency accelerate Ca2+-transient and sarcomere shortening kinetics in R21C myocytes from older mice, they are unable to attain the corresponding WT values. When R21C myocytes from older mice are treated with isoproterenol, evidence of excitation-contraction uncoupling is indicated by an elevation in diastolic calcium that is frequency-dissociated and not coupled to shorter diastolic sarcomere lengths. Myocytes from older mice have smaller Ca2+ transient amplitudes (2.3-fold) that are associated with reductions (2.9-fold) in sarcoplasmic reticulum Ca2+ content. This abnormal Ca2+ handling within the cell may be attributed to a reduction (2.4-fold) in calsequestrin expression in conjunction with an up-regulation (1.5-fold) of Na+-Ca2+ exchanger. Incubation of permeabilized cardiac fibers from R21C mice with PKA confirmed that the mutation prevents facilitation of mechanical relaxation. Altogether, these results indicate that the inability to enhance myofilament relaxation through cTnI phosphorylation predisposes the heart to abnormal diastolic function, reduced accessibility of cardiac reserves, dysautonomia, and hypertrophy.	[Dweck, David; Sanchez-Gonzalez, Marcos A.; Badger, Crystal-Dawn; Koutnik, Andrew P.; Ruiz, Edda L.; Griffin, Brittany; Kabbaj, Mohamed; Overton, Michael; Pinto, Jose R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Sanchez-Gonzalez, Marcos A.; Fincham, Frank D.] Florida State Univ, Family Inst, Tallahassee, FL 32306 USA; [Chang, Audrey N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Dulce, Raul A.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Liang, Jingsheng] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Miami; University of Miami	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 W Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	Fincham, Frank/A-2357-2008; Pinto, Jose Renato/H-2631-2017; Kabbaj, Mohamed/M-9240-2016; Koutnik, Andrew/U-5194-2017	Fincham, Frank/0000-0001-5081-2283; Pinto, Jose Renato/0000-0001-9092-4976; Koutnik, Andrew/0000-0002-5491-3919	National Institutes of Health, NHLBI [HL103840, 5R01 HL094849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103840, R00HL103840, R01HL094849] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL103840 (to J. R. P.) and 5R01 HL094849 (to J. M. H.).	Alves ML, 2010, J MOL CELL CARDIOL, V48, P834, DOI 10.1016/j.yjmcc.2010.01.003; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Baker AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC85, DOI 10.1152/ajpcell.1997.273.1.C85; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Bers Donald M., 2002, Basic Research in Cardiology, V97; Camm AJ, 1996, CIRCULATION, V93, P1043; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; de Tombe PP, 1998, CARDIOVASC RES, V37, P367, DOI 10.1016/S0008-6363(97)00275-7; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Dulce RA, 2013, J BIOL CHEM, V288, P6522, DOI 10.1074/jbc.M112.412130; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTH K, 1987, J BIOL CHEM, V262, P13627; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Jimenez J, 2011, AM J PHYSIOL-HEART C, V300, pH627, DOI 10.1152/ajpheart.00247.2010; Katarzynska-Szymanska A, 2013, BRIT J CLIN PHARMACO, V75, P1516, DOI 10.1111/bcp.12027; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Neumann J, 2002, BASIC RES CARDIOL, V97, P1; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Reis S, 2008, PFLUG ARCH EUR J PHY, V457, P17, DOI 10.1007/s00424-008-0487-4; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Schotten U, 2000, AM J PHYSIOL-HEART C, V278, pH2076, DOI 10.1152/ajpheart.2000.278.6.H2076; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Simnett SJ, 1998, AM J PHYSIOL-HEART C, V275, pH951, DOI 10.1152/ajpheart.1998.275.3.H951; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2010, J MOL CELL CARDIOL, V48, P810, DOI 10.1016/j.yjmcc.2010.02.014; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; STEIN RB, 1988, BIOPHYS J, V54, P705, DOI 10.1016/S0006-3495(88)83006-6; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Syed F, 2005, J AM SOC ECHOCARDIOG, V18, P982, DOI 10.1016/j.echo.2005.05.001; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Varian KD, 2007, AM J PHYSIOL-HEART C, V292, pH2212, DOI 10.1152/ajpheart.00778.2006; Varian KD, 2009, CIRC-HEART FAIL, V2, P472, DOI 10.1161/CIRCHEARTFAILURE.109.853200; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhou YQ, 2003, AM J PHYSIOL-HEART C, V285, pH1563, DOI 10.1152/ajpheart.00384.2003; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	78	22	23	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23097	23111		10.1074/jbc.M114.561472	http://dx.doi.org/10.1074/jbc.M114.561472			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973218	Green Published, hybrid			2022-12-25	WOS:000341017200047
J	Garikipati, VNS; Jadhav, S; Pal, L; Prakash, P; Dikshit, M; Nityanand, S				Garikipati, Venkata Naga Srikanth; Jadhav, Sachin; Pal, Lily; Prakash, Prem; Dikshit, Madhu; Nityanand, Soniya			Mesenchymal Stem Cells from Fetal Heart Attenuate Myocardial Injury after Infarction: An In Vivo Serial Pinhole Gated SPECT-CT Study in Rats	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CARDIAC PROGENITOR CELLS; BONE-MARROW-CELLS; ISCHEMIC CARDIOMYOPATHY; MODEL; TRANSPLANTATION; DIFFERENTIATE; INJECTION; PERFUSION; THERAPY	Mesenchymal stem cells (MSC) have emerged as a potential stem cell type for cardiac regeneration after myocardial infarction (MI). Recently, we isolated and characterized mesenchymal stem cells derived from rat fetal heart (fC-MSC), which exhibited potential to differentiate into cardiomyocytes, endothelial cells and smooth muscle cells in vitro. In the present study, we investigated the therapeutic efficacy of intravenously injected fC-MSC in a rat model of MI using multi-pinhole gated SPECT-CT system. fC-MSC were isolated from the hearts of Sprague Dawley (SD) rat fetuses at gestation day 16 and expanded ex vivo. One week after induction of MI, 2610 6 fC-MSC labeled with PKH26 dye (n = 6) or saline alone (n = 6) were injected through the tail vein of the rats. Initial in vivo tracking of 99mTc-labeled fC-MSC revealed a focal uptake of cells in the anterior mid-ventricular region of the heart. At 4 weeks of fC-MSC administration, the cells labeled with PKH26 were located in abundance in infarct/peri-infarct region and the fC-MSC treated hearts showed a significant increase in left ventricular ejection fraction and a significant decrease in the end diastolic volume, end systolic volume and left ventricular myo-mass in comparison to the saline treated group. In addition, fC-MSC treated hearts had a significantly better myocardial perfusion and attenuation in the infarct size, in comparison to the saline treated hearts. The engrafted PKH26-fC-MSC expressed cardiac troponin T, endothelial CD31 and smooth muscle sm-MHC, suggesting their differentiation into all major cells of cardiovascular lineage. The fC-MSC treated hearts demonstrated an up-regulation of cardio-protective growth factors, anti-fibrotic and anti-apoptotic molecules, highlighting that the observed left ventricular functional recovery may be due to secretion of paracrine factors by fC-MSC. Taken together, our results suggest that fC-MSC therapy may be a new therapeutic strategy for MI and multi-pinhole gated SPECT-CT system may be a useful tool to evaluate cardiac perfusion, function and cell tracking after stem cell therapy in acute myocardial injury setting.	[Garikipati, Venkata Naga Srikanth; Jadhav, Sachin; Nityanand, Soniya] Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India; [Pal, Lily] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow, Uttar Pradesh, India; [Prakash, Prem; Dikshit, Madhu] Cent Drug Res Inst, Div Pharmacol, Cardiovasc Unit, Lucknow 226001, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nityanand, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India.	soniya@sgpgi.ac.in	Prakash, Prem/AAI-1672-2020	Prakash, Prem/0000-0001-9501-0065; Jadhav, S H/0000-0002-4752-4202	Department of Biotechnology, Government of India [BT/PR6519/MED/14/826/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extramural grant sanctioned by Department of Biotechnology, Government of India, to Dr. S. Nityanand (BT/PR6519/MED/14/826/2005). http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eisen HJ, 2008, NAT CLIN PRACT CARD, V5, P520, DOI 10.1038/ncpcardio1299; Fehlberg S, 2003, BRIT J PHARMACOL, V139, P495, DOI 10.1038/sj.bjp.0705275; Garikipati Venkata Naga Srikanth NKT, 2012, INT J REGENERATIVE M, V1, P1; Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Morrison AR, 2009, CARDIOL CLIN, V27, P329, DOI 10.1016/j.ccl.2008.12.008; Oskouei BN, 2012, STEM CELL TRANSL MED, V1, P116, DOI 10.5966/sctm.2011-0015; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Ramkisoensing AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024164; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Srikanth GVN, 2009, J STEM CELLS REGEN, V5, P30; Srikanth Garikipati Venkata Naga, 2013, World J Stem Cells, V5, P26, DOI 10.4252/wjsc.v5.i1.26; Tang XL, 2010, CIRC J, V74, P390, DOI 10.1253/circj.CJ-09-0923; Tran N, 2006, CELL TRANSPLANT, V15, P351, DOI 10.3727/000000006783981918; Tsui BMW, 2009, J NUCL MED, V50, P667, DOI 10.2967/jnumed.108.058479; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Wu JC, 2010, J NUCL MED, V51, p128S, DOI 10.2967/jnumed.109.068239; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100982	10.1371/journal.pone.0100982	http://dx.doi.org/10.1371/journal.pone.0100982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971627	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200080
J	Lee, JJ; Lin, MY; Chang, JS; Hung, CC; Chang, JM; Chen, HC; Yu, ML; Hwang, SJ				Lee, Jia-Jung; Lin, Ming-Yen; Chang, Jung-San; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Yu, Ming-Lung; Hwang, Shang-Jyh			Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; ASSOCIATION; POPULATION; SURVIVAL; DEATH; REPLACEMENT; PREVALENCE; MORTALITY; OUTCOMES	Background: Chronic kidney disease (CKD) and hepatitis C virus (HCV) infection are closely linked and both increase patient mortality. The association of HCV and risk of developing end-stage renal disease (ESRD) has not been analyzed with competing risk model. Method: We enrolled a prospective cohort of 4,185 patients (mean age, 62 years; 41% female) registered in the CKD integrated care program at two affiliated hospitals of Kaohsiung Medical University in Taiwan between November 11, 2002 and May 31, 2009. With competing risk model, we analyzed the association of HCV infection, defined by seropositive of anti-HCV antibody, and hepatitis B virus (HBV) infection, defined by seropositive of HBV surface antigen, with the risk of entering ESRD. Results: The prevalence of HCV infection was 7.6% and it increased with the CKD stages (trend test, P < 0.001), while the prevalence of HBV infection was 7.4% and no specific trend among CKD stages (tend test, P = 0.1). During the 9,101 person-year follow-up period, there were 446 death and 1,205 patients entering ESRD. After adjusting death as the competing risk, the estimated 5-year cumulative incidence rate of ESRD among patients with and without HCV infection were 52.6% and 38.4%, respectively (modified log-rank, P < 0.001). Multivariable analysis showed that HCV infection, but not HBV infection, had higher risk of developing ESRD compared with cases without infection (HCV, HR: 1.32, 95% CI: 1.07-1.62; HBV, HR: 1.10, 95% CI: 0.89-1.35). Subgroup analyses showed consistent results. Conclusions: With death-adjusted competing risk analysis, HCV infection is associated with an increased risk of developing ESRD in CKD cohort.	[Lee, Jia-Jung; Lin, Ming-Yen; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chang, Jung-San] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Lee, Jia-Jung; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Yu, Ming-Lung; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Lee, Jia-Jung; Chang, Jung-San; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Lin, Ming-Yen] Instrument Technol Res Ctr, Natl Appl Res Labs, Hsinchu, Taiwan; [Chang, Jer-Ming] Kaohsiung Med Univ, Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Applied Research Laboratories - Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Lee, Jia-Jung/0000-0002-7951-9571	National Science Council of Taiwan, R.O.C. [NSC: 99-2314-B-037-003-MY3, NSC 102-3114-Y-492-076-023]; Kaohsiung Medical University Hospital [1R09]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	The authors are grateful for the research support from the National Science Council of Taiwan, R.O.C. under grant number NSC: 99-2314-B-037-003-MY3, NSC 102-3114-Y-492-076-023, and from Kaohsiung Medical University Hospital under grant number 1R09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205; Chen YC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-187; Chuang WL, 2013, J GASTROENTEROL, V48, P22, DOI 10.1007/s00535-012-0669-x; Conway B, 2009, NEPHROL DIAL TRANSPL, V24, P1930, DOI 10.1093/ndt/gfn772; Crook ED, 2005, DIABETES CARE, V28, P2187, DOI 10.2337/diacare.28.9.2187; Dai CY, 2015, J GASTROEN HEPATOL, V30, P879, DOI 10.1111/jgh.12313; Dalrymple LS, 2011, J GEN INTERN MED, V26, P379, DOI 10.1007/s11606-010-1511-x; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; Fabrizi F, 2013, AM J KIDNEY DIS, V61, P623, DOI 10.1053/j.ajkd.2012.08.040; Fabrizi F, 2012, CLIN J AM SOC NEPHRO, V7, P549, DOI 10.2215/CJN.06920711; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2012, CLIN J AM SOC NEPHRO, V7, P1606, DOI 10.2215/CJN.03460412; Gray B, 2013, CMPRSK SUBDISTRIBUTI; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Satapathy SK, 2012, HEPATOL INT, V6, P369, DOI 10.1007/s12072-011-9284-9; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Su FH, 2012, AM J KIDNEY DIS, V60, P553, DOI 10.1053/j.ajkd.2012.04.003; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Yang JF, 2011, KAOHSIUNG J MED SCI, V27, P258, DOI 10.1016/j.kjms.2010.11.007; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023; Yu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052048; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	38	93	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100790	10.1371/journal.pone.0100790	http://dx.doi.org/10.1371/journal.pone.0100790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971499	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200063
J	Paquette, MA; Atlas, E; Wade, MG; Yauk, CL				Paquette, Martin A.; Atlas, Ella; Wade, Mike G.; Yauk, Carole L.			Thyroid Hormone Response Element Half-Site Organization and Its Effect on Thyroid Hormone Mediated Transcription	PLOS ONE			English	Article							X-RECEPTOR RXR; RETINOIC ACID; ENVIRONMENTAL CHEMICALS; GENE; HETERODIMER; EXPRESSION; PROMOTER; DEFICIENCY; INDUCTION; PARTNER	Thyroid hormone (TH) exerts its effects by binding to the thyroid hormone receptor (TR), which binds to TH response elements (TREs) to regulate target gene expression. We investigated the relative ability of liganded homodimers TR and retinoid X receptor (RXR), and the heterodimer TR/RXR, to regulate gene expression for the TRE half-site organizations: direct repeat 4 (DR4), inverted repeat 0 (IR0) and everted repeat 6 (ER6). Luciferase reporter assays using a DR4 TRE suggest that both the TR homodimer and TR/RXR heterodimer regulate luciferase expression in the presence of their respective ligands. However, in the presence of the IR0 TRE, transfection with TR/RXR and RXR alone increased luciferase activity and there was no effect of TR alone. The presence of 9-cis-retinoic acid was necessary for luciferase expression, whereas TH treatment alone was insufficient. For the ER6 TRE, transfection with TR/RXR, TR alone and RXR alone (in the presence of their respective ligands) all caused a significant increase in luciferase activity. When both ligands were present, transfection with both TR/RXR caused more activation. Finally, we investigated the efficacy of the TR-antagonist 1-850 in inhibiting transcription by TR or TR/RXR at DR4 and ER6 TREs. We found that 1-850 did not suppress luciferase activation in the presence of TR/RXR for the ER6 TRE, suggesting conformational changes of the ligand binding domain of the TR when bound to different TRE half-site organizations. Collectively, the findings indicate that there are fundamental differences between TRE configurations that affect nuclear receptor interactions with the response element and ability to bind ligands and antagonists.	[Paquette, Martin A.; Atlas, Ella; Wade, Mike G.; Yauk, Carole L.] Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Paquette, Martin A.; Yauk, Carole L.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Health Canada; Carleton University	Yauk, CL (corresponding author), Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	carole.yauk@hc-sc.gc.ca		Yauk, Carole/0000-0003-4919-876X; Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454	Health Canada Genomics RD Initiative; Canadian Regulatory System for Biotechnology	Health Canada Genomics RD Initiative; Canadian Regulatory System for Biotechnology	This work was funded by the Health Canada Genomics R&D Initiative and the Canadian Regulatory System for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; Bansal R, 2008, ENDOCRINOLOGY, V149, P4001, DOI 10.1210/en.2007-1774; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CARR FE, 1994, J BIOL CHEM, V269, P4175; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chin S, 1998, ENDOCRINOLOGY, V139, P3423, DOI 10.1210/en.139.8.3423; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720; Farsetti A, 1997, ENDOCRINOLOGY, V138, P4705, DOI 10.1210/en.138.11.4705; Giera S, 2011, ENDOCRINOLOGY, V152, P2909, DOI 10.1210/en.2010-1490; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Harbers M, 1996, NUCLEIC ACIDS RES, V24, P2252, DOI 10.1093/nar/24.12.2252; Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006; Lee CH, 1999, BIOCHEMISTRY-US, V38, P8820, DOI 10.1021/bi9903547; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li DS, 2004, J BIOL CHEM, V279, P7427, DOI 10.1074/jbc.M311596200; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zoeller TR, 2010, HORM-INT J ENDOCRINO, V9, P28, DOI 10.14310/horm.2002.1250	31	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101155	10.1371/journal.pone.0101155	http://dx.doi.org/10.1371/journal.pone.0101155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971931	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200099
J	Yang, YM; Wang, QS; Chen, Q; Liao, RR; Zhang, XZ; Yang, HJ; Zheng, YM; Zhang, ZW; Pan, YC				Yang, Yumei; Wang, Qishan; Chen, Qiang; Liao, Rongrong; Zhang, Xiangzhe; Yang, Hongjie; Zheng, Youmin; Zhang, Zhiwu; Pan, Yuchun			A New Genotype Imputation Method with Tolerance to High Missing Rate and Rare Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; HERITABILITY; GENE; SNPS; INFERENCE; SELECTION; ACCURACY; CATTLE; PHASE	We report a novel algorithm, iBLUP, to impute missing genotypes by simultaneously and comprehensively using identity by descent and linkage disequilibrium information. The simulation studies showed that the algorithm exhibited drastically tolerance to high missing rate, especially for rare variants than other common imputation methods, e. g. BEAGLE and fastPHASE. At a missing rate of 70%, the accuracy of BEAGLE and fastPHASE dropped to 0.82 and 0.74 respectively while iBLUP retained an accuracy of 0.95. For minor allele, the accuracy of BEAGLE and fastPHASE decreased to -0.1 and 0.03, while iBLUP still had an accuracy of 0.61. We implemented the algorithm in a publicly available software package also named iBLUP. The application of iBLUP for processing real sequencing data in an outbred pig population was demonstrated.	[Yang, Yumei; Wang, Qishan; Chen, Qiang; Liao, Rongrong; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yang, Hongjie; Zheng, Youmin] Natl Anim Husb Serv, Beijing, Peoples R China; [Zhang, Zhiwu] Cornell Univ, Inst Genom Div, Ithaca, NY 14850 USA; [Pan, Yuchun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Zhang, Zhiwu] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Shanghai Jiao Tong University; Cornell University; Washington State University	Zhang, ZW (corresponding author), Cornell Univ, Inst Genom Div, Ithaca, NY 14850 USA.	zhiwu.zhang@wsu.edu; panyc@sjtu.edu.cn	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Zhang, Zhiwu/0000-0002-5784-9684	Ministry of Agriculture of China; National Natural Science Foundation of China [31370043, 31272414, 31101706]; National 948 Project of China [2012-Z26, 2011-G2A]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project of China	This study was supported by the 2011-2012 animal germplasm resources conservation project from Ministry of Agriculture of China, the National Natural Science Foundation of China (grant no 31370043, 31272414, 31101706), and the National 948 Project of China (2012-Z26, 2011-G2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen Q, 2013, PLOS ONE; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; Elsen Jean-Michel, 2012, BMC Proc, V6 Suppl 2, pS1, DOI 10.1186/1753-6561-6-S2-S1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gengler N, 2007, ANIMAL, V1, P21, DOI 10.1017/S1751731107392628; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mulder HA, 2010, ANIMAL, V4, P9, DOI 10.1017/S1751731109990838; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Vingborg RKK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-134; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xu SZ, 2013, GENETICS, V195, P1209, DOI 10.1534/genetics.113.157032; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	36	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101025	10.1371/journal.pone.0101025	http://dx.doi.org/10.1371/journal.pone.0101025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972110	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200085
J	Duquette, JF; Belant, JL; Svoboda, NJ; Beyer, DE; Lederle, PE				Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.; Beyer, Dean E., Jr.; Lederle, Patrick E.			Effects of Maternal Nutrition, Resource Use and Multi-Predator Risk on Neonatal White-Tailed Deer Survival	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; ELK CALF SURVIVAL; HABITAT SELECTION; ANTIPREDATOR RESPONSE; POPULATION-DYNAMICS; TEMPORAL VARIATION; FAWN SURVIVAL; CANIS-LUPUS; WOLVES; WOLF	Growth of ungulate populations is typically most sensitive to survival of neonates, which in turn is influenced by maternal nutritional condition and trade-offs in resource selection and avoidance of predators. We assessed whether resource use, multi-predator risk, maternal nutritional effects, hiding cover, or interactions among these variables best explained variation in daily survival of free-ranging neonatal white-tailed deer (Odocoileus virginianus) during their post-partum period (14 May-31 Aug) in Michigan, USA. We used Cox proportional hazards mixed-effects models to assess survival related to covariates of resource use, composite predation risk of 4 mammalian predators, fawn body mass at birth, winter weather, and vegetation growth phenology. Predation, particularly from coyotes (Canis latrans), was the leading cause of mortality; however, an additive model of non-ideal resource use and maternal nutritional effects explained 71% of the variation in survival. This relationship suggested that dams selected areas where fawns had poor resources, while greater predation in these areas led to additive mortalities beyond those related to resource use alone. Also, maternal nutritional effects suggested that severe winters resulted in dams producing smaller fawns, which decreased their likelihood of survival. Fawn resource use appeared to reflect dam avoidance of lowland forests with poor forage and greater use by wolves (C. lupus), their primary predator. While this strategy led to greater fawn mortality, particularly by coyotes, it likely promoted the life-long reproductive success of dams because many reached late-age (>10 years old) and could have produced multiple generations of fawns. Studies often link resource selection and survival of ungulates, but our results suggested that multiple factors can mediate that relationship, including multi-predator risk. We emphasize the importance of identifying interactions among biological and environmental factors when assessing survival of ungulates.	[Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA; [Lederle, Patrick E.] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA	Mississippi State University	Duquette, JF (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	jduquette@cfr.msstate.edu	Belant, Jerrold/HDM-7749-2022		Michigan Department of Natural Resources [W-147-R]; Safari Club International; Safari Club International Michigan Involvement Committee	Michigan Department of Natural Resources; Safari Club International; Safari Club International Michigan Involvement Committee	This study was funded by the Michigan Department of Natural Resources through the Federal Aid in Wildlife Restoration Act under Pittman-Robertson project W-147-R, Safari Club International, and Safari Club International Michigan Involvement Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Atwood TC, 2007, J WILDLIFE MANAGE, V71, P1098, DOI 10.2193/2006-102; Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beauchamp G, 2011, AM NAT, V177, P143, DOI 10.1086/657437; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; BERGERUD AT, 1987, CAN J ZOOL, V65, P1597, DOI 10.1139/z87-249; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; DeCesare NJ, 2014, J ANIM ECOL, V83, P343, DOI 10.1111/1365-2656.12144; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Demma DJ, 2009, CAN FIELD NAT, V123, P299, DOI 10.22621/cfn.v123i4.997; Duquette JF, 2012, WILDLIFE SOC B, V36, P115, DOI 10.1002/wsb.115; Duquette JF, 2014, POPUL ECOL, V56, P481, DOI 10.1007/s10144-014-0432-7; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Environmental Systems Research Institute Inc, 2010, ARCGIS 10 0; Farmer CJ, 2006, J WILDLIFE MANAGE, V70, P1403, DOI 10.2193/0022-541X(2006)70[1403:RFAMOB]2.0.CO;2; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Fox J., 2002, R S PLUS COMPANION A; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frid A, 2002, CONSERV ECOL, V6; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grovenburg TW, 2012, ANIM BEHAV, V84, P59, DOI 10.1016/j.anbehav.2012.04.005; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Jackson AM, 2011, THESIS AUBURN U AUBU; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Kjellander P, 2004, P ROY SOC LOND B BIO, V271, P338; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lomas LA, 2007, J WILDLIFE MANAGE, V71, P884, DOI 10.2193/2006-203; Manly B.F.J., 2002, RESOURCE SELECTION A; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nelson ME, 1981, WILDLIFE MONOGR, V77, P3; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P281, DOI 10.2307/3808640; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P1, DOI 10.2307/3808402; Panzacchi M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1267, DOI 10.1007/s00265-010-0941-0; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Petroelje TR, 2013, WILDLIFE BIOL, V19, P41, DOI 10.2981/12-022; Pettorelli N, 2005, J ANIM ECOL, V74, P972, DOI 10.1111/j.1365-2656.2005.00988.x; Pierce BM, 2004, J WILDLIFE MANAGE, V68, P533, DOI 10.2193/0022-541X(2004)068[0533:HSBMDF]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; Relyea Rick A., 2005, P189; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Sams MG, 1996, J MAMMAL, V77, P179, DOI 10.2307/1382719; Sih Andrew, 2005, P240; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sirot E, 2010, ANIM BEHAV, V80, P737, DOI 10.1016/j.anbehav.2010.07.014; Sivertsen TR, 2012, EUR J WILDLIFE RES, V58, P863, DOI 10.1007/s10344-012-0626-2; Stricker HK, 2012, WILDLIFE SOC B, V36, P257, DOI 10.1002/wsb.137; SUTHERLAND WJ, 1983, J ANIM ECOL, V52, P821, DOI 10.2307/4456; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Therrien JF, 2008, ANIM BEHAV, V75, P235, DOI 10.1016/j.anbehav.2007.04.030; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Tollefson TN, 2011, J WILDLIFE MANAGE, V75, P919, DOI 10.1002/jwmg.113; United State Geological Survey, 2013, 250 M MODIS NORM DIF; van Beest FM, 2013, OECOLOGIA, V173, P409, DOI 10.1007/s00442-013-2647-2; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; VERME LJ, 1977, J WILDLIFE MANAGE, V41, P700, DOI 10.2307/3799992; VERME LJ, 1985, J WILDLIFE MANAGE, V49, P962, DOI 10.2307/3801379; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; White CG, 2010, J WILDLIFE MANAGE, V74, P355, DOI 10.2193/2007-506; WHITE M, 1973, J MAMMAL, V54, P291, DOI 10.2307/1378900; Zar JH, 1999, BIOSTATISTICAL ANAL	92	24	24	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100841	10.1371/journal.pone.0100841	http://dx.doi.org/10.1371/journal.pone.0100841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968318	gold, Green Submitted, Green Published			2022-12-25	WOS:000338280800073
J	Espinosa, F; Garrido, I; Ortega, A; Casimiro, I; Alvarez-Tinaut, MC				Espinosa, Francisco; Garrido, Inmaculada; Ortega, Alfonso; Casimiro, Ilda; Carmen Alvarez-Tinaut, Ma			Redox Activities and ROS, NO and Phenylpropanoids Production by Axenically Cultured Intact Olive Seedling Roots after Interaction with a Mycorrhizal or a Pathogenic Fungus	PLOS ONE			English	Article							NITRIC-OXIDE ACCUMULATION; ARBUSCULAR MYCORRHIZA; PLANT DEFENSE; VERTICILLIUM-DAHLIAE; GLOMUS-INTRARADICES; HYDROGEN-PEROXIDE; OXIDATIVE BURST; JASMONATE; RESPONSES; CELL	Roots of intact olive seedlings, axenically cultured, were alternatively placed in contact with Rhizophagus irregularis (mycorrhizal) or Verticillim dahliae (pathogenic) fungi. MeJA treatments were also included. In vivo redox activities in the apoplast of the intact roots (anion superoxide generation, superoxide dismutase and peroxidase activities) were measured. All our results showed that apoplastic redox activities of intact seedling roots in contact with the compatible mycorrhizal fungus were clearly attenuated in comparison with the pathogenic fungus or treated with MeJA, even at the early stages of treatment used. Total phenolics, flavonoids and phenylpropanoid glycosides were also quantified. Roots in contact with the mycorrhizal fungus did not enhance the biosynthesis of phenolic compounds with respect to controls, while those in contact with the pathogenic one significantly enhanced the biosynthesis of all phenolic fractions measured. Reactive oxygen species and nitric oxid accumulation in roots were examined by fluorescence microscopy. All of them presented much higher accumulation in roots in contact with the pathogenic than with the mycorrhizal fungus. Altogether these results indicate that intact olive seedling roots clearly differentiated between mycorrhizal and pathogenic fungi, attenuating defense reactions against the first to facilitate its establishment, while inducing a strong and sustained defense reaction against the second. Both reactive oxygen and nitrogen species seemed to be involved in these responses from the first moments of contact. However, further investigations are required to clarify the proposed crosstalk between them and their respective roles in these responses since fluorescence images of roots revealed that reactive oxygen species were mainly accumulated in the apoplast (congruently with the measured redox activities in this compartment) while nitric oxid was mainly stored in the cytosol.	[Espinosa, Francisco; Garrido, Inmaculada; Ortega, Alfonso; Carmen Alvarez-Tinaut, Ma] Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain; [Casimiro, Ilda] Univ Extremadura, Dept Anat Biol Celular & Zool, Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Ave Elvas S-N, Badajoz, Spain.	espinosa@unex.es	Casimiro, Ilda/R-3506-2019; Espinosa, Francisco/I-8205-2018	Espinosa, Francisco/0000-0002-6467-0359; GARRIDO CARBALLO, INMACULADA/0000-0002-2367-0985	Ministerio de Ciencia e Innovacion, Spain [CGL2009-12406]; regional government of Extremadura [PRI09A023]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional government of Extremadura	This research was supported by the Ministerio de Ciencia e Innovacion, Spain (grant number CGL2009-12406) and the regional government of Extremadura (PRI09A023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Apel K, 2004, ANNU REV PLANT BIOL, V109, P1247; Baptista P, 2007, MYCORRHIZA, V17, P185, DOI 10.1007/s00572-006-0091-4; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Blilou I, 2000, J EXP BOT, V51, P1969, DOI 10.1093/jexbot/51.353.1969; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bolwell PP, 2001, PROTOPLASMA, V217, P20, DOI 10.1007/BF01289409; Calcagno C, 2012, MYCORRHIZA, V22, P259, DOI 10.1007/s00572-011-0400-4; CANAS LA, 1987, PLANT SCI, V50, P85, DOI 10.1016/0168-9452(87)90034-3; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Correa-Aragunde N, 2008, NEW PHYTOL, V179, P386, DOI 10.1111/j.1469-8137.2008.02466.x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dotan Y, 2004, PROG LIPID RES, V43, P200, DOI 10.1016/j.plipres.2003.10.001; Dumas-Gaudot E, 2000, ARBUSCULAR MYCORRHIZ, P173; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Estaun V, 2003, J AM SOC HORTIC SCI, V128, P767, DOI 10.21273/JASHS.128.5.0767; Fester T, 2005, MYCORRHIZA, V15, P373, DOI 10.1007/s00572-005-0363-4; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Garcia-Garrido JM, 2002, J EXP BOT, V53, P1377, DOI 10.1093/jexbot/53.373.1377; Garrido I, 2012, PLANT GROWTH REGUL, V68, P203, DOI 10.1007/s10725-012-9708-0; Garrido I, 2003, PROTOPLASMA, V221, P79, DOI 10.1007/s00709-002-0073-0; Garrido I, 2009, PROTOPLASMA, V237, P27, DOI 10.1007/s00709-009-0069-0; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gianinazzi-Pearson V, 2008, ADV BOT RES, V46, P181, DOI DOI 10.1016/S0065-2296(07)46005-0; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hause B, 2005, PLANTA, V221, P184, DOI 10.1007/s00425-004-1436-x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Jimenez-Diaz RM, 1998, COMPENDIUM VERTICILL, P13; Kapulnik Y, 1996, NEW PHYTOL, V133, P59, DOI 10.1111/j.1469-8137.1996.tb04341.x; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lambais MR, 2003, NEW PHYTOL, V160, P421, DOI 10.1046/j.1469-8137.2003.00881.x; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MISRA HP, 1972, J BIOL CHEM, V247, P188; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; NGO TT, 1980, ANAL BIOCHEM, V105, P389, DOI 10.1016/0003-2697(80)90475-3; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Peipp H, 1997, PHYTOCHEMISTRY, V44, P581, DOI 10.1016/S0031-9422(96)00561-4; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Ruiz-Lozano JM, 2001, J EXP BOT, V52, P2241, DOI 10.1093/jexbot/52.364.2241; Salzer P, 1999, PLANTA, V208, P319, DOI 10.1007/s004250050565; Samalova M, 2013, NEW PHYTOL, V197, P207, DOI 10.1111/j.1469-8137.2012.04368.x; Scheler C, 2013, CURR OPIN PLANT BIOL, V16, P534, DOI 10.1016/j.pbi.2013.06.020; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Siciliano V, 2007, PLANT PHYSIOL, V144, P1455, DOI 10.1104/pp.107.097980; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SPANU P, 1989, PLANTA, V177, P447, DOI 10.1007/BF00392612; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; STASWICK PE, 1992, PLANT PHYSIOL, V99, P804, DOI 10.1104/pp.99.3.804; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TSAI SM, 1991, APPL ENVIRON MICROB, V57, P1485, DOI 10.1128/AEM.57.5.1485-1488.1991; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Vierheilig H, 2002, ADV EXP MED BIOL, V505, P23; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wrzaczek M, 2013, CURR OPIN PLANT BIOL, V16, P575, DOI 10.1016/j.pbi.2013.07.002; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	66	31	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100132	10.1371/journal.pone.0100132	http://dx.doi.org/10.1371/journal.pone.0100132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967716	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800026
J	Qin, HX; Ma, J; Wang, CN; Wu, Y				Qin, Huixin; Ma, Jun; Wang, Chunni; Wu, Ying			Autapse-Induced Spiral Wave in Network of Neurons under Noise	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCES; SMALL-WORLD NETWORKS; SYNAPTIC-TRANSMISSION; TRANSITION; EMERGENCE; DYNAMICS; PHASE; MODEL	Autapse plays an important role in regulating the electric activity of neuron by feedbacking time-delayed current on the membrane of neuron. Autapses are considered in a local area of regular network of neurons to investigate the development of spatiotemporal pattern, and emergence of spiral wave is observed while it fails to grow up and occupy the network completely. It is found that spiral wave can be induced to occupy more area in the network under optimized noise on the network with periodical or no-flux boundary condition being used. The developed spiral wave with self-sustained property can regulate the collective behaviors of neurons as a pacemaker. To detect the collective behaviors, a statistical factor of synchronization is calculated to investigate the emergence of ordered state in the network. The network keeps ordered state when self-sustained spiral wave is formed under noise and autapse in local area of network, and it independent of the selection of periodical or no-flux boundary condition. The developed stable spiral wave could be helpful for memory due to the distinct self-sustained property.	[Qin, Huixin; Ma, Jun; Wang, Chunni] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China; [Wu, Ying] Xi An Jiao Tong Univ, Sch Aerosp, Xian 710049, Peoples R China	Lanzhou University of Technology; Xi'an Jiaotong University	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.	hyperchaos@163.com	Wang, Chunni/J-2666-2012; Ma, Jun/G-2376-2010	Wang, Chunni/0000-0002-4688-7888; Ma, Jun/0000-0002-6127-000X; Wu, Ying/0000-0002-3778-8183	National Nature Science Foundation of China [11265008, 11372122, 11365014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Nature Science Foundation of China under the Grant No. 11265008, and is partially supported by the National Nature Science Foundation of China under the Grant No. 11372122, and it is also partially supported by the National Nature Science Foundation of China under the Grant No. 11365014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao X, 2013, MATH BIOSCI, V245, P49, DOI 10.1016/j.mbs.2013.02.007; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; Bekkers JM, 2002, CURR BIOL, V12, pR648, DOI 10.1016/S0960-9822(02)01157-0; Bekkers JM, 2009, CURR BIOL, V19, pR296, DOI 10.1016/j.cub.2009.02.010; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; Herrmann CS, 2004, INT J BIFURCAT CHAOS, V14, P623, DOI 10.1142/S0218127404009338; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Hu BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069251; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Li F, 2013, INT J MOD PHYS B, V27, DOI 10.1142/S0217979213501154; Li YY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061907; Liao XH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056204; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2013, NONLINEAR DYNAM, V73, P73, DOI 10.1007/s11071-013-0767-1; Ma J, 2013, SCI CHINA PHYS MECH, V56, P1126, DOI 10.1007/s11433-013-5096-3; Ma J, 2013, COMMUN NONLINEAR SCI, V18, P1665, DOI 10.1016/j.cnsns.2012.11.016; Ma J, 2012, CHINESE SCI BULL, V57, P2094, DOI 10.1007/s11434-012-5114-2; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; Ma J, 2009, CHINESE PHYS B, V18, P98, DOI 10.1088/1674-1056/18/1/017; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Rinzel J., 1989, METHODS NEURONAL MOD, P251; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Schmid G, 2004, PHYS BIOL, V1, P61, DOI 10.1088/1478-3967/1/2/002; Sinha S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015101; Storace M, 2008, CHAOS, V18, DOI 10.1063/1.2975967; Tamas G, 1997, J NEUROSCI, V17, P6352; Tang J, 2013, PHYSICA A, V392, P5764, DOI 10.1016/j.physa.2013.07.043; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang CN, 2010, COMMUN THEOR PHYS, V53, P382, DOI 10.1088/0253-6102/53/2/32; Wang HT, 2014, COMMUN NONLINEAR SCI, V19, P3242, DOI 10.1016/j.cnsns.2014.02.018; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Weber S, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28003; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Zhao YH, 2013, CHAOS, V23, DOI 10.1063/1.4822417	47	46	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100849	10.1371/journal.pone.0100849	http://dx.doi.org/10.1371/journal.pone.0100849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967577	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800074
J	Rain-Franco, A; Munoz, C; Fernandez, C				Rain-Franco, Angel; Munoz, Claudia; Fernandez, Camila			Ammonium Production off Central Chile (36 degrees S) by Photodegradation of Phytoplankton-Derived and Marine Dissolved Organic Matter	PLOS ONE			English	Article							BIOLOGICALLY AVAILABLE NITROGEN; COASTAL UPWELLING AREA; SOLAR-RADIATION; PHOTOCHEMICAL PRODUCTION; SYSTEM; BACTERIOPLANKTON; TRANSFORMATIONS; VARIABILITY; METABOLISM; PACIFIC	We investigated the production of ammonium by the photodegradation of dissolved organic matter (DOM) in the coastal upwelling system off central Chile (36 degrees S). The mean penetration of solar radiation (Z1%) between April 2011 and February 2012 was 9.4 m, 4.4 m and 3.2 m for Photosynthetically Active Radiation (PAR; 400-700 nm), UV-A (320-400 nm) and UV-B (280-320 nm), respectively. Ammonium photoproduction experiments were carried out using exudates of DOM obtained from cultured diatom species (Chaetoceros muelleri and Thalassiosira minuscule) as well as natural marine DOM. Diatom exudates showed net photoproduction of ammonium under exposure to UVR with a mean rate of 0.56 +/- 0.4 mu mol L-1 h(-1) and a maximum rate of 1.49 mu mol L-1 h(-1). Results from natural marine DOM showed net photoproduction of ammonium under exposure to PAR+UVR ranging between 0.06 and 0.2 mu mol L-1 h(-1). We estimated the potential contribution of photochemical ammonium production for phytoplankton ammonium demand. Photoammonification of diatom exudates could support between 117 and 453% of spring-summer NH4+ assimilation, while rates obtained from natural samples could contribute to 50-178% of spring-summer phytoplankton NH4+ requirements. These results have implications for local N budgets, as photochemical ammonium production can occur year-round in the first meters of the euphotic zone that are impacted by full sunlight.	[Rain-Franco, Angel] Univ Concepcion, Dept Oceanog, Grad Program Oceanog, Concepcion, Chile; [Munoz, Claudia; Fernandez, Camila] Univ Concepcion, Dept Oceanog, COPAS SURAUSTRAL Program, Concepcion, Chile; [Munoz, Claudia; Fernandez, Camila] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile; [Fernandez, Camila] Univ Paris 06, Univ Sorbonne, UMR 7621, Lab Oceanog Microbienne, Banyuls Sur Mer, France; [Fernandez, Camila] CNRS, UMR 7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France	Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Fernandez, C (corresponding author), Univ Concepcion, Dept Oceanog, COPAS SURAUSTRAL Program, Concepcion, Chile.	fernandez@obs-banyuls.fr		Rain, Angel/0000-0002-0389-7154	FONDECYT [1100358]; AMMONITE (CNRS-LEFE CIBER); ECOS-CONICYT [C09B02]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); AMMONITE (CNRS-LEFE CIBER); ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was funded by projects FONDECYT 1100358, AMMONITE (CNRS-LEFE CIBER) and ECOS-CONICYT C09B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi M, 2008, MICROB ECOL, V55, P344, DOI 10.1007/s00248-007-9280-8; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001226; Berman T, 1999, AQUAT MICROB ECOL, V16, P295, DOI 10.3354/ame016295; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; Bouchard JN, 2008, J EXP MAR BIOL ECOL, V359, P67, DOI 10.1016/j.jembe.2008.02.022; Buffam I, 2003, LIMNOL OCEANOGR, V48, P723, DOI 10.4319/lo.2003.48.2.0723; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; Bushaw-Newton KL, 1999, AQUAT MICROB ECOL, V18, P285, DOI 10.3354/ame018285; CABRERA S, 1995, J PHOTOCH PHOTOBIO B, V28, P137, DOI 10.1016/1011-1344(94)07103-U; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; De Lange HJ, 2003, J PLANKTON RES, V25, P111, DOI 10.1093/plankt/25.1.111; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Escribano R, 2007, PROG OCEANOGR, V75, P343, DOI 10.1016/j.pocean.2007.08.020; Farias L, 2009, BIOGEOSCIENCES, V6, P3053, DOI 10.5194/bg-6-3053-2009; Fernandez C, 2012, MAR ECOL PROG SER, V451, P1, DOI 10.3354/meps09683; Fernandez C, 2009, PROG OCEANOGR, V83, P159, DOI 10.1016/j.pocean.2009.07.010; Gao HZ, 1998, ENVIRON SCI TECHNOL, V32, P2940, DOI 10.1021/es9803660; Gao KS, 2007, PHOTOCHEM PHOTOBIOL, V83, P802, DOI 10.1111/j.1751-1097.2007.00154.x; Gardner WS, 1998, LIMNOL OCEANOGR, V43, P1814; Godoy N, 2012, BIOGEOSCIENCES, V9, P1267, DOI 10.5194/bg-9-1267-2012; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Helbling EW, 2001, MAR ECOL PROG SER, V211, P43, DOI 10.3354/meps211043; Hernandez K, 2012, PROG OCEANOGR, V92-95, P18, DOI 10.1016/j.pocean.2011.07.011; Hernandez KL, 2006, MAR ECOL PROG SER, V315, P19, DOI 10.3354/meps315019; Holm-Hansen Osmund, 1997, P375; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Huovinen P, 2011, CONT SHELF RES, V31, P254, DOI 10.1016/j.csr.2010.09.004; Kieber RJ, 1999, ENVIRON SCI TECHNOL, V33, P993, DOI 10.1021/es980188a; Kitidis V, 2006, BIOGEOSCIENCES, V3, P439, DOI 10.5194/bg-3-439-2006; Koopmans DJ, 2002, AQUAT MICROB ECOL, V26, P295, DOI 10.3354/ame026295; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Marie D., 2000, SPRING LAB MAN, P421, DOI 10.1007/978-3-642-57049-0_34; Montero P, 2007, PROG OCEANOGR, V75, P518, DOI 10.1016/j.pocean.2007.08.013; Mopper K., 2002, BIOGEOCHEMISTRY DISS, P455, DOI [10.1016/b978-012323841-2/50011-7, DOI 10.1016/B978-012323841-2/50011-7]; Morell JM, 2001, J GEOPHYS RES-OCEANS, V106, P16807, DOI 10.1029/1999JC000268; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Pakulski JD, 2007, AQUAT MICROB ECOL, V47, P153, DOI 10.3354/ame047153; Sobarzo M, 2004, J GEOPHYS RES-OCEANS, P109; Sobarzo M, 2007, PROG OCEANOGR, V75, P363, DOI 10.1016/j.pocean.2007.08.022; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Vahatalo AV, 2007, LIMNOL OCEANOGR, V52, P132; Wang WW, 2000, AQUAT GEOCHEM, V6, P275, DOI 10.1023/A:1009679730079; Whitehead RF, 2000, EFFECTS UV RAD MARIN, P1; WMO, 2011, 52 WMO; Xie H., 2012, BIOGEOSCIENCES DISCU, V9, P4441, DOI [DOI 10.5194/BGD-9-4441-2012, 10.5194/bgd-9-4441-2012]	46	10	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100224	10.1371/journal.pone.0100224	http://dx.doi.org/10.1371/journal.pone.0100224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968138	Green Submitted, gold, Green Published			2022-12-25	WOS:000338280800030
J	SidAhmed-Mezi, M; Kurcewicz, I; Rose, C; Louvel, J; Sokoloff, P; Pumain, R; Laschet, JJ				SidAhmed-Mezi, Mounia; Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques; Sokoloff, Pierre; Pumain, Rene; Laschet, Jacques J.			Mass Spectrometric Detection and Characterization of Atypical Membrane-Bound Zinc-Sensitive Phosphatases Modulating GABAA Receptors	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASES; GAMMA-AMINOBUTYRIC-ACID; GATED ION CHANNELS; SUBUNIT COMPOSITION; TYROSINE-PHOSPHATASE; DEPENDENT MODULATION; ALPHA-SUBUNIT; KINASE-C; PHOSPHORYLATION; PURIFICATION	Background: GABA(A) receptor (GABA(A)R) function is maintained by an endogenous phosphorylation mechanism for which the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is the kinase. This phosphorylation is specific to the long intracellular loop I-2 of the alpha 1 subunit at two identified serine and threonine residues. The phosphorylation state is opposed by an unknown membrane-bound phosphatase, which inhibition favors the phosphorylated state of the receptor and contributes to the maintenance of its function. In cortical nervous tissue from epileptogenic areas in patients with drug-resistant epilepsies, both the endogenous phosphorylation and the functional state of the GABA(A)R are deficient. Methodology/Principal Findings: The aim of this study is to characterize the membrane-bound phosphatases counteracting the endogenous phosphorylation of GABA(A)R. We have developed a new analytical tool for in vitro detection of the phosphatase activities in cortical washed membranes by liquid chromatography coupled to mass spectrometry. The substrates are two synthetic phosphopeptides, each including one of the identified endogenous phosphorylation sites of the I2 loop of GABA(A)R alpha 1 subunit. We have shown the presence of multiple and atypical phosphatases sensitive to zinc ions. Patch-clamp studies of the rundown of the GABA(A)R currents on acutely isolated rat pyramidal cells using the phosphatase inhibitor okadaic acid revealed a clear heterogeneity of the phosphatases counteracting the function of the GABA(A)R. Conclusion/Significance: Our results provide new insights on the regulation of GABA(A)R endogenous phosphorylation and function by several and atypical membrane-bound phosphatases specific to the alpha 1 subunit of the receptor. By identifying specific inhibitors of these enzymes, novel development of antiepileptic drugs in patients with drug-resistant epilepsies may be proposed.	[SidAhmed-Mezi, Mounia; Pumain, Rene; Laschet, Jacques J.] INSERM, Infantile Epilepsies & Brain Plast U1129, Paris, France; [SidAhmed-Mezi, Mounia; Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques; Pumain, Rene; Laschet, Jacques J.] Univ Paris 05, Paris, France; [SidAhmed-Mezi, Mounia; Pumain, Rene; Laschet, Jacques J.] CEA, Gif Sur Yvette, France; [Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques] INSERM, Ctr Psychiat & Neurosci, U894, Paris, France; [Sokoloff, Pierre] Inst Rech Pierre Fabre Neurol & Psychiat, Castres, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	SidAhmed-Mezi, M (corresponding author), INSERM, Infantile Epilepsies & Brain Plast U1129, Paris, France.	mounia.sid-ahmed@inserm.fr; jacques.laschet@inserm.fr			Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE)	Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE)	This work was supported by the Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2001, MOL BIOL EVOL, V18, P448, DOI 10.1093/oxfordjournals.molbev.a003823; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BOIVIN P, 1987, INT J BIOCHEM, V19, P613, DOI 10.1016/0020-711X(87)90227-8; Brandon NJ, 2001, NEUROPHARMACOLOGY, V41, P745, DOI 10.1016/S0028-3908(01)00121-6; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Dawson GR, 2005, CNS SPECTRUMS, V10, P21, DOI 10.1017/S1092852900009871; de Seve JE, 1819, NOUVEAU DICT HIST NA, V36, P387; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Filippova N, 2000, MOL PHARMACOL, V57, P847; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; John H, 2005, ANAL BIOANAL CHEM, V381, P51, DOI 10.1007/s00216-004-2868-7; Korpi ER, 2002, PROG NEUROBIOL, V67, P113, DOI 10.1016/S0301-0082(02)00013-8; Kostiainen R, 2009, J CHROMATOGR A, V1216, P685, DOI 10.1016/j.chroma.2008.08.095; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Kumar S, 2005, PSYCHOPHARMACOLOGY, V183, P241, DOI 10.1007/s00213-005-0161-x; Laschet J, 1999, EPILEPSY RES, V35, P161, DOI 10.1016/S0920-1211(99)00009-1; Laschet JJ, 2007, P NATL ACAD SCI USA, V104, P3472, DOI 10.1073/pnas.0606451104; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Luo JX, 2000, AM J PHYSIOL-CELL PH, V279, pC108, DOI 10.1152/ajpcell.2000.279.1.C108; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Minier F, 2000, NEUROCHEM INT, V36, P499, DOI 10.1016/S0197-0186(99)00158-8; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; PATO MD, 1991, MOL CELL BIOCHEM, V101, P31; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Thissen M, 2009, RES LETT BIOCH; TONKS NK, 1990, J BIOL CHEM, V265, P10674; TONKS NK, 1988, J BIOL CHEM, V263, P6731; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; WANG RA, 1995, J NEUROPHYSIOL, V73, P2099, DOI 10.1152/jn.1995.73.5.2099; WANG YX, 1995, J BIOL CHEM, V270, P25607, DOI 10.1074/jbc.270.43.25607; YANG Q, 1993, J BIOL CHEM, V268, P17650; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	54	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100612	10.1371/journal.pone.0100612	http://dx.doi.org/10.1371/journal.pone.0100612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967814	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800047
J	Tian, CR; Qian, L; Shen, XZ; Li, JJ; Wen, JT				Tian, Chang-Rong; Qian, Li; Shen, Xiao-Zhu; Li, Jia-Jing; Wen, Jiang-Tao			Distribution of Serum Total Protein in Elderly Chinese	PLOS ONE			English	Article							LABORATORY TESTS; HEPATIC-INJURY; HEART-FAILURE; ALBUMIN; RISK; RECOMMENDATIONS; COMPLICATIONS; DIAGNOSIS; DIETARY	The serum total protein levels of the elderly possibly decrease gradually with aging. However, serum total protein levels are not suitable as a uniform reference standard for the elderly at different ages and genders. Thus, we investigated the total serum protein distribution in different gender and age groups of 11,453 elderly individuals aged >= 60 years and without liver or renal disease from Lianyungang, Jiangsu, China. The total protein levels (TPL) of these individuals exhibited normal distribution (Z = 1.206, P = 0.109), whereas the reference range (95% CI) was 54.1 g/L to 82.3 g/L. TPL was higher in females than in males for those aged between 60 and 75 years, whereas no significant difference was observed for those aged between 80 and 95 years. TPL was negatively correlated with age in males (r = -0.1342, P < 0.05), females (r = -0.304, P < 0.05), and the total group (r = -0.2136, P < 0.05). TPL also decreased with aging and showed a faster rate in women than in men. These results indicated that an appropriate range of serum total protein based on age and gender differences should be used for clinical applications.	[Tian, Chang-Rong; Shen, Xiao-Zhu] Second Peoples Hosp Lianyungang, Dept Geriatr, Xinpu, Peoples R China; [Qian, Li] Second Peoples Hosp Lianyungang, Dept Microbiol Lab, Xinpu, Peoples R China; [Li, Jia-Jing] Second Peoples Hosp Lianyungang, Dept Elect & Informat Engn Ctr, Xinpu, Peoples R China; [Wen, Jiang-Tao] Second Peoples Hosp Lianyungang, Dept Clin Sci Expt Ctr, Xinpu, Peoples R China		Tian, CR (corresponding author), Second Peoples Hosp Lianyungang, Dept Geriatr, Xinpu, Peoples R China.	tinasxz@yahoo.com.cn; qianlilyg@163.com			Foundation for Scientific research project of Lianyungang Health Bureau [2010-1014]	Foundation for Scientific research project of Lianyungang Health Bureau	This study was supported by Foundation for Scientific research project of Lianyungang Health Bureau (No. 2010-1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques S, 2011, ARCH CARDIOVASC DIS, V104, P502, DOI 10.1016/j.acvd.2011.06.003; Brennan DS, 2012, J NUTR HEALTH AGING, V16, P437, DOI 10.1007/s12603-012-0006-3; BURKHARDT RT, 1978, AM J CLIN PATHOL, V70, P508; Chow E, 2008, BRIT J BIOMED SCI, V65, P128, DOI 10.1080/09674845.2008.11732815; DAWNAY ABSJ, 1991, ANN CLIN BIOCHEM, V28, P556, DOI 10.1177/000456329102800604; DECSI T, 1990, Acta Paediatrica Hungarica, V30, P373; Dequanter D, 2011, B-ENT, V7, P181; DOUMAS BT, 1975, CLIN CHEM, V21, P1159; DOUMAS BT, 1981, CLIN CHEM, V27, P1642; Doumas BT, 1981, CLIN CHEM, V27, P1641; Dufour DR, 2000, CLIN CHEM, V46, P2027; Dufour DR, 2000, CLIN CHEM, V46, P2050; Dzoga-Litwinowicz M, 1976, Wiad Lek, V29, P1411; Friedman R B, 1980, Clin Chem, V26, p1D; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Haynes GR, 2003, EUR J ANAESTH, V20, P771, DOI 10.1097/00003643-200310000-00003; He ML, 2011, CLIN CHEM LAB MED, V49, P989, DOI 10.1515/CCLM.2011.153; Ibrahim K, 1989, J Pak Med Assoc, V39, P12; Kaplan A., 1979, CLIN CHEM INTERPRETA; Krohn Randall I, 2011, Curr Protoc Cell Biol, VAppendix 3, p3H, DOI 10.1002/0471143030.cba03hs52; Lai KS, 1973, MED J MALAYSIA, V28, P115; LAKHANI S, 1984, E AFR MED J, V61, P606; Li J, 2011, CLIN LAB MED, V8, P2110; Li M, 2010, PR PREV MED, V17, P994; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Mahkovic-Hergouth K, 2011, J CLIN ANESTH, V23, P42, DOI 10.1016/j.jclinane.2010.06.007; Malik SI, 2011, J PAK MED ASSOC, V61, P23; Neel DR, 2011, BEST PRACT RES-CLIN, V25, P395, DOI 10.1016/j.bpa.2011.07.006; Orsitto G, 2012, J NUTR HEALTH AGING, V16, P468, DOI 10.1007/s12603-012-0024-1; PETRAS G, 1978, ACTA MED HUNG, V35, P249; Prajapati KD, 2011, REV NEUROSCIENCE, V22, P355, DOI 10.1515/RNS.2011.028; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rahman M Z, 2005, Mymensingh Med J, V14, P38; SINTON TJ, 1986, CLIN CHEM, V32, P76; Tietz NW., 1983, CLIN GUIDE LAB TESTS; Tsutsumi R, 2012, ASIA PAC J CLIN NUTR, V21, P44; Wengreen HJ, 2004, J BONE MINER RES, V19, P537, DOI 10.1359/JBMR.040208; YOUNG DS, 1975, CLIN CHEM, V21, pD1; Zhou Bai-yu, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1068	39	6	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101242	10.1371/journal.pone.0101242	http://dx.doi.org/10.1371/journal.pone.0101242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967900	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800118
J	Valko, PO; Hauser, S; Sommerauer, M; Werth, E; Baumann, CR				Valko, Philipp O.; Hauser, Sabrina; Sommerauer, Michael; Werth, Esther; Baumann, Christian R.			Observations on Sleep-Disordered Breathing in Idiopathic Parkinson's Disease	PLOS ONE			English	Article							REM-SLEEP; DAYTIME SLEEPINESS; APNEA; PRAMIPEXOLE; LEVODOPA; EPISODES; SCALE; NREM	Background: This study has two main goals: 1.) to determine the potential influence of dopaminergic drugs on sleep-disordered breathing (SDB) in Parkinson's disease (PD) and 2.) to elucidate whether NREM and REM sleep differentially impact SDB severity in PD. Methods: Retrospective clinical and polysomnographic study of 119 consecutive PD patients and comparison with age-, sex- and apnea-hypopnea-index-matched controls. Results: SDB was diagnosed in 57 PD patients (48%). Apnea-hypopnea index was significantly higher in PD patients with central SDB predominance (n = 7; 39.3 +/- 16.7/h) than obstructive SDB predominance (n = 50; 20.9 +/- 16.8/h; p = 0.003). All PD patients with central SDB predominance appeared to be treated with both levodopa and dopamine agonists, whereas only 56% of those with obstructive SDB predominance were on this combined treatment (p = 0.03). In the whole PD group with SDB (n = 57), we observed a significant decrease of apnea-hypopnea index from NREM to REM sleep (p = 0.02), while controls revealed the opposite tendency. However, only the PD subgroup with SDB and treatment with dopamine agonists showed this phenomenon, while those without dopamine agonists had a similar NREM/REM pattern as controls. Conclusions: Our findings suggest an ambiguous impact of dopamine agonists on SDB. Medication with dopamine agonists seems to enhance the risk of central SDB predominance. Loss of normal muscle atonia may be responsible for decreased SDB severity during REM sleep in PD patients with dopamine agonists.	[Valko, Philipp O.; Hauser, Sabrina; Sommerauer, Michael; Werth, Esther; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Valko, PO (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	philipp.valko@usz.ch	Werth, E/AAN-7955-2021	Baumann, Christian/0000-0003-3417-1978; Werth, Esther/0000-0002-5099-3122				Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Chervin RD, 1998, CHEST, V113, P980, DOI 10.1378/chest.113.4.980; De Cock VC, 2010, SLEEP MED, V11, P247, DOI 10.1016/j.sleep.2009.05.008; DEKEYSER J, 1985, NEUROLOGY, V35, P235; Dhawan V, 2006, AGE AGEING, V35, P220, DOI 10.1093/ageing/afj087; Diederich NJ, 2005, MOVEMENT DISORD, V20, P1413, DOI 10.1002/mds.20624; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FINDLEY LJ, 1985, CHEST, V87, P432, DOI 10.1378/chest.87.4.432; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Haba-Rubio J, 2005, CHEST, V128, P3350, DOI 10.1378/chest.128.5.3350; Hauser RA, 2000, MOVEMENT DISORD, V15, P658, DOI 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N; Herer B, 2001, CHEST, V119, P387, DOI 10.1378/chest.119.2.387; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; Hogl B, 2010, SLEEP MED, V11, P233, DOI 10.1016/j.sleep.2009.11.008; Iber C., 2007, AASM MANUAL SCORING; Koo BB, 2008, CHEST, V134, P1156, DOI 10.1378/chest.08-1311; Maria B, 2003, RESP MED, V97, P1151, DOI 10.1016/S0954-6111(03)00188-4; Monaca C, 2006, SLEEP MED, V7, P448, DOI 10.1016/j.sleep.2005.12.002; Norlinah MI, 2009, PARKINSONISM RELAT D, V15, P670, DOI 10.1016/j.parkreldis.2009.02.012; Punjabi NM, 2002, SLEEP, V25, P307; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Schafer D, 2001, SOMNOLOGIE, V5, P103; Schapira AHV, 2000, LANCET, V355, P1332, DOI 10.1016/S0140-6736(00)02118-8; SERIES F, 1990, AM REV RESPIR DIS, V141, P1522, DOI 10.1164/ajrccm/141.6.1522; Siddiqui F, 2006, SLEEP MED, V7, P281, DOI 10.1016/j.sleep.2005.10.006; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trotti LM, 2010, MOVEMENT DISORD, V25, P2246, DOI 10.1002/mds.23231; Weatherwax KJ, 2003, SLEEP MED, V4, P517, DOI 10.1016/j.sleep.2003.07.004; Wetter TC, 2000, SLEEP, V23, P361; Yong MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022511; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	35	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100828	10.1371/journal.pone.0100828	http://dx.doi.org/10.1371/journal.pone.0100828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968233	gold, Green Accepted, Green Published			2022-12-25	WOS:000338280800072
J	Fina, BL; Lombarte, M; Rigalli, JP; Rigalli, A				Lorena Fina, Brenda; Lombarte, Mercedes; Pablo Rigalli, Juan; Rigalli, Alfredo			Fluoride Increases Superoxide Production and Impairs the Respiratory Chain in ROS 17/2.8 Osteoblastic Cells	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; SODIUM MONOFLUOROPHOSPHATE; OXIDATIVE STRESS; MITOCHONDRIA; GLUTATHIONE; OXYGEN; INFLAMMATION; INHIBITION; GENERATION; REDUCTASE	It is known that fluoride produces oxidative stress. Inflammation in bone tissue and an impairment of the respiratory chain of liver have been described in treatments with fluoride. Whether the impairment of the respiratory chain and oxidative stress are related is not known. The aim of this work was to study the effects of fluoride on the production of superoxide radical, the function of the respiratory chain and the increase in oxidative stress in ROS 17/2.8 osteoblastic cells. We measured the effect of fluoride (100 mu M) on superoxide production, oxygen consumption, lipid peroxidation and antioxidant enzymes activities of cultured cells following the treatment with fluoride. Fluoride decreased oxygen consumption and increased superoxide production immediately after its addition. Furthermore, chronic treatment with fluoride increased oxidative stress status in osteoblastic cells. These results indicate that fluoride could damage bone tissue by inhibiting the respiratory chain, increasing the production of superoxide radicals and thus of the others reactive oxygen species.	[Lorena Fina, Brenda; Lombarte, Mercedes; Rigalli, Alfredo] Rosario Natl Univ, Sch Med, Bone Biol Lab, Rosario, Santa Fe, Argentina; [Pablo Rigalli, Juan] Consejo Nacl Invest Cient & Tecn, Inst Expt Physiol, Rosario, Santa Fe, Argentina	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fina, BL (corresponding author), Rosario Natl Univ, Sch Med, Bone Biol Lab, Rosario, Santa Fe, Argentina.	brendafina@conicet.gov.ar	Lombarte, Mercedes/M-2774-2016; Fina, Brenda/M-2971-2016; Rigalli, Juan Pablo/E-2099-2018; Rigalli, Alfredo/M-2591-2016	Lombarte, Mercedes/0000-0003-1114-319X; Fina, Brenda/0000-0003-3708-0756; Rigalli, Juan Pablo/0000-0003-4168-9396; Rigalli, Alfredo/0000-0002-3953-278X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [112-200801-00462]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This paper was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant 112-200801-00462 (http://www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Bergandi L, 2010, CHEM-BIOL INTERACT, V183, P405, DOI 10.1016/j.cbi.2009.11.021; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Boveris A, 1999, METHOD ENZYMOL, V301, P188; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; BRIANCON D, 1981, ORTHOP CLIN N AM, V12, P629; Brun LR, 2012, ACTUAL OSTEOL, V8, P19; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Caverzasio J, 1998, BONE, V22, P585, DOI 10.1016/S8756-3282(98)00058-1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; de Mendiburu F, 2012, AGRICOLAE STAT PROCE; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; EISENBERG AD, 1981, ANTIMICROB AGENTS CH, V19, P807, DOI 10.1128/AAC.19.5.807; EKSTRAND J, 1978, CARIES RES, V12, P123; FATT I, 1968, ANN NY ACAD SCI, V148, P81, DOI 10.1111/j.1749-6632.1968.tb20342.x; Fina BL, 2012, FLUORIDE, V45, P325; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Gazzano E, 2010, CURR MED CHEM, V17, P2431, DOI 10.2174/092986710791698503; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nathan AT, 1999, BRIT MED BULL, V55, P96, DOI 10.1258/0007142991902312; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; R Core Team, 2021, R LANG ENV STAT COMP; RIGALLI A, 1994, ARZNEIMITTEL-FORSCH, V44-1, P762; RIGALLI A, 1995, ARZNEIMITTEL-FORSCH, V45-1, P289; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P614, DOI 10.1210/me.8.5.614; TRAUTNER K, 1988, ARCH ORAL BIOL, V33, P543, DOI 10.1016/0003-9969(88)90127-6; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Wang Z, 2011, ARCH TOXICOL, V85, P1407, DOI 10.1007/s00204-011-0697-y; WATANABE N, 1986, CLIN CHEM, V32, P1551; Xu H, 2008, BIOL TRACE ELEM RES, V123, P109, DOI 10.1007/s12011-007-8082-7	42	32	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100768	10.1371/journal.pone.0100768	http://dx.doi.org/10.1371/journal.pone.0100768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964137	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500079
J	Rui, XL; Mehrbod, M; Van Agthoven, JF; Anand, S; Xiong, JP; Mofrad, MRK; Arnaout, MA				Rui, Xianliang; Mehrbod, Mehrdad; Van Agthoven, Johannes F.; Anand, Saurabh; Xiong, Jian-Ping; Mofrad, Mohammad R. K.; Arnaout, M. Amin			The alpha-Subunit Regulates Stability of the Metal Ion at the Ligand-associated Metal Ion-binding Site in beta(3) Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; ALPHA(V)BETA(3); ALPHA-V-BETA-3; ACTIVATION; ECTODOMAIN; AFFINITY; DOMAIN	The aspartate in the prototypical integrin-binding motif Arg-Gly-Asp binds the integrin beta A domain of the beta-subunit through a divalent cation at the metal ion-dependent adhesion site (MIDAS). An auxiliary metal ion at a ligand-associated metal ion-binding site (LIMBS) stabilizes the metal ion at MIDAS. LIMBS contacts distinct residues in the alpha-subunits of the two beta 3 integrins alpha(IIb)beta(3) and alpha(V)beta(3), but a potential role of this interaction on stability of the metal ion at LIMBS in beta(3) integrins has not been explored. Equilibrium molecular dynamics simulations of fully hydrated beta 3 integrin ectodomains revealed strikingly different conformations of LIMBS in unliganded alpha(IIb)beta(3) versus alpha(V)beta(3), the result of stronger interactions of LIMBS with alpha(V), which reduce stability of the LIMBS metal ion in alpha(V)beta(3). Replacing the alpha(IIb)-LIMBS interface residue Phe(191) in alpha(IIb) (equivalent to Trp179 in alpha(V)) with Trp strengthened this interface and destabilized the metal ion at LIMBS in alpha(IIb)beta(3); a Trp179 to Phe mutation in alpha(V) produced the opposite but weaker effect. Consistently, an F191/W substitution in cellular alpha(IIb)beta 3 and a W179/F substitution in alpha(V)beta(3) reduced and increased, respectively, the apparent affinity of Mn2+ to the integrin. These findings offer an explanation for the variable occupancy of the metal ion at LIMBS in alpha(V)beta(3) structures in the absence of ligand and provide new insights into the mechanisms of integrin regulation.	[Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Charlestown, MA 02129 USA; [Van Agthoven, Johannes F.; Xiong, Jian-Ping; Arnaout, M. Amin] Massachusetts Gen Hosp, Struct Biol Program, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, 208A Stanley Hall 1762, Berkeley, CA 94720 USA.	mofrad@berkeley.edu; aarnaout1@mgh.harvard.edu			National Institutes of Health [DK088327, DK096334, DK007540]; National Science Foundation CAREER Award [CBET-0955291]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088327, T32DK007540, R21DK096334] Funding Source: NIH RePORTER; Directorate For Engineering [0955291] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grants DK088327, DK096334, and DK007540 (to M. A. A.) and by a National Science Foundation CAREER Award CBET-0955291 (to M. R. K. M.).	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Brandt M, 1986, MANGANESE METABOLISM, P3; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Richards J, 2003, J MOL BIOL, V326, P1475, DOI 10.1016/S0022-2836(03)00082-2; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; SMITH JW, 1994, J BIOL CHEM, V269, P960; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Agthoven JF, 2014, NAT STRUCT MOL BIOL, V21, P383, DOI 10.1038/nsmb.2797; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	34	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23256	23263		10.1074/jbc.M114.581470	http://dx.doi.org/10.1074/jbc.M114.581470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24975416	hybrid, Green Published			2022-12-25	WOS:000341017200061
J	Paatero, I; Seagroves, TN; Vaparanta, K; Han, W; Jones, FE; Johnson, RS; Elenius, K				Paatero, Ilkka; Seagroves, Tiffany N.; Vaparanta, Katri; Han, Wen; Jones, Frank E.; Johnson, Randall S.; Elenius, Klaus			Hypoxia-inducible Factor-1 alpha Induces ErbB4 Signaling in the Differentiating Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CANCER-CELL-GROWTH; ESTROGEN-RECEPTOR; INTRACELLULAR DOMAIN; NUCLEAR-LOCALIZATION; NEUREGULIN RECEPTOR; MICE LACKING; ISOFORM; STAT5; ACTIVATION	Conditional knock-out of Hif1a in the mouse mammary gland impairs lobuloalveolar differentiation during lactation. Here, we demonstrate that expression of ErbB4 was reduced in the lobulalveoli of mice with mammary gland-specific deletion of Hif1a. Erbb4 was not, however, a direct target gene for transcriptional regulation by HIF-1 alpha in vitro. HIF-1 alpha overexpression or HIF accumulating prolyl hydroxylase inhibitors reduced ErbB4 endocytosis, promoted transcriptional co-regulatory activity of ErbB4, and stimulated ErbB4-induced differentiation of mammary carcinoma cells. Consistently, RNA interference-mediated down-regulation of HIF-1 alpha resulted in reduced ErbB4 protein amount and reduced mammary carcinoma cell differentiation. These findings indicate that HIF-1 alpha is a physiologically relevant regulator of ErbB4 and that ErbB4 is involved in HIF-regulated differentiation of the mammary gland.	[Paatero, Ilkka; Vaparanta, Katri; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Paatero, Ilkka; Vaparanta, Katri; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Paatero, Ilkka] Turku Grad Sch Biomed Sci, Turku 20520, Finland; [Seagroves, Tiffany N.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Han, Wen; Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1TN, England; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Tennessee System; University of Tennessee Health Science Center; Tulane University; University of Cambridge; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Seagroves, Tiffany/AAE-3278-2019; Elenius, Klaus/AAI-7594-2021; Paatero, Ilkka/AAE-7542-2019; Johnson, Randall/AAM-1189-2021	Seagroves, Tiffany/0000-0002-6937-943X; Elenius, Klaus/0000-0001-5700-0827; Paatero, Ilkka/0000-0001-5926-2396; Johnson, Randall/0000-0002-4084-6639	Academy of Finland; Finnish Cancer Organisations; Finnish Cultural Foundation; K. Albin Johansson Foundation; Sigrid Juselius Foundation; Turku University Foundation; Turku University Central Hospital; Wellcome Trust [092738/Z/10/Z] Funding Source: researchfish; Cancer Foundation Finland sr [130077] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); K. Albin Johansson Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Foundation; Turku University Central Hospital; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Foundation Finland sr	This work was supported by the Academy of Finland, the Finnish Cancer Organisations, the Finnish Cultural Foundation, the K. Albin Johansson Foundation, the Sigrid Juselius Foundation, the Turku University Foundation, and Turku University Central Hospital.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Das PM, 2010, ONCOGENE, V29, P5214, DOI 10.1038/onc.2010.271; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058; Gullick WJ, 2003, J PATHOL, V200, P279, DOI 10.1002/path.1335; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hollmen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039413; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155	46	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22459	22469		10.1074/jbc.M113.533497	http://dx.doi.org/10.1074/jbc.M113.533497			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966332	hybrid, Green Published			2022-12-25	WOS:000340593500055
J	Bose, P; Hermetz, KE; Conneely, KN; Rudd, MK				Bose, Promita; Hermetz, Karen E.; Conneely, Karen N.; Rudd, M. Katharine			Tandem Repeats and G-Rich Sequences Are Enriched at Human CNV Breakpoints	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATIONS; DNA; MECHANISMS; COMMON; RECOMBINATION; JUNCTIONS; BREAKAGE; ELEMENTS; CANCER; GENE	Chromosome breakage in germline and somatic genomes gives rise to copy number variation (CNV) responsible for genomic disorders and tumorigenesis. DNA sequence is known to play an important role in breakage at chromosome fragile sites; however, the sequences susceptible to double-strand breaks (DSBs) underlying CNV formation are largely unknown. Here we analyze 140 germline CNV breakpoints from 116 individuals to identify DNA sequences enriched at breakpoint loci compared to 2800 simulated control regions. We find that, overall, CNV breakpoints are enriched in tandem repeats and sequences predicted to form G-quadruplexes. G-rich repeats are overrepresented at terminal deletion breakpoints, which may be important for the addition of a new telomere. Interstitial deletions and duplication breakpoints are enriched in Alu repeats that in some cases mediate non-allelic homologous recombination (NAHR) between the two sides of the rearrangement. CNV breakpoints are enriched in certain classes of repeats that may play a role in DNA secondary structure, DSB susceptibility and/or DNA replication errors.	[Bose, Promita; Hermetz, Karen E.; Conneely, Karen N.; Rudd, M. Katharine] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Conneely, Karen N.] Emory Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University	Rudd, MK (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	katie.rudd@emory.edu			National Institutes of Health [MH092902]; March of Dimes [12-FY11-203]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Health (grant number MH092902 to MKR) and a grant from the March of Dimes (grant number #12-FY11-203 to MKR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ballif BC, 2003, HUM MOL GENET, V12, P2153, DOI 10.1093/hmg/ddg231; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; FLINT J, 1994, AM J HUM GENET, V55, P505; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gajecka M, 2006, HUM GENET, V120, P519, DOI 10.1007/s00439-006-0222-1; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Hermetz KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004139; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kim HM, 2008, EMBO J; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; LAMB J, 1993, AM J HUM GENET, V52, P668; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Luo Y, 2011, HUM MOL GENET, V20, P3769, DOI 10.1093/hmg/ddr293; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; POUSI B, 1994, AM J HUM GENET, V55, P899; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Rudd MK, 2007, SUBTELOMERES EVOLUTI; Rudd MK, 2014, SUBTELOMERES, P153; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	51	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101607	10.1371/journal.pone.0101607	http://dx.doi.org/10.1371/journal.pone.0101607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983241	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000123
J	Graham, NAJ; Chong-Seng, KM; Huchery, C; Januchowski-Hartley, FA; Nash, KL				Graham, Nicholas A. J.; Chong-Seng, Karen M.; Huchery, Cindy; Januchowski-Hartley, Fraser A.; Nash, Kirsty L.			Coral Reef Community Composition in the Context of Disturbance History on the Great Barrier Reef, Australia	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; MARINE RESERVE PROTECTION; FISH COMMUNITIES; PHASE-SHIFTS; RECOVERY; RESILIENCE; HABITAT; RECRUITMENT; BIOMASS; ASSEMBLAGES	Much research on coral reefs has documented differential declines in coral and associated organisms. In order to contextualise this general degradation, research on community composition is necessary in the context of varied disturbance histories and the biological processes and physical features thought to retard or promote recovery. We conducted a spatial assessment of coral reef communities across five reefs of the central Great Barrier Reef, Australia, with known disturbance histories, and assessed patterns of coral cover and community composition related to a range of other variables thought to be important for reef dynamics. Two of the reefs had not been extensively disturbed for at least 15 years prior to the surveys. Three of the reefs had been severely impacted by crown-of-thorns starfish outbreaks and coral bleaching approximately a decade before the surveys, from which only one of them was showing signs of recovery based on independent surveys. We incorporated wave exposure (sheltered and exposed) and reef zone (slope, crest and flat) into our design, providing a comprehensive assessment of the spatial patterns in community composition on these reefs. Categorising corals into life history groupings, we document major coral community differences in the unrecovered reefs, compared to the composition and covers found on the undisturbed reefs. The recovered reef, despite having similar coral cover, had a different community composition from the undisturbed reefs, which may indicate slow successional processes, or a different natural community dominance pattern due to hydrology and other oceanographic factors. The variables that best correlated with patterns in the coral community among sites included the density of juvenile corals, herbivore fish biomass, fish species richness and the cover of macroalgae. Given increasing impacts to the Great Barrier Reef, efforts to mitigate local stressors will be imperative to encouraging coral communities to persist into the future.	[Graham, Nicholas A. J.; Chong-Seng, Karen M.; Huchery, Cindy; Januchowski-Hartley, Fraser A.; Nash, Kirsty L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Januchowski-Hartley, Fraser A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	James Cook University; University of Exeter	Graham, NAJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	nick.graham@jcu.edu.au	Nash, Kirsty L/B-5456-2015; Graham, Nicholas AJ/C-8360-2014; Januchowski-Hartley, Fraser A./H-8904-2019	Nash, Kirsty L/0000-0003-0976-3197; Graham, Nicholas AJ/0000-0002-0304-7467; Januchowski-Hartley, Fraser A./0000-0003-2468-8199; huchery, cindy/0000-0002-5657-7584; Chong-Seng, Karen/0000-0001-9178-5891	Queensland Smart Futures Fund; Australian Research Council	Queensland Smart Futures Fund; Australian Research Council(Australian Research Council)	This work was funded through research fellowships from the Queensland Smart Futures Fund and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; ANDREWS JC, 1986, CONT SHELF RES, V6, P491, DOI 10.1016/0278-4343(86)90020-8; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Australian Institute of Marine Science, 2013, REEF MON SURV; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Bozec YM, 2013, OIKOS, V122, P428, DOI 10.1111/j.1600-0706.2012.20576.x; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GBRMPA, 2011, IMP TROP CYCL YAS GR; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harmelin-Vivien M.L., 1994, J COASTAL RES, P211, DOI DOI 10.1111/NYAS.13322; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Johns KA, 2014, CORAL REEFS, V33, P553, DOI 10.1007/s00338-014-1148-z; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Letourneur Y, 1998, NAGA, V21, P39; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Myers MR, 2009, AQUAT CONSERV, V19, P736, DOI 10.1002/aqc.1053; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett M, 2008, P 11 INT COR REEF S; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; SAMMARCO PW, 1991, LIMNOL OCEANOGR, V36, P496, DOI 10.4319/lo.1991.36.3.0496; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Shugart H.H., 1984, THEORY FOREST DYNAMI; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Stoeckl N, 2011, ANN NY ACAD SCI, V1219, P113, DOI 10.1111/j.1749-6632.2010.05892.x; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; WILLIAMS DM, 1994, B MAR SCI, V54, P314; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x	81	42	43	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101204	10.1371/journal.pone.0101204	http://dx.doi.org/10.1371/journal.pone.0101204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983747	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339635000067
J	Karve, SS; Weiss, AA				Karve, Sayali S.; Weiss, Alison A.			Glycolipid Binding Preferences of Shiga Toxin Variants	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; B-SUBUNIT; SHIGELLA DIARRHEA; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; HYBRID TOXINS; PATHOGENESIS; SITE; IDENTIFICATION; STABILITY	The major virulence factor of Shiga toxin producing E. coli, is Shiga toxin (Stx), an AB(5) toxin that consists of a ribosomal RNA-cleaving A-subunit surrounded by a pentamer of receptor-binding B subunits. The two major isoforms, Stx1 and Stx2, and Stx2 variants (Stx2a-h) significantly differ in toxicity. The exact reason for this toxicity difference is unknown, however different receptor binding preferences are speculated to play a role. Previous studies used enzyme linked immunosorbent assay (ELISA) to study binding of Stx1 and Stx2a toxoids to glycolipid receptors. Here, we studied binding of holotoxin and B-subunits of Stx1, Stx2a, Stx2b, Stx2c and Stx2d to glycolipid receptors globotriaosylceramide (Gb3) and globotetraosylceramide (Gb4) in the presence of cell membrane components such as phosphatidylcholine (PC), cholesterol (Ch) and other neutral glycolipids. In the absence of PC and Ch, holotoxins of Stx2 variants bound to mixtures of Gb3 with other glycolipids but not to Gb3 or Gb4 alone. Binding of all Stx holotoxins significantly increased in the presence of PC and Ch. Previously, Stx2a has been shown to form a less stable B-pentamer compared to Stx1. However, its effect on glycolipid receptor binding is unknown. In this study, we showed that even in the absence of the A-subunit, the B-subunits of both Stx1 and Stx2a were able to bind to the glycolipids and the more stable B-pentamer formed by Stx1 bound better than the less stable pentamer of Stx2a. B-subunit mutant of Stx1 L41Q, which shows similar stability as Stx2a B-subunits, lacked glycolipid binding, suggesting that pentamerization is more critical for binding of Stx1 than Stx2a.	[Karve, Sayali S.; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA	University of Cincinnati	Weiss, AA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.	weissaa@ucmail.uc.edu		Weiss, Alison/0000-0002-4726-8376	National Institutes of Health [R01 AI 064893, U01 AI 075498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064893, U01AI075498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI 064893 and U01 AI 075498 (AAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz J, 2011, J LIPID RES, V52, P618, DOI 10.1194/jlr.M010819; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Collins C, 2010, PRACT GASTROENTEROL, V34, P41; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; DONOHUEROLFE A, 1984, J EXP MED, V160, P1767, DOI 10.1084/jem.160.6.1767; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; HEAD SC, 1991, J BIOL CHEM, V266, P3617; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Jacobson JM, 2014, J BIOL CHEM, V289, P885, DOI 10.1074/jbc.M113.518886; Karmali MA, 1994, RECENT ADV VEROCYTOT, P245; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Kitova EN, 2005, J AM SOC MASS SPECTR, V16, P1957, DOI 10.1016/j.jasms.2005.07.016; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; MacDonald IAR, 1996, EPIDEMIOL INFECT, V116, P279, DOI 10.1017/S0950268800052584; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Melton-Celsa A, 2012, CURR TOP MICROBIOL, V357, P67, DOI 10.1007/82_2011_176; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Pina DG, 2008, FEBS LETT, V582, P185, DOI 10.1016/j.febslet.2007.11.086; ROWE PC, 1993, EPIDEMIOL INFECT, V110, P9, DOI 10.1017/S0950268800050627; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Saito M, 2012, J BIOL CHEM, V287, P16073, DOI 10.1074/jbc.M111.318196; SAXENA SK, 1989, J BIOL CHEM, V264, P596; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Soltyk AM, 2002, J BIOL CHEM, V277, P5351, DOI 10.1074/jbc.M107472200; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Torgersen ML, 2011, FEMS IMMUNOL MED MIC, V61, P63, DOI 10.1111/j.1574-695X.2010.00749.x; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Watanabe M, 2006, INFECT IMMUN, V74, P1984, DOI 10.1128/IAI.74.3.1984-1988.2006; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	54	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101173	10.1371/journal.pone.0101173	http://dx.doi.org/10.1371/journal.pone.0101173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983355	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000064
J	Santoferrara, LF; Guida, S; Zhang, H; McManus, GB				Santoferrara, Luciana F.; Guida, Stephanie; Zhang, Huan; McManus, George B.			De Novo Transcriptomes of a Mixotrophic and a Heterotrophic Ciliate from Marine Plankton	PLOS ONE			English	Article							MONODEHYDROASCORBATE REDUCTASE; OXIDATIVE STRESS; ASCORBATE PEROXIDASE; MOLECULAR-CLONING; ALIGNMENT; RNA; METABOLISM; MODELS; FAMILY; GENE	Studying non-model organisms is crucial in the context of the current development of genomics and transcriptomics for both physiological experimentation and environmental characterization. We investigated the transcriptomes of two marine planktonic ciliates, the mixotrophic oligotrich Strombidium rassoulzadegani and the heterotrophic choreotrich Strombidinopsis sp., and their respective algal food using Illumina RNAseq. Our aim was to characterize the transcriptomes of these contrasting ciliates and to identify genes potentially involved in mixotrophy. We detected approximately 10,000 and 7,600 amino acid sequences for S. rassoulzadegani and Strombidinopsis sp., respectively. About half of these transcripts had significant BLASTP hits (E-value <10(-6)) against previously-characterized sequences, mostly from the model ciliate Oxytricha trifallax. Transcriptomes from both the mixotroph and the heterotroph species provided similar annotations for GO terms and KEGG pathways. Most of the identified genes were related to housekeeping activity and pathways such as the metabolism of carbohydrates, lipids, amino acids, nucleotides, and vitamins. Although S. rassoulzadegani can keep and use chloroplasts from its prey, we did not find genes clearly linked to chloroplast maintenance and functioning in the transcriptome of this ciliate. While chloroplasts are known sources of reactive oxygen species (ROS), we found the same complement of antioxidant pathways in both ciliates, except for one enzyme possibly linked to ascorbic acid recycling found exclusively in the mixotroph. Contrary to our expectations, we did not find qualitative differences in genes potentially related to mixotrophy. However, these transcriptomes will help to establish a basis for the evaluation of differential gene expression in oligotrichs and choreotrichs and experimental investigation of the costs and benefits of mixotrophy.	[Santoferrara, Luciana F.; Zhang, Huan; McManus, George B.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Guida, Stephanie] Natl Ctr Genome Resources, Santa Fe, NM USA	University of Connecticut; National Center for Genome Resources (NCGR)	Santoferrara, LF (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	luciana.santoferrara@uconn.edu	McManus, George/AAW-9055-2020	McManus, George/0000-0002-2768-1286; Santoferrara, Luciana/0000-0001-5587-2111	Gordon and Betty Moore Foundation [GBMF2637]; US National Science Foundation [OCE1130033]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF))	This research was funded by the Gordon and Betty Moore Foundation through Grant GBMF2637 to NCGR and by the US National Science Foundation through Grant OCE1130033 to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Carter CJ, 2004, PLANT MOL BIOL, V54, P415, DOI 10.1023/B:PLAN.0000036373.84579.13; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CLARK KB, 1990, VELIGER, V33, P339; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Esteban GF, 2010, PROTIST, V161, P621, DOI 10.1016/j.protis.2010.08.002; Flores HS, 2012, AQUAT MICROB ECOL, V66, P199, DOI 10.3354/ame01570; Flynn KJ, 2013, J PLANKTON RES, V35, P3, DOI 10.1093/plankt/fbs062; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grant J.R., 2012, PROTIST GENOMICS, V1, P3; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hossain MA, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P235; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; Johnson MD, 2011, J EUKARYOT MICROBIOL, V58, P185, DOI 10.1111/j.1550-7408.2011.00545.x; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Kawano T, 2004, Z NATURFORSCH C, V59, P538; Keeling PJ, 2014, PLOS BIOL IN PRESS; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Kuo RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060826; LAVALPEUTO M, 1988, HYDROBIOLOGIA, V159, P99, DOI 10.1007/BF00007371; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Leterrier M, 2005, PLANT PHYSIOL, V138, P2111, DOI 10.1104/pp.105.066225; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lunde C, 2006, PLANT MOL BIOL, V60, P259, DOI 10.1007/s11103-005-3881-8; Lynn D.H., 2008, CIL PROT CHAR CLASS; McManus GB, 2004, LIMNOL OCEANOGR, V49, P308, DOI 10.4319/lo.2004.49.1.0308; McManus GB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00321; McManus GB, 2010, J EUKARYOT MICROBIOL, V57, P369, DOI 10.1111/j.1550-7408.2010.00485.x; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; MURTHY SS, 1994, J BIOL CHEM, V269, P31129; Ohkawa H, 2011, PLANT SIGNAL BEHAV, V6, P773, DOI 10.4161/psb.6.6.15239; Perez MT, 1997, MAR ECOL PROG SER, V155, P89, DOI 10.3354/meps155089; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pierce SK, 2012, MOL BIOL EVOL, V29, P1545, DOI 10.1093/molbev/msr316; Pillet Loic, 2013, Mob Genet Elements, V3, pe24773; Pillet L, 2013, MOL BIOL EVOL, V30, P66, DOI 10.1093/molbev/mss226; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Santoferrara LF, 2011, J PLANKTON RES, V33, P457, DOI 10.1093/plankt/fbq128; Schoener DM, 2012, AQUAT MICROB ECOL, V67, P177, DOI 10.3354/ame01601; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stoecker DK, 1998, EUR J PROTISTOL, V34, P281, DOI 10.1016/S0932-4739(98)80055-2; Strom SL, 2007, LIMNOL OCEANOGR, V52, P1480, DOI 10.4319/lo.2007.52.4.1480; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Takeda T, 1997, PHYSIOL PLANTARUM, V99, P49, DOI 10.1111/j.1399-3054.1997.tb03429.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	75	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101418	10.1371/journal.pone.0101418	http://dx.doi.org/10.1371/journal.pone.0101418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983246	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000103
J	Chu, DK; Zhu, SJ; Li, JP; Ji, G; Wang, WZ; Wu, GS; Zheng, JY				Chu, Dake; Zhu, Shaojun; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong			CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; INCREASES CHEMOSENSITIVITY; CELL INVASION; EMMPRIN; OVEREXPRESSION; CHEMOTHERAPY; CISPLATIN; MARKER	CD147 is correlated with tumor aggressiveness in various human malignancies. Here, we investigated CD147 protein expression in 223 patients with gastric cancer by immunohistochemistry and analyzed its association with disease-free and overall survival. CD147 was increased in gastric cancer compared to normal tissues. Additionally, CD147 expression was associated with gastric cancer invasion, metastasis and TNM stage, whereas it was not related to age, sex, differentiation status, tumor site or Lauren classification. Kaplan-Meier analysis confirmed that CD147 was associated with disease-free and overall survival in patients with gastric cancer; i.e., patients with positive CD147 staining tend to have worse disease-free and overall survival. Moreover, Cox's proportional hazards analysis demonstrated that CD147 was an independent marker of disease-free and overall survival for patients with gastric cancer. These results confirm the association of CD147 with gastric cancer invasion and metastasis and prove that CD147 might be an indicator of tumor recurrence and prognosis in gastric cancer.	[Chu, Dake; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Zhu, Shaojun] Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wu, GS (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	guosheng_w@yahoo.com; zhjy68@163.com	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275	National Natural Science Foundation of China [81201927, 81272204, 31270812]; China Postdoctoral Science Foundation [2012M521862]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from National Natural Science Foundation of China (No. 81201927, 81272204 and 31270812) and China Postdoctoral Science Foundation (No. 2012M521862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso J, 2011, EJSO-EUR J SURG ONC, V37, P811, DOI 10.1016/j.ejso.2011.06.006; Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; An JY, 2012, ANN SURG ONCOL, V19, P2452, DOI 10.1245/s10434-012-2267-9; Bi XC, 2012, CLIN TRANSL ONCOL, V14, P190, DOI 10.1007/s12094-012-0783-5; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Luo JQ, 2009, PROTEINS, V77, P1009, DOI 10.1002/prot.22577; Nakamura K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-191; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Pinheiro C, 2009, EUR J CANCER, V45, P2418, DOI 10.1016/j.ejca.2009.06.018; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Ruiz S, 2008, J BIOL CHEM, V283, P5554, DOI 10.1074/jbc.M708566200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tang Y, 2004, MOL CANCER RES, V2, P73; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058069; Vigneswaran N, 2006, EXP MOL PATHOL, V80, P147, DOI 10.1016/j.yexmp.2005.09.011; Wang B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-61; Xue YJ, 2011, MED ONCOL, V28, P1363, DOI 10.1007/s12032-010-9582-4; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zheng HC, 2006, BRIT J CANCER, V95, P1371, DOI 10.1038/sj.bjc.6603425; Zhong X, 2012, ANN SURG ONCOL; Zou W, 2007, CANCER LETT, V248, P211, DOI 10.1016/j.canlet.2006.07.005	30	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101027	10.1371/journal.pone.0101027	http://dx.doi.org/10.1371/journal.pone.0101027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979746	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400064
J	Cullen, CL; Burne, THJ; Lavidis, NA; Moritz, KM				Cullen, Carlie L.; Burne, Thomas H. J.; Lavidis, Nickolas A.; Moritz, Karen M.			Low Dose Prenatal Alcohol Exposure Does Not Impair Spatial Learning and Memory in Two Tests in Adult and Aged Rats	PLOS ONE			English	Article							ETHANOL EXPOSURE; MODERATE LEVELS; SYNAPTIC PLASTICITY; WATER-MAZE; SPECTRUM DISORDERS; POSTNATAL EXPOSURE; CRITICAL PERIODS; DENTATE GYRUS; CELL LOSS; FETAL	Consumption of alcohol during pregnancy can have detrimental impacts on the developing hippocampus, which can lead to deficits in learning and memory function. Although high levels of alcohol exposure can lead to severe deficits, there is a lack of research examining the effects of low levels of exposure. This study used a rat model to determine if prenatal exposure to chronic low dose ethanol would result in deficits in learning and memory performance and if this was associated with morphological changes within the hippocampus. Sprague Dawley rats were fed a liquid diet containing 6% (vol/vol) ethanol (EtOH) or an isocaloric control diet throughout gestation. Male and Female offspring underwent behavioural testing at 8 (Adult) or 15 months (Aged) of age. Brains from these animals were collected for stereological analysis of pyramidal neuron number and dendritic morphology within the CA1 and CA3 regions of the dorsal hippocampus. Prenatal ethanol exposed animals did not differ in spatial learning or memory performance in the Morris water maze or Y maze tasks compared to Control offspring. There was no effect of prenatal ethanol exposure on pyramidal cell number or density within the dorsal hippocampus. Overall, this study indicates that chronic low dose prenatal ethanol exposure in this model does not have long term detrimental effects on pyramidal cells within the dorsal hippocampus or impair spatial learning and memory performance.	[Cullen, Carlie L.; Lavidis, Nickolas A.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	k.moritz1@uq.edu.au	Burne, Thomas H/C-5656-2009; Cullen, Carlie/J-7706-2014; Moritz, Karen/G-2508-2015	Burne, Thomas H/0000-0003-3502-9789; Cullen, Carlie/0000-0001-6929-6258; Moritz, Karen/0000-0002-8085-0034	National Health and Medical Research Council of Australia; Australian Post-graduate award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Post-graduate award(Australian Government)	This work was supported by the National Health and Medical Research Council of Australia. CC was the recipient of an Australian Post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1980, PSYCHOL BULL, V87, P29; ABEL EL, 1983, NEUROBEH TOXICOL TER, V5, P363; ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P437, DOI 10.1016/0892-0362(95)00005-C; An L, 2013, ALCOHOL CLIN EXP RES, V37, P763, DOI 10.1111/acer.12040; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; BROWN RT, 1991, NEUROTOXICOL TERATOL, V13, P369, DOI 10.1016/0892-0362(91)90085-B; CLAUSING P, 1995, NEUROTOXICOL TERATOL, V17, P545, DOI 10.1016/0892-0362(95)00014-I; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Cronise K, 2001, BEHAV NEUROSCI, V115, P138, DOI 10.1037//0735-7044.115.1.138; Cullen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054924; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dobson CC, 2012, BEHAV BRAIN RES, V233, P162, DOI 10.1016/j.bbr.2012.04.042; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; GIANOULAKIS C, 1990, BEHAV BRAIN RES, V36, P217, DOI 10.1016/0166-4328(90)90060-R; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Glavas MM, 2007, ALCOHOL CLIN EXP RES, V31, P1598, DOI 10.1111/j.1530-0277.2007.00460.x; Gonzalez-Burgos I, 2006, NEUROSCI RES, V56, P400, DOI 10.1016/j.neures.2006.08.007; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; HOFF SF, 1988, BRAIN RES BULL, V21, P47, DOI 10.1016/0361-9230(88)90119-0; Hofmann CE, 2005, PHARMACOL BIOCHEM BE, V82, P549, DOI 10.1016/j.pbb.2005.10.010; Howell KK, 2006, J PEDIATR PSYCHOL, V31, P116, DOI 10.1093/jpepsy/jsj029; Iqbal U, 2005, J NEUROENDOCRINOL, V17, P600, DOI 10.1111/j.1365-2826.2005.01349.x; JONES KL, 1973, LANCET, V1, P1267; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; KELLY SJ, 1988, BEHAV BRAIN RES, V27, P247, DOI 10.1016/0166-4328(88)90121-0; Kerns KA, 1997, J LEARN DISABIL-US, V30, P685, DOI 10.1177/002221949703000612; LEDIG M, 1988, ALCOHOL ALCOHOLISM, V23, P63; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; LOCHRY EA, 1980, NEUROTOXICOL TERATOL, V2, P107; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; Mattson SN, 1999, J INT NEUROPSYCH SOC, V5, P462, DOI 10.1017/S1355617799555082; McAdam TD, 2008, BEHAV BRAIN RES, V191, P202, DOI 10.1016/j.bbr.2008.03.029; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Mineur YS, 2007, OPEN BEHAV SCI J, V1, P5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nagahara AH, 1997, ALCOHOL CLIN EXP RES, V21, P710, DOI 10.1111/j.1530-0277.1997.tb03826.x; O'Connor MJ, 2000, ALCOHOL CLIN EXP RES, V24, P1084, DOI 10.1097/00000374-200007000-00021; Olson HC, 1997, J AM ACAD CHILD PSY, V36, P1187, DOI 10.1097/00004583-199709000-00010; OSBORNE GL, 1980, PHARMACOL BIOCHEM BE, V12, P393, DOI 10.1016/0091-3057(80)90043-X; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Rasmussen C, 2011, CHILD CARE HLTH DEV, V37, P711, DOI 10.1111/j.1365-2214.2010.01152.x; REYES E, 1989, PHYSIOL BEHAV, V46, P45, DOI 10.1016/0031-9384(89)90319-3; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Savage DD, 2002, ALCOHOL CLIN EXP RES, V26, P1752, DOI 10.1097/01.ALC.0000038265.52107.20; Schneider ML, 2001, ALCOHOL CLIN EXP RES, V25, P1383; Sluyter F, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-5; Sowell ER, 2007, NEUROREPORT, V18, P635, DOI 10.1097/WNR.0b013e3280bad8dc; Streissguth A P, 2000, Semin Clin Neuropsychiatry, V5, P177, DOI 10.1053/scnp.2000.6729; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1989, ANN NY ACAD SCI, V562, P145, DOI 10.1111/j.1749-6632.1989.tb21013.x; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Sutherland RJ, 2000, PSYCHOBIOLOGY, V28, P532; Sutherland RJ, 1997, HIPPOCAMPUS, V7, P232, DOI 10.1002/(SICI)1098-1063(1997)7:2<232::AID-HIPO9>3.0.CO;2-O; TANAKA H, 1991, INT J DEV NEUROSCI, V9, P509, DOI 10.1016/0736-5748(91)90037-M; Tarelo-Acuna L, 2000, NEUROSCI LETT, V286, P13, DOI 10.1016/S0304-3940(00)01075-2; Tomlinson D, 1998, PHYSIOL BEHAV, V63, P205, DOI 10.1016/S0031-9384(97)00424-1; Tran TD, 2003, NEUROTOXICOL TERATOL, V25, P519, DOI 10.1016/S0892-0362(03)00074-6; Vega MCS, 2013, BEHAV BRAIN RES, V252, P326, DOI 10.1016/j.bbr.2013.06.003; Watson C, 2006, RAT BRAIN STEREOTAXI; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; Willoughby KA, 2008, J INT NEUROPSYCH SOC, V14, P1022, DOI 10.1017/S1355617708081368	71	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101482	10.1371/journal.pone.0101482	http://dx.doi.org/10.1371/journal.pone.0101482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978807	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400130
J	Ro, J; Harvanek, ZM; Pletcher, SD				Ro, Jennifer; Harvanek, Zachary M.; Pletcher, Scott D.			FLIC: High-Throughput, Continuous Analysis of Feeding Behaviors in Drosophila	PLOS ONE			English	Article							TASTE; QUANTIFICATION; MELANOGASTER; RESTRICTION; FLY	We present a complete hardware and software system for collecting and quantifying continuous measures of feeding behaviors in the fruit fly, Drosophila melanogaster. The FLIC (Fly Liquid-Food Interaction Counter) detects analog electronic signals as brief as 50 mu s that occur when a fly makes physical contact with liquid food. Signal characteristics effectively distinguish between different types of behaviors, such as feeding and tasting events. The FLIC system performs as well or better than popular methods for simple assays, and it provides an unprecedented opportunity to study novel components of feeding behavior, such as time-dependent changes in food preference and individual levels of motivation and hunger. Furthermore, FLIC experiments can persist indefinitely without disturbance, and we highlight this ability by establishing a detailed picture of circadian feeding behaviors in the fly. We believe that the FLIC system will work hand-in-hand with modern molecular techniques to facilitate mechanistic studies of feeding behaviors in Drosophila using modern, high-throughput technologies.	[Ro, Jennifer] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.; Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pletcher, SD (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Harvanek, Zachary/AGR-7656-2022; Harvanek, Zachary M/GPJ-9798-2022	Harvanek, Zachary/0000-0003-3702-1051; Ro, Jennifer/0000-0002-6351-2498	US National Institutes of Health [R01AG030593, TR01 AG043972, R01AG023166]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Glenn/AFAR Scholarship for Research in the Biology of Aging; Systems and Integrative Biology Training Grant [T32 GM008322]; Research Training in Biogerontology [T32 AG000114]; National Institute of Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, T32GM007863, T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283, R01AG043972, F31AG047696, R01AG030593, T32AG000114, R01AG023166] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn/AFAR Scholarship for Research in the Biology of Aging; Systems and Integrative Biology Training Grant; Research Training in Biogerontology; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research was supported by US National Institutes of Health (R01AG030593, TR01 AG043972, and R01AG023166), the Glenn Foundation, the American Federation for Aging Research, the Ellison Medical Foundation (to S. D. P.), a Glenn/AFAR Scholarship for Research in the Biology of Aging (to Z.M.H.), the Systems and Integrative Biology Training Grant (T32 GM008322 to Z.M.H.), and the Research Training in Biogerontology (T32 AG000114, to J.R.). This work utilized the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging funded by the National Institute of Aging (P30-AG-013283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson NS, 2009, J NEUROGENET, V23, P293, DOI 10.1080/01677060802572937; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chatterjee A, 2010, FLY, V4, P283, DOI 10.4161/fly.4.4.13010; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dethier VG, 1976, HUNGRY FLY; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; GEER BW, 1970, J INSECT PHYSIOL, V16, P33, DOI 10.1016/0022-1910(70)90110-1; Gordesky-Gold B, 2008, CHEM SENSES, V33, P301, DOI 10.1093/chemse/bjm088; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Itskov PM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00012; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JACOBS HL, 1969, ANN NY ACAD SCI, V157, P1084, DOI 10.1111/j.1749-6632.1969.tb12939.x; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Pfeiffenberger C, 2010, COLD SPRING HARB PRO; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Tanoue S, 2008, CURR BIOL, V18, P787, DOI 10.1016/j.cub.2008.04.062; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wong R, 2008, NAT METHODS, V5, P214, DOI 10.1038/nmeth0308-214; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006	23	76	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101107	10.1371/journal.pone.0101107	http://dx.doi.org/10.1371/journal.pone.0101107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978054	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400079
J	Stojmirovic, A; Yu, YK				Stojmirovic, Aleksandar; Yu, Yi-Kuo			Building a Hierarchical Organization of Protein Complexes Out of Protein Association Data	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INFORMATION-FLOW; NETWORK; SUM; PURIFICATION; INTERACTOME; CHAPERONE; RESOURCE; GENES; ATLAS	Organizing experimentally determined protein associations as a hierarchy can be a good approach to elucidating the content of protein complexes and the modularity of subcomplexes. Several challenges exist. First, intrinsically sticky proteins, such as chaperones, are often falsely assigned to many functionally unrelated complexes. Second, the reported collections of proteins may not be true "complexes" in the sense that they bind together and perform a joint cellular function. Third, due to imperfect sensitivity of protein detection methods, both false positive and false negative assignments of a protein to complexes may occur. We mitigate the first issue by down-weighting sticky proteins by their occurrence frequencies. We approach the other two problems by merging nearly identical complexes and by constructing a directed acyclic graph (DAG) based on the relationship of partial inclusion. The constructed DAG, within which smaller complexes form parts of the larger, can reveal how different complexes are joined. By merging almost identical complexes one can deemphasize the influence of false positives, while allowing false negatives to be rescued by other nearly identical association data. We investigate several protein weighting schemes and compare their corresponding DAGs using yeast and human complexes. We find that the scheme incorporating weights based on information flow in the network of direct protein-protein interactions produces biologically most meaningful DAGs. In either yeast or human, isolated nodes form a large proportion of the final hierarchy. While most connected components encompass very few nodes, the largest one for each species contains a sizable portion of all nodes. By considering examples of subgraphs composed of nodes containing a specified protein, we illustrate that the graphs' topological features can correctly suggest the biological roles of protein complexes. The input data, final results and the source code are available at ftp://ftp.ncbi.nlm.nih.gov/pub/qmbpmn/ProteinComplexDAG/.	[Stojmirovic, Aleksandar; Yu, Yi-Kuo] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	yyu@ncbi.nlm.nih.gov		Stojmirovic, Aleksandar/0000-0003-0957-6893	Intramural Research Program of the National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Havugimana PC, 2007, J CHROMATOGR B, V847, P54, DOI 10.1016/j.jchromb.2006.10.075; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Isserlin R, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq037; Kemeny J.G., 1976, MARKOV CHAINS, V6; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; LUGANNANI R, 1980, ADV APPL PROBAB, V12, P475, DOI 10.2307/1426607; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stojmircivic A, 2007, J COMPUT BIOL, V14, P1115, DOI 10.1089/cmb.2007.0069; Stojmirovic A, 2012, J COMPUT BIOL, V19, P379, DOI 10.1089/cmb.2010.0228; Stojmirovic A, 2012, BIOINFORMATICS, V28, P893, DOI 10.1093/bioinformatics/bts041; Stojmirovic A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar036; Stojmirovic A, 2010, BIOINFORMATICS, V26, P2752, DOI 10.1093/bioinformatics/btq511; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	46	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100098	10.1371/journal.pone.0100098	http://dx.doi.org/10.1371/journal.pone.0100098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978199	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400020
J	Kokkinopoulou, M; Guler, MA; Lieb, B; Barbeck, M; Ghanaati, S; Markl, J				Kokkinopoulou, Maria; Gueler, M. Alptekin; Lieb, Bernhard; Barbeck, Mike; Ghanaati, Shahram; Markl, Jurgen			3D-Ultrastructure, Functions and Stress Responses of Gastropod (Biomphalaria glabrata) Rhogocytes	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; PORE CELLS; CONNECTIVE-TISSUE; SALIVARY-GLANDS; NEPHRIN; PROTEIN; ACTIN; HEMOGLOBIN; MOLECULES; EVOLUTION	Rhogocytes are pore cells scattered among the connective tissue of different body parts of gastropods and other molluscs, with great variation in their number, shape and size. They are enveloped by a lamina of extracellular matrix. Their most characteristic feature is the "slit apparatus", local invaginations of the plasma membrane bridged by cytoplasmic bars, forming slits of ca. 20 nm width. A slit diaphragm creates a molecular sieve with permeation holes of 20620 nm. In blue-blooded gastropods, rhogocytes synthesize and secrete the respiratory protein hemocyanin, and it has been proposed-though not proven-that in the rare red-blooded snail species they might synthesize and secrete the hemoglobin. However, the cellular secretion pathway for respiratory proteins, and the functional role(s) of the enigmatic rhogocyte slit apparatus are still unclear. Additional functions for rhogocytes have been proposed, notably a role in protein uptake and degradation, and in heavy metal detoxification. Here we provide new structural and functional information on the rhogocytes of the red-blooded freshwater snail Biomphalaria glabrata. By in situ hybridization of mantle tissues, we prove that rhogocytes indeed synthesize hemoglobin. By electron tomography, the first three dimensional (3D) reconstructions of the slit apparatus are provided, showing detail of highly dense material in the cytoplasmic bars close to the slits. By immunogold labelling, we collected evidence that a major component of this material is actin. By genome databank mining, the complete sequence of a B. glabrata nephrin was obtained, and localized to the rhogocytes by immunofluorescence microscopy. The presence of both proteins fit the ultrastructure-based hypothesis that rhogocytes are related to mammalian podocytes and insect nephrocytes. Reactions of the rhogocytes to deprivation of food and cadmium toxification are also documented, and a possible secretion pathway of newly synthesized respiratory proteins through the slit apparatus is discussed.	[Kokkinopoulou, Maria; Gueler, M. Alptekin; Lieb, Bernhard; Markl, Jurgen] Johannes Gutenberg Univ Mainz, Inst Zool, Mainz, Germany; [Barbeck, Mike; Ghanaati, Shahram] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Markl, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, Mainz, Germany.	markl@uni-mainz.de	Lieb, Bernhard/AFT-2157-2022; Barbeck, Mike/U-4340-2018	Barbeck, Mike/0000-0002-3001-1347; Ghanaati, Shahram/0000-0002-7897-0854; Guler, Alptekin/0000-0001-7073-2125	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	This work was funded in part by the Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany (MK: grant; JM: consumables, instruments) and the Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University (JM: instruments). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2001, CELL TISSUE RES, V304, P455, DOI 10.1007/s004410100368; BANI G, 1990, Z MIKROSK ANAT FORSC, V104, P856; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; BOER HH, 1976, CELL TISSUE RES, V170, P221; Brugge J, 1999, AM J PHYSIOL-REG I, V276, pR347, DOI 10.1152/ajpregu.1999.276.2.R347; BRUMMENDORF T, 1994, PROTEIN PROFILE, V1, P951; Dallinger R, 2005, AM J PHYSIOL-REG I, V289, pR1185, DOI 10.1152/ajpregu.00052.2005; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; De Carlo S, 2011, MICRON, V42, P117, DOI 10.1016/j.micron.2010.06.003; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; FIORONI P, 1984, ZOOL ANZ, V212, P193; FOURNIE J, 1982, MALACOLOGIA, V22, P265; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003; Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006; Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; Harris JR, 2002, MICRON, V33, P461, DOI 10.1016/S0968-4328(01)00039-7; Haszprunar G, 1996, J MOLLUS STUD, V62, P185, DOI 10.1093/mollus/62.2.185; HELMY S, 1986, CELL, V44, P497, DOI 10.1016/0092-8674(86)90471-X; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; Lieb B, 2004, J MOL EVOL, V59, P536, DOI 10.1007/s00239-004-2646-3; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; MARIGOMEZ JA, 1990, HISTOCHEMISTRY, V94, P191, DOI 10.1007/BF02440187; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Martin AM, 2011, INVERTEBR BIOL, V130, P302, DOI 10.1111/j.1744-7410.2011.00249.x; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meister G., 1977, Zoologische Jb (Anat), V97, P54; Moeller V, 2011, IUBMB LIFE, V63, P323, DOI 10.1002/iub.453; Nott JA, 1993, J MAR BIOL ASSOC UK, V13, P396; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Raghavan N, 2006, TRENDS PARASITOL, V22, P148, DOI 10.1016/j.pt.2006.02.008; RUPPERT EE, 1994, AM ZOOL, V34, P542; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Saur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043685; Schaffeld M, 2004, METHOD CELL BIOL, V78, P627; Schneider SW, 2001, J MEMBRANE BIOL, V181, P67; Segawa A, 1998, CELL TISSUE RES, V291, P325, DOI 10.1007/s004410051002; SKELDING JM, 1975, CELL TISSUE RES, V156, P381; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V130, P497, DOI 10.1007/BF00307004; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V135, P563, DOI 10.1007/BF00583437; SMINIA T, 1973, Z ZELLFORSCH MIK ANA, V145, P443, DOI 10.1007/BF00307166; SMINIA T, 1977, CELL TISSUE RES, V183, P299; Stewart H, 2014, INVERTEBR BIOL, V133, P47, DOI 10.1111/ivb.12041; Streit K, 2005, DIFFERENTIATION, V73, P341, DOI 10.1111/j.1432-0436.2005.00035.x; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; WOOD EJ, 1981, COMP BIOCHEM PHYS B, V69, P877, DOI 10.1016/0305-0491(81)90398-9; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	61	18	18	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101078	10.1371/journal.pone.0101078	http://dx.doi.org/10.1371/journal.pone.0101078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971744	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200089
J	Shi, Y; Ivannikov, MV; Walsh, ME; Liu, YH; Zhang, YQ; Jaramillo, CA; Macleod, GT; Van Remmen, H				Shi, Yun; Ivannikov, Maxim V.; Walsh, Michael E.; Liu, Yuhong; Zhang, Yiqiang; Jaramillo, Carlos A.; Macleod, Gregory T.; Van Remmen, Holly			The Lack of CuZnSOD Leads to Impaired Neurotransmitter Release, Neuromuscular Junction Destabilization and Reduced Muscle Strength in Mice	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; MOUSE MODEL; OXIDATIVE STRESS; KNOCKOUT MICE; MOTOR-NEURONS; ION CHANNELS; SYNAPSE; TRANSMISSION	Elevated reactive oxygen species (ROS) production and ROS-dependent protein damage is a common observation in the pathogenesis of many muscle wasting disorders, including sarcopenia. However, the contribution of elevated ROS levels to -a breakdown in neuromuscular communication and muscle atrophy remains unknown. In this study, we examined a copper zinc superoxide dismutase [CuZnSOD (Sod1)] knockout mouse (Sod1(-/-)), a mouse model of elevated oxidative stress that exhibits accelerated loss of muscle mass, which recapitulates many phenotypes of sarcopenia as early as 5 months of age. We found that young adult Sod1(-/-) mice display a considerable reduction in hind limb skeletal muscle mass and strength when compared to age-matched wild-type mice. These changes are accompanied by gross alterations in neuromuscular junction (NMJ) morphology, including reduced occupancy of the motor endplates by axons, terminal sprouting and axon thinning and irregular swelling. Surprisingly however, the average density of acetylcholine receptors in endplates is preserved. Using in vivo electromyography and ex vivo electrophysiological studies of hind limb muscles in Sod1(-/-) mice, we found that motor axons innervating the extensor digitorum longus (EDL) and gastrocnemius muscles release fewer synaptic vesicles upon nerve stimulation. Recordings from individually identified EDL NMJs show that reductions in neurotransmitter release are apparent in the Sod1(-/-) mice even when endplates are close to fully innervated. However, electrophysiological properties, such as input resistance, resting membrane potential and spontaneous neurotransmitter release kinetics (but not frequency) are similar between EDL muscles of Sod1(-/-) and wild-type mice. Administration of the potassium channel blocker 3,4-diaminopyridine, which broadens the presynaptic action potential, improves both neurotransmitter release and muscle strength. Together, these results suggest that ROS-associated motor nerve terminal dysfunction is a contributor to the observed muscle changes in Sod1(-/-) mice.	[Shi, Yun; Ivannikov, Maxim V.; Walsh, Michael E.; Liu, Yuhong; Zhang, Yiqiang; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Shi, Yun; Walsh, Michael E.; Liu, Yuhong; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Shi, Yun; Liu, Yuhong; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ivannikov, Maxim V.; Zhang, Yiqiang; Macleod, Gregory T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Jaramillo, Carlos A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, San Antonio, TX 78229 USA; [Van Remmen, Holly] Oklahoma City VA Med Ctr, Oklahoma City, OK USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Oklahoma System; University of Oklahoma Health Sciences Center	Van Remmen, H (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA.	holly-vanremmen@omrf.org	Zhang, Yiqiang/AAA-3143-2019	Macleod, Gregory/0000-0003-3782-6968	NIH [AG020591, NS061914, T32-AG021890]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020591, T32AG021890] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by NIH grants AG020591 to HVR, NS061914 to GTM and T32-AG021890 to MVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseenko AV, 2008, BRAIN RES, V1241, P193, DOI 10.1016/j.brainres.2008.09.012; BORODIC GE, 1994, MOVEMENT DISORD, V9, P31, DOI 10.1002/mds.870090106; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Chen J, 2012, J COMP NEUROL, V520, P434, DOI 10.1002/cne.22764; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b; DUVAL A, 1985, PFLUG ARCH EUR J PHY, V403, P407, DOI 10.1007/BF00589254; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; Frey D, 2000, J NEUROSCI, V20, P2534; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Kassmann M, 2008, PFLUG ARCH EUR J PHY, V456, P1085, DOI 10.1007/s00424-008-0477-6; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kostrominova TY, 2010, FREE RADICAL BIO MED, V49, P1582, DOI 10.1016/j.freeradbiomed.2010.08.022; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; Mori S, 2012, J NEUROIMMUNOL, V245, P75, DOI 10.1016/j.jneuroim.2012.02.010; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390; Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SPECTOR SA, 1985, J NEUROSCI, V5, P2189; Tsentsevitsky A, 2011, NEUROSCIENCE, V189, P93, DOI 10.1016/j.neuroscience.2011.05.033; Urbano FJ, 2014, AM J PHYSIOL-CELL PH, V306, pC396, DOI 10.1152/ajpcell.00301.2013; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; vanLunteren E, 1996, J APPL PHYSIOL, V81, P2214, DOI 10.1152/jappl.1996.81.5.2214; Vasilaki A, 2010, AGING CELL, V9, P979, DOI 10.1111/j.1474-9726.2010.00635.x; Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130	52	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100834	10.1371/journal.pone.0100834	http://dx.doi.org/10.1371/journal.pone.0100834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971750	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200066
J	Veiga, ABG; Ribeiro, JMC; Francischetti, IMB; Xu, XQ; Guimaraes, JA; Andersen, JF				Veiga, Ana B. G.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.; Xu, Xueqing; Guimaraes, Jorge A.; Andersen, John F.			Examination of the Ligand-Binding and Enzymatic Properties of a Bilin-Binding Protein from the Poisonous Caterpillar Lonomia obliqua	PLOS ONE			English	Article							OXYGENASE HMU O; MANDUCA-SEXTA L; CORYNEBACTERIUM-DIPHTHERIAE; PSEUDOMONAS-AERUGINOSA; HEMORRHAGIC SYNDROME; MOLECULAR-STRUCTURE; OXIDATIVE CLEAVAGE; COUPLED OXIDATION; CRYSTAL-STRUCTURE; TOBACCO HORNWORM	The bilin-binding proteins (BBP) from lepidopteran insects are members of the lipocalin family of proteins and play a special role in pigmentation through the binding of biliverdin IX gamma. Lopap, a BBP-like protein from the venom of the toxic caterpillar Lonomia obliqua has been reported to act as a serine protease that activates the coagulation proenzyme prothrombin. Here we show that BBPLo, a variant of lopap from the same organism binds biliverdin IX gamma, forming a complex that is spectrally identical with previously described BBP proteins. Although BBPLo is nearly identical in sequence to lopap, no prothrombinase activity was detected in our recombinant preparations using reconstituted systems containing coagulation factors Xa and Va, as well as anionic phospholipids. In addition to biliverdin, BBPLo was found to form a 1:1 complex with heme prompting us to examine whether the unusual biliverdin IX gamma ligand of BBPs forms as a result of oxidation of bound heme in situ rather than by a conventional heme oxygenase. Using ascorbate or a NADPH+-ferredoxin reductase-ferredoxin system as a source of reducing equivalents, spectral changes are seen that suggest an initial reduction of heme to the Fe(II) state and formation of an oxyferrous complex. The complex then disappears and a product identified as a 5-coordinate carbonyl complex of verdoheme, an intermediate in the biosynthesis of biliverdin, is formed. However, further reaction to form biliverdin was not observed, making it unlikely that biliverdin IX gamma is formed by this pathway.	[Veiga, Ana B. G.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.; Xu, Xueqing; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Veiga, Ana B. G.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio Grande do Sul	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	da Veiga, Ana Beatriz Gorini/N-8581-2013; Guimarães, Jorge Almeida/V-2196-2019; Ribeiro, Jose/J-7011-2015	da Veiga, Ana Beatriz Gorini/0000-0003-1462-5506; Ribeiro, Jose/0000-0002-9107-0818; Guimaraes, Jorge A./0000-0001-6354-6789	intramural research program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	intramural research program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the NIAID, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JF, 1998, STRUCTURE, V6, P1315, DOI 10.1016/S0969-2126(98)00131-2; Andersen JF, 2000, J BIOL CHEM, V275, P30496, DOI 10.1074/jbc.M002857200; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Avila L, 2003, J AM CHEM SOC, V125, P4103, DOI 10.1021/ja029311v; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; GOODMAN WG, 1985, BIOCHEMISTRY-US, V24, P1168, DOI 10.1021/bi00326a017; Gudderra NP, 2005, J BIOL CHEM, V280, P25022, DOI 10.1074/jbc.M504386200; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325; RILEY CT, 1984, J BIOL CHEM, V259, P3159; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u; Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002; Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020; Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 2000, J BIOL CHEM, V275, P11686, DOI 10.1074/jbc.275.16.11686; Wilks A, 1996, BIOCHEMISTRY-US, V35, P930, DOI 10.1021/bi952405f; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837	25	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e95424	10.1371/journal.pone.0095424	http://dx.doi.org/10.1371/journal.pone.0095424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972000	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200003
J	Wang, HY; Zhao, GH; Chen, GY; Jian, FC; Zhang, SM; Feng, C; Wang, RJ; Zhu, JF; Dong, HJ; Hua, J; Wang, M; Zhang, LX				Wang, Haiyan; Zhao, Guanghui; Chen, Gongyi; Jian, Fuchun; Zhang, Sumei; Feng, Chao; Wang, Rongjun; Zhu, Jinfeng; Dong, Haiju; Hua, Jun; Wang, Ming; Zhang, Longxian			Multilocus Genotyping of Giardia duodenalis in Dairy Cattle in Henan, China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM SPP.; GENETIC CHARACTERIZATIONS; ENTEROCYTOZOON-BIENEUSI; ZOONOTIC TRANSMISSION; PREVALENCE; INFECTIONS; CALVES; IDENTIFICATION; EPIDEMIOLOGY	Giardia duodenalis is a common and widespread intestinal protozoan parasite of both humans and animals. Previous epidemiological and molecular studies have identified Giardia infections in different animals and humans, but only limited information is available about the occurrence and genotypes of Giardia in cattle in China. In this study, we determined the occurrence of giardiasis and genetically characterized G. duodenalis in dairy cattle in Henan Province, central China. The overall prevalence of G. duodenalis was 7.2% (128/1777) on microscopic analysis, with the highest infection rate (22.7%) in calves aged less than 1 month. G. duodenalis assemblages and subtypes were identified with multilocus genotyping based on the SSU rRNA, beta-giardin (bg), glutamate dehydrogenase (gdh), and triosephosphate isomerase (tpi) genes. Two assemblages were detected in the successfully sequenced samples: assemblage A (n = 58), assemblage E (n = 21), with a mixed E and A assemblage (n = 2). Four novel subtypes of the gdh gene and seven of the bg gene were found among the G. duodenalis assemblage E isolates. Using the nomenclature for the multilocus genotype (MLG) model, nine novel multilocus genotypes E (MLGs E1-E9) and three MLGs A (a novel subtype AI, previously detected subtype AII-1, and a combination of both) were identified. MLG AII-1 identified in this study may be an important zoonotic subtype. The dairy cattle in Henan are a potential public health concern.	[Wang, Haiyan; Jian, Fuchun; Zhang, Sumei; Feng, Chao; Wang, Rongjun; Dong, Haiju; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China; [Wang, Haiyan; Chen, Gongyi; Zhu, Jinfeng; Hua, Jun] Henan Vocat Coll Agr, Dept Anim Sci, Zhongmu, Henan Province, Peoples R China; [Wang, Haiyan; Wang, Ming] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zhao, Guanghui] Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi Province, Peoples R China	Henan Agricultural University; China Agricultural University; Northwest A&F University - China	Zhang, LX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China.	zhanglx8999@gmail.com	Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022	Zhang, Longxian/0000-0002-5706-131X; 	State Key Program of National Natural Science Foundation of China [31330079]; funds for the International Cooperation and Exchange of the National Natural Science Foundation of China [31110103901]; Program for Science&Technology Innovation Talents in Universities of Henan Province [134200510012]; Key National Science and Technology Specific Projects [2012ZX10004220-001]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); funds for the International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science&Technology Innovation Talents in Universities of Henan Province; Key National Science and Technology Specific Projects	This study was supported in part by the State Key Program of National Natural Science Foundation of China (31330079), http://www.nsfc.gov.cn/publish/portal0/default.htm; the funds for the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 31110103901), http://www.nsfc.gov.cn/nsfc/cen/gjhzj/index.html; the Program for Science&Technology Innovation Talents in Universities of Henan Province (134200510012), http://www.hnkjt.gov.cn/new/; and the Key National Science and Technology Specific Projects (No. 2012ZX10004220-001), http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbee AJ, 2003, VET PARASITOL, V112, P289, DOI 10.1016/S0304-4017(02)00422-3; Becher KA, 2004, VET PARASITOL, V123, P1, DOI 10.1016/j.vetpar.2004.05.020; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Castro-Hermida JA, 2006, J VET MED B, V53, P244, DOI 10.1111/j.1439-0450.2006.00946.x; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Geurden T, 2008, VET PARASITOL, V153, P384, DOI 10.1016/j.vetpar.2008.01.031; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; Huetink REC, 2001, VET PARASITOL, V102, P53, DOI 10.1016/S0304-4017(01)00514-3; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Li J, 2012, VET PARASITOL, V188, P368, DOI 10.1016/j.vetpar.2012.04.004; Li W, 2013, EXP PARASITOL, V135, P223, DOI 10.1016/j.exppara.2013.07.009; Liu AQ, 2012, PARASITOL RES, V111, P655, DOI 10.1007/s00436-012-2883-0; Mark-Carew MP, 2012, VET PARASITOL, V185, P151, DOI 10.1016/j.vetpar.2011.09.030; MAYRHOFER G, 1995, PARASITOLOGY, V111, P11, DOI 10.1017/S0031182000064556; Mendonca C, 2007, VET PARASITOL, V147, P47, DOI 10.1016/j.vetpar.2007.03.019; Monis PT, 2003, INFECT GENET EVOL, V3, P29, DOI 10.1016/S1567-1348(02)00149-1; O'Handley RM, 1999, J AM VET MED ASSOC, V214, P391; Quilez J, 1996, VET PARASITOL, V66, P139, DOI 10.1016/S0304-4017(96)01015-1; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2009, VET PARASITOL, V162, P40, DOI 10.1016/j.vetpar.2009.02.008; Smith HV, 2006, TRENDS PARASITOL, V22, P160, DOI 10.1016/j.pt.2006.02.009; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Thompson RCA, 2004, VET PARASITOL, V126, P15, DOI 10.1016/j.vetpar.2004.09.008; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Trout JM, 2005, VET PARASITOL, V130, P177, DOI 10.1016/j.vetpar.2005.03.032; Wade SE, 2000, VET PARASITOL, V93, P1, DOI 10.1016/S0304-4017(00)00337-X; Wade SE, 2000, VET PARASITOL, V89, P11, DOI 10.1016/S0304-4017(99)00228-9; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Winkworth CL, 2008, NEW ZEAL VET J, V56, P15, DOI 10.1080/00480169.2008.36799; Winkworth CL, 2008, APPL ENVIRON MICROB, V74, P5100, DOI 10.1128/AEM.00232-08; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	47	54	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100453	10.1371/journal.pone.0100453	http://dx.doi.org/10.1371/journal.pone.0100453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971639	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200033
J	Wu, HY; Chen, CY; Lai, EM				Wu, Hung-Yi; Chen, Chao-Ying; Lai, Erh-Min			Expression and Functional Characterization of the Agrobacterium VirB2 Amino Acid Substitution Variants in T-pilus Biogenesis, Virulence, and Transient Transformation Efficiency	PLOS ONE			English	Article							IV SECRETION SYSTEM; TUMEFACIENS; PROTEINS; PILIN; CONJUGATION; DIVERSITY	Agrobacterium tumefaciens is a phytopathogenic bacterium that causes crown gall disease by transferring transferred DNA (T-DNA) into the plant genome. The translocation process is mediated by the type IV secretion system (T4SS) consisting of the VirD4 coupling protein and 11 VirB proteins (VirB1 to VirB11). All VirB proteins are required for the production of T-pilus, which consists of processed VirB2 (T-pilin) and VirB5 as major and minor subunits, respectively. VirB2 is an essential component of T4SS, but the roles of VirB2 and the assembled T-pilus in Agrobacterium virulence and the T-DNA transfer process remain unknown. Here, we generated 34 VirB2 amino acid substitution variants to study the functions of VirB2 involved in VirB2 stability, extracellular VirB2/T-pilus production and virulence of A. tumefaciens. From the capacity for extracellular VirB2 production (ExB2(+) or ExB2(-)) and tumorigenesis on tomato stems (Vir(+) or Vir(-)), the mutants could be classified into three groups: ExB2(-)/Vir(-), ExB2(-)/Vir(+), and ExB2(+)/Vir(+). We also confirmed by electron microscopy that five ExB2(-)/Vir(+) mutants exhibited a wild-type level of virulence with their deficiency in T-pilus formation. Interestingly, although the five T-pilus(-)/Vir(+) uncoupling mutants retained a wild-type level of tumorigenesis efficiency on tomato stems and/or potato tuber discs, their transient transformation efficiency in Arabidopsis seedlings was highly attenuated. In conclusion, we have provided evidence for a role of T-pilus in Agrobacterium transformation process and have identified the domains and amino acid residues critical for VirB2 stability, T-pilus biogenesis, tumorigenesis, and transient transformation efficiency.	[Wu, Hung-Yi; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wu, Hung-Yi; Chen, Chao-Ying; Lai, Erh-Min] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	emlai@gate.sinica.edu.tw	Lai, Erh-Min/ABG-9558-2020; Wu, Hung-Yi/HGF-2679-2022	Lai, Erh-Min/0000-0003-3630-8683; CHEN, CHAO-YING/0000-0003-0455-832X	National Science Council [NSC 101-2321-B-001 -033 -]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by a research grant from the National Science Council (NSC 101-2321-B-001 -033 -) and a grant from Academia Sinica to EML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Banta LM, 2011, J BACTERIOL, V193, P2566, DOI 10.1128/JB.00038-11; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Cameron TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042219; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2013, J BACTERIOL, V195, P2691, DOI 10.1128/JB.00114-13; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Garza I, 2013, J BACTERIOL, V195, P3022, DOI 10.1128/JB.00287-13; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; Julio Salinas JJS-S, 2006, METHODS MOL BIOL; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lacroix B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025578; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, FEMS MICROBIOL LETT, V210, P111, DOI 10.1111/j.1574-6968.2002.tb11168.x; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; Shu AC, 2008, LANGMUIR, V24, P6796, DOI 10.1021/la703384n; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Wu HY, 2014, PLANT METHO IN PRESS	50	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101142	10.1371/journal.pone.0101142	http://dx.doi.org/10.1371/journal.pone.0101142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971727	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200097
J	Zaafar, DK; Zaitone, SA; Moustafa, YM				Zaafar, Dalia K.; Zaitone, Sawsan A.; Moustafa, Yasser M.			Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell Proliferation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; 1ST-LINE TREATMENT; COLORECTAL-CANCER; RAT-LIVER; MELLITUS; INSULIN; RISK; OXALIPLATIN; CARCINOMA	Several studies indicated that type 2 diabetes mellitus and insulin resistance are associated with increased colon cancer risk. Recently, studies suggest that metformin can reduce cancer risk in diabetic or non-diabetic patients with unclear mechanisms. This work aimed to determine the effect of metformin on chemically-induced colon cancer in mice. Colon cancer was induced using 1,2-dimethylhydrazine (DMH, 20 mg/kg/week, s.c.) for fifteen weeks. Experiment I: healthy mice were fed with basal diet for four weeks and then allocated into seven groups, (i) saline, (ii) DMH, (iii) oxaliplatin, (iv-v): metformin (100 or 200 mg/kg) and (vi-vii): oxaliplatin+metformin (100 or 200 mg/kg), respectively. Experiment II: type 2 diabetes mellitus was induced by injection of STZ (30 mg/kg) after four weeks of high-fat feeding and then mice were allocated into seven groups similar to those reported in experiment I. Examination of the colonic tissue at the end of the experiment highlighted an increase in angiogenic markers and cell proliferation and showed a greater immunostaining for insulin growth factor I receptors and CD34 in the colon of diabetic mice compared to non-diabetics. In general, metformin downregulated tumor angiogenesis and augmented the antitumor effect of oxaliplatin. Overall, the current results showed that metformin protected against DMH-induced colon cancer in non-diabetic and diabetic mice. This therapeutic effect was, at least in part, attributed to its anti-angiogenic and anti-proliferative mechanisms.	[Zaafar, Dalia K.] Directorate Hlth & Populat, Ismailia, Egypt; [Zaitone, Sawsan A.; Moustafa, Yasser M.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University	Zaitone, SA (corresponding author), Directorate Hlth & Populat, Ismailia, Egypt.	Sawsan_zaytoon@pharm.suez.edu.eg	Zaitone, Sawsan A/G-8930-2017; Moustafa, Yasser/AAS-1212-2021; Zaafar, Dalia/T-2301-2019	Zaitone, Sawsan A/0000-0002-9688-7683; Moustafa, Yasser/0000-0001-5394-5559; Zaafar, Dalia/0000-0002-7201-3658				Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Banchroft J.D., 1996, THEORY PRACTICE HIST; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bhattacharyya S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005967; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Castleden, 1979, J CANC, V39, P731; Chiarelli F, 2000, DIABETIC MED, V17, P650, DOI 10.1046/j.1464-5491.2000.00350.x; Colussi C, 2001, J NATL CANCER I, V93, P1534, DOI 10.1093/jnci/93.20.1534; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Engel S, 2003, NEW ENGL J MED, V348, P2294; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Gerstein HC, 2010, JAMA-J AM MED ASSOC, V303, P446, DOI 10.1001/jama.2010.60; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Haisa M, 2013, J INT MED RES, V41, P253, DOI 10.1177/0300060513476585; Hanahan D, 1998, NAT MED, V4, P13, DOI 10.1038/nm0198-013; HAYES MA, 1987, CARCINOGENESIS, V8, P1155, DOI 10.1093/carcin/8.8.1155; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Hvid H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079710; Ikemura M, 2013, J CONTROL RELEASE, V170, P191, DOI 10.1016/j.jconrel.2013.05.028; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Ito K, 2013, CANCER SCI, V104, P835, DOI 10.1111/cas.12162; Jackson PE, 1999, CARCINOGENESIS, V20, P509, DOI 10.1093/carcin/20.3.509; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LEWIS JG, 1982, CANCER RES, V42, P89; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu J, 2013, UROL ONCOL-SEMIN ORI, V31, P264, DOI 10.1016/j.urolonc.2011.01.003; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McFarland MS, 2010, PHARMACOTHERAPY, V30, P1159, DOI 10.1592/phco.30.11.1159; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Micic D, 2011, HORM-INT J ENDOCRINO, V10, P5, DOI 10.14310/horm.2002.1288; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oh JS, 2002, NEOPLASIA, V4, P204, DOI 10.1038/sj.neo.7900229; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rothenberg ML, 2000, ONCOLOGY-NY, V14, P9; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Shank JJ, 2012, GYNECOL ONCOL, V127, P390, DOI 10.1016/j.ygyno.2012.07.115; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Will JC, 1998, AM J EPIDEMIOL, V147, P816, DOI 10.1093/oxfordjournals.aje.a009534; Yabe Y, 2001, J PHARMACOL EXP THER, V298, P894; Yilmaz A, 1999, J ANIM SCI, V77, P835; YING TS, 1979, CHEM-BIOL INTERACT, V28, P363, DOI 10.1016/0009-2797(79)90176-5	64	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100562	10.1371/journal.pone.0100562	http://dx.doi.org/10.1371/journal.pone.0100562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971882	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200042
J	Bianchini, P; Cardarelli, F; Di Luca, M; Diaspro, A; Bizzarri, R				Bianchini, Paolo; Cardarelli, Francesco; Di Luca, Mariagrazia; Diaspro, Alberto; Bizzarri, Ranieri			Nanoscale Protein Diffusion by STED-Based Pair Correlation Analysis	PLOS ONE			English	Article							ARGININE-RICH MOTIF; CORRELATION SPECTROSCOPY; CROSS-CORRELATION; NUCLEAR-ENVELOPE; PARTICLES CLPS; IN-VITRO; MICROSCOPY; DYNAMICS; DISPLAY; VIVO	We describe for the first time the combination between cross-pair correlation function analysis (pair correlation analysis or pCF) and stimulated emission depletion (STED) to obtain diffusion maps at spatial resolution below the optical diffraction limit (super-resolution). Our approach was tested in systems characterized by high and low signal to noise ratio, i.e. Capsid Like Particles (CLPs) bearing several (>100) active fluorescent proteins and monomeric fluorescent proteins transiently expressed in living Chinese Hamster Ovary cells, respectively. The latter system represents the usual condition encountered in living cell studies on fluorescent protein chimeras. Spatial resolution of STED-pCF was found to be about 110 nm, with a more than twofold improvement over conventional confocal acquisition. We successfully applied our method to highlight how the proximity to nuclear envelope affects the mobility features of proteins actively imported into the nucleus in living cells. Remarkably, STED-pCF unveiled the existence of local barriers to diffusion as well as the presence of a slow component at distances up to 500-700 nm from either sides of nuclear envelope. The mobility of this component is similar to that previously described for transport complexes. Remarkably, all these features were invisible in conventional confocal mode.	[Bianchini, Paolo; Diaspro, Alberto; Bizzarri, Ranieri] Italian Inst Technol, Genoa, Italy; [Cardarelli, Francesco] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy; [Di Luca, Mariagrazia; Bizzarri, Ranieri] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Di Luca, Mariagrazia; Bizzarri, Ranieri] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Bizzarri, Ranieri] CNR, Ist Biofis, I-56100 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Diaspro, A (corresponding author), Italian Inst Technol, Genoa, Italy.	alberto.diaspro@iit.it; r.bizzarri@sns.it	Diaspro, Alberto/E-7833-2010; Bizzarri, Ranieri/ABH-8343-2020; Bianchini, Paolo/A-9500-2008; Bizzarri, Ranieri/H-1779-2011	Diaspro, Alberto/0000-0002-4916-5928; Bianchini, Paolo/0000-0001-6457-751X; Bizzarri, Ranieri/0000-0002-8222-2672; Di Luca, Mariagrazia/0000-0002-0688-034X	Regione Toscana; Bando Salute; PRIN [2010BJ23MN_004]	Regione Toscana(Regione Toscana); Bando Salute; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Regione Toscana under the framework of the project "New diagnostic strategies from nano-engineered viral capsid proteins'', Bando Salute 2009 and by the PRIN project 2010BJ23MN_004 "Nanostructured Soft Matter: from Fundamental Research to Novel Applications''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizzarri R, 2012, ANAL BIOANAL CHEM, V403, P2339, DOI 10.1007/s00216-012-6025-4; Brinkmeier M, 1999, ANAL CHEM, V71, P609, DOI 10.1021/ac980820i; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2012, P NATL ACAD SCI USA, V109, P9863, DOI 10.1073/pnas.1200486109; Cardarelli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010475; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Digman MA, 2009, WIRES SYST BIOL MED, V1, P273, DOI 10.1002/wsbm.5; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Hedde PN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3093; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hinde E, 2011, BIOPHYS J, V100, P67; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Hotta JI, 2010, J AM CHEM SOC, V132, P5021, DOI 10.1021/ja100079w; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Leutenegger M, 2010, OPT EXPRESS, V18, P26417, DOI 10.1364/OE.18.026417; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Ringemann C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103054; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Weidemann T, 2002, SINGLE MOL, V3, P49, DOI 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.3.CO;2-K; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931	35	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99619	10.1371/journal.pone.0099619	http://dx.doi.org/10.1371/journal.pone.0099619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967681	Green Published, gold			2022-12-25	WOS:000338280800016
J	Lindblom, P; Wilhelmsson, P; Fryland, L; Matussek, A; Haglund, M; Sjowall, J; Vene, S; Nyman, D; Forsberg, P; Lindgren, PE				Lindblom, Pontus; Wilhelmsson, Peter; Fryland, Linda; Matussek, Andreas; Haglund, Mats; Sjowall, Johanna; Vene, Sirkka; Nyman, Dag; Forsberg, Pia; Lindgren, Per-Eric			Factors Determining Immunological Response to Vaccination against Tick-Borne Encephalitis Virus in Older Individuals	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; FOLLOW-UP; SEROLOGICAL RESPONSE; TBE VACCINATION; FAR-EASTERN; VACCINES; HUMANS; PERSISTENCE; IMMUNITY; DISEASE	We performed a cross-sectional study including 533 individuals (median age 61) from the highly TBE endemic A land Islands in the archipelago between Sweden and Finland. Blood samples, questionnaires and vaccination records were obtained from all study participants. The aim was to investigate if there was any association between TBEV antibody titer and 12 health-related factors. Measurement of TBEV IgG antibodies was performed using two commercial ELISA assays (Enzygnost and Immunozym), and a third in-house rapid fluorescent focus inhibition test was used to measure TBEV neutralizing antibodies. The age of the individual and the number of vaccine doses were the two most important factors determining the immunological response to vaccination. The response to each vaccine dose declined linearly with increased age. A 35 year age difference corresponds to a vaccine dose increment from 3 to 4 to achieve the same immunological response. Participants previously vaccinated against other flaviviruses had lower odds of being seropositive for neutralizing TBEV antibodies on average, while participants with self-reported asthma had higher odds of being seropositive. By comparing the 3 serological assays we show that the Enzygnost and Immunozym assay differ due to choice of cutoffs, but not in overall accuracy.	[Lindblom, Pontus; Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden; [Fryland, Linda; Forsberg, Pia] Linkoping Univ, Dept Clin & Expt Med, Div Infect Dis, Linkoping, Sweden; [Matussek, Andreas; Lindgren, Per-Eric] Cty Hosp Ryhov, Dept Microbiol, Div Med Serv, Jonkoping, Sweden; [Haglund, Mats] Cty Hosp Kalmar, Dept Infect Dis, Kalmar, Sweden; [Sjowall, Johanna; Forsberg, Pia] Linkoping Univ, Clin Infect Dis, Linkoping, Sweden; [Vene, Sirkka] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Nyman, Dag] Aland Cent Hosp, Mariehamn, Aland, Finland	Linkoping University; Linkoping University; Linkoping University; Public Health Agency of Sweden	Lindblom, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden.	pontus.lindblom@liu.se	Matussek, Andreas/AAB-3629-2021	Sjowall, Johanna/0000-0001-5622-866X; Wilhelmsson, Peter/0000-0002-9200-2964	Swedish Research Council branch of Medicine; Medical Research Council of South-East Sweden; County Council of Ostergotland; Wilhelm and Else Stockmann Foundation; Foundation for A land Medical Research of the A land Culture Foundation; ScandTick	Swedish Research Council branch of Medicine(Swedish Research Council); Medical Research Council of South-East Sweden; County Council of Ostergotland; Wilhelm and Else Stockmann Foundation; Foundation for A land Medical Research of the A land Culture Foundation; ScandTick	This study was supported by grants from The Swedish Research Council branch of Medicine, The Medical Research Council of South-East Sweden, Grants from the County Council of Ostergotland, the Wilhelm and Else Stockmann Foundation and the Foundation for A land Medical Research of the A land Culture Foundation, and the EU Interreg IV A supported project ScandTick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2013, AGE, V35, P371, DOI 10.1007/s11357-011-9371-9; Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Baldovin T, 2012, J MED VIROL, V84, P1274, DOI 10.1002/jmv.23313; Bender A, 2004, J NEUROL, V251, P353, DOI 10.1007/s00415-004-0329-z; Brossard M, 2004, PARASITOLOGY, V129, pS161, DOI 10.1017/S0031182004004834; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Enmarker I, 2012, SCAND J PUBLIC HEALT, V40, P718, DOI 10.1177/1403494812465031; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; Fritz R, 2012, VACCINE, V30, P1165, DOI 10.1016/j.vaccine.2011.12.013; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Haglund M, 1996, SCAND J INFECT DIS, V28, P217, DOI 10.3109/00365549609027160; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jaaskelainen A., 2011, EpiNorth - Journal of the Network for Communicable Disease Control in Northern and Eastern Europe, V12, P40; Jilkova E, 2009, EXPERT OPIN BIOL TH, V9, P797, DOI 10.1517/14712590903066711; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2002, INT J MED MICROBIOL, V291, P58, DOI 10.1016/S1438-4221(02)80012-1; Kriz B, 2004, INT J MED MICROBIOL, V293, P63, DOI 10.1016/S1433-1128(04)80010-X; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Leonova GN, 2009, VACCINE, V27, P2899, DOI 10.1016/j.vaccine.2009.02.069; Lindblom P, 2014, TICKS TICK-BORNE DIS, V5, P21, DOI 10.1016/j.ttbdis.2013.07.009; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; OKERBLOM N, 1962, BIOLOGY VIRUSES TICK, P423; Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122; Paulke-Korinek M, 2013, VACCINE; Paulke-Korinek M, 2009, VACCINE, V27, P7027, DOI 10.1016/j.vaccine.2009.09.068; Rendi-Wagner P, 2007, VACCINE, V25, P5097, DOI 10.1016/j.vaccine.2007.01.116; Rendi-Wagner P, 2006, INT J MED MICROBIOL, V296, P202, DOI 10.1016/j.ijmm.2006.01.030; Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145; Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069; Studahl M, 2013, DRUGS, V73, P131, DOI 10.1007/s40265-013-0007-5; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; van Ree R, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-12; Vene S, 1998, J VIROL METHODS, V73, P71, DOI 10.1016/S0166-0934(98)00041-X; Vene S, 2007, VACCINE, V25, P366, DOI 10.1016/j.vaccine.2006.07.026; Wahlberg P, 2006, SCAND J INFECT DIS, V38, P1057, DOI 10.1080/00365540600868297; Weinberger B, 2012, CLIN MICROBIOL INFEC, V18, P100, DOI 10.1111/j.1469-0691.2012.03944.x; Weinberger B, 2010, VACCINE, V28, P3511, DOI 10.1016/j.vaccine.2010.03.024; Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	51	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100860	10.1371/journal.pone.0100860	http://dx.doi.org/10.1371/journal.pone.0100860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967619	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800075
J	Sedeno, L; Couto, B; Melloni, M; Canales-Johnson, A; Yoris, A; Baez, S; Esteves, S; Velasquez, M; Barttfeld, P; Sigman, M; Kichic, R; Chialvo, D; Manes, F; Bekinschtein, TA; Ibanez, A				Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Canales-Johnson, Andres; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Barttfeld, Pablo; Sigman, Mariano; Kichic, Rafael; Chialvo, Dante; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin			How Do You Feel when You Can't Feel Your Body? Interoception, Functional Connectivity and Emotional Processing in Depersonalization-Derealization Disorder	PLOS ONE			English	Article							RESTING-STATE NETWORKS; HUMAN BRAIN; PHYSIOLOGICAL CONDITION; BEHAVIORAL VARIANT; EMBODIED EMPATHY; SOCIAL COGNITION; PANIC DISORDER; SMALL-WORLD; TEST SCORE; EXPERIENCE	Depersonalization-Derealization Disorder (DD) typically manifests as a disruption of body self-awareness. Interoception defined as the cognitive processing of body signals-has been extensively considered as a key processing for body self-awareness. In consequence, the purpose of this study was to investigate whether there are systematic differences in interoception between a patient with DD and controls that might explain the disembodiment symptoms suffered in this disease. To assess interoception, we utilized a heartbeat detection task and measures of functional connectivity derived from fMRI networks in interoceptive/exteroceptivo/mind-wandering states. Additionally, we evaluated empathic abilities to test the association between interoception and emotional experience. The results showed patient's impaired performance in the heartbeat detection task when compared to controls. Furthermore, regarding functional connectivity, we found a lower global brain connectivity of the patient relative to controls only in the interoceptive state. He also presented a particular pattern of impairments in affective empathy. To our knowledge, this is the first experimental research that assesses the relationship between interoception and DD combining behavioral and neurobiological measures. Our results suggest that altered neural mechanisms and cognitive processes regarding body signaling might be engaged in DD phenomenology. Moreover, our study contributes experimental data to the comprehension of brain-body interactions and the emergence of self-awareness and emotional feelings.	[Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin] Favaloro Univ, LPEN, INECO Inst Cognit Neurol, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Canales-Johnson, Andres; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Diego Port Univ, UDP INECO Fdn Core Neurosci UIFCoN, Santiago, Chile; [Canales-Johnson, Andres; Bekinschtein, Tristan A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Barttfeld, Pablo; Sigman, Mariano] FCEyN UBA, Lab Integrat Neurosci, Dept Phys, Buenos Aires, DF, Argentina; [Barttfeld, Pablo; Sigman, Mariano] IFIBA, Buenos Aires, DF, Argentina; [Kichic, Rafael] INECO Inst Cognit Neurol, Anxiety Clin, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Baez, Sandra; Sigman, Mariano; Chialvo, Dante; Manes, Facundo] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina; [Barttfeld, Pablo] INSERM, Cognit Neuroimaging Unit, Paris, France; [Sigman, Mariano] Univ Torcuato Di Tella, Buenos Aires, DF, Argentina; [Chialvo, Dante] Univ San Andres, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Chialvo, Dante] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Manes, Facundo; Ibanez, Agustin] Macquarie Univ, Australian Res Council ACR Ctr Excellence Cognit, Sydney, NSW 2109, Australia	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universidad Torcuato Di Tella; Universidad de San Andres Argentina; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Macquarie University	Ibanez, A (corresponding author), Favaloro Univ, LPEN, INECO Inst Cognit Neurol, Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Chialvo, Dante R/A-4658-2009; Chialvo, Dante R./P-5279-2019	Ibanez, Agustin/0000-0001-6758-5101; Chialvo, Dante R/0000-0002-1038-3637; Chialvo, Dante R./0000-0002-1038-3637; Baez, Sandra/0000-0003-0875-1709; Bekinschtein, Tristan/0000-0001-5501-8628; melloni, margherita/0000-0003-0931-8640	CONICYT/FONDECYT [1130920, 1140114]; Foncyt-PICT [2012-0412, 2012-1309]; CONICET; INECO Foundation	CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Foncyt-PICT(ANPCyTFONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INECO Foundation	This research was partially supported by grants CONICYT/FONDECYT Regular (1130920 and 1140114), Foncyt-PICT 2012-0412, Foncyt-PICT 2012-1309, CONICET and INECO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Baez S, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00080; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Baker D, 2003, BRIT J PSYCHIAT, V182, P428, DOI 10.1192/bjp.182.5.428; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Barttfeld P, J NEURODEVELOPMENTAL; Barttfeld P, 2014, NEUROPSYCHOBIOLOGY, V69, P65, DOI 10.1159/000356964; Barttfeld P, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-16; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Beck AT, 1996, MANUAL HE BECK DEPRE; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bolognini N, 2013, J NEUROSCI, V33, P4201, DOI 10.1523/JNEUROSCI.4498-12.2013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Couto B, 2012, CORTEX; Couto B, 2014, SOC COGN AFFECT NEUR, V9, P1253, DOI 10.1093/scan/nst108; Couto B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00467; Couto B, 2013, CORTEX, V49, P1420, DOI 10.1016/j.cortex.2012.08.006; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Crawford JR, 2009, NEUROPSYCHOLOGIA, V47, P2690, DOI 10.1016/j.neuropsychologia.2009.04.011; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Ernst J, 2012, HUM BRAIN MAPP; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; First MB, 2002, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fukushima H, 2011, INT J PSYCHOPHYSIOL, V79, P259, DOI 10.1016/j.ijpsycho.2010.10.015; Gallagher S., 2005, BODY SHAPES MIND; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; HANTAS M, 1982, PSYCHOPHYSIOLOGY, V19, P563; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Hunter ECM, 2003, BEHAV RES THER, V41, P1451, DOI 10.1016/S0005-7967(03)00066-4; Iacoboni M., 2005, PERSPECTIVES IMITATI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; IBANEZ A, 2013, SOC COGN AFFECT NEUR; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2010, BRAIN STRUCT FUNCT, V214, P397, DOI 10.1007/s00429-010-0256-y; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lavin Claudio, 2013, Front Neurosci, V7, P64, DOI 10.3389/fnins.2013.00064; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lawrence EJ, 2007, SOC NEUROSCI-UK, V2, P292, DOI 10.1080/17470910701391794; Lee WE, 2012, SOC PSYCH PSYCH EPID, V47, P253, DOI 10.1007/s00127-010-0327-7; Lemche E, 2008, BRIT J PSYCHIAT, V193, P222, DOI 10.1192/bjp.bp.107.044263; Lemche E, 2007, NEUROREPORT, V18, P473, DOI 10.1097/WNR.0b013e328057deb3; Lemche E, 2013, PSYCHIAT RES-NEUROIM, V214, P66, DOI 10.1016/j.pscychresns.2013.05.006; Medford N, 2006, PSYCHIAT RES-NEUROIM, V148, P93, DOI 10.1016/j.pscychresns.2006.05.007; Melloni M, 2013, EMPATHY CONTEXTUAL S; Melloni M, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-47; Michal M, 2005, J NERV MENT DIS, V193, P629, DOI 10.1097/01.nmd.0000178038.87332.ec; Castillo JJM, 2006, ACTAS ESP PSIQUIATRI, V34, P185; Novembre G, 2014, SOC COGN AFFECT NEUR; NOYES R, 1992, J NERV MENT DIS, V180, P369, DOI 10.1097/00005053-199206000-00006; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Phillips ML, 2003, STRESS, V6, P157, DOI 10.1080/1025389031000138538; Phillips ML, 2001, PSYCHIAT RES-NEUROIM, V108, P145, DOI 10.1016/S0925-4927(01)00119-6; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Rizzolatti G, 2006, SCI AM, V295, P54, DOI 10.1038/scientificamerican1106-54; ROUSE CH, 1988, PSYCHOPHYSIOLOGY, V25, P400, DOI 10.1111/j.1469-8986.1988.tb01876.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaefer M, 2012, NEUROIMAGE, V60, P952, DOI 10.1016/j.neuroimage.2012.01.112; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Sierra M, 1998, BIOL PSYCHIAT, V44, P898, DOI 10.1016/S0006-3223(98)00015-8; Sierra M, 2002, ARCH GEN PSYCHIAT, V59, P833, DOI 10.1001/archpsyc.59.9.833; Sierra M, 2005, PSYCHOL MED, V35, P1523, DOI 10.1017/S0033291705005325; Sierra M, 2002, J NEUROL NEUROSUR PS, V72, P530; Sierra M, 2012, PSYCHIAT RES, V197, P123, DOI 10.1016/j.psychres.2011.12.017; Sierra M, 2011, CONSCIOUS COGN, V20, P99, DOI 10.1016/j.concog.2010.10.018; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spielberg C.D., 1970, MANUAL STATE TRAIT I; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Straube T, 2010, NEUROPSYCHOLOGIA, V48, P1735, DOI 10.1016/j.neuropsychologia.2010.02.022; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Terasawa Y, 2011, HUM BRAIN MAPP; Toni C, 1996, COMPR PSYCHIAT, V37, P125, DOI 10.1016/S0010-440X(96)90573-8; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	129	79	79	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98769	10.1371/journal.pone.0098769	http://dx.doi.org/10.1371/journal.pone.0098769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24967634	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800005
J	Sun, TQ; Zhang, Y; Shan, P; Zhang, ZC; Chen, SL; Kong, YF; Xu, JJ				Sun, Tongqing; Zhang, Yu; Shan, Pai; Zhang, Zichang; Chen, Shaolin; Kong, Yongfa; Xu, Jingjun			Growth, Structure, Thermal Properties and Spectroscopic Characteristics of Nd3+-Doped KGdP4O12 Crystal	PLOS ONE			English	Article							SPECTRAL PROPERTIES; LASER OPERATION; OPTICAL-PROPERTIES; PERFORMANCE; INTENSITIES; MORPHOLOGY	A single crystal of Nd3+-doped KGdP4O12 was successfully grown with the top-seeded solution growth and slow cooling (TSSG-SC) technique. It crystallizes in space group C2/c with cell parameters a = 7.812(2) angstrom, b = 12.307(3) angstrom, c = 10.474(2) angstrom, beta = 110.84(3)degrees and Z = 4. The IR and Raman spectra also indicated that the phosphoric polyhedra of Nd:KGdP4O12 has a cyclic symmetry. The chemical composition of the crystal was analyzed and the distribution coefficient of Nd3+ was calculated. The crystal morphology of KGdP4O12 was identified using X-ray diffraction. The compound has good thermal stability to 920 degrees C. Its specific heat and thermal conductivity were determined for potential applications. The spectral properties of Nd: KGdP4O12 indicates that it exhibits broad absorption and emission bands, which are attributed to low symmetry of the crystal. The broad absorption band around 798 nm has a full-width at half-maximum (FWHM) of 14.8 nm and is suitable for AlGaAs laser diode pumping. Moreover, 5 at% Nd3+-doped KGdP4O12 crystal has a long luminescence lifetime of 300 mu s and a high quantum efficiency of 96%.	[Sun, Tongqing; Chen, Shaolin; Kong, Yongfa; Xu, Jingjun] Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China; [Sun, Tongqing; Zhang, Yu; Shan, Pai; Zhang, Zichang; Kong, Yongfa; Xu, Jingjun] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Chen, Shaolin; Kong, Yongfa; Xu, Jingjun] Nankai Univ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Sun, TQ (corresponding author), Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China.	suntq@nankai.edu.cn	Jingjun, Xu/A-1282-2010; xu, jing/GRR-8698-2022		National Natural Science Foundation of China [21271109]; Fundamental Research Funds for the Central Universities of China [65122011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (Grant No. 21271109) and the Fundamental Research Funds for the Central Universities of China (65122011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulon G, 2003, OPT MATER, V22, P85, DOI 10.1016/S0925-3467(02)00350-6; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Cheng Y, 2009, LASER PHYS LETT, V6, P740, DOI 10.1002/lapl.200910065; Cheng ZX, 2001, JPN J APPL PHYS 1, V40, P4038, DOI 10.1143/JJAP.40.4038; Ettis H, 2003, CRYST GROWTH DES, V3, P599, DOI 10.1021/cg0200659; Faure N, 1996, APPL PHYS B-LASERS O, V63, P593; Horchani K, 2002, MATER RES BULL, V37, P1259, DOI 10.1016/S0025-5408(02)00772-9; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; JUNGOWSKA W, 1990, J THERM ANAL, V36, P2095, DOI 10.1007/BF01914131; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; Kaminsky W, 2007, J APPL CRYSTALLOGR, V40, P382, DOI 10.1107/S0021889807003986; Koechner W., 2006, SOLID STATE LASER EN, V6th, P54; Li DZ, 2011, LASER PHYS LETT, V8, P647, DOI 10.1002/lapl.201110040; Li DZ, 2011, APPL PHYS B-LASERS O, V104, P53, DOI 10.1007/s00340-010-4302-5; Li DZ, 2010, LASER PHYS LETT, V7, P798, DOI 10.1002/lapl.201010069; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Li H, 2009, J ALLOY COMPD, V478, P484, DOI 10.1016/j.jallcom.2008.11.079; Maksimova SI, 1981, IAN SSSR NEORG MATER, V17, P116; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; Pan ZB, 2013, OPT EXPRESS, V21, P6091, DOI 10.1364/OE.21.006091; Parreu I, 2003, CHEM MATER, V15, P5059, DOI 10.1021/cm034812g; Parreu I, 2005, CHEM MATER, V17, P822, DOI 10.1021/cm048442n; Parreu I, 2007, CHEM MATER, V19, P2868, DOI 10.1021/cm0621242; Parreu I, 2007, OPT EXPRESS, V15, P2360, DOI 10.1364/OE.15.002360; Parreu I, 2007, CRYST GROWTH DES, V7, P557, DOI 10.1021/cg060400j; Parreu I, 2006, CHEM MATER, V18, P221, DOI 10.1021/cm052114l; Parreu I, 2006, CRYSTAL GROWTH CHARA, P114; Rekik W, 2004, ACTA CRYSTALLOGR C, V60, pI50, DOI 10.1107/S0108270104004603; Sato Y, 2005, IEEE J SEL TOP QUANT, V11, P613, DOI 10.1109/JSTQE.2005.850569; Sole R, 2009, J CRYST GROWTH, V311, P3656, DOI 10.1016/j.jcrysgro.2009.05.005; Song MJ, 2007, J CRYST GROWTH, V308, P208, DOI 10.1016/j.jcrysgro.2007.07.049; Song MJ, 2011, J ALLOY COMPD, V509, P2164, DOI 10.1016/j.jallcom.2010.10.175; Song MJ, 2009, J ALLOY COMPD, V480, P839, DOI 10.1016/j.jallcom.2009.02.082; Wang GF, 1999, PHYS REV B, V60, P15469, DOI 10.1103/PhysRevB.60.15469; WEBER HP, 1975, OPT QUANT ELECTRON, V7, P431, DOI 10.1007/BF00619318; Xiao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040229; Xiao B, 2012, OPTOELECTRON ADV MAT, V6, P404; Xu XD, 2010, OPT EXPRESS, V18, P21370, DOI 10.1364/OE.18.021370; Zhang JJ, 2011, CHEM MATER, V23, P3752, DOI 10.1021/cm2015143; Zhang YY, 2011, IEEE J QUANTUM ELECT, V47, P1506, DOI 10.1109/JQE.2011.2172975	41	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100922	10.1371/journal.pone.0100922	http://dx.doi.org/10.1371/journal.pone.0100922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968165	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800081
J	Bond, DS; Thomas, JG; Raynor, HA; Moon, J; Sieling, J; Trautvetter, J; Leblond, T; Wing, RR				Bond, Dale S.; Thomas, J. Graham; Raynor, Hollie A.; Moon, Jon; Sieling, Jared; Trautvetter, Jennifer; Leblond, Tiffany; Wing, Rena R.			B-MOBILE - A Smartphone-Based Intervention to Reduce Sedentary Time in Overweight/Obese Individuals: A Within-Subjects Experimental Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; LEISURE-TIME; SITTING TIME; ADULTS; ASSOCIATIONS; BEHAVIOR; BREAKING; MORTALITY; MONITORS	Purpose: Excessive sedentary time (SED) has been linked to obesity and other adverse health outcomes. However, few sedentary-reducing interventions exist and none have utilized smartphones to automate behavioral strategies to decrease SED. We tested a smartphone-based intervention to monitor and decrease SED in overweight/obese individuals, and compared 3 approaches to prompting physical activity (PA) breaks and delivering feedback on SED. Design and Methods: Participants [N = 30; Age = 47.5(13.5) years; 83% female; Body Mass Index (BMI) = 36.2(7.5) kg/m(2)] wore the SenseWear Mini Armband (SWA) to objectively measure SED for 7 days at baseline. Participants were then presented with 3 smartphone-based PA break conditions in counterbalanced order: (1) 3-min break after 30 SED min; (2) 6-min break after 60 SED min; and (3) 12-min break after 120 SED min. Participants followed each condition for 7 days and wore the SWA throughout. Results: All PA break conditions yielded significant decreases in SED and increases in light (LPA) and moderate-to-vigorous PA (MVPA) (p<0.005). Average % SED at baseline (72.2%) decreased by 5.9%, 5.6%, and 3.3% [i.e. by mean (95% CI) -47.2(-66.3, -28.2), -44.5(-65.2, -23.8), and -26.2(-40.7, -11.6) min/d] in the 3-, 6-, and 12-min conditions, respectively. Conversely, % LPA increased from 22.8% to 26.7%, 26.7%, and 24.7% [i.e. by 31.0(15.8, 46.2), 31.0(13.6, 48.4), and 15.3(3.9, 26.8) min/d], and % MVPA increased from 5.0% to 7.0%, 6.7%, and 6.3% (i.e. by 16.2(8.5, 24.0), 13.5(6.3, 20.6), and 10.8(4.2, 17.5) min/d] in the 3-, 6-, and 12-min conditions, respectively. Planned pairwise comparisons revealed the 3-min condition was superior to the 12-min condition in decreasing SED and increasing LPA (p<0.05). Conclusion: The smartphone-based intervention significantly reduced SED. Prompting frequent short activity breaks may be the most effective way to decrease SED and increase PA in overweight/obese individuals. Future investigations should determine whether these SED reductions can be maintained long-term.	[Bond, Dale S.; Thomas, J. Graham; Trautvetter, Jennifer; Leblond, Tiffany; Wing, Rena R.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA; [Raynor, Hollie A.] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Moon, Jon; Sieling, Jared] MEI Res Ltd, Edina, MN USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of Tennessee System; University of Tennessee Knoxville	Bond, DS (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA.	dbond@lifespan.org		Moon, Jon/0000-0002-2339-7130; Raynor, Hollie/0000-0002-3782-9504	National Institutes of Health; NIDDK [DK095740]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a grant from the National Institutes of Health, NIDDK DK095740 (PI: Bond) (http://www.niddk.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bond DS, 2013, SURG OBES RELAT DIS, V9, P123, DOI 10.1016/j.soard.2012.09.008; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Carr LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003261; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Consolvo S, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1797; Consolvo S, 2009, COMPUTER, V42, P86, DOI 10.1109/MC.2009.185; Du HD, 2013, AM J CLIN NUTR, V97, P487, DOI 10.3945/ajcn.112.046854; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Fujiki Y, 2010, P ACM C HUM FACT COM, P4315; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Global System for Mobile Communications Association, 2013, MOB EC 2013; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Klasnja Predrag, 2009, AMIA Annu Symp Proc, V2009, P338; Kozey-Keadle S, 2013, J PHYS ACT HLTH; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; Leon-Munoz LM, 2013, MED SCI SPORT EXER, V45, P1501, DOI 10.1249/MSS.0b013e3182897e87; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Newton RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063171; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Rutten GM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-1; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Smith A., 2013, SMARTPHONE OWNERSHIP; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Unick JL, 2012, OBES SURG, V22, P347, DOI 10.1007/s11695-011-0491-1; van Dijk JW, 2013, DIABETES CARE, V36, P3448, DOI 10.2337/dc12-2620; Wetten AA, 2014, J PHYS ACT HEALTH, V11, P638, DOI 10.1123/jpah.2011-0167	35	115	120	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100821	10.1371/journal.pone.0100821	http://dx.doi.org/10.1371/journal.pone.0100821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964010	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500086
J	Svensson, B; Hansson, L				Svensson, Bengt; Hansson, Lars			Effectiveness of Mental Health First Aid Training in Sweden. A Randomized Controlled Trial with a Six-Month and Two-Year Follow-Up	PLOS ONE			English	Article							STIGMATIZING ATTITUDES; DISORDERS; KNOWLEDGE; ILLNESS; PEOPLE; EXPERIENCES; DEPRESSION; AUSTRALIA; LITERACY; BEHAVIOR	Background: According to a recent report from the European Brain Council and the European Colleague of Neuropsychopharmacology the one year prevalence of some kind of mental disorder is around 27% among the adult population in Europe. Research has shown a lack of mental health literacy in the population in general and it is thus important to find ways to improve the public's knowledge and skills to provide first hand support to people with mental disorders. Mental Health First Aid (MHFA) is a training program that has shown positive changes in knowledge and helping behavior. This study investigates if MHFA training in a Swedish context provides a sustained improvement in knowledge about mental disorders, a better ability to be helpful in contacts with people who are ill and if it changes attitudes in a positive direction. Methods and Findings: The introduction of the training program was made in accordance with the constructor's instructions. Participants were mainly public sector employees from a county in the west of Sweden. The study was a randomized controlled trial with an experiment group (n = 199) and a control group (n = 207) placed on a waiting list during a 6-month follow-up. A two-year follow-up was conducted for participants (n = 155) from both the intervention and waiting list group who had completed the training and during the follow-up been in contact with persons with mental disorders. The intervention group improved in knowledge as well as in confidence in providing help for someone in need. The two-year follow-up showed that the improvements were to a great extent maintained. Conclusions: Mental Health First Aid might raise the level of awareness of mental disorders and have an influence on the number of people who can receive professional treatment for their problems.	[Svensson, Bengt; Hansson, Lars] Lund Univ, Dept Hlth Sci, Lund, Sweden	Lund University	Svensson, B (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.	Bengt.svensson@med.lu.se			Swedish Board of Health and Welfare	Swedish Board of Health and Welfare	The study was funded by the Swedish Board of Health and Welfare, (www.socialstyrelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2013, BRIT J PSYCHIAT, V203, P146, DOI 10.1192/bjp.bp.112.122978; Eekhout I, 2013, J CLIN EPIDEMIOL; Griffiths KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-25; Griffiths KM, 2004, BRIT J PSYCHIAT, V185, P342, DOI 10.1192/bjp.185.4.342; Hossain D, 2010, RURAL REMOTE HEALTH, V10; Hossain D., 2009, AUSTRALAS PSYCHIATRY, V17, P116, DOI [DOI 10.1080/10398560902948365, 10.1080/10398560902948365]; Jorm AF, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-43; Jorm AF, 2007, INT J CLIN HLTH PSYC, V7, P141; Jorm AF, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-33; Jorm AF, 2010, AUST NZ J PSYCHIAT, V44, P1072, DOI 10.3109/00048674.2010.516426; Jorm AF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-51; Kanowski Len G, 2009, Int J Ment Health Syst, V3, P10, DOI 10.1186/1752-4458-3-10; Kelly CM, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-4; Kitchener BA, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-23; Kitchener BA, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-10; Lam AYK, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-18; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Minas Harry, 2009, Int J Ment Health Syst, V3, P19, DOI 10.1186/1752-4458-3-19; O'Reilly CL, 2011, AUST NZ J PSYCHIAT, V45, P549, DOI 10.3109/00048674.2011.585454; Pierce D, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-10; Reavley NJ, 2012, BRIT J PSYCHIAT, V200, P419, DOI 10.1192/bjp.bp.111.104208; Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P1086, DOI 10.3109/00048674.2011.621061; Sartore GM, 2008, AUST J RURAL HEALTH, V16, P313, DOI 10.1111/j.1440-1584.2008.01005.x; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Terry J, 2010, J PSYCHIATR MENT HLT, V17, P594, DOI 10.1111/j.1365-2850.2010.01557.x; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012	28	47	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100911	10.1371/journal.pone.0100911	http://dx.doi.org/10.1371/journal.pone.0100911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964164	gold, Green Published			2022-12-25	WOS:000338709500097
J	Oberli, A; Slater, LM; Cutts, E; Brand, F; Mundwiler-Pachlatko, E; Rusch, S; Masik, MFG; Erat, MC; Beck, HP; Vakonakis, I				Oberli, Alexander; Slater, Leanne M.; Cutts, Erin; Brand, Francoise; Mundwiler-Pachlatko, Esther; Rusch, Sebastian; Masik, Martin F. G.; Erat, Michele C.; Beck, Hans-Peter; Vakonakis, Ioannis			A Plasmodium falciparum PHIST protein binds the virulence factor PfEMP1 and comigrates to knobs on the host cell surface	FASEB JOURNAL			English	Article						cytoadherence; exported proteins; interactions; malaria; protein structure	RED-BLOOD-CELLS; HISTIDINE-RICH PROTEIN; ERYTHROCYTE-MEMBRANE PROTEIN-1; MALARIA PARASITES; INFECTED ERYTHROCYTES; MAURERS CLEFTS; LIFE-CYCLE; IDENTIFICATION; TRAFFICKING; SKELETON	Uniquely among malaria parasites, Plasmodium falciparum-infected erythrocytes (iRBCs) develop membrane protrusions, known as knobs, where the parasite adhesion receptor P. falciparum erythrocyte membrane protein 1 (PfEMP1) clusters. Knob formation and the associated iRBC adherence to host endothelium are directly linked to the severity of malaria and are functional manifestations of protein export from the parasite to the iRBC. A family of exported proteins featuring Plasmodium helical interspersed subtelomeric (PHIST) domains has attracted attention, with members being implicated in host-parasite protein interactions and differentially regulated in severe disease and among parasite isolates. Here, we show that PHIST member PFE1605w binds the PfEMP1 intracellular segment directly with K-d = 5 +/- 0.6 mu M, comigrates with PfEMP1 during export, and locates in knobs. PHIST variants that do not locate in knobs (MAL8P1.4) or bind PfEMP1 30 times more weakly (PFI1780w) used as controls did not display the same pattern. We resolved the first crystallographic structure of a PHIST protein and derived a partial model of the PHIST-PfEMP1 interaction from nuclear magnetic resonance. We propose that PFE1605w reinforces the PfEMP1-cytoskeletal connection in knobs and discuss the possible role of PHIST proteins as interaction hubs in the parasite exportome.-Oberli, A., Slater, L. M., Cutts, E., Brand, F., Mundwiler-Pachlatko, E., Rusch, S., Masik, M. F. G., Erat, M. C., Beck, H.-P., Vakonakis, I. A Plasmodium falciparum PHIST protein binds the virulence factor PfEMP1 and comigrates to knobs on the host cell surface.	[Oberli, Alexander; Brand, Francoise; Mundwiler-Pachlatko, Esther; Rusch, Sebastian; Beck, Hans-Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Oberli, Alexander; Brand, Francoise; Mundwiler-Pachlatko, Esther; Rusch, Sebastian; Beck, Hans-Peter] Univ Basel, Basel, Switzerland; [Slater, Leanne M.; Cutts, Erin; Masik, Martin F. G.; Erat, Michele C.; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Oxford	Beck, HP (corresponding author), Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	hans-peter.beck@unibas.ch; ioannis.vakonakis@bioch.ox.ac.uk		Cutts, Erin E./0000-0003-3290-4293; Beck, Hans-Peter/0000-0001-8326-4834	Wellcome Trust for the Oxford Biochemistry NMR facility [094872/Z/10/Z, 088497/Z/09/Z]; Swiss National Science Foundation [31003A_132709/1, 31003A_149297/1]; BBSRC [BB/J008265/1] Funding Source: UKRI	Wellcome Trust for the Oxford Biochemistry NMR facility; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to David Staunton, Nick Soffe, Edward Lowe, and Philip Fowler for the upkeep of the supporting facilities at Oxford Biochemistry and to Henning Stahlberg and his team at the Center for Cellular Imaging and NanoAnalytics (C-CINA) and the Image Core Facility, Biozentrum, University of Basel, for the access and support. The authors acknowledge the Diamond Light Source (Harwell, UK) for access to synchrotron beamlines and the Oxford Protein Production Facility (Harwell, UK) for assistance with expression of PHIST domains. This work received support from the Wellcome Trust for the Oxford Biochemistry NMR facility (grant 094872/Z/10/Z, grant 088497/Z/09/Z to I.V., and a Ph.D. studentship to E.C.). The cell biological part of this study was supported by the Swiss National Science Foundation (grants 31003A_132709/1 and 31003A_149297/1).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bricogne G., 2011, BUSTER VERSION 2 10; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Crabb BS, 2004, METH MOL B, V270, P263; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eksi S, 2005, MOL BIOCHEM PARASIT, V143, P90, DOI 10.1016/j.molbiopara.2005.05.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Gruring C, 2012, METHOD ENZYMOL, V506, P81, DOI 10.1016/B978-0-12-391856-7.00029-9; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; McMillan PJ, 2013, CELL MICROBIOL, V15, P1401, DOI 10.1111/cmi.12125; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silvestrini F, 2005, MOL BIOCHEM PARASIT, V143, P100, DOI 10.1016/j.molbiopara.2005.04.015; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014; Wickham Mark E., 2001, EMBO (European Molecular Biology Organization) Journal, V20, P5636, DOI 10.1093/emboj/20.20.5636; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	57	59	59	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4420	4433		10.1096/fj.14-256057	http://dx.doi.org/10.1096/fj.14-256057			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24983468	hybrid, Green Published			2022-12-25	WOS:000342222700020
J	Basu, RS; Warner, BA; Molodtsov, V; Pupov, D; Esyunina, D; Fernandez-Tornero, C; Kulbachinskiy, A; Murakami, KS				Basu, Ritwika S.; Warner, Brittany A.; Molodtsov, Vadim; Pupov, Danil; Esyunina, Daria; Fernandez-Tornero, Carlos; Kulbachinskiy, Andrey; Murakami, Katsuhiko S.			Structural Basis of Transcription Initiation by Bacterial RNA Polymerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Promoter; RNA Polymerase; Transcription; Transcription Initiation Factor; X-ray Crystallography	II-TFIIB COMPLEX; SIGMA-SUBUNIT; X-RAY; ACTIVE-CENTER; ABORTIVE INITIATION; PROMOTER CLEARANCE; GENE-EXPRESSION; SPECIFICITY; NUCLEOTIDE; MECHANISM	Background: Cellular RNA polymerases start transcription by de novo RNA priming. Results: Structures and biochemical studies of initially transcribing complexes elucidate the de novo transcription initiation and early stage of RNA transcription. Conclusion: 5-end of RNA in the transcribing complex starts sigma ejection from core enzyme. Significance: Insights from this study can be applicable to all cellular RNA polymerases. The bacterial RNA polymerase (RNAP) holoenzyme containing sigma factor initiates transcription at specific promoter sites by de novo RNA priming, the first step of RNA synthesis where RNAP accepts two initiating ribonucleoside triphosphates (iNTPs) and performs the first phosphodiester bond formation. We present the structure of de novo transcription initiation complex that reveals unique contacts of the iNTPs bound at the transcription start site with the template DNA and also with RNAP and demonstrate the importance of these contacts for transcription initiation. To get further insight into the mechanism of RNA priming, we determined the structure of initially transcribing complex of RNAP holoenzyme with 6-mer RNA, obtained by in crystallo transcription approach. The structure highlights RNAP-RNA contacts that stabilize the short RNA transcript in the active site and demonstrates that the RNA 5-end displaces sigma region 3.2 from its position near the active site, which likely plays a key role in sigma ejection during the initiation-to-elongation transition. Given the structural conservation of the RNAP active site, the mechanism of de novo RNA priming appears to be conserved in all cellular RNAPs.	[Basu, Ritwika S.; Warner, Brittany A.; Molodtsov, Vadim; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Fernandez-Tornero, Carlos] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Pupov, Danil; Esyunina, Daria; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Lab Mol Genet Microorganisms, Moscow 123182, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Russian Academy of Sciences	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu	Fernandez-Tornero, Carlos/I-6888-2015; Fernandez-Tornero, Carlos/AAV-8028-2021; Esyunina, Daria/L-7604-2018; Pupov, Danil/CAF-6818-2022; Kulbachinskiy, Andrey/P-5401-2016	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Kulbachinskiy, Andrey/0000-0002-2292-6424; Molodtsov, Vadim/0000-0003-3002-4794; Esyunina, Daria/0000-0002-3706-4425; Pupov, Danil/0000-0003-4961-6888; Basu, Ritwika/0000-0001-6410-7905; Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health [GM087350-A1]; Spanish government [BFU2010-16336]; Russian Foundation for Basic Research [14-04-01696, 14-04-31994]; Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish government(Spanish GovernmentEuropean Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087350-A1 (to K. S. M.). This work was also supported in part by the Spanish government through Grant BFU2010-16336 (to C. F.-T.). This work was also supported by the Russian Foundation for Basic Research (Grants 14-04-01696 and 14-04-31994) and the Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to A. K.).	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen YY, 2011, J AM CHEM SOC, V133, P12544, DOI 10.1021/ja201557w; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gleghorn ML, 2011, P NATL ACAD SCI USA, V108, P3566, DOI 10.1073/pnas.1016691108; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pupov D, 2014, NUCLEIC ACIDS RES, V42, P4494, DOI 10.1093/nar/gkt1384; Pupov D, 2010, NUCLEIC ACIDS RES, V38, P5784, DOI 10.1093/nar/gkq355; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zhang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02450; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	42	106	107	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24549	24559		10.1074/jbc.M114.584037	http://dx.doi.org/10.1074/jbc.M114.584037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24973216	Green Published, hybrid			2022-12-25	WOS:000341505600046
J	Ishikawa, H; Takaki, A; Tsuzaki, R; Yasunaka, T; Koike, K; Shimomura, Y; Seki, H; Matsushita, H; Miyake, Y; Ikeda, F; Shiraha, H; Nouso, K; Yamamoto, K				Ishikawa, Hisashi; Takaki, Akinobu; Tsuzaki, Ryuichiro; Yasunaka, Tetsuya; Koike, Kazuko; Shimomura, Yasuyuki; Seki, Hiroyuki; Matsushita, Hiroshi; Miyake, Yasuhiro; Ikeda, Fusao; Shiraha, Hidenori; Nouso, Kazuhiro; Yamamoto, Kazuhide			L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway	PLOS ONE			English	Article							FATTY LIVER-DISEASE; OXIDATIVE DNA-DAMAGE; VITAMIN-E; ATP HOMEOSTASIS; ANTIOXIDANTS; ASSOCIATION; EXPRESSION; OBESITY; STRESS; CANCER	Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). Mitochondrial dysfunction appears to play a role in the progression from simple steatosis to NASH. L-carnitine (L-b-hydroxy-g-N-trimethylaminobutyric acid), an essential nutrient that converts fat into energy in mitochondria, has been shown to ameliorate liver damage. The aim of the present study was to explore the preventive and therapeutic effect of L-carnitine in NASH model mice. Eight-week-old male STAM mice, a NASH-cirrhosis-hepatocarcinogenic model, were divided into 3 experimental groups and fed as follows: 1) high-fat diet (HFD) (control group); 2) HFD mixed with 0.28% L-carnitine (L-carnitine group); and 3) HFD mixed with 0.01% alpha-tocopherol (alpha-tocopherol group). After 4 or 8 weeks, mice were sacrificed. Blood samples and livers were collected, and hepatic tumors were counted and measured. Livers were subjected to histological study, immunohistochemical staining of 4-hydroxynonenal and ferritin, determination of 8-OHdG levels, mRNA and protein expressions for multiple genes, and metabolomic analysis. The intestinal microbiome was also analyzed. L-carnitine increased hepatic expression of genes related to long-chain fatty acid transport, mitochondrial beta-oxidation, and antioxidant enzymes following suppression of hepatic oxidative stress markers and inflammatory cytokines in NASH, and mice treated with L-carnitine developed fewer liver tumors. Although alpha-tocopherol resulted in NASH improvement in the same manner as L-carnitine, it increased periodontitis-related microbiotic changes and hepatic iron transport-related gene expression and led to less effective for anti-hepatocarcinogenesis. Conclusion: L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model by upregulating the mitochondrial beta-oxidation and redox system.	[Ishikawa, Hisashi; Takaki, Akinobu; Tsuzaki, Ryuichiro; Yasunaka, Tetsuya; Koike, Kazuko; Shimomura, Yasuyuki; Seki, Hiroyuki; Matsushita, Hiroshi; Miyake, Yasuhiro; Ikeda, Fusao; Shiraha, Hidenori; Nouso, Kazuhiro; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Takaki, A (corresponding author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	akitaka@md.okayama-u.ac.jp						Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Bergmann OM, 2008, LAB INVEST, V88, P1349, DOI 10.1038/labinvest.2008.95; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Cave MC, 2008, NUTR CLIN PRACT, V23, P16, DOI 10.1177/011542650802300116; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang BJ, 2005, INT J CANCER, V113, P719, DOI 10.1002/ijc.20636; Chang CY, 2006, J CLIN GASTROENTEROL, V40, pS51; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gohil K, 2010, MOL NUTR FOOD RES, V54, P693, DOI 10.1002/mnfr.200900575; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Jo M, 2011, J GASTROENTEROL, V46, P809, DOI 10.1007/s00535-011-0392-z; KERNER J, 1990, BIOCHEMISTRY-US, V29, P4326, DOI 10.1021/bi00470a010; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Kuwajima M, 2007, ENDOCR J, V54, P911, DOI 10.1507/endocrj.K07-044; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malaguarnera M, 2010, AM J GASTROENTEROL, V105, P1338, DOI 10.1038/ajg.2009.719; Malaguarnera M, 2011, AM J CLIN NUTR, V93, P799, DOI 10.3945/ajcn.110.007393; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nishikawa T, 2009, LIVER INT, V29, P846, DOI 10.1111/j.1478-3231.2008.01963.x; Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schurks M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5702; Selman C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0432; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; Sokol RJ, 1998, GASTROENTEROLOGY, V114, P164, DOI 10.1016/S0016-5085(98)70644-4; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Takaki A, 2013, INT J MOL SCI, V14, P20704, DOI 10.3390/ijms141020704; Tanaka S, 2013, J GASTROENTEROL, V48, P1249, DOI 10.1007/s00535-012-0739-0; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; Xia YQ, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-31; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	41	57	63	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100627	10.1371/journal.pone.0100627	http://dx.doi.org/10.1371/journal.pone.0100627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983359	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000034
J	Parra-Lopez, CA; Bernal-Estevez, D; Vargas, LE; Pulido-Calixto, C; Salazar, LM; Calvo-Calle, JM; Stern, LJ				Parra-Lopez, Carlos A.; Bernal-Estevez, David; Eduardo Vargas, Luis; Pulido-Calixto, Carolina; Salazar, Luz Mary; Calvo-Calle, J. Mauricio; Stern, Lawrence J.			An Unstable Th Epitope of P. falciparum Fosters Central Memory T Cells and Anti-CS Antibody Responses	PLOS ONE			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE MALARIA VACCINE; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; HLA-DM; SYNTHETIC PEPTIDE; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; KINETIC STABILITY	Malaria is transmitted by Plasmodium-infected anopheles mosquitoes. Widespread resistance of mosquitoes to insecticides and resistance of parasites to drugs highlight the urgent need for malaria vaccines. The most advanced malaria vaccines target sporozoites, the infective form of the parasite. A major target of the antibody response to sporozoites are the repeat epitopes of the circumsporozoite (CS) protein, which span almost one half of the protein. Antibodies to these repeats can neutralize sporozoite infectivity. Generation of protective antibody responses to the CS protein (anti-CS Ab) requires help by CD4 T cells. A CD4 T cell epitope from the CS protein designated T* was previously identified by screening T cells from volunteers immunized with irradiated P. falciparum sporozoites. The T* sequence spans twenty amino acids that contains multiple T cell epitopes restricted by various HLA alleles. Subunit malaria vaccines including T* are highly immunogenic in rodents, non-human primates and humans. In this study we characterized a highly conserved HLA-DR beta 1*04: 01 (DR4) restricted T cell epitope (QNT-5) located at the C-terminus of T*. We found that a peptide containing QNT-5 was able to elicit long-term anti-CS Ab responses and prime CD4 T cells in HLA-DR4 transgenic mice despite forming relatively unstable MHC-peptide complexes highly susceptible to HLA-DM editing. We attempted to improve the immunogenicity of QNT-5 by replacing the P1 anchor position with an optimal tyrosine residue. The modified peptide QNT-Y formed stable MHC-peptide complexes highly resistant to HLA-DM editing. Contrary to expectations, a linear peptide containing QNT-Y elicited almost 10-fold lower long-term antibody and IFN-gamma responses compared to the linear peptide containing the wild type QNT-5 sequence. Some possibilities regarding why QNT-5 is more effective than QNT-Y in inducing long-term T cell and anti-CS Ab when used as vaccine are discussed.	[Parra-Lopez, Carlos A.; Bernal-Estevez, David; Eduardo Vargas, Luis; Pulido-Calixto, Carolina] Univ Nacl Colombia, Sch Med, Dept Microbiol, Bogota, Colombia; [Parra-Lopez, Carlos A.; Bernal-Estevez, David] Univ Nacl Colombia, Grad Sch Biomed Sci, Bogota, Colombia; [Salazar, Luz Mary] Univ Nacl Colombia, Fac Sci, Bogota, Colombia; [Bernal-Estevez, David] Fdn Salud Andes, Res Grp Immunol & Clin Oncol GIIOC, Bogota, Colombia; [Calvo-Calle, J. Mauricio; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol & Biochem, Worcester, MA USA; [Calvo-Calle, J. Mauricio; Stern, Lawrence J.] Dept Mol Pharmacol, Worcester, MA USA	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; University of Massachusetts System; University of Massachusetts Worcester	Parra-Lopez, CA (corresponding author), Univ Nacl Colombia, Sch Med, Dept Microbiol, Bogota, Colombia.	caparral@unal.edu.co; Lawrence.Stern@umassmed.edu		PARRA LOPEZ, CARLOS ALBERTO/0000-0002-6084-8981; Bernal-Estevez, David Andres/0000-0002-7330-0333	COLCIENCIAS [RC-302-2010 (CD 110151928955)]; Universidad Nacional de Colombia - Bogota [8009074];  [NIH-AI38996];  [NIH-U19-57319]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038996, R37AI038996, R01AI038996] Funding Source: NIH RePORTER	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Nacional de Colombia - Bogota; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by COLCIENCIAS grant No. RC-302-2010 (CD 110151928955); by DIB grant (8009074) from Universidad Nacional de Colombia - Bogota and by NIH-AI38996 (LJS) and NIH-U19-57319 (LJS and JMCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; AK M, 1993, INFECT IMMUN, V61, P2493, DOI 10.1128/IAI.61.6.2493-2497.1993; Amria S, 2008, EUR J IMMUNOL, V38, P1961, DOI 10.1002/eji.200738100; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Calvo-Calle JM, 2005, J IMMUNOL, V175, P7575, DOI 10.4049/jimmunol.175.11.7575; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; Cameron TO, 2002, J IMMUNOL METHODS, V268, P51, DOI 10.1016/S0022-1759(02)00200-4; Carapau D, 2013, INFECT IMMUN, V81, P4350, DOI 10.1128/IAI.00263-13; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Chaves FA, 2006, BIOCHEMISTRY-US, V45, P6426, DOI 10.1021/bi060194g; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; COCHRANE AH, 1985, INFECT IMMUN, V50, P58, DOI 10.1128/IAI.50.1.58-61.1985; COCHRANE AH, 1982, P NATL ACAD SCI-BIOL, V79, P5651, DOI 10.1073/pnas.79.18.5651; DELACRUZ VF, 1987, J BIOL CHEM, V262, P11935; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; GUTTINGER M, 1988, EMBO J, V7, P2555, DOI 10.1002/j.1460-2075.1988.tb03104.x; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; GYSIN J, 1984, J EXP MED, V160, P935, DOI 10.1084/jem.160.3.935; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HERRINGTON DA, 1990, B WORLD HEALTH ORGAN, V68, P33; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Jensen PE, 1998, CURR BIOL, V8, pR128, DOI 10.1016/S0960-9822(98)70988-1; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2005, J MOL BIOL, V350, P170, DOI 10.1016/j.jmb.2005.04.069; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; MORENO A, 1993, J IMMUNOL, V151, P489; MORENO A, 1991, INT IMMUNOL, V3, P997, DOI 10.1093/intimm/3.10.997; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; NARDIN EH, 1989, SCIENCE, V246, P1603, DOI 10.1126/science.2480642; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Parra-Lopez C, 2006, J BIOL CHEM, V281, P14907, DOI 10.1074/jbc.M511571200; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Raddrizzani L, 1999, EUR J IMMUNOL, V29, P660, DOI 10.1002/(SICI)1521-4141(199902)29:02<660::AID-IMMU660>3.0.CO;2-I; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Rinderknecht CH, 2010, IMMUNOLOGY, V131, P18, DOI 10.1111/j.1365-2567.2010.03282.x; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Schwenk R, 2011, VACCINE, V29, P8847, DOI 10.1016/j.vaccine.2011.09.098; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Siklodi B, 1998, HUM IMMUNOL, V59, P463, DOI 10.1016/S0198-8859(98)00038-X; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh JPN, 2009, TROP MED INT HEALTH, V14, P957, DOI 10.1111/j.1365-3156.2009.02314.x; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Sinnis P, 1997, TRENDS MICROBIOL, V5, P52, DOI 10.1016/S0966-842X(97)84657-4; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WOODS A, 1994, J EXP MED, V180, P173, DOI 10.1084/jem.180.1.173; World Health Organization, 2011, WORLD HLTH STAT 2011; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; YOSHIDA N, 1990, EXP PARASITOL, V71, P386, DOI 10.1016/0014-4894(90)90064-J; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430; ZEVERING Y, 1994, EUR J IMMUNOL, V24, P1418, DOI 10.1002/eji.1830240627; Zirlik KM, 2006, BLOOD, V108, P3865, DOI 10.1182/blood-2006-04-014415	97	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100639	10.1371/journal.pone.0100639	http://dx.doi.org/10.1371/journal.pone.0100639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983460	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000035
J	Zhang, YW; Calado, R; Rao, M; Hong, JA; Meeker, AK; Dumitriu, B; Atay, S; McCormick, PJ; Garfield, SH; Wangsa, D; Padilla-Nash, HM; Burkett, S; Zhang, M; Kunst, TF; Peterson, NR; Xi, SC; Inchauste, S; Altorki, NK; Casson, AG; Beer, DG; Harris, CC; Ried, T; Young, NS; Schrump, DS				Zhang, Yuwei; Calado, Rodrigo; Rao, Mahadev; Hong, Julie A.; Meeker, Alan K.; Dumitriu, Bogdan; Atay, Scott; McCormick, Peter J.; Garfield, Susan H.; Wangsa, Danny; Padilla-Nash, Hesed M.; Burkett, Sandra; Zhang, Mary; Kunst, Tricia F.; Peterson, Nathan R.; Xi, Sichuan; Inchauste, Suzanne; Altorki, Nasser K.; Casson, Alan G.; Beer, David G.; Harris, Curtis C.; Ried, Thomas; Young, Neal S.; Schrump, David S.			Telomerase Variant A279T Induces Telomere Dysfunction and Inhibits Non-Canonical Telomerase Activity in Esophageal Carcinomas	PLOS ONE			English	Article							BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; CANCER-CELLS; APLASTIC-ANEMIA; BETA-CATENIN; MUTATIONS; TERT; BARRETTS; LENGTH; MAINTENANCE	Background: Although implicated in the pathogenesis of several chronic inflammatory disorders and hematologic malignancies, telomerase mutations have not been thoroughly characterized in human cancers. The present study was performed to examine the frequency and potential clinical relevance of telomerase mutations in esophageal carcinomas. Methods: Sequencing techniques were used to evaluate mutational status of telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) in neoplastic and adjacent normal mucosa from 143 esophageal cancer (EsC) patients. MTS, flow cytometry, time lapse microscopy, and murine xenograft techniques were used to assess proliferation, apoptosis, chemotaxis, and tumorigenicity of EsC cells expressing either wtTERT or TERT variants. Immunoprecipitation, immunoblot, immunofluorescence, promoter-reporter and qRT-PCR techniques were used to evaluate interactions of TERT and several TERT variants with BRG-1 and beta-catenin, and to assess expression of cytoskeletal proteins, and cell signaling. Fluorescence in-situ hybridization and spectral karyotyping techniques were used to examine telomere length and chromosomal stability. Results: Sequencing analysis revealed one deletion involving TERC (TERC del 341-360), and two non-synonymous TERT variants [A279T (2 homozygous, 9 heterozygous); A1062T (4 heterozygous)]. The minor allele frequency of the A279T variant was five-fold higher in EsC patients compared to healthy blood donors (p<0.01). Relative to wtTERT, A279T decreased telomere length, destabilized TERT-BRG-1-beta-catenin complex, markedly depleted beta-catenin, and down-regulated canonical Wnt signaling in cancer cells; these phenomena coincided with decreased proliferation, depletion of additional cytoskeletal proteins, impaired chemotaxis, increased chemosensitivity, and significantly decreased tumorigenicity of EsC cells. A279T expression significantly increased chromosomal aberrations in mouse embryonic fibroblasts (MEFs) following Zeocin (TM) exposure, as well as Li Fraumeni fibroblasts in the absence of pharmacologically-induced DNA damage. Conclusions: A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal cancer cells. These findings warrant further analysis of A279T expression in esophageal cancers and premalignant esophageal lesions.	[Zhang, Yuwei; Rao, Mahadev; Hong, Julie A.; Atay, Scott; Zhang, Mary; Kunst, Tricia F.; Xi, Sichuan; Inchauste, Suzanne; Schrump, David S.] NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Bethesda, MD 20892 USA; [Calado, Rodrigo; Dumitriu, Bogdan; Peterson, Nathan R.; Young, Neal S.] NHLBI, Bethesda, MD 20892 USA; [Meeker, Alan K.] Johns Hopkins Univ Med, Dept Pathol, Baltimore, MD USA; [Meeker, Alan K.] Johns Hopkins Univ Med, Dept Oncol, Baltimore, MD USA; [McCormick, Peter J.] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA; [Garfield, Susan H.] NCI, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA; [Wangsa, Danny; Padilla-Nash, Hesed M.] NCI, Sect Canc Genom, Bethesda, MD 20892 USA; [Burkett, Sandra] NCI, Comparat Mol Cytogenet Core Facil, Frederick, MD 21701 USA; [Altorki, Nasser K.] Weill Cornell Med Ctr, Dept Thorac Surg, New York, NY USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Beer, David G.] Univ Michigan, Med Ctr, Thorac Surg Sect, Ann Arbor, MI USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; University of Saskatchewan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schrump, DS (corresponding author), NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Bethesda, MD 20892 USA.	David_Schrump@nih.gov	Calado, Rodrigo T./G-2619-2011; CTC USP, CEPID 13 18/J-8951-2014; McCormick, Peter/E-7387-2012	Calado, Rodrigo T./0000-0002-7966-6029; Burkett, Sandra/0000-0002-5476-4028; CTC USP, CEPID 13 18/0000-0002-7123-9524; McCormick, Peter/0000-0002-2225-5181	NIH; NATIONAL CANCER INSTITUTE [ZIABC011496, ZIABC011115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH intramural grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Calado RT, 2012, LEUKEMIA, V26, P700, DOI 10.1038/leu.2011.272; Calado RT, 2009, EUR J CLIN INVEST, V39, P1025, DOI 10.1111/j.1365-2362.2009.02209.x; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Chiodi I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00133; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai ZY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-44; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Gollahon LS, 1998, ONCOGENE, V17, P709, DOI 10.1038/sj.onc.1201987; Gosepath EM, 2008, INT J CANCER, V123, P2013, DOI 10.1002/ijc.23721; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; He HP, 2012, CELL CYCLE, V11, P617, DOI 10.4161/cc.11.3.19115; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jaskelioff M, 2009, ONCOGENE, V28, P4225, DOI 10.1038/onc.2009.268; Jenkins GJS, 2003, BRIT J CANCER, V88, P1271, DOI 10.1038/sj.bjc.6600891; Kammori M, 2007, INT J MOL MED, V20, P793; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Maida Y, 2014, MOL CELL BIOL, V34, P1576, DOI 10.1128/MCB.00093-14; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Ohigashi T, 2005, PROSTATE, V62, P61, DOI 10.1002/pros.20117; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shay JW, 2012, SCIENCE, V336, P1388, DOI 10.1126/science.1222394; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Smith V, 2009, J CHEMOTHERAPY, V21, P542, DOI 10.1179/joc.2009.21.5.542; Streppel MM, 2013, CURR MOL MED; Taboski MAS, 2012, CELL REP, V1, P91, DOI 10.1016/j.celrep.2011.12.004; Uziel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009132; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Wege H, 2011, MOL CANCER RES, V9, P1222, DOI 10.1158/1541-7786.MCR-10-0474; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zantl R, 2011, METHODS MOL BIOL, V769, P191, DOI 10.1007/978-1-61779-207-6_13; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	66	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101010	10.1371/journal.pone.0101010	http://dx.doi.org/10.1371/journal.pone.0101010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983628	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000046
J	Jasna, JM; Anandbabu, K; Bharathi, SR; Angayarkanni, N				Jasna, Jagan Mohan; Anandbabu, Kannadasan; Bharathi, Subramaniam Rajesh; Angayarkanni, Narayanasamy			Paraoxonase Enzyme Protects Retinal Pigment Epithelium from Chlorpyrifos Insult	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; OXIDATIVE STRESS; INSECTICIDE CHLORPYRIFOS; BARRIER DYSFUNCTION; GENE-TRANSCRIPTION; HEART-DISEASE; RPE CELLS; KINASE-C; PON1	Retinal pigment epithelium (RPE) provides nourishment and protection to the eye. RPE dysfunction due to oxidative stress and inflammation is one of the major reason for many of the retinal disorders. Organophosphorus pesticides are widely used in the agricultural, industrial and household activities in India. However, their effects on the eye in the context of RPE has not been studied. In this study the defense of the ARPE19 cells exposed to Chlorpyrifos (1 nM to 100 mM) in terms of the enzyme paraoxonase (PON) was studied at 24 hr and 9 days of treatment. Chlorpyrifos was found to induce oxidative stress in the ARPE19 cells as seen by significant increase in ROS and decrease in glutathione (GSH) levels without causing cell death. Tissue resident Paraoxonase 2 (PON2) mRNA expression was elevated with chlorpyrifos exposure. The three enzymatic activities of PON namely, paraoxonase (PONase), arylesterase (PON AREase) and thiolactonase (PON HCTLase) were also found to be significantly altered to detoxify and as an antioxidant defense. Among the transcription factors regulating PON2 expression, SP1 was significantly increased with chlorpyrifos exposure. PON2 expression was found to be crucial as ARPE19 cells showed a significant loss in their ability to withstand oxidative stress when the cells were subjected to chlorpyrifos after silencing PON2 expression. Treatment with N-acetyl cysteine positively regulated the PON 2 expression, thus promoting the antioxidant defense put up by the cells in response to chlorpyrifos.	[Jasna, Jagan Mohan; Anandbabu, Kannadasan; Bharathi, Subramaniam Rajesh; Angayarkanni, Narayanasamy] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Madras, Tamil Nadu, India		Angayarkanni, N (corresponding author), Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, KBIRVO Block, Madras, Tamil Nadu, India.	drak@snmail.org	Narayanasamy, Angayarkanni/ABD-8584-2020; K, Anand Babu/AAN-8619-2020	K, Anand Babu/0000-0002-9910-2044	Indian Council of Medical Research (ICMR), India [5/8/4-18(Env)/08-NCD-1]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	The research work was financially supported by the Indian Council of Medical Research (ICMR), India. Grant number is 5/8/4-18(Env)/08-NCD-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2009, J ENVIRON BIOL, V30, P1047; Angayarkanni N, 2008, EYE, V22, P969, DOI 10.1038/sj.eye.6703062; Arii K, 2010, METABOLISM, V59, P1287, DOI 10.1016/j.metabol.2009.12.003; Bastiaans J, 2013, GRAEF ARCH CLIN EXP, V251, P1723, DOI 10.1007/s00417-013-2335-2; Bayram B, 2012, REJUV RES, V15, P71, DOI 10.1089/rej.2011.1245; BOYES WK, 1994, J APPL TOXICOL, V14, P135, DOI 10.1002/jat.2550140216; Cabana VG, 2003, J LIPID RES, V44, P780, DOI 10.1194/jlr.M200432-JLR200; Charlton-Menys V, 2006, CLIN CHEM, V52, P453, DOI 10.1373/clinchem.2005.063412; Chen WQ, 2012, NEUROSCI LETT, V528, P148, DOI 10.1016/j.neulet.2012.08.084; Cheng XG, 2012, J PHARMACOL EXP THER, V342, P688, DOI 10.1124/jpet.112.194803; Chiapella G, 2013, PLACENTA, V34, P792, DOI 10.1016/j.placenta.2013.06.007; Dahrouj M, 2013, J PHARMACOL EXP THER, V344, P96, DOI 10.1124/jpet.112.199307; Danell RM, 2000, J AM SOC MASS SPECTR, V11, P1107, DOI 10.1016/S1044-0305(00)00188-4; Deakin SP, 2008, PROTEINS CELL REG, V6, P241, DOI 10.1007/978-1-4020-6561-3_16; DEMENTI B, 1994, J APPL TOXICOL, V14, P119, DOI 10.1002/jat.2550140214; Devarajan A, 2012, MOL GENET METAB, V107, P416, DOI 10.1016/j.ymgme.2012.06.020; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Ekinci D, 2010, CHEM BIOL DRUG DES, V76, P552, DOI 10.1111/j.1747-0285.2010.01036.x; Fuhrman B, 2009, CARDIOVASC RES, V84, P145, DOI 10.1093/cvr/cvp184; Garcia-Ramirez M, 2011, METHODS MOL BIOL, V763, P179, DOI 10.1007/978-1-61779-191-8_12; Geller AM, 2005, DOC OPHTHALMOL, V110, P79, DOI 10.1007/s10633-005-7347-8; Geller AM, 1998, INVEST OPHTH VIS SCI, V39, P1290; Hines CJ, 2001, ANN OCCUP HYG, V45, P309, DOI 10.1093/annhyg/45.4.309; Jin ML, 2005, INVEST OPHTH VIS SCI, V46, P4311, DOI 10.1167/iovs.05-0353; Kim JH, 2012, INT J BIOCHEM CELL B, V44, P808, DOI 10.1016/j.biocel.2012.02.005; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Koubaa N, 2008, CLIN CHEM LAB MED, V46, P187, DOI 10.1515/CCLM.2008.046; Loscalzo J, 2008, CIRC-CARDIOVASC GENE, V1, P79, DOI 10.1161/CIRCGENETICS.108.837179; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Martinelli N, 2013, ADV CLIN CHEM, V59, P65, DOI 10.1016/B978-0-12-405211-6.00003-6; MISRA UK, 1982, LANCET, V1, P288; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Osaki F, 2004, ATHEROSCLEROSIS, V176, P279, DOI 10.1016/j.atherosclerosis.2004.05.029; Pauer GJT, 2010, AM J OPHTHALMOL, V149, P513, DOI 10.1016/j.ajo.2009.09.024; Perla-Kajan J, 2010, FASEB J, V24, P931, DOI 10.1096/fj.09-144410; Shamir R, 2005, FREE RADICAL BIO MED, V39, P336, DOI 10.1016/j.freeradbiomed.2005.03.016; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; Shirasawa M, 2013, EXP EYE RES, V110, P59, DOI 10.1016/j.exer.2013.02.012; TANDON P, 1994, TOXICOL APPL PHARM, V125, P271, DOI 10.1006/taap.1994.1073; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; Tripathi S, 2013, MICROSC RES TECHNIQ, V76, P673, DOI 10.1002/jemt.22217; Verma Radhey Shyam, 2001, Indian Journal of Experimental Biology, V39, P174; Yoshikawa H, 1990, Nihon Eiseigaku Zasshi, V45, P884; Yu F, 2008, EXP TOXICOL PATHOL, V59, P415, DOI 10.1016/j.etp.2007.11.007; Yuan Jinyun, 2010, J Stem Cells, V5, P43, DOI jsc.2010.5.1.43	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101380	10.1371/journal.pone.0101380	http://dx.doi.org/10.1371/journal.pone.0101380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979751	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400124
J	Mehta, V; Abi-Nader, KN; Shangaris, P; Shaw, SWS; Filippi, E; Benjamin, E; Boyd, M; Peebles, DM; Martin, J; Zachary, I; David, AL				Mehta, Vedanta; Abi-Nader, Khalil N.; Shangaris, Panicos; Shaw, S. W. Steven; Filippi, Elisa; Benjamin, Elizabeth; Boyd, Michael; Peebles, Donald M.; Martin, John; Zachary, Ian; David, Anna L.			Local Over-Expression of VEGF-D-Delta N Delta C in the Uterine Arteries of Pregnant Sheep Results in Long-Term Changes in Uterine Artery Contractility and Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FETAL-GROWTH; BLOOD-FLOW; TROPHOBLAST INVASION; DEPENDENT RELAXATION; GENE-TRANSFER; NITRIC-OXIDE; RESTRICTION; CELLS; PREECLAMPSIA	Background: The normal development of the uteroplacental circulation in pregnancy depends on angiogenic and vasodilatory factors such as vascular endothelial growth factor (VEGF). Reduced uterine artery blood flow (UABF) is a common cause of fetal growth restriction; abnormalities in angiogenic factors are implicated. Previously we showed that adenovirus (Ad)-mediated VEGF-A(165) expression in the pregnant sheep uterine artery (UtA) increased nitric oxide synthase (NOS) expression, altered vascular reactivity and increased UABF. VEGF-D is a VEGF family member that promotes angiogenesis and vasodilatation but, in contrast to VEGF-A, does not increase vascular permeability. Here we examined the effect of Ad. VEGF-D-Delta N Delta C vector encoding a fully processed form of VEGF-D, on the uteroplacental circulation. Methods: UtA transit-time flow probes and carotid artery catheters were implanted in mid-gestation pregnant sheep (n = 5) to measure baseline UABF and maternal haemodynamics respectively. 7-14 days later, after injection of Ad.VEGF-D-Delta N Delta C vector (5x10(11) particles) into one UtA and an Ad vector encoding beta-galactosidase (Ad. LacZ) contralaterally, UABF was measured daily until scheduled post-mortem examination at term. UtAs were assessed for vascular reactivity, NOS expression and endothelial cell proliferation; NOS expression was studied in ex vivo transduced UtA endothelial cells (UAECs). Results: At 4 weeks post-injection, Ad.VEGF-D-Delta N Delta C treated UtAs showed significantly lesser vasoconstriction (E(max)144.0 v/s 184.2, p = 0.002). There was a tendency to higher UABF in Ad.VEGF-D-Delta N Delta C compared to Ad.LacZ transduced UtAs (50.58% v/s 26.94%, p = 0.152). There was no significant effect on maternal haemodynamics. An increased number of proliferating endothelial cells and adventitial blood vessels were observed in immunohistochemistry. Ad. VEGF-D DNDC expression in cultured UAECs upregulated eNOS and iNOS expression. Conclusions: Local over-expression of VEGF-D-Delta N Delta C in the UtAs of pregnant mid-gestation sheep reduced vasoconstriction, promoted endothelial cell proliferation and showed a trend towards increased UABF. Studies in cultured UAECs indicate that VEGF-D-Delta N Delta C may act in part through upregulation of eNOS and iNOS.	[Mehta, Vedanta; Abi-Nader, Khalil N.; Shangaris, Panicos; Shaw, S. W. Steven; Filippi, Elisa; Benjamin, Elizabeth; Peebles, Donald M.; David, Anna L.] UCL, Inst Womens Hlth, London, England; [Boyd, Michael] Univ London Royal Vet Coll, BSU, London, England; [Mehta, Vedanta; Martin, John; Zachary, Ian] UCL, Ctr Cardiovasc Biol & Med, Div Med, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London	Mehta, V (corresponding author), UCL, Inst Womens Hlth, London, England.	v.mehta@ucl.ac.uk	Shangaris, Panicos/AAJ-7725-2020	Shangaris, Panicos/0000-0003-2750-8405; David, Anna/0000-0002-0199-6140	University College London Hospital (UCLH) Charities; Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council; UCLH Charities; BHF; Department of Health's NIHR Biomedical Research Center's funding scheme; British Heart Foundation [RG/11/11/29050] Funding Source: researchfish; Sparks Charity [12WTUCL02] Funding Source: researchfish	University College London Hospital (UCLH) Charities; Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council; UCLH Charities; BHF(British Heart Foundation); Department of Health's NIHR Biomedical Research Center's funding scheme; British Heart Foundation(British Heart Foundation); Sparks Charity	This study was partly funded by University College London Hospital (UCLH) Charities. VM is supported by a Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council and UCLH Charities. Work in IZ's group is funded by the BHF. This work was undertaken at UCLH/UCL who received a proportion of the funding from the Department of Health's NIHR Biomedical Research Center's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Nader KN, 2010, REPROD SCI, V17, P13, DOI 10.1177/1933719109344772; ARDUINI D, 1992, OBSTET GYNECOL, V79, P605; Barbera A, 1995, AM J OBSTET GYNECOL, V173, P1765, DOI 10.1016/0002-9378(95)90424-7; Baschat AA, 2001, ULTRASOUND OBST GYN, V18, P571, DOI 10.1046/j.0960-7692.2001.00591.x; Baschat AA, 2000, ULTRASOUND OBST GYN, V16, P407, DOI 10.1046/j.1469-0705.2000.00284.x; Bird IM, 2000, ENDOCRINOLOGY, V141, P1107, DOI 10.1210/en.141.3.1107; David AL, 2008, GENE THER, V15, P1344, DOI 10.1038/gt.2008.102; Delotte J, 2009, EUR J OBSTET GYN R B, V145, P129, DOI 10.1016/j.ejogrb.2009.03.013; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Gifford SM, 2003, ENDOCRINOLOGY, V144, P3639, DOI 10.1210/en.2002-0006; HEISTAD DD, 1981, AM J PHYSIOL, V240, pH781, DOI 10.1152/ajpheart.1981.240.5.H781; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; Laitinen M, 1997, HUM GENE THER, V8, P1737, DOI 10.1089/hum.1997.8.15-1737; Lang U, 2003, EUR J OBSTET GYN R B, V110, pS55, DOI 10.1016/S0301-2115(03)00173-8; Mehta V, 2012, GENE THER, V19, P925, DOI 10.1038/gt.2011.158; Naicker T, 2003, ACTA OBSTET GYN SCAN, V82, P722, DOI 10.1034/j.1600-0412.2003.00220.x; Ong SS, 2005, AM J OBSTET GYNECOL, V192, P572, DOI 10.1016/j.ajog.2004.08.015; Reister F, 2001, LAB INVEST, V81, P1143, DOI 10.1038/labinvest.3780326; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Savvidou MD, 2006, AM J OBSTET GYNECOL, V195, P1668, DOI 10.1016/j.ajog.2006.03.065; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Takeshita S, 1998, CIRCULATION, V98, P1261, DOI 10.1161/01.CIR.98.13.1261; Turam OM, 2008, ULTRASOUND OBST GYN, V32, P160, DOI 10.1002/uog.5386; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831; Werner A, 1998, J NEUROCYTOL, V27, P219, DOI 10.1023/A:1006928830251; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6; Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011; Zezula-Szpyra A, 1997, Rocz Akad Med Bialymst, V42 Suppl 2, P134; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	35	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100021	10.1371/journal.pone.0100021	http://dx.doi.org/10.1371/journal.pone.0100021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977408	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400017
J	Mercadel, L; Metzger, M; Haymann, JP; Thervet, E; Boffa, JJ; Flamant, M; Vrtovsnik, F; Houillier, P; Froissart, M; Stengel, B				Mercadel, Lucile; Metzger, Marie; Haymann, Jean Philippe; Thervet, Eric; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Houillier, Pascal; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease	PLOS ONE			English	Article							SERUM HEPCIDIN; ERYTHROPOIETIN THERAPY; HEMODIALYSIS; ANEMIA; PATHOGENESIS; PROHEPCIDIN; DEFICIENCY; EXPRESSION; FERRITIN	The metabolism of hepcidin is profoundly modified in chronic kidney disease (CKD). We investigated its relation to iron disorders, inflammation and hemoglobin (Hb) level in 199 non-dialyzed, non-transplanted patients with CKD stages 1-5. All had their glomerular filtration rate measured by Cr-51-EDTA renal clearance (mGFR), as well as measurements of iron markers including hepcidin and of erythropoietin (EPO). Hepcidin varied from 0.2 to 193 ng/mL. The median increased from 23.3 ng/mL [8.8-28.7] to 36.1 ng/mL [14.1-92.3] when mGFR decreased from >= 60 to <15 mL/min/1.73 m(2) (p = 0.02). Patients with absolute iron deficiency (transferrin saturation (TSAT) <20% and ferritin <40 ng/mL) had the lowest hepcidin levels (5.0 ng/mL [0.7-11.7]), and those with a normal iron profile (TSAT >= 20% and ferritin >= 40), the highest (34.5 ng/mL [23.7-51.6]). In multivariate analysis, absolute iron deficiency was associated with lower hepcidin values, and inflammation combined with a normal or functional iron profile with higher values, independent of other determinants of hepcidin concentration, including EPO, mGFR, and albuminemia. The hepcidin level, although it rose overall when mGFR declined, collapsed in patients with absolute iron deficiency. There was a significant interaction with iron status in the association between Hb and hepcidin. Except in absolute iron deficiency, hepcidin's negative association with Hb level indicates that it is not downregulated in CKD anemia.	[Mercadel, Lucile; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France; [Mercadel, Lucile] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, U1018, Villejuif, France; [Haymann, Jean Philippe] Univ Paris 06, INSERM, U702, Hop Tenon,Assistance Publ Hop Paris,Dept Physiol, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Boffa, Jean-Jacques] Univ Paris 06, Hop Tenon, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Physiol, F-75877 Paris, France; [Flamant, Martin; Vrtovsnik, Francois] INSERM, U699, Paris, France; [Vrtovsnik, Francois] Univ Paris 06, Hop Bichat, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Houillier, Pascal] Univ Paris 05, Hop Europe G Pompidou, Assistance Publ Hop Paris, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Mercadel, L (corresponding author), INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France.	lucile.mercadal@psl.aphp.fr	Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Houillier, Pascal/AAD-4903-2019; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Houillier, Pascal/0000-0003-4953-6917; Metzger, Marie/0000-0003-3597-5409; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302; DAUGAS, Eric/0000-0001-7256-7979; Eladari, Dominique/0000-0003-1067-0844; Vrtovsnik, Francois/0000-0003-1554-314X	Inserm GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; Inserm [AO 8022LS]; Agence de la Biomedecine [RO 8156LL]; AURA; Roche [2009-152-447G]; F. Hoffman-La Roche Ltd.	Inserm GIS-IReSP; French Ministry of Health; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); F. Hoffman-La Roche Ltd.	The NephroTest CKD cohort study is supported by grants from Inserm GIS-IReSP AO 8113LS TGIR (BS); French Ministry of Health AOM 09114 (MFr); Inserm AO 8022LS (BS); Agence de la Biomedecine RO 8156LL (BS), AURA (MFr), and Roche 2009-152-447G (MFr). The Nephrotest initiative was also sponsored by unrestricted grants from F. Hoffman-La Roche Ltd. (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Canavesi Elena, 2012, World J Nephrol, V1, P166, DOI 10.5527/wjn.v1.i6.166; Costa E, 2009, ACTA HAEMATOL-BASEL, V122, P226, DOI 10.1159/000253590; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Grebenchtchikov N, 2009, BRIT J HAEMATOL, V146, P317, DOI 10.1111/j.1365-2141.2009.07758.x; Hintze Korry J, 2011, Adv Hematol, V2011, P510304, DOI 10.1155/2011/510304; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Li Hongyan, 2009, Journal of Pharmacological and Toxicological Methods, V59, P171, DOI 10.1016/j.vascn.2009.02.004; Lipschitz D A, 1992, Nutrition, V8, P443; Malyszko J, 2009, TRANSPL P, V41, P3056, DOI 10.1016/j.transproceed.2009.08.003; Malyszko J, 2009, RENAL FAILURE, V31, P544, DOI 10.1080/08860220903082606; Mercadal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084144; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Pelusi S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-48; Peters HPE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-70; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Uehata T, 2012, NEPHROL DIAL TRANSPL, V27, P1076, DOI 10.1093/ndt/gfr431; Ulukol B, 2007, ACTA HAEMATOL-BASEL, V118, P70, DOI 10.1159/000102606; Valenti L, 2013, CLIN CHEM LAB MED, V14, P1; van der Weerd NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039783; Zaritsky J, 2010, CLIN J AM SOC NEPHRO, V5, P1010, DOI 10.2215/CJN.08161109; Zaritsky J, 2009, CLIN J AM SOC NEPHRO, V4, P1051, DOI 10.2215/CJN.05931108	30	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99781	10.1371/journal.pone.0099781	http://dx.doi.org/10.1371/journal.pone.0099781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978810	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400010
J	Shawish, HB; Wong, WY; Wong, YL; Loh, SW; Looi, CY; Hassandarvish, P; Phan, AYL; Wong, WF; Wang, H; Paterson, IC; Ea, CK; Mustafa, MR; Maah, MJ				Shawish, Hana Bashir; Wong, Wan Ying; Wong, Yi Li; Loh, Sheng Wei; Looi, Chung Yeng; Hassandarvish, Pouya; Phan, Alicia Yi Ling; Wong, Won Fen; Wang, Hao; Paterson, Ian C.; Ea, Chee Kwee; Mustafa, Mohd Rais; Maah, Mohd Jamil			Nickel(II) Complex of Polyhydroxybenzaldehyde N4-Thiosemicarbazone Exhibits Anti-Inflammatory Activity by Inhibiting NF-kappa B Transactivation	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; INDUCED APOPTOSIS; INFLAMMATION; THIOSEMICARBAZONE; CANCER; TNF; COPPER(II); CHLORIDE; AGENTS; ASSAYS	Background: The biological properties of thiosemicarbazone have been widely reported. The incorporation of some transition metals such as Fe, Ni and Cu to thiosemicarbazone complexes is known to enhance its biological effects. In this study, we incorporated nickel(II) ions into thiosemicarbazone with N4-substitution groups H3L (H; H3L1, CH3; H3L2, C6H5; H3L3 and C2H5; H3L4) and examined its potential anti-inflammatory activity. Methodology/Principal Findings: Four ligands (1-4) and their respective nickel-containing complexes (5-8) were synthesized and characterized. The compounds synthesized were tested for their effects on NF-kappa B nuclear translocation, pro-inflammatory cytokines secretion and NF-kappa B transactivation activity. The active compound was further evaluated on its ability to suppress carrageenan-induced acute inflammation in vivo. A potential binding target of the active compound was also predicted by molecular docking analysis. Conclusions/Significance: Among all synthesized compounds tested, we found that complex [Ni(H2L1)(PPh3)]Cl (5) (complex 5), potently inhibited I kappa B alpha degradation and NF-kappa B p65 nuclear translocation in LPS-stimulated RAW264.7 cells as well as TNF alpha-stimulated HeLa S3 cells. In addition, complex 5 significantly down-regulated LPS- or TNF alpha-induced transcription of NF-kappa B target genes, including genes that encode the pro-inflammatory cytokines TNF alpha, IFN beta and IL6. Luciferase reporter assays confirmed that complex 5 inhibited the transactivation activity of NF-kappa B. Furthermore, the anti-inflammatory effect of complex 5 was also supported by its suppressive effect on carrageenan-induced paw edema formation in wild type C57BL/6 mice. Interestingly, molecular docking study showed that complex 5 potentially interact with the active site of IKK beta. Taken together, we suggest complex 5 as a novel NF-kappa B inhibitor with potent anti-inflammatory effects.	[Shawish, Hana Bashir; Maah, Mohd Jamil] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Wong, Wan Ying; Loh, Sheng Wei; Ea, Chee Kwee] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Wong, Yi Li; Looi, Chung Yeng; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Hassandarvish, Pouya; Phan, Alicia Yi Ling; Wong, Won Fen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Wang, Hao] Ningxia Med Univ, Sch Pharm, Ningxia, Peoples R China; [Wang, Hao; Paterson, Ian C.] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur, Malaysia; [Wang, Hao; Paterson, Ian C.] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Ningxia Medical University; Universiti Malaya; Universiti Malaya	Looi, CY (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	looicy@um.edu.my; mjamil@um.edu.my	Mohd Jamil Maah, DPhil/Professor/B-5230-2010; Paterson, Ian/G-8688-2011; Mustafa, Mohamed R/B-1647-2009; Hassandarvish, Pouya/K-8112-2012; Looi, Chung Yeng/A-2623-2013; Wong, Won Fen/D-3087-2012	Mohd Jamil Maah, DPhil/Professor/0000-0002-0381-8954; Paterson, Ian/0000-0001-9156-401X; Mustafa, Mohamed R/0000-0002-7864-5189; Hassandarvish, Pouya/0000-0003-0364-5587; Looi, Chung Yeng/0000-0002-4830-3495; Wong, Won Fen/0000-0003-1082-1956	Postgraduate Research Fund [PS 484/ 2010B]; University of Malaya [RG206-11AFR]; University of Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/CHAN-02: H-50001-A000022]	Postgraduate Research Fund; University of Malaya(Universiti Malaya); University of Malaya High Impact Research Grant	This study was supported by Postgraduate Research Fund (PS 484/ 2010B) and RG206-11AFR from University of Malaya. C.K. Ea is supported by the University of Malaya High Impact Research Grant UM.C/625/1/HIR/MOHE/CHAN-02: H-50001-A000022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrasiabi Z, 2005, J INORG BIOCHEM, V99, P1526, DOI 10.1016/j.jinorgbio.2005.04.012; [Anonymous], 2007, APEX2 SAINT; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beg AA, 2004, NAT IMMUNOL, V5, P14, DOI 10.1038/ni0104-14; Botelho FV, 2007, J INORG BIOCHEM, V101, P935, DOI 10.1016/j.jinorgbio.2007.03.007; Bukhari SB, 2009, SPECTROCHIM ACTA A, V71, P1901, DOI 10.1016/j.saa.2008.07.030; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dilovic I, 2008, BIOORGAN MED CHEM, V16, P5189, DOI 10.1016/j.bmc.2008.03.006; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI [10.1107/S0021889897003117, DOI 10.1107/S0021889897003117]; Ferrari MB, 2002, J INORG BIOCHEM, V90, P113, DOI 10.1016/S0162-0134(02)00428-2; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KLAYMAN DL, 1979, J MED CHEM, V22, P855, DOI 10.1021/jm00193a020; Krishnamoorthy S, 2006, CANCER METAST REV, V25, P481, DOI 10.1007/s10555-006-9016-0; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Looi CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056643; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pelosi G., 2010, OPEN CRYSTALLOGR J, V3, P16, DOI [10.1021/jm1007616, DOI 10.2174/1874846501003020016, 10.2174/1874846501003010016]; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; Sankaraperumal A, 2013, POLYHEDRON, V50, P264, DOI 10.1016/j.poly.2012.11.006; Shawish HB, 2010, ACTA CRYSTALLOGR E, V66, pM1366, DOI 10.1107/S1600536810039292; Shawish HB, 2010, ACTA CRYSTALLOGR E, V66, pM1074, DOI 10.1107/S1600536810031065; Sheldrick G. M., 1996, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Swesi AT FY, 2007, SAINS MALAYS, V36, P21; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VENANZI LM, 1958, J CHEM SOC, P719, DOI 10.1039/jr9580000719; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zulueta A, 2009, FOOD CHEM, V114, P310, DOI 10.1016/j.foodchem.2008.09.033	38	48	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100933	10.1371/journal.pone.0100933	http://dx.doi.org/10.1371/journal.pone.0100933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977407	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400053
J	Sugisaki, N; Kurokawa, S; Okada, J; Kanehisa, H				Sugisaki, Norihide; Kurokawa, Sadao; Okada, Junichi; Kanehisa, Hiroaki			Difference in the Recruitment of Hip and Knee Muscles between Back Squat and Plyometric Squat Jump	PLOS ONE			English	Article							KINETIC CHAIN EXERCISES; MUSCULAR ENDURANCE; ELECTROMYOGRAPHIC ACTIVITY; POWER OUTPUT; FIBER-TYPE; PROTON T2; MR-IMAGES; INTENSITY; LOAD; BIOMECHANICS	Athletes who aim to improve both muscular endurance and power often perform exercises that involve similar joint actions under different lifting conditions, such as changes in the load or speed, which are implemented at different times during a periodized exercise program or simultaneously. The prescribed exercises are considered to recruit the same muscles even if the lifting conditions differ to each other. The present study aimed to clarify this by examining whether the recruitment of individual hip and knee muscles during the squat exercise differs between lifting conditions adopted for muscular endurance and power training regimens. Moderately trained men performed back squats (BS), with a load of approximately 60% of one repetition maximum, as a muscular endurance training exercise, and they performed plyometric squat jumping (PSJ) for power training. During each exercise, the lower limb joint torques and the recruitment of five hip and knee muscles were determined with inverse-dynamics and T2-weighted magnetic resonance imaging, respectively. While the maximal and mean knee joint torques were greater during PSJ than during BS (p<0.01), the T2 values for the quadriceps femoris muscle did not differ between the exercises. In contrast, the T2 values of the gluteus maximus and hip adductor muscles were higher during PSJ (p<0.05) than during BS, although there was no significant difference in the mean hip extension torque between the two exercises. The current results indicate that the individual use of the agonist muscles differs between BS and PSJ, and it does not always correspond with the joint kinetics during the exercises. Therefore, in addition to the exercise type, the lifting condition should also be taken into consideration as a determinant of the major muscles trained during a resistance exercise.	[Sugisaki, Norihide] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan; [Sugisaki, Norihide] Waseda Univ, Waseda Inst Sport Sci, Tokorozawa, Saitama, Japan; [Kurokawa, Sadao] Meiji Gakuin Univ, Ctr Liberal Arts, Yokohama, Kanagawa, Japan; [Okada, Junichi] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima, Japan	Chiba University; Waseda University; Waseda University; National Institute Fitness & Sports Kanoya	Sugisaki, N (corresponding author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan.	sugisaki@chiba-u.jp			JSPS [24700667]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS Grant-in-Aid for Scientific Research (24700667), (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1992, J APPL PHYSIOL, V73, P1578, DOI 10.1152/jappl.1992.73.4.1578; ADAMS GR, 1993, J APPL PHYSIOL, V74, P532, DOI 10.1152/jappl.1993.74.2.532; Baechle T. R., 2008, ESSENTIALS STRENGTH, P414; Baker D, 2001, J STRENGTH COND RES, V15, P92; Ball N, 2011, EUR J SPORT SCI, V11, P447, DOI 10.1080/17461391.2010.536583; CAVAGNA GA, 1968, J APPL PHYSIOL, V24, P21, DOI 10.1152/jappl.1968.24.1.21; DOSTAL WF, 1986, PHYS THER, V66, P351, DOI 10.1093/ptj/66.3.351; Earle R. W., 2008, ESSENTIALS STRENGTH, V3th, P325; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Enocson AG, 2005, EUR J APPL PHYSIOL, V94, P357, DOI 10.1007/s00421-005-1339-y; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P1552, DOI 10.1097/00005768-200109000-00020; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; FLECKENSTEIN JL, 1993, J APPL PHYSIOL, V74, P2855, DOI 10.1152/jappl.1993.74.6.2855; Ishikawa M, 2003, ACTA PHYSIOL SCAND, V178, P205, DOI 10.1046/j.1365-201X.2003.01149.x; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kawakami Y, 2006, AM J HUM BIOL, V18, P845, DOI 10.1002/ajhb.20561; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; PLOUTZSNYDER LL, 1995, AM J PHYSIOL-REG I, V269, pR536, DOI 10.1152/ajpregu.1995.269.3.R536; Potach DH., 2008, ESSENTIALS STRENGTH, P413; Price TB, 1998, MED SCI SPORT EXER, V30, P1374, DOI 10.1097/00005768-199809000-00006; Prior BM, 2001, J APPL PHYSIOL, V90, P615, DOI 10.1152/jappl.2001.90.2.615; Ratamess A, 2011, ACSMS FDN STRENGTH T, P192; Ratamess A, 2011, ACSMS FDN STRENGTH T, P331; Rhea MR, 2003, J STRENGTH COND RES, V17, P82; Sedano S, 2013, J STRENGTH COND RES, V27, P2433, DOI 10.1519/JSC.0b013e318280cc26; Smilios I, 2010, J STRENGTH COND RES, V24, P2122, DOI 10.1519/JSC.0b013e3181a5bc44; Taipale RS, 2013, EUR J APPL PHYSIOL, V113, P325, DOI 10.1007/s00421-012-2440-7; Voigt M, 1998, ACTA PHYSIOL SCAND, V163, P181; Wakahara T, 2012, EUR J APPL PHYSIOL, V112, P1569, DOI 10.1007/s00421-011-2121-y; Wathen D., 2008, ESSENTIALS STRENGTH, V3rd, P507; Weiss LW, 2000, J ORTHOP SPORT PHYS, V30, P143, DOI 10.2519/jospt.2000.30.3.143; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418; Willardson JM, 2006, J STRENGTH COND RES, V20, P400; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yamaguchi GT., 1990, MULTIPLE MUSCLE SYST, P717; [No title captured]	40	9	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101203	10.1371/journal.pone.0101203	http://dx.doi.org/10.1371/journal.pone.0101203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979707	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400099
J	Roy, S; Shrinivas, K; Bagchi, B				Roy, Susmita; Shrinivas, Krishna; Bagchi, Biman			A Stochastic Chemical Dynamic Approach to Correlate Autoimmunity and Optimal Vitamin-D Range	PLOS ONE			English	Article							REGULATORY T-CELLS; D ENDOCRINE SYSTEM; DENDRITIC CELLS; D-RECEPTOR; 25-HYDROXYVITAMIN D-3; IMMUNE-SYSTEM; DIFFERENTIATION; ACTIVATION; EXPRESSION; SUBPOPULATIONS	Motivated by several recent experimental observations that vitamin-D could interact with antigen presenting cells (APCs) and T-lymphocyte cells (T-cells) to promote and to regulate different stages of immune response, we developed a coarse grained but general kinetic model in an attempt to capture the role of vitamin-D in immunomodulatory responses. Our kinetic model, developed using the ideas of chemical network theory, leads to a system of nine coupled equations that we solve both by direct and by stochastic (Gillespie) methods. Both the analyses consistently provide detail information on the dependence of immune response to the variation of critical rate parameters. We find that although vitamin-D plays a negligible role in the initial immune response, it exerts a profound influence in the long term, especially in helping the system to achieve a new, stable steady state. The study explores the role of vitamin-D in preserving an observed bistability in the phase diagram (spanned by system parameters) of immune regulation, thus allowing the response to tolerate a wide range of pathogenic stimulation which could help in resisting autoimmune diseases. We also study how vitamin-D affects the time dependent population of dendritic cells that connect between innate and adaptive immune responses. Variations in dose dependent response of anti-inflammatory and pro-inflammatory T-cell populations to vitamin-D correlate well with recent experimental results. Our kinetic model allows for an estimation of the range of optimum level of vitamin-D required for smooth functioning of the immune system and for control of both hyper-regulation and inflammation. Most importantly, the present study reveals that an overdose or toxic level of vitamin-D or any steroid analogue could give rise to too large a tolerant response, leading to an inefficacy in adaptive immune function.	[Roy, Susmita; Shrinivas, Krishna; Bagchi, Biman] Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Bagchi, B (corresponding author), Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India.	profbiman@gmail.com	Shrinivas, Krishna/ABF-1250-2020	Shrinivas, Krishna/0000-0002-4167-9385; BAGCHI, BIMAN/0000-0002-7146-5994	Department of Science and Technology (DST), India; Sir J.C. Bose Fellowship (DST)	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Sir J.C. Bose Fellowship (DST)	This work was supported in parts by grants from Department of Science and Technology (DST), India and Sir J.C. Bose Fellowship (DST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Alberts B, 2002, MOL BIOL CELL; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Bates MF, 2014, PEDIATRICS, V133, pE39, DOI 10.1542/peds.2013-2418; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Chaudhury S, 2013, J PHYS CHEM B, V117, P503, DOI 10.1021/jp3096659; Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cutolo M, 2011, AUTOIMMUN REV, V11, P84, DOI 10.1016/j.autrev.2011.08.003; Cutolo M, 2011, VITAM HORM, V86, P327, DOI 10.1016/B978-0-12-386960-9.00014-9; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; de Pillis L, 2013, DISCRETE CONT DYN-B, V18, P915, DOI 10.3934/dcdsb.2013.18.915; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Fearnley DB, 1999, BLOOD, V93, P728, DOI 10.1182/blood.V93.2.728.402k03_728_736; Finsen NR, 1903, COUNT KAH MORN RECT; Fleet JC, 2004, J NUTR, V134, P3215, DOI 10.1093/jn/134.12.3215; Fouchet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002306; Ghosh S, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12011-4; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Harris SS, 2005, J NUTR, V135, P323, DOI 10.1093/jn/135.2.323; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hong T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-66; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; Jeffery LE, 2012, IMMUNOLOGY, V137, P125; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Leon K, 2000, J THEOR BIOL, V207, P231, DOI 10.1006/jtbi.2000.2169; LIGTHART GJ, 1985, IMMUNOLOGY, V55, P15; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mandlik V, 2012, INTEGR BIOL-UK, V4, P1130, DOI 10.1039/c2ib20037f; Martinez-Pasamar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-34; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Min W, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3207274; Moller KI, 2005, PHOTODERMATOL PHOTO, V21, P118, DOI 10.1111/j.1600-0781.2005.00159.x; Moyad MA, 2009, DERMATOLOGY NURSING, V21, P1; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Pike JW, 2012, REV ENDOCR METAB DIS, V13, P45, DOI 10.1007/s11154-011-9198-9; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Qian H, 2009, PHYS CHEM CHEM PHYS, V11, P4861, DOI 10.1039/b900335p; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1; Santra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066112; Santra M, 2012, J PHYS CHEM B, V116, P11809, DOI 10.1021/jp305045w; Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473; Schuster I, 2006, ANTICANCER RES, V26, P2653; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Williams CJ, 1849, LOND J MED, V1, P1, DOI DOI 10.1136/BMJ.S2-1.1.1; Wu ZH, 2012, BIOPHYS J, V103, P1052, DOI 10.1016/j.bpj.2012.08.008	71	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100635	10.1371/journal.pone.0100635	http://dx.doi.org/10.1371/journal.pone.0100635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971516	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000338512200047
J	Wu, AC; Ral, JP; Morell, MK; Gilbert, RG				Wu, Alex Chi; Ral, Jean-Philippe; Morell, Matthew K.; Gilbert, Robert G.			New Perspectives on the Role of alpha- and beta-Amylases in Transient Starch Synthesis	PLOS ONE			English	Article							GRANULE BIOSYNTHESIS; ARABIDOPSIS LEAVES; LEAF STARCH; DISPROPORTIONATING ENZYME; CHLAMYDOMONAS-REINHARDTII; DEBRANCHING ENZYMES; BRANCHING ENZYMES; DOWN-REGULATION; RICE ENDOSPERM; WATER DIKINASE	Transient starch in leaves is synthesized by various biosynthetic enzymes in the chloroplasts during the light period. This paper presents the first mathematical model for the (bio) synthesis of the chain-length distribution (CLD) of transient starch to aid the understanding of this synthesis. The model expresses the rate of change of the CLD in terms of the actions of the enzymes involved. Using this to simulate the experimental CLD with different enzyme combinations is a new means to test for enzymes that are significant to the rate of change of the CLD during synthesis. Comparison between the simulated CLD from different enzyme combinations and the experimental CLD in the leaves of the model plant Arabidopsis thaliana indicate alpha-amylase, in addition to the core starch biosynthetic enzymes, is also involved in the modification of glucans for the synthesis of insoluble starch granules. The simulations suggest involvement of beta-amylase, in the absence of alpha-amylase in mutants, slows the rate of attaining a crystalline-competent CLD for crystallization of glucans to form insoluble starch. This suggests a minor role of beta-amylase in shaping normal starch synthesis. The model simulation predicts that debranching of glucans is an efficient mechanism for the attainment of crystalline-competent CLD; however, attaining this is still possible, albeit slower, through combinations of alpha- and beta-amylase in the absence of isoamylase-type debranching enzyme. In Arabidopsis defective in one of the isoamylase-type debranching enzymes, the impact of alpha-amylase in starch synthesis is reduced, while beta-amylase becomes significantly involved, slowing the rate of synthesis in this mutant. Modeling of transient starch CLD brings to light previously unrecognized but significant effects of alpha- and beta-amylase on the rate of transient starch synthesis.	[Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China; [Wu, Alex Chi; Gilbert, Robert G.] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Ral, Jean-Philippe; Morell, Matthew K.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Ral, Jean-Philippe; Morell, Matthew K.] CSIRO, Canberra, ACT, Australia	Huazhong University of Science & Technology; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China.	b.gilbert@uq.edu.au	Morell, Matthew/AAQ-5368-2021; Gilbert, Robert G/C-5660-2009; Wu, Alex/C-3513-2017; Ral, Jean-Philippe/H-5632-2012; Ral, Jean-Philippe/Q-1711-2019	Morell, Matthew/0000-0003-4467-1626; Gilbert, Robert G/0000-0001-6988-114X; Wu, Alex/0000-0002-6612-7691; Ral, Jean-Philippe/0000-0002-3226-6204	Australian Postgraduate Award; CSIRO Food Future Flagship Postgraduate (top-up) Scholarship	Australian Postgraduate Award(Australian Government); CSIRO Food Future Flagship Postgraduate (top-up) Scholarship	This work is supported by an Australian Postgraduate Award (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx) and CSIRO Food Future Flagship Postgraduate (top-up) Scholarship (http://www.csiro.au/Portals/Careers/Work-experience-and-scholarships/Postgraduate-scholarships/Flagship-Postgrad-Scholarships.aspx#food). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; Rathore RS, 2009, CRIT REV BIOTECHNOL, V29, P214, DOI 10.1080/07388550902926063; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; TABATA S, 1978, CARBOHYD RES, V67, P189, DOI 10.1016/S0008-6215(00)83741-6; TAKEDA Y, 1981, CARBOHYD RES, V89, P174, DOI 10.1016/S0008-6215(00)85242-8; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2003, PLANT PHYSIOL, V132, P137, DOI 10.1104/pp.102.016527; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Wu AC, 2013, AUST J CHEM, V66, P1550, DOI 10.1071/CH13397; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	36	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100498	10.1371/journal.pone.0100498	http://dx.doi.org/10.1371/journal.pone.0100498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971464	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200038
J	Howison, M; Zapata, F; Edwards, EJ; Dunn, CW				Howison, Mark; Zapata, Felipe; Edwards, Erika J.; Dunn, Casey W.			Bayesian Genome Assembly and Assessment by Markov Chain Monte Carlo Sampling	PLOS ONE			English	Article								Most genome assemblers construct point estimates, choosing only a single genome sequence from among many alternative hypotheses that are supported by the data. We present a Markov chain Monte Carlo approach to sequence assembly that instead generates distributions of assembly hypotheses with posterior probabilities, providing an explicit statistical framework for evaluating alternative hypotheses and assessing assembly uncertainty. We implement this approach in a prototype assembler, called Genome Assembly by Bayesian Inference (GABI), and illustrate its application to the bacteriophage Phi X174. Our sampling strategy achieves both good mixing and convergence on Illumina test data for Phi X174, demonstrating the feasibility of our approach. We summarize the posterior distribution of assembly hypotheses generated by GABI as a majority-rule consensus assembly. Then we compare the posterior distribution to external assemblies of the same test data, and annotate those assemblies by assigning posterior probabilities to features that are in common with GABI's assembly graph. GABI is freely available under a GPL license from https://bitbucket.org/mhowison/gabi.	[Howison, Mark] Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA; [Zapata, Felipe; Edwards, Erika J.; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University; Brown University	Howison, M (corresponding author), Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA.	mhowison@brown.edu		Howison, Mark/0000-0002-0764-4090; Zapata, Felipe/0000-0002-9386-0573; Dunn, Casey/0000-0003-0628-5150	National Science Foundation through the Alan T. Waterman Award; Brown Division of Biology and Medicine;  [DEB-1026611]	National Science Foundation through the Alan T. Waterman Award; Brown Division of Biology and Medicine; 	This work was supported by the National Science Foundation (http://www.nsf.gov) through the Alan T. Waterman Award to CWD and award DEB-1026611 to EJE, and through additional support from the Brown Division of Biology and Medicine (http://biomed.brown.edu) to EJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; Gelman A, 1997, ANN APPL PROBAB, V7, P110, DOI [10.1214/aoap/1034625254, DOI 10.1214/AOAP/1034625254]; GEYER CJ, 1991, COMP SCI STAT, V23, P156, DOI DOI 10.1080/01621459.1995.10476590; Ghodsi Mohammadreza, 2013, BMC Res Notes, V6, P334, DOI 10.1186/1756-0500-6-334; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Howison M, 2012, P 4 USENIX WORKSH TH; Howison M, 2014, GENOME ASSEMBLY BAYE, DOI DOI 10.7301/Z0H41PB7; Howison M, 2013, BIOINFORMATICS, V29, P2959, DOI 10.1093/bioinformatics/btt525; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lin D, 2012, P 15 INT C ART INT S, P694; Matropolis N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Medvedev P, 2009, J COMPUT BIOL, V16, P1101, DOI 10.1089/cmb.2009.0047; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Rahman A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Varma A, 2011, P 1 IEEE INT C COMP, P165, DOI 10.1109/ICCABS.2011.5729873.; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99497	10.1371/journal.pone.0099497	http://dx.doi.org/10.1371/journal.pone.0099497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968249	gold, Green Submitted, Green Published			2022-12-25	WOS:000338280800012
J	Levin, A; Wang, SA; Levin, C; Tsu, V; Hutubessy, R				Levin, Ann; Wang, Susan A.; Levin, Carol; Tsu, Vivien; Hutubessy, Raymond			Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION	Background: In November 2011, the GAVI Alliance made the decision to add HPV vaccine as one of the new vaccines for which countries eligible for its funding (less than $1520 per capita income) could apply to receive support for national HPV vaccination, provided they could demonstrate the ability to deliver HPV vaccines. This paper describes the data and analysis shared with GAVI policymakers for this decision regarding GAVI HPV vaccine support. The paper reviews why strategies and costs for HPV vaccine delivery are different from other vaccines and what is known about the cost components from available data that originated primarily from HPV vaccine delivery costing studies in low and middle income-countries. Methods: Financial costs of HPV vaccine delivery were compared across three sources of data: 1) vaccine delivery costing of pilot projects in five low and lower-middle income countries; 2) cost estimates of national HPV vaccination in two low income countries; and 3) actual expenditure data from national HPV vaccine introduction in a low income country. Both costs of resources required to introduce the vaccine (or initial one-time investment, such as cold chain equipment purchases) and recurrent (ongoing costs that repeat every year) costs, such as transport and health personnel time, were analyzed. The cost per dose, cost per fully immunized girl (FIG) and cost per eligible girl were compared across studies. Results: Costs varied among pilot projects and estimates of national programs due to differences in scale and service delivery strategy. The average introduction costs per fully immunized girl ranged from $1.49 to $18.94 while recurrent costs per girl ranged from $1.00 to $15.69, with both types of costs varying by delivery strategy and country. Evaluating delivery costs along programme characteristics as well as country characteristics (population density, income/cost level, existing service delivery infrastructure) are likely the most informative and useful for anticipating costs for HPV vaccine delivery. Conclusions: This paper demonstrates the importance of country level cost data to inform global donor policies for vaccine introduction support. Such data are also valuable for informing national decisions on HPV vaccine introduction.	[Levin, Ann] WHO, Washington, DC USA; [Wang, Susan A.; Hutubessy, Raymond] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland; [Levin, Carol] Univ Washington, Seattle, WA 98195 USA; [Tsu, Vivien] PATH, Seattle, WA USA	World Health Organization; World Health Organization; University of Washington; University of Washington Seattle	Hutubessy, R (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.	hutubessyr@who.int			GAVI Alliance in Geneva, Switzerland	GAVI Alliance in Geneva, Switzerland	The external body who funded this research was the GAVI Alliance in Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutan Ministry of Health, 2012, COMMUNICATION; Brownson R C, 1999, J Public Health Manag Pract, V5, P86; Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jit M, 2014, LANCET GLOB IN PRESS; Jit M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-23; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Levin A, 2013, COSTS INTRO 3 UNPUB; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; MONATH TP, 1993, AM J TROP MED HYG, V48, P274, DOI 10.4269/ajtmh.1993.48.274; PATH, 2011, HPV VACC MONTHL IMM; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; WHO | World Health Organization, 2009, PER INT ROUT IMM LES; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P118	14	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101114	10.1371/journal.pone.0101114	http://dx.doi.org/10.1371/journal.pone.0101114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968002	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800109
J	Rohrbeck, A; Schroder, A; Hagemann, S; Pich, A; Holtje, M; Ahnert-Hilger, G; Just, I				Rohrbeck, Astrid; Schroeder, Anke; Hagemann, Sandra; Pich, Andreas; Hoeltje, Markus; Ahnert-Hilger, Gudrun; Just, Ingo			Vimentin Mediates Uptake of C3 Exoenzyme	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; INTERMEDIATE-FILAMENTS; CLOSTRIDIUM-BOTULINUM; ADP-RIBOSYLTRANSFERASE; PROTEIN TOXINS; HIPPOCAMPAL-NEURONS; GUANINE-NUCLEOTIDE; CRYSTAL-STRUCTURE; CELL-SURFACE; RHO PROTEINS	Clostridium botulinum C3 exoenzyme (C3) selectively inactivates RhoA/B/C GTPases by ADP-ribosylation. Based on this substrate specificity C3 is a well-established tool in cell biology. C3 is taken up by eukaryotic cells although lacking an uptake and translocation domain. Based on different approaches vimentin was identified as membranous C3-interaction partner by mass spectrometry. Vimentin in fact was partly localized at the outer surface of hippocampal HT22 cells and J744A.1 macrophages. Domain analysis identified the rod domain as binding partner of C3. Vimentin was also involved in uptake of C3 as shown by knock down of vimentin in HT22 and J774A.1 cells. The involvement of vimentin in uptake of C3 was further supported by the findings that the vimentin disruptor acrylamide blocked uptake of C3. Vimentin is not only a major organizing element of the intermediate filament network but is also involved in both binding and uptake of C3 exoenzyme.	[Rohrbeck, Astrid; Schroeder, Anke; Hagemann, Sandra; Pich, Andreas; Just, Ingo] Charite, Hannover Med Sch, Inst Toxicol, D-13353 Berlin, Germany; [Hoeltje, Markus; Ahnert-Hilger, Gudrun] Charite, Ctr Anat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohrbeck, A (corresponding author), Charite, Hannover Med Sch, Inst Toxicol, D-13353 Berlin, Germany.	rohrbeck.astrid@mh-hannover.de		Holtje, Markus/0000-0003-3193-4140	Deutsche Forschungsgemeinschaft (DFG) [JU231/5]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG project JU231/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; Auer M, 2013, J PERIPHER NERV SYST, V18, P30, DOI 10.1111/jns5.12004; Auer M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00043; Bhattacharya B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-7; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Chou YH, 2000, J CELL BIOL, V150, pF101, DOI 10.1083/jcb.150.3.F101; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; ECKERT BS, 1985, EUR J CELL BIOL, V37, P169; Eckes B, 1998, J CELL SCI, V111, P1897; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; Galou M, 1997, BIOL CELL, V89, P85, DOI 10.1016/S0248-4900(99)80068-9; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Haudenschild DR, 2011, J ORTHOP RES, V29, P20, DOI 10.1002/jor.21198; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Holtje M, 2011, ANN ANAT, V193, P314, DOI 10.1016/j.aanat.2011.01.008; Hoffmann A, 2008, GLIA, V56, P1162, DOI 10.1002/glia.20687; HOLMGREN J, 1974, MED BIOL, V52, P229; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Huelsenbeck SC, 2012, NEUROTHERAPEUTICS, V9, P185, DOI 10.1007/s13311-011-0072-y; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Ise H, 2012, GLYCOBIOLOGY, V22, P788, DOI 10.1093/glycob/cws052; Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izmiryan A, 2009, EXP CELL RES, V315, P769, DOI 10.1016/j.yexcr.2008.12.009; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; Just I, 2000, CURR TOP MICROBIOL, V250, P97; Just I, 2011, N-S ARCH PHARMACOL, V383, P247, DOI 10.1007/s00210-010-0589-3; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Levin EC, 2009, BRAIN RES, V1298, P194, DOI 10.1016/j.brainres.2009.08.072; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; LILIENBAUM A, 1990, J VIROL, V64, P256, DOI 10.1128/JVI.64.1.256-263.1990; Luecke N, 2010, RAPID COMMUN MASS SP, V24, P561, DOI 10.1002/rcm.4412; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Merritt EA, 2002, J AM CHEM SOC, V124, P8818, DOI 10.1021/ja0202560; Mitchell BS, 1997, HISTOCHEM J, V29, P393, DOI 10.1023/A:1026490901926; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; PERIDES G, 1987, J BIOL CHEM, V262, P13742; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; PIEPER FR, 1992, EUR J BIOCHEM, V210, P509, DOI 10.1111/j.1432-1033.1992.tb17449.x; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; Risco C, 2002, J VIROL, V76, P1839, DOI 10.1128/JVI.76.4.1839-1855.2002; RITTLING SR, 1989, NUCLEIC ACIDS RES, V17, P1619, DOI 10.1093/nar/17.4.1619; Rohrbeck A, 2012, FEBS J, V279, P2657, DOI 10.1111/j.1742-4658.2012.08645.x; Rotsch J, 2012, N-S ARCH PHARMACOL, V385, P883, DOI 10.1007/s00210-012-0764-9; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shime H, 2002, INFECT IMMUN, V70, P6460, DOI 10.1128/IAI.70.11.6460-6463.2002; Steinmetz Nicole F, 2011, Cancers (Basel), V3, P2870, DOI 10.3390/cancers3032870; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Teshigawara K, 2013, BRIT J PHARMACOL, V168, P903, DOI 10.1111/j.1476-5381.2012.02211.x; Thomas EK, 1996, VIRAL IMMUNOL, V9, P73, DOI 10.1089/vim.1996.9.73; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	80	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101071	10.1371/journal.pone.0101071	http://dx.doi.org/10.1371/journal.pone.0101071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967582	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800104
J	Sode, J; Vogel, U; Bank, S; Andersen, PS; Thomsen, MK; Hetland, ML; Locht, H; Heegaard, NHH; Andersen, V				Sode, Jacob; Vogel, Ulla; Bank, Steffen; Andersen, Paal Skytt; Thomsen, Marianne Kragh; Hetland, Merete Lund; Locht, Henning; Heegaard, Niels H. H.; Andersen, Vibeke			Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DANISH DANBIO REGISTRY; THERAPY; ADHERENCE; PATHWAYS; DISEASE; RISK	Objective: Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-alpha blocking treatment (anti-TNF), but about one third do not respond. The objective of this study was to replicate and extend previously found associations between anti-TNF treatment response and genetic variation in the TNF-, NF-kappa B-and pattern recognition receptor signalling pathways. Methods: Forty-one single nucleotide polymorphisms (SNPs), including 34 functional, in 28 genes involved in inflammatory pathways were assessed in 538 anti-TNF naive Danish RA patients with clinical data. Multivariable logistic regression analyses were performed to test associations between genotypes and treatment response at 3-6 months using the European League Against Rheumatism (EULAR) response criterion. American College of Rheumatology treatment response (ACR50) and relative change in 28-joint disease activity score (relDAS28) were used as secondary outcomes. Subgroup analyses were stratified according to smoking status, type of anti-TNF drug and IgM-Rheumatoid Factor (IgM-RF) status. False discovery rate (FDR) controlling was used to adjust for multiple testing. Results: Statistically significant associations with EULAR response were found for two SNPs in NLRP3(rs4612666) (OR (odds ratio) for good/moderate response = 0.64 (95% confidence interval: 0.44-0.95), p = 0.025, q = 0.95) and INFG(rs2430561) (OR = 0.40 (0.21-0.76), p = 0.005, q = 0.18) and among IgM-RF positive patients for TNFRS1A(rs4149570) (0.59 (0.36-0.98), p = 0.040, q = 0.76). Current smokers who carried the NLRP3(rs4612666) variant allele were less likely to benefit from anti-TNF treatment (OR = 0.24 (0.10-0.56), p = 0.001, q = 0.04). Conclusions: In a population of Danish RA patients, we confirm the NLRP3 gene as associated with EULAR anti-TNF response as previously reported. The NLRP3 variant (T) allele is associated with lower treatment response, in particular among current smokers. Furthermore, we find that a functional polymorphism in the interferon-gamma gene is associated with anti-TNF response. All findings should be tested by replication in independent validation cohorts and augmented by assessing cytokine levels and activities of the relevant gene products.	[Sode, Jacob; Heegaard, Niels H. H.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Sode, Jacob; Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Sode, Jacob; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen] Univ Aarhus, Aarhus, Denmark; [Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Thomsen, Marianne Kragh] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Hetland, Merete Lund] Glostrup Cty Hosp, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res, DANBIO Registry, Glostrup, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN, DK-5000 Odense, Denmark	Statens Serum Institut; University of Southern Denmark; National Research Centre for the Working Environment; Aarhus University; Aarhus University; Statens Serum Institut; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Sode, J (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	jaso@ssi.dk	Vogel, Ulla B/I-5048-2012; Hetland, Merete L/AAE-5297-2019; Thomsen, Marianne Kragh/AAJ-5115-2020; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020; Andersen, Paal S/H-2087-2015; Sode, Jacob/AAD-9615-2020	Vogel, Ulla B/0000-0001-6807-1524; Hetland, Merete L/0000-0003-4229-6818; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Andersen, Paal S/0000-0001-5656-0427; Sode, Jacob/0000-0002-2718-9320; Thomsen, Marianne Kragh/0000-0002-3645-6689	Danish Rheumatism Association; Region of Southern Denmark's PhD Fund; Department of Rheumatology, Frederiksberg Hospital	Danish Rheumatism Association; Region of Southern Denmark's PhD Fund; Department of Rheumatology, Frederiksberg Hospital	This study was supported by the Danish Rheumatism Association (www.gigtforeningen.dk), Region of Southern Denmark's PhD Fund (www.regionsyddanmark.dk) and the Department of Rheumatology, Frederiksberg Hospital (www.frederiksberghospital.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE IN PRESS; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Coenen MJH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014326; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Gu W, 2007, ANN SURG, V246, P151, DOI 10.1097/01.sla.0000262788.67171.3f; Hetland ML, 2008, ANN RHEUM DIS, V67, P1023, DOI 10.1136/ard.2007.087262; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Mirkov MU, 2013, ANN RHEUM DIS, V72, P1375, DOI 10.1136/annrheumdis-2012-202405; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Potter C, 2010, ANN RHEUM DIS, V69, P1315, DOI 10.1136/ard.2009.117309; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Toonen EJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033199; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; van Loo G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3324; Wang GB, 2011, HUM IMMUNOL, V72, P451, DOI 10.1016/j.humimm.2011.02.004	36	47	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100361	10.1371/journal.pone.0100361	http://dx.doi.org/10.1371/journal.pone.0100361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967817	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800037
J	Burns, JR; Baldwin, MR				Burns, Joshua R.; Baldwin, Michael R.			Tetanus Neurotoxin Utilizes Two Sequential Membrane Interactions for Channel Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM NEUROTOXIN; LOW PH; CLOSTRIDIAL NEUROTOXINS; LIGHT-CHAIN; PROTECTIVE ANTIGEN; PROTEIN-RECEPTOR; SYNAPTOTAGMIN-I; CELL ENTRY; TRANSLOCATION; BINDING	Tetanus neurotoxin (TeNT) causes neuroparalytic disease by entering the neuronal soma to block the release of neurotransmitters. However, the mechanism by which TeNT translocates its enzymatic domain (light chain) across endosomal membranes remains unclear. We found that TeNT and a truncated protein devoid of the receptor binding domain (TeNT-LHN) associated with membranes enriched in acidic phospholipids in a pH-dependent manner. Thus, in contrast to diphtheria toxin, the formation of a membrane-competent state of TeNT requires the membrane interface and is modulated by the bilayer composition. Channel formation is further enhanced by tethering of TeNT to the membrane through ganglioside co-receptors prior to acidification. Thus, TeNT channel formation can be resolved into two sequential steps: 1) interaction of the receptor binding domain (heavy chain receptor binding domain) with ganglioside co-receptors orients the translocation domain (heavy chain translocation domain) as the lumen of the endosome is acidified and 2) low pH, in conjunction with acidic lipids within the membrane drives the conformational changes in TeNT necessary for channel formation.	[Burns, Joshua R.; Baldwin, Michael R.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Baldwin, MR (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, 1 Hosp Dr, Columbia, MO 65212 USA.	baldwinmr@missouri.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Burns, Joshua/0000-0003-4245-5524	National Institutes of Health [1-R00-NS-061763]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R00-NS-061763 (to M. R. B.).	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Benson MA, 2011, J BIOL CHEM, V286, P34015, DOI 10.1074/jbc.M111.272054; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Blum FC, 2014, INFECT IMMUN, V82, P873, DOI 10.1128/IAI.01539-13; BOQUET P, 1982, P NATL ACAD SCI-BIOL, V79, P7614, DOI 10.1073/pnas.79.24.7614; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cai SW, 2006, PROTEIN J, V25, P455, DOI 10.1007/s10930-006-9028-1; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fischer A, 2012, J BIOL CHEM, V287, P1657, DOI 10.1074/jbc.C111.319400; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Karalewitz APA, 2012, J BIOL CHEM, V287, P40806, DOI 10.1074/jbc.M112.404244; Kyrychenko A, 2009, BIOCHEMISTRY-US, V48, P7584, DOI 10.1021/bi9009264; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lemichez E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013573; MCCROSKEY LM, 1991, J CLIN MICROBIOL, V29, P2618, DOI 10.1128/JCM.29.11.2618-2620.1991; Peng LS, 2012, J CELL SCI, V125, P3233, DOI 10.1242/jcs.103564; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; POULET S, 1992, BIOCHEM BIOPH RES CO, V183, P107, DOI 10.1016/0006-291X(92)91615-W; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1990, J PHYSIOLOGY PARIS, V84, P180; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; ULRICHBOTT B, 1984, J LIPID RES, V25, P1233	43	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22450	22458		10.1074/jbc.M114.559302	http://dx.doi.org/10.1074/jbc.M114.559302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973217	Green Published, hybrid			2022-12-25	WOS:000340593500054
J	Gill, K; Nigam, L; Singh, R; Kumar, S; Subbarao, N; Chauhan, SS; Dey, S				Gill, Kamaldeep; Nigam, Lokesh; Singh, Ratnakar; Kumar, Suresh; Subbarao, Naidu; Chauhan, Shyam Singh; Dey, Sharmistha			The Rational Design of Specific Peptide Inhibitor against p38 alpha MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38; CANCER; BINDING; HEAD; SECRETION; CARCINOMA; BIRB-796; TARGETS; JNK	p38 alpha is a significant target for drug designing against cancer. The overproduction of p38 alpha MAPK promotes tumorigenesis in head and neck squamous cell carcinoma (HNSCC). The ATP binding and an allosteric site referred as DFG are the key sites of the p38 alpha mitogen activated protein kinase (MAPK) exploited for the design of inhibitors. This study demonstrated design of peptide inhibitor on the basis of allosteric site using Glide molecular docking software and the biochemical analysis of the best modeled peptide. The best fitted tetrapeptide (FWCS) in the allosteric site inhibited the pure recombinant and serum p38 alpha of HNSCC patients by 74 and 72%, respectively. The potency of the peptide was demonstrated by its IC50 (4.6 nM) and K-D (3.41x10(-10) M) values, determined by ELISA and by surface plasmon resonance (SPR) technology, respectively. The cell viability of oral cancer i.e. KB cell line was reduced in dose dependent manner by 60 and 97% by the treatment of peptide and the IC50 was 600 and 210 mu M after 24 and 72 h incubation, respectively. Our result provides an insight for the development of a proficient small peptide as a promising anticancer agent targeting DFG site of p38 alpha kinase.	[Gill, Kamaldeep; Kumar, Suresh; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Ratnakar; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Nigam, Lokesh; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi	Dey, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	Singh, Ratnakar/K-2848-2018; Subbarao, Prof Naidu/AAZ-1832-2020	Singh, Ratnakar/0000-0002-3226-3847; Subbarao, Prof Naidu/0000-0002-1720-2165; Nigam, Lokesh/0000-0003-2350-9910; Kumar, Suresh/0000-0003-0710-2520	Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India; Indian Council Medical Research, Government of India	Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India; Indian Council Medical Research, Government of India(Indian Council of Medical Research (ICMR))	Author acknowledge Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India, for providing funds for the consumable items; Indian Council Medical Research, Government of India, for the fellowship of Kamaldeep Gill and are thankful to Prof. Jiahuai Han, The Scripps Research Institute, United States of America, for providing p38 alpha cDNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GLID VERS 9 1; Boussac M, 2000, ELECTROPHORESIS, V21, P665, DOI 10.1002/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U; Davidson B, 2006, GYNECOL ONCOL, V102, P453, DOI 10.1016/j.ygyno.2006.01.034; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dietrich J, 2010, BIOORGAN MED CHEM, V18, P5738, DOI 10.1016/j.bmc.2010.05.063; Forrer P, 1998, BIOL CHEM, V379, P1101, DOI 10.1515/bchm.1998.379.8-9.1101; Gill K, 2013, BBA-GEN SUBJECTS, V1830, P2763, DOI 10.1016/j.bbagen.2012.12.001; Gill K, 2012, CLIN CHIM ACTA, V413, P219, DOI 10.1016/j.cca.2011.09.031; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Klebl B, 2003, METHODS PRINCIPLES M; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kroe RR, 2003, J MED CHEM, V46, P4669, DOI 10.1021/jm030120s; Kulkarni RG, 2006, CURR PHARM DESIGN, V12, P2437, DOI 10.2174/138161206777698945; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Okaniwa M, 2013, J MED CHEM, V56, P6478, DOI 10.1021/jm400778d; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riebe C, 2007, INT J MOL MED, V20, P883; Schaefer Martina, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P5, DOI 10.2174/187152307779939778; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Vulpetti Anna, 2004, Farmaco (Lausanne), V59, P759; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Yasui H, 2007, BRIT J HAEMATOL, V136, P414, DOI 10.1111/j.1365-2141.2006.06443.x; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	39	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101525	10.1371/journal.pone.0101525	http://dx.doi.org/10.1371/journal.pone.0101525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983631	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000116
J	Silva, PA; Monnerat-Cahli, G; Pereira-Acacio, A; Luzardo, R; Sampaio, LS; Luna-Leite, MA; Lara, LS; Einicker-Lamas, M; Panizzutti, R; Madeira, C; Vieira, LD; Castro-Chaves, C; Ribeiro, VS; Paixao, ADO; Medei, E; Vieyra, A				Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Luna-Leite, Marcia A.; Lara, Lucienne S.; Einicker-Lamas, Marcelo; Panizzutti, Rogerio; Madeira, Caroline; Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.; Medei, Emiliano; Vieyra, Adalberto			Mechanisms Involving Ang II and MAPK/ERK1/2 Signaling Pathways Underlie Cardiac and Renal Alterations during Chronic Undernutrition	PLOS ONE			English	Article							ANGIOTENSIN-II; BLOOD-PRESSURE; PROTEIN RESTRICTION; SODIUM-PUMP; NA+-ATPASE; KIDNEY; ACTIVATION; HYPERTENSION; EXPRESSION; RECEPTORS	Background: Several studies have correlated protein restriction associated with other nutritional deficiencies with the development of cardiovascular and renal diseases. The driving hypothesis for this study was that Ang II signaling pathways in the heart and kidney are affected by chronic protein, mineral and vitamin restriction. Methodology/Principal Findings: Wistar rats aged 90 days were fed from weaning with either a control or a deficient diet that mimics those used in impoverished regions worldwide. Such restriction simultaneously increased ouabain-insensitive Na+-ATPase and decreased (Na++K+) ATPase activity in the same proportion in cardiomyocytes and proximal tubule cells. Type 1 angiotensin II receptor (AT(1)R) was downregulated by that restriction in both organs, whereas AT(2)R decreased only in the kidney. The PKC/PKA ratio increased in both tissues and returned to normal values in rats receiving Losartan daily from weaning. Inhibition of the MAPK pathway restored Na+-ATPase activity in both organs. The undernourished rats presented expanded plasma volume, increased heart rate, cardiac hypertrophy, and elevated systolic pressure, which also returned to control levels with Losartan. Such restriction led to electrical cardiac remodeling represented by prolonged ventricular repolarization parameters, induced triggered activity, early after-depolarization and delayed after-depolarization, which were also prevented by Losartan. Conclusion/Significance: The mechanisms responsible for these alterations are underpinned by an imbalance in the PKC- and PKA-mediated pathways, with participation of angiotensin receptors and by activation of the MAPK/ERK1/2 pathway. These cellular and molecular alterations culminate in cardiac electric remodeling and in the onset of hypertension in adulthood.	[Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Luna-Leite, Marcia A.; Einicker-Lamas, Marcelo; Medei, Emiliano; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Lara, Lucienne S.; Einicker-Lamas, Marcelo; Panizzutti, Rogerio; Madeira, Caroline; Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.; Medei, Emiliano; Vieyra, Adalberto] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Lara, Lucienne S.; Panizzutti, Rogerio; Madeira, Caroline] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Pernambuco	Vieyra, A (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil.	avieyra@biof.ufrj.br	Monnerat, Gustavo/J-6907-2019; Morcillo, Lucienne/F-5771-2017; monnerat cahli, gustavo/M-2647-2014; monnerat, gustavo/E-3398-2015; Sampaio, Luzia/X-9805-2019	Morcillo, Lucienne/0000-0002-2204-8799; monnerat, gustavo/0000-0002-1010-6314; Sampaio, Luzia/0000-0002-4944-7116; Vieira, Leucio/0000-0002-6041-1720; Medei, Emiliano/0000-0002-0044-1311	Brazilian National Research Council [302513/2008-6, 474712/2010-9, 470740/2010/8]; Carlos Chagas Filho Rio de Janeiro State Research Foundation [E-26/102.764/2008]; Pernambuco State Research Foundation [IBPG-1228-2.07/08]; Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health [552162/2005-1]; Brazilian Federal Agency for Support and Evaluation of Graduate Education [00852NF]; National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil [573767/2008-4]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Foundation; Pernambuco State Research Foundation(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health; Brazilian Federal Agency for Support and Evaluation of Graduate Education; National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil	This work was funded by the Brazilian National Research Council (grants 302513/2008-6 to A. V., 474712/2010-9 to E. M., and 470740/2010/8 to A. D. P.), the Carlos Chagas Filho Rio de Janeiro State Research Foundation (grant E-26/102.764/2008 to A. V.), the Pernambuco State Research Foundation (grant IBPG-1228-2.07/08 to A.D.O.P.), the Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health (grant 552162/2005-1 to A. V.), the Brazilian Federal Agency for Support and Evaluation of Graduate Education (grant 00852NF), and the National Institute of Science and Technology for Structural Biology and Bioimaging (grant 573767/2008-4), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Beilin LJ, 1999, AM J HYPERTENS, V12, P934, DOI 10.1016/S0895-7061(99)00057-6; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; BENABE JE, 1993, KIDNEY INT, V44, P285, DOI 10.1038/ki.1993.243; Benabe JE, 1998, MINER ELECTROL METAB, V24, P20, DOI 10.1159/000057346; Cabral LMP, 2010, ARCH BIOCHEM BIOPHYS, V498, P57, DOI 10.1016/j.abb.2010.04.004; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; CAMEJO JL, 1995, COMP BIOCHEM PHYS B, V110, P345, DOI 10.1016/0305-0491(94)00150-S; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Cornock R, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-105; Costa-Silva JH, 2009, EUR J NUTR, V48, P437, DOI 10.1007/s00394-009-0032-z; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Fernandez-Twinn DS, 2006, AM J PHYSIOL-REG I, V291, pR429, DOI 10.1152/ajpregu.00608.2005; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Fryer RM, 2001, J PHARMACOL EXP THER, V296, P642; Gildea JJ, 2012, HYPERTENSION, V60, P396, DOI 10.1161/HYPERTENSIONAHA.112.194175; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; HE J, 1994, AM J EPIDEMIOL, V139, P380, DOI 10.1093/oxfordjournals.aje.a117010; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; ICHIKAWA I, 1980, J CLIN INVEST, V65, P982, DOI 10.1172/JCI109784; IKEDA K, 1991, LAB ANIM-UK, V25, P26, DOI 10.1258/002367791780808176; Kaufman JS, 1999, HUM BIOL, V71, P641; Kovacs K, 2009, MOL CELL BIOCHEM, V321, P155, DOI 10.1007/s11010-008-9929-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Li XC, 2012, AM J PHYSIOL-RENAL, V303, pF1617, DOI 10.1152/ajprenal.00219.2012; Li XC, 2011, KIDNEY INT, V80, P620, DOI 10.1038/ki.2011.161; Liu L, 2011, AM J PHYSIOL-RENAL, V301, pF1195, DOI 10.1152/ajprenal.00339.2011; Lo J, 2013, EXP PHYSIOL, V98, P109, DOI 10.1113/expphysiol.2012.067165; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luzardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021232; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; MARTINEZMALDONADO M, 1993, AM J PHYSIOL, V264, pF981, DOI 10.1152/ajprenal.1993.264.6.F981; Medei E, 2010, J MOL CELL CARDIOL, V49, P165, DOI 10.1016/j.yjmcc.2010.04.014; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Miura S, 2010, BIOCHEM BIOPH RES CO, V391, P85, DOI 10.1016/j.bbrc.2009.11.008; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rocafull MA, 2012, PFLUG ARCH EUR J PHY, V463, P755, DOI 10.1007/s00424-012-1101-3; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; Rodrigues-Ferreira S, 2010, TRENDS ENDOCRIN MET, V21, P684, DOI 10.1016/j.tem.2010.08.009; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sebrell W., 1954, VITAMINS, V3, P2; Sicouri S, 2011, J CARDIOVASC ELECTR, V22, P698, DOI 10.1111/j.1540-8167.2010.01972.x; Szymanski MK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0242-4; Tanaka Y, 2005, FEBS LETT, V579, P1579, DOI 10.1016/j.febslet.2005.01.068; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vieira LD, 2014, BRIT J NUTR, V111, P1932, DOI 10.1017/S0007114513004236; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673	68	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100410	10.1371/journal.pone.0100410	http://dx.doi.org/10.1371/journal.pone.0100410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983243	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000023
J	Wang, BH; Wu, BL; Liu, J; Yao, WM; Xia, D; Li, L; Chen, ZQ; Ye, ZQ; Yu, X				Wang, Bohan; Wu, Bolin; Liu, Jun; Yao, Weimin; Xia, Ding; Li, Lu; Chen, Zhiqiang; Ye, Zhangqun; Yu, Xiao			Analysis of Altered MicroRNA Expression Profiles in Proximal Renal Tubular Cells in Response to Calcium Oxalate Monohydrate Crystal Adhesion: Implications for Kidney Stone Disease	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELLS; OXIDATIVE STRESS; HK-2; RISK; LINE	Background: Calcium oxalate monohydrate (COM) is the major crystalline component in kidney stones and its adhesion to renal tubular cells leads to tubular injury. However, COM-induced toxic effects in renal tubular cells remain ambiguous. MicroRNAs (miRNAs) play an important role in gene regulation at the posttranscriptional levels. Objective: The present study aimed to assess the potential changes in microRNAs of proximal renal tubular cells in response to the adhesion of calcium oxalate monohydrate (COM) crystals. Methodology: Lactate dehydrogenase (LDH) activity and DAPI staining were used to measure the toxic effects of HK-2 cells exposed to COM crystals. MicroRNA microarray and mRNA microarray were applied to evaluate the expression of HK-2 cells exposed to COM crystals. Quantitative real-time PCR (qRT-PCR) technology was used to validate the microarray results. Target prediction, Gene Ontology (GO) analysis and pathway analysis were applied to predict the potential roles of microRNAs in biological processes. Principal Findings: Our study showed that COM crystals significantly altered the global expression profile of miRNAs in vitro. After 24 h treatment with a dose (1 mmol/L), 25 miRNAs were differentially expressed with a more than 1.5-fold change, of these miRNAs, 16 were up-regulated and 9 were down-regulated. A majority of these differentially expressed miRNAs were associated with cell death, mitochondrion and metabolic process. Target prediction and GO analysis suggested that these differentially expressed miRNAs potentially targeted many genes which were related to apoptosis, regulation of metabolic process, intracellular signaling cascade, insulin signaling pathway and type 2 diabetes. Conclusion: Our study provides new insights into the role of miRNAs in the pathogenesis associated with nephrolithiasis.	[Wu, Bolin; Yao, Weimin; Xia, Ding; Li, Lu; Chen, Zhiqiang; Ye, Zhangqun; Yu, Xiao] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urinary Surg, Wuhan 430074, Hubei Province, Peoples R China; [Wang, Bohan] Zhejiang Univ, Affiliated Hosp 2, Dept Urinary Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Jun] Suining Ctr Hosp, Dept Urinary Surg, Suining, Sichuan Provinc, Peoples R China	Huazhong University of Science & Technology; Zhejiang University	Yu, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urinary Surg, Wuhan 430074, Hubei Province, Peoples R China.	yujiuhu8366@126.com			National Natural Science Foundation of China [81000292]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81000292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Chaturvedi LS, 2002, J BIOL CHEM, V277, P13321, DOI 10.1074/jbc.M108203200; Chen SS, 2010, UROL RES, V38, P7, DOI 10.1007/s00240-009-0226-0; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; Hovda KE, 2010, TOXICOL LETT, V192, P365, DOI 10.1016/j.toxlet.2009.11.013; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khaskhali MH, 2009, UROL RES, V37, P1, DOI 10.1007/s00240-008-0160-6; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043886; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Rabinovich YI, 2006, J COLLOID INTERF SCI, V300, P131, DOI 10.1016/j.jcis.2006.03.070; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schubert G, 2006, UROL RES, V34, P146, DOI 10.1007/s00240-005-0028-y; Sheng XX, 2005, J AM SOC NEPHROL, V16, P1904, DOI 10.1681/ASN.2005040400; SHUM DKY, 1995, UROL RES, V23, P103, DOI 10.1007/BF00307940; THALASSINOS NC, 1993, DIABETIC MED, V10, P341, DOI 10.1111/j.1464-5491.1993.tb00076.x; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Tozawa K, 2008, INT J UROL, V15, P924, DOI 10.1111/j.1442-2042.2008.02131.x; Weinberg AE, 2014, EUR UROL, V65, P242, DOI 10.1016/j.eururo.2013.03.026; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang H, 2012, UROLOGY, V80, P1298, DOI 10.1016/j.urology.2012.08.013; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	32	27	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101306	10.1371/journal.pone.0101306	http://dx.doi.org/10.1371/journal.pone.0101306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983625	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000086
J	Bodnar, M; Hovington, CL; Buchy, L; Malla, AK; Joober, R; Lepage, M				Bodnar, Michael; Hovington, Cindy L.; Buchy, Lisa; Malla, Ashok K.; Joober, Ridha; Lepage, Martin			Cortical Thinning in Temporo-Parietal Junction (TPJ) in Non-Affective First-Episode of Psychosis Patients with Persistent Negative Symptoms	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; TRANSCRANIAL MAGNETIC STIMULATION; AUTOMATED 3-D EXTRACTION; 1ST EPISODE; GRAY-MATTER; AUDITORY HALLUCINATIONS; BRAIN VOLUMES; FALSE POSITIVES; SCHIZOPHRENIA; THICKNESS	Background: Negative symptoms represent an unmet therapeutic need in many patients with schizophrenia. In an extension to our previous voxel-based morphometry findings, we employed a more specific, vertex-based approach to explore cortical thinning in relation to persistent negative symptoms (PNS) in non-affective first-episode of psychosis (FEP) patients to advance our understanding of the pathophysiology of primary negative symptoms. Methods: This study included 62 non-affective FEP patients and 60 non-clinical controls; 16 patients were identified with PNS (i.e., at least 1 primary negative symptom at moderate or greater severity sustained for at least 6 consecutive months). Using cortical thickness analyses, we explored for differences between PNS and non-PNS patients as well as between each patient group and healthy controls; cut-off threshold was set at p<0.01, corrected for multiple comparisons. Results: A thinner cortex prominently in the right superior temporal gyrus extending into the temporo-parietal junction (TPJ), right parahippocampal gyrus, and left orbital frontal gyrus was identified in PNS patients vs. non-PNS patients. Compared with healthy controls, PNS patients showed a thinner cortex prominently in the right superior temporal gyrus, right parahippocampal gyrus, and right cingulate; non-PNS patients showed a thinner cortex prominently in the parahippocampal gyrus bi-laterally. Conclusion: Cortical thinning in the early stages of non-affective psychosis is present in the frontal and temporo-parietal regions in patients with PNS. With these brain regions strongly related to social cognitive functioning, our finding suggests a potential link between primary negative symptoms and social cognitive deficits through common brain etiologies.	[Bodnar, Michael; Malla, Ashok K.; Joober, Ridha; Lepage, Martin] Douglas Mental Hlth Univ Inst, Prevent & Early Intervent Program Psychoses PEPP, Montreal, PQ, Canada; [Bodnar, Michael; Lepage, Martin] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Hovington, Cindy L.; Buchy, Lisa; Lepage, Martin] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Malla, Ashok K.; Joober, Ridha; Lepage, Martin] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Lepage, M (corresponding author), Douglas Mental Hlth Univ Inst, Prevent & Early Intervent Program Psychoses PEPP, Montreal, PQ, Canada.	martin.lepage@mcgill.ca			CIHR [68961]; Sackler Foundation; Fonds de la Recherche en Sante du Quebec (FRSQ); Canada Research Chairs Program	CIHR(Canadian Institutes of Health Research (CIHR)); Sackler Foundation; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs Program(Canada Research Chairs)	The study was supported by operating grants from CIHR (#68961) and the Sackler Foundation to Drs. M. Lepage/A.K Malla; Fonds de la Recherche en Sante du Quebec (FRSQ) (salary award to M. L.); Canada Research Chairs Program (to A. K. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad-Dabbagh Y, 2006, P 12 ANN M ORG HUM B; ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC., 1984, MODIFIED SCALE ASSES; Arzy S, 2006, NATURE, V443, P287, DOI 10.1038/443287a; Benoit Audrey, 2012, Front Psychiatry, V3, P42, DOI 10.3389/fpsyt.2012.00042; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Bodnar M, 2012, PSYCHIAT RES-NEUROIM, V201, P40, DOI 10.1016/j.pscychresns.2011.07.012; Bodnar Michael, 2011, Clin Schizophr Relat Psychoses, V4, P217, DOI 10.3371/CSRP.4.4.2; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buchanan RW, 2012, J CLIN PSYCHOPHARM, V32, P36, DOI 10.1097/JCP.0b013e31823f880a; Buchy L, 2010, J PSYCHIAT RES; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Cassidy CM, 2010, J CLIN PSYCHOPHARM, V30, P64, DOI 10.1097/JCP.0b013e3181ca03df; Chang WC, 2011, SCHIZOPHR RES, V133, P22, DOI 10.1016/j.schres.2011.09.006; Chechlacz M, 2013, CORTEX, V49, P487, DOI 10.1016/j.cortex.2011.11.008; Chiao JY, 2009, NEUROPSYCHOLOGIA, V47, P354, DOI 10.1016/j.neuropsychologia.2008.09.023; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Crespo-Facorro B, 2011, PSYCHOL MED, V41, P1449, DOI 10.1017/S003329171000200X; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; First M. B., 1998, STRUCTURED CLIN INTE; Freitas C, 2009, SCHIZOPHR RES, V108, P11, DOI 10.1016/j.schres.2008.11.027; Galderisi S, 2008, SCHIZOPHRENIA BULL, V34, P393, DOI 10.1093/schbul/sbm097; Galderisi S, 2013, EUR NEUROPSYCHOPHARM, V23, P196, DOI 10.1016/j.euroneuro.2012.04.019; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harris JM, 2004, BIOL PSYCHIAT, V55, P141, DOI 10.1016/S0006-3223(03)00789-3; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hobbs N, 2008, VBM VOXEL BASED MORP, V37; Hoffman RE, 2005, BIOL PSYCHIAT, V58, P97, DOI 10.1016/j.biopsych.2005.03.041; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hovington CL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-224; Hovington CL, 2012, EXPERT REV NEUROTHER, V12, P53, DOI [10.1586/ERN.11.173, 10.1586/ern.11.173]; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jardri R, 2007, MOL PSYCHIATR, V12, P320, DOI 10.1038/sj.mp.4001968; Jensen B, 2012, DRUG COMPARISON CHAR; Jhamnani K, 2013, J NEUROPSYCH CLIN N, V25, pE6, DOI 10.1176/appi.neuropsych.11120376; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Koutsouleris N, 2008, NEUROIMAGE, V39, P1600, DOI 10.1016/j.neuroimage.2007.10.029; Kulynych JJ, 1997, BIOL PSYCHIAT, V41, P995, DOI 10.1016/S0006-3223(96)00292-2; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Lepage M, 2011, PSYCHOL MED, V41, P1833, DOI 10.1017/S0033291711000031; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Malla A, 2003, AUST NZ J PSYCHIAT, V37, P407, DOI 10.1046/j.1440-1614.2003.01194.x; Malla AK, 2004, J NERV MENT DIS, V192, P455, DOI 10.1097/01.nmd.0000131804.34977.c1; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2012, SCHIZOPHR RES, V142, P209, DOI 10.1016/j.schres.2012.10.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2012, SCHIZOPHR RES, V137, P169, DOI 10.1016/j.schres.2012.01.038; Palaniyappan L, 2012, NEUROIMAGE, V60, P693, DOI 10.1016/j.neuroimage.2011.12.058; Park HJ, 2004, NEUROIMAGE, V22, P1231, DOI 10.1016/j.neuroimage.2004.03.009; Pletson JE, 2007, PSYCHOL SCHIZOPHRENI; Poulet E, 2005, BIOL PSYCHIAT, V57, P188, DOI 10.1016/j.biopsych.2004.10.007; Puri BK, 2011, EXPERT REV NEUROTHER, V11, P943, DOI [10.1586/ern.11.87, 10.1586/ERN.11.87]; Quarantelli M, 2002, NEUROIMAGE, V17, P373, DOI 10.1006/nimg.2002.1157; ROBBINS SM, 2004, ANATOMICAL STANDARDI, P315; Roiz-Santianez R, 2010, PSYCHIAT RES-NEUROIM, V182, P216, DOI 10.1016/j.pscychresns.2010.03.001; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schultz CC, 2012, BIOL PSYCHIAT, V71, P146, DOI 10.1016/j.biopsych.2011.08.015; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Singh V, 2005, 11 ANN M ORG HUM BRA; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Tang JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040247; Thacker NA, 2008, TURORIAL CRITICAL AN; TURETSKY B, 1995, ARCH GEN PSYCHIAT, V52, P1061; Venkatasubramanian G, 2008, ACTA PSYCHIAT SCAND, V117, P420, DOI 10.1111/j.1600-0447.2008.01198.x; Voineskos AN, 2013, JAMA PSYCHIAT, V6, P1; Wechsler D., 1997, WECHSLER ADULT INTEL; Wheeler DG, 2007, PROG NEURO-PSYCHOPH, V31, P319, DOI 10.1016/j.pnpbp.2006.09.009; Wible CG, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/920485; Williams Leanne M, 2008, Expert Rev Neurother, V8, P1049, DOI 10.1586/14737175.8.7.1049; Woods S.W., 2011, CHLORPROMAZINE EQUIV, P1; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	100	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101372	10.1371/journal.pone.0101372	http://dx.doi.org/10.1371/journal.pone.0101372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979583	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400122
J	Lundholm, J; Heim, A; Tran, S; Smith, T				Lundholm, Jeremy; Heim, Amy; Tran, Stephanie; Smith, Tyler			Leaf and Life History Traits Predict Plant Growth in a Green Roof Ecosystem	PLOS ONE			English	Article							LAND-USE; FUNCTIONAL TYPES; PERFORMANCE; ECOLOGY; DEPTH	Green roof ecosystems are constructed to provide services such as stormwater retention and urban temperature reductions. Green roofs with shallow growing media represent stressful conditions for plant survival, thus plants that survive and grow are important for maximizing economic and ecological benefits. While field trials are essential for selecting appropriate green roof plants, we wanted to determine whether plant leaf traits could predict changes in abundance ( growth) to provide a more general framework for plant selection. We quantified leaf traits and derived life-history traits ( Grime's C-S-R strategies) for 13 species used in a four-year green roof experiment involving five plant life forms. Changes in canopy density in monocultures and mixtures containing one to five life forms were determined and related to plant traits using multiple regression. We expected traits related to stress-tolerance would characterize the species that best grew in this relatively harsh setting. While all species survived to the end of the experiment, canopy species diversity in mixture treatments was usually much lower than originally planted. Most species grew slower in mixture compared to monoculture, suggesting that interspecific competition reduced canopy diversity. Species dominant in mixture treatments tended to be fast-growing ruderals and included both native and non-native species. Specific leaf area was a consistently strong predictor of final biomass and the change in abundance in both monoculture and mixture treatments. Some species in contrasting life-form groups showed compensatory dynamics, suggesting that life-form mixtures can maximize resilience of cover and biomass in the face of environmental fluctuations. This study confirms that plant traits can be used to predict growth performance in green roof ecosystems. While rapid canopy growth is desirable for green roofs, maintenance of species diversity may require engineering of conditions that favor less aggressive species.	[Lundholm, Jeremy; Heim, Amy; Tran, Stephanie] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [Lundholm, Jeremy; Heim, Amy; Tran, Stephanie] St Marys Univ, Dept Environm Sci, Halifax, NS B3H 3C3, Canada; [Smith, Tyler] Agr & Agri Food Canada, Eastern Cereal & Oilseen Resarch Ctr, Ottawa, ON, Canada	Saint Marys University - Canada; Saint Marys University - Canada; Agriculture & Agri Food Canada	Lundholm, J (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	jlundholm@smu.ca		Smith, Tyler William/0000-0001-7683-2653	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery grant to J. Lundholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Boivin MA, 2001, HORTTECHNOLOGY, V11, P409, DOI 10.21273/HORTTECH.11.3.409; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Butler C, 2012, URBAN FOR URBAN GREE, V11, P1, DOI 10.1016/j.ufug.2011.11.002; Butler C, 2011, ECOL ENG, V37, P1796, DOI 10.1016/j.ecoleng.2011.06.025; Cook-Patton SC, 2012, J ENVIRON MANAGE, V106, P85, DOI 10.1016/j.jenvman.2012.04.003; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; de Bello F, 2013, J ECOL, V101, P1237, DOI 10.1111/1365-2745.12139; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Dunnett N., 2004, PLANTING GREEN ROOFS; Dunnett Nigel, 2008, Urban Ecosystems, V11, P373, DOI 10.1007/s11252-007-0042-7; Eumorfopoulou E, 1998, ENERG BUILDINGS, V27, P29, DOI 10.1016/S0378-7788(97)00023-6; Farrell C, 2013, PLANT SOIL, V372, P177, DOI 10.1007/s11104-013-1725-x; FLOYD DA, 1987, J ECOL, V75, P221, DOI 10.2307/2260547; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Harper J. L., 1977, Population biology of plants.; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Kadas Gyongyver, 2006, Urban Habitats, V4, P66; Kohler M, 2010, ECOL ENG, V36, P722, DOI 10.1016/j.ecoleng.2009.12.019; Kohler M., 2006, URBAN HABITATS, V4, P3; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; MacIvor JS, 2011, ECOL ENG, V37, P407, DOI 10.1016/j.ecoleng.2010.10.004; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; McIntyre S, 2008, AGR ECOSYST ENVIRON, V128, P251, DOI 10.1016/j.agee.2008.06.015; Monterusso MA, 2005, HORTSCIENCE, V40, P391, DOI 10.21273/HORTSCI.40.2.391; Gross N, 2007, J VEG SCI, V18, P289, DOI 10.1111/j.1654-1103.2007.tb02540.x; Oberndorfer EC, 2009, BIODIVERS CONSERV, V18, P1523, DOI 10.1007/s10531-008-9539-5; Owen E., 1998, ROLANDS FLORA NOVA S; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; R Core Team, 2021, R LANG ENV STAT COMP; Ranalli M., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, DOI 10.1079/PAVSNNR20083034; Ranalli M, 2008, 6 N AM GREEN ROOF C; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Rowe DB, 2012, LANDSCAPE URBAN PLAN, V104, P310, DOI 10.1016/j.landurbplan.2011.11.010; Speak AF, 2013, URBAN CLIM, V3, P40, DOI 10.1016/j.uclim.2013.01.001; VanWoert ND, 1995, J ENVIRON QUAL, V34, P1036; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729	41	29	31	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101395	10.1371/journal.pone.0101395	http://dx.doi.org/10.1371/journal.pone.0101395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978031	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400127
J	Martins, R; Simard, F; Monchi, O				Martins, Ruben; Simard, France; Monchi, Oury			Differences between Patterns of Brain Activity Associated with Semantics and Those Linked with Phonological Processing Diminish with Age	PLOS ONE			English	Article							WORKING-MEMORY; FRONTAL-CORTEX; OLDER-ADULTS; AGING BRAIN; LANGUAGE; ACTIVATION; COMPREHENSION; PERFORMANCE; TASK; SET	It is widely believed that language function tends to show little age-related performance decline. Indeed, some older individuals seem to use compensatory mechanisms to maintain a high level of performance when submitted to lexical tasks. However, how these mechanisms affect cortical and subcortical activity during semantic and phonological processing has not been extensively explored. The purpose of this study was to look at the effect of healthy aging on cortico-subcortical routes related to semantic and phonological processing using a lexical analogue of the Wisconsin Cart-Sorting Task. Our results indicate that while young adults tend to show increased activity in the ventrolateral prefrontal cortex, the dorsolateral prefrontal cortex, the fusiform gyrus, the ventral temporal lobe and the caudate nucleus during semantic decisions and in the posterior Broca's area (area 44), the temporal lobe (area 37), the temporoparietal junction (area 40) and the motor cortical regions during phonological decisions, older individuals showed increased activity in the dorsolateral prefrontal cortex and motor cortical regions during both semantic and phonological decisions. Furthermore, when semantic and phonological decisions were contrasted with each other, younger individuals showed significant brain activity differences in several regions while older individuals did not. Therefore, in older individuals, the semantic and phonological routes seem to merge into a single pathway. These findings represent most probably neural reserve/compensation mechanisms, characterized by a decrease in specificity, on which the elderly rely to maintain an adequate level of performance.	[Martins, Ruben; Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Monchi, Oury] Univ Montreal, Fac Med, Dept Radiol, Montreal, PQ H3C 3J7, Canada; [Simard, France] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Monchi, O (corresponding author), Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Monchi, Oury/N-8417-2019		Natural Sciences and Engineering Research Council of Canada [RGPIN: 327518]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by an individual Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN: 327518) to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansado J, 2013, EUR J NEUROSCI, V37, P1887, DOI 10.1111/ejn.12252; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Burke DM, 2000, DEBATES PSYCHOL, P204; Burke DM, 2008, HDB AGEING COGNITION, P373; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R., 2004, COGNITIVE NEUROSCIEN, P3; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Devlin JT, 2008, NEURAL CORRELATES TH, pxv; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P3197, DOI 10.1016/j.neuropsychologia.2008.07.017; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Fristoe NM, 1997, NEUROPSYCHOLOGY, V11, P428, DOI 10.1037/0894-4105.11.3.428; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; Grossman M, 2002, BRAIN LANG, V80, P296, DOI 10.1006/brln.2001.2581; Hampshire A, 2008, J COGNITIVE NEUROSCI, V20, P1670, DOI 10.1162/jocn.2008.20115; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Jonides J, 1998, J NEUROSCI, V18, P5026; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Madden DJ, 1997, HUM BRAIN MAPP, V5, P389, DOI 10.1002/(SICI)1097-0193(1997)5:6<389::AID-HBM1>3.0.CO;2-#; Martins R, 2012, CEREB CORTEX, V22, P1395, DOI 10.1093/cercor/bhr222; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.band1.2010.03.001, 10.1016/j.bandl.2010.03.001]; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Resnick SM, 2003, J NEUROSCI, V23, P3295; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Seghier ML, 2004, HUM BRAIN MAPP, V23, P140, DOI 10.1002/hbm.20053; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Simard F, 2011, NEW LEXICAL CARD SOR; Simard F, 2011, CEREB CORTEX, V21, P1084, DOI 10.1093/cercor/bhq182; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Talairach J., 1988, COPLANAR STEREOTAXIC; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Van der Linden M, 1999, AGING NEUROPSYCHOL C, V6, P32, DOI 10.1076/anec.6.1.32.791; Verhaeghen P, 2003, PSYCHOL AGING, V18, P332, DOI 10.1037/0882-7974.18.2.332; Waters G, 2005, MEMORY, V13, P403, DOI 10.1080/09658210344000459; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wingfield A, 2006, J NEUROPHYSIOL, V96, P2830, DOI 10.1152/jn.00628.2006; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99710	10.1371/journal.pone.0099710	http://dx.doi.org/10.1371/journal.pone.0099710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24972020	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200012
J	Cousins, MM; Konikoff, J; Sabin, D; Khaki, L; Longosz, AF; Laeyendecker, O; Celum, C; Buchbinder, SP; Seage, GR; Kirk, GD; Moore, RD; Mehta, SH; Margolick, JB; Brown, J; Mayer, KH; Kobin, BA; Wheeler, D; Justman, JE; Hodder, SL; Quinn, TC; Brookmeyer, R; Eshleman, SH				Cousins, Matthew M.; Konikoff, Jacob; Sabin, Devin; Khaki, Leila; Longosz, Andrew F.; Laeyendecker, Oliver; Celum, Connie; Buchbinder, Susan P.; Seage, George R., III; Kirk, Gregory D.; Moore, Richard D.; Mehta, Shruti H.; Margolick, Joseph B.; Brown, Joelle; Mayer, Kenneth H.; Kobin, Beryl A.; Wheeler, Darrell; Justman, Jessica E.; Hodder, Sally L.; Quinn, Thomas C.; Brookmeyer, Ron; Eshleman, Susan H.			A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; UNITED-STATES; GENETIC DIVERSITY; INFECTION; VACCINE; TRIALS; COHORT; PERFORMANCE; NETWORK; PLASMA	Background: Multi-assay algorithms (MAAs) can be used to estimate HIV incidence in cross-sectional surveys. We compared the performance of two MAAs that use HIV diversity as one of four biomarkers for analysis of HIV incidence. Methods: Both MAAs included two serologic assays (LAg-Avidity assay and BioRad-Avidity assay), HIV viral load, and an HIV diversity assay. HIV diversity was quantified using either a high resolution melting (HRM) diversity assay that does not require HIV sequencing (HRM score for a 239 base pair env region) or sequence ambiguity (the percentage of ambiguous bases in a 1,302 base pair pol region). Samples were classified as MAA positive (likely from individuals with recent HIV infection) if they met the criteria for all of the assays in the MAA. The following performance characteristics were assessed: (1) the proportion of samples classified as MAA positive as a function of duration of infection, (2) the mean window period, (3) the shadow (the time period before sample collection that is being assessed by the MAA), and (4) the accuracy of cross-sectional incidence estimates for three cohort studies. Results: The proportion of samples classified as MAA positive as a function of duration of infection was nearly identical for the two MAAs. The mean window period was 141 days for the HRM-based MAA and 131 days for the sequence ambiguity-based MAA. The shadows for both MAAs were,1 year. Both MAAs provided cross-sectional HIV incidence estimates that were very similar to longitudinal incidence estimates based on HIV seroconversion. Conclusions: MAAs that include the LAg-Avidity assay, the BioRad-Avidity assay, HIV viral load, and HIV diversity can provide accurate HIV incidence estimates. Sequence ambiguity measures obtained using a commercially-available HIV genotyping system can be used as an alternative to HRM scores in MAAs for cross-sectional HIV incidence estimation.	[Cousins, Matthew M.; Sabin, Devin; Khaki, Leila; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Konikoff, Jacob; Brookmeyer, Ron] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Longosz, Andrew F.; Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Moore, Richard D.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Buchbinder, Susan P.] San Francisco Dept Hlth, Bridge HIV, San Francisco, CA USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kirk, Gregory D.; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Brown, Joelle] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Brown, Joelle] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Inst, Boston, MA 02215 USA; [Kobin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Wheeler, Darrell] Loyola Univ Chicago, Grad Sch Social Work, Chicago, IL USA; [Justman, Jessica E.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Justman, Jessica E.] Columbia Univ, Dept Med, New York, NY USA; [Hodder, Sally L.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA	Johns Hopkins University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New York Blood Center; Loyola University Chicago; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Justman, Jessica/AAA-3572-2020	Laeyendecker, Oliver/0000-0002-6429-4760; Cousins, Matthew/0000-0003-0067-9087	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA) [UM1-AI068613]; Division of Intramural Research, NIAID, NIH; National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services;  [R01-AI095068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069496, U01AI035042, U01AI035041, N01AI045200, U01AI035043, ZIAAI000361, U01AI035039, R01AI095068, UM1AI069470, UM1AI068613, N01AI035176, UM1AI068619, UM1AI035043, U01AI035040, UM1AI068617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935, R01DA012568, R01DA011602, U01DA036297, R01DA004334] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: (1) the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services (UM1-AI068613 to SE); (2) R01-AI095068 (to SE and RB); and (3) the Division of Intramural Research, NIAID, NIH. Support for the studies that provided samples for this project was as follows: HIVNET 001/001.1: N01-AI35176, N01-AI-45200, and AI-45202; ALIVE: R01-DA-04334 and R01-DA12568; MACS: U01-AI35042, U01-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, and UL1-RR025005; JHHCC: R01-DA011602 to RDM and R01-AA016893 to RDM; HPTN 061 and HPTN 064: UM1-AI068619, UM1-AI068617, and UM1-AI068613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; Cousins MM, 2014, J CLIN MICROBIOL, V52, P115, DOI 10.1128/JCM.02040-13; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Galli Rick, 2002, Am Clin Lab, V21, P13; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004; Huang DD, 2005, J CLIN MICROBIOL, V43, P3963, DOI 10.1128/JCM.43.8.3963-3970.2005; Huang DD, 2003, J CLIN MICROBIOL, V41, P3265, DOI 10.1128/JCM.41.7.3265-3272.2003; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; James MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057350; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Longosz AF, 2014, AIDS; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Masciotra S, 2010, 17 C RETR OPP INF SA; Mellquist JL, 1999, AIDS RES HUM RETROV, V15, P217, DOI 10.1089/088922299311637; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Park SY, 2014, J VIROL, V88, P2977, DOI 10.1128/JVI.03128-13; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wendel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055525; Yang J, 2012, SCI CHINA LIFE SCI, V55, P328, DOI 10.1007/s11427-012-4312-0; Yang OO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007388	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101043	10.1371/journal.pone.0101043	http://dx.doi.org/10.1371/journal.pone.0101043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968135	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800100
J	Mathys, L; Francois, KO; Quandte, M; Braakman, I; Balzarini, J				Mathys, Leen; Francois, Katrien O.; Quandte, Matthias; Braakman, Ineke; Balzarini, Jan			Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSES; ENVELOPE GLYCOPROTEIN; GLYCOSYLATION SITES; DISULFIDE BONDS; TYPE-1 GP120; CLEAVAGE; EVOLUTION; DOMAINS; COMPLEX	N-linked glycans covering the surface of the HIV-1 glycoprotein gp120 are of major importance for the correct folding of this glycoprotein. Of the, on average, 24 N-linked glycans present on gp120, the glycan at Asn260 was reported to be essential for the correct expression of gp120 and gp41 in the virus particle and deletion of the N260 glycan in gp120 heavily compromised virus infectivity. We show here that gp160 containing the N260Q mutation reaches the Golgi apparatus during biosynthesis. Using pulse-chase experiments with [S-35] methionine/cysteine, we show that oxidative folding was slightly delayed in case of mutant N260Q gp160 and that CD4 binding was markedly compromised compared to wild-type gp160. In the search of compensatory mutations, we found a mutation in the V1/V2 loop of gp120 (S128N) that could partially restore the infectivity of mutant N260Q gp120 virus. However, the mutation S128N did not enhance any of the above-mentioned processes so its underlying compensatory mechanism must be a conformational effect that does not affect CD4 binding per se. Finally, we show that mutant N260Q gp160 was cleaved to gp120 and gp41 to a much lower extent than wild-type gp160, and that it was subject of lysosomal degradation to a higher extent than wild-type gp160 showing a prominent role of this process in the breakdown of N260-glycan-deleted gp160, which could not be counteracted by the S128N mutation. Moreover, at least part of the wild-type or mutant gp160 that is normally targeted for lysosomal degradation reached a conformation that enabled CD4 binding.	[Mathys, Leen; Francois, Katrien O.; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Quandte, Matthias; Braakman, Ineke] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	KU Leuven; Utrecht University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.	jan.balzarini@rega.kuleuven.be		Braakman, Ineke/0000-0003-1592-4364	KU Leuven Centers of Excellence [PF-10/018]; KU Leuven Geconcerteerde Onderzoeksacties (GOA) [10/014]; Fonds voor Wetenschappelijk Onderzoek (FWO) [G. 0485.08]; CHAARM Network Project of the European Commission; Leen Mathys is supported by a fellowship from L'Oreal-UNESCO; Belgian FWO (Aspirant); European Union	KU Leuven Centers of Excellence; KU Leuven Geconcerteerde Onderzoeksacties (GOA); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); CHAARM Network Project of the European Commission; Leen Mathys is supported by a fellowship from L'Oreal-UNESCO; Belgian FWO (Aspirant); European Union(European Commission)	This work was supported by grants from the KU Leuven Centers of Excellence (PF-10/018), the KU Leuven Geconcerteerde Onderzoeksacties (GOA) (no. 10/014), the Fonds voor Wetenschappelijk Onderzoek (FWO) (G. 0485.08) and the CHAARM Network Project of the European Commission. Leen Mathys is supported by a fellowship from L'Oreal-UNESCO, in collaboration with the Belgian FWO (Aspirant). Matthias Quandte was supported by the European Union 7th framework program, ITN "Virus entry''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2011, J BIOL CHEM, V286, P42900; Bergeron JJ, 1996, P NATL ACAD SCI US, V93, P9606; Bonifacino JS, 1988, P NATL ACAD SCI US, V85, P9580; Bonomelli C, 2010, P NATL ACAD SCI US, V107, P13800; Busser E, 2004, AIDS RES HUM RETROVI, V20, P742; Cherepanov P, 2002, ANTIMICROB AGENTS CH, V46, P3954; Dankers MM, 2004, RETROVIROLOGY, V1, P3; Dekeersmaeker N, 2009, CLIN MICROBIOL, V47, P2232; Desai K, 2005, PLOS MED, V2, pe142; Doores KJ, 2011, PLOS ONE, V6; Francois KO, 2008, VIROLOGY, V382, P10; Gennero L, 2001, J CLIN VIROL, V20, P131; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holschbach C, 1988, J BIOL CHEM, V263, P11760; Hsu ST, 2008, MOL BIOL CELL, V19, P4707; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Laethem K, 2005, J VIROL METHODS, V123, P25; Land A, 2009, J VIROL, V83, P368; Lao S, 2012, J VIROL, V86, P2153; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Macovei A, 2012, PLOS ONE, V7; Molbert E, 1970, J MOL BIOL, V49, P99; Nie J, 2013, RETROVIROLOGY, V10, P14; Parodi AJ, 2003, ANN REV CELL DEV BIO, V19, P649; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ross EK, 1989, J VIROL, V63, P3595; Sassaroli M, 1996, CLIN THER, V18, P1080; Smith DH, 1988, J VIROL, V62, P139; Spellman MW, 1990, J BIOL CHEM, V265, P10373; Syu WJ, 1992, P NATL ACAD SCI US, V89, P2213; Thayer RM, 1991, NUCL ACIDS RES, V19, P3979; Weberova J, 2006, J VIROL METHODS, V136, P102; Willey RL, 1994, J VIROL, V68, P6836; Wyatt R, 1998, NATURE, V393, P648; Zonneveld D, 2003, FASEB J, V17, P1058	36	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101181	10.1371/journal.pone.0101181	http://dx.doi.org/10.1371/journal.pone.0101181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967714	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800116
J	Mumah, JN; Jackson-Smith, D				Mumah, Joyce N.; Jackson-Smith, Douglas			Why Are the Benefits of Increased Resources Not Impacting the Risk of HIV Infection for High SES Women in Cameroon?	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIOECONOMIC-STATUS; SEXUAL-BEHAVIOR; HEALTH SURVEY; SOUTH-AFRICA; ADULT-POPULATION; POVERTY; COUNTRIES; TANZANIA; GENDER	Background: Despite evidence of a positive SES-HIV gradient in some SSA countries, researchers and policy-makers frequently assume that a range of protective interventions - increasing awareness of mechanisms of HIV transmission, techniques for prevention, greater access to health care facilities, and greater availability of condoms - will reduce the likelihood of contracting HIV, even among higher SES populations. We therefore explore the relationships between SES and these intervening behaviors to illuminate the complex factors that link SES and HIV among women in Cameroon. Methods: We use bivariate and multivariate statistical analysis to examine patterns among the 5, 155 women aged 15-49 who participated in the 2004 CDHS. Results: The results show a strong pattern where higher SES women have greater access to and use of health care facilities, higher levels of condom use, more HIV knowledge, and command higher power within their relationships, yet also have higher rates of HIV. These traditionally protective factors appear to be offset by riskier sexual behaviors on the part of women with increased resources, most notably longer years of premarital sexual experience, multiple partners in last 12 months, and sexual encounters outside of relationship. Multivariate analyses suggests net of the effect of other factors, women who command higher decision-making power, have greater access to health care, more negative attitudes toward wife beating, longer years of premarital sexual exposure, and partners with professional/white collar jobs (characteristics associated with rising SES) had higher odds of testing positive for HIV. Conclusion: Results show that higher riskier sexual practices on part of high SES women offset benefits that may have accrued from their increased access to resources. The results suggest that traditional approaches to HIV prevention which rely on poverty reduction, improving access to health care, improving HIV knowledge, and boosting women's social and economic power may be insufficient to address other drivers of HIV infection among women in SSA.	[Mumah, Joyce N.] African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Program, Nairobi, Kenya; [Jackson-Smith, Douglas] Utah State Univ, Dept Sociol Social Work & Anthropol, Logan, UT 84322 USA	African Population & Health Research Centre; Utah System of Higher Education; Utah State University	Mumah, JN (corresponding author), African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Program, Nairobi, Kenya.	nduehice@gmail.com	Jackson-Smith, Douglas/AAQ-8400-2021	Jackson-Smith, Douglas/0000-0002-0671-5862; Mumah, Joyce/0000-0001-6181-6837				Abimanyi-Ochom J, 2011, AIDS CARE, V23, P1545, DOI 10.1080/09540121.2011.582477; Adair T, 2008, J BIOSOC SCI, V40, P743, DOI 10.1017/S0021932007002556; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Bingenheimer JB, 2007, INT FAM PLAN PERSPEC, V33, P83, DOI 10.1363/3308307; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Coovadia HM, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-13; Defo BK, 1997, SOC SCI MED, V44, P1023, DOI 10.1016/S0277-9536(96)00228-6; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Glynn JR, 2004, TROP MED INT HEALTH, V9, P4, DOI 10.1046/j.1365-3156.2003.01168.x; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Institut National de la Statistique (INS) et ORC Macro, 2004, ENQ DEM SANT CAM 200 ENQ DEM SANT CAM 200; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kapiga SH, 2002, AIDS CARE, V14, P455, DOI [10.1080/09540120208629665, 10.1080/09540120220132991]; Kathewera-Banda M, 2005, INT SOC SCI J, V57, P649, DOI 10.1111/j.1468-2451.2005.00582.x; Kongnyuy E., 2006, BMC INT HEALTH HUM R, V6, P1; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Macro ORC, 2005, DEM HLTH SURV INT MA; Measure DHS:, 2004, HIV FACT SHEET; MISHRA V, 2007, STUDY ASS HIV INFECT; Mishra V., 2009, LEVELS SPREAD HIV SE; Mishra V, 2007, HIV AIDS IMPL M MEAS; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Mumah J, 2011, THESIS UTAH STATE U; Mumah JN, 2014, J BIOSOC SCI, V46, P431, DOI 10.1017/S0021932013000631; Muthengi E, 2009, AFRICAN POPULATION S, V23, P161; Nattrass N, 2012, AJAR-AFR J AIDS RES, V11, P307, DOI 10.2989/16085906.2012.754830; O'Farrell N, 2001, LANCET, V357, P636, DOI 10.1016/S0140-6736(05)71428-8; Obermeyer CM, 2013, TROP MED INT HEALTH, V18, P1110, DOI 10.1111/tmi.12155; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Pisani E, 2008, WISDOM WHORES BUREAU, P372; Reither EN, 2009, J AFRI POP STUD, V23, P127; Sa ZH, 2008, J BIOSOC SCI, V40, P505, DOI 10.1017/S002193200700257X; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Zaba B, 2002, P ANN M POP ASS AM A	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100507	10.1371/journal.pone.0100507	http://dx.doi.org/10.1371/journal.pone.0100507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968350	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800043
J	Sabatino, R; Antonelli, A; Battistelli, S; Schwendener, R; Magnani, M; Rossi, L				Sabatino, Raffaella; Antonelli, Antonella; Battistelli, Serafina; Schwendener, Reto; Magnani, Mauro; Rossi, Luigia			Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; IN-VITRO; DRUG-DELIVERY; MOUSE MODEL; CLODRONATE; ACID; ERYTHROCYTES; APOPTOSIS; CARRIERS; VIVO	Bisphosphonates, besides being important drugs for the treatment of various bone diseases, could also be used to induce apoptosis in macrophage-like and cancer cells. However, their activity in vivo is limited by a short plasma half-life and rapid uptake within bone. Therefore, several delivery systems have been proposed to modify their pharmacokinetic profile and biodistribution. Among these, red blood cells (RBCs) represent one of the most promising biological carriers. The aim of this study was to select the best performing compound among Clodronate, Pamidronate, Ibandronate and Zoledronate in killing macrophages and to investigate RBCs as innovative carrier system to selectively target bisphosphonates to macrophages. To this end, the encapsulation of the selected bisphosphonates in autologous RBCs as well as the effect on macrophages, both in vitro and in vivo were studied. This work shows that, among the tested bisphosphonates, Zoledronate has proven to be the most active molecule. Human and murine RBCs have been successfully loaded with Zoledronate by a procedure of hypotonic dialysis and isotonic resealing, obtaining a dose-dependent drug entrapment with a maximal loading of 7.96 +/- 2.03, 6.95 +/- 3.9 and 7.0 +/- 1.89 mu moles of Zoledronate/ml of packed RBCs for human, Swiss and Balb/C murine RBCs, respectively. Engineered RBCs were able to detach human and murine macrophages in vitro, leading to a detachment of 66 +/- 8%, 67 +/- 8% and 60.5 +/- 3.5% for human, Swiss and Balb/C RBCs, respectively. The in vivo efficacy of loaded RBCs was tested in Balb/C mice administering 59 mu g/mouse of RBC-encapsulated Zoledronate. By a single administration, depletion of 29.0 +/- 16.38% hepatic macrophages and of 67.84 +/- 5.48% spleen macrophages was obtained, confirming the ability of encapsulated Zoledronate to deplete macrophages in vivo. In conclusion, RBCs loaded with Zoledronate should be considered a suitable system for targeted delivery to macrophages, both in vitro and in vivo.	[Sabatino, Raffaella; Antonelli, Antonella; Battistelli, Serafina; Magnani, Mauro; Rossi, Luigia] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Magnani, Mauro; Rossi, Luigia] EryDel SpA, Urbino, PU, Italy	University of Urbino; University of Zurich	Rossi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	luigia.rossi@uniurb.it	ANTONELLI, ANTONELLA/C-6238-2011; Schwendener, Reto A/F-6373-2011; Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Sabatino, Raffaella/0000-0003-0093-7808	FIRB project [RBFR1299K0_003]; Ministry of Education; University and Research; EryDel	FIRB project; Ministry of Education; University and Research; EryDel	This work was partially supported by: FIRB project n. RBFR1299K0_003, Ministry of Education, University and Research (MIUR,www.istruzione.it) to RS, AA, MM and LR.; and EryDel S.p.A. (www.erydel.com) to MM LR. The funder did not provide support in the form of salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, CALCIFIED TISSUE INT, V86, P421, DOI 10.1007/s00223-010-9364-1; Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Alves-Rosa F, 2000, BLOOD, V96, P2834, DOI 10.1182/blood.V96.8.2834.h8002834_2834_2840; Barros ER, 2012, J PEDIATR ENDOCR MET, V25, P485, DOI 10.1515/jpem-2012-0016; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Bonabello A, 2003, BONE, V33, P567, DOI 10.1016/S8756-3282(03)00229-1; Bottino R, 1997, TRANSPL P, V29, P2057, DOI 10.1016/S0041-1345(97)00228-5; CECCHINI MG, 1987, J BONE MINER RES, V2, P135; Chapurlat RD, 2013, OSTEOPOROSIS INT, V24, P311, DOI 10.1007/s00198-012-1947-4; Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x; Crowley R, 2013, CLIN MED, V13, P287, DOI 10.7861/clinmedicine.13-3-287; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Fan T, 2013, CLINICOECONOMIC OUTC, V5, P589, DOI 10.2147/CEOR.S39076; Frith JC, 2003, J BONE MINER RES, V18, P204, DOI 10.1359/jbmr.2003.18.2.204; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Hafeman S, 2010, CANCER IMMUNOL IMMUN, V59, P441, DOI 10.1007/s00262-009-0763-y; Hamidi M, 2007, J CONTROL RELEASE, V118, P145, DOI 10.1016/j.jconrel.2006.06.032; Jedynak M, 2012, ANAESTH INTENSIVE TH, V44, P221; Jordan MB, 2003, BLOOD, V101, P594, DOI 10.1182/blood-2001-11-0061; Katzav A, 2013, IMMUNOL RES, V56, P334, DOI 10.1007/s12026-013-8406-y; Kolesnikova TA, 2013, EXPERT OPIN DRUG DEL, V10, P47, DOI 10.1517/17425247.2013.730516; Lutz HU, 2012, ADV EXP MED BIOL, V750, P76, DOI 10.1007/978-1-4614-3461-0_6; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MAGNANI M, 1992, P NATL ACAD SCI USA, V89, P6477, DOI 10.1073/pnas.89.14.6477; MAGNANI M, 1992, BIOTECHNOL APPL BIOC, V16, P188; Magnani M, 2011, ENCY NANOSCIENCE NAN, V22, P309; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Matsuo A, 2003, J RHEUMATOL, V30, P1280; MEBIUS RE, 1991, IMMUNOBIOLOGY, V182, P277, DOI 10.1016/S0171-2985(11)80663-7; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Millan CG, 2004, J CONTROL RELEASE, V95, P27, DOI 10.1016/j.jconrel.2003.11.018; Monkkonen H, 2001, PHARMACEUT RES, V18, P1550, DOI 10.1023/A:1013026313647; Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031; Mukthavaram R, 2014, J CONTROL RELEASE, V183, P146, DOI 10.1016/j.jconrel.2014.03.038; Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633; Oldenborg PA, 2004, LEUKEMIA LYMPHOMA, V45, P1319, DOI 10.1080/1042819042000201989; Reid Ian R, 2012, Expert Opin Pharmacother, V13, P637, DOI 10.1517/14656566.2012.662486; Reid IR, 2009, BONE, V44, P4, DOI 10.1016/j.bone.2008.09.012; Rodan Gideon A., 2002, Current Molecular Medicine (Hilversum), V2, P571, DOI 10.2174/1566524023362104; Rogers MJ, 1996, J BONE MINER RES, V11, P1482; Rossi L, 2005, J DRUG TARGET, V13, P99, DOI 10.1080/10611860500064123; Rossi L, 2008, TRANSPLANTATION, V85, P648, DOI 10.1097/TP.0b013e31816360f3; Ruiz P, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210506; Selander KS, 1996, MOL PHARMACOL, V50, P1127; Serafini S, 2009, ANTIVIR RES, V81, P93, DOI 10.1016/j.antiviral.2008.09.006; Shi GX, 2014, ADV HEALTHC MATER, V3, P142, DOI 10.1002/adhm.201300084; Shih JY, 2006, J CANC MOL, V2, P101; Shmeeda H, 2013, J CONTROL RELEASE, V167, P265, DOI 10.1016/j.jconrel.2013.02.003; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spencer Andrew, 2008, BMC Clin Pharmacol, V8, P2, DOI 10.1186/1472-6904-8-2; Stasi R, 2012, SEMIN THROMB HEMOST, V38, P454, DOI 10.1055/s-0032-1305780; Strobach D, 2003, BIOCHEM BIOPH RES CO, V307, P23, DOI 10.1016/S0006-291X(03)01127-6; Takayama J, 2000, TRANSPLANT P, V32, P1016, DOI 10.1016/S0041-1345(00)01090-3; Valleala H, 2003, LIFE SCI, V73, P2413, DOI 10.1016/S0024-3205(03)00657-X; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; Veldboer K, 2011, J CHROMATOGR B, V879, P2073, DOI 10.1016/j.jchromb.2011.05.037; Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814; WU LX, 1994, MICROB PATHOGENESIS, V16, P387, DOI 10.1006/mpat.1994.1039; Ylitalo R, 2002, PHARMACOL TOXICOL, V90, P139, DOI 10.1034/j.1600-0773.2002.900305.x; Young RJ, 2013, FUTURE ONCOL, V9, P633, DOI [10.2217/fon.13.28, 10.2217/FON.13.28]; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	66	27	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101260	10.1371/journal.pone.0101260	http://dx.doi.org/10.1371/journal.pone.0101260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968029	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338280800119
J	Tianpei, XZ; Zhu, YG; Li, SQ				Tianpei, Xiuzi; Zhu, Yingguo; Li, Shaoqing			Optimized Scorpion Polypeptide LMX: A Pest Control Protein Effective against Rice Leaf Folder	PLOS ONE			English	Article							INSECT RESISTANCE; DEPRESSANT TOXIN; BT CROPS; BACULOVIRUS; EXPRESSION; NEUROTOXIN; CHANNELS; COTTON; INHIBITORS; POTASSIUM	Lepidopteran insect pests are the main class of pests causing significant damage to crop plant yields. Insecticidal scorpion peptides exhibit toxicity specific for insects. Here, we report that a peptide LMX, optimized from the insect-specific scorpion neurotoxin LqhIT2, showed high levels of activity against rice leaf folder in vitro and in planta. Oral ingestion of LMX protein led to a significant decrease in feeding on rice leaves, repression of larval growth and development, delay in molting, and increase in larval lethality. Compared with LqhIT2 protein, the stability and insecticidal efficacy of LMX was better. Meanwhile, biochemical analysis showed that LMX protein ingestion dramatically decreased ecdysone content in rice leaf folder larvae, and down-regulated enzymatic activities of the detoxification system (a-naphthyl acetate esterase and glutathione S-transferase), the digestive system (tryptase and chymotrypsin), and the antioxidant system (catalase). These changes were tightly correlated with the dosage of LMX protein. Transgene analysis showed that the rate of leaf damage, and the number of damaged tillers and leaves in the transgenic line were greatly reduced relative to wild type plants and empty vector plants. Based on these observations, we propose that the insect-specific scorpion neurotoxin peptide LMX is an attractive and effective alternative molecule for the protection of rice from rice leaf folder.	[Tianpei, Xiuzi; Zhu, Yingguo; Li, Shaoqing] Wuhan Univ, State Key Lab Hybrid Rice,Coll Life Sci,Minist Ed, Key Lab Res & Utilizat Heterosis Indica Rice, Minist Agr,Engn Res Ctr Plant Biotechol & Germpla, Wuhan 430072, Peoples R China	Ministry of Agriculture & Rural Affairs; Wuhan University	Li, SQ (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice,Coll Life Sci,Minist Ed, Key Lab Res & Utilizat Heterosis Indica Rice, Minist Agr,Engn Res Ctr Plant Biotechol & Germpla, Wuhan 430072, Peoples R China.	shaoqingli@whu.edu.cn			National High Technology Program [2012AA10A304]; Transgenic Research and Development Program [2011ZX08001004]	National High Technology Program; Transgenic Research and Development Program	This work was supported by the National High Technology Program (2012AA10A304), Transgenic Research and Development Program (2011ZX08001004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020278; Alvi Shah Muhammad, 2003, International Journal of Agriculture and Biology, V5, P615; Benedict JH, 2001, GENETIC IMPROVEMENT OF COTTON, P137; Benkhalifa R, 1997, LIFE SCI, V61, P819, DOI 10.1016/S0024-3205(97)00564-X; Bergeron ZL, 2012, TOXINS, V4, P1082, DOI 10.3390/toxins4111082; Christian P, 1994, P S BIOP OPP AUSTR I, P40; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; DEDIANOUS S, 1987, TOXICON, V25, P411, DOI 10.1016/0041-0101(87)90074-2; Deka S, 2010, BIOTECHNOL ADV, V28, P70, DOI 10.1016/j.biotechadv.2009.09.003; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Fan XJ, 2008, CHINESE SCI BULL, V53, P1855, DOI 10.1007/s11434-008-0242-4; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Fitches E, 2002, INSECT BIOCHEM MOLEC, V32, P1653, DOI 10.1016/S0965-1748(02)00105-4; Food and Agriculture Organization of the United Nations (FAO), 2004, STAT FOOD SEC WORLD, P30; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Hagele BF, 2004, J INSECT PHYSIOL, V50, P621, DOI 10.1016/j.jinsphys.2004.04.008; HERRMANN R, 1995, TOXICON, V33, P1099, DOI 10.1016/0041-0101(95)98053-X; Ho NH, 2006, CROP SCI, V46, P781, DOI 10.2135/cropsci2005.06-0111; Hu J, 2011, PLANT PHYSIOL, V156, P856, DOI 10.1104/pp.111.174334; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; Khush GS, 2002, P 20 SESS INT RIC CO; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Koundal K. R., 2003, Indian Journal of Biotechnology, V2, P110; Kumar S, 2008, J ENVIRON BIOL, V29, P641; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Luo ShouJin, 2010, Plant Diseases and Pests, V1, P13; MURRAY EE, 1989, NUCLEIC ACIDS RES, V17, P477, DOI 10.1093/nar/17.2.477; Pava-Ripoll M, 2008, J INVERTEBR PATHOL, V99, P220, DOI 10.1016/j.jip.2008.05.004; Peng XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-125; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Rajendra W, 2006, BBA-GEN SUBJECTS, V1760, P158, DOI 10.1016/j.bbagen.2005.11.008; RAMACHANDRAN R, 1991, J CHEM ECOL, V17, P41, DOI 10.1007/BF00994421; Regev A, 2003, FEBS LETT, V537, P106, DOI 10.1016/S0014-5793(03)00104-2; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Smigocki AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057303; Strugatsky D, 2005, BIOCHEMISTRY-US, V44, P9179, DOI 10.1021/bi050235t; Sun XL, 2009, BIOL CONTROL, V49, P77, DOI 10.1016/j.biocontrol.2008.12.011; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Trung NP, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-18; van Beek N, 2003, BIOL CONTROL, V27, P53, DOI 10.1016/S1049-9644(02)00172-X; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Wang JX, 2005, PLANT CELL REP, V24, P549, DOI 10.1007/s00299-005-0967-3; Wu JH, 2008, BIOTECHNOL LETT, V30, P547, DOI 10.1007/s10529-007-9555-7; Wudayagiri R, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-16; ZLOTKIN E, 1991, BIOCHEMISTRY-US, V30, P4814, DOI 10.1021/bi00233a025	52	3	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100232	10.1371/journal.pone.0100232	http://dx.doi.org/10.1371/journal.pone.0100232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964088	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500033
J	Gruning, CSR; Mirecka, EA; Klein, AN; Mandelkow, E; Willbold, D; Marino, SF; Stoldt, M; Hoyer, W				Gruening, Clara S. R.; Mirecka, Ewa A.; Klein, Antonia N.; Mandelkow, Eckhard; Willbold, Dieter; Marino, Stephen F.; Stoldt, Matthias; Hoyer, Wolfgang			Alternative Conformations of the Tau Repeat Domain in Complex with an Engineered Binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; IN-VITRO; SEEDING BARRIER; BETA-HAIRPIN; AGGREGATION; OLIGOMERS; CORE; IDENTIFICATION; STABILIZATION; PROTOFIBRILS	The aggregation of Tau into paired helical filaments is involved in the pathogenesis of several neurodegenerative diseases, including Alzheimer disease. The aggregation reaction is characterized by conformational conversion of the repeat domain, which partially adopts a cross-beta-structure in the resulting amyloid-like fibrils. Here, we report the selection and characterization of an engineered binding protein, beta-wrapin TP4, targeting the Tau repeat domain. TP4 was obtained by phage display using the four-repeat Tau construct K18 Delta K280 as a target. TP4 binds K18 Delta K280 as well as the longest isoform of human Tau, hTau40, with nanomolar affinity. NMR spectroscopy identified two alternative TP4-binding sites in the four-repeat domain, with each including two hexapeptide motifs with high beta-sheet propensity. Both binding sites contain the aggregation- determining PHF6 hexapeptide within repeat 3. In addition, one binding site includes the PHF6* hexapeptide within repeat 2, whereas the other includes the corresponding hexapeptide Tau(337-342) within repeat 4, denoted PHF6**. Comparison of TP4-binding with Tau aggregation reveals that the same regions of Tau are involved in both processes. TP4 inhibits Tau aggregation at substoichiometric concentration, demonstrating that it interferes with aggregation nucleation. This study provides residue-level insight into the interaction of Tau with an aggregation inhibitor and highlights the structural flexibility of Tau.	[Gruening, Clara S. R.; Mirecka, Ewa A.; Willbold, Dieter; Marino, Stephen F.; Stoldt, Matthias; Hoyer, Wolfgang] Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Klein, Antonia N.; Willbold, Dieter; Stoldt, Matthias; Hoyer, Wolfgang] Res Ctr Julich, Inst Struct Biochem ICS 6, D-52425 Julich, Germany; [Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Mandelkow, Eckhard] CAESAR, D-53175 Bonn, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Hoyer, W (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	wolfgang.hoyer@uni-duesseldorf.de	Willbold, Dieter/A-6280-2013; Stoldt, Matthias/G-5738-2013; Hoyer, Wolfgang/H-6193-2013	Willbold, Dieter/0000-0002-0065-7366; Stoldt, Matthias/0000-0002-5060-4844; Hoyer, Wolfgang/0000-0003-4301-5416; Marino, Stephen/0000-0001-5696-9679	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	This work was supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gronwall C, 2007, J BIOTECHNOL, V128, P162, DOI 10.1016/j.jbiotec.2006.09.013; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Macao B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-82; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Mirecka EA, 2014, ANGEW CHEM INT EDIT, V53, P4227, DOI 10.1002/anie.201309001; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P22822, DOI 10.1074/jbc.M112.367474; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875	50	16	16	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23209	23218		10.1074/jbc.M114.560920	http://dx.doi.org/10.1074/jbc.M114.560920			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24966331	Green Published, hybrid			2022-12-25	WOS:000341017200057
J	Rodriguez, M; Domingo, E; Alonso, S; Frade, JG; Eiros, J; Crespo, MS; Fernandez, N				Rodriguez, Mario; Domingo, Esther; Alonso, Sara; Garcia Frade, Javier; Eiros, Jose; Sanchez Crespo, Mariano; Fernandez, Nieves			The Unfolded Protein Response and the Phosphorylations of Activating Transcription Factor 2 in the trans-Activation of il23a Promoter Produced by beta-Glucans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP HOMOLOGOUS PROTEIN; HUMAN DENDRITIC CELLS; MAP KINASE; ANKYLOSING-SPONDYLITIS; BINDING PROTEIN; TYROSINE-PHOSPHATASE; DUAL PHOSPHORYLATION; SIGNALING PATHWAYS; IL-23 EXPRESSION; INNATE IMMUNITY	Current views on the control of IL-23 production focus on the regulation of il23a, the gene encoding IL-23 p19, by NF-kappa B in combination with other transcription factors. C/EBP homologous protein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-binding protein (C/EBP beta), and cAMP-response element-binding protein (CREB) have been involved in response to LPS, but no data are available regarding the mechanism triggered by the fungal mimic and beta-glucan-containing stimulus zymosan, which produces IL-23 and to a low extent the related cytokine IL-12 p70. Zymosan induced the mobilization of CHOP from the nuclear fractions to phagocytic vesicles. Hypha-forming Candida also induced the nuclear disappearance of CHOP. Assay of transcription factor binding to the il23a promoter showed an increase of Thr(P)-71-Thr(P)-69-activating transcription factor 2 (ATF2) binding in response to zymosan. PKC and PKA/mitogen-and stress-activated kinase inhibitors down-regulated Thr(P)-71-ATF2 binding to the il23a promoter and il23a mRNA expression. Consistent with the current concept of complementary phosphorylations on N-terminal Thr-71 and Thr-69 of ATF2 by ERK and p38 MAPK, MEK, and p38 MAPK inhibitors blunted Thr(P)-69-ATF2 binding. Knockdown of atf2 mRNA with siRNA correlated with inhibition of il23a mRNA, but it did not affect the expression of il12/23b and il10 mRNA. These data indicate the following: (i) zymosan decreases nuclear proapoptotic CHOP, most likely by promoting its accumulation in phagocytic vesicles; (ii) zymosan-induced il23a mRNA expression is best explained through coordinated kappa B- and ATF2-dependent transcription; and (iii) il23a expression relies on complementary phosphorylation of ATF2 on Thr-69 and Thr-71 dependent on PKC and MAPK activities.	[Rodriguez, Mario; Fernandez, Nieves] Univ Valladolid, Fac Med, Dept Bioquim & Biol Mol, E-47005 Valladolid, Spain; [Domingo, Esther; Alonso, Sara; Sanchez Crespo, Mariano] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Garcia Frade, Javier] Hosp Univ Rio Hortega, Div Hematol, Valladolid 47012, Spain; [Eiros, Jose] Hosp Univ Rio Hortega, Div Microbiol, Valladolid 47012, Spain	Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Hospital del Rio Hortega; Hospital del Rio Hortega	Crespo, MS (corresponding author), Inst Biol & Genet Mol, C Sanz & Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Rodríguez, Mario/AAE-9602-2020; Fernández, Nieves/N-5426-2018	Rodríguez, Mario/0000-0002-4587-3863; Fernández, Nieves/0000-0002-9141-3956	Plan Nacional de Salud y Farmacia [SAF2010-15070]; Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III; Junta de Castilla y Leon	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Plan Nacional de Salud y Farmacia Grant SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III, and Junta de Castilla y Leon.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Alvarez Y, 2012, J BIOL CHEM, V287, P35689, DOI 10.1074/jbc.M112.391839; Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baan B, 2009, MOL CELL ENDOCRINOL, V311, P94, DOI 10.1016/j.mce.2009.07.023; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen D, 2007, CANCER RES, V67, P8914, DOI 10.1158/0008-5472.CAN-06-4751; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Chooi KP, 2014, J AM CHEM SOC, V136, P1698, DOI 10.1021/ja4095318; Ciccia F, 2014, ANN RHEUM DIS, V73, P1566, DOI 10.1136/annrheumdis-2012-202925; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Clavaud C, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P387; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hale KK, 1999, J IMMUNOL, V162, P4246; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Humphreys JM, 2013, J BIOL CHEM, V288, P23322, DOI 10.1074/jbc.M113.462101; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kocieda VP, 2012, J BIOL CHEM, V287, P36922, DOI 10.1074/jbc.M112.402958; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Wang QW, 2013, J IMMUNOL, V190, P3246, DOI 10.4049/jimmunol.1201484; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	60	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22942	22957		10.1074/jbc.M113.522656	http://dx.doi.org/10.1074/jbc.M113.522656			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982422	Green Published, hybrid			2022-12-25	WOS:000341017200034
J	Bennitt, E; Bonyongo, MC; Harris, S				Bennitt, Emily; Bonyongo, Mpaphi Casper; Harris, Stephen			Habitat Selection by African Buffalo (Syncerus caffer) in Response to Landscape-Level Fluctuations in Water Availability on Two Temporal Scales	PLOS ONE			English	Article							MOUNTAIN-NATIONAL-PARK; OKAVANGO DELTA; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; RESOURCE SELECTION; EQUUS-BURCHELLI; PROTECTED AREAS; CLIMATE-CHANGE; TRADE-OFF; SOIL TYPE	Seasonal fluctuations in water availability cause predictable changes in the profitability of habitats in tropical ecosystems, and animals evolve adaptive behavioural and spatial responses to these fluctuations. However, stochastic changes in the distribution and abundance of surface water between years can alter resource availability at a landscape scale, causing shifts in animal behaviour. In the Okavango Delta, Botswana, a flood-pulsed ecosystem, the volume of water entering the system doubled between 2008 and 2009, creating a sudden change in the landscape. We used African buffalo (Syncerus caffer) to test the hypotheses that seasonal habitat selection would be related to water availability, that increased floodwater levels would decrease forage abundance and affect habitat selection, and that this would decrease buffalo resting time, reduce reproductive success and decrease body condition. Buffalo selected contrasting seasonal habitats, using habitats far from permanent water during the rainy season and seasonally-flooded habitats close to permanent water during the early and late flood seasons. The 2009 water increase reduced forage availability in seasonally-flooded habitats, removing a resource buffer used by the buffalo during the late flood season, when resources were most limited. In response, buffalo used drier habitats in 2009, although there was no significant change in the time spent moving or resting, or daily distance moved. While their reproductive success decreased in 2009, body condition increased. A protracted period of high water levels could prove detrimental to herbivores, especially to smaller-bodied species that require high quality forage. Stochastic annual fluctuations in water levels, predicted to increase as a result of anthropogenically-induced climate change, are likely to have substantial impacts on the functioning of water-driven tropical ecosystems, affecting environmental conditions within protected areas. Buffer zones around critical seasonal resources are essential to allow animals to engage in compensatory behavioural and spatial mechanisms in response to changing environmental conditions.	[Bennitt, Emily; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bonyongo, Mpaphi Casper] Univ Botswana, Okavango Res Inst, Maun, Botswana	University of Bristol; University of Botswana	Bennitt, E (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Emily.Bennitt@gmail.com	Bonyongo, Mpaphi Casper/AAS-1423-2021; Bennitt, Emily/AAB-6032-2020		Dulverton Trust; Idea Wild; North of England Zoological Society; Roberts Fund; Wilderness Safaris Wildlife Trust	Dulverton Trust; Idea Wild; North of England Zoological Society; Roberts Fund; Wilderness Safaris Wildlife Trust	This work was funded by Jenny & Martin Bennitt, the Dulverton Trust (www.dulverton.org), Harry Ferguson, Ian Fuhr, Rodney Fuhr, Dane Hawk, Idea Wild (www.ideawild.org), the North of England Zoological Society (www.chesterzoo.org/global/about-us/north-of-england-zoological-society), the Roberts Fund and the Wilderness Safaris Wildlife Trust (www.wildernesstrust.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J HYDROL, V331, P43, DOI 10.1016/j.jhydrol.2006.04.039; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bartlam-Brooks HLA, 2013, ECOL EVOL, V3, P2795, DOI 10.1002/ece3.676; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Bennitt E., 2012, THESIS U BRISTOL; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Bradley J, 2012, THESIS U BRISTOL; BRANSBY DI, 1977, AGRON J, V69, P393, DOI 10.2134/agronj1977.00021962006900030016x; Brooks CJ, 2008, ANIM BEHAV, V76, P277, DOI 10.1016/j.anbehav.2008.02.005; Burthe S, 2011, J ANIM ECOL, V80, P1134, DOI 10.1111/j.1365-2656.2011.01865.x; Calenge C, 2007, J STAT SOFTW, V22, P1; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Christensen RHB, 2013, ANAL ORDINAL DATA CI; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; ELLERY WN, 1993, AFR J ECOL, V31, P118, DOI 10.1111/j.1365-2028.1993.tb00526.x; FARRAR TJ, 1994, REMOTE SENS ENVIRON, V50, P121, DOI 10.1016/0034-4257(94)90039-6; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Gaidet N, 2008, CAN J ZOOL, V86, P24, DOI 10.1139/Z07-111; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Hassler SK, 2010, J ARID ENVIRON, V74, P1516, DOI 10.1016/j.jaridenv.2010.05.021; Heinl M, 2006, LANDSCAPE ECOL, V21, P699, DOI 10.1007/s10980-005-5243-y; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hughes DA, 2011, HYDROL EARTH SYST SC, V15, P931, DOI 10.5194/hess-15-931-2011; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kumar L, 2002, ECOL MODEL, V149, P143, DOI 10.1016/S0304-3800(01)00520-8; KUTILEK MJ, 1979, J WILDLIFE MANAGE, V43, P899, DOI 10.2307/3808273; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Lorrilliere R, 2012, ECOL MODEL, V224, P103, DOI 10.1016/j.ecolmodel.2011.10.015; Manly B.F.J., 2002, RESOURCE SELECTION A; Mbatha K. R., 2006, African Journal of Range & Forage Science, V23, P131, DOI 10.2989/10220110609485896; Midgley GF, 2011, REG ENVIRON CHANGE, V11, pS127, DOI 10.1007/s10113-010-0191-8; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Murray-Hudson M, 2006, J HYDROL, V331, P73, DOI 10.1016/j.jhydrol.2006.04.041; Musters CJM, 2000, SCIENCE, V287, P1759, DOI 10.1126/science.287.5459.1759; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Ogutu Joseph O., 2013, Open Conservation Biology Journal, V7, P11, DOI 10.2174/1874839201307010011; Ogutu Joseph O., 2012, Open Ecology Journal, V5, P1, DOI 10.2174/1874213001205010001; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith Norman, 2008, V23, P159; Patterson L, 1978, STUDIES POPULATION B; Peinetti HR, 2002, LANDSCAPE ECOL, V17, P341, DOI 10.1023/A:1020530710891; Poilecot P, 2011, AFR J ECOL, V49, P150, DOI 10.1111/j.1365-2028.2010.01241.x; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sinclair A.R.E., 1972, East African Wildlife Journal, V10, P143; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Taolo CL, 2003, THESIS NORWEGIAN U S; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; TROLLOPE W, 2000, SIMPLIFIED TECHNIQUE; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Van der Boogaart KG, 2006, GEOL SOC SPEC PUBL, V264, P119, DOI 10.1144/GSL.SP.2006.264.01.09; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Wada Y, 2011, HYDROL EARTH SYST SC, V15, P3785, DOI 10.5194/hess-15-3785-2011; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wang GM, 2002, CLIMATIC CHANGE, V54, P205, DOI 10.1023/A:1015725103348; Watson R. M., 1965, East African Wildlife Journal, V3, P95; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	83	34	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101346	10.1371/journal.pone.0101346	http://dx.doi.org/10.1371/journal.pone.0101346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983377	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000094
J	Rijken, MJ; De Livera, AM; Lee, SJ; Boel, ME; Rungwilailaekhiri, S; Wiladphaingern, J; Paw, MK; Pimanpanarak, M; Pukrittayakamee, S; Simpson, JA; Nosten, F; McGready, R				Rijken, Marcus J.; De Livera, Alysha M.; Lee, Sue J.; Boel, Machteld E.; Rungwilailaekhiri, Suthatsana; Wiladphaingern, Jacher; Paw, Moo Kho; Pimanpanarak, Mupawjay; Pukrittayakamee, Sasithon; Simpson, Julie A.; Nosten, Francois; McGready, Rose			Quantifying Low Birth Weight, Preterm Birth and Smallf-or-Gestational-Age Effects of Malaria in Pregnancy: A Population Cohort Study	PLOS ONE			English	Article							PROSPECTIVE ULTRASOUND; FETAL-GROWTH; MORTALITY; RISK	Background: The association between malaria during pregnancy and low birth weight (LBW) is well described. This manuscript aims to quantify the relative contribution of malaria to small-for-gestational-age (SGA) infants and preterm birth (PTB) in pregnancies accurately dated by ultrasound on the Thai-Myanmar border at the Shoklo Malaria Research Unit. Methods and Findings: From 2001 to 2010 in a population cohort of prospectively followed pregnancies, we analyzed all singleton newborns who were live born, normal, weighed in the first hour of life and with a gestational age (GA) between 28+0 and 41+6 weeks. Fractional polynomial regression was used to determine the mean birthweight and standard deviation as functions of GA. Risk differences and factors of LBW and SGA were studied across the range of GA for malaria and non-malaria pregnancies. From 10,264 newborns records, population centiles were created. Women were screened for malaria by microscopy a median of 22 [range 1-38] times and it was detected and treated in 12.6% (1,292) of pregnancies. Malaria was associated with LBW, PTB, and SGA compared to those without malaria. Nearly two-thirds of PTB were classified as LBW (68% (539/789)), most of which 83% (447/539) were not SGA. After GA 39 weeks, 5% (298/5,966) of non-LBW births were identified as SGA. Low body mass index, primigravida, hypertension, smoking and female sex of the newborn were also significantly and independently associated with LBW and SGA consistent with previous publications. Conclusions: Treated malaria in pregnancy was associated with an increased risk for LBW, PTB, and SGA, of which the latter are most important for infant survival. Using LBW as an endpoint without adjusting for GA incorrectly estimated the effects of malaria in pregnancy. Ultrasound should be used for dating pregnancies and birth weights should be expressed as a function (or adjusted for GA) of GA in future malaria in pregnancy studies.	[Rijken, Marcus J.; Lee, Sue J.; Boel, Machteld E.; Rungwilailaekhiri, Suthatsana; Wiladphaingern, Jacher; Paw, Moo Kho; Pimanpanarak, Mupawjay; Nosten, Francois; McGready, Rose] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [De Livera, Alysha M.; Simpson, Julie A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Lee, Sue J.; Nosten, Francois; McGready, Rose] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Melbourne; University of Oxford; Mahidol University	Rijken, MJ (corresponding author), Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand.	marcus@shoklo-unit.com	De Livera, Alysha/AAU-6661-2021; Simpson, Julie A/P-7299-2014; McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019	De Livera, Alysha/0000-0003-4981-4155; McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Simpson, Julie/0000-0002-2660-2013; Paw, Moo Kho/0000-0002-4008-3168; Rijken, Marcus/0000-0003-0914-5508	Wellcome Trust of Great Britain; Christophe Merieux Prize; National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence [1035261]	Wellcome Trust of Great Britain(Wellcome Trust); Christophe Merieux Prize; National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence	The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and supported by the Wellcome Trust of Great Britain. MJR and MEB were supported by the Christophe Merieux Prize to FN (2008). AL was supported by the National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence 1035261, awarded to the Victorian Centre for Biostatistics (ViCBiostat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001152; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Benner A, 2005, R NEWS, V5, P20; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Leung TN, 2008, ULTRASOUND OBST GYN, V31, P321, DOI 10.1002/uog.5192; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Owen P, 1998, BRIT J OBSTET GYNAEC, V105, P536, DOI 10.1111/j.1471-0528.1998.tb10155.x; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-222; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Wylie BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-183; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889	32	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100247	10.1371/journal.pone.0100247	http://dx.doi.org/10.1371/journal.pone.0100247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983755	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000017
J	Kim, SK; Jung, WH; Koo, JS				Kim, Sang Kyum; Jung, Woo Hee; Koo, Ja Seung			Differential Expression of Enzymes Associated with Serine/Glycine Metabolism in Different Breast Cancer Subtypes	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MOLECULAR SUBTYPE; OXIDATIVE STRESS; FIBROBLASTS; PROTEINS; GLYCINE; GLUT-1; GROWTH; CELLS; CAIX	Purpose: Glycine and serine are well-known, classic metabolites of glycolysis. Here, we profiled the expression of enzymes associated with serine/glycine metabolism in different molecular subtypes of breast cancer and discuss their potential clinical implications. Methods: We used western blotting and immunohistochemistry to examine five serine-/glycine-metabolism-associated proteins (PHGDH, PSAT, PSPH, SHMT, and GLDC) in six breast cancer cell lines and 709 breast cancer cases using tissue microarray (TMA). Results: PHGDH and PSPH, associated with serine metabolism, were highly expressed in the TNBC cells. GLDC, associated with glycine metabolism, was highly expressed in HER-2-positive MDA-MB-453 and TNBC-related MDA-MB-435S. TMA showed that the TNBC-type breast cancer tissues highly expressed PHGDH, PSPH, and SHMT1, but not the luminal-A-type tissues (p<0.001). PSPH and SHMT1 expression in the tumor stroma of HER-2-type cancers was the highest, but the luminal-A tissues showed the lowest expression (p<0.001). GLDC was most frequently expressed in cancer cells and stroma of the HER-2-positive cancers and least frequently in TNBC (p<0.001). By Cox multivariate analysis, tumor PSPH positivity (hazard ratio [HR]: 2.068, 95% confidence interval [CI]: 1.049-4.079, p = 0.036), stromal PSPH positivity (HR: 2.152, 95% CI: 1.107-4.184, p = 0.024), and stromal SHMT1 negativity (HR: 2.142, 95% CI: 1.219-3.764, p = 0.008) were associated with short overall survival. Conclusions: Expression of serine-metabolism-associated proteins was increased in TNBC and decreased in the luminal-A cancers. Expression of glycine-metabolism-associated proteins was high in the tumor and stroma of HER-2-positive cancers.	[Kim, Sang Kyum; Jung, Woo Hee; Koo, Ja Seung] Yonsei Univ Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pathol, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pathol, Severance Hosp, Seoul, South Korea.	kjs1976@yuhs.ac		Kim, Sang Kyum/0000-0003-0768-9923; koo, ja seung/0000-0003-4546-4709	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1002886]; Yonsei University College of Medicine [6-2013-0146]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Yonsei University College of Medicine(General Electric)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1002886). This study was supported by a faculty research grant from Yonsei University College of Medicine for 2013 (6-2013-0146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kim S, 2013, J BREAST CANCER, V16, P146, DOI 10.4048/jbc.2013.16.2.146; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stackhouse BL, 2005, BREAST CANCER RES TR, V93, P247, DOI 10.1007/s10549-005-5158-y; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Younes M, 1995, ANTICANCER RES, V15, P2895; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	23	59	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101004	10.1371/journal.pone.0101004	http://dx.doi.org/10.1371/journal.pone.0101004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979213	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400060
J	Lorenzi, T; Nitulescu, EA; Zizzi, A; Lorenzi, M; Paolinelli, F; Aspriello, SD; Banita, M; Craitoiu, S; Goteri, G; Barbatelli, G; Lombardi, T; Di Felice, R; Marzioni, D; Rubini, C; Castellucci, M				Lorenzi, Teresa; Nitulescu, Elena Annabel; Zizzi, Antonio; Lorenzi, Maria; Paolinelli, Francesca; Aspriello, Simone Domenico; Banita, Monica; Craitoiu, Stefania; Goteri, Gaia; Barbatelli, Giorgio; Lombardi, Tommaso; Di Felice, Roberto; Marzioni, Daniela; Rubini, Corrado; Castellucci, Mario			The Novel Role of HtrA1 in Gingivitis, Chronic and Aggressive Periodontitis	PLOS ONE			English	Article							SERINE-PROTEASE HTRA1; 5TH EUROPEAN WORKSHOP; TISSUE DESTRUCTION; CONSENSUS REPORT; NECROSIS-FACTOR; EXPRESSION; DISEASE; METALLOPROTEINASES; FAMILY	Proteolytic tissue degradation is a typical phenomenon in inflammatory periodontal diseases HtrA1 (High temperature requirement A 1) has a serine protease activity and is able to degrade fibronectin whose fragments induce the expression and secretion of several matrix metalloproteinases (MMPs). The aim of this study was to investigate for the first time if HtrA1 has a role in gingivitis and in generalized forms of chronic and aggressive periodontitis. Expression of HtrA1 was investigated in clinically healthy gingiva, 16 gingivitis, 4 generalized chronic periodontitis and 10 generalized aggressive periodontitis by immunohistochemistry and real PCR. Statistical comparisons were performed by the Kruskall-Wallis test. Significantly higher levels of HtrA1 mRNA and protein expression were observed in pathological respect to healthy tissues. In particular, we detected an increase of plasma cell HtrA1 immunostaining from gingivitis to chronic and aggressive periodontitis, with the higher intensity in aggressive disease. In addition we observed the presence of HtrA1 in normal and pathological epithelium, an increased expression, particularly in its superficial layer, associated with increasingly severe forms of periodontal disease. We can affirm that HtrA1 expression in plasma cells could be correlated with the destruction of pathological periodontal tissue, probably due to its ability to trigger the overproduction of MMPs and to increase the inflammatory mediators TNF-alpha and IL-1 beta by inhibition of TGF-beta. Moreover, epithelial HtrA1 immunostaining suggests a participation of the molecule in the host inflammatory immune responses for the control of periodontal infection.	[Lorenzi, Teresa; Lorenzi, Maria; Paolinelli, Francesca; Barbatelli, Giorgio; Marzioni, Daniela; Castellucci, Mario] Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy; [Nitulescu, Elena Annabel; Banita, Monica; Craitoiu, Stefania] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Zizzi, Antonio; Goteri, Gaia; Rubini, Corrado] Univ Politecn Marche, United Hosp, Dept Med Sci & Publ Hlth, Ancona, Italy; [Aspriello, Simone Domenico] Univ Politecn Marche, Dept Clin Specialist & Dent Sci, Ancona, Italy; [Lombardi, Tommaso] Univ Geneva, Div Stomatol & Oral Surg, Lab Oral & Maxillofacial Pathol, Geneva, Switzerland; [Di Felice, Roberto] San Benedetto Tronto, Ascoli Piceno, Italy	Marche Polytechnic University; University of Medicine & Pharmacy of Craiova; Marche Polytechnic University; Marche Polytechnic University; University of Geneva	Lorenzi, T (corresponding author), Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy.	teresalorenzi@yahoo.it; d.marzioni@univpm.it		Zizzi, Antonio/0000-0001-5253-693X; Lorenzi, Teresa/0000-0002-3723-5378	Universita Politecnica delle Marche; European Union - AM POS-DRU project [-7603]	Universita Politecnica delle Marche; European Union - AM POS-DRU project	This work was funded by Universita Politecnica delle Marche with grants to G. G., G.B., D.M., C.R., M.C. EAN was supported by a fellowship from European Union - AM POS-DRU project with title "Supporting young people through PhD doctoral scholarships " ID -7603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Artese L, 2011, CLIN ORAL INVEST, V15, P233, DOI 10.1007/s00784-009-0374-1; Aspriello SD, 2011, J PERIODONTAL RES, V46, P164, DOI 10.1111/j.1600-0765.2010.01324.x; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Berglundh T, 2005, J CLIN PERIODONTOL, V32, P87, DOI 10.1111/j.1600-051X.2005.00820.x; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cutler CW, 2004, PERIODONTOL 2000, V35, P135, DOI 10.1111/j.0906-6713.2004.003560.x; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Goncalves LDR, 2008, J PERIODONTAL RES, V43, P570, DOI 10.1111/j.1600-0765.2008.01101.x; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Haffajee AD, 2005, PERIODONTOL 2000, V38, P9, DOI 10.1111/j.1600-0757.2005.00112.x; Hannas AR, 2007, ACTA ODONTOL SCAND, V65, P1, DOI 10.1080/00016350600963640; Lorenzi T, 2009, PLACENTA, V30, P35, DOI 10.1016/j.placenta.2008.10.016; Marzioni D, 2009, HISTOL HISTOPATHOL, V24, P1213, DOI 10.14670/HH-24.1213; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Sanz M, 2005, J CLIN PERIODONTOL, V32, P54, DOI 10.1111/j.1600-051X.2005.00827.x; Stanton H, 2002, BIOCHEM J, V364, P181, DOI 10.1042/bj3640181; Steinsvoll S, 1999, J CLIN PERIODONTOL, V26, P366, DOI 10.1034/j.1600-051X.1999.260606.x; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e96978	10.1371/journal.pone.0096978	http://dx.doi.org/10.1371/journal.pone.0096978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979214	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400001
J	Milovanovic, I; Njuieyon, F; Deghmoun, S; Chevenne, D; Levy-Marchal, C; Beltrand, J				Milovanovic, Ivana; Njuieyon, Falucar; Deghmoun, Samia; Chevenne, Didier; Levy-Marchal, Claire; Beltrand, Jacques			SGA Children with Moderate Catch-Up Growth Are Showing the Impaired Insulin Secretion at the Age of 4	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; FOR-GESTATIONAL-AGE; BETA-CELL MASS; ORAL GLUCOSE-TOLERANCE; X-RAY ABSORPTIOMETRY; SKINFOLD MEASUREMENTS; METABOLIC SYNDROME; PROSPECTIVE COHORT; POSTNATAL-GROWTH; BODY-COMPOSITION	Background: Being born small for gestational age (SGA) is a risk factor for later development of type 2 diabetes. The development of glucose tolerance disorders in adults involves insulin resistance and impaired insulin secretion. Objective: To evaluate insulin secretion and insulin sensitivity in a 4-yr old cohort of SGA. Methods: 85 children were prospectively followed from mid-gestation to 4 years of age. Fetal growth velocity (FGV) was measured using ultrasound measurements. Body composition and hormonal profile were measured at birth, 1 and 4 years. Results: 23 SGA babies had lower birth weight compared to 62 AGA (-1.9 +/- 0.3 vs. 0.6 +/- 0.8 z-score; p<0.0001) and they were thinner at birth (ponderal index 24.8 +/- 1.8 vs. 26.3 +/- 3.1 kg/m3; p=0.01 and fat mass 11 +/- 2.6 vs. 12.9 +/- 3.1%; p =0.01). No significant differences in other measured metabolic and hormonal parameters were observed between two groups at birth. SGA infants experienced an early catch-up growth in weight (mean gain of 1.1 +/- 0.6 SD) during the first year of life. At 4 years, SGA children remain lighter than AGA, but with weight z-score in the normal range (-0.1 +/- 1.3 vs. 0.5 +/- 1.3 z-score; p = 0.05). No excess of fat mass was observed (19 +/- 4.8 vs. 19.7 +/- 4.1%; pz=0.45). 120-min plasma glucose was significantly higher (6.2 +/- 1.1 vs. 5.6 +/- 0.9 mmol/1; p =0.006) and insulinogenic index was significantly lower (0.28 +/- 0.15 vs. 0.40 +/- 2.4; p=0.02) in the SGA group at 4-yrs of life contrasting with a preserved insulin sensitivity (QUICK! 0.47 +/- 0.09 vs. 0.43 +/- 0.05; p = 0.06). Conclusion: SGA children with compensatory catch-up growth in first year of life show mild disturbances of glucose tolerance associated to a lower insulinogenic index at 4-yrs of age suggesting impairment of 13-cell function.	[Milovanovic, Ivana; Njuieyon, Falucar; Deghmoun, Samia; Levy-Marchal, Claire] Hop Robert Debre, INSERM, CIE 05, Unite Epidemiol Clin, F-75019 Paris, France; [Chevenne, Didier] Hop Robert Debre, Serv Biochimie & Hormonol, F-75019 Paris, France; [Beltrand, Jacques] Hop Necker Enfants Malad, Paris, France; [Beltrand, Jacques] Univ Paris 05, Rene Descartes, Paris, France; [Beltrand, Jacques] INSERM, U845, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Milovanovic, I (corresponding author), Hop Robert Debre, INSERM, CIE 05, Unite Epidemiol Clin, F-75019 Paris, France.	ivana.milovanovic@inserm.fr	beltrand, jacques/AAV-6455-2021	beltrand, jacques/0000-0002-3759-3490	Institut National de la Sante et de la Recherche Medicale (INSERM); Programme Hospitalier de Recherche Clinique [06-136]; Pfizer Inc.; Institut Appert; INSERM; SFEDP	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Programme Hospitalier de Recherche Clinique; Pfizer Inc.(Pfizer); Institut Appert(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); SFEDP	This work was supported by a grant from the "Institut National de la Sante et de la Recherche Medicale (INSERM)", a grant from the "Programme Hospitalier de Recherche Clinique" (AOM 06-136, 2006) and from Pfizer Inc. Jacques Beltrand was supported by a fellowship from the "Institut Appert" (France, 2006) and by INSERM (Poste d'accueil, 2007). Ivana Milovanovic was supported by a fellowship SFP 2011. Falucar Njuieyon was supported by a fellowship SFEDP 2009. Claire Levy-Marchal was awarded a Contrat d'Interface de Recherche Hospitaliere 2007-2012 from Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Beltrand J, 2008, BEST PRACT RES CL EN, V22, P503, DOI 10.1016/j.beem.2008.01.015; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; COOK JTE, 1993, BRIT MED J, V306, P302, DOI 10.1136/bmj.306.6873.302; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Holness MJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE946, DOI 10.1152/ajpendo.1996.270.6.E946; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Kumar PU, 2013, INDIAN J MED RES, V137, P302; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meas T, 2010, DIABETOLOGIA, V53, P907, DOI 10.1007/s00125-009-1650-y; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Picaud JC, 2003, J CLIN DENSITOM, V6, P17, DOI 10.1385/JCD:6:1:17; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Rodriguez G, 2005, ARCH DIS CHILD-FETAL, V90, P273, DOI 10.1136/adc.2004.060723; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Schou JH, 2005, J CLIN ENDOCR METAB, V90, P4912, DOI 10.1210/jc.2005-0382; SEMPE M, 1977, ARCH FR PEDIATR, V34, P687; Silva AAM, 2012, NUTR METAB CARDIOVAS, V22, P533, DOI 10.1016/j.numecd.2010.09.012; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stefan N, 2004, METABOLISM, V53, P904, DOI 10.1016/j.metabol.2004.01.014; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yuan QX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025167	42	40	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100337	10.1371/journal.pone.0100337	http://dx.doi.org/10.1371/journal.pone.0100337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979613	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400026
J	Vandrovcova, M; Jirka, I; Novotna, K; Lisa, V; Frank, O; Kolska, Z; Stary, V; Bacakova, L				Vandrovcova, Marta; Jirka, Ivan; Novotna, Katarina; Lisa, Vera; Frank, Otakar; Kolska, Zdenka; Stary, Vladimir; Bacakova, Lucie			Interaction of Human Osteoblast-Like Saos-2 and MG-63 Cells with Thermally Oxidized Surfaces of a Titanium-Niobium Alloy	PLOS ONE			English	Article							MARROW STROMAL CELLS; DIOXIDE FILMS; IN-VITRO; GROWTH; EXPRESSION; ADHESION; BIOCOMPATIBILITY; DIFFERENTIATION; TOPOGRAPHY; MEMBRANES	An investigation was made of the adhesion, growth and differentiation of osteoblast-like MG-63 and Saos-2 cells on titanium (Ti) and niobium (Nb) supports and on TiNb alloy with surfaces oxidized at 165 degrees C under hydrothermal conditions and at 600 degrees C in a stream of air. The oxidation mode and the chemical composition of the samples tuned the morphology, topography and distribution of the charge on their surfaces, which enabled us to evaluate the importance of these material characteristics in the interaction of the cells with the sample surface. Numbers of adhered MG-63 and Saos-2 cells correlated with the number of positively-charged (related with the Nb2O5 phase) and negatively-charged sites (related with the TiO2 phase) on the alloy surface. Proliferation of these cells is correlated with the presence of positively-charged (i. e. basic) sites of the Nb2O5 alloy phase, while cell differentiation is correlated with negatively-charged (acidic) sites of the TiO2 alloy phase. The number of charged sites and adhered cells was substantially higher on the alloy sample oxidized at 600 degrees C than on the hydrothermally treated sample at 165 degrees C. The expression values of osteoblast differentiation markers (collagen type I and osteocalcin) were higher for cells grown on the Ti samples than for those grown on the TiNb samples. This was more particularly apparent in the samples treated at 165 degrees C. No considerable immune activation of murine macrophage-like RAW 264.7 cells on the tested samples was found. The secretion of TNF-alpha by these cells into the cell culture media was much lower than for either cells grown in the presence of bacterial lipopolysaccharide, or untreated control samples. Thus, oxidized Ti and TiNb are both promising materials for bone implantation; TiNb for applications where bone cell proliferation is desirable, and Ti for induction of osteogenic cell differentiation.	[Vandrovcova, Marta; Novotna, Katarina; Lisa, Vera; Bacakova, Lucie] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Jirka, Ivan; Frank, Otakar] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Prague, Czech Republic; [Kolska, Zdenka] Univ JE Purkyne, Fac Sci, Usti Nad Labem, Czech Republic; [Stary, Vladimir] Czech Tech Univ, Fac Mech Engn, CR-16635 Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; University of Jan Evangelista Purkyne; Czech Technical University Prague	Bacakova, L (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	lucy@biomed.cas.cz	Kolska, Zdenka/B-1938-2009; Jirka, Ivan/G-7224-2014; Bacakova, Lucie/C-2664-2012; Frank, Otakar/D-9231-2011; Vandrovcova, Marta/C-2217-2012	Jirka, Ivan/0000-0002-0222-4855; Bacakova, Lucie/0000-0002-1818-9484; Frank, Otakar/0000-0002-9661-6250; Vandrovcova, Marta/0000-0001-8632-5321; Kolska, Zdenka/0000-0003-0239-9046	Grant Agency of the Czech Republic [P108/10/1858, P107/12/1025]; Ministry of Industry and Trade [FR-TI3/088]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Industry and Trade	This study was financially supported by the Grant Agency of the Czech Republic (grants No. P108/10/1858 and P107/12/1025), and by the Ministry of Industry and Trade (grant No. FR-TI3/088). The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacakova L, 2001, J BIOMED MATER RES, V54, P567; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bello SA, 2010, J MATER SCI-MATER M, V21, P1739, DOI 10.1007/s10856-010-4016-6; Born AK, 2009, EUR CELLS MATER, V18, P49; Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7; Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Czekanska EM, 2012, EUR CELLS MATER, V24, P1473; Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012; Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C; Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598; Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/j.6480.2005.00028.x; Helth A, 2014, J BIOMED MATER RES B, V102, P31, DOI 10.1002/jbm.b.32976; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n; Jirka I, 2013, MAT SCI ENG C-MATER, V33, P1636, DOI 10.1016/j.msec.2012.12.073; Kokubo T, 2010, J R SOC INTERFACE, V7, pS503, DOI 10.1098/rsif.2010.0129.focus; Kosmulski M., 2001, CHEM PROPERTIES MAT; Lai M, 2013, J BIOMED MATER RES A, V101, P653, DOI 10.1002/jbm.a.34371; Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006; Lee YJ, 2012, J PERIODONTAL IMPLAN, V42, P81, DOI 10.5051/jpis.2012.42.3.81; Lesny P, 2006, J MATER SCI-MATER M, V17, P829, DOI 10.1007/s10856-006-9842-1; Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Luxbacher T, 2006, DESALINATION, V199, P376, DOI 10.1016/j.desal.2006.03.085; Olivares-Navarrete R, 2011, COATINGS, V1, P72, DOI 10.3390/coatings1010072; Parizek M, 2012, INT J NANOMED, V7, P1931, DOI 10.2147/IJN.S26665; Park YJ, 2007, J MATER SCI-MATER M, V18, P565, DOI 10.1007/s10856-007-2303-7; Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0; Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075; Saldana L, 2006, J BIOMED MATER RES A, V77A, P220, DOI 10.1002/jbm.a.30599; Saldana L, 2005, J BIOMED MATER RES A, V73A, P97, DOI 10.1002/jbm.a.30264; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084; Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x; Treves C, 2010, J BIOMED MATER RES A, V92A, P1623, DOI 10.1002/jbm.a.32507; Tsou HK, 2012, J BIOMED MATER RES A, V100A, P2787, DOI 10.1002/jbm.a.34215; Vandrovcova M, 2012, J BIOMED MATER RES A, V100A, P1016, DOI 10.1002/jbm.a.34047; Velten D, 2004, J MATER SCI-MATER M, V15, P457, DOI 10.1023/B:JMSM.0000021120.86985.f7; Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055; Zhao XB, 2013, ACS APPL MATER INTER, V5, P8203, DOI 10.1021/am402319a; Zorn G, 2006, SURF COAT TECH, V201, P612, DOI 10.1016/j.surfcoat.2005.12.009	45	45	45	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100475	10.1371/journal.pone.0100475	http://dx.doi.org/10.1371/journal.pone.0100475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977704	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400030
J	Zhang, TT; Liu, D; Calabro, S; Eisenbarth, SC; Cattoretti, G; Haberman, AM				Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Cattoretti, Giorgio; Haberman, Ann M.			Dynamic Expression of BCL6 in Murine Conventional Dendritic Cells during In Vivo Development and Activation	PLOS ONE			English	Article							CENTER B-CELLS; TRANSCRIPTIONAL REPRESSOR BCL6; GERMINAL CENTER FORMATION; STEADY-STATE; SIGNALING PATHWAY; DOWN-REGULATION; FACTOR ZDC; RECEPTOR; DIFFERENTIATION; LINEAGE	The transcriptional repressor BCL6 plays an essential role in the development of germinal center B cells and follicular helper T cells. However, much less is known about the expression and function of BCL6 in other cell types. Here we report that during murine dendritic cell (DC) ontogeny in vivo, BCL6 is not expressed in bone marrow hematopoietic stem cells, common DC precursors and committed precursors of conventional DCs (pre-cDCs), but is elevated in peripheral pre-cDCs. BCL6 protein levels rise as pre-cDCs differentiate into cDCs in secondary lymphoid organs. Elevated protein levels of Bcl6 are observed in all cDC subsets, with CD8 alpha(+) cDCs displaying the greatest levels. Co-staining of Ki-67 revealed BCL6(hi) cDCs to be more proliferative than BCL6(lo) cDCs. After adjuvant inoculation, BCL6 levels are significantly reduced in the CD11c(int) MHC class IIhi CD86(hi) cDCs. Activation-induced BCL6 reduction correlated with reduced proliferation. A LPS injection study further confirmed that, in response to microbial stimuli, BCL6 levels are dynamically regulated during the maturation of CD11c(int) MHC class IIhi splenic cDCs. This reduction of BCL6 levels in cDCs does not occur after LPS injection in MyD88(-/-) TRIF-/- mice. Thus, regulation of Bcl6 protein levels is dynamic in murine cDCs during development, maturation and activation in vivo.	[Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Cattoretti, Giorgio] Univ Milano Bicocca, Dept Pathol, Monza, MB, Italy	Yale University; Yale University; University of Milano-Bicocca	Haberman, AM (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.	ann.haberman@yale.edu		Eisenbarth, Stephanie/0000-0002-1244-208X; Cattoretti, Giorgio/0000-0003-3799-3221; Zhang, Ting-ting/0000-0002-7868-9624	National Institutes of Health [R01 A1080850]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the National Institutes of Health (R01 A1080850) tp A.M.H and TT.Z was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2012, J EXP MED, V209, P2455, DOI 10.1084/jem.20121387; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pantano S, 2006, EXP CELL RES, V312, P1312, DOI 10.1016/j.yexcr.2005.12.020; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sawant DV, 2013, MOL IMMUNOL, V54, P435, DOI 10.1016/j.molimm.2013.01.006; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101208	10.1371/journal.pone.0101208	http://dx.doi.org/10.1371/journal.pone.0101208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979752	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400100
J	Kurita, M; Nishino, S; Numata, Y; Okubo, Y; Sato, T				Kurita, Masatake; Nishino, Satoshi; Numata, Yukio; Okubo, Yoshiro; Sato, Tadahiro			The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study	PLOS ONE			English	Article							PLASMA-CATECHOLAMINE METABOLITES; NEUROTROPHIC FACTOR; BRAIN; DEPRESSION; ANTIPSYCHOTICS; 3-METHOXY-4-HYDROXYPHENYLGLYCOL; RISPERIDONE; LIQUID; PHASE; SCALE	Remission is the primary goal of treatment for bipolar disorder I (BDI). Metabolites of noradrenaline and dopamine, 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA), respectively, are reduced by treatment with antipsychotics, but whether these phenomena are caused by antipsychotics or by the pathophysiology of BDI is not known. Interactions between brain-derived neurotrophic factor (BDNF) and mood disorders have also been suggested. We conducted a multifaceted study in BDI patients to ascertain if biological markers are associated with the manic state. Patients with Young Mania Rating Scale (YMRS) scores >20 participated in the study. Final analyses involved 24 BDI patients (13 men and 11 women). We used YMRS scores to identify mania stages in individual BDI patients (i.e., manic syndrome, response and remission stages). Statistical analyses were done using one-way repeated-measures analyses of variance (rep-ANOVA) throughout manic syndrome, response and remission stages. Plasma concentrations of MHPG and HVA were analyzed by high-performance liquid chromatography with electrochemical detection. Plasma levels of BDNF were measured by sandwich enzyme-linked immunosorbent assay. BDI patients had significantly reduced plasma levels of MHPG throughout manic syndrome, response and remission stages (rep-ANOVA, p = 0.002). Without a case of response state, there was a significant positive correlation between YMRS scores and plasma levels of MHPG (rho = 0.33, p = 0.033, n = 48). Plasma levels of HVA and BDNF were not significantly altered throughout manic syndrome, response and remission stages. These data suggest that the peripheral level of MHPG (which is associated with noradrenaline levels in the brain) could be used as a biomarker for the manic state in BDI. The MHPG level is likely to reflect the clinical characteristics of the manic syndrome in BDI, and noradrenaline may reflect the pathophysiology from manic to remission states.	[Kurita, Masatake; Nishino, Satoshi; Numata, Yukio; Sato, Tadahiro] Sato Hosp, Nanyo, Yamagata, Japan; [Kurita, Masatake; Nishino, Satoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, Sendai, Miyagi 980, Japan; [Kurita, Masatake; Okubo, Yoshiro] Nippon Med Sch, Grad Sch Med, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo 113, Japan	Tohoku University; Nippon Medical School	Kurita, M (corresponding author), Sato Hosp, 948-1 Kunugizuka, Nanyo, Yamagata, Japan.	kurita@koutoku.or.jp			Koutokukai, Sato Hospital	Koutokukai, Sato Hospital	This study was supported by funding from Koutokukai, Sato Hospital. The study did not receive funding from any pharmaceutical corporations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; AZORIN JM, 1990, ACTA PSYCHIAT SCAND, V81, P14, DOI 10.1111/j.1600-0447.1990.tb06442.x; BOWERS MB, 1989, BIOL PSYCHIAT, V25, P734, DOI 10.1016/0006-3223(89)90245-X; Calabrese JR, 2005, AM J PSYCHIAT, V162, P2152, DOI 10.1176/appi.ajp.162.11.2152; Choi SW, 2011, PSYCHIAT RES, V186, P427, DOI 10.1016/j.psychres.2010.07.028; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; GWIRTSMAN HE, 1989, AM J PSYCHIAT, V146, P1427; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015; Kastrup MC, 2007, DAN MED BULL, V54, P42; Koenigsberg HW, 2004, J PSYCHIATR RES, V38, P503, DOI 10.1016/j.jpsychires.2004.03.006; KUKOPULOS A, 1980, PHARMAKOPSYCH NEURO, V13, P156; Kurita M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039212; Macrithie K, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004052; Monteleone P, 2008, BIPOLAR DISORD, V10, P95, DOI 10.1111/j.1399-5618.2008.00459.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Piccinni A, 2008, CHRONOBIOL INT, V25, P819, DOI 10.1080/07420520802387773; Rosa AR, 2008, PSYCHOTHER PSYCHOSOM, V77, P390, DOI 10.1159/000151520; Rush AJ, 2003, J CLIN PSYCHIAT, V64, P4; SCHANBER.SM, 1968, BIOCHEM PHARMACOL, V17, P2006, DOI 10.1016/0006-2952(68)90119-6; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; Tohen M, 1999, AM J PSYCHIAT, V156, P702; Vieta E, 2005, BIPOLAR DISORD, V7, P21, DOI 10.1111/j.1399-5618.2005.00212.x; WHITE E, 1993, INT CLIN PSYCHOPHARM, V8, P119, DOI 10.1097/00004850-199300820-00007; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x; Yeung PKF, 1996, J PHARM SCI, V85, P451, DOI 10.1021/js950361q; Yildiz A, 2011, NEUROPSYCHOPHARMACOL, V36, P375, DOI 10.1038/npp.2010.192; Yoshimura R, 2005, HUM PSYCHOPHARM CLIN, V20, P243, DOI 10.1002/hup.685; Yoshimura R, 2006, HUM PSYCHOPHARM CLIN, V21, P433, DOI 10.1002/hup.804; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	30	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100634	10.1371/journal.pone.0100634	http://dx.doi.org/10.1371/journal.pone.0100634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971450	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200046
J	Osland, MJ; Day, RH; Larriviere, JC; From, AS				Osland, Michael J.; Day, Richard H.; Larriviere, Jack C.; From, Andrew S.			Aboveground Allometric Models for Freeze-Affected Black Mangroves (Avicennia germinans): Equations for a Climate Sensitive Mangrove-Marsh Ecotone	PLOS ONE			English	Article							GULF-OF-MEXICO; NITROGEN-CONTENT; PUERTO-RICO; FORESTS; BIOMASS; CARBON; EXPANSION; PRODUCTIVITY; VEGETATION; IMPACTS	Across the globe, species distributions are changing in response to climate change and land use change. In parts of the southeastern United States, climate change is expected to result in the poleward range expansion of black mangroves (Avicennia germinans) at the expense of some salt marsh vegetation. The morphology of A. germinans at its northern range limit is more shrub-like than in tropical climes in part due to the aboveground structural damage and vigorous multi-stem regrowth triggered by extreme winter temperatures. In this study, we developed aboveground allometric equations for freeze-affected black mangroves which can be used to quantify: (1) total aboveground biomass; (2) leaf biomass; (3) stem plus branch biomass; and (4) leaf area. Plant volume (i.e., a combination of crown area and plant height) was selected as the optimal predictor of the four response variables. We expect that our simple measurements and equations can be adapted for use in other mangrove ecosystems located in abiotic settings that result in mangrove individuals with dwarf or shrub-like morphologies including oligotrophic and arid environments. Many important ecological functions and services are affected by changes in coastal wetland plant community structure and productivity including carbon storage, nutrient cycling, coastal protection, recreation, fish and avian habitat, and ecosystem response to sea level rise and extreme climatic events. Coastal scientists in the southeastern United States can use the identified allometric equations, in combination with easily obtained and non-destructive plant volume measurements, to better quantify and monitor ecological change within the dynamic, climate sensitive, and highly-productive mangrove-marsh ecotone.	[Osland, Michael J.; Day, Richard H.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA; [Larriviere, Jack C.; From, Andrew S.] US Geol Survey, Rivers Serv LLC 5, Natl Wetlands Res Ctr, Lafayette, LA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Osland, MJ (corresponding author), US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA.	mosland@usgs.gov	Osland, Michael J./D-1814-2014	Osland, Michael J./0000-0001-9902-8692; Day, Richard/0000-0002-5959-7054; From, Andrew/0000-0002-6543-2627	Department of Interior Southeast Climate Science Center	Department of Interior Southeast Climate Science Center	This project was supported by the Department of Interior Southeast Climate Science Center (doi.gov/csc/southeast/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; Alleman LK, 2011, WETL ECOL MANAG, V19, P47, DOI 10.1007/s11273-010-9199-6; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Alongi DM, 2009, ENERGETICS MANGROVE; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BEAUCHAMP JJ, 1973, ECOLOGY, V54, P1403, DOI 10.2307/1934208; Bianchi TS, 2013, ESTUAR COAST SHELF S, V119, P7, DOI 10.1016/j.ecss.2012.12.007; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Castaneda-Moya E, 2013, FOREST ECOL MANAG, V307, P226, DOI 10.1016/j.foreco.2013.07.011; Caudill M.C., 2005, THESIS LOUISIANA STA; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chavez-Ramirez F, 2012, WETLANDS, V32, P11, DOI 10.1007/s13157-011-0250-z; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CINTRON G, 1978, BIOTROPICA, V10, P110, DOI 10.2307/2388013; Cintron G., 1984, MANGROVE ECOSYSTEM R, P91; Cleary MB, 2008, J ARID ENVIRON, V72, P285, DOI 10.1016/j.jaridenv.2007.07.013; Clough B. F., 1989, Forest Ecology and Management, V27, P117, DOI 10.1016/0378-1127(89)90034-0; Clough BF, 1997, AUST J BOT, V45, P1023, DOI 10.1071/BT96075; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; DAY JW, 1987, AQUAT BOT, V27, P267, DOI 10.1016/0304-3770(87)90046-5; Dayton P. K., 1972, P C CONSERVATION PRO, P81, DOI DOI 10.1007/S00442-010-1685-2; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Feagin RA, 2009, P NATL ACAD SCI USA, V106, P10109, DOI 10.1073/pnas.0901297106; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Fromard F, 1998, OECOLOGIA, V115, P39, DOI 10.1007/s004420050489; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Giri C, 2011, J COASTAL RES, V27, P1059, DOI 10.2112/JCOASTRES-D-11-00028.1; Henry KM, 2013, J COASTAL RES, V29, P1273, DOI 10.2112/JCOASTRES-D-12-00184.1; Jiang J, 2012, THEOR POPUL BIOL, V82, P29, DOI 10.1016/j.tpb.2012.02.007; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; Krauss KW, 2014, ECOHYDROLOGY, V7, P354, DOI 10.1002/eco.1353; Lewis DB, 2014, ESTUAR COAST SHELF S, V139, P11, DOI 10.1016/j.ecss.2013.12.032; Lovelock CE, 2006, PLANT CELL ENVIRON, V29, P793, DOI 10.1111/j.1365-3040.2005.01446.x; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Marani M, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001600; McClaran MP, 2013, J ARID ENVIRON, V88, P39, DOI 10.1016/j.jaridenv.2012.08.015; MCKEE K, 2012, GLOBAL CHANGE FUNCTI, P63, DOI DOI 10.1007/978-94-007-4494-3_2; Mckee KL, 2008, GLOBAL CHANGE BIOL, V14, P971, DOI 10.1111/j.1365-2486.2008.01547.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Michot T.C., 2010, NEWSLETTER LOUSIANA, P4; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; NEILSON RP, 1993, ECOL APPL, V3, P385, DOI 10.2307/1941907; Northup BK, 2005, J ARID ENVIRON, V62, P23, DOI 10.1016/j.jaridenv.2004.09.019; Odum W.E., 1982, ECOLOGY MANGROVES S; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Osland MJ, 2012, ECOSYSTEMS, V15, P848, DOI 10.1007/s10021-012-9551-1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parvaresh H., 2012, J BASIC APPL SCI RES, V2, P1763; Patterson CS., 1997, MANGROVES SALT MARSH, V1, P103, DOI 10.1023/A:1009923917812; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Pickens CN, 2011, ESTUAR COAST, V34, P824, DOI 10.1007/s12237-010-9358-2; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Ross Michael S., 2001, Wetlands Ecology and Management, V9, P27, DOI 10.1023/A:1008411103288; Ross MS, 2009, GLOBAL CHANGE BIOL, V15, P1817, DOI 10.1111/j.1365-2486.2009.01900.x; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Smith Thomas J. III, 2006, Wetlands Ecology and Management, V14, P409, DOI 10.1007/s11273-005-6243-z; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; URESK DW, 1977, J RANGE MANAGE, V30, P311, DOI 10.2307/3897313; West R. C., 1977, Wet coastal ecosystems., P193; WOODROFFE CD, 1985, ESTUAR COAST SHELF S, V20, P265, DOI 10.1016/0272-7714(85)90042-3; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	72	37	37	7	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99604	10.1371/journal.pone.0099604	http://dx.doi.org/10.1371/journal.pone.0099604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971938	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200011
J	Reece, P; Gauvreau, GM; Sehmi, R; Denburg, JA				Reece, Pia; Gauvreau, Gail M.; Sehmi, Roma; Denburg, Judah A.			IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation of Cord Blood CD34(+) Progenitor Cells	PLOS ONE			English	Article							CYTOKINE PRODUCTION; ALLERGEN CHALLENGE; PERIPHERAL-BLOOD; MATERNAL ALLERGY; PROTEIN-KINASE; ASTHMA; EXPRESSION; CHILDREN; INTERLEUKIN-13; RECEPTORS	Intrauterine environmental exposures have been shown to influence neonatal immunity and subsequent allergic disease development. We have previously shown that fewer lipopolysaccharide (LPS)-stimulated eosinophil-basophil (Eo/B) colonies grow from cord blood (CB) of high-atopic risk infants, compared to low-atopic risk infants. In the present study, we investigated whether a surrogate ex vivo T(H)2 milieu (i.e., either IL-4 or IL-13) could represent an underlying mechanism to explain our previous findings. CB CD34(+) cells from healthy donors were cultured with IL-4 or IL-13 (in combination with LPS) and assessed for Eo/B differentiation using methylcellulose cultures and flow cytometry for related intracellular signalling pathways. Pharmacological inhibitors were added to the methylcellulose cultures to determine the effect of blocking intracellular signalling in CB CD34(+) cells in relation to Eo/B colony forming unit (CFU) formation. Stimulation of CD34(+) cells with IL-4, but not IL-13, reduced Eo/B CFU formation in the presence of LPS; this was found to be dependent on IL-4R alpha and not IL-13R alpha 1. Additionally, IL-4 reduced the expression of ERK 1/2 after LPS stimulation, which was recovered by inhibition of IL-4R alpha. While IL-13 did not have an inhibitory effect on ERK 1/2 expression, inhibition of ERK 1/2 significantly reduced Eo/B CFU formation. Thus, the responsiveness of CB CD34(+) progenitor cells to LPS is differentially regulated by the T(H)2 cytokines, IL-4 and IL-13. This may have implications for in utero interactions between placental-derived pro-allergic cytokines and neonatal progenitor cells influencing Eo/B-mediated inflammatory responses in early life.	[Reece, Pia; Gauvreau, Gail M.; Denburg, Judah A.] McMaster Univ, Div Clin Immunol & Allergy, Hamilton, ON, Canada; [Sehmi, Roma] McMaster Univ, Firestone Inst Resp Hlth, Asthma Res Grp, Hamilton, ON, Canada	McMaster University; McMaster University	Denburg, JA (corresponding author), McMaster Univ, Div Clin Immunol & Allergy, Hamilton, ON, Canada.	denburg@mcmaster.ca			CIHR [MOP 111029]	CIHR(Canadian Institutes of Health Research (CIHR))	This work is supported by a grant from CIHR [MOP 111029]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Amoudruz P, 2005, J ALLERGY CLIN IMMUN, V115, P1304, DOI 10.1016/j.jaci.2005.02.036; Amoudruz P, 2009, CLIN EXP IMMUNOL, V155, P387, DOI 10.1111/j.1365-2249.2008.03792.x; BJORKSTEN B, 1995, INT ARCH ALLERGY IMM, V107, P34, DOI 10.1159/000236922; Brown M, 2004, HUM IMMUNOL, V65, P1336, DOI 10.1016/j.humimm.2004.08.176; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Denburg JA, 2005, PEDIATR RES, V57, P276, DOI 10.1203/01.PDR.0000148279.72611.1D; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Fernandes R, 2008, PEDIATR ALLERGY IMMU, V19, P239, DOI 10.1111/j.1399-3038.2007.00615.x; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Hinz D, 2010, CLIN EXP ALLERGY, V40, P419, DOI 10.1111/j.1365-2222.2009.03434.x; HUANG SK, 1995, J IMMUNOL, V155, P2688; Kajitani H, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000252; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; OCHIAI K, 1995, CLIN EXP IMMUNOL, V99, P124; Okoye IS, 2011, IMMUNOLOGY, V134, P368, DOI 10.1111/j.1365-2567.2011.03497.x; Oymar K, 2000, PEDIATR ALLERGY IMMU, V11, P220, DOI 10.1034/j.1399-3038.2000.00094.x; Prefontaine D, 2010, CLIN EXP ALLERGY, V40, P1648, DOI 10.1111/j.1365-2222.2010.03570.x; Prescott SL, 2010, P NUTR SOC, V69, P366, DOI 10.1017/S0029665110001874; Punia N, 2012, CLIN EXP ALLERGY, V42, P255, DOI 10.1111/j.1365-2222.2011.03889.x; Queto T, 2010, J LEUKOCYTE BIOL, V87, P885, DOI 10.1189/jlb.1108709; Radinger M, 2009, PHARMACOL THERAPEUT, V121, P174, DOI 10.1016/j.pharmthera.2008.10.008; Reece P, 2013, IMMUNOLOGY, V139, P256, DOI 10.1111/imm.12078; Reece P, 2011, J ALLERGY CLIN IMMUN, V127, P447, DOI 10.1016/j.jaci.2010.11.006; Robinson DS, 1999, AM J RESP CELL MOL, V20, P9, DOI 10.1165/ajrcmb.20.1.3449; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Saghafian-Hedengren S, 2008, CLIN EXP ALLERGY, V38, P449, DOI 10.1111/j.1365-2222.2007.02917.x; Schaub B, 2009, J ALLERGY CLIN IMMUN, V123, P774; Upham JW, 1999, J ALLERGY CLIN IMMUN, V104, P370, DOI 10.1016/S0091-6749(99)70381-7; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; Wedi B, 1998, J ALLERGY CLIN IMMUN, V102, P1013, DOI 10.1016/S0091-6749(98)70340-9; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	37	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100734	10.1371/journal.pone.0100734	http://dx.doi.org/10.1371/journal.pone.0100734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971469	gold, Green Submitted, Green Published			2022-12-25	WOS:000338512200054
J	Wang, Q; Yuan, XZ; Willison, JHM; Zhang, YW; Liu, H				Wang, Qiang; Yuan, Xingzhong; Willison, J. H. Martin; Zhang, Yuewei; Liu, Hong			Diversity and Above-Ground Biomass Patterns of Vascular Flora Induced by Flooding in the Drawdown Area of China's Three Gorges Reservoir	PLOS ONE			English	Article							RIVER-MARGIN VEGETATION; RIPARIAN VEGETATION; DAM; CONSERVATION; TOLERANCE; RESPONSES; SURVIVAL; IMPACTS; TIME	Hydrological alternation can dramatically influence riparian environments and shape riparian vegetation zonation. However, it was difficult to predict the status in the drawdown area of the Three Gorges Reservoir (TGR), because the hydrological regime created by the dam involves both short periods of summer flooding and long-term winter impoundment for half a year. In order to examine the effects of hydrological alternation on plant diversity and biomass in the drawdown area of TGR, twelve sites distributed along the length of the drawdown area of TGR were chosen to explore the lateral pattern of plant diversity and above-ground biomass at the ends of growing seasons in 2009 and 2010. We recorded 175 vascular plant species in 2009 and 127 in 2010, indicating that a significant loss of vascular flora in the drawdown area of TGR resulted from the new hydrological regimes. Cynodon dactylon and Cyperus rotundus had high tolerance to short periods of summer flooding and long-term winter flooding. Almost half of the remnant species were annuals. Species richness, Shannon-Wiener Index and above-ground biomass of vegetation exhibited an increasing pattern along the elevation gradient, being greater at higher elevations subjected to lower submergence stress. Plant diversity, above-ground biomass and species distribution were significantly influenced by the duration of submergence relative to elevation in both summer and previous winter. Several million tonnes of vegetation would be accumulated on the drawdown area of TGR in every summer and some adverse environmental problems may be introduced when it was submerged in winter. We conclude that vascular flora biodiversity in the drawdown area of TGR has dramatically declined after the impoundment to full capacity. The new hydrological condition, characterized by long-term winter flooding and short periods of summer flooding, determined vegetation biodiversity and above-ground biomass patterns along the elevation gradient in the drawdown area.	[Wang, Qiang] Southwest Univ, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Wang, Qiang; Yuan, Xingzhong; Zhang, Yuewei; Liu, Hong] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China; [Yuan, Xingzhong; Zhang, Yuewei; Liu, Hong] Chongqing Univ, Coll Resources & Environm Sci, Chongqing 630044, Peoples R China; [Yuan, Xingzhong] Chongqing Univ, Coll Architecture & Urban Planning, Chongqing 630044, Peoples R China; [Willison, J. H. Martin] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada	Southwest University - China; Chongqing University; Chongqing University; Chongqing University; Dalhousie University	Wang, Q (corresponding author), Southwest Univ, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.	wang1984china@gmail.com; 1072000659@qq.com		Willison, J.H. Martin/0000-0003-3024-296X	National Natural Science Foundation of China [51179214]; China Postdoctoral Science Foundation [2014M552296]; National Science & Technology Major Project [2013ZX07104-004-05]; Natural Science Foundation Project of China SWU [SWU112049]; Fundamental Research Funds for the Central Universities [XDJK2013C127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science & Technology Major Project; Natural Science Foundation Project of China SWU(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financed by the National Natural Science Foundation of China (51179214), China Postdoctoral Science Foundation (2014M552296), National Science & Technology Major Project (2013ZX07104-004-05), the Natural Science Foundation Project of China SWU (SWU112049) and the Fundamental Research Funds for the Central Universities (XDJK2013C127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts HC, 2004, SYST RES BEHAV SCI, V21, P585, DOI 10.1002/sres.604; Ali MM, 2003, LIMNOLOGICA, V33, P305, DOI 10.1016/S0075-9511(03)80025-7; [Anonymous], ILLUSTRATED SPECIES; Auble GT, 2007, ENVIRON MANAGE, V39, P806, DOI 10.1007/s00267-006-0018-z; [白宝伟 BAI Baowei], 2005, [西南农业大学学报, Journal of Southwest Agricultural University], V27, P684; Banach K, 2009, ANN BOT-LONDON, V103, P341, DOI 10.1093/aob/mcn183; Bao Da-Chuan, 2010, Wuhan Zhiwuxue Yanjiu, V28, P711, DOI 10.3724/SP.J.1142.2010.60711; Batalha MA, 2002, FLORA, V197, P452, DOI 10.1078/0367-2530-00062; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Changming Zhao, 2007, Shengwu Duoyangxing, V15, P510, DOI 10.1360/biodiv.070084; [程瑞梅 CHENG Rui-mei], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P156; Cheng WL, 2008, PLANTS VEGETATION VA; Ellender ER, 2009, THESIS RHODES U LAKE; Elstad S, 2001, CHEM PHYSICAL PROPER; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Guo QuanShui, 2013, Scientia Silvae Sinicae, V49, P1; Jansson R, 2000, ECOL APPL, V10, P203; [贾中民 JIA Zhong-min], 2009, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V31, P124; Koutecky Petr, 2005, Ecohydrology & Hydrobiology, V5, P33; Li Y, 2010, ACTA ECOLOGICA SINIC, V28, P1923; [梁福庆 LIANG FuQing], 2008, [湿地科学, Wetland Science], V6, P326; [刘维暐 Liu Weiwei], 2012, [生态学报, Acta Ecologica Sinica], V32, P5454; Liu X, 2008, RESOURCES ENV YANGTZ, V17, P60; [罗芳丽 LUO FangLi], 2008, [生态学报, Acta Ecologica Sinica], V28, P1964; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; NILSSON C, 1988, CAN J FISH AQUAT SCI, V45, P1896, DOI 10.1139/f88-221; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Sophocleous Marios., 2004, NAT RESOUR RES, V13, P61, DOI [DOI 10.1007/978-0-387-21706-2, 10.1023/B:NARR.0000032644.16734.f5]; Stokes KE, 2008, PLANT ECOL, V197, P91, DOI 10.1007/s11258-007-9363-0; Strom L, 2011, GLOBAL CHANGE BIOL, V17, P254, DOI 10.1111/j.1365-2486.2010.02230.x; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Tan Shu-Duan, 2009, Wuhan Zhiwuxue Yanjiu, V27, P391; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thomaz SM, 2006, HYDROBIOLOGIA, V570, P53, DOI 10.1007/s10750-006-0161-9; Tian ZQ, 2007, ACTA ECOLOGICA SINIC, V28, P3110; USDI-U.S. Departmentof the Interior, 2013, LAK MEAD HOOV DAM EL; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vervuren PJA, 2003, J ECOL, V91, P135, DOI 10.1046/j.1365-2745.2003.00749.x; [王建超 WANG Jianchao], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P603; Wang Q, 2012, POL J ECOL, V60, P95; [王晓荣 Wang Xiaorong], 2010, [生态学报, Acta Ecologica Sinica], V30, P5821; Wang Yong, 2006, Wuhan Zhiwuxue Yanjiu, V24, P574; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Water-data Web, 2013, LAK POW WAT DAIL WAT; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Yang F., 2012, ACTA ECOLOGICA SINIC, V32, P89, DOI [10.1016/j.chnaes.2012.02.004, DOI 10.1016/J.CHNAES.2012.02.004]; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; [张虹 ZHANG Hong], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P46; Zhang JianJun, 2012, Scientia Silvae Sinicae, V48, P154; Zhenli H., 2001, BIODIVERS SCI, V9, P472, DOI [DOI 10.3321/J.ISSN:1005-0094.2001.04.021, 10.17520/biods.2001068, DOI 10.17520/BIODS.2001068]	53	23	30	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100889	10.1371/journal.pone.0100889	http://dx.doi.org/10.1371/journal.pone.0100889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971514	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200071
J	Alcalde, M; Campuzano, O; Berne, P; Garcia-Pavia, P; Doltra, A; Arbelo, E; Sarquella-Brugada, G; Iglesias, A; Alonso-Pulpon, L; Brugada, J; Brugada, R				Alcalde, Mireia; Campuzano, Oscar; Berne, Paola; Garcia-Pavia, Pablo; Doltra, Ada; Arbelo, Elena; Sarquella-Brugada, Georgia; Iglesias, Anna; Alonso-Pulpon, Luis; Brugada, Josep; Brugada, Ramon			Stop-Gain Mutations in PKP2 Are Associated with a Later Age of Onset of Arrhythmogenic Right Ventricular Cardiomyopathy	PLOS ONE			English	Article							DYSPLASIA/CARDIOMYOPATHY; PLAKOPHILIN-2; DISEASE; PHENOTYPE; DESMOSOME; FAMILY; DIAGNOSIS; INSIGHTS; TITIN; GENE	Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiac disease characterized by the presence of fibrofatty replacement of the right ventricular myocardium, which may cause ventricular arrhythmias and sudden cardiac death. Pathogenic mutations in several genes encoding mainly desmosomal proteins have been reported. Our aim is to perform genotype-phenotype correlations to establish the diagnostic value of genetics and to assess the role of mutation type in age-related penetrance in ARVC. Methods and Results: Thirty unrelated Spanish patients underwent a complete clinical evaluation. They all were screened for PKP2, DSG2, DSC2, DSP, JUP and TMEM43 genes. A total of 70 relatives of four families were also studied. The 30 patients fulfilled definite disease diagnostic criteria. Genetic analysis revealed a pathogenic mutation in 19 patients ( 13 in PKP2, 3 in DSG2, 2 in DSP, and 1 in DSC2). Nine of these mutations created a truncated protein due to the generation of a stop codon. Familial assessment revealed 28 genetic carriers among family members. Stop-gain mutations were associated to a later age of onset of ARVC, without differences in the severity of the pathology. Conclusions: Familial genetic analysis helps to identify the cause responsible for the pathology. In discrepancy with previous studies, the presence of a truncating protein does not confer a worse severity. This information could suggest that truncating proteins may be compensated by the normal allele and that missense mutations may act as poison peptides.	[Alcalde, Mireia; Campuzano, Oscar; Iglesias, Anna; Brugada, Ramon] Univ Girona IDIBGI, Cardiovasc Genet Ctr, Girona, Spain; [Berne, Paola; Doltra, Ada; Arbelo, Elena; Brugada, Josep] Hosp Clin Barcelona, Thorax Inst, Arrhythmia Sect, Barcelona, Spain; [Garcia-Pavia, Pablo; Alonso-Pulpon, Luis] Hosp Univ Puerta Hierro, Dept Cardiol, Heart Failure & Heart Transplant Sect, Cardiomyopathy Unit, Madrid, Spain; [Sarquella-Brugada, Georgia] Hosp St Joan de Deu, Arrhythmia Sect, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Barcelona; Hospital Clinic de Barcelona; Hospital Puerta de Hierro-Majadahonda; University of Barcelona	Brugada, R (corresponding author), Univ Girona IDIBGI, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@gencardio.com	Alcalde, Mireia/AAB-1499-2019; Arbelo, Elena/GRS-2793-2022; Arbelo, Elena/GMX-0351-2022; Garcia-Pavia, Pablo/T-9100-2019; campuzano, oscar/J-1968-2014; Berne, Paola/HHM-4858-2022; Sarquella-Brugada, Georgia/W-9278-2018	Alcalde, Mireia/0000-0002-7222-0913; campuzano, oscar/0000-0001-5298-5276; Sarquella-Brugada, Georgia/0000-0002-6857-8904; Berne, Paola/0000-0003-1160-4064; ARBELO, ELENA/0000-0003-0424-6393; BRUGADA, JOSEP/0000-0002-5662-8302	CNIC [CNIC-03-2008]; Obra Social "la Caixa,''Fondo de Investigacion Sanitaria [PI11/00019]; RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III)	CNIC; Obra Social "la Caixa,''Fondo de Investigacion Sanitaria; RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III)	This work was supported by CNIC-Translational 2008 (CNIC-03-2008), Obra Social "la Caixa,''Fondo de Investigacion Sanitaria (PI11/00019), and RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aad G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.272002; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andreasen C, 2013, EUR J HUM GENET; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Barahona-Dussault C, CLIN GENET, V77, P37; Campuzano O, 2013, J MED GENET, V50, P280, DOI 10.1136/jmedgenet-2013-101523; Christensen AH, 2010, CARDIOLOGY, V115, P148, DOI 10.1159/000263456; Corrado D, 2000, CIRCULATION, V101, pE101, DOI 10.1161/01.CIR.101.11.e101; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Dalal D, 2006, J AM COLL CARDIOL, V48, P1416, DOI 10.1016/j.jacc.2006.06.045; ExomeVariantServer. NHLBI Exome Sequencing Project (ESP) S WA, 2012, EX VARIANTSERVER; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Joshi-Mukherjee R, 2008, HEART RHYTHM, V5, P1715, DOI 10.1016/j.hrthm.2008.09.009; Kannankeril PJ, 2006, HEART RHYTHM, V3, P939, DOI 10.1016/j.hrthm.2006.04.028; Li Mura IE, 2013, EUR J HUM GENET; Lombardi R, 2010, CURR OPIN CARDIOL, V25, P222, DOI 10.1097/HCO.0b013e3283376daf; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Marcus FI, 2009, HEART RHYTHM, V6, P984, DOI 10.1016/j.hrthm.2009.03.013; Nakajima T, 2012, CIRC J, V76, P737, DOI 10.1253/circj.CJ-11-0927; Pedra SRFF, 2005, PEDIATR CARDIOL, V26, P543, DOI 10.1007/s00246-004-0688-3; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Rampazzo A, 2006, HEART INT, V2, P17, DOI 10.4081/hi.2006.17; Rasmussen TB, 2013, HUM MUTAT, V34, P697, DOI 10.1002/humu.22289; Roberts JD, 2013, CLIN GENET, V83, P452, DOI 10.1111/j.1399-0004.2012.01950.x; Saffitz JE, 2009, J INVEST MED, V57, P861, DOI 10.2310/JIM.0b013e3181c5e631; Sato T, 2011, LEGAL MED-TOKYO, V13, P298, DOI 10.1016/j.legalmed.2011.08.004; Sen-Chowdhry S, 2007, J AM COLL CARDIOL, V50, P1813, DOI 10.1016/j.jacc.2007.08.008; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	37	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100560	10.1371/journal.pone.0100560	http://dx.doi.org/10.1371/journal.pone.0100560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967631	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800045
J	Camilli, R; Spencer, BL; Moschioni, M; Pinto, V; Berti, F; Nahm, MH; Pantosti, A				Camilli, Romina; Spencer, Brady L.; Moschioni, Monica; Pinto, Vittoria; Berti, Francesco; Nahm, Moon H.; Pantosti, Annalisa			Identification of Streptococcus pneumoniae Serotype 11E, Serovariant 11Av and Mixed Populations by High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Flow Cytometric Serotyping Assay (FCSA)	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; DISCOVERY; CARRIAGE; STRAINS	Background: Recent studies have identified Streptococcus pneumoniae serotype 11E and serovariant 11Av among isolates previously typed as 11A by classical serotyping methods. Serotype 11E and serovariant 11Av differ from serotype 11A by having totally or partially inactive wcjE, a gene in cps locus coding for an O-acetyl transferase. Serotype 11E is rare among carriage isolates but common among invasive isolates suggesting that it survives better during invasion. Aim of this work was to investigate the epidemiology of serotype 11A in a pneumococcal collection using a new serotyping approach based on High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) spectroscopy to distinguish serotypes 11A and 11E. Methods: A collection of 48 (34 invasive and 14 carriage) S. pneumoniae isolates from Italy, previously identified as serotype 11A by the Quellung reaction, were investigated by wcjE sequencing, HR-MAS NMR spectroscopy and the reference flow cytometric serotyping assay (FCSA) based on monoclonal antibodies. Results: HR-MAS NMR spectra from serotypes 11A and 11E showed different NMR peaks indicating that HR-MAS NMR could be used to distinguish these serotypes, although HR-MAS NMR could not distinguish serotype 11Av from serotype 11E unambiguously. Thirty-eight isolates were confirmed to be serotype 11A, 8 isolates with a mutated wcjE were serotype 11E, 1 isolate belonged to serovariant 11Av, and 1 isolate was a mixed population 11A/11Av. All 11E isolates were identified among invasive isolates. Conclusions: We proved that HR-MAS NMR can be of potential use for pneumococcal serotyping. The detection of serotype 11E among invasive isolates in our collection, supports previous epidemiological studies suggesting that mutations in wcjE can represent a mechanism promoting pneumococcal survival during invasion. The discovery of a spectrum of immunochemical diversity within established serotypes should stimulate efforts to develop new serotyping approaches.	[Camilli, Romina; Pantosti, Annalisa] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Spencer, Brady L.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Moschioni, Monica; Pinto, Vittoria; Berti, Francesco] Novartis Vaccines & Diagnost, Siena, Italy; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Alabama System; University of Alabama Birmingham; Novartis; University of Alabama System; University of Alabama Birmingham	Pantosti, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	annalisa.pantosti@iss.it	CAMILLI, ROMINA/C-8811-2016; Pantosti, Annalisa/A-7291-2013	CAMILLI, ROMINA/0000-0003-1309-5670; Pantosti, Annalisa/0000-0002-8409-4731; Spencer, Brady/0000-0003-4374-6403; Nahm, Moon/0000-0002-6922-1042	Italian Ministry of Health, CCM	Italian Ministry of Health, CCM(Ministry of Health, Italy)	This study was funded in part by a grant from the Italian Ministry of Health, CCM 2009, project "Surveillance of invasive bacterial diseases due to Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae'' (www.ccm-network.it/home.html) given to Istituto Superiore di Sanita' (ISS) that only supported the experiments performed at ISS, while experiments performed at the University of Alabama at Birmingham (UAB) or Novartis were funded by their respective Institution or Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Camilli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-25; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; LUND E, 1960, Bull World Health Organ, V23, P5; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Oliver MB, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.488528; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Richter SS, 2009, CLIN INFECT DIS, V48, pE23, DOI 10.1086/595857; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; VANN WF, 1983, INFECT IMMUN, V39, P623, DOI 10.1128/IAI.39.2.623-629.1983; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0; Zartler ER, 2009, J BIOL CHEM, V284, P7318, DOI 10.1074/jbc.M807952200	25	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100722	10.1371/journal.pone.0100722	http://dx.doi.org/10.1371/journal.pone.0100722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967818	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800057
J	Zhang, JB; Zhuang, PW; Wang, Y; Song, LL; Zhang, MX; Lu, ZQ; Zhang, L; Wang, J; Alemu, PN; Zhang, YJ; Wei, HJ; Li, HY				Zhang, Jinbao; Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Lu, Zhiqiang; Zhang, Lu; Wang, Jing; Alemu, Paulos N.; Zhang, Yanjun; Wei, Hongjun; Li, Hongyan			Reversal of Muscle Atrophy by Zhimu-Huangbai Herb-Pair via Akt/mTOR/FoxO3 Signal Pathway in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; KINASE-B; HYPERTROPHY; ACTIVATION; EXPRESSION; ABLATION	Skeletal muscle atrophy is one of the serious complications of diabetes. Zhimu-Huangbai herb-pair (ZB) is widely used in Chinese traditional medicine formulas for treating Xiaoke (known as diabetes) and its complications. However, the effect of ZB on reversal of muscle atrophy and the underlying mechanisms remain unknown. In this research, we investigated the effect and possible mechanisms of ZB on skeletal muscle atrophy in diabetic mice. Animal model of diabetic muscle atrophy was developed by high fat diet (HFD) feeding plus streptozotocin (STZ) injection. After oral adminstration of ZB for 6 weeks, the effects of ZB on reversal of muscle atrophy and the underlying mechanisms were evaluated by biochemical, histological and western blot methods. The skeletal muscle weight, strength, and cross-sectional area of diabetic mice were significantly increased by ZB treatment. Biochemical results showed that ZB treatment reduced the serum glucose level, and elevated the serum insulin-like growth factor 1 (IGF-1) and insulin levels significantly compared with untreated diabetic group. The western blot results showed that ZB activated the mTOR signal pathway, shown as increased phosphorylations (p-) of Akt, mTOR, Raptor, S6K1 and reduced Foxo3 expression compared with the model group. ZB could reverse muscle atrophy in diabetic mice. This may be through activation of mTOR signaling pathway that promotes protein synthesis, and inactivation foxo3 protein that inhibits protein degradation. These findings suggested that ZB may be considered as a potential candidate drug in treatment of diabetic muscle atrophy.	[Zhang, Jinbao; Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Lu, Zhiqiang; Zhang, Lu; Wang, Jing; Alemu, Paulos N.; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Tianjin, Peoples R China; [Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhuang, Pengwei; Wei, Hongjun; Li, Hongyan] Tianjin JF Pharmaland Technol Dev Co Ltd, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Zhang, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Tianjin, Peoples R China.	zyjsunye@163.com	Zhang, Lu/GLU-9890-2022		National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' [2012ZX09101202]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program''	This work was supported by the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' (2012ZX09101202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke OAJ, 2012, APPL PHYSIOL NUTR ME, V37, P395, DOI [10.1139/h2012-009, 10.1139/H2012-009]; Bassil MS, 2013, CURR OPIN CLIN NUTR, V16, P83, DOI 10.1097/MCO.0b013e32835a88ee; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Hill AJ, 2012, BRIT J PHARMACOL, V167, P1629, DOI 10.1111/j.1476-5381.2012.02207.x; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lambertucci AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050390; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Liu YW, 2012, J ETHNOPHARMACOL, V139, P194, DOI 10.1016/j.jep.2011.11.004; Ma CH, 2008, BIOMED CHROMATOGR, V22, P835, DOI 10.1002/bmc.1000; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Tang YH, 2012, PLANTA MED, V78, P18, DOI 10.1055/s-0031-1280268; Tong XL, 2012, AM J CHINESE MED, V40, P877, DOI 10.1142/S0192415X12500656; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Workeneh B, 2013, INT J BIOCHEM CELL B, V45, P2239, DOI 10.1016/j.biocel.2013.06.028; Wu MZ, 2011, J CELL PHYSIOL, V226, P29, DOI 10.1002/jcp.22353; Wu Y, 2012, BRIT J PHARMACOL, V165, P1319, DOI 10.1111/j.1476-5381.2011.01572.x; Xie WD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/726723; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042529; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zhuang PW, 2013, CNS NEUROSCI THER, V19, P154, DOI 10.1111/cns.12050; Zhuang PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035636	58	27	31	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100918	10.1371/journal.pone.0100918	http://dx.doi.org/10.1371/journal.pone.0100918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968071	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800080
J	Zhang, HF; An, D; Liu, W; Mao, QY; Jin, J; Xu, L; Sun, SY; Jiang, LP; Li, XJ; Shao, J; Ma, HX; Huang, XY; Guo, SJ; Chen, HY; Cheng, T; Yang, LS; Su, WH; Kong, W; Liang, ZL; Jiang, CL				Zhang, Huafei; An, Dong; Liu, Wei; Mao, Qunying; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Shao, Jie; Ma, Hongxia; Huang, Xueyong; Guo, Shijie; Chen, Haiying; Cheng, Tong; Yang, Lisheng; Su, Weiheng; Kong, Wei; Liang, Zhenglun; Jiang, Chunlai			Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; ASIA-PACIFIC REGION; COXSACKIEVIRUS A16; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; GENETIC-CHARACTERISTICS; DOUBLE-BLIND; VACCINE; STRAINS; HAND	Hand, foot and mouth disease, associated with enterovirus 71 (EV71) infections, has recently become an important public health issue throughout the world. Serum neutralizing antibodies are major indicators of EV71 infection and protective immunity. However, the potential for cross-reactivity of neutralizing antibodies for different EV71 genotypes and subgenotypes is unclear. Here we measured the cross-reactive neutralizing antibody titers against EV71 of different genotypes or subgenotypes in sera collected from EV71-infected children and vaccine-inoculated children in a phase III clinical trial (ClinicalTrials.gov Identifier: NCT01636245) using a new pseudovirus-based neutralization assay. Antibodies induced by EV71-C4a were cross-reactive for different EV71 genotypes, demonstrating that C4a is a good candidate strain for an EV71 vaccine. Our study also demonstrated that this new assay is practical for analyses of clinical samples from epidemiological and vaccine studies.	[Zhang, Huafei; An, Dong; Liu, Wei; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Zhang, Huafei; An, Dong; Liu, Wei; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Mao, Qunying; Shao, Jie; Liang, Zhenglun] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Ma, Hongxia; Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Guo, Shijie; Chen, Haiying] Jilin Univ, Dept Pediat, Hosp 1, Changchun 130023, Peoples R China; [Cheng, Tong; Yang, Lisheng] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen, Peoples R China; [Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University; National Institute of Food & Drug Control - China; Jilin University; Xiamen University; Jilin University	Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	lzhenglun@126.com; jiangcl@jlu.edu.cn	An, Dong/ABB-6635-2021	An, Dong/0000-0002-7770-2284; Cheng, Tong/0000-0002-1638-6214	Ministry of Science and Technology of the People's Republic of China [2012ZX10001009]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The current study was sponsored by the National 12th Five Major Special Projects Funding Program (No. 2012ZX10001009) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Hancil J, 1985, Cesk Pediatr, V40, P731; Hu YM, 2013, CLIN VACCINE IMMUNOL, V20, P1805, DOI 10.1128/CVI.00491-13; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jin J, 2013, J VIROL METHODS, V187, P362, DOI 10.1016/j.jviromet.2012.11.014; Jun Jin LX, 2012, CHEM RES CHINESE U, V28, P91; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li XJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-250; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McCutchan FE, 2000, AIDS RES HUM RETROV, V16, P801, DOI 10.1089/088922200308792; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; MIWA C, 1980, JPN J MED SCI BIOL, V33, P167, DOI 10.7883/yoken1952.33.167; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Nie JH, 2012, J VIROL METHODS, V185, P267, DOI 10.1016/j.jviromet.2012.07.011; Sanders SA, 2006, ARCH VIROL, V151, P1003, DOI 10.1007/s00705-005-0684-9; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Teng Zheng, 2010, Chinese Journal of Virology, V26, P437; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Vicat JM, 1998, NAT BIOTECHNOL, V16, P702, DOI 10.1038/nbt0898-702b; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wu JS, 2013, J VIROL METHODS, V193, P713, DOI 10.1016/j.jviromet.2013.07.051; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064116; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	49	24	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100545	10.1371/journal.pone.0100545	http://dx.doi.org/10.1371/journal.pone.0100545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964084	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500060
J	Grosso, H; Woo, JM; Lee, KW; Im, JY; Masliah, E; Junn, E; Mouradian, MM				Grosso, Hilary; Woo, Jong-Min; Lee, Kang-Woo; Im, Joo-Young; Masliah, Eliezer; Junn, Eunsung; Mouradian, M. Maral			Transglutaminase 2 exacerbates alpha-synuclein toxicity in mice and yeast	FASEB JOURNAL			English	Article						Parkinson's disease; protein misfolding; neurodegeneration	TISSUE TRANSGLUTAMINASE; PARKINSONS-DISEASE; MOUSE MODEL; MEMBRANE INTERACTIONS; CROSS-LINKING; INHIBITION; NEURON; ACCUMULATION; AGGREGATION; MECHANISMS	alpha-Synuclein is a key pathogenic protein that aggregates in hallmark lesions in Parkinson's disease and other alpha-synucleinopathies. Prior in vitro studies demonstrated that it is a substrate for cross-linking by transglutaminase 2 (TG2) into higher-order species. Here we investigated whether this increased aggregation occurs in vivo and whether TG2 exacerbates alpha-synuclein toxicity in Mus musculus and Saccharomyces cerevisiae. Compared with alpha-synuclein transgenic (Syn(Tg)) mice, animals double transgenic for human alpha-synuclein and TG2 (TG2(Tg)/Syn(Tg)) manifested greater high-molecular-weight insoluble species of alpha-synuclein in brain lysates and developed alpha-synuclein aggregates in the synaptic vesicle fraction. In addition, larger proteinase K-resistant aggregates developed, along with increased thioflavin-S-positive amyloid fibrils. This correlated with an exaggerated neuroinflammatory response, as seen with more astrocytes and microglia. Further neuronal damage was suggested by greater morphological disruption of nerve fibers and a trend toward decreased c-Fos immunoreactive neurons. Finally, the performance of TG2(Tg)/Syn(Tg) animals on motor behavioral tasks was worse relative to Syn(Tg) mice. Greater toxicity of alpha-synuclein was also demonstrated in yeast cells coexpressing TG2. Our findings demonstrate that TG2 promotes the aggregation of alpha-synuclein in vivo and that this is associated with aggravated toxicity of alpha-synuclein and its downstream neuropathologic consequences.	[Grosso, Hilary; Woo, Jong-Min; Lee, Kang-Woo; Im, Joo-Young; Junn, Eunsung; Mouradian, M. Maral] Rutgers RWJMS, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego	Mouradian, MM (corresponding author), Rutgers RWJMS, 683 Hoes Ln West,Rm 180, Piscataway, NJ 08854 USA.	m.mouradian@rutgers.edu	Grosso Jasuktar, Hilary/AGX-7358-2022	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Lipton, Stuart/0000-0002-3490-1259; Mouradian, M. Maral/0000-0002-9937-412X	U.S. National Institutes of Health (NIH) [AG-18440, AG-022074, NS-070898, NS-059869, NS-073994, AT-006868]; National Center for Complementary & Integrative Health [R01AT006868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070898, R01NS073994, P30NS076411, R01NS059869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, P50AG005131, P01AG022074, R37AG018440] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	E.M. is supported by U.S. National Institutes of Health (NIH) grants AG-18440 and AG-022074. E.J. is supported by NIH grant NS-070898. M.M.M. is the William Dow Lovett Professor of Neurology and is supported by NIH grants NS-059869, NS-073994, and AT-006868. The authors thank Dr. Gail V. Johnson (University of Rochester, Rochester, NY, USA) for providing TG2<SUP>Tg</SUP> mice, and Dr. Takeshi Iwatsubo (University of Tokyo, Tokyo, Japan) for p-alpha-synuclein antibody. The authors declare no conflicts of interest.	Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Campisi A, 2004, FEBS LETT, V578, P80, DOI 10.1016/j.febslet.2004.10.074; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Grosso H, 2012, PHARMACOL THERAPEUT, V133, P392, DOI 10.1016/j.pharmthera.2011.12.003; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Iwata M, 2005, NEUROSCI LETT, V386, P145, DOI 10.1016/j.neulet.2005.06.004; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; KANO T, 1995, NEUROREPORT, V6, P2197, DOI 10.1097/00001756-199511000-00023; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Koob AO, 2010, EXP NEUROL, V221, P267, DOI 10.1016/j.expneurol.2009.11.015; Kurz A, 2012, J NEURAL TRANSM, V119, P297, DOI 10.1007/s00702-011-0717-3; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Przedborski S, 2010, MOVEMENT DISORD, V25, pS55, DOI 10.1002/mds.22638; Quinn L, 2008, BRIT J PHARMACOL, V154, P226, DOI 10.1038/bjp.2008.78; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Tucholski J, 2006, J NEUROCHEM, V97, P582, DOI 10.1111/j.1471-4159.2006.03780.x; Vermes I, 2004, MOVEMENT DISORD, V19, P1252, DOI 10.1002/mds.20197; Wilhelmus MMM, 2011, BRAIN PATHOL, V21, P130, DOI 10.1111/j.1750-3639.2010.00429.x; Zhang X, 2007, NEUROSCIENCE, V150, P950, DOI 10.1016/j.neuroscience.2007.09.059	55	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4280	4291		10.1096/fj.14-251413	http://dx.doi.org/10.1096/fj.14-251413			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970392	Green Published			2022-12-25	WOS:000342222700008
J	Zhang, S; Zis, O; Ly, PTT; Wu, YL; Zhang, ST; Zhang, MM; Cai, F; Bucala, R; Shyu, WC; Song, WH				Zhang, Si; Zis, Odysseus; Ly, Philip T. T.; Wu, Yili; Zhang, Shuting; Zhang, Mingming; Cai, Fang; Bucala, Richard; Shyu, Woei-Cherng; Song, Weihong			Down-regulation of MIF by NF kappa B under hypoxia accelerated neuronal loss during stroke	FASEB JOURNAL			English	Article						macrophage migration inhibitory factor; caspase-3; nuclear factor kappa B	MIGRATION-INHIBITORY FACTOR; BINDING PROTEIN CREB; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ALZHEIMERS-DISEASE; CELL-DEATH; MACROPHAGE; CYTOKINE; GENE; ACTIVATION	Neuronal apoptosis is one of the major causes of poststroke neurological deficits. Inflammation during the acute phase of stroke results in nuclear translocation of NF kappa B in affected cells in the infarct area. Macrophage migration inhibitory factor (MIF) promotes cardiomyocyte survival in mice following heart ischemia. However, the role of MIF during stroke remains limited. In this study, we showed that MIF expression is down-regulated by 0.75 +/- 0.10-fold of the control in the infarct area in the mouse brains. Two functional cis-acing NF kappa B response elements were identified in the human MIF promoter. Dual activation of hypoxia and NF kappa B signaling resulted in significant reduction of MIF promoter activity to 0.86 +/- 0.01-fold of the control. Furthermore, MIF reduced caspase-3 activation and protected neurons from oxidative stress- and in vitro ischemia/reperfusion-induced apoptosis. H2O2 significantly induced cell death with 12.81 +/- 0.58-fold increase of TUNEL-positive cells, and overexpression of MIF blocked the H2O2-induced cell death. Disruption of the MIF gene in MIF-knockout mice resulted in caspase-3 activation, neuronal loss, and increased infarct development during stroke in vivo. The infarct volume was increased from 6.51 +/- 0.74% in the wild-type mice to 9.07 +/- 0.66% in the MIF-knockout mice. Our study demonstrates that MIF exerts a neuronal protective effect and that down-regulation of MIF by NF kappa B-mediated signaling under hypoxia accelerates neuronal loss during stroke. Our results suggest that MIF is an important molecule for preserving a longer time window for stroke treatment, and strategies to maintain MIF expression at physiological level could have beneficial effects for stroke patients.-Zhang, S., Zis, O., Ly, P. T. T., Wu, Y., Zhang, S., Zhang, M., Cai, F., Bucala, R., Shyu, W.-C., Song, W. Down-regulation of MIF by NF kappa B under hypoxia accelerated neuronal loss during stroke.	[Zhang, Si; Zis, Odysseus; Ly, Philip T. T.; Wu, Yili; Zhang, Shuting; Zhang, Mingming; Cai, Fang; Song, Weihong] Univ British Columbia, Dept Psychiat, Grad Program Neurosci, Townsend Family Labs,Brain Res Ctr, Vancouver, BC V6T IZ3, Canada; [Bucala, Richard] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Bucala, Richard] Yale Univ, Dept Pathol, New Haven, CT USA; [Shyu, Woei-Cherng] China Med Univ & Hosp, Dept Neurol, Ctr Neuropsychiat, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ & Hosp, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; Yale University; Yale University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Song, WH (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Westbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR) [MOP-97825]; Jack Brown and Family Alzheimer's Research Foundation; U.S. National Institutes of Health [AI042310]; National Sciences and Engineering Research Council of Canada-Canada Graduate Scholarships Doctoral (NSERC-CGSD); UBC 4YF Scholarship; Chinese Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Jack Brown and Family Alzheimer's Research Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council of Canada-Canada Graduate Scholarships Doctoral (NSERC-CGSD); UBC 4YF Scholarship; Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Cheryl Wellington [University of British Columbia (UBC)] for providing the BV-2 cell line. This work was supported by Canadian Institutes of Health Research (CIHR) operating grant MOP-97825, the Jack Brown and Family Alzheimer's Research Foundation (to W.S.), and U.S. National Institutes of Health grant AI042310 (to R.B.). W.S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Si Z. is the recipient of a National Sciences and Engineering Research Council of Canada-Canada Graduate Scholarships Doctoral (NSERC-CGSD) scholarship and a UBC 4YF Scholarship. M.Z. is supported by UBC 4YF Scholarship. Sh.Z. was supported by the Chinese Scholarship Council award. The authors declare no conflicts of interest.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Amaral FA, 2007, AM J PATHOL, V171, P1887, DOI 10.2353/ajpath.2007.060642; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bakirtzi K, 2009, J NEUROSCI, V29, P5193, DOI 10.1523/JNEUROSCI.0858-09.2009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Cai F, 2008, J NEUROCHEM, V105, P512, DOI 10.1111/j.1471-4159.2007.05167.x; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chen CH, 2011, INT J NEUROPSYCHOPH, V18, P1, DOI DOI 10.1017/S1461145711000149; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Huang FP, 2003, J NEUROSCI RES, V73, P698, DOI 10.1002/jnr.10654; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Inacio AR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-75; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; PARALKAR V, 1994, GENOMICS, V19, P48, DOI 10.1006/geno.1994.1011; Rassaf T, 2014, CARDIOVASC RES, V102, P321, DOI 10.1093/cvr/cvu071; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; Stockley JH, 2007, BIOCHEM SOC T, V35, P574, DOI 10.1042/BST0350574; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Waeber G, 1998, MOL ENDOCRINOL, V12, P698, DOI 10.1210/me.12.5.698; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xu Q, 2012, J NEUROCHEM, V122, P251, DOI 10.1111/j.1471-4159.2012.07676.x; Zhang L, 2003, STROKE, V34, P1790, DOI 10.1161/01.STR.0000077016.55891.2E; Zhang XM, 2010, BRAIN RES, V1343, P143, DOI 10.1016/j.brainres.2010.04.027; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	63	35	39	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4394	4407		10.1096/fj.14-253625	http://dx.doi.org/10.1096/fj.14-253625			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970391	Green Published			2022-12-25	WOS:000342222700018
J	Maeda, S; Sun, DW; Singhal, A; Foggetta, M; Schmid, G; Standfuss, J; Hennig, M; Dawson, RJP; Veprintsev, DB; Schertler, GFX				Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Foggetta, Marcello; Schmid, Georg; Standfuss, Joerg; Hennig, Michael; Dawson, Roger J. P.; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.			Crystallization Scale Preparation of a Stable GPCR Signaling Complex between Constitutively Active Rhodopsin and G-Protein	PLOS ONE			English	Article							COUPLED RECEPTOR RHODOPSIN; NANOSCALE LIPID-BILAYERS; NATIVE DISC MEMBRANES; TRANSDUCIN COMPLEX; PROTONATION SWITCHES; THERMAL-STABILITY; CRYSTAL-STRUCTURE; METARHODOPSIN-II; ACTIVATION; MUTANT	The activation of the G-protein transducin (Gt) by rhodopsin (Rho) has been intensively studied for several decades. It is the best understood example of GPCR activation mechanism and serves as a template for her GPCRs. The structure of the Rho/G protein complex, which is transiently formed during the signaling reaction, is of particular interest. It can help understanding the molecular details of how retinal isomerization leads to the G protein activation, as well as shed some on how GPCR recognizes its cognate G protein. The native Rho/Gt complex isolated from bovine retina suffers from low stability and loss of the retinal ligand. Recently, we reported that constitutively active mutant of rhodopsin E113Q forms a Rho/Gt complex that is stable In detergent solution. Here, we introduce methods for a large scale preparation of he formed formed by the thermo-stabilized and constitutively active rhodopsin mutant N2C/M257Y/D282C(RhoM257Y) and he native Gt purified from bovine retinas We demonstrate that the light-activated rhodopsin in this complex contains a covalently bound unprotonated retinal and therefore corresponds to the active metarhodopin II state; ha the isolated complex is active and dissociates upon addition of GTP gamma S; and that the stoichiometry corresponds to a 11 molar ratio of rhodopsin to the heterotrimeric G-protein. And finally, we show that the rhodopsin also forms stable complex with Gi. This complex has significantly higher thermostability than RhoM257Y/Gt complex and is resistant to a variety of detergents. Overall, our data suggest that the RhoM257Y/Gi complex is an ideal target for future structural and mechanistic studies of signaling in the visual system	[Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Standfuss, Joerg; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Standfuss, Joerg; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] ETH, Dept Biol, Zurich, Switzerland; [Foggetta, Marcello; Schmid, Georg; Hennig, Michael; Dawson, Roger J. P.] F Hoffmann La Roche & Co Ltd, PRED Pharma Res & Early Dev, Small Mol Res, Discovery Technol, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Novartis; Roche Holding	Veprintsev, DB (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	dmitry.veprintsev@psi.ch; gebhard.schertler@psi.ch	Schertler, Gebhard/M-9512-2014; Standfuss, Joerg/G-5126-2011; Veprintsev, Dmitry B/H-2228-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; Schertler, Gebhard F.X./0000-0002-5846-6810; Maeda, Shoji/0000-0002-7762-9793; Sun, Dawei/0000-0002-2010-6051; Dawson, Roger/0000-0003-2161-5883	Roche [RPF113]; Swiss National Science Foundation [133810, 135754, 141898, 132815, 141235]; NCCR Structural Biology	Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Structural Biology(Swiss National Science Foundation (SNSF))	SM is supported by the Roche postdoctoral fellowship (RPF113, www.roche.com). This work was supported by the Swiss National Science Foundation (www.snf.ch) grants 133810 (DBV, JS, GFXS), 135754 (DBV), 141898 (DBV, GFXS), 132815 (GFXS, JS), 141235 (JS) and NCCR Structural Biology (GFXS). Roche provided funding in the form of salaries for the employees and co-authors (MF, GS, MH and RJPD). The Swiss National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Han M, 2000, METHOD ENZYMOL, V315, P251; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Moukhametzianov R, 2008, ACTA CRYSTALLOGR D, V64, P158, DOI 10.1107/S090744490705812X; Orban T, 2012, STRUCTURE, V20, P826, DOI 10.1016/j.str.2012.03.017; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Vogel R, 2007, PHOTOCHEM PHOTOBIOL, V83, P286, DOI 10.1562/2006-06-19-IR-937; Webb DR, 2013, BIOCHEM PHARMACOL, V85, P147, DOI 10.1016/j.bcp.2012.08.021; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r	53	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e98714	10.1371/journal.pone.0098714	http://dx.doi.org/10.1371/journal.pone.0098714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979345	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400002
J	Subramanian, S; Gomez, RD				Subramanian, Sowmya; Gomez, Romel D.			An Empirical Approach for Quantifying Loop-Mediated Isothermal Amplification (LAMP) Using Escherichia coli as a Model System	PLOS ONE			English	Article							RAPID DETECTION; DNA; DIAGNOSIS; ACCURATE; ASSAY	Loop mediated isothermal amplification (LAMP) is a highly efficient, selective and rapid DNA amplification technique for genetic screening of pathogens. However, despite its popularity, there is yet no mathematical model to quantify the outcome and no well-defined metric for comparing results that are available. LAMP is intrinsically complex and involves multiple pathways for gene replication, making fundamental modelling nearly intractable. To circumvent this difficulty, an alternate, empirical model is introduced that will allow one to extract a set of parameters from the concentration versus time curves. A simple recipe to deduce the time to positive, T-p - a parameter analogous to the threshold cycling time in polymerase chain reaction (PCR), is also provided. These parameters can be regarded as objective and unambiguous indicators of LAMP amplification. The model is exemplified on Escherichia coli strains by using the two gene fragments responsible for vero-toxin (VT) production and tested against VT-producing (O157 and O45) and non-VT producing (DH5 alpha) strains. Selective amplification of appropriate target sequences was made using well established LAMP primers and protocols, and the concentrations of the amplicons were measured using a Qubit 2.0 fluorometer at specific intervals of time. The data is fitted to a generalized logistic function. Apart from providing precise screening indicators, representing the data with a small set of numbers offers significant advantages. It facilitates comparisons of LAMP reactions independently of the sampling technique. It also eliminates subjectivity in interpretation, simplifies data analysis, and allows easy data archival, retrieval and statistical analysis for large sample populations. To our knowledge this work represents a first attempt to quantitatively model LAMP and offer a standard method that could pave the way towards high throughput automated screening.	[Subramanian, Sowmya; Gomez, Romel D.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Gomez, RD (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.	rdgomez@umd.edu	Subramanian, Sowmya/AAW-3878-2021		JIFSAN at the University of Maryland	JIFSAN at the University of Maryland	The authors acknowledge support from JIFSAN at the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fekedulegn D, 1999, SILVA FENN, V33, P327, DOI 10.14214/sf.653; Ge BL, 2009, JALA-J LAB AUTOM, V14, P235, DOI 10.1016/j.jala.2008.12.012; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; Hara-Kudo Y, 2007, J MED MICROBIOL, V56, P398, DOI 10.1099/jmm.0.46819-0; Hill J, 2008, J CLIN MICROBIOL, V46, P2800, DOI 10.1128/JCM.00152-08; Hsieh KW, 2012, ANGEW CHEM INT EDIT, V51, P4896, DOI 10.1002/anie.201109115; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Soleimani M, 2013, J APPL MICROBIOL, V115, P828, DOI 10.1111/jam.12290; Thorpe CM, 2004, CLIN INFECT DIS, V38, P1298, DOI 10.1086/383473; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tomlinson JA, 2010, LETT APPL MICROBIOL, V51, P650, DOI 10.1111/j.1472-765X.2010.02949.x; Toumazou C, 2013, NAT METHODS, V10, P641, DOI 10.1038/nmeth.2520; Veigas B, 2014, BIOSENS BIOELECTRON, V52, P50, DOI 10.1016/j.bios.2013.08.029	18	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100596	10.1371/journal.pone.0100596	http://dx.doi.org/10.1371/journal.pone.0100596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979038	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400035
J	Yu, Y; Su, FC; Callaghan, BC; Goutman, SA; Batterman, SA; Feldman, EL				Yu, Yu; Su, Feng-Chiao; Callaghan, Brian C.; Goutman, Stephen A.; Batterman, Stuart A.; Feldman, Eva L.			Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan	PLOS ONE			English	Article							WESTERN WASHINGTON-STATE; MOTOR-NEURON DISEASE; GULF-WAR VETERANS; NEURODEGENERATIVE DISEASES; ELECTROMAGNETIC-FIELDS; OCCUPATIONAL-EXPOSURE; CEREBROSPINAL-FLUID; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; UTILITY WORKERS	An interim report of a case-control study was conducted to explore the role of environmental factors in the development of amyotrophic lateral sclerosis (ALS). Sixty-six cases and 66 age-and gender-matched controls were recruited. Detailed information regarding residence history, occupational history, smoking, physical activity, and other factors was obtained using questionnaires. The association of ALS with potential risk factors, including smoking, physical activity and chemical exposure, was investigated using conditional logistic regression models. As compared to controls, a greater number of our randomly selected ALS patients reported exposure to fertilizers to treat private yards and gardens and occupational exposure to pesticides in the last 30 years than our randomly selected control cases. Smoking, occupational exposures to metals, dust/fibers/fumes/gas and radiation, and physical activity were not associated with ALS when comparing the randomly selected ALS patients to the control subjects. To further explore and confirm results, exposures over several time frames, including 0-10 and 10-30 years earlier, were considered, and analyses were stratified by age and gender. Pesticide and fertilizer exposure were both significantly associated with ALS in the randomly selected ALS patients. While study results need to be interpreted cautiously given the small sample size and the lack of direct exposure measures, these results suggest that environmental and particularly residential exposure factors warrant close attention in studies examining risk factors of ALS.	[Yu, Yu; Su, Feng-Chiao; Batterman, Stuart A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Callaghan, Brian C.; Goutman, Stephen A.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Batterman, SA (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	stuartb@umich.edu; efeldman@umich.edu	Yu, Yu/AAV-4449-2020	Goutman, Stephen/0000-0001-8780-6637; Batterman, Stuart/0000-0001-9894-5325; Feldman, Eva/0000-0002-9162-2694	Agency for Toxic Substances and Disease Registry [200-2013-56856]; National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS)) [P30ES017885]; National Institutes of Health (National Institute for Occupational Safety and Health (NIOSH)) [5T42OH008455-08]; University of Michigan; A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (National Institute for Occupational Safety and Health (NIOSH)); University of Michigan(University of Michigan System); A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding support was provided by the Agency for Toxic Substances and Disease Registry (contract # 200-2013-56856), the National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS) P30ES017885 and National Institute for Occupational Safety and Health (NIOSH) 5T42OH008455-08), the University of Michigan MCubed funding program, and the A. Alfred Taubman Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, NEUROL CLIN, V29, P689, DOI 10.1016/j.ncl.2011.06.001; Alonso A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-6; ANNEGERS JF, 1991, ARCH NEUROL-CHICAGO, V48, P589, DOI 10.1001/archneur.1991.00530180041015; ARMON C, 1991, NEUROLOGY, V41, P1077, DOI 10.1212/WNL.41.7.1077; Armon C, 2009, NEUROLOGY, V73, P1693, DOI 10.1212/WNL.0b013e3181c1df48; Bergomi M, 2002, ENVIRON RES, V89, P116, DOI 10.1006/enrs.2002.4361; BHARUCHA NE, 1983, NEUROLOGY, V33, P911, DOI 10.1212/WNL.33.7.911; BOBOWICK AR, 1973, NEW ENGL J MED, V288, P1047, DOI 10.1056/NEJM197305172882005; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Callaghan B, 2011, NEURODEGENER DIS, V8, P1, DOI 10.1159/000315405; CDC NCHS, 2013, NAT HLTH NUTR EX SUR; CHANCELLOR AM, 1992, J NEUROL NEUROSUR PS, V55, P1106, DOI 10.1136/jnnp.55.12.1106; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; Davanipour Z, 1997, BIOELECTROMAGNETICS, V18, P28, DOI 10.1002/(SICI)1521-186X(1997)18:1<28::AID-BEM6>3.0.CO;2-7; Elbaz A, 2007, CR BIOL, V330, P318, DOI 10.1016/j.crvi.2007.02.018; Fang F, 2010, AM J EPIDEMIOL, V171, P1126, DOI 10.1093/aje/kwq063; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; FARRELL DF, 1968, NEUROLOGY, V18, P601, DOI 10.1212/WNL.18.6.601; Gallo V, 2009, ANN NEUROL, V65, P378, DOI 10.1002/ana.21653; GIAGHEDDU M, 1983, ACTA NEUROL SCAND, V68, P394, DOI 10.1111/j.1600-0404.1983.tb04849.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Johansen C, 2000, EPIDEMIOLOGY, V11, P539, DOI 10.1097/00001648-200009000-00009; KALFAKIS N, 1991, NEUROEPIDEMIOLOGY, V10, P170, DOI 10.1159/000110266; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; KAPAKI E, 1989, EXPERIENTIA, V45, P1108, DOI 10.1007/BF01950171; Kasarskis EJ, 2009, AMYOTROPH LATERAL SC, V10, P35, DOI 10.1080/17482960802351029; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; LONGSTRETH WT, 1991, MED HYPOTHESES, V34, P144, DOI 10.1016/0306-9877(91)90183-Y; Malek AM, 2013, ENV OCCUPATIONAL RIS; McGuire V, 1996, NEUROLOGY, V47, P571, DOI 10.1212/WNL.47.2.571; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Morahan JM, 2006, NEUROEPIDEMIOLOGY, V27, P130, DOI 10.1159/000095552; MORIWAKA F, 1993, J NEUROL SCI, V118, P38, DOI 10.1016/0022-510X(93)90243-R; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; NINDS, 2012, AM LET SCLER ALS FAC; Noonan CW, 2002, SCAND J WORK ENV HEA, V28, P42, DOI 10.5271/sjweh.645; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Riggs JE, 2001, MIL MED, V166, P731, DOI 10.1093/milmed/166.8.731; SAVETTIERI G, 1991, NEUROEPIDEMIOLOGY, V10, P242, DOI 10.1159/000110279; Savitz DA, 1998, ARCH ENVIRON HEALTH, V53, P71, DOI 10.1080/00039899809605691; Savitz DA, 1998, EPIDEMIOLOGY, V9, P398, DOI 10.1097/00001648-199807000-00009; STOBER T, 1983, J NEUROL SCI, V61, P21, DOI 10.1016/0022-510X(83)90051-5; Stozicka Z, 2007, ACTA VIROL, V51, P205; Strickland D, 1996, ARCH NEUROL-CHICAGO, V53, P730, DOI 10.1001/archneur.1996.00550080044011; Sutedja NA, 2007, NEUROLOGY, V69, P1508, DOI 10.1212/01.wnl.0000277463.87361.8c; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Vinceti M, 1997, ITAL J NEUROL SCI, V18, P87, DOI 10.1007/BF01999568; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Weisskopf MG, 2009, ANN NEUROL, V65, P361, DOI 10.1002/ana.21700; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179; Weisskopf MG, 2005, AM J EPIDEMIOL, V162, P1146, DOI 10.1093/aje/kwi343; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	62	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101186	10.1371/journal.pone.0101186	http://dx.doi.org/10.1371/journal.pone.0101186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979055	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400095
J	Zhang, DF; Xia, T; Yan, MM; Dai, XG; Xu, J; Li, SX; Yin, TM				Zhang, Defang; Xia, Tao; Yan, Maomao; Dai, Xiaogang; Xu, Jin; Li, Shuxian; Yin, Tongming			Genetic Introgression and Species Boundary of Two Geographically Overlapping Pine Species Revealed by Molecular Markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; HYBRID ZONE; TIBETAN PLATEAU; POPULATION DIFFERENTIATION; REPRODUCTIVE ISOLATION; HYBRIDIZATION; EXTINCTION; SPECIATION; MASSONIANA; MORPHOLOGY	Gene introgression and hybrid barriers have long been a major focus of studies of geographically overlapping species. Two pine species, Pinus massoniana and P. hwangshanensis, are frequently observed growing adjacent to each other, where they overlap in a narrow hybrid zone. As a consequence, these species constitute an ideal system for studying genetic introgression and reproductive barriers between naturally hybridizing, adjacently distributed species. In this study, we sampled 270 pine trees along an elevation gradient in Anhui Province, China and analyzed these samples using EST-SSR markers. The molecular data revealed that direct gene flow between the two species was fairly low, and that the majority of gene introgression was intermediated by backcrossing. On the basis of empirical observation, the on-site distribution of pines was divided into a P. massoniana zone, a hybrid zone, and a P. hwangshanensis zone. STRUCTURE analysis revealed the existence of a distinct species boundary between the two pine species. The genetic boundary of the hybrid zone, on the other hand, was indistinct owing to intensive backcrossing with parental species. Compared with P. massoniana, P. hwangshanensis was found to backcross with the hybrids more intensively, consistent with the observation that morphological and anatomical characteristics of trees in the contact zone were biased towards P. hwangshanensis. The introgression ability of amplified alleles varied across species, with some being completely blocked from interspecific introgression. Our study has provided a living example to help explain the persistence of adjacently distributed species coexisting with their interfertile hybrids.	[Zhang, Defang; Xia, Tao; Yan, Maomao; Dai, Xiaogang; Xu, Jin; Li, Shuxian; Yin, Tongming] Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			Natural Science Foundation [31125008, 31270661]; Program for Innovative Research Team in Universities of Jiangsu Province; Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province [CXZZ13-0528]; Educational Department of China	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Universities of Jiangsu Province; Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province; Educational Department of China	Natural Science Foundation (31125008, 31270661) Program for Innovative Research Team in Universities of Jiangsu Province and the Educational Department of China. Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province (CXZZ13-0528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold ML, 1997, NATURE HYBRIDIZATION, P20; Barluenga M, 2011, HEREDITY, V106, P13, DOI 10.1038/hdy.2010.38; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Chen ZY, 1986, NATURAL HYBRIDIZATIO, V1, P38; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cullingham CI, 2012, EVOL APPL, V5, P879, DOI 10.1111/j.1752-4571.2012.00266.x; DONG J, 1993, THEOR APPL GENET, V86, P573, DOI 10.1007/BF00838711; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Du FK, 2011, NEW PHYTOL, V192, P1024, DOI 10.1111/j.1469-8137.2011.03853.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Falush D, 2003, GENETICS, V164, P1567; Fu L, 1999, FLORA CHINA; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Jensen AB, 2005, MOL ECOL, V14, P93, DOI 10.1111/j.1365-294X.2004.02399.x; Jiang WB, 2008, HIST HUANGSHAN MMOUN, P320; Kawakami T, 2012, HYBRID ZONES EVOLUTI, V1, P1; Ke BF, 1983, J ANHUI AGR U, V2, P1; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Li SX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-37; Luo ShiJia, 2001, Scientia Silvae Sinicae, V37, P118; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; Panwar P, 2010, MOL BIOL REP, V37, P4075, DOI 10.1007/s11033-010-0067-5; Pritchard JK, 2000, GENETICS, V155, P945; Qi CJ, 1988, BOT RES, V3, P143; Qu JiTeng, 2012, Journal of Nanjing Forestry University (Natural Sciences Edition), V36, P143; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Runyeon-Lager H, 2000, CAN J BOT, V78, P1384, DOI 10.1139/cjb-78-11-1384; Schilthuizen M, 2013, J EVOLUTION BIOL, V26, P288, DOI 10.1111/jeb.12056; Song YC, 1980, CHINESE VEGETATION, P234; STRAUSS SH, 1993, THEOR APPL GENET, V86, P605, DOI 10.1007/BF00838716; Tongming Y, 2012, TREE GENETICS MOL BR, V2, P1, DOI [10.5376/tgmb.2012.02.0001, DOI 10.5376/TGMB.2012.02.0001]; Vines TH, 2003, EVOLUTION, V57, P1876; Wang B., 2011, PLOS ONE, P8; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Wright S, 1978, VARIABILITY NATURAL, V4; Xing YH, 1992, J ANHUI FOR SCI TECH, V4, P5; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	48	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101106	10.1371/journal.pone.0101106	http://dx.doi.org/10.1371/journal.pone.0101106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977711	gold, Green Submitted, Green Published			2022-12-25	WOS:000338506400078
J	Bruno, AE; Ruby, AM; Luft, JR; Grant, TD; Seetharaman, J; Montelione, GT; Hunt, JF; Snell, EH				Bruno, Andrew E.; Ruby, Amanda M.; Luft, Joseph R.; Grant, Thomas D.; Seetharaman, Jayaraman; Montelione, Gaetano T.; Hunt, John F.; Snell, Edward H.			Comparing Chemistry to Outcome: The Development of a Chemical Distance Metric, Coupled with Clustering and Hierarchal Visualization Applied to Macromolecular Crystallography	PLOS ONE			English	Article							CRYSTALLIZATION CONDITIONS; PROTEIN; SIMILARITY; SALT	Many bioscience fields employ high-throughput methods to screen multiple biochemical conditions. The analysis of these becomes tedious without a degree of automation. Crystallization, a rate limiting step in biological X-ray crystallography, is one of these fields. Screening of multiple potential crystallization conditions (cocktails) is the most effective method of probing a proteins phase diagram and guiding crystallization but the interpretation of results can be time-consuming. To aid this empirical approach a cocktail distance coefficient was developed to quantitatively compare macromolecule crystallization conditions and outcome. These coefficients were evaluated against an existing similarity metric developed for crystallization, the C6 metric, using both virtual crystallization screens and by comparison of two related 1,536-cocktail high-throughput crystallization screens. Hierarchical clustering was employed to visualize one of these screens and the crystallization results from an exopolyphosphatase-related protein from Bacteroides fragilis, (BfR192) overlaid on this clustering. This demonstrated a strong correlation between certain chemically related clusters and crystal lead conditions. While this analysis was not used to guide the initial crystallization optimization, it led to the re-evaluation of unexplained peaks in the electron density map of the protein and to the insertion and correct placement of sodium, potassium and phosphate atoms in the structure. With these in place, the resulting structure of the putative active site demonstrated features consistent with active sites of other phosphatases which are involved in binding the phosphoryl moieties of nucleotide triphosphates. The new distance coefficient, CDcoeff, appears to be robust in this application, and coupled with hierarchical clustering and the overlay of crystallization outcome, reveals information of biological relevance. While tested with a single example the potential applications related to crystallography appear promising and the distance coefficient, clustering, and hierarchal visualization of results undoubtedly have applications in wider fields.	[Bruno, Andrew E.; Ruby, Amanda M.] SUNY Buffalo, Ctr Computat Res, Buffalo, NY 14260 USA; [Luft, Joseph R.; Grant, Thomas D.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Luft, Joseph R.; Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Seetharaman, Jayaraman; Hunt, John F.] Columbia Univ, Northeast Struct Genom Consortium, Dept Biol Sci, New York, NY USA; [Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Northeast Struct Genom Consortium,Robert Wood Joh, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Snell, EH (corresponding author), Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.	esnell@hwi.buffalo.edu	Snell, Edward/G-2055-2018; Grant, Thomas/GXH-9990-2022; Grant, Thomas/T-2921-2019	Snell, Edward/0000-0001-8714-3191; Grant, Thomas/0000-0002-8583-3700; Grant, Thomas/0000-0002-8583-3700; Montelione, Gaetano/0000-0002-9440-3059	DTRA; NIH [R01GM088396, R01GM100494]; NSF [1231306]; Protein Structure Initiative of the National Institutes of Health, NIGMS [R01GM100494, U54 GM094597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM088396, R01GM100494] Funding Source: NIH RePORTER	DTRA(United States Department of DefenseDefense Threat Reduction Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Protein Structure Initiative of the National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research is supported by DTRA, NIH R01GM088396, R01GM100494 and NSF 1231306. The protein samples used in this work were provided in part by the Protein Structure Initiative of the National Institutes of Health, NIGMS grant U54 GM094597 and R01GM100494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Collins KD, 2006, BIOPHYS CHEM, V119, P271, DOI 10.1016/j.bpc.2005.08.010; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Dumetz AC, 2007, PROTEIN SCI, V16, P1867, DOI 10.1110/ps.072957907; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones E., 2001, SCIPY OPEN SOURCE SC; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Krause EF., 1987, TAXICAB GEOMETRY ADV; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luft JR, 2007, PROTEIN SCI, V16, P715, DOI 10.1110/ps.062699707; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Luft JR, 2011, CRYST GROWTH DES, V11, P651, DOI 10.1021/cg1013945; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagel RM, 2008, J APPL CRYSTALLOGR, V41, P1173, DOI 10.1107/S0021889808028938; Newman J, 2012, ACTA CRYSTALLOGR F, V68, P253, DOI 10.1107/S1744309112002618; Newman J, 2010, CRYST GROWTH DES, V10, P2785, DOI 10.1021/cg1004209; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Skokal R, 1926, TAXON, V11, P33; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1240, DOI 10.1107/S0907444908032411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	38	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100782	10.1371/journal.pone.0100782	http://dx.doi.org/10.1371/journal.pone.0100782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971458	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200062
J	Jovanovic, K; Loos, B; Dias, BDC; Penny, C; Weiss, SFT				Jovanovic, Katarina; Loos, Ben; Dias, Bianca Da Costa; Penny, Clement; Weiss, Stefan F. T.			High Resolution Imaging Study of Interactions between the 37 kDa/67 kDa Laminin Receptor and APP, Beta-Secretase and Gamma-Secretase in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CELLULAR PRION PROTEIN; INFECTED NEURONAL CELLS; LIPID RAFTS; PRPSC PROPAGATION; PLASMA-MEMBRANE; BINDING-SITES; CLEAVAGE; MICROSCOPY; BACE1	Alzheimer's disease (AD) is the most prevalent form of dementia affecting the elderly. Neurodegeneration is caused by the amyloid beta (A beta) peptide which is generated from the sequential proteolytic cleavage of the Amyloid Precursor Protein (APP) by the beta- and gamma-secretases. Previous reports revealed that the 37 kDa/67 kDa laminin receptor (LRP/LR) is involved in APP processing, however, the exact mechanism by which this occurs remains largely unclear. This study sought to assess whether LRP/LR interacted with APP, beta- or gamma-secretase. Detailed confocal microscopy revealed that LRP/LR showed a strong co-localisation with APP, beta- and gamma-secretase, respectively, at various sub-cellular locations. Superresolution Structured Illumination Microscopy (SR-SIM) showed that interactions were unlikely between LRP/LR and APP and beta-secretase, respectively, while there was strong co-localisation between LRP/LR and gamma-secretase at this 80 nm resolution. FRET was further employed to assess the possibility of protein-protein interactions and only an interaction between LRP/LR and gamma-secretase was found. FLAG co-immunoprecipitation confirmed these findings as LRP/LR co-immunoprecipitated with gamma-secretase, but failed to do so with APP. These findings indicate that LRP/LR exerts its influence on A beta shedding via a direct interaction with the gamma-secretase and possibly an indirect interaction with the beta-secretase.	[Jovanovic, Katarina; Dias, Bianca Da Costa; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Loos, Ben] Univ Stellenbosch, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa; [Penny, Clement] Univ Witwatersrand, Dept Internal Med, Johannesburg, South Africa	University of Witwatersrand; Stellenbosch University; University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	Stefan.weiss@wits.ac.za		Loos, Ben/0000-0002-5517-373X	National Research Foundation (NRF), the Republic of South Africa (RSA)	National Research Foundation (NRF), the Republic of South Africa (RSA)	This work is based upon research supported by the National Research Foundation (NRF), the Republic of South Africa (RSA). Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Beckman M, 2006, BIOCHEMISTRY-US, V45, P6703, DOI 10.1021/bi052498t; Chetty C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096268; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Da Costa Dias B, 2013, SCI REPORTS, V3, P2702; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jovanovic K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02699; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Patey SJ, 2005, BIOCHEM SOC T, V33, P1116, DOI 10.1042/BST0331116; Patra SK, 2008, J PHYSIOL PHARMACOL, V59, P217; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verdier Y, 2004, CURR PROTEIN PEPT SC, V5, P19, DOI 10.2174/1389203043486937; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100373	10.1371/journal.pone.0100373	http://dx.doi.org/10.1371/journal.pone.0100373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972054	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200029
J	Yang, J; d'Esterre, CD; Amtul, Z; Cechetto, DF; Lee, TY				Yang, Jun; d'Esterre, Christopher D.; Amtul, Zareen; Cechetto, David F.; Lee, Ting Yim			Hemodynamic Effects of Combined Focal Cerebral Ischemia and Amyloid Protein Toxicity in a Rat Model: A Functional CT Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BLOOD-FLOW; ALZHEIMERS-DISEASE; A-BETA; EMISSION-TOMOGRAPHY; TRANSGENIC MICE; PERFUSION CT; FDG-PET; BRAIN; DEMENTIA	Background/Objective: Clinical evidence indicates that cerebral ischemia (CI) and a pathological factor of Alzheimer's disease, the beta-amyloid (A beta) protein, can increase the rate of cognitive impairment in the ageing population. Using the CT Perfusion (CTP) functional imaging, we sought to investigate the interaction between CI and the A beta protein on cerebral hemodynamics. Methods: A previously established rat model of CI and A beta was used for the CTP study. Iodinated contrast was given intravenously, while serial CT images of sixteen axial slices were acquired. Cerebral blood flow (CBF) and blood volume (CBV) parametric maps were co-registered to a rat brain atlas and regions of interest were drawn on the maps. Microvascular alteration was investigated with histopathology. Results: CTP results revealed that ipsilateral striatum of A beta+CI and CI groups showed significantly lower CBF and CBV than control at the acute phase. Striatal CBF and CBV increased significantly at week 1 in the CI and A beta+CI groups, but not in the A beta alone or control group. Histopathology showed that average density of dilated microvessels in the ipsilateral striatum in CI and A beta+CI groups was significantly higher than control at week 1, indicating this could be associated with hyperperfusion and hypervolemia observed from CTP results. Conclusion: These results demonstrate that CTP can quantitatively measure the hemodynamic disturbance on CBF and CBV functional maps in a rat model of CI interacting with A beta.	[Yang, Jun; Lee, Ting Yim] Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Imaging Labs, London, ON, Canada; [d'Esterre, Christopher D.] Univ Calgary, Foothills Med Ctr, Dept Radiol, Calgary, AB, Canada; [Amtul, Zareen; Cechetto, David F.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Lee, Ting Yim] Lawson Hlth Res Inst, Imaging Div, London, ON, Canada	Western University (University of Western Ontario); University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario)	Lee, TY (corresponding author), Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Imaging Labs, London, ON, Canada.	tlee@robarts.ca	AMTUL, ZAREEN/Y-6364-2019; Lee, Ting-Yim/M-1721-2013		Canadian Institutes of Health Research (CIHR); Canadian Foundation of Innovation; Ontario Research Fund	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); Ontario Research Fund	This study is funded by Canadian Institutes of Health Research (CIHR), Canadian Foundation of Innovation and Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Austin BP, 2011, J ALZHEIMERS DIS, V26, P123, DOI 10.3233/JAD-2011-0010; BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372; Bisdas S, 2006, EUR RADIOL, V16, P2220, DOI 10.1007/s00330-006-0209-2; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Cenic A, 1999, AM J NEURORADIOL, V20, P63; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; d'Esterre CD, 2012, TRANSL STROKE RES, V3, P205, DOI 10.1007/s12975-012-0178-5; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Dietrich HH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-15; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Heyman A, 1998, NEUROLOGY, V51, P159, DOI 10.1212/WNL.51.1.159; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Jantaratnotai N, 2011, INT J ALZHEIMERS DIS, V2011, P1; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kogure D, 2000, J NUCL MED, V41, P1155; Koistinaho M, 2002, P NATL ACAD SCI USA, V99, P1610, DOI 10.1073/pnas.032670899; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053; Miles KA, 2010, CLIN RADIOL, V65, P549, DOI 10.1016/j.crad.2010.04.007; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; NARIAI T, 1995, AM J NEURORADIOL, V16, P563; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; Pakrasi S, 2005, NUCL MED COMMUN, V26, P189, DOI 10.1097/00006231-200503000-00003; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Pluta Ryszard, 2008, Neuropsychiatr Dis Treat, V4, P855; Riekse RG, 2004, J AM GERIATR SOC, V52, P1442, DOI 10.1111/j.1532-5415.2004.52405.x; Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Song IU, 2007, COGN BEHAV NEUROL, V20, P93, DOI 10.1097/WNN.0b013e31805d859e; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Villemagne VL, 2011, INT PSYCHOGERIATR, V23, pS41, DOI 10.1017/S1041610211000895; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Whitehead SN, 2007, STROKE, V38, P3245, DOI 10.1161/STROKEAHA.107.492660; Whitehead SN, 2005, STROKE, V36, P107, DOI 10.1161/01.STR.0000149627.30763.f9; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wolk DA, 2009, CURR NEUROL NEUROSCI, V9, P345, DOI 10.1007/s11910-009-0051-4; Zaknun JJ, 2008, NUCL MED COMMUN, V29, P260, DOI 10.1097/MNM.0b013e3282f38f8f; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997	53	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100575	10.1371/journal.pone.0100575	http://dx.doi.org/10.1371/journal.pone.0100575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971942	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200043
J	Garbaisz, D; Turoczi, Z; Aranyi, P; Fulop, A; Rosero, O; Hermesz, E; Ferencz, A; Lotz, G; Harsanyi, L; Szijarto, A				Garbaisz, David; Turoczi, Zsolt; Aranyi, Peter; Fulop, Andras; Rosero, Oliver; Hermesz, Edit; Ferencz, Agnes; Lotz, Gabor; Harsanyi, Laszlo; Szijarto, Attila			Attenuation of Skeletal Muscle and Renal Injury to the Lower Limb following Ischemia-Reperfusion Using mPTP Inhibitor NIM-811	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CYCLOSPORINE-A; CELL-DEATH; VASCULAR-SURGERY; NITRIC-OXIDE; PEROXYNITRITE; LIVER; PORE; MECHANISM; RAT	Introduction: Operation on the infrarenal aorta and large arteries of the lower extremities may cause rhabdomyolysis of the skeletal muscle, which in turn may induce remote kidney injury. NIM-811 (N-metyl-4-isoleucine-cyclosporine) is a mitochondria specific drug, which can prevent ischemic-reperfusion (IR) injury, by inhibiting mitochondrial permeability transition pores (mPTP). Objectives: Our aim was to reduce damages in the skeletal muscle and the kidney after IR of the lower limb with NIM-811. Materials and methods: Wistar rats underwent 180 minutes of bilateral lower limb ischemia and 240 minutes of reperfusion. Four animal groups were formed called Sham (receiving vehicle and sham surgery), NIM-Sham (receiving NIM811 and sham surgery), IR (receiving vehicle and surgery), and NIM-IR (receiving NIM-811 and surgery). Serum, urine and histological samples were taken at the end of reperfusion. NADH-tetrazolium staining, muscle Wet/Dry (W/D) ratio calculations, laser Doppler-flowmetry (LDF) and mean arterial pressure (MAP) monitoring were performed. Renal peroxynitrite concentration, serum TNF-alpha and IL-6 levels were measured. Results: Less significant histopathological changes were observable in the NIM-IR group as compared with the IR group. Serum K+ and necroenzyme levels were significantly lower in the NIM-IR group than in the IR group (LDH: p<0.001; CK: p< 0.001; K+: p = 0.017). Muscle mitochondrial viability proved to be significantly higher (p = 0.001) and renal function parameters were significantly better (creatinine: p = 0.016; FENa: p<0.001) in the NIM-IR group in comparison to the IR group. Serum TNF-alpha and IL-6 levels were significantly lower (TNF-alpha: p = 0.003, IL-6: p = 0.040) as well as W/D ratio and peroxynitrite concentration were significantly lower (p = 0.014; p<0.001) in the NIM-IR group than in the IR group. Conclusion: NIM-811 could have the potential of reducing rhabdomyolysis and impairment of the kidney after lower limb IR injury.	[Garbaisz, David; Turoczi, Zsolt; Aranyi, Peter; Fulop, Andras; Rosero, Oliver; Harsanyi, Laszlo; Szijarto, Attila] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Hermesz, Edit; Ferencz, Agnes] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Lotz, Gabor] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary	Semmelweis University; Szeged University; Semmelweis University	Garbaisz, D (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	garbaiszdavid@t-online.hu	Hermesz, Edit/M-7661-2018; Edit, Hermesz/AAH-5969-2020	Hermesz, Edit/0000-0002-0543-6693; Edit, Hermesz/0000-0002-0543-6693				Abdulhannan P, 2012, BRIT MED BULL, V104, P21, DOI 10.1093/bmb/lds027; Aranyi P TZ, 2011, HYPERTONIA NEPHROLOG, V15, P117; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Carroll CMA, 1997, PLAST RECONSTR SURG, V100, P58, DOI 10.1097/00006534-199707000-00010; Cheng CH, 2013, TRANSPLANTATION, V95, P559, DOI 10.1097/TP.0b013e31827e6b02; Cour M, 2011, EUR HEART J, V32, P226, DOI 10.1093/eurheartj/ehq112; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; FREEMAN R, 1972, J CLIN PATHOL, V25, P912, DOI 10.1136/jcp.25.10.912; Garbaisz D, 2013, J SURG RES, V185, P469, DOI 10.1016/j.jss.2013.05.022; Gill RS, 2012, SHOCK, V37, P341, DOI 10.1097/SHK.0b013e31824bc9ab; Goksin I, 2011, ANN VASC SURG, V25, P1118, DOI 10.1016/j.avsg.2011.07.007; Gomez L, 2009, CARDIOVASC RES, V83, P226, DOI 10.1093/cvr/cvp063; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Groeneveld ABJ, 1997, EUR J VASC ENDOVASC, V14, P351, DOI 10.1016/S1078-5884(97)80284-5; Gyurkovics E, 2010, INTERV MED APPL SCI, V2, P169, DOI 10.1556/IMAS.2.2010.4.5; Gyurkovics E, 2011, J SURG RES, V169, P139, DOI 10.1016/j.jss.2009.10.014; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halloran PF, 1996, CLIN TRANSPLANT, V10, P118; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Homer-Vanniasinkam S, 2001, EUR J VASC ENDOVASC, V22, P523, DOI 10.1053/ejvs.2001.1467; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Javadov S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00076; Klebl BM, 1998, FEBS LETT, V422, P381, DOI 10.1016/S0014-5793(98)00053-2; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li W, 2013, STEM CELL RES, V10, P405, DOI 10.1016/j.scr.2013.01.005; Lim SY, 2007, CARDIOVASC RES, V75, P530, DOI 10.1016/j.cardiores.2007.04.022; Lin HC, 2012, TRANSPLANTATION, V93, P265, DOI 10.1097/TP.0b013e31823ef335; LUCAS CE, 1976, SURG CLIN N AM, V56, P953; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; McAllister SE, 2008, AM J PHYSIOL-REG I, V295, pR681, DOI 10.1152/ajpregu.90303.2008; MENGER MD, 1988, RES EXP MED, V188, P151, DOI 10.1007/BF01852316; Miller CC, 2008, EUR J CARDIO-THORAC, V33, P691, DOI 10.1016/j.ejcts.2008.01.006; Mowlavi A, 2001, ANN PLAS SURG, V46, P426, DOI 10.1097/00000637-200104000-00013; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; Naparus A, 2012, EUR J PHARMACOL, V686, P90, DOI 10.1016/j.ejphar.2012.04.045; Norwood MGA, 2004, EUR J VASC ENDOVASC, V28, P234, DOI 10.1016/j.ejvs.2004.03.026; ODEH M, 1991, NEW ENGL J MED, V324, P1417; Olivas TP, 2001, PLAST RECONSTR SURG, V107, P785, DOI 10.1097/00006534-200103000-00020; PACKER MA, 1994, FEBS LETT, V345, P237, DOI 10.1016/0014-5793(94)00461-7; PATERSON IS, 1989, ANN SURG, V209, P231, DOI 10.1097/00000658-198902000-00015; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pottecher J, 2013, J VASC SURG, V57, P1100, DOI 10.1016/j.jvs.2012.09.020; Puglisi RN, 1996, J SURG RES, V65, P115, DOI 10.1006/jsre.1996.0352; Rajan DK, 2009, J VASC INTERV RADIOL, V20, pS208, DOI 10.1016/j.jvir.2009.04.010; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Rieber J, 1998, TRANSPLANT P, V30, P1098, DOI 10.1016/S0041-1345(98)00168-7; ROSENTHAL SM, 1945, ARCH SURG-CHICAGO, V51, P244, DOI 10.1001/archsurg.1945.01230040253004; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Squadrito F, 1999, EUR J PHARMACOL, V364, P159, DOI 10.1016/S0014-2999(98)00823-1; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143; Szijarto A, 2006, J SURG RES, V131, P150, DOI 10.1016/j.jss.2005.09.002; Troitzsch D, 2013, SHOCK, V39, P220, DOI 10.1097/SHK.0b013e31828044f6; Turoczi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084783; Wang WZ, 2011, J SURG RES, V171, P175, DOI 10.1016/j.jss.2011.07.015; Zhong Z, 2007, AM J TRANSPLANT, V7, P1103, DOI 10.1111/j.1600-6143.2007.01770.x; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	61	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101067	10.1371/journal.pone.0101067	http://dx.doi.org/10.1371/journal.pone.0101067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968303	gold, Green Submitted, Green Published			2022-12-25	WOS:000338280800102
J	Thavamanikumar, S; Southerton, S; Thumma, B				Thavamanikumar, Saravanan; Southerton, Simon; Thumma, Bala			RNA-Seq Using Two Populations Reveals Genes and Alleles Controlling Wood Traits and Growth in Eucalyptus nitens	PLOS ONE			English	Article							KRAFT PULP YIELD; TRANSCRIPTOME ANALYSIS; BASIC DENSITY; GENOME-WIDE; EXPRESSION; IDENTIFICATION; RESISTANCE; EVOLUTION; SELECTION; GLOBULUS	Eucalyptus nitens is a perennial forest tree species grown mainly for kraft pulp production in many parts of the world. Kraft pulp yield (KPY) is a key determinant of plantation profitability and increasing the KPY of trees grown in plantations is a major breeding objective. To speed up the breeding process, molecular markers that can predict KPY are desirable. To achieve this goal, we carried out RNA-Seq studies on trees at extremes of KPY in two different trials to identify genes and alleles whose expression correlated with KPY. KPY is positively correlated with growth measured as diameter at breast height (DBH) in both trials. In total, six RNA bulks from two treatments were sequenced on an Illumina HiSeq platform. At 5% false discovery rate level, 3953 transcripts showed differential expression in the same direction in both trials; 2551 (65%) were down-regulated and 1402 (35%) were up-regulated in low KPY samples. The genes up-regulated in low KPY trees were largely involved in biotic and abiotic stress response reflecting the low growth among low KPY trees. Genes down-regulated in low KPY trees mainly belonged to gene categories involved in wood formation and growth. Differential allelic expression was observed in 2103 SNPs (in 1068 genes) and of these 640 SNPs (30%) occurred in 313 unique genes that were also differentially expressed. These SNPs may represent the cis-acting regulatory variants that influence total gene expression. In addition we also identified 196 genes which had Ka/Ks ratios greater than 1.5, suggesting that these genes are under positive selection. Candidate genes and alleles identified in this study will provide a valuable resource for future association studies aimed at identifying molecular markers for KPY and growth.	[Thavamanikumar, Saravanan] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Southerton, Simon; Thumma, Bala] CSIRO Plant Ind, Acton, ACT, Australia	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thumma, B (corresponding author), CSIRO Plant Ind, Acton, ACT, Australia.	reddy.thumma@csiro.au	Thavamanikumar, Saravanan/J-3804-2014; Thumma, Bala/AAF-6143-2020	Thumma, Bala/0000-0002-1749-0611	University of Melbourne	University of Melbourne(University of Melbourne)	ST received an Early Career Researcher grant from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett IJ, 2013, GENET EPIDEMIOL, V37, P142, DOI 10.1002/gepi.21699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; da Fonseca RR, 2010, FEBS LETT, V584, P469, DOI 10.1016/j.febslet.2009.12.022; Downes Geoff, 2006, New Zealand Journal of Forestry, V51, P13; Edwards NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038864; EINSPAHR DEAN W., 1967, SILVAE GENET, V16, P106; Elissetche J, 2011, BMC P, V5, pP108; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Foucart C, 2006, NEW PHYTOL, V170, P739, DOI 10.1111/j.1469-8137.2006.01705.x; GODDARD ME, 2007, J ANIM BREED GENET, V124, P323; Grattapaglia D, 1996, GENETICS, V144, P1205; Greaves BL, 1997, SILVAE GENET, V46, P264; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; Gurwitz D, 2013, PHARMACOGENOMICS, V14, P337, DOI [10.2217/PGS.13.35, 10.2217/pgs.13.35]; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jung KH, 2013, RICE, V6, DOI 10.1186/1939-8433-6-19; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Provost G, 2007, BIOL RES, V40, P291, DOI [10.4067/S0716-97602007000400003, /S0716-97602007000400003]; Li J, 2005, HUM MOL GENET, V14, pR163, DOI 10.1093/hmg/ddi267; Liu JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-884; Masclaux FG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-227; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Paux E, 2004, PLANT MOL BIOL, V55, P263, DOI 10.1007/s11103-004-0621-4; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Prassinos C, 2005, PLANT CELL PHYSIOL, V46, P1213, DOI 10.1093/pcp/pci130; Qiu D, 2008, NEW PHYTOL, V179, P94, DOI 10.1111/j.1469-8137.2008.02439.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schimleck L, 2005, CAN J FOREST RES, V35, P2797, DOI 10.1139/X05-193; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Thavamanikumar S, 2013, TREE GENET GENOMES, V9, P627, DOI 10.1007/s11295-013-0594-z; Thumma BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-364; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Tibbits WN, 1997, 24 SO FOR TREE IMPR, P81; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yang X, 2013, PRINCIPLES, METHODOLOGIES, AND SERVICE-ORIENTED APPROACHES FOR CLOUD COMPUTING, P1, DOI 10.4018/978-1-4666-2854-0; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	54	21	22	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101104	10.1371/journal.pone.0101104	http://dx.doi.org/10.1371/journal.pone.0101104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967893	gold, Green Published			2022-12-25	WOS:000338280800108
J	Vasu, S; Moffett, RC; Thorens, B; Flatt, PR				Vasu, Srividya; Moffett, R. Charlotte; Thorens, Bernard; Flatt, Peter R.			Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FAT-FED MICE; PANCREATIC ALPHA-CELLS; GLUCOSE-HOMEOSTASIS; RECEPTOR ACTIVATION; ENTEROINSULAR AXIS; HORMONE MIMETICS; SECRETION; INCRETINS; POLYPEPTIDE	Role of GLP-1 and GIP in beta cell compensatory responses to beta cell attack and insulin resistance were examined in C57BL/6 mice lacking functional receptors for GLP-1 and GIP. Mice were treated with multiple low dose streptozotocin or hydrocortisone. Islet parameters were assessed by immunohistochemistry and hormone measurements were determined by specific enzyme linked immunoassays. Wild-type streptozotocin controls exhibited severe diabetes, irregularly shaped islets with lymphocytic infiltration, decreased Ki67/TUNEL ratio with decreased beta cell and increased alpha cell areas. GLP-1 and GIP were co-expressed with glucagon and numbers of alpha cells mainly expressing GLP-1 were increased. In contrast, hydrocortisone treatment and induction of insulin resistance increased islet numbers and area, with enhanced beta cell replication, elevated mass of beta and alpha cells, together with co-expression of GLP-1 and GIP with glucagon in islets. The metabolic responses to streptozotocin in GLP-1RKO and GIPRKO mice were broadly similar to C57BL/6 controls, although decreases in islet numbers and size were more severe. In contrast, both groups of mice lacking functional incretin receptors displayed substantially impaired islet adaptations to insulin resistance induced by hydrocortisone, including marked curtailment of expansion of islet area, beta cell mass and islet number. Our observations cannot be explained by simple changes in circulating incretin concentrations, suggesting that intra-islet GLP-1 and GIP make a significant contribution to islet adaptation, particularly expansion of beta cell mass and compensatory islet compensation to hydrocortisone and insulin resistance.	[Vasu, Srividya; Moffett, R. Charlotte; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	Ulster University; University of Lausanne	Vasu, S (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland.	s.vasu@ulster.ac.uk		Moffett, R Charlotte/0000-0002-7196-7863; Flatt, Peter/0000-0001-8548-7943	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland	The study was supported in part by an EFSD/Boehringer Ingelheim Grant and a research scholarship to RCM from Department of Education and Learning, Northern Ireland. Professor DJ Drucker is thanked for provision of GLP-1RKO mice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAILEY CJ, 1982, METABOLISM, V31, P238, DOI 10.1016/0026-0495(82)90059-2; Barnett AH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4382; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Creutzfeldt W, 2001, EXP CLIN ENDOCR DIAB, V109, pS288, DOI 10.1055/s-2001-18589; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Heller RS, 1995, AM J PHYSIOL-GASTR L, V269, pG852, DOI 10.1152/ajpgi.1995.269.6.G852; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2009, DIABETES OBES METAB, V11, P603, DOI 10.1111/j.1463-1326.2009.01036.x; Irwin N, 2013, CURR OPIN PHARMACOL, V13, P989, DOI 10.1016/j.coph.2013.09.009; Irwin N, 2013, BIOCHEM PHARMACOL, V85, P81, DOI 10.1016/j.bcp.2012.10.008; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Kaiser D, 2014, BR J PHARM; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; MOJSOV S, 1990, J BIOL CHEM, V265, P8001; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nauck MA, 2013, DIABETOLOGIA, V56, P1878, DOI 10.1007/s00125-013-2953-6; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; OBrien BA, 1996, J PATHOL, V178, P176; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Salehi M, 2010, DIABETES, V59, P1330, DOI 10.2337/db09-1253; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Swali A, 2008, DIABETOLOGIA, V51, P2003, DOI 10.1007/s00125-008-1137-2; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Thorens B, 2013, J INTERN MED, V274, P203, DOI 10.1111/joim.12096; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Ugleholdt R, 2006, J BIOL CHEM, V281, P11050, DOI 10.1074/jbc.M601203200; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563	45	61	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101005	10.1371/journal.pone.0101005	http://dx.doi.org/10.1371/journal.pone.0101005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967820	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800097
J	Yue, J; Li, C; Liu, YW; Yu, JJ				Yue, Jing; Li, Cong; Liu, Yuwei; Yu, Jingjuan			A Remorin Gene SiREM6, the Target Gene of SiARDP, from Foxtail Millet (Setaria italica) Promotes High Salt Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							PLASMA-MEMBRANE; LOW-TEMPERATURE; TRANSCRIPTIONAL ACTIVATOR; MEDICAGO-TRUNCATULA; RESPONSIVE GENES; ABIOTIC-STRESS; WATER-DEFICIT; PROTEINS; EXPRESSION; DROUGHT	Remorin proteins (REMs) form a plant-specific protein family, with some REMs being responsive to abiotic stress. However, the precise functions of REMs in abiotic stress tolerance are not clear. In this study, we identified 11 remorin genes from foxtail millet (Setaria italica) and cloned a remorin gene, SiREM6, for further investigation. The transcript level of SiREM6 was increased by high salt stress, low temperature stress and abscisic acid (ABA) treatment, but not by drought stress. The potential oligomerization of SiREM6 was examined by negative staining electron microscopy. The overexpression of SiREM6 improved high salt stress tolerance in transgenic Arabidopsis at the germination and seedling stages as revealed by germination rate, survival rate, relative electrolyte leakage and proline content. The SiREM6 promoter contains two dehydration responsive elements (DRE) and one ABA responsive element (ABRE). An ABA responsive DRE-binding transcription factor, SiARDP, and an ABRE-binding transcription factor, SiAREB1, were cloned from foxtail millet. SiARDP could physically bind to the DREs, but SiAREB1 could not. These results revealed that SiREM6 is a target gene of SiARDP and plays a critical role in high salt stress tolerance.	[Yue, Jing; Li, Cong; Liu, Yuwei; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yujj@cau.edu.cn			National Basic Research Program of China [2012CB215301]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2012CB215301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bechtold N, 1998, METH MOL B, V82, P259; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen L, 2010, MOL BIOL REP, V37, P737, DOI 10.1007/s11033-009-9582-7; Coaker GL, 2004, MOL PLANT MICROBE IN, V17, P1019, DOI 10.1094/MPMI.2004.17.9.1019; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; FARMER EE, 1991, J BIOL CHEM, V266, P3140; FARMER EE, 1989, P NATL ACAD SCI USA, V86, P1539, DOI 10.1073/pnas.86.5.1539; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; JACINTO T, 1993, PLANT PHYSIOL, V103, P1393, DOI 10.1104/pp.103.4.1393; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Lin F, 2003, CELL RES, V13, P59, DOI 10.1038/sj.cr.7290151; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Ofosu-Anim J., 2006, International Journal of Agriculture and Biology, V8, P576; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Sanchez-Moran E, 2005, CYTOGENET GENOME RES, V109, P181, DOI 10.1159/000082398; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030817; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YEO AR, 1984, PLANT PHYSIOL, V75, P298, DOI 10.1104/pp.75.2.298; Zhao L, 2009, PLANT BIOTECHNOL J, V7, P550, DOI 10.1111/j.1467-7652.2009.00423.x	45	23	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100772	10.1371/journal.pone.0100772	http://dx.doi.org/10.1371/journal.pone.0100772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967625	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800065
J	Zaccaria, E; van Baarlen, P; de Greeff, A; Morrison, DA; Smith, H; Wells, JM				Zaccaria, Edoardo; van Baarlen, Peter; de Greeff, Astrid; Morrison, Donald A.; Smith, Hilde; Wells, Jerry M.			Control of Competence for DNA Transformation in Streptococcus suis by Genetically Transferable Pherotypes	PLOS ONE			English	Article							GENE-TRANSFER; PEPTIDE; PNEUMONIAE; ACTIVATION; EXPRESSION; SYSTEM; IDENTIFICATION; MECHANISMS; REGULATOR; EVOLUTION	Here we show that S. suis, a major bacterial pathogen of pigs and emerging pathogen in humans responds to a peptide pheromone by developing competence for DNA transformation. This species does not fall within any of the phylogenetic clusters of streptococci previously shown to regulate competence via peptide pheromones suggesting that more species of streptococci may be naturally competent. Induction of competence was dependent on ComX, a sigma factor that controls the streptococcal late competence regulon, extracellular addition of a comX-inducing peptide (XIP), and ComR, a regulator of comX. XIP was identified as an N-terminally truncated variant of ComS. Different comS alleles are present among strains of S. suis. These comS alleles are not functionally equivalent and appear to operate in conjuction with a cognate ComR to regulate comX through a conserved comR-box promoter. We demonstrate that these 'pherotypes' can be genetically transferred between strains, suggesting that similar approaches might be used to control competence induction in other lactic acid bacteria that lack ComR/ComS homologues but possess comX and the late competence regulon. The approaches described in this paper to identify and optimize peptide-induced competence may also assist other researchers wishing to identify natural competence in other bacteria. Harnessing natural competence is expected to accelerate genetic research on this and other important streptococcal pathogens and to allow high-throughput mutation approaches to be implemented, opening up new avenues for research.	[Zaccaria, Edoardo; van Baarlen, Peter; Wells, Jerry M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [de Greeff, Astrid; Smith, Hilde] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [Morrison, Donald A.] Univ Illinois, Chicago, IL USA	Wageningen University & Research; Wageningen University & Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wells, JM (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	Zaccaria, Edoardo/AAP-9740-2020	van Baarlen, Peter/0000-0003-3530-5472	National Science Foundation [MCB-1020863]	National Science Foundation(National Science Foundation (NSF))	J.W. and E.Z. gratefully acknowledge their financial support. D. M. acknowledges support from the National Science Foundation (MCB-1020863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1990, MOL MICROBIOL, V4, P633, DOI 10.1111/j.1365-2958.1990.tb00632.x; Blomqvist T, 2006, ARCH MICROBIOL, V186, P465, DOI 10.1007/s00203-006-0162-0; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12; FACKLAM RR, 1977, J CLIN MICROBIOL, V5, P184; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fleuchot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066042; Fontaine L, 2013, MOL MICROBIOL, V87, P1113, DOI 10.1111/mmi.12157; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Maughan H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005854; Morrison DA, 2013, J BACTERIOL, V195, P2612, DOI 10.1128/JB.00230-13; NAKAYAMA J, 1994, J BACTERIOL, V176, P7405, DOI 10.1128/JB.176.23.7405-7408.1994; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okinaga T, 2010, J BACTERIOL, V192, P1844, DOI 10.1128/JB.01667-09; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Takeuchi N, 2014, G3-GENES GENOM GENET, V4, P325, DOI 10.1534/g3.113.009845; VONHEIJNE G, 1984, EMBO J, V3, P2315, DOI 10.1002/j.1460-2075.1984.tb02132.x; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	45	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99394	10.1371/journal.pone.0099394	http://dx.doi.org/10.1371/journal.pone.0099394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968201	Green Submitted, Green Published, gold			2022-12-25	WOS:000338280800011
J	Brom, L; Pasman, HRW; Widdershoven, GAM; van der Vorst, MJDL; Reijneveld, JC; Postma, TJ; Onwuteaka-Philipsen, BD				Brom, Linda; Pasman, H. Roeline W.; Widdershoven, Guy A. M.; van der Vorst, Maurice J. D. L.; Reijneveld, Jaap C.; Postma, Tjeerd J.; Onwuteaka-Philipsen, Bregje D.			Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients	PLOS ONE			English	Article							RECURRENT OVARIAN-CANCER; BREAST-CANCER; OF-LIFE; COLORECTAL-CANCER; PROSTATE-CANCER; INFORMATION NEEDS; INVOLVEMENT; WOMEN; CARE; PERCEPTIONS	Purpose: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more emphasis on weighing quantity against quality of life, such as whether or not to start treatment aimed at life prolongation but with the possibility of side effects. This study aimed to obtain insight into cancer patients' preferences and the reasons for patients' preferred role in treatment decision-making at the end of life. Methods: 28 advanced cancer patients were included at the start of their first line treatment. In-depth interviews were held prior to upcoming treatment decisions whether or not to start a life prolonging treatment. The Control Preference Scale was used to start discussing the extent and type of influence patients wanted to have concerning upcoming treatment decision-making. Interviews were audio taped and transcribed. Results: All patients wanted their physician to participate in the treatment decision-making process. The extent to which patients themselves preferred to participate seemed to depend on how patients saw their own role or assessed their own capabilities for participating in treatment decision-making. Patients foresaw a shift in the preferred level of participation to a more active role depending in the later phase of illness when life prolongation would become more limited and quality of life would become more important. Conclusion: Patients vary in how much involvement they would like to have in upcoming treatment decision-making. Individual patients' preferences may change in the course of the illness, with a shift to more active participation in the later phases. Communication about patients' expectations, wishes and preferences for participation in upcoming treatment decisions is of great importance. An approach in which these topics are openly discussed would be beneficial.	[Brom, Linda; Pasman, H. Roeline W.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, Amsterdam, Netherlands; [Widdershoven, Guy A. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Med Humanities, Amsterdam, Netherlands; [van der Vorst, Maurice J. D. L.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Reijneveld, Jaap C.; Postma, Tjeerd J.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Brom, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, Amsterdam, Netherlands.	eol@vumc.nl		Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Innovational Research Incentives Scheme VICI from the Netherlands Organisation for Scientific Research (NWO)	Innovational Research Incentives Scheme VICI from the Netherlands Organisation for Scientific Research (NWO)	This study was funded by the Innovational Research Incentives Scheme VICI 2008 from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Beaver K, 2005, HEALTH EXPECT, V8, P103, DOI 10.1111/j.1369-7625.2005.00320.x; Beaver K, 2007, EUR J ONCOL NURS, V11, P409, DOI 10.1016/j.ejon.2007.04.004; Berendsen AJ, 2010, PATIENT EDUC COUNS, V79, P100, DOI 10.1016/j.pec.2009.07.032; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Brown R, 2012, J CLIN ONCOL, V30, P857, DOI 10.1200/JCO.2011.37.7952; Brundage Michael D., 2000, Health Expect, V3, P55, DOI 10.1046/j.1369-6513.2000.00083.x; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Caress AL, 2005, THORAX, V60, P199, DOI 10.1136/thx.2004.029041; Carey M, 2012, PATIENT EDUC COUNS, V88, P87, DOI 10.1016/j.pec.2011.12.014; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Clark JA, 2003, J CLIN ONCOL, V21, P3777, DOI 10.1200/JCO.2003.02.115; Clark JA, 2001, J CLIN ONCOL, V19, P72, DOI 10.1200/JCO.2001.19.1.72; Cohen H, 2003, FAM PRACT, V20, P724, DOI 10.1093/fampra/cmg617; Colorectal Canc Collaborative Grp, 2000, BMJ-BRIT MED J, V321, P531; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Degner L F, 1997, Can J Nurs Res, V29, P21; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Donovan KA, 2002, GYNECOL ONCOL, V86, P200, DOI 10.1006/gyno.2002.6748; Elit L, 2010, PSYCHO-ONCOLOGY, V19, P318, DOI 10.1002/pon.1562; Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922; Fiset Valerie, 2000, Health Expect, V3, P125, DOI 10.1046/j.1369-6513.2000.00067.x; Fried Terri R, 2003, J Palliat Med, V6, P237, DOI 10.1089/109662103764978489; Gattellari M, 2001, SOC SCI MED, V52, P1865, DOI 10.1016/S0277-9536(00)00303-8; Glaser B, 1978, DISCOV GROUNDED THEO; Hack TF, 2006, PSYCHO-ONCOL, V15, P9, DOI 10.1002/pon.907; HACK TF, 1994, SOC SCI MED, V39, P279, DOI 10.1016/0277-9536(94)90336-0; Hubbard G, 2008, EUR J ONCOL NURS, V12, P299, DOI 10.1016/j.ejon.2008.03.004; Kremer H, 2007, MED DECIS MAKING, V27, P522, DOI 10.1177/0272989x07306782; Labianca R, 2010, CRIT REV ONCOL HEMAT, V74, P106, DOI 10.1016/j.critrevonc.2010.01.010; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Lanz NK, 2004, J CLIN ONCOL, V22, P3091, DOI 10.1200/JCO.2004.09.069; LEVY SM, 1989, J CLIN ONCOL, V7, P367, DOI 10.1200/JCO.1989.7.3.367; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; MCQUELLON RP, 1995, J CLIN ONCOL, V13, P858, DOI 10.1200/JCO.1995.13.4.858; Payne DK, 2000, ANN SURG ONCOL, V7, P150, DOI 10.1007/s10434-000-0150-6; Pentz RD, 2012, ONCOLOGIST, V17, P881, DOI 10.1634/theoncologist.2011-0446; POZO C, 1992, J CLIN ONCOL, V10, P1292, DOI 10.1200/JCO.1992.10.8.1292; Purbrick RMJ, 2006, EYE, V20, P1034, DOI 10.1038/sj.eye.6702074; Rothenbacher D, 1997, EUR J CANCER, V33, P1184, DOI 10.1016/S0959-8049(97)00034-8; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sepucha KR, 2009, MED DECIS MAKING, V29, P475, DOI 10.1177/0272989X09333124; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Strauss A., 1990, BASICS QUALITATIVE R; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; Tariman JD, 2010, ANN ONCOL, V21, P1145, DOI 10.1093/annonc/mdp534; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wright AA, 2010, CANCER-AM CANCER SOC, V116, P4656, DOI 10.1002/cncr.25217	52	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100435	10.1371/journal.pone.0100435	http://dx.doi.org/10.1371/journal.pone.0100435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964036	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500050
J	Aarabi, M; Balakier, H; Bashar, S; Moskovtsev, SI; Sutovsky, P; Librach, CL; Oko, R				Aarabi, Mahmoud; Balakier, Hanna; Bashar, Siamak; Moskovtsev, Sergey I.; Sutovsky, Peter; Librach, Clifford L.; Oko, Richard			Sperm-derived WW domain-binding protein, PAWP, elicits calcium oscillations and oocyte activation in humans and mice	FASEB JOURNAL			English	Article						fertilization; reproductive biology	PHOSPHOLIPASE-C-ZETA; MOUSE EGG ACTIVATION; KIT TYROSINE KINASE; CA2+ OSCILLATIONS; PLC-ZETA; INTRACELLULAR CALCIUM; MEDIATED ACTIVATION; PERINUCLEAR THECA; HUMAN SPERMATOZOA; TRUNCATED FORM	Mammalian zygotic development is initiated by sperm-mediated intracellular calcium oscillations, followed by activation of metaphase II-arrested oocytes. Sperm postacrosomal WW binding protein (PAWP) fulfils the criteria set for an oocyte-activating factor by inducing oocyte activation and being stored in the perinuclear theca, the sperm compartment whose content is first released into oocyte cytoplasm during fertilization. However, proof that PAWP initiates mammalian zygotic development relies on demonstration that it acts upstream of oocyte calcium oscillations. Here, we show that PAWP triggers calcium oscillations and pronuclear formation in human and mouse oocytes similar to what is observed during intracytoplasmic sperm injection (ICSI). Most important, sperm-induced calcium oscillations are blocked by coinjection of a competitive inhibitor, derived from the WWI domain-binding motif of PAWP, implying the requirement of sperm PAWP and an oocyte-derived WWI domain protein substrate of PAWP for successful fertilization. Sperm-delivered PAWP is, therefore, a unique protein with a nonredundant role during human and mouse fertilization, required to trigger zygotic development. Presented data confirm our previous findings in non-mammalian models and suggest potential applications of PAWP in the diagnosis and treatment of infertility.-Aarabi, M., Balakier, H., Bashar, S., Moskovtsev, S. I., Sutovsky, P., Librach, C. L., and Oko, R. Sperm-derived WW domain-binding protein, PAWP, elicits calcium oscil-lations and oocyte activation in humans and mice.	[Aarabi, Mahmoud; Oko, Richard] Queens Univ, Sch Med, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Aarabi, Mahmoud] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Balakier, Hanna; Bashar, Siamak; Moskovtsev, Sergey I.; Librach, Clifford L.] CReATe Fertil Ctr, Toronto, ON, Canada; [Moskovtsev, Sergey I.; Librach, Clifford L.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Sutovsky, Peter] Univ Missouri, Sch Med, Div Anim Sci, Columbia, MO USA; [Sutovsky, Peter] Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA	Queens University - Canada; McGill University; University of Toronto; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Oko, R (corresponding author), Queens Univ, Sch Med, Dept Biomed & Mol Sci, Botterell Hall,Rm 927, Kingston, ON K7L 3N6, Canada.	ro3@queensu.ca	Aarabi, Mahmoud/AAN-2984-2021	Sutovsky, Peter/0000-0002-9231-2823	Canadian Institutes of Health Research [MOP-84440]; U.S. Department of Agriculture/National Institute of Food and Agriculture [2011-67015-20025]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	The authors are grateful to Dr. Hugh Clarke and Dr. Jiao Suzuki (McGill University, Montreal, Quebec, Canada) and Dr. Young-Joo Yi (University of Missouri, Columbia, MO, USA) for their generous help in optimization of mouse ICSI. The authors appreciate technical advice for mouse calcium imaging from Dr. Christopher Ward, Mr. Jeffrey Mewburn and Mr. Matthew Gordon (Queen's University, Kingston, ON, Canada); and for human calcium imaging from Mr. Paul Paroutis (Hospital for Sick Children, Toronto, ON, Canada). The authors acknowledge the great assistance from Ms. Wei Xu (Queen's University) on sample collection and analysis. The authors are grateful to the physicians, nurses, and staff of the CReATe Fertility Centre (Toronto, ON, Canada), especially to Ms. Agata Sojecki for assistance in human ICSI. The authors are also indebted to infertile couples who generously agreed to donate their surplus gametes for this study. This study was supported by a Canadian Institutes of Health Research grant (MOP-84440 to R.O.). Work in the laboratory of P.S. was supported by award 2011-67015-20025 from the U.S. Department of Agriculture/National Institute of Food and Agriculture; no such funds were used for work with donated human oocytes.	Aarabi M, 2014, FERTIL STERIL, V102, P440, DOI 10.1016/j.fertnstert.2014.05.003; Aarabi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033496; Aarabi M, 2010, MOL REPROD DEV, V77, P249, DOI 10.1002/mrd.21140; Balakier H, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.015; Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Browaeys-Poly E, 2007, CELL SIGNAL, V19, P2540, DOI 10.1016/j.cellsig.2007.08.002; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dale B, 2010, REPROD BIOMED ONLINE, V21, P1, DOI 10.1016/j.rbmo.2010.02.015; Ferrer M, 2012, CELL TISSUE RES, V349, P881, DOI 10.1007/s00441-012-1429-1; Grasa P, 2008, HUM REPROD, V23, P2513, DOI 10.1093/humrep/den280; Harada Y, 2007, DEV BIOL, V306, P797, DOI 10.1016/j.ydbio.2007.04.019; Ito J, 2011, MOL REPROD DEV, V78, P846, DOI 10.1002/mrd.21359; Kashir J, 2013, FERTIL STERIL, V99, P107, DOI 10.1016/j.fertnstert.2012.09.001; Kennedy CE, 2014, MOL REPROD DEV, V81, P436, DOI 10.1002/mrd.22309; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Mehlmann LM, 2005, REPRODUCTION, V129, P557, DOI 10.1530/rep.1.00638; Morozumi K, 2006, P NATL ACAD SCI USA, V103, P17661, DOI 10.1073/pnas.0608183103; Muciaccia B, 2010, HUM REPROD, V25, P2188, DOI 10.1093/humrep/deq168; NIGGLI E, 1994, AM J PHYSIOL, V266, pC303, DOI 10.1152/ajpcell.1994.266.1.C303; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Oko R, 2009, J REPROD IMMUNOL, V83, P2, DOI 10.1016/j.jri.2009.05.008; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Rogers NT, 2004, REPRODUCTION, V128, P697, DOI 10.1530/rep.1.00484; Runft LL, 2000, DEVELOPMENT, V127, P3227; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Sette C, 2002, EMBO J, V21, P5386, DOI 10.1093/emboj/cdf553; Sette C, 1998, J CELL BIOL, V142, P1063, DOI 10.1083/jcb.142.4.1063; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P362, DOI 10.1002/jemt.10350; Swann K, 2013, CELL CALCIUM, V53, P55, DOI 10.1016/j.ceca.2012.11.001; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tovich PR, 2004, BIOL REPROD, V71, P1182, DOI 10.1095/biolreprod.104.030445; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Wu ATH, 2007, J BIOL CHEM, V282, P12164, DOI 10.1074/jbc.M609132200; XU Z, 1994, DEVELOPMENT, V120, P1851; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021	40	85	89	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4434	4440		10.1096/fj.14-256495	http://dx.doi.org/10.1096/fj.14-256495			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24970390				2022-12-25	WOS:000342222700021
J	Campbell, J; Huang, YM; Liu, YJ; Schenken, R; Arulanandam, B; Zhong, GM				Campbell, Jessica; Huang, Yumeng; Liu, Yuanjun; Schenken, Robert; Arulanandam, Bernard; Zhong, Guangming			Bioluminescence Imaging of Chlamydia muridarum Ascending Infection in Mice	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; PELVIC-INFLAMMATORY-DISEASE; TRACHOMATIS PLASMID; TRANSCRIPTIONAL REGULATOR; PROTECTIVE IMMUNITY; VIRULENCE; DISSEMINATION; HYDROSALPINX; CONTRIBUTES; PATHOLOGY	Chlamydial pathogenicity in the upper genital tract relies on chlamydial ascending from the lower genital tract. To monitor chlamydial ascension, we engineered a luciferase-expressing C. muridarum. In cells infected with the luciferase-expressing C. muridarum, luciferase gene expression and enzymatic activity (measured as bioluminescence intensity) correlated well along the infection course, suggesting that bioluminescence can be used for monitoring chlamydial replication. Following an intravaginal inoculation with the luciferase-expressing C. muridarum, 8 of 10 mice displayed bioluminescence signal in the lower with 4 also in the upper genital tracts on day 3 after infection. By day 7, all 10 mice developed bioluminescence signal in the upper genital tracts. The bioluminescence signal was maintained in the upper genital tract in 6 and 2 mice by days 14 and 21, respectively. The bioluminescence signal was no longer detectable in any of the mice by day 28. The whole body imaging approach also revealed an unexpected airway infection following the intravaginal inoculation. Although the concomitant airway infection was transient and did not significantly alter the genital tract infection time courses, caution should be taken during data interpretation. The above observations have demonstrated that C. muridarum can not only achieve rapid ascending infection in the genital tract but also cause airway infection following a genital tract inoculation. These findings have laid a foundation for further optimizing the C. muridarum intravaginal infection murine model for understanding chlamydial pathogenic mechanisms.	[Huang, Yumeng; Liu, Yuanjun; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Campbell, Jessica; Schenken, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Arulanandam, Bernard] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.edu	Arulanandam, Bernard P/O-9501-2014		US NIH [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by US NIH grants R01AI064537 and R01AI047997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS J, 1970, Infection and Immunity, V1, P259; Barry MA, 2012, METHODS MOL BIOL, V797, P79, DOI 10.1007/978-1-61779-340-0_6; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Davies B, 2013, SEX TRANSM DIS, V40, P230, DOI 10.1097/OLQ.0b013e31827b9d75; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Gonzalez RJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-147; Kong Ying, 2011, Curr Protoc Microbiol, VChapter 2, DOI [10.1002/9780471729259.mc02c04s21, 10.1002/9780471729259.mc02c03s21]; Last AR, 2014, J CLIN MICROBIOL, V52, P324, DOI 10.1128/JCM.02618-13; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Perry LL, 1999, INFECT IMMUN, V67, P3686, DOI 10.1128/IAI.67.7.3686-3689.1999; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Sigar IM, 2014, PATHOG DIS, V70, P61, DOI 10.1111/2049-632X.12086; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Tang LL, 2014, VACCINE, V32, P1407, DOI 10.1016/j.vaccine.2013.10.018; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	26	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101634	10.1371/journal.pone.0101634	http://dx.doi.org/10.1371/journal.pone.0101634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983626	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000126
J	Chen, J; Shao, JS; Cai, RT; Shen, YZ; Zhang, RF; Liu, L; Qi, TK; Lu, HZ				Chen, Jun; Shao, Jiasheng; Cai, Rentian; Shen, Yinzhong; Zhang, Renfang; Liu, Li; Qi, Tangkai; Lu, Hongzhou			Anti-Retroviral Therapy Decreases but Does Not Normalize Indoleamine 2,3-Dioxygenase Activity in HIV-Infected Patients	PLOS ONE			English	Article							T-CELL; INTERFERON-GAMMA; MICROBIAL TRANSLOCATION; TRYPTOPHAN CATABOLISM; IMMUNE ACTIVATION; DENDRITIC CELLS; KYNURENINE; INDUCTION; PROLIFERATION; DEGRADATION	Background: Indoleamine 2,3-dioxygenase (IDO), which is mainly expressed in activated dendritic cells, catabolizes tryptophan to kynurenine and other downstream catabolites. It is known to be an immune mediator in HIV pathogenesis. The impact of anti-retroviral therapy on its activity has not been well established. Methods: We measured systemic IDO activity (the ratio of plasma kynurenine to tryptophan) in HIV-infected patients before and after highly active antiretroviral therapy (HAART) and its association with a microbial translocation marker, soluble CD14 (sCD14). Results: Among 76 participants, higher baseline IDO activity was associated with lower CD4(+) T cell counts (P<0.05) and higher plasma sCD14 levels (P<0.001). After 1 year of HAART, IDO activity decreased significantly (P<0.01), but was still higher than in healthy controls (P<0.05). The baseline IDO activity did not predict CD4(+) T cell recovery after 1 year of therapy. The percentages of myeloid and plasmacytoid dendritic cells were not correlated with IDO activity. Conclusions: IDO activity is elevated in HIV-infected patients, which is partially associated with microbial translocation. HAART reduced, but did not normalize the activity of IDO.	[Chen, Jun; Shao, Jiasheng; Cai, Rentian; Shen, Yinzhong; Zhang, Renfang; Liu, Li; Qi, Tangkai; Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, HuaShan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Lu, HZ (corresponding author), Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn	Chen, Jun/K-2085-2012	Chen, Jun/0000-0002-3850-4875	National Natural Science Foundation of China [81301420, 81071353]; Program for the 12th Five-year Plan [2012ZX10001003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the 12th Five-year Plan	JC and HL received grant from National Natural Science Foundation of China (No. 81301420 and 81071353, http://www.nsfc.gov.cn/). HL also received funding from Program for the 12th Five-year Plan (grant No. 2012ZX10001003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Byakwaga H, 2014, J INFECT DIS; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121; Dinel AL, 2014, PSYCHONEUROENDOCRINO, V40, P48, DOI 10.1016/j.psyneuen.2013.10.014; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Frick B, 2004, CLIN BIOCHEM, V37, P684, DOI 10.1016/j.clinbiochem.2004.02.007; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Grant RS, 2000, REDOX REP, V5, P105, DOI 10.1179/135100000101535366; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Huengsberg M, 1998, CLIN CHEM, V44, P858; Jenabian MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078146; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Karris MY, 2014, AIDS, V28, P841, DOI 10.1097/QAD.0000000000000149; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Loughman JA, 2012, J INFECT DIS, V205, P1830, DOI 10.1093/infdis/jis280; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Martinez P, 2014, JAIDS-J ACQ IMM DEF, V65, P456, DOI 10.1097/QAI.0000000000000062; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pertovaara M, 2006, MECH AGEING DEV, V127, P497, DOI 10.1016/j.mad.2006.01.020; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Planes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074551; Samikkannu T, 2010, J NEUROVIROL, V16, P255, DOI 10.3109/13550284.2010.497809; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wirthgen E, 2014, INNATE IMMUN-LONDON, V20, P30, DOI 10.1177/1753425913481252; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100446	10.1371/journal.pone.0100446	http://dx.doi.org/10.1371/journal.pone.0100446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983463	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000025
J	Dumble, M; Crouthamel, MC; Zhang, SY; Schaber, M; Levy, D; Robell, K; Liu, Q; Figueroa, DJ; Minthorn, EA; Seefeld, MA; Rouse, MB; Rabindran, SK; Heerding, DA; Kumar, R				Dumble, Melissa; Crouthamel, Ming-Chih; Zhang, Shu-Yun; Schaber, Michael; Levy, Dana; Robell, Kimberly; Liu, Qi; Figueroa, David J.; Minthorn, Elisabeth A.; Seefeld, Mark A.; Rouse, Meagan B.; Rabindran, Sridhar K.; Heerding, Dirk A.; Kumar, Rakesh			Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; BREAST-CANCER; ACTIVATING MUTATION; PHOSPHORYLATION; INDUCTION; APOPTOSIS; RICTOR; EGFR	Tumor cells upregulate many cell signaling pathways, with AKT being one of the key kinases to be activated in a variety of malignancies. GSK2110183 and GSK2141795 are orally bioavailable, potent inhibitors of the AKT kinases that have progressed to human clinical studies. Both compounds are selective, ATP-competitive inhibitors of AKT 1, 2 and 3. Cells treated with either compound show decreased phosphorylation of several substrates downstream of AKT. Both compounds have desirable pharmaceutical properties and daily oral dosing results in a sustained inhibition of AKT activity as well as inhibition of tumor growth in several mouse tumor models of various histologic origins. Improved kinase selectivity was associated with reduced effects on glucose homeostasis as compared to previously reported ATP-competitive AKT kinase inhibitors. In a diverse cell line proliferation screen, AKT inhibitors showed increased potency in cell lines with an activated AKT pathway (via PI3K/PTEN mutation or loss) while cell lines with activating mutations in the MAPK pathway (KRAS/BRAF) were less sensitive to AKT inhibition. Further investigation in mouse models of KRAS driven pancreatic cancer confirmed that combining the AKT inhibitor, GSK2141795 with a MEK inhibitor (GSK2110212; trametinib) resulted in an enhanced antitumor effect accompanied with greater reduction in phospho-S6 levels. Taken together these results support clinical evaluation of the AKT inhibitors in cancer, especially in combination with MEK inhibitor.	[Dumble, Melissa; Crouthamel, Ming-Chih; Zhang, Shu-Yun; Levy, Dana; Robell, Kimberly; Liu, Qi; Figueroa, David J.; Minthorn, Elisabeth A.; Seefeld, Mark A.; Rouse, Meagan B.; Rabindran, Sridhar K.; Heerding, Dirk A.; Kumar, Rakesh] GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA; [Schaber, Michael] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Kumar, R (corresponding author), GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA.	rakesh.2.kumar@gsk.com	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for the work was provided by GlaxoSmithKline. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Burris HA, 2011, J CLIN ONCOL S, V29, P2003; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Ricciardi MR, 2012, J MOL MED, V90, P1133, DOI 10.1007/s00109-012-0886-z; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Saleh M, 2013, AM ASS CANC RES ANN; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Spencer A, 2011, P 53 AM SOC HEM ANN; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Turke AB, 2012, CANCER RES, V72, P1; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	38	88	91	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100880	10.1371/journal.pone.0100880	http://dx.doi.org/10.1371/journal.pone.0100880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978597	Green Submitted, gold, Green Published			2022-12-25	WOS:000338506400045
J	Kaldenbach, M; Cubero, FJ; Erschfeld, S; Liedtke, C; Trautwein, C; Streetz, K				Kaldenbach, Michaela; Cubero, Francisco Javier; Erschfeld, Stephanie; Liedtke, Christian; Trautwein, Christian; Streetz, Konrad			Hepatic Tissue Environment in NEMO-Deficient Mice Critically Regulates Positive Selection of Donor Cells after Hepatocyte Transplantation	PLOS ONE			English	Article							NF-KAPPA-B; LIVER-INJURY; HEPATOCELLULAR-CARCINOMA; IN-VIVO; CIRRHOSIS; RATS; REGENERATION; REPOPULATION; REPLACEMENT; PROGRESSION	Background: Hepatocyte transplantation (HT) is a promising alternative treatment strategy for end-stage liver diseases compared with orthotopic liver transplantation. A limitation for this approach is the low engraftment of donor cells. The deletion of the I-kappa B kinase-regulatory subunit IKK gamma/NEMO in hepatocytes prevents nuclear factor (NF)-kB activation and triggers spontaneous liver apoptosis, chronic hepatitis and the development of liver fibrosis and hepatocellular carcinoma. We hypothesized that NEMO Delta hepa mice may therefore serve as an experimental model to study HT. Methods: Pre-conditioned NEMO Delta hepa mice were transplanted with donor-hepatocytes from wildtype (WT) and mice deficient for the pro-apoptotic mediator Caspase-8 (CaspehePa). Results: Transplantation of isolated WT-hepatocytes into pre-conditioned NEMO Delta hepa mice resulted in a 6-7 fold increase of donor cells 12 weeks after HT, while WT-recipients showed no liver repopulation. The use of apoptosis-resistant Casp8(Delta hepa)-derived donor cells further enhanced the selection 3-fold after 12-weeks and up to 10-fold increase after 52 weeks compared with WT donors. While analysis of NEMO Delta hepa mice revealed strong liver injury, HT-recipient NEMO Delta hepa mice showed improved liver morphology and decrease in serum transaminases. Concomitant with these findings, the histological examination elicited an improved liver tissue architecture associated with significantly lower levels of apoptosis, decreased proliferation and a lesser amount of liver fibrogenesis. Altogether, our data clearly support the therapeutic benefit of the HT procedure into NEMO Delta hepa mice. Conclusion: This study demonstrates the feasibility of the NEMO Delta hepa mouse as an in vivo tool to study liver repopulation after HT. The improvement of the characteristic phenotype of chronic liver injury in NEMO Delta hepa ice after HT suggests the therapeutic potential of HT in liver diseases with a chronic inflammatory phenotype and opens a new door for the applicability of this technique to combat liver disease in the human clinic.	[Kaldenbach, Michaela; Cubero, Francisco Javier; Erschfeld, Stephanie; Liedtke, Christian; Trautwein, Christian; Streetz, Konrad] Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, D-52062 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Streetz, K (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, D-52062 Aachen, Germany.	kstreetz@ukaachen.de	Liedtke, Christian/DTV-1874-2022	Liedtke, Christian/0000-0003-4681-7887; Cubero, Francisco Javier/0000-0003-1499-650X	Deutsche Forschungsgemeinschaft (DFG) [5TR661/4-2]; DFG SFB/TRR [57]; faculty of medicine [691405]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG SFB/TRR(German Research Foundation (DFG)); faculty of medicine	KS, MK, SE were supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) grant nr. 5TR661/4-2. CL and CT were supported by a grant of the DFG SFB/TRR 57, and FJC was supported by the faculty of medicine grant nr. 691405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Chaudhary K, 2013, J HEPATOL, V59, P1292, DOI 10.1016/j.jhep.2013.07.026; Christ B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00168; Cubero FJ, 2013, CELL DEATH DIFFER, V20, P1580, DOI 10.1038/cdd.2013.112; FITZGERALD MJ, 1995, CELL GROWTH DIFFER, V6, P417; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Freimuth J, 2013, HEPATOLOGY; Grompe M, 2001, J INHERIT METAB DIS, V24, P231, DOI 10.1023/A:1010375203539; Guha C, 2001, ARTIF ORGANS, V25, P522, DOI 10.1046/j.1525-1594.2001.025007522.x; Kaldenbach M, 2012, GUT, V61, P1209, DOI 10.1136/gutjnl-2011-301345; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Nagata H, 2003, GASTROENTEROLOGY, V124, P422, DOI 10.1053/gast.2003.50065; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Pareja E, 2013, EUR SURG RES, V50, P273, DOI 10.1159/000351332; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; QUINN PS, 1965, AM J PATHOL, V47, P353; Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; Streetz KL, 2008, HEPATOLOGY, V47, P706, DOI 10.1002/hep.22012; Tschaharganeh DF, 2010, LIVER TRANSPLANT, V16, P23, DOI 10.1002/lt.21962; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100786	10.1371/journal.pone.0100786	http://dx.doi.org/10.1371/journal.pone.0100786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979756	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400040
J	Kwatra, G; Adrian, PV; Shiri, T; Buchmann, EJ; Cutland, CL; Madhi, SA				Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Buchmann, Eckhart J.; Cutland, Clare L.; Madhi, Shabir A.			Serotype-Specific Acquisition and Loss of Group B Streptococcus Recto-Vaginal Colonization in Late Pregnancy	PLOS ONE			English	Article							RISK-FACTORS; WOMEN; AGALACTIAE; DISEASE; SUSCEPTIBILITY; PREVALENCE; CARRIAGE; ANTIBODY; BURDEN	Background: Maternal recto-vaginal colonization with Group B Streptococcus (GBS) and consequent vertical transmission to the newborn predisposes neonates to early-onset invasive GBS disease. This study aimed to determine the acquisition and loss of serotype-specific recto-vaginal GBS colonization from 20-37+ weeks of gestational age. Methods: Vaginal and rectal swabs were collected from HIV-uninfected women at 20-25 weeks of gestation age and at 5-6 weekly intervals thereafter. Swabs were cultured for GBS and isolates were serotyped by latex agglutination. Serologically non-typable isolates and pilus islands were characterized by PCR. Results: The prevalence of recto-vaginal GBS colonization was 33.0%, 32.7%, 28.7% and 28.4% at 20-25 weeks, 26-30 weeks, 31-35 weeks and 37+ weeks of gestational age, respectively. The most common identified serotypes were Ia (39.2%), III (32.8%) and V (12.4%). Of 507 participants who completed all four study visits, the cumulative overall recto-vaginal acquisition rate of new serotypes during the study was 27.9%, including 11.2%, 8.2% and 4.3% for serotypes Ia, III and V, respectively. Comparing the common colonizing serotypes, serotype III was more likely to be associated with persistent colonization throughout the study (29%) than Ia (18%; p = 0.045) or V (6%; p = 0.002). The median duration of recto-vaginal GBS colonization for serotype III was 6.35 weeks, which was longer than other serotypes. Pilus island proteins were detected in all GBS isolates and their subtype distribution was associated with specific serotypes. Conclusion: South African pregnant women have a high prevalence of GBS recto-vaginal colonization from 20 weeks of gestational age onwards, including high GBS acquisition rates in the last pregnancy-trimesters. There are differences in specific-serotype colonization patterns during pregnancy.	[Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Cutland, Clare L.; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Cutland, Clare L.; Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Buchmann, Eckhart J.] Univ Witwatersrand, Dept Obstet & Gynaecol, Johannesburg, South Africa	National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Adrian, PV (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa.	adrianp@rmpru.co.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307; Shiri, Tinevimbo/0000-0002-9092-3268	South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology; National Research Foundation; Novartis Vaccines, Italy	South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology; National Research Foundation; Novartis Vaccines, Italy	This work was funded by research supported by the South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology and National Research Foundation. Part-funding was also granted by Novartis Vaccines, Italy. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; BAKER CJ, 1981, PEDIATRICS, V68, P544; BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; BAKER CJ, 1975, AM J OBSTET GYNECOL, V122, P820, DOI 10.1016/0002-9378(75)90721-8; Chan SHS WK, 2000, HONG KONG J PAEDIATR, V5, P8; Davies HD, 2001, J INFECT DIS, V184, P285, DOI 10.1086/322029; Dzowela T, 2005, MALAWI MED J, V17, P97, DOI 10.4314/mmj.v17i3.10888; Edwards MS, 2013, VACCINE, V31, pD66, DOI 10.1016/j.vaccine.2012.11.046; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; Gilbert GL, 2002, AUST NZ J OBSTET GYN, V42, P497, DOI 10.1111/j.0004-8666.2002.00497.x; Goodman J R, 1997, Infect Dis Obstet Gynecol, V5, P237, DOI 10.1155/S1064744997000409; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437; Kwatra G, 2013, J CLIN MICROBIOL, V51, P2515, DOI 10.1128/JCM.00251-13; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madzivhandila M, 2013, J MED MICROBIOL, V62, P249, DOI 10.1099/jmm.0.052951-0; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mavenyengwa RT, 2010, ACTA OBSTET GYN SCAN, V89, P250, DOI 10.3109/00016340903398029; Meyn LA, 2002, AM J EPIDEMIOL, V155, P949, DOI 10.1093/aje/155.10.949; Mohammed M, 2012, ETHIOP J HEALTH DEV, V26, P36; Motlova J, 2004, INDIAN J MED RES, V119, P84; Moyo S. R., 2000, Central African Journal of Medicine, V46, P115; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Schrag SJ, 2004, CLIN INFECT DIS, V38, P1209, DOI 10.1086/382889; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Zamzami TY, 2011, ARCH GYNECOL OBSTET, V284, P677, DOI 10.1007/s00404-010-1752-2	32	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e98778	10.1371/journal.pone.0098778	http://dx.doi.org/10.1371/journal.pone.0098778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979575	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400003
J	Leslie, HH; Karasek, DA; Harris, LF; Chang, E; Abdulrahim, N; Maloba, M; Huchko, MJ				Leslie, Hannah H.; Karasek, Deborah A.; Harris, Laura F.; Chang, Emily; Abdulrahim, Naila; Maloba, May; Huchko, Megan J.			Cervical Cancer Precursors and Hormonal Contraceptive Use in HIV-Positive Women: Application of a Causal Model and Semi-Parametric Estimation Methods	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ORAL-CONTRACEPTIVES; DISEASE; RISK; INFERENCE	Objective: To demonstrate the application of causal inference methods to observational data in the obstetrics and gynecology field, particularly causal modeling and semi-parametric estimation. Background: Human immunodeficiency virus (HIV)-positive women are at increased risk for cervical cancer and its treatable precursors. Determining whether potential risk factors such as hormonal contraception are true causes is critical for informing public health strategies as longevity increases among HIV-positive women in developing countries. Methods: We developed a causal model of the factors related to combined oral contraceptive (COC) use and cervical intraepithelial neoplasia 2 or greater (CIN2+) and modified the model to fit the observed data, drawn from women in a cervical cancer screening program at HIV clinics in Kenya. Assumptions required for substantiation of a causal relationship were assessed. We estimated the population-level association using semi-parametric methods: g-computation, inverse probability of treatment weighting, and targeted maximum likelihood estimation. Results: We identified 2 plausible causal paths from COC use to CIN2+: via HPV infection and via increased disease progression. Study data enabled estimation of the latter only with strong assumptions of no unmeasured confounding. Of 2,519 women under 50 screened per protocol, 219 (8.7%) were diagnosed with CIN2+. Marginal modeling suggested a 2.9% (95% confidence interval 0.1%, 6.9%) increase in prevalence of CIN2+ if all women under 50 were exposed to COC; the significance of this association was sensitive to method of estimation and exposure misclassification. Conclusion: Use of causal modeling enabled clear representation of the causal relationship of interest and the assumptions required to estimate that relationship from the observed data. Semi-parametric estimation methods provided flexibility and reduced reliance on correct model form. Although selected results suggest an increased prevalence of CIN2+ associated with COC, evidence is insufficient to conclude causality. Priority areas for future studies to better satisfy causal criteria are identified.	[Leslie, Hannah H.; Karasek, Deborah A.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Harris, Laura F.] Univ Calif Berkeley, Joint Med Program, Berkeley, CA 94720 USA; [Harris, Laura F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chang, Emily] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Abdulrahim, Naila] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Maloba, May] FACES, Kisumu, Kenya; [Huchko, Megan J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco	Leslie, HH (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA.	Hannah.leslie@berkeley.edu	Huchko, Megan/S-6063-2019	Chang, Emily/0000-0002-5542-261X; Leslie, Hannah Hogan/0000-0002-7464-3645	NIH/NCRR/ODUCSF-CTSI [KL2 RR024130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NIH/NCRR/ODUCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial support for the original study was provided by NIH/NCRR/ODUCSF-CTSI grant no. KL2 RR024130. No financial support was provided the authors for this secondary analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; Cremer M, 2011, INT J GYNECOL OBSTET, V113, P68, DOI 10.1016/j.ijgo.2010.10.018; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gilbert SA, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.002; Glymour M., 2008, CAUSAL DIAGRAMS MODE, P183; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Gruber S., 2009, UC BERKELEY DIV BIOS; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; Heard I, 2000, OBSTET GYNECOL, V96, P403, DOI 10.1016/S0029-7844(00)00948-0; Heard I, 2004, ANTIVIR THER, V9, P13; Huchko MJ, 2014, INT J CANCER, V134, P740, DOI 10.1002/ijc.28401; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Lash TL, 2011, APPL QUANTITATIVE BI; Lippman SA, 2010, SEX TRANSM DIS, V37, P512, DOI 10.1097/OLQ.0b013e3181d73feb; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Maldonado G, 2002, INT J EPIDEMIOL, V31, P422, DOI 10.1093/ije/31.2.422; Miller K, 2004, CONTRACEPTION, V69, P347, DOI 10.1016/j.contraception.2003.12.012; Munoz ID, 2012, BIOMETRICS, V68, P541, DOI 10.1111/j.1541-0420.2011.01685.x; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Polley E, 2012, SUPERLEARNER SUPER L; Poole C, 2010, EPIDEMIOLOGY, V21, P3, DOI 10.1097/EDE.0b013e3181c30eba; Ralph LJ, 2013, LANCET, V382, P1467, DOI 10.1016/S0140-6736(13)61420-8; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2012, WOM OUT LOUD WOM LIV; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, pe25; Vessey M, 2013, CONTRACEPTION, V88, P678, DOI 10.1016/j.contraception.2013.08.008; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	43	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101090	10.1371/journal.pone.0101090	http://dx.doi.org/10.1371/journal.pone.0101090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979709	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400075
J	Bazil, JN; Stamm, KD; Li, X; Thiagarajan, R; Nelson, TJ; Tomita-Mitchell, A; Beard, DA				Bazil, Jason N.; Stamm, Karl D.; Li, Xing; Thiagarajan, Raghuram; Nelson, Timothy J.; Tomita-Mitchell, Aoy; Beard, Daniel A.			The Inferred Cardiogenic Gene Regulatory Network in the Mammalian Heart	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION PROFILES; STEM-CELLS; INFERENCE; GATA4; ONTOLOGY; BIOLOGY; IDENTIFICATION; MORPHOGENESIS; SIMILARITY	Cardiac development is a complex, multiscale process encompassing cell fate adoption, differentiation and morphogenesis. To elucidate pathways underlying this process, a recently developed algorithm to reverse engineer gene regulatory networks was applied to time-course microarray data obtained from the developing mouse heart. Approximately 200 genes of interest were input into the algorithm to generate putative network topologies that are capable of explaining the experimental data via model simulation. To cull specious network interactions, thousands of putative networks are merged and filtered to generate scale-free, hierarchical networks that are statistically significant and biologically relevant. The networks are validated with known gene interactions and used to predict regulatory pathways important for the developing mammalian heart. Area under the precision-recall curve and receiver operator characteristic curve are 9% and 58%, respectively. Of the top 10 ranked predicted interactions, 4 have already been validated. The algorithm is further tested using a network enriched with known interactions and another depleted of them. The inferred networks contained more interactions for the enriched network versus the depleted network. In all test cases, maximum performance of the algorithm was achieved when the purely data-driven method of network inference was combined with a data-independent, functional-based association method. Lastly, the network generated from the list of approximately 200 genes of interest was expanded using gene-profile uniqueness metrics to include approximately 900 additional known mouse genes and to form the most likely cardiogenic gene regulatory network. The resultant network supports known regulatory interactions and contains several novel cardiogenic regulatory interactions. The method outlined herein provides an informative approach to network inference and leads to clear testable hypotheses related to gene regulation.	[Bazil, Jason N.; Thiagarajan, Raghuram; Beard, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Stamm, Karl D.; Tomita-Mitchell, Aoy] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Li, Xing] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Nelson, Timothy J.] Dept Med, Rochester, MN USA; [Nelson, Timothy J.] Dept Mol Pharmacol, Rochester, MN USA; [Nelson, Timothy J.] Dept Expt Therapeut, Rochester, MN USA; [Nelson, Timothy J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA	University of Michigan System; University of Michigan; Medical College of Wisconsin; Mayo Clinic; Mayo Clinic	Beard, DA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	beardda@umich.edu		Stamm, Karl/0000-0002-7844-7326	National Institutes of Health [P50-GM09450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant P50-GM09450 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bazil JN, 2012, B MATH BIOL, V74, P688, DOI 10.1007/s11538-011-9686-9; Bazil JN, 2011, INTEGR BIOL-UK, V3, P1215, DOI 10.1039/c1ib00117e; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bounova G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016117; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055635; Chiriac A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009943; Civelek M, 2010, AM J PHYSIOL-HEART C, V298, pH163, DOI 10.1152/ajpheart.00652.2009; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Donahue MM, 2010, IET SYST BIOL, V4, P249, DOI 10.1049/iet-syb.2009.0031; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Groh WJ, 2012, HEART RHYTHM, V9, P1890, DOI 10.1016/j.hrthm.2012.06.038; Haller ST, 2012, AM J HYPERTENS, V25, P690, DOI 10.1038/ajh.2012.17; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kangas J A, 1990, IEEE Trans Neural Netw, V1, P93, DOI 10.1109/72.80208; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KOHONEN T, 1990, NATURE, V346, P24, DOI 10.1038/346024b0; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Li X, 2014, PHYSL GENOMICS; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nazri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028713; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Perdomo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050637; Popescu M, 2006, IEEE ACM T COMPUT BI, V3, P263, DOI 10.1109/TCBB.2006.37; Prall OWJ, 2002, ANN MED, V34, P148; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Shaw OJ, 2004, BIOINFORMATICS, V20, P3638, DOI 10.1093/bioinformatics/bth395; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Tomita-Mitchell A, 2012, PHYSIOL GENOMICS, V44, P518, DOI 10.1152/physiolgenomics.00013.2012; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Vohradsky J, 2001, FASEB J, V15, P2054, DOI 10.1096/fj.00-0889fje; Wahde M, 2000, BIOSYSTEMS, V55, P129, DOI 10.1016/S0303-2647(99)00090-8; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	78	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100842	10.1371/journal.pone.0100842	http://dx.doi.org/10.1371/journal.pone.0100842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971943	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200068
J	Boehler, CJ; Raines, AM; Sunde, RA				Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.			Toxic-Selenium and Low-Selenium Transcriptomes in Caenorhabditis elegans: Toxic Selenium Up-Regulates Oxidoreductase and Down-Regulates Cuticle-Associated Genes	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; THIOREDOXIN REDUCTASE; MICROARRAY ANALYSIS; CANCER PREVENTION; ESCHERICHIA-COLI; OXIDATIVE STRESS; CONTROLLED TRIAL; PROSTATE-CANCER; VITAMIN-E; SUPPLEMENTATION	Selenium (Se) is an element that in trace quantities is both essential in mammals but also toxic to bacteria, yeast, plants and animals, including C. elegans. Our previous studies showed that selenite was four times as toxic as selenate to C. elegans, but that deletion of thioredoxin reductase did not modulate Se toxicity. To characterize Se regulation of the full transcriptome, we conducted a microarray study in C. elegans cultured in axenic media supplemented with 0, 0.05, 0.1, 0.2, and 0.4 mM Se as selenite. C. elegans cultured in 0.2 and 0.4 mM Se displayed a significant delay in growth as compared to 0, 0.05, or 0.1 mM Se, indicating Se-induced toxicity, so worms were staged to mid-L4 larval stage for these studies. Relative to 0.1 mM Se treatment, culturing C. elegans at these Se concentrations resulted in 1.9, 9.7, 5.5, and 2.3%, respectively, of the transcriptome being altered by at least 2-fold. This toxicity altered the expression of 295 overlapping transcripts, which when filtered against gene sets for sulfur and cadmium toxicity, identified a dataset of 182 toxic-Se specific genes that were significantly enriched in functions related to oxidoreductase activity, and significantly depleted in genes related to structural components of collagen and the cuticle. Worms cultured in low Se (0 mM Se) exhibited no signs of deficiency, but low Se was accompanied by a transcriptional response of 59 genes changed >= 2-fold when compared to all other Se concentrations, perhaps due to decreases in Se-dependent TRXR-1 activity. Overall, these results suggest that Se toxicity in C. elegans causes an increase in ROS and stress responses, marked by increased expression of oxidoreductases and reduced expression of cuticle-associated genes, which together underlie the impaired growth observed in these studies.	[Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			Wisconsin Agricultural Experiment Station [WIS-01435]; UW Foundation Selenium Nutrition Research fund [12046295]	Wisconsin Agricultural Experiment Station; UW Foundation Selenium Nutrition Research fund	This work was supported by the Wisconsin Agricultural Experiment Station project WIS-01435 and by the UW Foundation Selenium Nutrition Research fund no. 12046295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alehagen U, 2013, INT J CARDIOL, V167, P1860, DOI 10.1016/j.ijcard.2012.04.156; Altun ZF, 2012, WORMATLAS; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Bjornstedt M, 2010, EPMA J, V1, P389, DOI 10.1007/s13167-010-0033-2; Boehler CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071525; Bosse AC, 2010, BIOSCIENCE REP, V30, P293, DOI 10.1042/BSR20090089; BRENNER S, 1974, GENETICS, V77, P71; Buettner C, 1999, J BIOL CHEM, V274, P21598, DOI 10.1074/jbc.274.31.21598; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P185, DOI 10.1128/AEM.53.1.185-188.1987; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; El-Bayoumy K, 2003, CARCINOGENESIS, V24, P1505, DOI 10.1093/carcin/bgg103; Food and Nutrition Board USA Institute of Medicine, 2000, DIET REF INT VIT C V, P284; GERRARD TL, 1974, J BACTERIOL, V119, P1057, DOI 10.1128/JB.119.3.1057-1060.1974; Gladyshev V.N., 2001, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0308S20.:UNIT; Gladyshev VN, 1999, BIOCHEM BIOPH RES CO, V259, P244, DOI 10.1006/bbrc.1999.0765; Goulet AC, 2007, CANCER BIOL THER, V6, P494, DOI 10.4161/cbt.6.4.3813; Greenwald P, 2004, J NUTR, V134, p3507S, DOI 10.1093/jn/134.12.3507S; Hooven LA, 2006, BIOL TRACE ELEM RES, V109, P173, DOI 10.1385/BTER:109:2:173; Hurst R, 2008, CANCER LETT, V269, P117, DOI 10.1016/j.canlet.2008.04.025; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUCHARZ EJ, 1993, TOXICOL LETT, V68, P295, DOI 10.1016/0378-4274(93)90020-X; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LAPAGE SP, 1968, J APPL BACTERIOL, V31, P568, DOI 10.1111/j.1365-2672.1968.tb00407.x; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MacFarquhar JK, 2010, ARCH INTERN MED, V170, P256, DOI 10.1001/archinternmed.2009.495; McDermott JR, 2010, MOL BIOL CELL, V21, P3934, DOI 10.1091/mbc.E10-06-0513; Miller DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025476; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; Page A. P., 2007, CUTICLE; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rao L, 2001, J NUTR, V131, P3175, DOI 10.1093/jn/131.12.3175; Rosenfeld I, 1964, SELENIUM GEOBOTANY B, P142; SAFER B, 1980, J BIOL CHEM, V255, P6913; SALBE AD, 1990, J NUTR, V120, P200, DOI 10.1093/jn/120.2.200; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; SCALA J, 1962, ARCH BIOCHEM BIOPHYS, V99, P363, DOI 10.1016/0003-9861(62)90280-1; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Sunde R. A., 1997, Handbook of nutritionally essential mineral elements., P493; Sunde RA, 2010, J NUTR BIOCHEM, V21, P665, DOI 10.1016/j.jnutbio.2009.11.012; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; Winter AD, 2007, DEV BIOL, V308, P449, DOI 10.1016/j.ydbio.2007.05.041; YANG G, 1994, J TRACE ELEM ELECT H, V8, P159; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872; Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082; Zhang Haitao, 2005, Cancer Genomics & Proteomics, V2, P97	61	13	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101408	10.1371/journal.pone.0101408	http://dx.doi.org/10.1371/journal.pone.0101408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971995	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200116
J	Tan, X; Zhao, SS; Lei, Q; Lu, XP; He, GY; Ostrikov, K				Tan, Xiao; Zhao, Shasha; Lei, Qian; Lu, Xinpei; He, Guangyuan; Ostrikov, Kostya			Single-Cell-Precision Microplasma-Induced Cancer Cell Apoptosis	PLOS ONE			English	Article							NANOSCALE CORONA DISCHARGE; LEVEL; MEMBRANE; PLASMAS	The issue of single-cell control has recently attracted enormous interest. However, in spite of the presently achievable intracellular-level physiological probing through bio-photonics, nano-probe-based, and some other techniques, the issue of inducing selective, single-cell-precision apoptosis, without affecting neighbouring cells remains essentially open. Here we resolve this issue and report on the effective single-cell-precision cancer cell treatment using the reactive chemistry of the localized corona-type plasma discharge around a needle-like electrode with the spot size similar to 1 mu m. When the electrode is positioned with the micrometer precision against a selected cell, a focused and highly-localized micro-plasma discharge induces apoptosis in the selected individual HepG2 and HeLa cancer cells only, without affecting any surrounding cells, even in small cell clusters. This is confirmed by the real-time monitoring of the morphological and structural changes at the cellular and cell nucleus levels after the plasma exposure.	[Tan, Xiao; Lu, Xinpei] Huazhong Univ Sci & Technol, State Key Lab Adv Electromagnet Engn & Technol, Wuhan 430074, Hubei, Peoples R China; [Zhao, Shasha; Lei, Qian; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Chinese Minist Sci & Technol,Chinese Minist Educ, Wuhan 430074, Peoples R China; [Ostrikov, Kostya] CSIRO, Mat Sci & Engn, Lindfield, NSW, Australia; [Ostrikov, Kostya] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT)	Lu, XP (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Adv Electromagnet Engn & Technol, Wuhan 430074, Hubei, Peoples R China.	luxinpei@hotmail.com	Lu, Xinpei/D-9540-2015; Lu, XinPei/M-5570-2013	Lu, XinPei/0000-0003-0676-9585; Ostrikov, Kostya (Ken)/0000-0001-8672-9297	National Science Foundation of China [51077063, 51277087]; ARC; CSIRO OCE Science Leadership Scheme	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARC(Australian Research Council); CSIRO OCE Science Leadership Scheme	XL acknowledges support from the National Science Foundation of China (Grant No. 51077063, 51277087). KO acknowledges support from the ARC and the CSIRO OCE Science Leadership Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya S, 2009, ADV MATER, V21, P4039, DOI 10.1002/adma.200900673; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Dumont EA, 2001, NAT MED, V7, P1352, DOI 10.1038/nm1201-1352; Ishaq M, 2014, MOL BIOL CELL, V25, P1523, DOI 10.1091/mbc.E13-10-0590; Ishaq M, 2014, INT J CANCER, V134, P1517, DOI 10.1002/ijc.28323; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim JY, 2011, SMALL, V7, P2291, DOI 10.1002/smll.201100456; Kim JY, 2010, SMALL, V6, P1474, DOI 10.1002/smll.201000480; Kim M, 2002, CLIN CANCER RES, V8, P22; Kim SH, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3605508; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lin ZY, 2009, ANGEW CHEM INT EDIT, V48, P2044, DOI 10.1002/anie.200805743; Meziane M, 2011, EUR PHYS J-APPL PHYS, V56, DOI 10.1051/epjap/2011110154; Orynbayeva Z, 2012, NANOMED-NANOTECHNOL, V8, P590, DOI 10.1016/j.nano.2011.08.008; Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047; Schulte A, 2007, ANGEW CHEM INT EDIT, V46, P8760, DOI 10.1002/anie.200604851; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Staack D, 2008, ANGEW CHEM INT EDIT, V47, P8020, DOI 10.1002/anie.200802891; Steinmeyer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035603; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vermesh U, 2011, ANGEW CHEM INT EDIT, V50, P7378, DOI 10.1002/anie.201102249; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Yan RX, 2012, NAT NANOTECHNOL, V7, P191, DOI [10.1038/nnano.2011.226, 10.1038/NNANO.2011.226]; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665	33	31	32	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101299	10.1371/journal.pone.0101299	http://dx.doi.org/10.1371/journal.pone.0101299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971517	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200111
J	Xu, KN; Zhang, YF; Wang, Y; Ling, P; Xie, X; Jiang, CY; Zhang, ZZ; Lian, XY				Xu, Kangning; Zhang, Yufen; Wang, Yan; Ling, Peng; Xie, Xin; Jiang, Chenyao; Zhang, Zhizhen; Lian, Xiao-Yuan			Ginseng Rb Fraction Protects Glia, Neurons and Cognitive Function in a Rat Model of Neurodegeneration	PLOS ONE			English	Article							GABAERGIC NEURONS; CORTICAL ASTROCYTES; STATUS EPILEPTICUS; CELL-DEATH; HIPPOCAMPAL; INTERNEURONS; PARVALBUMIN; ACTIVATION; MEMORY; OSCILLATIONS	The loss and injury of neurons play an important role in the onset of various neurodegenerative diseases, while both microgliosis and astrocyte loss or dysfunction are significant causes of neuronal degeneration. Previous studies have suggested that an extract enriched panaxadiol saponins from ginseng has more neuroprotective potential than the total saponins of ginseng. The present study investigated whether a fraction of highly purified panaxadiol saponins (termed as Rb fraction) was protective for both glia and neurons, especially GABAergic interneurons, against kainic acid (KA)-induced excitotoxicity in rats. Rats received Rb fraction at 30 mg/kg (ip), 40 mg/kg (ip or saline followed 40 min later by an intracerebroventricular injection of KA. Acute hippocampal injury was determined at 48 h after KA, and impairment of hippocampus-dependent learning and memory as well as delayed neuronal injury was determined 16 to 21 days later. KA injection produced significant acute hippocampal injuries, including GAD67-positive GABAergic interneuron loss in CA1, paralbumin (PV)-positive GABAergic interneuron loss, pyramidal neuron degeneration and astrocyte damage accompanied with reactive microglia in both CA1 and CA3 regions of the hippocampus. There was also a delayed loss of GAD67-positive interneurons in CA1, CA3, hilus and dentate gyrus. Microgliosis also became more severe 21 days later. Accordingly, KA injection resulted in hippocampus-dependent spatial memory impairment. Interestingly, the pretreatment with Rb fraction at 30 or 40 mg/kg significantly protected the pyramidal neurons and GABAergic interneurons against KA-induced acute excitotoxicity and delayed injury. Rb fraction also prevented memory impairments and protected astrocytes from KA-induced acute excitotoxicity. Additionally, microglial activation, especially the delayed microgliosis, was inhibited by Rb fraction. Overall, this study demonstrated that Rb fraction protected both astrocytes and neurons, especially GABAergic interneurons, and maintained microglial homeostasis against KA-induced excitotoxicity. Therefore, Rb fraction has the potential to prevent and treat neurodegenerative diseases.	[Xu, Kangning; Wang, Yan; Xie, Xin; Jiang, Chenyao; Lian, Xiao-Yuan] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhizhen] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yufen; Ling, Peng] Anhui Univ Chinese Med, Hefei, Peoples R China	Zhejiang University; Zhejiang University; Anhui University of Chinese Medicine	Zhang, ZZ (corresponding author), Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China.	zzhang88@zju.edu.cn; xylian@zju.edu.cn	ZHANG, ZHIZHEN/GYA-3230-2022		National Basic Research Program of China (973 program) [2011CB504403]; Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality [08DZ1972000]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality	This study was financially supported by grants from the National Basic Research Program of China (973 program, No 2011CB504403) and the Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality (No. 08DZ1972000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bechstein M, 2012, EXP NEUROL, V236, P141, DOI 10.1016/j.expneurol.2012.04.009; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BENARI Y, 1979, BRAIN RES, V163, P176, DOI 10.1016/0006-8993(79)90163-X; Bissonette GB, 2014, BEHAV BRAIN RES, V259, P143, DOI 10.1016/j.bbr.2013.10.051; Budd SL, 1998, NAT NEUROSCI, V1, P431, DOI 10.1038/2147; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cho IH, 2006, J NEUROSCI RES, V84, P1505, DOI 10.1002/jnr.21052; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colangelo AM, 2012, BIOTECHNOL ADV, V30, P261, DOI 10.1016/j.biotechadv.2011.06.016; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lazarus MS, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht1322, DOI 10.1093/CERCOR/BHT1322]; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053569; Li TF, 2012, GLIA, V60, P83, DOI 10.1002/glia.21250; Lian XY, 2006, EPILEPSY RES, V70, P244, DOI 10.1016/j.eplepsyres.2006.05.010; Lian XY, 2005, ANN NEUROL, V57, P642, DOI 10.1002/ana.20450; Lian XY, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.0013-9580.2005.40904.x; Liu B, 2013, NEUROSCI RES, V75, P160, DOI 10.1016/j.neures.2012.12.002; Liu Z, 2013, NEUROL SCI, V34, P1189, DOI 10.1007/s10072-012-1220-9; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MITCHELL J, 1993, EXP NEUROL, V121, P224, DOI 10.1006/exnr.1993.1089; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Ratte Stephanie, 2006, Adv Neurol, V97, P69; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Shetty AK, 2001, EXP NEUROL, V169, P276, DOI 10.1006/exnr.2001.7668; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volman V, 2011, J NEUROSCI, V31, P18137, DOI 10.1523/JNEUROSCI.3041-11.2011; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Watson C, 2006, RAT BRAIN STEREOTAXI; Wenk G.L., 2004, CURRENT PROTOCOLS NE; WILLIAMS SM, 1992, J COMP NEUROL, V320, P353, DOI 10.1002/cne.903200307; Zhang Z, 2011, PHARM CROPS, V2, P65; Zheng HH, 2010, NEUROIMMUNOMODULAT, V17, P31, DOI 10.1159/000243083; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	59	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101077	10.1371/journal.pone.0101077	http://dx.doi.org/10.1371/journal.pone.0101077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971630	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200088
J	Zhang, XM; Kampuansai, J; Qi, XB; Yan, S; Yang, ZH; Serey, B; Sovannary, T; Bunnath, L; Aun, HS; Samnom, H; Kutanan, W; Luo, X; Liao, SY; Kangwanpong, D; Jin, L; Shi, H; Su, B				Zhang, Xiaoming; Kampuansai, Jatupol; Qi, Xuebin; Yan, Shi; Yang, Zhaohui; Serey, Bun; Sovannary, Tuot; Bunnath, Long; Aun, Hong Seang; Samnom, Ham; Kutanan, Wibhu; Luo, Xin; Liao, Shiyu; Kangwanpong, Daoroong; Jin, Li; Shi, Hong; Su, Bing			An Updated Phylogeny of the Human Y-Chromosome Lineage O2a-M95 with Novel SNPs	PLOS ONE			English	Article							EAST-ASIA; GENETIC-STRUCTURE; POPULATION; MITOCHONDRIAL; LANDSCAPE; DIVERSITY; SUGGESTS; ORIGINS	Though the Y-chromosome O2a-M95 lineage is one of the major haplogroups present in eastern Asian populations, especially among Austro-Asiatic speaking populations from Southwestern China and mainland Southeast Asia, to date its phylogeny lacks structure due to only one downstream SNP marker (M88) assigned to the lineage. A recent array-capture-based Y chromosome sequencing of Asian samples has yielded a variety of novel SNPs purportedly belonging to the O2a-M95 lineage, but their phylogenetic positions have yet to be determined. In this study, we sampled 646 unrelated males from 22 Austro-Asiatic speaking populations from Cambodia, Thailand and Southwestern China, and genotyped 12 SNP makers among the sampled populations, including 10 of the newly reported markers. Among the 646 males, 343 belonged to the O2a-M95 lineage, confirming the supposed dominance of this Y chromosome lineage in Austro-Asiatic speaking populations. We further characterized the phylogeny of O2a-M95 by defining 5 sub-branches: O2a1*-M95, O2a1a-F789, O2a1b*-F1252, O2a1b1*-M88 and O2a1b1a -F761. This updated phylogeny not only improves the resolution of this lineage, but also allows for greater tracing of the prehistory of human populations in eastern Asia and the Pacific, which may yield novel insights into the patterns of language diversification and population movement in these regions.	[Zhang, Xiaoming; Qi, Xuebin; Yang, Zhaohui; Luo, Xin; Liao, Shiyu; Shi, Hong; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Kampuansai, Jatupol; Kangwanpong, Daoroong] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Yan, Shi; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Fudan Univ, Key Lab Contemporary Anthropol, Sch Life Sci, Minist Educ, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Royal Univ Phnom Penh, Dept Geog & Land Management, Phnom Penh, Cambodia; [Samnom, Ham] Capac Dev Facilitator Handicap Int Federat & Free, Battambang, Cambodia; [Zhang, Xiaoming; Yang, Zhaohui; Luo, Xin; Liao, Shiyu] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China; [Kutanan, Wibhu] Khon Kaen Univ, Fac Sci, Dept Biol, Khon Kaen, Thailand	Chinese Academy of Sciences; Kunming Institute of Zoology; Chiang Mai University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Khon Kaen University	Shi, H (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shihong@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Jin, Li/C-1468-2009; Yan, Shi/GYR-3441-2022; yang, zhaohui/AAD-2158-2019; Kutanan, Wibhu/AAG-5801-2019; Zhang, Xiaoming/AFS-9807-2022; Xuebin, Qi/L-7139-2019; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Yan, Shi/0000-0001-8304-8445; Zhang, Xiaoming/0000-0003-3139-2361; yang, zhaohui/0000-0003-0958-4439	National 973 Program of China [2012CB518202]; National Natural Science Foundation of China [31130051, 91231203, 31371268, 91131001, 31371269]; Natural Science Foundation of Yunnan Province [2010CI044]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was supported by the National 973 Program of China (2012CB518202 to X. Q.), the National Natural Science Foundation of China (31130051 and 91231203 to B. S., 31371268 and 91131001 to H. S. and 31371269 to X. Q.) and the Natural Science Foundation of Yunnan Province (2010CI044 to H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; [Anonymous], 2013, Y CHROMOSOMES 40 CHI; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Gan RJ, 2008, J HUM GENET, V53, P303, DOI 10.1007/s10038-008-0250-x; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; Inagaki Sachiyo, 2002, Leg Med (Tokyo), V4, P202, DOI 10.1016/S1344-6223(02)00032-9; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Zhang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3599; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	29	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101020	10.1371/journal.pone.0101020	http://dx.doi.org/10.1371/journal.pone.0101020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972021	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200084
J	Rustgi, S; Matanguihan, J; Mejias, JH; Gemini, R; Brew-Appiah, RAT; Wen, N; Osorio, C; Ankrah, N; Murphy, KM; von Wettstein, D				Rustgi, Sachin; Matanguihan, Janet; Mejias, Jaime H.; Gemini, Richa; Brew-Appiah, Rhoda A. T.; Wen, Nuan; Osorio, Claudia; Ankrah, Nii; Murphy, Kevin M.; von Wettstein, Diter			Assessment of Genetic Diversity among Barley Cultivars and Breeding Lines Adapted to the US Pacific Northwest, and Its Implications in Breeding Barley for Imidazolinone-Resistance	PLOS ONE			English	Article							PLANT ACETOHYDROXYACID SYNTHASE; LENGTH POLYMORPHISMS; COMPARATIVE GENOMICS; WHEAT; HERBICIDE; MAP	Extensive application of imidazolinone (IMI) herbicides had a significant impact on barley productivity contributing to a continuous decline in its acreage over the last two decades. A possible solution to this problem is to transfer IMI-resistance from a recently characterized mutation in the 'Bob' barley AHAS (acetohydroxy acid synthase) gene to other food, feed and malting barley cultivars. We focused our efforts on transferring IMI-resistance to barley varieties adapted to the US Pacific Northwest (PNW), since it comprises similar to 23% (335,000 ha) of the US agricultural land under barley production. To effectively breed for IMI-resistance, we studied the genetic diversity among 13 two-rowed spring barley cultivars/breeding-lines from the PNW using 61 microsatellite markers, and selected six barley genotypes that showed medium to high genetic dissimilarity with the 'Bob' AHAS mutant. The six selected genotypes were used to make 29-53 crosses with the AHAS mutant and a range of 358-471 F-1 seeds were obtained. To make informed selection for the recovery of the recipient parent genome, the genetic location of the AHAS gene was determined and its genetic nature assessed. Large F-2 populations ranging in size from 2158-2846 individuals were evaluated for herbicide resistance and seedling vigor. Based on the results, F-3 lines from the six most vigorous F-2 genotypes per cross combination were evaluated for their genetic background. A range of 20%-90% recovery of the recipient parent genome for the carrier chromosome was observed. An effort was made to determine the critical dose of herbicide to distinguish between heterozygotes and homozygotes for the mutant allele. Results suggested that the mutant can survive up to the 10x field recommended dose of herbicide, and the 86x and 10x herbicide doses can distinguish between the two AHAS mutant genotypes. Finally, implications of this research in sustaining barley productivity in the PNW are discussed.	[Rustgi, Sachin; Matanguihan, Janet; Mejias, Jaime H.; Gemini, Richa; Brew-Appiah, Rhoda A. T.; Wen, Nuan; Osorio, Claudia; Ankrah, Nii; Murphy, Kevin M.; von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Mejias, Jaime H.] Inst Invest Agr INIA, Vilcun, Chile; [von Wettstein, Diter] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Rustgi, S (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	rustgi@wsu.edu; diter@wsu.edu	Rustgi, Sachin/AAF-5590-2020; Bassaletti, Jaime H Mejias/V-8967-2019; Brew-Appiah, Rhoda Araba Tawiah/N-9817-2019	Bassaletti, Jaime H Mejias/0000-0002-5510-1955; Brew-Appiah, Rhoda Araba Tawiah/0000-0003-2123-0828; Osorio, Claudia E./0000-0001-6205-0730; Rustgi, Sachin/0000-0002-6881-9501	Washington Grain Commission [13C-3019-3590]	Washington Grain Commission	This work was supported by the Washington Grain Commission Grant # 13C-3019-3590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Anderson JA, 2004, WEED SCI, V52, P83, DOI 10.1614/WS-03-055R; Baik B.-K., 2011, BARLEY PRODUCTION IM; Bandopadhyay R, 2011, J GENET GENOMICS, V38, P315, DOI 10.1016/j.jgg.2011.06.003; Black AL, 1986, P HANDS ON WORKSH IM; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brester G, 2012, BARLEY PROFILE; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Duggleby RG, 2008, PLANT PHYSIOL BIOCH, V46, P309, DOI 10.1016/j.plaphy.2007.12.004; Garstang J.R., 2011, BARLEY PRODUCTION IM, P221, DOI DOI 10.1002/9780470958636.CH1; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; JANOSKY J, 2002, PACIFIC NW CONSERVAT, V16, pCH10; Kasha KJ, 2001, EUPHYTICA, V120, P379, DOI 10.1023/A:1017564100823; Lee H, 2011, P NATL ACAD SCI USA, V108, P8909, DOI 10.1073/pnas.1105612108; Lee YT, 2001, BIOCHEMISTRY-US, V40, P6836, DOI 10.1021/bi002775q; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; Molnar I, 2011, ANN BOT-LONDON, V107, P65, DOI 10.1093/aob/mcq215; Newman RK, 2008, BARLEY FOOD HLTH SCI; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Randhawa HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005752; Rustgi S, 2013, MED AROMATIC PLANTS, V2, pe148; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; Schillinger WF, 2006, PLANT DIS, V90, P302, DOI 10.1094/PD-90-0302; Shaner DL., 1997, HERBICIDE ACTIVITY T, P69; SINGH BK, 1988, ANAL BIOCHEM, V171, P173, DOI 10.1016/0003-2697(88)90139-X; SMILEY RW, 1992, PLANT DIS, V76, P937, DOI 10.1094/PD-76-0937; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tegelstrom Hakan, 1992, P89; Turner W. J., 2001, CROP PROFILE BARLEY; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7	35	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100998	10.1371/journal.pone.0100998	http://dx.doi.org/10.1371/journal.pone.0100998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967712	gold, Green Published, Green Submitted			2022-12-25	WOS:000338280800096
J	Shin, SS; Choi, YM; Han, JY; Lee, K				Shin, Sangsu; Choi, Young Min; Han, Jae Yong; Lee, Kichoon			Inhibition of Lipolysis in the Novel Transgenic Quail Model Overexpressing G(0)/G(1) Switch Gene 2 in the Adipose Tissue during Feed Restriction	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLET BINDING; TRIGLYCERIDE LIPASE; NUTRITIONAL REGULATION; MEDIATED LIPOLYSIS; TERMINAL REGION; JAPANESE-QUAIL; CLONING; FAT; CHICKEN	In addition to the issue of obesity in humans, the production of low-fat meat from domestic animals is important in the agricultural industry to satisfy consumer demand. Understanding the regulation of lipolysis in adipose tissue could advance our knowledge to potentially solve both issues. Although the G(0)/G(1) switch gene 2 (G0S2) was recently identified as an inhibitor of adipose triglyceride lipase (ATGL) in vitro, its role in vivo has not been fully clarified. This study was conducted to investigate the role of G0S2 gene in vivo by using two independent transgenic quail lines during different energy conditions. Unexpectedly, G0S2 overexpression had a negligible effect on plasma NEFA concentration, fat cell size and fat pad weight under ad libitum feeding condition when adipose lipolytic activity is minimal. A two-week feed restriction in non-transgenic quail expectedly caused increased plasma NEFA concentration and dramatically reduced fat cell size and fat pad weight. Contrary, G0S2 overexpression under a feed restriction resulted in a significantly less elevation of plasma NEFA concentration and smaller reductions in fat pad weights and fat cell size compared to non-transgenic quail, demonstrating inhibition of lipolysis and resistance to loss of fat by G0S2. Excessive G0S2 inhibits lipolysis in vivo during active lipolytic conditions, such as food restriction and fasting, suggesting G0S2 as a potential target for treatment of obesity. In addition, transgenic quail are novel models for studying lipid metabolism and mechanisms of obesity.	[Shin, Sangsu; Choi, Young Min; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, World Class Univ Biomodulat Major,Dept Agr Biotec, Seoul, South Korea	University System of Ohio; Ohio State University; Seoul National University (SNU)	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu	Choi, Young Min/J-6027-2014; Lee, Kichoon/G-2234-2012	Choi, Young Min/0000-0003-3015-6316; , Young Min Choi/0000-0003-2376-7784	Korea Research Foundation [KRF-2009-220-F00006]; Next-Generation BioGreen 21 Program [PJ008142012013]; Rural Development Administration of Republic of Korea; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65206-20716]	Korea Research Foundation(National Research Foundation of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration of Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by Korea Research Foundation (KRF-2009-220-F00006), Next-Generation BioGreen 21 Program (No. PJ008142012013) funded by Rural Development Administration of Republic of Korea and by Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Chen P, 2014, POULT SCI, DOI org/10.3382/ps.2013-03816.; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Koksal F, 2004, BEHAV RES THER, V42, P1421, DOI 10.1016/j.brat.2003.10.001; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lee K, 2009, POULTRY SCI, V88, P620, DOI 10.3382/ps.2008-00265; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Oh SA, 2011, J ANIM SCI, V89, P367, DOI 10.2527/jas.2010-3339; Ottinger MA, 2004, EXP GERONTOL, V39, P1679, DOI 10.1016/j.exger.2004.06.021; Poynter G, 2009, COLD SPRING HARB PRO, V2009; SANG H, 1994, TRENDS BIOTECHNOL, V12, P415, DOI 10.1016/0167-7799(94)90030-2; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Scott BB, 2010, ILAR J, V51, P353, DOI 10.1093/ilar.51.4.353; Seidl AH, 2013, J COMP NEUROL, V521, P5, DOI 10.1002/cne.23187; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Serr J, 2009, POULTRY SCI, V88, P2585, DOI 10.3382/ps.2009-00265; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, pE153, DOI 10.1152/ajpendo.00338.2011; Yang SJ, 2013, LIPIDS, V48, P13, DOI 10.1007/s11745-012-3742-6; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100905	10.1371/journal.pone.0100905	http://dx.doi.org/10.1371/journal.pone.0100905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964090	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500096
J	Tietz, SM; Hofmann, R; Thomas, T; Tackenberg, B; Gaestel, M; Berghoff, M				Tietz, Silvia M.; Hofmann, Regina; Thomas, Tobias; Tackenberg, Bjoern; Gaestel, Matthias; Berghoff, Martin			MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; PERIPHERAL-BLOOD; CEREBROSPINAL-FLUID; MESSENGER-RNA	Models of inflammatory or degenerative diseases demonstrated that the protein-kinase MK2 is a key player in inflammation. In this study we examined the role of MK2 in MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. In MK2-deficient (MK2(-/-)) mice we found a delayed onset of the disease and MK2(-/-) mice did not recover until day 24 after EAE induction. At this day a higher number of leukocytes in the CNS of MK2(-/-) mice was found. TNF alpha was not detectable in serum of MK2(-/-) mice in any stage of EAE, while high TNF alpha levels were found at day 16 in wild-type mice. Further investigation revealed an increased expression of FasR mRNA in leukocytes isolated from CNS of wild-type mice but not in MK2(-/-) mice, however in vitro stimulation of MK2(-/-) splenocytes with rmTNF alpha induced the expression of FasR. In addition, immunocomplexes between the apoptosis inhibitor cFlip and the FasR adapter molecule FADD were only detected in splenocytes of MK2(-/-) mice at day 24 after EAE induction. Moreover, the investigation of blood samples from relapsing-remitting multiple sclerosis patients revealed reduced FasR mRNA expression compared to healthy controls. Taken together, our data suggest that MK2 is a key regulatory inflammatory cytokines in EAE and multiple sclerosis. MK2(-/-) mice showed a lack of TNFa and thus might not undergo TNF alpha-induced up-regulation of FasR. This may prevent autoreactive leukocytes from apoptosis and may led to prolonged disease activity. The findings indicate a key role of MK2 and FasR in the regulation and limitation of the immune response in the CNS.	[Tietz, Silvia M.; Thomas, Tobias; Berghoff, Martin] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Tietz, Silvia M.] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Hofmann, Regina] Univ Giessen, Dept Child Neurol, D-35390 Giessen, Germany; [Tackenberg, Bjoern] Univ Marburg, Dept Neurol, Clin Neuroimmunol Grp, Marburg, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany	Justus Liebig University Giessen; University of Bern; Justus Liebig University Giessen; Philipps University Marburg; Hannover Medical School	Tietz, SM (corresponding author), Univ Giessen, Dept Neurol, D-35390 Giessen, Germany.	Silvia.Tietz@neuro.med.uni-giessen.de	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Tietz, Silvia/0000-0002-9154-0912	Biogen Idec GmbH; Deutsche Forschungsgemeinschaft (DFG) [SFB566]	Biogen Idec GmbH(Biogen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by Biogen Idec GmbH (www.biogenidec.de). Matthias Gaestel was funded by a grant of SFB566 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Di Pauli F, 2010, J NEUROL SCI, V288, P147, DOI 10.1016/j.jns.2009.09.016; Ewald F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.138; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Gomes AC, 2003, J NEUROIMMUNOL, V135, P126, DOI 10.1016/S0165-5728(02)00437-X; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hofstetter HH, 2006, NEUROSCI LETT, V391, P127, DOI 10.1016/j.neulet.2005.08.042; Julia E, 2006, J NEUROIMMUNOL, V180, P147, DOI 10.1016/j.jneuroim.2006.07.001; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kruglov AA, 2011, J IMMUNOL, V187, P5660, DOI 10.4049/jimmunol.1100663; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lange C, 2011, BRAIN BEHAV IMMUN, V25, P120, DOI 10.1016/j.bbi.2010.09.004; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Lopatinskaya L, 2003, J NEUROIMMUNOL, V138, P123, DOI 10.1016/S0165-5728(03)00089-4; Macchi B, 1999, NEUROREPORT, V10, P399, DOI 10.1097/00001756-199902050-00034; NAGAFUJI K, 1995, BLOOD, V86, P883, DOI 10.1182/blood.V86.3.883.bloodjournal863883; Namiki K, 2012, J BIOL CHEM, V287, P24228, DOI 10.1074/jbc.M111.338541; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Okuda Y, 2006, J NEUROIMMUNOL, V171, P163, DOI 10.1016/j.jneuroim.2005.09.020; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Rafei M, 2009, J IMMUNOL, V182, P2620, DOI 10.4049/jimmunol.0803495; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Saresella M, 2005, J NEUROIMMUNOL, V166, P173, DOI 10.1016/j.jneuroim.2005.05.010; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shi N, 2009, MULT SCLER J, V15, P120, DOI 10.1177/1352458508096871; Starace D, 2004, FASEB J, V18, P473, DOI 10.1096/fj.04-2726fje; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Targoni OS, 2001, J IMMUNOL, V166, P4757, DOI 10.4049/jimmunol.166.7.4757; Thomas T, 2008, J NEUROCHEM, V105, P2039, DOI 10.1111/j.1471-4159.2008.05310.x; Waldner H, 1997, J IMMUNOL, V159, P3100; Wang XK, 2002, J BIOL CHEM, V277, P43968, DOI 10.1074/jbc.M206837200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhu B, 2002, J IMMUNOL, V169, P1561, DOI 10.4049/jimmunol.169.3.1561; Ziaber J, 2000, J INVEST ALLERG CLIN, V10, P98	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100363	10.1371/journal.pone.0100363	http://dx.doi.org/10.1371/journal.pone.0100363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964076	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500042
J	Abdul-Majeed, S; Mell, B; Nauli, SM; Joe, B				Abdul-Majeed, Shakila; Mell, Blair; Nauli, Surya M.; Joe, Bina			Cryptorchidism and Infertility in Rats with Targeted Disruption of the Adamts16 Locus	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RODENT GUBERNACULUM; TESTICULAR DESCENT; EXPRESSION; METALLOPROTEINASES; OVULATION; SPERMATOGENESIS; HYPERTENSION; INHIBITORS; FOLLICLES	A Disintegrin And Metalloproteinase with ThromboSpondin motifs16 (ADAMTS-16) is a member of a family of metalloproteinases. Using a novel zinc-finger nuclease based gene-edited rat model harboring a targeted mutation of the Adamts16 locus, we previously reported this gene to be linked to blood pressure regulation. Here we document our observation with this model that Adamts16 is essential for normal development of the testis. Absence of Adamts16 in the homozygous Adamts16(mutant) males resulted in cryptorchidism and male sterility. Heterozygous Adamts16(mutant) males were normal, indicating that this is a recessive trait. Testes of homozygous Adamts16(mutant) males were significantly smaller with significant histological changes associated with the lack of sperm production. Temporal histological assessments of the testis demonstrated that the seminiferous tubules did not support active spermatogenesis, but progressively lost germ cells, accumulated vacuoles and did not have any sperm. These observations, taken together with our previous report of renal abnormalities observed with the same Adamts16(mutant) rats, suggest an important mechanistic link between Adamts16 and the functioning of the male genitourinary system.	[Abdul-Majeed, Shakila; Mell, Blair; Joe, Bina] Univ Toledo, Ctr Hypertens & Personalized Med, Program Physiol Gen, Dept Physiol & Pharmacol,Coll Med, Toledo, OH 43606 USA; [Nauli, Surya M.] Univ Toledo, Dept Pharmacol, Coll Pharm, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Joe, B (corresponding author), Univ Toledo, Ctr Hypertens & Personalized Med, Program Physiol Gen, Dept Physiol & Pharmacol,Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu			National Institutes of Health [HL112641, HL020176]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020176, R01HL112641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by RO1 grants from the National Institutes of Health to Bina Joe. Grant numbers: HL112641 and HL020176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Chen N, 2011, J PEDIATR SURG, V46, P2363, DOI 10.1016/j.jpedsurg.2011.09.032; Churchill JA, 2011, J PEDIATR SURG, V46, P2353, DOI 10.1016/j.jpedsurg.2011.09.025; Costa WS, 2002, J UROLOGY, V167, P2171, DOI 10.1016/S0022-5347(05)65122-1; Darnell DK, 2010, RNA, V16, P632, DOI 10.1261/rna.1775610; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Dun MD, 2012, INT J ANDROL, V35, P572, DOI 10.1111/j.1365-2605.2011.01235.x; Espey LL, 2000, BIOL REPROD, V62, P1090, DOI 10.1095/biolreprod62.4.1090; Gao S, 2007, MOL HUM REPROD, V13, P465, DOI 10.1093/molehr/gam037; Gopalakrishnan K, 2012, P NATL ACAD SCI USA, V109, P20555, DOI 10.1073/pnas.1211290109; Hutson JM, 2009, THER ADV UROL, V1, P115, DOI 10.1177/1756287209105266; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Joe B, 2009, HUM MOL GENET, V18, P2825, DOI 10.1093/hmg/ddp218; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Lee PA, 2013, CURR OPIN ENDOCRINOL, V20, P210, DOI 10.1097/MED.0b013e32835ffc7d; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; McGrath LM, 2013, AM J MED GENET B, V162, P779, DOI 10.1002/ajmg.b.32190; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Nation TR, 2011, ANAT REC, V294, P1249, DOI 10.1002/ar.21393; Ohnishi J, 2005, BBA-PROTEINS PROTEOM, V1751, P95, DOI 10.1016/j.bbapap.2005.05.002; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Sakamoto N, 2010, CANCER SCI, V101, P1038, DOI 10.1111/j.1349-7006.2009.01477.x; SAPSFORD CS, 1963, J ANAT, V97, P225; Siu MKY, 2008, ADV EXP MED BIOL, V636, P74, DOI 10.1007/978-0-387-09597-4_5; Surridge AK, 2009, MATRIX BIOL, V28, P416, DOI 10.1016/j.matbio.2009.07.001; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Wang XN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003645	32	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100967	10.1371/journal.pone.0100967	http://dx.doi.org/10.1371/journal.pone.0100967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983376	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000044
J	Thaler, AD; Plouviez, S; Saleu, W; Alei, F; Jacobson, A; Boyle, EA; Schultz, TF; Carlsson, J; Van Dover, CL				Thaler, Andrew David; Plouviez, Sophie; Saleu, William; Alei, Freddie; Jacobson, Alixandra; Boyle, Emily A.; Schultz, Thomas F.; Carlsson, Jens; Van Dover, Cindy Lee			Comparative Population Structure of Two Deep-Sea Hydrothermal-Vent-Associated Decapods (Chorocaris sp 2 and Munidopsis lauensis) from Southwestern Pacific Back-Arc Basins	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; GULF-OF-MEXICO; GENETIC DIFFERENTIATION; SQUAT-LOBSTER; DISPERSAL; BATHYMODIOLUS; GALATHEIDAE; SOFTWARE; DNA; ALVINICONCHA	Studies of genetic connectivity and population structure in deep-sea chemosynthetic ecosystems often focus on endosymbiont-hosting species that are directly dependent on chemical energy extracted from vent effluent for survival. Relatively little attention has been paid to vent-associated species that are not exclusively dependent on chemosynthetic ecosystems. Here we assess connectivity and population structure of two vent-associated invertebrates-the shrimp Chorocaris sp. 2 and the squat lobster Munidopsis lauensis-that are common at deep-sea hydrothermal vents in the western Pacific. While Chorocaris sp. 2 has only been observed at hydrothermal vent sites, M. lauensis can be found throughout the deep sea but occurs in higher abundance around the periphery of active vents We sequenced mitochondrial COI genes and deployed nuclear microsatellite markers for both species at three sites in Manus Basin and either North Fiji Basin (Chorocaris sp. 2) or Lau Basin (Munidopsis lauensis). We assessed genetic differentiation across a range of spatial scales, from approximately 2.5 km to more than 3000 km. Population structure for Chorocaris sp. 2 was comparable to that of the vent-associated snail Ifremeria nautilei, with a single seemingly well-mixed population within Manus Basin that is genetically differentiated from conspecifics in North Fiji Basin. Population structure for Munidopsis lauensis was more complex, with two genetically differentiated populations in Manus Basin and a third well-differentiated population in Lau Basin. The unexpectedly high level of genetic differentiation between M. lauensis populations in Manus Basin deserves further study since it has implications for conservation and management of diversity in deep-sea hydrothermal vent ecosystems.	[Thaler, Andrew David; Plouviez, Sophie; Jacobson, Alixandra; Boyle, Emily A.; Schultz, Thomas F.; Van Dover, Cindy Lee] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Saleu, William] Nautilus Minerals, Port Moresby, NCD, Papua N Guinea; [Alei, Freddie] Univ Papua New Guinea, Sch Nat & Phys Sci, Environm Sci & Geog Div, Port Moresby, Papua N Guinea; [Carlsson, Jens] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	Duke University; University of Papua New Guinea; University College Dublin	Thaler, AD (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA.	andrew.david.thaler@gmail.com		Schultz, Thomas/0000-0001-9694-9920; Carlsson, Jens/0000-0002-9262-5627; Van Dover, Cindy/0000-0001-9845-8391	Nautilus Minerals Niugini Ltd.; Duke University; InterRidge; International Seabed Authority; National Science Foundation [OCE-1031050]; NSF [OCE-0241613]	Nautilus Minerals Niugini Ltd.; Duke University; InterRidge; International Seabed Authority; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by a research contract from Nautilus Minerals Niugini Ltd. (CLVD, JC, TFS), Duke University (ADT, CLVD), InterRidge (ADT and FA), the International Seabed Authority (WS) and the National Science Foundation (OCE-1031050 to CLVD). Samples from North Fiji and Lau Basin were provided by Dr. Robert Vrijenhoek (NSF Grant: OCE-0241613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GALATHEA REP, V20, P1; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Avise J.C., 2004, MOL MARKERS NATURAL; Bailie DA, 2010, J CRUSTACEAN BIOL, V30, P664, DOI 10.1651/09-3252.1; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beinart RA, 2012, P NATL ACAD SCI USA, V109, pE3241, DOI 10.1073/pnas.1202690109; Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boyle EA, 2013, CONSERV GENET RESOUR, V5, P647, DOI 10.1007/s12686-013-9872-1; Cabezas P, 2009, CONSERV GENET, V10, P673, DOI 10.1007/s10592-008-9611-4; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffey Natural Systems, 2008, DROP; COHEN D, 1991, THEOR POPUL BIOL, V39, P63, DOI 10.1016/0040-5809(91)90041-D; Collins PC, 2012, MAR ECOL PROG SER, V452, P89, DOI 10.3354/meps09646; Collins PC, 2013, MAR POLICY, V42, P334, DOI 10.1016/j.marpol.2013.03.002; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cornuet JM, 1996, GENETICS, V144, P2001; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Coykendall DK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-96; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; Creasey S, 2000, DEEP-SEA RES PT II, V47, P87, DOI 10.1016/S0967-0645(99)00098-3; Cubelio SS, 2007, J CRUSTACEAN BIOL, V27, P513, DOI 10.1651/0278-0372(2007)27[513:VAMDAG]2.0.CO;2; DENIS F, 1993, BIOCHEM SYST ECOL, V21, P431, DOI 10.1016/0305-1978(93)90101-V; Desbruyeres D, 2006, GEOPHYS MONOGR SER, V166, P215; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Galkin SV, 1997, MAR GEOL, V142, P197, DOI 10.1016/S0025-3227(97)00051-0; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRASSLE JP, 1985, B BIOL SOC WASH, V6, P429; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Ilves KL, 2010, MOL ECOL, V19, P4505, DOI 10.1111/j.1365-294X.2010.04790.x; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Jones WJ, 2007, J CRUSTACEAN BIOL, V27, P477, DOI 10.1651/S-2791.1; Kojima S, 2001, BIOL BULL-US, V200, P298, DOI 10.2307/1543511; Kojima S, 2000, ZOOL SCI, V17, P1167, DOI 10.2108/zsj.17.1167; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Macpherson Enrique, 2005, Zootaxa, V1095, P1; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Matabos M, 2011, J BIOGEOGR, V38, P575, DOI 10.1111/j.1365-2699.2010.02418.x; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; MORAGA D, 1994, DEEP-SEA RES PT I, V41, P1551, DOI 10.1016/0967-0637(94)90060-4; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plouviez S, 2013, DEEP-SEA RES PT I, V82, P73, DOI 10.1016/j.dsr.2013.08.004; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Shulman MJ, 1998, AUST J ECOL, V23, P216, DOI 10.1111/j.1442-9993.1998.tb00723.x; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Thaler AD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-372; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wares JP, 2001, EVOLUTION, V55, P2455; WILKENS H, 1990, J CRUSTACEAN BIOL, V10, P667, DOI 10.2307/1548411; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Yearsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023063; Young CR, 2008, MOL ECOL, V17, P1718, DOI 10.1111/j.1365-294X.2008.03609.x; Zelnio KA, 2010, CONSERV GENET RESOUR, V2, P223, DOI 10.1007/s12686-010-9243-0; Zenk W, 2005, PROG OCEANOGR, V67, P245, DOI 10.1016/j.pocean.2005.05.003	81	25	26	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101345	10.1371/journal.pone.0101345	http://dx.doi.org/10.1371/journal.pone.0101345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983244	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000093
J	Chen, HJ; Qiang, H; Fan, KC; Wang, SS; Zheng, ZC				Chen, Hongjie; Qiang, Hao; Fan, Kaichun; Wang, Shousen; Zheng, Zhaocong			The snoRNA MBII-52 Regulates Cocaine-Induced Conditioned Place Preference and Locomotion in Mice	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; IN-VIVO; SEROTONIN2C RECEPTORS; CONSTITUTIVE ACTIVITY; ADDICTION; BEHAVIOR; RATS; IDENTIFICATION; REINFORCEMENT; REINSTATEMENT	Cocaine dependence involves in the brain's reward circuit as well as nucleus accumbens (NAc), a key region of the mesolimbic dopamine pathway. Many studies have documented altered expression of genes and identified transcription factor networks and epigenetic processes that are fundamental to cocaine addiction. However, all these investigations have focused on mRNA and/or miRNA, which may not reflect the involvement of small nucleolar RNAs (snoRNAs), which has been implied in a broad range of biological processes and complex diseases including brain development and neuropathologocal process. To further address the role of snoRNA in cocaine addiction, we show that repeated exposure and conditioned place preference (CPP) training to cocaine negatively regulates the expression of MBII-52 mRNA level, which is a brain-specific C/D box snoRNA, but not influences the serotonin receptor 2C (5HT2CR) mRNA level in NAc. Furthemore, we show, developing lentiviral vector (LV)-expressing MBII-52 and LV-5HT2CR for stable and regulatable MBII-52 and LV-5HT2CR expression. LV-MBII-52 and LV-5HT2CR expression in NAc attenuate cocaine induced CPP and locomotor activity. Taken together, these findings show that MBII-52 and 5HT2CR exert an inhibitory influence on the behavioral responses to cocaine exposure.	[Chen, Hongjie; Wang, Shousen; Zheng, Zhaocong] Second Mil Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou, Fujian, Peoples R China; [Qiang, Hao] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai, Peoples R China; [Fan, Kaichun] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Chinese People's Liberation Army General Hospital	Wang, SS (corresponding author), Second Mil Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.	shousenwang@163.com			Shanghai Science and Technology Committee [10411952700]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study was supported by grants from Funded by Shanghai Science and Technology Committee (NO. 10411952700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Boothman L, 2006, BRIT J PHARMACOL, V149, P861, DOI 10.1038/sj.bjp.0706935; Bu Q, 2012, J NEUROCHEMISTRY; CALCAGNETTI DJ, 1995, LIFE SCI, V56, P475, DOI 10.1016/0024-3205(94)00414-N; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Craige CP, 2012, BEHAV BRAIN RES; De Deurwaerdere P, 2004, J NEUROSCI, V24, P3235, DOI 10.1523/JNEUROSCI.0112-04.2004; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6; Jonkman S, 2012, NEUROPSYCHOPHARMACOL; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Navailles S, 2008, NEUROPSYCHOPHARMACOL, V33, P237, DOI 10.1038/sj.npp.1301414; Navailles S, 2006, J NEUROCHEM, V99, P1311, DOI 10.1111/j.1471-4159.2006.04188.x; Neisewander JL, 2007, BEHAV PHARMACOL, V18, P791, DOI 10.1097/FBP.0b013e3282f1c94b; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; O'Brien CP, 2005, PHARMACOL THERAPEUT, V108, P18, DOI 10.1016/j.pharmthera.2005.06.018; Pritchard LM, 2012, PSYCHOPHARMACOLOGY, P1; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; WHITE NM, 1985, PHARMACOL BIOCHEM BE, V23, P37, DOI 10.1016/0091-3057(85)90127-3	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99986	10.1371/journal.pone.0099986	http://dx.doi.org/10.1371/journal.pone.0099986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979384	Green Submitted, Green Published, gold			2022-12-25	WOS:000338506400013
J	Rijkenberg, MJA; Middag, R; Laan, P; Gerringa, LJA; van Aken, HM; Schoemann, V; de Jong, JTM; de Baar, HJW				Rijkenberg, Micha J. A.; Middag, Rob; Laan, Patrick; Gerringa, Loes J. A.; van Aken, Hendrik M.; Schoemann, Veronique; de Jong, Jeroen T. M.; de Baar, Hein J. W.			The Distribution of Dissolved Iron in the West Atlantic Ocean	PLOS ONE			English	Article							SOUTHERN-OCEAN; NORTH-ATLANTIC; TROPICAL ATLANTIC; BIOGEOCHEMICAL CYCLES; MARINE-PHYTOPLANKTON; COMPLEXING LIGANDS; TRACE-ELEMENTS; SAHARAN DUST; INDIAN-OCEAN; RIVER PLUME	Iron (Fe) is an essential trace element for marine life. Extremely low Fe concentrations limit primary production and nitrogen fixation in large parts of the oceans and consequently influence ocean ecosystem functioning. The importance of Fe for ocean ecosystems makes Fe one of the core chemical trace elements in the international GEOTRACES program. Despite the recognized importance of Fe, our present knowledge of its supply and biogeochemical cycle has been limited by mostly fragmentary datasets. Here, we present highly accurate dissolved Fe (DFe) values measured at an unprecedented high intensity (1407 samples) along the longest full ocean depth transect (17500 kilometers) covering the entire western Atlantic Ocean. DFe measurements along this transect unveiled details about the supply and cycling of Fe. External sources of Fe identified included off-shelf and river supply, hydrothermal vents and aeolian dust. Nevertheless, vertical processes such as the recycling of Fe resulting from the remineralization of sinking organic matter and the removal of Fe by scavenging still dominated the distribution of DFe. In the northern West Atlantic Ocean, Fe recycling and lateral transport from the eastern tropical North Atlantic Oxygen Minimum Zone (OMZ) dominated the DFe-distribution. Finally, our measurements showed that the North Atlantic Deep Water (NADW), the major driver of the so-called ocean conveyor belt, contains excess DFe relative to phosphate after full biological utilization and is therefore an important source of Fe for biological production in the global ocean.	[Rijkenberg, Micha J. A.; Middag, Rob; Laan, Patrick; Gerringa, Loes J. A.; van Aken, Hendrik M.; Schoemann, Veronique; de Jong, Jeroen T. M.; de Baar, Hein J. W.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands; [Middag, Rob] Univ Otago, Dept Chem, Dunedin, New Zealand; [de Baar, Hein J. W.] Univ Groningen, Dept Ocean Ecosyst, Groningen, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Otago; University of Groningen	Rijkenberg, MJA (corresponding author), Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands.	micha.rijkenberg@nioz.nl	Middag, Rob/D-6423-2013	Middag, Rob/0000-0002-3326-530X; de Jong, Jeroen/0000-0002-3034-5929	Dutch National Program Sea and Coastal Research (ZKO) of the Netherlands Organisation for Scientific Research (NWO) [839.08.410]	Dutch National Program Sea and Coastal Research (ZKO) of the Netherlands Organisation for Scientific Research (NWO)	This research was funded by the Dutch National Program Sea and Coastal Research (ZKO, project number 839.08.410) of the Netherlands Organisation for Scientific Research (NWO, www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; Blain S, 2008, BIOGEOSCIENCES, V5, P269, DOI 10.5194/bg-5-269-2008; Blain S, 2008, DEEP-SEA RES PT II, V55, P594, DOI 10.1016/j.dsr2.2007.12.028; Borer PM, 2005, MAR CHEM, V93, P179, DOI 10.1016/j.marchem.2004.08.006; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1271, DOI 10.4319/lo.2010.55.3.1271; Boye M, 2010, MAR CHEM, V122, P20, DOI 10.1016/j.marchem.2010.09.001; Broecker W. S., 1991, OCEANOGRAPHY, V4, P79, DOI [10.5670/oceanog.1991.07, DOI 10.5670/0CEAN0G.1991.07, DOI 10.5670/OCEANOG.1991.07]; Bruland KW, 2014, TREATISE GEOCHEMISTR, P19, DOI DOI 10.1016/B978-0-08-095975-7.00602-1; DAI MH, 1995, EARTH PLANET SC LETT, V131, P127, DOI 10.1016/0012-821X(95)00021-4; Dammshauser A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049847; De Baar HJW, 2008, MAR CHEM, V111, P4, DOI 10.1016/j.marchem.2007.07.009; de Baar H.J.W., 2001, BIOGEOCHEMISTRY IRON; de Baar HJW, 2003, MARINE SCIENCE FRONTIERS FOR EUROPE, P79; de Baar HJW, 2012, OC SCI M SALT LAK CI; de Jong J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001679; DEBAAR HJW, 1990, MAR ECOL PROG SER, V65, P105, DOI 10.3354/meps065105; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Deng FF, 2014, EARTH PLANET SC LETT, V390, P93, DOI 10.1016/j.epsl.2013.12.038; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Dulaquais G, 2014, BIOGEOSCIENCES, V11, P1561, DOI 10.5194/bg-11-1561-2014; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Erickson DJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017241; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Fitzsimmons JN, 2013, MAR CHEM, V154, P87, DOI 10.1016/j.marchem.2013.05.009; FOX LE, 1988, GEOCHIM COSMOCHIM AC, V52, P771, DOI 10.1016/0016-7037(88)90337-7; Gasso S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027693; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; Gerringa LJA, 2012, DEEP-SEA RES PT II, V71-76, P16, DOI 10.1016/j.dsr2.2012.03.007; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Gonzalez-Silvera A, 2004, CONT SHELF RES, V24, P983, DOI 10.1016/j.csr.2004.03.002; Grasshoff K., 1999, METHODS SEAWATER ANA; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; Hassler CS, 2009, BIOGEOSCIENCES, V6, P2281, DOI 10.5194/bg-6-2281-2009; Hawkes JA, 2013, EARTH PLANET SC LETT, V375, P280, DOI 10.1016/j.epsl.2013.05.047; Hawkes JA, 2014, GEOPHYS RES LETT, V41; Hayes CT, 2013, EARTH PLANET SC LETT, V383, P16, DOI 10.1016/j.epsl.2013.09.025; Henderson GM, 2007, CHEM ERDE-GEOCHEM, V67, P85, DOI 10.1016/j.chemer.2007.02.001; Hopkinson BM, 2007, MAR CHEM, V106, P2, DOI 10.1016/j.marchem.2006.02.008; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Klunder MB, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007135; Klunder MB, 2011, DEEP-SEA RES PT II, V58, P2678, DOI 10.1016/j.dsr2.2010.10.042; Klunder MB, 2014, BIOGEOSCIENCES, V10, P7433; Kondo Y, 2013, DEEP-SEA RES PT I, V73, P73, DOI 10.1016/j.dsr.2012.11.014; Kuma K, 1996, LIMNOL OCEANOGR, V41, P396, DOI 10.4319/lo.1996.41.3.0396; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Lannuzel D, 2011, DEEP-SEA RES PT II, V58, P2094, DOI 10.1016/j.dsr2.2011.05.027; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lohan MC, 2006, MAR CHEM, V98, P260, DOI 10.1016/j.marchem.2005.10.003; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Maldonado MT, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002481; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Measures CI, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003042; Melchert B, 2008, EARTH PLANET SC LETT, V275, P61, DOI 10.1016/j.epsl.2008.08.010; Middag R, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007434; Middag R, 2011, DEEP-SEA RES PT II, V58, P2647, DOI 10.1016/j.dsr2.2011.03.001; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Nishioka J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004055; Nishioka J, 2013, EARTH PLANET SC LETT, V361, P26, DOI 10.1016/j.epsl.2012.11.040; Noble AE, 2012, LIMNOL OCEANOGR, V57, P989, DOI 10.4319/lo.2012.57.4.0989; Parekh P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002280; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; Planquette H, 2007, DEEP-SEA RES PT II, V54, P1999, DOI 10.1016/j.dsr2.2007.06.019; Powell RT, 2003, ESTUAR COAST SHELF S, V58, P757, DOI 10.1016/S0272-7714(03)00182-3; PROSPERO JM, 1972, J GEOPHYS RES, V77, P5255, DOI 10.1029/JC077i027p05255; Rijkenberg MJA, 2008, MAR CHEM, V109, P29, DOI 10.1016/j.marchem.2007.12.001; Rijkenberg MJA, 2008, MAR CHEM, V110, P56, DOI 10.1016/j.marchem.2008.02.006; Rijkenberg MJA, 2006, GEOCHIM COSMOCHIM AC, V70, P2790, DOI 10.1016/j.gca.2006.03.004; Rijkenberg MJA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004264; Rijkenberg MJA, 2006, MAR CHEM, V100, P11, DOI 10.1016/j.marchem.2005.10.005; Rijkenberg MJA, 2005, MAR CHEM, V93, P119, DOI 10.1016/j.marchem.2004.03.021; Ruth C, 2000, DEEP-SEA RES PT I, V47, P1059, DOI 10.1016/S0967-0637(99)00077-1; Ryan-Keogh TJ, 2013, LIMNOL OCEANOGR, V58, P533, DOI 10.4319/lo.2013.58.2.0533; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Saito MA, 2013, NATURE GEOSCI; Santana-Casiano JM, 2005, ENVIRON SCI TECHNOL, V39, P2073, DOI 10.1021/es049748y; Schott FA, 1998, J PHYS OCEANOGR, V28, P1904, DOI 10.1175/1520-0485(1998)028<1904:TAPOTU>2.0.CO;2; SHOLKOVITZ ER, 1978, EARTH PLANET SC LETT, V40, P130, DOI 10.1016/0012-821X(78)90082-1; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Stramma L, 2004, DEEP-SEA RES PT I, V51, P1033, DOI 10.1016/j.dsr.2004.04.001; Stramma L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004369; Tagliabue A, 2011, BIOGEOSCIENCES, V8, P3025, DOI 10.5194/bg-8-3025-2011; Tagliabue A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003363; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Thuroczy CE, 2010, DEEP-SEA RES PT I, V57, P1444, DOI 10.1016/j.dsr.2010.08.004; Tovar-Sanchez A, 2011, BIOGEOSCIENCES, V8, P217, DOI 10.5194/bg-8-217-2011; Turner DR, 2001, IUPAC SERIES ANAL PH, P1; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; van Aken H.M., 2007, OCEANIC THERMOHALINE; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; WELLS ML, 1995, MAR CHEM, V48, P157, DOI 10.1016/0304-4203(94)00055-I; Wen LS, 1999, MAR CHEM, V63, P185, DOI 10.1016/S0304-4203(98)00062-0; Witter AE, 2000, DEEP-SEA RES PT II, V47, P1517, DOI 10.1016/S0967-0645(99)00152-6	97	109	110	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101323	10.1371/journal.pone.0101323	http://dx.doi.org/10.1371/journal.pone.0101323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978190	Green Published, gold, Green Submitted			2022-12-25	WOS:000338506400116
J	Tandogan, N; Abadian, PN; Epstein, S; Aoi, Y; Goluch, ED				Tandogan, Nil; Abadian, Pegah N.; Epstein, Slava; Aoi, Yoshiteru; Goluch, Edgar D.			Isolation of Microorganisms Using Sub-Micrometer Constrictions	PLOS ONE			English	Article							HIGH-THROUGHPUT; SINGLE-CELL; SHEAR-STRESS; CULTIVATION; GROWTH; ANTIBIOTICS; DIVERSITY; DETACHMENT; CHEMOSTAT; BACTERIA	We present an automated method for isolating pure bacterial cultures from samples containing multiple species that exploits the cell's own physiology to perform the separation. Cells compete to reach a chamber containing nutrients via a constriction whose cross-sectional area only permits a single cell to enter, thereby blocking the opening and preventing other cells from entering. The winning cell divides across the constriction and its progeny populate the chamber. The devices are passive and require no user interaction to perform their function. Device fabrication begins with the creation of a master mold that contains the desired constriction and chamber features. Replica molding is used to create patterned polymer chips from the master, which are bonded to glass microscope cover slips to create the constrictions. We tested constriction geometries ranging from 500 nanometers to 5 micrometers in width, 600 to 950 nanometers in height, and 10 to 40 micrometers in length. The devices were used to successfully isolate a pure Pseudomonas aeruginosa culture from a mixture that also contained Escherichia coli. We demonstrated that individual strains of the same species can be separated out from mixtures using red and green fluorescently-labeled E. coli. We also used the devices to isolate individual environmental species. Roseobacter sp. was separated from another marine species, Psychroserpens sp.	[Tandogan, Nil; Abadian, Pegah N.; Goluch, Edgar D.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Epstein, Slava; Aoi, Yoshiteru] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Aoi, Yoshiteru] Hiroshima Univ, Inst Sustainable Sci & Dev, Hiroshima, Japan	Northeastern University; Northeastern University; Hiroshima University	Epstein, S (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu; yoshiteruaoi@hiroshima-u.ac.jp; e.goluch@neu.edu	Goluch, Edgar/AAK-1528-2020; Goluch, Edgar D/C-2344-2008	Goluch, Edgar D/0000-0001-9319-8906	National Science Foundation [1125535]; Northeastern University; Div Of Biological Infrastructure [1353853] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Northeastern University; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported in part by the National Science Foundation under grant number 1125535 and a Northeastern University Tier 1 Interdisciplinary Research Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Ben-Dov E, 2009, FEMS MICROBIOL ECOL, V68, P363, DOI 10.1111/j.1574-6941.2009.00682.x; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Choi YC, 2003, WATER SCI TECHNOL, V47, P69, DOI 10.2166/wst.2003.0284; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; EBERSOLE RC, 1993, BIO-TECHNOL, V11, P1278; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Fotouhi L, 2010, COLLOID SURFACE B, V81, P110, DOI 10.1016/j.colsurfb.2010.06.030; HARRIS RD, 1995, SENSOR ACTUAT B-CHEM, V29, P261, DOI 10.1016/0925-4005(95)01692-9; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hu XY, 2005, P NATL ACAD SCI USA, V102, P15757, DOI 10.1073/pnas.0507719102; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ingham CJ, 2008, LAB CHIP, V8, P1604, DOI 10.1039/b804790a; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Jara CC, 2007, APPL CATAL B-ENVIRON, V70, P479, DOI 10.1016/j.apcatb.2005.11.035; Jones PV, 2014, ANAL BIOANAL CHEM, V406, P183, DOI 10.1007/s00216-013-7437-5; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Kim MC, 2011, LAB CHIP, V11, P1089, DOI [10.1039/c0lc00362j, 10.1039/c01c00362j]; LaCourse WR, 1999, J PHARMACEUT BIOMED, V19, P239, DOI 10.1016/S0731-7085(98)00089-2; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nam KH, 2010, J MICROELECTROMECH S, V19, P375, DOI 10.1109/JMEMS.2010.2040459; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Paul E, 2012, WATER RES, V46, P5499, DOI 10.1016/j.watres.2012.07.029; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Pires L, 2013, BIOSENS BIOELECTRON, V47, P157, DOI 10.1016/j.bios.2013.03.015; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Sipkema D, 2011, APPL ENVIRON MICROB, V77, P2130, DOI 10.1128/AEM.01203-10; Sizova MV, 2012, APPL ENVIRON MICROB, V78, P194, DOI 10.1128/AEM.06813-11; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WHITAKER GW, 1988, J LIQ CHROMATOGR, V11, P3011, DOI 10.1080/01483918808076776; Zago A, 2009, ENCY MICROBIOLOGY, VThird, P245, DOI DOI 10.1016/B978-012373944-5.00203-0	41	16	18	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101429	10.1371/journal.pone.0101429	http://dx.doi.org/10.1371/journal.pone.0101429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978477	gold, Green Submitted, Green Published			2022-12-25	WOS:000338506400129
J	Goswami, P; Murty, US; Mutheneni, SR; Krishnan, ST				Goswami, Prashant; Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao; Krishnan, Swathi Trithala			Relative Roles of Weather Variables and Change in Human Population in Malaria: Comparison over Different States of India	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; GLOBAL CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; TEMPERATURE-VARIATION; TRANSMISSION; RISK; AFRICA; MICROCLIMATE; STEPHENSI; SETTINGS	Background: Pro-active and effective control as well as quantitative assessment of impact of climate change on malaria requires identification of the major drivers of the epidemic. Malaria depends on vector abundance which, in turn, depends on a combination of weather variables. However, there remain several gaps in our understanding and assessment of malaria in a changing climate. Most of the studies have considered weekly or even monthly mean values of weather variables, while the malaria vector is sensitive to daily variations. Secondly, rarely all the relevant meteorological variables have been considered together. An important question is the relative roles of weather variables (vector abundance) and change in host (human) population, in the change in disease load. Method: We consider the 28 states of India, characterized by diverse climatic zones and changing population as well as complex variability in malaria, as a natural test bed. An annual vector load for each of the 28 states is defined based on the number of vector genesis days computed using daily values of temperature, rainfall and humidity from NCEP daily Reanalysis; a prediction of potential malaria load is defined by taking into consideration changes in the human population and compared with the reported number of malaria cases. Results: For most states, the number of malaria cases is very well correlated with the vector load calculated with the combined conditions of daily values of temperature, rainfall and humidity; no single weather variable has any significant association with the observed disease prevalence. Conclusion: The association between vector-load and daily values of weather variables is robust and holds for different climatic regions (states of India). Thus use of all the three weather variables provides a reliable means of pro-active and efficient vector sanitation and control as well as assessment of impact of climate change on malaria.	[Goswami, Prashant; Krishnan, Swathi Trithala] CSIR Fourth Paradigm Inst, Bengaluru, India; [Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao] CSIR Indian Inst Chem Technol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Fourth Paradigm Institute (CSIR 4PI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Goswami, P (corresponding author), CSIR Fourth Paradigm Inst, Bengaluru, India.	goswami@cmmacs.ernet.in	Mutheneni, Srinivasa Rao/AAI-2262-2020	Mutheneni, Srinivasa Rao/0000-0003-3263-3905	project Integrated Analysis for Impact, Mitigation and Sustainability - CSIR, India	project Integrated Analysis for Impact, Mitigation and Sustainability - CSIR, India	This work was supported by the project Integrated Analysis for Impact, Mitigation and Sustainability funded by CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Caminade C, 2011, ATMOS SCI LETT, V12, P96, DOI 10.1002/asl.296; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DAVIDSON G, 1973, B WORLD HEALTH ORGAN, V49, P475; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; GILL C. A., 1921, Indian Journal of Medical Research, V8, P633; GILL CA, 1920, INDIAN J MED RES, V37, P618; Gillett JD, 1974, S BRIT SOC PARASITOL, V12, P79; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P9; Goswami P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027594; Goswami P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049713; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kiszewski AE, 2004, AM J TROP MED HYG, V71, P128, DOI 10.4269/ajtmh.2004.71.128; Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20; KUMAR A, 1994, J AM MOSQUITO CONTR, V10, P534; LEAF A, 1989, NEW ENGL J MED, V321, P1577, DOI 10.1056/NEJM198912073212305; Leeson H., 1939, B ENTOMOL RES, V30, P103; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Macdonald G, 1958, P ROY SOC MED, V51, P223; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Matsuoka Y, 1994, J GLOBAL ENV ENG, V1, P1; Mo KC, 1996, J CLIMATE, V9, P1531, DOI 10.1175/1520-0442(1996)009<1531:LSAMTA>2.0.CO;2; Mohapatra PK, 2001, NATL MED J INDIA, V14, P139; Paaijmans KP, 2009, PNAS, V106, P33; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; Singh N, 2004, TROP MED INT HEALTH, V9, P364, DOI 10.1046/j.1365-3156.2003.01181.x; Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tiwari S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-179; Vinayak S, 2003, ACTA TROP, V87, P287, DOI 10.1016/S0001-706X(03)00021-4; Yang GJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000385	46	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99867	10.1371/journal.pone.0099867	http://dx.doi.org/10.1371/journal.pone.0099867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971510	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200015
J	Janssens, L; Stoks, R				Janssens, Lizanne; Stoks, Robby			Chronic Predation Risk Reduces Escape Speed by Increasing Oxidative Damage: A Deadly Cost of an Adaptive Antipredator Response	PLOS ONE			English	Article							LIFE-HISTORY; SURVIVAL SELECTION; CHRONIC STRESS; TRADE-OFF; PERFORMANCE; BEHAVIOR; GROWTH; SHAPE; PROTEINS; DEFENSES	Prey organisms evolved a multitude of plastic responses to avoid being eaten by predators. Besides the evolution of plastic morphological responses to escape predation, prey also evolved a set of physiological stress responses to avoid dying because of chronic predator stress per se due to disruption of cellular homeostasis. As physiological stress theory predicts increased energy consumption and the inhibition of essential nonemergency body functions, we tested whether chronic predation risk may increase oxidative damage thereby generating negative effects on escape performance. Specifically, we evaluated whether predation risk reduces escape swimming speed in damselfly larvae and whether this operates through stress-associated increases in oxidative damage. Counterintuitively and in contrast with many empirical studies, chronic predation risk decreased escape performance. This is however entirely consistent with the expectation of it being a long-term cost of responding to predation risk (e.g. by increasing respiration or upregulating the stress protein levels). The decreased swimming speed could be explained by an increased oxidative damage to proteins, thereby providing one of the poorly studied ecological links between oxidative damage and whole-animal performance. This likely widespread, understudied cost of chronic predation risk may provide an important pathway of non-consumptive predator effects on prey population dynamics. Moreover, it could play an evolutionary role by acting as a selective force causing prey organisms to adjust the magnitude of the physiological stress response and should be considered when evaluating life history trade-offs thought to be mediated by oxidative damage.	[Janssens, Lizanne; Stoks, Robby] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium	KU Leuven	Janssens, L (corresponding author), Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium.	lizanne.janssens@bio.kuleuven.be	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	KU Leuven research fund; Fund for Scientific Research (FWO) Flanders	KU Leuven research fund(KU Leuven); Fund for Scientific Research (FWO) Flanders(FWO)	RS received funding from the KU Leuven research fund and the Fund for Scientific Research (FWO) Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2011, HORM BEHAV, V60, P478, DOI 10.1016/j.yhbeh.2011.07.015; Archer CR, 2013, EVOLUTION, V67, P620, DOI 10.1111/j.1558-5646.2012.01805.x; Arnold KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1857, DOI 10.1007/s00265-010-0997-x; Beckerman AP, 2007, OECOLOGIA, V152, P335, DOI 10.1007/s00442-006-0642-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; De Block M, 2004, OIKOS, V106, P587; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Guerra C, 2013, COMP BIOCHEM PHYS A, V165, P89, DOI 10.1016/j.cbpa.2013.02.006; Halliwell B., 2007, FREE RADICAL BIO MED, P260; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Iserbyt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032648; Janssens L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0350; Karatas F, 2002, ANAL BIOCHEM, V311, P76, DOI 10.1016/S0003-2697(02)00387-1; Lee WS, 2010, J EXP BIOL, V213, P3289, DOI 10.1242/jeb.043083; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; McPeek MA, 1997, EVOLUTION, V51, P459, DOI 10.1111/j.1558-5646.1997.tb02433.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miyamoto S, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P440; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Peacor SD, 2006, HYDROBIOLOGIA, V573, P39, DOI 10.1007/s10750-006-0256-3; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea Rick A., 2005, P189; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Stoks R, 2003, ECOLOGY, V84, P3327, DOI 10.1890/02-0696; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; Stoks R, 2006, AM NAT, V168, pS50, DOI 10.1086/509045; Strobbe F, 2009, J EVOLUTION BIOL, V22, P1172, DOI 10.1111/j.1420-9101.2009.01733.x; Strobbe F, 2010, FUNCT ECOL, V24, P1306, DOI 10.1111/j.1365-2435.2010.01752.x; Teplitsky C, 2005, J EVOLUTION BIOL, V18, P180, DOI 10.1111/j.1420-9101.2004.00790.x; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x	44	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101273	10.1371/journal.pone.0101273	http://dx.doi.org/10.1371/journal.pone.0101273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968142	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800120
J	Tam, A; Wadsworth, S; Dorscheid, D; Man, SFP; Sin, DD				Tam, Anthony; Wadsworth, Samuel; Dorscheid, Delbert; Man, Shu-Fan Paul; Sin, Don D.			Estradiol Increases Mucus Synthesis in Bronchial Epithelial Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MENSTRUAL-CYCLE; REGULATES MUCIN; MESSENGER-RNA; GOBLET CELLS; MUC5AC MUCIN; EXPRESSION; IDENTIFICATION; RECEPTOR; ALPHA	Airway epithelial mucus hypersecretion and mucus plugging are prominent pathologic features of chronic inflammatory conditions of the airway (e.g. asthma and cystic fibrosis) and in most of these conditions, women have worse prognosis compared with male patients. We thus investigated the effects of estradiol on mucus expression in primary normal human bronchial epithelial cells from female donors grown at an air liquid interface (ALI). Treatment with estradiol in physiological ranges for 2 weeks caused a concentration-dependent increase in the number of PAS-positive cells (confirmed to be goblet cells by MUC5AC immunostaining) in ALI cultures, and this action was attenuated by estrogen receptor beta (ER-beta) antagonist. Protein microarray data showed that nuclear factor of activated T-cell (NFAT) in the nuclear fraction of NHBE cells was increased with estradiol treatment. Estradiol increased NFATc1 mRNA and protein in ALI cultures. In a human airway epithelial (1HAE(0)) cell line, NFATc1 was required for the regulation of MUC5AC mRNA and protein. Estradiol also induced post-translational modification of mucins by increasing total fucose residues and fucosyltransferase (FUT-4, -5, -6) mRNA expression. Together, these data indicate a novel mechanism by which estradiol increases mucus synthesis in the human bronchial epithelium.	[Sin, Don D.] Univ British Columbia, Providence Heart Lung Ctr, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Sin, DD (corresponding author), Univ British Columbia, Providence Heart Lung Ctr, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	Don.Sin@hli.ubc.ca	Sin, Don/AAC-2219-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Farha S, 2009, AM J RESP CRIT CARE, V180, P304, DOI 10.1164/rccm.200904-0497OC; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Johannesson M, 2000, RESP MED, V94, P1043, DOI 10.1053/rmed.2000.0891; Kohri K, 2002, EUR RESPIR J, V20, P1263, DOI 10.1183/09031936.02.00001402; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Voynow JA, 1999, AM J PHYSIOL-LUNG C, V276, pL835; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yoon JH, 1999, ACTA OTO-LARYNGOL, V119, P905	25	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100633	10.1371/journal.pone.0100633	http://dx.doi.org/10.1371/journal.pone.0100633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964096	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500070
J	Kohlmaier, A; Fassnacht, C; Jin, Y; Reuter, H; Begum, J; Dutta, D; Edgar, BA				Kohlmaier, A.; Fassnacht, C.; Jin, Y.; Reuter, H.; Begum, J.; Dutta, D.; Edgar, B. A.			Src kinase function controls progenitor cell pools during regeneration and tumor onset in the Drosophila intestine	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; STEM-CELL; C-SRC; TERMINAL DIFFERENTIATION; DEPENDENT REGULATION; BACTERIAL-INFECTION; TYROSINE KINASES; STAT3 ACTIVATION; CYCLE REGULATION; FACTOR RECEPTOR	Src non-receptor kinases have been implicated in events late in tumor progression. Here, we study the role of Src kinases in the Drosophila intestinal stem cell (ISC) lineage, during tissue homeostasis and tumor onset. The adult Drosophila intestine contains only two progenitor cell types, division-capable ISCs and their daughters, postmitotic enteroblasts (EBs). We found that Drosophila Src42a and Src64b were required for optimal regenerative ISC division. Conversely, activation of Src42a, Src64b or another nonreceptor kinase, Ack, promoted division of quiescent ISCs by coordinately stimulating G1/S and G2/M cell cycle phase progression. Prolonged Src kinase activation caused tissue overgrowth owing to cytokine receptor-independent Stat92E activation. This was not due to increased symmetric division of ISCs, but involved accumulation of weakly specified Notch(+) but division-capable EB-like cells. Src activation triggered expression of a mitogenic module consisting of String/Cdc25 and Cyclin E that was sufficient to elicit division not only of ISCs but also of EBs. A small pool of similarly division-capable transit-amplifying Notch(+) EBs was also identified in the wild type. Expansion of intermediate cell types that do not robustly manifest their transit-amplifying potential in the wild type may also contribute to regenerative growth and tumor development in other tissues in other organisms.	[Kohlmaier, A.; Fassnacht, C.; Jin, Y.; Reuter, H.; Begum, J.; Dutta, D.; Edgar, B. A.] Univ Heidelberg ZMBH Allianz, Deutsch Krebsforschungszentrum DKFZ, Zentrum Mol Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Edgar, BA (corresponding author), DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	b.edgar@zmbh.uni-heidelberg.de	Jin, Yinhua/AAU-5460-2021	Jin, Yinhua/0000-0003-4698-8555; Dutta, Devanjali/0000-0002-4993-9639; von Gugelberg (born Fassnacht), Christina/0000-0001-5379-2687	ERC [268515]; NIH [R01 GM51186]; DFG [SFB873]; Human Frontiers in Science Program Long-Term postdoctoral fellowship [LT00316/2008-L]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Human Frontiers in Science Program Long-Term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Ibbserson and the Deep Sequencing Core Facility of CellNetworks University of Heidelberg and the Fred Hutchinson Cancer Research Center Seattle for RNA and library preparations and sequencing. We thank Nicholas Harden, Yuh Nung Jan, Marco Milan, Steven Hou, Sarah Bray, Sol Sotillos and the Yale FlyTrap consortium (USA) for gifts of fly stocks. We are grateful to Sylvia Kreger for experimental support and Monika Langlotz (ZMBH) for help with FACS. We thank Juanita Reetz for critically reading of the manuscript. Work in BAE's laboratory was funded by ERC Grant 268515, NIH Grant R01 GM51186 and DFG Grant SFB873. AK was supported by a Human Frontiers in Science Program Long-Term postdoctoral fellowship (LT00316/2008-L).	Abdallah AM, 2013, DEV BIOL, V378, P141, DOI 10.1016/j.ydbio.2013.02.025; Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Baonza A, 2002, NAT CELL BIOL, V4, P976, DOI 10.1038/ncb887; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Buttitta LA, 2007, DEV CELL, V12, P631, DOI 10.1016/j.devcel.2007.02.020; Buttitta LA, 2010, J CELL BIOL, V189, P981, DOI 10.1083/jcb.200910006; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Chau J, 2009, GENETICS, V182, P121, DOI 10.1534/genetics.109.100693; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cordero JB, 2012, DEVELOPMENT, V139, P4524, DOI 10.1242/dev.078261; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; de Navascues J, 2012, EMBO J, V31, P2473, DOI 10.1038/emboj.2012.106; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Fernandez BG, 2014, ONCOGENE, V33, P2027, DOI 10.1038/onc.2013.155; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Guest ST, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-65; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Herranz H, 2012, GENE DEV, V26, P1602, DOI 10.1101/gad.192021.112; Herranz H, 2012, CURR BIOL, V22, P651, DOI 10.1016/j.cub.2012.02.050; Huang HL, 2014, DEV BIOL, V385, P211, DOI 10.1016/j.ydbio.2013.11.008; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; Kim M, 2004, MOL CELL BIOL, V24, P573, DOI 10.1128/MCB.24.2.573-583.2004; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nasmyth K, 2001, CELL, V107, P689, DOI 10.1016/S0092-8674(01)00604-3; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Prokopenko SN, 2005, SEMIN CELL DEV BIOL, V16, P423, DOI 10.1016/j.semcdb.2005.02.005; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Ren FF, 2013, CELL RES, V23, P1133, DOI 10.1038/cr.2013.101; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Schaeffer V, 2004, CURR BIOL, V14, P630, DOI 10.1016/j.cub.2004.03.040; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoenherr JA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002725; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; Sotillos S, 2013, DEVELOPMENT, V140, P1507, DOI 10.1242/dev.092320; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zielke N, 2008, GENE DEV, V22, P1690, DOI 10.1101/gad.469108; Zielke N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012948; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	98	28	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2371	2384		10.1038/onc.2014.163	http://dx.doi.org/10.1038/onc.2014.163			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24975577				2022-12-25	WOS:000353824800010
J	Teichmann, A; Gibert, A; Lampe, A; Grzesik, P; Rutz, C; Furkert, J; Schmoranzer, J; Krause, G; Wiesner, B; Schulein, R				Teichmann, Anke; Gibert, Arthur; Lampe, Andre; Grzesik, Paul; Rutz, Claudia; Furkert, Jens; Schmoranzer, Jan; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf			The Specific Monomer/Dimer Equilibrium of the Corticotropin-releasing Factor Receptor Type 1 Is Established in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Endoplasmic Reticulum (ER); Fluorescence Correlation Spectroscopy (FCS); G Protein-coupled Receptor (GPCR); Plasma Membrane; Corticotropin-releasing Factor Receptors; Fluorescence Cross-correlation Spectroscopy; Monomer; Oligomer Equilibrium; Receptor Oligomerization	FLUORESCENCE CORRELATION SPECTROSCOPY; DELTA-OPIOID RECEPTORS; ENDOTHELIN-B RECEPTOR; PSEUDO SIGNAL PEPTIDE; MONOMERIC RHODOPSIN; PROTEIN; HETERODIMERIZATION; HOMODIMERIZATION; DIMER; BIOSYNTHESIS	Background: GPCRs may be expressed in a monomer/dimer equilibrium at the plasma membrane. Results: For the dimeric CRF1R, we found a constant monomer/dimer equilibrium not only at the plasma membrane but also in the ER. Conclusion: The monomer/dimer equilibrium of the CRF1R is established already in the ER. Significance: Our findings shed new light on the monomer/dimer equilibrium of GPCRs and on ER functions. G protein-coupled receptors (GPCRs) represent the most important drug targets. Although the smallest functional unit of a GPCR is a monomer, it became clear in the past decades that the vast majority of the receptors form dimers. Only very recently, however, data were presented that some receptors may in fact be expressed as a mixture of monomers and dimers and that the interaction of the receptor protomers is dynamic. To date, equilibrium measurements were restricted to the plasma membrane due to experimental limitations. We have addressed the question as to where this equilibrium is established for the corticotropin-releasing factor receptor type 1. By developing a novel approach to analyze single molecule fluorescence cross-correlation spectroscopy data for intracellular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a specific monomer/dimer equilibrium that is already established in the endoplasmic reticulum (ER). It remains constant at the plasma membrane even following receptor activation. Moreover, we demonstrate for seven additional GPCRs that they are expressed in specific but substantially different monomer/dimer ratios. Although it is well known that proteins may dimerize in the ER in principle, our data show that the ER is also able to establish the specific monomer/dimer ratios of GPCRs, which sheds new light on the functions of this compartment.	[Teichmann, Anke; Gibert, Arthur; Lampe, Andre; Grzesik, Paul; Rutz, Claudia; Furkert, Jens; Schmoranzer, Jan; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wiesner, B (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	wiesner@fmp-berlin.de; schuelein@fmp-berlin.de		Schmoranzer, Jan/0000-0002-4482-7080; Lampe, Andre/0000-0003-0750-4757				Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Beyermann M, 1996, J MED CHEM, V39, P3324, DOI 10.1021/jm960116z; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; Cottet M, 2010, CURR OPIN PHARMACOL, V10, P59, DOI 10.1016/j.coph.2009.10.003; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gregan B, 2004, J CARDIOVASC PHARM, V44, pS30, DOI 10.1097/01.fjc.0000166218.35168.79; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Murat B, 2012, MOL ENDOCRINOL, V26, P502, DOI 10.1210/me.2011-1202; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Schmidt V, 2012, EMBO J, V31, P187, DOI 10.1038/emboj.2011.352; Schulz K, 2010, J BIOL CHEM, V285, P32878, DOI 10.1074/jbc.M110.129627; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Teichmann A, 2012, J BIOL CHEM, V287, P27265, DOI 10.1074/jbc.M112.360594; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Westendorf C, 2011, J BIOL CHEM, V286, P35588, DOI 10.1074/jbc.M111.239244; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zampatis DE, 2012, FEBS LETT, V586, P2351, DOI 10.1016/j.febslet.2012.05.042	53	34	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24250	24262		10.1074/jbc.M114.553644	http://dx.doi.org/10.1074/jbc.M114.553644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24966326	Green Published, hybrid			2022-12-25	WOS:000341505600022
J	Liu, DH; He, XC; Qian, PX; Barker, N; Trainor, PA; Clevers, H; Liu, HW; Li, LH				Liu, Donghua; He, Xi C.; Qian, Pengxu; Barker, Nick; Trainor, Paul A.; Clevers, Hans; Liu, Huiwen; Li, Linheng			Leucine-rich Repeat-containing G-protein-coupled Receptor 5 Marks Short-term Hematopoietic Stem and Progenitor Cells during Mouse Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo; Hematopoiesis; Proliferation; Stem Cells; Transplantation; Lgr5; Hematopoietic Stem Cells; Progenitor Cells	GONAD-MESONEPHROS REGION; SELF-RENEWAL; IN-VITRO; EXPRESSION; AORTA; HSCS; LGR5; ENDOTHELIUM; GENERATION; EMERGENCE	Background: Lgr5 was shown to mark proliferating stem cells in several adult organs. Results: Lgr5 expression was detected in proliferating hematopoietic stem and progenitor cells (HSPCs) at the early stage of hematopoiesis. Conclusion: Lgr5 marks short-term (ST) hematopoietic stem and progenitor cells during the embryonic and fetal hematopoiesis. Significance: Extending Lgr5 as a HSPC marker into the hematopoietic system during development. Lgr5 is a marker for proliferating stem cells in adult intestine, stomach, and hair follicle. However, Lgr5 is not expressed in adult hematopoietic stem and progenitor cells (HSPCs). Whether Lgr5 is expressed in the embryonic and fetal HSPCs that undergo rapid proliferation is unknown. Here we report the detection of Lgr5 expression in HSPCs in the aorta-gonad-mesonephros (AGM) and fetal liver. We also found that a portion of Lgr5(+) cells expressed the Runx1 gene that is critical for the ontogeny of HSPCs. A small portion of Lgr5(+) cells also expressed HSPC surface markers c-Kit and CD34 in AGM or CD41 in fetal liver. Furthermore, the majority of Lgr5(+) cells expressed Ki67, indicating their proliferating state. Transplantation of fetal liver-derived Lgr5-GFP(+) cells (E12.5) demonstrated that Lgr5-GFP(+) cells were able to reconstitute myeloid and lymphoid lineages in adult recipients, but the engraftment was short-term (4-8 weeks) and 20-fold lower compared with the Lgr5-GFP(-) control. Our data show that Lgr5-expressing cells mark short-term hematopoietic stem and progenitor cells, consistent with the role of Lgr5 in supporting HSPCs rapid proliferation during embryonic and fetal development.	[Liu, Donghua; Liu, Huiwen] Harbin Med Univ, Dept Histol & Embryol, Harbin 150086, Heilongjiang, Peoples R China; [Liu, Donghua; He, Xi C.; Qian, Pengxu; Trainor, Paul A.; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Barker, Nick] Inst Med Biol, Singapore 138648, Singapore; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA	Harbin Medical University; Stowers Institute for Medical Research; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Liu, HW (corresponding author), Harbin Med Univ, Dept Histol & Embryol, 157 Baojian Rd Nangang Dist, Harbin 150086, Heilongjiang, Peoples R China.	liuhw_11@126.com; lil@stowers.org	Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Qian, Pengxu/B-9376-2016	Barker, Nick/0000-0003-3566-4475; Li, Linheng/0000-0001-9963-430X; Trainor, Paul/0000-0003-2774-3624; Qian, Pengxu/0000-0001-5636-6704	China Scholarship Council; Stowers Institute for Medical Research	China Scholarship Council(China Scholarship Council); Stowers Institute for Medical Research	This work was supported by the China Scholarship Council and the Stowers Institute for Medical Research.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Dzierzak E, 2003, CURR OPIN HEMATOL, V10, P229, DOI 10.1097/00062752-200305000-00006; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Li LH, 2005, DEV CELL, V8, P297, DOI 10.1016/j.devcel.2005.02.005; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Ma XQ, 2002, BRIT J HAEMATOL, V116, P401, DOI 10.1046/j.1365-2141.2002.03250.x; Mascarenhas MI, 2009, BLOOD, V114, P4645, DOI 10.1182/blood-2009-06-230037; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ohneda O, 1998, BLOOD, V92, P908; Pietras EM, 2013, NAT CELL BIOL, V15, P885, DOI 10.1038/ncb2817; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Yoder MC, 2004, ONCOGENE, V23, P7161, DOI 10.1038/sj.onc.1207931; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441	35	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23809	23816		10.1074/jbc.M114.568170	http://dx.doi.org/10.1074/jbc.M114.568170			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24966324	hybrid, Green Published			2022-12-25	WOS:000341505000048
J	Saeed, AA; Genove, G; Li, T; Lutjohann, D; Olin, M; Mast, N; Pikuleva, IA; Crick, P; Wang, YQ; Griffiths, W; Betsholtz, C; Bjorkhem, I				Saeed, Ahmed A.; Genove, Guillem; Li, Tian; Luetjohann, Dieter; Olin, Maria; Mast, Natalia; Pikuleva, Irina A.; Crick, Peter; Wang, Yuqin; Griffiths, William; Betsholtz, Christer; Bjorkhem, Ingemar			Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Metabolism; Cholesterol Regulation; Hydroxylase; Neurodegeneration; Sterol	CHAIN OXIDIZED OXYSTEROLS; IN-VIVO; HUMAN CIRCULATION; PLANT STEROLS; RECEPTOR; 24S-HYDROXYCHOLESTEROL; PLASMA; LIVER; MICE; METABOLISM	Background: The role of the blood-brain barrier for cholesterol homeostasis in the brain is not known. Results: Significant influx of cholesterol into the brain and increased efflux of 24(S)-hydroxycholesterol were observed in mice with a defect blood-brain barrier. Conclusion: A defect blood-brain barrier increases permeability for steroid flux in both directions. Significance: Elucidation of the role of the blood-brain barrier for brain cholesterol turnover. The presence of the blood-brain barrier (BBB) is critical for cholesterol metabolism in the brain, preventing uptake of lipoprotein-bound cholesterol from the circulation. The metabolic consequences of a leaking BBB for cholesterol metabolism have not been studied previously. Here we used a pericyte-deficient mouse model, Pdgfb(ret/ret), shown to have increased permeability of the BBB to a range of low-molecular mass and high-molecular mass tracers. There was a significant accumulation of plant sterols in the brains of the Pdgfb(ret/ret) mice. By dietary treatment with 0.3% deuterium-labeled cholesterol, we could demonstrate a significant flux of cholesterol from the circulation into the brains of the mutant mice roughly corresponding to about half of the measured turnover of cholesterol in the brain. We expected the cholesterol flux into the brain to cause a down-regulation of cholesterol synthesis. Instead, cholesterol synthesis was increased by about 60%. The levels of 24(S)-hydroxycholesterol (24S-OHC) were significantly reduced in the brains of the pericyte-deficient mice but increased in the circulation. After treatment with 1% cholesterol in diet, the difference in cholesterol synthesis between mutants and controls disappeared. The findings are consistent with increased leakage of 24S-OHC from the brain into the circulation in the pericyte-deficient mice. This oxysterol is an efficient suppressor of cholesterol synthesis, and the results are consistent with a regulatory role of 24S-OHC in the brain. To our knowledge, this is the first demonstration that a defective BBB may lead to increased flux of a lipophilic compound out from the brain. The relevance of the findings for the human situation is discussed.	[Saeed, Ahmed A.; Olin, Maria; Bjorkhem, Ingemar] Karolinska Inst, Div Clin Chem, Dept Lab Med, Karolinska Univ Hosp, S-14186 Stockholm, Sweden; [Saeed, Ahmed A.] Univ Khartoum, Dept Biochem, Fac Med, Khartoum 11111, Sudan; [Genove, Guillem; Li, Tian; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Crick, Peter; Wang, Yuqin; Griffiths, William] Swansea Univ, Inst Mass Spectrometry, Coll Med, Swansea SA2 8PP, W Glam, Wales	Karolinska Institutet; Karolinska University Hospital; University of Khartoum; Karolinska Institutet; University of Bonn; Case Western Reserve University; Swansea University	Bjorkhem, I (corresponding author), Karolinska Inst, Div Clin Chem, Dept Lab Med, Karolinska Univ Hosp, S-14186 Stockholm, Sweden.	ingemar.bjorkhem@karolinska.se	Griffiths, William/N-4641-2016	Griffiths, William/0000-0002-4129-6616; Pikuleva, Irina/0000-0001-9742-6232; Bjorkhem, Ingemar/0000-0002-0575-9425; wang, yuqin/0000-0002-3063-3066; Genove, Guillem/0000-0002-8558-3107; Bjorkhem, Ingemar/0000-0001-6087-9190; Crick, Peter/0000-0002-3282-1239	National Institutes of Health [GM 62282]; Swedish Research Council; Brain Power; Biotechnology and Biological Sciences Research Council [BB/I001735/1, BBH0010181]; BBSRC [BB/H001018/1, BB/I001735/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001018/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882, R01GM062282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Brain Power; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 62282. This work was also supported by grants from the Swedish Research Council and Brain Power. Work in Swansea was supported by Biotechnology and Biological Sciences Research Council Grants BB/I001735/1 and BBH0010181.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Ali Z, 2013, J LIPID RES, V54, P1033, DOI 10.1194/jlr.M034124; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Babiker A, 1998, BBA-LIPID LIPID MET, V1392, P333, DOI 10.1016/S0005-2760(98)00047-2; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; CHOBANIAN AV, 1962, J CLIN INVEST, V41, P1732, DOI 10.1172/JCI104631; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Diraison F, 1996, METABOLISM, V45, P817, DOI 10.1016/S0026-0495(96)90152-3; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Griffiths WJ, 2013, FREE RADICAL BIO MED, V59, P69, DOI 10.1016/j.freeradbiomed.2012.07.027; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; LANGE Y, 1995, J LIPID RES, V36, P1092; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUND E, 1992, J BIOL CHEM, V267, P25092; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Meaney S, 2000, BBA-MOL CELL BIOL L, V1486, P293, DOI 10.1016/S1388-1981(00)00070-6; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Raines SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE517, DOI 10.1152/ajpendo.00241.2011; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Turley SD, 1996, J LIPID RES, V37, P1953; Vanmierlo T, 2012, J LIPID RES, V53, P726, DOI 10.1194/jlr.M017244; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	40	59	60	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23712	23722		10.1074/jbc.M114.556159	http://dx.doi.org/10.1074/jbc.M114.556159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24973215	Green Published, hybrid			2022-12-25	WOS:000341505000039
J	Matange, N; Podobnik, M; Visweswariah, SS				Matange, Nishad; Podobnik, Marjetka; Visweswariah, Sandhya S.			The Non-catalytic "Cap Domain" of a Mycobacterial Metallophosphoesterase Regulates Its Expression and Localization in the Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PROTEIN; WALL; GENE; TRANSLOCATION; SECRETION; MEMBRANE; REVEAL; SYSTEM; FOLD	Despite highly conserved core catalytic domains, members of the metallophosphoesterase (MPE) superfamily perform diverse and crucial functions ranging from nucleotide and nucleic acid metabolism to phospholipid hydrolysis. Unique structural elements outside of the catalytic core called "cap domains" are thought to provide specialization to these enzymes; however, no directed study has been performed to substantiate this. The cap domain of Rv0805, an MPE from Mycobacterium tuberculosis, is located C-terminal to its catalytic domain and is dispensable for the catalytic activity of this enzyme in vitro. We show here that this C-terminal extension (CTE) mediates in vivo localization of the protein to the cell membrane and cell wall as well as modulates expression levels of Rv0805 in mycobacteria. We also demonstrate that Rv0805 interacts with the cell wall of mycobacteria, possibly with the mycolyl-arabinogalactan-peptidoglycan complex, by virtue of its C terminus, a hitherto unknown property of this MPE. Using a panel of mutant proteins, we identify interactions between active site residues of Rv0805 and the CTE that determine its association with the cell wall. Finally, we show that Rv0805 and a truncated mutant devoid of the CTE produce different phenotypic effects when expressed in mycobacteria. Our study thus provides a detailed dissection of the functions of the cap domain of an MPE and suggests that the repertoire of cellular functions of MPEs cannot be understood without exploring the modulatory effects of these subdomains.	[Matange, Nishad; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Podobnik, Marjetka] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia	Indian Institute of Science (IISC) - Bangalore; National Institute of Chemistry - Slovenia	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	matange, nishad/AAF-9653-2020; Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Matange, Nishad/0000-0002-2947-3931	Department of Biotechnology, Government of India; Council for Scientific and Industrial Research, Government of India; Indian Institute of Science, Bangalore	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore	This work was supported by the Department of Biotechnology, Government of India.; Recipient of a Senior Research Fellowship from the Council for Scientific and Industrial Research, Government of India and a Research Associate Fellowship from the Indian Institute of Science, Bangalore.	Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; Daumann LJ, 2014, DALTON T, V43, P910, DOI 10.1039/c3dt52287c; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; Feltcher ME, 2013, J BACTERIOL, V195, P672, DOI 10.1128/JB.02032-12; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; Kocincova D, 2004, FEMS MICROBIOL LETT, V231, P191, DOI 10.1016/S0378-1097(03)00964-9; Li J, 2012, J MOL BIOL, V415, P382, DOI 10.1016/j.jmb.2011.11.016; Matange N, 2013, TUBERCULOSIS, V93, P492, DOI 10.1016/j.tube.2013.05.004; McLoughlin SY, 2004, APPL ENVIRON MICROB, V70, P404, DOI 10.1128/AEM.70.1.404-412.2004; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Muller JP, 1999, FEMS MICROBIOL LETT, V180, P287; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Tyagi R, 2009, J BIOL CHEM, V284, P5217, DOI 10.1074/jbc.M805996200; Wang LK, 2013, NUCLEIC ACIDS RES, V41, P5864, DOI 10.1093/nar/gkt221; Yao Y, 2012, J MOL BIOL, V416, P208, DOI 10.1016/j.jmb.2011.12.030	43	7	7	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22470	22481		10.1074/jbc.M114.578328	http://dx.doi.org/10.1074/jbc.M114.578328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24970891	Green Published, hybrid			2022-12-25	WOS:000340593500056
J	Robker, RL; Watson, LN; Robertson, SA; Dunning, KR; McLaughlin, EA; Russell, DL				Robker, Rebecca L.; Watson, Laura N.; Robertson, Sarah A.; Dunning, Kylie R.; McLaughlin, Eileen A.; Russell, Darryl L.			Identification of Sites of STAT3 Action in the Female Reproductive Tract through Conditional Gene Deletion	PLOS ONE			English	Article							SIGNAL TRANSDUCER; TROPHOBLAST INVASION; GROWTH-FACTORS; PREIMPLANTATION EMBRYO; OVARIAN-FOLLICLE; GRANULOSA-CELLS; EXPRESSION; MOUSE; IMPLANTATION; ACTIVATION	The STAT3 transcription factor is a pleiotropic transducer of signalling by hormones, growth factors and cytokines that has been identified in the female reproductive tract from oocytes and granulosa cells of the ovary to uterine epithelial and stromal cells. In the present study we used transgenic models to investigate the importance of STAT3 for reproductive performance in these different tissues. The Cre-LoxP system was used to delete STAT3 in oocytes by crossing Stat3(fl/fl) with Zp3-cre+ mice, or in ovarian granulosa cells and uterine stroma by crossing with Amhr2-Cre+ mice. Surprisingly, deletion of STAT3 in oocytes had no effect on fertility indicating that the abundance of STAT3 protein in maturing oocytes and fertilized zygotes is not essential to these developmental stages. In Stat3(fl/fl);Amhr2-cre+ females impaired fertility was observed through significantly fewer litters and smaller litter size. Ovulation rate, oocyte fertilization and development to blastocyst were unaffected in this line; however, poor recombination efficiency in granulosa cells had yielded no net change in STAT3 protein abundance. In contrast, uteri from these mice showed STAT3 protein depletion selectively from the stomal compartment. A significant reduction in number of viable fetuses on gestational day 18, increased fetal resorptions and disrupted placental morphology were evident causes of the reduced fertility. In conclusion, this study defines an important role for STAT3 in uterine stromal cells during embryo implantation and the development of a functional placenta.	[Robker, Rebecca L.; Watson, Laura N.; Robertson, Sarah A.; Dunning, Kylie R.; Russell, Darryl L.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Robinson Research Institute; University of Adelaide; University of Newcastle	Russell, DL (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	Darryl.Russell@adelaide.edu.au	Robertson, Sarah A/C-8182-2009; Russell, Darryl L/I-6654-2012; McLaughlin, Eileen/AAF-5588-2021; McLaughlin, Eileen A/G-7620-2013; Dunning, Kylie/GLU-0471-2022	Robertson, Sarah A/0000-0002-9967-0084; Russell, Darryl L/0000-0002-4930-7658; Dunning, Kylie/0000-0002-0462-6479; McLaughlin, Eileen/0000-0002-5837-3876; Robker, Rebecca/0000-0002-1538-4604	Australian Research Council [DP0878355]; Future Fellowship [FT0990785]	Australian Research Council(Australian Research Council); Future Fellowship(Australian Research Council)	Supported by the Australian Research Council through Discovery Grant DP0878355 and Future Fellowship to DLR FT0990785, www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Burton GJ, 2012, PLACENTA, V33, pS23, DOI 10.1016/j.placenta.2011.11.013; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Kim H, 2009, BIOL REPROD, V81, P1002, DOI 10.1095/biolreprod.108.070599; Lague MN, 2010, AM J PHYSIOL-ENDOC M, V299, pE936, DOI 10.1152/ajpendo.00255.2010; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Merhi Z, 2013, HUM REPROD, V28, P1661, DOI 10.1093/humrep/det072; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Pawar S, 2013, MOL ENDOCRINOL; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Ren Y, 2009, MOL ENDOCRINOL, V23, P711, DOI 10.1210/me.2008-0391; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Richards JS, 2002, RECENT PROG HORM RES, V57, P195, DOI 10.1210/rp.57.1.195; Richter KS, 2008, CURR OPIN OBSTET GYN, V20, P292, DOI 10.1097/GCO.0b013e3282fe743b; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Ruiz-Cortes ZT, 2003, BIOL REPROD, V68, P789, DOI 10.1095/biolreprod.102.010702; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Russell DL, 1996, BIOL REPROD, V55, P1029, DOI 10.1095/biolreprod55.5.1029; Sferruzzi-Perri AN, 2009, BIOL REPROD, V81, P207, DOI 10.1095/biolreprod.108.073312; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Sirard MA, 2011, J ASSIST REPROD GEN, V28, P483, DOI 10.1007/s10815-011-9554-4; Sobinoff AP, 2013, MOL HUM REPROD, V19, P265, DOI 10.1093/molehr/gas065; Suman P, 2009, J REPROD IMMUNOL, V82, P1, DOI 10.1016/j.jri.2009.07.002; Sutherland JM, 2012, J CELL PHYSIOL, V227, P1188, DOI 10.1002/jcp.22837; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Truchet S, 2004, BIOL REPROD, V71, P1330, DOI 10.1095/biolreprod.104.029405; Wen LH, 2006, REPRODUCTION, V132, P511, DOI 10.1530/rep.1.01055; Zhang XH, 2013, MOL CELL ENDOCRINOL, V381, P272, DOI 10.1016/j.mce.2013.08.011	47	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101182	10.1371/journal.pone.0101182	http://dx.doi.org/10.1371/journal.pone.0101182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983622	Green Published, gold			2022-12-25	WOS:000339635000066
J	Tuite, AR; Burchell, AN; Fisman, DN				Tuite, Ashleigh R.; Burchell, Ann N.; Fisman, David N.			Cost-Effectiveness of Enhanced Syphilis Screening among HIV-Positive Men Who Have Sex with Men: A Microsimulation Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SINGLE-DOSE AZITHROMYCIN; UNITED-STATES; SECONDARY SYPHILIS; SEROLOGIC TESTS; TRANSMISSION; RESURGENCE; COMMUNITY; THERAPY; PREVALENCE	Background: Syphilis co-infection risk has increased substantially among HIV-infected men who have sex with men (MSM). Frequent screening for syphilis and treatment of men who test positive might be a practical means of controlling the risk of infection and disease sequelae in this population. Purpose: We evaluated the cost-effectiveness of strategies that increased the frequency and population coverage of syphilis screening in HIV-infected MSM receiving HIV care, relative to current standard of care. Methods: We developed a state-transition microsimulation model of syphilis natural history and medical care in HIV-infected MSM receiving care for HIV. We performed Monte Carlo simulations using input data derived from a large observational cohort in Ontario, Canada, and from published biomedical literature. Simulations compared usual care (57% of the population screened annually) to different combinations of more frequent (3-or 6-monthly) screening and higher coverage (100% screened). We estimated expected disease-specific outcomes, quality-adjusted survival, costs, and cost-effectiveness associated with each strategy from the perspective of a public health care payer. Results: Usual care was more costly and less effective than strategies with more frequent or higher coverage screening. Higher coverage strategies (with screening frequency of 3 or 6 months) were expected to be cost-effective based on usually cited willingness-to-pay thresholds. These findings were robust in the face of probabilistic sensitivity analyses, alternate cost-effectiveness thresholds, and alternate assumptions about duration of risk, program characteristics, and management of underlying HIV. Conclusions: We project that higher coverage and more frequent syphilis screening of HIV-infected MSM would be a highly cost-effective health intervention, with many potentially viable screening strategies projected to both save costs and improve health when compared to usual care. The baseline requirement for regular blood testing in this group (i.e., for viral load monitoring) makes intensification of syphilis screening appear readily practicable.	[Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tuite, Ashleigh R.; Burchell, Ann N.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Burchell, Ann N.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Tuite, AR (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	ashleigh.tuite@utoronto.ca			Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR New Investigator award	Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR))	ART is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). ANB is supported by a CIHR New Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONT HLTH INS SCHED B; Aral SO, 2007, SEX TRANSM INFECT, V83; Ballini A, 2012, J SEX MED, V9, P372, DOI 10.1111/j.1743-6109.2011.02515.x; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bissessor M, 2009, INT J STD AIDS, V20, P52, DOI 10.1258/ijsa.2008.008254; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Blandford JM, 2003, SEX TRANSM DIS, V30, P502, DOI 10.1097/00007435-200306000-00006; Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Blank LJ, 2011, SEX TRANSM INFECT, V87, P9, DOI 10.1136/sti.2010.043893; Briggs A, 2005, VALUE HEALTH, V8, P1, DOI 10.1111/j.1524-4733.2005.08101.x; Burchell AN, 2012, 21 ANN CAN C HIV AID; Burchell AN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-246; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P358; Fenton KA, 2001, SEX TRANSM INFECT, V77, P309, DOI 10.1136/sti.77.5.309; Fenton KA, 2008, LANCET INFECT DIS, V8, P244, DOI 10.1016/S1473-3099(08)70065-3; Fisman DN, 2012, VACCINE, V30, P7601, DOI 10.1016/j.vaccine.2012.10.034; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; Goswami ND, 2013, SEX TRANSM DIS, V40, P839, DOI 10.1097/OLQ.0000000000000025; Grap MJ, 2012, J EMERG MED, V42, P353, DOI 10.1016/j.jemermed.2010.05.042; Gray RT, 2010, SEX TRANSM DIS, V37, P298, DOI 10.1097/OLQ.0b013e3181ca3c0a; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; JACKMAN JD, 1989, AM J MED, V87, P425, DOI 10.1016/S0002-9343(89)80826-5; Kourbatova EV, 2008, SEX TRANSM DIS, V35, P453, DOI 10.1097/OLQ.0b013e31816f1c65; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Larsen SA, 1998, MANUAL TESTS SYPHILI; Leber A, 2008, CAN J PUBLIC HEALTH, V99, P401, DOI 10.1007/BF03405250; Lee Ma, 2007, Morbidity and Mortality Weekly Report, V56, P625; Lukehart SA, 2006, SEX TRANSM DIS, P311; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-181; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Mishra S, 2011, SEX TRANSM DIS, V38, P190, DOI 10.1097/OLQ.0b013e3181f07e91; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Muldoon E, 2011, INT J STD AIDS, V22, P493, DOI 10.1258/ijsa.2011.010438; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P448, DOI 10.1097/OLQ.0b013e3182036a0f; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P1, DOI 10.1097/OLQ.0b013e3181ec51f1; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Pepper PV, 2002, MED DECIS MAKING, V22, pS45, DOI 10.1177/027298902237705; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Public Health Agency of Canada, 2010, CAN GUID SEX TRANSM; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; SHAFER JK, 1954, PUBLIC HEALTH REP, V69, P684, DOI 10.2307/4588863; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Statistics Canada, 2006, COMPL LIF TABL CAN 2; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; TSEVAT J, 1989, AM J PUBLIC HEALTH, V79, P739, DOI 10.2105/AJPH.79.6.739; Tuite AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-606; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Ward MJ, 2012, ACAD EMERG MED, V19, P1134, DOI 10.1111/j.1553-2712.2012.01455.x; WHO-CHOICE, CHOOS INT AR COST EF; World Health Organization, 2008, GLOBAL BURDEN DIS	65	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101240	10.1371/journal.pone.0101240	http://dx.doi.org/10.1371/journal.pone.0101240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983455	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000075
J	Liu, G; Neelamegham, S				Liu, Gang; Neelamegham, Sriram			A Computational Framework for the Automated Construction of Glycosylation Reaction Networks	PLOS ONE			English	Article							MATHEMATICAL-MODEL; SELECTIN; TRANSPORT	Glycosylation is among the most common and complex post-translational modifications identified to date. It proceeds through the catalytic action of multiple enzyme families that include the glycosyltransferases that add monosaccharides to growing glycans, and glycosidases which remove sugar residues to trim glycans. The expression level and specificity of these enzymes, in part, regulate the glycan distribution or glycome of specific cell/tissue systems. Currently, there is no systematic method to describe the enzymes and cellular reaction networks that catalyze glycosylation. To address this limitation, we present a streamlined machine-readable definition for the glycosylating enzymes and additional methodologies to construct and analyze glycosylation reaction networks. In this computational framework, the enzyme class is systematically designed to store detailed specificity data such as enzymatic functional group, linkage and substrate specificity. The new classes and their associated functions enable both single-reaction inference and automated full network reconstruction, when given a list of reactants and/or products along with the enzymes present in the system. In addition, graph theory is used to support functions that map the connectivity between two or more species in a network, and that generate subset models to identify rate-limiting steps regulating glycan biosynthesis. Finally, this framework allows the synthesis of biochemical reaction networks using mass spectrometry (MS) data. The features described above are illustrated using three case studies that examine: i) O-linked glycan biosynthesis during the construction of functional selectin-ligands; ii) automated N-linked glycosylation pathway construction; and iii) the handling and analysis of glycomics based MS data. Overall, the new computational framework enables automated glycosylation network model construction and analysis by integrating knowledge of glycan structure and enzyme biochemistry. All the implemented features are provided as part of the Glycosylation Network Analysis Toolbox (GNAT), an open-source, platform-independent, MATLAB based toolbox for studies of Systems Glycobiology.	[Liu, Gang] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; SUNY Buffalo, NY State Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liu, G (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.	gangliu@buffalo.edu; neel@buffalo.edu	; Liu, Gang/F-7414-2011	Neelamegham, Sriram/0000-0002-1371-8500; Liu, Gang/0000-0002-8758-1797	National Institutes of Health [HL103411, HL63014]; Program of Excellence in Glycosciences grant [HL107146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411, R01HL063014, P01HL107146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Excellence in Glycosciences grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health grants HL103411 and HL63014, and Program of Excellence in Glycosciences grant HL107146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Aoki-Kinoshita Kiyoko F, 2013, Methods Mol Biol, V951, P257, DOI 10.1007/978-1-62703-146-2_17; Bennun SV, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002813; Bohne-Lang A, 2001, CARBOHYD RES, V336, P1, DOI 10.1016/S0008-6215(01)00230-0; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Costa AR, 2013, GLYCOSYLATION IMPACT; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Konishi Y, 2012, GLYCOMEATLAS TOOL VI; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Krambeck FJ, 2009, GLYCOBIOLOGY, V19, P1163, DOI 10.1093/glycob/cwp081; Liu G, 2013, BIOINFORMATICS, V29, P404, DOI 10.1093/bioinformatics/bts703; Liu G, 2008, BIOINFORMATICS, V24, P2740, DOI 10.1093/bioinformatics/btn515; Lo CY, 2013, J BIOL CHEM, V288, P13974, DOI 10.1074/jbc.M113.463653; Neelamegham S, 2004, CELL COMMUN ADHES, V11, P35, DOI 10.1080/15419060490471793; Neelamegham S, 2011, GLYCOBIOLOGY, V21, P1541, DOI 10.1093/glycob/cwr036; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Novotny MV, 2013, CURR OPIN CHEM BIOL; Puri A, 2012, ANN BIOMED ENG, V40, P816, DOI 10.1007/s10439-011-0464-5; Ribeiro JP, 2013, CURR OPIN CHEM BIOL; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Taniguchi N, 2002, HDB GLYCOSYLTRANSFER, pxviii; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; Varki A., 2009, ESSENTIALS GLYCOBIOL	26	22	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100939	10.1371/journal.pone.0100939	http://dx.doi.org/10.1371/journal.pone.0100939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978019	Green Published, gold			2022-12-25	WOS:000338506400055
J	Shen, Z; Fahey, JV; Bodwell, JE; Rodriguez-Garcia, M; Kashuba, ADM; Wira, CR				Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Kashuba, Angela D. M.; Wira, Charles R.			Sex Hormones Regulate Tenofovir-Diphosphate in Female Reproductive Tract Cells in Culture	PLOS ONE			English	Article							EPITHELIAL-CELLS; HIV PREVENTION; PREEXPOSURE PROPHYLAXIS; ADAPTIVE IMMUNITY; MENSTRUAL-CYCLE; INNATE IMMUNITY; GENITAL-TRACT; SECRETION; PHARMACOKINETICS; FIBROBLASTS	The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) to prevent HIV infection in women led us to evaluate the accumulation of intracellular TFV-diphosphate (TFV-DP) in cells from the female reproductive tract (FRT) and whether sex hormones influence the presence of TFV-DP in these cells. Following incubation with TFV, isolated epithelial cells, fibroblasts, CD4(+) T cells and CD14(+) cells from the FRT as well as blood CD4(+) T cells and monocyte-derived macrophages convert TFV to TFV-DP. Unexpectedly, we found that TFV-DP concentrations (fmol/million cells) vary significantly with the cell type analyzed and the site within the FRT. Epithelial cells had 5-fold higher TFV-DP concentrations than fibroblasts; endometrial epithelial cells had higher TFV-DP concentrations than cells from the ectocervix. Epithelial cells had 125-fold higher TFV-DP concentrations than FRT CD4(+) T cells, which were comparable to that measured in peripheral blood CD4(+) T cells. These findings suggest the existence of a TFV-DP gradient in the FRT where epithelial cells > fibroblasts > CD4(+) T cells and macrophages. In other studies, estradiol increased TFV-DP concentrations in endometrial and endocervical/ectocervical epithelial cells, but had no effect on fibroblasts or CD4(+) T cells from FRT tissues. In contrast, progesterone alone and in combination with estradiol decreased TFV-DP concentrations in FRT CD4(+) T cells. Our results suggest that epithelial cells and fibroblasts are a repository of TFV-DP that is under hormonal control. These cells might act either as a sink to decrease TFV availability to CD4(+) T cells and macrophages in the FRT, or upon conversion of TFV-DP to TFV increase TFV availability to HIV-target cells. In summary, these results indicate that intracellular TFV-DP varies with cell type and location in the FRT and demonstrate that estradiol and/or progesterone regulate the intracellular concentrations of TFV-DP in FRT epithelial cells and CD4(+) T cells.	[Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA	Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill	Wira, CR (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA.	Charles.R.Wira@Dartmouth.edu			NIH - Advanced BioScience Laboratories, Inc. [HHSN272201000001C]; NIH [AI102838, AI071761, AI013541]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071761, R01AI102838, R37AI013541, R55AI013541, R01AI117739, P30AI050410, R56AI071761, R01AI013541] Funding Source: NIH RePORTER	NIH - Advanced BioScience Laboratories, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was supported by NIH contract HHSN272201000001C, which was DISPERSED indirectly funded by Advanced BioScience Laboratories, Inc., and by NIH grants AI102838, AI071761 and AI013541 (CRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-61; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2012, HIV AIDS; CAC, 2003, HIV AIDS SURVEILLANC; Chen JM, 2012, JAIDS-J ACQ IMM DEF, V61, P593, DOI 10.1097/QAI.0b013e3182717c98; Coleman J, 2012, 19 INT AIDS C AIDS 2; Coleman KD, 2009, FERTIL STERIL, V92, P1107, DOI 10.1016/j.fertnstert.2008.10.047; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P51, DOI 10.1111/aji.12027; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Koumas L, 2001, AM J PATHOL, V159, P925, DOI 10.1016/S0002-9440(10)61768-3; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Meter RA, 2005, FERTIL STERIL, V84, P191, DOI 10.1016/j.fertnstert.2005.01.104; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Rodriguez-Garcia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062069; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Romano J, 2013, AIDS RES HUM RETROV, V29, P1418, DOI [10.1089/aid.2013.0122, 10.1089/AID.2013.0122]; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	34	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100863	10.1371/journal.pone.0100863	http://dx.doi.org/10.1371/journal.pone.0100863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978212	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400044
J	Wang, B; Liu, ZH; Chen, QJ; Gao, ZM; Fang, F; Chang, HY; Chen, JJ; Xu, B; Chen, Z				Wang, Ba; Liu, Zhihua; Chen, Quanjiao; Gao, Zhimin; Fang, Fang; Chang, Haiyan; Chen, Jianjun; Xu, Bing; Chen, Ze			Genotype Diversity of H9N2 Viruses Isolated from Wild Birds and Chickens in Hunan Province, China	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; HUMAN INFECTION; SOUTHERN CHINA; MAINLAND CHINA; HONG-KONG; EVOLUTION; POULTRY; GENES; PATHOGENICITY; DUCKS	Three H9N2 avian influenza viruses were isolated from the Dongting Lake wetland, among which one was from fresh egret feces, the other two were from chicken cloacal swabs in poultry markets. Phylogenetic analyses suggested that eight genes of the egret-derived H9N2 virus might come from Korean-like or American-like lineages. The two poultry-derived H9N2 viruses were reassortants between the CK/BJ/94-like and G1-like viruses. Except the PB1 genes (90.6%), the nucleotide sequence of other internal genes of the two viruses exhibited high homology (>95%). In addition, they also exhibited high homology (96-98.3%) with some genes of the H7N9 virus that caused an epidemic in China in 2013. Nucleotide sequence of the poultry-derived and egret-derived H9N2 viruses shared low homology. Infection studies showed that the egret-derived H9N2 virus was non-pathogenic to both mice and chickens, and the virus was unable to infect chickens even through 8 passages continuously in the lung. On the other hand, the chickens infected by poultry-derived viruses showed obvious clinical symptoms and even died; the infected mice showed no noticeable clinical symptoms and weight loss, but viruses could be detected in their lungs. In conclusion, for the egret-derived H9N2 virus, it would take a long adaptation process to achieve cross-species transmission in poultry and mammals. H9N2 viruses isolated at different times from the same host species in the same geographical region presented different evolutionary status, and virus isolated from different hosts in the same geographical region exhibited genetic diversity. Therefore, it is important to continue the H9N2 virus surveillance for understanding their evolutionary trends so as to provide guidance for disease control and prevention.	[Chen, Quanjiao; Gao, Zhimin; Chen, Jianjun; Chen, Ze] Chinese Acad Sci, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Wang, Ba; Liu, Zhihua; Fang, Fang; Chang, Haiyan; Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China; [Xu, Bing] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hunan Normal University; Tsinghua University	Chen, QJ (corresponding author), Chinese Acad Sci, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn; chenze2005@hotmail.com	Xu, Bing/C-7732-2015		National 973 Project [2010CB530301]; National Natural Science Foundation of China [81172738, 31070141, 31100132]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the following research funds: National 973 Project (no. 2010CB530301) and National Natural Science Foundation of China (no. 81172738, no. 31070141, no. 31100132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; BUCKLERWHITE AJ, 1986, J VIROL, V57, P697, DOI 10.1128/JVI.57.2.697-700.1986; Chen B, 1994, CHIN J VET MED, V22, P3; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOMME PJ, 1970, AVIAN DIS, V14, P277, DOI 10.2307/1588472; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; WARD AC, 1995, ARCH VIROL, V140, P383, DOI 10.1007/BF01309872; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang HB, 2011, ARCH VIROL, V156, P95, DOI 10.1007/s00705-010-0836-4	26	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101287	10.1371/journal.pone.0101287	http://dx.doi.org/10.1371/journal.pone.0101287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979703	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400111
J	Yang, H; Aprecio, RM; Zhou, XD; Wang, Q; Zhang, W; Ding, Y; Li, YM				Yang, Heng; Aprecio, Raydolfo M.; Zhou, Xiaodong; Wang, Qi; Zhang, Wu; Ding, Yi; Li, Yiming			Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; INTER-ALPHA-INHIBITOR; MARROW STROMAL CELLS; LINK MODULE; IN-VIVO; BONE; REGENERATION; INFLAMMATION; GENERATION	Background: We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodontitis. Methods: A total of 30 female Sprague-Dawley (SD) rats were randomly divided into four groups: healthy control group (Group-N, n = 5), untreated periodontitis group (Group-P, n = 5), iPS-MSCs-treated and iPSC-MSCs/TSG-6-treated periodontitis groups (Group-P1 and P2, n = 10 per group). Experimental periodontitis was established by ligature and infection with Porphyromonas gingivalis around the maxillae first molar bilaterally. MSC-like cells were generated from rat iPSCs, and transducted with TSG-6. iPSC-MSCs or iPSC-MSCs/TSG-6 were administrated to rats in Group-P1 or P2 intravenously and topically, once a week for three weeks. Blood samples were obtained one week post-injection for the analysis of serum pro-inflammatory cytokines. All animals were killed 3 months post-treatment; maxillae were then dissected for histological analysis, tartrate-resistant acid phosphatase (TRAP) staining, and morphological analysis of alveolar bone loss. Results: Administration of iPSC-MSC/TSG-6 significantly decreased serum levels of IL-1 beta and TNF-alpha in the Group-P2 rats (65.78 pg/ml and 0.56 pg/ml) compared with those in Group-P (168.31 pg/ml and 1.15 pg/ml respectively) (p<0.05). Both alveolar bone loss and the number of TRAP-positive osteoclasts showed a significant decrease in rats that received iPSC-MSC/TSG-6 treatment compared to untreated rats in Group-P (p<0.05), Conclusions: We demonstrated that overexpression of TSG-6 in rat iPSC-derived MSCs were capable of decreasing inflammation in experimental periodontitis and inhibiting alveolar bone resorption. This may potentially serve as an alternative stem-cell-based approach in the treatment and regeneration of periodontal tissues.	[Yang, Heng; Wang, Qi] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Aprecio, Raydolfo M.; Zhou, Xiaodong; Zhang, Wu; Li, Yiming] Loma Linda Univ, Sch Dent, Dent Res Ctr, Loma Linda, CA 92350 USA; [Ding, Yi] Sichuan Univ, Dept Periodontol, West China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Loma Linda University; Sichuan University	Ding, Y (corresponding author), Sichuan Univ, Dept Periodontol, West China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China.	jessie.yh@163.com		Ding, Yi/0000-0002-0948-4991	Loma Linda University Grants for Research and School Partnerships (GRASP) [699310-2938]	Loma Linda University Grants for Research and School Partnerships (GRASP)	This study was supported by Loma Linda University Grants for Research and School Partnerships (GRASP) number 699310-2938. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CCP, 2006, J PERIODONTOL, V77, P350, DOI 10.1902/jop.2006.050184; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bianco P, 2011, BEST PRACT RES CL HA, V24, P37, DOI 10.1016/j.beha.2011.01.005; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; de Hemptinne I, 2004, J NEUROCHEM, V91, P155, DOI 10.1111/j.1471-4159.2004.02709.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Emerton KB, 2011, J DENT RES, V90, P1416, DOI 10.1177/0022034511423665; Furth ME, 2009, J CELL BIOCHEM, V106, P507, DOI 10.1002/jcb.22000; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Meng XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037569; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Stavropoulos A, 2011, J PERIODONTOL, V82, P462, DOI 10.1902/jop.2010.100331; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tu YK, 2012, J CLIN PERIODONTOL, V39, P303, DOI 10.1111/j.1600-051X.2011.01844.x; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yilmaz S, 2010, J CLIN PERIODONTOL, V37, P544, DOI 10.1111/j.1600-051X.2010.01567.x; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	37	48	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100285	10.1371/journal.pone.0100285	http://dx.doi.org/10.1371/journal.pone.0100285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979372	gold, Green Published, Green Submitted			2022-12-25	WOS:000338506400025
J	Zhu, JH; Mu, XY; Zeng, J; Xu, CY; Liu, J; Zhang, MS; Li, CP; Chen, J; Li, TY; Wang, YP				Zhu, Jiahong; Mu, Xinyi; Zeng, Jin; Xu, Chunyan; Liu, Jun; Zhang, Mengsi; Li, Chengpeng; Chen, Jie; Li, Tinyu; Wang, Yaping			Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced Aging	PLOS ONE			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; ADVANCED GLYCATION; DEPENDENT KINASES; OXIDATIVE DAMAGE; GENE-EXPRESSION; MEMORY LOSS; MICE; NEUROGENESIS; ASTROCYTES	Neurogenesis continues throughout the lifetime in the hippocampus, while the rate declines with brain aging. It has beenhypothesized that reduced neurogenesis may contribute to age-related cognitive impairment. Ginsenoside Rg1 is an active ingredient of Panax ginseng in traditional Chinese medicine, which exerts anti-oxidative and anti-aging effects. This study explores the neuroprotective effect of ginsenoside Rg1 on the hippocampus of the D-gal (D-galactose) induced aging rat model. Sub-acute aging was induced in male SD rats by subcutaneous injection of D-gal (120 mg/kg.d) for 42 days, and the rats were treated with ginsenoside Rg1 (20 mg/kg.d, intraperitoneally) or normal saline for 28 days after 14 days of D-gal injection. In another group, normal male SD rats were treated with ginsenoside Rg1 alone (20 mg/kg.d, intraperitoneally) for 28 days. It showed that administration of ginsenoside Rg1 significantly attenuated all the D-gal-induced changes in the hippocampus, including cognitive capacity, senescence-related markers and hippocampal neurogenesis, compared with the D-gal-treated rats. Further investigation showed that ginsenoside Rg1 protected NSCs/NPCs (neural stem cells/progenitor cells) shown by increased level of SOX-2 expression; reduced astrocytes activation shown by decrease level of Aeg-1 expression; increased the hippocampal cell proliferation; enhanced the activity of the antioxidant enzymes GSH-Px (glutathione peroxidase) and SOD (Superoxide Dismutase); decreased the levels of IL-1 beta, IL-6 and TNF-alpha, which are the proinflammatory cytokines; increased the telomere lengths and telomerase activity; and down-regulated the mRNA expression of cellular senescence associated genes p53, p21(Cip1/Waf1) and p19(Arf) in the hippocampus of aged rats. Our data provides evidence that ginsenoside Rg1 can improve cognitive ability, protect NSCs/NPCs and promote neurogenesis by enhancing the antioxidant and anti-inflammatory capacity in the hippocampus.	[Zhu, Jiahong; Mu, Xinyi; Xu, Chunyan; Liu, Jun; Zhang, Mengsi; Li, Chengpeng; Wang, Yaping] Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, Chongqing, Peoples R China; [Zeng, Jin] Land Force Lintong Sanat, Xian, Shanxi, Peoples R China; [Chen, Jie; Li, Tinyu] Chongqing Stem Cell Therapy Engn Tech Ctr, Chongqing, Peoples R China	Chongqing Medical University	Wang, YP (corresponding author), Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, Chongqing, Peoples R China.	ypwangcq@aliyun.com		Mu, Xinyi/0000-0002-3738-0882	National Natural Science Foundation of China [30973818]; Science Foundation of Ministry of Education of China [20125503110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China)	The work was supported by National Natural Science Foundation of China (No 30973818), and the Science Foundation of Ministry of Education of China (No 20125503110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Chen C, 2014, ACTA PHARMACOL SIN, V35, P143, DOI 10.1038/aps.2013.136; Chen XC, 2008, J GERONTOL A-BIOL, V63, P253, DOI 10.1093/gerona/63.3.253; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Geloso MC, 2004, NEUROSCI LETT, V357, P103, DOI 10.1016/j.neulet.2003.11.076; Gemma C, 2010, AGING DIS, V1, P232; Geng YQ, 2010, BIOCHEM BIOPH RES CO, V396, P866, DOI 10.1016/j.bbrc.2010.05.011; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Groth A, 2000, J BIOL CHEM, V275, P27473; HARPER JW, 1993, CELL, V75, P805; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Jeong K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-14; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kim JH, 2012, J GINSENG RES, V36, P16, DOI 10.5142/jgr.2012.36.1.16; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151; Limoli CL, 2006, INT J RADIAT BIOL, V82, P640, DOI 10.1080/09553000600887816; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; [彭彬 Peng Bin], 2011, [中国细胞生物学学报, Chinese Journal of Cell Biology], V33, P1116; Peng Bin (et al), 2011, Journal of Chongqing Medical University, V36, P419; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Wang Z, 2002, ACTA PHARMACOL SIN, V23, P974; Wei HF, 2008, CELL MOL NEUROBIOL, V28, P781, DOI 10.1007/s10571-007-9177-6; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Yoo DY, 2012, NEUROCHEM RES, V37, P223, DOI 10.1007/s11064-011-0597-9; Yoo DY, 2012, J PINEAL RES, V52, P21, DOI 10.1111/j.1600-079X.2011.00912.x; Zhang XP, 2013, CELL BIOL INT, V37, P940, DOI 10.1002/cbin.10121; Zhang XL, 2008, FOOD CHEM TOXICOL, V46, P2888, DOI 10.1016/j.fct.2008.05.032	52	126	148	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101291	10.1371/journal.pone.0101291	http://dx.doi.org/10.1371/journal.pone.0101291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979747	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400112
J	Bengtsson, D; Avril, A; Gunnarsson, G; Elmberg, J; Soderquist, P; Norevik, G; Tolf, C; Safi, K; Fiedler, W; Wikelski, M; Olsen, B; Waldenstrom, J				Bengtsson, Daniel; Avril, Alexis; Gunnarsson, Gunnar; Elmberg, Johan; Soderquist, Par; Norevik, Gabriel; Tolf, Conny; Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin; Olsen, Bjorn; Waldenstrom, Jonas			Movements, Home-Range Size and Habitat Selection of Mallards during Autumn Migration	PLOS ONE			English	Article							TEAL ANAS-CRECCA; GREEN-WINGED TEAL; DABBLING DUCKS; STOPOVER ECOLOGY; FEEDING ECOLOGY; PROTECTED AREAS; KERNEL METHODS; TRADE-OFF; WATERFOWL; STRATEGIES	The mallard (Anas platyrhynchos) is a focal species in game management, epidemiology and ornithology, but comparably little research has focused on the ecology of the migration seasons. We studied habitat use, time-budgets, home-range sizes, habitat selection, and movements based on spatial data collected with GPS devices attached to wild mallards trapped at an autumn stopover site in the Northwest European flyway. Sixteen individuals (13 males, 3 females) were followed for 15-38 days in October to December 2010. Forty-nine percent (SD = 8.4%) of the ducks' total time, and 85% of the day-time (SD = 28.3%), was spent at sheltered reefs and bays on the coast. Two ducks used ponds, rather than coast, as day-roosts instead. Mallards spent most of the night (76% of total time, SD = 15.8%) on wetlands, mainly on alvar steppe, or in various flooded areas (e.g. coastal meadows). Crop fields with maize were also selectively utilized. Movements between roosting and foraging areas mainly took place at dawn and dusk, and the home-ranges observed in our study are among the largest ever documented for mallards (mean = 6,859 ha; SD = 5,872 ha). This study provides insights into relatively unknown aspects of mallard ecology. The fact that autumn-staging migratory mallards have a well-developed diel activity pattern tightly linked to the use of specific habitats has implications for wetland management, hunting and conservation, as well as for the epidemiology of diseases shared between wildlife and domestic animals.	[Bengtsson, Daniel; Avril, Alexis; Tolf, Conny; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Gunnarsson, Gunnar; Elmberg, Johan; Soderquist, Par] Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden; [Norevik, Gabriel] Ottenby Bird Observ, Degerhamn, Sweden; [Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; Kristianstad University; Max Planck Society; University of Konstanz; Uppsala University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	Jonas.Waldenstrom@lnu.se	Safi, Kamran/B-2079-2008; Fiedler, Wolfgang/AAG-4510-2021; Waldenström, Jonas/E-4460-2013	Safi, Kamran/0000-0002-8418-6759; Fiedler, Wolfgang/0000-0003-1082-4161; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council VR [2010-3067, 2011-3568]; Swedish Research Council FORMAS [2009-1220]	Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Funding for this project was provided by the Swedish Research Councils VR (2010-3067, 2011-3568) and FORMAS (2009-1220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Arzel C, 2007, CAN J ZOOL, V85, P81, DOI 10.1139/Z06-201; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Arzel C, 2009, J ORNITHOL, V150, P61, DOI 10.1007/s10336-008-0318-6; Bergstrom U., 1938, Fauna och Flora Uppsala, V1938, P1; Brochet AL, 2012, WATERBIRDS, V35, P555, DOI 10.1675/063.035.0406; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calenge C, 2007, J STAT SOFTW, V22, P1; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; Cox RR, 1996, CONDOR, V98, P810, DOI 10.2307/1369861; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; CURIO E, 1983, EXPERIENTIA, V39, P25, DOI 10.1007/BF01960617; DWYER TJ, 1979, J WILDLIFE MANAGE, V43, P526, DOI 10.2307/3800366; Edelstam C, 1972, VISIBLE MIGRATION S7; Forsyth B., 1965, Proceedings of the Arkansas Academy of Science, V19, P74; Foster MA, 2010, J WILDLIFE MANAGE, V74, P489, DOI 10.2193/2008-588; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; GILMER DS, 1975, J WILDLIFE MANAGE, V39, P781, DOI 10.2307/3800242; Glutz von Blotzheim UN, 1990, HDB VOGEL MITTELEURO, V2; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Guillemain M, 2002, BIODIVERS CONSERV, V11, P1721, DOI 10.1023/A:1020322032114; Guillemain M, 2002, BIOL CONSERV, V103, P183, DOI 10.1016/S0006-3207(01)00120-3; Guillemain M, 2010, WILDLIFE BIOL, V16, P215, DOI 10.2981/09-042; Gunnarsson G, 2012, IBIS, P1; Gunnarsson G, 2006, OECOLOGIA, V149, P203, DOI 10.1007/s00442-006-0446-8; Helseth A, 2005, ARDEA, V93, P213; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hirsch BT, 2011, BEHAV ECOL, V22, P648, DOI 10.1093/beheco/arr026; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Johnson WP, 2000, WETLANDS, V20, P184, DOI 10.1672/0277-5212(2000)020[0184:FBOGWT]2.0.CO;2; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; JORDE DG, 1983, J WILDLIFE MANAGE, V47, P1044, DOI 10.2307/3808163; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kery M, 2006, J ANIM ECOL, V75, P1172, DOI 10.1111/j.1365-2656.2006.01140.x; King J.R., 1974, Publications Nuttall Orn Club, VNo. 15, P4; KIRBY RE, 1985, WILSON BULL, V97, P215; Kozulin Alexander, 1995, Acta Ornithologica (Warsaw), V30, P125; Krapu Gary L., 1992, P1; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Legagneux P, 2009, J ORNITHOL, V150, P183, DOI 10.1007/s10336-008-0333-7; LINDSTROM A, 1995, ISR J ZOOL, V41, P407; Mack GG, 2006, AUK, V123, P467, DOI 10.1642/0004-8038(2006)123[467:HCABSA]2.0.CO;2; Manly BFJ, 2003, RESOURCE SELECTION A; Martin AC, 1939, TECHNICAL B, V634; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Nichols JD, 2007, J ORNITHOL, V148, pS343, DOI 10.1007/s10336-007-0256-8; Nilsson Leif, 2013, Ornis Svecica, V23, P46; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Paracuellos M, 2006, BIODIVERS CONSERV, V15, P4569, DOI 10.1007/s10531-005-5820-z; PAULUS S L, 1988, P135; POYSA H, 1987, BEHAVIOUR, V103, P108, DOI 10.1163/156853987X00297; Poysa H, 2001, OIKOS, V94, P365, DOI 10.1034/j.1600-0706.2001.940218.x; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Roshier DA, 2009, MAR FRESHWATER RES, V60, P299, DOI 10.1071/MF08152; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Sauter A, 2012, J ORNITHOL, V153, P713, DOI 10.1007/s10336-011-0788-9; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; Tamisier A., 1981, Verhandlungen der Ornithologischen Gesellschaft in Bayern, V23, P229; Tamisier A., 1999, CAMARGUE CANARDS FOU; THOMAS GJ, 1982, J ZOOL, V197, P131, DOI 10.1111/jzo.1982.197.1.131; Tidwell PR, 2013, J FISH WILDL MANAG, V4, P63, DOI 10.3996/072012-JFWM-062; van Eerden R. E., 1984, COASTAL WADERS WILDF, P84; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 1997, J ANIM ECOL, V66, P297, DOI 10.2307/5976; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	73	37	42	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100764	10.1371/journal.pone.0100764	http://dx.doi.org/10.1371/journal.pone.0100764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971887	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200058
J	Dujardin, S; Begard, S; Caillierez, R; Lachaud, C; Delattre, L; Carrier, S; Loyens, A; Galas, MC; Bousset, L; Melki, R; Auregan, G; Hantraye, P; Brouillet, E; Buee, L; Colin, M				Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Bousset, Luc; Melki, Ronald; Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel; Buee, Luc; Colin, Morvane			Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CELL-DERIVED MICROPARTICLES; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; EXTRACELLULAR VESICLES; NEUROFIBRILLARY TANGLES; NEUROBLASTOMA-CELLS; CEREBROSPINAL-FLUID; MEMBRANE-VESICLES; PLASMA-MEMBRANE	Tau is a microtubule-associated protein that aggregates in neurodegenerative disorders known as tauopathies. Recently, studies have suggested that Tau may be secreted and play a role in neural network signalling. However, once deregulated, secreted Tau may also participate in the spreading of Tau pathology in hierarchical pathways of neurodegeneration. The mechanisms underlying neuron-to-neuron Tau transfer are still unknown; given the known role of extra-cellular vesicles in cell-to-cell communication, we wondered whether these vesicles could carry secreted Tau. We found, among vesicles, that Tau is predominately secreted in ectosomes, which are plasma membrane-originating vesicles, and when it accumulates, the exosomal pathway is activated.	[Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Buee, Luc; Colin, Morvane] INSERM, UMR837, F-59045 Lille, France; [Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Buee, Luc; Colin, Morvane] Univ Lille, Fac Med, IMPRT, JPARC, Lille, France; [Galas, Marie-Christine; Buee, Luc; Colin, Morvane] Hop A Calmette, CHR, CMRR, Lille, France; [Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, Gif Sur Yvette, France; [Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel] Atom Energy Commiss CEA, Inst Biomed Imaging I2BM, Mol Imaging Res Ctr MIRCen, Fontenay Aux Roses, France; [Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel] CNRS, Mol Imaging Res Ctr MIRCen, URA2210, Fontenay Aux Roses, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Buee, L (corresponding author), INSERM, UMR837, F-59045 Lille, France.	luc.buee@inserm.fr; morvane.colin@inserm.fr	Dujardin, Simon/ABA-1796-2020; Galas, Marie-Christine/AAL-9812-2020; BUEE, Luc/B-3126-2010; Brouillet, Emmanuel/B-4784-2014	BUEE, Luc/0000-0002-6261-4230; bousset, luc/0000-0002-0433-4337; Dujardin, Simon/0000-0002-5614-341X; Galas, Marie-Christine/0000-0002-3766-7103; Colin, Morvane/0000-0003-0611-4167; Brouillet, Emmanuel/0000-0001-6322-7403	LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease); FUI MEDIALZ; CPER DN2M (VICTAUR); Inserm; CNRS; University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais; FEDER; 'Fondation Plan Alzheimer' (PRIMATAU)	LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease); FUI MEDIALZ; CPER DN2M (VICTAUR); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); FEDER(European Commission); 'Fondation Plan Alzheimer' (PRIMATAU)	This work was supported through the LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease), the FUI MEDIALZ and CPER DN2M (VICTAUR), Inserm, CNRS, University of Lille 2, Lille Metropole Communaute Urbaine (LMCU), Region Nord/Pas-de-Calais, FEDER and the 'Fondation Plan Alzheimer' (PRIMATAU). We thank the IMPRT (Lille) for access to core facilities (animal housing, D. Taillieu; EM, C. Allet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; [Anonymous], NEUROBIOL AGING33; Baron M, 2012, J CELL MOL MED, V16, P1365, DOI 10.1111/j.1582-4934.2011.01486.x; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Caillierez R, 2013, MOL THER, V21, P1358, DOI 10.1038/mt.2013.66; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Choi DS, 2013, MOL DIAGN THER, V17, P265, DOI 10.1007/s40291-013-0042-7; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cuervo AM, 2010, MOVEMENT DISORD, V25, pS49, DOI 10.1002/mds.22718; Davizon P, 2010, SEMIN THROMB HEMOST, V36, P857, DOI 10.1055/s-0030-1267039; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; Dujardin S, 2014, ACTA NEUROPATHOLOGIC; Ekinci FJ, 2000, CELL MOL NEUROBIOL, V20, P497, DOI 10.1023/A:1007075115574; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Hanisch K, 2010, J PROTEOME RES, V9, P1476, DOI 10.1021/pr901002t; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kaufman SK, 2013, NEUROTHERAPEUTICS, V10, P371, DOI 10.1007/s13311-013-0196-3; Kempf M, 1996, J NEUROSCI, V16, P5583; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Lecolle K, 2013, GENE THER, V20, P283, DOI 10.1038/gt.2012.39; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P172837, DOI 10.1155/2012/172837; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Ramcharitar J, 2013, J NEUROPATH EXP NEUR, V72, P824, DOI 10.1097/NEN.0b013e3182a0a39f; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; SAUTIERE PE, 1994, NEURODEGENERATION, V3, P53; Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Shea TB, 1996, J NEUROCHEM, V66, P1539; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Usardi A, 2011, FEBS J, V278, P2927, DOI 10.1111/j.1742-4658.2011.08218.x; Verny M, 1996, BRAIN, V119, P1123, DOI 10.1093/brain/119.4.1123; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2010, AUTOPHAGY, V6, P182, DOI 10.4161/auto.6.1.10815; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	69	135	139	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100760	10.1371/journal.pone.0100760	http://dx.doi.org/10.1371/journal.pone.0100760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971751	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200057
J	Hu, ZY; Wang, YZ; Im, WT; Wang, SY; Zhao, GP; Zheng, HJ; Quan, ZX				Hu, Zi-Ye; Wang, Yue-Zhu; Im, Wan-Taek; Wang, Sheng-Yue; Zhao, Guo-Ping; Zheng, Hua-Jun; Quan, Zhe-Xue			The First Complete Genome Sequence of the Class Fimbriimonadia in the Phylum Armatimonadetes	PLOS ONE			English	Article							BACTERIAL; IDENTIFICATION; GENE; PROTECTION; CANDIDATE; EVOLUTION; PROTEIN; STRESS; SYSTEM; REGION	In this study, we present the complete genome of Fimbriimonas ginsengisoli Gsoil 348(T) belonging to the class Fimbriimonadia of the phylum Armatimonadetes, formerly called as candidate phylum OP10. The complete genome contains a single circular chromosome of 5.23 Mb including a 45.5 kb prophage. Of the 4820 open reading frames (ORFs), 3,000 (62.2%) genes could be classified into Clusters of Orthologous Groups (COG) families. With the split of rRNA genes, strain Gsoil 348(T) had no typical 16S-23S-5S ribosomal RNA operon. In this genome, the GC skew inversion which was usually observed in archaea was found. The predicted gene functions suggest that the organism lacks the ability to synthesize histidine, and the TCA cycle is incomplete. Phylogenetic analyses based on ribosomal proteins indicated that strain Gsoil 348(T) represents a deeply branching lineage of sufficient divergence with other phyla, but also strongly involved in superphylum Terrabacteria.	[Hu, Zi-Ye; Zhao, Guo-Ping; Quan, Zhe-Xue] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Wang, Yue-Zhu; Wang, Sheng-Yue; Zhao, Guo-Ping; Zheng, Hua-Jun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Im, Wan-Taek] Hankyoung Natl Univ, Dept Biotechnol, Kyonggi Do, South Korea; [Zheng, Hua-Jun] Shanghai Inst Planned Parenthood Res, Lab Med Foods, Shanghai, Peoples R China	Fudan University	Zheng, HJ (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	quanzx@fudan.edu.cn; zhenghj@chgc.sh.cn	Quan, Zhexue/B-8046-2013; Zheng, Huajun/AAN-4973-2020	Quan, Zhexue/0000-0002-7561-8572; Zhao, Guo-Ping/0000-0002-7621-6620	Program for New Century Excellent Talents in University, Ministry of Education, China [NCET-13010]	Program for New Century Excellent Talents in University, Ministry of Education, China(Program for New Century Excellent Talents in University (NCET))	This work was supported by Program for New Century Excellent Talents in University (NCET-13010), Ministry of Education, China (http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Bruno-Barcena JM, 2004, APPL ENVIRON MICROB, V70, P4702, DOI 10.1128/AEM.70.8.4702-4710.2004; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunfield PF, 2012, ENVIRON MICROBIOL, V14, P3069, DOI 10.1111/j.1462-2920.2012.02742.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hwang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030090; Im WT, 2012, ANTON LEEUW INT J G, V102, P307, DOI 10.1007/s10482-012-9739-6; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Lee KCY, 2014, ISME J, V8, P1522, DOI 10.1038/ismej.2013.251; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Portillo MC, 2009, WORLD J MICROB BIOT, V25, P347, DOI 10.1007/s11274-008-9895-z; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Thibessard A, 2004, APPL ENVIRON MICROB, V70, P2220, DOI 10.1128/AEM.70.4.2220-2229.2004; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	36	11	12	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100794	10.1371/journal.pone.0100794	http://dx.doi.org/10.1371/journal.pone.0100794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967843	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800068
J	Mayfield, JA; Liang, Z; Agrahari, G; Lee, SW; Donahue, DL; Ploplis, VA; Castellino, FJ				Mayfield, Jeffrey A.; Liang, Zhong; Agrahari, Garima; Lee, Shaun W.; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.			Mutations in the Control of Virulence Sensor Gene from Streptococcus pyogenes after Infection in Mice Lead to Clonal Bacterial Variants with Altered Gene Regulatory Activity and Virulence	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; DISSEMINATED M1T1 CLONE; IN-VIVO; CYSTEINE PROTEASE; EXPRESSION; STRAIN; SEQUENCE; BINDING; GROWTH; DEGRADATION	The cluster of virulence sensor (CovS)/responder (CovR) two-component operon (CovRS) regulates similar to 15% of the genes of the Group A Streptococcal pyogenes (GAS) genome. Bacterial clones containing inactivating mutations in the covS gene have been isolated from patients with virulent invasive diseases. We report herein an assessment of the nature and types of covS mutations that can occur in both virulent and nonvirulent GAS strains, and assess whether a nonvirulent GAS can attain enhanced virulence through this mechanism. A group of mice were infected with a globally-disseminated clonal M1T1 GAS (isolate 5448), containing wild-type (WT) CovRS (5448/CovR(+)S(+)), or less virulent engineered GAS strains, AP53/CovR(+)S(+) and Manfredo M5/CovR(+)S(+). SpeB negative GAS clones from wound sites and/or from bacteria disseminated to the spleen were isolated and the covS gene was subjected to DNA sequence analysis. Numerous examples of inactivating mutations were found in CovS in all regions of the gene. The mutations found included frame-shift insertions and deletions, and in-frame small and large deletions in the gene. Many of the mutations found resulted in early translation termination of CovS. Thus, the covS gene is a genomic mutagenic target that gives GAS enhanced virulence. In cases wherein CovS-was discovered, these clonal variants exhibited high lethality, further suggesting that randomly mutated covS genes occur during the course of infection, and lead to the development of a more invasive infection.	[Mayfield, Jeffrey A.; Liang, Zhong; Agrahari, Garima; Lee, Shaun W.; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Liang, Zhong; Agrahari, Garima; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu			 [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by HL013423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Flores AR, 2013, INFECT IMMUN, V81, P4128, DOI 10.1128/IAI.00405-13; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Garcia AF, 2010, MICROBIOL-SGM, V156, P3085, DOI 10.1099/mic.0.042614-0; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; Horstmann N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002311; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Maamary PG, 2010, J INNATE IMMUN, V2, P596, DOI 10.1159/000317640; McIver KS, 1997, J BACTERIOL, V179, P5178, DOI 10.1128/jb.179.16.5178-5187.1997; MILLER L, 1988, J BIOL CHEM, V263, P5668; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tatsuno Ichiro, 2013, BMC Res Notes, V6, P126, DOI 10.1186/1756-0500-6-126; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Vachon P, 2002, CONTEMP TOP LAB ANIM, V41, P15; Venturini C, 2013, INFECT IMMUN, V81, P2062, DOI 10.1128/IAI.00192-13; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Walker JS, 1996, INFLAMM RES, V45, P557, DOI 10.1007/BF02342227; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANNAMAKER LW, 1983, REV INFECT DIS, V5, pS723; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	51	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100698	10.1371/journal.pone.0100698	http://dx.doi.org/10.1371/journal.pone.0100698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968349	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800053
J	Moore, HC; Jacoby, P; Hogan, AB; Blyth, CC; Mercer, GN				Moore, Hannah C.; Jacoby, Peter; Hogan, Alexandra B.; Blyth, Christopher C.; Mercer, Geoffry N.			Modelling the Seasonal Epidemics of Respiratory Syncytial Virus in Young Children	PLOS ONE			English	Article							INFECTIONS; POPULATION; VACCINATION; BURDEN; HEALTH; AGE	Background: Respiratory syncytial virus (RSV) is a major cause of paediatric morbidity. Mathematical models can be used to characterise annual RSV seasonal epidemics and are a valuable tool to assess the impact of future vaccines. Objectives: Construct a mathematical model of seasonal epidemics of RSV and by fitting to a population-level RSV dataset, obtain a better understanding of RSV transmission dynamics. Methods: We obtained an extensive dataset of weekly RSV testing data in children aged less than 2 years, 2000-2005, for a birth cohort of 245,249 children through linkage of laboratory and birth record datasets. We constructed a seasonally forced compartmental age-structured Susceptible-Exposed-Infectious-Recovered-Susceptible (SEIRS) mathematical model to fit to the seasonal curves of positive RSV detections using the Nelder-Mead method. Results: From 15,830 specimens, 3,394 were positive for RSV. RSV detections exhibited a distinct biennial seasonal pattern with alternating sized peaks in winter months. Our SEIRS model accurately mimicked the observed data with alternating sized peaks using disease parameter values that remained constant across the 6 years of data. Variations in the duration of immunity and recovery periods were explored. The best fit to the data minimising the residual sum of errors was a model using estimates based on previous models in the literature for the infectious period and a slightly lower estimate for the immunity period. Conclusions: Our age-structured model based on routinely collected population laboratory data accurately captures the observed seasonal epidemic curves. The compartmental SEIRS model, based on several assumptions, now provides a validated base model. Ranges for the disease parameters in the model that could replicate the patterns in the data were identified. Areas for future model developments include fitting climatic variables to the seasonal parameter, allowing parameters to vary according to age and implementing a newborn vaccination program to predict the effect on RSV incidence.	[Moore, Hannah C.; Jacoby, Peter] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hogan, Alexandra B.; Mercer, Geoffry N.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Blyth, Christopher C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Blyth, Christopher C.] Princess Margaret Hosp Children, Dept Paediat & Adolescent Med, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; Australian National University; University of Western Australia; University of Western Australia	Moore, HC (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	hannah.moore@telethonkids.org.au	Moore, Hannah/AHH-1092-2022; Blyth, Christopher/ABG-8231-2020; Moore, Hannah C/W-4727-2018; Moore, Hannah/AAA-4107-2019	Moore, Hannah/0000-0001-6434-8290; Blyth, Christopher/0000-0003-2017-0683; Moore, Hannah C/0000-0001-6434-8290; Moore, Hannah/0000-0001-6434-8290; Hogan, Alexandra/0000-0002-6271-9921	National Health and Medical Research Council Fellowship [1034254]	National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	HCM is funded by National Health and Medical Research Council Fellowship #1034254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo L, 2010, EPIDEMIOL INFECT, V138, P853, DOI 10.1017/S0950268809991373; Australian Bureau of Statistics, 2011, 3101 0 AUSTR DEM STA; Bihorel S, 2012, NELDERMEAD R PORT SC; Bolisetty Srinivas, 2005, Aust J Rural Health, V13, P265, DOI 10.1111/j.1440-1584.2005.00715.x; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hall C. B., 1981, TXB PEDIATRIC INFECT, VII, P1247; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Leecaster M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-105; Malkin E, 2013, SAFETY SHEDDING IMMU; Meijboom MJ, 2012, VACCINE, V30, P4691, DOI 10.1016/j.vaccine.2012.04.072; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Moore H, 2007, J PAEDIATR CHILD H, V43, P451, DOI 10.1111/j.1440-1754.2007.01110.x; Moore HC, 2012, J PAEDIATR CHILD H, V48, P520, DOI 10.1111/j.1440-1754.2011.02229.x; Moore HC, 2012, J EPIDEMIOL COMMUN H, V66, P489, DOI 10.1136/jech.2010.122762; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Moore HC, 2009, PEDIATR INFECT DIS J, V28, P598, DOI 10.1097/INF.0b013e318199cefd; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; R Core Team, 2021, R LANG ENV STAT COMP; Ranmuthugala G, 2011, COMMUN DIS INTELL, V35, P177; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Vicente D, 2003, EPIDEMIOL INFECT, V131, P867, DOI 10.1017/S0950268803008926; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Walton NA, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-68; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Yang CF, 2013, VACCINE, V31, P2822, DOI 10.1016/j.vaccine.2013.04.006	33	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100422	10.1371/journal.pone.0100422	http://dx.doi.org/10.1371/journal.pone.0100422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968133	gold, Green Published			2022-12-25	WOS:000338280800040
J	Ray, PS; Fox, PL				Ray, Partho Sarothi; Fox, Paul L.			Origin and Evolution of Glutamyl-prolyl tRNA Synthetase WHEP Domains Reveal Evolutionary Relationships within Holozoa	PLOS ONE			English	Article							NONCANONICAL FUNCTION; MAXIMUM-LIKELIHOOD; ANIMAL EVOLUTION; GENOME; PHYLOGENY; GENE; EXPRESSION; RELATIVES; CLADE	Repeated domains in proteins that have undergone duplication or loss, and sequence divergence, are especially informative about phylogenetic relationships. We have exploited divergent repeats of the highly structured, 50-amino acid WHEP domains that join the catalytic subunits of bifunctional glutamyl-prolyl tRNA synthetase (EPRS) as a sequence-informed repeat (SIR) to trace the origin and evolution of EPRS in holozoa. EPRS is the only fused tRNA synthetase, with two distinct aminoacylation activities, and a non-canonical translation regulatory function mediated by the WHEP domains in the linker. Investigating the duplications, deletions and divergence of WHEP domains, we traced the bifunctional EPRS to choanozoans and identified the fusion event leading to its origin at the divergence of ichthyosporea and emergence of filozoa nearly a billion years ago. Distribution of WHEP domains from a single species in two or more distinct clades suggested common descent, allowing the identification of linking organisms. The discrete assortment of choanoflagellate WHEP domains with choanozoan domains as well as with those in metazoans supported the phylogenetic position of choanoflagellates as the closest sister group to metazoans. Analysis of clustering and assortment of WHEP domains provided unexpected insights into phylogenetic relationships amongst holozoan taxa. Furthermore, observed gaps in the transition between WHEP domain groupings in distant taxa allowed the prediction of undiscovered or extinct evolutionary intermediates. Analysis based on SIR domains can provide a phylogenetic counterpart to palaentological approaches of discovering "missing links'' in the tree of life.	[Ray, Partho Sarothi; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India	Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	foxp@ccf.org	Ray, Partho Sarothi/H-3020-2019	Ray, Partho Sarothi/0000-0002-8795-3060	Wellcome Trust/DBT India Alliance Fellow Award; National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL029582] Funding Source: NIH RePORTER	Wellcome Trust/DBT India Alliance Fellow Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Wellcome Trust/DBT India Alliance Fellow Award (to P.S.R.) and by National Institutes of Health grants P01 HL029582, P01 HL076491, and R01 GM086430 (to P.L.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cerini C, 1997, EUR J BIOCHEM, V244, P176, DOI 10.1111/j.1432-1033.1997.00176.x; de Pouplana LR, 2001, J MOL EVOL, V53, P261, DOI 10.1007/s002390010216; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jermiin LS, 2005, SCIENCE, V310, P1910, DOI 10.1126/science.1122440; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; PUSTELL J, 1982, NUCLEIC ACIDS RES, V10, P4765, DOI 10.1093/nar/10.15.4765; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shiba K, 2002, J MOL EVOL, V55, P727, DOI 10.1007/s00239-002-2368-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404	38	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98493	10.1371/journal.pone.0098493	http://dx.doi.org/10.1371/journal.pone.0098493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968216	Green Published, Green Submitted, gold			2022-12-25	WOS:000338280800001
J	Rahbek-Clemmensen, T; Bay, T; Eriksen, J; Gether, U; Jorgensen, TN				Rahbek-Clemmensen, Troels; Bay, Tina; Eriksen, Jacob; Gether, Ulrik; Jorgensen, Trine Nygaard			The Serotonin Transporter Undergoes Constitutive Internalization and Is Primarily Sorted to Late Endosomes and Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DOPAMINE TRANSPORTER; MONOAMINE TRANSPORTERS; RECEPTOR; TRAFFICKING; PHOSPHORYLATION; ACTIVATION; REVEALS; FAMILY; CELLS	The serotonin transporter (SERT) plays a critical role in regulating serotonin signaling by mediating reuptake of serotonin from the extracellular space. The molecular and cellular mechanisms controlling SERT levels in the membrane remain poorly understood. To study trafficking of the surface resident SERT, two functional epitope-tagged variants were generated. Fusion of a FLAG-tagged one-transmembrane segment protein Tac to the SERT N terminus generated a transporter with an extracellular epitope suited for trafficking studies (TacSERT). Likewise, a construct with an extracellular antibody epitope was generated by introducing an HA (hemagglutinin) tag in the extracellular loop 2 of SERT (HA-SERT). By using TacSERT and HA-SERT in antibody-based internalization assays, we show that SERT undergoes constitutive internalization in a dynamin-dependent manner. Confocal images of constitutively internalized SERT demonstrated that SERT primarily co-localized with the late endosomal/lysosomal marker Rab7, whereas little co-localization was observed with the Rab11, a marker of the "long loop" recycling pathway. This sorting pattern was distinct from that of a prototypical recycling membrane protein, the beta(2)-adrenergic receptor. Furthermore, internalized SERT co-localized with the lysosomal marker LysoTracker and not with transferrin. The sorting pattern was further confirmed by visualizing internalization of SERT using the fluorescent cocaine analog JHC1-64 and by reversible and pulse-chase biotinylation assays showing evidence for lysosomal degradation of the internalized transporter. Finally, we found that SERT internalized in response to stimulation with 12-myristate 13-acetate co-localized primarily with Rab7- and LysoTracker-positive compartments. We conclude that SERT is constitutively internalized and that the internalized transporter is sorted mainly to degradation.	[Rahbek-Clemmensen, Troels; Bay, Tina; Eriksen, Jacob; Gether, Ulrik; Jorgensen, Trine Nygaard] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Mol Neuropharmacol Lab,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Rahbek-Clemmensen, Troels; Eriksen, Jacob; Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2200 Copenhagen, Denmark	University of Copenhagen; Lundbeckfonden; University of Copenhagen	Gether, U (corresponding author), Panum Inst 18 6, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	gether@sund.ku.dk		Rahbek-Clemmensen, Troels/0000-0003-2067-5411; Gether, Ulrik/0000-0002-0020-3807; Eriksen, Jacob/0000-0003-0726-9769	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408. This work was also supported by the Danish Medical Research Council, University of Copenhagen BioScaRT Program of Excellence, Lundbeck Foundation Center for Biomembranes in Nanomedicine, Novo Nordisk Foundation, and Fabrikant Vilhelm Pedersen og Hustrus Mindelegat.	Adachi K, 2007, ARCH VIROL, V152, P2217, DOI 10.1007/s00705-007-1061-7; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jayanthi LD, 2005, MOL PHARMACOL, V67, P2077, DOI 10.1124/mol.104.009555; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Li Y, 2012, J NEUROSCI, V32, P7178, DOI 10.1523/JNEUROSCI.0008-12.2012; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qi YP, 1997, J NEUROSCI, V17, P1217; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; RAMAMOORTHY JD, 1995, J BIOL CHEM, V270, P17189, DOI 10.1074/jbc.270.29.17189; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Rasmussen TN, 2009, NEUROPHARMACOLOGY, V57, P287, DOI 10.1016/j.neuropharm.2009.05.009; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tao-Cheng JH, 1999, NEUROSCIENCE, V94, P821, DOI 10.1016/S0306-4522(99)00373-5; TATE CG, 1994, J BIOL CHEM, V269, P26303; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	47	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23004	23019		10.1074/jbc.M113.495754	http://dx.doi.org/10.1074/jbc.M113.495754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973209	Green Published, hybrid			2022-12-25	WOS:000341017200039
J	Darby, AC; McInnes, CJ; Kjaer, KH; Wood, AR; Hughes, M; Martensen, PM; Radford, AD; Hall, N; Chantrey, J				Darby, Alistair C.; McInnes, Colin J.; Kjaer, Karina Hansen; Wood, Ann R.; Hughes, Margaret; Martensen, Pia Moller; Radford, Alan D.; Hall, Neil; Chantrey, Julian			Novel Host-Related Virulence Factors Are Encoded by Squirrelpox Virus, the Main Causative Agent of Epidemic Disease in Red Squirrels in the UK	PLOS ONE			English	Article							PROTEIN-KINASE PKR; SCIURUS-VULGARIS; GREY SQUIRRELS; POXVIRUS; VACCINIA; GENE; INTERFERON; BINDING; E3L; IDENTIFICATION	Squirrelpox virus (SQPV) shows little evidence for morbidity or mortality in North American grey squirrels (Sciurus carolinensis), in which the virus is endemic. However, more recently the virus has emerged to cause epidemics with high mortality in Eurasian red squirrels (S. vulgaris) in Great Britain, which are now threatened. Here we report the genome sequence of SQPV. Comparison with other Poxviridae revealed a core set of poxvirus genes, the phylogeny of which showed SQPV to be in a new Chordopoxvirus subfamily between the Molluscipoxviruses and Parapoxviruses. A number of SQPV genes were related to virulence, including three major histocomaptibility class I homologs, and one CD47 homolog. In addition, a novel potential virulence factor showing homology to mammalian oligoadenylate synthetase (OAS) was identified. This family of proteins normally causes activation of an endoribonuclease (RNaseL) within infected cells. The putative function of this novel SQPV protein was predicted in silico.	[Darby, Alistair C.; Hughes, Margaret; Radford, Alan D.; Hall, Neil; Chantrey, Julian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [McInnes, Colin J.; Wood, Ann R.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Kjaer, Karina Hansen; Martensen, Pia Moller] Univ Aarhus, Aarhus, Denmark; [Hall, Neil] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University of Liverpool; Moredun Research Institute; Aarhus University; King Abdulaziz University	Hall, N (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Neil.Hall@liv.ac.uk	Darby, Alistair/I-6485-2012; Martensen, Pia/I-3996-2012	Darby, Alistair/0000-0002-3786-6209; McInnes, Colin/0000-0002-1465-9901; Martensen, Pia Moller/0000-0002-1259-0226; Radford, Alan/0000-0002-4590-1334; Hall, Neil/0000-0003-2808-0009	Royal College of Veterinary Surgeons trust; Danish Council for Independent Research/Natural Sciences	Royal College of Veterinary Surgeons trust; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF))	We thank the Wildlife Ark Trust for their funding of this work, as part of their overall strategy to develop a vaccine against squirrel poxvirus. ACD was funded by the Royal College of Veterinary Surgeons trust. KHK and PMM were supported by the The Danish Council for Independent Research/Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Bruemmer CM, 2010, EPIDEMIOL INFECT, V138, P941, DOI 10.1017/S0950268810000816; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gil J, 2001, J GEN VIROL, V82, P3027, DOI 10.1099/0022-1317-82-12-3027; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kjaer KH, 2009, J MOL EVOL, V69, P612, DOI 10.1007/s00239-009-9299-1; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; McInnes CJ, 2009, VET REC, V164, P528, DOI 10.1136/vr.164.17.528; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; Moss B, 2001, FIELDS VIROLOGY, P2849; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Pettersen RD, 2000, APOPTOSIS, V5, P299, DOI 10.1023/A:1009612821625; Rushton SP, 2006, EPIDEMIOL INFECT, V134, P521, DOI 10.1017/S0950268805005303; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sainsbury AW, 2008, ECOHEALTH, V5, P305, DOI 10.1007/s10393-008-0191-z; Sainsbury AW, 2000, ANIM CONSERV, V3, P229, DOI 10.1017/S1367943000000949; SCOTT AC, 1981, VET REC, V109, P202, DOI 10.1136/vr.109.10.202; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Senkevich TG, 1998, VIROLOGY, V250, P397, DOI 10.1006/viro.1998.9390; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Wauters LA, 2000, ECOL RES, V15, P271, DOI 10.1046/j.1440-1703.2000.00354.x	42	20	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96439	10.1371/journal.pone.0096439	http://dx.doi.org/10.1371/journal.pone.0096439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983354	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000004
J	Villamor, A; Costantini, F; Abbiati, M				Villamor, Adriana; Costantini, Federica; Abbiati, Marco			Genetic Structuring across Marine Biogeographic Boundaries in Rocky Shore Invertebrates	PLOS ONE			English	Article							MACARONESIAN ISLANDS; POPULATION-GROWTH; MEDITERRANEAN SEA; RANGE EXPANSION; PHYLOGEOGRAPHY; FLOW; CONNECTIVITY; REVEALS; EASTERN; HISTORY	Biogeography investigates paw patterns of species distribution. Discontinuities in species distribution are identified boundaries between biogeographic areas. Do these boundaries affect genetic connectivity? To address his question multifactorial hierarchical sampling design, across three of the major marine biogeographic boundaries in the cent Mediterranean Sea (Ligurian-Tyrrhenian, Tyrrhenian-Ionian and Ionian-Adriatic) was carried out. Mitochondrial COI sequence polymorphism of seven species of Mediterranean benthic invertebrates was analysed. Two species showed significant genetic structure across the Tyrrhenian-Ionian boundary, as well as two other species across the Ionian Sea, a previously unknown phylogeographic barrier. The hypothesized barrier in the Ligurian-Tyrrhenian cannot be detected in the genetic structure of the investigated species. Connectivity patterns across species at distances up to 800 km apart confirmed that estimates of pelagic larval dispersal were poor predictors of the genetic structure. The detected genetic discontinuities seem more related to the effect of past historical events, though maintained by present day oceanographic processes. Multivariate statistical tools were used to test the consistency of the patterns across species, providing a conceptual framework for across-species barrier locations and strengths. Additional sequences retrieved from public databases supported our findings. Heterogeneity of phylogeographic patterns shown by the 7 investigated species is relevant to the understanding of the genetic diversity, and carry implications for conservation biology.	[Villamor, Adriana; Costantini, Federica; Abbiati, Marco] Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Emilia Romagna, Italy; [Abbiati, Marco] CNR, Inst Marine Sci, Bologna, Emilia Romagna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Villamor, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Emilia Romagna, Italy.	adriana.villamor@unibo.it	COSTANTINI, FEDERICA/ABH-9194-2020; CNR, Ismar/P-1247-2014	COSTANTINI, FEDERICA/0000-0002-8813-1923; Abbiati, Marco/0000-0002-2426-4524; CNR, Ismar/0000-0001-5351-1486	MIUR project (PRIN project on "Coastal bioconstructions: structure, function and management") of the Italian Government	MIUR project (PRIN project on "Coastal bioconstructions: structure, function and management") of the Italian Government	The study was funded by a MIUR project (PRIN 2011 project on "Coastal bioconstructions: structure, function and management") of the Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astraldi M, 1999, PROG OCEANOGR, V44, P65, DOI 10.1016/S0079-6611(99)00021-X; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bianchi C.N., 2004, NOTIZIARIO SIBM, V46, P57; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; BROWN SK, 1985, J CRUSTACEAN BIOL, V5, P574, DOI 10.2307/1548236; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Collins CJ, 2010, MOL ECOL, V19, P4572, DOI 10.1111/j.1365-294X.2010.04842.x; CorteReal HBSM, 1996, MAR BIOL, V125, P141, DOI 10.1007/BF00350768; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CRISP DJ, 1960, BIOL BULL, V118, P31, DOI 10.2307/1539053; Desai B. N., 1966, Proceedings of the Malacological Society of London, V37, P1; Dodd J. M., 1957, PUBBLICAZIONI STAZIO, V29, P172; Domingues VS, 2005, MOL ECOL, V14, P4051, DOI 10.1111/j.1365-294X.2005.02723.x; Drew JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047710; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gharbi A, 2011, J MAR BIOL ASSOC UK, V91, P1599, DOI 10.1017/S0025315411000245; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kim WJ, 2012, BIOCHEM SYST ECOL, V44, P128, DOI 10.1016/j.bse.2012.04.020; Lahbib Y, 2010, MAR BIOL RES, V6, P600, DOI 10.1080/17451000903437075; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Luttikhuizen PC, 2008, MOL PHYLOGENET EVOL, V46, P1015, DOI 10.1016/j.ympev.2007.11.011; Maggio T, 2009, ICES J MAR SCI, V66, P1883, DOI 10.1093/icesjms/fsp160; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Marske KA, 2013, ECOGRAPHY, V36, P1169, DOI 10.1111/j.1600-0587.2013.00244.x; Marti-Puig Patricia, 2014, Advances in Oceanography and Limnology, V4, P138, DOI 10.1080/19475721.2013.850445; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Papetti C, 2012, J BIOGEOGR, V39, P1361, DOI 10.1111/j.1365-2699.2011.02682.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Perez-Portela R, 2010, MAR BIOL, V157, P2015, DOI 10.1007/s00227-010-1470-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Riesgo A, 2008, INVERTEBR BIOL, V127, P357, DOI 10.1111/j.1744-7410.2008.00128.x; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rock J, 2007, HEREDITY, V99, P102, DOI 10.1038/sj.hdy.6800971; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ryland JS, 1995, HDB MARINE FAUNA N W; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sa-Pinto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050330; Santic M, 2010, ARCH BIOL SCI, V62, P1007, DOI 10.2298/ABS1004007S; SCHIFANO G, 1983, PALAEOGEOGR PALAEOCL, V44, P215, DOI 10.1016/0031-0182(83)90104-9; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stefanni S, 2003, MOL PHYLOGENET EVOL, V28, P601, DOI 10.1016/S1055-7903(03)00054-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1987, GENETICS, V117, P343; Teske PR, 2011, MOL ECOL, V20, P5025, DOI 10.1111/j.1365-294X.2011.05307.x; Vasconcelos P, 2004, INVERTEBR REPROD DEV, V46, P125, DOI 10.1080/07924259.2004.9652616; Virgilio M, 2009, MOL ECOL, V18, P1980, DOI 10.1111/j.1365-294X.2009.04170.x; Wares JP, 2001, EVOLUTION, V55, P2455; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030	74	43	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101135	10.1371/journal.pone.0101135	http://dx.doi.org/10.1371/journal.pone.0101135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983738	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000057
J	Blum, Y; Vejdani, HR; Birn-Jeffery, AV; Hubicki, CM; Hurst, JW; Daley, MA				Blum, Yvonne; Vejdani, Hamid R.; Birn-Jeffery, Aleksandra V.; Hubicki, Christian M.; Hurst, Jonathan W.; Daley, Monica A.			Swing-Leg Trajectory of Running Guinea Fowl Suggests Task-Level Priority of Force Regulation Rather than Disturbance Rejection	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ENERGY CHANGES; BODY-SIZE; BIPEDAL LOCOMOTION; PASSIVE DYNAMICS; MUSCLE MECHANICS; UNEVEN TERRAIN; LIMB POSTURE; STABILITY; MODEL	To achieve robust and stable legged locomotion in uneven terrain, animals must effectively coordinate limb swing and stance phases, which involve distinct yet coupled dynamics. Recent theoretical studies have highlighted the critical influence of swing-leg trajectory on stability, disturbance rejection, leg loading and economy of walking and running. Yet, simulations suggest that not all these factors can be simultaneously optimized. A potential trade-off arises between the optimal swing-leg trajectory for disturbance rejection (to maintain steady gait) versus regulation of leg loading (for injury avoidance and economy). Here we investigate how running guinea fowl manage this potential trade-off by comparing experimental data to predictions of hypothesis-based simulations of running over a terrain drop perturbation. We use a simple model to predict swing-leg trajectory and running dynamics. In simulations, we generate optimized swing-leg trajectories based upon specific hypotheses for task-level control priorities. We optimized swing trajectories to achieve i) constant peak force, ii) constant axial impulse, or iii) perfect disturbance rejection (steady gait) in the stance following a terrain drop. We compare simulation predictions to experimental data on guinea fowl running over a visible step down. Swing and stance dynamics of running guinea fowl closely match simulations optimized to regulate leg loading (priorities i and ii), and do not match the simulations optimized for disturbance rejection (priority iii). The simulations reinforce previous findings that swing-leg trajectory targeting disturbance rejection demands large increases in stance leg force following a terrain drop. Guinea fowl negotiate a downward step using unsteady dynamics with forward acceleration, and recover to steady gait in subsequent steps. Our results suggest that guinea fowl use swing-leg trajectory consistent with priority for load regulation, and not for steadiness of gait. Swing-leg trajectory optimized for load regulation may facilitate economy and injury avoidance in uneven terrain.	[Blum, Yvonne; Birn-Jeffery, Aleksandra V.; Daley, Monica A.] Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England; [Vejdani, Hamid R.; Hubicki, Christian M.; Hurst, Jonathan W.] Oregon State Univ, Corvallis, OR 97331 USA; [Birn-Jeffery, Aleksandra V.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of London; University of London Royal Veterinary College; Oregon State University; University of California System; University of California Riverside	Daley, MA (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England.	mdaley@rvc.ac.uk	Daley, Monica A/AAE-5079-2019	Daley, Monica A/0000-0001-8584-2052; Vejdani, Hamid/0000-0001-5352-9846; Hubicki, Christian/0000-0002-2092-3772	Human Frontier Science Program (HFSP) [RGY0062/2010]	Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This study was funded by grant RGY0062/2010 of the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; Andrews B, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026009; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Birn-Jeffery AV, 2012, J EXP BIOL, V215, P2117, DOI 10.1242/jeb.065557; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Blum Y, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026006; Blum Y, 2011, J THEOR BIOL, V281, P97, DOI 10.1016/j.jtbi.2011.04.029; Byl K, 2009, INT J ROBOT RES, V28, P1040, DOI 10.1177/0278364909340446; Cavagna GA, 2006, J EXP BIOL, V209, P4051, DOI 10.1242/jeb.02344; CAVAGNA GA, 1988, J PHYSIOL-LONDON, V399, P81; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; Daley MA, 2011, PHILOS T R SOC B, V366, P1580, DOI 10.1098/rstb.2010.0338; Daley MA, 2010, BIOL LETTERS, V6, P418, DOI 10.1098/rsbl.2010.0175; Daley MA, 2009, J PHYSIOL-LONDON, V587, P2693, DOI 10.1113/jphysiol.2009.171017; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; DOW SM, 1991, EQUINE VET J, V23, P266, DOI 10.1111/j.2042-3306.1991.tb03715.x; Ernst M, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046002; Ernst M, 2009, INT C CLIMB WALK ROB; FARLEY CT, 1993, J EXP BIOL, V185, P71; FEDAK MA, 1982, J EXP BIOL, V97, P23; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Full RJ, 1999, J EXP BIOL, V202, P3325; Garcia M, 2000, DYNAM STABIL SYST, V15, P75, DOI 10.1080/713603737; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Harrison SM, 2010, J EXP BIOL, V213, P3998, DOI 10.1242/jeb.044545; HEGLUND NC, 1982, J EXP BIOL, V97, P57; HEGLUND NC, 1982, J EXP BIOL, V97, P41; Herr HM, 2001, INT J ROBOT RES, V20, P26, DOI 10.1177/02783640122067255; Hobbelen DGE, 2007, IEEE T ROBOT, V23, P1213, DOI 10.1109/TRO.2007.904908; Karssen J. G. Daniel, 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P4000, DOI 10.1109/ICRA.2011.5980168; KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Moritz CT, 2004, J APPL PHYSIOL, V97, P1313, DOI 10.1152/japplphysiol.00393.2004; Poulakakis I, 2006, INT J ROBOT RES, V25, P669, DOI 10.1177/0278364906066768; Riese S, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/1/016006; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Schmitt J, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/4/046005; Seipel J, 2007, REGUL CHAOTIC DYN, V12, P502, DOI 10.1134/S1560354707050048; Seipel JE, 2004, BIOL CYBERN, V91, P76, DOI 10.1007/s00422-004-0498-y; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Vejdani HR, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046006; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030	57	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100399	10.1371/journal.pone.0100399	http://dx.doi.org/10.1371/journal.pone.0100399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979750	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000338506400028
J	Rumaney, MB; Bitoungui, VJN; Vorster, AA; Ramesar, R; Kengne, AP; Ngogang, J; Wonkam, A				Rumaney, Maryam Bibi; Bitoungui, Valentina Josiane Ngo; Vorster, Anna Alvera; Ramesar, Raj; Kengne, Andre Pascal; Ngogang, Jeanne; Wonkam, Ambroise			The Co-Inheritance of Alpha-Thalassemia and Sickle Cell Anemia Is Associated with Better Hematological Indices and Lower Consultations Rate in Cameroonian Patients and Could Improve Their Survival	PLOS ONE			English	Article							GENETIC MODIFIERS; CHILDREN; DISEASE; RISK; HEMOGLOBIN; SEVERITY; ALPHA(+)-THALASSEMIA; POLYMORPHISMS; EPIDEMIOLOGY; DETERMINANTS	Background: Co-inheritance of alpha-thalassemia was reported to be associated with a delayed age of disease onset among Cameroonian Sickle Cell Anemia (SCA) patients. The present study aimed to explore the correlation between alpha-thalassemia, hematological indices, and clinical events in these patients. Methods and Findings: We studied 161 Cameroonian SCA patients and 103 controls (59.1% HbAA) with median ages of 17.5 and 23 years. RFLP-PCR was used to confirm SCA genotype and to describe haplotypes in the HBB-like genes cluster. Multiplex Gap-PCR was performed to investigate the 3.7 kb alpha-globin gene deletions. SNaPshot PCR, capillary electrophoresis and cycle sequencing were used for the genotyping of 10 SNPs in BCL11A, HMIP1/2, OR51B5/6 and HBG loci, known to influence HbF levels. Generalised linear regression models adjusted for age, sex and SNPs genotypes was used to investigate effects of alpha-thalassemia on clinical and hematological indices. The median rate of vaso-occlusive painful crisis and hospitalisations was two and one per year, respectively. Stroke was reported in eight cases (7.4%). Benin haplotype was the most prevalent (66.3%; n = 208 chromosomes). Among patients, 37.3% (n = 60) had at least one 3.7 kb deletion, compared to 10.9% (n = 6) among HbAA controls (p<0.001). Among patients, the median RBC count increased with the number of 3.7 kb deletions [2.6, 3.0 and 3.4 million/dl, with no, one and two deletions (p = 0.01)]. The median MCV decreased with the number of 3.7 kb deletion [86, 80, and 68fl, with no, one and two deletions (p<0.0001)], as well as median WBC counts [13.2, 10.5 and 9.8x10(9)/L (p<0.0001. The co-inheritance of alpha-thalassemia was associated with lower consultations rate (p = 0.038). Conclusion: The co-inheritance of alpha-thalassemia and SCA is associated with improved hematological indices, and lower consultations rate in this group of patients. This could possibly improve their survival and explain the higher proportion of alpha-thalassemia among patients than controls.	[Rumaney, Maryam Bibi; Vorster, Anna Alvera; Ramesar, Raj; Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, Div Human Genet, ZA-7925 Cape Town, South Africa; [Bitoungui, Valentina Josiane Ngo; Ngogang, Jeanne] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol Parasitol & Haematol, Yaounde, Cameroon; [Ramesar, Raj] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, MRC,Human Genet Res Unit, ZA-7925 Cape Town, South Africa; [Kengne, Andre Pascal] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Yaounde I; University of Cape Town; South African Medical Research Council; University of Cape Town	Wonkam, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, Div Human Genet, ZA-7925 Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Kengne, Andre Pascal/ABB-3696-2020; Wonkam, Ambroise/AFU-6901-2022; Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634; Kengne, Andre Pascal/0000-0002-5183-131X; Rumaney, Maryam Bibi/0000-0003-3463-336X	National Health Laboratory Services, South Africa; University Research Committee; Carnegie Research Development Grant, University of Cape Town, South Africa; National Research Foundation-DAAD scholarship, South Africa; Third World Academy of Sciences	National Health Laboratory Services, South Africa; University Research Committee; Carnegie Research Development Grant, University of Cape Town, South Africa; National Research Foundation-DAAD scholarship, South Africa; Third World Academy of Sciences	The molecular experiments of the study were funded by the National Health Laboratory Services, South Africa; the University Research Committee and Carnegie Research Development Grant, University of Cape Town, South Africa. The students' bursaries were provided by the National Research Foundation-DAAD scholarship, South Africa, and the Third World Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsultan A, 2012, J PEDIAT HEMATOL ONC, V34, P79, DOI 10.1097/MPH.0b013e3182422844; Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bartolucci P, 2012, CURR OPIN HEMATOL, V19, P149, DOI 10.1097/MOH.0b013e328351c35f; Belisario AR, 2010, HEMOGLOBIN, V34, P516, DOI 10.3109/03630269.2010.526003; Bernaudin F, 2008, BLOOD, V112, P4314, DOI 10.1182/blood-2008-03-143891; Chong SS, 2000, BLOOD, V95, P360; Coelho A, 2012, EUR J HAEMATOL, V89, P501, DOI 10.1111/ejh.12011; Cox SE, 2013, INT SCHOLARLARY RES, P1; Darbari DS, 2012, J PEDIATR-US, V160, P286, DOI 10.1016/j.jpeds.2011.07.018; Day TG, 2012, HAEMATOL-HEMATOL J, V97, P201, DOI 10.3324/haematol.2011.050336; El-Hazmi MAF, 1999, J TROP PEDIATRICS, V45, P370, DOI 10.1093/tropej/45.6.370; Embury SH, 2012, EUR J HAEMATOL, V88, P363, DOI 10.1111/j.1600-0609.2011.01743.x; Enevold A, 2007, J INFECT DIS, V196, P451, DOI 10.1086/519390; FABRY ME, 1984, BLOOD, V64, P1042; Flanagan JM, 2011, BLOOD, V117, P6681, DOI 10.1182/blood-2011-01-332205; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Gahutu JB, 2012, T ROY SOC TROP MED H, V106, P63, DOI 10.1016/j.trstmh.2011.09.002; Galanello R, 2011, GENET MED, V13, P83, DOI 10.1097/GIM.0b013e3181fcb468; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Guasch A, 1999, J AM SOC NEPHROL, V10, P1014; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hsu LL, 2003, J PEDIAT HEMATOL ONC, V25, P622, DOI 10.1097/00043426-200308000-00007; Martinez G, 1996, BLOOD, V88, P1898; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Millimono TS, 2012, HEMOGLOBIN, V50, P118; Mouele R, 2000, HUM HERED, V50, P118, DOI 10.1159/000022899; Nebor D, 2010, BLOOD CELL MOL DIS, V45, P154, DOI 10.1016/j.bcmd.2010.06.003; Njamnshi AK, 2006, J NEUROL SCI, V250, P79, DOI 10.1016/j.jns.2006.07.003; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Ondei LS, 2007, GENET MOL RES, V6, P453; Pandey Sanjay, 2011, Korean J Hematol, V46, P192, DOI 10.5045/kjh.2011.46.3.192; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Ruffieux N, 2013, CHILD NEUROPSYCHOL, V19, P143, DOI 10.1080/09297049.2011.640932; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Steinberg MH, 1998, AM J HEMATOL, V59, P121, DOI 10.1002/(SICI)1096-8652(199810)59:2<121::AID-AJH4>3.0.CO;2-#; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; Wali YA, 2002, PEDIATR HEMAT ONCOL, V19, P491, DOI 10.1080/08880010290097314; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Wonkam A, 2014, AM J HEMATOL, V89, P664, DOI 10.1002/ajh.23711; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506; Wonkam A, 2014, J GENET COUNS, V23, P192, DOI 10.1007/s10897-013-9630-2; World Bank, 2010, 48373CM WORLD BANK, P1	47	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100516	10.1371/journal.pone.0100516	http://dx.doi.org/10.1371/journal.pone.0100516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978191	Green Published, Green Submitted, gold			2022-12-25	WOS:000338506400032
J	Cupi, ML; Sarra, M; De Nitto, D; Franze, E; Marafini, I; Monteleone, I; Blanco, GDV; Paoluzi, OA; Di Fusco, D; Gentileschi, P; Ortenzi, A; Colantoni, A; Pallone, F; Monteleone, G				Cupi, Maria Laura; Sarra, Massimiliano; De Nitto, Daniela; Franze, Eleonora; Marafini, Irene; Monteleone, Ivan; Blanco, Giovanna Del Vecchio; Paoluzi, Omero Alessandro; Di Fusco, Davide; Gentileschi, Paolo; Ortenzi, Angela; Colantoni, Alfredo; Pallone, Francesco; Monteleone, Giovanni			Defective Expression of Scavenger Receptors in Celiac Disease Mucosa	PLOS ONE			English	Article							IMMUNE-RESPONSES; T-CELLS; RECOGNITION; MACROPHAGES; APOPTOSIS; PHAGOCYTOSIS; NEUTROPHILS; MECHANISMS; IL-21	Celiac disease (CD) is a gluten sensitive enteropathy characterized by a marked infiltration of the mucosa with immune cells, over-production of inflammatory cytokines and epithelial cell damage. The factors/mechanisms that sustain and amplify the ongoing mucosal inflammation in CD are not however fully understood. Here, we have examined whether in CD there is a defective clearance of apoptotic cells/bodies, a phenomenon that helps promote tolerogenic signals thus liming pathogenic responses. Accumulation of apoptotic cells and bodies was more pronounced in the epithelial and lamina propria compartments of active CD patients as compared to inactive CD patients and normal controls. Expression of scavenger receptors, which are involved in the clearance of apoptotic cells/bodies, namely thrombospondin (TSP)-1, CD36 and CD61, was significantly reduced in active CD as compared to inactive CD and normal mucosal samples. Consistently, lamina propria mononuclear cells (LPMC) of active CD patients had diminished ability to phagocyte apoptotic cells. Interleukin (IL)-15, IL-21 and interferon-gamma, cytokines over-produced in active CD, inhibited the expression of TSP-1, CD36, and CD61 in normal intestinal LPMC. These results indicate that CD-related inflammation is marked by diminished clearance of apoptotic cells/bodies, thus suggesting a role for such a defect in the ongoing mucosal inflammation in this disorder.	[Cupi, Maria Laura; Sarra, Massimiliano; De Nitto, Daniela; Franze, Eleonora; Marafini, Irene; Monteleone, Ivan; Blanco, Giovanna Del Vecchio; Paoluzi, Omero Alessandro; Di Fusco, Davide; Gentileschi, Paolo; Ortenzi, Angela; Colantoni, Alfredo; Pallone, Francesco; Monteleone, Giovanni] Univ Tor Vergata, Dipartimento Med Sistemi, Rome, Italy	University of Rome Tor Vergata	Monteleone, G (corresponding author), Univ Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.	Gi.Monteleone@Med.uniroma2.it	marafini, irene/AHD-5205-2022; Monteleone, Ivan/AEW-2892-2022; Monteleone, Giovanni/AAE-1418-2021	DEL VECCHIO BLANCO, Giovanna/0000-0002-6327-563X; paoluzi, omero alessandro/0000-0002-5393-5796; Franze, Eleonora/0000-0003-4343-221X; Monteleone, Ivan/0000-0002-3212-832X; Di Fusco, Davide/0000-0002-8908-9237	Giuliani SpA, Milan, Italy; Fondazione Umberto Di Mario, Rome, Italy	Giuliani SpA, Milan, Italy; Fondazione Umberto Di Mario, Rome, Italy	The authors received support for this study by Giuliani SpA, Milan, Italy, and Fondazione Umberto Di Mario, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Ciccocioppo R, 2001, AM J CLIN PATHOL, V115, P494; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Di Sabatino A, 2001, IMMUNOLOGY, V103, P435, DOI 10.1046/j.1365-2567.2001.01245.x; Erwig LP, 1999, BLOOD, V93, P1406, DOI 10.1182/blood.V93.4.1406.404k10_1406_1412; FADOK VA, 1993, J IMMUNOL, V151, P4274; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Gianfrani C, 2005, IMMUNOL LETT, V99, P141, DOI 10.1016/j.imlet.2005.02.017; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Sarra M, 2013, MUCOSAL IMMUNOL, V6, P244, DOI 10.1038/mi.2012.65; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100980	10.1371/journal.pone.0100980	http://dx.doi.org/10.1371/journal.pone.0100980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971453	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200078
J	Duraisingham, SS; Buckland, M; Dempster, J; Lorenzo, L; Grigoriadou, S; Longhurst, HJ				Duraisingham, Sai S.; Buckland, Matthew; Dempster, John; Lorenzo, Lorena; Grigoriadou, Sofia; Longhurst, Hilary J.			Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; INTRAVENOUS IMMUNOGLOBULIN; IMMUNE-DEFICIENCY; HYPOGAMMAGLOBULINEMIA; RITUXIMAB; MANAGEMENT; CLASSIFICATION; DIAGNOSIS; PROPHYLAXIS; DISORDERS	Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients with primary or secondary antibody deficiencies on immunoglobulin (Ig)-replacement treatment. The demographics, causes of immunodeficiency, diagnostic delay, clinical and laboratory features, and infection frequency were analysed retrospectively. Chemotherapy for B cell lymphoma and the use of Rituximab, corticosteroids or immunosuppressive medications were the most common causes of secondary antibody deficiency in this cohort. There was no difference in diagnostic delay or bronchiectasis between primary and secondary antibody deficiency patients, and both groups experienced disorders associated with immune dysregulation. Secondary antibody deficiency patients had similar baseline levels of serum IgG, but higher IgM and IgA, and a higher frequency of switched memory B cells than primary antibody deficiency patients. Serious and non-serious infections before and after Ig-replacement were also compared in both groups. Although secondary antibody deficiency patients had more serious infections before initiation of Ig-replacement, treatment resulted in a significant reduction of serious and non-serious infections in both primary and secondary antibody deficiency patients. Patients with secondary antibody deficiency experience similar delays in diagnosis as primary antibody deficiency patients and can also benefit from immunoglobulin-replacement treatment.	[Duraisingham, Sai S.; Buckland, Matthew; Dempster, John; Lorenzo, Lorena; Grigoriadou, Sofia; Longhurst, Hilary J.] Barts Hlth NHS Trust, Dept Immunol, London, England	Barts Health NHS Trust	Longhurst, HJ (corresponding author), Barts Hlth NHS Trust, Dept Immunol, London, England.	hilary.longhurst@bartshealth.nhs.uk	Buckland, Matthew/H-7049-2019	Buckland, Matthew/0000-0002-5646-4707	CSL Behring	CSL Behring	SD's salary was funded by CSL Behring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Bousfiha AA, 2013, J CLIN IMMUNOL, V33, P1078, DOI 10.1007/s10875-013-9901-6; Baris S, 2011, J INVEST ALLERG CLIN, V21, P514; Becerra E, 2012, INT J CLIN RHEUMATOL, V7, P383, DOI [DOI 10.2217/IJR.12.31, 10.2217/ijr.12.31]; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1157, DOI 10.1093/rheumatology/kem076; BLORE J, 1989, BRIT MED J, V298, P516, DOI 10.1136/bmj.298.6672.516; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Boumans MJH, 2011, ARTHRITIS RHEUM-US, V63, P3187, DOI 10.1002/art.30567; Bright P, 2013, CLIN EXP IMMUNOL, V171, P195, DOI 10.1111/cei.12010; BUNCH C, 1988, NEW ENGL J MED, V319, P902; Castigli E, 2006, J ALLERGY CLIN IMMUN, V117, P740, DOI 10.1016/j.jaci.2006.01.038; Casulo C, 2013, CL LYMPH MYELOM LEUK, V13, P106, DOI 10.1016/j.clml.2012.11.011; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; CHAPEL HM, 1994, LANCET, V343, P1059, DOI 10.1016/S0140-6736(94)90180-5; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; De La Torre I, 2012, RHEUMATOLOGY, V51, P833, DOI 10.1093/rheumatology/ker417; Duraisingham SS, 2014, EXPERT REV CLIN IMMU, V10, P583, DOI 10.1586/1744666X.2014.902314; Edgar JDM, 2014, CLIN EXP IMMUNOL, V175, P68, DOI 10.1111/cei.12172; Florescu DF, 2013, AM J TRANSPLANT, V13, P2601, DOI 10.1111/ajt.12401; Freeman JA, 2013, LEUKEMIA LYMPHOMA, V54, P99, DOI 10.3109/10428194.2012.706285; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Gathmann B, 2014, J ALLERGY C IN PRESS; GRIFFITHS H, 1992, CLIN EXP IMMUNOL, V89, P374; Gunther G, 2013, MICROBIOL IMMUNOL, V57, P527, DOI 10.1111/1348-0421.12060; Herriot R, 2008, J CLIN PATHOL, V61, P994, DOI 10.1136/jcp.2007.051177; Kawano T, 2002, INT ARCH ALLERGY IMM, V128, P240, DOI 10.1159/000064258; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Makatsori M, 2014, QJM IN PRESS; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Molica S, 1996, HAEMATOLOGICA, V81, P121; Mouthon L, 2013, CURR OPIN ALLERGY CL, V13, pS56, DOI 10.1097/01.all.0000433132.16436.b5; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; Ozaras N, 2012, SEIZURE-EUR J EPILEP, V21, P229, DOI 10.1016/j.seizure.2011.12.013; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rose ME, 2006, CLEV CLIN J MED, V73, P133, DOI 10.3949/ccjm.73.2.133; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Seymour B, 2005, J CLIN PATHOL, V58, P546, DOI 10.1136/jcp.2004.016204; Shortt J, 2006, BONE MARROW TRANSPL, V38, P433, DOI 10.1038/sj.bmt.1705463; STROBER W, 1967, J CLIN INVEST, V46, P1643, DOI 10.1172/JCI105656; Venhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037626; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC; Yomota M, 2012, INTERNAL MED, V51, P2715, DOI 10.2169/internalmedicine.51.7775	50	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100324	10.1371/journal.pone.0100324	http://dx.doi.org/10.1371/journal.pone.0100324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971644	Green Published, Green Submitted, gold			2022-12-25	WOS:000338512200025
J	Eltom, S; Dale, N; Raemdonck, KRG; Stevenson, CS; Snelgrove, RJ; Sacitharan, PK; Recchi, C; Wavre-Shapton, S; McAuley, DF; O'Kane, C; Belvisi, MG; Birrell, MA				Eltom, Suffwan; Dale, Nicole; Raemdonck, Kristof R. G.; Stevenson, Christopher S.; Snelgrove, Robert J.; Sacitharan, Pradeep K.; Recchi, Chiara; Wavre-Shapton, Silene; McAuley, Daniel F.; O'Kane, Cecilia; Belvisi, Maria G.; Birrell, Mark A.			Respiratory Infections Cause the Release of Extracellular Vesicles: Implications in Exacerbation of Asthma/COPD	PLOS ONE			English	Article							INDUCED AIRWAY INFLAMMATION; INDUCED LUNG INJURY; GLOBAL BURDEN; PULMONARY; SECRETION; SMOKE; PREVALENCE; RECEPTORS; COPD	Background: Infection-related exacerbations of respiratory diseases are a major health concern; thus understanding the mechanisms driving them is of paramount importance. Despite distinct inflammatory profiles and pathological differences, asthma and COPD share a common clinical facet: raised airway ATP levels. Furthermore, evidence is growing to suggest that infective agents can cause the release of extracellular vesicle (EVs) in vitro and in bodily fluids. ATP can evoke the P2X(7)/caspase 1 dependent release of IL-1 beta/IL-18 from EVs; these cytokines are associated with neutrophilia and are increased during exacerbations. Thus we hypothesized that respiratory infections causes the release of EVs in the airway and that the raised ATP levels, present in respiratory disease, triggers the release of IL-1b/IL-18, neutrophilia and subsequent disease exacerbations. Methods: To begin to test this hypothesis we utilised human cell-based assays, ex vivo murine BALF, in vivo pre-clinical models and human samples to test this hypothesis. Results: Data showed that in a murine model of COPD, known to have increased airway ATP levels, infective challenge causes exacerbated inflammation. Using cell-based systems, murine models and samples collected from challenged healthy subjects, we showed that infection can trigger the release of EVs. When exposed to ATP the EVs release IL-1 beta/IL-18 via a P2X(7)/caspase-dependent mechanism. Furthermore ATP challenge can cause a P2X(7) dependent increase in LPS-driven neutrophilia. Conclusions: This preliminary data suggests a possible mechanism for how infections could exacerbate respiratory diseases and may highlight a possible signalling pathway for drug discovery efforts in this area.	[Eltom, Suffwan; Dale, Nicole; Raemdonck, Kristof R. G.; Snelgrove, Robert J.; Sacitharan, Pradeep K.; Recchi, Chiara; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Stevenson, Christopher S.] Novartis, Horsham, W Sussex, England; [Wavre-Shapton, Silene] UCL, Inst Ophthalmol, London, England; [McAuley, Daniel F.; O'Kane, Cecilia] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, MRC Asthma UK Ctr Allerg Mech Asthma, London, England	Imperial College London; Novartis; University of London; University College London; Queens University Belfast; Imperial College London; University of London; King's College London	Birrell, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	m.birrell@imperial.ac.uk	Raemdonck, Kristof/Y-7125-2019; Sacitharan, Pradeep Kumar/AAA-6866-2019; Raemdonck, Kristof/K-5554-2013	Sacitharan, Pradeep Kumar/0000-0003-1487-3059; Raemdonck, Kristof/0000-0002-7073-7484; Recchi, Chiara/0000-0003-1605-0945; McAuley, Daniel/0000-0002-3283-1947; O'Kane, Cecilia/0000-0002-7138-5396	Rosetree Trust [A523]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; Rosetrees Trust [M376] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish; Public Health Agency [CDV/3778/08] Funding Source: researchfish	Rosetree Trust(Rosetrees Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Asthma UK; Public Health Agency	The Rosetree Trust helped with the funding for the Nanosight work (grant - A523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ANN RES DAY DIV PULM; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Birrell MA, 2003, RESPIR RES, V4, DOI 10.1186/rr197; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; de Kluijver J, 2003, CLIN EXP ALLERGY, V33, P1415, DOI 10.1046/j.1365-2222.2003.01770.x; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gulinelli S, 2012, EUR J IMMUNOL, P1; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haddad E, 2001, BRIT J PHARMACOL, V132, P1715, DOI 10.1038/sj.bjp.0704022; Hardaker EL, 2010, BRIT J PHARMACOL, V160, P1985, DOI 10.1111/j.1476-5381.2010.00857.x; Harris P, 2013, MUCOSAL IMMUNOL, V6, P474, DOI 10.1038/mi.2012.86; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marin A, 2012, COPD, V9, P121, DOI 10.3109/15412555.2011.636407; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; O'Byrne PM, 2009, ALLERGY ASTHMA IMMUN, V1, P3, DOI 10.4168/aair.2009.1.1.3; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Organisation WH, 2007, GLOB SURV PREV CONTR, P12; Pauwels Romain A, 2004, Proc Am Thorac Soc, V1, P73, DOI 10.1513/pats.2306024; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Polosa R, 2006, TRENDS PHARMACOL SCI, V30, P528; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Schwenkglenks M, 2003, VALUE HEALTH, V6, P75, DOI 10.1046/j.1524-4733.2003.00206.x; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8	41	29	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101087	10.1371/journal.pone.0101087	http://dx.doi.org/10.1371/journal.pone.0101087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972036	Green Published, gold, Green Submitted			2022-12-25	WOS:000338512200092
J	Suzuki, S; Suzuki, C; Hinokio, Y; Ishigaki, Y; Katagiri, H; Kanzaki, M; Azev, VN; Chakraborty, N; d'Alarcao, M				Suzuki, Susumu; Suzuki, Chitose; Hinokio, Yoshinori; Ishigaki, Yasushi; Katagiri, Hideki; Kanzaki, Makoto; Azev, Viatcheslav N.; Chakraborty, Nilanjana; d'Alarcao, Marc			Insulin-Mimicking Bioactivities of Acylated Inositol Glycans in Several Mouse Models of Diabetes with or without Obesity	PLOS ONE			English	Article							PHOSPHOLIPASE-D; RAT ADIPOCYTES; GLYCOSYL-PHOSPHATIDYLINOSITOL; SIGNAL-TRANSDUCTION; SERUM-LEVELS; GENERATION; RESISTANCE; HYDROLYSIS; DIACYLGLYCEROL; EXPRESSION	Insulin-mimetic species of low molecular weight are speculated to mediate some intracellular insulin actions. These inositol glycans, which are generated upon insulin stimulation from glycosylphosphatidylinositols, might control the activity of a multitude of insulin effector enzymes. Acylated inositol glycans (AIGs) are generated by cleavage of protein-free GPI precursors through the action of GPI-specific phospholipase C (GPI-PLC) and D (GPI-PLD). We synthesized AIGs (IG-1, IG-2, IG-13, IG-14, and IG-15) and then evaluated their insulin-mimicking bioactivities. IG-1 significantly stimulated glycogen synthesis and lipogenesis in 3T3-L1 adipocytes and rat isolated adipocytes dose-dependently. IG-2 significantly stimulated lipogenesis in rat isolated adipocytes dose-dependently. IG-15 also enhanced glycogen synthesis and lipogenesis in 3T3-L1 adipocytes. The administration of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with normal diets. The administration of IG-1 decreased plasma glucose in STZ-diabetic C57B6N mice. The treatment of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with high fat-diets and db/db mice. The long-term treatment of IG-1 decreased plasma glucose and reduced food intake and body weight in C57B6N mice with high fat-diets and ob/ob mice. Thus, IG-1 has insulin-mimicking bioactivities and improves glucose tolerance in mice models of diabetes with or without obesity.	[Suzuki, Susumu; Suzuki, Chitose; Hinokio, Yoshinori; Ishigaki, Yasushi; Katagiri, Hideki] Tohoku Univ Hosp, Dept Diabet & Metab, Sendai, Miyagi, Japan; [Suzuki, Susumu] Ohta Nishinouchi Hosp, Ctr Diabet, Koriyama, Fukushima, Japan; [Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Azev, Viatcheslav N.; Chakraborty, Nilanjana; d'Alarcao, Marc] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [d'Alarcao, Marc] San Jose State Univ, Dept Chem, San Jose, CA 95192 USA	Tohoku University; Tohoku University; Tufts University; California State University System; San Jose State University	Suzuki, S (corresponding author), Tohoku Univ Hosp, Dept Diabet & Metab, Sendai, Miyagi, Japan.	ssuzuki@med.tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017; Azev, Viatcheslav/AAQ-9663-2021	Kanzaki, Makoto/0000-0002-6884-2955; Azev, Viatcheslav/0000-0003-3275-4811; d'Alarcao, Marc/0000-0003-2057-4557	Ministry of Education, Culture, Sports, Science and Technology in Japan [21570122]; NIH [GM084819, DK082974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK082974] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S. Suzuki received financial support from the Ministry of Education, Culture, Sports, Science and Technology in Japan (#21570122). M d'Alarcao received financial support from the NIH (GM084819 and DK082974) for support of a portion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JF, 1991, BIOCHEM J, V274, P369, DOI 10.1042/bj2740369; Armesto J, 1996, EUR J BIOCHEM, V238, P259, DOI 10.1111/j.1432-1033.1996.0259q.x; Boudot C, 2002, CELL SIGNAL, V14, P869, DOI 10.1016/S0898-6568(02)00036-0; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bowen RF, 2001, METABOLISM, V50, P1489, DOI 10.1053/meta.2001.28087; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; Chakraborty N, 2005, BIOORGAN MED CHEM, V13, P6732, DOI 10.1016/j.bmc.2005.07.020; Chalasani N, 2006, J CLIN ENDOCR METAB, V91, P2279, DOI 10.1210/jc.2006-0075; Deborde S, 2003, J REPROD IMMUNOL, V59, P277, DOI 10.1016/S0165-0378(03)00054-8; Deeg MA, 2001, AM J PHYSIOL-ENDOC M, V281, pE147, DOI 10.1152/ajpendo.2001.281.1.E147; Deeg MA, 2001, J LIPID RES, V42, P442; Deeg MA, 1997, ENDOCRINOLOGY, V138, P819, DOI 10.1210/en.138.2.819; DEEG MA, 1994, BRAZ J MED BIOL RES, V27, P375; Deeg MA, 2007, TRANSL RES, V150, P153, DOI 10.1016/j.trsl.2007.03.008; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Gray DL, 2008, METABOLISM, V57, P473, DOI 10.1016/j.metabol.2007.11.007; Hecht ML, 2010, ACS CHEM BIOL, V5, P1075, DOI 10.1021/cb1002152; Jaworek CH, 1999, TETRAHEDRON LETT, V40, P667, DOI 10.1016/S0040-4039(98)02530-1; Jones DR, 1997, BIOCHEM BIOPH RES CO, V233, P432, DOI 10.1006/bbrc.1997.6475; Jones DR, 1998, INT J BIOCHEM CELL B, V30, P313, DOI 10.1016/S1357-2725(97)00144-1; Jones DR, 1999, MOL MED, V5, P505, DOI 10.1007/BF03401978; Kessler A, 1998, BIOCHEM J, V330, P277, DOI 10.1042/bj3300277; Kunjara S, 1999, MOL GENET METAB, V68, P488, DOI 10.1006/mgme.1999.2936; Kurtz TA, 2004, METABOLISM, V53, P138, DOI 10.1016/j.metabol.2003.09.004; LARNER J, 1979, SCIENCE, V206, P1408, DOI 10.1126/science.228395; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; Larner J, 1999, DIABETES REV, V7, P217; MERIDA I, 1990, P NATL ACAD SCI USA, V87, P9421, DOI 10.1073/pnas.87.23.9421; METZ CN, 1991, J BIOL CHEM, V266, P17733; MISEK DE, 1992, J BIOL CHEM, V267, P16266; Muller G, 1997, ENDOCRINOLOGY, V138, P3459, DOI 10.1210/en.138.8.3459; Muller G, 2005, BIOCHEM PHARMACOL, V69, P761, DOI 10.1016/j.bcp.2004.11.014; Muller G, 2002, ARCH BIOCHEM BIOPHYS, V408, P7, DOI 10.1016/S0003-9861(02)00450-2; Muller G, 1999, CELL MOL LIFE SCI, V56, P945, DOI 10.1007/s000180050485; Paneda C, 2001, MOL MED, V7, P454, DOI 10.1007/BF03401850; Raikwar NS, 2006, AM J PHYSIOL-ENDOC M, V290, P463, DOI 10.1152/ajpendo.00593.2004; Rhode H, 1999, CLIN CHIM ACTA, V281, P127, DOI 10.1016/S0009-8981(98)00218-6; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; RuizAlbusac JM, 1997, J NEUROCHEM, V68, P10; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; Schofield JN, 2002, MOL GENET METAB, V75, P154, DOI 10.1006/mgme.2001.3287; Schofield JN, 2000, BBA-GENE STRUCT EXPR, V1494, P189, DOI 10.1016/S0167-4781(00)00194-9; Shashkin PN, 1997, DIABETOLOGIA, V40, P557, DOI 10.1007/s001250050715; Shashkin PN, 2001, DIABETES-METAB RES, V17, P273, DOI 10.1002/dmrr.218; Sleight S, 2002, G Q 11 IS INVOLVED I; SUZUKI S, 1991, J BIOL CHEM, V266, P8115; SUZUKI S, 1993, DIABETES, V42, P988, DOI 10.2337/diabetes.42.7.988; SUZUKI S, 1992, DIABETES, V41, P1373, DOI 10.2337/diabetes.41.11.1373; Turner DI, 2005, BIOORG MED CHEM LETT, V15, P2023, DOI 10.1016/j.bmcl.2005.02.061; Yamada T, 2008, PHARMACOL THERAPEUT, V117, P188, DOI 10.1016/j.pharmthera.2007.09.006	51	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100466	10.1371/journal.pone.0100466	http://dx.doi.org/10.1371/journal.pone.0100466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971987	gold, Green Published, Green Submitted			2022-12-25	WOS:000338512200036
J	Warhurst, S; McCabe, P; Heard, R; Yiu, E; Wang, GW; Madill, C				Warhurst, Samantha; McCabe, Patricia; Heard, Rob; Yiu, Edwin; Wang, Gaowu; Madill, Catherine			Quantitative Measurement of Vocal Fold Vibration in Male Radio Performers and Healthy Controls Using High-Speed Videoendoscopy	PLOS ONE			English	Article							GLOTTAL AIR-FLOW; TERM AVERAGE SPECTRUM; OPEN QUOTIENT; SUBGLOTTAL PRESSURE; VOICE; LARYNGEAL; SPEAKERS; WAVE; SINGERS; FORM	Purpose: Acoustic and perceptual studies show a number of differences between the voices of radio performers and controls. Despite this, the vocal fold kinematics underlying these differences are largely unknown. Using high-speed videoendoscopy, this study sought to determine whether the vocal vibration features of radio performers differed from those of non-performing controls. Method: Using high-speed videoendoscopy, recordings of a mid-phonatory/i/in 16 male radio performers (aged 25-52 years) and 16 age-matched controls (aged 25-52 years) were collected. Videos were extracted and analysed semiautomatically using High-Speed Video Program, obtaining measures of fundamental frequency (f0), open quotient and speed quotient. Post-hoc analyses of sound pressure level (SPL) were also performed (n = 19). Pearson's correlations were calculated between SPL and both speed and open quotients. Results: Male radio performers had a significantly higher speed quotient than their matched controls (t = 3.308, p = 0.005). No significant differences were found for f0 or open quotient. No significant correlation was found between either open or speed quotient with SPL. Discussion: A higher speed quotient in male radio performers suggests that their vocal fold vibration was characterised by a higher ratio of glottal opening to closing times than controls. This result may explain findings of better voice quality, higher equivalent sound level and greater spectral tilt seen in previous research. Open quotient was not significantly different between groups, indicating that the durations of complete vocal fold closure were not different between the radio performers and controls. Further validation of these results is required to determine the aetiology of the higher speed quotient result and its implications for voice training and clinical management in performers.	[Warhurst, Samantha; McCabe, Patricia; Heard, Rob; Madill, Catherine] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Yiu, Edwin; Wang, Gaowu] Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China	University of Sydney; University of Hong Kong	Warhurst, S (corresponding author), Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia.	swar0066@uni.sydney.edu.au	Madill, Cate/J-6156-2017; Yiu, Edwin Man Lai/A-3201-2010; McCabe, Patricia/E-9435-2010	Madill, Cate/0000-0001-8114-1427; McCabe, Patricia/0000-0002-5182-1007	Australian Postgraduate Award; Speech Pathology Australia Postgraduate Research Grant; Deirdre Russell Memorial Scholarship	Australian Postgraduate Award(Australian Government); Speech Pathology Australia Postgraduate Research Grant; Deirdre Russell Memorial Scholarship	The first author was supported by an Australian Postgraduate Award, a Speech Pathology Australia Postgraduate Research Grant and the Deirdre Russell Memorial Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKEN RJ, 1992, J VOICE, V6, P98, DOI 10.1016/S0892-1997(05)80123-7; Baken RJ., 1998, CLIN MEASUREMENT SPE, P209; Barrichelo VMO, 2001, J VOICE, V15, P344, DOI 10.1016/S0892-1997(01)00036-4; Bele IV, 2007, J VOICE, V21, P257, DOI 10.1016/J.JVOICE.2005.12.001; Bele IV, 2006, J VOICE, V20, P555, DOI 10.1016/j.jvoice.2005.07.001; Bonilha HS, 2008, AM J SPEECH-LANG PAT, V17, P367, DOI 10.1044/1058-0360(2008/07-0059); Bonilha HS, 2009, LOGOP PHONIATR VOCO, V34, P128, DOI 10.1080/14015430903150210; Deliyski DD, 2008, FOLIA PHONIATR LOGO, V60, P33, DOI 10.1159/000111802; DROMEY C, 1992, J VOICE, V6, P44, DOI 10.1016/S0892-1997(05)80008-6; Echternach M, 2013, J ACOUST SOC AM, V133, pEL82, DOI 10.1121/1.4773200; Echternach M, 2010, J VOICE, V24, P644, DOI 10.1016/j.jvoice.2009.05.003; GAUFFIN J, 1989, J SPEECH HEAR RES, V32, P556, DOI 10.1044/jshr.3203.556; HANSON DG, 1990, J SPEECH HEAR RES, V33, P45, DOI 10.1044/jshr.3301.45; Henrich N, 2004, J ACOUST SOC AM, V115, P1321, DOI 10.1121/1.1646401; Hitech, 2008, SOUNDSW; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Inwald EC, 2011, J VOICE, V25, P576, DOI 10.1016/j.jvoice.2010.04.004; Jiang J, 2000, OTOLARYNG CLIN N AM, V33, P699, DOI 10.1016/S0030-6665(05)70238-3; Kong JP, 2011, HDB VOICE ASSESSMENT; Kunduk M, 2010, LARYNGOSCOPE, V120, P981, DOI 10.1002/lary.20832; Leino T, 2009, J VOICE, V23, P671, DOI 10.1016/j.jvoice.2008.03.008; Lohscheller J, 2007, MED IMAGE ANAL, V11, P400, DOI 10.1016/j.media.2007.04.005; Lohscheller J, 2013, LOGOP PHONIATR VOCO, V38, P182, DOI 10.3109/14015439.2012.731083; Marquardt TP, 2011, COMMUNICATION SCI DI; Master S, 2008, J VOICE, V22, P146, DOI 10.1016/j.jvoice.2006.09.006; Master S, 2013, J VOICE, V27, P187, DOI 10.1016/j.jvoice.2012.10.010; Mecke AC, 2012, J ACOUST SOC AM, V131, P435, DOI 10.1121/1.3662061; Medrado R, 2005, J VOICE, V19, P340, DOI 10.1016/j.jvoice.2004.04.008; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mehta DD, 2010, ANN OTO RHINOL LARYN, V119, P1; Murdoch BE, 1997, CLIN LINGUIST PHONET, V11, P245, DOI 10.3109/02699209708985194; Neil E., 2003, ADV SPEECH LANG PATH, V5, P1, DOI [DOI 10.1080/14417040510001669001, 10.1080/14417040510001669001]; Noh H, 2012, CLIN EXP OTORHINOLAR, V5, P68, DOI 10.3342/ceo.2012.5.2.68; Noordzij JP, 2000, ANN OTO RHINOL LARYN, V109, P441, DOI 10.1177/000348940010900501; Orlikoff RF, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.04.009; Qiu QJ, 2003, FOLIA PHONIATR LOGO, V55, P128, DOI 10.1159/000070724; Sapienza CM, 1998, J VOICE, V12, P31, DOI 10.1016/S0892-1997(98)80073-8; SLAVIT DH, 1990, OTOLARYNG HEAD NECK, V103, P947, DOI 10.1177/019459989010300611; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; SUNDBERG J, 1995, FOLIA PHONIATR LOGO, V47, P218, DOI 10.1159/000266353; Sundberg J, 1999, J ACOUST SOC AM, V105, P1965, DOI 10.1121/1.426731; Sundberg J, 2004, J VOICE, V18, P56, DOI 10.1016/j.jvoice.2003.05.006; Sundberg J, 1999, J VOICE, V13, P168, DOI 10.1016/S0892-1997(99)80021-6; SUNDBERG J, 1993, J VOICE, V7, P15, DOI 10.1016/S0892-1997(05)80108-0; Sundberg J., 1987, SCI SINGING VOICE; Svec JG, 1996, J VOICE, V10, P201, DOI 10.1016/S0892-1997(96)80047-6; TIMCKE R, 1959, ARCHIV OTOLARYNGOL, V69, P438; Titze I. R., 2000, PRINCIPLES VOICE PRO; Warhurst S, 2013, VOIC FDN 42 ANN S PH; Warhurst S, 2013, J VOICE, V27, P217, DOI 10.1016/j.jvoice.2012.08.010; Yamauchi A, 2013, J VOICE, V27, P39, DOI 10.1016/j.jvoice.2012.08.002; Yamauchi A, 2012, J VOICE, V26, P742, DOI 10.1016/j.jvoice.2011.12.010; Yan YL, 2005, J VOICE, V19, P161, DOI 10.1016/j.jvoice.2004.04.006; Yiu EML, 2013, J VOICE, V27, P753, DOI 10.1016/j.jvoice.2013.06.010; Yiu EML, 2010, INT J SPEECH-LANG PA, V12, P520, DOI 10.3109/17549501003759221; Zhang Y, 2010, J VOICE, V24, P21, DOI 10.1016/j.jvoice.2008.03.003	56	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101128	10.1371/journal.pone.0101128	http://dx.doi.org/10.1371/journal.pone.0101128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971625	Green Submitted, Green Published, gold			2022-12-25	WOS:000338512200096
J	Lynam-Lennon, N; Maher, SG; Maguire, A; Phelan, J; Muldoon, C; Reynolds, JV; O'Sullivan, J				Lynam-Lennon, Niamh; Maher, Stephen G.; Maguire, Aoife; Phelan, James; Muldoon, Cian; Reynolds, John V.; O'Sullivan, Jacintha			Altered Mitochondrial Function and Energy Metabolism Is Associated with a Radioresistant Phenotype in Oesophageal Adenocarcinoma	PLOS ONE			English	Article							HUMAN-TUMOR XENOGRAFTS; COLON-CANCER-CELLS; NEOADJUVANT CHEMORADIOTHERAPY; OXIDATIVE STRESS; PREOPERATIVE CHEMORADIOTHERAPY; GENOMIC INSTABILITY; IONIZING-RADIATION; DNA-REPAIR; EXPRESSION; EXPOSURE	Neoadjuvant chemoradiation therapy (CRT) is increasingly the standard of care for locally advanced oesophageal cancer. A complete pathological response to CRT is associated with a favourable outcome. Radiation therapy is important for local tumour control, however, radioresistance remains a substantial clinical problem. We hypothesise that alterations in mitochondrial function and energy metabolism are involved in the radioresistance of oesophageal adenocarcinoma (OAC). To investigate this, we used an established isogenic cell line model of radioresistant OAC. Radioresistant cells (OE33 R) demonstrated significantly increased levels of random mitochondrial mutations, which were coupled with alterations in mitochondrial function, size, morphology and gene expression, supporting a role for mitochondrial dysfunction in the radioresistance of this model. OE33 R cells also demonstrated altered bioenergetics, demonstrating significantly increased intracellular ATP levels, which was attributed to enhanced mitochondrial respiration. Radioresistant cells also demonstrated metabolic plasticity, efficiently switching between the glycolysis and oxidative phosphorylation energy metabolism pathways, which were accompanied by enhanced clonogenic survival. This data was supported in vivo, in pre-treatment OAC tumour tissue. Tumour ATP5B expression, a marker of oxidative phosphorylation, was significantly increased in patients who subsequently had a poor pathological response to neoadjuvant CRT. This suggests for the first time, a role for specific mitochondrial alterations and metabolic remodelling in the radioresistance of OAC.	[Lynam-Lennon, Niamh; Maher, Stephen G.; Phelan, James; Reynolds, John V.; O'Sullivan, Jacintha] Univ Dublin Trinity Coll, Dept Surg, Dublin 2, Ireland; [Maher, Stephen G.] Univ Hull, Sch Biol Biomed & Environm Sci, Canc Biol & Therapeut Lab, Kingston Upon Hull HU6 7RX, N Humberside, England; [Maguire, Aoife; Muldoon, Cian] St James Hosp, Dept Pathol, Dublin 8, Ireland	Trinity College Dublin; University of Hull; Trinity College Dublin	O'Sullivan, J (corresponding author), Univ Dublin Trinity Coll, Dept Surg, Dublin 2, Ireland.	osullij4@tcd.ie	Maher, Stephen/HHM-9099-2022	Reynolds, John V/0000-0002-5501-9521; Lynam-Lennon, Niamh/0000-0001-8659-4943; Phelan, James J./0000-0001-9431-2002; Maher, Stephen/0000-0003-0126-7906; O'Sullivan, Jacintha/0000-0001-8622-9858; Maguire, Aoife/0000-0002-9120-6383	Health Research Board [HRA_POR/2011/63]	Health Research Board	This work was supported by the Health Research Board (http://www.hrb.ie), HRA_POR/2011/63 to S. G. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Bellance N, 2009, INT J BIOCHEM CELL B, V41, P2566, DOI 10.1016/j.biocel.2009.08.012; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAUTHIER T, 1990, INT J BIOCHEM, V22, P411, DOI 10.1016/0020-711X(90)90145-S; Geh JI, 2001, BRIT J SURG, V88, P338, DOI 10.1046/j.1365-2168.2001.01670.x; Goetze K, 2013, STRAHLENTHER ONKOL, V189, P782, DOI 10.1007/s00066-013-0371-9; Gorman S, 2010, J MOL MED, V88, P701, DOI 10.1007/s00109-010-0616-3; Grishko VI, 2005, J BIOL CHEM, V280, P8901, DOI 10.1074/jbc.M413022200; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; Hunt CR, 1998, CANCER RES, V58, P3986; Ilson D H, 1997, Surg Oncol Clin N Am, V6, P723; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ito A, 2006, RADIAT RES, V165, P703, DOI 10.1667/RR3557.1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Limoli CL, 2003, CANCER RES, V63, P3107; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Luu TD, 2008, ANN THORAC SURG, V85, P1217, DOI 10.1016/j.athoracsur.2007.11.070; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Lynam-Lennon N, 2010, RADIAT RES, V174, P703, DOI 10.1667/RR2295.1; Mader S. S., 2004, BIOLOGY; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; Malakhova L, 2005, CELL MOL BIOL LETT, V10, P721; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Murphy TJ, 2008, EXPERT OPIN PHARMACO, V9, P3197, DOI 10.1517/14656560802560237 ; Nugent SME, 2007, RADIAT RES, V168, P134, DOI 10.1667/RR0769.1; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Petkau A, 1987, BR J CANC S, V8, P87; Reynolds JV, 2007, ANN SURG, V245, P707, DOI 10.1097/01.sla.0000254367.15810.38; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Swennen ELR, 2008, BIOCHEM BIOPH RES CO, V367, P383, DOI 10.1016/j.bbrc.2007.12.125; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; WARBURG O, 1956, Oncologia, V9, P75; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Zastawny TH, 1998, FREE RADICAL BIO MED, V24, P722, DOI 10.1016/S0891-5849(97)00331-6; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	47	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100738	10.1371/journal.pone.0100738	http://dx.doi.org/10.1371/journal.pone.0100738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968221	Green Published, gold, Green Submitted			2022-12-25	WOS:000338280800061
J	Aggarwal, R; Subramanyam, S; Zhao, CY; Chen, MS; Harris, MO; Stuart, JJ				Aggarwal, Rajat; Subramanyam, Subhashree; Zhao, Chaoyang; Chen, Ming-Shun; Harris, Marion O.; Stuart, Jeff J.			Avirulence Effector Discovery in a Plant Galling and Plant Parasitic Arthropod, the Hessian Fly (Mayetiola destructor)	PLOS ONE			English	Article							RESISTANCE GENE H13; NEMATODE RESISTANCE; DISEASE RESISTANCE; ADAPTIVE RADIATION; SALIVARY-GLANDS; PROTEINS; APHID; DEFENSE; TOMATO; MIDGES	Highly specialized obligate plant-parasites exist within several groups of arthropods (insects and mites). Many of these are important pests, but the molecular basis of their parasitism and its evolution are poorly understood. One hypothesis is that plant parasitic arthropods use effector proteins to defeat basal plant immunity and modulate plant growth. Because avirulence (Avr) gene discovery is a reliable method of effector identification, we tested this hypothesis using high-resolution molecular genetic mapping of an Avr gene (vH13) in the Hessian fly (HF, Mayetiola destructor), an important gall midge pest of wheat (Triticum spp.). Chromosome walking resolved the position of vH13, and revealed alleles that determine whether HF larvae are virulent (survive) or avirulent (die) on wheat seedlings carrying the wheat H13 resistance gene. Association mapping found three independent insertions in vH13 that appear to be responsible for H13-virulence in field populations. We observed vH13 transcription in H13-avirulent larvae and the salivary glands of H13-avirulent larvae, but not in H13-virulent larvae. RNA-interference-knockdown of vH13 transcripts allowed some H13-avirulent larvae to escape H13-directed resistance. vH13 is the first Avr gene identified in an arthropod. It encodes a small modular protein with no sequence similarities to other proteins in GenBank. These data clearly support the hypothesis that an effector-based strategy has evolved in multiple lineages of plant parasites, including arthropods.	[Aggarwal, Rajat; Zhao, Chaoyang; Stuart, Jeff J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Subramanyam, Subhashree] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Harris, Marion O.] N Dakota State Univ, Dept Entomol, Fargo, ND 58105 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; North Dakota State University Fargo	Stuart, JJ (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	stuartjj@purdue.edu		Zhao, Chaoyang/0000-0003-3378-3163; Harris, Marion/0000-0002-1123-8079	Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture [09-35302-05262]	Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture	This work was supported by grant No. 09-35302-05262 from the Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture (to J.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-293; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023170; Behura SK, 2004, GENETICS, V167, P343, DOI 10.1534/genetics.167.1.343; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Biradar SK, 2004, THEOR APPL GENET, V109, P1468, DOI 10.1007/s00122-004-1763-0; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen MS, 2008, J INSECT PHYSIOL, V54, P1, DOI 10.1016/j.jinsphys.2007.07.007; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Gagne RJ, 1994, GALL MIDGES NEOTROPI; GILL BS, 1987, J HERED, V78, P97, DOI 10.1093/oxfordjournals.jhered.a110344; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Harris MO, 2010, PHYTOPATHOLOGY, V100, P279, DOI 10.1094/PHYTO-100-3-0279; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; Harris MO, 2003, ANNU REV ENTOMOL, V48, P549, DOI 10.1146/annurev.ento.48.091801.112559; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joy JB, 2007, EVOLUTION, V61, P784, DOI 10.1111/j.1558-5646.2007.00069.x; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Liu XM, 2005, THEOR APPL GENET, V111, P1308, DOI 10.1007/s00122-005-0059-3; Liu XM, 2005, THEOR APPL GENET, V111, P243, DOI 10.1007/s00122-005-2009-5; Lobo NF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-7; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; PATTERSON FL, 1994, CROP SCI, V34, P315, DOI 10.2135/cropsci1994.0011183X003400010084x; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Price PW, 2005, BASIC APPL ECOL, V6, P413, DOI 10.1016/j.baae.2005.07.002; Richards S, 2011, HESSIAN FLY BASE; Rider SD, 2002, GENOME, V45, P812, DOI [10.1139/G02-047, 10.1139/g02-047]; Rodriguez PA, 2013, MOL PLANT MICROBE IN, V26, P25, DOI 10.1094/MPMI-05-12-0119-FI; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Roskam HC, 2005, BIOL ECOLOGY EVOLUTI, P307; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stuart JJ, 2012, ANNU REV PHYTOPATHOL, V50, P339, DOI 10.1146/annurev-phyto-072910-095255; Stuart Jeffrey J., 2008, V1, P93, DOI 10.1007/978-3-540-73833-6_7; Subramanyam S, 2006, PLANT SCI, V170, P90, DOI 10.1016/j.plantsci.2005.08.006; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	48	49	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100958	10.1371/journal.pone.0100958	http://dx.doi.org/10.1371/journal.pone.0100958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964065	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500105
J	Fremier, AK; Girvetz, EH; Greco, SE; Larsen, EW				Fremier, Alexander K.; Girvetz, Evan H.; Greco, Steven E.; Larsen, Eric W.			Quantifying Process-Based Mitigation Strategies in Historical Context: Separating Multiple Cumulative Effects on River Meander Migration	PLOS ONE			English	Article							SACRAMENTO RIVER; RIPARIAN FOREST; BANK EROSION; CALIFORNIA; USA; ECOSYSTEMS; IMPACTS; CONSERVATION; RESTORATION; COMMUNITIES	Environmental legislation in the US (i.e. NEPA) requires defining baseline conditions on current rather than historical ecosystem conditions. For ecosystems with long histories of multiple environmental impacts, this baseline method can subsequently lead to a significantly altered environment; this has been termed a 'sliding baseline'. In river systems, cumulative effects caused by flow regulation, channel revetment and riparian vegetation removal significantly impact floodplain ecosystems by altering channel dynamics and precluding subsequent ecosystem processes, such as primary succession. To quantify these impacts on floodplain development processes, we used a model of river channel meander migration to illustrate the degree to which flow regulation and riprap impact migration rates, independently and synergistically, on the Sacramento River in California, USA. From pre-dam conditions, the cumulative effect of flow regulation alone on channel migration is a reduction by 38%, and 42-44% with four proposed water diversion project scenarios. In terms of depositional area, the proposed water project would reduce channel migration 51-71 ha in 130 years without current riprap in place, and 17-25 ha with riprap. Our results illustrate the utility of a modeling approach for quantifying cumulative impacts. Model-based quantification of environmental impacts allow scientists to separate cumulative and synergistic effects to analytically define mitigation measures. Additionally, by selecting an ecosystem process that is affected by multiple impacts, it is possible to consider process-based mitigation scenarios, such as the removal of riprap, to allow meander migration and create new floodplains and allow for riparian vegetation recruitment.	[Fremier, Alexander K.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Girvetz, Evan H.] Ctr Int Agr Trop, Nairobi, Kenya; [Girvetz, Evan H.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Greco, Steven E.; Larsen, Eric W.] Univ Calif Davis, Dept Human Ecol, Davis, CA 95616 USA	Washington State University; Alliance; International Center for Tropical Agriculture - CIAT; University of Washington; University of Washington Seattle; University of California System; University of California Davis	Fremier, AK (corresponding author), Washington State Univ, Sch Environm, Pullman, WA 99164 USA.	alex.fremier@wsu.edu	, Steve/AAT-4120-2020; Fremier, Alexander/AAC-7706-2019	Fremier, Alexander/0000-0002-4104-6633	California Department of Water Resources (CDWR); Northern District, Red Bluff, California; CDWR Planning and Local Assistance Office, Sacramento, California [4600001950, 4600000736]	California Department of Water Resources (CDWR); Northern District, Red Bluff, California; CDWR Planning and Local Assistance Office, Sacramento, California	The authors are grateful for funding for this research that was provided by the California Department of Water Resources (CDWR), Northern District, Red Bluff, California, and the CDWR Planning and Local Assistance Office, Sacramento, California, under Interagency Agreements #4600001950 and #4600000736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER WL, 1995, ANN ASSOC AM GEOGR, V85, P320, DOI 10.1111/j.1467-8306.1995.tb01797.x; BEDFORD BL, 1988, ENVIRON MANAGE, V12, P751, DOI 10.1007/BF01867550; Brice J. C., 1977, LATERAL MIGRATION MI, P77; *CALFED, 2000, FIN PROGR ENV IMP ST; *CDWR, 2005, MEM REP BANK SURV RE; CDWR, 1995, 155 CDWR RES AG; CEQ (Council on Enviromental Quality), 1997, HDB NATL; CEQ (Council on Enviromental Quality), 2019, NEPA NAT ENV POL ACT; CHURCH M, 1995, REGUL RIVER, V11, P3, DOI 10.1002/rrr.3450110103; Constantine JA, 2008, GEOLOGY, V36, P23, DOI 10.1130/G24130A.1; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Duinker PN, 2007, ENVIRON IMPACT ASSES, V27, P206, DOI 10.1016/j.eiar.2006.11.001; Florsheim JL, 2008, BIOSCIENCE, V58, P519, DOI 10.1641/B580608; GOSSELINK JG, 1990, BIOSCIENCE, V40, P588, DOI 10.2307/1311299; Greco DE, 2003, LANDSCAPE RES, V28, P405; Greco SE, 2013, RIVER RES APPL, V29, P707, DOI 10.1002/rra.2568; Greco SE, 2007, LANDSCAPE URBAN PLAN, V81, P354, DOI 10.1016/j.landurbplan.2007.01.002; Hughes FMR, 2001, REGUL RIVER, V17, P325, DOI 10.1002/rrr.656; HUNSAKER CT, 1993, ENVIRONMENTAL ANALYSIS, P480; Johanesson H, 1989, RIVER MEANDERING; Katibah E.F., 1984, CALIFORNIA RIPARIAN, P23; Larsen EW, 2007, LANDSCAPE URBAN PLAN, V79, P338, DOI 10.1016/j.landurbplan.2006.04.003; Larsen EW, 2006, J AM WATER RESOUR AS, V42, P1077, DOI 10.1111/j.1752-1688.2006.tb04515.x; Larsen EW, 2006, J AM WATER RESOUR AS, V42, P1063, DOI 10.1111/j.1752-1688.2006.tb04514.x; Larsen EW, 2006, ENVIRON MANAGE, V37, P880, DOI 10.1007/s00267-004-0220-9; Larsen EW, 2002, ENVIRON MANAGE, V30, P209, DOI 10.1007/s00267-002-2663-1; MacDonald LH, 2000, ENVIRON MANAGE, V26, P299, DOI 10.1007/s002670010088; Mahoney JM, 1998, WETLANDS, V18, P634, DOI 10.1007/BF03161678; McCold LN, 1996, ENVIRON MANAGE, V20, P767, DOI 10.1007/BF01204147; Michalkova M, 2011, EARTH SURF PROC LAND, V36, P257, DOI 10.1002/esp.2106; Micheli ER, 2011, RIVER RES APPL, V27, P328, DOI 10.1002/rra.1360; Micheli ER, 2004, RIVER RES APPL, V20, P537, DOI 10.1002/rra.756; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perucca E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005234; Pickett STA, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P101; Shields FD, 2000, ENVIRON CONSERV, V27, P54, DOI 10.1017/S0376892900000072; Shin N, 2005, PLANT ECOL, V178, P15, DOI 10.1007/s11258-004-2484-9; Stella J, 2011, ECOSYSTEMS, V14, P776, DOI 10.1007/s10021-011-9446-6; United States Army Corps of Engineers (USACE), 2002, SACR SAN JOAQ RIV BA	41	9	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99736	10.1371/journal.pone.0099736	http://dx.doi.org/10.1371/journal.pone.0099736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964145	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500016
J	Guzman-Moreno, J; Flores-Martinez, A; Brieba, LG; Herrera-Estrella, A				Guzman-Moreno, Jesus; Flores-Martinez, Alberto; Brieba, Luis G.; Herrera-Estrella, Alfredo			The Trichoderma reesei Cry1 Protein Is a Member of the Cryptochrome/Photolyase Family with 6-4 Photoproduct Repair Activity	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; DNA-REPAIR; CRYSTAL-STRUCTURE; PHOTOLYASE/CRYPTOCHROME FAMILY; PHOTOLYASE; GENE; DASH; TRANSCRIPTION; ATROVIRIDE; HISTIDINES	DNA-photolyases use UV-visible light to repair DNA damage caused by UV radiation. The two major types of DNA damage are cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts (6-4PP), which are repaired under illumination by CPD and 6-4 photolyases, respectively. Cryptochromes are proteins related to DNA photolyases with strongly reduced or lost DNA repair activity, and have been shown to function as blue-light photoreceptors and to play important roles in circadian rhythms in plants and animals. Both photolyases and cryptochromes belong to the cryptochrome/photolyase family, and are widely distributed in all organisms. Here we describe the characterization of cry1, a member of the cryptochrome/photolyase protein family of the filamentous fungus Trichoderma reesei. We determined that cry1 transcript accumulates when the fungus is exposed to light, and that such accumulation depends on the photoreceptor Blr1 and is modulated by Envoy. Conidia of cry1 mutants show decreased photorepair capacity of DNA damage caused by UV light. In contrast, strains over-expressing Cry1 show increased repair, as compared to the parental strain even in the dark. These observations suggest that Cry1 may be stimulating other systems involved in DNA repair, such as the nucleotide excision repair system. We show that Cry1, heterologously expressed and purified from E. coli, is capable of binding to undamaged and 6-4PP damaged DNA. Photorepair assays in vitro clearly show that Cry1 repairs 6-4PP, but not CPD and Dewar DNA lesions.	[Guzman-Moreno, Jesus; Flores-Martinez, Alberto] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico; [Brieba, Luis G.; Herrera-Estrella, Alfredo] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	Universidad de Guanajuato; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Herrera-Estrella, A (corresponding author), Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	aherrera@langebio.cinvestav.mx	Brieba, Luis/I-8447-2016; Herrera-Estrella, Alfredo/F-3185-2011; Herrera-Estrella, Alfredo/J-8210-2019	Brieba, Luis/0000-0002-6073-5207; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Guzman-Moreno, Jesus/0000-0003-0237-6493	Consejo Nacional de Ciencia y Tecnologia [83798, I0110/193/10 FON.INST.-30-10]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funder of this work, Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) grant 83798 and I0110/193/10 FON.INST.-30-10 to AH-E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; Bayram O, 2008, MOL BIOL CELL, V19, P3254, DOI 10.1091/mbc.E08-01-0061; Berrocal-Tito G, 1999, J BIOL CHEM, V274, P14288, DOI 10.1074/jbc.274.20.14288; Berrocal-Tito GM, 2007, EUKARYOT CELL, V6, P1682, DOI 10.1128/EC.00208-06; Bluhm BH, 2008, FUNGAL GENET BIOL, V45, P1364, DOI 10.1016/j.fgb.2008.07.005; Casas-Flores S, 2006, EUKARYOT CELL, V5, P499, DOI 10.1128/EC.5.3.499-506.2006; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Casas-Flores S, 2013, TRICHODERMA: BIOLOGY AND APPLICATIONS, P43, DOI 10.1079/9781780642475.0043; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Esquivel-Naranjo EU, 2007, MICROBIOL-SGM, V153, P3909, DOI 10.1099/mic.0.2007/007302-0; Froehlich AC, 2010, EUKARYOT CELL, V9, P738, DOI 10.1128/EC.00380-09; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rosales-Saavedra T, 2006, MICROBIOL-SGM, V152, P3305, DOI 10.1099/mic.0.29000-0; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SANCAR GB, 1989, MOL CELL BIOL, V9, P4767, DOI 10.1128/MCB.9.11.4767; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schmoll M, 2010, FUNGAL GENET BIOL, V47, P909, DOI 10.1016/j.fgb.2010.04.010; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110; Zhang FW, 2011, CURR MICROBIOL, V62, P146, DOI 10.1007/s00284-010-9687-1; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s	54	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100625	10.1371/journal.pone.0100625	http://dx.doi.org/10.1371/journal.pone.0100625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964051	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500069
J	Chen, JQ; Shi, Y; Regan, J; Karuppaiah, K; Ornitz, DM; Long, FX				Chen, Jianquan; Shi, Yu; Regan, Jenna; Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin			Osx-Cre Targets Multiple Cell Types besides Osteoblast Lineage in Postnatal Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; OSTERIX; MOUSE; DIFFERENTIATION; MAINTENANCE; ACTIVATION; HEDGEHOG; ROLES	Osterix (Osx or Sp7) is a zinc-finger-family transcriptional factor essential for osteoblast differentiation in mammals. The Osx-Cre mouse line (also known as Osx1-GFP:: Cre) expresses GFP:: Cre fusion protein from a BAC transgene containing the Osx regulatory sequence. The mouse strain was initially characterized during embryogenesis, and found to target mainly osteoblast-lineage cells. Because the strain has been increasingly used in postnatal studies, it is important to evaluate its targeting specificity in mice after birth. By crossing the Osx-Cre mouse with the R26-mT/mG reporter line and analyzing the progenies at two months of age, we find that Osx-Cre targets not only osteoblasts, osteocytes and hypertrophic chondrocytes as expected, but also stromal cells, adipocytes and perivascular cells in the bone marrow. The targeting of adipocytes and perivascular cells appears to be specific to those residing within the bone marrow, as the same cell types elsewhere are not targeted. Beyond the skeleton, Osx-Cre also targets the olfactory glomerular cells, and a subset of the gastric and intestinal epithelium. Thus, potential contributions from the non-osteoblast-lineage cells should be considered when Osx-Cre is used to study gene functions in postnatal mice.	[Chen, Jianquan; Shi, Yu; Regan, Jenna; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	longf@wudosis.wustl.edu	Shi, Yu/J-5370-2018	Regan, Jenna/0000-0002-6698-3340; Chen, Jianping/0000-0001-5685-8581; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [DK065789, AR055923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work is funded by National Institutes of Health grants DK065789 and AR055923 to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055134; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, DEV CELL, V19, P329; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Park JS, 2011, BIOCHEM BIOPH RES CO, V407, P842, DOI 10.1016/j.bbrc.2011.03.129; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	255	264	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85161	10.1371/journal.pone.0085161	http://dx.doi.org/10.1371/journal.pone.0085161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24971451	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100058
J	Feng, Q; Zhang, QL; Du, Y; Ye, YL; He, QQ				Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang			Associations of Physical Activity, Screen Time with Depression, Anxiety and Sleep Quality among Chinese College Freshmen	PLOS ONE			English	Article							MENTAL-HEALTH; SEDENTARY BEHAVIOR; EXERCISE; ADOLESCENTS; CHILDREN; STUDENTS; TELEVISION; INSTRUMENT; DISORDERS; AVENA	Objectives: To investigate the independent and interactive associations of physical activity (PA) and screen time (ST) with depression, anxiety and sleep quality among Chinese college students. Methods: A cross-sectional study was conducted in Wuhan University, China from November to December 2011. The students reported their PA, ST and socio-economic characteristics using self-administered questionnaires. Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI). Depression and anxiety were assessed using the Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS), respectively. Multivariate logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the independent and interactive relationships of PA and ST with depression, anxiety and sleep quality. Results: A total of 1106 freshmen (471 females and 635 males) aged 18.9 +/- 0.9 years were included in the study. After adjustment for potential confounders, high PA and low ST were independently associated with significantly lower risks for poor sleep quality (OR: 0.48, 95% CI: 0.30-0.78) and depression (OR: 0.67, 95% CI: 0.44-0.89), respectively. An interactive inverse association was observed for combined effects of PA and low ST on depression (OR: 0.62, 95% CI: 0.40-0.92) and sleep quality (OR: 0.51, 95% CI: 0.27-0.91). No statistically significant associations were found between PA, ST and anxiety among the participants. Conclusions: These findings suggest an independent and interactive relationship of high PA and low ST with significantly reduced prevalence of depressive problems and favorable sleep quality among Chinese college freshmen.	[Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012	FENG, QI/0000-0001-9323-9421	Fundamental Research Funds for the Central Universities [2012GSP101]; National Undergraduate Innovative Research Training Program of Wuhan University [201310486083]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Undergraduate Innovative Research Training Program of Wuhan University	This study is a social science research project at Wuhan University, supported by the Fundamental Research Funds for the Central Universities (No. 2012GSP101) and National Undergraduate Innovative Research Training Program of Wuhan University (No. 201310486083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buckworth J, 2004, J AM COLL HEALTH, V53, P28, DOI 10.3200/JACH.53.1.28-34; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Carney CE, 2006, CHRONOBIOL INT, V23, P623, DOI 10.1080/07420520600650695; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Kalak N, 2012, J ADOLESCENT HEALTH, V51, P615, DOI 10.1016/j.jadohealth.2012.02.020; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lemma S, 2012, SLEEP DISORD, V2012; Li XZ, 2005, ZHONGGUO LINCHUANG K, V8, P20; Liu XC, 1995, CHINESE J PSYCHIAT, p[2, 102]; Martinez-Gomez D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-274; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Pearsall R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-117; Peng H, 2013, SHANGHAI MED PHARM J, V14, P20, DOI [10.3969/j.issn.1006-1533.2013.14.011, DOI 10.3969/J.ISSN.1006-1533.2013.14.011]; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Sloan RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-885; Stein C, 2007, J ADOLESCENT HEALTH, V40; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tao M., 1994, CHIN J NERV MENT DIS, V5, P301; Torsheim T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-324; van Berkel J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-558; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Xie CJ, 2007, CHINESE J PUBLIC HLT, V5, P42; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Youngstedt SD, 2003, PHYSIOL BEHAV, V78, P395, DOI 10.1016/S0031-9384(03)00004-0; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	39	121	128	8	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100914	10.1371/journal.pone.0100914	http://dx.doi.org/10.1371/journal.pone.0100914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964250	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500098
